PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Siopi, E; Calabria, S; Plotkine, M; Marchand-Leroux, C; Jafarian-Tehrani, M				Siopi, Eleni; Calabria, Silvia; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz			Minocycline Restores Olfactory Bulb Volume and Olfactory Behavior after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						minocycline; neuroprotection; olfactory avoidance test; olfactory bulb lesion; traumatic brain injury	POSTTRAUMATIC ANOSMIA; HEAD TRAUMA; MICROGLIAL ACTIVATION; STEROID TREATMENT; DYSFUNCTION; INFLAMMATION; SMELL; NEUROGENESIS; INFORMATION; MECHANISMS	Permanent olfactory dysfunction can often arise after traumatic brain injury (TBI) and while one of the main causes is the immediate loss of neurons in the olfactory bulb (OB), the emergent neuroinflammatory environment following TBI may further promote OB deterioration. Therefore, we examined the effects of acute antiinflammatory treatment with minocycline on post-TBI olfactory behavior and on OB surface. The mouse model of closed-head injury by mechanical percussion was applied to anesthetized Swiss mice. The treatment protocol included three injections of minocycline (i.p.) at 5 min (90 mg/kg), 3 h, and 9 h (45 mg/kg) post-TBI. An olfactory avoidance test was run up to 12 weeks post-TBI. The mice were then sacrificed and their OB surface was measured. Our results demonstrated a post-TBI olfactory behavior deficit that was significant up to at least 12 weeks post-TBI. Additionally, substantial post-TBI OB atrophy was observed that was strongly correlated with the behavioral impairment. Minocycline was able to attenuate both the olfactory lesions and corresponding functional deficit in the short and long term. These results emphasize the potential role of minocycline as a promising neuroprotective agent for the treatment of TBI-related olfactory bulb lesions and deficits.	[Siopi, Eleni; Calabria, Silvia; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale EA 4475, F-75006 Paris, France	Jafarian-Tehrani, M (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale EA 4475, Sorbonne Paris Cite,4 Ave Observ, F-75006 Paris, France.	mehrnaz.jafarian@parisdescartes.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856	nonprofit organization Fondation des Gueules Cassees	This work was supported by the nonprofit organization Fondation des Gueules Cassees (grants to E.S. and M.J.T.).	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Collet S, 2009, B-ENT, P97; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; Doty RL, 1997, NEW ENGL J MED, V336, P1918, DOI 10.1056/NEJM199706263362617; Drummond M., 2007, BRAIN IMPAIR, V8, P31; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hebb ALO, 2002, NEUROPSYCHOPHARMACOL, V27, P744, DOI 10.1016/S0893-133X(02)00354-8; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Ikeda K, 1995, TOHOKU J EXP MED, V177, P343, DOI 10.1620/tjem.177.343; Jiang RS, 2010, EUR ARCH OTO-RHINO-L, V267, P1563, DOI 10.1007/s00405-010-1240-0; Jimenez D F, 1997, J Craniomaxillofac Trauma, V3, P8; Joung YI, 2007, J KOREAN NEUROSURG S, V42, P1; Kang HM, 2010, NEUROREPORT, V21, P179, DOI 10.1097/WNR.0b013e328334884c; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; LEGG JW, 1873, LANCET, V2, P659, DOI DOI 10.1016/S0140-6736(02)66313-5; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; Mucignat-Caretta C, 2004, NEUROBIOL DIS, V16, P386, DOI 10.1016/j.nbd.2004.03.007; Mucignat-Caretta C, 2006, PHYSIOL BEHAV, V89, P637, DOI 10.1016/j.physbeh.2006.08.003; NYBY J, 1985, J COMP PSYCHOL, V99, P479, DOI 10.1037/0735-7036.99.4.479; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Ongle W., 1870, MED CHIR T, V53, P263; Prediger R.D., 2011, J NEURAL TRANSM; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; SLOTNICK BM, 1977, J COMP PHYSIOL PSYCH, V91, P942, DOI 10.1037/h0077370; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wachowiak M, 2009, ANN NY ACAD SCI, V1170, P286, DOI 10.1111/j.1749-6632.2009.04015.x; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	54	30	31	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					354	361		10.1089/neu.2011.2055			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300014	21910642				2021-06-18	
J	Ketchum, JM; Getachew, MA; Krch, D; Banos, JH; Kolakowsky-Hayner, SA; Lequerica, A; Jamison, L; Arango-Lasprilla, JC				Ketchum, Jessica M.; Getachew, Mimi Almaz; Krch, Denise; Banos, James H.; Kolakowsky-Hayner, Stephanie A.; Lequerica, Anthony; Jamison, Laura; Arango-Lasprilla, Juan Carlos			Early predictors of employment outcomes 1 year post traumatic brain injury in a population of Hispanic individuals	NEUROREHABILITATION			English	Article						Employment; traumatic brain injury; hispanics	RACIAL-DIFFERENCES; RETURN; WORK; REHABILITATION; STABILITY; MODERATE; HEALTH; TBI	Objective: To determine which demographic, injury, and rehabilitation factors are associated with employment rates in Hispanic individuals 1 year post traumatic brain injury (TBI). Design: Retrospective study. Setting: Longitudinal dataset of the TBI Model Systems National Database. Participants: 418 Hispanic individuals with TBI hospitalized between 1990 and 2009 having year 1 follow-up data (18-55 years and not retired at injury). Main outcome measure: Competitive employment status 1 year post-injury (yes/no). Results: A multiple logistic regression model indicated that pre-injury employment status, pre-injury level of education, etiology, days of posttraumatic amnesia (PTA), associated spinal cord injury, Functional Independence Measure (FIM) motor at rehabilitation discharge, and length of stay in rehabilitation were significant predictors of competitive employment post-injury, controlling for the effects of each other (all p-values <= 0.014). Increases in the odds of not being employed post-injury were associated with not being employed pre-injury, having lower levels of education pre-injury, etiologies due to violence or falls, increased PTA, an associated spinal cord injury, lower FIM motor scores, and greater lengths of stay in rehabilitation. Conclusions: The first year post-TBI is critical for recovery and gainful employment, particularly for Hispanic individuals. Early identification of factors influencing successful gainful employment and expeditious implementation of services to ameliorate these issues are paramount in improving employment outcomes for Hispanic individuals with TBI.	[Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Krch, Denise; Lequerica, Anthony] Kessler Fdn Res Ctr, W Orange, NJ USA; [Banos, James H.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Kolakowsky-Hayner, Stephanie A.; Jamison, Laura] Santa Clara Valley Med Ctr, Rehabil Res Ctr, Santa Clara, CA USA; [Krch, Denise; Lequerica, Anthony] UMDNJ New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA	Ketchum, JM (corresponding author), Virginia Commonwealth Univ, Dept Biostat, POB 980032, Richmond, VA 23298 USA.	McKinneyJL@vcu.edu	Ketchum, Jessica/AAE-8200-2020; Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Ketchum, Jessica/0000-0002-5566-3691	National Institute of Disability and Rehabilitation Research (NIDRR), United States Department of Education [H133A070036, H133A07009, H133A080060]; Department of Education, NIDRR [H133P090009]	This work was supported by the National Institute of Disability and Rehabilitation Research (NIDRR), United States Department of Education (Grants: H133A070036, H133A07009, H133A080060).; The contents of this article were developed partially under a grant from the Department of Education, NIDRR grant number H133P090009. However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Arango J. C., 2011, PM R J INJURY UNPUB; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Deutsch PM, 2006, NEUROREHABILITATION, V21, P305; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Heckman JJ, 2001, J POLIT ECON, V109, P673, DOI 10.1086/322086; Holtslag H. R., 2001, CLIN REHABIL, V21, P373; Hosmer D. W., 2010, APPL LOGICAL REGRESS; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Ostrosky-Solis F, 1998, ARCH CLIN NEUROPSYCH, V13, P645, DOI 10.1016/S0887-6177(97)00094-2; Parks Jennifer K, 2010, Proc (Bayl Univ Med Cent), V23, P355; Ramirez R. R., 2002, HISPANIC POPULATION; Riddell WC, 2011, LABOUR ECON, V18, P453, DOI 10.1016/j.labeco.2011.01.003; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1999, BRAIN INJURY, V13, P973; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Strully K, 2009, SOC SCI MED, V69, P768, DOI 10.1016/j.socscimed.2009.06.025; [United States Department of Labor Bureau of Labor Statistics], EMPL PROJ ED PAYS; [United States Department of Labor Bureau of Labor Statistics], PERS DIS LAB FORC CH; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wilson KB, 2005, J COUNS DEV, V83, P86, DOI 10.1002/j.1556-6678.2005.tb00583.x	49	30	30	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	1					13	22		10.3233/NRE-2011-0723			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	904ZT	WOS:000301240900003	22349838				2021-06-18	
J	Loughran, T				Loughran, Tracey			Shell Shock, Trauma, and the First World War: The Making of a Diagnosis and Its Histories	JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES			English	Article						shell shock; trauma; First World War; post-traumatic stress disorder; psychology; psychiatry	BRAIN-INJURY	During the First World War, thousands of soldiers were treated for "shell shock," a condition which encompassed a range of physical and psychological symptoms. Shell shock has most often been located within a "genealogy of trauma," and identified as an important marker in the gradual recognition of the psychological afflictions caused by combat. In recent years, shell shock has increasingly been viewed as a powerful emblem of the suffering of war. This article, which focuses on Britain, extends scholarly analyses which question characterizations of shell shock as an early form of post-traumatic stress disorder. It also considers some of the methodological problems raised by recasting shell shock as a wartime medical construction rather than an essentially timeless manifestation of trauma. It argues that shell shock must be analyzed as a diagnosis shaped by a specific set of contemporary concerns, knowledges, and practices. Such an analysis challenges accepted understandings of what shell shock "meant" in the First World War, and also offers new perspectives on the role of shell shock in shaping the emergence of psychology and psychiatry in the early part of the twentieth century. The article also considers what relation, if any, might exist between intellectual and other histories, literary approaches, and perceptions of trauma as timeless and unchanging.	Cardiff Univ, Cardiff CF10 3EU, S Glam, Wales	Loughran, T (corresponding author), Cardiff Univ, Humanities Bldg,Colum Dr, Cardiff CF10 3EU, S Glam, Wales.	loughrantl@cardiff.ac.uk			Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [PTA 026-27-1613]; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/F015003/1] Funding Source: researchfish	I gratefully acknowledge the support of the Economic and Social Research Council (PTA 026-27-1613).	*AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P463; [Anonymous], 1896, KINGS COLL HOSP MED; [Anonymous], 2009, DAILY TELEGRAPH 1109; [Anonymous], 1922, REPORT WAR OFFICE CO, P119; [Anonymous], 1914, LANCET, V2, P802; [Anonymous], 1917, MED WORLD, V9, P173; Armstrong-Jones R., 1917, J STATE MED, V25, P289; Armstrong-Jones Robert, 1917, J STATE MED, V25, P290; Binneveld Hans, 1997, SHELL SHOCK COMBAT S, P106; Bond Brian, 2002, UNQUIET W FRONT BRIT, p[vii, 88]; Bourke Joanna, 1996, DISMEMBERING MALE ME, P108; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bury JS, 1918, LANCET, V2, P97; Bury Judson Sykes, 1918, LANCET, V2, P98; Campbell H., 1916, PRACTITIONER, V96, P501; Campbell Harry, 1916, PRACTITIONER, V96, P503; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Das Santanu, 2006, TOUCH INTIMACY 1 WOR; Eager R, 1918, Br Med J, V1, P422; Eager Richard, 1918, BMJ-BRIT MED J, V1, P425; Elliott Thomas, REPORT WAR OFFICE CO, p[29, 71]; Elliott TR, 1914, BRIT MED J, V1914, P1005, DOI 10.1136/bmj.2.2815.1005; Flood Alison, 2009, GUARDIAN        1109; FUSSELL P, 1975, GREAT WAR MODERN MEM, P3; Hacking I, 1994, CAUSAL COGNITION MUL, P351; Hacking I., 1986, RECONSTRUCTING INDIV, P222; Holmes Richard, 2005, TOMMY BRIT SOLDIER W, P485; Hunter P. D., 1919, PRACTITIONER, V103, P343; Hurst AF, 1917, BRIT MED J, V1917, P409, DOI 10.1136/bmj.2.2961.409; Hurst Arthur, 1917, BMJ-BRIT MED J, V2, P413; Hynes Samuel, 1991, WAR IMAGINED 1 WORLD, P27; Ismail Sharif, 2005, Psychoanal Hist, V7, P171, DOI 10.3366/pah.2005.7.2.171; Ismail Sharif, 2005, PSYCHOANAL HIST, V7, P181; Johnson W, 1919, BMJ-BRIT MED J, V1919, P335, DOI 10.1136/bmj.1.3038.335; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones Edgar, 2005, SHELL SHOCK PTSD MIL, P30; Jordanova L, 1995, SOC HIST MED, V8, P361, DOI 10.1093/shm/8.3.361; Leese Peter, 2002, SHELL SHOCK TRAUMATI, P1; Loughran T., 2007, MANCHESTER PAPERS EC, V58, P2; Loughran T., 2007, MANCHESTER PAPERS EC, V58, P1; Loughran T, 2009, SOC HIST MED, V22, P79, DOI 10.1093/shm/hkn093; Loughran Tracey, 2006, THESIS U LONDON, P141; Loughran Tracey, 2007, MANCHESTER PAPERS EC, V58, P7; Merskey H., 1991, 150 YEARS BRIT PSYCH, P245; Micale M., 2001, TRAUMATIC HIST PSYCH; Motion Andrew, 2009, GUARDIAN        1107; Mott F. W., 1917, J ROY ARMY MED CORPS, V29, P662; Myers Charles, 1940, SHELL SHOCK FRANCE 1, P11; Myers CS, 1915, LANCET, V1, P316; Pines Malcom, 150 YEARS BRIT PSYCH, p[206, 206, 213]; Roper Michael, 2009, SECRET BATTLE EMOTIO, P54; Rose Nikolas, 1989, GOVERNING SOUL SHAPI, P20; Rose Nikolas, 1985, PSYCHOL COMPLEX PSYC, P182; Rows RG, 1916, BMJ-BRIT MED J, V1916, P441, DOI 10.1136/bmj.1.2882.441; Rylance Rick, 2000, VICTORIAN PSYCHOL BR, V5, P8; Sheffield Gary, 2001, FORGOTTEN VICTORY 1, pxiv; SHEPHARD B, 1996, 150 YEARS BRIT PSYCH, P434; Shephard Ben, 2002, WAR NERVES SOLDIERS, pxxiii; Showalter Elaine, 1987, FEMALE MALADY WOMEN, P167; Stevenson David, 2004, 1914 1918 HIST 1 WOR, P208; Stewart JP, 1919, ARCH NEURO PSYCHIATR, V1, P14, DOI 10.1001/archneurpsyc.1919.02180010017002; Stone M, 1985, ANATOMY MADNESS, V2, P242; TAYLOR M, 2007, GUARDIAN        1027; Thomson Mathew, 2006, PSYCHOL SUBJECTS IDE, P182; Thomson Mathew, 1999, RACE SCI MED 1700 19, P235; Todman Dan, 2005, GREAT WAR MYTH MEMOR, P153; TURNER WA, 1915, BMJ-BRIT MED J, V1, P833; Turner William Aldren, 1915, BMJ-BRIT MED J, V1, P835; Veale R. A., 1917, J ROY ARMY MED CORPS, V29, P607; Veale Rawdon, 1917, J ROY ARMY MED CORPS, V29, P608; Von Wild K, 2001, BRAIN INJURY, V15, P273; Wessely S, 2004, WAR SOC, V22, P89, DOI DOI 10.1179/072924704791202130; Wiltshire H, 1916, LANCET, V1, P1207; Young A., 1997, HARMONY ILLUSIONS IN	74	30	30	1	29	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-5045	1468-4373		J HIST MED ALL SCI	J. Hist. Med. Allied Sci.	JAN	2012	67	1					94	119		10.1093/jhmas/jrq052			26	Health Care Sciences & Services; History & Philosophy Of Science	Health Care Sciences & Services; History & Philosophy of Science	860TY	WOS:000297971800005	20713494	Bronze			2021-06-18	
J	Nayil, K; Ramzan, A; Sajad, A; Zahoor, S; Wani, A; Nizami, F; Laharwal, M; Kirmani, A; Bhat, R				Nayil, Khursheed; Ramzan, Altaf; Sajad, Arif; Zahoor, Sheikh; Wani, Abrar; Nizami, Furqan; Laharwal, Masood; Kirmani, Altaf; Bhat, Rashid			Subdural Hematomas: An Analysis of 1181 Kashmiri Patients	WORLD NEUROSURGERY			English	Article						Head injury; Subdural empyema; Subdural hematoma	CLOSED-SYSTEM DRAINAGE; BURR-HOLE CRANIOSTOMY; SURGICAL-TREATMENT; RECURRENCE; HEMORRHAGE; CRANIOTOMY; SURGERY; SERIES; ADULTS	BACKGROUND: We endeavored to analyze patients of subacute and chronic subdural hematomas studied in a 4-year period at the Sher-i-Kashmir Institute of Medical Sciences, Kashmir, India. METHODS: The study was a retrospective analysis of 1181 patients of subdural hematomas. Demographic characteristics, clinico-radiologic features, operative modalities, and outcome were studied. Acute subdural hematomas were excluded from the study. RESULTS: The mean age was 60.4 +/- 12.4 and males outnumbered females. Chronic subdural collections were more common than subacute subdural hematomas and left side predominated. Two burr holes with closed-system drainage was used in most patients. Incidence of postoperative seizures is very low. Overall recurrence rates were low; however, multilocular hematomas had the highest incidence of recurrence. Morbidity and mortality were 7.53% and 2.96%, respectively. Preoperative neurologic grade correlated with outcome. CONCLUSIONS: Subdural hematomas are common in elderly males. Preoperative neurologic grade dictates the outcome. Multilocular hematomas have a higher chance of recurrence. Craniotomy should be reserved for recurrent hematomas, and there may be a scope of craniotomy for multilocular chronic subdural hematomas at the outset. Antiepileptic prophylaxis is not routinely recommended.	[Nayil, Khursheed; Ramzan, Altaf; Sajad, Arif; Zahoor, Sheikh; Wani, Abrar; Nizami, Furqan; Laharwal, Masood; Kirmani, Altaf; Bhat, Rashid] Sherikashmir Inst Med Sci, Dept Neurosurg, Kashmir, India	Nayil, K (corresponding author), Sherikashmir Inst Med Sci, Dept Neurosurg, Kashmir, India.	nkhursh@rediffmail.com					Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; BROTT T, 1994, STROKE, V25, P1122, DOI 10.1161/01.STR.25.6.1122; DESTANDAU J, 1987, NEUROCHIRURGIE, V33, P17; Diaz P, 2003, NEUROCIRUGIA, V14, P333; Drapkin AJ, 1997, SURG NEUROL, V48, P427, DOI 10.1016/S0090-3019(97)00211-5; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; Gastone P, 2004, NEUROL INDIA, V52, P475; Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; GRISOLI F, 1988, NEUROSURGERY, V23, P616, DOI 10.1227/00006123-198811000-00012; Gruber DP, 1997, PEDIATR NEUROSURG, V27, P292, DOI 10.1159/000121273; HAMILTON MG, 1993, NEUROSURGERY, V33, P67; Horn EM, 2006, SURG NEUROL, V65, P150, DOI 10.1016/j.surneu.2005.05.030; JENNETT B, 1975, LANCET, V1, P480; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; Kuroki T, 2001, ACTA NEUROCHIR, V143, P1041, DOI 10.1007/s007010170010; Kwon TH, 2000, J NEUROSURG, V93, P796, DOI 10.3171/jns.2000.93.5.0796; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; MacFarlane MR, 2009, J CLIN NEUROSCI, V16, P642, DOI 10.1016/j.jocn.2008.07.074; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Markwalder TM, 1975, ACTA NEUROCHIR WIEN, V79, P623; Matsumoto K, 1999, NEUROL RES, V21, P277, DOI 10.1080/01616412.1999.11740931; Mellergard P, 1996, ACTA NEUROCHIR, V138, P708, DOI 10.1007/BF01411476; Misra M, 1996, SURG NEUROL, V46, P378, DOI 10.1016/S0090-3019(96)00188-7; Mohamed EEHH, 2003, BRIT J NEUROSURG, V17, P244, DOI 10.1080/0268869031000153134; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Muzii V F, 2005, J Neurosurg Sci, V49, P41; Osborn AG, 1994, DIAGNOSTIC NEURORADI, P205; Rai P K, 2006, J Assoc Physicians India, V54, P665; Ratilal B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004893.pub2; RICHTER HP, 1984, ACTA NEUROCHIR, V71, P179, DOI 10.1007/BF01401313; ROHDE V, 2001, NEUROSURG REV, V69, P40; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Smely C, 1997, ACTA NEUROCHIR, V139, P818, DOI 10.1007/BF01411399; Stanisic M, 1997, ACTA NEUROCHIR WIEN, V147, P1249; STROOBANDT G, 1995, ACTA NEUROCHIR, V137, P6, DOI 10.1007/BF02188772; Suzuki M, 1998, ACTA NEUROCHIR, V140, P51, DOI 10.1007/s007010050057; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; WEISSE A, 1994, ACTA NEUROCHIR, V127, P37, DOI 10.1007/BF01808544; Wilkins RH, 1995, NEUROSURGERY, V2; Yoshimoto Y, 1997, BRIT J NEUROSURG, V11, P150; Zumofen D, 2009, NEUROSURGERY, V64, P1116, DOI 10.1227/01.NEU.0000345633.45961.BB	44	30	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2012	77	1					103	110		10.1016/j.wneu.2011.06.012			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	919DD	WOS:000302300300036	22405391				2021-06-18	
J	Powell, T; Gilson, R; Collin, C				Powell, Trevor; Gilson, Rachael; Collin, Christine			TBI 13 years on: factors associated with post-traumatic growth	DISABILITY AND REHABILITATION			English	Article						Head injury; meaning; post-traumatic growth; purpose; social support; spirituality; TBI	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; HEAD-INJURY; SCALE; DEPRESSION; OPTIMISM; REHABILITATION; PREDICTORS; COMMUNITY; ANXIETY	Purpose: To investigate factors associated with post-traumatic growth (PTG) 13 years after severe traumatic brain injury (TBI) and to see if PTG had remained consistent between 11 and 13 years after injury. Method: TBI survivors (n = 21), were interviewed and completed face-to face administration of questionnaires measuring PTG and factors potentially associated with PTG. The design was a longitudinal follow-up study. Results: Factors significantly associated with PTG included: having a sense of personal meaning (purpose and coherence), high life satisfaction now, social support, high-activity levels, a high number of life events, having paid work, new stable relationships after injury, milder disability, and having religious faith. Having a high level of "purpose" was the best predictor of PTG. There was no change in PTG between 11 and 13 years after injury suggesting PTG is a relatively stable phenomenon once established after the early years. Conclusion: Clinicians should be aware of PTG and how it is associated with factors such as "meaning" and "purpose" as well as demographic factors such as, social support, activity such as work, new and stable relationships, milder disability and a shift towards spiritual values. Clinicians can focus advice, resource and effort on supporting these developments.	[Powell, Trevor] Berkshire Healthcare NHS Fdn Trust, Erleigh Rd Clin, Reading RG1 5LR, Berks, England; [Collin, Christine] Fdn Trust, RBH, Reading, Berks, England	Powell, T (corresponding author), Berkshire Healthcare NHS Fdn Trust, Erleigh Rd Clin, 25 Erleigh Rd, Reading RG1 5LR, Berks, England.	trevor.powell@berkshire.nhs.uk					Anderson-Parente JK, 1990, COGNITIVE REHABILITA, P22; [Anonymous], 2003, SPSS PC VERS 14 0 IB; Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441; Branholm I, 1991, J REHABIL SCI, V4, P29; Brooks N, 1981, J HEAD TRAUMA REHAB, V2, P1; Crown S, 1979, MANUAL CROWN CRISP E; Frankl V.E, 1963, MANS SEARCH MEANING; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; IDLER EL, 1992, AM J SOCIOL, V97, P1052, DOI 10.1086/229861; JENNETT B, 1975, LANCET, V1, P480; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lelorain S, 2010, J CLIN PSYCHOL MED S, V17, P14, DOI 10.1007/s10880-009-9183-6; Linge FR, 1997, INJURED BRAINS MED M; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Medical Disability Society, 1998, MAN TRAUM BRAIN INJ; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Reker GT, 1997, GERONTOLOGIST, V37, P709, DOI 10.1093/geront/37.6.709; Reker GT, 2007, LIFE ATTITUDE PROFIL; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Sherer M., 2004, The Awareness Questionnaire. The center for outcome measurement in brain injury; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tedeschi R, 2006, HDB POSTTRAMATIC GRO; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tennen H., 2002, HDB POSITIVE PSYCHOL, P584; Weinman J., 1995, MEASURES HLTH PSYCHO; Wood RL, 2004, NEUROPSYCHOL REHABIL, V14, P329, DOI 10.1080/09602010343000255; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	38	30	32	0	28	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2012	34	17					1461	1467		10.3109/09638288.2011.644384			7	Rehabilitation	Rehabilitation	965VH	WOS:000305794900007	22233144				2021-06-18	
J	Szymanowicz, D; Ciuffreda, KJ; Thiagarajan, P; Ludlam, DP; Green, W; Kapoor, N				Szymanowicz, Dora; Ciuffreda, Kenneth J.; Thiagarajan, Preethi; Ludlam, Diana P.; Green, Wesley; Kapoor, Neera			Vergence in mild traumatic brain injury: A pilot study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injury; head injury; rehabilitation; TBI; traumatic brain injury; vergence; vergence dysfunction; vision; vision rehabilitation; visual dysfunction	ACCOMMODATION; POPULATION; DYNAMICS; PROTOCOL; DEFICITS; LESIONS; MODEL	Vergence dysfunction in individuals with mild traumatic brain injury (mTBI) may have a negative effect on quality of life, functional abilities, and rehabilitative progress. In this study, we used a range of dynamic and static objective and subjective measures of vergence to assess 21 adult patients with mTBI and nearwork symptoms. The results were compared with 10 control adult subjects. With respect to dynamic parameters, responses in those with mTBI were slowed, variable, and delayed. With respect to static parameters, reduced near point of convergence and restricted near vergence ranges were found in those with mTBI. The present results provide evidence for the substantial adverse effect of mTBI on vergence function.	[Szymanowicz, Dora; Ciuffreda, Kenneth J.; Thiagarajan, Preethi; Ludlam, Diana P.; Green, Wesley] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Kapoor, Neera] SUNY Coll Optometry, Dept Clin Educ, New York, NY 10036 USA	Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			SUNY Optometry Graduate Program [NEI-5T53EY02048103]	This material was based on work supported by the SUNY Optometry Graduate Program and grant NEI-5T53EY02048103.	Benjamin WJ, 2006, BORISHS CLIN REFRACT; BERNE SA, 1990, J OPTOM VIS DEV, V21, P13; Ciuffreda K, 1983, VERGENCE EYE MOVEMEN, P101; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda KJ, 2009, OPTOM VIS DEV, V40, P16; Ciuffreda KJ, 1995, EYE MOVEMENT BASICS; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Cross AG, 1945, T OPHTHAL SOC UK, V65, P20; Cuiffreda K., 1992, J BEHAV OPTOM, V3, P3; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; GRISHAM JD, 1991, OPTOMETRY VISION SCI, V68, P441, DOI 10.1097/00006324-199106000-00005; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hibbard M. R., 2001, VISUAL VESTIBULAR CO, P32; HUNG GK, 1986, IEEE T BIO-MED ENG, V33, P1021, DOI 10.1109/TBME.1986.325868; Jaensch PA., 1945, KLIN MBL AUGENHEILK, V6, P142; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; OGLE KN, 1967, OCULOMOTOR IMBALANCE; Rambold H, 2004, NEUROLOGY, V62, P1850, DOI 10.1212/01.WNL.0000125331.95849.62; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; SCHAEFFEL F, 1993, J PHYSIOL-LONDON, V461, P301, DOI 10.1113/jphysiol.1993.sp019515; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Scheiman M, 2002, CLIN MANAGEMENT BINO; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Semmlow JL, 2007, COMPUT BIOL MED, V37, P910, DOI 10.1016/j.compbiomed.2006.03.007; Stark Lawrence, 1968, NEUROLOGICAL CONTROL; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wiest G, 2000, NEUROLOGY, V54, P1997, DOI 10.1212/WNL.54.10.1997; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495	39	30	30	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1083	1100		10.1682/JRRD.2010.07.0129			18	Rehabilitation	Rehabilitation	149EZ	WOS:000319303100011	23341281	Bronze			2021-06-18	
J	DeJong, G; Hsieh, CH; Putman, K; Smout, RJ; Horn, SD; Tian, WQ				DeJong, Gerben; Hsieh, Ching-Hui; Putman, Koen; Smout, Randall J.; Horn, Susan D.; Tian, Wenqiang			Physical Therapy Activities in Stroke, Knee Arthroplasty, and Traumatic Brain Injury Rehabilitation: Their Variation, Similarities, and Association With Functional Outcomes	PHYSICAL THERAPY			English	Article							SKILLED NURSING FACILITIES; INPATIENT REHABILITATION; BLACK-BOX; PATIENT CHARACTERISTICS; SEVERITY; ILLNESS; LENGTH; WHITE; STAY; INDEPENDENCE	Background. The mix of physical therapy services is thought to be different with different impairment groups. However, it is not clear how much variation there is across impairment groups. Furthermore, the extent to which the same physical therapy activities are associated with functional outcomes across different types of patients is unknown. Objective. The purposes of this study were: (1) to examine similarities and differences in the mix of physical therapy activities used in rehabilitation among patients from different impairment groups and (2) to examine whether the same physical therapy activities are associated with functional improvement across impairment groups. Design. This was a prospective observational cohort study. Methods. The study was conducted in inpatient rehabilitation facilities. The participants were 433 patients with stroke, 429 patients with total knee arthroplasty (TKA), and 207 patients with traumatic brain injury (TBI). Measures used in this study included: (1) the Comprehensive Severity Index to measure the severity of each patient's medical condition, (2) the Functional Independence Measure (FIM) to measure function, and (3) point-of-care instruments to measure time spent in specific physical therapy activities. Results. All 3 groups had similar admission motor FIM scores but varying cognitive FIM scores. Patients with TKA spent more time on exercise than the other 2 groups (average = 31.7 versus 6.2 minutes per day). Patients with TKA received the most physical therapy (average = 65.3 minutes per day), whereas the TBI group received the least physical therapy (average = 38.3 minutes per day). Multivariate analysis showed that only 2 physical therapy activities (gait training and community mobility) were both positively associated with discharge motor FIM outcomes across all 3 groups. Three physical therapy activities (assessment time, bed mobility, and transfers) were negatively associated with discharge motor FIM outcome. Limitations. The study focused primarily on physical therapy without concurrently considering other therapies such as occupational therapy, speech-language pathology, nursing care, and case management or the potential interaction of these inputs. This analysis did not consider the interventions that physical therapists used when patients participated in discrete physical therapy activities. Conclusions. All 3 patient groups spent a considerable portion of their physical therapy time in gait training relative to other activities. Both gait training and community mobility are higher-level activities that were positively associated with outcomes, although all 3 groups spent little time in community mobility activities. Further research studies, such as randomized clinical trials and predictive validity studies, are needed to investigate whether higher-level or more-integrated therapy activities are associated with better patient outcomes.	[DeJong, Gerben; Hsieh, Ching-Hui; Tian, Wenqiang] Natl Rehabil Hosp, Ctr Postacute Innovat & Res, Washington, DC 20010 USA; [Putman, Koen] Vrije Univ Brussel, Fac Med & Pharm, I CHER, Brussels, Belgium; [Smout, Randall J.; Horn, Susan D.] Inst Clin Outcomes Res, Salt Lake City, UT USA	DeJong, G (corresponding author), Natl Rehabil Hosp, Ctr Postacute Innovat & Res, 102 Irving St NW, Washington, DC 20010 USA.	gerben.dejong@medstar.net		Putman, Koen/0000-0002-7235-3759	National Institute of Disability and Rehabilitation Research, Department of Education [H133G050153]; National Center for Medical Rehabilitation Research (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R01 HD050439]; National Institute of Disability and Rehabilitation Research [H133A080023]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	The stroke study was funded by National Institute of Disability and Rehabilitation Research, Department of Education grant H133G050153 (to Dr DeJong). The JOINTS study was privately and jointly funded by multiple institutions and organizations (to Dr DeJong). The TBI study was funded by National Center for Medical Rehabilitation Research (NIH) grant 1 R01 HD050439 (to Dr Horn and Dr Corrigan) and National Institute of Disability and Rehabilitation Research grant H133A080023 (to Dr Corrigan and Dr Horn).	AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Bode RK, 2004, STROKE, V35, P2537, DOI 10.1161/01.STR.0000145200.02380.a3; BUCKLE JM, 1992, ARCH INTERN MED, V152, P1596, DOI 10.1001/archinte.152.8.1596; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1284, DOI 10.1016/j.apmr.2009.02.009; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Deutscher D, 2010, ARCH PHYS MED REHAB, V91, P1722, DOI 10.1016/j.apmr.2010.08.007; Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Grasel E, 2005, CLIN REHABIL, V19, P725, DOI 10.1191/0269215505cr900oa; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.2002.126925; HORN SD, 1991, MED CARE, V29, P305, DOI 10.1097/00005650-199104000-00001; Horn SD, 2010, ARCH PHYS MED REHAB, V91, P1712, DOI 10.1016/j.apmr.2010.04.013; Horner RD, 2003, STROKE, V34, P1027, DOI 10.1161/01.STR.0000060028.60365.5D; Karges Joy, 2009, J Allied Health, V38, pE1; Koizumi D, 2009, J PHYS ACT HEALTH, V6, P467, DOI 10.1123/jpah.6.4.467; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P1647, DOI 10.1053/S0003-9993(03)00317-4; STOSKOPF C, 1991, MED CARE, V29, P179, DOI 10.1097/00005650-199103000-00001; *UN DAT SYST MED R, 2001, INP REH FAC PAT ASS; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Willson D F, 2000, Pediatr Crit Care Med, V1, P127, DOI 10.1097/00130478-200010000-00007	27	30	31	0	35	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	DEC	2011	91	12					1826	1837		10.2522/ptj.20100424			12	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	860DM	WOS:000297928700013	22003165	Green Published, Bronze			2021-06-18	
J	Corcoran, TB; Mas, E; Barden, AE; Durand, T; Galano, JM; Roberts, LJ; Phillips, M; Ho, KM; Mori, TA				Corcoran, Tomas B.; Mas, Emilie; Barden, Anne E.; Durand, Thierry; Galano, Jean-Marie; Roberts, L. Jackson, II; Phillips, Michael; Ho, Kwok M.; Mori, Trevor A.			Are Isofurans and Neuroprostanes Increased After Subarachnoid Hemorrhage and Traumatic Brain Injury?	ANTIOXIDANTS & REDOX SIGNALING			English	Article							CEREBROSPINAL-FLUID; LIPID-PEROXIDATION; OXIDATIVE STRESS; CHILDREN; MARKERS; INFANTS	Current diagnostic tools to assess neurological injury after aneurysmal subarachnoid hemorrhage (aSAH) and traumatic brain injury (TBI) have poor discriminatory abilities. Free radicals are associated with the pathophysiology of secondary damage after brain trauma. We examined cerebrospinal fluid (CSF) lipid markers of oxidative stress, isofurans (IsoFs), F(4)-neuroprostanes (F(4)-NeuroPs), and F(2)-isoprostanes (F(2)-IsoPs), in two case-controlled studies in patients with aSAH or severe TBI. Patients with aSAH (n = 18) or TBI (n = 18) were age and gender matched with separate control groups. CSF samples were collected from patients within 24 h of the injury. CSF IsoFs and F(4)-NeuroPs were increased in aSAH patients compared with their controls. In TBI patients, IsoFs and F(4)-NeuroPs were increased compared with their controls. F(2)-IsoPs were increased in aSAH patients, but not in TBI patients, compared with their respective controls. CSF IsoFs and F(4)-NeuroPs are consistently increased after a catastrophic central nervous system injury. These results suggest their measurement may enhance the management of unconscious patients in neurological care. Antioxid. Redox Signal. 15, 2663-2667.	[Mas, Emilie; Barden, Anne E.; Mori, Trevor A.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia; [Mas, Emilie; Barden, Anne E.; Mori, Trevor A.] Cardiovasc Res Ctr, Perth, WA, Australia; [Corcoran, Tomas B.] Royal Perth Hosp, Dept Anaesthesia & Pain Med, Perth, WA, Australia; [Durand, Thierry; Galano, Jean-Marie] Inst Biomol Max Mousseron IBMM UMR 5247 CNRS UM 1, Fac Pharm, Montpellier, France; [Roberts, L. Jackson, II] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Phillips, Michael] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6847, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6847, Australia	Mori, TA (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Med Res Fdn Bldg,GPO Box X2213, Perth, WA 6847, Australia.	trevor.mori@uwa.edu.au	Ho, Kwok M./E-3546-2010; Mori, Trevor/H-5485-2014	Ho, Kwok M./0000-0002-6705-6004; Mori, Trevor/0000-0002-5264-9229; Phillips, Michael/0000-0002-0252-9085	West Australian Institute of Medical Research; University of Western Australia; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM42056]; University Montpellier 1 [BQR-2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM042056, R37GM042056] Funding Source: NIH RePORTER	We acknowledge Lynette McCahon for technical assistance. The study was supported by a grant from the Neurotrauma Research Program of the West Australian Institute of Medical Research and the University of Western Australia. The synthesis of the isofurans (Prof Roberts II L.J.) was supported by a National Institutes of Health Grant GM42056. The synthesis of the neuroprostanes (Dr. Durand T.) was supported by a University Montpellier 1 Grant BQR-2008.	Asaeda M, 2005, NEUROSCI LETT, V373, P222, DOI 10.1016/j.neulet.2004.10.008; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Hsieh YP, 2009, FREE RADICAL BIO MED, V47, P814, DOI 10.1016/j.freeradbiomed.2009.06.026; Lin CL, 2006, FREE RADICAL BIO MED, V40, P1466, DOI 10.1016/j.freeradbiomed.2005.12.019; Proudfoot J, 1999, ANAL BIOCHEM, V272, P209, DOI 10.1006/abio.1999.4187; Roberts LJ, 2004, CHEM PHYS LIPIDS, V128, P173, DOI 10.1016/j.chemphyslip.2003.09.016; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596	9	30	31	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864			ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	NOV	2011	15	10					2663	2667		10.1089/ars.2011.4125			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	831MF	WOS:000295734400002	21702684	Green Published			2021-06-18	
J	Fourtassi, M; Hajjioui, A; El Ouahabi, A; Benmassaoud, H; Hajjaj-Hassouni, N; El Khamlichi, A				Fourtassi, Maryam; Hajjioui, Abderrazak; El Ouahabi, Abdessamad; Benmassaoud, Hind; Hajjaj-Hassouni, Najia; El Khamlichi, Abdeslam			Long term outcome following mild traumatic brain injury in Moroccan patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Mild traumatic brain injury; Outcome; Quality of life; Post-concussion syndrome	MINOR HEAD-INJURY; QUALITY-OF-LIFE; POST-CONCUSSION SYMPTOMS; POPULATION; ADULTS; EPIDEMIOLOGY	Primary objectives: To describe the symptoms of chronic post-concussion syndrome (PCS) and to investigate the relationship between the persistence of these symptoms and different aspects of social life (return to work, quality of life, sport and leisure activities and family relationships) in Moroccan patients with mild traumatic brain injury (MTBI), one year after the trauma. Methods: Forty-two adult patients who sustained MTBI were reviewed one year after trauma. We investigated the persistence of PCS by using the "Problem Checklist" questionnaire. We also assessed their quality of life using a visual analogue scale, and noted the changes in employment status, social activities and family relationships. Then, we examined whether there were significant relationships between these different data. Results: More than half of the patients (n = 23, 54.8%) were found with persistent post-concussion symptoms at one year post-injury. Chronic PCS was significantly more common in married persons (p = 0.008) and significantly related to both non return to work (p <= 0.01), and QoL deterioration (p <= 0.001). Conclusion: In this study, a large proportion of persons who sustained a MTBI experienced persistent symptoms up to one year after trauma. MTBI might have significant and lasting impact on the quality of life, which is to be verified by further studies. (C) 2011 Elsevier B.V. All rights reserved.	[Fourtassi, Maryam; Hajjioui, Abderrazak; Benmassaoud, Hind; Hajjaj-Hassouni, Najia] Mohammed V Univ, Phys Med & Rehabil Dept, Rabat, Morocco; [El Ouahabi, Abdessamad; El Khamlichi, Abdeslam] Mohammed V Univ, Dept Neurosurg, Rabat, Morocco	Fourtassi, M (corresponding author), Mohammed V Univ, Phys Med & Rehabil Dept, Rabat, Morocco.	fourtmary@yahoo.fr		Hajjioui, Abderrazak/0000-0002-2311-5543; El Ouahabi, Abdessamad/0000-0003-2132-3397; FOURTASSI, Maryam/0000-0003-4915-5399; Hajjaj-Hassouni, Najia/0000-0003-0722-6822			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; FERRARI R, 2002, MED SCI MONITOR, V8, P728; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, AUST PSYCHOL, V30, P125, DOI 10.1080/00050069508258916; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Teasdale TW, 1997, BRIT MED J, V315, P569; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218	30	30	30	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2011	113	9					716	720		10.1016/j.clineuro.2011.07.010			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	837EF	WOS:000296173200003	21840643				2021-06-18	
J	Funck, VR; de Oliveira, CV; Pereira, LM; Rambo, LM; Ribeiro, LR; Royes, LFF; Ferreira, J; Guerra, GP; Furian, AF; Oliveira, MS; Mallmann, CA; de Mello, CF; Oliveira, MS				Funck, Vinicius Rafael; de Oliveira, Clarissa Vasconcelos; Pereira, Leticia Meier; Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo; Freire Royes, Luiz Fernando; Ferreira, Juliano; Guerra, Gustavo Petri; Furian, Ana Flavia; Oliveira, Mauricio Schneider; Mallmann, Carlos Augusto; de Mello, Carlos Fernando; Oliveira, Mauro Schneider			Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures	EPILEPSIA			English	Article						Statin; Cholesterol; EEG; Epilepsy; Rat; Blood-brain barrier	BLOOD-BRAIN-BARRIER; HMG-COA REDUCTASE; HIPPOCAMPAL CELL-DEATH; INDUCED EXCITOTOXICITY; OXIDATIVE STRESS; CORTICAL-NEURONS; QUINOLINIC ACID; MICE; STATINS; INHIBITORS	Purpose: Statins are selective inhibitors of 3-hydroxyl-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme of the mevalonate pathway for cholesterol biosynthesis. Increasing evidence indicates that statins, particularly atorvastatin, are neuroprotective in several conditions, including stroke, cerebral ischemia, traumatic brain injury, and excitotoxic amino acid exposure. However, only a few studies have investigated whether statins modulate seizure activity. In the current study we investigated whether atorvastatin or simvastatin alters the seizures induced by pentylenetetrazol (PTZ), a classical convulsant. Methods: Adult male Wistar rats were treated with atorvastatin or simvastatin for 7 days (10 mg/kg/day). Seizure activity was induced by PTZ (60 mg/kg, i.p.), and evaluated by behavioral and electrographic methods. Cholesterol levels were determined by a standard spectrophotometric method. Blood-brain barrier (BBB) permeability was assessed by the fluorescein method. Atorvastatin levels in the plasma and cerebral cortex were determined by high-performance liquid chromatography tandem mass spectrometry. Key Findings: We found that oral atorvastatin treatment increased the latency to PTZ-induced generalized seizures. In contrast, when the 7-day atorvastatin treatment was withheld for 1 day (i.e., atorvastatin withdrawal), PTZ-induced seizures were facilitated, as evidenced by a decrease in the latency to clonic and generalized tonic-clonic seizures induced by PTZ. In contrast, simvastatin treatment for 7 days (10 mg/kg/day, p.o.), with or without withdrawal, did not alter PTZ-induced seizures. Interestingly, the effects of atorvastatin treatment and withdrawal were not accompanied by changes in plasma or cerebral cortex cholesterol levels or in the BBB permeability. Atorvastatin levels in the plasma and cerebral cortex after 7 days of treatment were above the half maximal inhibitory concentration for inhibition of HMG-CoA reductase, whereas atorvastatin was not detectable in the plasma or cerebral cortex following a 24 h washout period (atorvastatin withdrawal). Significance: We conclude that atorvastatin treatment and withdrawal have differential effects on pentylenetetrazol-induced seizures, which are not related to changes in plasma or cerebral cortex cholesterol levels or in BBB permeability. Additional studies are necessary to evaluate the molecular mechanisms underlying our findings as well as its clinical implications.	[Oliveira, Mauro Schneider] Univ Fed Pampa, BR-97650000 Itaqui, RS, Brazil; [Funck, Vinicius Rafael; Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo; Freire Royes, Luiz Fernando; Ferreira, Juliano; Guerra, Gustavo Petri; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Postgrad Program Biol Sci Biochem, BR-97119900 Santa Maria, RS, Brazil; [de Oliveira, Clarissa Vasconcelos; Pereira, Leticia Meier; Freire Royes, Luiz Fernando; Ferreira, Juliano; Furian, Ana Flavia; de Mello, Carlos Fernando; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Postgrad Program Pharmacol, BR-97119900 Santa Maria, RS, Brazil; [Oliveira, Mauricio Schneider; Mallmann, Carlos Augusto] Univ Fed Santa Maria, Postgrad Program Vet Med, BR-97119900 Santa Maria, RS, Brazil	Oliveira, MS (corresponding author), Univ Fed Pampa, Campus Itaqui,Rua Luiz Joaquim de Sa Britto S-N, BR-97650000 Itaqui, RS, Brazil.	oliveira.ms@gmail.com; oliveira.ms@gmail.com	Oliveira, Mauro Schneider/G-3437-2012; Rambo, Leonardo/F-8195-2012; Funck, Vinicius Rafael/M-6968-2014; Mello, Carlos/C-7188-2013; Ferreira, Juliano/A-9803-2013	Oliveira, Mauro Schneider/0000-0002-5381-1208; Funck, Vinicius Rafael/0000-0002-3569-3711; Mello, Carlos/0000-0002-1326-1045; Ferreira, Juliano/0000-0002-9562-0602; Ribeiro, Leandro/0000-0002-8442-4075; Meier, Leticia/0000-0002-9848-9814; Mallmann, Carlos/0000-0003-2376-2705; Rambo, Leonardo/0000-0002-4769-3663	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [150905/2009-0, 306469/2009-0, 301552/2007-0]; FapergsFundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [10/0685-8]; PIBIC [507049/2010-1]; CapesCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by CNPq (grants #150905/2009-0, #306469/2009-0 and #301552/2007-0), Fapergs (grant #10/0685-8), PIBIC (grant #507049/2010-1), and Capes.	Bazan NG, 2002, PROG BRAIN RES, V135, P175; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candrilli SD, 2010, EPILEPSY RES, V91, P260, DOI 10.1016/j.eplepsyres.2010.07.021; ENDO A, 1976, J ANTIBIOT, V29, P841, DOI 10.7164/antibiotics.29.841; ENDO A, 1992, J LIPID RES, V33, P1569; Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Endres M, 2005, J CEREBR BLOOD F MET, V25, P1093, DOI 10.1038/sj.jcbfm.9600116; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Friedman A, 2011, EPILEPSIA, V52, P33, DOI 10.1111/j.1528-1167.2011.03034.x; Gertz K, 2003, STROKE, V34, P551, DOI 10.1161/01.STR.0000054055.28435.BF; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Lau YY, 2006, DRUG METAB DISPOS, V34, P1175, DOI 10.1124/dmd.105.009076; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; MARCHI N, 2007, CARDIOVASC PSYCHIAT; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi Nicola, 2011, Cardiovasc Psychiatry Neurol, V2011, P482415, DOI 10.1155/2011/482415; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; McColl CD, 2003, NEUROPHARMACOLOGY, V44, P234, DOI 10.1016/S0028-3908(02)00369-6; Nagotani S, 2005, STROKE, V36, P670, DOI 10.1161/01.STR.0000155732.27333.3c; Oliveira MS, 2008, EPILEPSY RES, V79, P14, DOI 10.1016/j.eplepsyres.2007.12.008; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Serbanescu I, 2004, J LIPID RES, V45, P2038, DOI 10.1194/jlr.M400097-JLR200; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Thomas M, 1998, LANCET, V352, P1830, DOI 10.1016/S0140-6736(05)79893-7; Trinder P., 1969, ANN CLIN BIOCHEM, V6, P165; TURPIN JC, 1991, DEV NEUROSCI-BASEL, V13, P304, DOI 10.1159/000112177; van Vliet EA, 2011, EPILEPSIA, V52, P1319, DOI 10.1111/j.1528-1167.2011.03073.x; Vecchione C, 2002, CIRC RES, V91, P173, DOI 10.1161/01.RES.0000028004.76218.B8; Velisek L, 2006, MODELS OF SEIZURES AND EPILEPSY, P127, DOI 10.1016/B978-012088554-1/50013-X; VEZZANI A, 1989, EXP NEUROL, V106, P90, DOI 10.1016/0014-4886(89)90149-0; White HS, 2006, MODELS OF SEIZURES AND EPILEPSY, P539, DOI 10.1016/B978-012088554-1/50046-3; Zacco A, 2003, J NEUROSCI, V23, P11104	43	30	31	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0013-9580			EPILEPSIA	Epilepsia	NOV	2011	52	11					2094	2104		10.1111/j.1528-1167.2011.03261.x			11	Clinical Neurology	Neurosciences & Neurology	848KE	WOS:000297049700026	21906051	Bronze			2021-06-18	
J	Sarkar, B; Brunsvold, ME; Cherry-Bukoweic, JR; Hemmila, MR; Park, PK; Raghavendran, K; Wahl, WL; Wang, SC; Napolitano, LM				Sarkar, Bedabrata; Brunsvold, Melissa E.; Cherry-Bukoweic, Jill R.; Hemmila, Mark R.; Park, Pauline K.; Raghavendran, Krishnan; Wahl, Wendy L.; Wang, Stewart C.; Napolitano, Lena M.			American College of Surgeons' Committee on Trauma Performance Improvement and Patient Safety Program: Maximal Impact in a Mature Trauma Center	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-25, 2010	Boston, MA	Amer Assoc Surg Trauma (AAST)		Trauma; Trauma systems; Trauma outcomes; Performance improvement; Level 1 trauma center; Committee on trauma	LEVEL-I; CENTER DESIGNATION; MORTALITY; CARE; PATTERNS; SYSTEMS	Background: To examine the impact of an ongoing comprehensive performance improvement and patient safety (PIPS) program implemented in 2005 on mortality outcomes for trauma patients at an established American College of Surgeons (ACS)-verified Level I Trauma Center. Methods: The primary outcome measure was in-hospital mortality. Age, Injury Severity Score (ISS), and intensive care unit admissions were used as stratifying variables to examine outcomes over a 5-year period (2004-2008). Institution mortality rates were compared with the National Trauma Data Bank mortality rates stratified by ISS score. Enhancements to our comprehensive PIPS program included revision of trauma activation criteria, development of standardized protocols for initial resuscitation, massive transfusion, avoidance of over-resuscitation, tourniquet use, pelvic fracture management, emphasis on timely angiographic and surgical intervention, prompt spine clearance, reduction in time to computed tomography imaging, reduced dwell time in emergency department, evidence-based traumatic brain injury management, and multidisciplinary efforts to reduce healthcare-associated infections. Results: In 2004 (baseline data), the in-hospital mortality rate for the most severely injured trauma patients (ISS >24) at our trauma center was 30%, consistent with the reported mortality rate from the National Trauma Data Bank for patients with this severity of injury. Over 5 years, our mortality rate decreased significantly for severely injured patients with an ISS >24, from 30.1% (2004) to 18.3% (2008), representing a 12% absolute reduction in mortality (p = 0.011). During the same 5-year time period, the proportion of elderly patients (age >65 years) cared for at our trauma center increased from 23.5% in 2004 to 30.6% in 2008 (p = 0.0002). Class I trauma activations increased significantly from 5.5% in 2004 to 15.5% in 2008 based on our reclassification. A greater percentage of patients were admitted to the intensive care unit (25.8% in 2004 to 37.3% in 2007 and 30.4% in 2008). No difference was identified in the rate of blunt (95%) or penetrating (5%) mechanism of injury in our patients over this time period. Trauma Quality Improvement Program confirmed improved trauma outcomes with observed-to-expected ratio and 95% confidence intervals of 0.64 (0.42-0.86) for all patients, 0.54 (0.15-0.91) for blunt single-system patients, and 0.78 (0.51-1.06) for blunt multisystem patients. Conclusion: Implementation of a multifaceted trauma PIPS program aimed at improving trauma care significantly reduced in-hospital mortality in a mature ACS Level I trauma center. Optimal care of the injured patient requires uncompromising commitment to PIPS.	[Sarkar, Bedabrata; Brunsvold, Melissa E.; Cherry-Bukoweic, Jill R.; Hemmila, Mark R.; Park, Pauline K.; Raghavendran, Krishnan; Wahl, Wendy L.; Wang, Stewart C.; Napolitano, Lena M.] Univ Michigan, Dept Surg, Div Acute Care Surg, Ann Arbor, MI 48109 USA	Napolitano, LM (corresponding author), Univ Michigan Hlth Syst, Dept Surg, Room 1C421 Univ Hosp,1500 E Med Dr, Ann Arbor, MI 48109 USA.	lenan@umich.edu					Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Chua WC, 2009, ANZ J SURG, V79, P443, DOI 10.1111/j.1445-2197.2009.04946.x; Committee on Trauma of the American College of Surgeons, 2006, RES OPT CAR INJ PAT; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Davenport RA, 2010, BRIT J SURG, V97, P109, DOI 10.1002/bjs.6806; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2010, J TRAUMA, V69, pS5, DOI 10.1097/TA.0b013e3181e421f3; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Nathens AB, 2008, J TRAUMA, V65, P628, DOI 10.1097/TA.0b013e3181837994; Scarborough K, 2008, ARCH SURG-CHICAGO, V143, P22, DOI 10.1001/archsurg.2007.2-b; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Shafi S, 2010, J TRAUMA, V68, P716, DOI 10.1097/TA.0b013e3181a7bec0; Shafi S, 2009, ARCH SURG-CHICAGO, V144, P64, DOI 10.1001/archsurg.2008.509; Sihler KC, 2009, CHEST, V136, P1654, DOI 10.1378/chest.09-0251; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Tinkoff GH, 2010, J TRAUMA, V69, P245, DOI 10.1097/TA.0b013e3181e493b9; Ursic C, 2009, INJURY, V40, P99, DOI 10.1016/j.injury.2008.06.034	25	30	33	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1447	1453		10.1097/TA.0b013e3182325d32			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	849IG	WOS:000297118600068	22071936				2021-06-18	
J	Sukumari-Ramesh, S; Bentley, JN; Laird, MD; Singh, N; Vender, JR; Dhandapani, KM				Sukumari-Ramesh, Sangeetha; Bentley, J. Nicole; Laird, Melissa D.; Singh, Nagendra; Vender, John R.; Dhandapani, Krishnan M.			Dietary phytochemicals induce p53-and caspase-independent cell death in human neuroblastoma cells	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Ayurveda; Akt; Pediatric cancer; Nutrition; Chemotherapy	NF-KAPPA-B; CHEMOTHERAPY-INDUCED APOPTOSIS; TRAUMATIC BRAIN-INJURY; COMBINATION KAN-JANG; OXIDATIVE STRESS; FERULIC ACID; CURCUMIN; PATHWAY; RATS; ACTIVATION	Neuroblastoma (NB) is the most prevalent pediatric solid tumor and a leading cause of cancer-related death in children. In the present study, a novel cytotoxic role for the dietary compounds, curcumin, andrographolide, wedelolactone, dibenzoylmethane, and tanshinone IIA was identified in human S-type NB cells, SK-N-AS and SK-N-BE(2). Mechanistically, cell death appeared apoptotic by flow cytometry; however, these effects proceeded independently from both caspase-3 and p53 activation, as assessed by both genetic (shRNA) and pharmacological approaches. Notably, cell death induced by both curcumin and andrographolide was associated with decreased NF kappa B activity and a reduction in Bcl-2 and Bcl-xL expression. Finally, curcumin and andrographolide increased cytotoxicity following co-treatment with either cisplatin or doxorubicin, two chemotherapeutic agents widely used in the clinical management of NB. Coupled with the documented safety in humans, dietary compounds may represent a potential adjunct therapy for NB. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[Sukumari-Ramesh, Sangeetha; Bentley, J. Nicole; Laird, Melissa D.; Vender, John R.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA 30912 USA; [Singh, Nagendra] Georgia Hlth Sci Univ, Dept Biochem, Augusta, GA 30912 USA	Dhandapani, KM (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, 1120 15th St, Augusta, GA 30912 USA.	kdhandapani@georgiahealth.edu		Bentley, Nicole/0000-0002-8303-071X; Dhandapani, Krishnan/0000-0001-7044-1117	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS065172]; American Heart AssociationAmerican Heart Association [BGIA2300135, 2250690]; A.R. Staulcup Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065172] Funding Source: NIH RePORTER	The authors' research was supported in part by grants from the National Institutes of Health (NS065172) and the American Heart Association (BGIA2300135) to KMD, by a fellowship from the American Heart Association (2250690) to MDL, and by a grant from the A.R. Staulcup Foundation.	Alonso M, 2003, MOL CANCER THER, V2, P139; Aristotle L, 2004, ANTICANCER RES, V24, P987; Balachandran P, 2005, PHARMACOL RES, V51, P19, DOI 10.1016/j.phrs.2004.04.010; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Biedler J L, 1988, Prog Clin Biol Res, V271, P265; BIEDLER JL, 1973, CANCER RES, V33, P2643; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Cui HJ, 2002, MOL CANCER THER, V1, P679; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; DOLE M, 1994, CANCER RES, V54, P3253; DOLE MG, 1995, CANCER RES, V55, P2576; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gabrielian ES, 2002, PHYTOMEDICINE, V9, P589, DOI 10.1078/094471102321616391; HOLDER GM, 1978, XENOBIOTICA, V8, P761, DOI 10.3109/00498257809069589; HUMPL T, 1995, WORLD J UROL, V13, P233; Karacay B, 2004, CANCER GENE THER, V11, P681, DOI 10.1038/sj.cgt.7700749; Karmakar S, 2006, NEUROSCI LETT, V407, P53, DOI 10.1016/j.neulet.2006.08.013; Kelloff GJ, 2000, J NUTR, V130, p467S, DOI 10.1093/jn/130.2.467S; Kim NH, 2007, J CELL BIOCHEM, V102, P1160, DOI 10.1002/jcb.21344; KING MD, 2011, J NEUROSURG; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kulichenko L. L., 2003, Journal of Herbal Pharmacotherapy, V3, P77, DOI 10.1080/J157v03n01_04; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lavoie S, 2009, J NEUROCHEM, V108, P1410, DOI 10.1111/j.1471-4159.2009.05908.x; Meng FY, 2002, J BIOL CHEM, V277, P29674, DOI 10.1074/jbc.M112464200; Mora J, 2001, CANCER RES, V61, P6892; Murakami Y, 2005, IN VIVO, V19, P1039; Negi AS, 2008, MED RES REV, V28, P746, DOI 10.1002/med.20115; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Ouyang W, 2006, CARCINOGENESIS, V27, P864, DOI 10.1093/carcin/bgi321; Panossian A, 2000, PHYTOMEDICINE, V7, P351, DOI 10.1016/S0944-7113(00)80054-9; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Ronchetti D, 2006, EUR J PHARMACOL, V532, P162, DOI 10.1016/j.ejphar.2005.12.034; ROSS RA, 1983, J NATL CANCER I, V71, P741; Scapagnini G, 2006, ANTIOXID REDOX SIGN, V8, P395, DOI 10.1089/ars.2006.8.395; Schmidt ML, 2000, J CLIN ONCOL, V18, P1260, DOI 10.1200/JCO.2000.18.6.1260; Singletary K, 1998, CARCINOGENESIS, V19, P1039, DOI 10.1093/carcin/19.6.1039; STILLER CA, 1992, INT J CANCER, V52, P538, DOI 10.1002/ijc.2910520407; Sukumari-Ramesh S, 2010, GLIA, V58, P1858, DOI 10.1002/glia.21055; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Venkatesan N, 1998, BRIT J PHARMACOL, V124, P425, DOI 10.1038/sj.bjp.0701877; Venkatesan N, 2000, BRIT J PHARMACOL, V129, P231, DOI 10.1038/sj.bjp.0703067; Wakade C, 2009, ANTIOXID REDOX SIGN, V11, P35, DOI 10.1089/ars.2008.2056; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004	47	30	31	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	NOV	2011	29	7					701	710		10.1016/j.ijdevneu.2011.06.002			10	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	837MR	WOS:000296208400004	21704149	Green Accepted			2021-06-18	
J	Herkenham, M; Rathore, P; Brown, P; Listwak, SJ				Herkenham, Miles; Rathore, Priyanka; Brown, Pierre; Listwak, Samuel J.			Cautionary notes on the use of NF-kappa B p65 and p50 antibodies for CNS studies	JOURNAL OF NEUROINFLAMMATION			English	Article						NF-kappa?kappa?B; transcription factor; immunohistochemistry; antibody specificity	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; RAT-BRAIN; PROINFLAMMATORY CYTOKINES; TRANSCRIPTIONAL ACTIVITY; TRYPANOSOMA-BRUCEI; DEFICIENT MOUSE; MESSENGER-RNA	Background: The characterization and cellular localization of transcription factors like NF-kappa B requires the use of antibodies for western blots and immunohistochemistry. However, if target protein levels are low and the antibodies not well characterized, false positive data can result. In studies of NF-kappa B activity in the CNS, antibodies detecting NF-kappa B proteins have been used to support the finding that NF-kappa B is constitutively active in neurons, and activity levels are further increased by neurotoxic treatments, glutamate stimulation, or elevated synaptic activity. The specificity of the antibodies used was analyzed in this study. Methods: Selectivity and nonselectivity of commonly used commercial and non-commercial p50 and p65 antibodies were demonstrated in western blot assays conducted in tissues from mutant gene knockout mice lacking the target proteins. Results: A few antibodies for p50 and p65 each mark a single band at the appropriate molecular weight in gels containing proteins from wildtype tissue, and this band is absent in proteins from knockout tissues. Several antibodies mark proteins that are present in knockout tissues, indicating that they are nonspecific. These include antibodies raised against the peptide sequence containing the nuclear localization signals of p65 (MAB3026; Chemicon) and p50 (sc-114; Santa Cruz). Some antibodies that recognize target proteins at the correct molecular weight still fail in western blot analysis because they also mark additional proteins and inconsistently so. We show that the criterion for validation by use of blocking peptides can still fail the test of specificity, as demonstrated for several antibodies raised against p65 phosphorylated at serine 276. Finally, even antibodies that show specificity in western blots produce nonspecific neuronal staining by immunohistochemistry. Conclusions: We note that many of the findings in the literature about neuronal NF-kappa B are based on data garnered with antibodies that are not selective for the NF-kappa B subunit proteins p65 and p50. The data urge caution in interpreting studies of neuronal NF-kappa B activity in the brain.	[Herkenham, Miles; Rathore, Priyanka; Brown, Pierre; Listwak, Samuel J.] NIMH, Funct Neuroanat Sect, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA	Herkenham, M (corresponding author), NIMH, Funct Neuroanat Sect, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA.	herkenh@mail.nih.gov		Herkenham, Miles/0000-0003-2228-4238	National Institute of Mental Health, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIAMH001090] Funding Source: NIH RePORTER	The work was supported by the Intramural Research Program, National Institute of Mental Health, NIH.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Acarin L, 1998, NEUROREPORT, V9, P2869, DOI 10.1097/00001756-199808240-00035; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Barger SW, 2005, CURR PHARM DESIGN, V11, P985, DOI 10.2174/1381612053381594; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Brochu S, 1999, J NEUROSCI RES, V57, P801, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;801::AID-JNR5&gt;3.0.CO;2-B; Caba E, 2004, ACTA NEUROPATHOL, V108, P173, DOI 10.1007/s00401-004-0876-5; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Cohen H, 2011, NEUROPSYCHOPHARMACOL; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; Dixon EP, 1997, BRAIN RES, V776, P222, DOI 10.1016/S0006-8993(97)01040-8; Duckworth EAM, 2006, BRAIN RES, V1088, P167, DOI 10.1016/j.brainres.2006.02.103; Freudenthal R, 2004, HIPPOCAMPUS, V14, P677, DOI 10.1002/hipo.20020; Gabriel C, 1999, MOL BRAIN RES, V65, P61, DOI 10.1016/S0169-328X(98)00330-1; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339; GOSLIN K, 1992, CULTURING NERVE CELL, P252; Gu ZZ, 2000, INT J DEV NEUROSCI, V18, P185, DOI 10.1016/S0736-5748(99)00087-8; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Juttler E, 2007, J NEUROIMMUNOL; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; KALTSCHMIDT C, 1995, BIOL CHEM H-S, V376, P9; Laflamme N, 1999, J NEUROSCI, V19, P10923; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; Mao XRR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-16; Matsuoka Y, 1999, EXP BRAIN RES, V124, P215, DOI 10.1007/s002210050616; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Nadeau S, 1999, J NEUROPATH EXP NEUR, V58, P61, DOI 10.1097/00005072-199901000-00008; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nadjar A, 2003, J NEUROCHEM, V87, P1024, DOI 10.1046/j.1471-4159.2003.02097.x; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; O'Sullivan NC, 2010, BRAIN RES BULL, V81, P385, DOI 10.1016/j.brainresbull.2009.11.001; Pennypacker KR, 2001, EXP NEUROL, V172, P307, DOI 10.1006/exnr.2001.7817; Pereira DS, 1996, ONCOGENE, V13, P445; PerezOtano I, 1996, GLIA, V16, P306, DOI 10.1002/(SICI)1098-1136(199604)16:4<306::AID-GLIA3>3.0.CO;2-Y; Quan N, 1999, J COMP NEUROL, V414, P114, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;114::AID-CNE9&gt;3.0.CO;2-G; Quan N, 1999, J NEUROIMMUNOL, V93, P72, DOI 10.1016/S0165-5728(98)00193-3; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; Quan N, 1997, P NATL ACAD SCI USA, V94, P10985, DOI 10.1073/pnas.94.20.10985; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schneider A, 1999, NAT MED, V5, P554; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Spooren A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/275892; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; Terai K, 1996, BRAIN RES, V739, P343, DOI 10.1016/S0006-8993(96)01073-6; Tounai H, 2007, METAB BRAIN DIS, V22, P89, DOI 10.1007/s11011-006-9040-3; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Voutsinos-Porche B, 2004, NEUROBIOL DIS, V17, P385, DOI 10.1016/j.nbd.2004.07.023; Ward NL, 2000, EUR J NEUROSCI, V12, P1867, DOI 10.1046/j.1460-9568.2000.00070.x; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Won SJ, 1999, NEUROSCIENCE, V94, P83, DOI 10.1016/S0306-4522(99)00196-7; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	63	30	30	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	OCT 14	2011	8								141	10.1186/1742-2094-8-141			14	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	843VM	WOS:000296703100001	21999414	DOAJ Gold, Green Published			2021-06-18	
J	De Bonis, P; Pompucci, A; Mangiola, A; Paternoster, G; Festa, R; Nucci, CG; Maviglia, R; Antonelli, M; Anile, C				De Bonis, Pasquale; Pompucci, Angelo; Mangiola, Annunziato; Paternoster, Giovanna; Festa, Rossano; Nucci, Carlotta Ginevra; Maviglia, Riccardo; Antonelli, Massimo; Anile, Carmelo			Decompressive Craniectomy for Elderly Patients with Traumatic Brain Injury: It's Probably not Worth the While	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; DC; elderly; outcome	AGE	Decompressive craniectomy (DC) has been regarded as an ultima ratio measure in the treatment of refractory intracranial hypertension after brain injury. Most discussion about its benefits is based on studies performed in patients who are < 65 years of age. The aim of this study was to identify patients aged >= 66 years who underwent DC after traumatic brain injury (TBI), in order to assess patient outcome and to correlate the values of potential predictors of survival on prognosis. From January 2002 to December 2009, 44 patients aged >= 66 underwent DC (follow-up, 12-102 months). Potential predictors of outcome were analyzed, including age, post-resuscitation Glasgow Coma Scale (GCS) score, presence of mass lesion, Simplified Acute Physiology Score (SAPS) II, Injury Severity Score (ISS), and timing of surgical decompression. Mortality was 48% at discharge from the intensive care unit (ICU), 57% at hospital discharge, and 77% at 1-year follow-up and at last follow-up. A bad outcome Glasgow Outcome Scale Dead-Vegetative State-Severely Disabled (GOS D-VS-SD) was observed in 36/44 patients both at hospital discharge and at 1-year follow-up. Mean SAPS II was 45.2 for patients who survived and 57.3 for patients who had died (p = 0.0022). Patients who survived had a higher mean post-resuscitation GCS score (p = 0.02). Logistical regression analysis indicated post-resuscitation GCS score as the only independent predictive factor for outcome. None of the 22 patients with a post-resuscitation GCS score of 3-5 had a good outcome, 2/10 (20%) patients with a post-resuscitation GCS score of 6-8 and 6/12 patients (50%) with a post-resuscitation GCS score >= 9 had a good outcome.	[De Bonis, Pasquale; Pompucci, Angelo; Mangiola, Annunziato; Paternoster, Giovanna; Nucci, Carlotta Ginevra; Anile, Carmelo] Catholic Univ, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Festa, Rossano; Maviglia, Riccardo; Antonelli, Massimo] Catholic Univ, Sch Med, Dept Anaesthesiol & Intens Care, I-00168 Rome, Italy	De Bonis, P (corresponding author), Catholic Univ, Sch Med, Inst Neurosurg, Lgo F Vito 1, I-00168 Rome, Italy.	debonisvox@gmail.com	de bonis, pasquale/K-8200-2016; maviglia, riccardo/AAK-9195-2020; Antonelli, Massimo/K-9915-2016; Nucci, Carlotta Ginevra/AAE-4748-2019	de bonis, pasquale/0000-0002-9879-8940; Antonelli, Massimo/0000-0003-3007-1670; maviglia, riccardo/0000-0001-8009-6943; Festa, Rossano/0000-0002-6685-1719; Nucci, Carlotta Ginevra/0000-0002-9016-7503			Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2010, J NEUROSURG, V112, P1150, DOI 10.3171/2009.7.JNS09505; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Savers S, 2000, J NEUROTRAUM, V17, P507; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d	15	30	30	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2011	28	10					2043	2048		10.1089/neu.2011.1889			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	839OX	WOS:000296378500005	21639728				2021-06-18	
J	Franschman, G; Peerdeman, SM; Andriessen, TMJC; Greuters, S; Toor, AE; Vos, PE; Bakker, FC; Loer, SA; Boer, C				Franschman, Gaby; Peerdeman, Saskia M.; Andriessen, Teuntje M. J. C.; Greuters, Sjoerd; Toor, Annelies E.; Vos, Pieter E.; Bakker, Fred C.; Loer, Stephan A.; Boer, Christa		ALARM-TBI Investigators	Effect of Secondary Prehospital Risk Factors on Outcome in Severe Traumatic Brain Injury in the Context of Fast Access to Trauma Care	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Dutch-Association-of-Anaesthesiologists (NVA)	OCT 04, 2009	Ulm, GERMANY	Dutch Assoc Anesthesiol (NVA)		Traumatic brain injury; Prehospital endotracheal intubation; Emergency medical service; Outcome	RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; NEUROPROTECTIVE AGENTS; CLINICAL-TRIALS; IMPACT; HYPOXIA; HYPERVENTILATION; VENTILATION; MANAGEMENT; KETAMINE	Background: Prevention of secondary prehospital risk factors such as hypoxia and hypotension is likely to improve patient prognosis in severe traumatic brain injury (TBI). Because the Dutch trauma care organization is characterized by fast access to specialized trauma care due to the geographical situation, we investigated whether and to what extend secondary risk factors, such as hypoxia and hypotension, and measures, such as endotracheal intubation, affect outcome in severe TBI in the context of a region with fast access to trauma care. Methods: The medical records of 339 subsequent computed tomography-confirmed patients with TBI with a Glasgow coma scale (GCS) score <= 8 who were primarily referred to a Level I trauma center in Amsterdam or Nijmegen in the Netherlands were retrospectively analyzed. Results: Multinomial logistic regression revealed that the strongest outcome predictors in our population were a disturbed pupillary reflex (odds ratio [OR], 5.8), a GCS score of 3 (OR, 4.9), and arterial hypotension (OR, 3.5). Interestingly, we observed no differences between intubated and nonintubated patients with respect to metabolic and respiratory parameters or mortality whereby the injury severity score was slightly higher in endotracheally intubated patients (32 [25-41]) versus nonintubated patients (25 [22-29]). Conclusion: In agreement with others, GCS, a disturbed pupil reflex, and arterial hypotension were predictive for the prognosis of primarily referred patients with severe TBI in the Netherlands. In contrast, in the perspective of slightly higher injury scores in intubated patients, prehospital endotracheal intubation was not predictive for patient outcome.	[Franschman, Gaby; Greuters, Sjoerd; Loer, Stephan A.; Boer, Christa] Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, NL-1081 HV Amsterdam, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam Med Ctr, Dept Neurosurg, NL-1081 HV Amsterdam, Netherlands; [Bakker, Fred C.] Vrije Univ Amsterdam Med Ctr, Dept Traumatol, NL-1081 HV Amsterdam, Netherlands; [Andriessen, Teuntje M. J. C.; Vos, Pieter E.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Franschman, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl	Vos, Pieter/A-6043-2012	Boer, Christa/0000-0002-7781-6951			Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2008, PREHOSP EMERG CARE, V12, P46, DOI 10.1080/10903120701710470; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; *FDN NAT AMB EM RO, 2007, LAND PROT AMB LPA7; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang H E, 2001, Prehosp Emerg Care, V5, P134, DOI 10.1080/10903120190939995; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	37	30	31	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					826	832		10.1097/TA.0b013e31820cebf0			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	833ZT	WOS:000295925700016	21427618				2021-06-18	
J	Silva, LFA; Hoffmann, MS; Rambo, LM; Ribeiro, LR; Lima, FD; Furian, AF; Oliveira, MS; Fighera, MR; Royes, LFF				Almeida Silva, Luiz Fernando; Hoffmann, Mauricio Scope; Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo; Lima, Frederico Diniz; Furian, Ana Flavia; Oliveira, Mauro Schneider; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			The involvement of Na+, K+-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Na+,K+-ATPase; Fluid percussion brain injury; Oxidative damage; Seizures; Protein carbonylation; TBARS	OXIDATIVE STRESS; NITRIC-OXIDE; POSTTRAUMATIC EPILEPSY; NA+,K+-ATPASE ACTIVITY; HEAD-INJURY; MODEL; INHIBITION; ACID; PEROXYNITRITE; QUANTITATION	Although the importance of brain trauma as risk factor for the development of epilepsy is well established, the mechanisms of epileptogenesis are not well understood. In the present study, we revealed that the injection of a subthreshold dose of PTZ (30 mg/Kg, i.p.) after 5 weeks of injury induced by Fluid Percussion Brain Injury (FPI) decreased latency for first clonic seizures, increased the time of spent generalized tonic-clonic seizures and electrocorticographic (EEG) wave amplitude. In addition, statistical analysis revealed that N-acetylcysteine (NAC) (100 mg/kg) supplementation during 5 weeks after neuronal injury protected against behavioral and electrographical seizure activity elicited by subthreshold dose of PTZ. The supplementation of this antioxidant compound also protected against the Na+,K+-ATPase activity inhibition and concomitant increase in the levels of oxidative stress markers (protein carbonylation and thiobarbituric acid-reactive substances-TBARS) in site and peri-contusional cortical tissue. In summary, the current experiments clearly showed that FPI model induces early posttraumatic seizures and suggest that an alteration in the lipid/protein oxidation, membrane fluidity, and Na+, K+-ATPase activity may be correlated with neuronal excitability, a significant component of the secondary injury cascade that accompanies TBI. Crown Copyright (c) 2011 Published by Elsevier B.V All rights reserved.	[Hoffmann, Mauricio Scope; Furian, Ana Flavia; Oliveira, Mauro Schneider; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Ciencias Saude, Lab Neurotoxicidade & Psicofarmacol, Dept Fisiol, BR-97105900 Santa Maria, RS, Brazil; [Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim, BR-90035003 Porto Alegre, RS, Brazil; [Almeida Silva, Luiz Fernando; Lima, Frederico Diniz; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Dept Metodos & Tecn Desport, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Pontificia Univ Catolica Rio de Janeiro PUC, InsCer, BR-90619900 Porto Alegre, RS, Brazil	Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecn Desport, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Oliveira, Mauro Schneider/G-3437-2012; Hoffmann, Mauricio/AAM-9899-2020; Rambo, Leonardo/F-8195-2012; Fighera, Michele R/J-9576-2014	Oliveira, Mauro Schneider/0000-0002-5381-1208; Hoffmann, Mauricio/0000-0003-4232-3169; Ribeiro, Leandro/0000-0002-8442-4075; Almeida Silva, Luiz Fernando/0000-0002-7621-4836; Rambo, Leonardo/0000-0002-4769-3663			ARMSTEAD WM, 1993, AM J PHYSIOL, V264, pH381; Ashman TA, 2006, MT SINAI J MED, V73, P999; Barriviera MD, 2005, NITRIC OXIDE-BIOL CH, V13, P10, DOI 10.1016/j.niox.2005.04.007; Boldyrev AA, 1997, BBA-BIOENERGETICS, V1321, P243, DOI 10.1016/S0005-2728(97)00053-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; Chen G, 2008, MEDIAT INFLAMM, V71, P1; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dawson VL, 1996, P SOC EXP BIOL MED, V211, P33; Devi PU, 2006, FUND CLIN PHARMACOL, V20, P247, DOI 10.1111/j.1472-8206.2006.00401.x; Erakovic V, 2003, NEUROCHEM INT, V42, P173, DOI 10.1016/S0197-0186(02)00070-0; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Fighera MR, 2006, NEUROBIOL DIS, V22, P611, DOI 10.1016/j.nbd.2006.01.002; Frantseva MV, 2000, NEUROSCIENCE, V97, P431, DOI 10.1016/S0306-4522(00)00041-5; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gluck MR, 2000, EPILEPSY RES, V39, P63, DOI 10.1016/S0920-1211(99)00111-4; Golarai G, 2001, J NEUROSCI, V21, P8523; GRISAR T, 1992, EPILEPSY RES, V12, P141, DOI 10.1016/0920-1211(92)90034-Q; Gupta YK, 2003, PHARMACOL BIOCHEM BE, V74, P579, DOI 10.1016/S0091-3057(02)01044-4; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; IKEDA Y, 1989, Neurological Research, V11, P213; Jamme I, 1995, NEUROREPORT, V7, P333; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Love R, 2005, LANCET NEUROL, V4, P458, DOI 10.1016/S1474-4422(05)70128-9; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Muriel P, 2000, NITRIC OXIDE-BIOL CH, V4, P333, DOI 10.1006/niox.2000.0285; Muriel P, 2003, J APPL TOXICOL, V23, P275, DOI 10.1002/jat.922; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Patsoukis N, 2005, EPILEPSIA, V46, P1205, DOI 10.1111/j.1528-1167.2005.63704.x; Petrushanko I, 2006, AM J PHYSIOL-REG I, V290, pR916, DOI 10.1152/ajpregu.00038.2005; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Prigol M, 2007, BRAIN RES, V1147, P226, DOI 10.1016/j.brainres.2007.01.126; PSARROPOULOU C, 1994, EPILEPSIA, V35, P12, DOI 10.1111/j.1528-1157.1994.tb02906.x; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rauca C, 1999, BRAIN RES, V847, P347, DOI 10.1016/S0006-8993(99)02084-3; Ribeiro MCP, 2005, EPILEPSY RES, V66, P185, DOI 10.1016/j.eplepsyres.2005.08.005; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Samuelsson C, 2003, EPILEPSY RES, V56, P165, DOI 10.1016/j.eplepsyres.2003.09.004; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scantlebury MH, 2005, ANN NEUROL, V58, P41, DOI 10.1002/ana.20512; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Walsh LA, 1999, J PHARMACOL EXP THER, V289, P1626; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86	65	30	31	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2011	308	1-2					35	40		10.1016/j.jns.2011.06.030			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	816IO	WOS:000294592100008	21737104				2021-06-18	
J	Cappa, KA; Conger, JC; Conger, AJ				Cappa, Kimberly A.; Conger, Judith C.; Conger, Anthony J.			Injury Severity and Outcome: A Meta-Analysis of Prospective Studies on TBI Outcome	HEALTH PSYCHOLOGY			English	Article						meta-analysis; traumatic brain injury; injury severity; outcome	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; ACUTE PREDICTORS; RETURN; WORK; EMPLOYMENT; SCORE; HETEROGENEITY; PRODUCTIVITY; SATISFACTION	Objective: The recent movement to apply evidenced-based approaches to medical and rehabilitation care has increased the importance of approximating outcomes as early in the recovery process as possible. The relationship between injury severity and outcome following traumatic brain injury (TBI), however, has remained unclear due to the variety of predictor and criterion variables used throughout the literature. Method: A meta-analysis of eligible prospective studies that assessed the bivariate association between injury severity and outcome at 1-year postinjury was conducted. Results: Twenty-six studies met the inclusion criteria (total N = 21,050 patients). Injury severity was a significant predictor of outcome at 1-year postinjury (r =.257). Homogeneity testing by means of the Q test, Q(n), indicated that injury severity measurement, Q(68) = 1140.76, p < .00001, outcome measurement, Q(42) = 516.63, p < .00001, and outcome measurement construct, Q(4) = 14.65, p = .006, were significant moderators of the injury severity/outcome link. Further, the magnitude of the effect between injury severity and outcome resulted from a significant interaction between the measure of injury severity and the outcome construct. Conclusions: Overall, measures of injury severity were most significantly associated with measures of global outcome and most poorly associated with measures of satisfaction with life. Additionally, a significant interaction was found between the measure of injury severity and the outcome construct indicating that different measures of injury severity more precisely predict one outcome construct over another. Methodological concerns were discussed and recommendations for creating a more parsimonious and integrated literature base were made.	[Cappa, Kimberly A.; Conger, Judith C.; Conger, Anthony J.] Purdue Univ, Dept Psychol, W Lafayette, IN 47907 USA	Cappa, KA (corresponding author), Purdue Univ, Dept Psychol, 703 3rd St, W Lafayette, IN 47907 USA.	kcappa@psych.purdue.edu		Davis, Kimberly/0000-0002-3695-4784			Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; COPES WS, 1989, 33RD P ASS ADV AUT M, P205; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FINKELSTEIN EA, 2006, INCIDENCE EC BURDEN, DOI DOI 10.1093/ACPROF:OSO/9780195179484.001.001; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hawkins ML, 2005, AM SURGEON, V71, P920; Hedges LV., 1982, J EDUC STAT, V7, P119; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lipsey M.W., 2001, PRACTICAL META ANAL; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nightingale EJ, 2007, BRAIN IMPAIR, V8, P101, DOI [10.1375/brim.8.2.101, DOI 10.1375/BRIM.8.2.101]; Novack T., 2000, ORIENTATION LOG; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright J., 2000, DISABILITY RATING SC	50	30	32	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	SEP	2011	30	5					542	560		10.1037/a0025220			19	Psychology, Clinical; Psychology	Psychology	819ZU	WOS:000294876100006	21875208				2021-06-18	
J	Scheurer, E; Lovblad, KO; Kreis, R; Maier, SE; Boesch, C; Dirnhofer, R; Yen, K				Scheurer, E.; Lovblad, K-O; Kreis, R.; Maier, S. E.; Boesch, C.; Dirnhofer, R.; Yen, K.			Forensic Application of Postmortem Diffusion-Weighted and Diffusion Tensor MR Imaging of the Human Brain in Situ	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; MULTIPLE-SCLEROSIS BRAIN; MAGNETIC-RESONANCE; WATER DIFFUSION; WHITE-MATTER; HUMAN STROKE; COEFFICIENT; ANISOTROPY; FIXATION; INJURY	BACKGROUND AND PURPOSE: DWI and DTI of the brain have proved to be useful in many neurologic disorders and in traumatic brain injury. This prospective study aimed at the evaluation of the influence of the PMI and the cause of death on the ADC and FA for the application of DWI and DTI in forensic radiology. MATERIALS AND METHODS: DWI and DTI of the brain were performed in situ in 20 deceased subjects with mapping of the ADC and FA. Evaluation was performed in different ROIs, and the influence of PM) and cause of death was assessed. RESULTS: Postmortem ADC values of the brain were decreased by 49%-72% compared with healthy living controls. With increasing PMI, ADCs were significantly reduced when considering all ROIs together and, particularly, GM regions (all regions, P < .05; GM, P < .01), whereas there was no significant effect in WM. Concerning the cause of death, ADCs were significantly lower in mechanical and hypoxic brain injury than in brains from subjects having died from heart failure (traumatic brain injury, P < .005; hypoxia, P < .001). Postmortem FA was not significantly different from FA in living persons and showed no significant influence of PMI or cause of death. CONCLUSIONS: Performing postmortem DWI and DTI of the brain in situ can provide valuable information for application in forensic medicine. ADC could be used as an indicator of PM! and could help in the assessment of the cause of death.	[Scheurer, E.; Yen, K.] Ludwig Boltzmann Inst Clin Forens Imaging, A-8010 Graz, Austria; [Scheurer, E.; Yen, K.] Med Univ Graz, Graz, Austria; [Scheurer, E.; Dirnhofer, R.; Yen, K.] Univ Bern, Inst Forens Med, Bern, Switzerland; [Lovblad, K-O] Univ Geneva, Dept Radiol, Geneva, Switzerland; [Lovblad, K-O] Univ Bern, Inselspital, Dept Neuroradiol, CH-3010 Bern, Switzerland; [Kreis, R.; Boesch, C.] Univ Bern, Dept Clin Res, MR Spect & Methodol, Bern, Switzerland; [Maier, S. E.] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA	Scheurer, E (corresponding author), Ludwig Boltzmann Inst Clin Forens Imaging, Univ Pl 4-11, A-8010 Graz, Austria.	eva.scheurer@cfi.lbg.ac.at	Scheurer, Eva/AAE-6161-2019; Kreis, Roland/F-2550-2010; Lovblad, Karl/AAF-7678-2020; Boesch, Chris/F-2577-2010	Scheurer, Eva/0000-0002-2742-0422; Kreis, Roland/0000-0002-8618-6875; Boesch, Chris/0000-0001-8498-8543; lovblad, karl-olof/0000-0003-2768-9779	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB010195] Funding Source: NIH RePORTER; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB010195] Funding Source: Medline		Aghayev E, 2004, NEURORADIOLOGY, V46, P559, DOI 10.1007/s00234-004-1212-4; Anon J, 2008, J MAGN RESON IMAGING, V28, P823, DOI 10.1002/jmri.21495; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; D'Arceuil H, 2007, NEUROIMAGE, V36, P64, DOI 10.1016/j.neuroimage.2007.02.039; Engelter ST, 2000, AM J ROENTGENOL, V175, P425, DOI 10.2214/ajr.175.2.1750425; Englund E, 2004, J NEUROL, V251, P350, DOI 10.1007/s00415-004-0318-2; Filippi CG, 2003, RADIOLOGY, V229, P44, DOI 10.1148/radiol.2291020049; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ith M, 2002, MAGNET RESON MED, V48, P915, DOI 10.1002/mrm.10294; Jones NR, 1998, J CLIN NEUROSCI, V5, P73, DOI 10.1016/S0967-5868(98)90207-7; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; Larsson EM, 2004, DEMENT GERIATR COGN, V17, P316, DOI 10.1159/000077162; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lovblad KO, 2000, STROKE, V31, P539, DOI 10.1161/01.STR.31.2.539; MOONEN CTW, 1991, MAGNET RESON MED, V19, P327, DOI 10.1002/mrm.1910190223; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1; Pfefferbaum A, 2004, NEUROIMAGE, V21, P1585, DOI 10.1016/j.neuroimage.2003.11.024; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheurer E, 2005, NMR BIOMED, V18, P163, DOI 10.1002/nbm.934; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Shepherd TM, 2009, NEUROIMAGE, V44, P820, DOI 10.1016/j.neuroimage.2008.09.054; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sun SW, 2009, NEUROIMAGE, V44, P611, DOI 10.1016/j.neuroimage.2008.10.032; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Watanabe T, 2004, J NEUROSURG, V100, P56, DOI 10.3171/jns.2004.100.1.0056; Weber J, 2000, NEURORADIOLOGY, V42, P184, DOI 10.1007/s002340050042; Yen K, 2006, AM J NEURORADIOL, V27, P70; Yen K, 2005, INT J LEGAL MED, V119, P129, DOI 10.1007/s00414-004-0507-7	40	30	30	0	8	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2011	32	8					1518	1524		10.3174/ajnr.A2508			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	831CL	WOS:000295706200026	21659482	Other Gold, Green Published			2021-06-18	
J	Wagner, AK; Amin, KB; Niyonkuru, C; Postal, BA; McCullough, EH; Ozawa, H; Dixon, CE; Bayir, H; Clark, RS; Kochanek, PM; Fabio, A				Wagner, Amy K.; Amin, Krutika B.; Niyonkuru, Christian; Postal, Brett A.; McCullough, Emily H.; Ozawa, Haishin; Dixon, C. Edward; Bayir, Hulya; Clark, Robert S.; Kochanek, Patrick M.; Fabio, Anthony			CSF Bcl-2 and cytichrome C temporal profiles in outcome prediction for adults with severe TBI	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Bcl-2; biomarker; cerebral spinal fluid; cytochrome C; outcome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; SEVERE HEAD-INJURY; CYTOCHROME-C; CEREBROSPINAL-FLUID; TRANSGENIC MICE; CELL-DEATH; OXIDATIVE-STRESS; APOPTOSIS; PROTEIN	The biochemical cascades associated with cell death after traumatic brain injury (TBI) involve both pro-survival and pro-apoptotic proteins. We hypothesized that elevated cerebrospinal fluid (CSF) BcI-2 and cytochrome "C (CytoC) levels over time would reflect cellular injury response and predict long-term outcomes after TBI. Cerebrospinal fluid BcI-2.and CytoC levels were measured for 6 days after injury for adults with severe TBI (N=76 subjects; N=277 samples). Group-based trajectory analysis was used to generate distinct temporal biomarker profiles that were compared with Glasgow Outcome Scale (GOS) and Disability Rating Scale (DRS) scores at 6 and 12 months after TBI. Subjects with persistently elevated temporal BcI-2 and CytoC profiles compared with healthy controls had the worst outcomes at 6 and 12 months (P <= 0.027). Those with CytoC profiles near controls had better long-term outcomes, and those with declining CytoC levels over time had intermediate outcomes. Subjects with BcI-2 profiles that remained near controls had better outcomes than those with consistently elevated BcI-2 profiles. However, subjects with BcI-2 values that started near controls and steadily rose over time had 100% good outcomes by 12 months after TBI. These results show the prognostic value of BcI-2 and CytoC profiles and suggest a dynamic apoptotic and pro-survival response to TBI. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1886-1896: doi:10.1038/jcbfm.2011.31; published online 30 March 2011	[Wagner, Amy K.; Amin, Krutika B.; Niyonkuru, Christian; Postal, Brett A.; McCullough, Emily H.; Ozawa, Haishin; Dixon, C. Edward; Fabio, Anthony] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, Amy K.; Dixon, C. Edward; Bayir, Hulya; Clark, Robert S.; Kochanek, Patrick M.] Univ Pittsburgh, Safer Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Bayir, Hulya; Clark, Robert S.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Fabio, Anthony] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Fabio, Anthony/0000-0002-6808-4939	DODUnited States Department of Defense [PT073914 W81XWH-08-1-0237, R49 CCR323155-03]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01NS030318-16];  [DODW81XWH-071-0701]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER	This work was supported by DODW81XWH-071-0701 (AKW, AF), DOD PT073914 W81XWH-08-1-0237 (AKW, AF), R49 CCR323155-03 (AKW, AF, PMK, HB), NIH 5P01NS030318-16 (CED, PMK, RSB).	Alkayed NJ, 2001, J NEUROSCI, V21, P7543; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Bayir H, 2009, J BIOL CHEM, V284, P15951, DOI 10.1074/jbc.M900418200; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Camlica H, 2008, AM J CLIN ONCOL-CANC, V31, P585, DOI 10.1097/COC.0b013e318174dbd2; Cardali S, 2006, J Neurosurg Sci, V50, P25; Clark RSB, 2005, CRIT CARE MED, V33, pS407, DOI 10.1097/01.CCM.0000191712.96336.51; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Comim CM, 2008, MITOCHONDRION, V8, P313, DOI 10.1016/j.mito.2008.07.002; Conti AC, 1998, J NEUROSCI, V18, P5663; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; GOURIEROUX C, 1982, ECONOMETRICA, V50, P63, DOI 10.2307/1912529; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; JENNETT B, 1975, LANCET, V1, P480; Jones KE, 2001, J PHYSIOL-LONDON, V536, P635, DOI 10.1111/j.1469-7793.2001.0635c.xd; Kavathia N, 2009, AGING-US, V1, P652, DOI 10.18632/aging.100069; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Love S, 1999, BRAIN PATHOL, V9, P119; Nagin D., 2005, GROUP BASED MODELING; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Ozawa H, 2009, J NEUROTRAUM, V26, pA71; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Renz A, 2001, ADV EXP MED BIOL, V495, P331; RINK A, 1995, AM J PATHOL, V147, P1575; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	43	30	30	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2011	31	9					1886	1896		10.1038/jcbfm.2011.31			11	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	815KK	WOS:000294524300007	21448217	Green Published, Bronze			2021-06-18	
J	Baxter, PS; Martel, MA; McMahon, A; Kind, PC; Hardingham, GE				Baxter, Paul S.; Martel, Marc-Andre; McMahon, Aoife; Kind, Peter C.; Hardingham, Giles E.			Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1	JOURNAL OF NEUROCHEMISTRY			English	Article						Ca(2+) signaling; CREB; gene regulation; neuroprotective signalling; neurotoxicity; transcription factors	CAM KINASE-IV; SENSITIVE COINCIDENCE DETECTOR; VASOACTIVE-INTESTINAL-PEPTIDE; MEDIATED GENE-EXPRESSION; RAT CORTICAL-NEURONS; CLOSED-HEAD INJURY; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; SYNAPTIC ACTIVITY; TERM POTENTIATION	Pituitary adenylate cyclase-activating peptide (PACAP) is a neuroprotective peptide which exerts its effects mainly through the cAMP-protein kinase A (PKA) pathway. Here, we show that in cortical neurons, PACAP-induced PKA signaling exerts a major part of its neuroprotective effects indirectly, by triggering action potential (AP) firing. Treatment of cortical neurons with PACAP induces a rapid and sustained PKA-dependent increase in AP firing and associated intracellular Ca(2+) transients, which are essential for the anti-apoptotic actions of PACAP. Transient exposure to PACAP induces long-lasting neuroprotection in the face of apoptotic insults which is reliant on AP firing and the activation of cAMP response element (CRE) binding protein (CREB)-mediated gene expression. Although direct, activity-independent PKA signaling is sufficient to trigger phosphorylation on CREB's activating serine-133 site, this is insufficient for activation of CREB-mediated gene expression. Full activation is dependent on CREB-regulated transcription co-activator 1 (CRTC1), whose PACAP-induced nuclear import is dependent on firing activity-dependent calcineurin signaling. Over-expression of CRTC1 is sufficient to rescue PACAP-induced CRE-mediated gene expression in the face of activity-blockade, while dominant negative CRTC1 interferes with PACAP-induced, CREB-mediated neuroprotection. Thus, the enhancement of AP firing may play a significant role in the neuroprotective actions of PACAP and other adenylate cyclase-coupled ligands.	[Baxter, Paul S.; Martel, Marc-Andre; McMahon, Aoife; Kind, Peter C.; Hardingham, Giles E.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	Hardingham, GE (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	giles.hardingham@ed.ac.uk		Hardingham, Giles/0000-0002-7629-5314; Kind, Peter/0000-0002-4256-9639; McMahon, Aoife/0000-0003-0978-0309	Wellcome TrustWellcome TrustEuropean Commission; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601584, G0700967, G0902044] Funding Source: researchfish	We thank Paulo Sassone-Corsi, Yang Zhou and Dong-Yan Jin for plasmids. This work is funded by the Wellcome Trust, the MRC and the BBSRC.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Atlasz T, 2010, ANN NY ACAD SCI, V1200, P128, DOI 10.1111/j.1749-6632.2010.05512.x; Aubert N, 2006, J NEUROCHEM, V99, P1237, DOI 10.1111/j.1471-4159.2006.04148.x; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bell KFS, 2011, CURR OPIN NEUROBIOL, V21, P299, DOI 10.1016/j.conb.2011.01.002; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Brandon EP, 1998, J NEUROSCI, V18, P3639; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Costa L, 2009, HIPPOCAMPUS, V19, P99, DOI 10.1002/hipo.20488; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Dejda A, 2008, J MOL NEUROSCI, V36, P26, DOI 10.1007/s12031-008-9087-1; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Falktoft B, 2009, NEUROPEPTIDES, V43, P387, DOI 10.1016/j.npep.2009.08.002; Falluel-Morel A, 2004, J NEUROCHEM, V91, P1231, DOI 10.1111/j.1471-4159.2004.02810.x; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gonzalez-Rey E, 2007, CURR PHARM DESIGN, V13, P1113, DOI 10.2174/138161207780618966; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hu EL, 2011, CEREB CORTEX, V21, P708, DOI 10.1093/cercor/bhq143; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Lancaster B, 2006, J PHYSIOL-LONDON, V576, P403, DOI 10.1113/jphysiol.2006.115295; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MacDonald JF, 2007, BBA-BIOMEMBRANES, V1768, P941, DOI 10.1016/j.bbamem.2006.12.006; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; MINTA A, 1989, J BIOL CHEM, V264, P8171; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Otto C, 2001, J NEUROSCI, V21, P5520; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pedarzani P, 1995, J NEUROPHYSIOL, V74, P2749; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Pokorska A, 2003, J NEUROCHEM, V84, P447, DOI 10.1046/j.1471-4159.2003.01504.x; Racz B, 2006, ANN NY ACAD SCI, V1070, P507, DOI 10.1196/annals.1317.070; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Reglodi D, 2006, ANN NY ACAD SCI, V1070, P518, DOI 10.1196/annals.1317.072; Reglodi D, 2000, STROKE, V31, P1411, DOI 10.1161/01.STR.31.6.1411; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shintani N, 2005, REGUL PEPTIDES, V126, P123, DOI 10.1016/j.regpep.2004.08.014; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Soriano FX, 2007, J PHYSIOL-LONDON, V584, P381, DOI 10.1113/jphysiol.2007.138875; Soriano FX, 2011, ANTIOXID REDOX SIGN, V14, P1425, DOI 10.1089/ars.2010.3568; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; Tamas A, 2006, ANN NY ACAD SCI, V1070, P570, DOI 10.1196/annals.1317.083; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Uchida D, 1996, BRAIN RES, V736, P280, DOI 10.1016/S0006-8993(96)00716-0; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Walton M, 1999, J NEUROCHEM, V73, P1836; Wang G, 2008, NEUROPEPTIDES, V42, P267, DOI 10.1016/j.npep.2008.03.002; Watson RF, 2006, J NEUROSCI, V26, P5393, DOI 10.1523/JNEUROSCI.0750-06.2006; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	91	30	30	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	AUG	2011	118	3					365	378		10.1111/j.1471-4159.2011.07330.x			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	791GY	WOS:000292654300006	21623792	Green Published, Bronze			2021-06-18	
J	Cotton, BA; Kao, LS; Kozar, R; Holcomb, JB				Cotton, Bryan A.; Kao, Lillian S.; Kozar, Rosemary; Holcomb, John B.			Cost-Utility Analysis of Levetiracetam and Phenytoin for Posttraumatic Seizure Prophylaxis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Phenytoin; Fosphenytoin; Levetiracetam; Seizure; Brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FOLLOW-UP; EPILEPSY; MORTALITY; IMPACT; ADULTS; DEATH	Background: The standard for early posttraumatic brain injury (TBI) seizure prophylaxis is phenytoin. Despite its effectiveness, some argue for the use of newer antiepileptics (e.g., levetiracetam) because phenytoin requires close monitoring to maintain its therapeutic window and is associated with rare cutaneous hypersensitivity reactions. The purpose of this study was to evaluate whether phenytoin or levetiracetam would be more cost-effective in preventing early post-TBI seizures and reducing their negative impact on TBI outcomes. Methods: Cost-effectiveness analysis with the following base case assumptions: (1) phenytoin patients receive 1.0 g fosphenytoin load + 3 days of 100 mg three times a day (TID), have level drawn on day 3, "therapeutic" patients receive 100 mg TID on days 4 to 7, and "subtherapeutic" patients receive 200 mg TID on days 4 to 7; (2) levetiracetam patients receive 500 mg load + 7 days of 500 mg two times a day. Glasgow Outcome Scale (GOS) scores 4 to 5 represent good outcome, and GOS scores 2 to 3 represent poor outcome. Patients who develop early seizures: 40% good outcome, 50% poor outcome, and 10% death. Those who do not develop seizures: 75% good outcome, 20% poor outcome, and 5% death. Quality of life outcomes by GOS: good = 0.7, poor = 0.3, and death = 0.0. Severe adverse events and those impacting costs are rare for each agent. Assumptions were obtained through hospital query and exhaustive literature review. Results: The cost of a 7-day course of fosphenytoin, phenytoin, and free phenytoin level was $37.50, whereas the cost of a 7-day course of levetiracetam was $480.00. Literature review noted phenytoin to be as effective as levetiracetam in preventing early post-TBI seizures (and more effective in subclinical seizures). Quality-adjusted life years (QALY) were 23.6 for phenytoin and 23.2 for levetiracetam. As a result, the cost/effectiveness ratios were $1.58/QALY for phenytoin and $20.72/QALY for levetiracetam. All sensitivity analyses favored phenytoin unless levetiracetam prevented 100% of seizures and cost <$400 for 7-day course. Conclusions: Phenytoin is more cost-effective than levetiracetam at all reasonable prices and at all clinically plausible reductions in post-TBI seizure potential.	[Cotton, Bryan A.] Univ Texas Hlth Sci Ctr, Ctr Translat Injury Res, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr, Dept Surg, Houston, TX 77030 USA	Cotton, BA (corresponding author), Univ Texas Hlth Sci Ctr, Ctr Translat Injury Res, 6410 Fannin St,1100-20 UPB, Houston, TX 77030 USA.	bryan.a.cotton@uth.tmc.edu		holcomb, john/0000-0001-8312-9157			BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Dasgupta AK, 1998, OCCUP MED-OXFORD, V48, P487, DOI 10.1093/occmed/48.8.487; Day SM, 2005, NEUROLOGY, V65, P216, DOI 10.1212/01.wnl.0000169018.44950.68; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dooley M, 2000, DRUGS, V60, P871, DOI 10.2165/00003495-200060040-00004; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fierro LS, 1996, AM J HEALTH-SYST PH, V53, P2707, DOI 10.1093/ajhp/53.22.2707; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Hesdorffer DC, 2005, EPILEPSIA, V46, P43, DOI 10.1111/j.1528-1167.2005.00408.x; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Maltoni S, 2003, CLIN DRUG INVEST, V23, P225, DOI 10.2165/00044011-200323040-00002; McCluggage LK, 2009, NEUROCRIT CARE, V10, P222, DOI 10.1007/s12028-008-9165-9; McNamara B, 2003, BRIT J ANAESTH, V90, P39, DOI 10.1093/bja/aeg008; Petkov T, 2007, EUR J DERMATOL, V17, P422, DOI 10.1684/ejd.2007.0241; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; So EL, 2009, EPILEPSIA, V50, P917, DOI 10.1111/j.1528-1167.2008.01906.x; Szaflarski JP, 2007, NEUROCRIT CARE, V7, P140, DOI 10.1007/s12028-007-0042-8; SZAFLARSKI JP, NEUROCRIT CARE, V12, P165; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Teasdale TW, 2000, BRAIN INJURY, V14, P363; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tisdall M, 2006, BRIT J NEUROSURG, V20, P285, DOI 10.1080/02688690600999786; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4	35	30	31	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2011	71	2					375	379		10.1097/TA.0b013e318224d307			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	806XH	WOS:000293850200034	21825941				2021-06-18	
J	Majdan, M; Mauritz, W; Brazinova, A; Rusnak, M; Leitgeb, J; Janciak, I; Wilbacher, I				Majdan, Marek; Mauritz, Walter; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes; Janciak, Ivan; Wilbacher, Ingrid			Severity and outcome of traumatic brain injuries (TBI) with different causes of injury	BRAIN INJURY			English	Article						Traumatic brain injuries; severity of outcome; causes of injury	EPIDEMIOLOGY; MANAGEMENT; VARIABLES; TREE	Introduction: Most epidemiological studies and reports have reached a consensus on the leading causes of traumatic brain injury (TBI). Despite the fact that the area of TBI is relatively well studied, reports on differences in severity and outcome of TBI with different causes are lacking. Goal: This paper analyses the differences in severity and in short- and long-term outcome of TBIs with different causes. Method: This study analysed data on 1109 patients with severe TBI by dividing them into three injury-cause groups: ''traffic-related'', ''falls'' and ''other causes''. Severity and outcome was evaluated using chosen direct and indirect indicators. Results: The most severe trauma occurred in the traffic-related group followed by falls and injuries with other causes. On the other hand, patients with traffic-related TBI had the best outcome. Age improves the outcome in the traffic-related group significantly. However, in the multivariate analysis after adjusting for age (and other important predictors including level of care) the odds for favourable long-term outcome stayed significantly higher in the traffic-related group. Conclusions: It is concluded that the causes of TBI should be considered by both clinicians and public health professionals as a lead in prognosis of outcome and policy planning.	[Majdan, Marek; Rusnak, Martin] Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, Marek; Mauritz, Walter; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes; Janciak, Ivan; Wilbacher, Ingrid] INRO Int Neurotrauma Res Org, Vienna, Austria	Majdan, M (corresponding author), Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Brazinova, Alexandra/C-4265-2016; Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board [FK 33/2003]; Austrian National Bank [8987]	The data used for this study were collected for a project funded by a European Union grant (Project 'Research-Treat-TBI'; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; contract number: ICA2-CT-2002-100) and for another project funded by the Austrian Worker's Compensation Board (AUVA; contract number FK 33/2003) and by the 'Jubilaeumsfonds' of the Austrian National Bank (project number 8987). INRO was supported by an annual grant from Mrs Ala Auersperg-Isham and Mr Ralph Isham and by donations from various other sources.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; R Development Core Team, 2010, R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	19	30	30	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					797	805		10.3109/02699052.2011.581642			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300001	21631184				2021-06-18	
J	Ward, JL; Harting, MT; Cox, CS; Mercer, DW				Ward, Jeremy L.; Harting, Matthew T.; Cox, Charles S., Jr.; Mercer, David W.			Effects of Ketamine on Endotoxin and Traumatic Brain Injury Induced Cytokine Production in the Rat	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cytokine; Cerebral edema; Ketamine; Lipopolysaccharide; Traumatic brain injury	CLOSED-HEAD INJURY; INFLAMMATORY CYTOKINES; IMPROVES SURVIVAL; ANESTHESIA; SEPSIS; INTERLEUKIN-1; SUPPRESSION; SUFENTANIL; EXPRESSION; PRESSURE	Background: Endotoxemia from lipopolysaccharide (LPS) induces systemic cytokine production, whereas traumatic brain injury (TBI) increases intracerebral cytokine production. In anesthetic doses, ketamine has potent anti-inflammatory properties. However, its anti-inflammatory effects at subanesthetic doses and its effects on TBI-induced inflammation have not been fully investigated. We hypothesized that ketamine would attenuate both LPS- and TBI-induced inflammatory responses. Methods: Male rats received intraperitoneal (i.p.) ketamine (70 mg/kg, 7 mg/kg, or 1 mg/kg) or saline 1 hour before LPS (20 mg/kg i.p.) or saline. Five hours after LPS, rats were killed. Serum was collected for cytokine analysis. In other experiments, male rats were given ketamine (7 mg/kg i.p.) or saline 1 hour before induction of TBI with controlled cortical impact (or sham). One hour and 6 hours after injury, brain was extracted for analysis of cerebral edema and cytokine production. Results: LPS increased the serum concentrations of interleukin (IL)-1 alpha, IL-1 beta, IL-6, IL-10, tumor necrosis factor-alpha, and interferon-gamma. Ketamine dose dependently attenuated these changes. TBI caused cerebral edema and increased concentrations of cerebral IL-1 alpha, IL-1 beta, IL-6, IL-10, and tumor necrosis factor-alpha. However, ketamine had minimal effect on TBI-induced inflammation. Conclusions: Although ketamine did not seem to exert any beneficial effects against TBI in the rat, it did not exacerbate cytokine production or enhance cerebral edema as some studies have suggested.	[Ward, Jeremy L.] NYU, Dept Surg, Langone Med Ctr, New York, NY 10016 USA; [Harting, Matthew T.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA; [Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Dept Pediat Surg, Houston, TX USA; [Mercer, David W.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA	Ward, JL (corresponding author), NYU, Dept Surg, Langone Med Ctr, New Bellevue 15 N 1,550 1st Ave, New York, NY 10016 USA.	jeremy.ward@nyumc.org		Harting, Matthew/0000-0002-8929-8311	NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-38529, 08782]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM038529, T32GM008792] Funding Source: NIH RePORTER	Supported by NIGMS GM-38529 and 08782.	Adams SD, 2008, J TRAUMA, V65, P170, DOI 10.1097/TA.0b013e31805824ca; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bartoc C, 2006, J CARDIOTHOR VASC AN, V20, P217, DOI 10.1053/j.jvca.2005.12.005; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Camara CR, 2008, WORLD J GASTROENTERO, V14, P5192, DOI 10.3748/wjg.14.5192; Chang Y, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/705379; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; DeClue AE, 2008, AM J VET RES, V69, P228, DOI 10.2460/ajvr.69.2.228; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; Gurfinkel R, 2006, ANESTH ANALG, V103, P396, DOI 10.1213/01.ane.0000226140.84281.3e; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Harting MT, 2010, J SURG RES, V159, P557, DOI 10.1016/j.jss.2008.10.014; Helmer KS, 2006, DIGEST DIS SCI, V51, P1571, DOI 10.1007/s10620-005-9013-0; Helmer KS, 2003, J SURG RES, V112, P70, DOI 10.1016/S0022-4804(03)00138-0; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shaked G, 2004, RESUSCITATION, V62, P237, DOI 10.1016/j.resuscitation.2004.02.015; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Suliburk JW, 2005, SURGERY, V138, P134, DOI 10.1016/j.surg.2005.03.024; Suliburk JW, 2005, J SURG RES, V127, P203, DOI 10.1016/j.jss.2005.03.021; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Ward JL, 2010, DIGEST DIS SCI, V55, P902, DOI 10.1007/s10620-009-0800-x; Ward JL, 2010, J TRAUMA, V68, P69, DOI 10.1097/TA.0b013e3181a8b3a7; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Wu GJ, 2008, TOXICOL APPL PHARM, V228, P105, DOI 10.1016/j.taap.2007.11.027; Yu M, 2007, J PHARM PHARM SCI, V10, P434, DOI 10.18433/J3RP46; Yu M, 2007, INT IMMUNOPHARMACOL, V7, P1076, DOI 10.1016/j.intimp.2007.04.003; Zeyneloglu P, 2007, EXP CLIN TRANSPLANT, V5, P690	42	30	36	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2011	70	6					1471	1479		10.1097/TA.0b013e31821c38bd			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	775QR	WOS:000291478500036	21817985	Green Accepted			2021-06-18	
J	Ley, EJ; Srour, MK; Clond, MA; Barnajian, M; Tillou, A; Mirocha, J; Salim, A				Ley, Eric J.; Srour, Marissa K.; Clond, Morgan A.; Barnajian, Moshe; Tillou, Areti; Mirocha, James; Salim, Ali			Diabetic Patients With Traumatic Brain Injury: Insulin Deficiency Is Associated With Increased Mortality	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Diabetes mellitus; Hyperglycemia	CRITICALLY-ILL PATIENTS; GLUCOSE CONTROL; THERAPY	Background: Hyperglycemia after traumatic brain injury (TBI) is an independent predictor of mortality. Insulin deficiency, as opposed to elevated blood glucose, might be the reason for increased mortality. TBI patients with diabetes mellitus (DM) were analyzed to determine how insulin deficiency affects mortality after TBI. Methods: NTDB version 7 was queried for patients with isolated moderate to severe TBI (head abbreviated injury score [AIS] >= 3 with AIS <= 3 for other body regions). Demographics and outcomes were compared between TBI patients with insulin-dependent DM (IDDM), noninsulin-dependent DM (NIDDM), and those without DM. Logistic regression analysis was used to investigate the relationship between mortality and DM. Results: Overall, 51,585 patients with isolated moderate to severe TBI were analyzed. Mortality was 14.4% and 8.2% in patients with and without DM, respectively (p < 0.0001). Although head AIS scores were similar, patients with DM had a statistically higher Glasgow coma scale (GCS) at presentation compared with patients without DM (GCS score 12.4 vs. GCS score 10.9; p < 0.0001). After multivariable logistic regression analysis, DM was an independent predictor for mortality (odds ratio 1.5, confidence interval 1.29-1.74, p < 0.0001). When comparing TBI patients with IDDM to NIDDM, mortality was 17.1% for IDDM and 13.0% for NIDDM (p = 0.025). Conclusion: DM is a significant predictor for mortality after moderate to severe TBI. Insulin deficiency is a likely contributor to increased mortality after TBI as IDDM patients have higher mortality than NIDDM patients who have higher mortality than no-DM patients.	[Ley, Eric J.; Srour, Marissa K.; Clond, Morgan A.; Barnajian, Moshe; Mirocha, James; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Tillou, Areti] Univ Calif Los Angeles, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90024 USA	Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	eric.ley@cshs.org		Srour, Marissa/0000-0001-9206-2716; Clond, Morgan/0000-0002-3036-4193	American Association for the Surgery of Trauma Research and Education Foundation	Supported, in part, by a grant from the American Association for the Surgery of Trauma Research and Education Foundation.	Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340; Salim A, 2009, AM SURGEON, V75, P25; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	10	30	30	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5					1141	1144		10.1097/TA.0b013e3182146d66			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	762LQ	WOS:000290480300034	21610428				2021-06-18	
J	McClure, J				McClure, John			The Role of Causal Attributions in Public Misconceptions About Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						brain injury; misconceptions; attribution; stigma; rehabilitation	PHYSICAL-DISABILITY; REHABILITATION; DISCRIMINATION; BEHAVIOR; PROFESSIONALS; DEPRESSION; PEOPLE; STIGMA; DAMAGE; TBI	Objective: Social psychological theories such as attribution theory have been applied to conditions such as depression and physical disability, but not to traumatic brain injury (TBI). The goal of this paper is to show that that attribution theory and related concepts help to explain the public's misconceptions about TBI and other challenges faced by clinicians and families of persons with TBI. Results: Research shows that misconceptions about brain injury occur because people misattribute the actions of persons with brain injury. These misattributions reflect two features: (a) the absence of visible markers of the injury, and (b) the tendency to compare persons with TBI with their peers rather than their own preinjury performance. These two processes lead to the opposite pattern to the stigma that occurs with visible disabilities: specifically, a failure among members of the public to recognize that problematic behaviors may result from the injury. This analysis suggests several therapeutic strategies for managing public misconceptions in ways that enhance coping and recovery. Conclusion: Clarifying the attribution processes that underpin misconceptions about brain injury provides a framework for enhancing rehabilitation and addressing these misconceptions effectively.	Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand	McClure, J (corresponding author), Victoria Univ Wellington, Sch Psychol, POB 600, Wellington, New Zealand.	john.mcclure@vuw.ac.nz	McClure, John/O-9060-2015	McClure, John/0000-0002-9261-4995			ALLOY LB, 1999, J COGN PSYCHOTHER, V13, P226; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Boysen GA, 2008, J SOC CLIN PSYCHOL, V27, P447, DOI 10.1521/jscp.2008.27.5.447; Buchanan G.M., 1995, EXPLANATORY STYLE; COLLINS JK, 1983, ADOLESCENT BOY AUSTR; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Dunn D. S., 2010, HDB REHABILITATION P, P379; Dunn DS, 2008, REHABIL PSYCHOL, V53, P254, DOI 10.1037/a0012962; Dunn DS, 2005, REHABIL PSYCHOL, V50, P183, DOI 10.1037/0090-5550.50.2.183; Dunn DS, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P565, DOI 10.1037/10361-027; Dunn DS, 1996, REHABIL PSYCHOL, V41, P285, DOI 10.1037/0090-5550.41.4.285; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; FELDMAN DB, 2009, J SOC CLIN PSYCHOL, V26, P137; FINE M, 1988, J SOC ISSUES, V44, P3, DOI 10.1111/j.1540-4560.1988.tb02045.x; FOSTER LA, 2010, EFFECT FAMILIA UNPUB; Gibb BE, 2006, J CLIN CHILD ADOLESC, V35, P264, DOI 10.1207/s15374424jccp3502_10; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; GOUVIER WD, 1991, REHABIL PSYCHOL, V36, P121, DOI 10.1037/0090-5550.36.2.121; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hart H. L. A., 1985, CAUSATION LAW; Hastings RP, 1995, J INTELL DISABIL RES, V39, P474, DOI 10.1111/j.1365-2788.1995.tb00567.x; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Heider, 1958, PSYCHOL INTERPERSONA; HILTON DJ, 1986, PSYCHOL REV, V93, P75, DOI 10.1037/0033-295X.93.1.75; INGLIS M, 2002, NO MEAN FEAT; JONES EE, 1979, AM PSYCHOL, V34, P107, DOI 10.1037/0003-066X.34.2.107; Kapur N, 1997, INJURED BRAINS MED M; KARP DA, 2001, BURDEN SYMPATHY FAMI; Kelley H.H., 1967, NEBRASKA S MOTIVATIO, P192; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; KLECK RE, 1980, J PERS SOC PSYCHOL, V39, P861, DOI 10.1037/0022-3514.39.5.861; KLECK RE, 1983, REHABIL PSYCHOL, V28, P79, DOI 10.1037/h0090997; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; LERNER MJ, 1977, J PERS, V45, P3; LEVIN HS, 1993, HEAD INJURY; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Livneh H., 2001, J VOCATIONAL REHABIL, V16, P227; Martz E., 2003, J VOCATIONAL REHABIL, V18, P153; Matthews C., 2000, HDB COMMUNICATION PE, P405; McClure J, 1998, J PERS SOC PSYCHOL, V74, P7, DOI 10.1037/0022-3514.74.1.7; MCCLURE J, 1985, J PERS SOC PSYCHOL, V48, P1534, DOI 10.1037/0022-3514.48.6.1534; MCCLURE J, J HEAD TRAU IN PRESS; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2009, BRAIN IMPAIR, V10, P180, DOI 10.1375/brim.10.2.180; McGrath JC, 2007, ETHICAL PRACTICE BRA; Moore M., 2009, CAUSATION RESPONSIBI; MUKHERJEE D, 2003, WOMEN VISIBLE INVISI, P3; Olkin R, 2003, AM PSYCHOL, V58, P296, DOI 10.1037/0003-066X.58.4.296; OSBORN CL, 1998, MY HEAD DOCTORS STOR; PAULHUS DL, 1991, J PERS SOC PSYCHOL, V60, P307, DOI 10.1037/0022-3514.60.2.307; PHILLIPS J, 2000, EVEREST LIFE BRAIN I; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Rohmer O, 2009, REHABIL PSYCHOL, V54, P76, DOI 10.1037/a0014445; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; SELIGMAN MEP, 1998, SCI CLIN PSYCHOL ACC; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; SNYDER ML, 1979, J PERS SOC PSYCHOL, V37, P2297, DOI 10.1037/0022-3514.37.12.2297; Sutton RM, 2001, J PERS SOC PSYCHOL, V80, P222, DOI 10.1037/0022-3514.80.2.222; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TAYLOR AJW, 1999, TRAUMATOLOGYE, V5; Taylor S. E., 1978, ADV EXPT SOCIAL PSYC, V11, P249, DOI DOI 10.1016/S0065-2601(08)60009-X; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VALLACHER RR, 1987, PSYCHOL REV, V94, P3, DOI 10.1037/0033-295X.94.1.3; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Weiner B., 1995, JUDGMENTS RESPONSIBI; WILLIAMSON G, 1996, PSYCHOL AGING, V4, P502; Williamson GA, 2005, REHABIL PSYCHOL, V50, P215, DOI 10.1037/0090-5550.50.3.215; Wright B.A., 1983, PHYS DISABILITY PSYC, V2nd edition; Wright BA., 1972, REHABIL PSYCHOL, V19, P38, DOI DOI 10.1037/H0090869; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12	79	30	30	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2011	56	2					85	93		10.1037/a0023354			9	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	769KL	WOS:000291011800001	21574726				2021-06-18	
J	Sacco, S; Altobelli, E; Pistarini, C; Cerone, D; Cazzulani, B; Carolei, A				Sacco, Simona; Altobelli, Emma; Pistarini, Caterina; Cerone, Davide; Cazzulani, Benedetta; Carolei, Antonio			Validation of the Italian version of the Coma Recovery Scale-Revised (CRS-R)	BRAIN INJURY			English	Article						Vegetative state; minimally conscious state; consciousness; coma; rehabilitation	MINIMALLY CONSCIOUS STATES; TRAUMATIC BRAIN-INJURY; 4 SCORE; DISORDERS	Primary objective: To validate the Italian version of the Coma Recovery Scale-Revised (CRS-R). Methods: Two observers applied the Italian version of the CRS-R to selected patients. On day 1, observer A and B independently scored each patient; the comparison of their observations was used to evaluate inter-observer agreement. On day 2, observer A completed a second evaluation and the comparison of this observation with that obtained on day 1 by the same observer was used to evaluate test-re-test agreement. For each evaluation, also diagnostic impression (vegetative state/minimally conscious state) was reported. Results: Thirty-eight patients were evaluated (mean age +/- SD, 58.9 +/- 13.8 years). Inter-observer (rho = 0.81; p < 0.001) as well as test-re-test agreement (rho = 0.97; p < 0.001) for the total score was high. Inter-observer agreement was excellent for the communication sub-scale, good for the auditory, visual and motor sub-scales and moderate for the oromotor/verbal and arousal sub-scales. Test-re-test agreement was excellent for the visual, motor, oromotor/verbal and communication sub-scales, good for the auditory sub-scale and moderate for the arousal sub-scale. When considering the diagnostic impression, inter-observer agreement was good (kappa = 0.75; p < 0.001) and test-re-test agreement was excellent (kappa = 0.92; p < 0.001). Conclusions: The Italian version of the CRS-R can be administered reliably and can be also employed to discriminate patients in vegetative and in minimally conscious state.	[Sacco, Simona; Cerone, Davide; Carolei, Antonio] Univ Aquila, Dept Neurol, I-67100 Laquila, Italy; [Altobelli, Emma] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy; [Pistarini, Caterina; Cazzulani, Benedetta] IRCCS Salvatore Maugeri, Pavia, Italy	Sacco, S (corresponding author), Univ Aquila, Dept Neurol, Piazzale Salvatore Tommasi 1, I-67100 Laquila, Italy.	simona.sacco@cc.univaq.it	Pistarini, CATERINA/K-5234-2018; Sacco, Simona/I-5253-2012; Cazzulani, Benedetta/AAC-1818-2020	Pistarini, CATERINA/0000-0001-8925-0484; Sacco, Simona/0000-0003-0651-1939; Cazzulani, Benedetta/0000-0002-1219-9163			Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Carolei A, 2007, FUNCT NEUROL, V22, P9; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	18	30	34	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2011	25	5					488	495		10.3109/02699052.2011.558043			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	745KQ	WOS:000289164700006	21401371				2021-06-18	
J	Claudia, C; Claudia, R; Agostino, O; Simone, M; Stefano, G				Claudia, Casula; Claudia, Ranalli; Agostino, Ognibene; Simone, Magazzini; Stefano, Grifoni			Minor Head Injury in Warfarinized Patients: Indicators of Risk for Intracranial Hemorrhage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head injury; Warfarin; Intracranial hemorrhage; Computed tomography; INR	ELDERLY TRAUMA PATIENTS; PREINJURY WARFARIN; ANTICOAGULATED PATIENTS; BRAIN-INJURY; IMPACT	Background: Head injury represents one of the most important and frequent traumatic pathology in the emergency department. Among the different risk factors, preinjury use of warfarin has received considerable attention in trauma literature. The aim of this study was to identify further risk indicators of intracranial hemorrhage (ICH) to improve risk stratification of warfarinized patients with minor head injuries. Methods: Medical records of 1,554 adult patients with minor head injuries evaluated by the Emergency Department of Azienda Ospedaliera, Universitaria Careggi from January 2007 to February 2008 were analyzed retrospectively. All the patients included in the study were subjected to blood tests. The international normalized ratio (INR) measured on admission was correlated with the results of head computed tomography scan. Results: Of the 1,410 patients included in the study, 75 (5.2%) were warfarin anticoagulated at the time of trauma. The INR measured on admission was 2.37 +/- 1.04 (mean +/- standard deviation), and this value was significantly associated with occurrence of ICH after head trauma (r = 0.37; p < 0.005). For 12 (of 75) patients of this group, the findings of the computed tomography scans were positive. The receiver operating characteristic curve show that the most effective INR cutoff value was 2.43, with a sensitivity of 92%, a specificity of 66%, and positive and negative predictive values of 33% and 97%, respectively. Conclusions: This study highlights the strong relationship between INR values and the probability of ICH, as shown in previous studies. The high negative predictive value of the identified cutoff, if confirmed, could be used to exclude ICH.	[Claudia, Casula; Claudia, Ranalli; Simone, Magazzini; Stefano, Grifoni] Azienda Osped Univ Careggi, Dept Emergency, I-50139 Florence, Italy; [Agostino, Ognibene] Azienda Osped Univ Careggi, Gen Lab Clin Biochem, I-50139 Florence, Italy	Agostino, O (corresponding author), Azienda Osped Univ Careggi, Dipartimento Lab, Lab Gen, Piastra Serv, Viale Morgagni 85, I-50139 Florence, Italy.	a.ognibene@med.unifi.it		Ognibene, Agostino/0000-0001-5287-4250			[Anonymous], 1996, J NEUROSURG SCI, V40, P11; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Parmar K. A., 2006, SMJ Singapore Medical Journal, V47, P676; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Saab M, 1996, J ACCID EMERG MED, V13, P208; Volans AP, 1998, J ACCID EMERG MED, V15, P159; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	18	30	30	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2011	70	4					906	909		10.1097/TA.0b013e3182031ab7			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	750OV	WOS:000289558700030	21610395				2021-06-18	
J	Edut, S; Rubovitch, V; Schreiber, S; Pick, CG				Edut, Shahaf; Rubovitch, Vardit; Schreiber, Shaul; Pick, Chaim G.			The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI)	PSYCHOPHARMACOLOGY			English	Article						Mice; Minimal traumatic brain injury (MTBI); MDMA (3,4-methylenedioxymethamphetamine); Novel object recognition; Ecstasy; Spatial learning; Cognitive test; Behavioral assessment	ELEVATED PLUS-MAZE; CLOSED-HEAD-INJURY; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; ADULT RATS; INDUCED NEUROTOXICITY; TYROSINE-HYDROXYLASE; CORTICAL-NEURONS; PATH-INTEGRATION; OXIDATIVE STRESS; MEMORY	The use of ecstasy (MDMA) among young adults has dramatically increased over the years. Since MDMA may impair the users' driving ability, the risk of being involved in a motor vehicle accident (MVA) is notably increased. Minimal traumatic brain injury (mTBI) a common consequence of MVAs-produces short- and long-term physical, cognitive, and emotional impairments. To investigate the effects of an acute dose of MDMA in mice subjected to closed head mTBI. Mice received 10 mg/kg MDMA 1 h prior to the induction of mTBI. Behavioral tests were conducted 7 and 30 days post-injury. In addition to the behavioral tests, phosphorylation of IGF-1R, ERK, and levels of tyrosine hydroxylase (TH) were measured. mTBI mice showed major cognitive impairments in all cognitive tests conducted. No additional impairments were seen if mTBI was preceded by one dose of MDMA. On the contrary, a beneficial effect was seen in these mice. The western blot analysis of TH revealed a significant decrease in the mTBI mice. These decreases were reversed in mice that were subjected to MDMA prior to the trauma. The presence of MDMA at the time of mTBI minimizes the alteration of visual and spatial memory of the injured mice. The IGF-1R pathway was activated due to mTBI and MDMA but was not the main contributor to the cognitive improvements. MDMA administration inverted the TH decreases seen after injury. We believe this may be the major cause of the cognitive improvements seen in these mice.	[Edut, Shahaf; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-69978 Tel Aviv, Israel	Pick, CG (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	shahafed@post.tau.ac.il; rubovitc@post.tau.ac.il; shaulsch@tasmc.health.gov.il; pickc@post.tau.ac.il	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693	Dr. Herman Schauder Endownment Fund for Research; The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel	This study was supported (in part) by a grant from the Dr. Herman Schauder Endownment Fund for Research and by a grant from The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel.	Able JA, 2006, BIOL PSYCHIAT, V59, P1219, DOI 10.1016/j.biopsych.2005.09.006; Alcalay RN, 2004, NEUROSCI LETT, V361, P128, DOI 10.1016/j.neulet.2003.12.005; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Brookhuis KA, 2004, PSYCHOPHARMACOLOGY, V173, P440, DOI 10.1007/s00213-003-1714-5; Brown PL, 2004, EUR J NEUROSCI, V20, P51, DOI 10.1111/j.0953-816X.2004.03453.x; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cadet JL, 2001, ANN MED INTERNE, V152, pS57; Camarasa J, 2008, EUR J PHARMACOL, V589, P132, DOI 10.1016/j.ejphar.2008.05.014; Camarero J, 2002, J NEUROCHEM, V81, P961, DOI 10.1046/j.1471-4159.2002.00879.x; Capela JP, 2007, NEUROTOXICOLOGY, V28, P868, DOI 10.1016/j.neuro.2007.04.005; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Carvalho M, 2002, ARCH TOXICOL, V76, P166, DOI 10.1007/s00204-002-0324-z; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Colado MI, 2004, PSYCHOPHARMACOLOGY, V173, P249, DOI 10.1007/s00213-004-1788-8; Colado MI, 2001, BRIT J PHARMACOL, V134, P1711, DOI 10.1038/sj.bjp.0704435; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Darke S, 2004, ADDICTION, V99, P175, DOI 10.1046/j.1360-0443.2003.00604.x; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dhillon HS, 1998, BRAIN RES, V804, P231, DOI 10.1016/S0006-8993(98)00639-8; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Drummer OH, 2003, FORENSIC SCI INT, V134, P154, DOI 10.1016/S0379-0738(03)00134-8; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Fantegrossi WE, 2008, NEUROSCIENCE, V151, P533, DOI 10.1016/j.neuroscience.2007.11.007; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Granado N, 2008, SYNAPSE, V62, P80, DOI 10.1002/syn.20466; Green AR, 2009, PSYCHOPHARMACOLOGY, V204, P375, DOI 10.1007/s00213-008-1453-8; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Gudelsky GA, 2008, PHARMACOL BIOCHEM BE, V90, P198, DOI 10.1016/j.pbb.2007.10.003; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Henry JM, 1997, J INVEST SURG, V10, P281, DOI 10.3109/08941939709032167; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; HOOFT PJ, 1994, INT J LEGAL MED, V106, P328, DOI 10.1007/BF01224781; Kern CH, 2010, SYNAPSE, V64, P363, DOI 10.1002/syn.20736; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kumer SC, 1996, J NEUROCHEM, V67, P443; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Kuypers Kim P. C., 2009, P501, DOI 10.1007/978-3-7643-9923-8_30; Logan BK, 2001, J FORENSIC SCI, V46, P1426; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; McBeth BD, 2005, ACAD EMERG MED, V12, P483, DOI 10.1197/j.aem.2004.11.028; McGregor IS, 2003, NEUROPSYCHOPHARMACOL, V28, P1472, DOI 10.1038/sj.npp.1300185; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Milman A, 2006, BEHAV BRAIN RES, V170, P141, DOI 10.1016/j.bbr.2006.02.017; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morgan MJ, 2000, PSYCHOPHARMACOLOGY, V152, P230, DOI 10.1007/s002130000545; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Morton J, 2005, CURR OPIN PHARMACOL, V5, P79, DOI 10.1016/j.coph.2004.08.007; Movig KLL, 2004, ACCIDENT ANAL PREV, V36, P631, DOI 10.1016/S0001-4575(03)00084-8; Nochajski TH, 2006, CLIN PSYCHOL REV, V26, P179, DOI 10.1016/j.cpr.2005.11.006; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Petrasek T, 2009, PHYSIOL RES, V58, P299, DOI 10.33549/physiolres.931729; Pick CG, 1997, BRAIN RES, V744, P41, DOI 10.1016/S0006-8993(96)01069-4; PICK CG, 1991, BRAIN RES, V566, P295, DOI 10.1016/0006-8993(91)91712-A; Piper BJ, 2005, DEV PSYCHOBIOL, V47, P145, DOI 10.1002/dev.20085; Piper BJ, 2004, PHARMACOL BIOCHEM BE, V79, P723, DOI 10.1016/j.pbb.2004.10.001; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Simola N, 2009, NEUROSCIENCE, V158, P1625, DOI 10.1016/j.neuroscience.2008.11.009; Skelton MR, 2008, NEUROPHARMACOLOGY, V55, P1121, DOI 10.1016/j.neuropharm.2008.07.006; Smink BE, 2008, TRAFFIC INJ PREV, V9, P105, DOI 10.1080/15389580701824443; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Sprague JE, 2003, PHYSIOL BEHAV, V79, P281, DOI 10.1016/S0031-9384(03)00092-1; Tang YP, 1999, NATURE, V401, P63; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Weinbroum AA, 2003, EUR J EMERG MED, V10, P19, DOI 10.1097/00063110-200303000-00006; Weizman R, 2001, PHARMACOL BIOCHEM BE, V68, P491, DOI 10.1016/S0091-3057(01)00450-6; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Yan H. Q., 2001, Society for Neuroscience Abstracts, V27, P567; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	95	30	30	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	APR	2011	214	4					877	889		10.1007/s00213-010-2098-y			13	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	739XQ	WOS:000288755500009	21120456				2021-06-18	
J	Gray, E; Ginty, M; Kemp, K; Scolding, N; Wilkins, A				Gray, Elizabeth; Ginty, Mark; Kemp, Kevin; Scolding, Neil; Wilkins, Alastair			Peroxisome proliferator-activated receptor-alpha agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						fenofibrate; nitric oxide; peroxisome; peroxisome proliferator activated receptor	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; MULTIPLE-SCLEROSIS; PPAR-ALPHA; IN-VITRO; NEURODEGENERATIVE DISEASES; AUTOIMMUNE-DISEASE; AXONAL INJURY; FATTY-ACIDS	Inflammation is known to cause significant neuronal damage and axonal injury in many neurological disorders. Among the range of inflammatory mediators, nitric oxide is a potent neurotoxic agent. Recent evidence has suggested that cellular peroxisomes may be important in protecting neurons from inflammatory damage. To assess the influence of peroxisomal activation on nitric oxide-mediated neurotoxicity, we investigated the effects of the peroxisomal proliferator-activated receptor (PPAR)-alpha agonist fenofibrate on cortical neurons exposed to a nitric oxide donor or co-cultured with activated microglia. Fenofibrate protected neurons and axons against both nitric oxide donor-induced and microglia-derived nitric oxide-induced toxicity. Moreover, cortical neurons treated with this compound showed a significant increase in gene expression of ABCD3 (the gene encoding for peroxisomal membrane protein-70), with a concomitant increase in protein levels of PPAR-alpha and catalase, which was associated with a functional increase in the activity of this enzyme. Collectively, these observations provide evidence that modulation of PPAR-alpha activity and peroxisomal function by fenofibrate attenuates nitric oxide-mediated neuronal and axonal damage, suggesting a new therapeutic approach to protect against neurodegenerative changes associated with neuroinflammation.	[Gray, Elizabeth; Ginty, Mark; Kemp, Kevin; Scolding, Neil; Wilkins, Alastair] Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Burden Ctr,MS Labs, Bristol BS16 1JB, Avon, England	Gray, E (corresponding author), Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Burden Ctr,MS Labs, Bristol BS16 1JB, Avon, England.	elizabeth.gray@bristol.ac.uk	; Kemp, Kevin/B-9755-2017	Scolding, Neil/0000-0001-9177-1043; Kemp, Kevin/0000-0003-1465-1309	Multiple Sclerosis Society of Great Britain; Multiple Sclerosis Society of Northern Ireland	This work was supported by a Junior Research Fellowship grant from the Multiple Sclerosis Society of Great Britain and Northern Ireland.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bernardo A, 2009, J NEUROPATH EXP NEUR, V68, P797, DOI 10.1097/NEN.0b013e3181aba2c1; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chinetti G, 2001, NAT MED, V7, P53; Cunard R, 2002, J IMMUNOL, V169, P6806, DOI 10.4049/jimmunol.169.12.6806; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Deplanque D, 2003, J NEUROSCI, V23, P6264; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Drew PD, 2006, NEUROCHEM INT, V49, P183, DOI 10.1016/j.neuint.2006.04.003; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Finn JT, 2000, J NEUROSCI, V20, P1333; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gocke AR, 2009, J IMMUNOL, V182, P4479, DOI 10.4049/jimmunol.0713927; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Guo QM, 2010, J CEREBR BLOOD F MET, V30, P70, DOI 10.1038/jcbfm.2009.185; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Imanaka T, 2000, CELL BIOCHEM BIOPHYS, V32, P131, DOI 10.1385/CBB:32:1-3:131; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Jones DC, 2002, J BIOL CHEM, V277, P6838, DOI 10.1074/jbc.M106908200; Jung TW, 2007, J NEUROL SCI, V253, P53, DOI 10.1016/j.jns.2006.11.020; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEE VMY, 1987, J NEUROSCI, V7, P3474; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Singh I, 2004, BRAIN RES, V1022, P1, DOI 10.1016/j.brainres.2004.06.059; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van Horssen J., 2010, BIOCHIM BIOPHYS ACTA, V1812, P141; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2004, NEURON GLIA BIOL, V1, P297, DOI 10.1017/S1740925X05000104; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x	57	30	31	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	APR	2011	33	8					1421	1432		10.1111/j.1460-9568.2011.07637.x			12	Neurosciences	Neurosciences & Neurology	751TY	WOS:000289641700007	21375604				2021-06-18	
J	Gullo, JD; Bertotti, MM; Silva, CCP; Schwarzbold, M; Diaz, AP; Soares, FMS; Freitas, FC; Nunes, J; Pinheiro, JT; Morato, EF; Prediger, RD; Linhares, MN; Walz, R				Gullo, Jackson da Silva; Bertotti, Melina More; Pestana Silva, Claudia Carvalho; Schwarzbold, Marcelo; Diaz, Alexandre Paim; Schneider Soares, Flavia Mahatma; Freitas, Fernando Cini; Nunes, Jean; Pinheiro, Jose Tadeu; Morato, Edelton Flavio; Prediger, Rui Daniel; Linhares, Marcelo Neves; Walz, Roger			Hospital Mortality of Patients with Severe Traumatic Brain Injury is Associated with Serum PTX3 Levels	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Serum PTX3 levels; Prognosis	LONG PENTRAXIN PTX3; COMA DATA-BANK; NEURONAL PENTRAXIN; PROTEINS; PENTAXIN; DISEASE; SYSTEM; FAMILY; IMPACT; MEMBER	Traumatic brain injury (TBI) is a worldwide cause of morbidity and mortality. Pentraxin 3 (PTX3) is a humoral component of the innate immune system which has been studied as a marker of inflammatory, infections or cardiovascular pathologies. To investigate the association between serum levels of PTX3 and the hospital mortality of patients with severe TBI. The independent association between serum PTX3 levels after severe TBI (Glasgow Coma Scale, GCS a parts per thousand currency sign 8) and hospital mortality was analyzed in a prospective study of 83 consecutive patients by a multiple logistic regression analysis. The leukocyte count in the same sample was analyzed as another marker of inflammatory response. The mean age of patients was 35 years and 85% were male. Serum PTX3 levels were determined 18.0 (SD +/- A 17.0) h after TBI. Patients who died showed a mean serum PTX3 level of 9.95 mu g/ml (SD +/- A 6.42) in comparison to 5.46 mu g/ml (SD +/- A 4.87) of the survivor group (P = 0.007). Elevated serum PTX3 levels remain significantly associated with mortality (P = 0.04) in the subset of patients with isolated TBI (n = 34). There were no differences in the leukocytes count measured in the same blood sample used for PTX3 determination in survivors and non-survivors (P = 0.56). The final multiple logistic regression model including age, pupillary examination, GCS, associated trauma, and PTX3 levels shows that serum levels of PTX3 which were higher than 10 mu g/ml were independently associated with the patients mortality (adjusted OR 3.06, CI 95% 1.03-9.15, P = 0.04). Serum PTX3 levels after severe TBI are independently associated with higher hospital mortality and may be a useful marker of TBI and its prognosis.	[Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Dept Clin Med, Florianopolis, SC, Brazil; [Gullo, Jackson da Silva; Pestana Silva, Claudia Carvalho; Schwarzbold, Marcelo; Diaz, Alexandre Paim; Schneider Soares, Flavia Mahatma; Freitas, Fernando Cini; Nunes, Jean; Prediger, Rui Daniel; Linhares, Marcelo Neves; Walz, Roger] Univ Fed Santa Catarina, CeNAp, HU, Florianopolis, SC, Brazil; [Bertotti, Melina More; Freitas, Fernando Cini] Hosp Governador Celso Ramos, Unidade Terapia Intens, Florianopolis, SC, Brazil; [Pinheiro, Jose Tadeu] Univ Fed Santa Catarina, CCS, Dept Anal Clin, Florianopolis, SC, Brazil; [Morato, Edelton Flavio] Univ Fed Santa Catarina, CCB, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil; [Prediger, Rui Daniel] Univ Fed Santa Catarina, Dept Farmacol, Lab Doencas Neurodegenerat, Florianopolis, SC, Brazil; [Bertotti, Melina More; Linhares, Marcelo Neves; Walz, Roger] Hosp Governador Celso Ramos, CEPESC, Florianopolis, SC, Brazil	Walz, R (corresponding author), Univ Fed Santa Catarina, Univ Hosp, Dept Clin Med, 3 Andar,Campus Univ, Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Prediger, Rui Daniel/AAV-3419-2020; Neurociencia, Inct/I-1011-2013; Diaz, Alexandre Paim/J-9042-2014; Walz, Roger/K-9096-2013; Schwarzbold, Marcelo Liborio/J-8960-2014; Prediger, Rui D/C-4036-2013; Diaz, Alexandre Paim/AAD-8323-2019	Prediger, Rui Daniel/0000-0002-7547-6463; Walz, Roger/0000-0002-9875-6687; Prediger, Rui D/0000-0002-7547-6463; Diaz, Alexandre Paim/0000-0002-6591-6648; Mahatma Schneider Soares, Flavia/0000-0001-5968-1312	CNPq (Brazilian Council for Scientific and Technologic Development, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESC (Foundation for Scientific Research and Technology of Santa Catarina State)	This work was financed by CNPq (Brazilian Council for Scientific and Technologic Development, Brazil), FAP-ESC (Foundation for Scientific Research and Technology of Santa Catarina State). The technical support for biological sample collection came from Laboratorio Biomedico (Florianopolis) under the Pharm. Saulo Correia de Mello supervision. We acknowledge Dr. Alberto Mantovani from the Research Laboratory in Immunology and Inflammation, Instituto Clinico Humanitas, Rozzano, Milano, and Department of Translacional Medicine, University of Milan (Milan), Italy who gently provided some of the reagents used in this work.	Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Brugger-Andersen T, 2009, THROMB HAEMOSTASIS, V102, P555, DOI 10.1160/TH09-02-0137; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NOLAND TD, 1994, J BIOL CHEM, V269, P32607; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Polentarutti N, 2000, J NEUROIMMUNOL, V106, P87, DOI 10.1016/S0165-5728(00)00214-9; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; REID MS, 1994, J BIOL CHEM, V269, P32615; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Tsui CC, 1996, J NEUROSCI, V16, P2463	25	30	30	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2011	14	2					194	199		10.1007/s12028-010-9462-y			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	738SY	WOS:000288663800008	20972645				2021-06-18	
J	Vrkljan, BH; McGrath, CE; Letts, LJ				Vrkljan, Brenda H.; McGrath, Colleen E.; Letts, Lori J.			Assessment tools for evaluating fitness to drive: A critical appraisal of evidence	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Automobile driving; Occupational therapy assessment	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; MOTOR-VEHICLE CRASHES; FIELD-OF-VIEW; OLDER-ADULTS; COGNITIVE PREDICTORS; AUTOMOBILE CRASHES; ALZHEIMERS-DISEASE; MEDICAL CONDITIONS; ELDERLY DRIVERS	Background. Many office-based assessment tools are used by occupational therapists to predict fitness to drive. Purpose. To appraise psychometric properties of such tools, specifically predictive validity for on-road performance. Methods. A literature search was conducted to identify assessment tools and studies involving on-road outcomes (behind-the-wheel evaluation, crashes, traffic violations). Using a standardized appraisal process, reviewers rated each tool's psychometric properties, including its predictive validity with on-road performance. Findings. Seventeen measures met the inclusion criteria. Evidence suggests many tools do not have cutoff scores linked with on-road outcomes, although some had stronger evidence than others. Implications. When making a determination regarding driver fitness, clinicians should consider the psychometric properties of the tool as well as existing evidence concerning its utility in predicting on-road performance. Caution is warranted in using any one office-based tool to predict driving fitness; rather, a multifactorial-based assessment approach that includes physical, cognitive, and visual-perceptual components, is recommended.	[Vrkljan, Brenda H.; Letts, Lori J.] McMaster Univ, Occupat Therapy Program, Sch Rehabil Sci, Hamilton, ON L8S 1C7, Canada; [McGrath, Colleen E.] Univ Western Ontario, London, ON, Canada	Vrkljan, BH (corresponding author), McMaster Univ, Occupat Therapy Program, Sch Rehabil Sci, IAHS Bldg,Rm 450,1400 Main St W, Hamilton, ON L8S 1C7, Canada.	vrkljan@mcmaster.ca; lettsl@mcmaster.ca			Canadian Occupational Therapy Foundation (COTF); Auto21-Network of Centres of Excellence	This manuscript was supported in part by the Canadian Occupational Therapy Foundation (COTF) and funding from Auto21-Network of Centres of Excellence provided to the first author.	Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; Amick MM, 2007, ARCH CLIN NEUROPSYCH, V22, P957, DOI 10.1016/j.acn.2007.07.004; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P1903, DOI 10.1111/j.1572-0241.2007.01424.x; Ball K, 1993, J Am Optom Assoc, V64, P71; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bedard M, 2008, TRAFFIC INJ PREV, V9, P336, DOI 10.1080/15389580802117184; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Canadian Medical Association, 2006, DET MED FITN DRIV GU; *CAOT, 2009, POS STAT DRIV REH; Colarusso R., 2003, MOTOR FREE VISUAL PE, V3rd edn; Colarusso R. P., 1972, MOTOR FREE VISUAL PE; Colarusso RP, 1996, MOTOR FREE VISUAL PE; D'Elia L., 1996, COLOR TRAILS TEST PR; Dickerson AE, 2007, GERONTOLOGIST, V47, P578, DOI 10.1093/geront/47.5.578; Diegelman Nathan M, 2004, BMC Geriatr, V4, P10, DOI 10.1186/1471-2318-4-10; DILLER L, 1974, REHABILITATION MONOG, V50; Dobbs BM, 2008, TRAFFIC INJ PREV, V9, P379, DOI 10.1080/15389580802045823; DOUGLAS A, 2007, GERIATRICS, V26, P13, DOI DOI 10.1080/02703180801963758; *DRIVEABLE ASS CTR, 1998, DRIVEABLE COMP SCREE; Edwards JD, 2008, ACCIDENT ANAL PREV, V40, P1157, DOI 10.1016/j.aap.2007.12.008; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; Freund B, 2005, J GEN INTERN MED, V20, P240, DOI 10.1111/j.1525-1497.2005.40069.x; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goode KT, 1998, J CLIN PSYCHOL MED S, V5, P425, DOI 10.1023/A:1026206927686; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; Hoffman L, 2005, PSYCHOL AGING, V20, P610, DOI 10.1037/0882-7974.20.4.610; Hunt LA, 1997, ALZ DIS ASSOC DIS, V11, P13, DOI 10.1097/00002093-199706001-00004; Jang RW, 2007, J GEN INTERN MED, V22, P531, DOI 10.1007/s11606-006-0043-x; Justiss MD, 2006, TOP GERIATR REHABIL, V22, P121; KLAVORA P, 1994, PERCEPT MOTOR SKILL, V79, P448, DOI 10.2466/pms.1994.79.1.448; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; Klavora P, 2000, ARCH PHYS MED REHAB, V81, P701, DOI 10.1053/apmr.2000.6285; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Korner-Bitensky N, 2007, OCCUPATIONAL THERAPY, V9, P10; Korner-Bitensky N, 2005, PHYS OCCUP THER GERI, V23, P123, DOI 10.1300/J148v23n02_08; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korner-Bitensky N, 2009, AUST OCCUP THER J, V56, P200, DOI 10.1111/j.1440-1630.2008.00749.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAW M, 2004, OUTCOME MEASURES REV; LAW M, 1999, ALL OUTCOMES; Law M, 2002, EVIDENCE BASED REHAB, P3; Law M.C., 2005, MEASURING OCCUPATION; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Lloyd S, 2001, Can J Occup Ther, V68, P149; MacGregor JM, 2001, J AM GERIATR SOC, V49, P466, DOI 10.1046/j.1532-5415.2001.49095.x; MAROTTOLI RA, 1994, ANN INTERN MED, V121, P842, DOI 10.7326/0003-4819-121-11-199412010-00003; Marshall S., 2007, SENIOR DRIVER ASSESS; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Marshall SC, 2008, TRAFFIC INJ PREV, V9, P291, DOI 10.1080/15389580801895244; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McGwin G, 2000, AM J EPIDEMIOL, V152, P424, DOI 10.1093/aje/152.5.424; Molnar FJ, 2007, ACCIDENT ANAL PREV, V39, P1056, DOI 10.1016/j.aap.2007.02.003; Molnar FJ, 2006, J AM GERIATR SOC, V54, P1809, DOI 10.1111/j.1532-5415.2006.00967.x; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; ODENHEIMER GL, 1994, J GERONTOL, V49, pM153, DOI 10.1093/geronj/49.4.M153; Oswanski MF, 2007, AM J PHYS MED REHAB, V86, P190, DOI 10.1097/PHM.0b013e31802b7de5; OWSLEY C, 1994, OPTOMETRY VISION SCI, V71, P727, DOI 10.1097/00006324-199412000-00002; Parker D, 2000, ACCIDENT ANAL PREV, V32, P751, DOI 10.1016/S0001-4575(99)00125-6; Rapoport MJ, 2007, CAN MED ASSOC J, V177, P599, DOI 10.1503/cmaj.070342; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Reimer B, 2005, ACCIDENT ANAL PREV, V37, P996, DOI 10.1016/j.aap.2005.05.002; Reitan R, 1986, TRAIL MAKING TEST MA; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.3.CO;2-L; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Staplin L, 2003, J SAFETY RES, V34, P389, DOI 10.1016/j.jsr.2003.09.002; Stav WB, 2008, J SAFETY RES, V39, P1, DOI 10.1016/j.jsr.2007.10.004; Stav WB, 2008, AM J OCCUP THER, V62, P149, DOI 10.5014/ajot.62.2.149; Stephens BW, 2005, PHYS OCCUP THER GERI, V23, P103, DOI 10.1300/J148v23n02_07; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; *TRANSP CAN, 2001, RS200104TP TRANSP CA; Vernon DD, 2002, ACCIDENT ANAL PREV, V34, P237, DOI 10.1016/S0001-4575(01)00019-7	77	30	30	0	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2011	78	2					80	96		10.2182/cjot.2011.78.2.3			17	Rehabilitation	Rehabilitation	755UA	WOS:000289961500003	21560912				2021-06-18	
J	Nelson, DW; Thornquist, B; MacCallum, RM; Nystrom, H; Holst, A; Rudehill, A; Wanecek, M; Bellander, BM; Weitzberg, E				Nelson, David W.; Thornquist, Bjorn; MacCallum, Robert M.; Nystrom, Harriet; Holst, Anders; Rudehill, Anders; Wanecek, Michael; Bellander, Bo-Michael; Weitzberg, Eddie			Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement	BMC MEDICINE			English	Article							INTRACEREBRAL MICRODIALYSIS; BLOOD-FLOW; EXTRACELLULAR GLUCOSE; ARTERY OCCLUSION; METABOLISM; LACTATE; TISSUE; REPERFUSION; GLUTAMATE; DAMAGE	Background: Cerebral microdialysis (MD) is used to monitor local brain chemistry of patients with traumatic brain injury (TBI). Despite an extensive literature on cerebral MD in the clinical setting, it remains unclear how individual levels of real-time MD data are to be interpreted. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) are important continuous brain monitors in neurointensive care. They are used as surrogate monitors of cerebral blood flow and have an established relation to outcome. The purpose of this study was to investigate the relations between MD parameters and ICP and/or CPP in patients with TBI. Methods: Cerebral MD, ICP and CPP were monitored in 90 patients with TBI. Data were extensively analyzed, using over 7,350 samples of complete (hourly) MD data sets (glucose, lactate, pyruvate and glycerol) to seek representations of ICP, CPP and MD that were best correlated. MD catheter positions were located on computed tomography scans as pericontusional or nonpericontusional. MD markers were analyzed for correlations to ICP and CPP using time series regression analysis, mixed effects models and nonlinear (artificial neural networks) computer-based pattern recognition methods. Results: Despite much data indicating highly perturbed metabolism, MD shows weak correlations to ICP and CPP. In contrast, the autocorrelation of MD is high for all markers, even at up to 30 future hours. Consequently, subject identity alone explains 52% to 75% of MD marker variance. This indicates that the dominant metabolic processes monitored with MD are long-term, spanning days or longer. In comparison, short-term (differenced or.) changes of MD vs. CPP are significantly correlated in pericontusional locations, but with less than 1% explained variance. Moreover, CPP and ICP were significantly related to outcome based on Glasgow Outcome Scale scores, while no significant relations were found between outcome and MD. Conclusions: The multitude of highly perturbed local chemistry seen with MD in patients with TBI predominately represents long-term metabolic patterns and is weakly correlated to ICP and CPP. This suggests that disturbances other than pressure and/or flow have a dominant influence on MD levels in patients with TBI.	[Nelson, David W.; Thornquist, Bjorn; Rudehill, Anders; Wanecek, Michael; Weitzberg, Eddie] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden; [MacCallum, Robert M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Immunogen Grp, London, England; [Nystrom, Harriet] Karolinska Inst, Sect Neuroradiol, Dept Clin Neurosci, Stockholm, Sweden; [Holst, Anders] SICS, Kista, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Sect Neurosurg, Dept Clin Neurosci, Stockholm, Sweden	Nelson, DW (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden.	david.nelson@karolinska.se	Wanecek, Michael/AAE-7998-2021		Karolinska InstitutetKarolinska Institutet; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Cancer and Traffic Injury Fund (CTRF); Stockholm County CouncilStockholm County Council	Funding for this study was provided in part by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet, funds from the Karolinska Institutet, The Swedish Research Council, The Swedish Cancer and Traffic Injury Fund (CTRF). In addition, we thank Gunilla Bornhall Malmborg for her work with the Karolinska Brain Trauma Databank. The study was conducted at the neurointensive care unit of the Karolinska University Hospital.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 2003, SCAND CARDIOVASC J, V37, P13, DOI 10.1080/14017430310006974; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mazzeo AT, 2005, NEUROCRIT CARE, V2, P282, DOI 10.1385/NCC:2:3:282; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Peerdeman SM, 2000, INTENS CARE MED, V26, P662, DOI 10.1007/s001340051230; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; R Development Core Team, 2008, R LANGUAGE ENV STAT; Reinert M, 2000, Neurosurg Focus, V8, pe10; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Salci Kontsantin, 2006, J Clin Monit Comput, V20, P25, DOI 10.1007/s10877-006-2864-x; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	51	30	32	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	MAR 2	2011	9								21	10.1186/1741-7015-9-21			17	Medicine, General & Internal	General & Internal Medicine	763NG	WOS:000290565500001	21366904	DOAJ Gold, Green Published			2021-06-18	
J	Vu, JA; Babikian, T; Asarnow, RF				Vu, Jennifer A.; Babikian, Talin; Asarnow, Robert F.			Academic and Language Outcomes in Children After Traumatic Brain Injury: A Meta-Analysis	EXCEPTIONAL CHILDREN			English	Article							CLOSED-HEAD-INJURY; EARLY-CHILDHOOD; NEUROBEHAVIORAL RECOVERY; FUNCTIONAL RECOVERY; DISCOURSE; ACHIEVEMENT; SEVERITY; COHORT; TBI; ADOLESCENTS	Expanding on Babikian and Asarnow's (2009) meta-analytic study examining neurocognitive domains, this current meta-analysis examined academic and language outcomes at different time points post-traumatic brain injury (TBI) in children and adolescents. Although children with mild TBI exhibited no significant deficits, studies indicate that children with moderate and severe TBI exhibit persistent deficits. In children with moderate TBI, academic skills were impaired both postacutely and chronically, although there were no deficits in language skills at any time point. Children with severe TBI showed the most impairment, with deficits in all measured areas, and partial recovery in some domains over time. The results of this meta-analysis may have important implications for school reentry, academic placement, and identifying children who require special services in school.	[Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Vu, Jennifer A.] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA USA	Vu, JA (corresponding author), Univ Delaware, Dept Human Dev & Family Studies, 122 Alison Hall, Newark, DE 19716 USA.	jvu@udel.edu					Agency for Health Care Policy and Research, 1999, EVIDENCE REPORTS T S; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Borenstein M., 2005, COMPREHENSIVE METAAN; Borenstein M., 2007, METAANALYSIS FIXED E; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; CARROWWOOLFOLK E, 1985, EXAMINERS MANUAL TES; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman S, 2006, NEUROTOXICOLOGY, V27, P277, DOI 10.1016/j.neuro.2005.11.009; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Chomsky Noam, 1986, KNOWLEDGE LANGUAGE; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, pXXI; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dunn L., 1981, PEABODY PICTURE VOCA; DUNN LM, 1979, PEABODY INDIVIDUAL A; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FEAGANS L, 1982, LANGUAGE CHILDREN RE, P95; FREDERICKSON CH, 1990, DISCOURSE ABILITY BR, P1; GARDNER MF, 1979, MANUAL EXPRESSIVE ON; GLARIG A, 2004, NEUROREHABILITATION, V19, P219; Graesser A., 1991, HDB READING RES, P171; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; HEDRICK DL, 1974, SEQUENCED INVENTORY; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jastak J., 1978, WIDE RANGE ACHIEVEME; Jastak S, 1984, WIDE RANGE ACHIEVEME; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Langlois JA, 2000, TRAUMATIC BRAIN INJU; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; McCarthy D., 1972, MCCARTHY SCALES CHIL; Piaget J., 1952, ORIGINS INTELLIGENCE; PiattelliPalmarini Massimo, 1980, LANGUAGE LEARNING DE; RENFREW C, 1995, RENFREW BUS STORY MA; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; SNOW CE, 1990, 1 LANGUAGE, V0010; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1991, MANUAL WECHSLER INTE; Wilkinson G.S., 1993, WRAT 3 WIDE RANGE AC; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9	57	30	30	0	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0014-4029	2163-5560		EXCEPT CHILDREN	Except. Child.	SPR	2011	77	3					263	281		10.1177/001440291107700301			19	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	729VK	WOS:000287979400002					2021-06-18	
J	Zhang, LX; Seitz, LC; Abramczyk, AM; Liu, L; Chan, C				Zhang, Linxia; Seitz, Linsey C.; Abramczyk, Amy M.; Liu, Li; Chan, Christina			cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						cAMP; Morphology; Apoptosis; Neural differentiation	MARROW STROMAL CELLS; PROTEIN-KINASE-A; IN-VITRO DIFFERENTIATION; TRAUMATIC BRAIN-INJURY; BONE-MARROW; CYCLIC-AMP; CARCINOMA-CELLS; PHOSPHORYLATION; RHO; INDUCTION	The intracellular second messenger cAMP is frequently used in induction media to induce mesenchymal stem cells (MSCs) into neural lineage cells. To date, an understanding of the role cAMP exerts on MSCs and whether cAMP can induce MSCs into functional neurons is still lacking. We found cAMP initiated neuron-like morphology changes early and neural differentiation much later. The early phase changes in morphology were due to cell shrinkage, which subsequently rendered some cells apoptotic. While the morphology changes occurred prior to the expression of neural markers, it is not required for neural marker expression and the two processes are differentially regulated downstream of cAMP-activated protein kinase A. cAMP enabled MSCs to gain neural marker expressions with neuronal function, such as, calcium rise in response to neuronal activators, dopamine, glutamate, and potassium chloride. However, only some of the cells induced by cAMP responded to the three neuronal activators and further lack the neuronal morphology, suggesting that although cAMP is able to direct MSCs towards neural differentiation, they do not achieve terminal differentiation.	[Zhang, Linxia; Seitz, Linsey C.; Abramczyk, Amy M.; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Liu, Li] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chan, C (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, 2527 EB, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Seitz, Linsey/Y-4345-2019; liu, li/C-2428-2015	Seitz, Linsey/0000-0001-6831-6747	National Science FoundationNational Science Foundation (NSF) [CBET 0941055]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM079688, R21RR024439]; MUCI; MSU Foundation; Center for Systems Biology; Div Of Chem, Bioeng, Env, & Transp SysNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [0941055] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM079688] Funding Source: NIH RePORTER	We thank Dr. Carlose Molina at New Jersey Medical School for kindly providing the ICER antibody and Dr. David Ginty at Johns Hopkins University for kindly providing the M1-CREB plasmid. This study was supported in part by the National Science Foundation (CBET 0941055), the National Institute of Health (R01GM079688 and R21RR024439), the MUCI, and the MSU Foundation and the Center for Systems Biology.	Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; BELL PB, 1995, SCANNING MICROSCOPY, V9, P843; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; BERRY L, 1992, J CELL SCI, V101, P333; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flusberg DA, 2001, MOL BIOL CELL, V12, P3087, DOI 10.1091/mbc.12.10.3087; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211; Herbertson A, 1997, BONE, V21, P491, DOI 10.1016/S8756-3282(97)00197-X; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuznetsov SA, 1997, J BONE MINER RES, V12, pF440; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Park SY, 2005, CANCER LETT, V224, P123, DOI 10.1016/j.canlet.2004.10.009; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Rocchi S, 2000, BIOCHEM J, V352, P483, DOI 10.1042/0264-6021:3520483; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Wang TT, 2007, BIOCHEM BIOPH RES CO, V357, P1021, DOI 10.1016/j.bbrc.2007.04.046; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang L, 2010, JOVE-J VIS EXP, V37, P1852, DOI [10.3791/1852, DOI 10.3791/1852]	58	30	31	0	11	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	MAR	2011	68	5					863	876		10.1007/s00018-010-0497-1			14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	719WY	WOS:000287243400009	20725762	Green Accepted			2021-06-18	
J	Hawthorne, G; Kaye, AH; Gruen, R; Houseman, D; Bauer, I				Hawthorne, G.; Kaye, A. H.; Gruen, R.; Houseman, D.; Bauer, I.			Traumatic brain injury and quality of life: Initial Australian validation of the QOLIBRI	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Clinical trials; Evaluation; Participant reported outcome; Quality of life; QOLIBRI; Traumatic brain injury	GLASGOW COMA SCALE; MINI-MENTAL-STATE; SUBJECTIVE EXPERIENCE; CLOSE RELATIVES; MULTIPLE TRAUMA; HEALTH; REHABILITATION; SATISFACTION; RELIABILITY; VALIDITY	The Quality of Life after Brain Injury (QOLIBRI) is a new international instrument for assessing quality of life after traumatic brain injury (TBI). We report first use and validation. Patients previously admitted with TBI to the Royal Melbourne Hospital, Melbourne, Australia, were randomly sampled (n = 66, 61% response rate) and administered the QOLIBRI. Fifty-five re-completed it at 2-week follow-up. QOLIBRI scales (with two exceptions) met standard criteria for internal consistency, homogeneity and test-re-test reliability. Correlations with the Assessment of Quality of Life, Short Form-36 version 2 and the Satisfaction with Life Scale were moderate. The QOLIBRI was sensitive to the Glasgow Outcome Scale - Extended scores, Hospital Anxiety and Depression scale, and measures of social isolation (Friendship Scale). There was evidence that further refinement may improve the QOLIBRI. The QOLIBRI should be considered as an outcome measure by clinicians and researchers conducting treatment trials, rehabilitation studies or epidemiological surveys into the treatment or sequelae of trauma. (C) 2010 Elsevier Ltd. All rights reserved.	[Hawthorne, G.; Houseman, D.; Bauer, I.] Univ Melbourne, Royal Melbourne Hosp, Fac Med Dent & Hlth Sci, Dept Psychiat, Parkville, Vic 3050, Australia; [Kaye, A. H.] Univ Melbourne, Dept Surg, Parkville, Vic 3050, Australia; [Gruen, R.] Alfred Hosp, Natl Trauma Res Inst, Prahran, Vic 3181, Australia; [Gruen, R.] Monash Univ, Prahran, Vic, Australia	Hawthorne, G (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Fac Med Dent & Hlth Sci, Dept Psychiat, Level 1 N,Grattan St, Parkville, Vic 3050, Australia.	graemeeh@unimelb.edu.au	Bauer, Isabelle Esther/C-5839-2015	Bauer, Isabelle Esther/0000-0001-9613-9354; Kaye, Andrew Henry/0000-0001-5049-8861	Victorian Neurotrauma Initiative; Department of Psychiatry; Faculty of Medicine, Dentistry and Health Sciences at the University of MelbourneUniversity of Melbourne; Royal Melbourne Hospital (RMH)	This project was supported by the Victorian Neurotrauma Initiative, the Department of Psychiatry, and the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne, and the Royal Melbourne Hospital (RMH). We would like to thank those organisations for their support. We would also like to thank Professor Nicole von Steinbuechel for her encouragement and support, and the interviewers who collected the data, Ms Janifer Anderson and Ms Maritza Thompson. Finally we would like to thank the many former patients of the RMH who so willingly gave their time to participate in the study.	Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Bjorkdahl Ann, 2004, J Stroke Cerebrovasc Dis, V13, P122, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.004; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Coetzer R, 2005, INT J REHABIL RES, V28, P361, DOI 10.1097/00004356-200512000-00010; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, pXXI; Collins R, 2000, J HEAD TRAUMA REHAB, V15, P1139, DOI 10.1097/00001199-200010000-00007; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; English TC, 1904, LANCET, V1, P485; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736; Hawthorne G, 2008, SOC PSYCH PSYCH EPID, V43, P140, DOI 10.1007/s00127-007-0279-8; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Hawthorne G, 2006, SOC INDIC RES, V77, P521, DOI 10.1007/s11205-005-7746-y; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; HSU LM, 1994, MULTIVAR BEHAV RES, V29, P127, DOI 10.1207/s15327906mbr2902_1; Hutter BO, 2001, ZBL NEUROCHIR, V62, P37, DOI 10.1055/s-2002-19476; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; Mathiesen Birgit Bork, 2004, Cogn Neuropsychiatry, V9, P249, DOI 10.1080/13546800344000237; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; MOKKEN RJ, 1982, APPL PSYCH MEAS, V6, P417, DOI 10.1177/014662168200600404; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P87; NUNNALLY J, 1994, PSYCHOMETRIC THOERY; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Pirente N, 2002, UNFALLCHIRURG, V105, P413; Pirente N, 2001, UNFALLCHIRURG, V104, P57, DOI 10.1007/s001130050688; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Sherwin E, 2006, BRAIN INJURY, V20, P383, DOI 10.1080/02699050600663097; Snaith R.P., 1994, HOSP ANXIETY DEPRESS; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Streiner DL, 2006, HLTH MEASUREMENT SCA; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Tazopoulou E, 2005, ACTA NEUROPSYCHOL, V1, P13; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; TRUELLE JL, BRAIN INJUR IN PRESS; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P29, DOI 10.1076/jcen.21.1.29.939; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware JE., 2000, SCORE VERSION 2 SF 3; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	71	30	32	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2011	18	2					197	202		10.1016/j.jocn.2010.06.015			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	719BH	WOS:000287173700006	21163654				2021-06-18	
J	Sinopoli, KJ; Schachar, R; Dennis, M				Sinopoli, Katia J.; Schachar, Russell; Dennis, Maureen			Traumatic brain injury and secondary attention-deficit/hyperactivity disorder in children and adolescents: The effect of reward on inhibitory control	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Attention-deficit/hyperactivity disorder; Inhibitory control; Rewards; Development	DEFICIT-HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; RESPONSE-INHIBITION; SUSTAINED ATTENTION; COGNITIVE CONTROL; ADHD; PERFORMANCE; AD/HD; BEHAVIOR; MEMORY	Poor inhibitory control and abnormalities in responding to rewards are characteristic of the developmental or primary form of attention-deficit/hyperactivity disorder (P-ADHD). A secondary form of ADHD (S-ADHD) may occur as a consequence of childhood traumatic brain injury (TBI), but the similarities and differences between these two forms of ADHD have not been well characterized. To address these issues, we studied two inhibitory control tasks under different reward conditions in four groups of children and adolescents: TBI who did not exhibit S-ADHD, TBI who did exhibit S-ADHD, P-ADHD, and healthy controls. Participants with TBI exhibited poor cancellation inhibition relative to controls. Although reward facilitated both cancellation and restraint inhibition similarly across groups, poor performance persisted in the P-ADHD group, and participants with S-ADHD exhibited a selective deficit in cancellation inhibition.	[Sinopoli, Katia J.] Univ Toronto, Fac Med, BrainFit Lab, Toronto, ON M5G 1V7, Canada; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Sinopoli, Katia J.] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5G 1V7, Canada	Sinopoli, KJ (corresponding author), Univ Toronto, Fac Med, BrainFit Lab, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	katia.sinopoli@sickkids.ca	Sinopoli, Katia/AAO-7803-2020	Schachar, Russell/0000-0002-2015-4395	Ontario Neurotrauma Foundation [2007-ABI-PHD-565]; NIH (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD048946-01A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Funding was provided by the Ontario Neurotrauma Foundation to Katia J. Sinopoli (2007-ABI-PHD-565, The Regulation of Thoughts and Actions in Children Following Traumatic Brain Injury). This research was also supported by an NIH (National Institutes of Health) 1RO1 grant to Keith O. Yeates and Maureen Dennis (HD048946-01A2, Social Outcomes in Pediatric Traumatic Brain Injury). We thank Shirley Chen for her help with the stop signal task and Renee Farrell and Alexandra Basile for their help with scoring and coding of demographic and questionnaire information.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; BAND GPH, 1997, THESIS U AMSTERDAM A; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berwid OG, 2005, J CHILD PSYCHOL PSYC, V46, P1219, DOI 10.1111/j.1469-7610.2005.00417.x; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Conners C. K., 2008, CONNERS, V3rd; Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Desman C, 2008, CHILD NEUROPSYCHOL, V14, P483, DOI 10.1080/09297040701625831; Douglas V. I., 1999, HDB DISRUPTIVE BEHAV, Vxiii, P105, DOI [10.1007/978-1-4615-4881-2_5, DOI 10.1007/978-1-4615-4881-2_5]; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gomez R, 2003, J Atten Disord, V6, P111, DOI 10.1177/108705470300600303; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Huang-Pollock CL, 2007, J CLIN CHILD ADOLESC, V36, P127, DOI 10.1080/15374410701274124; IABONI F, 1995, J ABNORM PSYCHOL, V104, P232, DOI 10.1037/0021-843X.104.1.232; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kalff AC, 2005, J INT NEUROPSYCH SOC, V11, P173; Kieling C, 2008, CHILD ADOL PSYCH CL, V17, P285, DOI 10.1016/j.chc.2007.11.012; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levy Y, 2009, J CHILD PSYCHOL PSYC, V50, P657, DOI 10.1111/j.1469-7610.2008.01986.x; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2008, J CHILD PSYCHOL PSYC, V49, P712, DOI 10.1111/j.1469-7610.2008.01910.x; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; Oosterlaan J, 1998, J ABNORM CHILD PSYCH, V26, P161, DOI 10.1023/A:1022650216978; Padmala S, 2010, NEUROPSYCHOLOGIA, V48, P558, DOI 10.1016/j.neuropsychologia.2009.10.017; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Rubia K, 2007, CHILD NEUROPSYCHOL, V13, P276, DOI 10.1080/09297040600770761; Rubia K, 2010, HUM BRAIN MAPP, V31, P287, DOI 10.1002/hbm.20864; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; SCHACHAR R, 1995, J ABNORM CHILD PSYCH, V23, P411, DOI 10.1007/BF01447206; Schachar RJ, 2004, J ABNORM CHILD PSYCH, V32, P285, DOI 10.1023/B:JACP.0000026142.11217.f2; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Scheres A, 2001, CHILD NEUROPSYCHOL, V7, P172, DOI 10.1076/chin.7.3.172.8746; Seidman LJ, 2006, BIOL PSYCHIAT, V60, P1071, DOI 10.1016/j.biopsych.2006.04.031; Shanahan MA, 2008, DEV NEUROPSYCHOL, V33, P137, DOI 10.1080/87565640701884238; Sinopoli K. J., DEV PSYCHOL IN PRESS; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Slusarek M, 2001, J AM ACAD CHILD PSY, V40, P355, DOI 10.1097/00004583-200103000-00016; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Stevens J, 2002, DEV NEUROPSYCHOL, V21, P117, DOI 10.1207/S15326942DN2102_1; Tabachnick BG, 2007, USING MULTIVARIATE S; Tamm Leanne, 2007, J Atten Disord, V10, P372, DOI 10.1177/1087054706289946; TEASDALE G, 1974, LANCET, V2, P81; The Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Vaidya CJ, 2005, AM J PSYCHIAT, V162, P1605, DOI 10.1176/appi.ajp.162.9.1605; Van Meel CS, 2005, J AM ACAD CHILD PSY, V44, P451, DOI 10.1097/01.chi.0000155326.22394.e6; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Wodka EL, 2007, J CLIN EXP NEUROPSYC, V29, P345, DOI 10.1080/13803390600678046; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Young SE, 2009, J ABNORM PSYCHOL, V118, P117, DOI 10.1037/a0014657	87	30	30	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	7					805	819		10.1080/13803395.2011.562864			15	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882HE	WOS:000299553600008	21598155	Green Accepted			2021-06-18	
J	Bowman, SM; Aitken, ME				Bowman, Stephen M.; Aitken, Mary E.			Still Unsafe, Still in Use: Ongoing Epidemic of All-Terrain Vehicle Injury Hospitalizations Among Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						All-terrain vehicle; Injury; Hospitalizations; Children; Trends	IMPACT; PREVENTION; PATTERNS; HELMETS	Background: The injury risks to children who ride all-terrain vehicles (ATVs) are well documented and include increased risk of death or hospitalization. We identify pediatric hospitalization trends for ATV injuries, provide national benchmarks, and discuss policy and prevention implications. Methods: We used data (1997-2006) from the kid's inpatient database, the only all-payer inpatient care database for children in the United States. Children and adolescents aged 0 year to 17 years were included. We generate national estimates of hospitalizations. Results: Total pediatric hospitalizations for ATV injuries have increased 150% from an estimated 1,618 in 1997 to 4,039 in 2006. The overall ATV-related injury hospitalization rate increased 139% from 2.3 per 100,000 in 1997 to 5.5 per 100,000 in 2006. Rates increased for both males and females, although the rate for males remained much larger than for females in 2006 (8.1 per 100,000 vs. 2.7 per 100,000, p < 0.001). For all age groups, ATV hospitalizations increased significantly between 1997 and 2006, but this change was most pronounced among those aged 15 years to 17 years. ATV hospitalization rates also increased significantly for patients hospitalized with traumatic brain injuries. Conclusions: ATVs are associated with a significant and increasing number of hospitalizations for children. Reexamination of previous federal policies, including the potential for a new consent decree between the Consumer Product Safety Commission and ATV industry representatives, should be considered to address this alarming trend and to adopt effective strategies to minimize the use by children. Enforceable state-level policy to promote helmet use among ATV riders seems to be critically needed.	[Bowman, Stephen M.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Aitken, Mary E.] Univ Arkansas Med Sci, Dept Pediat, Arkansas Childrens Hosp, Little Rock, AR 72205 USA	Bowman, SM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Dept Hlth Policy & Management, 624 N Broadway,Room 539, Baltimore, MD 21205 USA.	smbowman@jhsph.edu	Bowman, Stephen/AAF-2154-2019	Aitken, Mary/0000-0002-8318-9755	Arkansas Biosciences Institute	Supported, in part, by the Arkansas Biosciences Institute, the major research component of the Tobacco Settlement Proceeds Act of 2000.	Aitken ME, 2004, INJURY PREV, V10, P303, DOI 10.1136/ip.2003.004176; American College of Surgeons, 2009, Bull Am Coll Surg, V94, P37; [Anonymous], 2000, PEDIATRICS, V105, P1352; BARRETT M, 2006, 200606 US AG HEALTHC; Bhutta ST, 2004, PEDIATR RADIOL, V34, P130, DOI 10.1007/s00247-003-1085-4; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; FELICIANO DV, 1996, TRAUMA, P55; Fonseca AH, 2005, AM SURGEON, V71, P937; Greenberg BS, 2009, PEDIATR RADIOL, V39, P657, DOI 10.1007/s00247-009-1258-x; *HCUP, 2003, KIDS INP DAT KID 200; *J HOPK U, 1997, ICDMAP 90 INJ SEV CO; Jones CS, 2005, J RURAL HEALTH, V21, P70, DOI 10.1111/j.1748-0361.2005.tb00064.x; Kelleher CM, 2005, J PEDIATR SURG, V40, P929, DOI 10.1016/j.jpedsurg.2005.03.007; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; MAYNARD FM, 1988, ANN EMERG MED, V17, P30, DOI 10.1016/S0196-0644(88)80499-2; RODGERS GB, 1990, ACCIDENT ANAL PREV, V22, P47, DOI 10.1016/0001-4575(90)90006-7; Ross RT, 1999, AM SURGEON, V65, P870; Stolz U, 2009, J SAFETY RES, V40, P149, DOI 10.1016/j.jsr.2009.02.005; Streeter RA, 2007, 2007 ANN REPORT ATV; Su W, 2006, J PEDIATR SURG, V41, P931, DOI 10.1016/j.jpedsurg.2006.01.011; *US CONS PROD SAF, 2009, CPSC APPR CONS DECR; Westfall JM, 2001, MED CARE, V39, P459, DOI 10.1097/00005650-200105000-00006; Wu HY, 2007, J UROLOGY, V178, P1672, DOI 10.1016/j.juro.2007.03.160; 2009, ATV CONNECTION MAGAZ	24	30	30	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2010	69	6					1344	1349		10.1097/TA.0b013e3181ea283d			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	695RT	WOS:000285391000016	20962681				2021-06-18	
J	Wagner, AK				Wagner, A. K.			TBI translational rehabilitation research in the 21(st) Century: exploring a Rehabilomics research model	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Rehabilitation; Biological markers; Evidence based medicine; Rehabilomics	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTERNATIONAL CLASSIFICATION; DISABILITY; MICROARRAY; BIOMARKERS; DOPAMINE; HEALTH; IMPACT	Globally, traumatic brain injury (TBI) is a leading cause of death and persistent disability. Although improvements in standard of care have reduced the overall mortality rates associated with this disease, there is a paucity of effective neuroprotective therapies. However, some rehabilitation focused strategies have shown promise with enhancing neurorecovery. One major challenge in identifying effective therapies is that TBI is an inherently heterogeneous disease. Despite many patients having similar injury factors and clinical care after their TBI, recovery and outcomes can be very different. This commentary discusses the value of treatment effectiveness research that also incorporates theranostic principles of individualized care. Key to this concept is the utilization of state-of-the-art biomarker platforms and technologies that can identify relevant molecular or physiological fingerprints that can assist rehabilitation practitioners in delineating long term outcome that can be linked to plasticity, treatment response, and natural recovery. This commentary proposes a unique concept of "Rehabilomics" as a field of study involving the systematic collection and study of rehabilitation relevant phenotypes, in conjunction with a transdisciplinary evaluation of biomarkers, in order to better understand the biology, function, prognosis, complications, treatments, adaptation, and recovery for persons with disabilities. Specific Rehabilomics applications to TBI research, as well as relevance to the National Institutes of Health Roadmap, are discussed.	Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, Pittsburgh, PA 15237 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 202, Pittsburgh, PA 15237 USA.	wagnerak@upmc.edu					Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berman BP, 2009, NAT BIOTECHNOL, V27, P341, DOI 10.1038/nbt0409-341; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; Bornman J, 2004, DISABIL REHABIL, V26, P182, DOI 10.1080/09638280410001665218; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dahl TH, 2002, J REHABIL MED, V34, P201, DOI 10.1080/165019702760279170; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; *DEPL HLTH CLIN CT, EM HLTH CONC TBI; Hobbs A, 1999, J HEAD TRAUMA REHAB, V14, P616, DOI 10.1097/00001199-199912000-00010; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rice F, 2003, INT J GERIATR PSYCH, V18, P155, DOI 10.1002/gps.808; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, pVII, DOI 10.1097/00001199-200104000-00002; Schuntermann MF, 1996, INT J REHABIL RES, V19, P1, DOI 10.1097/00004356-199603000-00001; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WAGNER AK, ACUTE SERUM IN PRESS; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wyszynski M E, 1999, Clin Excell Nurse Pract, V3, P262	27	30	30	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	DEC	2010	46	4					549	555					7	Rehabilitation	Rehabilitation	712SX	WOS:000286687600011	21224787				2021-06-18	
J	Sumowski, JF; Wood, HG; Chiaravalloti, N; Wylie, GR; Lengenfelder, J; Deluca, J				Sumowski, James F.; Wood, Hali G.; Chiaravalloti, Nancy; Wylie, Glenn R.; Lengenfelder, Jeannie; Deluca, John			Retrieval practice A simple strategy for improving memory after traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Memory; Memory disorders; Cognition; Rehabilitation; Testing effect	COGNITIVE REHABILITATION; DIVIDED ATTENTION; EPISODIC MEMORY; HIPPOCAMPUS; BENEFITS; MULTIPLE; RECALL; TESTS	Memory impairment is common following traumatic brain injury (TBI) but interventions to improve memory in persons with TBI have been ineffective Retrieval practice is a robust memory strategy among healthy undergraduates whereby practice retrieving information shortly after it is presented leads to better delayed recall than simple restudy In a verbal paired associate paradigm we investigated the effect of retrieval practice relative to massed and spaced restudy on delayed recall in 14 persons with chronic memory impairment following a TBI and 14 age matched healthy controls A significant learning condition (massed restudy spaced restudy retrieval practice) by group (TBI healthy) interaction emerged whereby only healthy controls benefited from spaced restudy (i e distributed learning) over massed restudy but both groups greatly benefited from retrieval practice over massed and spaced restudy That is retrieval practice greatly Improves memory in persons with TBI, even when other mnemonic strategies (e g distributed learning) are less effective (JINS 2010 16 1147-1150)	[Sumowski, James F.] Kessler Fdn, Neuropsychol & Neurosci Lab, Res Ctr, W Orange, NJ 07052 USA; [Sumowski, James F.; Chiaravalloti, Nancy; Wylie, Glenn R.; Lengenfelder, Jeannie; Deluca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Deluca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA	Sumowski, JF (corresponding author), Kessler Fdn, Neuropsychol & Neurosci Lab, Res Ctr, 300 Execut Dr,Suite 10, W Orange, NJ 07052 USA.				National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD060765]; National Institute on Disability and Rehabilitation Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R00HD060765] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K99HD060765] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health (HD060765 to J FS) and National Institute on Disability and Rehabilitation Research (Research Grant to N C) The authors have no conflicts of interest to report	Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Balota DA, 2006, PSYCHOL AGING, V21, P19, DOI 10.1037/0882-7974.21.1.19; Carpenter SK, 2005, APPL COGNITIVE PSYCH, V19, P619, DOI 10.1002/acp.1101; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cull WL, 2000, APPL COGNITIVE PSYCH, V14, P215, DOI 10.1002/(SICI)1099-0720(200005/06)14:3<215::AID-ACP640>3.0.CO;2-1; Delis DC, 2000, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Nelson D. L., 1998, U S FLORIDA WORD ASS; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Roediger HL, 2006, PERSPECT PSYCHOL SCI, V1, P181, DOI 10.1111/j.1745-6916.2006.00012.x; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sumowski JF, 2010, NEUROPSYCHOLOGY, V24, P267, DOI 10.1037/a0017533; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	25	30	31	3	23	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2010	16	6					1147	1150		10.1017/S1355617710001128			4	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	690RL	WOS:000285023200022	20946709				2021-06-18	
J	Wood, RLL; Williams, C; Lewis, R				Wood, Rodger L. L.; Williams, Claire; Lewis, Ruth			Role of alexithymia in suicide ideation after traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Emotions; Affective symptoms; Depression; Hopelessness; Worthlessness	DEPRESSION; SCALE; RISK	A high frequency of suicide ideation (SI) has been reported following traumatic brain injury (TBI) (Simpson & Tate 2002 Teasdale & Engberg 2001) This study examined the frequency of SI following TBI and its relationship to alexithymia, and depression plus two components of depression-hopelessness and worthlessness One hundred and five TBI patients and 74 demographically matched controls completed the Toronto Alexithymia Scale-20 (TAS-20) and the Beck Depression Inventory (BDI-II) Ratings of SI hopelessness and worthlessness were extracted from the BDI-II Results confirm a high frequency of SI (33%) and alexithymia (61%) after TBI compared with healthy controls (1 4% and 6 5% respectively) A high frequency of alexithymia was also found in a sub-group of moderate severely depressed TBI patients (70 68%) compared with two non-TBI depressed samples (53 92% and 44 8%) A significant association was found between SI and alexithymia in the TBI group with the SI group reporting significantly higher TAS-20 total scores However, logistic regression analysis found that worthlessness was the strongest predictor of SI after TBI The results of this study suggest that increased attention should be directed toward emotional change after TBI, as alexithymia may mediate the development of worthlessness and in turn, increase the risk of SI (JINS 2010 16 1108-1114)	[Wood, Rodger L. L.; Williams, Claire; Lewis, Ruth] Swansea Univ, Sch Human & Hlth Sci, Dept Psychol, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales	Wood, RLL (corresponding author), Swansea Univ, Sch Human Sci, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.			Williams, Claire/0000-0002-0791-744X			BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beck A.T., 1996, MANUAL BECK DEPRESSI; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, pXXI; DIEKSTRA RFW, 1995, SUICIDE LIFE-THREAT, V25, P36; Hall RCW, 1999, PSYCHOSOMATICS, V40, P18, DOI 10.1016/S0033-3182(99)71267-3; Hintikka J, 2004, COMPR PSYCHIAT, V45, P340, DOI 10.1016/j.comppsych.2004.06.008; Hirsch N, 2001, ENCEPHALE, V27, P61; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Honkalampi K, 2001, PSYCHOTHER PSYCHOSOM, V70, P247, DOI 10.1159/000056262; Iancu I, 2001, COMPR PSYCHIAT, V42, P477, DOI 10.1053/comp.2001.27893; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; Kauhanen J, 1996, J PSYCHOSOM RES, V41, P541, DOI 10.1016/S0022-3999(96)00226-7; Kuhner C, 2007, RESPONSE STYLES QUES; Larsson B, 1998, EUR CHILD ADOLES PSY, V7, P201, DOI 10.1007/s007870050068; SCHOTTE DE, 1982, J CONSULT CLIN PSYCH, V50, P690, DOI 10.1037/0022-006X.50.5.690; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Steer RA, 1998, J PSYCHOPATHOL BEHAV, V20, P127, DOI 10.1023/A:1023091529735; Taiminen TJ, 1996, ACTA PSYCHIAT SCAND, V93, P195, DOI 10.1111/j.1600-0447.1996.tb10631.x; Taylor G J, 1997, DISORDERS FECT REGUL; TAYLOR GJ, 1992, PSYCHOTHER PSYCHOSOM, V57, P34, DOI 10.1159/000288571; Teasdale T W, 2006, EVIDENCE BASED MENTA, V6, P11; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Wechsler D., 2001, WECHSLER TEST ADULT; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518	29	30	30	1	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2010	16	6					1108	1114		10.1017/S1355617710001013			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	690RL	WOS:000285023200018	20875201				2021-06-18	
J	Roehl, AB; Hein, M; Loetscher, PD; Rossaint, J; Weis, J; Rossaint, R; Coburn, M				Roehl, Anna B.; Hein, Marc; Loetscher, Philipp D.; Rossaint, Jan; Weis, Joachim; Rossaint, Rolf; Coburn, Mark			Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury	BMC NEUROLOGY			English	Article							RESUSCITATION; MECHANISMS; CULTURES; ISCHEMIA	Background: We investigated the neuroprotective properties of levosimendan, a novel inodilator, in an in vitro model of traumatic brain injury. Methods: Organotypic hippocampal brain slices from mouse pups were subjected to a focal mechanical trauma. Slices were treated after the injury with three different concentrations of levosimendan (0.001, 0.01 and 0.1 mu M) and compared to vehicle-treated slices. After 72 hrs, the trauma was quantified using propidium iodide to mark the injured cells. Results: A significant dose-dependent reduction of both total and secondary tissue injury was observed in cells treated with either 0.01 or 0.1 mu M levosimendan compared to vehicle-treated slices. Conclusion: Levosimendan represents a promising new pharmacological tool for neuroprotection after brain injury and warrants further investigation in an in vivo model.	[Roehl, Anna B.; Hein, Marc; Loetscher, Philipp D.; Rossaint, Jan; Rossaint, Rolf; Coburn, Mark] RWTH Aachen Univ Hosp, Dept Anaesthesiol, D-52074 Aachen, Germany; [Weis, Joachim] RWTH Aachen Univ Hosp, Inst Neuropathol, D-52074 Aachen, Germany	Roehl, AB (corresponding author), RWTH Aachen Univ Hosp, Dept Anaesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	aroehl@ukaachen.de	Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773; Coburn, Mark/0000-0002-7930-0270			AbdelHamid KM, 1997, J NEUROSCI, V17, P3538; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Hein M, 2009, ACTA ANAESTH SCAND, V53, P941, DOI 10.1111/j.1399-6576.2009.01994.x; Koudouna E, 2007, ACTA ANAESTH SCAND, V51, P1123, DOI 10.1111/j.1399-6576.2007.01383.x; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Shimizu K, 2002, AM J PHYSIOL-HEART C, V283, pH1005, DOI 10.1152/ajpheart.00054.2002	11	30	34	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	OCT 21	2010	10								97	10.1186/1471-2377-10-97			4	Clinical Neurology	Neurosciences & Neurology	678GX	WOS:000284063200001	20964834	DOAJ Gold, Green Published			2021-06-18	
J	Stulemeijer, M; Vos, PE; van der Werf, S; van Dijk, G; Rijpkema, M; Fernandez, G				Stulemeijer, Maja; Vos, Pieter E.; van der Werf, Sieberen; van Dijk, Gert; Rijpkema, Mark; Fernandez, Guillen			How Mild Traumatic Brain Injury May Affect Declarative Memory Performance in the Post-Acute Stage	JOURNAL OF NEUROTRAUMA			English	Article						functional magnetic resonance imaging; memory; mild brain concussion; neuropsychological tests	DIFFUSE AXONAL INJURY; MEDIAL TEMPORAL-LOBE; CLOSED-HEAD-INJURY; AUDITORY-EVOKED-RESPONSES; PHOTON EMISSION CT; WORKING-MEMORY; FUNCTIONAL MRI; TECHNETIUM-99M-HMPAO SPECT; POSTCONCUSSION SYNDROME; POSTTRAUMATIC AMNESIA	Memory deficits are among the most frequently reported sequelae of mild traumatic brain injury (MTBI), especially early after injury. To date, these cognitive deficits remain poorly understood, as in most patients the brain is macroscopically intact. To identify the mechanism by which MTBI causes declarative memory impairments, we probed the functionality of the medial temporal lobe (MTL) and the prefrontal cortex (PFC), within 6 weeks after injury in 43 patients from a consecutive cohort, and matched healthy controls. In addition to neuropsychological measures of declarative memory and other cognitive domains, all subjects underwent functional magnetic resonance imaging (fMRI). Behavioral results showed poorer declarative memory performance in patients than controls, and decreasing performance with increasing duration of post-traumatic amnesia (a measure of injury severity). Task performance in the scanner was, as intended by the task and design, similar in patients and controls, and did not relate to injury severity. The task used reliably activated the MTL and PFC. Although we did not find significant differences in brain activity when comparing patients and controls, we revealed, in agreement with our neuropsychological findings, an inverse correlation between MTL activity and injury severity. In contrast, no difference in prefrontal activation was found between patients and controls, nor was there a relation with injury severity. On a behavioral level, injury severity was inversely related to declarative memory performance. In all, these findings suggest that reduced medial temporal functionality may contribute to poorer declarative memory performance in the post-acute stage of MTBI, especially in patients with longer post-traumatic amnesia.	[Vos, Pieter E.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Stulemeijer, Maja; van der Werf, Sieberen] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands; [van Dijk, Gert] Canisius Wilhelmina Hosp, Dept Neurol, Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands	Vos, PE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol 935, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.vos@neuro.umcn.nl	Fernandez, Guillen/B-3771-2009; Vos, Pieter/A-6043-2012; Rijpkema, Mark/D-1974-2010	Fernandez, Guillen/0000-0002-5522-0604; Rijpkema, Mark/0000-0002-8495-4703	Top Center Traumatology Nijmegen	We would like to thank all subjects for their participation, and Jeske Broeren, Sanne Rasing, and Paul Gaalman for their assistance with the data acquisition. The Top Center Traumatology Nijmegen is kindly acknowledged for its financial support.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Ahmed S, 2000, BRAIN INJURY, V14, P765; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Delis DC, 1987, CALIFORNIA VERBAL LE; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Easdon C, 2004, BRAIN COGNITION, V54, P136; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fernandez G, 2001, BRAIN RES BULL, V55, P1, DOI 10.1016/S0361-9230(01)00494-4; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; ICHISE M, 1994, J NUCL MED, V35, P217; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JACOBS A, 1994, J NUCL MED, V35, P942; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Joy S, 2003, ASSESSMENT, V10, P56, DOI 10.1177/0095399702250335; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Piekema C, 2006, NEUROIMAGE, V33, P374, DOI 10.1016/j.neuroimage.2006.06.035; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; RIZZO PA, 1983, NEUROPSYCHOBIOLOGY, V9, P78, DOI 10.1159/000117941; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Snaphaan L, 2009, BRAIN, V132, P1882, DOI 10.1093/brain/awp133; SOUSTIEL JF, 2005, BRAIN INJURY, V9, P805; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Ulug AM, 1999, AM J NEURORADIOL, V20, P1044; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VAN DER NAALT J, 1999, J NEUROL NEUROSUR PS, V66, P207; VONWOWERN F, 1966, ACTA NEUROL SCAND, V42, P373; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	82	30	30	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1585	1595		10.1089/neu.2010.1298			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500005	20629484				2021-06-18	
J	Fletcher, JJ; Bergman, K; Blostein, PA; Kramer, AH				Fletcher, Jeffrey J.; Bergman, Karen; Blostein, Paul A.; Kramer, Andreas H.			Fluid Balance, Complications, and Brain Tissue Oxygen Tension Monitoring Following Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Fluid balance; Traumatic brain injury; Refractory intracranial hypertension; Pulmonary edema; Brain tissue oxygen tension	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; MANAGEMENT STRATEGIES; CEREBRAL EDEMA; HYPERTENSION; CLASSIFICATION; PREDICTORS; PRINCIPLES; THERAPY; TRIAL	Refractory intracranial hypertension (RIH) frequently complicates severe traumatic brain injury (TBI) and is associated with worse outcomes. Aggressive fluid resuscitation contributes to the development of peripheral and pulmonary edema, but an effect on cerebral edema is not well established. Some clinicians, including advocates of the "Lund Concept", practice fluid restriction as a means of limiting cerebral edema and reducing intracranial pressure (ICP). We performed a retrospective cohort study involving 41 consecutive patients with severe TBI to assess the association between fluid balance and the development of RIH or pulmonary complications. There was no difference in cumulative fluid balance between patients who did, or did not, develop RIH. Patients in the tertile with the largest fluid balance were no more likely to develop RIH than those in the more restrictive groups (HR 1.05, 0.78-1.42, P = 0.73). In contrast, there was a strong association between fluid balance and the development of bilateral pulmonary infiltrates, which persisted even after adjusting for Glasgow Coma Scale and Injury Severity Score (HR 1.69, 1.40-2.04, P < 0.0001). The use of P(bt)O(2) monitors to guide therapy was associated with higher cumulative fluid balance, more vasopressor use, and the development of both pulmonary edema and RIH. We found no association between cumulative fluid balance and the development of RIH. However, more judicious volume management has the potential to reduce the occurrence of pulmonary complications. Further research is needed to clarify optimal approaches to fluid management among patients with severe TBI and to guide the interpretation and integration of information derived from P(bt)O(2) monitors.	[Fletcher, Jeffrey J.] Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, Taubman Hlth Care Ctr 3552, Ann Arbor, MI 48109 USA; [Fletcher, Jeffrey J.; Bergman, Karen; Blostein, Paul A.] Bronson Methodist Hosp, Dept Trauma Surg & Crit Care, Kalamazoo, MI 49007 USA; [Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Dept Crit Care Med, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada	Fletcher, JJ (corresponding author), Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, Taubman Hlth Care Ctr 3552, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jeffletc@med.umich.edu; BergmanK@bronsonhg.org; Andreas.Kramer@albertahealthservices.ca					[Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brain Trauma Foundation American Association of Neurological Surgeons Joint Section on Neurotrauma and Critical Care, 1996, J NEUROTRAUMA, V13, P641; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; GRANDE PO, 2006, INTENS CARE MED, V17, P561; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lodeserto F, 2009, CHEST, V136, p15S; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; PACULT A, 1989, TXB HEAD INJURY, P192; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; SHENKIN HA, 1967, J NEUROSURG, V28, P417; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	37	30	34	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2010	13	1					47	56		10.1007/s12028-010-9345-2			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	620NF	WOS:000279505900008	20376708				2021-06-18	
J	Patel, HC; Bouamra, O; Woodford, M; Yates, DW; Lecky, FE				Patel, H. C.; Bouamra, Omar; Woodford, Maralyn; Yates, David W.; Lecky, Fiona E.			Clinical article: mortality associated with severe head injury in the elderly	ACTA NEUROCHIRURGICA			English	Article						Elderly; Mortality; Severe head injury	TRAUMATIC BRAIN-INJURY; AGE; SCORE	Age is an important factor in determining prognosis following severe head injury (SHI), although mortality in patients a parts per thousand yen65 years is poorly reported. The aim of this study was to document mortality in patients with SHI a parts per thousand yen65 years. A retrospective analysis of prospectively collected data from the TARN (Trauma Audit and Research Network) database (1996-2004) was performed. Six hundred and sixty-nine patients aged a parts per thousand yen65 with a GCS < 9 after a head injury were identified, and mortality at 3 months was recorded. Mortality was 71% in 65- to 70-year-old patients (n = 137) (CI, 64-79), 75% for patients aged 70-75 years (n = 147) (CI, 68-82), 85% in patients aged 75-80 years (n = 160) (79-91), and 87% for patients > 80 years (n = 225) (CI, 83-91). Mortality for all patients a parts per thousand yen65 years with a GCS 3-5 was > 80%. A better outcome was observed in patients with a GCS = 6-8 [65-70 years, 47% (CI, 30-64); 70-75 years, 56% (CI, 43-69); 75-80 years, 73% (CI, 62-85); > 80 years, 79% (CI, 70-87)]. SHI-related mortality continues to increase with age. Overall, these data support a conservative approach to the severely head-injured elderly patient; however, patients presenting with a GCS = 6-8 and below the age of 75 may represent a group where more aggressive therapy may be indicated.	[Bouamra, Omar; Woodford, Maralyn; Yates, David W.; Lecky, Fiona E.] Univ Manchester, Hope Hosp, Trauma Audit & Res Network, Manchester Med Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England; [Patel, H. C.] Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England	Lecky, FE (corresponding author), Univ Manchester, Hope Hosp, Trauma Audit & Res Network, Manchester Med Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England.	Fiona.Lecky@manchester.ac.uk	Patel, Hiren/AAL-3811-2021	Patel, Hiren/0000-0002-1439-8801	TARN	Omar Bouamra and Maralyn Woodford are employed by the University of Manchester as a result of TARN funding.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; *AM ASS NEUR SURG, 2000, EARL IND PROGN SEV T, P171; *ASS ADV AUT MED C, 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; JOHNSON CL, 1994, AM SURGEON, V60, P899; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763	16	30	32	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	AUG	2010	152	8					1353	1357		10.1007/s00701-010-0666-x			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	622YV	WOS:000279704300013	20437280				2021-06-18	
J	Bishop, GM; Scheiber, IF; Dringen, R; Robinson, SR				Bishop, Glenda M.; Scheiber, Ivo F.; Dringen, Ralf; Robinson, Stephen R.			Synergistic accumulation of iron and zinc by cultured astrocytes	JOURNAL OF NEURAL TRANSMISSION			English	Article						Zinc; Astrocyte; NTBI; Zip14; DMT1	TRANSPORT PROTEINS; ZNT-1 EXPRESSION; MESSENGER-RNA; INDUCED DEATH; FERROUS IRON; BRAIN; TOXICITY; MECHANISMS; NEURONS; CELLS	Iron and zinc are essential for normal brain function, yet the mechanisms used by astrocytes to scavenge non-transferrin-bound iron (NTBI) and zinc are not well understood. Ischaemic stroke, traumatic brain injury and Alzheimer's disease are associated with perturbations in the metabolism of NTBI and zinc, suggesting that these two metals may collectively contribute to pathology. The present study has investigated the accumulation of NTBI and zinc by rat primary astrocyte cultures. It was found that astrocytes express mRNA for both divalent metal transporter 1 (DMT1) and Zip14, indicating the potential for these transporters to contribute to the accumulation of NTBI and zinc by these cells. Astrocytes were found to accumulate iron from ferric chloride in a time- and dose-dependent manner, and the rate of accumulation was strongly stimulated by co-incubation with zinc acetate. In addition, cultured astrocytes rapidly accumulated zinc from zinc acetate, and this accumulation was stimulated by co-incubation with ferric chloride. Because a synergistic stimulation of iron and zinc accumulation is inconsistent with the known properties of DMT1 and Zip14, the present results suggest that additional mechanisms assist astrocytes to scavenge iron and zinc when they are present together in the extracellular compartment. These mechanisms may be involved in disorders that involve elevations in the extracellular concentrations of these metal ions.	[Bishop, Glenda M.; Dringen, Ralf; Robinson, Stephen R.] Monash Univ, Sch Psychol & Psychiat, Blood Brain Interact Grp, Clayton, Vic 3800, Australia; [Scheiber, Ivo F.; Dringen, Ralf] Univ Bremen, Ctr Biomol Interact Bremen, Fac Biol Chem 2, Bremen, Germany; [Scheiber, Ivo F.; Dringen, Ralf] Univ Bremen, Ctr Environm Res & Sustainable Technol, Bremen, Germany	Bishop, GM (corresponding author), Monash Univ, Sch Psychol & Psychiat, Blood Brain Interact Grp, Wellington Rd, Clayton, Vic 3800, Australia.	glenda.bishop@monash.edu	Bishop, Glenda M/G-6031-2010; Robinson, Stephen R/B-7155-2013	Bishop, Glenda/0000-0002-2736-0415; Robinson, Stephen/0000-0002-0987-0075; Dringen, Ralf/0000-0001-7869-1305	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [284393]; NeuroSciences Victoria; NHMRCNational Health and Medical Research Council of Australia [334129]; School of Psychology and Psychiatry, Monash UniversityMonash University	GMB was supported by a National Health and Medical Research Council Peter Doherty Fellowship (ID: 284393), and RD was supported by NeuroSciences Victoria for a Senior Research Fellowship. This work was supported by an NHMRC Project Grant (ID: 334129) to SRR and RD and also by the School of Psychology and Psychiatry, Monash University.	ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Attieh ZK, 1999, J BIOL CHEM, V274, P1116, DOI 10.1074/jbc.274.2.1116; Belloni-Olivi L, 2009, J NEUROSCI RES, V87, P3221, DOI 10.1002/jnr.22144; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Bishop GM, 2002, DEV NEUROSCI-BASEL, V24, P184, DOI 10.1159/000065696; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Chowanadisai W, 2005, J NUTR, V135, P1002; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Deng ZP, 2009, BIOMETALS, V22, P803, DOI 10.1007/s10534-009-9227-2; Dineley KE, 2000, NEUROBIOL DIS, V7, P310, DOI 10.1006/nbdi.2000.0303; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; Erikson KM, 2006, NEUROTOXICOLOGY, V27, P125, DOI 10.1016/j.neuro.2005.07.003; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Gaasch JA, 2007, NEUROCHEM RES, V32, P1686, DOI 10.1007/s11064-007-9313-1; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Gao J, 2008, J BIOL CHEM, V283, P21462, DOI 10.1074/jbc.M803150200; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Hoepken HH, 2004, J NEUROCHEM, V88, P1194, DOI 10.1046/j.1471-4159.2003.02236.x; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kramer KK, 1996, TOXICOL APPL PHARM, V136, P94, DOI 10.1006/taap.1996.0011; Kress GJ, 2002, J NEUROSCI, V22, P5848; Lin AMY, 2001, FREE RADICAL BIO MED, V30, P225, DOI 10.1016/S0891-5849(00)00464-0; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Lovell MA, 2009, J ALZHEIMERS DIS, V16, P471, DOI 10.3233/JAD-2009-0992; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Marciani P, 2004, J MEMBRANE BIOL, V197, P91, DOI 10.1007/s00232-003-0644-9; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Meguro R, 2008, ARCH HISTOL CYTOL, V71, P205, DOI 10.1679/aohc.71.205; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Sheline CT, 2004, GLIA, V46, P18, DOI 10.1002/glia.10313; Simovich M, 2003, AM J HEMATOL, V74, P32, DOI 10.1002/ajh.10383; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tiffany-Castiglioni E, 2001, NEUROTOXICOLOGY, V22, P577, DOI 10.1016/S0161-813X(01)00050-X; Tulpule K, 2010, J NEUROSCI RES, V88, P563, DOI 10.1002/jnr.22217; Varea E, 2006, GLIA, V54, P304, DOI 10.1002/glia.20382; Wang XS, 2001, J NEUROCYTOL, V30, P353, DOI 10.1023/A:1014464514793; Waring P, 2005, ARCH BIOCHEM BIOPHYS, V434, P33, DOI 10.1016/j.abb.2004.08.001	51	30	31	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JUL	2010	117	7					809	817		10.1007/s00702-010-0420-9			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	619XT	WOS:000279464300002	20549524				2021-06-18	
J	Jovanovic, V; Pekic, S; Stojanovic, M; Tasic, G; Djurovic, B; Soldatovic, I; Doknic, M; Miljic, D; Djurovic, M; Medic-Stojanoska, M; Popovic, V				Jovanovic, Vladimir; Pekic, Sandra; Stojanovic, Marko; Tasic, Goran; Djurovic, Branko; Soldatovic, Ivan; Doknic, Mirjana; Miljic, Dragana; Djurovic, Marina; Medic-Stojanoska, Milica; Popovic, Vera			Neuroendocrine dysfunction in patients recovering from subarachnoid hemorrhage	HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM			English	Article						Cerebral aneurysm; Hypopituitarism; Subarachnoid hemorrhage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; GH DEFICIENCY; HYPOPITUITARISM; DIAGNOSIS; ADULTS; IMPAIRMENT; PREVALENCE; GUIDELINES; LESIONS	OBJECTIVE: Subarachnoid hemorrhage (SAH) is a recently identified risk factor for hypopituitarism, particularly growth hormone (GH) and corticotrophins deficiencies. The aim of our study was to identify possible predictor(s) for neuroendocrine dysfunction in SAH survivors. DESIGN: Pituitary function was evaluated in 93 patients (30 males, 63 females), aged 48.0 +/- 1.1 years (mean +/- SE), and with a Glasgow Outcome Scale score of 4.6 +/- 0.6 (mean +/- SE) more than one year following SAH. In the acute phase, SAH was complicated by vasospasm (VS) in 18 and by hydrocephalus (HDC) in 9 patients. Baseline serum values of Insulin Growth Factor 1 (IGF-I), cortisol, Thyroxine (T4), Thyroid Stimulating Hormone (TSH), Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), testosterone (in males), estradiol (in females) and prolactin were determined. RESULTS: According to the results of baseline hormonal evaluation, 47 patients (50.5%) had no hormonal abnormalities. Seven patients (7.5%) had multiple pituitary hormone deficiencies: Four patients (4.3%) had two (GH and cortisol), one patient had three (gonadal, adrenal and GH) and two patients had deficiency of all pituitary axes. Thirty-nine patients (42%) had one abnormal axis (13 adrenal, 2 thyroid, 4 gonadal and 20 GH). None of the subjects was treated with desmopressin or exhibited symptomatic polyuria. The VS and HDC during the acute phase of SAH were related to abnormal pituitary status (VS with low IGF-I levels and HDC with low cortisol levels). CONCLUSION: Through a screening procedure, neuroendocrine dysfunction was identified in a substantial number of asymptomatic patients with previous SAH. Cerebral VS and HDC at the time of SAH emerged as risk factors possibly predicting development of pituitary dysfunction. Low basal levels of IGF 1 and cortisol may help in selecting patients requiring further evaluation of pituitary function.	[Pekic, Sandra; Stojanovic, Marko; Doknic, Mirjana; Miljic, Dragana; Djurovic, Marina; Popovic, Vera] Univ Clin Ctr, Inst Endocrinol, Belgrade 11000, Serbia; [Jovanovic, Vladimir; Tasic, Goran; Djurovic, Branko] Univ Clin Ctr, Inst Neurosurg, Belgrade 11000, Serbia; [Soldatovic, Ivan] Fac Med, Inst Med Stat & Hlth Res, Belgrade, Serbia; [Medic-Stojanoska, Milica] Univ Novi Sad, Inst Endocrinol, Novi Sad 21000, Serbia	Popovic, V (corresponding author), Univ Clin Ctr, Inst Endocrinol, Dr Subotica 13, Belgrade 11000, Serbia.		Pekic, Sandra/S-7175-2016	Soldatovic, Ivan/0000-0003-4893-1683			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Bjeljac M, 2002, ACT NEUR S, V82, P83; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HOFF WV, 1961, BRIT MED J, V5261, P1190; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lamberts SWJ, 1998, LANCET, V352, P127; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rap Z, 1971, Pol Med J, V10, P188; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sesmilo Gemma, 2007, Hormones (Athens), V6, P132; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306	30	30	31	0	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1109-3099	2520-8721		HORM-INT J ENDOCRINO	Horm.-Int. J. Endocrinol. Metab.	JUL-SEP	2010	9	3					235	244		10.14310/horm.2002.1273			10	Endocrinology & Metabolism	Endocrinology & Metabolism	642HW	WOS:000281200600005	20688621	Bronze			2021-06-18	
J	Ibrahim, NG; Ralston, J; Smith, C; Margulies, SS				Ibrahim, Nicole G.; Ralston, Jill; Smith, Colin; Margulies, Susan S.			Physiological and Pathological Responses to Head Rotations in Toddler Piglets	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; pediatric head injury; pig; toddler	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; CORTICAL IMPACT; IMMATURE RAT; AGE; MODEL; DAMAGE; CHILDREN; CALCIUM	Closed head injury is the leading cause of death in children less than 4 years of age, and is thought to be caused in part by rotational inertial motion of the brain. Injury patterns associated with inertial rotations are not well understood in the pediatric population. To characterize the physiological and pathological responses of the immature brain to inertial forces and their relationship to neurological development, toddler-age (4-week-old) piglets were subjected to a single non-impact head rotation at either low (31.6 +/- 4.7 rad/sec(2), n = 4) or moderate (61.0 +/- 7.5 rad/sec(2), n = 6) angular acceleration in the axial direction. Graded outcomes were observed for both physiological and histopathological responses such that increasing angular acceleration and velocity produced more severe responses. Unlike low-acceleration rotations, moderate-acceleration rotations produced marked EEG amplitude suppression immediately post-injury, which remained suppressed for the 6-h survival period. In addition, significantly more severe subarachnoid hemorrhage, ischemia, and axonal injury by beta-amyloid precursor protein (beta-APP) were observed in moderate-acceleration animals than low-acceleration animals. When compared to infant-age (5-day-old) animals subjected to similar (54.1 +/- 9.6 rad/sec(2)) acceleration rotations, 4-week-old moderate-acceleration animals sustained similar severities of subarachnoid hemorrhage and axonal injury at 6 h post-injury, despite the larger, softer brain in the older piglets. We conclude that the traditional mechanical engineering approach of scaling by brain mass and stiffness cannot explain the vulnerability of the infant brain to acceleration-deceleration movements, compared with the toddler.	[Ibrahim, Nicole G.; Ralston, Jill; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Neuropathol, Edinburgh, Midlothian, Scotland	Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	National Institute of Neurological Disorders and Stroke (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	This work was funded by the National Institute of Neurological Disorders and Stroke (NIH).	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; BRUCE D, 1990, HEAD INJURIES PEDIAT; Danelson KA, 2008, STAPP CAR C, V52, P59; Dobbing J, 1968, Prog Brain Res, V29, P417; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DOBBING J, 1974, BRIT MED BULL, V30, P164, DOI 10.1093/oxfordjournals.bmb.a071188; Dobbing J, 1981, LATER DEV BRAIN ITS; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Eucker S. A., 2009, THESIS U PENNSYLVANI; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FERREIRA A, 1993, J NEUROSCI, V13, P3112; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; IBRAHIM NG, 2009, THESIS U PENNSYLVANI; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Irwin AL, 1997, BIOMECHANICAL BASES; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 1967, P 11 STAPP CAR CRASH, P670906; OMMAYA AK, 1966, P 10 STAPP CAR CRASH, P191; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Snyder R.C., 1977, UMHSRI77 CONS PROD S; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Verger K, 2000, BRAIN INJURY, V14, P495; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Walter P., 2002, RNA PROTEIN MOL BIOL; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; Zhang CL, 1999, FEMS MICROBIOL ECOL, V30, P367, DOI 10.1111/j.1574-6941.1999.tb00664.x	63	30	30	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					1021	1035		10.1089/neu.2009.1212			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300006	20560753	Green Published			2021-06-18	
J	Lu, J; Marmarou, A; Lapane, K; Turf, E; Wilson, L				Lu, Juan; Marmarou, Anthony; Lapane, Kate; Turf, Elizabeth; Wilson, Lindsay		IMPACT Grp Ctr; Amer Brain Injury Consortium Study	A Method for Reducing Misclassification in the Extended Glasgow Outcome Score	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; extended Glasgow Outcome Scale; inter-rater variation; misclassification; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CLINICAL-TRIALS; AGREEMENT; SCALE; MULTICENTER; EXPERIENCE; DISABILITY; EFFICACY; KAPPA	The eight-point extended Glasgow Outcome Scale (GOSE) is commonly used as the primary outcome measure in traumatic brain injury (TBI) clinical trials. The outcome is conventionally collected through a structured interview with the patient alone or together with a caretaker. Despite the fact that using the structured interview questionnaires helps reach agreement in GOSE assessment between raters, significant variation remains among different raters. We introduce an alternate GOSE rating system as an aid in determining GOSE scores, with the objective of reducing inter-rater variation in the primary outcome assessment in TBI trials. Forty-five trauma centers were randomly assigned to three groups to assess GOSE scores on sample cases, using the alternative GOSE rating system coupled with central quality control (Group 1), the alternative system alone (Group 2), or conventional structured interviews (Group 3). The inter-rater variation between an expert and untrained raters was assessed for each group and reported through raw agreement and with weighted kappa (kappa) statistics. Groups 2 and 3 without central review yielded inter-rater agreements of 83% (weighted kappa=0.81; 95% CI 0.69, 0.92) and 83% (weighted kappa=0.76, 95% CI 0.63, 0.89), respectively, in GOS scores. In GOSE, the groups had an agreement of 76% (weighted kappa=0.79; 95% CI 0.69, 0.89), and 63% (weighted kappa=0.70; 95% CI 0.60, 0.81), respectively. The group using the alternative rating system coupled with central monitoring yielded the highest inter-rater agreement among the three groups in rating GOS (97%; weighted kappa=0.95; 95% CI 0.89, 1.00), and GOSE (97%; weighted kappa=0.97; 95% CI 0.91, 1.00). The alternate system is an improved GOSE rating method that reduces inter-rater variations and provides for the first time, source documentation and structured narratives that allow a thorough central review of information. The data suggest that a collective effort can be made to minimize inter-rater variation.	[Lu, Juan; Marmarou, Anthony] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Lapane, Kate; Turf, Elizabeth] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23298 USA; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland	Lu, J (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, POB 980508, Richmond, VA 23298 USA.	jlu1@vcu.edu	Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Lu, Juan/0000-0002-5389-7603	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 42691]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER	Support for this work was provided by National Institutes of Health grant NS 42691.	BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Marmarou A, 2005, J NEUROTRAUM, V22, P1444, DOI 10.1089/neu.2005.22.1444; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marmarou A., 2001, HEAD TRAUMA BASIC PR, P15; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	19	30	30	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2010	27	5					843	852		10.1089/neu.2010.1293			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	599LX	WOS:000277915400006	20334503	Green Published			2021-06-18	
J	Doble, JE; Feinberg, DL; Rosner, MS; Rosner, AJ				Doble, Jennifer E.; Feinberg, Debby L.; Rosner, Mark S.; Rosner, Arthur J.			Identification of Binocular Vision Dysfunction (Vertical Heterophoria) in Traumatic Brain Injury Patients and Effects of Individualized Prismatic Spectacle Lenses in the Treatment of Postconcussive Symptoms: A Retrospective Analysis	PM&R			English	Article								Objective: To identify a form of binocular vision dysfunction (vertical heterophoria) in a traumatic brain injury (TBI) population and to assess the effect of individualized prismatic spectacle lenses on postconcussive symptoms. Design: Retrospective study. Setting: Private physical medicine and rehabilitation practice and private optometric practice. Patients: A subset of TBI patients who were initially evaluated by a single physiatrist and who received standard treatments and medications yet had persistent postconcussive symptoms. These patients were then assessed by a single optometrist, and those found to have vertical heterophoria were treated with individualized prismatic spectacle lenses. A total of 83 patients were referred for testing; 77 were positive for vertical heterophoria on screening, of which 43 had complete data sets and were included for analysis. Interventions: All patients were treated with individualized prismatic spectacle lenses to correct for vertical heterophoria. Main Outcome Measures: Outcomes were measured by the difference in score before and after intervention of an objective, self-administered vertical heterophoria symptom burden instrument (Vertical Heterophoria Symptom Questionnaire [VHS-Q], presently undergoing validation) and by subjective improvement in symptoms as expressed by the patient at the end of intervention. Results: There was a 71.8% decrease in subjective symptom burden when compared with preintervention baseline. There was a mean 16.7 point absolute reduction in the VHS-Q score on a 75-point scale, which represents a relative reduction in VHS-Q score of 48.1%. Conclusion: Vertical heterophoria was identified in a group of TBI patients with postconcussive symptoms and treatment of the vertical heterophoria with individualized prismatic spectacle lenses resulted in a 71.8% decrease in subjective symptom burden and a relative reduction in VHS-Q score of 48.1%. It appears that vertical heterophoria can be acquired from TBI. PM R 2010;2:244-253	[Rosner, Mark S.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Doble, Jennifer E.] Special Tree Rehabil Syst, Romulus, MI USA; [Feinberg, Debby L.] Vis Specialists Birmingham, Birmingham, MI USA; [Rosner, Mark S.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI 48104 USA; [Rosner, Arthur J.] William Beaumont Hosp, Dept Otolaryngol, Troy, MI USA	Rosner, MS (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.	msr50@comcast.net					BIXENMAN WW, 1984, SURV OPHTHALMOL, V29, P70, DOI 10.1016/0039-6257(84)90115-2; Borish IM, 1975, CLIN REFRACTION, P327; Borish IM, 1975, CLIN REFRACTION, P866; Duke-Elder S, 1973, SYSTEM OPHTHALMOLOGY, V6, p[536, 553]; Furman JM, 1997, NEUROLOGY, V48, P1161, DOI 10.1212/WNL.48.5.1161; Gall Ronald, 2003, Optometry, V74, P309; Gray LS, 2008, GRAEF ARCH CLIN EXP, V246, P627, DOI 10.1007/s00417-008-0799-2; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; MITCHELL SW, 1876, AM J MED SCI, V71, P363; Roy RR, 1953, OPTOM WKLY, V44, P1513; Roy RR., 1958, OPTOM WKLY, V49, P907; Schrier M., 1997, BJOD, V5, P68; Schroeder TL, 1996, OPTOMETRY VISION SCI, V73, P389, DOI 10.1097/00006324-199606000-00006; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Stevens GT., 1887, FUNCTIONAL NERVOUS D, P200; Wick BB., 1997, J OPTOM VIS DEV, V28, P77	17	30	30	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	APR	2010	2	4					244	253		10.1016/j.pmrj.2010.01.011			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	V23SA	WOS:000208361300003	20430325	Green Published			2021-06-18	
J	Allen, DN; Thaler, NS; Donohue, B; Mayfield, J				Allen, Daniel N.; Thaler, Nicholas S.; Donohue, Brad; Mayfield, Joan			WISC-IV Profiles in Children With Traumatic Brain Injury: Similarities to and Differences From the WISC-III	PSYCHOLOGICAL ASSESSMENT			English	Article						WISC-IV; traumatic brain injury; Processing Speed Index; Cognitive Performance Index; General Abilities Index	WECHSLER INTELLIGENCE SCALE; CRITERION VALIDITY; PROCESSING SPEED; HEAD-INJURY; EDITION; DISCREPANCIES; SENSITIVITY; PERFORMANCE; PATTERNS; LANGUAGE	The Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV; D. Wechsler, 2003a) is often utilized to assess children with traumatic brain injury (TBI), although little information is available regarding its psychometric properties in these children. The current study examined WISC-IV performance in a sample of 61 children with TBI. As compared to the standardization sample, results indicated that the TBI group exhibited relative deficits on all subtest and index scores, with the greatest deficits on the Processing Speed Index (PSI) and Coding subtest scores. However, the Perceptual Reasoning Index score was not uniquely sensitive to brain injury, and the Cognitive Processing Index score was less sensitive to TBI than the PSI score. Also, the PSI did not uniquely predict learning and memory abilities, as had been reported in previous studies of the Wechsler Intelligence Scale for Children Third Edition (WISC-III; D. Wechsler, 1991). The present findings indicate substantive differences between the WISC-III and WISC-IV profiles of children with TBI.	[Allen, Daniel N.; Thaler, Nicholas S.; Donohue, Brad] Univ Nevada, Dept Psychol, Neuropsychol Res Program, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA	Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Neuropsychol Res Program, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2007, NEUROPSYCHOLOGY, V21, P713, DOI 10.1037/0894-4105.21.6.713; ALLEN DN, CHILD NEURO IN PRESS; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; ASARNOW RF, 1987, J CHILD PSYCHOL PSYC, V28, P273, DOI 10.1111/j.1469-7610.1987.tb00210.x; BLAHA J, 1984, J CLIN PSYCHOL, V40, P556, DOI 10.1002/1097-4679(198403)40:2<556::AID-JCLP2270400230>3.0.CO;2-W; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; CARAMAZZA A, 1976, BRAIN LANG, V3, P41, DOI 10.1016/0093-934X(76)90005-5; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Dalen K, 2008, NEUROPEDIATRICS, V39, P146, DOI 10.1055/s-0028-1085463; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; DUMONT R, 2009, USE TELLEGEN BRIGGS; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; FLETCHER JM, 1992, J CLIN EXP NEUROPSYC, V14, P593, DOI 10.1080/01688639208402847; GAZZANIGA MS, 1984, BRAIN, V107, P145, DOI 10.1093/brain/107.1.145; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Goldstein G, 2008, NEUROPSYCHOLOGY, V22, P301, DOI 10.1037/0894-4105.22.3.301; Jennett B, 1981, MANAGEMENT HEAD INJU; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Langdon D, 2000, CORTEX, V36, P691, DOI 10.1016/S0010-9452(08)70546-X; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Prigatano GP, 2008, CLIN NEUROPSYCHOL, V22, P603, DOI 10.1080/13854040701440501; RAIFORD SE, 2008, 4 PEARS ED; READ DE, 1981, BRAIN LANG, V12, P116, DOI 10.1016/0093-934X(81)90008-0; Reynolds C.R., 1994, TEST MEMORY LEARNING; Schafer RJ, 2009, BRAIN, V132, P661, DOI 10.1093/brain/awn353; Schoenberg MR, 2008, PSYCHOL ASSESSMENT, V20, P377, DOI 10.1037/a0014010; Solanto MV, 2007, J ABNORM CHILD PSYCH, V35, P729, DOI 10.1007/s10802-007-9123-6; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2003, WISC 4 TECHNICAL INT; Wechsler D., 1991, WECHSLER INTELLIGENC; Weiss L.G., 2006, WISC 4 ADV CLIN INTE; WEISS LG, 2008, 6 PEARS ED; Yeates KO., 2005, WISC 4 CLIN USE INTE, P415, DOI [10.1016/B978-012564931-5/50014-1, DOI 10.1016/B978-012564931-5/50014-1]	42	30	30	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	MAR	2010	22	1					57	64		10.1037/a0016056			8	Psychology, Clinical	Psychology	576KZ	WOS:000276144600007	20230152				2021-06-18	
J	Sarnaik, AA; Conley, YP; Okonkwo, DO; Barr, TL; Fink, EL; Szabo, C; Kochanek, PM; Clark, RSB				Sarnaik, Ajit A.; Conley, Yvette P.; Okonkwo, David O.; Barr, Taura L.; Fink, Ericka L.; Szabo, Csaba; Kochanek, Patrick M.; Clark, Robert S. B.			Influence of PARP-1 Polymorphisms in Patients after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ADP-ribosyltransferase; traumatic brain injury; poly(ADP-ribose) polymerase; poly-ADP-ribosylation	POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; NAD(+) DEPLETION; CELL-DEATH; ADP-RIBOSYLATION; OXIDATIVE STRESS; MICE; ACTIVATION; ISCHEMIA; PROTEINS; DAMAGE	Poly(ADP-ribose) polymerase-1 (PARP-1) plays an important role in the cellular response to stress and DNA damage. However, excessive activity of PARP-1 exacerbates brain injury via NAD(+) depletion and energy failure. The purpose of this study was to determine if tagging single nucleotide polymorphisms (tSNPs) covering multiple regions of the PARP-1 gene are related to outcome after traumatic brain injury (TBI) in humans. DNA from 191 adult patients with severe TBI was assayed for four tSNPs corresponding to haplotype blocks spanning the PARP-1 gene. Categorization as favorable or poor outcome was based on Glasgow Outcome Scale (GOS) score assigned at 6 months. PARP-1 enzyme activity was indirectly evaluated by quantifying poly-ADP-ribose (PAR)-modified proteins in cerebrospinal fluid (CSF) using an enzyme-linked immunosorbent assay. In multiple logistic regression analysis controlling for age, initial Glasgow Coma Scale score, and gender, the AA genotype of SNP rs3219119 was an independent predictor of favorable neurologic outcome. This SNP tags a haplotype block spanning the automodification and catalytic domains of the PARP-1 gene. SNP rs2271347 correlated with CSF PAR-modified protein level. This SNP, which did not correlate with outcome, tags a haplotype block spanning the promoter region of the PARP-1 gene. We conclude that after severe TBI in humans, a PARP-1 polymorphism within the automodification-catalytic domain is associated with neurological outcome, while a polymorphism within the promoter region was associated with CSF PAR-modified protein level. These findings must be replicated in a prospective study before the relevance of PARP-1 polymorphisms after TBI can be established.	[Sarnaik, Ajit A.; Fink, Ericka L.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Sarnaik, Ajit A.; Fink, Ericka L.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Conley, Yvette P.; Barr, Taura L.] Univ Pittsburgh, Dept Genet & Dev, Pittsburgh, PA 15260 USA; [Conley, Yvette P.; Barr, Taura L.] Univ Pittsburgh, Dept Hlth Promot, Pittsburgh, PA 15260 USA; [Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA; [Sarnaik, Ajit A.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Barr, Taura L.] NINR, Tissue Injury Unit, Bethesda, MD 20892 USA	Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Szabo, Csaba/D-1882-2013; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Fink, Ericka/0000-0002-3683-4571	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD 40686]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, P50NS030318, P20NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors would like to thank the National Institute of Child Health and Human Development (T32 HD 40686), the National Institute of Neurological Disorders and Stroke (NS30318), and the National Institute of Nursing Research (R01NR008424).	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1998, EUR J PHARMACOL, V351, P377, DOI 10.1016/S0014-2999(98)00381-1; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GANDHI S, 2005, MOL GENET, V14, P2749; Halmosi R, 2001, MOL PHARMACOL, V59, P1497; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hur JW, 2006, RHEUMATOLOGY, V45, P711, DOI 10.1093/rheumatology/kei262; Infante J, 2007, J NEUROL SCI, V256, P68, DOI 10.1016/j.jns.2007.02.008; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Mabley JG, 2005, J PHARMACOL EXP THER, V315, P812, DOI 10.1124/jpet.105.090480; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.bi.54.070185.000445; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	30	30	31	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2010	27	3					465	471		10.1089/neu.2009.1171			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	575PJ	WOS:000276079100001	19925161	Green Published			2021-06-18	
J	Sommer, M; Heidinger, C; Arendasy, M; Schauer, S; Schmitz-Gielsdorf, J; Hausler, J				Sommer, M.; Heidinger, Ch.; Arendasy, M.; Schauer, S.; Schmitz-Gielsdorf, J.; Haeusler, J.			Cognitive and Personality Determinants of Post-injury Driving Fitness	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Stroke; Traumatic brain injury; Fitness to drive; Standardized driving test; Artificial neural network	TRAUMATIC BRAIN-INJURY; STROKE; ROAD; ACCIDENTS; DRIVERS; ABILITY; PERFORMANCE; MULTICENTER; VALIDATION; VALIDITY	Increasingly often, practitioners in neuropsychological rehabilitation centers are called upon to assess patients' fitness to drive after brain injury. There is, therefore, a need for valid and reliable psychometric test batteries that enable unsafe drivers to be identified. This article investigates the contribution of five driving-related personality traits to the prediction of fitness to drive in patients suffering from traumatic brain injuries (TBI) or strokes over and above cognitive ability traits that have already shown to be related to safe driving. A total of 178 patients suffering from either strokes or TBI participated in this study. All the participants completed a standardized psychometric test battery and subsequently took a standardized driving test. The contribution of the driving-related ability and personality traits to the prediction of fitness to drive was investigated by means of a logistic regression analysis and an artificial neural network. The results indicate that both cognitive ability and personality factors are important in predicting fitness to drive, although cognitive ability factors contribute slightly more to the prediction of patients' actual fitness to drive than personality factors. Furthermore, even though there are subtle differences in the predictive models obtained for the two subsamples (stroke and TBI patients), these differences are adequately accounted for by a more unitary model calculated by means of an artificial neural network that is capable of taking account of moderating effects between the predictor variables.	[Sommer, M.; Heidinger, Ch.; Haeusler, J.] SCHUHFRIED GmbH, Dept Psychol Assessment, A-2340 Modling, Austria; [Sommer, M.; Arendasy, M.] Graz Univ, Inst Psychol, Dept Psychol Methods & Computer Based Modelling, Graz, Austria; [Schauer, S.] Univ Munich, Humanwissensch Zentrum, Generat Res Program, Munich, Germany; [Schmitz-Gielsdorf, J.] Praxis Allgemeine & Neuropsychol Psychotherapie, Aachen, Germany	Sommer, M (corresponding author), SCHUHFRIED GmbH, Dept Psychol Assessment, Hyrtlstr 45, A-2340 Modling, Austria.	sommer@schuhfried.at			SCHUHFRIED GmbH, Modling, Austria	This work was supported by the SCHUHFRIED GmbH, Modling, Austria.; Sommer, Heidinger and Hausler worked at the SCHUHFRIED GmbH, who financially supported the present study. Schauer and Schmitz-Gielsdorf were responsible for the data collection for which they received financial support from the SCHUHFRIED GmbH. There are no conflicts of interests for Arendasy.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akinwuntan AE, 2002, ARCH PHYS MED REHAB, V83, P334, DOI 10.1053/apmr.2002.29662; Anderson J., 1988, NEUROCOMPUTING FDN R; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; BIEHL B, 1996, MANUAL TACHISTOSCOPI; Bishop CM., 1995, NEURAL NETWORKS PATT; Bortz J., 1999, STAT SOZIALWISSENSCH, V5th; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Bridle J. S., 1990, Neurocomputing, Algorithms, Architectures and Applications. Proceedings of the NATO Advanced Research Workshop, P227; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; Brown M.T., 2000, HDB APPL MULTIVARIAT, P209, DOI DOI 10.1016/B978-012691360-6/50009-4; Brown S. D., 2000, HDB APPL MULTIVARIAT, P152; BUKASA B, 1990, VALIDIERUNG VERKEHRS; BURGARD E, 2005, THESIS LMU MUNCHEN; CHALOUPKA C, 1995, SAFETY SCI, V19, P137, DOI 10.1016/0925-7535(94)00015-U; Chapman P, 2000, APPL COGNITIVE PSYCH, V14, P31, DOI 10.1002/(SICI)1099-0720(200001)14:1<31::AID-ACP622>3.0.CO;2-9; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Evans, 1991, TRAFFIC SAFETY DRIVE; FAHLMAN SE, 1988, FASTER LEARNING VARI; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Golz D, 2004, Z NEUROPSYCHOL, V15, P157; Groeger J.A., 2000, UNDERSTANDING DRIVIN; GROEGER JA, 1997, ASSESSING DRIVER, P59; Hannen P, 1998, NERVENARZT, V69, P864, DOI 10.1007/s001150050355; HARTJE W, 2004, FAHREIGNUNG BEI NEUR, P19; HARTJE W, 1991, Z NEUROPSYCHOLOGIE, V2, P100; Hatakka M., 2002, TRANSPORTATION RES F, V5, P201, DOI [10.1016/S1369-8478(02)00018-9., 10.1016/S1369-8478]; HAUSLER J, 2005, 7 C TASK FORC PSYCH; Hergovich A., 2005, MANUAL VIENNA RISK T; Herle M., 2004, MANUAL INVENTORY DRI; Hjalmdahl M, 2004, TRANSPORT RES A-POL, V38, P127, DOI 10.1016/j.tra.2003.09.001; Hornke L. F., 2003, MANUAL ADAPTIVE MATR; Kinnebrock W, 1992, NEURONALE NETZE GRUN; Klebelsberg D., 1982, VERKEHRSPSYCHOLOGIE; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; MAHONEY F I, 1965, Md State Med J, V14, P61; Masters T., 1995, ADV ALGORITHMS NEURA; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485; MIELKE A, 2001, NEURONALE NETZE; Niemann H, 1999, EMPIRISCHE VERKEHRSP, P69; NOURI FM, 1988, CLIN REHABIL, V2, P99; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rakes T., 1991, DECISION LINE, V22, P11; RANNEY TA, 1994, ACCIDENT ANAL PREV, V26, P733, DOI 10.1016/0001-4575(94)90051-5; RIM PA, 1999, TRANSPORT RES F-TRAF, V2, P151; Risser R, 2008, ACCIDENT ANAL PREV, V40, P149, DOI 10.1016/j.aap.2006.12.018; Risser R., 1997, ASSESSING DRIVER, P89; Risser R., 1985, KLEINE FACHBUCHREIHE, V21; ROJAS R, 2000, NEURONAL NETWORKS SY; Scheiblechner H., 1985, TEST DESIGN DEV PSYC, P219, DOI 10.1016/B978-0-12-238180-5.50012-4; Schuhfried G., 2005, MANUAL EXPERT SYSTEM; Schuhfried G., 1997, MANUAL REACTION TEST; Schuhfried G., 1998, MANUAL DETERMINATION; Schuhfried G., 2002, MANUAL PERIPHERAL PE; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Somers MJ, 2001, J OCCUP ORGAN PSYCH, V74, P47, DOI 10.1348/096317901167226; Sommer M, 2008, TRANSPORT RES F-TRAF, V11, P362, DOI 10.1016/j.trf.2008.03.001; SOMMER M, 2008, FACTORIAL CRITERION; Sommer M, 2005, DRIVER BEHAV TRAININ, P425; SOMMER M, 2008, ZWEIT OST S PSYCH MI; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; SZLYK JP, 1995, HUM FACTORS, V37, P430, DOI 10.1518/001872095779064645; Wagner M., 2001, MANUAL COGNITRONE CO; Wilde GJS., 1994, TARGET RISK DEALING	73	30	32	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2010	25	2					99	117		10.1093/arclin/acp109			19	Psychology, Clinical; Psychology	Psychology	555BD	WOS:000274481100003	20080833	Bronze			2021-06-18	
J	Berg, C; Oeffner, A; Schumm-Draeger, PM; Badorrek, F; Brabant, G; Gerbert, B; Bornstein, S; Zimmermann, A; Weber, M; Broecker-Preuss, M; Mann, K; Herrmann, BL				Berg, C.; Oeffner, A.; Schumm-Draeger, P. -M.; Badorrek, F.; Brabant, G.; Gerbert, B.; Bornstein, S.; Zimmermann, A.; Weber, M.; Broecker-Preuss, M.; Mann, K.; Herrmann, B. L.			Prevalence of Anterior Pituitary Dysfunction in Patients following Traumatic Brain Injury in a German Multi-centre Screening Program	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						hypopituitarism; insufficiencies; GH adrenal gland; hormones; cerebrovascular disease; neuropathy	ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; GH DEFICIENCY; TSH RESPONSE; IGF-I; DIAGNOSIS; REHABILITATION; INVOLVEMENT	Introduction: We determined the prevalence of anterior pituitary dysfunction in a multi-centre screening program across five German endocrine centres in patients rehabilitating from TBI (GCS < 13). Patients & Methods: 246 patients (39 +/- 14 yrs; 133 males, 12 +/- 8 months after TBI) underwent a series of baseline endocrine tests with central assessment of TSH, free T4, prolactin, LH, FSH, testosterone (m), estradiol (f), cortisol, GH, and IGF-I. If IGF-I was < - 2 SDS dynamic testing was performed. GHD was defined according to BMI-dependent cut-off values for GH response to GHRH + arginine of < 4.2, < 8.0 and < 11.5 ng/ml in obese, overweight and lean subjects, respectively, or < 3 micro g/l in ITT. Hypocortisolism was suggested when basal cortisol was < 200 nmol/l and confirmed by ITT (peak < 500 nmol/l). Results: In TBI patients some degree of impaired pituitary function was shown in 21 % (n = 52/246). Total, multiple and isolated deficits were present in 1 %, 2 % and 18 %, respectively. 19 % had an IGF- I of < - 1 SDS, 9 % of < - 2 SDS. In 5 % GHD was confirmed. 9 % had hypogonadism. 4 % had hypocortisolism and 1 % of patients had confirmed ACTH-deficiency. 12 % had TSH-deficiency. Summary: In summary, in this large series carried out on an unselected group of TBI survivors we have found hypopituitarism in every fifth patient with predominantly secondary hypogonadism and hypothyreosis. Regarding somatotrope insufficiency IGF-I is decreased in 50 % of GHD patients. Conclusion: These findings strongly suggest that patients who suffer head trauma should routinely undergo endocrine evaluation.	[Berg, C.; Broecker-Preuss, M.; Mann, K.; Herrmann, B. L.] Univ Hosp Essen, Clin Endocrinol, Essen, Germany; [Oeffner, A.; Schumm-Draeger, P. -M.] Hosp Bogenhausen, Med Clin 3, Munich, Germany; [Badorrek, F.; Brabant, G.] Univ Hosp Hannover, Dept Endocrinol, Hannover, Germany; [Brabant, G.] Christie Hosp, Dept Endocrinol, Manchester, Lancs, England; [Gerbert, B.; Bornstein, S.] Univ Hosp Dresden, Dept Endocrinol, Dresden, Germany; [Zimmermann, A.; Weber, M.] Univ Hosp Mainz, Dept Endocrinol, Mainz, Germany; [Herrmann, B. L.] Technol Ctr Bochum, Bochum, Germany	Berg, C (corresponding author), Univ Duisburg Essen, Univ Clin Essen, Clin Endocrinol, Duisburg, Germany.	christian.berg@uni-essen.de			NovoNordisk GmbH, Mainz, GermanyNovo Nordisk	The study was supported by a grant from NovoNordisk GmbH, Mainz, Germany. (Responsibility T. Knittel) Moreover, we gratefully acknowledge the excellent support of the personnel at the Metabolic Laboratory, Division of Endocrinology, University Hospital of Essen, Germany.	Abs R, 2003, EUR J ENDOCRINOL, V148, pS3, DOI 10.1530/eje.0.148S003; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J ENDOCRINOL INVEST, V21, P506, DOI 10.1007/BF03347336; Aimaretti G, 2004, HORM RES, V62, P26, DOI 10.1159/000080755; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; BENGTSSON BA, 1990, HORM RES, V33, P19, DOI 10.1159/000181579; Benvenga S, 1997, J ENDOCRINOL INVEST, V20, P675, DOI 10.1007/BF03348031; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Coiro V, 2000, J INVEST MED, V48, P133; EDWARDS OM, 1986, MEDICINE, V65, P281; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goni MJ, 1997, METABOLISM, V46, P1305, DOI 10.1016/S0026-0495(97)90235-3; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Herrmann BL, 2004, HORM METAB RES, V36, P54, DOI 10.1055/s-2004-814199; Jean-Bay E, 2000, J Neurosci Nurs, V32, P169; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MULLER EE, 1987, PHYSIOL REV, V67, P962; Radetti G, 2000, J ENDOCRINOL INVEST, V23, P744, DOI 10.1007/BF03345064; Rees P, 2001, LANCET, V358, P1812, DOI 10.1016/S0140-6736(01)06814-3; Richard I., 2001, Annales de Readaptation et de Medecine Physique, V44, P19, DOI 10.1016/S0168-6054(00)00059-3; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; TEASDALE G, 1974, LANCET, V2, P81; VALENTA LJ, 1980, AM J MED, V68, P614, DOI 10.1016/0002-9343(80)90314-9; Webster JB, 1997, ARCH PHYS MED REHAB, V78, P314, DOI 10.1016/S0003-9993(97)90040-X; WEEKE J, 1974, SCAND J CLIN LAB INV, V33, P101, DOI 10.3109/00365517409082475	41	30	33	0	4	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	FEB	2010	118	2					139	144		10.1055/s-0029-1225611			6	Endocrinology & Metabolism	Endocrinology & Metabolism	563NE	WOS:000275138500014	19691014				2021-06-18	
B	Anderson, V; Anderson, PJ; Jacobs, R; Smith, MS		Anderson, V; Jacobs, R; Anderson, PJ		Anderson, Vicki; Anderson, Peter J.; Jacobs, Rani; Smith, Megan Spencer			Development and assessment of executive function: From preschool to adolescence	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; HUMAN PREFRONTAL CORTEX; PROBLEM-SOLVING SKILLS; CLOSED HEAD-INJURY; COGNITIVE-DEVELOPMENT; FRONTAL LOBES; CONCEPT GENERATION; CEREBRAL-CORTEX; EARLY-CHILDHOOD; WORKING-MEMORY		[Anderson, Vicki; Smith, Megan Spencer] Univ Melbourne, Dept Psychol, Royal Childrens Hosp, Sch Behav Sci, Melbourne, Vic, Australia; [Jacobs, Rani] Univ Melbourne, Dept Psychol, Royal Childrens Hosp, Sch Psychol, Melbourne, Vic, Australia	Anderson, V (corresponding author), Univ Melbourne, Dept Psychol, Royal Childrens Hosp, Sch Behav Sci, Melbourne, Vic, Australia.		Anderson, Peter John/O-5302-2019; Anderson, Peter J/B-6839-2015	Anderson, Peter John/0000-0001-7430-868X; Anderson, Peter J/0000-0001-7430-868X; Spencer-Smith, Megan/0000-0002-1047-0829			Albert M., 1980, NEW DIRECTIONS MEMOR, P403; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson P., 2000, CLIN NEUROPSYCHOL AS, V1, P247, DOI DOI 10.1076/chin.8.4.231.13509; Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2002, CHILD NEUROPSYCHOL, V8, P69, DOI 10.1076/chin.8.2.69.8725; ANDERSON V, 1988, P 13 ANN BRAIN IMP C, P223; Anderson V., 1995, NEUROPSYCHOLOGICAL A; Anderson V., 2002, PRINCIPLES FRONTAL L; Anderson V A, 1996, Appl Neuropsychol, V3, P128, DOI 10.1207/s15324826an0303&4_5; Anderson V.A, 2001, DEV NEUROPSYCHOLOGY; Anderson VA, 2004, J CLIN EXP NEUROPSYC, V26, P684, DOI 10.1080/13803390490504344; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Baddeley A. D., 1986, WORKING MEMORY; Barbas H, 1992, Adv Neurol, V57, P91; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Baron I., 2004, NEUROPSYCHOLOGICAL E; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; BARTSCH K, 1989, CHILD DEV, V60, P946, DOI 10.1111/j.1467-8624.1989.tb03526.x; BECKER MG, 1987, DEV NEUROPSYCHOL, V3, P275, DOI 10.1080/87565648709540381; BELL MA, 1992, CHILD DEV, V63, P1142, DOI 10.1111/j.1467-8624.1992.tb01685.x; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BJORKLAND DV, 1989, CHILDRENS THINKING D; BLAKEMORE C, 1974, BRIT MED BULL, V30, P152, DOI 10.1093/oxfordjournals.bmb.a071186; BROUWERS P, 1984, J CLIN NEUROPSYCHOL, V6, P325, DOI 10.1080/01688638408401222; Burden V., 2003, BEHAV ASSESSMENT DYS; CAESER P, 1993, J CHILD PSYCHOL PSYC, V34, P101; Case R., 1985, INTELLECTUAL DEV BIR; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; CHUGANI HT, 1987, ANN NEUROL, V22, P287; CONDOR A, 1996, DEV NEUROPSYCHOL, V11, P485; Couper E, 2002, BRAIN IMPAIR, V3, P105, DOI DOI 10.1375/BRIM.3.2.105; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Delis DC, 2001, DELISKAPLAN EXECUTIV; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M., 1989, CLIN NEUROPSYCHOLOGY, P89; DESPOSITO M, 2002, PRINCIPLES FRONTAL L, P168, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0011; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; DIAMOND A, 1985, NEUR ABSTR 2, V11, P832; DIDUS E, 2000, PEDIAT REHABILITATIO, V3, P177; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P379, DOI 10.1207/s15326942dn2601_1; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Espy KA, 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fuster J M, 1993, Curr Opin Neurobiol, V3, P160, DOI 10.1016/0959-4388(93)90204-C; Fuster J.M., 2002, PRINCIPLES FRONTAL L, P96, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0006; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; Garth J, 1997, Pediatr Rehabil, V1, P99; Gibbs J. C., 1992, MORAL MATURITY MEASU; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gioia G.A., 2000, BEHAV RATING INVENTO; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golden C. J., 1981, NEUROPSYCHOLOGICAL A, P277; Goldman-Rakic P. S., 2002, PRINCIPLES FRONTAL L, P85, DOI DOI 10.1093/ACPR0F:0S0/9780195134971.003.0005; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.1111/j.1467-8624.1987.tb01404.x; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Hale S, 1997, DEV PSYCHOL, V33, P364, DOI 10.1037/0012-1649.33.2.364; HALFORD GS, 1980, COGNITIVE PSYCHOL, V12, P356, DOI 10.1016/0010-0285(80)90014-6; HALPERIN JM, 1989, J CLIN EXP NEUROPSYC, V11, P518, DOI 10.1080/01688638908400910; Halstead WC, 1985, HALSTEAD REITAN NEUR; Heaton R. K, 1981, WISCONSIN CARD SORTI; HOWARD L, 1985, DEV PSYCHOL, V21, P283, DOI 10.1037/0012-1649.21.2.283; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Jacobs R, 2001, J DEV PHYS DISABIL, V13, P389, DOI 10.1023/A:1012289513829; JACOBS R, 2001, CLIN NEUROPSYCHOL, V2, P101; Jacques S, 2001, DEV NEUROPSYCHOL, V20, P573, DOI 10.1207/875656401753549807; JERNIGAN TL, 1990, DEV MED CHILD NEUROL, V32, P379; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; KAIN W, 2001, SOCIAL BRAIN EVOLUTI, P197; Kirk U, 1985, HEMISPHERIC FUNCTION, P193; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; KOENDERINK MJT, 1994, BRAIN RES, V653, P173, DOI 10.1016/0006-8993(94)90387-5; Korkman M., 1998, MANUAL NEPSY; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; LANDRY SH, 1994, ADV CH NEUR, V2, P85; LENNENBERG EH, 1967, BIOL FDN LANGUAGE; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; LIDOW MS, 1991, P NATL ACAD SCI USA, V88, P10218, DOI 10.1073/pnas.88.22.10218; Logan Gordon D., 1994, P189; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luria A. R, 1973, WORKING BRAIN; Manly T., 1999, TEST EVERYDAY ATTENT; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P69; MATTHEWS L, 2001, CLIN NEUROPSYCHOL, V2, P85; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MELTZOFF A, 1997, DEV THEORIES INTENTI, P17; Mesulam M.-M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; MILLER PH, 1981, CHILD DEV, V52, P1183, DOI 10.1111/j.1467-8624.1981.tb03165.x; Neisser, 1967, COGNITIVE PSYCHOL; Orzhekhovskaya N S, 1981, Neurosci Behav Physiol, V11, P379, DOI 10.1007/BF01184205; PARKER DM, 1992, HDB NEUROPSYCHOLOGIC, P267; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; Piaget J, 1963, ORIGINS INTELLIGENCE; Porteus SD., 1950, PORTEUS MAZE TEST IN; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Reitan RM., 1969, MANUAL ADM NEUROPSYC; Rey A, 1964, EXAMEN CLIN PSYCHOL; ROLLS ET, 2002, PRINCIPLES FRONTAL L, P354; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1990, NEUROPSYCHOLOGY MENT; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; SODIAN B, 1991, CHILD DEV, V62, P468, DOI 10.1111/j.1467-8624.1991.tb01545.x; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; STEHBENS J A, 1991, Neuropsychology Review, V2, P147, DOI 10.1007/BF01109052; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Taylor H. G., 1990, HDB PSYCHOL ASSESSME, P228; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; TRANEL D, 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; WABER DP, 1985, J CLIN EXP NEUROPSYC, V7, P264, DOI 10.1080/01688638508401259; WALSH K, 1978, NEUROPSYCHOLOGY CLIN; Walsh K. W., 1985, UNDERSTANDING BRAIN; WANSART WL, 1990, J LEARN DISABIL, V23, P164, DOI 10.1177/002221949002300306; Wechsler D, 1991, MANUAL WECHSLER SCAL; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; YAKOVLEV P I, 1962, Res Publ Assoc Res Nerv Ment Dis, V39, P3; Yakovlev P.I., 1967, RETIONAL DEV BRAIN E, P3; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005	156	30	31	0	7	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							123	154					32	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	BVE09	WOS:000291249500008					2021-06-18	
J	Demery, JA; Larson, MJ; Dixit, NK; Bauer, RM; Perlstein, WM				Demery, Jason A.; Larson, Michael J.; Dixit, Neha K.; Bauer, Russell M.; Perlstein, William M.			Operating Characteristics of Executive Functioning Tests Following Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Operating characteristics; Executive functioning; Traumatic brain injury	DEFICIT HYPERACTIVITY DISORDER; FRONTAL-LOBE LESIONS; MILD HEAD-INJURY; ATTENTION; OUTCOMES; SCORES; TRAIL; SCALE	The primary purposes of this study were to determine if controls, and mild and moderate/severe traumatic brain injury (TBI) patients performed differently on a battery of executive functioning (EF) tests, and to identify the operating characteristics of EF tests in this population. Participants consisted of 46 brain-injured individuals and 24 healthy controls. All participants completed an extensive battery of EF tests. Results showed that mild TBI participants performed worse than controls on the Trail Making Test Part B, and that moderate/severe TBI participants consistently performed worse than either group on a variety of EF measures. Tests of EF exhibited a wide range of operating characteristics, suggesting that some EF tests are better than others in identifying TBI-related neurocognitive impairment. Predictive values were better for individuals with moderate/severe TBI than mild TBI. Overall, the Digit Span Backward Test showed the best positive predictive power in differentiating TBI. Our results provide useful data that may guide test selection in evaluating EF in patients with traumatic brain injury.	[Demery, Jason A.; Dixit, Neha K.] N Florida S Georgia Vet Hlth Syst, Psychol Serv, Gainesville, FL 32608 USA; [Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bauer, Russell M.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA	Demery, JA (corresponding author), N Florida S Georgia Vet Hlth Syst, Psychol Serv 116B, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	jasondemery@gmail.com	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	Evelyn F. McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Trust; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH01857]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH001857, R21MH073076] Funding Source: NIH RePORTER	Supported by grants from the Evelyn F. McKnight Brain Research Grant Program, the Florida Brain and Spinal Cord Injury Trust Fund, and the National Institute of Mental Health (K01 MH01857) to W. M. P. We thank Kay Waid-Ebbs and Paul J. Seignourel for their assistance with patient recruitment and data collection. This research was conducted in partial fulfillment of the first author's Ph.D. dissertation.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson V., 2002, PRINCIPLES FRONTAL L; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BENSON DF, 1999, BEHAV NEUROLOGY NEUR, P401; Bieliauskas LA, 1997, J CLIN EXP NEUROPSYC, V19, P889, DOI 10.1080/01688639708403769; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ELWOOD RW, 1993, CLIN NEUROPSYCHOL, V7, P224, DOI 10.1080/13854049308401527; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Gennarelli T. A., 2005, TXB TRAUMATIC BRAIN, P27; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Golden J. C., 1978, STROOP COLOR WORD TE; Grodzinsky GM, 1999, CLIN NEUROPSYCHOL, V13, P12, DOI 10.1076/clin.13.1.12.1983; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Halstead WC, 1985, HALSTEAD REITAN NEUR; Heaton R., 1993, WISCONSIN CARD SORTI; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lovejoy DW, 1999, J INT NEUROPSYCH SOC, V5, P222, DOI 10.1017/S1355617799533055; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RETZLAFF PD, 2000, CLIN GUIDE NEUROPSYC; ROEBUCKSPENCER T, 2008, TXB CLIN NEUROPSYCHO; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; Sarazin M, 1998, NEUROLOGY, V51, P142, DOI 10.1212/WNL.51.1.142; Spielberger C.D., 1970, STATE TRAIT ANXIETY; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1997, WAIS 3 ADM SCORING M	49	30	31	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	8					1292	1308	PII 929450664	10.1080/13854046.2010.528452			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	685LA	WOS:000284629000004	21069617	Green Accepted			2021-06-18	
J	Fridman, EA; Krimchansky, BZ; Bonetto, M; Galperin, T; Gamzu, ER; Leiguarda, RC; Zafonte, R				Fridman, Esteban A.; Krimchansky, Ben Zion; Bonetto, Mariana; Galperin, Tatyana; Gamzu, Elkan R.; Leiguarda, Ramon C.; Zafonte, Ross			Continuous subcutaneous apomorphine for severe disorders of consciousness after traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; vegetative state; minimally conscious state; dopaminergic; apomorphine	PERSISTENT VEGETATIVE STATE; DIFFUSE AXONAL INJURY; PARKINSONS-DISEASE; LEVODOPA; BROMOCRIPTINE; AMANTADINE; COMA	Methods: In a prospective open-labelled clinical study, the feasibility, relative efficacy and safety of continuous subcutaneous (s.c.) administration of apomorphine in Vegetative State (VS) or Minimally Conscious State (MCS) patients due to severe traumatic brain injury (TBI) was tested. Apomorphine was administered to eight patients. Outcome measures were the Coma Near-Coma Scale (CNCS) and Disability Rating Scale (DRS). Results: Drug management was implemented without any problems. There was improvement in the primary outcomes for all patients. Awakening was seen as rapidly as within the first 24 hours of drug administration and as late as 4 weeks. Seven of the patients had completely recovered consciousness. All improvements were sustained for at least 1 year, even after apomorphine was discontinued. Drug-related adverse events were all anticipated and resolved after the dose was reduced. Conclusion: Based on this open-label pilot study, continuous s.c. apomorphine infusion appears to be feasible, safe and potentially effective in improving consciousness in patients in VS and MCS due to severe TBI.	[Fridman, Esteban A.] FLENI, Neurol Res Inst, Neurorehabil Sect, Dept Neurol, RA-2325 Buenos Aires, DF, Argentina; [Fridman, Esteban A.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Fridman, Esteban A.] FLENI, Neurol Res Inst, Dept Neurosci, RA-2325 Buenos Aires, DF, Argentina; [Krimchansky, Ben Zion; Galperin, Tatyana] Loewenstein Hosp & Rehabil Ctr, Intens Care Unit, Raanana, Israel; [Zafonte, Ross] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Boston, MA USA	Fridman, EA (corresponding author), FLENI, Neurol Res Inst, Neurorehabil Sect, Dept Neurol, C1428AQK, RA-2325 Buenos Aires, DF, Argentina.	efridman@fleni.org.ar		Fridman, Esteban/0000-0001-7879-8874			Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BROGDEN RN, 1982, DRUGS, V24, P360, DOI 10.2165/00003495-198224050-00002; Deleu D, 2004, DRUG AGING, V21, P687, DOI 10.2165/00002512-200421110-00001; Deleu D, 2002, CLIN PHARMACOKINET, V41, P261, DOI 10.2165/00003088-200241040-00003; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Fridman EA, 2009, BRAIN INJURY, V23, P172, DOI 10.1080/02699050802649662; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Hurst RS, 2003, EUR J PHARMACOL, V482, P31, DOI 10.1016/j.ejphar.2003.09.054; Kaplan M, 2003, CLIN NEUROL NEUROSUR, V105, P153, DOI 10.1016/S0303-8467(02)00133-6; Katzenschlager R, 2005, MOVEMENT DISORD, V20, P151, DOI 10.1002/mds.20276; Kolls BJ, 2006, CLIN NEUROPHARMACOL, V29, P292, DOI 10.1097/01.WNF.0000220824.57769.E5; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MAWDSLEY C, 1972, CLIN PHARMACOL THER, V13, P575; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MONTASTRUC JL, 1989, J NEUROL NEUROSUR PS, V52, P773, DOI 10.1136/jnnp.52.6.773; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; *THOMS PDR, 2006, AP PACK INS PHYS DES, P2132; Tyne HL, 2004, J NEUROL, V251, P1370, DOI 10.1007/s00415-004-0547-4; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	31	30	30	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	4					636	641		10.3109/02699051003610433			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	570ML	WOS:000275682300008	20235766				2021-06-18	
J	Hofgren, C; Esbjornsson, E; Sunnerhagen, KS				Hofgren, C.; Esbjornsson, E.; Sunnerhagen, K. S.			Return to work after acquired brain injury: Facilitators and hindrances observed in a sub-acute rehabilitation setting	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Stroke; TBI; cognition; ADL; vocational; outcome	NEUROLOGICAL-INSTITUTE SCREEN; HIGHER CEREBRAL FUNCTIONS; REACTION LEVEL SCALE; ISCHEMIC-STROKE; YOUNG-ADULTS; FOLLOW-UP; ACUTE PREDICTORS; OUTCOMES; EMPLOYMENT; NEUROREHABILITATION	Objectives: There is great variability in the rate of return to work for persons who have suffered from brain injury. The aims of this study was: 1) to describe employment status of persons with stroke or traumatic brain injury, one year after the incident and 2) to investigate the impact of injury/stroke severity, length of stay, the ability to perform activities of daily living and cognitive function on return to work. Participants and Methods: Information was collected from 72 persons; 48 with a diagnosis of stroke and 24 with a traumatic brain injury. All patients had attended to a Rehabilitation Centre with inpatient and outpatient facilities. Data of the above mentioned variables was gathered retrospectively and information about employment status was retrieved from the medical records. Results: After one year, 13 persons (approximate to 18%), 5 with a stroke and 8 with a traumatic brain injury (one with mild brain injury, 9 with moderate and 3 persons with severe injuries) had returned to work. They had significantly shorter length of stay at the rehabilitation hospital and were younger than those that did not return to work. Somewhat better results at the neuropsychological screening were seen among those that returned to work, although with a significant difference only in the subscale assessing affect. Some persons with severe injury returned to work, while a majority of those with mild brain injury did not. Conclusion: Traumatic brain injury, younger age and less need of rehabilitation were associated with a higher rate of returning to work. Patients with stroke were older and seem to need more support in order to be successful in work return. It is of importance to reach primary rehabilitation goals, such as being ADL independent, as this was also favourable for work return. The impact of injury severity seemed complex and should to be further explored. Persons with mild brain injury should be followed-up with respect to work return. An important cognitive factor was ability to perceive and express affective responses, reflecting the need of social skills in today's work-life.	[Hofgren, C.; Esbjornsson, E.; Sunnerhagen, K. S.] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, S-41345 Gothenburg, Sweden; [Sunnerhagen, K. S.] Univ Oslo, Fac Med, N-0316 Oslo, Norway	Hofgren, C (corresponding author), Univ Gothenburg, HSahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Guldhedsgatan 19, S-41345 Gothenburg, Sweden.	caisa.hofgren@rehab.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400			Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; Appelros Peter, 2004, J Stroke Cerebrovasc Dis, V13, P52, DOI 10.1016/j.jstrokecerebrovasdis.2004.02.005; BARNES MP, 2000, TXB REHABILITATION M, P257; BERGMANN H, 1991, J NEURAL TRANSM-GEN, P157; BLACKSCHAFFER RM, 1990, ARCH PHYS MED REHAB, V71, P285; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Dafer RM, 2008, TOP STROKE REHABIL, V15, P13, DOI 10.1310/tsr1501-13; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; FERRO JM, 1994, STROKE, V25, P1611, DOI 10.1161/01.STR.25.8.1611; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Glozier N, 2008, STROKE, V39, P1526, DOI 10.1161/STROKEAHA.107.503219; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hinckley JJ, 2002, J COMMUN DISORD, V35, P543, DOI 10.1016/S0021-9924(02)00119-3; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Hsieh CL, 1997, SCAND J REHABIL MED, V29, P113; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Malm J, 1998, NEUROLOGY, V51, P433, DOI 10.1212/WNL.51.2.433; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Perk J, 2004, SCAND J PUBLIC HEALT, V32, P181, DOI 10.1080/14034950410021880; Prigatano G., 1991, BNI Q, V7, P2; Prigatano GP, 1993, BNI Q, V9, P2; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SAEKI S, 1995, STROKE, V26, P399, DOI 10.1161/01.STR.26.3.399; Saeki Satoru, 2004, J Stroke Cerebrovasc Dis, V13, P160, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.006; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Vestling Monika, 2005, Scand J Occup Ther, V12, P89, DOI 10.1080/11038120510031770; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568; Wozniak MA, 2002, NEUROEPIDEMIOLOGY, V21, P159, DOI 10.1159/000059516	42	30	33	0	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2010	36	4					431	439		10.3233/WOR-2010-1039			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	639IY	WOS:000280969700009	20714099				2021-06-18	
J	Komuta, Y; Teng, X; Yanagisawa, H; Sango, K; Kawamura, K; Kawano, H				Komuta, Yukari; Teng, Xichuan; Yanagisawa, Hiroko; Sango, Kazunori; Kawamura, Koki; Kawano, Hitoshi			Expression of Transforming Growth Factor-beta Receptors in Meningeal Fibroblasts of the Injured Mouse Brain	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Transforming growth factor-beta; Receptor; Fibrotic scar; Astrocyte; Immunohistochemistry; In situ hybridization	SPINAL-CORD-INJURY; NIGROSTRIATAL DOPAMINERGIC AXONS; MESSENGER-RNA; RAT-BRAIN; EXTRACELLULAR-MATRIX; CEREBRAL HEMISPHERE; ENHANCED EXPRESSION; GENE-EXPRESSION; NERVOUS-SYSTEM; SCAR FORMATION	The fibrotic scar which is formed after traumatic damage of the central nervous system (CNS) is considered as a major impediment for axonal regeneration. In the process of the fibrotic scar formation, meningeal fibroblasts invade and proliferate in the lesion site to secrete extracellular matrix proteins, such as collagen and laminin. Thereafter, end feet of reactive astrocytes elaborate a glia limitans surrounding the fibrotic scar. Transforming growth factor-beta 1 (TGF-beta 1), a potent scar-inducing factor, which is upregulated after CNS injury, has been implicated in the formation of the fibrotic scar and glia limitans. In the present study, expression of receptors to TGF-beta 1 was examined by in situ hybridization histochemistry in transcortical knife lesions of the striatum in the mouse brain in combination with immunofluorescent staining for fibroblasts and astrocytes. Type I and type II TGF-beta receptor mRNAs were barely detected in the intact brain and first found in meningeal cells near the lesion 1 day postinjury. Many cells expressing TGF-beta receptors were found around the lesion site 3 days postinjury, and some of them were immunoreactive for fibronectin. After 5 days postinjury, many fibroblasts migrated from the meninges to the lesion site formed the fibrotic scar, and most of them expressed TGF-beta receptors. In contrast, few of reactive astrocytes expressed the receptors throughout the postinjury period examined. These results indicate that meningeal fibroblasts not reactive astrocytes are a major target of TGF-beta 1 that is upregulated after CNS injury.	[Komuta, Yukari; Teng, Xichuan; Yanagisawa, Hiroko; Sango, Kazunori; Kawamura, Koki; Kawano, Hitoshi] Tokyo Metropolitan Inst Neurosci, Dept Dev Morphol, Tokyo 1838526, Japan; [Teng, Xichuan] Eastern Liaoning Univ, Dept Pathol, Coll Med, Dandong 118000, Peoples R China	Kawano, H (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Dev Morphol, 2-6 Musashidai, Tokyo 1838526, Japan.	kawano-ht@igakuken.or.jp			Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [20500318]	The authors would like to thank Dr. Geoffrey Raisman, UCL Institute of Neurology, Queen Square, London for reviewing the manuscript and valuable advice. This work was supported by the Ministry of Education, Science, Sports and Culture of Japan (20500318).	BAGHDASSARIAN D, 1993, GLIA, V7, P193, DOI 10.1002/glia.440070302; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; De Groot CJA, 1999, J NEUROPATH EXP NEUR, V58, P174, DOI 10.1097/00005072-199902000-00007; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Gold LI, 1997, AM J PATHOL, V150, P209; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Homma A, 2006, J COMP NEUROL, V499, P120, DOI 10.1002/cne.21097; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; Kawano H, 2007, NEURAL PROTEOGLYCANS, P215; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Li HP, 2007, J NEUROSCI RES, V85, P536, DOI 10.1002/jnr.21141; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; McTigue DM, 2000, EXP NEUROL, V163, P220, DOI 10.1006/exnr.2000.7372; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; RIBOTTA MGY, 2001, PROG BRAIN RES, V132, P587; Schmid P, 1998, AM J PATHOL, V152, P485; SempleRowland SL, 1995, J NEUROTRAUM, V12, P1003, DOI 10.1089/neu.1995.12.1003; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Unsicker K, 2000, EUR J BIOCHEM, V267, P6972, DOI 10.1046/j.1432-1327.2000.01824.x; Vivien D, 1998, J NEUROCHEM, V70, P2296; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S	40	30	39	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2010	30	1					101	111		10.1007/s10571-009-9435-x			11	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	549XI	WOS:000274087400011	19653094				2021-06-18	
J	Malinauskas, R				Malinauskas, Romualdas			THE ASSOCIATIONS AMONG SOCIAL SUPPORT, STRESS, AND LIFE SATISFACTION AS PERCEIVED BY INJURED COLLEGE ATHLETES	SOCIAL BEHAVIOR AND PERSONALITY			English	Article						perceived stress; perceived social support; life satisfaction; sports injury; college athletes	TRAUMATIC BRAIN-INJURY; MULTIDIMENSIONAL SCALE; BUFFERING HYPOTHESIS; COPING RESPONSES; SELF-ESTEEM; PERCEPTIONS; REHABILITATION; ADJUSTMENT; PREINJURY; PEOPLE	The relationships were examined among severity of injury, and participants' perceptions of stress, social support, and life satisfaction. Participants were 123 college athletes (male, n = 69, female n = 54) with minor (69) or severe (54) injuries, who ranged in age from 18 to 25 years. Participants completed measures of perceived social support, stress, and satisfaction with life. Greater perceived stress was associated with diminished life satisfaction for athletes with a major injury more than for those with a minor injury. The interaction between perceived stress and perceived social support was associated most with diminished life satisfaction for participants with a major injury.	Lithuanian Acad Phys Educ, Dept Psychol, LT-44221 Kaunas, Lithuania	Malinauskas, R (corresponding author), Lithuanian Acad Phys Educ, Dept Psychol, Sporto 6, LT-44221 Kaunas, Lithuania.	r.malinauskas@lkka.lt	Malinauskas, Romualdas/E-6589-2018	Malinauskas, Romualdas/0000-0001-5578-3100			Adam M. U., 2004, J DANCE MED SCI, V8, P43; AFFLECK G, 1988, ARTHRIT CARE RES, V1, P71; Ahern DK, 1997, CLIN SPORT MED, V16, P755, DOI 10.1016/S0278-5919(05)70052-1; Albinson CB, 2003, J SPORT REHABIL, V12, P306, DOI 10.1123/jsr.12.4.306; Andrews F. M., 1976, SOCIAL INDICATORS WE; Bone JB, 2006, J SPORT REHABIL, V15, P156, DOI 10.1123/jsr.15.2.156; BREWER BW, 1995, CLIN J SPORT MED, V5, P241, DOI 10.1097/00042752-199510000-00006; Brewer BW, 2007, HDB SPORT PSYCHOL, P404, DOI DOI 10.1002/9781118270011.CH18; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Cohen S., 2000, SOCIAL SUPPORT MEASU; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; FORDYCE MW, 1977, J COUNS PSYCHOL, V24, P511, DOI 10.1037/0022-0167.24.6.511; Hamarat E., 2002, COLL STUDENT J, V36, P129; Hampton NZ, 2004, REHABIL COUNS BULL, V48, P31, DOI 10.1177/00343552040480010401; HARDY CJ, 1991, SPORT PSYCHOL, V5, P128; Jaccard J., 1990, INTERACTION EFFECTS; KAZARIAN SS, 1991, J COMMUNITY PSYCHOL, V19, P150, DOI 10.1002/1520-6629(199104)19:2<150::AID-JCOP2290190206>3.0.CO;2-J; Krause JS, 1998, REHABIL PSYCHOL, V43, P282, DOI 10.1037/0090-5550.43.4.282; Malinauskas R, 2008, J SPORT MED PHYS FIT, V48, P107; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Park JK, 2000, SPORT PSYCHOL, V14, P63, DOI 10.1123/tsp.14.1.63; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; PETRIE TA, 1992, BEHAV MED, V18, P127, DOI 10.1080/08964289.1992.9936963; Petrie TA, 1993, J APPL SPORT PSYCHOL, V5, P1, DOI DOI 10.1080/10413209308411301; POWELL JW, 1991, PREVENTION ATHLETIC, P11; Quackenbush N., 1994, Journal of Sport Behavior, V17, P178; Reed S, 2004, J ATHL TRAINING, V39, P193; Rees T, 2007, J SPORT SCI, V25, P1057, DOI 10.1080/02640410600982279; Robbins J.E, 2001, Journal of Sport Behavior, V24, P277; Ryska TA, 1999, CURR PSYCHOL, V18, P381, DOI 10.1007/s12144-999-1011-5; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; SMITH RE, 1990, J PERS SOC PSYCHOL, V58, P360, DOI 10.1037/0022-3514.58.2.360; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Trieschmann R.B., 1988, SPINAL CORD INJURIES, V2nd edition; Udry E, 1997, J SPORT EXERCISE PSY, V19, P368, DOI 10.1123/jsep.19.4.368; Warren L, 1996, J REHABIL RES DEV, V33, P404; Washington-Lofgren L, 2004, INT SPORTS J, V8, P94; Wasley D, 1998, PERCEPT MOTOR SKILL, V86, P1402, DOI 10.2466/pms.1998.86.3c.1402; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	46	30	30	3	19	SOC PERSONALITY RES INC	PALMERSTON NORTH	P O BOX 1539, PALMERSTON NORTH 5330, NEW ZEALAND	0301-2212			SOC BEHAV PERSONAL	Soc. Behav. Pers.		2010	38	6					741	752		10.2224/sbp.2010.38.6.741			12	Psychology, Social	Psychology	632NL	WOS:000280431300003					2021-06-18	
J	Exo, JL; Shellington, DK; Bayir, H; Vagni, VA; Janesco-Feldman, K; Ma, L; Hsia, CJ; Clark, RSB; Jenkins, LW; Dixon, CE; Kochanek, PM				Exo, Jennifer L.; Shellington, David K.; Bayir, Huelya; Vagni, Vincent A.; Janesco-Feldman, Keri; Ma, Lil; Hsia, Carleton J.; Clark, Robert S. B.; Jenkins, Larry W.; Dixon, C. Edward; Kochanek, Patrick M.			Resuscitation of Traumatic Brain Injury and Hemorrhagic Shock with Polynitroxylated Albumin, Hextend, Hypertonic Saline, and Lactated Ringer's: Effects on Acute Hemodynamics, Survival, and Neuronal Death in Mice	JOURNAL OF NEUROTRAUMA			English	Article						colloid; head injury; nitroxide; oxidative stress; secondary insult	FOCAL CEREBRAL-ISCHEMIA; REDUCES INFARCT SIZE; BLOOD-FLOW; ISOVOLEMIC HEMODILUTION; INTRACRANIAL-PRESSURE; FLUID RESUSCITATION; CORTICAL IMPACT; TEMPOL; RAT	Outcome after traumatic brain injury (TBI) is worsened by hemorrhagic shock (HS), but the optimal resuscitation approach is unclear. In particular, treatment of TBI patients with colloids remains controversial. We hypothesized that resuscitation with the colloids polynitroxylated albumin (PNA) or Hextend (HEX) is equal or superior to resuscitation with the crystalloids hypertonic (3%) saline (HTS) or lactated Ringer's solution (LR) after TBI plus HS in mice. C57/BL6 mice (n=30) underwent controlled cortical impact (CCI) and 90 min of volume-controlled HS (2mL/100g). The mice were randomized to resuscitation with LR, HEX, HTS, or PNA, followed by 30 min of test fluid administration targeting a mean arterial pressure (MAP) of >50mm Hg. Shed blood was re-infused to target a MAP>70mm Hg. At 7 days post-insult, hippocampal neuron counts were assessed in hematoxylin and eosin-stained sections to quantify neuronal damage. Prehospital MAP was higher, and pre-hospital and total fluid requirements were lower in the PNA and HEX groups (p<0.05 versus HTS or LR). Also, 7-day survival was highest in the PNA group, but was not significantly different than the other groups. Ipsilateral hippocampal CA1 and CA3 neuron loss did not differ between groups. We conclude that the colloids PNA and HEX exhibited more favorable effects on acute resuscitation parameters than HTS or LR, and did not increase hippocampal neuronal death in this model.	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bayir, Huelya; Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Jenkins, Larry W.; Dixon, C. Edward; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Hsia, Carleton J.] SynZyme Technol, Irvine, CA USA; [Ma, Lil] Georgia So Univ, Statesboro, GA 30460 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	Kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Shellington, David/0000-0001-6708-6978	U.S. Army [PR054755 81-06-10247]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 38087, NS 30318]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038087, P01NS030318, P50NS030318, P20NS030318] Funding Source: NIH RePORTER	We would like to thank the U.S. Army for their support through grant PR054755 81-06-10247. We also thank the NIH for support, NS 38087 (P.M.K.) and NS 30318 (C.E.D.). Dr. Exo is supported by a T32 grant (HD 040686) from the National Institute of Child Health and Human Development. Drs. Ma and Hsia are officers at SynZyme Technologies, LLC. No other conflicting financial interests exist.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Beaulieu C, 1998, J CEREBR BLOOD F MET, V18, P1022; Bilotta F, 2007, NEW ENGL J MED, V357, P2635; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kaul DK, 2006, AM J PHYSIOL-HEART C, V291, pH167, DOI 10.1152/ajpheart.01096.2005; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; Kentner R, 2002, J TRAUMA, V53, P968, DOI 10.1097/00005373-200211000-00025; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; Li HQ, 2002, FREE RADICAL BIO MED, V32, P712, DOI 10.1016/S0891-5849(02)00762-1; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Myburgh J, 2007, NEW ENGL J MED, V357, P874; OHTAKI M, 1993, SURG NEUROL, V40, P196, DOI 10.1016/0090-3019(93)90068-C; PROUGH DS, 1991, CRIT CARE MED, V19, P364, DOI 10.1097/00003246-199103000-00015; Russell J, 1998, FREE RADICAL BIO MED, V25, P153, DOI 10.1016/S0891-5849(98)00022-7; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Sugawara T, 2001, NEUROREPORT, V12, P3609, DOI 10.1097/00001756-200111160-00047; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; TU YK, 1988, J NEUROSURG, V69, P72, DOI 10.3171/jns.1988.69.1.0072; TU YK, 1988, J NEUROSURG, V69, P82, DOI 10.3171/jns.1988.69.1.0082; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O	33	30	35	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2403	2408		10.1089/neu.2009.0980			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200024	19691424	Green Published			2021-06-18	
J	Larson, AN; Stans, AA; Shaughnessy, WJ; Dekutoski, MB; Quinn, MJ; McIntosh, AL				Larson, A. Noelle; Stans, Anthony A.; Shaughnessy, William J.; Dekutoski, Mark B.; Quinn, Michael J.; McIntosh, Amy L.			Motocross Morbidity: Economic Cost and Injury Distribution in Children	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						motocross; motorbike; injury; pediatric; children; dirtbike; trauma	FOOTBALL PLAYERS; CONCUSSION; SPORT	Background: Motocross is a nationally organized sport that is growing in popularity. The distribution and severity of motocross injuries in the pediatric population is not known. We hypothesize a high rate of musculoskeletal injuries requiring hospitalization and/or surgical intervention. Methods: All patients 17 years of age or younger with injuries sustained while using off-road 2-wheeled motorcycles were identified through surgical, diagnostic, and trauma registries at a level 1 regional trauma center. Type, severity, and mechanism of injury were assessed, as well as charges billed for medical care. Both recreational and competitive motocross activities were included. Results: From 2000 to 2007, 299 cases were noted in 249 unique patients. In 141 instances, hospital admission was required, for a total of 412 inpatient days. Twenty patients required ICU admission. Surgery was performed in 91 cases (81 orthopaedic, 6 general, 1 urology, and 4 facial reconstructions). Orthopaedic surgical procedures included treatment of 29 femur fractures, 8 forearm, 6 ankle, 5 tibial shaft, 6 proximal tibia, 5 spine, 6 proximal humerus, 4 hand, 4 foot, 3 elbow fractures, and 5 other. Orthopaedic interventions also included 8 reductions under general anesthesia and 31 conscious sedations. Mean age at injury was 14.1 years (range: 5.4 to 17.9). Ninety-four percent of patients were male and 85% were White. The majority of patients were wearing helmets/safety equipment. One hundred and eighty-four injuries occurred on a track, with 150 during competition. The mean charge billed per injury was $14,947 (range: $105 to $217,780), with a total cost of $4.5 million. Conclusions: Nearly half of motocross patients treated at a regional level 1 trauma center required hospitalization, and nearly one-third required surgery. The vast majority of surgical procedures (89%) were orthopaedic. Despite a high usage rate of helmets and protective gear, severe injuries were still sustained, including femur fracture (29), hemiparesis/spinal cord injury (2), and head injury (43). The majority of injuries occurred during organized race or practice. Families should be counseled with regard to the use of safety equipment and the severity of injuries sustained during competitive motocross activity.	[Larson, A. Noelle; Stans, Anthony A.; Shaughnessy, William J.; Dekutoski, Mark B.; Quinn, Michael J.; McIntosh, Amy L.] Mayo Clin, Rochester, MN 55905 USA	McIntosh, AL (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	mcintosh.amy@mayo.edu	shaughnessy, william/AAJ-4458-2020; Larson, A. Noelle/AAC-7158-2019	Larson, A. Noelle/0000-0001-6542-6975; McIntosh, Amy/0000-0002-3660-4901			*AM MOT ASS, 2008, 2008 RUL GOV PROAM S; Colburn NT, 2003, INJURY, V34, P207, DOI 10.1016/S0020-1383(02)00039-6; Collins CL, 2007, PEDIATRICS, V120, P134, DOI 10.1542/peds.2006-3612; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; *COMM ACC POIS PRE, 1987, PEDIATRICS, V79, P306; FONTIJNE WPJ, 1989, J SPORT MED PHYS FIT, V29, P199; Goldberg LD, 2006, SPORTS MED ARTHROSC, V14, P199, DOI 10.1097/01.jsa.0000212326.23560.09; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Pomerantz WJ, 2005, PEDIATRICS, V115, P704, DOI 10.1542/peds.2004-1304; STREETER RA, 2006, 2006 ANN REP ATV REL	13	30	30	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	DEC	2009	29	8					847	850		10.1097/BPO.0b013e3181c1e2fa			4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	526SN	WOS:000272313900003	19934696				2021-06-18	
J	Lee, C; Agoston, DV				Lee, Cheol; Agoston, Denes V.			Inhibition of VEGF receptor 2 increased cell death of dentate hilar neurons after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Hilar neurons; VEGF; VEGFR2; Neuroprotection	ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; TYROSINE KINASE; ADULT-RAT; DEGENERATION; EPILEPSY; MODEL; ANGIOGENESIS; GYRUS	Post-traumatic epilepsy, partly due to the loss of hilar neurons of the hippocampus, is a frequent long-term consequence of traumatic brain injury (TBI). We and others found that the levels of vascular endothelial growth factor (VEGF) that can act as a neuroprotectant increase after TBI. Here we tested whether VEGF and its receptor VEGFR2 are involved in mediating the death or survival of hilar neurons after injury. We demonstrated that VEGFR2 is expressed by most, if not all, hilar neurons and that these neurons are dying in large numbers as indicated by Fluoro-Jade B histology after fluid percussion TBI. To directly test the involvement of VEGFR2 and VEGF in the injury-induced apoptotic death of hilar neurons, we delivered an inhibitor to VEGFR2, or recombinant VEGF into the ipsilateral cerebral ventricle of injured SU5416, We found that blocking VEGFR2 by SU5416 significantly increased the number of apoptotic (TUNEL-animals. positive) cells in the hilus. Infusion of VEGF, however, failed to reduce the number of TUNEL-positive cells. Our results suggest that VEGFR2 is involved in mediating death or survival of hilar neurons after injury but delivering additional exogenous VEGF does not provide further protection from TBI-induced death of hilar neurons. (C) 2009 Elsevier Inc. All rights reserved.	[Agoston, Denes V.] USUHS, APG, Dept Anat Physiol & Genet, Sch Med, Bethesda, MD 20814 USA	Agoston, DV (corresponding author), USUHS, APG, Dept Anat Physiol & Genet, Sch Med, 4301 Jones Br Rd, Bethesda, MD 20814 USA.	vagoston@usuhs.edu			Translational Research Program of Defense Brain; Spinal Cord Injury Program of the Department of DefenseUnited States Department of Defense	The authors thank Ms. A. Thorburn for her editorial assistance and Mr. P. Kwon for his technical assistance. C.L. was supported by the Translational Research Program of Defense Brain and Spinal Cord Injury Program of the Department of Defense.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; Choi YS, 2007, J NEUROSCI, V27, P2999, DOI 10.1523/JNEUROSCI.4913-06.2007; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; Kawai T, 2006, NEUROSCIENCE, V141, P1209, DOI 10.1016/j.neuroscience.2006.04.064; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Matsuzaki H, 2001, FASEB J, V15, P1218; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pencea V, 2001, J NEUROSCI, V21, P6706; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000	33	30	32	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2009	220	2					400	403		10.1016/j.expneurol.2009.08.019			4	Neurosciences	Neurosciences & Neurology	528FV	WOS:000272428700025	19733172				2021-06-18	
J	Itoh, T; Satou, T; Nishida, S; Tsubaki, M; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Tsubaki, Masahiro; Hashimoto, Shigeo; Ito, Hiroyuki			The Novel Free Radical Scavenger, Edaravone, Increases Neural Stem Cell Number Around the Area of Damage Following Rat Traumatic Brain Injury	NEUROTOXICITY RESEARCH			English	Article						Neural stem cell; Traumatic brain injury; Nestin; Neurosphere; Edaravone	CENTRAL-NERVOUS-SYSTEM; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; OXYGEN RADICALS; SPINAL-CORD; MCI-186; ACTIVATION; PROLIFERATION; HIPPOCAMPUS; EXPRESSION	Edaravone is a novel free radical scavenger that is clinically employed in patients with acute cerebral infarction, but has not previously been used to treat traumatic brain injury (TBI). In this study, we investigated the effect of edaravone administration on rat TBI. In particular, we used immunohistochemistry to monitor neural stem cell (NSC) proliferation around the area damaged by TBI. Two separate groups of rats were administered saline or edaravone (3 mg/kg) after TBI and then killed chronologically. We also used ex vivo techniques to isolate NSCs from the damaged region and observed nestin-positive cells at 1, 3, and 7 days following TBI in both saline- and edaravone-treated groups. At 3 days following TBI in both groups, there were many large cells that morphologically resembled astrocytes. At 1 and 7 days following TBI in the saline group, there were a few small nestin-positive cells. However, in the edaravone group, there were many large nestin-positive cells at 7 days following TBI. At 3 and 7 days following TBI, the number of nestin-positive cells in the edaravone group increased significantly compared with the saline group. There were many single-stranded DNA-, 8-hydroxy-2'-deoxyguanosine-, and 4-hydroxy-2-nonenal-positive cells in the saline group following TBI, but only a few such cells in the edaravone group following TBI. Furthermore, almost all ssDNA-positive cells in the saline group co-localized with Hu, nestin, and glial fibrillary acidic protein (GFAP) staining, but not in the edaravone group. In the ex vivo study, spheres could only be isolated from injured brain tissue in the saline group at 3 days following TBI. However, in the edaravone group, spheres could be isolated from injured brain tissue at both 3 and 7 days following TBI. The number of spheres isolated from injured brain tissue in the edaravone group showed a significant increase compared with the saline group. The spheres isolated from both saline and edaravone groups were immunopositive for nestin, but not Tuj1 or vimentin. Moreover, the spheres differentiated into Tuj1-, GFAP-, and O4-positive cells after 4 days in culture without bFGF. This result indicated that the spheres were neurospheres composed of NSCs that could differentiate into neurons and glia. Edaravone administration inhibited production of free radicals known to induce neuronal degeneration and cell death after brain injury, and protected nestin-positive cells, including NSCs, with the potential to differentiate into neurons and glia around the area damaged by TBI.	[Itoh, Tatsuki; Satou, Takao; Ito, Hiroyuki] Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Sch Med, Div Hosp Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ, Inst Life Sci, Div Sports Med, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Sch Pharmaceut Sci, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan	Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20500472] Funding Source: KAKEN		Arai T, 2008, J PHARMACOL EXP THER, V324, P529, DOI 10.1124/jpet.107.131391; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lin HJ, 2004, FEBS LETT, V570, P102, DOI 10.1016/j.febslet.2004.06.019; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mizuno A, 1998, GEN PHARMACOL-VASC S, V30, P575, DOI 10.1016/S0306-3623(97)00311-X; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Niyaz M, 2007, J NEUROSCI RES, V85, P2933, DOI 10.1002/jnr.21412; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Walton KM, 1998, J NEUROCHEM, V70, P1764; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Wen J, 2006, BIOL PHARM BULL, V29, P713, DOI 10.1248/bpb.29.713; Wu T, 2006, BIOL PHARM BULL, V29, P1613, DOI 10.1248/bpb.29.1613; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3; Yasuoka N, 2004, DEV BRAIN RES, V151, P129, DOI 10.1016/j.devbrainres.2004.04.006	38	30	34	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428			NEUROTOX RES	Neurotox. Res.	NOV	2009	16	4					378	389		10.1007/s12640-009-9081-6			12	Neurosciences	Neurosciences & Neurology	509OS	WOS:000271028000005	19590930				2021-06-18	
J	Adamides, AA; Rosenfeldt, FL; Winter, CD; Pratt, NM; Tippett, NJ; Lewis, PM; Bailey, MJ; Cooper, DJ; Rosenfeld, JV				Adamides, Alexios A.; Rosenfeldt, Franklin L.; Winter, Craig D.; Pratt, Naomi M.; Tippett, Nicholas J.; Lewis, Philip M.; Bailey, Michael J.; Cooper, D. James; Rosenfeld, Jeffrey V.			Brain Tissue Lactate Elevations Predict Episodes of Intracranial Hypertension in Patients with Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							SEVERE HEAD-INJURY; MEMBRANE PHOSPHOLIPID DEGRADATION; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; EXTRACELLULAR POTASSIUM; INTERSTITIAL GLYCEROL; METABOLISM; ISCHEMIA; HUMANS		[Adamides, Alexios A.; Winter, Craig D.; Lewis, Philip M.; Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Cooper, D. James] Alfred Hosp, Dept Crit Care, Melbourne, Vic, Australia; [Rosenfeldt, Franklin L.; Bailey, Michael J.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeldt, Franklin L.; Bailey, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Adamides, Alexios A.; Pratt, Naomi M.; Tippett, Nicholas J.; Cooper, D. James] Natl Trauma Res Inst, Melbourne, Vic, Australia	Adamides, AA (corresponding author), Royal Melbourne Hosp, Dept Neurosurg, Grattan St, Parkville, Vic 3050, Australia.		Cooper, D. James/G-7961-2013; Bailey, Michael J/A-4499-2012; Rosenfeld, Jeffrey V/B-7249-2011	Cooper, D. James/0000-0002-5872-9051; Bailey, Michael J/0000-0002-5551-1401; 			Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Smith M, 2004, MICRODIALYSIS MONITORING TISSUE CHEMISTRY IN INTENSIVE CARE MEDICINE, P45; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	29	30	30	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515			J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2009	209	4					531	539		10.1016/j.jamcollsurg.2009.05.028			9	Surgery	Surgery	506CD	WOS:000270749900012	19801326				2021-06-18	
J	Qu, CS; Xiong, Y; Mahmood, A; Kaplan, DL; Goussev, A; Ning, RZ; Chopp, M				Qu, Changsheng; Xiong, Ye; Mahmood, Asim; Kaplan, David L.; Goussev, Anton; Ning, Ruizhuo; Chopp, Michael			Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						scaffold; human marrow stromal cell; lesion volume; traumatic brain injury; collagen; mouse	MESENCHYMAL STEM-CELLS; ADULT RATS; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; SPINAL-CORD; TRANSPLANTATION; TISSUE; STROKE; MODEL; MOUSE	Object. This study was designed to investigate new ways of delivering human marrow stromal cells (hMSCs) to the injured brain by impregnating them into collagen scaffolds in a mouse model of traumatic brain injury (TBI). Methods. Eight C57BL/6 J mice were injured with controlled cortical impact and received transplantation into the lesion cavity of 0.3 x 10(6) hMSCs impregnated into 3D porous collagen scaffolds. Additional experimental groups of 8 mice each received scaffolds implanted alone into the lesion cavity, hMSCs administered alone intracerebrally or intravenously, or saline injected into the lesion core. All treatments were performed 7 days after TBI. Spatial learning was measured using a modified Morris water maze test, and brain tissue samples were processed for histopathological analysis. Results. The results showed that hMSC-impregnated scaffolds were more effective than hMSCs administered alone (either intravenously or intracerebrally) in improving spatial learning, reducing lesion volume, and increasing vascular density after TBI. Conclusions. Collagen scaffolds populated with hMSCs may be a new way to reconstruct injured brain tissue and improve neurological function after TBI. (DOI: 10.3171/2009.4.JNS081681)	[Qu, Changsheng; Xiong, Ye; Mahmood, Asim; Goussev, Anton; Ning, Ruizhuo] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Qu, Changsheng; Xiong, Ye; Mahmood, Asim; Goussev, Anton; Ning, Ruizhuo] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Mahmood, A (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, K-11,2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu	ning, ruizhuo/E-6401-2012	Xiong, Ye/0000-0001-9770-6031	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01, NS042259, P01 NS42325]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042259, P01NS042345] Funding Source: NIH RePORTER	Asim Mahmood received funding from NIH R01, NS042259, and P01 NS42325 for this study.	Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kon E, 2000, J BIOMED MATER RES, V49, P328; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252; Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	42	30	35	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2009	111	4					658	665		10.3171/2009.4.JNS081681			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	503PL	WOS:000270550000006	19425888	Green Accepted			2021-06-18	
J	Baguley, IJ; Heriseanu, RE; Nott, MT; Chapman, J; Sandanam, J				Baguley, Ian J.; Heriseanu, Roxana E.; Nott, Melissa T.; Chapman, Jenny; Sandanam, Joseph			Dysautonomia after Severe Traumatic Brain Injury Evidence of Persisting Overresponsiveness to Afferent Stimuli	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Heart Rate; Dysautonomia; Sympathetic Nervous System; Nociception; Sympathetic Overactivity	HEART-RATE-VARIABILITY; AUTONOMIC DYSREFLEXIA; MANAGEMENT; DYSFUNCTION	Objective: To differentiate between dysautonomic and nondysautonomic subjects with acquired brain injury by measuring sympathetic reactivity after a nociceptive clinical procedure and to determine the utility of heart rate variability as an indicator of sympathetic overresponsivity in dysautonomic subjects. Design: This case-controlled study recruited subjects with acquired brain injury (mean, 5 yrs postinjury) attending a hospital-based outpatient clinic, comprising seven dysautonomic subjects with traumatic brain injury, eight nondysautonomic traumatic brain injury subjects, and 11 nondysautonomic subjects with nontraumatic acquired brain injury. Sympathetic reactivity after nociceptive stimuli (limb assessment and botulinum toxin injection for spasticity management) was compared among groups. Results: Sympathetic overactivity in dysautonomic subjects was evident across all physiologic parameters, whereas nondysautonomic subjects demonstrated limited reactivity. Heart rate variability measures of the balance between sympathetic and parasympathetic cardiac control showed a significant elevation in response to nociceptive stimuli, a response not observed in either nondysautonomic group. This sympathetic overactivity showed a normalizing tendency with increasing time postinjury. Conclusions: This study found persistent sympathetic overactivity in response to nociceptive stimuli in dysautonomic subjects (mean, 5 yrs postinjury). This significantly extends the duration over which such sympathetic overactivity has been quantified in this group, contributing to the accumulating empirical evidence that dysautonomic paroxysms result from sympathetic overresponsiveness. Given that sympathetic overactivity has now been observed from day 7 through 5 yrs postinjury, quantitative evaluation of patients for overresponsiveness to stimuli should be added to current diagnostic procedures at all stages of recovery.	[Baguley, Ian J.; Heriseanu, Roxana E.; Nott, Melissa T.] Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia; [Baguley, Ian J.] Univ Sydney, Rehabil Studies Unit, Fac Med, Sydney, NSW 2006, Australia; [Chapman, Jenny; Sandanam, Joseph] St Josephs Hosp, Dept Rehabil Med, Auburn, NSW, Australia	Baguley, IJ (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, POB 533, Wentworthville, NSW 2145, Australia.		Baguley, Ian/AAM-5828-2021; Nott, Melissa T/M-6778-2018; Baguley, Ian J/K-6878-2013	Nott, Melissa T/0000-0001-7088-5826; Baguley, Ian J/0000-0001-5650-3705			ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Diesing TS, 2006, MOVEMENT DISORD, V21, P868, DOI 10.1002/mds.20831; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; GUZZETTI S, 1994, AM J PHYSIOL, V266, pH1112; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; HUIKURI HV, 1990, AM J CARDIOL, V65, P391, DOI 10.1016/0002-9149(90)90308-N; LEMKE DM, 2004, J NEUROSCI NURS, V3, P4; Ori Z, 1992, Cardiol Clin, V10, P499; Penfield W, 1954, EPILEPSY FUNCTIONAL, P412; Rabchevsky AG, 2006, PROG BRAIN RES, V152, P265, DOI 10.1016/S0079-6123(05)52017-X; Rabinstein AA, 2004, ARCH NEUROL-CHICAGO, V61, P1625, DOI 10.1001/archneur.61.10.1625-a; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Sacha J, 2005, J ELECTROCARDIOL, V38, P47, DOI 10.1016/j.jelectrocard.2004.09.015; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; Tong CY, 2000, ANESTH ANALG, V91, P1450, DOI 10.1097/00000539-200012000-00028; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782	32	30	32	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2009	88	8					615	622		10.1097/PHM.0b013e3181aeab96			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	476VW	WOS:000268475400002	19620826				2021-06-18	
J	Olivecrona, M; Rodling-Wahlstrom, M; Naredi, S; Koskinen, LOD				Olivecrona, Magnus; Rodling-Wahlstrom, Marie; Naredi, Silvana; Koskinen, Lars-Owe D.			Prostacyclin Treatment in Severe Traumatic Brain Injury: A Microdialysis and Outcome Study	JOURNAL OF NEUROTRAUMA			English	Article						lactate-pyruvate ratio; microdialysis; prostacyclin; severe traumatic brain injury	CAT SKELETAL-MUSCLE; LOW-DOSE PROSTACYCLIN; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL PERFUSION-PRESSURE; INTRACEREBRAL MICRODIALYSIS; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; CAPILLARY-PERMEABILITY; TARGETED THERAPY; PROSTAGLANDIN ENDOPEROXIDES	Prostacyclin (PGI(2)) is a potent vasodilator, inhibitor of leukocyte adhesion, and platelet aggregation. In trauma the balance between PGI(2) and thromboxane A(2) (TXA(2)) is shifted towards TXA(2). Externally provided PGI(2) would, from a theoretical and experimental point of view, improve the microcirculation in injured brain tissue. This study is a prospective consecutive double-blinded randomized study on the effect of PGI(2) versus placebo in severe traumatic brain injury (sTBI). All patients with sTBI were eligible. Inclusion criteria: verified sTBI, Glasgow Coma Score (GCS) at intubation and sedation of <= 8, age 15-70 years, a first-recorded cerebral perfusion pressure (CPP) of >= 10 mm Hg, and arrival within 24 h of trauma. All subjects received an intracranial pressure (ICP) measuring device, bilateral intracerebral microdialysis catheters, and a microdialysis catheter in the abdominal subcutaneous adipose tissue. Subjects were treated according to an ICP-targeted therapy based on the Lund concept. 48 patients (mean age of 35.5 years and a median GCS of 6 [3-8]) were included. We found no significant effect of prostacyclin (epoprostenol, Flolan) on either the lactate-pyruvate ratio (L/P) at 24 h or the brain glucose levels. There was no significant difference in clinical outcome between the two groups. The median Glasgow Outcome Score (GOS) at 3 months was 4, and mortality was 12.5%. The favorable outcome (GOS 4-5) was 52%. The initial L/P did not prognosticate for outcome. Thus our results indicate that there is no effect of PGI(2) at a dose of 0.5 ng/kg/min on brain L/P, brain glucose levels, or outcome at 3 months.	[Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden; [Rodling-Wahlstrom, Marie; Naredi, Silvana] Umea Univ Hosp, Dept Anaesthesiol, S-90185 Umea, Sweden	Koskinen, LOD (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	Lars-Owe.Koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Naredi, Silvana/0000-0002-4409-6089; Koskinen, Lars-Owe/0000-0003-3528-8502	Department of Clinical Neurosciences University Hospital Research Fund,; Tore Nilsson Fund, Kempe Fund, Capio Research Fund,; Umea University	We thank the staff at the neurosurgical department and intensive care unit of Umea University, without whose kindness, interest, and dedicated work the study could not have been performed. A special thanks to our research nurses, Kristin Nyman and Anna-Lena Ostund, for their invaluable help and support in making this study possible. This study was financially supported by the Department of Clinical Neurosciences University Hospital Research Fund, Tore Nilsson Fund, Kempe Fund, Capio Research Fund, and Umea University.	Agren-Wilsson A, 2005, J NEUROL NEUROSUR PS, V76, P1088, DOI 10.1136/jnnp.2004.042838; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Bentzer P, 2001, AM J PHYSIOL-HEART C, V280, pH2697; Bentzer P, 1999, J VASC RES, V36, P516, DOI 10.1159/000025695; BLEBEA J, 1990, J VASC SURG, V12, P657, DOI 10.1067/mva.1990.25129; BLEBEA J, 1990, J VASC SURG, V12, P665; BOULLIN DJ, 1979, BRIT J CLIN PHARMACO, V7, P139, DOI 10.1111/j.1365-2125.1979.tb00914.x; BRANDT L, 1981, J NEUROSURG, V55, P877, DOI 10.3171/jns.1981.55.6.0877; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; DAVIES MG, 1993, ANN SURG, V218, P593, DOI 10.1097/00000658-199321850-00003; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; ERLANSSON M, 1991, PROSTAGLANDINS, V41, P157, DOI 10.1016/0090-6980(91)90028-E; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; GRANHOLM L, 1969, ACTA PHYSIOL SCAND, V75, P257, DOI 10.1111/j.1748-1716.1969.tb04379.x; GRYGLEWSKI RJ, 1978, ACTA BIOL MED GER, V37, P715; Hutchinson P, 2002, ACT NEUR S, V81, P341; Jahr J, 1996, INTENS CARE MED, V22, P1453; JONES G, 1984, J PATHOL, V142, P51, DOI 10.1002/path.1711420110; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LEWIS PJ, 1983, BRIT MED BULL, V39, P281, DOI 10.1093/oxfordjournals.bmb.a071834; Lourido J, 2002, SCAND J CLIN LAB INV, V62, P285, DOI 10.1080/003655102760145843; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; MIZUNOYAGYU Y, 1987, BIOCHEM PHARMACOL, V36, P3809; Moller AD, 1999, CRIT CARE MED, V27, P130, DOI 10.1097/00003246-199901000-00040; Moller AD, 1999, J VASC RES, V36, P245, DOI 10.1159/000025648; Moller AD, 1997, AM J PHYSIOL-HEART C, V273, pH200; MONCADA S, 1979, FED PROC, V38, P66; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MONCADA S, 1979, HAEMOSTASIS, V8, P252; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; MOREL NML, 1990, INFLAMMATION, V14, P571, DOI 10.1007/BF00914277; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; RITTER JM, 1983, LANCET, V1, P317; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; SEIFERT V, 1987, SURG NEUROL, V27, P243, DOI 10.1016/0090-3019(87)90037-1; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; J NEUROTRAUMA S1, V24, pS59	53	30	31	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1251	1262		10.1089/neu.2008.0605			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900008	19226191				2021-06-18	
J	Rael, LT; Bar-Or, R; Mains, CW; Slone, DS; Levy, AS; Bar-Or, D				Rael, Leonard T.; Bar-Or, Raphael; Mains, Charles W.; Slone, Denetta S.; Levy, A. Stewart; Bar-Or, David			Plasma Oxidation-Reduction Potential and Protein Oxidation in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						oxidation-reduction potential; oxidative stress; protein oxidation; traumatic brain injury	CLOSED-HEAD INJURY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; SERUM-ALBUMIN; ASCORBIC-ACID; IMMATURE RATS; STRESS; ANTIOXIDANT; MECHANISMS	The amount of oxidative stress in patients with an isolated traumatic brain injury (ITBI) can be estimated by measuring several biochemical parameters, such as total antioxidants, lipid peroxidation, protein oxidation, and others. Unfortunately, measuring these parameters is time-consuming, impractical in a clinical setting, and may miss important factors contributing to the overall redox balance. Here we suggest that the overall oxidative status in ITBI patients can be assessed by measuring plasma oxidation-reduction potential (ORP). Daily whole blood samples were obtained from severe ITBI patients (abbreviated injury score [AIS] >= 3, n = 32), and demographically similar non-head injury traumatized patients (n = 26) until discharge. Whole blood was also collected from patients with minor to moderate ITBI (AIS <= 2, n = 18) and healthy volunteers (n = 22). Admission plasma ORP was significantly elevated in all traumatized patients compared to controls. Maximum ORP was detected on day 6 for severe ITBI and non-head injury traumatized patients. However, maximum ORP values were significantly higher (p < 0.05) in the severe ITBI group (+8.5mV +/- 3.4 SEM) compared to the non-head injury group (-5.2mV +/- 2.9 SEM). Additionally, a significantly higher oxidation of human serum albumin (HSA) was measured in all trauma patients compared to controls. These results demonstrate the presence of an oxidative environment in the plasma of traumatized patients, specifically in severe ITBI patients. Therefore monitoring ORP is a potentially useful tool for assessing the degree of oxidative stress, inflammation, severity of injury, and potential efficacy of treatment in ITBI patients.	[Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] Swedish Med Ctr, Trauma Res Lab, Englewood, CO 80113 USA; [Slone, Denetta S.] Swedish Med Ctr, Trauma Serv, Englewood, CO 80113 USA; [Bar-Or, David] Swedish Med Ctr, Emergency Dept, Englewood, CO 80113 USA; [Mains, Charles W.] St Anthony Cent Hosp, Trauma Serv, Denver, CO USA; [Levy, A. Stewart] St Anthony Cent Hosp, Dept Neurosurg, Denver, CO USA	Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Lab, 501 E Hampden Ave,Room 4-454, Englewood, CO 80113 USA.	dbaror@dmbio.com	Bar-Or, David/AAE-9328-2020	Rael, Leonard/0000-0003-3282-7072	Swedish Medical Center (Englewood, CO); St. Anthony Central Hospital ( Denver, CO); Institute for Molecular Medicine (Englewood, CO	The authors gratefully acknowledge the collection of patient samples and maintenance of patient records by Rachel Aumann, R. N., and Anita Leyden, R. N. This study was supported by Trauma Research, L. L. C. (Englewood, CO), the Swedish Medical Center (Englewood, CO), St. Anthony Central Hospital ( Denver, CO), and the Institute for Molecular Medicine (Englewood, CO).	Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Moor E, 2001, NEUROSCI LETT, V316, P169, DOI 10.1016/S0304-3940(01)02394-1; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, P76, DOI DOI 10.1016/B978-012552110-9/50005-2; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; REITER RJ, 1995, FASEB J, V9, P526; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; SPECTOR R, 1984, FED PROC, V43, P196; Summa D, 2007, PROTEINS, V69, P369, DOI 10.1002/prot.21532; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vethanayagam JGG, 1999, FREE RADICAL BIO MED, V26, P1591, DOI 10.1016/S0891-5849(99)00031-3; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; WEI EP, 1986, AM J PHYSIOL, V251, pH693; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101	45	30	32	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1203	1211		10.1089/neu.2008.0816			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900004	19317602				2021-06-18	
J	Gamino, JF; Chapman, SB; Cook, LG				Gamino, Jacquelyn F.; Chapman, Sandra B.; Cook, Lori G.			Strategic Learning in Youth With Traumatic Brain Injury Evidence for Stall in Higher-Order Cognition	TOPICS IN LANGUAGE DISORDERS			English	Article						adolescence; brain injury; cognitive stall; discourse; executive function/executive control; frontal lobe; gist; neuroplasticity	WORKING-MEMORY; ACADEMIC-ACHIEVEMENT; CHILDREN; DISCOURSE; TEXT	Little is known about strategic learning ability in preteens and adolescents with traumatic brain injury (TBI). Strategic learning is the ability to combine and synthesize details to form abstracted gist-based meanings, a higher-order cognitive skill associated with frontal lobe functions and higher classroom performance. Summarization tasks were used to measure strategic learning ability through the production of abstracted gist-based concepts, and specific probes measured memory for explicit details. Twenty middle school-aged preteens and teenagers who sustained a moderate to severe TBI 1 year postinjury and a control group of 20 typically developing 10- to 15-year-old subjects participated in this study. The results revealed that the youth with moderate to severe TBI were able to recall specific details at a comparable level to the control group. However, the youth with TBI demonstrated significantly lower strategic learning competence, as manifested by a reduced ability to combine details into gist-based ideas. The present findings advance the notion that skills that have not yet developed at the time of brain injury or are in a stage of development may be particularly vulnerable to the long-term and lasting sequelae of TBI in youth, although a longitudinal study is needed to verify this claim.	[Gamino, Jacquelyn F.; Chapman, Sandra B.; Cook, Lori G.] Univ Texas Dallas, Ctr BrainHlth, Sch Behav & Brain Sci, Dallas, TX 75235 USA	Gamino, JF (corresponding author), Univ Texas Dallas, Ctr BrainHlth, Sch Behav & Brain Sci, 2200 W Mockingbird, Dallas, TX 75235 USA.	jgamino@utdallas.edu					Bjorklund DF, 1997, DEV REV, V17, P411, DOI 10.1006/drev.1997.0440; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; BRAINERD CJ, 1992, DEV REV, V12, P164, DOI 10.1016/0273-2297(92)90007-O; Brainerd CJ, 1998, DEV PSYCHOL, V34, P342, DOI 10.1037/0012-1649.34.2.342; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4; Chapman S. B., 1997, AM J SPEECH-LANG PAT, V6, P66; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; CHAPMAN SB, 2007, BRAIN INJ PROF, V3, P10; CHAPMAN SB, 2009, TEST STRATEGIC UNPUB; Cook LG, 2007, CHILDRENS COMPREHENS, P218; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gabrieli John D E, 2004, Cerebrum, V6, P39; Gamino J. F., 2008, INT NEUR SOC ANN M W; GAMINO JE, 2009, STRATEGIC LEAR UNPUB; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JOHNSON NS, 1983, CHILDRENS LANGUAGE, P314; KINTSCH E, 1990, COGNITION INSTRUCT, V7, P161, DOI 10.1207/s1532690xci0703_1; Kintsch W., 1994, HDB PSYCHOLINGUISTIC, P721; MALONE LD, 1992, EXCEPT CHILDREN, V58, P270; Mayer RE, 1996, EDUC PSYCHOL REV, V8, P357, DOI 10.1007/BF01463939; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Reyna VF, 1998, J EXP CHILD PSYCHOL, V71, P194, DOI 10.1006/jecp.1998.2472; STEIN BL, 1992, J READING BEHAV, V24, P217, DOI 10.1080/10862969209547773; TEASDALE G, 1974, LANCET, V2, P81; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; Wechsler D., 2011, WECHLSER ABBREVIATED	31	30	32	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2009	29	3					224	235		10.1097/TLD.0b013e3181b531da			12	Linguistics; Rehabilitation	Linguistics; Rehabilitation	488HT	WOS:000269340700004					2021-06-18	
J	Lundberg, J; Karimi, M; von Gertten, C; Holmin, S; Ekstrom, TJ; Sandberg-Nordqvist, AC				Lundberg, Johan; Karimi, Mohsen; von Gertten, Christina; Holmin, Staffan; Ekstrom, Tomas J.; Sandberg-Nordqvist, Ann-Christin			Traumatic brain injury induces relocalization of DNA-methyltransferase 1	NEUROSCIENCE LETTERS			English	Article						Methylation; Dnmt1; Traumatic brain injury; Astrocyte activation	METHYLATION; RATS	Secondary cerebral damage after traumatic brain injury (TBI) occurs following processes partly initiated by gene expression alterations. DNA methylation in promoter regions is one of several epigenetic modifications, that affect the regulation of gene expression and which is a part of the pathophysiological pathway following TBI. We have investigated expression and cellular localization of DNA-methyltransferase (Dnmts) enzymes by immunohistochemistry (1HC) and confocal microscopy. Nuclear as well as cytoplasmic Dnmt1 was observed in astrocytes, in contrast to its normal neuronal nuclear localization. Interestingly, double staining with Dnmt1 and nestin showed co-localization in some reactive astrocytes in the nucleus alone, while in others this expression pattern was evident both in the nucleus and cytoplasm, in a brain region specific manner. In normal brains, and contralateral to the injury, the great majority of Dnmt1 positive cells were neurons. We also observed cytoplasmic Dnmt1 in peri-ventricular nestin expressing cells. Our findings may form the basis for further epigenetic studies following TBI and new therapeutic strategies to treat TBI patients. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Neuroradiol Sect, SE-17176 Stockholm, Sweden; [Lundberg, Johan; von Gertten, Christina; Sandberg-Nordqvist, Ann-Christin] Karolinska Univ Hosp, Sect Clin CNS Res, Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Karimi, Mohsen; Ekstrom, Tomas J.] Karolinska Univ Hosp, Lab Med Epigenet, SE-17176 Stockholm, Sweden; [Karimi, Mohsen] Karolinska Univ Hosp, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden	Ekstrom, TJ (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Lab Med Epigenet, L8 01, S-17176 Stockholm, Sweden.	Tomas.Ekstrom@ki.se	Ekstrom, Tomas/B-7764-2013	Holmin, Staffan/0000-0002-1628-1615	Swedish Cancer Foundation; Karolinska InstitutetKarolinska Institutet; Ministry of Health, Iran	The work was supported by the Swedish Cancer Foundation, and funds from Karolinska Institutet. Mohsen Karimi was supported by a scholarship through the Pasteur Institute, Ministry of Health, Iran.	Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	13	30	30	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 19	2009	457	1					8	11		10.1016/j.neulet.2009.03.105			4	Neurosciences	Neurosciences & Neurology	449WE	WOS:000266360300003	19429151				2021-06-18	
J	Zuberovic, A; Wetterhall, M; Hanrieder, J; Bergquist, J				Zuberovic, Aida; Wetterhall, Magnus; Hanrieder, Joerg; Bergquist, Jonas			CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid	ELECTROPHORESIS			English	Article						CE MALDI-TOF/TOF MS; iTRAQ (TM); Multiplexed quantification; Proteomics; Ventricular cerebrospinal fluid	TRAUMATIC BRAIN-INJURY; CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; PROTEOMIC ANALYSIS; BIOMARKERS; EXPRESSION; DAMAGE; SERUM; IDENTIFICATION; DISCOVERY	CE, interfaced off-line to MALDI-TOF/TOF MS, was for the first time used to quantitatively monitor the protein content in complex biological and clinical samples with iTRAQ (TM) labeling. The usefulness and advantage of iTRAQ (TM) labeling, in combination, with CE MALDI-TOF/TOF MS is demonstrated on mixtures of protein standards and by a case study on human ventricular cerebrospinal fluid samples collected from a patient with traumatic brain injury during patient recovery. Mixtures of five standard proteins were initially analyzed to optimize the experimental conditions for the CE MALDI-MS and MS/MS analysis. The interactions of proteins and peptides with the capillary inner wall during CE separation were minimized using PolyE-323 modified capillaries. The analysis of the ventricular cerebrospinal fluid samples yielded 43 significantly (p < 0.05 MudPIT scoring) identified proteins that could be quantitatively monitored over time. The identified changes in protein levels for several of these proteins are well in line with the reports from previous studies on protein patterns that could be related to the post-traumatic processes of traumatic brain injury. This study shows that the presented approach, combining isobaric tags with CE MALDI-TOF/TOF MS, is a useful choice for quantitative proteomic analysis.	[Zuberovic, Aida; Wetterhall, Magnus; Hanrieder, Joerg; Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem Analyt Chem, Uppsala, Sweden	Bergquist, J (corresponding author), Uppsala Univ, Dept Phys & Analyt Chem Analyt Chem, POB 599, Uppsala, Sweden.	Jonas.Bergquist@kemi.uu.se	Bergquist, Jonas/C-5894-2015; Hanrieder, Jorg/E-9706-2011	Bergquist, Jonas/0000-0002-4597-041X	The Swedish Research CouncilSwedish Research Council [621-2005-5379, 342-2004-3944, 629-2002-6821]	The Swedish Research Council (Grant 621-2005-5379, 342-2004-3944 and 629-2002-6821 (J.B.)) is gratefully acknowledged for financial support. Lars Hillered and Per Enblad at the Department of Neurosurgery, Uppsala Academic Hospital, are acknowledged for providing the vCSF sample.	Barr JR, 1996, CLIN CHEM, V42, P1676; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bergstrom SK, 2006, ANALYST, V131, P791, DOI 10.1039/b601660j; Chaerkady R, 2007, PROTEOM CLIN APPL, V1, P1080, DOI 10.1002/prca.200700284; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Dekker LJ, 2006, EXPERT REV PROTEOMIC, V3, P297, DOI 10.1586/14789450.3.3.297; Fenselau C, 2007, J CHROMATOGR B, V855, P14, DOI 10.1016/j.jchromb.2006.10.071; Garza S, 2006, ANAL CHEM, V78, P7309, DOI 10.1021/ac0612269; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hanrieder J, 2009, J CHROMATOGR A, V1216, P3621, DOI 10.1016/j.chroma.2008.12.026; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Huck CW, 2006, ELECTROPHORESIS, V27, P2063, DOI 10.1002/elps.200600046; Issaq HJ, 2007, ELECTROPHORESIS, V28, P1980, DOI 10.1002/elps.200600834; Issaq HJ, 2001, ELECTROPHORESIS, V22, P3629, DOI 10.1002/1522-2683(200109)22:17<3629::AID-ELPS3629>3.0.CO;2-O; Julka S, 2004, J PROTEOME RES, V3, P350, DOI 10.1021/pr0340734; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kraly J, 2006, ANAL CHEM, V78, P4097, DOI 10.1021/ac060704c; Lau KW, 2007, PROTEOMICS, V7, P2787, DOI 10.1002/pmic.200700127; Neususs C, 2002, ELECTROPHORESIS, V23, P3149, DOI 10.1002/1522-2683(200209)23:18<3149::AID-ELPS3149>3.0.CO;2-8; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schiffer E, 2006, PROTEOMICS, V6, P5615, DOI 10.1002/pmic.200600230; Simpson DC, 2005, ELECTROPHORESIS, V26, P1291, DOI 10.1002/elps.200410132; Smith JC, 2007, ANAL CHEM, V79, P4325, DOI 10.1021/ac070741j; Sniehotta M, 2007, ELECTROPHORESIS, V28, P1407, DOI 10.1002/elps.200600581; Ullsten S, 2004, ELECTROPHORESIS, V25, P2090, DOI 10.1002/elps.200305787; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Zuberovic A, 2004, RAPID COMMUN MASS SP, V18, P2946, DOI 10.1002/rcm.1712; Zuberovic A, 2008, EUR J MASS SPECTROM, V14, P249, DOI 10.1255/ejms.929; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	40	30	30	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	MAY	2009	30	10			SI		1836	1843		10.1002/elps.200800714			8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	452FC	WOS:000266524500026	19441030				2021-06-18	
J	Williams, G; Morris, ME; Schache, A; McCrory, P				Williams, Gavin; Morris, Meg E.; Schache, Anthony; McCrory, Paul			Observational gait analysis in traumatic brain injury: Accuracy of clinical judgment	GAIT & POSTURE			English	Article						Gait; Brain injury; Observational gait analysis; Motion analysis; Validity	BOTULINUM-TOXIN-A; CEREBRAL-PALSY; ALCOHOL NEUROLYSIS; RELIABILITY; OUTCOMES; SCALE; RECOMMENDATIONS; MANAGEMENT; SPASTICITY; CHILDREN	Objective: To determine the accuracy of clinicians' visual observations of gait disorders following traumatic brain injury (TBI). Methods: 30 ambulant participants (sample of convenience) receiving physiotherapy for mobility limitations following TBI and 25 age, height, weight and sex matched healthy unimpaired controls (HQ were recruited. Kinematic and ground reaction force data during gait were captured and video recordings were concurrently collected. Participants with TBI walked at self-selected speed whilst HCs walked at preferred speed as well as the mean TBI speed for comparison. 40 doctors, experienced physiotherapists, new graduate physiotherapists and novices were observers. Each viewed and rated 36 gait variables for a randomized sub-sample of 10 participants with TBI. Observer inaccuracy was calculated for each gait variable. Results: Overall the accuracy of observational gait analysis was low and there was considerable variability in observations between clinicians. For most kinematic variables, observer inaccuracy ranged from 30% to 50%. Although experienced observers were generally more accurate, average inter-item correlations were low, indicating that experience did not consistently improve the accuracy of visual observations. Observational plane, gait variable type, the joint or the segment had little effect on accuracy of observations. Conclusions: Observational gait analysis for adults with TBI has relatively low accuracy. Some of the gait abnormalities evident from quantitative gait analysis were not detected by observational gait analysis. (C) 2008 Elsevier B.V. All rights reserved.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic 3121, Australia; [Williams, Gavin; McCrory, Paul] Univ Melbourne, Sch Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia; [Schache, Anthony] Univ Melbourne, Sch Mech Engn, Melbourne, Vic 3010, Australia	Williams, G (corresponding author), Epworth Med Fdn, 89 Bridge Rd, Melbourne, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016; McCrory, Paul/Q-8688-2019	Schache, Anthony G/0000-0002-1041-5213; Morris, Meg/0000-0002-0114-4175; McCrory, Paul/0000-0003-4850-0568; Williams, Gavin/0000-0003-2758-7473			BOENIG DD, 1977, PHYS THER, V57, P795; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Cappello A, 2005, IEEE T BIO-MED ENG, V52, P992, DOI 10.1109/TBME.2005.846728; Chang FM, 2006, J PEDIATR ORTHOPED, V26, P612, DOI 10.1097/01.bpo.0000229970.55694.5c; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Chua KSG, 2000, ARCH PHYS MED REHAB, V81, P1432, DOI 10.1053/apmr.2000.9395; Chua KSG, 2001, BRAIN INJURY, V15, P733, DOI 10.1080/02699050010009775; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; de Morais MC, 2008, GAIT POSTURE, V28, P316, DOI 10.1016/j.gaitpost.2008.01.013; EASTLACK ME, 1991, PHYS THER, V71, P465, DOI 10.1093/ptj/71.6.465; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Kawamura CM, 2007, GAIT POSTURE, V25, P18, DOI 10.1016/j.gaitpost.2005.12.005; Keenan AM, 1996, ARCH PHYS MED REHAB, V77, P651, DOI 10.1016/S0003-9993(96)90003-9; KOMAN LA, 1994, J PEDIATR ORTHOPED, V14, P299, DOI 10.1097/01241398-199405000-00005; KREBS DE, 1985, PHYS THER, V65, P1027, DOI 10.1093/ptj/65.7.1027; LEE EH, 1992, ARCH PHYS MED REHAB, V73, P642; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Lord SE, 1998, CLIN REHABIL, V12, P107, DOI 10.1191/026921598666182531; Mackey AH, 2003, DEV MED CHILD NEUROL, V45, P4, DOI 10.1017/S0012162203000021; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McGinley JL, 2003, PHYS THER, V83, P146, DOI 10.1093/ptj/83.2.146; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; OCONNOR P, 2002, HOSP DUE TRAUMATIC B; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Read HS, 1999, GAIT POSTURE, V10, P63; Riley PO, 2001, J BIOMECH, V34, P197, DOI 10.1016/S0021-9290(00)00174-3; ROBINSON JL, 1981, PHYS THER, V61, P351, DOI 10.1093/ptj/61.3.351; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Toro B, 2003, ARCH PHYS MED REHAB, V84, P1878, DOI 10.1016/S0003-9993(03)00482-9; Turani N, 2004, SCAND J CARING SCI, V18, P103, DOI 10.1111/j.1471-6712.2004.00262.x	33	30	30	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362			GAIT POSTURE	Gait Posture	APR	2009	29	3					454	459		10.1016/j.gaitpost.2008.11.005			6	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	423AR	WOS:000264469300018	19109020				2021-06-18	
J	Bevers, MB; Lawrence, E; Maronski, M; Starr, N; Amesquita, M; Neumar, RW				Bevers, Matthew B.; Lawrence, Eric; Maronski, Margaret; Starr, Neasa; Amesquita, Michael; Neumar, Robert W.			Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity	JOURNAL OF NEUROCHEMISTRY			English	Article						calpain; neuron; excitotoxicity; RNA interference; NMDA; adeno-associated virus	APOPTOSIS-INDUCING FACTOR; CYCLIN-DEPENDENT KINASE-5; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; CELL-DEATH; VULNERABLE NEURONS; GLOBAL-ISCHEMIA; AXONAL INJURY; RAT-BRAIN; INHIBITOR	The calpain family of cysteine proteases has a well-established causal role in neuronal cell death following acute brain injury. However, the relative contribution of calpain isoforms to the various forms of injury has not been determined as available calpain inhibitors are not isoform-specific. In this study, we evaluated the relative role of m-calpain and mu-calpain in a primary hippocampal neuron model of NMDA-mediated excitotoxicity. Baseline mRNA expression for the catalytic subunit of m-calpain (capn2 ) was found to be 50-fold higher than for the mu-calpain catalytic subunit (capn1) based on quantitative real-time PCR. Adeno-associated viral vectors designed to deliver short hairpin RNAs targeting capn1 or capn2 resulted in 60% and 90% knockdown of message respectively. Knockdown of capn2 but not capn1 increased neuronal survival after NMDA exposure at 21 days in vitro. Nuclear translocation of calpain substrates apoptosis inducing factor, p35/p25 and collapsin response mediator protein (CRMP) 2-4 was not detected after NMDA exposure in this model. However, nuclear translocation of CRMP-1 was observed and was prevented by capn2 knockdown. These findings provide insight into potential mechanisms of calpain-mediated neurodegeneration and have important implications for the development of isoform-specific calpain inhibitor therapy.	[Bevers, Matthew B.; Lawrence, Eric; Starr, Neasa; Amesquita, Michael; Neumar, Robert W.] Univ Penn, Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Maronski, Margaret] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	Neumar, RW (corresponding author), Univ Penn, Sch Med, Dept Emergency Med, Ground Floor,Ravdin Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	neumarr@uphs.upenn.edu			National Institutes of HeathUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS039481, P30-DK-047757-14]; American Heart AssociationAmerican Heart Association [0615345U]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK047757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039481] Funding Source: NIH RePORTER	This work was supported by National Institutes of Heath Grant NS039481 (RWN) and American Heart Association Grant 0615345U (MBB). All AAV vectors used in this study were generated by the University of Pennsylvania Vector Core. Vector production was supported by National Institutes of Health Grant P30-DK-047757-14. We would like to thank Dr. Robert Siman for the gift of antibody against calpain-cleaved spectrin, Dr. Virginia Lee for the gift of antibody against MAP2, Dr. Joachim Kappler for the gift of antibodies against CRMP-1, -2, -3, and -4, and Dr. Julie Blendy for the expertise and equipment required for real-time PCR assays.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; Bartus RT, 1998, BRAIN RES, V790, P1, DOI 10.1016/S0006-8993(97)01414-5; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; BARTUS RT, 1995, J CEREBR BLOOD F MET, V15, P969, DOI 10.1038/jcbfm.1995.123; BEDNARSKI E, 1995, BRAIN RES, V694, P147, DOI 10.1016/0006-8993(95)00851-G; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; BRORSON JR, 1995, STROKE, V26, P1259, DOI 10.1161/01.STR.26.7.1259; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Cao GD, 2003, J CEREBR BLOOD F MET, V23, P1137, DOI 10.1097/01.WCB.0000087090.01171.E7; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Cummings DD, 1996, J NEUROSCI, V16, P5312; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grammer M, 2005, NEUROBIOL LEARN MEM, V84, P222, DOI 10.1016/j.nlm.2005.07.007; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Honda S, 2004, J BIOL CHEM, V279, P10615, DOI 10.1074/jbc.M308841200; HONG SC, 1994, BRAIN RES, V661, P43, DOI 10.1016/0006-8993(94)91178-9; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Kawamura M, 2005, BRAIN RES, V1037, P59, DOI 10.1016/j.brainres.2004.12.050; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; Li PA, 1998, NEUROSCI LETT, V247, P17, DOI 10.1016/S0304-3940(98)00266-3; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Marcilhac A, 2006, INT J BIOCHEM CELL B, V38, P2128, DOI 10.1016/j.biocel.2006.06.005; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Neumar RW, 1996, J NEUROCHEM, V66, P421; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; TAKANO E, 1999, CALPAIN PHARM TOXICO, P25; Waghray A, 2004, BIOCHEM BIOPH RES CO, V324, P46, DOI 10.1016/j.bbrc.2004.09.012; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yokota M, 1999, BRAIN RES, V819, P8, DOI 10.1016/S0006-8993(98)01334-1; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	57	30	30	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2009	108	5					1237	1250		10.1111/j.1471-4159.2008.05860.x			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	402WW	WOS:000263044800014	19141074	Green Accepted			2021-06-18	
J	Obrenovitch, TP; Chen, SB; Farkas, E				Obrenovitch, Tihomir P.; Chen, Shangbin; Farkas, Eszter			Simultaneous, live imaging of cortical spreading depression and associated cerebral blood flow changes, by combining voltage-sensitive dye and laser speckle contrast methods	NEUROIMAGE			English	Article							ISCHEMIC NEUROLOGICAL DEFICITS; PERIINFARCT DEPOLARIZATIONS; SUBARACHNOID HEMORRHAGE; LOCAL CHANGES; RAT CORTEX; BRAIN; SIGNAL; OXYGENATION; HEMOGLOBIN; ACTIVATION	Cortical spreading depression (i.e. waves of cellular depolarization, CSD) causes the aura symptoms in classical migraine, and may contribute to delayed cellular damage after an ischemic or traumatic insult to the brain. In the latter cases, secondary neuronal injury may be worsened by some of the cerebral blood flow (CBF) changes that are associated with CSD. Here, we describe a new method for the simultaneous, live imaging of local cellular depolarization and CBF changes (i.e. two variables with well-defined and important biological significance), through a closed cranial window prepared in anesthetized rats. This novel experimental strategy was validated by imaging the changes associated with CSD elicited by application of high K(+) medium on the cortical surface. CSD was visualized directly by using a fluorescent voltage-sensitive (VS) dye, whereas laser speckle contrast (LSC) imaging allowed the visualization of the corresponding CBF changes. In addition to the high temporal and spatial resolution of VS dye and LSC imaging, their novel combination allows to determine how CBF changes relate to a heterogeneous and evolving pattern of cellular depolarization, in any area of interest of the cortical region under study. This methodological development is especially pertinent and timely for investigations into the peri-lesion depolarizations that occur in models of focal brain injury, situations where their site of spontaneous elicitation and propagation pattern cannot be predicted. It should also help advance our knowledge in epilepsy, CBF pharmacology, and neurovascular coupling under normal and pathophysiological conditions. (C) 2008 Elsevier Inc. All rights reserved.	[Obrenovitch, Tihomir P.; Farkas, Eszter] Univ Bradford, Sch Life Sci, Div Pharmacol, Bradford BD7 1DP, W Yorkshire, England; [Chen, Shangbin] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Farkas, Eszter] Univ Szeged, Sch Med, Dept Physiol, Szeged, Hungary	Obrenovitch, TP (corresponding author), Univ Bradford, Sch Life Sci, Div Pharmacol, Bradford BD7 1DP, W Yorkshire, England.	t.obrenovitch@bradford.ac.uk		Farkas, Eszter/0000-0002-8478-9664	Wellcome TrustWellcome TrustEuropean Commission [079430/A/06/Z]; Royal SocietyRoyal Society of LondonEuropean Commission [2007/R3]	This study was supported by grants from the Wellcome Trust (079430/A/06/Z) and The Royal Society (International Incoming Short Visits, 2007/R3). This work would not have been possible without the contribution from D. Brown, G. Pearson and A. Kershaw (Workshop, Bradford School of Life Sciences).	Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Briers JD, 2007, OPT APPL, V37, P139; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Chen G, 1999, J NEUROPHYSIOL, V81, P1992; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; Cheng HY, 2003, J BIOMED OPT, V8, P559, DOI 10.1117/1.1578089; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978; Dreier JP, 2004, NEUROCRIT CARE, V1, P85, DOI 10.1385/NCC:1:1:85; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Gold L, 1998, BRAIN RES, V783, P188, DOI 10.1016/S0006-8993(97)01341-3; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Jou MJ, 2004, ANN NY ACAD SCI, V1011, P45, DOI 10.1196/annals.1293.005; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2003, J NEUROSCI, V23, P3972; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Li PC, 2006, OPT LETT, V31, P1824, DOI 10.1364/OL.31.001824; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Nielsen AN, 2000, J VASC RES, V37, P513, DOI 10.1159/000054084; Obrenovitch T.P., 2004, PHARM CEREBRAL ISCHE, P157; Paul JS, 2006, NEUROIMAGE, V29, P38, DOI 10.1016/j.neuroimage.2005.07.019; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; RICHTER F, 1993, NEUROSCI LETT, V152, P65, DOI 10.1016/0304-3940(93)90484-3; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Strong AJ, 2006, J CEREBR BLOOD F MET, V26, P645, DOI 10.1038/sj.jcbfm.9600240; Wang Z, 2007, NEUROSCI LETT, V424, P133, DOI 10.1016/j.neulet.2007.07.027	41	30	34	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	MAR	2009	45	1					68	74		10.1016/j.neuroimage.2008.11.025			7	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	414KR	WOS:000263862900009	19100842				2021-06-18	
J	Strangman, GE; Goldstein, R; O'Neil-Pirozzi, TM; Kelkar, K; Supelana, C; Burke, D; Katz, DI; Rauch, SL; Savage, CR; Glenn, MB				Strangman, Gary E.; Goldstein, Richard; O'Neil-Pirozzi, Therese M.; Kelkar, Kalika; Supelana, Christina; Burke, David; Katz, Douglas I.; Rauch, Scott L.; Savage, Cary R.; Glenn, Mel B.			Neurophysiological Alterations During Strategy-Based Verbal Learning in Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						Cognitive rehabilitation; Functional neuroimaging; Behavioral neurology; Semantic clustering; Brain trauma	POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY; COGNITIVE REHABILITATION; SIGNIFICANT ACTIVATION; CORTEX CONTRIBUTES; PREFRONTAL CORTEX; FUNCTIONAL MRI; FREE-RECALL; AGE; DAMAGE	Background. Verbal learning and strategic processing deficits are common sequelae of traumatic brain injury (TBI); however, the neurophysiological mechanisms underlying such deficits remain poorly understood. Methods. We performed functional magnetic resonance imaging (fMRI) in 25 individuals with chronic TBI (> 1 year after injury) and 20 matched healthy controls. Subjects were scanned while encoding word lists, with free recall and recognition assessed after each scanning run. To vary the strategic processing load, participants learned semantically unrelated words (Unrelated condition), semantically related words under null instruction conditions (Spontaneous condition), and semantically related words following training on the use of a semantic clustering strategy (Directed condition). Results. Behavioral performance on recall, recognition, and semantic clustering improved significantly as follows: Unrelated < Spontaneous < Directed. Individuals with TBI exhibited impaired yet parallel behavioral performance relative to control participants. The fMRI measures of brain activity during verbal encoding revealed decreased activity in participants with TBI relative to controls in left dorsolateral prefrontal cortex (DLPFC; BA 9) and in a region spanning the left angular and supramarginal gyri (BA 39/40). Functional connectivity analysis revealed evidence of a functional-but not anatomical-breakdown in the connectivity between the DLPFC and other regions specifically when participants with TBI were directed to use the semantic encoding strategy. Conclusion. After TBI, the DLPFC appears to be decoupled from other active brain regions specifically when strategic control is required. We hypothesize that approaches designed to help re-couple DLPFC under such conditions may aid TBI cognitive rehabilitation.	[Strangman, Gary E.; Supelana, Christina] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Strangman, Gary E.; Goldstein, Richard; O'Neil-Pirozzi, Therese M.; Kelkar, Kalika; Glenn, Mel B.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Burke, David] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Rauch, Scott L.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA	Strangman, GE (corresponding author), Neural Syst Grp, 149 13th St Psychiat Room 2651, Charlestown, MA 02129 USA.	strang@nmr.mgh.harvard.edu	Oliver, Gretchen/L-7780-2019	Strangman, Gary/0000-0001-8896-2164; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation; US Department of EducationUS Department of Education [NIDRR: H133A020513]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS: K25-NS046554]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS046554] Funding Source: NIH RePORTER	We thank Dana Christina, the Statewide Head Injury Program, and Community Rehabilitation Care for their help and support. Funding for this project came from the National Institute on Disability and Rehabilitation, US Department of Education (NIDRR: H133A020513), and the NIH (NINDS: K25-NS046554).	Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 1997, J NEUROSCI, V17, P391; *CDCP, 2003, MMWR-MORBID MORTAL W, V56, P167; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DELUCA J, 2004, COMPREHENSIVE HDB PS, P217; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; GRADY CL, 1992, J COGNITIVE NEUROSCI, V4, P23, DOI 10.1162/jocn.1992.4.1.23; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; HICKS LH, 1970, PSYCHOL BULL, V74, P377, DOI 10.1037/h0033064; Jonides J., 1995, INVITATION COGNITIVE, V3, P215; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marchini JL, 2000, NEUROIMAGE, V12, P366, DOI 10.1006/nimg.2000.0628; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Miotto EC, 2006, HUM BRAIN MAPP, V27, P288, DOI 10.1002/hbm.20184; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; TULVING E, 1962, PSYCHOL REV, V69, P344, DOI 10.1037/h0043150; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; WILSON J T L, 1990, Brain Injury, V4, P349	44	30	30	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAR	2009	23	3					226	236		10.1177/1545968308324225			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	410NF	WOS:000263583700005	19047359				2021-06-18	
J	Chen, X; Zhang, KL; Yang, SY; Dong, JF; Zhang, JN				Chen, Xin; Zhang, Ke-Li; Yang, Shu-Yuan; Dong, Jing-Fei; Zhang, Jian-Ning			Glucocorticoids Aggravate Retrograde Memory Deficiency Associated with Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; glucocorticoid; retrograde memory deficiency; traumatic brain injury	APOPTOTIC CELL-DEATH; HEAD-INJURY; BASOLATERAL AMYGDALA; DNA FRAGMENTATION; SPATIAL MEMORY; WATER-MAZE; RETRIEVAL; HIPPOCAMPUS; ISCHEMIA; IMPAIRMENT	Administration of glucocorticoid to patients with head injury has previously been demonstrated to impair memory. We hypothesize that glucocorticoids promote post-traumatic hippocampal apoptosis, resulting in retrograde memory deficiency associated with traumatic brain injury (TBI). In the present study, we tested this hypothesis by measuring spatial memory deficiency in rats subjected to fluid percussion injury (FPI) and receiving dexamethasone (DXM at 0.5-10 mg/kg) or methylprednisolone (MP at 5-30 mg/kg); we also examined neuronal apoptosis in hippocampus. Adult male Wistar rats were trained for the acquisition of spatial memory, then subjected to FPI and tested for spatial reference memory on post-injury days 7 and 14 using the Morris Water Maze. Brain tissue from injured rats was examined 24 h to 2 weeks after injury. The percent time in the goal quadrant, which measures spatial reference memory, was significantly lower in injured rats receiving either high-dose DXM or MP than in control groups. TUNEL-positive cells in hippocampus were first detected 24 h post-injury, plateauing at 48 h. The number of TUNEL-positive cells was significantly higher in injured rats treated with either DXM or MP. The data suggest that glucocorticoid therapy for TBI may increase neuronal apoptosis in hippocampus and, as a result, aggravate retrograde memory deficits induced by TBI.	[Chen, Xin; Yang, Shu-Yuan; Zhang, Jian-Ning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Dong, Jing-Fei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; [Zhang, Ke-Li] Tianjin Baodi Hosp, Dept Neurosurg, Tianjin, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National 973 Projects of ChinaNational Basic Research Program of China [2005CB522605]; Tianjin Science and Techonology Development Plan [05YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]	We acknowledge Li Liu, Lanlan Luo, Weiyun Cui, Fanglian Chen, and Lei Zhou for excellent technical support. This work is supported by the National 973 Projects of China (grant 2005CB522605), Tianjin Science and Techonology Development Plan (grant 05YFGDSF02500), and Tianjin Natural Science Foundation (grant 033611511).	ALLEN TC, 1992, ARMED FORCES I PATHO, P53; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; NITATORI T, 1995, J NEUROSCI, V15, P1001; Okuda S, 2004, P NATL ACAD SCI USA, V101, P853, DOI 10.1073/pnas.0307803100; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; RINK A, 1995, AM J PATHOL, V147, P1575; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5181; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Woodson JC, 2003, LEARN MEMORY, V10, P326, DOI 10.1101/lm.62903; Wyllie A H, 1980, Int Rev Cytol, V68, P251	30	30	36	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					253	260		10.1089/neu.2007.0504			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100008	19236166				2021-06-18	
J	Elsworth, C; Dawes, H; Winward, C; Howells, K; Dennis, A; Sackley, C; Wade, D				Elsworth, Charlotte; Dawes, Helen; Winward, Charlotte; Howells, Ken; Dennis, Andrea; Sackley, Catherine; Wade, Derick			Pedometer step counts in individuals with neurological conditions	CLINICAL REHABILITATION			English	Article							ASSESSING PHYSICAL-ACTIVITY; ELECTRONIC PEDOMETERS; ACCURACY; VALIDITY; DISTANCE; WALKING; UTILITY; HEALTH	Objective: To examine the accuracy of measuring step counts using a pedometer in participants with neurological conditions and healthy volunteers in relation to a manual step count tally. Setting: Oxford Centre for Enablement, Nuffield Orthopaedic Centre NHS Trust, Oxford, UK. Subjects: Healthy adults (n = 13, age: mean 29, SD = 12) and adults with neurological conditions (n=20 stroke, n=16 multiple sclerosis, n=5 muscular dystrophy, n=1 spinal cord injury, n = 1 traumatic brain injury; age: mean 54, SD = 13), Main measures Individuals walked for 2 minutes at self-selected walking speeds (SSWS) wearing a pedometer. Healthy individuals were then asked to walk at slow walking speeds (SWS). Step counts were recorded manually and using a pedometer. Results: In healthy individuals there was no difference between manually measured and pedometer counts during walking (P>0.05). In adults with neurological conditions the pedometers undercounted (P=0.003); bias (random error): 27 (111); percentage variability 30% and intraclass correlation coefficient (ICC) 0.66. In neurological adults, from regression analysis the relationship between error and walking speed was cubic, with walking speed accounting for 29% of pedometer error. Healthy individuals showed greater variability and undercounting at SWS bias (random error): 10 (31), percentage variability 8% and ICC 0.73, compared with SSWS bias (random error): -3 (13), percentage variability 3% and ICC 0.84. Conclusions: Pedometers may undercount when used for people with neurological conditions. There may be variability in pedometer accuracy but this was not strongly related to walking speed. The suitability of pedometer use for exercise monitoring should be individually determined.	[Dawes, Helen] Oxford Brookes Univ, Movement Sci Grp, Sch Life Sci, Oxford OX3 0BP, England; [Elsworth, Charlotte; Sackley, Catherine] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Dawes, Helen] Univ Oxford, Oxford OX1 2JD, England	Dawes, H (corresponding author), Oxford Brookes Univ, Movement Sci Grp, Sch Life Sci, Oxford OX3 0BP, England.	celsworth@brookes.ac.uk	Winward, Charlie/AAE-6219-2021	Wade, Derick/0000-0002-1188-8442; sackley, catherine/0000-0002-8580-6622; Dawes, Helen/0000-0002-2933-5213; , Johnny/0000-0003-4138-2589	University of Birmingham	Funding for this study was provided by University of Birmingham.	Bassett DR, 1996, MED SCI SPORT EXER, V28, P1071, DOI 10.1097/00005768-199608000-00019; Beets MW, 2005, MED SCI SPORT EXER, V37, P513, DOI 10.1249/01.MSS.0000155395.49960.31; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Busse ME, 2004, J NEUROL NEUROSUR PS, V75, P884, DOI 10.1136/jnnp.2003.020180; Collen F M, 1991, Int Disabil Stud, V13, P50; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Cyarto EV, 2004, MED SCI SPORT EXER, V36, P205, DOI 10.1249/01.MSS.0000113476.62469.98; Le Masurier GC, 2003, RES Q EXERCISE SPORT, V74, P389, DOI 10.1080/02701367.2003.10609109; Macko RF, 2002, MED SCI SPORT EXER, V34, P394, DOI 10.1097/00005768-200203000-00002; Melanson EL, 2004, PREV MED, V39, P361, DOI 10.1016/j.ypmed.2004.01.032; Motl RW, 2005, MULT SCLER, V11, P343, DOI 10.1191/1352458505ms1161oa; Pearson OR, 2004, QJM-INT J MED, V97, P463, DOI 10.1093/qjmed/hch084; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Speck BJ, 2006, PUBLIC HEALTH NURS, V23, P88, DOI 10.1111/j.0737-1209.2006.230112.x; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2004, SPORTS MED, V34, P281, DOI 10.2165/00007256-200434050-00001; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; TUDORLOCKE C, 2002, PRESIDENTS COUNCIL P, V3, P1; Wade DT, 1992, MEASUREMENT NEUROLOG	19	30	30	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2009	23	2					171	175		10.1177/0269215508098895			5	Rehabilitation	Rehabilitation	407VT	WOS:000263393100009	19164404				2021-06-18	
J	Silasi, G; MacLellan, CL; Colbourne, F				Silasi, Gergely; MacLellan, Crystal L.; Colbourne, Frederick			Use of Telemetry Blood Pressure Transmitters to Measure Intracranial Pressure (ICP) in Freely Moving Rats	CURRENT NEUROVASCULAR RESEARCH			English	Article						Telemetry; blood pressure sensor; rodent; stroke; ischemia	CEREBRAL-ARTERY OCCLUSION; SUBARACHNOID HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; BRAIN TEMPERATURE; INJURY; HYPOTHERMIA; AWAKE; ISCHEMIA; RODENTS; MODEL	Stroke and traumatic brain injuries often lead to cerebral edema and persistent elevations in intracranial pressure (ICP) that can be life threatening. Thus, rodent models would benefit from a simple and reliable method to measure ICP in awake, mobile animals. Up to now most techniques have been limited to anesthetized or immobile animals, which is not practical for following the prolonged elevations in ICP that follow stroke and traumatic brain injury. With an initial set of data, we describe a simple method that uses blood pressure telemetry sensors, which are commercially available (Data Sciences Int.) to measure ICP in freely moving rats for several days following implantation. Basically, an epidural cannula is secured to the skull and connected to the catheter of the telemetry probe, which is then secured inside a protective plastic shield on the skull. We confirm the sensitivity of our measurements by experimentally modifying ICP by either the Valsalva maneuver (abdominal compression) or a large ischemic brain injury. The Valsalva maneuver caused a small brief spike in ICP (lasting about 2-3 sec), whereas a transient middle cerebral artery occlusion substantially increased ICP (up to 50 mmHg) for approximately 3 days post-surgery. In summary, the current method allows for ICP to be continuously monitored in rats for several days, and thus is suitable for studies investigating mechanisms of raised ICP and in testing experimental treatments that mitigate it.	[Silasi, Gergely; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB T6G 2E9, Canada; [Silasi, Gergely; Colbourne, Frederick] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2E9, Canada; [MacLellan, Crystal L.] Mem Univ Newfoundland, Div Biomed Sci, St John, NF, Canada	Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, P217 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082; Silasi, Gergely/0000-0003-1036-1304	Alberta Heritage Foundation for Medical Research (AHFMR)Alberta Heritage Foundation for Medical Research; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Canadian Stroke Network; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Astra-ZenecaAstraZeneca	Dr. Colbourne is supported by an Alberta Heritage Foundation for Medical Research ( AHFMR) senior medical scholar award. G. Silasi is supported by a Focus on Stroke doctoral research award from the Heart and Stroke Foundation of Canada, the Canadian Stroke Network, the Canadian Institutes of Health Research ( CIHR), and Astra-Zeneca. C. MacLellan is supported by a CIHR postdoctoral fellowship. Research supported by CIHR through a grant awarded to FC. The authors are also grateful to Cassandra Packham for the excellent technical assistance.	ANDREWS B T, 1988, Neurological Research, V10, P123; BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; Chu XF, 2008, J NEUROSCI METH, V168, P1, DOI 10.1016/j.jneumeth.2007.08.030; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; Colbourne F, 1996, J NEUROSCI METH, V67, P185; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; Eide PK, 2007, ACTA ANAESTH SCAND, V51, P501, DOI 10.1111/j.1399-6576.2007.01269.x; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; GARCIA JH, 1993, AM J PATHOL, V142, P623; Jallo J, 1997, J NEUROSCI METH, V75, P155, DOI 10.1016/S0165-0270(97)00064-2; Kolb B, 1997, BRAIN RES, V751, P289, DOI 10.1016/S0006-8993(96)01410-2; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; LEVINGER IM, 1971, J ANAT, V108, P447; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacLellan CL, 2006, STROKE, V37, P1266, DOI 10.1161/01.STR.0000217268.81963.78; MALKINSON TJ, 1985, BRAIN RES BULL, V15, P321, DOI 10.1016/0361-9230(85)90158-3; Morgalla MH, 2002, ACTA NEUROCHIR, V144, P57, DOI 10.1007/s701-002-8274-2; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Sehba FA, 2007, J NEUROSURG, V106, P321, DOI 10.3171/jns.2007.106.2.321; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Walberer M, 2008, J NEUROSURG, V109, P287, DOI 10.3171/JNS/2008/109/8/0287	22	30	30	1	11	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	FEB	2009	6	1					62	69		10.2174/156720209787466046			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	415SH	WOS:000263954500007	19355927				2021-06-18	
J	Byeon, HK; Lim, YC; Koo, BS; Choi, EC				Byeon, Hyung Kwon; Lim, Young Chang; Koo, Bon Seok; Choi, Eun Chang			Metastasis to the submandibular gland in oral cavity squamous cell carcinomas: Pathologic analysis	ACTA OTO-LARYNGOLOGICA			English	Article						Submandibular gland; metastasis; oral cavity; squamous cell carcinoma	SUBMAXILLARY-GLAND; NECK-CANCER; RADIATION; XEROSTOMIA; HEAD	Conclusion. This study demonstrates that the incidence of submandibular gland metastasis in oral cavity squamous cell carcinoma (SCC) is extremely rare and its involvement is through direct extension from a primary lesion. Therefore, if the primary lesion of the oral cavity carcinoma is not in close proximity and hence does not provide suspicion of direct extension, it may be safe to preserve the submandibular gland. Objectives. Radiotherapy may lead to injury to the salivary glands resulting in xerostomia. This study aimed to determine whether and how the submandibular gland is involved in metastases of SCC of the oral cavity and to provide an oncological basis for preservation of the submandibular gland. Patients and methods. This study reviewed the records and pathologic specimens of 201 patients who were diagnosed as having oral cavity SCC and underwent surgery at our institution, from 1991 to 2006, and pathologic metastasis to submandibular gland was evaluated. Results. In all, 44 cases (21.9%) were found to show ipsilateral level I metastasis on pathologic examination. Only two cases (1%) had carcinoma involvement in the submandibular gland. Both these two cases had direct extension from a primary lesion (retromolar trigone and floor of mouth) and no submandibular glands showed pathologic evidence of isolated metastasis or local extension of metastatic lymph nodes.	[Byeon, Hyung Kwon; Choi, Eun Chang] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Lim, Young Chang] Konkuk Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Koo, Bon Seok] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Taejon, South Korea	Choi, EC (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, 134 Shinchon Dong, Seoul 120752, South Korea.	eunchangmd@yumc.yonsei.ac.kr		Koo, Bon Seok/0000-0002-5928-0006			ABRAMSON AL, 1971, LARYNGOSCOPE, V81, P793, DOI 10.1288/00005537-197105000-00021; *AJCC, 2002, CANC STAG MAN; Bourdin S, 1982, Ann Otolaryngol Chir Cervicofac, V99, P265; DiNardo LJ, 1998, LARYNGOSCOPE, V108, P206, DOI 10.1097/00005537-199802000-00009; Eisbruch A, 2003, WORLD J SURG, V27, P832, DOI 10.1007/s00268-003-7105-6; Evans R W, 1970, Major Probl Pathol, V1, P1; GRAGE TB, 1962, SURGERY, V52, P284; Hughes PJ, 2000, HEAD NECK-J SCI SPEC, V22, P393, DOI 10.1002/1097-0347(200007)22:4<393::AID-HED13>3.0.CO;2-2; Jha N, 2000, INT J RADIAT ONCOL, V46, P7, DOI 10.1016/S0360-3016(99)00460-5; Junquera L, 2000, Minerva Stomatol, V49, P521; Kies MS, 2001, J CLIN ONCOL, V19, P1961, DOI 10.1200/JCO.2001.19.7.1961; Moudouni SM, 2006, INT J UROL, V13, P431, DOI 10.1111/j.1442-2042.2006.01318.x; RamirezAmador V, 1997, ORAL SURG ORAL MED O, V84, P149, DOI 10.1016/S1079-2104(97)90061-5; ROSTI G, 1987, TUMORI, V73, P413; Sanchez AJ Burgos, 2002, ACTA OTORRINOLARINGO, V53, P67; Seikaly H, 2004, ARCH OTOLARYNGOL, V130, P956, DOI 10.1001/archotol.130.8.956; SOLOMON MP, 1975, ORAL SURG ORAL MED O, V39, P469, DOI 10.1016/0030-4220(75)90092-4; Spiegel JH, 2001, ARCH OTOLARYNGOL, V127, P991, DOI 10.1001/archotol.127.8.991; SPIEGEL JH, 2004, HEAD NECK-J SCI SPEC, V12, P1064; VESSECCHIA G, 1995, VIRCHOWS ARCH, V427, P349, DOI 10.1007/BF00203404	20	30	30	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.		2009	129	1					96	100	PII 793945927	10.1080/00016480802032801			5	Otorhinolaryngology	Otorhinolaryngology	385XU	WOS:000261847700015	18607927				2021-06-18	
J	Greve, KW; Binder, LM; Bianchini, KJ				Greve, Kevin W.; Binder, Laurence M.; Bianchini, Kevin J.			[image omitted] Rates of Below-Chance Performance in Forced-Choice Symptom Validity Tests	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; Symptom validity test; Below chance	TRAUMATIC BRAIN-INJURY; CLASSIFICATION ACCURACY; HEAD-INJURY	The rates of significantly below-chance results on three neuropsychological symptom validity tests (SVTs) including the Portland Digit Recognition Test (PDRT), Test of Memory Malingering (TOMM), and Word Memory Test (WMT) were compared in a private practice forensic sample of 1032 examinees with alleged mild traumatic brain injury, moderate to severe traumatic brain injury, alleged toxic exposure, and reported chronic pain. The PDRT and WMT were equivalent to one another in the rates of below-chance results, with both yielding more frequent below-chance results than the TOMM. Seemingly more difficult sections of the PDRT and WMT had higher yields than seemingly easier sections. Multiple SVTs were more likely to yield below-chance results than a single test, supporting the use of multiple SVTs in forensic neuropsychological evaluations.	[Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA; [Binder, Laurence M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2002, DIAGN STAT MAN MENT, V4th; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P141; Bland M., 2000, INTRO MED STAT; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; FRANZEN MD, 1998, CLIN NEUROPSYCHOLOGY, P102; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Green P., 2003, GREENS WORD MEMORY T; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, NEUROTOXICOLOGY, V27, P940, DOI 10.1016/j.neuro.2006.06.009; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; ORD J, 2007, 35 ANN M INT NEUR SO; Reynolds CR, 1998, CRIT ISS NE, P261; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Tombaugh TN, 1996, TEST MEMORY MALINGER; Trueblood W, 1997, ARCH CLIN NEUROPSYCH, V12, P13, DOI 10.1016/S0887-6177(96)00027-3; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	33	30	30	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	3					534	544	PII 908739028	10.1080/13854040802232690			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	423QH	WOS:000264510300011	19221937				2021-06-18	
J	Gunning, M; O'Loughlin, E; Fletcher, M; Crilly, J; Hooper, M; Ellis, DY				Gunning, M.; O'Loughlin, E.; Fletcher, M.; Crilly, J.; Hooper, M.; Ellis, D. Y.			Emergency intubation: a prospective multicentre descriptive audit in an Australian helicopter emergency medical service	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INDUCTION; HOSPITAL ENDOTRACHEAL INTUBATION; MANAGEMENT; ANESTHESIA; AIRWAY; IMPACT; SCORE	Objective: To describe the safety profile of emergency airway management when performed by a prehospital team consisting of a doctor and a paramedic. Success rates, the incidence of difficult airways and the ability of prehospital doctors to determine a difficult airway are reported. Methods: A prospective audit and descriptive study of three Australian helicopter emergency medical service (HEMS) bases, over a 9-month period. Doctors completed questionnaires regarding the number of endotracheal intubation (ETI) attempts on patients transported intubated and ventilated, Cormack and Lehane view of the cords during laryngoscopy and the anticipated and actual ease of ETI. Results: A total of 114 (11.4%) patients transported by the HEMS was intubated and ventilated. Study questionnaires were completed on 89 of the 114 cases (78.1%), of which 32 (36%) were trauma related. HEMS were involved with 43 (48.3%) of the 89 intubations and performed 12.4% (n = 11) out of hospital. The HEMS ETI success rate was 97.6%. No surgical airways were performed. The actual incidence of difficult airways was higher (n = 4, 9.3%) than the anticipated incidence (n = 1, 2.3%). Six patients (14.0%) were successfully intubated by the doctor after the paramedic failed. Conclusions: Well-trained doctor paramedic teams, utilising standardised operating procedures, can safely perform rapid sequence induction and ETI in the prehospital and emergency environment. However, prehospital doctors are not always able to anticipate a difficult airway. The complication rate was similar to that in hospital emergency departments and to that of other physician-led HEMS.	[Gunning, M.; O'Loughlin, E.; Fletcher, M.; Hooper, M.; Ellis, D. Y.] CareFlight Med Serv, Brisbane, Qld 4000, Australia; [Crilly, J.] Gold Coast Hosp, So Area Hlth Serv, Emergency Dept Clin Network, Southport, Qld, Australia	Gunning, M (corresponding author), CareFlight Med Serv, Level 3,172 Edward St, Brisbane, Qld 4000, Australia.	MattGunning@rcsed.ac.uk		Crilly, Julia/0000-0002-1455-8983			Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; *AM COLL SURG COMM, 2005, ADV TRAUM LIF SUPP A; Bernard Stephen, 2002, Emerg Med (Fremantle), V14, P406, DOI 10.1046/j.1442-2026.2002.00382.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Chesnut RM, 1997, J TRAUMA, V42, pS19, DOI 10.1097/00005373-199705001-00004; Combes X, 2006, ACAD EMERG MED, V13, P828, DOI 10.1197/j.aem.2006.02.016; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis MJ, 2002, CHEM VAPOR DEPOS, V8, P7, DOI 10.1002/1521-3862(20020116)8:1<7::AID-CVDE7>3.0.CO;2-A; Ellis DY, 2007, EMERG MED J, V24, P139, DOI 10.1136/emj.2006.040428; Graham CA, 1997, J ACCID EMERG MED, V14, P219; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Lockey D, 2007, EMERG MED J, V24, P606, DOI 10.1136/emj.2007.047258; Mackay CA, 2001, EMERG MED J, V18, P20, DOI 10.1136/emj.18.1.20; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; POLIT D, 2004, ESSENTIALS NURSING R; SAKLES JC, 1998, ANN EMERG MED; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Swanson Eric R, 2005, Air Med J, V24, P40, DOI 10.1016/j.amj.2004.10.008; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; Timmermann A, 2007, ANAESTHESIST, V56, P328, DOI 10.1007/s00101-007-1153-5; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	25	30	30	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	JAN	2009	26	1					65	69		10.1136/emj.2008.059345			5	Emergency Medicine	Emergency Medicine	393SX	WOS:000262394300026	19104110				2021-06-18	
J	Holbein, M; Bechir, M; Ludwig, S; Sommerfeld, J; Cottini, SR; Keel, M; Stocker, R; Stover, JF				Holbein, Monika; Bechir, Markus; Ludwig, Silke; Sommerfeld, Jutta; Cottini, Silvia R.; Keel, Marius; Stocker, Reto; Stover, John F.			Differential influence of arterial blood glucose on cerebral metabolism following severe traumatic brain injury	CRITICAL CARE			English	Article							INTENSIVE INSULIN THERAPY; CORTICAL SPREADING DEPRESSION; PERIINFARCT DEPOLARIZATIONS; OXYGEN-METABOLISM; JUGULAR BULB; LACTATE/PYRUVATE RATIO; ENERGETIC IMPAIRMENT; LACTATE LEVELS; HEAD-INJURY; HYPERGLYCEMIA	Introduction Maintaining arterial blood glucose within tight limits is beneficial in critically ill patients. Upper and lower limits of detrimental blood glucose levels must be determined. Methods In 69 patients with severe traumatic brain injury (TBI), cerebral metabolism was monitored by assessing changes in arterial and jugular venous blood at normocarbia (partial arterial pressure of carbon dioxide (paCO(2)) 4.4 to 5.6 kPa), normoxia (partial arterial pressure of oxygen (paO(2)) 9 to 20 kPa), stable haematocrit (27 to 36%), brain temperature 35 to 38 C, and cerebral perfusion pressure (CPP) 70 to 90 mmHg. This resulted in a total of 43,896 values for glucose uptake, lactate release, oxygen extraction ratio (OER), carbon dioxide (CO2) and bicarbonate (HCO3) production, jugular venous oxygen saturation (SjvO(2)), oxygen-glucose index (OGI), lactate-glucose index (LGI) and lactate-oxygen index (LOI). Arterial blood glucose concentration-dependent influence was determined retrospectively by assessing changes in these parameters within pre-defined blood glucose clusters, ranging from less than 4 to more than 9 mmol/l. Results Arterial blood glucose significantly influenced signs of cerebral metabolism reflected by increased cerebral glucose uptake, decreased cerebral lactate production, reduced oxygen consumption, negative LGI and decreased cerebral CO2/HCO3 production at arterial blood glucose levels above 6 to 7 mmol/l compared with lower arterial blood glucose concentrations. At blood glucose levels more than 8 mmol/l signs of increased anaerobic glycolysis (OGI less than 6) supervened. Conclusions Maintaining arterial blood glucose levels between 6 and 8 mmol/l appears superior compared with lower and higher blood glucose concentrations in terms of stabilised cerebral metabolism. It appears that arterial blood glucose values below 6 and above 8 mmol/l should be avoided. Prospective analysis is required to determine the optimal arterial blood glucose target in patients suffering from severe TBI.	[Holbein, Monika; Keel, Marius] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland	Holbein, M (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	monika.holbein@access.unizh.ch; john.stover@access.unizh.ch			Swiss National Research Foundation (SNF)Swiss National Science Foundation (SNSF)	The help of the nursing staff in collecting clinical data is gratefully acknowledged. This study was supported in parts by a grant from the Swiss National Research Foundation (SNF) to JFS and the SUVA Fonds to JFS and RS.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Beards SC, 1998, ANAESTHESIA, V53, P627; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chieregato A, 2007, J NEUROSURG ANESTH, V19, P222, DOI 10.1097/ANA.0b013e31806589f6; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Gur RC, 2009, CEREB CORTEX, V19, P375, DOI 10.1093/cercor/bhn087; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hatazawa J, 1995, Ann Nucl Med, V9, P15; Hattori N, 2004, J NUCL MED, V45, P775; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Laitio RM, 2009, ANESTH ANALG, V108, P593, DOI 10.1213/ane.0b013e31818ffc9d; Leegsma-Vogt G, 2001, J NEUROSCI RES, V66, P795, DOI 10.1002/jnr.10046; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; McGoron Anthony J, 2008, BMC Med Imaging, V8, P4, DOI 10.1186/1471-2342-8-4; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; Moller K, 2002, ACTA ANAESTH SCAND, V46, P567, DOI 10.1034/j.1399-6576.2002.460515.x; Moritz S, 2008, J NEUROSURG ANESTH, V20, P8, DOI 10.1097/ANA.0b013e31814b1459; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; Oz G, 2007, AM J PHYSIOL-ENDOC M, V292, pE946, DOI 10.1152/ajpendo.00424.2006; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Shulman RG, 2001, NMR BIOMED, V14, P389, DOI 10.1002/nbm.741; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Strauss GI, 2003, LIVER TRANSPLANT, V9, P1244, DOI 10.1016/j.lts.2003.09.020; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	62	30	35	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2009	13	1							R13	10.1186/cc7711			12	Critical Care Medicine	General & Internal Medicine	421IC	WOS:000264351600013	19196488	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Jorgensen, M; Togher, L				Jorgensen, Mikaela; Togher, Leanne			Narrative after traumatic brain injury: A comparison of monologic and jointly-produced discourse	BRAIN INJURY			English	Article						Traumatic brain injury; communication; discourse; narrative; jointly-produced; participation; friends	CLOSED-HEAD-INJURY; COMMUNICATION PARTNERS; PEOPLE; CONVERSATION; INDIVIDUALS; VALIDATION; ABILITIES; CHILDREN; QUALITY; APHASIA	Primary objective: To investigate the effects of a familiar communication partner on the production of narrative after traumatic brain injury (TBI). Method: Ten participants with TBI were matched with 10 control participants for sex, age, and education. Participants independently retold a story from a picture sequence and also retold a video segment with a friend to a researcher. The resulting discourse was analyzed for productivity, cohesion, story grammar, informational content and exchange structure. Results: There was a significant difference between participants with and without TBI for all measures in the monologic narrative. In the jointly-produced narrative, there was no significant difference in performance and participation between individuals with TBI and control participants. Participants with TBI demonstrated a significant improvement between the monologic and the jointly-produced task in story grammar and informational content. Conclusions: The natural scaffolding provided by the friends of participants with TBI in a meaningful narrative task facilitated competent participation in and production of narrative. These findings indicate an avenue for training everyday communication partners in supporting narrative skills after TBI, and for the use of jointly-produced narrative as an additional assessment tool to create a holistic view of everyday skills.	[Jorgensen, Mikaela; Togher, Leanne] Univ Sydney, Speech Pathol, Fac Hlth Sci, Sydney, NSW, Australia; [Jorgensen, Mikaela; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Jorgensen, M (corresponding author), Univ Sydney, Fac Hlth Sci, 75 E St,POB 170, Lidcombe, NSW 2141, Australia.	mikaela.jorgensen@gmail.com	Jorgensen, Mikaela/A-2095-2016; Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748; Jorgensen, Mikaela/0000-0002-5490-0819			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Berry M., 1981, STUDIES DISCOURSE AN, P120; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Body R, 1998, BRAIN INJURY, V12, P963, DOI 10.1080/026990598122016; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Chapey R., 2001, LANGUAGE INTERVENTIO; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cherney L., 1993, CLIN APHASIOLOGY, V21, P123; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Eggins S., 1997, ANAL CASUAL CONVERSA; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; FERGUSON A, 1999, TEST LANGUAGE USE RE; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Halliday M., 1994, INTRO FUNCTIONAL GRA, V3rd; Halliday Michael A. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Hengst JA, 2005, J SPEECH LANG HEAR R, V48, P137, DOI 10.1044/1092-4388(2005/011); Hughes D., 1997, GUIDE NARRATIVE LANG; JENNETT B, 1977, INTRO NEUROSURGERY; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; Kertesz A., 1982, W APHASIA BATTERY; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; *LANG AN LAB, 2002, SALT WIND STAND VERS; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LOBAN W, 2005, J SPEECH LANG HEAR R, V48, P1048; Lock S, 2001, INT J LANG COMM DIS, V36, P25, DOI 10.3109/13682820109177853; Murphy K.R., 2005, PSYCHOL TESTING PRIN; Norrick N.R., 2000, CONVERSATIONAL NARRA; Nye CH, 1998, CLIN SOC WORK J, V26, P271, DOI 10.1023/A:1022820027167; Olness GS, 2005, APHASIOLOGY, V19, P251, DOI 10.1080/02687030444000723; Peterson C., 1983, DEV PSYCHOLINGUISTIC; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Quasthoff Uta, 2005, NARRATIVE INTERACTIO; Rayner H, 2003, INT J LANG COMM DIS, V38, P149, DOI 10.1080/1368282021000060308; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; *SPSS, 2005, SPSS VERS 14 0 WIND; Stein N. L., 1979, NEW DIRECTIONS DISCO, V2, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Ulatowska Hanna K., 2007, Seminars in Speech and Language, V28, P148, DOI 10.1055/s-2007-970572; VENTOLA E, 1996, SIGNS WORK SEMIOSIS; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P303	62	30	31	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	9					727	740	PII 913448130	10.1080/02699050903133954			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	475UR	WOS:000268387600004	19636998				2021-06-18	
J	Kasturi, BS; Stein, DG				Kasturi, Badrinarayanan S.; Stein, Donald G.			Progesterone decreases cortical and sub-cortical edema in young and aged ovariectomized rats with brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Progesterone; TBI; edema; hypothalamus; anterior pituitary; brain stem	AGING FEMALE RATS; PITUITARY DYSFUNCTION; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; KAPPA-B; STRESS; EXPRESSION; SECRETION; HYPOPITUITARISM; PREVALENCE	Purpose: Traumatic brain injury (TBI)-induced brain edema can be reduced by acute progesterone (PROG) treatment in young adult males and females, and in aged males. To extend these findings we tested these hypotheses: 1. Acute PROG treatment post-TBI will reduce cortical edema in aged females as much as in young adults. 2. TBI will induce edema in sub-cortical structures (SCS): the thalamus (TH), hypothalamus (HT), brain stem (BS) and anterior pituitary (AP). 3. Acute, systemic PROG treatment post-TBI will reduce edema in SCS. Methods: Young adult (n = 42) and aged (n = 40), bilaterally ovariectomized rats were given medial frontal cortical (MFC) contusion injury, treated with PROG (16 mg/kg body weight) or vehicle at 1, 6 and 24 hours post-injury and killed at 6, 24 and 48 hours post-injury. Their brains were removed and the target areas isolated and measured for water content. Results: TBI induced cortical and delayed sub-cortical edema. Acute PROG treatment decreased this edema. At 6 hours post-TBI serum PROG levels were substantially elevated in both young and aged, PROG-treated, groups, but were higher in the latter. Conclusion: Acute PROG treatment post-TBI could prove an effective intervention to prevent or attenuate systemic, post-injury cortical and sub-cortical edema in young and aged females.	[Kasturi, Badrinarayanan S.; Stein, Donald G.] Emory Univ, Sch Med, Brain Res Lab, Dept Emergency Med, Atlanta, GA 30322 USA	Kasturi, BS (corresponding author), Emory Univ, Sch Med, Brain Res Lab, Dept Emergency Med, 1365 B Clifton Rd,NE Suite 5100, Atlanta, GA 30322 USA.	bkastur@emory.edu	Stein, Donald/AAJ-5139-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5RO1NS048451]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048451] Funding Source: NIH RePORTER	We gratefully acknowledge the assistance provided by Craig Wirth for part of this study and by Ilana Garza of The Yerkes Biomarker Core Lab Facilities for providing the progesterone assays. We would also like to thank Leslie McCann for her help in the preparation of the manuscript. This study was supported by funding from NIH grant # 5RO1NS048451.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Andersen ML, 2005, J SLEEP RES, V14, P83, DOI 10.1111/j.1365-2869.2004.00428.x; Andersen ML, 2004, BRAZ J MED BIOL RES, V37, P791, DOI 10.1590/S0100-879X2004000600003; Ashley RL, 2006, ENDOCRINOLOGY, V147, P4151, DOI 10.1210/en.2006-0002; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; BOEHM N, 1982, J STEROID BIOCHEM, V16, P339, DOI 10.1016/0022-4731(82)90187-X; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Budec M, 2002, ALCOHOL, V26, P173, DOI 10.1016/S0741-8329(02)00197-0; Cai ZL, 2005, ENDOCRINOLOGY, V146, P5522, DOI 10.1210/en.2005-0759; CHEN G, 2007, J SURG RES; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; HUANG HH, 1975, NEUROENDOCRINOLOGY, V17, P289, DOI 10.1159/000122367; KASTURI BS, J NEUROTRAUMA UNPUB; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193; Marieb EN, 2005, HUMAN ANATOMY; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Muller E. E., 1989, BRAIN MESSENGERS PIT; NEMEROFF C, 1992, NEUROENDOCRINOLOGY; PERSENGIEV S, 1991, J PINEAL RES, V11, P57, DOI 10.1111/j.1600-079X.1991.tb00456.x; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Romeo RD, 2004, NEUROENDOCRINOLOGY, V80, P387, DOI 10.1159/000084203; Romeo RD, 2005, STRESS, V8, P265, DOI 10.1080/10253890500489320; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SCHAEFFER C, 1987, ACTA ENDOCRINOL-COP, V114, P440, DOI 10.1530/acta.0.1140440; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015	44	30	32	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2009	27	4					265	275		10.3233/RNN-2009-0476			11	Neurosciences	Neurosciences & Neurology	492BS	WOS:000269629700002	19738320	Green Accepted			2021-06-18	
J	Lovell, M				Lovell, Mark			The Management of Sports-Related Concussion: Current Status and Future Trends	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Sports management; Neuropsychology	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; AGREEMENT STATEMENT; RECOVERY; IMPAIRMENT; RETURN; PLAY	This article provides a review of current trends in the management of sports-related concussion. An evidence-based approach to concussion management is presented with a specific focus on return-to-play issues. The use of neuropsychological testing and other diagnostic tools is presented and reviewed.	Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15228 USA	Lovell, M (corresponding author), Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15228 USA.	lovellmr@upmc.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT., 1989, MILD HEAD INJURY, P257; Bergschneider M, 2003, J NEUROSURG, V86, P241; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; COLVIN A, 2008, AM ORTH SOC SPORTS M; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; LOVELL MR, 2000, NEUROLOGIC ATHLETIC; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P303; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; Riemann BL, 2000, J ATHL TRAINING, V35, P19; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; WOJYTS ED, 1999, AM J SPORTS MED, V27, P676	42	30	31	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2009	28	1					95	+		10.1016/j.csm.2008.08.008			18	Sport Sciences	Sport Sciences	392TD	WOS:000262324200010	19064168				2021-06-18	
J	Nestvold, K; Stavem, K				Nestvold, Knut; Stavem, Knut			Determinants of health-related quality of life 22 years after hospitalization for traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; quality of life; prospective cohort study	CLOSED-HEAD-INJURY; FOLLOW-UP; ADULTS; INDIVIDUALS; QUESTIONNAIRE; POPULATION; VALIDITY	Primary objective: To assess health-related quality of life (HRQoL) and its determinants in a cohort who had sustained a traumatic brain injury 22 years earlier. Research design: Cohort study with a postal follow-up survey. Methods and procedures: Two hundred and fifty-nine individuals with traumatic brain injury responded to the Short Form-36 (SF-36) and General Health Questionnaire-30 (GHQ-30) questionnaires. SF-36 scores were compared with a general population sample (n = 6800). In multiple linear regression analysis determinants of physical and mental component summary scores (PCS, MCS) of SF-36 and the GHQ-30 total score were assessed. Main outcomes and results: Except on the physical functioning scale, SF-36 scores were lower in the traumatic brain injury cohort than in the general population, after adjusting for age, sex and education. In multiple linear regression analysis, reported psychiatric disease and headache 1 day per month were associated with impaired MCS and GHQ-30 total scores. Age, severe headache 3 months after the injury, previous sick leave, lung disease and heart disease were associated with PCS. No injury variable was associated with HRQoL. Conclusions: Headache 3 months after traumatic brain injury and later comorbidity were associated with HRQoL 22 years after traumatic brain injury, but there was no association of HRQoL with injury data.	[Nestvold, Knut] Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway; [Nestvold, Knut; Stavem, Knut] Akershus Univ Hosp, HOKH, Res Ctr, N-1478 Lorenskog, Norway; [Stavem, Knut] Akershus Univ Hosp, Dept Pulm Med, Div Med, N-1478 Lorenskog, Norway; [Stavem, Knut] Univ Oslo, Fac Med, Oslo, Norway	Nestvold, K (corresponding author), Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway.	knut.nestvold@ahus.no			Norwegian Association of Traffic Wounded; Norwegian Foundation for Health and Rehabilitation	Thanks to T. Lundar (TL) for his contribution to the data collection in 1974/1975. The study received financial support from the Norwegian Association of Traffic Wounded and the Norwegian Foundation for Health and Rehabilitation.	Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; Grotvedt L, 2005, SCAND J PUBLIC HEALT, V33, P72, DOI 10.1080/14034940410028361; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Loge JH, 1998, SCAND J SOC MED, V26, P250; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; MALT U F, 1989, Tidsskrift for den Norske Laegeforening, V109, P1391; MALT UF, 1989, ACTA PSYCHIAT SCAND, V80, P103, DOI 10.1111/j.1600-0447.1989.tb05260.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Nestvold K, 2007, NEUROEPIDEMIOLOGY, V29, P113, DOI 10.1159/000109825; SYMONDS CP, 1945, BRIT MED BULL, V3, P14, DOI 10.1093/oxfordjournals.bmb.a071858; TEASDALE G, 1974, LANCET, V2, P81; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILSON JTL, 1993, J NEUROL NEUROSUR PS, V56, P198	22	30	30	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	1					15	21	PII 906993525	10.1080/02699050802530540			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	399FY	WOS:000262787000005	19096968				2021-06-18	
J	Eickhoff, SB; Dafotakis, M; Grefkes, C; Stoecker, T; Shah, NJ; Schnitzler, A; Zilles, K; Siebler, M				Eickhoff, S. B.; Dafotakis, M.; Grefkes, C.; Stoecker, T.; Shah, N. J.; Schnitzler, A.; Zilles, K.; Siebler, M.			fMRI reveals cognitive and emotional processing in a long-term comatose patient	EXPERIMENTAL NEUROLOGY			English	Article						Trauma; Language; Emotion; Persistent vegetative state; Minimally conscious state	MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; BRAIN-FUNCTION; VISUAL-CORTEX; COMPREHENSION; POTENTIALS; DISORDERS; AWARENESS; PROPOFOL; RECOVERY	We report on a 41-year old woman with prolonged comatose unresponsiveness following traumatic head injury. Structural MRI showed bilateral midbrain damage and ventriculomegalia. Functional MRI revealed robust cortical responses to visual, auditory and tactile stimulation. Speech stimuli moreover consistently elicited activation in Broca's and Wernicke's areas. Familiar speakers and direct addressing evoked significantly stronger amygdala activation than unfamiliar speakers and neutral phrases. This study hence demonstrates the potential of functional neuroimaging in the investigation of residual higher cortical functions in unresponsive comatose patients. (C) 2008 Elsevier Inc. All rights reserved.	[Eickhoff, S. B.; Dafotakis, M.; Stoecker, T.; Shah, N. J.; Zilles, K.] Forschungszentrum Julich, Inst Neurowissensch & Biophys Med INB 3, D-52425 Julich, Germany; [Grefkes, C.] Max Planck Inst Neurol Res, Cologne, Germany; [Zilles, K.] Univ Dusseldorf, C&O Vogt Inst Brain Res, Dusseldorf, Germany; [Shah, N. J.; Zilles, K.] Brain Imaging Ctr W BICW, Julich, Germany; [Schnitzler, A.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-4000 Dusseldorf, Germany; [Schnitzler, A.] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Zilles, K.] JARA Translat Brain Med, Julich, Germany; [Grefkes, C.] Univ Cologne, Dept Neurol, D-5000 Cologne 41, Germany	Eickhoff, SB (corresponding author), Forschungszentrum Julich, Inst Med IME, Postfach 1913, D-52425 Julich, Germany.	S.Eickhoff@fz-juelich.de	Grefkes, Christian/H-3972-2013; Zilles, Karl/J-9704-2013; Schnitzler, Alfons/Q-5520-2019; Shah, N. Jon/H-5849-2013; Zilles, Karl/Y-3784-2019; Eickhoff, Simon B./K-2061-2013	Grefkes, Christian/0000-0002-1656-720X; Zilles, Karl/0000-0001-9296-9959; Schnitzler, Alfons/0000-0002-6414-7939; Shah, N. Jon/0000-0002-8151-6169; Zilles, Karl/0000-0002-4705-4175; Eickhoff, Simon B./0000-0001-6363-2759; Dafotakis, Manuel/0000-0002-9680-7436	NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [KFO-112]; VolkswagenstiftungVolkswagen	This Human Brain Project/Neuroinformatics research was funded by the NIBIB, NINDS and NIMH. K.Z. acknowledges funding by the Deutsche Forschungsgemeinschaft (KFO-112) and the Volkswagenstiftung.	Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; HAYASHI T, 1999, MAPPING SOMATOSENSOR, P4451; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heinke W, 2004, BRIT J ANAESTH, V92, P641, DOI 10.1093/bja/aeh133; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Laureys S, 2004, ADV EXP MED BIOL, V550, P229; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2002, NEUROCASE, V8, P394, DOI 10.1076/neur.8.4.394.16184; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	24	30	32	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2008	214	2					240	246		10.1016/j.expneurol.2008.08.007			7	Neurosciences	Neurosciences & Neurology	380RW	WOS:000261483900010	18789930				2021-06-18	
J	Keenan, HT; Hall, GC; Marshall, SW				Keenan, Heather T.; Hall, Gillian C.; Marshall, Stephen W.			Early head injury and attention-deficit/hyperactivity disorder: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT-HYPERACTIVITY DISORDER; CHILDREN; SYMPTOMS; ILLNESS	Objective To explore the hypothesis that medically attended head injury in young children may be causal in the later development of attention- deficit/ hyperactivity disorder. Design Retrospective cohort study. Setting Health improvement network database ( 1988-2003), a longitudinal UK general practice dataset. Participants All children registered in the database from birth until their 10th birthday. Main outcome measures Risk of a child with a head injury before age 2 developing attention- deficit/ hyperactivity disorder before age 10 compared with children with a burn injury before age 2 and children with neither a burn nor a head injury. Results Of the 62 088 children who comprised the cohort, 2782 ( 4.5%) had a head injury and 1116 ( 1.8%) had a burn injury. The risk of diagnosis of attention- deficit/ hyperactivity disorder before 10 years of age after adjustment for sex, prematurity, socioeconomic status, and practice identification number was similar in the head injury ( relative risk 1.9, 95% confidence interval 1.5 to 2.5) and burn injury groups ( 1.7, 1.2 to 2.5) compared with all other children. Discussion Medically attended head injury before 2 years of age does not seem to be causal in the development of attention- deficit/ hyperactivity disorder. Medically attended injury before 2 years of age may be a marker for subsequent diagnosis of attention- deficit/ hyperactivity disorder.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27699 USA	Keenan, HT (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu		Marshall, Stephen/0000-0002-2664-9233			Bourke Alison, 2004, Inform Prim Care, V12, P171; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Huff N, 1999, J PUBLIC HEALTH MED, V21, P81, DOI 10.1093/pubmed/21.1.81; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	14	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2008	337								a1984	10.1136/bmj.a1984			4	Medicine, General & Internal	General & Internal Medicine	377FC	WOS:000261236100001	18988644	Green Published, Other Gold			2021-06-18	
J	Anon, J; Remonda, L; Spreng, A; Scheurer, E; Schroth, G; Boesch, C; Thali, M; Dirnhofer, R; Yen, K				Anon, Javier; Remonda, Luca; Spreng, Adrian; Scheurer, Eva; Schroth, Gerhard; Boesch, Chris; Thali, Michael; Dirnhofer, Richard; Yen, Kathrin			Traumatic extra-axial hemorrhage: Correlation of postmortem MSCT, MRI, and forensic-pathological findings	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						traumatic extra-axial hemorrhage; postmortem MSCT; postmortem MRI; forensic neuropathology; correlation	CLOSED-HEAD INJURY; MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; FIELD MR; CT; BRAIN; EXPERIENCE; AUTOPSY	Purpose: To evaluate the diagnostic accuracy of in situ postmortem multislice computed tomography (MSCT) and magnetic resonance imaging (MRI) in the detection of primary traumatic extra-axial hemorrhage. Materials and Methods: Thirty forensic neurotrauma cases and 10 nontraumatic controls who underwent both in situ postmortem cranial MSCT and MR imaging before autopsy were retrospectively reviewed. Both imaging modalities were analyzed in view of their accuracy, sensitivity, and specificity concerning the detection of extra-axial hemorrhage. Statistical significance was calculated using the McNemar test. K values for interobserver agreement were calculated for extra-axial hemorrhage types and to quantify the agreement between both modalities as well as MRI, CT, and forensics, respectively. Results: Analysis of the detection of hemorrhagic localizations showed an accuracy, sensitivity, and specificity of 89%, 82%, and 92% using CT, and 90%, 83%, and 94% using MRI, respectively. MRI was more sensitive than CT in the detection of subarachnoid hemorrhagic localizations (P = 0.001), whereas no significant difference resulted from the detection of epidural and subdural hemorrhagic findings, (P = 0.248 and P = 0.104, respectively). Interobserver agreement for all extra-axial hemorrhage types was substantial (CT kappa = 0,76; MRI kappa = 0.77). The agreement of both modalitites was almost perfect (readers 1 and 2 kappa = 0.88). Conclusion: CT and MRI are of comparable potential as forensic diagnostic tools for traumatic extra-axial hemorrhage. Not only of forensic, but also of clinical interest is the observation that most thin blood layers escape the radiological evaluation.	[Anon, Javier; Remonda, Luca; Spreng, Adrian; Schroth, Gerhard] Univ Bern, Dept Neuroradiol, Inselspital, CH-3010 Bern, Switzerland; [Anon, Javier; Scheurer, Eva; Thali, Michael; Dirnhofer, Richard; Yen, Kathrin] Univ Bern, Inst Forens Med, CH-3010 Bern, Switzerland; [Scheurer, Eva; Boesch, Chris] Univ Bern, Dept Clin Res Magnet Resonance Spect & Methodol, Inselspital, CH-3010 Bern, Switzerland; [Yen, Kathrin] Med Univ Graz, Inst Forens Med, Ctr Clin Theoret Med, Graz, Austria	Remonda, L (corresponding author), Univ Bern, Dept Neuroradiol, Inselspital, Freiburgstr 10, CH-3010 Bern, Switzerland.	luca.remonda@bluewin.ch	Scheurer, Eva/AAE-6161-2019; Boesch, Chris/F-2577-2010; Scheurer, Eva/C-6536-2011	Scheurer, Eva/0000-0002-2742-0422; Boesch, Chris/0000-0001-8498-8543; 			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Blamire AM, 1999, ACTA RADIOL, V40, P593, DOI 10.3109/02841859909175593; BOYKO OB, 1994, ARCH PATHOL LAB MED, V118, P219; BRADLEY WG, 1984, RADIOLOGY, V152, P695, DOI 10.1148/radiology.152.3.6463251; BROGDON BG, 1998, FORENSIC RADIOLOGY; BROOKS RA, 1980, J COMPUT ASSIST TOMO, V4, P489, DOI 10.1097/00004728-198008000-00016; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; HAN BK, 1990, AM J ROENTGENOL, V154, P361, DOI 10.2214/ajr.154.2.2105031; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HARRIS LS, 1991, FORENSIC SCI INT, V50, P179, DOI 10.1016/0379-0738(91)90149-D; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Klufas RA, 1996, AM J ROENTGENOL, V166, P675, DOI 10.2214/ajr.166.3.8623649; KRAULAND W, 1982, INJURIES INTRACRANIA; LANDIS JR, 1977, BIOMETRICS, V33, P174; LANGLOIS JA, 2004, TRAUMATIC BRAIN JURY; Lee Bruce, 2005, NeuroRx, V2, P372; LEE DH, 1995, CAN ASSOC RADIOL J, V46, P174; ORRISON WW, 1991, RADIOLOGY, V181, P121, DOI 10.1148/radiology.181.1.1887020; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P154; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; Patriquin L, 2001, J MAGN RESON IMAGING, V13, P277, DOI 10.1002/1522-2586(200102)13:2<277::AID-JMRI1040>3.0.CO;2-W; ROS PR, 1990, MAGN RESON IMAGING, V8, P303, DOI 10.1016/0730-725X(90)90103-9; SCHELLMANN B, 1978, Z RECHTSMED, V82, P199, DOI 10.1007/BF02092336; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Thali MJ, 2003, J FORENSIC SCI, V48, P386; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	30	30	30	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	OCT	2008	28	4					823	836		10.1002/jmri.21495			14	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	356PY	WOS:000259791300003	18821624	Bronze			2021-06-18	
J	Liu, WL; Lee, YH; Tsai, SY; Hsu, CY; Yu-Yo, S; Yang, LY; Tsai, SH; Yang, WCV				Liu, Wei-Lin; Lee, Yi-Hsuan; Tsai, Shih-Ying; Hsu, Chung Yi; Yu-Yo, Sun; Yang, Liang-Yo; Tsai, Shing-Han; Yang, Wei-Chung Vivian			Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes	GLIA			English	Article						central nervous system; chondroitin sulfate proteoglycans; gliosis; glucocorticoid; spinal cord injury	SPINAL-CORD-INJURY; AMPA RECEPTOR ACTIVATION; GLUCOCORTICOID-RECEPTOR; CNS INJURY; BRAIN; NEUROCAN; INFLAMMATION; OUTGROWTH; RESPONSES; CULTURE	Reactive gliosis caused by post-traumatic injury often results in marked expression of chondroitin sulfate proteoglycan (CSPG), which inhibits neurite outgrowth and regeneration. Methylprednisolone (MP), a synthetic glucocorticoid, has been shown to have neuroprotective and anti-inflammatory effects for the treatment of acute spinal cord injury (SCI). However, the effect of MP on CSPG expression in reactive glial cells remains unclear. In our study, we induced astrocyte reactivation using alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) and cyclothiazide to mimic the excitotoxic stimuli of SCI. The expression of glial fibrillary acidic protein (GFAP), a marker of astrocyte reactivation, and CSPG neurocan and phosphacan were significantly elevated by AMPA treatment. The conditioned media from AMPA-treated astrocytes strongly inhibited neurite outgrowth of rat dorsal root ganglion neurons, and this effect was reversed by pretreatment with MR Furthermore, MR downregulated GFAP and CSPG expression in adult rats with SCI. Additionally, both the glucocorticoid receptor (GR) antagonist RU486 and GR siRNA reversed the inhibitory effects of MR on GFAP and neurocan expression. Taken together, these results suggest that MR may improve neuronal repair and promote neurite outgrowth after excitotoxic insult via GR-mediated downregulation of astrocyte reactivation and inhibition of CSPG expression. (c) 2008 Wiley-Liss, Inc.	[Liu, Wei-Lin; Yang, Wei-Chung Vivian] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei 110, Taiwan; [Liu, Wei-Lin; Lee, Yi-Hsuan; Hsu, Chung Yi; Yang, Liang-Yo] Taipei Med Univ, Coll Med, Grad Inst Neurosci, Taipei 110, Taiwan; [Lee, Yi-Hsuan; Yu-Yo, Sun; Yang, Liang-Yo] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei 110, Taiwan; [Lee, Yi-Hsuan; Tsai, Shih-Ying; Yu-Yo, Sun; Yang, Liang-Yo] Taipei Med Univ, Grad Inst Med Sci, Div Physiol & Neurosci, Coll Med, Taipei 110, Taiwan; [Tsai, Shing-Han] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Tsai, Shing-Han] Taipei Municipal WanFang Hosp, Dept Neurosurg, Taipei, Taiwan	Yang, WCV (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Engn, 250 Wu Hsing St, Taipei 110, Taiwan.	vyang@tmu.edu.tw		Hsu, Chung Y./0000-0002-5632-2733; Sun, Yu-Yo/0000-0002-6608-1347	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC93-3112-B-038-003, NSC93-3112-B-038-004, NSC94-2314-B-038-017, NSC95-2745-B-038-005]; Ministry of Education, TaiwanMinistry of Education, Taiwan	National Science Council of Taiwan; Grant numbers: NSC93-3112-B-038-003, NSC93-3112-B-038-004 NSC94-2314-B-038-017, NSC95-2745-B-038-005. Grant sponsor: The Topnotch Stroke Research Center Grant, Ministry of Education, Taiwan.	Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; Asher RA, 2000, J NEUROSCI, V20, P2427; BALASINGAM V, 1994, J NEUROSCI, V14, P846; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Bracken M B, 1991, J Neurotrauma, V8 Suppl 1, pS47; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRACKEN MB, 1990, MED J AUSTRALIA, V153, P368, DOI 10.5694/j.1326-5377.1990.tb136976.x; BRACKEN MB, 1991, J NEUROTRAUMA S1, V8, pS51; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CANNING DR, 1993, EXP NEUROL, V124, P289, DOI 10.1006/exnr.1993.1199; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; DAHL D, 1976, BRAIN RES, V116, P150, DOI 10.1016/0006-8993(76)90257-2; DAHL D, 1974, J NEUROL SCI, V23, P551, DOI 10.1016/0022-510X(74)90027-6; David JC, 1996, J NEUROSCI, V16, P200; Deupree DL, 1996, NEUROCHEM INT, V29, P255, DOI 10.1016/0197-0186(96)00003-4; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Haas CA, 1999, J NEUROSCI, V19, P9953; HALL ED, 1981, EXP NEUROL, V73, P321, DOI 10.1016/0014-4886(81)90067-4; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Honer C, 2003, MOL PHARMACOL, V63, P1012, DOI 10.1124/mol.63.5.1012; HOSLI E, 1993, PROG NEUROBIOL, V40, P477, DOI 10.1016/0301-0082(93)90019-O; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; Levison S., 1991, CULTURING NERVE CELL, P309; Mace K, 2002, J NEUROSCI RES, V70, P46, DOI 10.1002/jnr.10381; Magnus T, 2001, J IMMUNOL, V167, P5004, DOI 10.4049/jimmunol.167.9.5004; MASOOD K, 1993, J NEUROCHEM, V61, P160, DOI 10.1111/j.1471-4159.1993.tb03551.x; McKeon RJ, 1999, J NEUROSCI, V19, P10778; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Powell EM, 1999, GLIA, V26, P73, DOI 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; ROZOVSKY I, 1995, ENDOCRINOLOGY, V136, P2066, DOI 10.1210/en.136.5.2066; SARID J, 1991, J NEUROSCI RES, V28, P217, DOI 10.1002/jnr.490280209; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Shank SS, 2003, AM J PHYSIOL-HEART C, V284, pH1751, DOI 10.1152/ajpheart.01033.2002; Shirakawa H, 2005, EUR J NEUROSCI, V21, P2329, DOI 10.1111/j.1460-9568.2005.04079.x; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Snow DM, 2003, EXP NEUROL, V182, P310, DOI 10.1016/S0014-4886(03)00034-7; SNOWDON AL, 1990, COLOUR ATLAS POSTHAR, V1, P11; SORRELL JM, 1993, MATRIX, V13, P351, DOI 10.1016/S0934-8832(11)80040-5; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; YOUNG W, 1992, J NEUROTRAUM, V9, pS397	58	30	32	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	OCT	2008	56	13					1390	1400		10.1002/glia.20706			11	Neurosciences	Neurosciences & Neurology	345KL	WOS:000258995300003	18618653				2021-06-18	
J	Magovern, B; Ramsey, ML				Magovern, Brian; Ramsey, Matthew L.			Percutaneous Fixation of Proximal Humerus Fractures	ORTHOPEDIC CLINICS OF NORTH AMERICA			English	Article							SURGICAL NECK FRACTURES; DISPLACED FRACTURES; INTERNAL-FIXATION; 3-PART FRACTURES; OPEN REDUCTION; THREADED PINS; 2-PART; PART; CLASSIFICATION; HEAD	Closed reduction and percutaneous fixation is a viable treatment option for displaced two-part, three-part, and valgus-impacted four-part proximal humerus fractures. Despite biomechanical studies demonstrating inferior stability compared with plate and intramedullary nail constructs, percutaneous fixation offers a minimally invasive approach with potential clinical advantages. Decreased scarring, improved cosmesis, and lower rates of avascular necrosis have been reported. Potential complications include pin migration, infection, avascular necrosis, neurovascular injury, and malunion. Clinical outcomes have been comparable with conventional techniques, with studies reporting approximately 70% good to excellent results.	[Magovern, Brian] Thomas Jefferson Univ, Dept Orthopaed Surg, Shoulder & Elbow Serv, Philadelphia, PA 19107 USA; [Ramsey, Matthew L.] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA	Magovern, B (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, Shoulder & Elbow Serv, 925 Chestnur St, Philadelphia, PA 19107 USA.	magovernb@hotmail.com					Anglen JO, 2005, J ORTHOP TRAUMA, V19, P724, DOI 10.1097/01.bot.0000192294.47047.99; Banco SP, 2001, J BONE JOINT SURG AM, V83A, P38, DOI 10.2106/00004623-200100021-00009; BLOOM MH, 1967, J BONE JOINT SURG AM, VA 49, P943, DOI 10.2106/00004623-196749050-00011; Boldin C, 2006, CLIN ORTHOP RELAT R, P222, DOI 10.1097/01.blo.0000203467.58431.a0; BUHR AJ, 1959, LANCET, V1, P531; Burkhead W Z Jr, 1992, J Shoulder Elbow Surg, V1, P31, DOI 10.1016/S1058-2746(09)80014-1; Calvo E, 2007, J SHOULDER ELB SURG, V16, P774, DOI 10.1016/j.jse.2007.03.019; Chen CY, 1998, J TRAUMA, V45, P1039, DOI 10.1097/00005373-199812000-00011; Cuomo F, 1992, J Shoulder Elbow Surg, V1, P287, DOI 10.1016/S1058-2746(09)80055-4; Durigan A, 2005, J SHOULDER ELB SURG, V14, P96, DOI 10.1016/j.jse.2004.04.013; Fankhauser F, 2004, ACTA ORTHOP SCAND, V75, P56, DOI 10.1080/00016470410001708110; Fenichel I, 2006, INT ORTHOP, V30, P153, DOI 10.1007/s00264-005-0058-7; FLATOW EL, 1991, J BONE JOINT SURG AM, V73A, P1213, DOI 10.2106/00004623-199173080-00011; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; HAWKINS RJ, 1986, J BONE JOINT SURG AM, V68A, P1410, DOI 10.2106/00004623-198668090-00014; HERSCOVICI D, 2000, CLIN ORTHOP RELAT R, V375, P97; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; HORAK J, 1975, CLIN ORTHOP RELAT R, P250, DOI 10.1097/00003086-197510000-00032; JABERG H, 1992, J BONE JOINT SURG AM, V74A, P508, DOI 10.2106/00004623-199274040-00006; JAKOB RP, 1991, J BONE JOINT SURG BR, V73, P295; Jiang CY, 2007, J SHOULDER ELB SURG, V16, P235, DOI 10.1016/j.jse.2006.05.011; Kamineni S, 2004, INJURY, V35, P1133, DOI 10.1016/j.injury.2003.08.008; Keener JD, 2007, J SHOULDER ELB SURG, V16, P330, DOI 10.1016/j.jse.2006.09.006; Klepps SJ, 2007, ORTHOPEDICS, V30, P636, DOI 10.3928/01477447-20070801-04; KOFOED H, 1980, ACTA ORTHOP SCAND, V51, P127, DOI 10.3109/17453678008990777; Koval K J, 1992, J Orthop Trauma, V6, P340, DOI 10.1097/00005131-199209000-00012; Koval KJ, 1997, J BONE JOINT SURG AM, V79A, P203, DOI 10.2106/00004623-199702000-00006; Koval KJ, 1996, J TRAUMA, V40, P778, DOI 10.1097/00005373-199605000-00017; Kralinger F, 2006, UNFALLCHIRURG, V109, P406, DOI 10.1007/s00113-005-1053-6; KRISTIANSEN B, 1986, ACTA ORTHOP SCAND, V57, P320, DOI 10.3109/17453678608994401; LEYSHON RL, 1984, ACTA ORTHOP SCAND, V55, P48, DOI 10.3109/17453678408992310; LIND T, 1989, ARCH ORTHOP TRAUM SU, V108, P285, DOI 10.1007/BF00932316; LYONS FA, 1990, J BONE JOINT SURG AM, V72A, P1262, DOI 10.2106/00004623-199072080-00023; Mazet R, 1943, J BONE JOINT SURG, V25, P477; Mellado J M, 2004, Emerg Radiol, V11, P49; Naidu SH, 1997, ORTHOPEDICS, V20, P1073; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; PARADIS G, 1993, CLIN ORTHOP RELAT R, P231; Resch H, 1997, J BONE JOINT SURG BR, V79B, P295, DOI 10.1302/0301-620X.79B2.6958; Robertson DD, 2000, J BONE JOINT SURG AM, V82A, P1594, DOI 10.2106/00004623-200011000-00013; ROSE SH, 1982, CLIN ORTHOP RELAT R, V168, P24; Rowles DJ, 2001, J BONE JOINT SURG AM, V83A, P1695, DOI 10.2106/00004623-200111000-00012; Schandelmaier P, 2001, INJURY, V32, P55, DOI 10.1016/S0020-1383(01)00184-X; SIDOR ML, 1993, J BONE JOINT SURG AM, V75A, P1745, DOI 10.2106/00004623-199312000-00002; SIEBENROCK KA, 1993, J BONE JOINT SURG AM, V75A, P1751, DOI 10.2106/00004623-199312000-00003; Taverna E, 2004, ARTHROSCOPY, V20, P105, DOI 10.1016/j.arthro.2004.04.027; Telwani NC, 2008, J SHOULDER ELB SURG, V17, P216, DOI 10.1016/j.jse.2007.07.016; Wheeler DL, 1997, J ORTHOP TRAUMA, V11, P363, DOI 10.1097/00005131-199707000-00012; Williams GR, 2000, ORTHOP CLIN N AM, V31, P1, DOI 10.1016/S0030-5898(05)70124-3	50	30	34	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-5898	1558-1373		ORTHOP CLIN N AM	Orthop. Clin. North Am.	OCT	2008	39	4					405	416		10.1016/j.ocl.2008.05.005			12	Orthopedics	Orthopedics	363SX	WOS:000260288200003	18803971				2021-06-18	
J	Dudkiewicz, M; Proctor, KG				Dudkiewicz, Michael; Proctor, Kenneth G.			Tissue oxygenation during management of cerebral perfusion pressure with phenylephrine or vasopressin	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; blast; pulmonary contusion; mannitol; swine; combat casualty care	ARGININE-VASOPRESSIN; BRAIN EDEMA; BLOOD-FLOW; HEMORRHAGIC-SHOCK; DOSE VASOPRESSIN; LIVER TRAUMA; RESUSCITATION; RAT; HYPOTENSION; ANTAGONIST	Objective: Phenylephrine is often used for management of cerebral perfusion pressure after traumatic brain injury, but can have undesirable actions. Few studies have evaluated alternatives. The hypothesis was that arginine vasopressin was as effective as pherylephrine for maintaining tissue oxygenation during cerebral perfusion pressure management. Design: Prospective randomized, blinded animal study, Setting: University laboratory. Subjects: Thirty-five anesthetized swine (46 +/- 1 kg). Interventions: Blunt trauma to the head and bilateral chests (estimated injury severity score was 25-32) was followed by hypoventilation. Resuscitation was divided into phases to simulate treatment in a typical prehospital, emergency room, and intensive care unit. For 30-45 mins postinjury, 1 L of normal saline was administered. For 45-120 mins, normal saline maintained systolic blood pressure >100 mm Hg plus-mannitol for intracranial hypertension. After 120 mins, phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure >70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure >12 mm Hg plus glucose to maintain normoglycemia. Measurements and Main Results: Mortality rate was 37% (13 of 35) within 2 hrs. Before resuscitation, mean arterial pressure was 61 +/- 5 mm Hg, heart rate was 110 +/- 6 beats/min, Pa0(2) was 46 +/- 2 mm Hg, and lactate was 5.0 +/- 0.4 mM. Intracranial pressure increased from 8 +/- 1 mm Hg to 20 +/- 1 mm Hg and brain tissue P0(2) decreased from 19 +/- 1 mm Hg to 8 +/- 1 mm Hg. Resuscitation corrected most variables, as well as mixed venous, renal, portal, and muscle oxygen saturations, but 90% (20 of 22) required pressor support. After 6 hrs with either pressor, hemodynamics were stable. However, with phenylephrine vs. arginine vasopressin, intracranial pressure averaged >10 mm Hg higher and brain tissue P0(2) was 6 mm Hg lower, whereas tissue oxygen saturations were >10% higher in the shoulder and hindlimb muscles (all p < 0.05). Conclusions: Arginine vasopressin was as effective as phenylephrine for maintaining cerebral perfusion pressure, but intracranial pressure and brain tissue oxygenation were improved at the expense of the periphery.	[Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Deiv Surg Crit Care, Miami, FL 33136 USA	Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA.	kproctor@miami.edu			Office of Naval ResearchOffice of Naval Research [N140610670]	Supported by grant# N140610670 from the Office of Naval Research.	Argenziano M, 1997, CIRCULATION, V96, P286; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Bilski TR, 2003, J TRAUMA, V54, P814, DOI 10.1097/01.TA.0000046627.87250.1D; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CACH R, 1989, BRAIN RES, V483, P221, DOI 10.1016/0006-8993(89)90166-2; Chambers LW, 2005, ARCH SURG-CHICAGO, V140, P26, DOI 10.1001/archsurg.140.1.26; Chieregato A, 2003, ACTA NEUROCHIR SUPPL, V86, P361; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cornwell E, 1999, J TRAUMA, V47, P703; DELGADO TJ, 1988, J NEUROSURG, V68, P266, DOI 10.3171/jns.1988.68.2.0266; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desselle WJ, 2001, J TRAUMA, V51, P239, DOI 10.1097/00005373-200108000-00005; DeWitt DS, 2000, CRIT CARE MED, V28, P3933, DOI 10.1097/00003246-200012000-00036; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Holmes Cheryl L, 2004, Curr Opin Crit Care, V10, P442, DOI 10.1097/01.ccx.0000144769.19213.0c; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; KATUSIC ZS, 1984, CIRC RES, V55, P575, DOI 10.1161/01.RES.55.5.575; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; Krismer Anette C, 2004, Crit Care Med, V32, pS432, DOI 10.1097/01.CCM.0000134267.91520.C0; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Landry DW, 1997, CIRCULATION, V95, P1122; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; Malay MB, 2004, CRIT CARE MED, V32, P1327, DOI 10.1097/01.CCM.0000128578.37822.F1; Maxwell RA, 2001, J TRAUMA, V51, P849, DOI 10.1097/00005373-200111000-00005; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; ONOUE H, 1988, STROKE, V19, P1388, DOI 10.1161/01.STR.19.11.1388; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; PROCTOR KG, 1987, CIRC RES, V61, P42, DOI 10.1161/01.RES.61.1.42; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robin JK, 2003, J TRAUMA, V54, pS149, DOI 10.1097/01.TA.0000064523.93060.60; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; SUZUKI Y, 1994, J AUTONOM NERV SYST, V49, pS129; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Trandafir CC, 2004, CLIN EXP PHARMACOL P, V31, P261, DOI 10.1111/j.1440-1681.2004.03986.x; TSUGANE S, 1994, J AUTONOM NERV SYST, V49, pS133; *US TOD, US TOD SPEC REP; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wenzel V, 2005, RESUSCITATION, V64, P219, DOI 10.1016/j.resuscitation.2004.07.013; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6	49	30	30	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2008	36	9					2641	2650		10.1097/CCM.0b013e3181847af3			10	Critical Care Medicine	General & Internal Medicine	345TV	WOS:000259020800022	18679110				2021-06-18	
J	Shuttleworth-Edwards, AB; Noakes, TD; Radloff, SE; Whitefield, VJ; Clark, SB; Roberts, CO; Essack, FB; Zoccola, D; Boulind, MJ; Case, SE; Smith, IP; Mitchell, JLG				Shuttleworth-Edwards, Ann B.; Noakes, Timothy D.; Radloff, Sarah E.; Whitefield, Victoria J.; Clark, Susan B.; Roberts, Craig O.; Essack, Fathima B.; Zoccola, Diana; Boulind, Melissa J.; Case, Stephanie E.; Smith, Ian P.; Mitchell, Julia L. G.			The comparative incidence of reported concussions presenting for follow-up management in South African Rugby Union	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article							INJURIES; STATEMENT; PLAYERS; SCHOOL; SOCCER	Objective: The objective of this study was to compare the seasonal concussion incidence for school, university, club and provincial level Rugby Union players in South Africa. Design: The study presents a retrospective statistical analysis of the number of reported concussions documented annually for groups Of Rugby Union players as a proportion of those who received preseason neurocognitive assessment. Setting: Between 2002 and 2006, concussion management programs using computerized neuropsychological assessment were implemented for clinical and research purposes by psychologists in selected South African institutions involved in Rugby Union from school through to the professional level. Participants: The incidence figures were based on 175 Concussive episodes reported for 165 athletes who were referred for neurocognitive assessment from a Population of 1366 athletes who received preseason baseline testing. Interventions: Concussion management routines varied according to the protocols adopted by the different psychologists and rugby organizations. Main Outcome Measurements: It was expected that the incidence of concussion Would vary significantly due to level of play and different management protocols. Results: There was wide disparity in the manner in which Concussion follow-up was managed by the various organizations. Within broadly comparable cohorts, fighter control was associated with a relatively higher concussion incidence for athletes per rugby playing season, with average institutional figures ranging from 4% to 14% at school level and 3% to 23% at adult level. Conclusions: This analysis suggests that concussion goes unrecognized and therefore incorrectly managed in a number of instances. Recommendations for optimal identification of concussed athletes for follow-up management are presented.	[Shuttleworth-Edwards, Ann B.] Rhodes Univ, Psychol Clin, NSCI, Dept Psychol, ZA-6139 Grahamstown, South Africa; [Noakes, Timothy D.] Univ Cape Town, S African Sports Sci Inst, Dept Human Biol, Newland, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, ZA-6139 Grahamstown, South Africa; [Roberts, Craig O.] Natal Rugby Union, Dept Med, Durban, South Africa	Shuttleworth-Edwards, AB (corresponding author), Rhodes Univ, Psychol Clin, NSCI, Dept Psychol, ZA-6139 Grahamstown, South Africa.	a.edwards@ru.ac.za	Noakes, Timothy D./E-7253-2011; Noakes, Tim/AAD-3162-2020	Noakes, Timothy D./0000-0001-7244-2375; Noakes, Tim/0000-0001-7244-2375	Rhodes University Council; National Research Foundation (NRF)	This research was supported by grants from the Rhodes University Council and the National Research Foundation (NRF). Incidence data from neuropsychological theses in progress for three doctoral students (co-authors Clark, Essack and Zoccola) are reported in this article. In each case the focus of these dissertations is the acute and chronic neuropsychological effects of concussion, and not incidence, and therefore this article does not pre-empt the presentation of their doctoral results. The first and fourth authors have a commercial relationship with ImPACT Applications, Inc. (USA) for the development of neurocognitive screening as a component of sports concussion management in South Africa and the UK.	[Anonymous], 2008, PREVALENCE INCIDENCE; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Garraway WM, 2000, BRIT J SPORT MED, V34, P348, DOI 10.1136/bjsm.34.5.348; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Jakoet I, 1998, S AFR MED J, V88, P45; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P287; LOVELL MR, TECHNICAL MANUAL PSY; MCCRORY P, 2001, BRIT J SPORT MED, V35, P379; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Micheli L J, 1974, J Sports Med, V2, P93; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; NATHAN M, 1983, S AFR MED J, V64, P132; ROUX CE, 1987, S AFR MED J, V71, P307; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Edwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P479, DOI 10.1016/j.acn.2008.07.002; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; SHUTTLEWORTHEDW.AB, 2008, J CLIN EXPE IN PRESS; SHUTTLEWORTHEDW.AB, 2007, S AFR J SPORTS MED, V19, P32; SOLOMON GS, 2006, HEADS UP SPORT CONCU; Varney N. R., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI DOI 10.1097/00001199-199303000-00005; WILLS SM, 2001, J INT NEUROPSYCH SOC, V7, P405	32	30	31	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2008	18	5					403	409		10.1097/JSM.0b013e3181895910			7	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	353SR	WOS:000259589000007	18806547				2021-06-18	
J	Shuttleworth-Rdwards, AB; Radloff, SE				Shuttleworth-Rdwards, Ann B.; Radloff, Sarah E.			Compromised visuomotor processing speed in players of Rugby Union from school through to the national adult level	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						sports concussion; processing speed; rugby; MTBI	TRAUMATIC BRAIN-INJURY; FOOTBALL SOCCER; NEUROPSYCHOLOGICAL IMPAIRMENT; CONCUSSION; PERFORMANCE	The aim of this study was to investigate the residual effects of concussion amongst players of Rugby Union from school through to the national adult level, with pre-season testing on tests of visuomotor processing speed (Digit Symbol; Trail Making Test A and B). Comparison groups included 124 male rugby players versus 102 non-contact sport controls; 71 forward versus 53 backline players. Across groups there was equivalence for age, education, estimated IQ, and hand motor dexterity. There was a significantly higher percentage of rugby players with 2+ concussions than controls. Poorer performance was in evidence for rugby players compared with controls on all tests of visuomotor speed, and for forward versus backline players on Digit Symbol, with clinically relevant medium effect sizes. The results implicate Vulnerability amongst rugby players on the prototypically sensitive function of visuomotor processing in association with years of exposure to repetitive concussive and subconcussive injury. (C) 2008 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Shuttleworth-Rdwards, Ann B.] Rhodes Univ, Dept Psychol, ZA-6140 Grahamstown, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, ZA-6140 Grahamstown, South Africa	Shuttleworth-Rdwards, AB (corresponding author), Rhodes Univ, Dept Psychol, ZA-6140 Grahamstown, South Africa.	a.edwards@ru.ac.za					Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/0013164401614002; Cumming G, 2001, EXPLORATORY SOFTWARE; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DELATORRE JC, 2002, STROKE, V33, P1; Demakis GJ, 2006, CLIN NEUROPSYCHOL, V20, P10, DOI 10.1080/13854040500203282; DENCKLA MB, 1973, DEV MED CHILD NEUROL, V15, P635; Farace E, 2003, J INT NEUROPSYCH SOC, V9, P207; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1997, NEUROLOGY, V48, P581; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LOWELL MR, 1999, CLIN J SPORT MED, V9, P193; MATSER E, 2000, JAMA-J AM MED ASSOC, V16, P883; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mitrushina M., 2005, HDB NORMATIVE DATA N; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; *NAT I PERS RES HS, 1969, S AFR WECHSL AD INT; NATHAN M, 1983, S AFR MED J, V64, P132; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reitan RM, 1979, MANUAL ADM NEUROPSYC; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards AB, 2002, CLIN NEUROPSYCHOL, V16, P232, DOI 10.1076/clin.16.3.232.13855; Shuttleworth-Jordan AB, 1993, P 5 NAT NEUR C S AFR, P38; SHUTTLEWORTHEDW.AB, J CLIN EXPT IN PRESS; SHUTTLEWORTHEDW.AB, CLIN J SPORT M UNPUB; ShuttleworthJordan AB, 1996, S AFR J PSYCHOL, V26, P96, DOI 10.1177/008124639602600205; VANTONDER P, 2008, WISC 4 PERFORMANCE S; Wechsler D, 1997, WAIS 3 ADM SCORING M	40	30	32	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2008	23	5					511	520		10.1016/j.acn.2008.05.002			10	Psychology, Clinical; Psychology	Psychology	351HN	WOS:000259415400004	18585890	Bronze			2021-06-18	
J	Ozturk, A; Sasson, AD; Farrell, JAD; Landman, BA; da Motta, ACBS; Aralasmak, A; Yousem, DM				Ozturk, A.; Sasson, A. D.; Farrell, J. A. D.; Landman, B. A.; da Motta, A. C. B. S.; Aralasmak, A.; Yousem, D. M.			Regional differences in diffusion tensor imaging measurements: Assessment of intrarater and interrater variability	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							WHITE-MATTER; MULTIPLE-SCLEROSIS; FRACTIONAL ANISOTROPY; HUMAN BRAIN; NOISE; MRI; ADRENOLEUKODYSTROPHY; REPRODUCIBILITY; TRACTOGRAPHY; ADOLESCENCE	BACKGROUND AND PURPOSE: Diffusion tensor imaging (DTI) has become a valuable tool in both the research and clinical evaluation of subjects, We sought to quantify interobserver and intraobserver variability of diffusivity and diffusion anisotropy measurements with regard to specific regions of interest (ROIs). MATERIALS AND METHODS: The subject group consisted of 5 healthy control subjects and 7 study subjects (all males; 16-19 years old; mean age = 17.5 years), as part of a protocol for closed head injury. Two whole-brain DTI scans were acquired on a 3T scanner for each subject. Analysis was performed using a ROI approach. Two independent observers analyzed the apparent diffusion coefficient (ADC) and fractional anisotropy (FA) indices in the corpus callosum, cortical spinal tract, internal capsules (ICs), basal ganglia, and centrum semiovale (CSO). Intraobserver and interobserver variability were calculated for the mean ADC, FA, and ordered eigenvalues of the diffusion tenser (lambda(1), lambda(2), and lambda(3)). RESULTS: The overall kappa statistic for intraobserver variability for both observers showed slight-to-substantial agreement (kappa = 0.02-0.69), however FA values in the CSO showed only slight agreement. Interobserver agreement was also slight to substantial for these DTI measurements with high variability in FA values in the IC and CSO. CONCLUSIONS: When one is comparing 2 DTI measurements, it is important to assess intraobserver and interobserver variability. We recommend caution in the analysis of DTI contrasts in the IC and CSO, because we have found the widest range of variability in measurements within these structures.	[Ozturk, A.; Sasson, A. D.; Farrell, J. A. D.; da Motta, A. C. B. S.; Yousem, D. M.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, FM Kirby Res Ctr Funct Brain Imaging, Kennedy Krieger Inst, Baltimore, MD 21287 USA; [Farrell, J. A. D.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Landman, B. A.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Aralasmak, A.] Akdeniz Univ, Dept Radiol, TR-07058 Antalya, Turkey	Yousem, DM (corresponding author), Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, FM Kirby Res Ctr Funct Brain Imaging, Kennedy Krieger Inst, 600 N Wolfe St,Phipps B112, Baltimore, MD 21287 USA.	dyousem1@jhu.edu	Landman, Bennett A/A-2343-2009	Landman, Bennett A/0000-0001-5733-2127			Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bastianetto S, 1998, ADV GINKGO, V7, P85; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Heim S, 2004, MAGN RESON MED, V52, P582, DOI 10.1002/mrm.20169; Holtmannspotter M, 2005, STROKE, V36, P2559, DOI 10.1161/01.STR.0000189696.70989.a4; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Ito R, 2001, NEUROLOGY, V56, P544, DOI 10.1212/WNL.56.4.544; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Schneider JFL, 2003, AM J NEURORADIOL, V24, P819; Schneider JFL, 2004, NEURORADIOLOGY, V46, P258, DOI 10.1007/s00234-003-1154-2; Sigmund EE, 2006, MAGN RESON IMAGING, V24, P7, DOI 10.1016/j.mri.2005.10.015; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626	37	30	31	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUN-JUL	2008	29	6					1124	1127		10.3174/ajnr.A0998			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	315QI	WOS:000256894100018	18356471	Green Published, Other Gold			2021-06-18	
J	Wade, SL; Taylor, HG; Walz, NC; Salisbury, S; Stancin, T; Bernard, LA; Oberjohn, K; Yeates, KO				Wade, Shari L.; Taylor, H. Gerry; Walz, Nicolay Chertkoff; Salisbury, Shelia; Stancin, Terry; Bernard, Lori A.; Oberjohn, Karen; Yeates, Keith Owen			Parent-child interactions during the initial weeks following brain injury in young children	REHABILITATION PSYCHOLOGY			English	Article						early childhood; traumatic brain injury; parent-child interaction; family impact	PREMATURITY STEREOTYPE; MATERNAL DEPRESSION; HEAD-INJURY; OUTCOMES; MOTHERS; TERM; PERCEPTIONS; ADJUSTMENT; FAMILIES; BEHAVIOR	To understand how traumatic brain injury (TBI) affects parent-child interactions acutely following injury. Participants: Young children hospitalized for TBI (n = 80) and orthopedic injuries (OI; n = 113). Method: Raters coded videotaped interactions during free play and structured tasks for parental warmth/responsiveness and negativity and child warmth, behavior regulation, and cooperation. Raters also counted parental directives, critical/restricting statements, and scaffolds. Results: Parents of children with TBI exhibited less warm responsiveness and made more directive statements during a structured task than parents in the OI group. Children with TBI displayed less behavior regulation than children with OI. Parental warm responsiveness was more strongly related to child cooperativeness in the 01 group than in the TBI group. Child behavior also mediated group differences in parental responsiveness and directiveness. TBI accounted for as much variance in parental behaviors as or more than did sociodemographic factors. Conclusion: TBI-related changes in child behavior may negatively influence parent-child interactions and disrupt the reciprocity between parent and child.	[Wade, Shari L.; Bernard, Lori A.; Oberjohn, Karen] Cincinnati Childrens Hosp, Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA; [Wade, Shari L.; Walz, Nicolay Chertkoff; Salisbury, Shelia] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Sch Med, Cleveland, OH 44106 USA; [Walz, Nicolay Chertkoff] Univ Cincinnati, Div Behav Med & Clin Psychol, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45221 USA; [Salisbury, Shelia] Univ Cincinnati, Div Epidemiol & Biostat, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45221 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Pediat, Cleveland, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Childrens Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Yeates, Keith Owen] Columbus Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA	Wade, SL (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Phys Med & Rehabil, Dept Pediat, MLC 4009,3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR008084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD042729] Funding Source: Medline		Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2000, BRAIN INJURY, V14, P679; Assel M.A., 2003, APPL DEV SCI, V7, P27, DOI [DOI 10.1207/S1532480XADS0701_, 10.1207/S1532480XADS0701_3, DOI 10.1207/S1532480XADS0701_3]; BAKEMAN R, 1980, CHILD DEV, V51, P437, DOI 10.2307/1129277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARKLEY RA, 1991, J ABNORM CHILD PSYCH, V19, P149, DOI 10.1007/BF00909976; BORNSTEIN MH, 1989, MATERNAL RESPONSIVEN, P49, DOI DOI 10.1002/CD.23219894306; Chronis AM, 2007, DEV PSYCHOL, V43, P70, DOI 10.1037/0012-1649.43.1.70; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DANFORTH JS, 1991, CLIN PSYCHOL REV, V11, P703, DOI 10.1016/0272-7358(91)90127-G; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DEROGATIS LR, 1982, BRIEF SYMPTOM INVENT, V1; DYERHARNISH J, 1995, CHILD DEV, V66, P739; Elgar FJ, 2004, CLIN PSYCHOL REV, V24, P441, DOI 10.1016/j.cpr.2004.02.002; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Floyd FJ, 2004, AM J MENT RETARD, V109, P507, DOI 10.1352/0895-8017(2004)109<507:FPWCWH>2.0.CO;2; FLOYD FJ, 1991, CHILD DEV, V62, P1434, DOI 10.2307/1130817; FLOYD FJ, 1992, J PEDIATR PSYCHOL, V17, P607, DOI 10.1093/jpepsy/17.5.607; FLOYD FJ, 1993, AM J MENT RETARD, V97, P673; FLOYD FJ, 1997, INT REV RES MENT RET, V20, P47; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Haskett ME, 2007, CHILD CARE HLTH DEV, V33, P67, DOI 10.1111/j.1365-2214.2006.00627.x; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Holmbeck GN, 2002, J CONSULT CLIN PSYCH, V70, P96, DOI 10.1037//0022-006X.70.1.96; Howe D., 2006, CHILD FAM SOC WORK, V11, P95, DOI [10.1111/j.1365-2206.2006.00397.x., DOI 10.1111/J.1365-2206.2006.00397.X]; Johnston C, 2001, CLIN CHILD FAM PSYCH, V4, P183, DOI 10.1023/A:1017592030434; Keogh BK, 2000, AM J MENT RETARD, V105, P32, DOI 10.1352/0895-8017(2000)105<0032:MOCIFC>2.0.CO;2; LANDRY SH, 1990, CHILD DEV, V61, P1605, DOI 10.2307/1130768; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; Landry SH, 1996, MERRILL PALMER QUART, V42, P177; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Mahoney G, 2004, RES DEV DISABIL, V25, P539, DOI 10.1016/j.ridd.2004.04.001; Mahoney G, 1998, TOP EARLY CHILD SPEC, V18, P5, DOI 10.1177/027112149801800104; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Pipp-Siegel S, 1998, VOLTA REV, V100, P237; QUITTNER AL, 1992, REHABIL PSYCHOL, V37, P275, DOI 10.1037/0090-5550.37.4.275; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Seefeldt T., 1997, PSI CHI J UNDERGRADU, V2, P5; Smith KE, 2006, PEDIATRICS, V117, P1608, DOI 10.1542/peds.2005-1284; Smith KE, 2005, J CONSULT CLIN PSYCH, V73, P711, DOI 10.1037/0022-006X.73.4.711; STANCIN T, J DEV BEHAV IN PRESS; STERN M, 1984, DEV PSYCHOL, V20, P360, DOI 10.1037/0012-1649.20.3.360; Stern M, 2000, INF MENTAL HLTH J, V21, P495, DOI 10.1002/1097-0355(200011/12)21:6<495::AID-IMHJ7>3.0.CO;2-F; TANNOCK R, 1988, AM J MENT RETARD, V93, P154; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tronick E. Z., 1997, P54; Vaughn B.E., 1999, HDB ATTACHMENT THEOR, P198; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Weizman ZO, 2001, DEV PSYCHOL, V37, P265, DOI 10.1037//0012-1649.37.2.265; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31	55	30	30	2	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2008	53	2					180	190		10.1037/0090-5550.53.2.180			11	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	313AF	WOS:000256712800008	25838616	Green Accepted			2021-06-18	
J	Feeney, TJ; Ylvisaker, M				Feeney, Timothy J.; Ylvisaker, Mark			Context-Sensitive Cognitive-Behavioral Supports for Young Children With TBI A Second Replication Study	JOURNAL OF POSITIVE BEHAVIOR INTERVENTIONS			English	Article						behavior disorders; pediatric rehabilitation; traumatic brain injury; positive behavior support; cognitive-behavioral intervention; functional assessment; school-based treatment; multicomponent intervention; ecological validity	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE INJURY; CLOSED-HEAD INJURY; PSYCHIATRIC-DISORDERS; SHORT-TERM; FAMILY; ADOLESCENTS; PREDICTORS; REHABILITATION; SEVERITY	This study produced a second replication of an investigation of the effects of a multicomponent cognitive-behavioral intervention on the challenging behavior of young children with growing behavioral concerns after traumatic brain injury (TBI). The participants were two young elementary-age children with escalating behavior problems after severe TBI. Single-subject reversal designs were used to document the effects of the combined behavioral, cognitive, and executive function intervention on the following: frequency and intensity of aggressive behaviors and amount of work accomplished. The intervention included integrated components of positive behavior supports, cognitive supports (e.g., graphic organizers), and an executive function routine (goal-plan-do-review). Results included reduced frequency and intensity of challenging behaviors and increased quantity of work completed. These two successful single-subject,experiments replicated four previously published single-subject experiments demonstrating the potential for successfully treating, behavior disorders in young children with TBI using a support-oriented intervention that combines behavioral, cognitive, and executive function components.	[Feeney, Timothy J.] Sch & Community Supports, Schenectady, NY 12305 USA; [Ylvisaker, Mark] Coll St Rose, Albany, NY USA	Feeney, TJ (corresponding author), Sch & Community Supports, 600 Franklin St,Suite 110, Schenectady, NY 12305 USA.	tfeeney@scssconsulting.com	Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barlow D.H., 1984, SINGLE CASE EXPT DES; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BIJOU SW, 1968, J APPL BEHAV ANAL, V1, P175, DOI 10.1901/jaba.1968.1-175; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bogdan R., 1984, INTRO QUALITATIVE RE; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Carr E.G., 1994, COMMUNICATION BASED; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; COSTEFF H, 1985, SCAND J REHABIL MED, P10; Damasio A., 1994, DESCARTESERROR EMOTI; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; DURAND VM, 1992, MOTIVATION ASSESSMEN; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FEENEY T, 1997, STUDENTS ACQUIRED BR, P229; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Glesne C., 1992, BECOMING QUALITATIVE; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Harchik A E, 1993, Ann Clin Psychiatry, V5, P151, DOI 10.3109/10401239309148979; HEBB DO, 1947, AM PSYCHOL, V2, P737; KEPPEL G, 1991, DESIGN ANAL INVESTIG; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; Kolb B., 1995, BRAIN PLASTICITY BEH; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; MACE FC, 1990, J EXP ANAL BEHAV, V54, P163, DOI 10.1901/jeab.1990.54-163; Mace FC, 1997, J APPL BEHAV ANAL, V30, P1, DOI 10.1901/jaba.1997.30-1; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McDonald S., 2005, BRAIN IMPAIR, V6, P56, DOI DOI 10.1375/BRIM.6.1.56.65481; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; REICHLE J, 1993, COMMUNICATIVE ALTERN; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Singh N. N., 1994, ABERRANT BEHAV CHECK; Sternberg RJ., 1993, TRANSFER TRIAL INTEL; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Varney N. R., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI DOI 10.1097/00001199-199303000-00005; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Wilson B. A., 1993, APPL PREV PSYCHOL, V2, P209, DOI [DOI 10.1016/S0962-1849(05)80091-5, 10.1016/S0962-1849(05)80091-5]; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P221; Ylvisaker M., 1998, COLLABORATIVE BRAIN; YLVISAKER M, 2005, REHABILITATION TRAUM, P205; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	83	30	30	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1098-3007	1538-4772		J POSIT BEHAV INTERV	J. Posit. Behav. Interv.	APR	2008	10	2					115	128		10.1177/1098300707312540			14	Psychology, Clinical; Education, Special	Psychology; Education & Educational Research	390MQ	WOS:000262168800005					2021-06-18	
J	Berne, JD; Reuland, KR; Villarreal, DH; McGovern, TM; Rowe, SA; Norwood, SH				Berne, John D.; Reuland, Kurt R.; Villarreal, David H.; McGovern, Thomas M.; Rowe, Stephen A.; Norwood, Scott H.			Internal carotid artery stenting for blunt carotid artery injuries with an associated pseudoaneurysm	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						carotid artery injury; carotid stent; blunt cerebrovascular injury; pseudoaneurysm	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CEREBROVASCULAR INJURIES; TRAUMATIC PSEUDOANEURYSM; EARLY-DIAGNOSIS; SCREENING-TEST; ENDARTERECTOMY; ANGIOPLASTY; EPISTAXIS; ANEURYSMS; IMPROVES	Background. Blunt carotid artery injuries (BCI) are being recognized and treated with increasing frequency because of improved screening protocols. Recent advances in endovascular techniques using microcoils, angioplasty, and stenting offer a new treatment strategy for those patients with traumatic pseudoaneurysms (PA) (BCI and PA). Experience with these techniques is limited because of the rarity of these injuries. Hypothesis. Early anticoagulation (AC) or antiplatelet (AP) therapy combined with carotid artery stenting is a safe alternative to AC alone for the treatment of grade III carotid artery injuries (BCI and PA). Design: Prospective cohort study. Setting: A rural, community Level I trauma center. Patients and Methods: All patients with a nonocclusive BCI and PA during a 5.5 year period from June 23, 2000 to December 31, 2005 were included in the study. Results. Eleven patients with grade BCI and PA underwent endovascular repair. Nine patients (81%) had associated traumatic intracranial hemorrhage. AC (heparin drip) or AP therapy (clopidogrel or aspirin or both) was initiated in all patients within 48 hours of diagnosis of BCI. Time from admission to AC or AP was 21 +/- 9.5 hours (mean +/- SD). Mortality rate was 18% (2 of 11). One death was attributed to severe brain injury. The other was attributed to a stroke from the carotid injury. No patient had radiologic progression of traumatic intracranial hemorrhage on head computed tomography despite AP or AC. One patient sustained a mild embolic cerebrovascular ischemic event before stenting. No other survivors developed a stroke or any other evidence of cerebral ischemic symptoms. Two recurrent PAs developed during hospitalization and were successfully managed with an additional stent. All survivors were discharged with a good neurologic outcome. Seven patients had follow-up from 6 months to 4 years: one developed asymptomatic 50% sterrosis at 6 months requiring successful angioplasty. All others showed complete healing without stenosis. Conclusions: Carotid artery stenting is safe and effective initial therapy for patients with nonocclusive BCI and PA. Initial intermediate-term follow-up also fails to demonstrate significant morbidity for up to 4 years.	[Berne, John D.; Villarreal, David H.; McGovern, Thomas M.; Rowe, Stephen A.; Norwood, Scott H.] E Texas Med Ctr, Div Trauma Surg, Tyler, TX USA; [Reuland, Kurt R.] E Texas Med Ctr, Div Radiol, Tyler, TX USA	Berne, JD (corresponding author), 1020 E Idel St, Tyler, TX USA.	jberne@aol.com					Berne JD, 2004, J TRAUMA, V57, P11, DOI 10.1097/01.TA.0000135499.70048.C7; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Brown MM, 2001, LANCET, V357, P1729; Chen DS, 1998, LARYNGOSCOPE, V108, P326, DOI 10.1097/00005537-199803000-00004; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Coldwell DM, 2000, J TRAUMA, V48, P470, DOI 10.1097/00005373-200003000-00016; Cothren CC, 2005, AM J SURG, V190, P845, DOI 10.1016/j.amsurg.2005.08.007; Cothren CC, 2005, ARCH SURG-CHICAGO, V140, P480, DOI 10.1001/archsurg.140.5.480; Cothren CC, 2004, ARCH SURG-CHICAGO, V139, P540, DOI 10.1001/archsurg.139.5.540; Duane TM, 2002, J TRAUMA, V52, P149, DOI 10.1097/00005373-200201000-00025; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Eskandari MK, 2004, ARCH SURG-CHICAGO, V139, P734, DOI 10.1001/archsurg.139.7.734; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; FABIAN TC, 1990, J TRAUMA, V30, P953, DOI 10.1097/00005373-199008000-00003; Fusonie GE, 2004, ANN VASC SURG, V18, P376, DOI 10.1007/s10016-004-0037-2; Gray WA, 2006, J VASC SURG, V44, P258, DOI 10.1016/j.jvs.2006.03.044; HAN MH, 1994, LARYNGOSCOPE, V104, P370; Kerby JD, 2000, J TRAUMA, V49, P784, DOI 10.1097/00005373-200010000-00036; Maras D, 2006, CARDIOVASC INTER RAD, V29, P958, DOI 10.1007/s00270-005-0367-7; Marotta TR, 1998, NEUROSURGERY, V42, P408, DOI 10.1097/00006123-199802000-00138; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Mulloy JP, 1998, RADIOLOGY, V207, P571, DOI 10.1148/radiology.207.3.9609876; Naylor AR, 1998, J VASC SURG, V28, P326, DOI 10.1016/S0741-5214(98)70182-X; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; PALMAZ JC, 1988, RADIOLOGY, V168, P727, DOI 10.1148/radiology.168.3.2970098; PARODI JC, 1995, J VASC SURG, V21, P549, DOI 10.1016/S0741-5214(95)70186-9; Pelz D, 2006, STROKE, V37, P309, DOI 10.1161/01.STR.0000201436.30248.ec; PERRY MO, 1980, ANN SURG, V192, P74, DOI 10.1097/00000658-198007000-00013; Popma JJ, 2004, CHEST, V126, p576S, DOI 10.1378/chest.126.3_suppl.576S; Shames ML, 1999, J TRAUMA, V46, P724, DOI 10.1097/00005373-199904000-00030; Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5; THOMAS MR, 1993, CATHETER CARDIO DIAG, V30, P169, DOI 10.1002/ccd.1810300219; ul Haq Tanveer, 2004, Australas Radiol, V48, P220; VERNEUIL M, 1872, B ACAD NAT MED PARIS, V1, P46; White RA, 2005, J VASC SURG, V42, P213, DOI 10.1016/j.jvs.2005.04.023; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001	44	30	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					398	405		10.1097/TA.0b013e31815eb788			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	264KV	WOS:000253287100031	18301205				2021-06-18	
J	Soustiel, JF; Mahamid, E; Goldsher, D; Zaaroor, M				Soustiel, Jean F.; Mahamid, Eugenia; Goldsher, Dorith; Zaaroor, Menashe			Perfusion-CT for early assessment of traumatic cerebral contusions	NEURORADIOLOGY			English	Article						perfusion-CT; traumatic brain injury; cerebral contusions; cerebral blood flow; cerebral blood volume	POSITRON-EMISSION-TOMOGRAPHY; DYNAMIC COMPUTED-TOMOGRAPHY; SEVERE HEAD TRAUMA; STABLE XENON-CT; BLOOD-FLOW; BRAIN-INJURY; QUANTITATIVE ASSESSMENT; TRANSIT-TIME; ACUTE STROKE; VOLUME	Introduction To investigate the value of perfusion-CT (PCT) for assessment of traumatic cerebral contusions (TCC) and to compare the abilities of early noncontrast CT and PCT modalities to evaluate tissue viability. Methods PCT studies performed in 30 patients suffering from TCC during the acute phase of their illness were retrospectively reviewed. Cerebral blood flow (CBF), volume (CBV) and mean transit time (MTT) were measured in three different areas: the hemorrhagic core of the TCC, the surrounding hypodense area and the perilesional normal-appearing parenchyma. TCC area was measured on CBF-, CBV- and MTT-derived maps and compared with the areas measured using the same slice obtained with CT scans performed on admission, at the time of PCT (follow-up CT) and at 1 week. Results TCC were characterized by low CBF and CBV values (9.2 +/- 6.6 ml/100 g per min and 0.9 +/- 0.7 ml/100 g, respectively) and a significant prolongation of MTT (11.9 +/- 10.7 s) in the hemorrhagic core whereas PCT parameters were more variable in the hypodense area. The TCC whole area showed a noticeable growth of the lesions during the first week of admission. In comparison with early noncontrast CT, CBV and CBF maps proved to be more congruent with the findings of noncontrast CT scans at 1 week. Conclusion PCT confirmed the results of xenon-CT studies and was shown to allow better evaluation of tissue viability than noncontrast CT. These findings suggest that PCT could be implemented in the future for the early assessment of patients with traumatic brain injury.	[Soustiel, Jean F.; Mahamid, Eugenia; Goldsher, Dorith; Zaaroor, Menashe] Technion Israel Inst Technol, Fac Med, Dept Neurosurg, Rambam Med Ctr, IL-31096 Haifa, Israel	Soustiel, JF (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Neurosurg, Rambam Med Ctr, POB 9602, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il					AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Furukawa M, 2002, J COMPUT ASSIST TOMO, V26, P272, DOI 10.1097/00004728-200203000-00019; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Muir KW, 2006, J NEUROL NEUROSUR PS, V77, P334, DOI 10.1136/jnnp.2005.074179; NORMAN D, 1981, AM J ROENTGENOL, V136, P759, DOI 10.2214/ajr.136.4.759; Sakoh M, 2000, STROKE, V31, P1958, DOI 10.1161/01.STR.31.8.1958; Sase S, 2005, J COMPUT ASSIST TOMO, V29, P270, DOI 10.1097/01.rct.0000156400.40836.68; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1998, ACT NEUR S, V71, P127; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sorensen AG, 1999, RADIOLOGY, V210, P519, DOI 10.1148/radiology.210.2.r99fe06519; Soustiel JF, 2006, NEURORADIOLOGY, V48, P670, DOI 10.1007/s00234-006-0099-7; Sviri GE, 2006, NEUROSURGERY, V59, P319, DOI 10.1227/01.NEU.0000222819.18834.33; TEASDALE G, 1974, LANCET, V2, P81; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707	34	30	34	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	FEB	2008	50	2					189	196		10.1007/s00234-007-0337-7			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	257AB	WOS:000252769900012	18040673				2021-06-18	
J	Warner, KJ; Cuschieri, J; Copass, MK; Jurkovich, GJ; Bulger, EM				Warner, Keir J.; Cuschieri, Joseph; Copass, Michael K.; Jurkovich, Gregory J.; Bulger, Eileen M.			Emergency department ventilation effects outcome in severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	37th Annual Meeting of the Western-Trauma-Association	FEB 25-MAR 02, 2007	Steamboat Springs, CO	Western Trauma Assoc		prehospital; intubation; traumatic brain injury; hyperventilation; outcome; target ventilation	RAPID-SEQUENCE INTUBATION; FACILITATE PREHOSPITAL INTUHATION; NEUROMUSCULAR BLOCKING-AGENTS; SEVERE HEAD-INJURY; PROLONGED HYPERVENTILATION; CEREBRAL OXYGENATION; HEMORRHAGIC-SHOCK; ARTERIAL PCO2; HYPOXIA; IMPACT	Background: Recently, we have demonstrated that patients with traumatic brain injury (TBI) with an arrival PaCo2 30 to 35 mm Hg have improved outcome compared with those outside this target range. We sought to determine whether achieving ventilation into a target range would translate into better outcomes in patients with TBI. Methods: Data were retrospectively reviewed for all trauma prehospital intubations during a period of 24 months (n=851). Targeted ventilation was defined as a PaCo2 between 30 and 39 mm Hg. Arterial blood gases collected within 15 minutes of patient arrival were assessed and compared with subsequent arterial blood gases to determine patient's ventilation status over time. Results: There was no difference in patient demographics between various ventilation groups. Patients with TBI who achieved the target range had a mortality of 21.2% compared with 33.7% for those who persistently remained outside this range (p=0.03). Logistic regression demonstrated a trend toward lower mortality for those TBI patients who achieved the target range while in the emergency department (odds ratio 0.33, 95% confidence interval 0.15 - 0.75). Conclusions: Optimal outcome is achieved when the patient is in the target ventilation range on arrival and remains within it. Ventilation status in trauma patients should be closely monitored after intubation to develop an optimal ventilation strategy for patients with severe TBI.	[Warner, Keir J.] Harborview Med Ctr, Seattle, WA 98104 USA; [Warner, Keir J.; Cuschieri, Joseph; Jurkovich, Gregory J.; Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98195 USA; [Copass, Michael K.] Univ Washington, Harborview Med Ctr, Dept Emergency Serv, Seattle, WA 98195 USA	Warner, KJ (corresponding author), Harborview Med Ctr, Box 359796,325 9th Ave, Seattle, WA 98104 USA.	keirw@u.washington.edu					Baker CC, 2005, J TRAUMA, V58, P723; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marion DW, 2000, J TRAUMA, V48, P1032; McSwain NE, 2004, J TRAUMA, V57, P8; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; No authors listed. Rating the severity of tissue damage, 1971, JAMA-J AM MED ASSOC, V215, P277; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; TEASDALE G, 1974, LANCET, V2, P81; van Hulst RA, 2004, CLIN PHYSIOL FUNCT I, V24, P243; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Yosefy C, 2004, EMERG MED J, V21, P557, DOI 10.1136/emj.2003.005819	22	30	31	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					341	347		10.1097/TA.0b013e318160dfb3			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	264KV	WOS:000253287100019	18301196				2021-06-18	
J	Weiss, N; Galanaud, D; Carpentier, A; de Montcel, ST; Naccache, L; Coriat, P; Puybasset, L				Weiss, Nicolas; Galanaud, Damien; Carpentier, Alexandre; de Montcel, Sophie Tezenas; Naccache, Lionel; Coriat, Pierre; Puybasset, Louis			A combined clinical and MRI approach for outcome assessment of traumatic head injured comatose patients	JOURNAL OF NEUROLOGY			English	Article						coma; MRI; TBI; brainstem; outcome	PERSISTENT VEGETATIVE STATE; MAGNETIC-RESONANCE; BRAIN-STEM; PATHOLOGY; LESION; VOLUME; DAMAGE	Traumatic brain injury (TBI) is associated with substantial consumption of health care resources. No clinical or paraclinical examination can reliably predict neurological evolution. In this study, we evaluated the ability of a combined clinical and MRI approach to predict outcome. Methods This prospective study took place between June 2001 and March 2005 in a Neurosurgical Intensive Care Unit in Paris, France. Inclusion criteria were TBI patients still mechanically ventilated and without clinical signs of awareness after 2 weeks. Four clinical signs were assessed after cessation of sedation: grasping, yawning, chewing and paroxysmal sympathetic storm. FLAIR and T2* acquisitions on MRI were used in order to localize brain lesions. Statistically linked regions (clusters) were defined. Outcome was assessed at one year by Glasgow Outcome Scale (GOS). Findings 73 patients were included: 41 had poor outcome (GOS 1-3) and 32 had good outcome (GOS 4-5). Lesions in the clusters "right upper pons and right lower midbrain"," hypothalamus and basal forebrain","left parietal, left temporal, left occipital lobes and left insula" and the presence of grasping or chewing were associated with poor outcome in multivariate analysis. This combined clinical and MRI approach gives a much better prediction than MRI approach only (P < 0.009), with an area under the ROC curve of 0.94 (95 % CI, 0.89-1.00). Interpretation These data suggest that MRI associated with clinical assessment improves outcome prediction in severe TBI patients.	[Weiss, Nicolas; Coriat, Pierre; Puybasset, Louis] Hop La Pitie Salpetriere, Dept Anesthesie Reanimat, Unite NeuroAnesthesie Renanimat, F-75013 Paris, France; [Galanaud, Damien; Carpentier, Alexandre; de Montcel, Sophie Tezenas; Naccache, Lionel] Univ Paris 06, Paris, France; [Galanaud, Damien; Carpentier, Alexandre] Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France; [de Montcel, Sophie Tezenas] Hop La Pitie Salpetriere, AP HP, Biostat & Med Informat Dept, Paris, France; [Naccache, Lionel] Hop La Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France	Puybasset, L (corresponding author), Hop La Pitie Salpetriere, Dept Anesthesie Reanimat, Unite NeuroAnesthesie Renanimat, 47-83 Bd Hop, F-75013 Paris, France.	louis.puybasset@psl.aphp.fr	WEISS, Nicolas/Q-2394-2019; Weiss, Nicolas/E-7345-2011	WEISS, Nicolas/0000-0001-5155-196X; naccache, lionel/0000-0002-2874-1009			Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; DENNYBROWN D, 1958, J NERV MENT DIS, V126, P9, DOI 10.1097/00005053-195801000-00003; DERENZI E, 1992, BRAIN, V115, P293, DOI 10.1093/brain/115.1.293; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; Jordan L M, 1992, Curr Opin Neurobiol, V2, P794, DOI 10.1016/0959-4388(92)90136-9; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Lavigne GJ, 2003, CRIT REV ORAL BIOL M, V14, P30, DOI 10.1177/154411130301400104; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1997, NEUROSURGERY, V40, P440; Mascia MM, 2005, MOVEMENT DISORD, V20, P26, DOI 10.1002/mds.20272; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249	25	30	32	0	4	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY	0340-5354			J NEUROL	J. Neurol.	FEB	2008	255	2					217	223		10.1007/s00415-008-0658-4			7	Clinical Neurology	Neurosciences & Neurology	269HV	WOS:000253641000010	18283406				2021-06-18	
J	Park, C; Cho, IH; Kim, D; Jo, EK; Choi, SY; Oh, SB; Park, K; Kim, JS; Lee, SJ				Park, Chanhee; Cho, Ik-Hyun; Kim, Donghoon; Jo, Eun-Kyeong; Choi, Se-Young; Oh, Seog Bae; Park, Kyoungpyo; Kim, Joong Soo; Lee, Sung Joong			Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						toll-like receptor 2; heme oxygenase-1; glial activation; stab-wound injury	SPINAL-CORD; MICROGLIAL CELLS; GENE-EXPRESSION; WALL COMPONENTS; STAB WOUNDS; RAT; ASTROCYTES; SIGNAL; ENCEPHALOMYELITIS; PROTEIN	Traumatic brain injury is accompanied by glial cell activation around the site of the injury. In this study, we investigated the role of toll-like receptor 2 (TLR2) in glial cell activation using a stab-wound injury (SWI) model with TLR2 knock-out mice. Penetration of a normal mouse brain with a 26-G needle using a stereotaxic instrument resulted in an 18- and 4-fold upregulation of GFAP and CD11b mRNA, respectively, along the needle track in the injury area. However, in the TLR2 knock-out mice, the induced expression of these genes was reduced by 70% and 40%, respectively. Likewise, there was a reduction in the area of activated glial cells detected by immunohistochemistry and the glial cells had a less-activated morphology in the TLR2 knock-out mice. In addition, the expression of the heme oxygenase-1 (HO-1) gene, a glia-expressing wound-responsive gene, was reduced after SWI in TLR2 knock-out mice. Taken together, these data argue that TLR2 contributes to the glial cell activation and HO-1 gene expression associated with traumatic brain injury. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	[Park, Chanhee; Kim, Donghoon; Choi, Se-Young; Oh, Seog Bae; Park, Kyoungpyo; Kim, Joong Soo; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Program Mol & Cell Neurosci,DRI, Seoul 110749, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon, South Korea	Lee, SJ (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Program Mol & Cell Neurosci,DRI, 28 Yeongun-dong, Seoul 110749, South Korea.	sjlee87@snu.ac.kr	Cho, Ik-Hyun/A-9348-2014; OH, Seog Bae/AAQ-2478-2020	Oh, Seog Bae/0000-0001-7975-6895; Eun-Kyeong, Jo/0000-0001-7191-0587; Choi, Se-Young/0000-0001-7534-5167			Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARRETT CP, 1981, EXP NEUROL, V73, P365, DOI 10.1016/0014-4886(81)90272-7; Berman JW, 1996, J IMMUNOL, V156, P3017; Dwyer BE, 1996, MOL BRAIN RES, V38, P251, DOI 10.1016/0169-328X(95)00341-O; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; KIN KJ, 2006, J NEUROSCI, V26, P1880; Laflamme N, 2001, J NEUROCHEM, V79, P648, DOI 10.1046/j.1471-4159.2001.00603.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Orihara Yoshiyuki, 2003, Leg Med (Tokyo), V5 Suppl 1, pS278; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; Park C, 2006, GLIA, V53, P248, DOI 10.1002/glia.20278; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schipper HM, 1999, NEUROTOX RES, V1, P57, DOI 10.1007/BF03033339; SMITH ME, 1983, BRAIN RES, V264, P241, DOI 10.1016/0006-8993(83)90822-3; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; VANDENBRINK WA, 1994, ACTA NEUROCHIR, P456	26	30	31	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 31	2008	431	2					123	128		10.1016/j.neulet.2007.11.057			6	Neurosciences	Neurosciences & Neurology	266MK	WOS:000253439800006	18164130				2021-06-18	
J	Sakellaris, G; Nasis, G; Kotsiou, M; Tamiolaki, M; Charissis, G; Evangeliou, A				Sakellaris, George; Nasis, George; Kotsiou, Maria; Tamiolaki, Maria; Charissis, Giorgos; Evangeliou, Athanasios			Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study	ACTA PAEDIATRICA			English	Article							BRAIN-INJURY; RAT; SUPPLEMENTATION; MITOCHONDRIA; DEFICIENCY; PROTECTS; RECOVERY; MUSCLE; DAMAGE; ADULT	Aim: The complex pathobiology of traumatic brain injury (TBI) offers numerous targets for potential neuroprotective agents. We evaluate the clinical benefit after creatine (Cr) administration in children and adolescents Methods: A prospective, randomized, comparative, open- labelled pilot study of the possible neuroprotective effect of Cr was carried out on 39 children and adolescents, aged between 1 and 18 years of age, with TBI. The Cr was administered for 6 months, at a dose of 0.4 g/kg in an oral suspension form every day. For categorical variables, we used the Chi-square test to identify differences between controls and cases. Statistical significance was defined as a p-value < 0.05 and not statistically significant if p-value > 0.1. Results: The administration of Cr to children and adolescents with TBI improved results in several parameters, including duration of post traumatic amnesia (PTA), duration of intubation, intensive care unit stay. Significant improvement was recorded in the categories of headache (p < 0.001), dizziness (p = 0.005) and fatigue (p < 0.001), aspects in all patients. No side effects were seen due to Cr administration. Conclusion: More specific examinations including brain spectroscopy for in vivo evaluation of Cr can be done, in order to draw conclusions for the optimal duration and manner of Cr supply, as well as its possible role for the prevention of TBI complications, in double blind studies.	[Sakellaris, George; Charissis, Giorgos] Univ Hosp Heraklio, Dept Paediat Surg, Iraklion, Greece; [Nasis, George] 417 Army Share Fund Hosp, Dept Neurol, Athens, Greece; [Kotsiou, Maria; Tamiolaki, Maria] Hippocratio Hosp Thessaloniki, Paediat Intens Care Unit, Thessaloniki, Greece; [Evangeliou, Athanasios] Univ Hosp Heraklio, Dept Paediat, Iraklion, Greece	Sakellaris, G (corresponding author), EL Venizelou 105, GR-70014 P Hersonissou, Greece.	gsakell@mycosmos.gr					Balestrino M, 1999, BRAIN RES, V816, P124, DOI 10.1016/S0006-8993(98)01131-7; BERGER R, 1999, BRAIN RES, V816, P124; Borges N, 2004, INT J NEUROSCI, V114, P217, DOI 10.1080/00207450490249419; EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Eviatar L, 1986, Pediatr Neurol, V2, P61, DOI 10.1016/0887-8994(86)90058-5; Felber S, 2000, NEUROL RES, V22, P145, DOI 10.1080/01616412.2000.11741051; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; Holtzman D, 1998, PEDIATR RES, V44, P410, DOI 10.1203/00006450-199809000-00024; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Schulze A, 2003, ANN NEUROL, V53, P248, DOI 10.1002/ana.10455; Stockler S, 1997, METABOLISM, V46, P1189, DOI 10.1016/S0026-0495(97)90215-8; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C; TEGAS JJ, 1990, J PEDIATR SURG, V25, P92; Wilson Maria-Carmen B, 2006, Curr Pain Headache Rep, V10, P387, DOI 10.1007/s11916-006-0065-4; YLIKOSKI J, 1982, AM J OTOL, V3, P343	24	30	30	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	JAN	2008	97	1					31	34		10.1111/j.1651-2227.2007.00529.x			4	Pediatrics	Pediatrics	251RX	WOS:000252392700007	18053002	Green Published, Bronze			2021-06-18	
J	Schaefer, S; Boegershausen, N; Meyer, S; Ivan, D; Schepelmann, K; Kann, PH				Schaefer, S.; Boegershausen, N.; Meyer, S.; Ivan, D.; Schepelmann, K.; Kann, P. H.			Hypothalamic-pituitary insufficiency following infectious diseases of the central nervous system	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL DIABETES-INSIPIDUS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; HYPOPITUITARISM; MENINGOENCEPHALITIS; ENCEPHALITIS; DYSFUNCTION; MENINGITIS; PANHYPOPITUITARISM; COMPLICATION	Objective: Hypothalamic-pituitary insufficiency may have diverse causes. The aim of this study was to determine the incidence of hypothalamic-pituitary insufficiency in patients with previous infectious diseases of the central nervous system (CNS) of different etiologies and mild-to-moderate clinical course. Design: Patient series. Basal and stimulated (insulin tolerance test) pituitary function testing was performed in 19 patients with previous neuroborreliosis. encephalitis, or meningitis following an interval of between 10 and 5 6 months (mean 2 6.1 +/- 13.1 months) after the acute event. Results: Four patients (21%; two males, two females) showed an isolated corticotropic insufficiency (peak cortisol <181.25 mu g/l during the insulin tolerance test). Two patients (11%, males) showed borderline gonadotropic insufficiency (basal testosterone between 2.4 and 3.0 mu g/l). No patient had somatotropic or thyrotropic insufficiency or evidence for diabetes insipidus: all had prolactin concentrations within the reference range. Conclusions: Hypothalamic-pituitary dysfunction and especially isolated corticotropic insufficiency may develop in a relevant proportion of patients after infectious diseases of the CNS.	[Schaefer, S.; Boegershausen, N.; Meyer, S.; Ivan, D.; Kann, P. H.] Philipps Univ Hosp, Div Endocrinol & Diabetol, D-35033 Marburg, Germany; [Schepelmann, K.] Philipps Univ Hosp, Dept Neurol, D-35033 Marburg, Germany	Schaefer, S (corresponding author), Philipps Univ Hosp, Div Endocrinol & Diabetol, Baldingerstr, D-35033 Marburg, Germany.	stscha@med.uni-marburg.de		Bogershausen, Nina/0000-0003-4300-8224			Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BROOKS MH, 1973, AM J MED, V54, P777, DOI 10.1016/0002-9343(73)90065-X; Canton A, 1996, J NEUROL NEUROSUR PS, V61, P325, DOI 10.1136/jnnp.61.3.325; DEXTER RN, 1995, PRINCIPLES PRACTICE; EDWARDS OM, 1986, MEDICINE, V65, P281; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Franco-Paredes C, 2001, ARCH INTERN MED, V161, P1114, DOI 10.1001/archinte.161.8.1114; GREGER NG, 1986, AM J DIS CHILD, V140, P551, DOI 10.1001/archpedi.1986.02140200061028; HAGG E, 1978, ACTA MED SCAND, V203, P231; HASLAM RHA, 1969, AM J DIS CHILD, V118, P903, DOI 10.1001/archpedi.1969.02100040905017; Ickenstein GW, 1999, FORTSCHR NEUROL PSYC, V67, P476, DOI 10.1055/s-2007-994998; JEW K, 1984, NEUROSURGERY, V14, P567, DOI 10.1227/00006123-198405000-00008; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; KUPARI M, 1980, ACTA ENDOCRINOL-COP, V94, P433, DOI 10.1530/acta.0.0940433; Lee YJ, 1995, J PEDIATR ENDOCR MET, V8, P301; LICHTENSTEIN MJ, 1982, J ENDOCRINOL INVEST, V5, P111, DOI 10.1007/BF03350501; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MADHOUN ZT, 1991, AM J MED, V90, P658, DOI 10.1016/S0002-9343(05)80025-7; MENA W, 1993, J PEDIATR-US, V122, P911, DOI 10.1016/S0022-3476(09)90017-8; Nieschlag E, 2005, EUR UROL, V48, P1, DOI 10.1016/j.eururo.2005.04.027; Richard I., 2001, Annales de Readaptation et de Medecine Physique, V44, P19, DOI 10.1016/S0168-6054(00)00059-3; SUMMERS VK, 1968, BRIT MED J, V1, P359, DOI 10.1136/bmj.1.5588.359; Torres A M, 2000, Endocr Pract, V6, P26; Vesely DL, 2000, AM J MED SCI, V320, P273, DOI 10.1097/00000441-200010000-00008; Woredekal Y, 1998, J Assoc Acad Minor Phys, V9, P22; 1998, J CLIN ENDOCRINOLOGY, V83, P379	30	30	31	0	4	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	JAN	2008	158	1					3	9		10.1530/EJE-07-0484			7	Endocrinology & Metabolism	Endocrinology & Metabolism	255SH	WOS:000252677200002	18166811	Bronze			2021-06-18	
J	Shum, D; Cross, B; Ford, R; Ownsworth, T				Shum, David; Cross, Belinda; Ford, Ruth; Ownsworth, Tamara			A Developmental Investigation of Prospective Memory: Effects of Interruption	CHILD NEUROPSYCHOLOGY			English	Article						Prospective memory; Executive function; Development; Children; Interruption; Prefrontal region	TRAUMATIC BRAIN-INJURY; COLOR-WORD; PERFORMANCE; COMPONENTS; CHILDHOOD; CHILDREN; TESTS	The effects of interrupting an event-based prospective memory (PM) task and its associated ongoing task were compared for two groups of children: 8- to 9-year-olds (n = 35) and 12- to 13-year-olds (n = 28). Additionally, PM performance was examined as a function of attainment on a battery of tests of executive functioning (viz., Controlled Oral Word Association Test, Letter Number Sequencing Test, Stroop Color and Word Test, and Trail Making Test). A significant main effect of age indicated that the older children correctly carried out intended actions more often than the younger children. Consistent with the prefrontal model of PM, interruption had no impact on PM accuracy in the older group but produced reliable decrements to the accuracy of the younger group. Whereas IQ showed no association with PM performance, reliable relations between PM skills and aspects of their executive functioning were found.	[Shum, David] Griffith Univ, Sch Psychol, Nathan, Qld 4111, Australia; Griffith Univ, Appl Cognit Neurosci Res Ctr, Nathan, Qld 4111, Australia	Shum, D (corresponding author), Griffith Univ, Sch Psychol, Nathan, Qld 4111, Australia.	d.shum@griffith.edu.au	Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262; Ownsworth, Tamara/0000-0003-1835-7094			Altmann EM, 2002, COGNITIVE SCI, V26, P39, DOI 10.1207/s15516709cog2601_2; Anderson V., 1995, NEUROPSYCHOLOGICAL A; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Ellis J., 1996, PROSPECTIVE MEMORY T, P115; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golden C., 1978, STROOP COLOUR WORD T; Golden CJ., 2000, NEUROPSYCHOLOGICAL I; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Lehr E, 1990, PSYCHOL MANAGEMENT T; Marlowe WB, 2000, DEV NEUROPSYCHOL, V18, P445, DOI 10.1207/S1532694209Marlowe; Maujean A., 2003, BRAIN IMPAIR, V4, P135, DOI DOI 10.1375/BRIM.4.2.135.27024; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Passolunghi MC, 1995, INT J BEHAV DEV, V18, P631, DOI 10.1177/016502549501800404; Reitan RM, 1979, MANUAL ADM NEUROPSYC; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D. H. K., 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Spreen O., 1998, COMPENDIUM NEUROPSYC; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; WARD HJ, 2004, THESIS GRIFFITH U BR; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; Yakovlev P.I., 1967, RETIONAL DEV BRAIN E, P3	33	30	30	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2008	14	6					547	561	PII 792002276	10.1080/09297040801947051			15	Clinical Neurology	Neurosciences & Neurology	368GK	WOS:000260609400005	18608222				2021-06-18	
J	Wood, RL				Wood, R. Ll.			Long-term outcome of serious traumatic brain injury	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			brain injury; trauma; psychology; outcome; neurobehavoural manifestations	SEVERE HEAD-INJURY; COMA-DATA-BANK; FOLLOW-UP; COMMUNITY INTEGRATION; ALZHEIMERS-DISEASE; PERSONALITY-TRAITS; COPING STRATEGIES; RISK-FACTOR; DISABILITY; PREDICTORS	Follow-up studies on individuals who suffer severe head injury give a picture of poor cognitive and psychosocial outcome. However, recent evidence suggests that with the passage of time, many individuals make adjustments that compensate for early disability, leading to a reduction in social handicap with a corresponding improvement in life quality and personal satisfaction. This article will attempt to briefly review the main sources of evidence contributing to long-term outcome following serious head trauma.	Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales	Wood, RL (corresponding author), Univ Coll Swansea, Dept Psychol, Singleton Pk Campus, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk					Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CORKIN S, 1989, J NEUROSCI, V9, P3876; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Craik F. I. M., 1990, NEUROPSYCHOLOGICAL I, P247; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finset A, 2000, BRAIN INJURY, V14, P887; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Holosko M, 1989, CANADIAN J REHABILIT, V2, P145; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1989, TRAUMATIC BRAIN INJU; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KRIKNESS CJ, 2004, BIOL RES NURS, V5, P299; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Newcombe F, 1996, J CLIN EXP NEUROPSYC, V18, P1, DOI 10.1080/01688639608408258; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Phillips LH, 1998, LEARN INDIVID DIFFER, V10, P217, DOI 10.1016/S1041-6080(99)80131-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith J, 1998, CANADIAN J REHABILIT, V11, P131; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; TESDALE GM, 2004, REPORT CHIEF SCI; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WALKER AE, 1989, ARCH NEUROL-CHICAGO, V46, P23, DOI 10.1001/archneur.1989.00520370025013; Walsh K. W., 1985, UNDERSTANDING BRAIN; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2004, NEUROPSYCHOL REHABIL, V14, P329, DOI 10.1080/09602010343000255; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; WOOD RLI, 2006, BRAIN INJURY, V12, P1; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	67	30	32	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			115	122		10.1017/S0265021507003432			8	Anesthesiology	Anesthesiology	283AY	WOS:000254610100020	18289428				2021-06-18	
J	Droll, KP; Broekhuyse, H; O'Brien, P				Droll, Kurt P.; Broekhuyse, Henry; O'Brien, Peter			Fracture of the femoral head	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							TRAUMATIC POSTERIOR DISLOCATION; TERM-FOLLOW-UP; HIP DISLOCATIONS; INJURY	Fracture of the femoral head is a severe, relatively uncommon injury; typically, it occurs following traumatic posterior dislocation of the hip joint. The Pipkin classification is the most commonly used classification system. Diagnosis is aided by a complete history, physical examination, and imaging, including computed tomography. Treatment consists of urgent closed reduction of the dislocated hip followed by nonsurgical or surgical management of any associated fractures. Controversies include the preferred surgical approach (anterior versus posterior) and whether to perform femoral head fragment excision or internal fixation. Complications associated with fracture of the femoral head and subsequent treatment include osteonecrosis, posttraumatic osteoarthritis, and heterotopic ossification. Fracture of the femoral head has been associated with a relatively poor functional outcome.	Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Orthopaed Surg, Div Orthopaed Trauma, Vancouver, BC V5Z 1M9, Canada	O'Brien, P (corresponding author), Univ British Columbia, Vancouver Gen Hosp, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.						Asghar FA, 2004, ORTHOP CLIN N AM, V35, P463, DOI 10.1016/S0030-5898(04)00042-2; Birkett J, 1869, Med Chir Trans, V52, P133; Brumback R J, 1987, Hip, P181; BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; Cornwall R, 2000, CLIN ORTHOP RELAT R, P84; DAVIS JB, 1950, AM J SURG, V80, P893, DOI 10.1016/0002-9610(50)90473-9; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1961, J BONE JOINT SURG AM, V43, P1079, DOI 10.2106/00004623-196143080-00002; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, V201, P9; Funsten RV, 1938, J BONE JOINT SURG, V20, P124; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; GOULET JA, 2003, SKELETAL TRAUMA BASI, V3, P1657; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; HOUGAARD K, 1987, J BONE JOINT SURG AM, V69A, P679, DOI 10.2106/00004623-198769050-00007; HOWE WW, 1950, J BONE JOINT SURG AM, V32-A, P856, DOI 10.2106/00004623-195032040-00015; Kloen P., 2002, EUROPEAN J TRAUMA, V28, P221, DOI [10.1007/s00068-002-1173-4, DOI 10.1007/S00068-002-1173-4]; LANGSTEVENSON A, 1987, INJURY, V18, P264, DOI 10.1016/0020-1383(87)90011-8; Marchetti ME, 1996, J ORTHOP TRAUMA, V10, P455, DOI 10.1097/00005131-199610000-00002; McKee MD, 1998, J ORTHOP TRAUMA, V12, P223, DOI 10.1097/00005131-199805000-00001; MOED BR, 1993, CLIN ORTHOP RELAT R, P161; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; ROEDER LF, 1980, CLIN ORTHOP RELAT R, V147, P121; ROSENTHAL RE, 1979, J TRAUMA, V19, P572, DOI 10.1097/00005373-197908000-00005; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; SEVITT S, 1965, J Bone Joint Surg Br, V47, P560; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; TRUETA J, 1953, J BONE JOINT SURG BR, V35, P442; UPADHYAY SS, 1985, J BONE JOINT SURG BR, V67, P232	32	30	40	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-151X	1940-5480		J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	DEC	2007	15	12					716	727		10.5435/00124635-200712000-00005			12	Orthopedics; Surgery	Orthopedics; Surgery	238RU	WOS:000251466100005	18063712				2021-06-18	
J	Moser, RS				Moser, Rosemarie Scolaro			The growing public health concern of sports concussion: The new psychology practice frontier	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						concussion; youth; sports; brain; testing	HIGH-SCHOOL	With youth participation in sports at an all-time high, youths have become more vulnerable to the silent epidemic of concussion. Psychologists should become aware of the alarming frequency of mild concussion and the subtle effects of concussion, which often go unnoticed or result in misdiagnosis. This article provides a basic survey of the research and literature on this topic, a simplified knowledge base for understanding updated assessment and management techniques, and a discussion of the important role psychologists can play in educating the public and their patients. Practitioners can become more aware of this developing practice opportunity.	[Moser, Rosemarie Scolaro] RSM Psychol Ctr LLC, Lawrenceville, NJ 08648 USA	Moser, RS (corresponding author), RSM Psychol Ctr LLC, 3131 Princeton Pike,Bldg 5,Suite 110, Lawrenceville, NJ 08648 USA.	r.moser@rcn.com					ALLEN K, 1998, US TODAY        1008, pE1; BARTH JT, 2006, SPORTS NEUROPSYCHOLO, P3; Barth JT., 1989, MILD HEAD INJURY, P257; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton AL, 1978, MULTILINGUAL APHASIA; Bleiberg J., 2006, SPORTS NEUROPSYCHOLO, P263; *BRAIN INJ ASS NEW, 2006, NEWL BRAIN INJ ASS N, P1; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Echemendia RJ, 2006, SPORTS NEUROPSYCHOLO; FERGUSON A, 1999, TIME            0503, P52; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Kaushik T., 2006, SPORTS NEUROPSYCHOLO, P216; Kelly JP, 1997, NEUROLOGY, V48, P581; LAPOINTE J, 1998, NY TIMES        0322, pLSP3; Lovell M.R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; MOSER RS, 2005, SPORTS CONCUSSION PR; PEDULLA T, 1998, US TODAY        0812, pC3; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SEEFELDT VDD, 1996, PCPFS RES DIGEST 2, P19; SOLOMON GS, 2006, HEADS UP SPORT CONCU; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; WEBBE FM, 2006, SPORTS NEUROPSYCHOLO, P45; WECHSLER D, 1977, WECHSLER ADULT INTEL, V3; 1999, NY TIMES        1228	37	30	30	1	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	DEC	2007	38	6					699	704		10.1037/0735-7028.38.6.699			6	Psychology, Multidisciplinary	Psychology	242VC	WOS:000251753300020					2021-06-18	
J	Maurer, MH; Haux, D; Sakowitz, OW; Unterberg, AW; Kuschinsky, W				Maurer, Martin H.; Haux, Daniel; Sakowitz, Oliver W.; Unterberg, Andreas W.; Kuschinsky, Wolfgang			Identification of early markers for symptomatic vasospasm in human cerebral microdialysate after subarachnoid hemorrhage: Preliminary results of a proteome-wide screening	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						aneurysmal or aneurismal subarachnoid hemorrhage; cardiac arrest; cerebral blood flow; cerebral hemodynamics and metabolism; CPR; gender differences; head injury; injury; microdialysis; neurogenesis; neurosurgery; proteomics; stroke; subarachnoid hemorrhage; traumatic brain injury; vasospasm	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NEUROLOGICAL DEFICITS; BEDSIDE MICRODIALYSIS; NUCLEAR TRANSLOCATION; STEM-CELLS; METABOLITES; PREDICTION; ISCHEMIA; EVENTS; OXYGEN	A major complication of aneurysmal subarachnoid hemorrhage (SAH) is symptomatic vasospasm, a complex syndrome consisting of neurological deterioration and exclusion of other sources of ischemia. Approximately 30% of SAH patients are affected. Although symptomatic vasospasm is associated with high mortality and poor clinical outcome, it is not possible to identify the individual risk on a molecular level for patients before symptoms have developed. In this study, we hypothesize that protein changes occur in the cerebral microdialysate of patients who later develop symptomatic vasospasm which are not found in matched-pairs control subjects. We searched for changes in protein concentrations in microdialysate sampled from the fronto- temporal brain tissue of five vasospastic and five nonvasospastic SAH patients using proteomics technology based on two-dimensional gel electrophoresis and mass spectrometry. Microdialysate samples were taken at least 1.5 days before the onset of symptomatic vasospasm. Comparing protein expression profiles, we found that the protein concentrations of several isoforms of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 1.79-fold +/- 1.29 ( N= 5, P < 0.05) higher in the group which later developed symptomatic vasospasm, whereas heat-shock cognate 71 kDa protein (HSP7C) isoforms were decreased to 0.50-fold +/- 0.19 ( N= 5, P < 0.05; all expression data means +/- s. d.). The changes in protein concentrations were detected 3.861.7 days ( N= 5, P < 0.05) before symptomatic vasospasm developed. We conclude that GAPDH and HSP7C may be used as early markers indicating the later development of symptomatic vasospasm after SAH, enabling selective early therapeutic intervention in this high-risk group of patients.	Univ Heidelberg, Dept Physiol & Pathophysiol, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Neurosurg, Heidelberg, Germany	Maurer, MH (corresponding author), Univ Heidelberg, Dept Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	maurer@physiologie.uni-heidelberg.de	Maurer, Martin/AAF-1337-2019	Maurer, Martin/0000-0001-7551-3415			Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Borderie D, 2000, CELL BIOL INT, V24, P285, DOI 10.1006/cbir.2000.0498; Brookes PS, 1997, FEBS LETT, V416, P90, DOI 10.1016/S0014-5793(97)01181-2; Brune B, 1995, Adv Pharmacol, V34, P351; Bulliard C, 1997, BIOCHEM J, V324, P555, DOI 10.1042/bj3240555; Dastoor Z, 2000, J CELL SCI, V113, P2845; DRAKE CG, 1988, J NEUROSURG, V68, P985; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Feldmann RE, 2005, ELECTROPHORESIS, V26, P2749, DOI 10.1002/elps.200410406; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Graven KK, 1998, AM J PHYSIOL-CELL PH, V274, pC347; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; HIJDRA A, 1987, STROKE, V18, P1061, DOI 10.1161/01.STR.18.6.1061; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Macdonald RL, 2003, J NEUROSURG, V99, P644, DOI 10.3171/jns.2003.99.4.0644; Maurer MH, 2006, CURR BIOINFORM, V1, P255, DOI 10.2174/157489306777011969; Maurer Martin H., 2005, Current Proteomics, V2, P179, DOI 10.2174/157016405774641165; Maurer Martin H, 2003, Proteome Sci, V1, P7, DOI 10.1186/1477-5956-1-7; Maurer MH, 2005, J PROTEOME RES, V4, P96, DOI 10.1021/pr049841l; Nakamura T, 2002, BIOCHEM BIOPH RES CO, V290, P858, DOI 10.1006/bbrc.2001.6271; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Peerdeman SM, 2003, J NEUROL, V250, P797, DOI 10.1007/s00415-003-1079-z; Pyne-Geithman GJ, 2005, J CEREBR BLOOD F MET, V25, P1070, DOI 10.1038/sj.jcbfm.9600101; Qureshi AI, 2001, NEUROSURGERY, V49, P607, DOI 10.1097/00006123-200109000-00014; Sakowitz OW, 2001, J CEREBR BLOOD F MET, V21, P1067, DOI 10.1097/00004647-200109000-00004; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Sickman A, 2002, J CHROMATOGR B, V771, P167, DOI 10.1016/S1570-0232(01)00626-2; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; VILO J, 2003, ANAL GENE EXPRESSION	38	30	31	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2007	27	10					1675	1683		10.1038/sj.jcbfm.9600466			9	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	212GV	WOS:000249583200003	17327882	Bronze			2021-06-18	
J	Zhang, S; Zhou, F; Ding, HH; Zhou, XQ; Sun, XL; Hu, G				Zhang, Shu; Zhou, Fang; Ding, Han-Hua; Zhou, Xi-Qiao; Sun, Xiii-Lan; Hu, Gang			ATP-sensitive potassium channel opener iptakalim protects against MPP+-induced astrocytic apoptosis via mitochondria and mitogen-activated protein kinase signal pathways	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; astrocyte; ATP-sensitive potassium channel opener; iptakalim; mitochondria; mitogen-activated protein kinase	JUN NH2-TERMINAL KINASE; TRAUMATIC BRAIN INJURY; CELL-DEATH; IN-VIVO; GLUTATHIONE DEPLETION; DEPENDENT MECHANISM; PARKINSONS-DISEASE; DNA FRAGMENTATION; REGULATED KINASE; OXIDATIVE STRESS	Inhibition of astrocytic apoptosis has been regarded as a novel prospective strategy for treating neurodegenerative disorders such as Parkinson's disease. In the present study, we demonstrated that iptakalim (IPT), an ATP-sensitive potassium channel (K-ATP channel) opener, exerted protective effect on MPP+-induced astrocytic apoptosis, which was reversed by selective mitochondrial KATP channel blocker 5-hydroxydecanoate. Further study revealed that IPT inhibited glutathione (GSH) depletion, mitochondrial membrane potential loss and subsequent release of pro-apoptotic factors (cytochrome c and apoptosis-inducing factor (AIF), and c-Jun NH2-terminal kinase/mitogen-activated protein kinases (MAPK) phosphorylation induced by MPP+. Meanwhile, extracellularsignalregulated kinase (ERK) 1/2 inhibitor PD98059 inhibited the protective effect of IPT on MPP+-induced astrocytic apoptosis. Furthermore, IPT could also activate ERK/MAPK and maintain increased phospho-ERK1/2 level after MPP+ exposure. Taken together, these findings reveal for the first time that IPT protects against MPP+-induced astrocytic apoptosis via inhibition of mitochondria apoptotic pathway and regulating the MAPK signal transduction pathways by opening mitochondrial ATP-sensitive potassium (mitoK(ATP)) channels in astrocytes. And targeting K-ATP channels expressed in astrocytes may provide a novel therapeutic strategy for neurodegenerative disorders.	Nanjing Med Univ, Inst Neurosci, Neuropharmacol Lab, Nanjing 210029, Peoples R China	Hu, G (corresponding author), Nanjing Med Univ, Inst Neurosci, Neuropharmacol Lab, 140 Hanzhong Rd, Nanjing 210029, Peoples R China.	ghu@njmu.edu.cn					Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Anderson CM, 2000, GLIA, V32, P1; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; Benjelloun N, 1998, CELL MOL BIOL, V44, P579; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chiueh C C, 1998, Adv Pharmacol, V42, P796; Cho IH, 2003, J NEUROSCI RES, V74, P736, DOI 10.1002/jnr.10794; CHO Y, 1990, J NEUROCHEM, V55, P2091, DOI 10.1111/j.1471-4159.1990.tb05800.x; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Girolamo LA, 2006, J NEUROSCI RES, V83, P680, DOI 10.1002/jnr.20765; Deutch AY, 2006, NAT MED, V12, P17, DOI 10.1038/nm0106-17; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Hansen JB, 2006, CURR MED CHEM, V13, P361, DOI 10.2174/092986706775527947; Henze C, 2005, J NEUROCHEM, V95, P1069, DOI 10.1111/j.1471-4159.2005.03416.x; Hu LF, 2005, J NEUROCHEM, V94, P1570, DOI 10.1111/j.1471-4159.2005.03306.x; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kobayashi K, 2002, NEUROPATH APPL NEURO, V28, P238, DOI 10.1046/j.1365-2990.2002.00390.x; Kruger N J, 1994, Methods Mol Biol, V32, P9; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Makarov P, 2006, MOL CELL BIOCHEM, V286, P95, DOI 10.1007/s11010-005-9098-y; Mazzanti M, 2001, NEUROSCIENTIST, V7, P396, DOI 10.1177/107385840100700509; McNaught KSP, 2000, BIOCHEM PHARMACOL, V60, P979, DOI 10.1016/S0006-2952(00)00415-9; Nakagawa I, 2005, NEUROSURGERY, V57, P334, DOI 10.1227/01.NEU.0000166681.88736.86; Parrizas M, 1997, J BIOL CHEM, V272, P154; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Saporito MS, 2000, J NEUROCHEM, V75, P1200, DOI 10.1046/j.1471-4159.2000.0751200.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Tai KK, 2003, J NEUROCHEM, V84, P1193, DOI 10.1046/j.1471-4159.2003.01625.x; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Tripanichkul W, 2006, BRAIN RES, V1084, P28, DOI 10.1016/j.brainres.2006.02.029; Wang H, 2004, MOL PHARMACOL, V66, P1160, DOI 10.1124/mol.104.003178; Wang H, 2003, DRUG DEVELOP RES, V58, P65, DOI 10.1002/ddr.10132; Wang S, 2006, NEUROPSYCHOPHARMACOL, V31, P933, DOI 10.1038/sj.npp.1300857; Wang S, 2005, NEUROPHARMACOLOGY, V48, P984, DOI 10.1016/j.neuropharm.2005.01.009; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; WU J, 2005, CURRENT NEUROPHARMAC, V3, P1; Wu J, 2006, J PHARMACOL EXP THER, V319, P155, DOI 10.1124/jpet.106.106286; Xie WP, 2005, EUR J PHARMACOL, V511, P81, DOI 10.1016/j.ejphar.2005.01.039; Yang H, 2006, LIFE SCI, V78, P1940, DOI 10.1016/j.lfs.2005.08.001; Yang Y, 2006, INT J NEUROPSYCHOPH, V9, P51, DOI 10.1017/S1461145705005547; Yang Y, 2005, J NEUROSCI RES, V80, P440, DOI 10.1002/jnr.20467; Yang Y, 2004, NEUROSCI LETT, V366, P53, DOI 10.1016/j.neulet.2004.05.009; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zawar C, 1999, J PHYSIOL-LONDON, V514, P327; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhang Yun, 2004, Yaoxue Xuebao, V39, P980; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	65	30	32	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2007	103	2					569	579		10.1111/j.1471-4159.2007.04775.x			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	223PN	WOS:000250384500013	17635669	Bronze			2021-06-18	
J	Vakili, A; Hosseinzadeh, F; Sadogh, T				Vakili, Abedin; Hosseinzadeh, Fezzeh; Sadogh, Toktam			Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia	BRAIN RESEARCH			English	Article						aminoguanidine; brain edema; BBB permeability; transient focal cerebral ischemic; rat	INFARCT VOLUME; RAT-BRAIN; DIABETIC-NEPHROPATHY; NEUROLOGICAL DEFICIT; ARTERY OCCLUSION; L-ARGININE; DAMAGE; INJURY; MICE; STROKE	Pervious experimental studies have shown that aminoguanidine (AG) is beneficial in the late phase of cerebral ischemia. Recently, it has been reported that AG reduces cerebral edema in traumatic brain injury. However, the effects of AG on post-ischemic cerebral edema and bloodbrain barrier (BBB) permeability are not clear. Under chloral hydrate anesthesia, transient focal cerebral ischemia was induced in rats by 60 min of middle cerebral artery occlusion (MCAO), followed by 23 h of reperfusion. Saline as vehicle or AG at the doses of 75, 150 and 300 mg/kg, i.p., was administered at the beginning or at 1 or 3 h after induction of ischemia. Subsequently, 24 h after MCAO brain edema, BBB permeability and infarct volume were evaluated. Administration of AG (150 mg/kg) at the beginning or at 1 or 3 h after MCAO, significantly reduced cerebral edema (P<0.001), while AG at the doses of 75 and 300 mg/kg had no effect. Moreover, treatment with AG (150 mg/kg) significantly reduces Evans Blue extravasation by 48% into ischemicbrain compared to the saline group (P<0.001). Additionally, AG at the doses of 75 and 150 mg/kg significantly reduces cortical and striatal infarctvolumes (P<0.001), while AG at the dose of 300 mg/kg did not change striatal infarct volumes (P>0.05). Our findings show that AG significantly reduced post-ischemic increase of brain edema with a 3-h therapeutic window in the transient model of focal cerebral ischemia. Moreover, it seems that at least part of the anti-edematous effects of AG is due to decrease of BBB disruption. (c) 2007 Elsevier B.V. All rights reserved.	Semnan Univ Med Sci, Fac Med, Res Ctr Physiol, Lab Cerebrovasc Res, Semnan, Iran; Univ Med Sci, Semnan, Iran	Vakili, A (corresponding author), Semnan Univ Med Sci, Fac Med, Res Ctr Physiol, Lab Cerebrovasc Res, Semnan, Iran.			Vakili, Abedin/0000-0002-4269-9978			Abdel-Rahman E, 2002, EXPERT OPIN INV DRUG, V11, P565, DOI 10.1517/13543784.11.4.565; Cash D, 2001, BRAIN RES, V905, P91, DOI 10.1016/S0006-8993(01)02508-2; CHAN PH, 1994, BRAIN PATHOL, V4, P59; Cockroft KM, 1996, STROKE, V27, P1393, DOI 10.1161/01.STR.27.8.1393; Danielisova V, 2004, PHYSIOL RES, V53, P533; Ding-Zhou L, 2002, EUR J PHARMACOL, V457, P137, DOI 10.1016/S0014-2999(02)02686-9; Giardino I, 1998, DIABETES, V47, P1114, DOI 10.2337/diabetes.47.7.1114; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; HATASHITA S, 1990, STROKE, V21, P581; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Iadecola C, 1995, AM J PHYSIOL, V268, P286; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; KAZACHKOV M, J PHARM EXP THER; Kondo T, 1997, J NEUROSCI, V17, P4180; KUCUK M, 2002, LIFE SCI, V12, P493; LADECOLA C, 1995, J CEREBR BLOOD FLOW, V15, P378; LASZLO F, 1995, EUR J PHARMACOL, V272, P169, DOI 10.1016/0014-2999(94)00637-M; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Nagayama M, 1998, J CEREBR BLOOD F MET, V18, P1107, DOI 10.1097/00004647-199810000-00007; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SLIVKA A, 1995, STROKE, V26, P1061, DOI 10.1161/01.STR.26.6.1061; Sugimoto K, 2002, NEUROSCI LETT, V331, P25, DOI 10.1016/S0304-3940(02)00834-0; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taguchi T, 2002, INT CONGR SER, V1245, P435, DOI 10.1016/S0531-5131(02)01009-9; Takizawa S, 1999, J CEREBR BLOOD F MET, V19, P667, DOI 10.1097/00004647-199906000-00010; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Vakili Abedin, 2006, Daru, V14, P31; Vakili A, 2007, BRAIN RES, V1144, P186, DOI 10.1016/j.brainres.2007.01.096; YAGIHASHI S, 1992, DIABETES, V41, P47, DOI 10.2337/diabetes.41.1.47; Yang GY, 1999, MOL BRAIN RES, V69, P135, DOI 10.1016/S0169-328X(99)00007-8; Yildiz G, 1998, BRIT J PHARMACOL, V124, P905, DOI 10.1038/sj.bjp.0701924; Zhang FY, 1998, BRAIN RES, V802, P104, DOI 10.1016/S0006-8993(98)00557-5; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; ZHANG XM, 1990, AM J PHYSIOL, V259, pH497; ZIMMERMAN GA, 1995, P NATL ACAD SCI USA, V92, P3744, DOI 10.1073/pnas.92.9.3744	38	30	31	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	SEP 19	2007	1170						97	102		10.1016/j.brainres.2007.07.016			6	Neurosciences	Neurosciences & Neurology	219ZN	WOS:000250126800011	17698046				2021-06-18	
J	Lambooij, E; Pilarczyk, M; Bialowas, H; van den Boogaart, JGM; van de Vis, JW				Lambooij, E.; Pilarczyk, M.; Bialowas, H.; van den Boogaart, J. G. M.; van de Vis, J. W.			Electrical and percussive stunning of the common carp (Cyprinus carpio L.): Neurological and behavioural assessment	AQUACULTURAL ENGINEERING			English	Article						common carp; Cyprinus carpio L.; electrical stunning; concussion stunning; EEG; ECG; behaviour	CATFISH CLARIAS-GARIEPINUS; ANGUILLA-ANGUILLA L.; FISH; WELFARE; PAIN; SLAUGHTER	The overall objective of the study was to evaluate electrical and percussive stunning methods under laboratory conditions in common carps. The electrical current needed to induce a general epileptiform insult was assessed in 13 carps. The insult was obtained by delivering a current of 0.24 +/- 0.03 A (163 +/- 1 V; 50 Hz, a.c.) to the head, via scissor-model stunning tongs for approximately 1 s. The duration of the tonic, the clonic and the exhaustion phases were I I 4 s, 5 3 s and 20 14 s on the EEG, respectively. An actual clonic phase was observed in two fish. The total duration of the insult was 31 14 s. The heart rate was 22 +/- 12 beats/min prior to stunning while after stunning, the ECG revealed fibrillation for 18 +/- 7 s and was irregular. The behaviour of 10 individual carp, which were allowed to move freely in water, was recorded following head-only stunning (164 V, 0.23 +/- 0.6 A). The duration of the tonic phase was approximately 10 s and the fish started fin movements after 48 +/- 8 s and resumed swimming after 121 +/- 83 s. A general epileptiform insult could be induced in carps (n = 25) by passing an electrical current through fresh water using 0.14 +/- 0.03 A/dm(2) (113 +/- 17 V; electrode distance 16 cm) for 1 s at a water conductivity of 200 mu S/cm. Twenty three carps were rendered unconscious and insensible during electrical stunning in fresh water, using 0.73 +/- 0.05 A/dm(2) (411 +/- 2 V; electrode distance 16 cm) for 5 s at a water conductivity of 330 mu S/cm, followed by chilling in ice water. As a second stunning procedure, carps were stunned mechanically using a percussion pistol at a maximal velocity of 10.99 +/- 0.88 J. Evidence of unconsciousness and insensibility of the carps was provided by the appearance of theta, delta waves and spikes on the EEG, which were proceeded by no brain activity. However, two carp responded after 0.5 min to administered pain stimuli and one carp after 3 min. It may be concluded from this study that common carp are effectively stunned in fresh water. The application of an electrical current of 0.73 A/dm(2) (26 V/cm, 50 Hz, a.c., 330 mu S/cm) to individual carps in a tank in combination with chilling in ice water is an effective procedure for slaughter. The mechanical method of percussion stunning did not provide assurance of effective stunning as not all carp were unconscious and insensible after its administration. (c) 2007 Elsevier B.V. All rights reserved.	Wageningen UR, Div Anim Husb, Anim Sci Grp, NL-8200 AB Lelystad, Netherlands; Wageningen IMARES BV, NL-1970 AB Ijmuiden, Netherlands; Wageningen UR, Anim Sci Grp, NL-6700 AH Wageningen, Netherlands; Polish Acad Sci, Ins Ichthyobiol & Aquaculture, PL-43520 Chybie, Poland	Lambooij, E (corresponding author), Wageningen UR, Div Anim Husb, Anim Sci Grp, POB 8200, NL-8200 AB Lelystad, Netherlands.	bert.lambooij@wur.nl					Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; DOWGIALLO A, 2005, J POLISH ARG U, V8; Dubin D., 1999, SNELLE INTERPRETATIE, P69; HEWITT L, 1999, POULTRY MEAT SCI, P422; JOHNSON NL, 1969, DISCRETE DISTRIBUTIO, P59; KESTIN SC, 1995, INT C AQ EUR 95 TRON, P380; KESTIN SC, 1994, PAIN STRESS FISH ROY, P366; Kooi K.A., 1978, FUNDAMENTALS ELECTRO, P125; Lambooij E, 2004, ANIM WELFARE, V13, P71; Lambooij E, 2003, AQUAC RES, V34, P1353, DOI 10.1046/j.1365-2109.2003.00966.x; Lambooij E, 2002, AQUACULTURE, V210, P159, DOI 10.1016/S0044-8486(02)00050-9; Lambooij E, 2002, AQUAC RES, V33, P643, DOI 10.1046/j.1365-2109.2002.00677.x; LAMBOOY E, 1982, MEAT SCI, V6, P15, DOI 10.1016/0309-1740(82)90047-X; LAMBOOY E, 1982, MEAT SCI, V6, P123, DOI 10.1016/0309-1740(82)90022-5; LAMBOOY E, 1981, VET REC, V109, P359, DOI 10.1136/vr.109.16.359; LANBOOIJ E, 2004, ELECT STUNNING ENCY, P1342; Lines J, 2004, AQUACULTURE, V241, P219, DOI 10.1016/j.aquaculture.2004.07.023; Lopes daSilva H.F., 1983, STUNNING ANIMALS SLA, P3; Meek J., 1998, P759; OVERMIER JB, 1990, NEUROBIOLOGY COMP CO, P205; Robb DHF, 2000, VET REC, V147, P298, DOI 10.1136/vr.147.11.298; Robb DHF, 2002, ANIM WELFARE, V11, P269; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; TESCH FW, 1999, AAL, P18; van de Vis H, 2003, AQUAC RES, V34, P211, DOI 10.1046/j.1365-2109.2003.00804.x; Verheijen FJ, 1997, AQUAC RES, V28, P361; WAGENEDER FM, 1967, P 1 INT S GRAZ AUSTR, P95; WIEPKEMA PR, 1997, ANIMAL CONSCIOUSNESS, P93	31	30	31	2	29	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0144-8609	1873-5614		AQUACULT ENG	Aquac. Eng.	SEP	2007	37	2					171	179		10.1016/j.aquaeng.2007.04.004			9	Agricultural Engineering; Fisheries	Agriculture; Fisheries	199HL	WOS:000248686700010					2021-06-18	
J	Dobkin, BH				Dobkin, Bruce H.			Curiosity and cure: Translational research strategies for neural repair-mediated rehabilitation	DEVELOPMENTAL NEUROBIOLOGY			English	Article						rehabilitation; stroke; spinal cord injury; neural repair; animal models	SPINAL-CORD-INJURY; OLFACTORY ENSHEATHING CELLS; CENTRAL-NERVOUS-SYSTEM; MORRIS WATER MAZE; CELLULAR TRANSPLANTS; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; AXON REGENERATION; CLINICAL-TRIALS; TRAUMATIC BRAIN		Univ Calif Los Angeles, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA 90095 USA	Dobkin, BH (corresponding author), Univ Calif Los Angeles, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA 90095 USA.	bdobkin@mednet.ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050838] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007479] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24 HD 050838, R24 HD050838, R24 HD039629, R01 HD06740, HD39629, T32 HD0741] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS007479] Funding Source: Medline		Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Anderson DK, 2005, SPINAL CORD, V43, P453, DOI 10.1038/sj.sc.3101746; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Bury SD, 2002, J NEUROSCI, V22, P8597; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; Dobkin B.H., 2003, CLIN SCI NEUROLOGIC; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Dobkin BH, 2005, NEUROREHAB NEURAL RE, V19, P276, DOI 10.1177/1545968305281892; Dobkin BH, 2004, ANNU REV MED, V55, P255, DOI 10.1146/annurev.med.55.091902.104338; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Dobkin BH, 2007, STROKE, V38, P832, DOI 10.1161/01.STR.0000248408.49398.9c; Dong Y, 2006, STROKE, V37, P1552, DOI 10.1161/01.STR.0000221281.69373.4e; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Geisler FH, 2001, SPINE, V26, pS68, DOI 10.1097/00007632-200112151-00014; Gharbawie OA, 2006, NEUROSCIENCE, V137, P1107, DOI 10.1016/j.neuroscience.2005.10.043; Gonzalez CLR, 2000, BEHAV BRAIN RES, V112, P43, DOI 10.1016/S0166-4328(00)00162-5; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Guest J, 2006, SPINAL CORD, V44, P135, DOI 10.1038/sj.sc.3101820; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hoang TX, 2006, NEUROSCIENCE, V138, P1149, DOI 10.1016/j.neuroscience.2005.11.066; Ibrahim A, 2006, LANCET NEUROL, V5, P453, DOI 10.1016/S1474-4422(06)70444-6; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Koski L, 2004, NEUROREHAB NEURAL RE, V18, P230, DOI 10.1177/1545968304269210; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Li SL, 2005, NEUROBIOL DIS, V18, P432, DOI 10.1016/j.nbd.2004.12.014; Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Mazevet D, 2003, BRAIN, V126, P988, DOI 10.1093/brain/awg088; Mills CD, 2001, J NEUROTRAUM, V18, P743, DOI 10.1089/089771501316919111; MOSELEY AM, 2005, COCHRANE DB SYST REV, V4; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichols CM, 2005, BEHAV BRAIN RES, V163, P143, DOI 10.1016/j.bbr.2005.05.003; Nothias JM, 2005, NEUROREHAB NEURAL RE, V19, P296, DOI 10.1177/1545968305281209; Oka S, 2004, BRAIN RES, V1030, P94, DOI 10.1016/j.brainres.2004.09.062; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; RALSTON DD, 1985, J COMP NEUROL, V242, P325, DOI 10.1002/cne.902420303; Ramos JMJ, 2002, NEUROBIOL LEARN MEM, V77, P109, DOI 10.1006/nlme.2000.3997; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Strangman G, 2005, NEUROREHAB NEURAL RE, V19, P93, DOI 10.1177/1545968305275284; Tuszynski MH, 2007, DEV NEUROBIOL, V67, P1204, DOI 10.1002/dneu.20510; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Tuszynski MH, 2002, J COMP NEUROL, V449, P88, DOI 10.1002/cne.10266; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; van der Harst JE, 2003, BEHAV BRAIN RES, V142, P151, DOI 10.1016/S0166-4328(02)00403-5; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Webb AA, 2005, BEHAV BRAIN RES, V165, P147, DOI 10.1016/j.bbr.2005.07.025; Webb AA, 2003, BEHAV BRAIN RES, V144, P143, DOI 10.1016/S0166-4328(03)00076-7; WHISHAW I, 2004, BEHAV LAB RAT HDB T; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577; Ziemann U, 2006, NEUROREHAB NEURAL RE, V20, P243, DOI 10.1177/1545968306287154	94	30	31	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	AUG	2007	67	9					1133	1147		10.1002/dneu.20514			15	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	197CZ	WOS:000248532600002	17514711	Green Accepted			2021-06-18	
J	Heegaard, W; Biros, M				Heegaard, William; Biros, Michelle			Traumatic brain injury	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article							RECOMBINANT-FACTOR-VIIA; ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; COMA SCALE SCORE; ENDOTRACHEAL INTUBATION; INTRACRANIAL HYPERTENSION; HYPERTONIC SALINE; SODIUM-CHLORIDE; IMPACT; CONCUSSION	Traumatic brain injury (TBI) refers to the potential for significant injury to the brain parenchyma following head trauma. This article covers pertinent principles, management approaches, and current controversies in severe, moderate, and minor TBI. Controversies covered include hypertonic saline (HTS) for increased intracranial pressure (ICP), prehospital intubation of patients who have experienced TBI, and the use of recombinant factor VIIa (rFVIIa). Traumatic head injury has plagued humankind since the beginning of civilization. The writings of Hippocrates refer to trephination [1], and early writings on the practice of neurosurgery describe the management of head trauma. Although the most common mechanism for TBI has changed since antiquity from assaults to motor vehicle-associated injuries, TBI remains the single largest cause of trauma morbidity and accounts for nearly one third of all trauma deaths (Fig. 1) [2-4]. An estimated 1.1 million patients are evaluated each year in emergency departments for acute TBI [3]. TBI occurs most. often in young people, with a peak incidence at 15 to 24 years of age [4]. Smaller peaks occur in children younger than 5 years of age and in individuals older than 85 years [4]. Child abuse is common in children younger than 4 years of age who present with severe to moderate TBI (Fig. 2) [5]. TBI is commonly categorized by means of the Glasgow Coma Scale (GCS) [6] as severe (GCS <= 8), moderate (GCS 9-13), and minor (GCS 14-15). Severe TBI accounts for approximately 10% of all cases, whereas moderate TBI accounts for another 10%; the remaining 80% are classified as minor [4].	Univ Minnesota, Sch Med, Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA	Heegaard, W (corresponding author), Univ Minnesota, Sch Med, Hennepin Cty Med Ctr, Dept Emergency Med, 701 Pk Ave S, Minneapolis, MN 55415 USA.	emdoc@yahoo.com					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; Bell Scott E, 2006, Curr Treat Options Neurol, V8, P167, DOI 10.1007/s11940-006-0007-9; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; BRITT P, 2000, HEAD INJURY, P27; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BULLOCK MR, 2000, J NEUROTRAUM, V17, P471; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHILES B, 1994, NEUROSURGICAL EMERGE, P73; COLOHAN ART, 1992, J NEUROTRAUM, V9, pS259; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; CRUZ J, 1998, NEUROLOGIC NEUROSURG, P405; Davies B, 2003, J EXP BOT, V54, P3; Davis D P, 2001, Prehosp Emerg Care, V5, P163, DOI 10.1080/10903120190940065; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gaab M R, 1990, Adv Neurol, V52, P391; GAAB MR, 1990, ACT NEUR S, V51, P320; Graham DI GT, 2000, HEAD INJURY, P133; GREENBERG M, 1997, GREEBERG GRAPHICS; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HEEGAARD WG, 2006, ROSENS EMERGENCY MED, P349; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kraus J, 2000, HEAD INJURY, P1; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; LLOYD GER, 1978, HIPPOCRATIC WRITINGS; MACLAREN RE, 1993, ARCH EMERG MED, V10, P138; MAHONEY BD, 1981, NEUROSURGERY, V8, P551, DOI 10.1227/00006123-198105000-00006; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Mayer SA, 2007, STROKE, V38, P763, DOI 10.1161/01.STR.0000254499.46122.22; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; Monro A, 1783, OBSERVATION STRUCTUR; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN R, 1994, PRINCIPLES NEUROSURG, P235; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; REIVICH M, 1964, AM J PHYSIOL, V206, P25; ROCKSWOLD G, 1996, EMERGEN MED, P913; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; Schierhout G, 2001, COCHRANE DB SYST REV, V4; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHAW N, 2002, NEUROPHYSIOLOGY CONC; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stein DM, 2005, J TRAUMA, V59, P609, DOI 10.1097/01.ta.0000177655.67763.df; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Weed LH, 1919, AM J PHYSIOL, V48, P531; Weiner H. L., 2000, HEAD INJURY, P419; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WILBERGER J, 2000, HEAD INJURY, P63; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Zwienenberg M, 2001, HEAD TRAUMA, P303; 1997, MMWR MORB MORTAL WKL, V46, P224	83	30	34	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2007	25	3					655	+		10.1016/j.emc.2007.07.001			25	Emergency Medicine	Emergency Medicine	216OF	WOS:000249886900006	17826211				2021-06-18	
J	Hamberger, MJ; Palmese, CA; Scarmeas, N; Weintraub, D; Choi, H; Hirsch, LJ				Hamberger, Marla J.; Palmese, Christina A.; Scarmeas, Nikolaos; Weintraub, David; Choi, Hyunmi; Hirsch, Lawrence J.			A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy	EPILEPSIA			English	Article						epilepsy; memory; donepezil; acetylcholine; acetylcholinesterase inhibitor	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CLINICAL-TRIALS; OPEN-LABEL; DEMENTIA; ADULTS; ACETYLCHOLINE; VOLUNTEERS	Purpose: To determine whether an acetylcholinesterase inhibitor, such as donepezil, would improve memory or other cognitive/psychological functions in epilepsy patients with subjective memory complaints. Methods: Twenty-three epilepsy patients with subjective memory difficulty were randornized to either 3 months of donepezil (10 mg/day) or 3 months of placebo treatment, and then crossed over to the other treatment arm. Patients and physicians were blinded to treatment phase throughout data acquisition. Assessment of memory and other cognitive functions, subjective memory, mood, and self-rated quality of life (QOL) and social functioning was performed at baseline and following completion of both treatment phases. Seizure frequency and severity as well as treatment emergent adverse effects were also monitored. Results: Donepezil treatment was not associated with improvement in memory or other cognitive functions, mood, social functioning or QOL. Comparable increases in self-rated memory functioning relative to baseline were evident during donepezil and placebo phases. Donepezil treatment was not associated with increased seizure frequency or severity. Similar to group results, analysis of change within individual patients as a function of treatment phase also showed neither significant benefit nor detriment associated with donepezil. Conclusion: This study found no benefit on memory or other cognitive/psychological functions in a heterogeneous group of epilepsy patients with subjective memory difficulty. Further investigation would be required to determine whether individual patients, or those with particular epilepsy syndromes, might benefit front donepezil or other acetylcholinesterase inhibitors, or if a higher dosage might he effective.	Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA	Hamberger, MJ (corresponding author), Neurol Inst, 710 W 168th St,Box 100, New York, NY 10032 USA.	mh61@columbia.edu	Scarmeas, Nikolaos/AAD-2512-2020; Scarmeas, Nikolaos/AAD-2517-2020	Scarmeas, Nikolaos/0000-0001-6453-8908; Scarmeas, Nikolaos/0000-0001-6453-8908; Hirsch, Lawrence/0000-0002-6333-832X			Albert SM, 1997, NEUROLOGY, V49, P38, DOI 10.1212/WNL.49.1.38; [Anonymous], 2007, PHYS DESK REFERENCE; Barkai E, 1997, MOL NEUROBIOL, V15, P17, DOI 10.1007/BF02740613; Beglinger LJ, 2005, J CLIN PSYCHOPHARM, V25, P159, DOI 10.1097/01.jcp.0000155822.51962.b4; Beglinger LJ, 2004, J PSYCHOPHARMACOL, V18, P102, DOI 10.1177/0269881104040248; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Burt T, 1999, BIOL PSYCHIAT, V45, P959, DOI 10.1016/S0006-3223(98)00320-5; Corcoran R, 1992, SEIZURE SA, V1, P14; Cummings JL, 2000, AM J GERIAT PSYCHIAT, V8, P134, DOI 10.1176/appi.ajgp.8.2.134; Fisher RS, 2001, EPILEPSY BEHAV, V2, P330, DOI 10.1006/ebeh.2001.0221; Golden C., 1978, STROOP COLOR WORD TE; Gron G, 2005, PSYCHOPHARMACOLOGY, V182, P170, DOI 10.1007/s00213-005-0043-2; Hermann B, 1995, J CLIN EXP NEUROPSYC, V17, P809, DOI 10.1080/01688639508402430; Hermann B P, 1996, Clin Nurs Pract Epilepsy, V3, P4; HERMANN BP, 1987, ANN NEUROL, P585; JACOBS LW, 1991, P 9 INT ASH US S, V3, P59; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Joschko M., 1991, CLIN NEUROPSYCHOL, V5, P53; Klove H, 1963, CLIN NEUROPSYCHOLOGY; Krupp LB, 2004, NEUROLOGY, V63, P1579, DOI 10.1212/01.WNL.0000142989.09633.5A; Lorr M, 1971, MANUAL PROFILE MOOD; Lutz MT, 2004, EPILEPSIA, V45, P809, DOI 10.1111/j.0013-9580.2004.54003.x; Martin R, 2005, EPILEPSY BEHAV, V7, P297, DOI 10.1016/j.yebeh.2005.05.003; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; MEADOR KJ, 1993, EPILEPSIA, V34, P153, DOI 10.1111/j.1528-1157.1993.tb02389.x; Mori S, 2006, PSYCHIAT CLIN NEUROS, V60, P190, DOI 10.1111/j.1440-1819.2006.01485.x; Muir JL, 1997, PHARMACOL BIOCHEM BE, V56, P687, DOI 10.1016/S0091-3057(96)00431-5; Passmore AP, 2005, J NEUROL SCI, V229, P141, DOI 10.1016/j.jns.2004.11.017; PERRINE K, 1995, ARCH NEUROL-CHICAGO, V52, P997, DOI 10.1001/archneur.1995.00540340089017; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rupniak NMJ, 1997, PSYCHOPHARMACOLOGY, V131, P406, DOI 10.1007/s002130050310; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Smith A., 1982, SYMBOL DIGIT MODALIT; STAFINIAK P, 1990, NEUROLOGY, V40, P1509, DOI 10.1212/WNL.40.10.1509; TURSKI L, 1986, BRAIN RES, V398, P37, DOI 10.1016/0006-8993(86)91247-3; VICKREY BG, 1993, EPILEPSIA S4, V34, P22; Vickrey BG, 1993, QUALITY LIFE EPILEPS; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	41	30	32	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUL	2007	48	7					1283	1291		10.1111/j.1528-1167.2007.01114.x			9	Clinical Neurology	Neurosciences & Neurology	190HF	WOS:000248049200007	17484756	Bronze			2021-06-18	
J	Koskinen, S; Hokkinen, EM; Sarajuuri, J; Alaranta, L; Alaranta, H				Koskinen, Sanna; Hokkinen, Eeva-Maija; Sarajuuri, Jaana; Alaranta, LicPsych; Alaranta, Hannu			Applicability of the icf checklist to traumatically brain-injured patients in post-acute rehabilitation settings	JOURNAL OF REHABILITATION MEDICINE			English	Article						ICF; checklist; traumatic brain injury; rehabilitation; agreement	INTERNATIONAL CLASSIFICATION; NEUROLOGICAL CONDITIONS; HEALTH ICF; CORE SET; DISABILITY; IDENTIFICATION; MEDICINE; FACILITIES; CATEGORIES; SCALE	Objective: To evaluate the applicability of the International Classification of Functioning, Disability and Health (ICF) checklist in post-acute traumatically brain-injured patients in rehabilitation settings. Design: A cross-sectional study based on the written documents of an interdisciplinary rehabilitation team. Subjects: A sample of 55 patients with traumatic brain injury. Methods: Two raters extracted information from the patients' medical documents using the ICF checklist. The most common ICF categories were identified and the agreement between the raters was evaluated. Results;: Of the 123 checklist categories, 30 reached a prevalence of 30% or more in the ratings of both raters, and 18 further categories reached a prevalence of 30% or more in the ratings of either one rater. Seventy-five categories (61%) did not reach the cut-off point and were thus considered irrelevant. Fourteen ICF categories not included in the checklist were also considered important. Extracting the data from pre-existing documents seems to be reliable: in 86% of the most relevant categories the difference between the raters in the qualifier values was at most 1. Conclusion: A checklist is a practical tool in clinical work. However, the current ICF checklist seems not to be adequate in characterizing patients with post-acute traumatic brain injury. Developing an ICF core set for these patients might prove useful.	Kapyla Rehabil Ctr, FI-00251 Helsinki, Finland	Koskinen, S (corresponding author), Kapyla Rehabil Ctr, Synapsia,POB 103, FI-00251 Helsinki, Finland.	sannakos@gmail.com	Sarajuuri, Jaana/AAD-8665-2019	Sarajuuri, Jaana/0000-0002-6432-0295			Alaranta H, 2000, Wien Med Wochenschr, V150, P444; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Ewert T, 2005, DISABIL REHABIL, V27, P367, DOI 10.1080/09638280400014014; Ewert T, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410015362; FLEISS JL, 1981, STAT METHODS RATES P, P140; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Grill E, 2005, DISABIL REHABIL, V27, P459, DOI 10.1080/09638280400014063; KOSKINEN S, 2001, 49 FIN SOC SEC HLTH, P179; Lantz CA, 1996, J CLIN EPIDEMIOL, V49, P431, DOI 10.1016/0895-4356(95)00571-4; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stier-Jarmer M, 2005, DISABIL REHABIL, V27, P389, DOI 10.1080/09638280400014022; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Stucki G, 2004, J REHABIL MED, V36, P5, DOI 10.1080/16501960410022300; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Weigl M, 2004, J REHABIL MED, V36, P12, DOI 10.1080/16501960410015443; *WHO, 2004, TOIM TOIM TERV KANS; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2001, INT CLASS FUNCT DIS	27	30	31	0	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUL	2007	39	6					467	472		10.2340/16501977-0077			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	192TR	WOS:000248226400006	17624481	DOAJ Gold			2021-06-18	
J	Yurgel, VC; Ikuta, N; Da Rocha, AB; Lunge, VR; Schneider, RF; Fonseca, ASK; Grivicich, I; Zanoni, C; Regner, A				Yurgel, Virginia Campello; Ikuta, Nilo; Da Rocha, Adriana Brondani; Lunge, Vagner Ricardo; Schneider, Rogerio Fett; Kazantzi Fonseca, Andre Salvador; Grivicich, Ivana; Zanoni, Caroline; Regner, Andrea			Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males	JOURNAL OF NEUROTRAUMA			English	Article						plasma DNA; prognostic marker; real; time PCR; traumatic brain injury	GLASGOW COMA SCALE; TRAUMATIC BRAIN-INJURY; SERUM S-100B PROTEIN; INTRACRANIAL-PRESSURE; FETAL DNA; MATERNAL PLASMA; S100B; MANAGEMENT; MORTALITY; DAMAGE	The prediction of outcome is one of the major problems associated with traumatic brain injury. Recently, investigations have been performed on the potential use of circulating cell-free DNA in plasma for clinical diagnosis and prognosis of a variety of conditions. In this study, we investigated DNA plasma concentrations after severe traumatic brain injury (TBI) and its correlation with primary outcome. We studied 41 male victims of TBI, with isolated severe TBI or severe TBI with associated exracranial injuries. Control samples were obtained from 13 healthy male volunteers. Plasma DNA was measured by a real-time PCR assay for the beta-globin gene. The mean time for first sampling (study entry) was 11.7 +/- 5.2 h after injury; subsequent DNA determinations were performed 24 h after study entry. Mean plasma DNA concentrations were significantly increased in TBI patients (366,485 and 131,708 kilogenomes-equivalents/L, at study entry and 24 h later, respectively) compared with the control group (3031 kilogenomes-equivalents/L). Additionally, a significant correlation between higher plasma DNA concentrations, determined 24 h after study entry, and fatal outcome was observed. However, at second sampling, there was no significant correlation between plasma DNA concentrations and the presence of associated extracranial injuries. High plasma DNA concentrations at second sampling time predicted fatal outcome with a sensitivity of 67% and specificity of 76%, considering a cut-off value of 77,883 kilogenomes-equivalents/L. Thus, this study showed that severe TBI is associated with elevated DNA plasma levels and suggests that persistent DNA elevations correlate with mortality.	ULBRA, Ctr Pesquisa Ciencias Med, Lab Marcadores Estresse Celular, BR-92425900 Bairro Sao Jose Canoas, RJ, Brazil; Univ Luterana Brasil, Curso Med, Canoas, Brazil; Univ Luterana Brasil, Programa Posgrad Genet & Toxicol Aplicada, Canoas, Brazil; Univ Luterana Brasil, Programa Posgrad Diagnost Genet & Mol, Canoas, Brazil; Simbios Biotecnol, Rio Grande do Sul, Brazil; Hosp Municipal Pronto Socorro Porto Alegre, SAMU, Porto Alegre, RS, Brazil	Regner, A (corresponding author), ULBRA, Ctr Pesquisa Ciencias Med, Lab Marcadores Estresse Celular, Avenida Farroupilha 8001,Predio 22,5 Andar, BR-92425900 Bairro Sao Jose Canoas, RJ, Brazil.	regner@uol.com.br	Grivicich, Ivana/A-6777-2013; Regner, Andrea/M-2596-2014; Lunge, Vagner/D-7915-2013	Grivicich, Ivana/0000-0001-9820-5730; Regner, Andrea/0000-0002-6657-7991; Lunge, Vagner/0000-0003-4012-8650			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Basso A, 2001, WORLD J SURG, V25, P1174; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Burns S, 2004, ANN NY ACAD SCI, V1022, P323; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; FACKELMAYER FO, 2001, CANCER RES, V61, P1659; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnson PJ, 2002, CLIN CHEM, V48, P1186; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Navratil O, 2006, Bratisl Lek Listy, V107, P110; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rothoerl RD, 1999, BRAIN INJURY, V13, P387; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Wang BG, 2003, CANCER RES, V63, P3966; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZAGARA G, 1992, J NEUROSURG SCI, V35, P77; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	44	30	33	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2007	24	7					1172	1181		10.1089/neu.2006.0160			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	186DV	WOS:000247760200008	17610356				2021-06-18	
J	Saboori, M; Ahmadi, M; Farajzadegan, Z				Saboori, Masih; Ahmadi, Mal; Farajzadegan, Zahra			Indications for brain CT scan in patients with minor head injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						minor head injury; brain CT scan; head traurna; mild head injury; computed tomography; traumatic brain injury	COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; INITIAL MANAGEMENT; TRAUMA; RISK; GUIDELINES; EXPERIENCE; ADMISSION; DIAGNOSIS; RULE	Objectives: Minor head injury is the most common type of head injury. Despite of high incidence and numerous studies performed, there is much controversy about correct evaluation of these patients. The aim of this study was to find clinical signs and symptoms which help to predict the indications for brain CT scan following minor head injury. Methods: A series of 682 consecutive patients who had been attended at two university hospitals (Alzahra and Kashani) with minor head injury (GCS = 15) were prospectively enrolled in this cohort study. In all cases clinical signs and symptoms were collected and a cranial computerized tomography (CT) scan was obtained. The relationship between the occurrence of clinical findings and appearance of intracranial posttraumatic lesions on cranial CT was analyzed by chi-square tests and statistic logistic regression methods, with 95% confidence intervals. Results: Of 682 patients, 46 (6.7%) presented brain injuries on CT scan. All patients with abnormal CT scans had at least one of the following factors (risk factors): posttraumatic amnesia, loss of consciousness, posttraumatic seizure, headache, vomiting, focal neurological deficit, skull fracture, coagulopathy or antecedent of treatment with anticoagulants and patient age older than 60 years. No abnormal CT scans were found among patients without any of those risk factors on admission. Vomiting, skull fracture and age greater than 60 years were risk factors significantly correlated to an abnormal cranial CT after head injury. The presence of several risk factors in a patient increased the probability of posttraumatic lesion on CT scan. Conclusion: Some clinical risk factors can be used as a guide to predict the probability of abnormal CT following minor head injury. (C) 2007 Elsevier B.V. All rights reserved.	Med Univ Isfahan, Dept Neurosurg, Sch Med, Esfahan, Iran; Isfahan Med Sch, Community Med Dept, Esfahan, Iran	Ahmadi, M (corresponding author), Med Univ Isfahan, Dept Neurosurg, Sch Med, Esfahan, Iran.	masih_saboori@yahoo.com; j_ahmadi@Resident.mui.ac.ir	saboori, masih/C-5247-2018	farajzadegan, ziba/0000-0001-8548-2843; Saboori, masih/0000-0002-1782-778X			Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Bellner J, 1999, Lakartidningen, V96, P5196; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brell M, 2001, NEUROCIRUGIA, V12, P105; DUUS BR, 1994, ANN EMERG MED, V23, P1279, DOI 10.1016/S0196-0644(94)70352-3; Eng J, 2003, NEUROIMAG CLIN N AM, V13, P273, DOI 10.1016/S1052-5149(03)00015-7; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; GETE Y, 2001, ULUS TRAVMA DERG, V7, P189; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; GREENBERG MS, 2004, HDB NEUROSURGERY, P626; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hung CC, 1996, J FORMOS MED ASSOC, V95, P294; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; LEVITT MA, 1994, ANN EMERG MED, V23, P1143; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MILLER EC, 1997, J EMERGENCY MED, V15, P435; Miller PF, 1996, SRA-J SOC RES ADMIN, V27, P3; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; Rees PM, 2004, ARCH PHYS MED REHAB, V85, P862, DOI 10.1016/j.apmr.2004.03.002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Romner B, 2000, Lakartidningen, V97, P3186; Sacco Frank, 2004, Alaska Med, V46, P58; SERVADEI F, 1993, SURG NEUROL, V39, P269, DOI 10.1016/0090-3019(93)90003-J; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Servadei F, 2004, YOUMANS NEUROSURGICA, P5065; SHACKFORD SR, 1993, J TRAUMA, V35, P490, DOI 10.1097/00005373-199309000-00031; Shiomi N, 2004, NEUROL SURG TOKYO, V32, P465; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Viola L, 2000, ACTA NEUROCHIR, V142, P1281, DOI 10.1007/s007010070026; Von Wild K, 2001, BRAIN INJURY, V15, P273; WILKE GM, 2000, AM J EMERG MED, V18, P159; 1996, J NEUROSURG SA, V40, P11	46	30	32	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2007	109	5					399	405		10.1016/j.clineuro.2007.01.013			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	171UN	WOS:000246761000002	17350162				2021-06-18	
J	Glang, A; McLaughlin, K; Schroeder, S				Glang, Ann; McLaughlin, Karen; Schroeder, Susan			Using interactive multimedia to teach parent advocacy skills: An exploratory study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						advocacy; communication skills; interactive multimedia; parent training; traumatic brain injury; Web-based training	TRAUMATIC BRAIN-INJURY; PROBLEM-SOLVING INTERVENTION; PRELIMINARY EFFICACY; FAMILY INTERVENTION; ACADEMIC PLACEMENT; SOCIAL SUPPORT; CHILDREN; TERM; REHABILITATION; ADAPTATION	Objective: To examine the efficacy of Brain Injury Partners: Advocacy Skills for Parents, an interactive multimedia intervention that provides training in educational advocacy skills for parents of children with traumatic brain injury (TB I). Design: Randomized trial, with participants assigned to treatment (Brain Injury Partners CD-ROM) or control (alternate CD-ROM) conditions. Main Outcome Measures: Knowledge; skill application; and attitude, behavioral intention, and self efficacy to use key advocacy skills. Participants: Thirty-one parents of children with TBI. Results: The Brain Injury Partners group reported higher postintervention adjusted means for application, knowledge, and attitudes scale scores than did the control group. Conclusions: The results demonstrate the utility of a computer-delivered intervention for training parents in key skills for communicating with school personnel.	Oregon Ctr Appl Sci, Eugene, OR 97401 USA	Glang, A (corresponding author), Oregon Ctr Appl Sci, 260 E 11th Ave, Eugene, OR 97401 USA.	aglang@orcasinc.com			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R44HD042892, R43HD042892] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42892] Funding Source: Medline		Ajzen I., 1980, UNDERSTANDING ATTITU, V278; Ajzen I., 2000, EUR REV SOC PSYCHOL, V11, P1, DOI [10.1080/14792779943000116, DOI 10.1080/14792779943000116]; ALLEN DA, 1987, MENT RETARD, V25, P133; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Balcazar FE, 1996, MENT RETARD, V34, P341; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1977, SOCIAL LEARNING THEO; Bandura A, 1997, SELFEFFICACY EXERCIS; Beauchamp N, 2005, GERONTOLOGIST, V45, P793, DOI 10.1093/geront/45.6.793; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; *BRAIN RES INF NET, 2002, TENN BRAIN INJ COAL; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Centers for Disease Control and Prevention, NAT CTR HLTH STAT IN; Chapman PM, 2000, ENVIRON TOXICOL CHEM, V19, P3, DOI [10.1897/1551-5028(2000)019&lt;0003:WETTUL&gt;2.3.CO;2, 10.1002/etc.5620190102]; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conoley J.C., 1997, CHILDHOOD TRAUMATIC, P177; DEPOMPEI R, 1999, REHABILITATION ADULT, P393; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Duncan TE, 2000, J BEHAV MED, V23, P59, DOI 10.1023/A:1005420304147; *ED TEST SERV, 1991, FOCUS, V26, P1; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; FEHRMANN PG, 1987, J EDUC RES, V80, P330, DOI 10.1080/00220671.1987.10885778; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GLANG A, 1996, CHILDREN ACQUIRED BR, P149; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Henderson AnneT., 1987, EVIDENCE CONTINUES G; HOOD D, 1999, FAMILY ADVOCACY SKIL; HOOD DR, 2001, HDB FAMILY ADVOCATES; Hourcade JJ, 2001, EDUC TRAIN MENT RET, V36, P272; Irvine AB, 2004, HEALTH EDUC RES, V19, P290, DOI 10.1093/her/cyg027; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kosciulek J.F., 1998, J APPL REHABILITATIO, V29, P8; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Leathem J, 1996, BRAIN INJURY, V10, P27; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; MARTIN R, 1988, J LEARN DISABIL, V21, P471, DOI 10.1177/002221948802100804; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; PLUNGE M, 1996, BEHAV APPROACH ASSES, P583; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; SELIGMAN M, 1983, FAMILY HANDICAPPED C; SKINNER CS, 1994, AM J PUBLIC HEALTH, V84, P43, DOI 10.2105/AJPH.84.1.43; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TURNBULL AP, 1986, FAMILIES PROFESSIONA; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Walker B., 1989, SUPPORT CAREGIVING F, P103; Walker B.R., 1996, STUDENTS ACQUIRED BR, P295; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	69	30	30	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					198	205		10.1097/01.HTR.0000271121.42523.3a			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100007	17510596				2021-06-18	
J	Soreide, K; Ellingsen, CL; Knutson, V				Soreide, Kjetil; Ellingsen, Christian Lycke; Knutson, Vibeke			How dangerous is BASE jumping? An analysis of adverse events in 20,850 jumps from the Kjerag Massif, Norway	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						athletic injuries; mortality; risk-taking; multiple injuries; prevention; rescue	INJURY SEVERITY SCORE; PARACHUTE INJURIES; FATALITIES; RISK; BEHAVIORS	Background: Extreme sports, including BASE (building, antenna, span, earth) jumping, are rapidly increasing in popularity. Associated with risk for injuries and deaths, this activity may pose a burden on the emergency system. Hitherto, no reports exist on accidents and deaths associated with BASE jumping. Methods: We reviewed records of 20,850 BASE jumps from 1995 to 2005 at the Kjerag massif in Norway. Frequency of deaths, accidents, and involvement of helicopter and climbers in rescue are analyzed. Fatalities were scored for injury severity scores (Abbreviated Injury Scale score, Injury Severity Score, New Injury Severity Score) on autopsy. Results: During an 11-year period, a total of 20,850 jumps (median, 1,959; range, 400-3,000) resulted in 9 fatal (0.04% of all jumps; I in every 2,317 jumps) and 82 nonfatal accidents (0.4% of all jumps; 1 in every 254 jumps). Accidents increased with the number of jumps (r = 0.66; p = 0.007), but fatalities did not increase, nor did activation of helicopter or climbers in rescue (p > 0.05). Helicopter activation (in one-third of accidents) in rescue correlated with number of accidents (r = 0.76, p = 0.007), but not climbers. Postmortem examination (n = 7) of fatalities revealed multiple, severe injuries (Abbreviated Injury Scale score >= 3) sustained in several body regions (median, Injury Severity Score 75; range, 23-75). Most nonfatal accidents were related to ankle sprains/fracture, minor head concussion, or a bruised knee. Conclusion: BASE jumping appears to hold a five- to eightfold increased risk of injury or death compared with that of skydiving. The number of accidents and helicopter activation increases with the annual number of jumps. Further analysis into the injury severity spectrum and associated hospital burden is required.	Univ Hosp, Dept Pathol, N-4068 Stavanger, Norway; Univ Stavanger, Dept Hlth Studies, Acutr Care Med Res Network, Stavanger, Norway	Soreide, K (corresponding author), Univ Hosp, Dept Pathol, POB 8100, N-4068 Stavanger, Norway.	ksoreide@mac.com	Soreide, Kjetil/A-9797-2010	Soreide, Kjetil/0000-0001-7594-4354			*AAAM, 2001, ABBR INJ SCAL AIS 19; Amoroso PJ, 1998, J TRAUMA, V45, P575, DOI 10.1097/00005373-199809000-00028; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrows TH, 2005, J EMERG MED, V28, P63, DOI 10.1016/j.jemermed.2004.07.008; CHUBB RM, 1964, AEROSPACE MED, V35, P962; Dawson M, 1998, INJURY, V29, P573; Ellitsgaard N, 1989, Br J Sports Med, V23, P27; ELLITSGAARD N, 1989, J SPORT MED PHYS FIT, V29, P405; Ellitsgaard N, 1987, Br J Sports Med, V21, P13; Field CA, 2001, J TRAUMA, V50, P13, DOI 10.1097/00005373-200101000-00002; Griffith JD, 2002, PERCEPT MOTOR SKILL, V94, P1089, DOI 10.2466/PMS.94.2.1089-1090; Hart CL, 2003, PERCEPT MOTOR SKILL, V97, P390, DOI 10.2466/PMS.97.6.390-392; Lee CT, 1999, INJURY, V30, P283, DOI 10.1016/S0020-1383(99)00083-2; LOWDON IMR, 1989, INJURY, V20, P257, DOI 10.1016/0020-1383(89)90161-7; MELLEN PF, 1990, AVIAT SPACE ENVIR MD, V61, P1149; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pain MT, 2005, LANCET, V366, pS33, DOI 10.1016/S0140-6736(05)67838-5; Patel D R, 2000, Adolesc Med, V11, P141; PIRSON J, 1990, MIL MED, V155, P383; PIRSON J, 1985, AVIAT SPACE ENVIR MD, V56, P564; Schmidt MD, 2005, INJURY PREV, V11, P163, DOI 10.1136/ip.2004.006304; Spain DA, 1997, J TRAUMA, V43, P423, DOI 10.1097/00005373-199709000-00006; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Westman A, 2005, ACCIDENT ANAL PREV, V37, P1040, DOI 10.1016/j.aap.2005.06.002; Young Craig C, 2002, Curr Sports Med Rep, V1, P306	25	30	30	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2007	62	5					1113	1117		10.1097/01.ta.0000239815.73858.88			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	168OF	WOS:000246533200010	17495709				2021-06-18	
J	Ward, H; Shum, D; McKinlay, L; Baker, S; Wallace, G				Ward, Heather; Shum, David; McKinlay, Lyn; Baker, Simone; Wallace, Geoff			Prospective memory and pediatric traumatic brain injury: Effects of cognitive demand	CHILD NEUROPSYCHOLOGY			English	Article							WORKING-MEMORY; FRONTAL-LOBE; HEAD-INJURY; EXPLICIT MEMORY; CHILDREN; PERFORMANCE; CHILDHOOD; TASK; IMPLICIT; LESIONS	This study investigated the effects of pediatric traumatic brain injury (TBI) on prospective memory. Fourteen children and 14 adolescents with TBI were compared with 25 and 23 noninjured children and adolescents, respectively. Based on a prefrontal model, the cognitive demand on the ongoing component of a prospective-memory task was manipulated. Overall, those with TBI had poorer prospective-memory performance than their noninjured peers. Performance was worse in a high cognitive-demand condition than a low, and younger children performed worse than adolescents. Decreases in performance from the low- to high-demand conditions were not significantly different between the two children's groups but were between the two adolescents' groups. Furthermore, the age and injury effects were reflected in the performances on executive function tests: the Self-ordered Pointing Task (SOPT), and the Stroop Color Word Interference Test The Tower of London (TOL), which did not produce age or injury effects, was nevertheless found to be an important predictor of performance on the high-demand task in those with TBI. Although previous research has demonstrated impaired prospective memory performance in children with TBI, this study attempted to explain why this might occur, specifically that the prefrontal regions might be implicated.	Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Appl Cognit Neurosci Res Ctr, Brisbane, Qld 4111, Australia; Royal Childrens Hosp, Queenland Paediat Rehabil Serv, Brisbane, Qld, Australia; Mater Childrens Hosp, Brisbane, Qld, Australia	Shum, D (corresponding author), Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia.	d.shum@griffith.edu.au	Wallace, Geoff/H-1252-2013; Shum, David/A-3914-2008	Wallace, Geoff/0000-0001-9306-3542; Shum, David/0000-0002-4810-9262; McKinlay, Lynne/0000-0002-6677-0628			ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adelson PD, 1999, TRAUMATIC BRAIN INJU, P283; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; BROADBENT NJ, 2002, NEUROPSYCHOLOGY MEMO, P3; *CEDR CORP, 1966, SUPERLAB PRO EXP LAB; CLUTTERBUCK PM, 1990, ART TEACHING SPELLIN; DAIGNEAULT S, 1993, J CLIN EXP NEUROPSYC, V15, P881, DOI 10.1080/01688639308402605; DIAMOND A, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P339; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golden CJ., 2000, NEUROPSYCHOLOGICAL I; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; HITCH GJ, 1988, MEM COGNITION, V16, P120, DOI 10.3758/BF03213479; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; Holbourn AHS, 1943, LANCET, V2, P438; Howell D.C., 1999, FUNDAMENTAL STAT BEH, V4th; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Leynes PA, 2003, CONSCIOUS COGN, V12, P1, DOI 10.1016/S1053-8100(02)00002-8; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; MAUJEAN A, 2003, BRAIN IMPAIRMENT; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Raizner RD, 2002, DEV NEUROPSYCHOL, V21, P1, DOI 10.1207/S15326942DN2101_1; RUSSO R, 1995, J EXP CHILD PSYCHOL, V59, P566, DOI 10.1006/jecp.1995.1026; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Shum D, 2000, BRAIN COGNITION, V44, P59; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Shum D. H. K., 1990, CLIN NEUROPSYCHOL, V4, P141; SNODGRASS JG, 1989, IMPLICIT MEMORY THEO, P261; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tanner J.M., 1990, FOETUS MAN PHYS GROW; The Psychological Corporation, 1999, WECHSL ABBR SCAL INT; TUNSTALL J, 1999, UNPUB IMPROVING UTIL; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Yamadori A, 1996, COGNITIVE BRAIN RES, V5, P49, DOI 10.1016/S0926-6410(96)00040-7; YIVISAKER M, 1998, TRAUMATIC BRAIN INJU, P1	51	30	31	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	MAY	2007	13	3					219	239		10.1080/09297040600910003			21	Clinical Neurology	Neurosciences & Neurology	164BR	WOS:000246208100002	17453831				2021-06-18	
J	Krakau, K; Hansson, A; Karlsson, T; de Boussard, CN; Tengvar, C; Borg, J				Krakau, Karolina; Hansson, Annette; Karlsson, Torbjorn; de Boussard, Catharina Nygren; Tengvar, Christer; Borg, Jorgen			Nutritional treatment of patients with severe traumatic brain injury during the first six months after injury	NUTRITION			English	Article						traumatic brain injury; parenteral nutrition; enteral nutrition; oral feeding; level of independence; malnutrition	SEVERE HEAD-INJURY; ENERGY-EXPENDITURE; NITROGEN-EXCRETION; ENTERAL NUTRITION; METABOLIC CHANGES; ESPEN GUIDELINES; SECONDARY; INSULT; REHABILITATION; REQUIREMENTS	Objective: This study explored current nutritional treatment policies and nutritional outcome in patients with severe traumatic brain injury. Methods: We performed a retrospective, structured survey of the medical records of 64 patients up to 6 months after injury or until the patients were independent in nutritional administration. Results: Enteral nutrition was administered to 86% of patients. Fourteen patients (22%) had a gastrostomy; after 6 months four were still in use. At 6 months, 92% of patients received all food orally and 84% had gained nutritional independence. Energy intake was equal to the calculated basal metabolic rate throughout the first month after injury and increased by 21% during the second month. Sixty-eight percent exhibited signs of malnourishment with weight losses of 10-29%. Conclusion: This study suggests that most patients with severe traumatic brain injury regain their nutritional independence within the first 6 months after injury, but also that most develop signs of malnutrition. (c) 2007 Elsevier Inc. All rights reserved.	Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden; Danderyd Hosp, Dept Rehabil Med Stockholm, Stockholm, Sweden; Karolinska Univ Hosp, Dept Neurosurg Intens Care, Stockholm, Sweden; Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care, Uppsala, Sweden; Cent Hosp Vasteras, Dept Rehabil Med, Vasteras, Sweden	Krakau, K (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden.	karolina.krakau@ds.se		Borg, Jorgen/0000-0002-2372-7478			Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aquilani R, 2000, ARCH PHYS MED REHAB, V81, P176, DOI 10.1016/S0003-9993(00)90137-0; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; *BRAIN TRAUMA FDN, 2000, NUTR J NEUROTRAUMA, V17, P539; BRANSON R D, 1990, Respiratory Care, V35, P640; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; CHARLIN V, 1993, REV MED CHILE, V121, P626; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; DICKERSON RN, 1990, J AM COLL NUTR, V9, P86; DOLCE G, 2002, POST TRAUMATIC VEGET, P22; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; FELL D, 1984, CRIT CARE MED, V12, P649, DOI 10.1097/00003246-198408000-00009; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; FUGAZZA G, 1998, EUROPA MEDICOPHYSICA, V34, P125; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Harris JA, 1919, BIOMETRIC STUDY BASA, P223; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Klodell CT, 2000, AM J SURG, V179, P168, DOI 10.1016/S0002-9610(00)00297-X; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Loser C, 2005, CLIN NUTR, V24, P848, DOI 10.1016/j.clnu.2005.06.013; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; Ott L, 1999, J NEUROTRAUM, V16, P233, DOI 10.1089/neu.1999.16.233; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stechmiller J, 1994, J Neurosci Nurs, V26, P224; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; THOMSON MA, 2000, P NUTR SOC LOND, V60, pA83; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yanagawa T, 2002, COCHRANE DB SYST REV; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	50	30	36	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007			NUTRITION	Nutrition	APR	2007	23	4					308	317		10.1016/j.nut.2007.01.010			10	Nutrition & Dietetics	Nutrition & Dietetics	159ES	WOS:000245848800005	17369022				2021-06-18	
J	Truettner, JS; Hu, BR; Alonso, OF; Bramlett, HM; Kokame, K; Dietrich, WD				Truettner, Jessie S.; Hu, Bingren; Alonso, Ofelia F.; Bramlett, Helen M.; Kokame, Koichi; Dietrich, W. Dalton			Subcellular stress response after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						hypoxia; stress genes; subcellular; traumatic brain injury; unfolded protein response	UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CORTICAL SPREADING DEPRESSION; CEREBRAL BLOOD-FLOW; CIS-ACTING ELEMENT; CELL-DEATH PROGRAM; ER STRESS; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; GENE-EXPRESSION	Traumatic brain injury (TBI) initiates a complex genetic response that may include the expression of organelle specific stress genes. We investigated the effects of brain trauma on the expression of a number of stress genes by in situ hybridization and Western blot analysis including the endoplasmic reticulum (ER) stress gene grp78, ER protein processing enzymes calnexin and protein disulphide isomerase (PDI), the mitochondrial stress gene hsp60, and the cytoplasmic stress gene hsp70. Male Sprague-Dawley rats were subjected either to sham-surgery or moderate (1.8-2.2 atm) parasagittal fluid-percussion (F-P) brain injury followed by 30 min of either normoxic or hypoxic (30-40 mm Hg) gas levels. Expression of grp78 was increased in the ipsilateral cerebral cortex and dentate gyrus beginning 4 h after trauma plus hypoxia. Similarly, mRNA encoding the mitochondrial hsp60 was induced in the ipsilateral outer cortical layers at 4-24 h after TBI plus hypoxia. Calnexin and PDI mRNAs were not significantly altered following TBI with or without secondary hypoxia. In contrast, mRNA of the cytoplasmic hsp70 was strongly induced at 4 h after brain injury in multiple brain regions within the injured hemisphere, and this expression was greatly enhanced by secondary hypoxia. Because subcellular stress gene expression may reflect where unfolded or damaged proteins are abundant, these findings suggest that abnormal proteins are localized mainly in the cytoplasm, and to a lesser degree in the ER lumen and mitochondria after brain trauma. Thus, distinct parts of the cellular machinery respond to traumatic and metabolic stresses in specific ways.	Univ Miami, Miami Project Cure Paralysis, Sch Med, Dept Neurol Surg, Miami, FL 33101 USA; Univ Miami, Miami Project Cure Paralysis, Sch Med, Dept Neurol, Miami, FL 33101 USA; Univ Miami, Miami Project Cure Paralysis, Sch Med, Neurotrauma Res Ctr, Miami, FL 33101 USA; Natl Cardiovasc Ctr, Inst Res, Osaka, Japan	Dietrich, WD (corresponding author), Univ Miami, Miami Project Cure Paralysis, Sch Med, Dept Neurol Surg, POB 016960,R-48, Miami, FL 33101 USA.	ddietrich@miami.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [NINDS 30291, NINDS 42133] Funding Source: Medline		Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; Bertolotti A, 2000, NAT CELL BIOL, V2, P326; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chesnut R M, 1995, New Horiz, V3, P366; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Corydon TJ, 2005, MOL GENET METAB, V85, P260, DOI 10.1016/j.ymgme.2005.04.003; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Dietrich WD, 2000, J CEREBR BLOOD F MET, V20, P103, DOI 10.1097/00004647-200001000-00014; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harding HP, 1999, NATURE, V397, P271; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; HOVDA DA, 1990, ACT NEUR S, V51, P331; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KADA T, 2002, BIOCHEM J, V366, P585; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim BH, 2002, J EXP BOT, V53, P371, DOI 10.1093/jexbot/53.367.371; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Knowlton AA, 2001, AM J PHYSIOL-HEART C, V280, pH455; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee KH, 2002, BIOCHEM BIOPH RES CO, V298, P216, DOI 10.1016/S0006-291X(02)02423-3; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; LONGO FM, 1993, J NEUROSCI RES, V36, P325, DOI 10.1002/jnr.490360310; LOWENSTEIN DH, 1994, BRAIN RES MOL BRAIN, V22, P229; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin J, 1997, J BIOENERG BIOMEMBR, V29, P35, DOI 10.1023/A:1022407705182; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Motoyama S, 2004, SHOCK, V22, P234, DOI 10.1097/01.shk.0000132459.68561.f4; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Pan YX, 2004, J CARDIOVASC PHARM, V44, pS117, DOI 10.1097/01.fjc.0000166234.11336.a9; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Paschen W, 1999, J CEREBR BLOOD F MET, V19, P1, DOI 10.1097/00004647-199901000-00001; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reddy RK, 2002, CANCER RES, V62, P7207; Rissanen A, 2006, BRAIN RES, V1087, P60, DOI 10.1016/j.brainres.2006.02.095; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Romano CC, 2004, INT IMMUNOPHARMACOL, V4, P1067, DOI 10.1016/j.intimp.2004.04.013; Schneeloch E, 2004, NEUROSCI LETT, V368, P37, DOI 10.1016/j.neulet.2004.06.061; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Siman R, 2001, J BIOL CHEM, V276, P44736, DOI 10.1074/jbc.M104092200; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Xu XH, 2006, BRAIN RES, V1102, P154, DOI 10.1016/j.brainres.2006.04.111; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; ZILLES L, 1985, STEREOTAXIC ATLAS	80	30	36	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2007	24	4					599	612		10.1089/neu.2006.0186			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	159NE	WOS:000245872000003	17439344				2021-06-18	
J	Schultheis, MT; Rehimbas, J; Mourant, R; Millis, SR				Schultheis, Maria T.; Rehimbas, Jose; Mourant, Ronald; Millis, Scott R.			Examining the usability of a virtual reality driving simulator	ASSISTIVE TECHNOLOGY			English	Article						virtual reality; driving; cognition; user feedback; usability; human factors	REHABILITATION; PERFORMANCE	The current study examined specific aspects of usability of a newly developed VR driver rehabilitation (VR-DR) system. Measures of user feedback and user comfort were examined among 54 participants: 33 individuals with acquired brain injury (20 with traumatic brain injury and 13 with cerebral vascular accident) and 21 healthy controls. All participants were administered the VR-DR and completed the VR-DR User Feedback Questionnaire. To examine group differences, a one-way analysis of variance was performed, comparing the user feedback total score between the three groups. The results indicated that the two clinical populations (traumatic brain injury and cerebral vascular accident) varied from the nonclinical population (healthy controls). A standard multiple regression analysis revealed that age was the only significant participant factor that contributed to the differences in user feedback ratings. Finally, consistent across the three groups, a distinct relationship was found between the self-reported user rating and the onset of simulation sickness. The current findings indicate that individuals with traumatic brain injury and cerebral vascular accident provided less favorable user feedback ratings than healthy controls in the use of a new VR-DR system. This difference was not accounted for by differences in gender, education, or cognitive status and was only slightly accounted for by age. Delineating these various aspects of user feedback can assist in identifying potential confounds in VR-DR performance and help refine the application of the VR-DR for clinical decision making.	Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Northeastern Univ, Dept Mech Engn, Boston, MA 02115 USA; Rehabil Inst Michigan, Detroit, MI USA	Schultheis, MT (corresponding author), Drexel Univ, Dept Psychol, 3141 Chestnut St,PSA 218, Philadelphia, PA 19104 USA.	schultheis@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Brooks BM, 2003, NEUROREHABILITATION, V18, P147; Burdea G, 1997, Stud Health Technol Inform, V39, P141; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; HIMELSTEIN J, 2003, J INT NEUROPSYCH SOC, V9, P236; HIX D, 2005, 28 INT C REH ENG ASS; HIX D, 2002, HDB VIRTUAL ENV, P701; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; MATHEIS R, 2003, P 2 INT WORKSH VIRT; McComas J, 2002, CYBERPSYCHOL BEHAV, V5, P185, DOI 10.1089/109493102760147150; Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x; Preece J., 1994, HUMAN COMPUTER INTER; Rizzo M, 2004, TRANSPORT RES REC, P1; Scerbo M. W., 2005, HUMAN FACTORS ERGONO, V48, P1; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; Schultheis MT, 2001, NEUROLOGY, V56, P1089, DOI 10.1212/WNL.56.8.1089; SCHULTHEIS MT, 2001, ANN C NEW JERS BRAIN; SCHULTHEIS MT, 2005, 11 ANN M INT HUM COM; SCHULTHEIS MT, 2004, ARCH CLIN NEUROPSYCH, V19, P905; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wald J, 2001, ST HEAL T, V81, P564; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	24	30	30	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.	SPR	2007	19	1					1	8		10.1080/10400435.2007.10131860			8	Rehabilitation	Rehabilitation	155XA	WOS:000245610700001	17461285				2021-06-18	
J	Zhang, ZY; Zhang, ZR; Fauser, U; Artelt, M; Burnet, M; Schluesener, HJ				Zhang, Zhiyuan; Zhang, Zhiren; Fauser, Uwe; Artelt, Matthias; Burnet, Michael; Schluesener, Hermann J.			FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						traumatic brain injury; FTY720; MHC-II; EMAP-II; monocytes	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ACTIVATING POLYPEPTIDE-II; SPINAL-CORD; INFLAMMATORY RESPONSE; LYMPHOCYTE EGRESS; HUMAN MICROGLIA; AXONAL INJURY; HLA-DR; EXPRESSION; CYTOKINES	FTY720 (Fingolimod) is a novel type of immunosuppressive agent inhibiting lymphocyte egress from secondary lymphoid tissues thereby causing peripheral lymphopenia. FTY720 can inhibit macrophage infiltration into inflammatory lesions under pathological conditions. FTY720 has been clinically evaluated for prophylaxis of allograft rejection and treatment of multiple sclerosis, showing promising immunosuppressive effects. A robust inflammatory response after traumatic brain injury (TBI) plays an important role in the secondary or delayed injuries of TBI. Here we have investigated by immunohistochemistry in a rat TBI model the effects of FTY720 on early cell accumulation into the inflammatory tissue response and on expression of major histo-compatibility complex class II (MHC-II) and endothelial-monocyte activating polypeptide II (EMAP-II). Accumulation of MHC-II+ or EMAP-II+ cells became significant 1 day after injury and continuously increased during the early time periods. Further, double-staining experiments confirmed that the major cellular sources of MHC-II were reactive macrophages, however MHC-II+ cells only constituted a small subpopulation of reactive macrophages. Immediately after TBI, peripheral administration of FTY720 (1 mg/kg in 1 mL saline, every second day) significantly attenuated the accumulation of MHC-II+ macrophages from Day 1 to 4 and significantly attenuated the accumulation of EMAP-II+ macrophages/microglia at Day 4. Our findings show that FTY720 attenuates early accumulation of EMAP-II+ and MHC-II+ reactive monocytes following TBI, indicating that FTY720 might be a drug candidate to inhibit brain inflammatory reaction following TBI.	Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany; Synovo GmbH, Tubingen, Germany	Zhang, ZR (corresponding author), Univ Tubingen, Inst Brain Res, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	Burnet, Michael/AAB-2958-2019; Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835			ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adelson PD, 1998, ACT NEUR S, V71, P104; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; CARLOS TM, 1994, BLOOD, V84, P2068; Cho BP, 2006, GLIA, V53, P92, DOI 10.1002/glia.20265; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; DESIMONE R, 1995, J NEUROPATH EXP NEUR, V54, P175; Engel S, 1996, ACT NEUR S, V66, P87; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; FUJITA T, 1995, BIOORG MED CHEM LETT, V5, P847, DOI 10.1016/0960-894X(95)00126-E; GEHRMANN J, 1992, LAB INVEST, V67, P100; Golarai G, 2001, J NEUROSCI, V21, P8523; GRAEBER MB, 1994, NEUROPATH APPL NEURO, V20, P406, DOI 10.1111/j.1365-2990.1994.tb00987.x; Graeber MB, 1998, J NEUROSCI RES, V52, P1; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Kaneider NC, 2004, FASEB J, V18, P1309, DOI 10.1096/fj.03-1050fje; KAO J, 1992, J BIOL CHEM, V267, P20239; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Knies UE, 1998, P NATL ACAD SCI USA, V95, P12322, DOI 10.1073/pnas.95.21.12322; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORI N, 1992, EPILEPSIA, V33, P994, DOI 10.1111/j.1528-1157.1992.tb01749.x; Mueller CA, 2003, J NEUROTRAUM, V20, P1007, DOI 10.1089/089771503770195858; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Rausch M, 2004, J MAGN RESON IMAGING, V20, P16, DOI 10.1002/jmri.20057; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schmitt AB, 1998, NEUROPATH APPL NEURO, V24, P167; Schmitt AB, 2000, ACTA NEUROPATHOL, V100, P528, DOI 10.1007/s004010000221; Soares HD, 1995, J NEUROSCI, V15, P8223; STREIT WJ, 1989, EXP NEUROL, V105, P115, DOI 10.1016/0014-4886(89)90111-8; Suzuki S, 1996, TRANSPLANTATION, V61, P200, DOI 10.1097/00007890-199601270-00006; Tas MPR, 1996, INT J BIOCHEM CELL B, V28, P837, DOI 10.1016/1357-2725(96)00038-6; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; WEINSTEIN DL, 1990, J NEUROSCI RES, V26, P55, DOI 10.1002/jnr.490260107; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9	46	30	34	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	MAR-APR	2007	11	2					307	314		10.1111/j.1582-4934.2007.00019.x			8	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	166WX	WOS:000246412600008	17488479	Green Published, Bronze			2021-06-18	
J	Higgins, M; Halstead, PD; Snyder-Mackler, L; Barlow, D				Higgins, Michael; Halstead, P. David; Snyder-Mackler, Lynn; Barlow, David			Measurement of impact acceleration: Mouthpiece accelerometer versus helmet accelerometer	JOURNAL OF ATHLETIC TRAINING			English	Article						helmet; head injury; measurement techniques	SPORT-RELATED CONCUSSION; FOOTBALL HELMETS; UNITED-STATES; BRAIN-INJURY	Context: Instrumented helmets have been used to estimate impact acceleration imparted to the head during helmet impacts. These instrumented helmets may not accurately measure the actual amount of acceleration experienced by the head due to factors such as helmet-to-head fit. Objective: To determine if an accelerometer attached to a mouthpiece (MP) provides a more accurate representation of headform center of gravity (HFCOG) acceleration during impact than does an accelerometer attached to a helmet fitted on the headform. Design: Single-factor research design in which the independent variable was accelerometer position (HFCOG, helmet, MP) and the dependent variables were g and Severity Index (SI). Setting: Independent impact research laboratory. Intervention(s):The helmeted headform was dropped (n = 168) using a National Operating Committee on Standards for Athletic Equipment (NOCSAE) drop system from the standard heights and impact sites according to NOCSAE test standards. Peak g and SI were measured for each accelerometer position during impact. Main Outcome Measures: Upon impact, the peak g and SI were recorded for each accelerometer location. Results: Strong relationships were noted for HFCOG and MP measures, and significant differences were seen between HFCOG and helmet g measures and HFCOG and helmet SI measures. No statistically significant differences were noted between HFCOG and MP g and SI measures. Regression analyses showed a significant relationship between HFCOG and MP measures but not between HFCOG and helmet measures. Conclusions: Upon impact, MP acceleration (g) and SI measurements were closely related to and more accurate in measuring HFCOG g and SI than helmet measurements. The MP accelerometer is a valid method for measuring head acceleration.	Towson Univ, Dept Kinesiol, Towson, MD 21252 USA; So Impact Res Ctr, Knoxville, TN USA; Univ Delaware, Newark, DE USA	Higgins, M (corresponding author), Towson Univ, Dept Kinesiol, 8000 York Rd, Towson, MD 21252 USA.	mhiggins@towson.edu					Barth JT, 2001, J ATHL TRAINING, V36, P253; Bishop P J, 1983, Can J Appl Sport Sci, V8, P19; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; BISHOP PJ, 1979, PHYSICIAN SPORTSMED, V7, P97; BISHOP PJ, 1976, BIOMECHANICS, VB, P299; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd C. W., 1966, P 10 STAPP CAR CRASH, P164; GURDJIAN E S, 1964, J Trauma, V4, P309; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; GURDJIAN ES, 1996, J TRAUMA, V6, P600; Guskiewicz K., 2005, J ATHL TRAIN S, V40, pS81; HODGSON VR, 1973, BIOMECHANICAL STUDY; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Lewis L. M., 2000, ACAD EMERG MED, V7, P437; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; MIHALIK JP, 2005, J ATHL TRAINING, V40, pS82; Myers Thomas J., 1993, Bio-Medical Materials and Engineering, V3, P15; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; *NCAA, 2000, NCAA INJ SURV SYST; *NOCSAE, 1998, STAND PERF SPEC NEWL; *NOCSAE, 1998, LAB PROC GUID CERT N; *NOCSAE, 1996, EQ CAL PROC; *NOCSAE, 1998, STAND DROP TEST METH; *NOCSAE, 1998, STAND PERF SPEC REC; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Sosin DM, 1996, BRAIN INJURY, V10, P47; THERRIEN RG, 1982, HUMAN BODY DYNAMICS, P498; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	32	30	30	1	15	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN-MAR	2007	42	1					5	10					6	Sport Sciences	Sport Sciences	158BS	WOS:000245766500001	17597937				2021-06-18	
J	Power, T; Catroppa, C; Coleman, L; Ditchfield, M; Anderson, V				Power, Tarah; Catroppa, Cathy; Coleman, Lee; Ditchfield, Michael; Anderson, Vicki			Do lesion site and severity predict deficits in attentional control after preschool traumatic brain injury (TBI)?	BRAIN INJURY			English	Article						child; traumatic brain injury; MRI; lesion location; severity; executive function; attention	CHILDHOOD HEAD-INJURY; EXECUTIVE FUNCTION; CHILDREN; PERFORMANCE; ADOLESCENTS; COGNITION; LONDON; SAMPLE; TOWER; TASKS	Primary objective: To determine the predictive value of structural neuroimaging in the clinical setting following TBI. Research design: Prospective between-group design, comparing groups with regard to: (i) the presence or absence of cerebral pathology and (ii) the location of cerebral pathology. The predictive value of injury variables was investigated using hierarchical regressions. Methods and procedures: Thirty-six children, between 6 and 14 years, who sustained a moderate to severe TBI 5 years previously participated in this study. Children's performances on five measures of attentional control were examined in relation to the presence, location and severity of their lesions, as coded by the Coffey classification system [ 1]. Main outcomes and results: Frontal lesion severity was not predictive of performance on any of the measures. However, generalized ( frontal and extrafrontal) and extrafrontal lesion severity was predictive of poor performance. Conclusions: These findings support the argument that functional organization in children may differ from that in adults, suggesting that multiple cerebral regions, or a diffuse cerebral network, may mediate children's executive functions ( EF). Results are also consistent with the hypothesis that the amount of damaged brain tissue, rather than its location, may be more predictive of neurobehavioural outcome following early TBI.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia	Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au					Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson V.A, 2001, DEV NEUROPSYCHOLOGY; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Bigler E. D., 1997, CHILDHOOD TRAUMATIC, P7; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P227, DOI 10.1016/S0887-6177(00)00081-0; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Casey BJ, 2002, DEVELOPMENTAL SCI, V5, P265, DOI 10.1111/1467-7687.00365; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; CATROPPA C, J PEDIAT PSYCHOL; Chase-Carmichael CA, 1999, CLIN NEUROPSYCHOL, V13, P405, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT405; COFFEY CE, 1991, AM PSYCHOP, P243; Daniel A. E., 1983, POWER PRIVILEGE PRES; DIAMOND A, 1991, J PIAGET SY, P67; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; FLETCHER JM, 1984, J CLIN NEUROPSYCHOL, V6, P39, DOI 10.1080/01688638408401195; Franzen M D, 2000, Crit Care Nurs Q, V23, P58; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; FUSTER JM, 1989, PREFRONTAL CORTEX AN; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gottlieb G., 1992, INDIVIDUAL DEV EVOLU; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; Johnson M. H., 1997, DEV COGNITIVE NEUROS; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Levin HS, 1989, NEUROPSYCHOLOGY, V3, P243, DOI 10.1037//0894-4105.3.4.243; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LEZAK MD, 1995, NEUROPSYCHOLOGCAL AS; Luria A. R, 1973, WORKING BRAIN; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1999, TEST EVERYDAY ATTENT; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Miller EK, 2000, NEUROIMAGE, V11, P447, DOI 10.1006/nimg.2000.0574; Moses P, 2002, DEV PSYCHOBIOL, V40, P266, DOI 10.1002/dev.10031; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1990, NEUROPSYCHOLOGY MENT; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sparrow S., 1984, VINELAND ADAPTIVE BE; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; STUSS DT, 1983, LOCALIZATION NEUROPS, P429; Tabachnick B.G., 2000, USING MULTIVARIATE S, V4th; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WALSH K, 1978, NEUROPSYCHOLOGY CLIN; Wechsler D., 1992, MANUAL WECHSLER INTE	70	30	30	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	3					279	292		10.1080/02699050701253095			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	168IW	WOS:000246518400003	17453756				2021-06-18	
J	Prigatano, GP; Gray, JA				Prigatano, George P.; Gray, Jennifer A.			Parental concerns and distress after paediatric traumatic brain injury: A qualitative study	BRAIN INJURY			English	Article						child; traumatic brain injury; parental distress; recovery; social integration	HEAD-INJURY; CHILDREN; FAMILY; REHABILITATION; RECOVERY; OUTCOMES; PERFORMANCE	Objective: To determine concerns of parents associated with high distress levels in the care of children with traumatic brain injury ( TBI). Setting and participants: Primary care hospital/ medical centre- based study on parental perspectives following TBI in school age children ( n = 100; 19 orthopaedic trauma controls and 81 children with a history of TBI). Main outcome measures: Verbatim reports regarding major concerns on the Child Behaviour Checklist ( CBCL), as well as parental ratings regarding their overall distress level when caring for the child. Results: Summary of verbatim comments indicated that parents who report high levels of distress in the care of their children were specifically concerned about the child's poor school performance, lack of friends, inability to control angry feelings and apathy. Fear of the future consequences of the TBI was also cited as a major concern. Parent ratings of distress level was significantly, but weakly correlated with the severity of TBI in their children ( r =+0.26, n = 94, p = 0.01). Conclusion: Reports of severe distress in the care of TBI children by parents are seen at all levels of severity of TBI. Addressing these parental concerns may increase parental engagement in the rehabilitation process.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA; Med Ctr, Phoenix, AZ USA	Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Achenbach T., 2001, CHILD BEHAV CHECKLIS; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Bettelheim B., 1975, USES ENCHANTMENT MEA; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braga LW, 2005, CHILD TRAUMATIC BRAI; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; CORRIGAN PW, 2005, TXB TRAUMATIC BRAIN, P661; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; Lenhard W, 2005, AM J MED GENET A, V133A, P170, DOI 10.1002/ajmg.a.30571; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; PRIGATANO GP, IN PRESS CLIN NEUROP; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 2004, COMMUNITY SCH REINTE, P151; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SAVAGE RC, 1994, ED DIMENSIONS ACQUIR, P393; Shaffer D, 1975, Ciba Found Symp, P191; Silver JM, 2005, TXB TRAUMATIC BRAIN, P609; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	37	30	30	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	7					721	729		10.1080/02699050701481605			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400008	17653946				2021-06-18	
J	Culmsee, C; Plesnila, N				Culmsee, C.; Plesnila, N.			Targeting Bid to prevent programmed cell death in neurons	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article; Proceedings Paper	8th International Symposium on Cytochrome P450 Biodiversity and Biotechnology	JUL 23-27, 2006	Swansea Med Sch, Swansea, WALES		Swansea Med Sch	apoptosis inducing factor (AIF); Bid; caspase; cytochrome c; mitochondrion; programmed cell death	APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; OXYGEN-GLUCOSE DEPRIVATION; TRAUMATIC BRAIN-INJURY; DNA-DAMAGE RESPONSE; NEURODEGENERATIVE DISORDERS; CASPASE ACTIVATION; BCL-2 FAMILY; GRANZYME-B; CLEAVAGE	Sustained progression of neuronal cell death causes brain tissue loss and subsequent functional deficits following stroke or central nervous system trauma and in neurodegenerative diseases. Despite obvious differences in the pathology of these neurological disorders, the underlying delayed neuronal demise is carried out by a common biochemical cell death programme. Mitochondrial membrane permeabilization and subsequent release of apoptotic factors are key mechanisms during this process. Bcl-2 family proteins, e.g. the pro-apoptotic Bid, Bax or Bad and the antiapoptotic Bcl-2, Bcl-X-L, play a crucial role in the regulation of this mitochondrial checkpoint in neurons. In particular, cleavage of cytosolic Bid and subsequent mitochondrial translocation have been detected in many paradigms of neuronal cell death related to acute or chronic neurodegeneration. The current review focuses on the emerging role of Bid as an integrating key regulator of the intrinsic death pathway that amplifies caspase-dependent and caspase-indepenclent execution of neuronal apoptosis. Therefore pharmacological inhibition of Bid provides a promising therapeutic strategy in neurological diseases where programmed cell death is prominent.	Univ Munich, Dept Pharm, D-81377 Munich, Germany; Univ Munich, Med Ctr Grosshadern, Dept Neurosurg, D-81377 Munich, Germany; Univ Munich, Med Ctr Grosshadern, Inst Surg Res, D-81377 Munich, Germany	Culmsee, C (corresponding author), Univ Munich, Dept Pharm, Butenandtstr 5-13,Bldg D, D-81377 Munich, Germany.	carsten.culmsee@cup.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019	Culmsee, Carsten/0000-0002-5121-5015			Becattini B, 2004, CHEM BIOL, V11, P1107, DOI 10.1016/j.chembiol.2004.05.022; Becattini B, 2006, P NATL ACAD SCI USA, V103, P12602, DOI 10.1073/pnas.0603460103; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Culmsee C, 2001, J CEREBR BLOOD F MET, V21, P334, DOI 10.1097/00004647-200104000-00002; Culmsee C., 2005, DRUG DISCOV TODAY, V2, P463, DOI DOI 10.1016/J.DDMEC.2005.11.006; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gillardon F, 1999, NEUROSCIENCE, V93, P1219, DOI 10.1016/S0306-4522(99)00292-4; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Henshall DC, 2001, NEUROBIOL DIS, V8, P568, DOI 10.1006/nbdi.2001.0415; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Liou AKF, 2005, FASEB J, V19, P1350, DOI 10.1096/fj.04-3258fje; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McLaughlin B, 2004, APOPTOSIS, V9, P111, DOI 10.1023/B:APPT.0000018793.10779.dc; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Plesnila N, 2004, ACTA NEUROCHIR SUPPL, V89, P15; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Riedout HJ, 2001, HISTOL HISTOPATHOL, V16, P895, DOI 10.14670/HH-16.895; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Ward MW, 2004, J BIOENERG BIOMEMBR, V36, P295, DOI 10.1023/B:JOBB.0000041756.23918.11; Waterhouse NJ, 2006, IMMUNOL CELL BIOL, V84, P72, DOI 10.1111/j.1440-1711.2005.01416.x; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Yin XM, 2002, J BIOL CHEM, V277, P42074, DOI 10.1074/jbc.M204991200; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	55	30	38	0	1	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	DEC	2006	34		6				1334	1340		10.1042/BST0341334			7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	119LJ	WOS:000243013500079	17073814				2021-06-18	
J	Itoh, T; Satou, T; Nishida, S; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Hashimoto, Shigeo; Ito, Hiroyuki			Cultured rat astrocytes give rise to neural stem cells	NEUROCHEMICAL RESEARCH			English	Article						neural stem cell; differentiation; astrocyte; neurosphere; culture	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; SPINAL-CORD; NEURONAL DIFFERENTIATION; PROLIFERATION; PROGENITORS; HIPPOCAMPUS	Previously, we reported the occurrence of neural stem cells (NSCs) around an area of damage after rat traumatic brain injury (TBI); but it was unclear if this was due to blastgenesis in astrocytes, or to NSCs migrating from the subventricular zone (SVZ). In this study, NSCs were isolated and cultured from cultured type I astrocytes taken from newborn rat cortex in which the subventricular zone, and hippocampus had been discarded. All cultured type 1 astrocytes showed glial fibrillary acidic protein (GFAP) immunopositivity. Nestin immunopositive spheres were isolated from type 1 astrocytes and cultured in the presence of bFGF and EGF in the medium. Neurospheres differentiated into Tuj1-, GFAP- and A2B5-positive cells after 4 days of culture without bFGF and EGF. These results indicate that isolated neurospheres from brain cortex astrocytes can differentiate into neurons and glia and might contribute to neurogenesis and neuroplasticity.	Kinki Univ, Sch Med, Dept Pathol, Osaka 589, Japan; Kinki Univ Hosp, Div Hosp Pathol, Sch Med, Osaka, Japan; Kinki Univ, Div Sports Med, Inst Life Sci, Osaka 589, Japan; Kinki Univ, Sch Pharmaceut Sci, Osaka 577, Japan; PL Hosp, Dept Pathol, Osaka, Japan	Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, Osaka 589, Japan.	tatsuki@med.kindai.ac.jp		Itoh, Tatsuki/0000-0003-2015-7788			Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bithell A, 2005, CLIN SCI, V108, P13, DOI 10.1042/CS20040276; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOMEZPINILLA F, 1995, J NEUROSCI, V15, P2021; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; ITOH T, 2006, IN PRESS NEUROL RES; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Morizane A, 2006, J NEUROSCI RES, V83, P1015, DOI 10.1002/jnr.20799; OMALLEY EK, 1992, BRAIN RES, V582, P65, DOI 10.1016/0006-8993(92)90317-3; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Roussa E, 2004, NEUROSCI LETT, V361, P52, DOI 10.1016/j.neulet.2003.12.106; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Simpson PB, 1998, J NEUROSCI RES, V52, P468, DOI 10.1002/(SICI)1097-4547(19980515)52:4<468::AID-JNR11>3.0.CO;2-#; WILKIN GP, 1990, TRENDS NEUROSCI, V13, P43, DOI 10.1016/0166-2236(90)90065-I; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xu Y, 2003, J NEUROSCI RES, V74, P533, DOI 10.1002/jnr.10769; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; YAZAKI N, 1994, J NEUROSCI RES, V37, P445, DOI 10.1002/jnr.490370403; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I	31	30	32	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	NOV	2006	31	11					1381	1387		10.1007/s11064-006-9186-8			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	110UM	WOS:000242406800010	17053966				2021-06-18	
J	Ragnarsson, KT				Ragnarsson, Kristjan T.			Traumatic brain injury research since the 1998 NIH Consensus Conference - Accomplishments and unmet goals	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	2nd Federal Interagency Conference on Traumatic Brain Injury	MAR   10, 2006	Bethesda, MD			caregivers; cognitive impairment; community; epidemiology; integration; psychiatric dysfunction; quality of life; rehabilitation research; traumatic brain injury	SPINAL-CORD-INJURY; REHABILITATION; SCIENCE; STATE	In 1998, an NIH sponsored Consensus Conference on Traumatic Brain Injury (TBI) Rehabilitation identified 30 different areas of needed research. A comprehensive review of recently generated research knowledge in the field of TBI has shown that a large number of Class III and IV evidence studies have been published, but relatively few of the more scientifically rigorous Class I or II studies. A rapid growth of publications on TBI rehabilitation has generated new knowledge in the epidemiology of TBI, the management of TBI and its secondary medical complications, rehabilitation of cognitive impairment, impact of TBI on community integration and quality of life, incidence of psychiatric dysfunction, and how caregivers and family members are affected. However, there is need to replicate many of these studies using more scientifically rigorous methodologies, while other areas of important TBI research remain largely unexplored.	CUNY Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	Ragnarsson, KT (corresponding author), CUNY Mt Sinai Sch Med, Dept Rehabil Med, 1425 Madison Ave,Box 1240, New York, NY 10029 USA.	kristjan.ragnarsson@mssm.edu					BULLOCK R, 1995, GUIDELINES MANAGEMEN; Esselman PC, 2006, AM J PHYS MED REHAB, V85, P383, DOI 10.1097/01.phm.0000202095.51037.a3; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Johnston MV, 2006, AM J PHYS MED REHAB, V85, P292, DOI 10.1097/01.phm.0000202079.58567.3b; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; LANGLOIS JA, 2004 TRAUMATIC BRAIN; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ragnarsson KT, 2006, AM J PHYS MED REHAB, V85, P289, DOI 10.1097/01.phm.0000202104.22458.aa; Sipski ML, 2006, AM J PHYS MED REHAB, V85, P310, DOI 10.1097/01.phm.0000202105.87011.bf	9	30	30	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2006	21	5					379	387		10.1097/00001199-200609000-00002			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	084JM	WOS:000240529200002	16983223				2021-06-18	
J	Marklund, N; Salci, K; Ronquist, G; Hillered, L				Marklund, Niklas; Salci, Konstantin; Ronquist, Gunnar; Hillered, Lars			Energy metabolic changes in the early post-injury period following traumatic brain injury in rats	NEUROCHEMICAL RESEARCH			English	Article						traumatic brain injury (TBI); adenylates; ATP; ADP; AMP; energy charge; microdialysis; hypoxanthine	LATERAL FLUID-PERCUSSION; CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; COMPRESSION CONTUSION TRAUMA; MITOCHONDRIAL DYSFUNCTION; BIOENERGETIC STATE; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; LACTATE CONCENTRATIONS; EXTRACELLULAR GLUCOSE	Impaired cerebral energy metabolism may be a major contributor to the secondary injury cascade that occurs following traumatic brain injury (TBI). To estimate the cortical energy metabolic state following mild and severe controlled cortical contusion (CCC) TBI in rats, ipsi-and contralateral cortical tissues were frozen in situ at 15 and 40 min post-injury and adenylate (ATP, ADP, AMP) levels were analyzed using high-performance liquid chromatography (HPLC) and the energy charge (EC) was calculated. At 15 min post-injury, mildly brain-injured animals showed a 43% decrease in cortical ATP levels and a 2.4-fold increase in AMP levels (P < 0.05), and there was a significant reduction of the ipsilateral cortical EC when compared to sham-injured animals (P < 0.05). At 40 min post-injury, the ipsilateral adenylate levels and EC had recovered to the values observed in the sham-injury group. In the severe CCC group, there was a 51% decrease in ipsilateral cortical ATP levels and a 5.3-fold increase in AMP levels with a significant reduction of cortical EC at 15 min post-injury (P < 0.05). At 40 min post-injury, a 2.6-fold ipsilateral increase in AMP levels and an 11% and 44% decrease in EC and ATP levels, respectively, remained (P < 0.05). A 37-38% reduction of the total adenylate pool was observed ipsilaterally in both CCC severity groups at the early time-point, and a 19% and 28% decrease remained in the mild and severe CCC groups, respectively, at 40 min post-injury. Significant contralateral ATP and EC changes were only observed in the severe CCC group at 40 min post-injury (P < 0.05). The energy-requiring secondary injury cascades that occur early post-injury do not challenge the brain tissue to the extent of ATP depletion and may provide a window of opportunity for therapeutic intervention.	Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden	Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Ing 85,2 Tr, SE-75185 Uppsala, Sweden.	Niklas.Marklund@neurokir.uu.se		Marklund, Niklas/0000-0002-9797-5626			ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Emery DL, 2000, J COMP NEUROL, V424, P521; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; ERICSON A, 1983, CLIN CHIM ACTA, V127, P47, DOI 10.1016/0009-8981(83)90074-8; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Folbergrova J, 1999, NEUROSCI LETT, V266, P121, DOI 10.1016/S0304-3940(99)00279-7; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; GINSBERG MD, 1990, CEREBROVAS BRAIN MET, V2, P58; Golarai G, 2001, J NEUROSCI, V21, P8523; HAMMER DF, 1988, ANAL BIOCHEM, V169, P300, DOI 10.1016/0003-2697(88)90288-6; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J NEUROTRAUM, V20, P139, DOI 10.1089/08977150360547062; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marklund N, 2000, ACTA NEUROCHIR, V142, P1135, DOI 10.1007/s007010070042; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MATZ H, 1989, J NEUROSCI RES, V24, P260, DOI 10.1002/jnr.490240218; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; RONQUIST G, 1993, CLIN CHIM ACTA, V223, P93, DOI 10.1016/0009-8981(93)90065-C; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schuhmann MU, 2002, ACT NEUR S, V81, P209; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1990, J NEUROSCI, V10, P3524; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	79	30	30	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2006	31	8					1085	1093		10.1007/s11064-006-9120-0			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	077TS	WOS:000240053900011	16909313				2021-06-18	
J	Weir, N; Doig, EJ; Fleming, JM; Wiemers, A; Zemljic, C				Weir, Nicole; Doig, Emmah J.; Fleming, Jennifer M.; Wiemers, Anna; Zemljic, Collette			Objective and behavioural assessment of the emergence from post-traumatic amnesia (PTA)	BRAIN INJURY			English	Article						post-traumatic amnesia; traumatic brain injury; behaviour	CLOSED-HEAD INJURY; TRAUMATIC BRAIN-INJURY; PRACTICAL SCALE; INCONTINENCE; DURATION	Primary objective: To determine the profile of resolution of typical PTA behaviours and describe new learning and improvements in self-care during PTA. Research design: Prospective longitudinal study monitoring PTA status, functional learning and behaviours on a daily basis. Methods and procedures: Participants were 69 inpatients with traumatic brain injury who were in PTA. PTA was assessed using the Westmead or Oxford PTA assessments. Functional learning capability was assessed using a routine set of daily tasks and behaviour was assessed using an observational checklist. Data was analysed using descriptive statistics. Main outcomes and results: Challenging behaviours that are typically associated with PTA, such as agitation, aggression and wandering resolved in the early stages of PTA and incidence rates of these behaviours were less than 20%. Independence in self-care and bowel and bladder continence emerged later during resolution of PTA. New learning in functional situations was demonstrated by patients in PTA. Conclusions: It is feasible to begin active rehabilitation focused on functional skills-based learning with patients in the later stages of PTA. Formal assessment of typically observed behaviours during PTA may complement memory-based PTA assessments in determining emergence from PTA.	Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld, Australia	Weir, N (corresponding author), Princess Alexandra Hosp, Occupat Therapy Dept, Ipswich Rd,Woolloongabba, Brisbane, Qld 4102, Australia.	nicole_weir@health.qld.gov.au	Fleming, Jennifer M/B-4436-2011; Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X			Ahmed S, 2000, BRAIN INJURY, V14, P765; ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; CHAPPARO C, 2001, OT AUSTR 21 NAT C BR; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Geffen G., 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; *RANCH LOS AM MED, 1980, LEV COGN FUNCT; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; TEASDALE G, 1974, LANCET, V2, P81; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412	24	30	30	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2006	20	9					927	935		10.1080/02699050600832684			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	094ZN	WOS:000241278100005	17062424				2021-06-18	
J	Khan, RB; Gutin, PH; Rai, SN; Zhang, LJ; Krol, G; DeAngelis, LM				Khan, Raja B.; Gutin, Philip H.; Rai, Shesh N.; Zhang, Lijun; Krol, George; DeAngelis, Lisa M.			Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection	NEUROSURGERY			English	Article						brain tumor; craniotomy; magnetic resonance imaging; neurological deficits; outcome	CLOSED-HEAD INJURY; SUPRATENTORIAL GLIOMAS; SURGICAL RESECTION; TIME-COURSE; RATS; COMPLICATIONS; CRANIOTOMY; MORBIDITY; HISTOLOGY; STROKE	OBJECTIVE: To study risk factors for the development of postoperative neurological deficits after brain tumor resection and to define prognostic factors for recovery. METHODS: We prospectively studied 82 brain tumor patients undergoing tumor resection. Pre- and postoperative neurological examination, functional and performance status, cancer treatment, cardiovascular risk factors; seizure history, and blood pressure and oxygen saturation were recorded perioperatvely. Postoperative magnetic resonance imaging scans were obtained within 72 hours of surgery, and the radiologist was blinded to the patient's status: Abnormalities on magnetic resonance diffusion weighted images were classified as new if they extended beyond the tumor cavity margins and were absent before surgery. RESULTS: Of the 80 assessable patients, 24 had a new or increased postoperative deficit by at least one point on the National Institutes of Health Stroke Scale. Presence of preoperative neurological deficits predicted development of postoperative deficits, whereas a new diffusion weighted imaging lesion after craniotomy predicted incomplete recovery of a new postoperative deficit. CONCLUSION: Postoperative diffusion magnetic resonance imaging is useful in predicting early functional recovery from new deficits after brain tumor surgery.	St Jude Childrens Hosp, Div Neurol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Div Neurooncol, Memphis, TN 38105 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Cornell Univ, Weill Coll Med, Dept Neurol Surg, Ithaca, NY 14853 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN USA; Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	Khan, RB (corresponding author), St Jude Childrens Hosp, Div Neurol & Neurooncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	raja.khan@stjude.org	Khan, Raja B/N-8150-2018	Khan, Raja B/0000-0003-3702-7250; DeAngelis, Lisa/0000-0002-6290-7818			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; AMMIRATI M, 1987, NEUROSURGERY, V21, P201, DOI 10.1227/00006123-198708000-00012; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088; CABANTOG AM, 1994, CAN J NEUROL SCI, V21, P213, DOI 10.1017/S0317167100041184; CIRIC I, 1987, NEUROSURGERY, V21, P21, DOI 10.1227/00006123-198707000-00005; Davis S, 2000, J CLIN NEUROSCI, V7, P3, DOI 10.1054/jocn.1999.0142; FADUL C, 1988, NEUROLOGY, V38, P1374, DOI 10.1212/WNL.38.9.1374; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Khan RB, 2001, PEDIATR NEUROSURG, V35, P225, DOI 10.1159/000050426; KRETH FW, 1993, J NEUROSURG, V78, P762, DOI 10.3171/jns.1993.78.5.0762; LYDEN PD, 1994, STROKE, V25, P2421, DOI 10.1161/01.STR.25.12.2421; MAHONEY F I, 1965, Md State Med J, V14, P61; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Wisoff JH, 1998, J NEUROSURG, V89, P52, DOI 10.3171/jns.1998.89.1.0052	20	30	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUL	2006	59	1					60	65		10.1227/01.NEU.0000219218.43128.FC			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	061PV	WOS:000238885600015	16823301				2021-06-18	
J	Koob, AO; Borgens, RB				Koob, Andrew O.; Borgens, Richard B.			Polyethylene glycol treatment after traumatic brain injury reduces beta-amyloid precursor protein accumulation in degenerating axons	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						membrane repair; secondary axotomy; polymer repair; cell survival	SPINAL-CORD-INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; AXOLEMMAL PERMEABILITY; CEREBROSPINAL-FLUID; MOLECULAR REPAIR; NERVE MEMBRANES; DAMAGE; PEPTIDE; RECOVERY	Polyethylene glycol (PEG; 2,000 MW; 30% v/v) is a nontoxic molecule that can be injected intravenously and possesses well-documented neuroprotective properties in the spinal cord of the guinea pig. Recent studies have shown that intravenous PEG can also enter the rat brain parenchyma after injury and repair cellular membrane damage in the region of the corpus callosum. Disrupted anterograde axonal transport and resulting P-amyloid precursor protein (APP) accumulation are byproducts of traumatic axonal injury (TAI) in the brain. APP accumulation indicates axonal degeneration as a result of axotomy, a detriment that can lead to cell death. In this study, we show that PEG treatment can eliminate APP accumulation in specific brain areas of rats receiving TAL Six areas of the brain were analyzed: the medial cortex, hippocampus, lateral cortex, thalamus, medial lemniscus, and medial longitudinal fasciculus. Increased APP expression after injury was abolished in the thalamus and reduced in the medial longitudinal fasciculus by PEG treatment. In all remaining areas except for the lateral cortex, APP expression was not increased between injured and uninjured brains, indicating that damage was undetected in those brain areas in this study. (c) 2006 Wiley-Liss, Inc.	Purdue Univ, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Borgens, RB (corresponding author), Purdue Univ, Ctr Paralysis Res, Dept Basic Med Sci, 408 S Univ St, W Lafayette, IN 47907 USA.	cpr@purdue.edu					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borgens R.B., 1986, Progress in Clinical and Biological Research, V210, P239; Borgens R.B., 2003, ADV ANAT EMBRYOL CEL, V171, P1; Borgens RB, 2000, FASEB J, V14, P27; Borgens RB, 2002, J EXP BIOL, V205, P1; Borgens RB, 2001, NEUROSURGERY, V49, P370, DOI 10.1097/00006123-200108000-00021; Borgens RB, 2001, J NEUROSCI RES, V66, P1179; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Donaldson J, 2002, NEUROSURGERY, V50, P147, DOI 10.1097/00006123-200201000-00023; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Harrington D, 2000, J CLIN FORENSIC MED, V7, P19; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Pierce JES, 1996, J NEUROSCI, V16, P1083; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Ramon y Cajal S, 1928, DEGENERATION REGENER; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1961, LANCET, V2, P443; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Working PK, 1997, ACS SYM SER, V680, P45	47	30	33	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2006	83	8					1558	1563		10.1002/jnr.20837			6	Neurosciences	Neurosciences & Neurology	051QX	WOS:000238176800019	16555285				2021-06-18	
J	Hartings, JA; Tortella, FC; Rolli, ML				Hartings, Jed A.; Tortella, Frank C.; Rolli, Michael L.			AC electrocorticographic correlates of peri-infarct depolarizations during transient focal ischemia and reperfusion	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						direct current potential; electrocorticography; focal cerebral ischemia; middle cerebral artery occlusion; peri-infarct depolarization; spreading depression	CORTICAL SPREADING DEPRESSION; CEREBRAL-ARTERY OCCLUSION; INTENSIVE-CARE-UNIT; PARTIAL STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CONTINUOUS EEG; NONCONVULSIVE SEIZURES; QUANTITATIVE EEG; BLOOD-FLOW; INTRACEREBRAL HEMORRHAGE	Several studies have highlighted a delayed secondary pathology developing after reperfusion in animals subjected to prolonged cerebral ischemia, and recently we have shown that peri-infarct depolarizations (PIDs) occur not only during ischemia, but also in this delayed period of infarct maturation. Here we study the electrocorticographic (ECoG) manifestations of PIDs as signatures of developing secondary pathology. DC- and traditional AC-ECoG signals were recorded continuously from epidural, nonpolarizable electrodes during 2 h of middle cerebral artery occlusion (MCAo) and 22 h of reperfusion in freely behaving rats. During MCAo, seizures and PIDs recurred frequently and their incidence was significantly correlated. After reperfusion, seizures and PIDs ceased, and for the next several hours delta wave abnormalities dominated the ECoG with progressively increasing amplitude. After a variable period ( 5 to 15 h), the ECoG amplitude decremented with the onset of a prolonged repetitive series of PIDs. Initial PIDs in this delayed phase produced transient depressions of the high amplitude ECoG signal, but thereafter the ECoG was persistently attenuated, with no transient depressions during subsequent PIDs. The time of onset of postreperfusion PIDs, and hence measures of ECoG attenuation, correlated with 24 h infarct volumes. PIDs could always be detected in baseline shifts of the AC-ECoG signal with a low high-pass cutoff setting. These results suggest that delayed PIDs after reperfusion contribute to a complex secondary pathology involving delayed edema, intracranial hypertension, and hypoperfusion. The manifestation of PIDs in ECoG/electroencephalography recordings may enable continuous real-time monitoring of infarct progression.	Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA	Hartings, JA (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jed.hartings@na.amedd.army.mil		Hartings, Jed/0000-0001-8583-3471			Afsar N, 2003, SEIZURE-EUR J EPILEP, V12, P23, DOI 10.1016/S1059131102001437; Assal F, 2001, SEIZURE-EUR J EPILEP, V10, P260, DOI 10.1053/seiz.2000.0506; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Back T, 2000, STROKE, V31, P2901, DOI 10.1161/01.STR.31.12.2901; Borck C, 1999, J NEUROPHYSIOL, V82, P2130; Cuspineda E, 2003, CLIN ELECTROENCEPHAL, V34, P1; DEAZEREDO FAM, 1992, METAB BRAIN DIS, V7, P101, DOI 10.1007/BF01000149; Donnet A, 1997, EPILEPSIA, V38, P1032, DOI 10.1111/j.1528-1157.1997.tb01487.x; Dreier JP, 2005, NEUROLOGY, V64, P2145, DOI 10.1212/01.WNL.0000176298.63840.99; FABRICIUS M, 2003, J CEREB BLOOD FLOW M, V23, P291; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; Finnigan SP, 2004, STROKE, V35, P899, DOI 10.1161/01.STR.0000122622.73916.d2; Garzon E, 2001, NEUROLOGY, V57, P1175, DOI 10.1212/WNL.57.7.1175; Gorji A, 2004, EUR J NEUROSCI, V19, P3371, DOI 10.1111/j.0953-816X.2004.03436.x; GUEDES RCA, 1987, EXP BRAIN RES, V69, P113, DOI 10.1007/BF00247034; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; GYNELL ML, 1995, NMR BIOMED, V8, P206; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; HANDFORTH A, 1994, EPILEPSIA, V35, P876, DOI 10.1111/j.1528-1157.1994.tb02526.x; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P332, DOI 10.1097/00004691-199907000-00005; Kager H, 2000, J NEUROPHYSIOL, V84, P495; KAGSTROM E, 1983, J CEREBR BLOOD F MET, V3, P170, DOI 10.1038/jcbfm.1983.24; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; Kempski O, 2000, ACT NEUR S, V76, P251; KOROLEVA VI, 1982, PHYSIOL BOHEMOSLOV, V31, P385; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; MATSUMOTO K, 1996, J CEREB BLOOD FLOW M, V16, P271; Murri L, 1998, NEUROPHYSIOL CLIN, V28, P249, DOI 10.1016/S0987-7053(98)80115-9; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Otori T, 2003, J CEREBR BLOOD F MET, V23, P43, DOI 10.1097/01.WCB.0000035180.38851.38; Pinard E, 2002, STROKE, V33, P606, DOI 10.1161/hs0202.102738; Procaccio F, 2001, Curr Opin Crit Care, V7, P74, DOI 10.1097/00075198-200104000-00004; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P47, DOI 10.1038/jcbfm.1985.7; SOMJEN GG, 1984, AN ACAD BRAS CIENC, V56, P495; SRAMKA M, 1978, APPL NEUROPHYSIOL, V40, P48; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; STRONG AJ, 2003, J CEREB BLOOD FLO S1, V23, P300; Taguchi J, 1996, J CEREBR BLOOD F MET, V16, P271, DOI 10.1097/00004647-199603000-00012; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, BRAIN RES, V482, P179, DOI 10.1016/0006-8993(89)90558-1; Toyota S, 2003, ACT NEUR S, V86, P153; Toyota S, 2002, STROKE, V33, P1383, DOI 10.1161/01.STR.0000015557.18508.DD; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; VANHARREVELD A, 1954, J NEUROPHYSIOL, V17, P505; Vanhatalo S, 2005, CLIN NEUROPHYSIOL, V116, P1, DOI 10.1016/j.clinph.2004.09.015; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Williams AJ, 2003, FUND CLIN PHARMACOL, V17, P581, DOI 10.1046/j.1472-8206.2003.00183.x; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Young GB, 1996, NEUROLOGY, V47, P83	63	30	30	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2006	26	5					696	707		10.1038/sj.jcbfm.9600223			12	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	038RA	WOS:000237239500011	16177810	Bronze			2021-06-18	
J	McKenna, K; Cooke, DM; Fleming, J; Jefferson, A; Ogden, S				McKenna, Kryss; Cooke, Deirdre M.; Fleming, Jennifer; Jefferson, Alanna; Ogden, Sarah			The incidence of visual perceptual impairment in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						OT-APST; visual perception; TBI	REHABILITATION; PERFORMANCE; RECOVERY; NEGLECT; ADULTS; TESTS; SPEED	Primary objectives: To investigate the incidence of visual perceptual impairments in a sample of patients with traumatic brain injury (TBI) using the Occupational Therapy Adult Perceptual Screening Test (OT-APST), compare incidence rates to a normative sample and explore the relationship between the presence of visual perceptual impairment and the severity of cognitive and functional impairment following TBI. Research design: Cohort study using a convenience sample of patients with TBI and a normative sample. Methods and procedures: Thirty-one patients with severe TBI and 195 healthy people were compared on the OT-APST and measures of cognition and function. Main outcomes and results: The most common impairments in the TBI sample were unilateral neglect (45.2%) and impairments of body scheme (25.8%) and constructional skills (25.8%). Significantly higher incidences of agnosia, apraxia, unilateral neglect and impairments in body scheme and constructional skills were found in the TBI sample compared to the normative sample. No significant relationship was found between the presence of visual perceptual impairments and the level of cognitive and functional impairment after TBI. Conclusions: Visual perceptual changes are evident in patients with severe TBI when compared to a normative sample. Routine use of a screening tool such as the OT-APST may help identify visual perceptual impairments in these patients and the need for more detailed assessment.	Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld, Australia; Mater Private Hosp, Rehabil Unit, Brisbane, Qld, Australia; Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld 4102, Australia	Cooke, DM (corresponding author), POB 118, Alderley, Qld 40511, Australia.	deecooke@powerup.com.au	Fleming, Jennifer M/B-4436-2011	Cooke, Deirdre/0000-0003-0920-2031			Ardila A, 1994, Int J Neurosci, V78, P177; Australian Bureau of Statistics, 1997, AUSTR STAND CLASS OC, V2nd; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; BARRY P, 1989, ARCH PHYS MED REHAB, V70, P902; Boyd A, 2000, PHYS OCCUP THER GERI, V17, P1; *BRAIN INJ ASS QUE, 2002, SURV ACQ BRAIN INJ; Cate Y, 2000, AM J OCCUP THER, V54, P326, DOI 10.5014/ajot.54.3.326; Cocchini G, 2002, NEUROPSYCHOLOGIA, V40, P2030, DOI 10.1016/S0028-3932(02)00054-4; Cooke D. M., 2005, BRIT J OCCUPATIONAL, V68, P509; Cooke Deirdre M, 2005, Scand J Occup Ther, V12, P59, DOI 10.1080/11038120410020683; COOKE DM, 2004, THESIS U QUEENSLAND; *DEP HHS, 2003, TRAUM BRAIN INJ US R; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fortune N, 1999, DEFINITION INCIDENCE; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Gilmore R, 2003, BRAIN INJURY, V17, P347, DOI 10.1080/0269905031000070233; Golisz K. M., 2003, WILLARD SPACKMANS OC, P395; Granger CV, 1993, GUIDE UNIFORM DATA S; GRIEVE J, 2000, NEUROPSYCHOLOGY OCCU; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; Iverson G L, 2000, Appl Neuropsychol, V7, P108, DOI 10.1207/S15324826AN0702_7; Katz N, 1997, AM J OCCUP THER, V51, P562, DOI 10.5014/ajot.51.7.562; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KLEIN D, 2004, INTRO VISUAL AGNOSIA; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Malina A, 2001, PERCEPT MOTOR SKILL, V92, P449, DOI 10.2466/PMS.92.2.449-455; MATEKOLE CC, 1994, ARCH PHYS MED REHAB, V75, P867; Neistadt M E, 1995, Occup Ther Health Care, V9, P3, DOI 10.1080/J003v09n01_02; Pulaski KH, 2003, WILLARD SPACKMANS OC, P767; REID D, 1997, OCCUPATIONAL THERAPY, V4, P81; Sherman EMS, 1995, PSYCHOL ASSESSMENT, V7, P440, DOI 10.1037//1040-3590.7.4.440; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SUTER PS, 1995, TRAUMATIC BRAIN INJU, P187; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; TOGLIA JP, 1991, OCCUPATIONAL THERAPY, V3, P18; Vieth AZ, 1996, BRAIN INJURY, V10, P465, DOI 10.1080/026990596124322; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; Wheatley C. J., 2001, OCCUPATIONAL THERAPY, P444; WILLIAMS TA, 1995, AM J OCCUP THER, V49, P923, DOI 10.5014/ajot.49.9.923; Wilson B. A., 1991, RIVERMEAD BEHAV MEMO; Wilson FC, 2003, NEUROPSYCHOL REHABIL, V13, P537, DOI 10.1080/09602010343000200	44	30	31	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2006	20	5					507	518		10.1080/02699050600664368			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	045GO	WOS:000237730800007	16716997				2021-06-18	
J	Earle, SA; Proctor, KG; Patel, MB; Majetschak, M				Earle, SA; Proctor, KG; Patel, MB; Majetschak, M			Ubiquitin reduces fluid shifts after traumatic brain injury	SURGERY			English	Article; Proceedings Paper	66th Annual Meeting of the Society-of-University-Surgeons	FEB 09-12, 2005	Nashville, TN	Soc Univ Surg			EXTRACELLULAR UBIQUITIN; POSSIBLE INVOLVEMENT; CEREBROSPINAL-FLUID; RESUSCITATION; BLOOD; CELLS; PRESSURE; EFFICACY; LACTATE	Background. Ubiquitin has well-described. intracellular properties. Recent data also suggest pleiotropic effects of extracellular ubiquitin, including induction of apoptosis, regulation of immune functions, and therapeutic potential during fluid resuscitation from severe trauma. However, the actions of exogenous ubiquitin after traumatic brain injury (TBI) are unknown. Methods. Series 1: Thirty-five minutes after TBI and hemorrhage, 1.5 mg ubiquitin/kg (n = 5) or albumin (n = 5) intravenous was followed by fluid resuscitation to maintain mean arterial and cerebral perfusion pressure. Series 2: Ubiquitin (n = 5) or vehicle (n = 6) was administered ater TBI only. Ubiquitin was measured with enzyme-linked immunosorbent assay in serum, urine (series 1), and cerebrospinal fluid (series 2) for 300 minutes. Results. Series 1: After intravenous bolus, serum ubiquitin peaked at t = 45 minutes with a half-life of 54 minutes. Recovery in urine was 10 %. With albumin versus ubiquitin, 85 % more resuscitation fluid was required to stabilize systemic and cerebral hemodynamics (P < .05 for t = 150 to 300 minutes), but hematocrit was similar. With albumin there were progressive increases in intracranial pressure, peak inspiratory pressure, and decreases in oxygenation. All were significantly attenuated by ubiquitin (all P < .05 vs albumin). Series 2: Intravenous ubiquitin altered cerebrospinal fluid ubiquitin with an increased time to peak (t = 88 +/- 13 min vs 45 +/- 7min, P < .05) and area under the concentration-tinie curve (82 +/- 22 vs 23 +/- 11 pg/min(1)/mL(-1), P < .05). Conclusions. After TBI, intravenous ubiquitin crossed the blood brain barrier and significantly reduced, third spacing of fluid into the brain and lung during resuscitation.	Univ Miami, Miller Sch Med, Ryder Trauma Ctr,Div Trauma & Surg Crit Care, Dewitt Daughtry Family Dept Surg, Miami, FL 33136 USA	Majetschak, M (corresponding author), Univ Miami, Miller Sch Med, Ryder Trauma Ctr,Div Trauma & Surg Crit Care, Dewitt Daughtry Family Dept Surg, 1800 NW 10th Ave, Miami, FL 33136 USA.	mmajetschak@med.miami.edu	Patel, Mayur/K-2363-2013				Akarsu E, 2001, NEPHRON, V88, P280, DOI 10.1159/000046005; Akarsu E, 2001, DIABETES CARE, V24, P100, DOI 10.2337/diacare.24.1.100; ASSEMAN C, 1994, J IMMUNOL METHODS, V173, P93, DOI 10.1016/0022-1759(94)90286-0; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cerovic O, 2003, INTENS CARE MED, V29, P1300, DOI 10.1007/s00134-003-1753-8; Daino H, 2000, BLOOD, V95, P2577; Daino H, 1996, BIOCHEM BIOPH RES CO, V223, P226, DOI 10.1006/bbrc.1996.0875; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holland KD, 2001, NEUROL CLIN, V19, P313, DOI 10.1016/S0733-8619(05)70021-9; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Moomey CB, 1999, CRIT CARE MED, V27, P154, DOI 10.1097/00003246-199901000-00044; Nabika T, 1999, BBA-MOL CELL RES, V1450, P25, DOI 10.1016/S0167-4889(99)00024-5; Ohe Y, 1996, J NEUROCHEM, V67, P964; OKADA M, 1993, CLIN CHIM ACTA, V220, P135, DOI 10.1016/0009-8981(93)90042-3; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; *ROYAL SWED AC SCI, 2004, ADV INF NOB PRIZ CHE; Takada K, 1997, CLIN CHEM, V43, P1188; Takagi M, 1999, ALCOHOL CLIN EXP RES, V23, p76S, DOI 10.1111/j.1530-0277.1999.tb04539.x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	29	30	33	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	SEP	2005	138	3					431	438		10.1016/j.surg.2005.06.026			8	Surgery	Surgery	974XV	WOS:000232625600012	16213895				2021-06-18	
J	Edvardsson, T; Ahlstrom, G				Edvardsson, T; Ahlstrom, G			Illness-related problems and coping among persons with low-grade glioma	PSYCHO-ONCOLOGY			English	Article						brain neoplasms; low-grade glioma; distress; coping; qualitative method	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVORS; DEFENSE-MECHANISMS; CANCER-PATIENTS; TUMOR PATIENTS; RADIOTHERAPY; ADAPTATION; STRATEGIES; EXPERIENCE	The literature reveals no qualitative study concerning the consequences of low-grade glioma in adults. The aim of the present study was to describe perceived illness-related problems in persons with low-grade glioma and the coping used in everyday living. The study was cross-sectional within a well-defined population. A semi-structured qualitative interview was conducted with each of 39 persons, and the data were subjected to inductive content analysis. There was a wide range of perceived problems, mainly concerning bodily functions, memory, cognition, emotion, communication and perception. Several coping strategies emerged, the most frequent being searching for a solution, which was often related to memory and communication problems. One characteristic of communication was the creation of new words. Other common strategies were refraining from and avoiding and laughing and joking. Caring about self involved prioritising of personal needs. A striving to feel a sense of solidarity within seeking social affinity was coping with a novel content. The study provides vivid narratives about previously unreported phenomena, conveying a deeper understanding. The variety and endurance of problems revealed verifies the need of support from several professionals, including in the form of out-patient post-medical care. Copyright (c) 2005 John Wiley & Sons, Ltd.	Orebro Cty Council, Rehabil Res Ctr, SE-70116 Orebro, Sweden; Univ Orebro, Swedish Inst Disabil Res, S-70130 Orebro, Sweden; Univ Orebro, Dept Caring Sci, S-70130 Orebro, Sweden; Orebro Univ Hosp, Ctr Nursing Sci, Orebro, Sweden	Edvardsson, T (corresponding author), Orebro Cty Council, Rehabil Res Ctr, SE-70116 Orebro, Sweden.	tanja.edvardsson@orebroll.se		Ahlstrom, Gerd/0000-0001-6230-7583			BOHAN EM, 2002, NEUROSCIENCE NURSING, P269; Bowman KF, 2003, PSYCHO-ONCOLOGY, V12, P226, DOI 10.1002/pon.630; Coyne JC, 2000, AM PSYCHOL, V55, P655, DOI 10.1037//0003-066X.55.6.655; Cramer P, 1998, J PERS, V66, P919, DOI 10.1111/1467-6494.00037; Cramer P, 2000, AM PSYCHOL, V55, P637, DOI 10.1037//0003-066X.55.6.637; Davies E, 2003, DISABIL REHABIL, V25, P259, DOI 10.1080/0963828021000024915; Davies EA, 1998, J ROY COLL PHYS LOND, V32, P406; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Duck, 1991, STUDYING INTERPERSON, P239; DUNKELSCHETTER C, 1992, HEALTH PSYCHOL, V11, P79, DOI 10.1037/0278-6133.11.2.79; Folkman S, 2000, AM PSYCHOL, V55, P647, DOI 10.1037//0003-066X.55.6.647; Gotay CC, 1998, JNCI-J NATL CANCER I, V90, P656, DOI 10.1093/jnci/90.9.656; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; LAMPIC C, 1994, ACTA ONCOL, V33, P887, DOI 10.3109/02841869409098451; Lazarus R.S., 1984, STRESS APPRAISAL COP; Lieblich A., 1998, NARRATIVE RES READIN; Lilja A, 1997, PSYCHOPATHOLOGY, V30, P316, DOI 10.1159/000285074; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Livneh H, 2000, J REHABIL, V66, P40; Maes S, 1996, HDB COPING THEORY RE, P221; Mathieson CM, 1998, QUAL HEALTH RES, V8, P581, DOI 10.1177/104973239800800502; MCCRAE RR, 1989, J GERONTOL, V44, P161; Meyers Christina A., 1993, Cancer Bulletin (Houston), V45, P362; Osoba D, 1997, QUAL LIFE RES, V6, P103; Pahlson A, 2003, J NEURO-ONCOL, V65, P149, DOI 10.1023/B:NEON.0000003727.09448.dd; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; Reijneveld JC, 2001, NEUROLOGY, V56, P618, DOI 10.1212/WNL.56.5.618; RICHARDS L, 2002, USING NVIVO QUALITAT; Ritvo P, 1999, PATIENT EDUC COUNS, V38, P161, DOI 10.1016/S0738-3991(99)00063-4; Salander P, 1996, SOC SCI MED, V42, P985, DOI 10.1016/0277-9536(95)00204-9; SALANDER P, 1995, J NEURO-ONCOL, V25, P227, DOI 10.1007/BF01053156; SOMERFIELD M, 1992, SOC SCI MED, V34, P1203, DOI 10.1016/0277-9536(92)90313-F; Sprangers MAG, 1998, QUAL LIFE RES, V7, P291; *STAT SWED, STAT YB SWED 2001, V87, P51; Strang S, 2001, PALLIATIVE MED, V15, P127, DOI 10.1191/026921601670322085; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; TAPHOORN MJB, 1994, ANN NEUROL, V36, P48, DOI 10.1002/ana.410360111; Tennen H., 1999, COPING PSYCHOL WHAT, P279; van't Spijker A, 1997, PSYCHOSOM MED, V59, P280; Verhoef MJ, 1999, NEUROLOGY, V52, P617, DOI 10.1212/WNL.52.3.617; WATSON M, 1994, J PSYCHOSOC ONCOL, V12, P33, DOI 10.1300/J077V12N03_03; Watson M., 1989, MENTAL ADJUSTMENT CA; WELCHMCCAFFREY D, 1989, ANN INTERN MED, V111, P517, DOI 10.7326/0003-4819-111-6-517	46	30	30	0	6	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	1057-9249			PSYCHO-ONCOL	Psycho-Oncol.	SEP	2005	14	9					728	737		10.1002/pon.898			10	Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences, Biomedical	Oncology; Psychology; Biomedical Social Sciences	964OU	WOS:000231891200004	15669016				2021-06-18	
J	Clausen, F; Lewen, A; Marklund, N; Olsson, Y; McArthur, DL; Hillered, L				Clausen, F; Lewen, A; Marklund, N; Olsson, Y; McArthur, DL; Hillered, L			Correlation of hippocampal morphological changes and Morris water maze performance after cortical contusion injury in rats	NEUROSURGERY			English	Article						alpha-phenyl-N- tert-butyl-nitrone; hippocampus; Morris water maze; rat; reactive oxygen species; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; FOCAL CEREBRAL-ISCHEMIA; FLUID PERCUSSION INJURY; SPATIAL MEMORY; DELAYED TREATMENT; ARTERY OCCLUSION; NEURONAL DEATH; CNS INJURY; NITRONE	OBJECTIVE: The hippocampus is essential to the processing and formation of memory. This study analyzed the relationship among memory dysfunction as revealed by Morris water maze (MWM) trial, cortical lesion volume, and regional hippocampal morphological changes after controlled cortical contusion (CCC). We also analyzed the influence of pretreatment with the nitrone radical scavenger alpha-phenyl-N-tert-butylnitrone (PBN). METHODS: Rats were subjected to CCC. We used two levels of CCC (mild, 1.5 mm and severe, 2.5 mm) and pretreated some severely injured animals with PBN. The animals were killed 15 days postinjury. We evaluated morphological changes to the hippocampus semiquantitatively by scoring sections immunohistochemically stained for microtubule-associated protein 2 with a four-point scale for the cornu ammonis (CA) 1, CA2, CA3, and hilus of the dentate gyrus (HDG). The cortical lesion volume was quantified. RESULTS: Rats subjected to severe, but not mild, CCC demonstrated impaired spatial learning ability in the MWM, but this impairment was attenuated with pretreatment with the radical scavenger PBN. We documented bilateral morphological changes in CA1, CA3, and HDG and an ipsilateral neocortical cavitation in severely injured rats. PBN treatment attenuated (P < 0.05) the morphological characteristics of abnormality in the ipsilateral CA1, CA2, HDG, and the contralateral HDG and reduced the cortical lesion volume. Mild injury led to minor ipsilateral hippocampal and cortical damage but no MWM deficiency. Hippocampal morphological scores and total mean latencies in the MWM task were strongly correlated (r = 0.69; P < 0.001). The correlation between the cortical lesion volume and MWM latency was weaker (r = 0.48; P = 0.02). CONCLUSION: Severe CCC causes bilateral morphological changes in the hippocampus and ipsilateral neocortical cavitation, which correlate to impairment in a spatial learning task (MWM). PBN protected the structure of the CA2 ipsilaterally and HDG bilaterally and reduced the cortical lesion volume, correlating to improved functional outcome.	Univ Uppsala Hosp, Dept Neurosci, Div Neurosurg, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Genet & Pathol, SE-75185 Uppsala, Sweden	Clausen, F (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Div Neurosurg, SE-75185 Uppsala, Sweden.	Fredrik.clausen@neurokir.uu.se	McArthur, David/E-6442-2013; Lewen, Anders/A-5156-2013	McArthur, David/0000-0003-3385-1314; Lewen, Anders/0000-0003-4925-1348; Marklund, Niklas/0000-0002-9797-5626; Clausen, Fredrik/0000-0003-3592-4417			CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Daugherty WP, 2001, BRAIN RES, V923, P103, DOI 10.1016/S0006-8993(01)03198-5; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Golarai G, 2001, J NEUROSCI, V21, P8523; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hannesson DK, 1998, BEHAV BRAIN RES, V90, P35, DOI 10.1016/S0166-4328(97)00081-8; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Kuroda S, 1996, NEUROBIOL DIS, V3, P149, DOI 10.1006/nbdi.1996.0015; Lenzlinger PM, 2001, HEAD TRAUMA, P3; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Li GL, 2000, APMIS, V108, P98; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Roos MW, 2003, BRAIN RES, V961, P15, DOI 10.1016/S0006-8993(02)03829-5; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; See V, 2001, J BIOL CHEM, V276, P35049, DOI 10.1074/jbc.M104988200; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Warburton EC, 2001, J NEUROSCI, V21, P7323, DOI 10.1523/JNEUROSCI.21-18-07323.2001; Warburton EC, 2000, EUR J NEUROSCI, V12, P1714, DOI 10.1046/j.1460-9568.2000.00039.x; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	56	30	35	1	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2005	57	1					154	162		10.1227/01.NEU.0000163412.07546.57			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	942ZQ	WOS:000230321800042	15987551				2021-06-18	
J	Enomoto, T; Osugi, T; Satoh, H; McIntosh, TK; Nabeshima, T				Enomoto, T; Osugi, T; Satoh, H; McIntosh, TK; Nabeshima, T			Pre-injury magnesium treatment prevents traumatic brain injury-induced hippocampal ERK activation, neuronal loss, and cognitive dysfunction in the radial-arm maze test	JOURNAL OF NEUROTRAUMA			English	Article						extracellular signal-regulated kinase; hippocampus; magnesium; radial-arm maze; reference memory; traumatic brain injury; working memory	FOCAL CEREBRAL-ISCHEMIA; PROTEIN-KINASE INHIBITION; EXTRACELLULAR LEVELS; GLUTAMATE RELEASE; AMINO-ACIDS; CELL-DEATH; IN-VIVO; RAT; SULFATE; MEMORY	We studied the effect of pre-injury magnesium (Mg2+) treatment on hippocampal extracellular signal-regulated kinase (ERK) activation induced by lateral fluid-percussion (FP) brain injury, and on working and reference memory in the radial-arm maze test in rats subjected to such traumatic brain injury (TBI) (n = 56) or to sham injury (n = 12). In the ipsilateral hippocampus, an increase in the phospho-ERK level was detected at 10 min after injury in rats subjected to FP brain injury of moderate severity (1.9-2.0 atm) as compared to sham-injured controls (p < 0.01), and was maintained for at least 120 min after injury (p < 0.05). In the contralateral hippocampus, the phospho-ERK level was transiently increased at 10 min after injury but fell to nearly its basal level by 30 min. When MgCl2 solution (150 mu mol) was infused intravenously from 20 min to 5 min before injury (n = 4-5), brain injury-induced ERK activation was significantly inhibited in the ipsilateral hippocampus at 60 min but not at 10 min after injury. Mg2+ treatment also significantly prevented injury-induced neuronal loss in the ipsilateral hippocampus (p < 0.05 vs. vehicle-treated, brain-injured controls). At 2 weeks after injury, Mg2+ treatment was found to have significantly prevented injury-induced impairments in working (p < 0.0001 vs. vehicle-treated, brain-injured controls) and reference memory (p < 0.05) in the radial-arm maze test. The present study demonstrates that pretreatment with Mg2+ prevents post-traumatic hippocampal ERK activation and neuronal loss, and cognitive dysfunction in the radial-arm maze test.	Nippon Boehringer Ingelheim Co Ltd, Kawanishi Pharma Res Inst, Dept Pharmacol, Kawanishi, Hyogo 6660193, Japan; Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol, Nagoya, Aichi, Japan; Nagoya Univ, Grad Sch Med, Hosp Pharm, Nagoya, Aichi, Japan; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA	Osugi, T (corresponding author), Nippon Boehringer Ingelheim Co Ltd, Kawanishi Pharma Res Inst, Dept Pharmacol, 1-20-1 Yato, Kawanishi, Hyogo 6660193, Japan.	oosugi@kaw.boehringer-ingelheim.com					Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baldassa S, 2003, MOL BRAIN RES, V119, P111, DOI 10.1016/j.molbrainres.2003.08.020; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; COTTON DB, 1993, AM J OBSTET GYNECOL, V168, P974, DOI 10.1016/S0002-9378(12)90855-8; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; ENOMOTO T, 2005, UNPUB MOL PHARM; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Iida N, 2001, J NEUROSCI, V21, P6459; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Runden E, 1998, J NEUROSCI, V18, P7296; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shohami E, 2003, J CEREBR BLOOD F MET, V23, P728, DOI 10.1097/01.WCB.0000067704.86573.83; SMITH DAS, 1989, BRIT J PHARMACOL, V97, P475, DOI 10.1111/j.1476-5381.1989.tb11975.x; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; VINK R, 1988, J BIOL CHEM, V263, P757; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	49	30	36	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2005	22	7					783	792		10.1089/neu.2005.22.783			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	945VQ	WOS:000230530800006	16004581				2021-06-18	
J	Gu, JW; Hasuo, H; Takeya, M; Akasu, T				Gu, JW; Hasuo, H; Takeya, M; Akasu, T			Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitro	NEUROPHARMACOLOGY			English	Article						emodin; hippocampus; EPSP; presynaptic inhibition; adenosine; glutamate release	PAIRED-PULSE FACILITATION; TRAUMATIC BRAIN INJURY; TRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; GLUTAMATE ANTAGONIST; CALCIUM-ANTAGONISTS; ADENOSINE; SYNAPSES; NEUROTOXICITY; RECEPTORS	Rhubarb extracts provide neuroprotection after brain injury, but the mechanism of this protective effect is not known. The present study tests the hypothesis that rhubarb extracts,interfere with the release of glutamate by brain neurons and, therefore, reduce glutamate excitotoxicity. To this end, the effects of emodin, an anthraquinone derivative extracted from Rheum tanguticum Maxim. Ex. Balf, on the synaptic transmission of CA1 pyramidal neurons in rat hippocampus were studied in vitro. The excitatory postsynaptic potential (EPSP) was depressed by bath-application of emodin (0.3-30 mu M). Paired-pulse facilitation (PPF) of the EPSP was significantly increased by emodin. The monosynaptic inhibitory postsynaptic potential (IPSP) recorded in the presence of glutamate receptor antagonists (DNQX and AP5) was not altered by emodin. Emodin decreased the frequency, but not the amplitude, of the miniature EPSP (mEPSP). The inhibition of the EPSP induced by emodin was blocked by either 8-CPT, an adenosine A(1) receptor antagonist, or by adenosine deaminase. These results suggest that emodin inhibits the EPSP by decreasing the release of glutamate from Schaffer collateral/commissural terminals via the activation of adenosine A(1) receptors in rat hippocampal CA1 area and that the neuroprotective effects of rhubarb extracts may result from decreased glutamate excitotoxicity. (c) 2005 Elsevier Ltd. All rights reserved.	Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 8300011, Japan; Kurume Univ, Cognit & Mol Res Inst Brain Dis, Open Res Ctr, Kurume, Fukuoka 8300011, Japan; Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China	Hasuo, H (corresponding author), Kurume Univ, Sch Med, Dept Physiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hhasuo@med.kurume-u.ac.jp					Arrigoni E, 2001, J NEUROSCI, V21, P1076; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Behr J, 2000, J NEUROPHYSIOL, V84, P112; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; GU J, 2001, NEUROSCIENCE RES S, V25, pS170; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; HASUO H, 1992, NEUROSCI RES, V13, P281, DOI 10.1016/0168-0102(92)90040-J; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KAMIYA H, 1991, SYNAPSE, V8, P229, DOI 10.1002/syn.890080309; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; Lin X. Z., 1995, Yaoxue Xuebao, V30, P307; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; OLNEY JW, 1990, PROG BRAIN RES, V86, P37; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; ROBINSON MJ, 1990, CEREBROVAS BRAIN MET, V2, P205; SATO H, 1992, YAKUGAKU ZASSHI, V112, P199, DOI 10.1248/yakushi1947.112.3_199; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Seutin V, 1997, NEUROPHARMACOLOGY, V36, P1653, DOI 10.1016/S0028-3908(97)00147-0; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Takeya M, 2002, NEUROSCI RES, V42, P175, DOI 10.1016/S0168-0102(01)00317-0; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; YOON KW, 1991, J NEUROSCI, V11, P1375	39	30	37	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUL	2005	49	1					103	111		10.1016/j.neuropharm.2005.02.003			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	945VX	WOS:000230531600010	15992585				2021-06-18	
J	Hostetler, SG; Hostetler, TL; Smith, GA; Xiang, HY				Hostetler, SG; Hostetler, TL; Smith, GA; Xiang, HY			Characteristics of water skiing-related and wakeboarding-related injuries treated in emergency departments in the United States, 2001-2003	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						water skiing; wakeboarding; athletic injuries; National Electronic Injury Surveillance System (NEISS)	RISK-FACTORS; PREVENTION; ACCIDENT; AVULSION; HAZARDS; DOUCHE; SPILL; TEAR	Background: Water skiing and wakeboarding are popular sports with high potential for injury due to rapid boat acceleration, lack of protective gear, and waterway obstacles. However, trends in water skiing- and wakeboarding-related injuries in the United States have not been described using national data. Hypothesis: The number of injuries, injury diagnoses, and body regions injured vary by sport. Study Design: Descriptive epidemiology study. Methods: Data regarding water skiing- and wakeboarding-related injuries presenting to 98 hospital emergency departments in the United States between January 1, 2001, and December 31, 2003, were extracted from the National Electronic Injury Surveillance System. Data included demographics, injury diagnosis, and body region injured. Results: Data were collected for 517 individuals with water skiing-related injuries and 95 individuals with wakeboarding-related injuries. These injuries represent an estimated 23 460 water skiing- and 4810 wakeboarding-related injuries treated in US emergency departments in 2001 to 2003. Head injuries represented the largest percentage of injuries for wakeboarders (28.8% of all injuries) and the smallest percentage for water skiers (4.3%) (P < .01; relative risk [95% confidence interval], 6.73 [3.89-11.66]). Analysis of injury diagnosis was consistent as wakeboarders had significantly more traumatic brain injuries (12.5% of all injuries) than did water skiers (2.4%) (P < .05; relative risk [95% confidence interval], 5.27 [2.21-12.60]). Strains or sprains were the leading injury diagnoses for water skiing (36.3% of all injuries), and the majority (55.7%) were to the lower extremity. Lacerations were the most common diagnoses for wakeboarders (31.1% of all injuries), and the majority (59.6%) were to the face. Conclusion: The analyses of water skiing- and wakeboarding-related injuries treated in US emergency departments in 2001 to 2003 highlight the differences in injury patterns for these 2 sports. The substantial number of head and facial injuries among wakeboarders underscores the need for research on the potential role of helmets or other protective gear to reduce these common injuries.	Ohio State Univ, Coll Med & Publ Hlth, Ctr Injury Res & Policy, Columbus Childrens Res Inst,Childrens Hosp, Columbus, OH USA; Ohio State Univ, Dept Internal Med Pediat, Med Ctr, Columbus, OH 43210 USA	Xiang, HY (corresponding author), Columbus Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	xiangh@pediatrics.ohio-state.edu	Xiang, Huiyun/E-4335-2011				[Anonymous], 2003, STAT ANAL SOFTWARE S; BANERJEE AK, 1985, BRIT J RADIOL, V58, P465, DOI 10.1259/0007-1285-58-689-465; BLASIER RB, 1990, AM J SPORT MED, V18, P435, DOI 10.1177/036354659001800419; BUNDGAARD A, 1984, LANCET, V2, P1157; Carson WG, 2004, AM J SPORT MED, V32, P164, DOI 10.1177/0363546503258910; Chalmers DJ, 2003, SPORTS MED, V33, P745, DOI 10.2165/00007256-200333100-00003; CHANDLER JR, 1972, ARCHIV OTOLARYNGOL, V96, P365; Chia JKK, 2000, PEDIATR NEUROSURG, V32, P291, DOI 10.1159/000028957; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; EDINGTON RF, 1978, CAN MED ASSOC J, V119, P310; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Grace N, 1974, J Sports Med, V2, P212; Greenberg J, 1998, CHEST, V113, P1138, DOI 10.1378/chest.113.4.1138; HUMMEL G, 1982, AM J SPORT MED, V10, P215, DOI 10.1177/036354658201000405; KIZER KW, 1980, ANN EMERG MED, V9, P268, DOI 10.1016/S0196-0644(80)80387-8; KUNTZ WD, 1983, NEW ENGL J MED, V309, P990; LEE RY, 1992, AM J GASTROENTEROL, V87, P662; Maldjian C, 2000, J COMPUT ASSIST TOMO, V24, P594, DOI 10.1097/00004728-200007000-00014; MCCARTHY GF, 1969, MED J AUSTRALIA, V1, P481; MORTON DC, 1970, MED J AUSTRALIA, V1, P1256, DOI 10.5694/j.1326-5377.1970.tb84562.x; Narita Tetsuya, 2004, Journal of Nippon Medical School, V71, P57, DOI 10.1272/jnms.71.57; *NAT CTR INJ PREV, FACTS AD INJ; *NAT EL INJ SURV S, TOOL RES; PATERSON DC, 1971, PRACTITIONER, V206, P655; PERLMAN SE, 1995, PEDIATRICS, V96, P782; RABINOWITCH BL, 1993, CLIN INFECT DIS, V16, P339, DOI 10.1093/clind/16.2.339; Radford A J, 1987, Aust Fam Physician, V16, P1661; ROMANO R L, 1962, Clin Orthop, V23, P140; RUDOFF JC, 1993, ANN EMERG MED, V22, P1072, DOI 10.1016/S0196-0644(05)82758-1; Sallay PI, 1996, AM J SPORT MED, V24, P130, DOI 10.1177/036354659602400202; *SGMA INT, SGMA REP SPORTS PART; STANISAVLJEVIC S, 1978, ORTHOPEDICS, V1, P125; TAIMELA S, 1990, SPORTS MED, V9, P205, DOI 10.2165/00007256-199009040-00002; WALTRIP RL, 2001, SPORTS INJURIES MECH, P804; WEIN P, 1990, AUST NZ J OBSTET GYN, V30, P384, DOI 10.1111/j.1479-828X.1990.tb02038.x; 2003, SOFTWARE SURVEY DESI	36	30	31	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2005	33	7					1065	1070		10.1177/0363546504271748			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	940JR	WOS:000230141300016	15888722				2021-06-18	
J	Rogatsky, GG; Kamenir, Y; Mayevsky, A				Rogatsky, GG; Kamenir, Y; Mayevsky, A			Effect of hyperbaric oxygenation on intracranial pressure elevation rate in rats during the early phase of severe traumatic brain injury	BRAIN RESEARCH			English	Article						fluid percussion brain injury; HBO2; intracranial pressure	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; FLUID-PERCUSSION INJURY; CARBON-MONOXIDE; BLOOD-FLOW; HYPERTENSION; EDEMA; METABOLISM; EXPERIENCE; MORTALITY	Intracranial pressure (ICP) was monitored to evaluate the therapeutic effect of hyperbaric oxygen (HBO2) treatment following traumatic brain injury (TBI). This subject is controversial. The aim of our study was to determine whether HBO2 treatment has a therapeutic effect on ICP dynamics and survival following severe fluid percussion brain injury (FPBI) in rats. Changes in ICP level were analyzed every 30 min during an 8-h monitoring period following trauma and at the end of experiment (20 h). The control (A) and experimental (B) groups consisted of 7 and 4 rats, respectively. Group B was subjected to 1.5 atmospheres absolute (ATA) 100% oxygen for 60 min beginning 2 h after FPBL No significant differences in ICP were noted between groups A and B before and after HBO2 treatment until 3.5 h after trauma. At 4 h, for the first time, the difference became significant (P = 0.025; n = 11) and remained significant (P < 0.05) for all measurement points until end of monitoring, when mean ICP values reached 37.17 +/- 14.25 and 20.25 +/- 2.63 mm Hg in groups A and B, respectively. Linear approximation models showed different trends (b1 = 3.80 +/- 0.23; r(2) = 0.65, P < 0.001 and b1 = 1.56 +/- 0.25; r(2) = 0.77, P < 0.001) for groups A and B, respectively. Covariance analysis confirmed significant differences between slopes for groups A and B (F = 148.04, P < 0.001; df = 2,177), i.e., a significant difference in mean rate of ICP elevation. By the end of the experiment, 3 out of 7 rats from group A had died, but none from group B. We conclude that the application of HBO2 during the early phase of severe FPBl significantly diminished ICP elevation rate and decreased mortality level. (c) 2005 Elsevier B.V. All rights reserved.	Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel	Mayevsky, A (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	rogatsg@mail.biu.ac.il; mayevsa@mail.biu.ac.il		Kamenir, Yury/0000-0002-9224-0495			ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Beaumont A, 2002, ACT NEUR S, V81, P217; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Durmaz E, 1999, Br J Nurs, V8, P1067; Hampson NB, 2001, ANN EMERG MED, V38, P36, DOI 10.1067/mem.2001.115532; HAYAKAWA T, 1971, J NEUROL NEUROSUR PS, V34, P580, DOI 10.1136/jnnp.34.5.580; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Hoshino S, 1996, BRAIN RES, V711, P73, DOI 10.1016/0006-8993(95)01329-6; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Manor T, 2003, ADV EXP MED BIOL, V510, P409; Marmarou A, 2003, ACT NEUR S, V86, P7; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1992, ADV EXP MED BIOL, V317, P707; MAYEVSKY A, 1995, J APPL PHYSIOL, V78, P1188; Mayevsky A, 1999, ACT NEUR S, V75, P63; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1973, EUR NEUROL, V10, P1, DOI 10.1159/000114256; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; NORUSIS MJ, 1999, SPSS 9 0 GUIDE DATA; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; PAPO I, 1980, ACTA NEUROCHIR, V52, P249, DOI 10.1007/BF01402080; Pierson David J, 2002, Respir Care, V47, P249; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Schaller Bernhard, 2002, Swiss Surg, V8, P123, DOI 10.1024/1023-9332.8.3.123; SUKOFF MH, 1982, NEUROSURGERY, V10, P29, DOI 10.1227/00006123-198201000-00006; van den Brink WA, 1998, ACT NEUR S, V71, P190; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	38	30	43	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 21	2005	1047	2					131	136		10.1016/j.brainres.2005.02.049			6	Neurosciences	Neurosciences & Neurology	939MH	WOS:000230076500001	15904900				2021-06-18	
J	Wang, YT; Kent, RD; Duffy, JR; Thomas, JE				Wang, YT; Kent, RD; Duffy, JR; Thomas, JE			Dysarthria associated with traumatic brain injury: speaking rate and emphatic stress	JOURNAL OF COMMUNICATION DISORDERS			English	Article							CLOSED-HEAD INJURY; KINEMATIC ANALYSIS; VERBAL IMPAIRMENT; UNITED-STATES; SPEECH; VARIABILITY; CHILDREN	Prosodic abnormality is common in the dysarthria associated with traumatic brain injury (TBI), and adjustments of speaking rate and emphatic stress are often used as steps in treating the speech disorder in patients with TBI-induced dysarthria. However, studies to date do not present a clear and detailed picture of how speaking rate and emphatic stress are affected in this speech disorder. This study, based on the acoustic analyses of syllable repetitions and sentence speech samples, reports on speaking rate and emphatic stress for 12 subjects with TBI and 8 healthy controls. For speaking rate, the subjects with TBI had (1) both slow speaking and articulation rates, (2) smaller phonation proportion and larger pause proportion, and (3) larger percentage change in speaking rate and smaller percentage change in articulation rate. For emphatic stress, the subjects with TBI had (1) significant increases in the difference and percentage change between pre-stressed and pre-unstressed pause durations, (2) significantly smaller difference between stressed and unstressed word durations, but not the percentage change between stressed and unstressed word durations, and (3) significantly reduced differences in f(0) movement and f(0) slope between stressed and unstressed words, but not in RMS range. This study demonstrates the multidimensional nature of prosodic deficits in the dysarthria related to TBI and illustrates the ability of acoustic measures to give a picture of the dysprosody related to TBI-induced dysarthria. Learning outcomes: As a result of this activity, the participant will be able to (1) describe the prosodic disturbances that have been reported in studies of dysarthria associated with TBI; (2) define acoustic measures appropriate to the analysis of changes in speaking rate and emphatic stress; and (3) discuss the importance of prosody to spoken communication. (c) 2005 Elsevier Inc. All rights reserved.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; Mayo Clin, Rochester, MN USA	Kent, RD (corresponding author), Univ Wisconsin, Waisman Ctr, 4th Floor,1500 Highland Ave, Madison, WI 53705 USA.		Kent, Raymond D/AAI-1928-2020				ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Cohen H, 2001, BRAIN COGNITION, V46, P73, DOI 10.1016/S0278-2626(01)80038-5; CONNAGHAN KP, 2000, INTERARTICULATOR COO; Dogil G, 2002, J NEUROLINGUIST, V15, P59, DOI 10.1016/S0911-6044(00)00021-X; Duffy J. R., 2020, MOTOR SPEECH DISORDE; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Kent RD, 1999, J MED SPEECH-LANG PA, V7, P83; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; Kent RD, 2000, J PHONETICS, V28, P273, DOI 10.1006/jpho.2000.0122; Kuehn D. P., 1976, J PHONETICS, V4, P303; McHenry M, 1998, BRAIN INJURY, V12, P495, DOI 10.1080/026990598122458; McHenry MA, 2003, J SPEECH LANG HEAR R, V46, P702, DOI 10.1044/1092-4388(2003/055); MILENKOVIC P, 2001, TIME FREQUENCY ANAL; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Nishio M, 2001, CLIN LINGUIST PHONET, V15, P309; Samuel C, 1998, J NEUROL NEUROSUR PS, V64, P482, DOI 10.1136/jnnp.64.4.482; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SIDTIS JJ, 2003, SEMINARS SPEECH LANG, V20, P93; Sosin DM, 1996, BRAIN INJURY, V10, P47; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; WANG YT, IN PRESS FOLIA PHONI; WEISMER G, 1997, HDB PHONETIC SCI, P191; Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; YORKSTON KM, 1991, COMMUNICATION DISORD, P251; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1; Zebenholzer K, 1998, WIEN KLIN WOCHENSCHR, V110, P253; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215	41	30	31	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAY-JUN	2005	38	3					231	260		10.1016/j.jcomdis.2004.12.001			30	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	907SX	WOS:000227739400005	15748726				2021-06-18	
J	Chen, JJ; Tu, YJ; Connolly, EC; Ronnett, GV				Chen, JJ; Tu, YJ; Connolly, EC; Ronnett, GV			Heme oxygenase-2 protects against glutathione depletion-induced neuronal apoptosis mediated by bilirubin and cyclic GMP	CURRENT NEUROVASCULAR RESEARCH			English	Article						heme oxygenase-2; oxidative stress; bilirubin; cyclic GMP; olfaction	OLFACTORY RECEPTOR NEURONS; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; RAT-BRAIN; OXIDATIVE STRESS; CARBON-MONOXIDE; CELL-DEATH; CEREBRAL-ISCHEMIA; BILIVERDIN REDUCTASE; MESSENGER-RNA	Heme oxygenase (HO) enzymes catalyze the breakdown of heme to iron, carbon monoxide (CO), and biliverdin, which is rapidly converted to bilirubin. HO-2 has been implicated in protection against oxidative stress, ischemia, and traumatic brain injury. The neuroprotective effects of HO-2 have been attributed to the generation of bilirubin, which is an important radical scavenger. However, the mechanism by which HO-2 provides protection is unclear. We utilized the olfactory system as a model to define the roles of HO-2 in glutathione depletion-induced oxidative injury, since olfactory receptor neurons (ORNs) express high levels of HO isoforms. We demonstrated that L-buthionine-[S, R]-sulfoximine (BSO), an inhibitor of glutathione biosynthesis, lowered glutathione levels and induced apoptosis of ORNs. Despite the presence of HO-1 in ORNs, HO-2 null animals displayed increased levels of neuronal death after BSO treatment compared to wild type mice. Levels of bilirubin and cGMP were also reduced in HO-2 null mice. Primary cultures of ORNs confirmed that the neuroprotective role of HO-2 was mediated by bilirubin and cGMP. Taken together, these results suggest that HO-2 plays a major role in neuroprotection from oxidative stress, an effect that is mediated by cGMP and bilirubin.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Ronnett, GV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 1006B Preclin Teaching Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	gronnett@jhmi.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-02979] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-39657] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC002979] Funding Source: NIH RePORTER		Abate C, 1990, Semin Cancer Biol, V1, P19; Arriaga SM, 1999, BBA-GEN SUBJECTS, V1473, P329, DOI 10.1016/S0304-4165(99)00201-9; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BARGER SW, 1995, J NEUROCHEM, V64, P2087; Belanger S, 1997, BIOL NEONATE, V71, P233; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Borras D, 2000, ACTA NEUROPATHOL, V99, P402, DOI 10.1007/s004010051142; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen J, 2003, J NEUROCHEM, V85, P1247, DOI 10.1046/j.1471-4159.2003.01776.x; Chen JJ, 2004, DEV BIOL, V269, P165, DOI 10.1016/j.ydbio.2004.01.024; Chen JJ, 1997, NEUROREPORT, V8, P1771, DOI 10.1097/00001756-199705060-00040; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; DWYER BE, 1995, MOL BRAIN RES, V30, P37, DOI 10.1016/0169-328X(94)00273-H; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; EWING JF, 1993, J NEUROCHEM, V61, P1015, DOI 10.1111/j.1471-4159.1993.tb03615.x; Farinelli SE, 1996, J NEUROSCI, V16, P2325; Ferris CD, 1999, NAT CELL BIOL, V1, P152; FRANDSEN A, 1992, NEUROCHEM RES, V17, P35, DOI 10.1007/BF00966863; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; GARTHWAITE G, 1988, NEUROSCIENCE, V26, P321, DOI 10.1016/0306-4522(88)90148-0; Geddes JW, 1996, NEUROSCI LETT, V210, P205, DOI 10.1016/0304-3940(96)12703-8; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; GRAZIADEI PPC, 1978, NEURONAL PLASTICITY, P131; Ingi T, 1996, NEURON, V16, P835, DOI 10.1016/S0896-6273(00)80103-8; Ingi T, 1995, J NEUROSCI, V15, P8214; Knickelbein RG, 1996, AM J PHYSIOL-LUNG C, V270, pL115; KWAK JY, 1991, BIOCHIM BIOPHYS ACTA, V1076, P369, DOI 10.1016/0167-4838(91)90478-I; Le W, 1999, J NEUROSCI RES, V56, P652; LEVY EJ, 1993, P NATL ACAD SCI USA, V90, P9171, DOI 10.1073/pnas.90.19.9171; Li YH, 1997, J CELL BIOL, V139, P1317, DOI 10.1083/jcb.139.5.1317; LOLLEY RN, 1977, SCIENCE, V196, P664, DOI 10.1126/science.193183; LUSTIG HS, 1992, BRAIN RES, V577, P343, DOI 10.1016/0006-8993(92)90295-K; MAINES MD, 1988, FASEB J, V2, P2557; Maines MD, 1996, BRAIN RES, V722, P83, DOI 10.1016/0006-8993(96)00184-9; Margolis FL, 1980, PROTEINS NERVOUS SYS, P59; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.0.CO;2-V; MENCO B, 1992, MICROSC RES TECHNIQ, V22, P215; Mytilineou C, 2002, PARKINSONISM RELAT D, V8, P385, DOI 10.1016/S1353-8020(02)00018-4; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; POSS KD, 1995, NEURON, V15, P867, DOI 10.1016/0896-6273(95)90177-9; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; RATAN RR, 1995, CLIN EXP PHARMACOL P, V22, P309, DOI 10.1111/j.1440-1681.1995.tb02006.x; RIZZARDINI M, 1994, BIOCHEM J, V304, P477, DOI 10.1042/bj3040477; RONNETT GV, 1991, J NEUROSCI, V11, P1243; ROSKAMS AJ, 1994, NEURON, V13, P289; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; SANO K, 1985, PEDIATR RES, V19, P587, DOI 10.1203/00006450-198506000-00017; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4; Simpson PJ, 2002, J NEUROSCI, V22, P5536; Simpson PJ, 2003, MOL CELL NEUROSCI, V24, P858, DOI 10.1016/S1044-7431(03)00259-8; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VETVICKA V, 1985, FOLIA MICROBIOL, V30, P373, DOI 10.1007/BF02927593; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; WEILL CL, 1984, NATURE, V308, P452, DOI 10.1038/308452a0; Wenisch S, 2000, HISTOCHEM J, V32, P381, DOI 10.1023/A:1004021832449; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7794; Zhang SY, 1998, BRAIN RES, V801, P101, DOI 10.1016/S0006-8993(98)00564-2; Zufall F, 1997, J NEUROSCI, V17, P2703	71	30	34	0	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	APR	2005	2	2					121	131		10.2174/1567202053586767			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	946ZX	WOS:000230612900004	16181104				2021-06-18	
J	McCrory, P; Johnston, K; Meeuwisse, W; Aubry, M; Cantu, R; Dvorak, J; Graf-Baumann, T; Kelly, J; Lovell, M; Schamasch, P				McCrory, P; Johnston, K; Meeuwisse, W; Aubry, M; Cantu, R; Dvorak, J; Graf-Baumann, T; Kelly, J; Lovell, M; Schamasch, P		Concussion Sport Grp	Summary and agreement statement of the Second International Conference on Concussion in Sport, Prague 2004	PHYSICIAN AND SPORTSMEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E EPSILON-4; COLLEGE FOOTBALL PLAYERS; AMYLOID BETA-PROTEIN; MINOR HEAD-INJURY; STANDARDIZED ASSESSMENT; MILD CONCUSSION; MANAGEMENT; SEVERITY; SYMPTOMS				pmccrory@bigpond.com	McCrory, Paul/Q-8688-2019				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; Cantu R, 2004, LANCET NEUROL, V3, P437; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; *COL MED SOC SPORT, 1991, GUID MAN CONC SPORTS; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; CREMONAMEYTARD SL, 1993, LIFE CYCLE DEV MATUR, P137; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Gross R, 1997, JAMA-J AM MED ASSOC, V278, P2143, DOI 10.1001/jama.1997.03550240033025; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Katzman R, 1996, NEUROLOGY, V46, P889; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; MCCRORY P, 1996, SMA ACSP ANN SCI C 1, P214; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McIntosh TK, 1996, LAB INVEST, V74, P315; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Orchard J, 1998, J Sci Med Sport, V1, P83, DOI 10.1016/S1440-2440(98)80016-9; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TURNER M, 1998, JOCK CLUB C HEAD INJ, P1; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863	64	30	30	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR	2005	33	4					29	+		10.3810/psm.2005.04.76			12	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	913RV	WOS:000228171600005	20086357				2021-06-18	
J	Rutherford, A; Stephens, R; Potter, D; Fernie, G				Rutherford, A; Stephens, R; Potter, D; Fernie, G			Neuropsychological impairment as a consequence of football (soccer) play and football heading: Preliminary analyses and report on University footballers	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CONCUSSION; SEVERITY	Previous research has claimed neuropsychological impairment occurs as a result of professional and amateur football play, and, specifically, football heading. However, much of this research exhibits substantial methodological problems (Rutherford, Stephens, & Potter, 2003). By investigating less committed amateur level footballers, the current study sought to gain some insight into the developmental history of any neuropsychological consequences of football play. University football, rugby and noncontact sports players were compared on a range of biographical and neuropsychological test variables. While playing their chosen sports, rugby players sustained many more head injuries than footballers and noncontact sportsmen, but footballers did not sustain significantly more head injuries than noncontact sportsmen. The number of head injuries sustained predicted Trails B and TAP Divided Attention latencies in a positive fashion. After controlling for the number of head injuries sustained, sport group effects were detected with TAP Divided Attention accuracy scores, with footballers exhibiting poorest performance. After controlling for the number of head injuries sustained, the total amount of heading done by footballers predicted the number of Wisconsin Card Sorting category shifts in a negative fashion. Nevertheless, over interpretation of all of these results should be resisted because of the exploratory nature of the analyses and the possibility that the sport groups may differ in ways other than just the nature of their sports activities.	Keele Univ, Dept Psychol, Keele ST55BG, Staffs, England; Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland	Rutherford, A (corresponding author), Keele Univ, Dept Psychol, Keele ST55BG, Staffs, England.	a.rutherford@psy.keele.ac.uk	Stephens, Richard/C-4062-2009	Stephens, Richard/0000-0002-5851-8975	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ANZIL F, 1979, 1 INT C SPORTS MED A, P643; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barth J T, 2000, Dent Clin North Am, V44, P67; Barth JT., 1989, MILD HEAD INJURY, P257; BEKC AT, 1987, BECK DEPRESSION INVE; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CHRISTENSEN PR, 1960, ALTERNATE USES FORM; Cohen J., 2003, APPL MULTIPLE CORREL; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC; *DEP HLTH, 2003, ALC POL TEAM; DICK RW, 1994, AM SOC TEST MATER, V1229, P13, DOI 10.1520/STP12799S; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; *FIFA, 2002, FIFA SURV; Golden C., 1978, STROOP COLOR WORD TE; GOODMAN JC, 1994, SEMIN NEUROL, V14, P19, DOI 10.1055/s-2008-1041054; GREEN G, 1996, US FOOTBALL SPORTS M, P191; GRONWALL D, 1975, LANCET, V2, P995; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hunt M, 1990, Br J Sports Med, V24, P265; Iverson G L, 2000, Appl Neuropsychol, V7, P247, DOI 10.1207/S15324826AN0704_7; Jaeger RG, 1998, HERPETOLOGICA, V54, pS64; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kelly JP, 1997, NEUROLOGY, V48, P581; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; LACAVA G, 1961, J SPORTS MED PHYS FI, V1, P8; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McMaster W C, 1978, Am J Sports Med, V6, P354, DOI 10.1177/036354657800600607; *OFF NAT STAT, 1998, LIV BRIT RES 1996 GE; *OL MED SOC SPORTS, 1991, GUID MAN CONC SPORTS; Parsons OA, 1998, J STUD ALCOHOL, V59, P180, DOI 10.15288/jsa.1998.59.180; Pedhazur E.J., 1997, MULTIPLE REGRESSION, V3rd ed.; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; REID SE, 1975, J TRAUMA, V15, P150, DOI 10.1097/00005373-197502000-00007; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; RUTHERFORD A, 1992, BRIT J MATH STAT PSY, V45, P197, DOI 10.1111/j.2044-8317.1992.tb00988.x; Rutherford A., 2001, INTRO ANOVA ANCOVA G; Sandelin J, 1985, Br J Sports Med, V19, P30; Spreen O., 1998, COMPENDIUM NEUROPSYC; Tysvaer A, 1981, Br J Sports Med, V15, P163; Walsh K. W., 1985, UNDERSTANDING BRAIN; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WEIGHTMAN D, 1974, BRIT J SPORT MED, V8, P183; Wilson, 1991, NATL ADULT READING T; WITHERS R T, 1982, Journal of Human Movement Studies, V8, P159; ZIMMERMAN P, 1995, TEST ATTENTIONAL PER; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	62	30	30	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	2005	27	3					299	319		10.1080/13803390490515504			21	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	913HD	WOS:000228141300003	15969354				2021-06-18	
J	Soussignan, R; Ehrle, N; Henry, A; Schaal, B; Bakchine, S				Soussignan, R; Ehrle, N; Henry, A; Schaal, B; Bakchine, S			Dissociation of emotional processes in response to visual and olfactory stimuli following frontotemporal damage	NEUROCASE			English	Article							FUNCTIONAL NEUROANATOMY; AMYGDALA ACTIVATION; PREFRONTAL CORTEX; NEURAL MECHANISMS; HEDONIC VALENCE; BRAIN ACTIVITY; AWARENESS; ODORS; FMRI; AROUSAL	Contemporary neuropsychological studies have stressed the widely distributed and multicomponential nature of human affective processes. Here, we examined facial electromyographic (EMG) (zygomaticus and corrugator muscle activity), autonomic ( skin conductance and heart rate) and subjective measures of affective valence and arousal in patient TG, a 30 year-old man with left anterior mediotemporal and left orbitofrontal lesions resulting from a traumatic brain injury. Both TG and a normal control group were exposed to hedonically valenced visual and olfactory stimuli. In contrast with control subjects, facial EMG and electrodermal activity in TG did not differentiate among pleasant, unpleasant and neutral pictures. In addition, the controls reacted spontaneously with larger corrugator EMG activity and higher skin conductance to unpleasant odors. By contrast, the subjective feeling states (pleasure and arousal ratings) remained preserved in TG. The covariation between facial and self-report measures of negative valence was also a function of the nature of the olfactory task in the patient only. Taken together, the data suggest a functional dissociation between brain substrates supporting generation of emotion and those supporting representation of emotion.	Hop La Pitie Salpetriere, Lab Vulnerabil Adaptat Psychopathol, CNRS, UMR 7593, F-75013 Paris, France; Hop Maison Blanche, CHU Reims, Serv Neurol, Reims, France; Univ Bourgogne, Ctr Europeen Sci Gout, Dijon, France	Soussignan, R (corresponding author), Hop La Pitie Salpetriere, Lab Vulnerabil Adaptat Psychopathol, CNRS, UMR 7593, Pavillon Clerambault,47 Bd Hop, F-75013 Paris, France.	soussign@ext.jussieu.fr					Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2001, HANDBOOK OF AFFECT AND SOCIAL COGNITION, P27; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; ANDERSON AK, 2002, J COGNITIVE NEUROSCI, V14, P1; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; Averill J.R, 1994, NATURE EMOTION FUNDA, P379; Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Bensafi M, 2002, NEUROSCI LETT, V319, P162, DOI 10.1016/S0304-3940(01)02572-1; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BRADLEY MM, 1994, EMOTIONS: ESSAYS ON EMOTION THEORY, P97; CACIOPPO JT, 1992, PERS SOC PSYCHOL B, V18, P515, DOI 10.1177/0146167292185001; CAIN WS, 1979, SCIENCE, V203, P467, DOI 10.1126/science.760202; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Damasio A., 1994, DESCARTESERROR EMOTI; Damasio A.R., 1995, NEUROSCIENTIST, V1, P19, DOI [DOI 10.1177/107385849500100104, 10.1177/107385849500100104]; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1998, BRAIN RES REV, V26, P83, DOI 10.1016/S0165-0173(97)00064-7; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DEBONIS M, 1996, CONNAITRE EMOTIONS H; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; FRIDLUND AJ, 1991, J PERS SOC PSYCHOL, V60, P229, DOI 10.1037/0022-3514.60.2.229; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Glascher J, 2003, J NEUROSCI, V23, P10274; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; JENNINGS JR, 1987, PSYCHOPHYSIOLOGY, V24, P474, DOI 10.1111/j.1469-8986.1987.tb00320.x; Keillor JM, 2002, J INT NEUROPSYCH SOC, V8, P130, DOI 10.1017/S1355617701020136; KUBOTA Y, 2000, J NEUROSCI, V20, P1; Lane R.D., 2000, SER AFFECTIVE SCI, P345; Lane R.D., 2000, COGNITIVE NEUROSCIEN; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; Lang P. J., 2001, INT AFFECTIVE PICTUR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Liberzon I, 2000, NEUROPSYCHOPHARMACOL, V23, P508, DOI 10.1016/S0893-133X(00)00157-3; Luminet O, 2004, COGNITION EMOTION, V18, P741, DOI 10.1080/02699930341000275; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; Ohman A., 2000, SER AFFECTIVE SCI; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Rouby C, 2002, OLFACTION, TASTE, AND COGNITION, P140, DOI 10.1017/CBO9780511546389.015; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schaal B., 1997, CHEM SENSES, V22, P212; Schaal B., 1998, GEOGRAPHIE ODEURS, P25; Schneider F, 1997, PSYCHIAT RES-NEUROIM, V76, P75, DOI 10.1016/S0925-4927(97)00063-2; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; Soussignan R, 1996, DEV PSYCHOL, V32, P367, DOI 10.1037/0012-1649.32.2.367; Soussignan R, 2004, ADV PSY RES, V31, P173; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	78	30	30	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	APR	2005	11	2					114	128		10.1080/13554790590922513			15	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	920XZ	WOS:000228730100003	16036466				2021-06-18	
J	Casanueva, FF; Leal, A; Koltowska-Haggstrom, M; Jonsson, P; Goth, MI				Casanueva, FF; Leal, A; Koltowska-Haggstrom, M; Jonsson, P; Goth, MI			Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; growth hormone deficiency dwarfism; head trauma; rehabilitation	POSTTRAUMATIC HYPOPITUITARISM; HEAD-INJURY; HYPOGONADISM; DYSFUNCTION; LESIONS; COMA	Objectives: To characterize further the clinical manifestations and the efficacy of growth hormone (GH) replacement therapy in patients with adult-onset growth hormone deficiency (GHD) reported in the KIMS (Pfizer's international metabolic database) as caused by traumatic brain injury (TBI) and to compare them with nonirradiated patients whose GHD was due to a nonfunctioning pituitary adenoma (NFPA). Design: Observational study. Setting: Subjects selected from the KIMS database. Participants: Fifty-one patients with GHD resulting from TBI and 688 patients with GHD resulting from NFPA. Both groups were selected from the KIMS and had adult-onset GHD with GH replacement therapy only after KIMS entry and before and after KIMS entry. Interventions: Not applicable. Main Outcome Measures: Age, body mass index, age at disease onset, age at disease diagnosis, age at KIMS entry, final height, GH peak at testing, GH replacement dose, routine biochemical analysis, clinical manifestations of disease, and quality of life measurements. Results: Patients with TBI were significantly younger at study entry and were younger both at pituitary disease onset and at GHD diagnosis, but they showed a significant delay in treatment. When comparing patients not treated with GH before entering in the KIMS, patients with TBI were significantly shorter (167.2 +/- 1.7cm) than those with NFPA (171.6 +/- 0.4cm) in final height. TBI patients had lower GH reserves than NFPA patients, and although the latter group experienced more positive changes, both groups benefited from GH replacement therapy. Conclusions: Patients with GHD due to TBI showed a significant reduction in height and a reduction in pituitary GH reserve and were diagnosed and treated with inappropriate delay. (C) 2005 by American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Santiago de Compostela, Univ Santiago, Complejo Hosp, Santiago De Compostela, Spain; Univ Santiago de Compostela, Sch Med, Dept Med, Endocrine Sect, Santiago De Compostela, Spain; Hosp Virgen Rocio, Div Endocrinol, Seville, Spain; Pharma AB, Outcomes Res, KIMS, KIGS, Stockholm, Sweden; Natl Med Ctr, Dept Med, Budapest, Hungary	Casanueva, FF (corresponding author), POB 563, E-15780 Santiago De Compostela, Spain.	endocrine@usc.es					ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Benvenga S, 1997, J ENDOCRINOL INVEST, V20, P675, DOI 10.1007/BF03348031; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; CASTANER MF, 1981, MED CLIN, V78, P358; Ceballos R, 1966, Ala J Med Sci, V3, P185; Centers for Disease Control and Prevention, 2003, TRAUM BRAIN INJ US R; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; DANIEL PM, 1961, MOD TRENDS ENDOCRINO, V2, P55; EDWARDS OM, 1986, MEDICINE, V65, P281; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; GUNN IR, 1991, ANN CLIN BIOCHEM, V28, P327, DOI 10.1177/000456329102800402; GUZMAN AL, 1992, ACTA PAEDIATR, V81, P698, DOI 10.1111/j.1651-2227.1992.tb12337.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lieberman SA, 1996, J PEDIATR-US, V128, pS58, DOI 10.1016/S0022-3476(96)70013-6; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MCGAULEY GA, 1990, HORM RES, V33, P52, DOI 10.1159/000181584; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PORTER RJ, 1948, J NEUROL NEUROSUR PS, V11, P258, DOI 10.1136/jnnp.11.4.258; RUDMAN D, 1977, J CLIN ENDOCR METAB, V45, P747, DOI 10.1210/jcem-45-4-747; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; WITTER M, 1957, FORTSCHR NEUROL PSYC, V25, P523	31	30	33	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2005	86	3					463	468		10.1016/j.apmr.2004.05.018			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	904DB	WOS:000227475200017	15759229				2021-06-18	
J	German, JW; Hart, BL; Benzel, EC				German, JW; Hart, BL; Benzel, EC			Nonoperative management of vertical C2 body fractures	NEUROSURGERY			English	Article						axis; C2 vertebra; cervical spine; odontoid; spondylolisthesis; trauma	AXIS; CLASSIFICATION	OBJECTIVE: To estimate the incidence and to describe the clinical results of the nonoperative management of vertical C2 body fractures. METHODS: An 8-year retrospective review of upper cervical spine injuries from the registry of a level I trauma center identified 21 patients with a vertical C2 body fracture. RESULTS: Sixteen coronally oriented Type 1 vertical C2 body fractures and 5 sagittally oriented Type 2 vertical C2 body fractures were identified. These fractures account for approximately 10% of the upper cervical spine fractures identified over this period of time. One elderly patient with a Type 1 fracture died as a result of pneumonia, and two patients with Type 2 fractures died from severe closed-head injuries. One patient had evidence of spinal cord injury. This was not related to the C2 body fracture but rather to a subaxial cervical spine injury. Of the surviving 18 patients, all were managed nonoperatively (with external orthoses) and showed evidence of fusion (union of fracture fragments) at the time of the last follow-up. CONCLUSION: Vertical C2 body fractures are not rare injuries and can account for up to 10% of upper cervical spine injuries. In general, vertical C2 body fractures are amenable to nonoperative treatment with external orthoses.	Univ New Mexico, Div Neurosurg, Albuquerque, NM 87131 USA; Cleveland Clin Fdn, Spine Inst, Albuquerque, NM USA; Univ New Mexico, Dept Radiol, Albuquerque, NM 87131 USA	German, JW (corresponding author), Albany Med Coll, Div Neurosurg, 47 New Scotland,MC 61-NE, Albany, NY 12208 USA.	jwgerman@hotmail.com					ANDERSON LD, 1974, J BONE JOINT SURG AM, VA 56, P1663, DOI 10.2106/00004623-197456080-00017; BENZEL EC, 1994, J NEUROSURG, V81, P206, DOI 10.3171/jns.1994.81.2.0206; Bohay D, 1992, J Orthop Trauma, V6, P416, DOI 10.1097/00005131-199212000-00004; BURKE JT, 1989, SKELETAL RADIOL, V18, P335, DOI 10.1007/BF00361422; EFFENDI B, 1981, J BONE JOINT SURG BR, V63, P319; Fujimura Y, 1996, J ORTHOP TRAUMA, V10, P536, DOI 10.1097/00005131-199611000-00005; Greene KA, 1997, SPINE, V22, P1843, DOI 10.1097/00007632-199708150-00009; Hadley MN, 2002, NEUROSURGERY, V50, pS125; Iizuka H, 2001, SPINE, V26, P2220, DOI 10.1097/00007632-200110150-00013; Korres D S, 1994, Eur Spine J, V3, P151, DOI 10.1007/BF02190577; LEVINE AM, 1985, J BONE JOINT SURG AM, V67A, P217, DOI 10.2106/00004623-198567020-00007; LOZANOREQUENA JA, 1994, INT ORTHOP, V18, P114, DOI 10.1007/BF02484421; MAROTTA TR, 1990, NEUROSURGERY, V26, P848, DOI 10.1227/00006123-199005000-00017; RAINOV NG, 2004, MINIM INVAS NEUROSUR, V41, P93; SMOKER WRK, 1987, AM J ROENTGENOL, V148, P609, DOI 10.2214/ajr.148.3.609; STARR JK, 1993, SPINE, V18, P1954, DOI 10.1097/00007632-199310001-00005; Vialle R, 2004, REV CHIR ORTHOP, V90, P152	17	30	32	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2005	56	3					516	520		10.1227/01.NEU.0000153908.53579.E4			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	905IP	WOS:000227562100033	15730577				2021-06-18	
J	Land, PW; Aizenman, E				Land, PW; Aizenman, E			Zinc accumulation after target loss: an early event in retrograde degeneration of thalamic neurons	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						apoptosis; kainate; lateral geniculate nucleus; rodent; target deprivation	LATERAL GENICULATE-NUCLEUS; NITRIC-OXIDE; CELL-DEATH; TRANSCRIPTION FACTOR; INTRACELLULAR ZINC; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; OXIDATIVE STRESS; VISUAL-CORTEX; KAINIC ACID	Accumulation of cytoplasmic zinc is linked with a cascade of events leading to neuronal death. In many in vivo models of zinc-induced cell death, toxic concentrations of synaptically released zinc enter vulnerable neurons via neurotransmitter- or voltage-gated ion channels. In vitro studies demonstrate, in addition, that zinc can be liberated from intracellular stores following oxidative stress and contribute to cell death processes, including apoptosis. Here we describe accumulation of intracellular zinc in an in vivo model of cell death in the absence of presynaptic zinc release. We focused on the lateral geniculate nucleus (LGN) because LGN neurons undergo apoptosis when separated from their target, the primary visual cortex (V1), and the LGN is mostly devoid of zinc-containing presynaptic terminals. Infant and adult rats and adult mice received unilateral ablation of V1, either by aspiration or kainate injection. One to 14 days later, brain sections were stained with selenium autometallography or fluorescently labeled to localize zinc, or stained immunochemically for activated caspase-3. V1 lesions led to zinc accumulation in LGN neurons in infant and adult subjects. Zinc-containing neurons were evident 1-3 days after aspiration lesions, depending on age, but not until 14 days after kainate injection. Zinc accumulation was followed rapidly by immunostaining for activated caspase-3. Our data indicate that like neurotrauma and excitotoxicity, target deprivation leads to accumulation of zinc in apoptotic neurons. Moreover, zinc accumulation in vivo can occur in the absence of presynaptic zinc release. Together these findings suggest that accumulation of intracellular zinc is a ubiquitous component of the cell death cascade in neurons.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neurosci, Pittsburgh, PA 15261 USA	Land, PW (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	pland@pitt.edu	Aizenman, Elias/K-2726-2012	Aizenman, Elias/0000-0001-9610-4194	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56 NS043277-06, R01 NS043277, R01 NS043277-10, R01 NS043277-08, R01 NS043277-09, NS43277, R56 NS043277, R01 NS043277-07A2, R01 NS043277-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS043277, R01NS043277] Funding Source: NIH RePORTER		Agarwala S, 1998, J COMP NEUROL, V392, P264; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Al-Abdulla NA, 2002, NEUROSCIENCE, V115, P7, DOI 10.1016/S0306-4522(02)00363-9; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Burdette SC, 2003, J AM CHEM SOC, V125, P1778, DOI 10.1021/ja0287377; Casanovas-Aguilar C, 1998, J CHEM NEUROANAT, V15, P97, DOI 10.1016/S0891-0618(98)00035-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; CUNNINGHAM TJ, 1979, J COMP NEUROL, V184, P423, DOI 10.1002/cne.901840213; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; DANSCHER G, 1985, HISTOCHEMISTRY, V83, P419, DOI 10.1007/BF00509203; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DYCK R, 1993, J COMP NEUROL, V329, P53, DOI 10.1002/cne.903290105; EAGLESON KL, 1990, EXP NEUROL, V110, P284, DOI 10.1016/0014-4886(90)90040-Y; EAGLESON KL, 1992, EXP NEUROL, V116, P156, DOI 10.1016/0014-4886(92)90163-K; Estevez AG, 1998, J NEUROSCI, V18, P923; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; Frederickson CJ, 2002, NEUROSCIENCE, V115, P471, DOI 10.1016/S0306-4522(02)00399-8; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GARRETT B, 1992, ANAT EMBRYOL, V186, P487; Hara H, 2004, J NEUROSCI METH, V137, P175, DOI 10.1016/j.jneumeth.2004.02.018; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; JONES KJ, 1986, J NEUROCYTOL, V15, P197, DOI 10.1007/BF01611656; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Land PW, 1999, SOMATOSENS MOT RES, V16, P139; Lashley KS, 1941, J COMP NEUROL, V75, P67, DOI 10.1002/cne.900750105; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; LEES GJ, 1989, ACTA NEUROPATHOL, V77, P519, DOI 10.1007/BF00687254; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; Martin LJ, 2003, J NEUROCHEM, V85, P234, DOI 10.1046/j.1471-4159.2003.01659.x; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MATTHEWS MA, 1973, J NEUROCYTOL, V2, P265, DOI 10.1007/BF01104030; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Mengual E, 2001, NEUROSCIENCE, V102, P863, DOI 10.1016/S0306-4522(00)00472-3; Pal S, 2004, PFLUG ARCH EUR J PHY, V448, P296, DOI 10.1007/s00424-004-1256-7; Pal S, 2003, J NEUROSCI, V23, P4798; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; Pearce LL, 2000, P NATL ACAD SCI USA, V97, P477, DOI 10.1073/pnas.97.1.477; Repici M, 2003, NEUROSCIENCE, V117, P859, DOI 10.1016/S0306-4522(02)00968-5; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; SCHWARCZ R, 1977, BRAIN RES, V127, P235, DOI 10.1016/0006-8993(77)90538-8; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; VONGUDDEN B, 1870, ARCH PSYCHIAT NERVEN, V2, P693; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x	59	30	31	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2005	21	3					647	657		10.1111/j.1460-9568.2005.03903.x			11	Neurosciences	Neurosciences & Neurology	906OU	WOS:000227652300005	15733083	Green Accepted			2021-06-18	
J	Katz, S; Kravetz, S; Grynbaum, F				Katz, S; Kravetz, S; Grynbaum, F			Wives' coping flexibility, time since husbands' injury and the perceived burden of wives of men with traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; FOLLOW-UP; FAMILY; RELATIVES; STRESS; PERSPECTIVE; CHILDREN; ADULTS; IMPACT	Primary objective: To examine the moderating effect of wives' coping flexibility on the relation between time since husband's traumatic brain injury (TBI) and wives' perceived burden and the hypotheses that wives of long duration TBI men and wives with less coping flexibility will express more burden than wives of short duration burden men and wives with more coping flexibility. Research design: Forty-four wives whose husbands had sustained brain injury were interviewed 1 year or more after hospital discharge. Methods and procedures: The Relatives' Burden Questionnaire and Ways of Coping Questionnaire for each of four different problem vignettes were administered to the wives. Main findings and conclusions: No statistically significant effects were found for TBI duration or for wives' coping flexibility, although longer duration TBI wives reported a statistically significant higher level of burden than short duration TBI wives, only if the wives were characterized by low coping flexibility.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel	Katz, S (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	katzsh2@mail.biu.ac.il					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; Block JH, 1980, MINNESOTA S CHILD PS, V13, P39; Brislin R.W., 1980, METHODOLOGY-EUR, P389; Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; BROWN BW, 1988, FAM RELAT, V37, P12, DOI 10.2307/584423; CHWALISZ K, 1992, REHABIL PSYCHOL, V37, P189, DOI 10.1037/h0079103; DAY AM, 1988, REHABIL PSYCHOL, V33, P113; DELORTO AE, 2000, BRAIN INJURY FAMILY; FELTON BJ, 1984, SOC SCI MED, V18, P889, DOI 10.1016/0277-9536(84)90158-8; FLEISHMAN JA, 1984, J HEALTH SOC BEHAV, V25, P229, DOI 10.2307/2136671; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FLORIAN V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Haan N., 1977, COPING DEFENDING PRO; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HOOFIEN D, 1993, FUNCTIONING ADULT PE; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KATZ S, 1990, MONOGRAPH WORLD REHA, V45; KIDARDARDASHTI M, 1991, THESIS BAR ILAN U RA; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Krohne HW., 1986, DYNAMICS OF STRESS, P207, DOI [10.1007/978-1-4684-5122-1_11, DOI 10.1007/978-1-4684-5122-1_11]; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEARY TF, 1975, INTERPERSONAL DIAGNO; LESTER N, 1994, PSYCHOL HEALTH, V9, P409, DOI 10.1080/08870449408407468; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; PERLESZ A, 1989, RECOVERY BRAIN INJUR, P180; Ponsford J., 1995, TRAUMATIC BRAIN INJU; POWER PW, 1985, REHABIL LIT, V46, P78; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; SCHWARZ CE, 1990, THESIS HARVARD BOSTO; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vaillant G.E., 1977, ADAPTATION LIFE; VANUNUYAACOBI A, 1986, THESIS BAR ILAN U RA; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	49	30	30	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2005	19	1					59	66		10.1080/02699050410001719970			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	875AS	WOS:000225392600006	15762101				2021-06-18	
J	Steiner, LA; Balestreri, M; Johnston, AJ; Czosnyka, M; Coles, JP; Chatfield, DA; Smielewski, P; Pickard, JD; Menon, DK				Steiner, LA; Balestreri, M; Johnston, AJ; Czosnyka, M; Coles, JP; Chatfield, DA; Smielewski, P; Pickard, JD; Menon, DK			Sustained moderate reductions in arterial CO2 after brain trauma Time-course of cerebral blood flow velocity and intracranial pressure	INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; human; carbon dioxide; ultrasonography; Doppler; transcranial; intracranial pressure; cerebral blood flow	SEVERE HEAD-INJURY; TRANSCRANIAL DOPPLER; CARBON-DIOXIDE; REACTIVITY; HYPERVENTILATION; HUMANS; HYPERTENSION; PROPOFOL; OXYGEN	Objective: In healthy volunteers cerebral blood flow starts to recover towards baseline within a few minutes of continued hyperventilation due to normalisation of perivascular pH. We investigated the time-course of changes in middle cerebral artery mean flow velocity (FVm) and intracranial pressure (ICP) in head-injured patients during sustained moderate reductions in arterial partial pressure of CO2 (PaCO2). Design: Observational study. Patients: Twenty-seven sedated, mechanically ventilated patients with severe head injury. Interventions: Measurements were made during and after routine determination Of CO2-reactivity: an acute 20% increase in respiratory minute volume was followed by a 10-min stabilisation period and 50 min of continued moderate hyperventilation at a constant PaCO2 (>3.5 kPa). Measurements and results: FVm was monitored with transcranial Doppler, ICP was monitored with intraparenchymal probes. During the 50-min period with stable PaCO2 FVm increased in 36% of patients. All other patients showed a decline in FVm over the same time period. Overall FVm recovery was -0.03+/-0.14%.min(-1). The time-course of ICP changes was significantly different from that of FVm, with ICP reaching its lowest value earlier than FVm (23+/-12 vs 37+/-20 min; P=0.001) and returning more rapidly towards baseline than FVm (0.23+/-0.23 vs -0.03+/-0.14%.min(-1) P<0.0001). Conclusions: Head-injured patients may adapt differently to hyperventilation than healthy volunteers. Potentially harmful reductions in cerebral blood flow may persist beyond the duration of useful ICP reduction.	Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland; Univ Cambridge, Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England	Steiner, LA (corresponding author), Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland.	lsteiner@uhbs.ch	Steiner, Luzius/J-1987-2019; Steiner, Luzius/C-9836-2011	Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		ARTRU AA, 1987, J CEREBR BLOOD F MET, V7, P471, DOI 10.1038/jcbfm.1987.90; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; ELLINGSEN I, 1987, ACTA PHYSIOL SCAND, V129, P157, DOI 10.1111/j.1748-1716.1987.tb08054.x; ENG C, 1992, ANESTHESIOLOGY, V77, P872, DOI 10.1097/00000542-199211000-00006; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2003, ACTA ANAESTH SCAND, V47, P391, DOI 10.1034/j.1399-6576.2003.00078.x; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; LAM AM, 1995, ANESTHESIOLOGY, V82, P1536, DOI 10.1097/00000542-199506000-00035; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Maddock RJ, 2001, J NEUROPSYCH CLIN N, V13, P22, DOI 10.1176/appi.neuropsych.13.1.22; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Poulin MJ, 1998, J APPL PHYSIOL, V85, P388; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; Ropper Allan H., 1993, P29; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; SHENKIN HA, 1970, NEW ENGL J MED, V282, P1465, DOI 10.1056/NEJM197006252822606; STEINER LA, 2003, CRIT CARE, V7; STREBEL S, 1994, ANESTH ANALG, V78, P884; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; ZABLOTNY W, 1994, INTRACRANIAL PRESSUR, V9, P439	25	30	31	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	DEC	2004	30	12					2180	2187		10.1007/s00134-004-2463-6			8	Critical Care Medicine	General & Internal Medicine	882ZG	WOS:000225978300006	15480563				2021-06-18	
J	Leone, M; Albanese, J; Viviand, X; Garnier, F; Bourgoin, A; Barrau, K; Martin, C				Leone, M; Albanese, J; Viviand, X; Garnier, F; Bourgoin, A; Barrau, K; Martin, C			The effects of remifentanil on endotracheal suctioning-induced increases in intracranial pressure in head-injured patients	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL-BLOOD-FLOW; PREVENTING INCREASES; DOSE REMIFENTANIL; PHARMACODYNAMICS; PHARMACOKINETICS; REACTIVITY; ALFENTANIL; FENTANYL	In patients with severe traumatic brain injury, bronchotracheal toilet may be accompanied by deleterious variations in intracranial pressure (ICP). To avoid these effects, IV opioids have been proposed. Twenty mechanically-ventilated patients received 3 ascending IV doses of remifentanil: dose 1 (1 mug/kg bolus, 0.25 mug/kg/min infusion); dose 2 (2 mug/kg bolus, 0.5 mug/kg/min infusion); and dose 3: (4 mug/kg bolus, 1 mug/kg/min infusion). Endotracheal suction was performed 20 min after the beginning of infusion to assess coughing. Heart rate, ICP, mean arterial blood pressure (MAP), cerebral perfusion pressure (CPP), middle cerebral artery mean flow velocity (V-MCA), and bispectral index were monitored throughout the 30-min study period. Twelve, 15, and 19 patients receiving dose 1, 2, and 3, respectively, required vasopressors to maintain CPP >60 mm Hg. Suctioning resulted in coughing in 16,15, and 5 patients receiving dose 1, 2, and 3, respectively. An increase in ICP, without change in VMCA, corresponded to the reduction in MAP consistent with the preservation of autoregulation. Remifentanil used as a continuous infusion in head-injured patients is not an effective drug to block responses to suctioning.	Washington Univ, Sch Med, Dept Anesthesiol & Crit Care Med, St Louis, MO 63110 USA; Marseilles Univ Hosp Syst, Nord Hosp, Intens Care Unit, Marseille, France; Marseilles Univ Hosp Syst, Nord Hosp, Dept Anesthesiol, Marseille, France; Marseilles Univ Hosp Syst, Nord Hosp, Dept Biostat & Epidemiol, Marseille, France; Marseilles Sch Med, Marseille, France	Leone, M (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.	leonem@msnotes.wustl.edu	Leone, Marc/P-4835-2016	Leone, Marc/0000-0002-3097-758X; Baumstarck, Karine/0000-0003-3602-6766			Abdallah C, 2002, CAN J ANAESTH, V49, P1070, DOI 10.1007/BF03017905; ARMITAGE P, 2002, STAT METHODS MED RES, P727; DUPONT WD, 2003, STAT MODELING BIOMED, P345; Egan TD, 1996, ANESTHESIOLOGY, V84, P821, DOI 10.1097/00000542-199604000-00009; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Glass PSA, 1999, ANESTH ANALG, V89, pS7; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; Guignard B, 2000, ANESTH ANALG, V90, P161, DOI 10.1097/00000539-200001000-00034; Guy J, 1997, ANESTHESIOLOGY, V86, P514, DOI 10.1097/00000542-199703000-00002; Hogue CW, 1996, ANESTH ANALG, V83, P279, DOI 10.1097/00000539-199608000-00014; JAMES MK, 1992, J PHARMACOL EXP THER, V263, P84; Kerr ME, 1999, CRIT CARE MED, V27, P2776, DOI 10.1097/00003246-199912000-00028; Klimscha W, 2003, ANESTHESIOLOGY, V99, P834, DOI 10.1097/00000542-200310000-00014; Lorenz IH, 2000, BRIT J ANAESTH, V85, P199, DOI 10.1093/bja/85.2.199; Lorenz IH, 2003, BRIT J ANAESTH, V90, P296, DOI 10.1093/bja/aeg055; Minto CF, 1997, ANESTHESIOLOGY, V86, P24, DOI 10.1097/00000542-199701000-00005; Myre K, 2003, ACTA ANAESTH SCAND, V47, P267, DOI 10.1034/j.1399-6576.2003.00073.x; Ostapkovich ND, 1998, ANESTHESIOLOGY, V89, P358, DOI 10.1097/00000542-199808000-00011; Paris A, 1998, ANESTH ANALG, V87, P569, DOI 10.1097/00000539-199809000-00013; Patel SS, 1996, DRUGS, V52, P417, DOI 10.2165/00003495-199652030-00009; RUDY EB, 1991, HEART LUNG, V20, P667; Shinohara K, 2000, CAN J ANAESTH, V47, P361, DOI 10.1007/BF03020954; Tipps LB, 2000, NEUROSURGERY, V46, P596, DOI 10.1097/00006123-200003000-00015; Warner DS, 1996, ANESTH ANALG, V83, P348, DOI 10.1097/00000539-199608000-00025; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019	26	30	33	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	OCT	2004	99	4					1193	1198		10.1213/01.ANE.0000132546.79769.91			6	Anesthesiology	Anesthesiology	856IW	WOS:000224039900043	15385374				2021-06-18	
J	Minoyama, O; Tsuchida, H				Minoyama, O; Tsuchida, H			Injuries in professional motor car racing drivers at a racing circuit between 1996 and 2000	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Background: Research on injuries in racing drivers is limited. Objective: To gain more information about such injuries. Methods: Injuries recorded during and after races between 1996 and 2000 were investigated using the medical charts from the circuit medical centre at Fuji Speedway, which is one of the biggest circuits in Japan. Races were in either single seat/formula cars or saloon cars. Results: Data were obtained from 39 races in single seat cars (1030 participating cars) and 42 races in saloon cars (1577 cars). Fifty injuries were recorded during the single seat car races, and 62 during the saloon car races (injury rate 1.2 per 1000 competitors per race and 0.9 per 1000 competitors per race respectively). Thirteen injuries were recorded after the race, 12 of them in saloon car racing. Bruises were the major injury in single seat car racing (58%). Lower limb bruising was more common than upper limb bruising. Most of the injuries in saloon car racing (53.2%) were neck sprains. The incidence of concussion was high in both groups compared with other high risk sports. Conclusions: There were some differences in injuries between the two types of car. No serious injuries occurred except for one death. However, the driver's body is subjected to large forces in a crash, hence the high incidence of concussion. The injuries recorded after the race emphasise that motor racing is a demanding sport.	Fuji Toranomon Orthopaed Hosp, Ctr Sports Med, Gotemba, Shizuoka 4120045, Japan	Minoyama, O (corresponding author), Fuji Toranomon Orthopaed Hosp, Ctr Sports Med, 1067-1 Kawashimada, Gotemba, Shizuoka 4120045, Japan.	msportsdr@aol.com					*ASS ADV AUT MED, ABBR INJ SCAL AIS 19; Burton A K, 1983, Br J Sports Med, V17, P150; BURTON AK, 1987, APPL ERGON, V18, P3, DOI 10.1016/0003-6870(87)90064-0; Chapman M A, 1991, Br J Sports Med, V25, P121; Chesser TJS, 1999, INJURY, V30, P293, DOI 10.1016/S0020-1383(99)00086-8; Hunter H C, 1996, J Am Osteopath Assoc, V96, P179; Jareno A, 1987, Br J Sports Med, V21, P48; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Mansfield NJ, 2001, BRIT J SPORT MED, V35, P314, DOI 10.1136/bjsm.35.5.314; Masmejean EH, 1999, BRIT J SPORT MED, V33, P270, DOI 10.1136/bjsm.33.4.270; NAHUM AM, 1993, ACCIDENTAL INJURY BI, P247; Videman T, 2000, CLIN BIOMECH, V15, P83, DOI 10.1016/S0268-0033(99)00047-9; WATKINS S, 1996, LIFE LIMIT TRIUMPH T, P188; YOGANANDAN N, 1989, 33 STAPP CAR CRASH C, P22	14	30	30	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	OCT 1	2004	38	5					613	616		10.1136/bjsm.2003.007674			4	Sport Sciences	Sport Sciences	856PE	WOS:000224056300020	15388550	Bronze, Green Published			2021-06-18	
J	Chiaretti, A; Antonelli, A; Piastra, M; Genovese, O; Polidori, G; Aloe, L				Chiaretti, A; Antonelli, A; Piastra, M; Genovese, O; Polidori, G; Aloe, L			Expression of neurotrophic factors in cerebrospinal fluid and plasma of children with viral and bacterial meningoencephalitis	ACTA PAEDIATRICA			English	Article						brain-derived neurotrophic factor; child; glial-derived neurotrophic factor; meningoencephalitis; nerve growth factor	NERVE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; TRKB RECEPTOR EXPRESSION; TYROSINE KINASE TRKA; UP-REGULATION; CELLS; PHOSPHORYLATION; INTERLEUKIN-6; MENINGITIS; DEATH	Aim: To evaluate the expression of neurotrophic factors (nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF)) and their association with the clinical-radiological characteristics and outcome of children with viral and bacterial meningoencephalitis (ME). Methods: Prospective observational clinical study performed on 13 children with ME and 12 controls with non-inflammatory obstructive hydrocephalus. Neurotrophic factor levels in the cerebro-spinal fluid (CSF) and plasma were measured using an immunoenzymatic assay. Results: High levels of NGF and BDNF were demonstrated in all patients, while GDNF levels did not undergo significant variations. NGF expression in the CSF was higher in viral ME than in bacterial ME and was correlated with CSF cellularity (particularly mononuclear cells). BDNF expression in the CSF was higher in bacterial ME than in viral ME and was correlated with CSF cellularity and blood platelet count. No relationships were noted between CSF protein or serum C-reactive protein levels and the expression of neurotrophic factors. Regarding clinical and radiological features, elevated NGF/BDNF levels in the CSF correlated with higher incidence of seizures and prolonged comatose state and with specific radiological lesions. No correlation was found between NGF/BDNF levels and final outcome. Conclusions: The variations in neurotrophic factor levels may reflect an endogenous attempt at neuroprotection against biochemical and molecular changes during both viral and bacterial ME. The expression of these factors is likely to play a neuro-immunomodulatory or neurosurvival role in ME infections.	Catholic Univ, Sch Med, Paediat Intens Care Unit, Rome, Italy; CNR, Inst Neurobiol, Rome, Italy	Chiaretti, A (corresponding author), Policlin Gemelli, IT-00168 Rome, Italy.	achiaretti@yahoo.it		GENOVESE, Orazio/0000-0002-1989-1363			Aronica E, 2001, ACTA NEUROPATHOL, V101, P383; Azmitia EC, 2001, BRAIN DEV-JPN, V23, pS1, DOI 10.1016/S0387-7604(01)00368-0; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BRDE YA, 1994, PROG CLIN BIOL RES, V390, P1855; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Kanai M, 2002, TOHOKU J EXP MED, V196, P241, DOI 10.1620/tjem.196.241; Kim DH, 1996, NEUROREPORT, V7, P2221, DOI 10.1097/00001756-199609020-00033; Kim JY, 2002, EPILEPSIA, V43, P220, DOI 10.1046/j.1528-1157.43.s.5.33.x; Korhonen L, 1998, NEUROSCI LETT, V240, P151, DOI 10.1016/S0304-3940(97)00937-3; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lappalainen R, 1996, J CHILD NEUROL, V11, P296, DOI 10.1177/088307389601100407; Laurenzi MA, 1998, J LEUKOCYTE BIOL, V64, P228; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Marz P, 1999, GLIA, V26, P191, DOI 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#; Mizuno Y, 2000, J CHILD NEUROL, V15, P19, DOI 10.1177/088307380001500104; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931; Qiao LY, 2002, J COMP NEUROL, V454, P200, DOI 10.1002/cne.10447; Qiao LY, 2002, J COMP NEUROL, V449, P217, DOI 10.1002/cne.10283; Santer R, 1996, ACTA PAEDIATR, V85, P902, DOI 10.1111/j.1651-2227.1996.tb14181.x; Seguier-Lipszyc E, 2001, J UROLOGY, V165, P2269, DOI 10.1016/S0022-5347(05)66182-4; Sherwood ER, 2000, CRIT CARE MED, V28, P1221, DOI 10.1097/00003246-200004000-00054; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Suzaki I, 1997, J CHILD NEUROL, V12, P205, DOI 10.1177/088307389701200310; Tokunaga Y, 2002, PEDIATR NEUROL, V27, P102, DOI 10.1016/S0887-8994(02)00387-9	30	30	31	0	2	TAYLOR & FRANCIS AS	OSLO	CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY	0803-5253			ACTA PAEDIATR	Acta Paediatr.	SEP	2004	93	9					1178	1184		10.1080/08035250410031314			7	Pediatrics	Pediatrics	850OE	WOS:000223621500010	15384880				2021-06-18	
J	Scott, GS; Szabo, C; Hooper, DC				Scott, GS; Szabo, C; Hooper, DC			Poly (ADP-ribse) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro	JOURNAL OF NEUROTRAUMA			English	Article						neurotoxicity; peroxynitrite; poly(ADP-ribose) polymerase; spinal cord injury	TRAUMATIC BRAIN-INJURY; DNA STRAND BREAKAGE; POLY(ADP-RIBOSE) POLYMERASE; NITRIC-OXIDE; ENERGY DEPLETION; ACTIVATION; INHIBITORS; SYNTHETASE; NICOTINAMIDE; NAD(+)	Peroxynitrite, which has been implicated in secondary neuronal damage resulting from spinal cord injury, is capable of mediating several toxic interactions including inducing DNA strand breaks and activating the nuclear enzyme, poly (ADP-ribose) polymerase (PARP). In the present study we have tested the hypothesis that peroxynitrite-induced cell death in spinal cord injury is due to activation of PARP. Initially we examined whether peroxynitrite exerts toxic effects on primary cultures of spinal cord neurons and then determined whether the spinal cord neuronal cell death triggered by peroxynitrite was associated with PARP activation. Peroxynitrite dose-dependently reduced the viability of spinal cord neurons in vitro. Furthermore, peroxynitrite exposure markedly increased the number of DNA strand breaks in primary spinal cord neurons, resulting in activation of PARP. To identify whether PARP activation plays a direct role in peroxynitrite-induced neurotoxicity we assessed the effects of the PARP inhibitors, nicotinamide, 3-aminobenzamide and 5-iodo-6-amino-1,2 benzopyrone on cell viability in spinal cord neurons exposed to peroxynitrite. The presence of the PARP inhibitors in the cultures not only inhibited peroxynitrite-induced PARP activity in spinal cord neurons but also protected the cells from the deleterious actions of peroxynitrite. Therefore, our results demonstrate that peroxynitrite exerts toxic effects on spinal cord neurons in vitro at least in part through a PARP-dependent pathway.	Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Dept Biochem Pharmacol, London, England; Inotek Pharmaceut Corp, Beverly, MA USA	Hooper, DC (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, 1020 Locust St, Philadelphia, PA 19107 USA.	c_hooper@mail.jci.tju.edu	Szabo, Csaba/D-1882-2013	Hooper, Douglas/0000-0002-8578-5104	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS037985] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44 NS 037985] Funding Source: Medline		Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Bao F, 2003, NEUROSCIENCE, V116, P59, DOI 10.1016/S0306-4522(02)00571-7; Bao F, 2002, NEUROSCIENCE, V115, P839, DOI 10.1016/S0306-4522(02)00506-7; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; BREWER KL, 2003, ACAD EMERG MED, V10, P464; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Colak A, 2003, J NEUROSURG, V98, P275, DOI 10.3171/spi.2003.98.3.0275; Cole KK, 2002, J NEUROCHEM, V82, P19, DOI 10.1046/j.1471-4159.2002.00935.x; Cookson MR, 1998, J NEUROCHEM, V70, P501; COSI C, 1994, J NEUROSCI RES, V39, P38, DOI 10.1002/jnr.490390106; Cosi C, 1996, BRAIN RES, V729, P264, DOI 10.1016/S0006-8993(96)00571-9; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEDOUX SP, 1988, DIABETES, V37, P1015, DOI 10.2337/diabetes.37.8.1015; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Nakazawa H, 2000, FREE RADICAL RES, V33, P771, DOI 10.1080/10715760000301291; PFLUEGER E, 1990, J IMMUNOL METHODS, V129, P165, DOI 10.1016/0022-1759(90)90436-Y; RALEY KM, 1990, NEUROSCI LETT, V110, P118, DOI 10.1016/0304-3940(90)90798-E; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; SCHRAUFSTATTER IU, 1986, J CLIN INVEST, V77, P1312, DOI 10.1172/JCI112436; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; Scott GS, 2003, GLIA, V41, P105, DOI 10.1002/glia.10137; Scott GS, 2001, J NEUROIMMUNOL, V117, P78, DOI 10.1016/S0165-5728(01)00329-0; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Szabo C, 1996, FREE RADICAL BIO MED, V21, P855, DOI 10.1016/0891-5849(96)00170-0; SZABO C, 2000, CELL DEATH ROLE PARP; TANUMA SI, 1978, EXP CELL RES, V117, P421, DOI 10.1016/0014-4827(78)90155-6; Toborek M, 1999, J NEUROCHEM, V73, P684, DOI 10.1046/j.1471-4159.1999.0730684.x; UETA K, 1985, ANNU REV BIOCHEM, V54, P73; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; WALLIS RA, 1993, NEUROREPORT, V5, P245; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zingarelli B, 1996, J IMMUNOL, V156, P350	55	30	32	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1255	1263		10.1089/neu.2004.21.1255			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900013	15453994				2021-06-18	
J	Robertson, CL; Bucci, CJ; Fiskum, G				Robertson, CL; Bucci, CJ; Fiskum, G			Mitochondrial response to calcium in the developing brain	DEVELOPMENTAL BRAIN RESEARCH			English	Article						cytochrome c; brain mitochondria; development; acidosis	IMMATURE RAT-BRAIN; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION; HYPOXIA-ISCHEMIA; CELL-DEATH; CEREBRAL-ISCHEMIA; LIVER MITOCHONDRIA; FOREBRAIN ISCHEMIA; LACTIC-ACIDOSIS; HEAD TRAUMA	Developmental differences in mitochondrial content and metabolic enzyme activities have been defined, but less is understood about the responses of brain mitochondria to stressful stimuli during development. Cerebral mitochondrial response to high Ca2+ loads after brain injury is a critical determinant of neuronal outcome. Brain mitochondria isolated from 16-18-day-old rats had lower maximal, respiration-dependent Ca2+ uptake capacity than brain mitochondria isolated from adult rats in the presence of ATP at both a pH of 7.0 and 6.5. However, in the absence of ATP, immature brain mitochondria exhibited greater Ca2+ uptake capacity at pH 7.0 and 6.5, indicating a greater resistance of immature brain mitochondria to Ca2+-induced dysfunction under conditions relevant to those that exist during acute ischemic and traumatic brain injury. Acidosis reduced the maximal Ca2+ uptake capacity in both immature and adult brain mitochondria. Cytochrome c was released from both immature and adult brain mitochondria, in response to Ca2+ exposure, but was not affected by cyclosporin A, an inhibitor of the mitochondrial membrane permeability transition. Developmental changes in mitochondrial response to Ca2+ loads may have important implications in the pathobiology of brain injury to the developing brain. (C) 2004 Elsevier B.V. All rights reserved.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA	Robertson, CL (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 22 S Greene St,S5D18, Baltimore, MD 21201 USA.	croberts@peds.umaryland.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034152, K08NS042805] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD16596] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS34152, K08 NS42805] Funding Source: Medline		AKERMAN KEO, 1978, ARCH BIOCHEM BIOPHYS, V189, P256, DOI 10.1016/0003-9861(78)90211-4; Andreyev AY, 1998, FEBS LETT, V439, P373, DOI 10.1016/S0014-5793(98)01394-5; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Bernardi P, 1999, PHYSIOL REV, V79, P1127; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; DIENEL G, 1977, BIOCHIM BIOPHYS ACTA, V496, P484, DOI 10.1016/0304-4165(77)90330-0; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gilland E, 1998, J CEREBR BLOOD F MET, V18, P297, DOI 10.1097/00004647-199803000-00008; GREENAWALT JW, 1964, J CELL BIOL, V23, P21, DOI 10.1083/jcb.23.1.21; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HILLERED L, 1984, J CEREBR BLOOD F MET, V4, P430, DOI 10.1038/jcbfm.1984.62; HILLERED L, 1985, J CEREBR BLOOD F MET, V5, P259, DOI 10.1038/jcbfm.1985.33; HOLTZMAN D, 1975, J NEUROCHEM, V24, P1011, DOI 10.1111/j.1471-4159.1975.tb03670.x; HOLTZMAN D, 1973, BIOL NEONATE, V22, P230; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; Keelan J, 1999, BRAIN RES, V821, P124, DOI 10.1016/S0006-8993(99)01084-7; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Kushnareva YE, 2001, ARCH BIOCHEM BIOPHYS, V386, P251, DOI 10.1006/abbi.2000.2201; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Nagao S, 1996, EXP BRAIN RES, V111, P51; Nakajima W, 2000, J NEUROSCI, V20, P7994; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Polster BM, 2003, CELL DEATH DIFFER, V10, P365, DOI 10.1038/sj.cdd.4401158; Polster BM, 2001, J BIOL CHEM, V276, P37887; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P43, DOI 10.1016/S0165-3806(00)00111-5; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; ROSENBERG JM, 1989, ANN EMERG MED, V18, P341, DOI 10.1016/S0196-0644(89)80565-7; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; ROTTENBERG H, 1989, FEBS LETT, V247, P483, DOI 10.1016/0014-5793(89)81396-1; SITKIEWICZ D, 1982, J NEUROCHEM, V39, P1308, DOI 10.1111/j.1471-4159.1982.tb12571.x; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; SUTTON LN, 1995, PEDIATR NEUROSURG, V22, P81, DOI 10.1159/000120881; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Wallin C, 2000, DEV BRAIN RES, V125, P51, DOI 10.1016/S0165-3806(00)00112-7; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611; WEINBACH EC, 1967, BIOCHIM BIOPHYS ACTA, V148, P256, DOI 10.1016/0304-4165(67)90301-7; WHITE RJ, 1995, J NEUROSCI, V15, P1318; Yager JY, 1996, BRAIN RES, V712, P230, DOI 10.1016/0006-8993(95)01423-3; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102	51	30	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-3806			DEV BRAIN RES	Dev. Brain Res.	JUL 19	2004	151	1-2					141	148		10.1016/j.devbrainres.2004.04.007			8	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	841VQ	WOS:000222960200014	15246700				2021-06-18	
J	Brvar, M; Mozina, H; Osredkar, J; Mozina, M; Noc, M; Brucan, A; Bunc, M				Brvar, M; Mozina, H; Osredkar, J; Mozina, M; Noc, M; Brucan, A; Bunc, M			S100B protein in carbon monoxide poisoning: a pilot study	RESUSCITATION			English	Article						carbon monoxide; hyperbaric oxygen; S100B; indications; prognosis	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; HYPERBARIC-OXYGEN; SERUM LEVELS; S-100B; MARKER	Carbon monoxide (CO) poisoning is the most common form of lethal poisoning. The aim of this prospective clinical study was to assess the possible role of S100B, the structural protein in the astroglia, as a biochemical marker of brain injury in carbon monoxide poisoning. Serum S100B determination was performed in 38 consecutive patients poisoned by carbon monoxide who were admitted to the Emergency Department (ED) in Ljubljana. All three unconscious patients had elevated S100B levels. The patient with the highest S100B died. S100B was elevated in two of the six patients with initial transitory unconsciousness at the scene. All 29 patients without loss of consciousness had normal S100B levels. Carbon monoxide poisoning appears to be associated with elevated S100B levels. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Sch Med, Inst Pathophysiol, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Clin Dept Cardiol, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Dept Emergency Med, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Ctr Intens Internal Med, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Poison Control Ctr, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Lab Biochem Anal, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Ctr Intens Internal Med, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Poison Control Ctr, Ljubljana 1000, Slovenia	Bunc, M (corresponding author), Sch Med, Inst Pathophysiol, Zaloska Cesta 4, Ljubljana 1000, Slovenia.	mbuncek@yahoo.com					Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Bottiger BW, 2001, CIRCULATION, V103, P2694; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Hampson NB, 2001, ANN EMERG MED, V38, P36, DOI 10.1067/mem.2001.115532; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; RAPHAEL JC, 1989, LANCET, V2, P414; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Schiltz KL, 2000, UNDERSEA HYPERBAR M, V27, P48; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121	13	30	32	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2004	61	3					357	360		10.1016/j.resuscitation.2004.01.009			4	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	831MQ	WOS:000222198900015	15172716				2021-06-18	
J	Masel, BE				Masel, BE			Rehabilitation and hypopituitarism after traumatic brain injury	GROWTH HORMONE & IGF RESEARCH			English	Article; Proceedings Paper	35th International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism	APR 04-05, 2003	Prague, CZECH REPUBLIC	Pfizer Inc		traumatic brain injury; rehabilitation; hypopituitarism; amnesia; Glasgow coma scale	ADULTS	Traumatic brain injury (TBI) is a leading cause of death and disability in the United States (US). The severity of a TBI is difficult to assess, and therefore, accurate determination of the prognosis is difficult. The symptoms of a TBI involve most major medical systems, and share many similarities with the symptoms of hypopituitarism. Although more than two-thirds of patients with severe head injuries who die have structural abnormalities in the hypothalamus and the pituitary, pituitary function is not routinely assessed after head trauma. Thus, studies have shown that anterior pituitary hormone deficiencies are common following brain injury [Endocrinologist 11 (2001) 275; J. Clin. Endocrinol. Metab. 86 (2001) 2752]. Survivors of brain injury should be screened for such deficiencies so that replacement therapy can be initiated to optimize rehabilitation and outcome. (C) 2004 Elsevier Ltd. All rights reserved.	Transit Learning Ctr Galveston, Galveston, TX 77550 USA	Masel, BE (corresponding author), Transit Learning Ctr Galveston, 1528 PO St, Galveston, TX 77550 USA.	bmasel@tlc-galveston.org					Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; EDWARDS OM, 1986, MEDICINE, V65, P281; Eledrisi M, 2001, ENDOCRINOLOGIST, V11, P275, DOI 10.1097/00019616-200107000-00005; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Fink M E, 1987, Emerg Med Clin North Am, V5, P783; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; GUPTA N, 2003, NEUROREVIEW; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; MAZZUCCHI A, 1992, J NEUROL, V239, P256; Simmonds M, 1914, DEUT MED WOCHENSCHR, V40, P322, DOI 10.1055/s-0029-1190185; TEASDALE G, 1974, LANCET, V2, P81; 1998, NIH CONSENSUS STATEM, V16, P1	18	30	32	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1096-6374	1532-2238		GROWTH HORM IGF RES	Growth Horm. IGF Res.	JUN	2004	14			A			S108	S113		10.1016/j.ghir.2004.03.024			6	Cell Biology; Endocrinology & Metabolism	Cell Biology; Endocrinology & Metabolism	827CS	WOS:000221876700025	15135790				2021-06-18	
J	Meythaler, JM; Clayton, W; Davis, LK; Guin-Renfroe, S; Brunner, RC				Meythaler, JM; Clayton, W; Davis, LK; Guin-Renfroe, S; Brunner, RC			Orally delivered baclofen to control spastic hypertonia in acquired brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anoxia; baclofen; brain injury; encephalopathy; gamma amino butyric acid (GABA); spasticity; stroke	INTRATHECAL BACLOFEN; MULTIPLE-SCLEROSIS; DRUG-THERAPY; GABAPENTIN; TIZANIDINE; INFUSION; STROKE/; ORIGIN; TRIAL	To determine if oral/systemic delivery of baclofen can effectively decrease spastic hypertonia due to acquired brain injury (traumatic brain injury, stroke, anoxia, or encephalopathy). Tertiary care outpatient rehabilitation center directly attached to a university hospital. Patients were a convenience sample recruited consecutively who had been referred for treatment of their spastic hypertonia to our spasticity clinic over a 5-year period. The spastic hypertonia was due to an acquired brain injury by either traumatic brain injury (TBI), stroke, or anoxic brain injury. All patients were more than 6 months postinjury or illness. Retrospective review of patients before and after initiation of treatment with oral baclofen, per standardized clinical data sheets. Thirty-five patients (22 TBI patients) were started on oral baclofen and were reevaluated between I to 3 months after initiation of treatment. Data for motor tone (Ashworth scores), spasm scores (Penn spasm frequency score), and deep tendon reflex scores were collected on the affected upper extremity (UE) and lower extremity (LE) side(s). Normal extremities were not assessed. Differences over time were assessed via descriptive statistics and Wilcoxon signed-rank. After 1 to 3 months of treatment when subjects had reached their maximal tolerated dosage, the average LE Ashworth score in the affected lower extremities (LEs) decreased from 3.5 to 3.2 (P =.0003), the reflex score decreased from 2.5 to 2.2 (P =.0274), and there was no statistical difference in the spasm score (P >.05). When the 22 TBI patients are analyzed separately, the average LE Ashworth score decreased from 3.5 to 3.2 (P =.0044) and the reflex score decreased from 2.7 to 2.0 (P =.0003). There was no statistically significant change in UE tone, spasm frequency, or reflexes after 1 to 3 months of treatment (P >.05). The average dosage at follow-up was 57 mg/day of baclofen (range 15120 mg/day). There was a 17% incidence of somnolence that limited the maximum daily dosage of the medication. The oral delivery of baclofen is capable of reducing LE spastic hypertonia resulting from acquired brain injury. The lack of effect upon the upper extremities may be due to receptor specificity issues. GABA-B receptors may be less involved in the modulation of UE spastic hypertonia.	Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr R157, Birmingham, AL 35249 USA	Meythaler, JM (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr R157, 619 6th Ave S, Birmingham, AL 35249 USA.	Jmeythal@uab.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 007420-13] Funding Source: Medline		ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ASHBY P, 1974, J NEUROL NEUROSUR PS, V37, P1352, DOI 10.1136/jnnp.37.12.1352; ASHWORTH B, 1964, PRACTITIONER, V192, P540; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Cutter NC, 2000, ARCH PHYS MED REHAB, V81, P164, DOI 10.1016/S0003-9993(00)90135-7; ELOVIC E, 2001, N AM CLIN PHYS MED R, V12, P793; Ford B, 1996, ARCH NEUROL-CHICAGO, V53, P1241, DOI 10.1001/archneur.1996.00550120049016; FRANCISCO GE, 2001, N AM CLIN PHYS MED R, V12, P875; Gelber DA, 2001, STROKE, V32, P1841, DOI 10.1161/01.STR.32.8.1841; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; Gracies JM, 1997, MUSCLE NERVE, pS92; Hattab J.R., 1980, SPASTICITY DISORDERE, P71; Mann NH, 1991, J NEUROL REHABIL, V5, P51; Meythaler JA, 2001, ARCH PHYS MED REHAB, V82, P1155, DOI 10.1053/apmr.2001.25141; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P638, DOI 10.1016/S0003-9993(03)00105-9; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1997, J HEAD TRAUMA REHAB, V12, P87, DOI 10.1097/00001199-199702000-00012; Meythaler JM, 1999, SPINAL DRUG DELIVERY, P513; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; MEYTHALER JM, 2001, N AM CLIN PHYS MED R, V12, P953; Mueller ME, 1997, ARCH PHYS MED REHAB, V78, P521, DOI 10.1016/S0003-9993(97)90168-4; NANCE PW, 1994, NEUROLOGY, V44, P44; NANCE PW, 2001, N AM CLIN PHYS MED R, V12, P889; Priebe MM, 1997, SPINAL CORD, V35, P171, DOI 10.1038/sj.sc.3100366; ROY CW, 1986, PARAPLEGIA, V24, P318, DOI 10.1038/sc.1986.45; RUDICK RA, 1987, ARCH NEUROL-CHICAGO, V44, P1033, DOI 10.1001/archneur.1987.00520220039013; SANDYK R, 1985, CLIN NEUROPHARMACOL, V8, P294, DOI 10.1097/00002826-198509000-00011; SMITH C, 1994, NEUROLOGY, V44, P34; YOUNG RR, 1981, NEW ENGL J MED, V304, P28; YOUNG RR, 1981, NEW ENGL J MED, V304, P96	32	30	31	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					101	108		10.1097/00001199-200403000-00003			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900003	15247821				2021-06-18	
J	Brown, SA; McCauley, SR; Levin, HS; Contant, C; Boake, C				Brown, SA; McCauley, SR; Levin, HS; Contant, C; Boake, C			Perception of health and quality of life in minorities after mild-to-moderate traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						mild traumatic brain injury; health perception; depression; ethnic minority	HEAD-INJURY; GENERAL HEALTH; SCALES; POPULATIONS; INDIVIDUALS; DEPRESSION; DISABILITY; IMPACT; ADULTS; SCORE	Much has been reported of the influence of age, affective symptoms, and satisfaction on self-ratings of health functioning, but little is known about the extent that race-based perceptions may have on influencing behavior or adjustment after a mild-to-moderate traumatic brain injury (MTBI). We investigated differences in perception of health functioning by race for mental and physical functioning using a global measure of health functioning. MTBI (n = 135) and general trauma (GT, n = 83) patients recruited from an area Level-1 trauma center at 3 months after injury were administered the Medical Outcomes Study: Short Form (SF-36), Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994), Community Integration Questionnaire, Social Support Questionnaire (SSQ), Center for Epidemiological Studies-Depression, and the Visual Analogue Scale of Depression. A significant interaction for Race x Group (p < .01) was found on the Physical Component Scale (PCS) of the SF-36 In the MTBI group, African Americans reported worse functioning (p < .04) on the PCS scale; they perceived functioning on subscales General Health Perception (p < .02) and Physical Functioning (p < .04) to be more limited. On the SSQ, Hispanic MTBI patients reported having fewer social supports available to them (p < .05), although the race groups were comparable for satisfaction with their support. Rate of depression across groups was comparable, although subjective reporting by minority MTBI patients indicated greater depressed feelings. Differences in perception of health functioning may be related to the unique interaction created between sustaining an MTBI and variations in cultural expression of disability Manifestations of physical difficulties may be better accepted for some cultures than having mental illness.	Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Biobehav Sci, Cognit Neurosci Lab, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA	Brown, SA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 6560 Fannin,Ste 1144,Box 67, Houston, TX 77030 USA.	sbrown@bcm.tmc.edu			ODCDC CDC HHS [R49-CCR 612707] Funding Source: Medline		AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Burnett DM, 2000, BRAIN INJURY, V14, P713; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; COOPER KD, 1983, NEUROEPIDEMIOLOGY, V2, P70; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; Dana RH, 1993, MULTICULTURAL ASSESS; Deane M, 1996, BRIT J NEUROSURG, V10, P187; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FIRST MB, 1995, USERS GUIDE STRUCTUR; Freeman HP, 1998, CANCER, V82, P219, DOI 10.1002/(SICI)1097-0142(19980101)82:1<219::AID-CNCR27>3.0.CO;2-4; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Jackson-Triche ME, 2000, J AFFECT DISORDERS, V58, P89, DOI 10.1016/S0165-0327(99)00069-5; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LINN MW, 1980, MED CARE, V18, P282, DOI 10.1097/00005650-198003000-00003; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RASKIN S, 2000, NEUROPSYCHOLOGICAL M, P269; Ren X S, 1996, Ethn Health, V1, P293; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Shetterly SM, 1996, AM J PUBLIC HEALTH, V86, P1798, DOI 10.2105/AJPH.86.12.1798; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; TEASDALE G, 1974, LANCET, V2, P81; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009	38	30	30	0	11	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2004	11	1					54	64		10.1207/s15324826an1101_7			11	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	858AR	WOS:000224163000007	15471747				2021-06-18	
J	Gordon, WA; Cantor, JB; Johanning, E; Charatz, HJ; Ashman, TA; Breeze, JL; Haddad, L; Abramowitz, S				Gordon, WA; Cantor, JB; Johanning, E; Charatz, HJ; Ashman, TA; Breeze, JL; Haddad, L; Abramowitz, S			Cognitive impairment associated with toxigenic fungal exposure: A replication and extension of previous findings	APPLIED NEUROPSYCHOLOGY			English	Article						toxic mold; brain injury; cognitive impairment; mycotoxins; neuropsychological	TRAUMATIC BRAIN-INJURY	In this study, neuropsychological data and symptom reports from 31 individuals exposed to toxic mold were examined. Most participants were found to have reduced cognitive functioning in multiple domains, with memory and executive functions the most commonly affected areas. Rates of dysfunction were significantly greater than chance on more than half of the tests. Number of cognitive impairments was found to be related to depression, although few neuropsychological test scores were correlated with depression. Results also indicated that symptom report of the mold-exposed participants was not significantly different from that of matched groups of 65 persons with mild traumatic brain injury (TBI) and 26 individuals with moderate TBI. The mold-exposed participants reported significantly more symptoms than 47 people with no disability. This study adds to a growing body of literature (e.g., Baldo, Ahmad, Ruff, 2002; Gordon, Johanning, & Haddad, 1999) relating exposure to mycotoxins to cognitive dysfunction.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Community & Prevent Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	Gordon, WA (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	wayne.gordon@msnyuhealth.org	Ashman, Teresa/B-1621-2013; D'Albuquerque, Luiz Augusto Carneiro/I-4011-2012	D'Albuquerque, Luiz Augusto Carneiro/0000-0001-7607-7168; Breeze, Janis/0000-0002-5458-1010			AUGERSON WS, 2000, REV SCI LIT PERTAINS, V5; BADDELEEY AD, 1976, PSYCHOL MEMORY; Baldo Juliana V, 2002, Appl Neuropsychol, V9, P193, DOI 10.1207/S15324826AN0904_1; Cassens G, 1990, J Neuropsychiatry Clin Neurosci, V2, P202; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE; CONNERS CK, 1995, CONNERS CONTINOYS PE; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DELIS D, 1987, CALIFORNIA VERBAL LE; Etzel RA, 2002, JAMA-J AM MED ASSOC, V287, P425, DOI 10.1001/jama.287.4.425; Gordon W. A., 1999, BIOAEROSOLS FUNGI MY, P94; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Heaton R.K., 1991, COMPREHENSIVE NORMS; Hodgson MJ, 1998, J OCCUP ENVIRON MED, V40, P241, DOI 10.1097/00043764-199803000-00006; JOHGANNING E, 1999, BIOAEROSOLS FUNGI MY; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Niederehe G., 1986, HDB CLIN MEMORY ASSE, P226; Picard M, 1991, HELPS BRIEF SCREENIN; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; *RES TRAINING CTR, 1997, BRAIN INJ SCREEN QUE; REY A, 1964, EXAM CLIN PSYCHOL; RICHMOND VA, TBI SYMPTOM CHECKLIS; Tombaugh TN, 1996, TEST MEMORY MALINGER; WECHSLER D, 1997, WAIS 3 ADM SCOR MANU; WECHSLER D, 1997, WMS 3 ADM SCOR MANUA; Wetzel L., 1987, SHORT CATEGORY TEST; WOODCOCK J, 1989, TESTS COGNITIVE ABIL	27	30	30	0	2	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2004	11	2					65	74		10.1207/s15324826an1102_1			10	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	864IB	WOS:000224626100001	15477176				2021-06-18	
J	Alessandri, B; Heimann, A; Filippi, R; Kopacz, L; Kempski, O				Alessandri, B; Heimann, A; Filippi, R; Kopacz, L; Kempski, O			Moderate controlled cortical contusion in pigs: Effects on multi-parametric neuromonitoring and clinical relevance	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; microdialysis; monitoring; pig; ptiO(2)	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; FLUID-PERCUSSION INJURY; INTRACRANIAL-PRESSURE; EXTRACELLULAR POTASSIUM; SUBSTRATE DELIVERY; OXYGEN-TENSION; INTENSIVE-CARE; TISSUE OXYGEN	Over the last decade, routine neuromonitoring of ICP and CPP has been extended with new on-line techniques such as microdialysis, tissue oxygen (ptiO(2)), acid-base balance (ptiCO(2), pH) and CBF measurements, which so far have not lead to clear-cut therapy approaches in the neurointensive care unit. This is partially due to the complex pathophysiology following a wide-range of brain injuries, and the lack of suitable animal models allowing simultaneous, clinically relevant neuromonitoring under controlled conditions. Therefore, a controlled cortical impact (CCI) model in large animals (pig) has been developed. After placement of microdialysis, ptiO(2), temperature and ICP catheters, an unilateral CCI injury (2.6-2.8 m/sec velocity, 9 mm depth, 400 ms dwell time) was applied and neuromonitoring continued for 10 h. CCI caused a rapid drop in CPP, ptiO(2) and glucose, whereas ICP, glutamate and lactate increased significantly. Most parameters returned to baseline values within hours. Lactate stayed elevated significantly throughout the experiment, but the lactate-to-pyruvate ratio (LPR) changed only slightly, indicating no severely ischemic CBF. Contralateral parameters were not affected significantly. Evaluation of brain water content and histology (12 h post-CCI) showed ipsilateral brain swelling by 5% and massive cell damage underneath the injury site which correlated with changes of ICP, CPP, glutamate, lactate, and ptiO(2) within the first hours post-CCI. Moderate controlled cortical contusion in pigs induced a complex pattern of pathophysiological processes which led to `early' histological damage. Thus, this new large animal model will enable us to investigate the effect of therapeutic interventions on multi-parametric neuromonitoring and histological outcome, and to translate the data into clinical practice.	Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, D-6500 Mainz, Germany; Johannes Gutenberg Univ Mainz, Dept Neurosurg, D-6500 Mainz, Germany	Alessandri, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, D-6500 Mainz, Germany.	beat.alessandri@uni-mainz.de		Heimann, Axel/0000-0003-2510-3228			ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alessandri B, 1996, ACT NEUR S, V67, P6; Alessandri B, 1998, PROG BRAIN RES, V116, P303, DOI 10.1016/S0079-6123(08)60445-8; Alessandri B, 1999, ACT NEUR S, V75, P21; Alessandri B, 1999, ACT NEUR S, V75, P25; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Barbiro-Micahely E, 2001, J NEUROTRAUM, V18, P711, DOI 10.1089/089771501750357654; Bardt TF, 1998, ACT NEUR S, V71, P153; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fray AE, 1996, J PHYSIOL-LONDON, V496, P49, DOI 10.1113/jphysiol.1996.sp021664; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Goodman JC, 1996, ACT NEUR S, V67, P37; Goodman JC, 1999, ACT NEUR S, V75, P35; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kempski O, 1990, Adv Neurol, V52, P219; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroppenstedt SN, 1999, J NEUROTRAUM, V16, P629, DOI 10.1089/neu.1999.16.629; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LANDOLT H, 1994, ACTA NEUROCHIR, P475; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vath A, 2000, ZBL NEUROCHIR, V61, P2, DOI 10.1055/s-2000-8258; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	58	30	30	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2003	20	12					1293	1305		10.1089/089771503322686094			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	756XH	WOS:000187510700002	14748978				2021-06-18	
J	Blackman, JA; Rice, SA; Matsumoto, JA; Conaway, MR; Elgin, KM; Patrick, PD; Farrell, WJ; Allaire, JH; Willson, DF				Blackman, JA; Rice, SA; Matsumoto, JA; Conaway, MR; Elgin, KM; Patrick, PD; Farrell, WJ; Allaire, JH; Willson, DF			Brain imaging as a predictor of early funcional outcome following traumatic brain injury in children, aldolescents, and young adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional outcome; neuroimaging; rehabilitation; traumatic brain injury; WeeFIM	CLOSED-HEAD INJURY; FUNCTIONAL INDEPENDENCE; ADOLESCENTS; DISABILITIES; TOMOGRAPHY; POPULATION; MODERATE; SEVERITY; MODEL; MILD	Objectives: A depth of lesion (DOL) model using brain imaging has been proposed to aid in medical decision-making and planning for rehabilitation resource needs. The purpose of this study was to determine the early prognostic value of a DOL classification system for children and young adults following severe traumatic brain injury. Methods and Outcome measures: CT/MRI brain imaging studies on 92 patients, aged 3 to 21, admitted to the Kluge Children's Rehabilitation Center, University of Virginia, were evaluated to determine DOL. Images were classified according to 5 DOL levels (cortical to brainstem). Functional outcomes in mobility, self-care, and cognition, as rated on the WeeFIM instrument, were compared by DOL levels. Results: Admission WeeFIM scores were significantly different for the DOL levels with the highest score for frontal and/or temporal lesions and the lowest for lesions including the brainstem or cerebellum (P < .001). However, the deeper the lesion, the greater the functional gains (P = .05), resulting in discharge WeeFIM scores that were not significantly different across DOL levels. Patients with deeper lesions tended to have longer lengths of stay in rehabilitation but were able to "catch up" with patients who had more superficial lesions. Conclusions: While relatively simple and convenient, the DOL classification system is limited in its usefulness as an early prognostic tool. It may not be possible to predict outcome in the early acute phase in the intensive care unit on the basis of standard brain imaging alone. Patients with deeper lesions may enter rehabilitation at a more impaired level but can make remarkable progress, though it may take longer than for less severely injured individuals.	Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Pediat, Charlottesville, VA 22902 USA; Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Radiol, Charlottesville, VA 22902 USA; Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Hlth Evaluat Sci, Charlottesville, VA 22902 USA	Blackman, JA (corresponding author), Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Pediat, 2270 Ivy Rd, Charlottesville, VA 22902 USA.		Matsumoto, Julie/D-6464-2013		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039631] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24 HD39631] Funding Source: Medline		BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; *CDCP, 2000, COMMUNICATION; Deutsch A, 1996, CRIT REV PHYS REHABI, V8, P267; Gean A D, 1995, New Horiz, V3, P549; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; JENKINS A, 1986, LANCET, V2, P445; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; MSALL ME, 1996, DEV DISABILITIES INF, P371; Msall ME, 1993, PHYS MED REHAB CLIN, V4, P517; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; *STAT U NY BUFF, 1997, GUID UN DAT SET MED; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; *U BUFF, 1998, UN DAT SYST MED REH; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	30	30	31	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					493	503		10.1097/00001199-200311000-00003			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200003	14707879				2021-06-18	
J	Ohlsson, M; Bellander, BM; Langmoen, IA; Svensson, M				Ohlsson, M; Bellander, BM; Langmoen, IA; Svensson, M			Complement activation following optic nerve crush in the adult rat	JOURNAL OF NEUROTRAUMA			English	Article						axotomy; CNS; complement; glia; MAC; optic nerve	AXONAL REGENERATION; TERMINAL PATHWAY; REGROWTH FAILURE; FACIAL-NERVE; HUMAN BRAIN; CELL-LINES; INJURY; SYSTEM; MACROPHAGES; EXPRESSION	Activation of the complement cascade following peripheral nerve axotomy and following traumatic brain injury has been demonstrated in previous studies. This study investigates the temporal pattern of microglia/macrophages and complement activation following axotomy of sensory CNS neurons, using a standardized experimental crush injury of the optic nerve in adult rats. Numerous ED1-labeled macrophages were found at the lesion site and distal to the injury at 7 days post injury (dpi). Complement C3-mRNA was upregulated 2-28 days post lesion, indicating local synthesis of complement in the optic nerve. Furthermore, increased immunoreactivity (IR) for the end product of the complement cascade, the membrane attack complex (MAC), was detected along disintegrating axons co-labeled with anti-neurofilament distal to the injury. Double-labeling for microglia show MAC-immunoreactivity expressed in their immediate vicinity, indicating a key role of microglia/macrophages in complement activation. The complement regulator Clusterin was upregulated in astrocytes at the lesion site as well as in the distal portion of the injured optic nerve, suggesting activation of a defense response to endogenous complement attack. A crush injury of the optic nerve leads to complement activation at the site of lesion and along the distal portion of the nerve, as well as upregulation of the complement inhibitor Clusterin at least in astrocytes. Reactive microglial cells seem to have a key role in complement activation as a local source of C3. We suggest that the balance between complement activation and their regulators may have impact on axonal degeneration following optic nerve injury.	Karolinska Hosp & Inst, Neurosurg Sect, Dept Clin Neurosci, Stockholm, Sweden	Ohlsson, M (corresponding author), Karolinska Hosp & Inst, Neurosurg Sect, Dept Clin Neurosci, Stockholm, Sweden.	marcus.ohlsson@ks.se	Ohlsson, Marcus R/H-1395-2011; Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003			AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Ben Zeev-Brann A, 1998, GLIA, V23, P181, DOI 10.1002/(SICI)1098-1136(199807)23:3<181::AID-GLIA1>3.0.CO;2-8; BLAUGRUND E, 1992, EXP NEUROL, V118, P105, DOI 10.1016/0014-4886(92)90027-N; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brecknell JE, 1996, BIOL REV, V71, P227, DOI 10.1111/j.1469-185X.1996.tb00748.x; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; D'Ambrosio AL, 2001, MOL MED, V7, P367, DOI 10.1007/BF03402183; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dieterich DC, 2002, NEUROSCI LETT, V317, P29, DOI 10.1016/S0304-3940(01)02418-1; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; Gasque P, 1996, J NEUROIMMUNOL, V66, P29, DOI 10.1016/0165-5728(96)00015-X; GASQUE P, 1995, J IMMUNOL, V154, P4726; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Gasque P, 1997, AM J PATHOL, V150, P31; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; GIULIAN D, 1993, J NEUROSCI, V13, P29; GREENBERG MS, 1997, HDB NEUROSURGERY; Haga S, 1996, NEUROSCI LETT, V216, P191, DOI 10.1016/0304-3940(96)13040-8; Kandel E.R., 2000, PRINCIPLES NEURAL SC; LAW SK, 1988, COMPLEMENT; Lazarov-Spiegler O, 1998, GLIA, V24, P329, DOI 10.1002/(SICI)1098-1136(199811)24:3<329::AID-GLIA7>3.0.CO;2-X; Lazarov-Spiegler O, 1999, VISION RES, V39, P169, DOI 10.1016/S0042-6989(98)00089-3; LazarovSpiegler O, 1996, FASEB J, V10, P1296; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.0.CO;2-7; LIU L, 1995, NEUROSCIENCE, V68, P167, DOI 10.1016/0306-4522(95)00103-P; MacLaren RE, 1998, BRIT J OPHTHALMOL, V82, P577, DOI 10.1136/bjo.82.5.577; Mattsson P, 1998, J NEUROIMMUNOL, V91, P180, DOI 10.1016/S0165-5728(98)00178-7; Mattsson P, 2001, J COMP NEUROL, V437, P106, DOI 10.1002/cne.1273; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; OHLSSON M, IN PRESS RESTORATIVE; Podhajsky RJ, 1997, EXP NEUROL, V143, P153, DOI 10.1006/exnr.1996.6354; RODDY J, 1994, J NEUROL, V241, P557, DOI 10.1007/BF00873519; Rus H, 2001, IMMUNOL RES, V24, P79, DOI 10.1385/IR:24:1:79; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; SCHMIDEK HH, 2000, OPERATIVE NEUROSURGI; Schwartz M, 1999, NEUROSURGERY, V44, P1041, DOI 10.1097/00006123-199905000-00057; Speth C, 1999, WIEN KLIN WOCHENSCHR, V111, P378; SVENSSON M, 1995, MOL CHEM NEUROPATHOL, V24, P53, DOI 10.1007/BF03160112; SVENSSON M, 1994, NEUROPATH APPL NEURO, V20, P185; SVENSSON M, 1992, J NEUROIMMUNOL, V40, P99, DOI 10.1016/0165-5728(92)90217-9; Tornqvist E, 1996, NEUROBIOL AGING, V17, P695; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65; Yoles E, 1997, J NEUROTRAUM, V14, P665, DOI 10.1089/neu.1997.14.665; YOUMANS JR, 1997, NEUROLOGICAL SURG	46	30	31	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2003	20	9					895	904		10.1089/089771503322385827			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	725BB	WOS:000185521800008	14577867				2021-06-18	
J	Petridou, E; Kedikoglou, S; Andrie, E; Farmakakis, T; Tsiga, A; Angelopoulos, M; Dessypris, N; Trichopoulos, D				Petridou, E; Kedikoglou, S; Andrie, E; Farmakakis, T; Tsiga, A; Angelopoulos, M; Dessypris, N; Trichopoulos, D			Injuries among disabled children: a study from Greece	INJURY PREVENTION			English	Article							DISABILITIES; PREVENTION; PEOPLE	Objective: To compare the differential implications of sociodemographic and situational factors on the risk of injury among disabled and non-disabled children. Design: Data from the Emergency Department Injury Surveillance System (EDISS) were used to compare, in a quasi case-control approach, injured children with or without disability with respect to sociodemographic, event and injury variables, and to estimate adjusted odds ratios for the injury in a disabled rather than a non-disabled child. Setting: Two teaching hospitals in Athens and two district hospitals in the countryside that participate in the EDISS. Patients: In the five year period 1996-2000, 110066 children were recorded with injuries; 251 among them were identified as having a motor/psychomotor or sensory disability before the injury event. Interventions: None. Main outcome measures: Mechanism of injury, type of injury, risk-predisposing socioeconomic and environmental variables, odds ratio for injury occurrence. Results: Falls and brain concussion are proportionally more common among disabled children, whereas upper limb and overexertion injuries are less common among them. Urban environment, migrant status, and cold months are also associated with increased odds for injuries to occur among disabled rather than non-disabled children. The odds ratio for the occurrence of an injury among disabled children increases with increasing age. Conclusions: The results of the study provide the information for the targeting of trials of preventive measure in disabled children at increased risk of severe injuries.	Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Petridou, E (corresponding author), Univ Athens, Sch Med, Dept Hyg & Epidemiol, 75 Mikras Asias Str, GR-11527 Athens, Greece.	epetrid@med.uoa.gr		PETRIDOU, ELENI/0000-0003-3695-3439			ANGLE CR, 1975, PEDIATRICS, V56, P819; Bergeron J W, 1999, Phys Med Rehabil Clin N Am, V10, P213; BRESLOW NE, 1993, IARC SCI PUBLICATION, V32; COPPENS NM, 1986, J PEDIATR PSYCHOL, V11, P189, DOI 10.1093/jpepsy/11.2.189; Dessypris N, 2002, J Cancer Epidemiol Prev, V7, P123; DUNNE RG, 1993, MENT RETARD, V31, P83; Forjuoh SN, 2001, BRIT MED J, V322, P940, DOI 10.1136/bmj.322.7292.940; LELAND NL, 1994, J DEV BEHAV PEDIATR, V15, P402; MELLINGER GD, 1967, J HEALTH SOC BEHAV, V8, P96, DOI 10.2307/2948340; MITCHELL PL, 1996, 6 NAT I DIS REH RES; *NAT I CHILD HLTH, 1993, NIH PUBL, P33; OLLI S, 1985, THEORETICAL EPIDEMIO; PERRIN MJ, 1993, HOME COMMUNITY CARE; RIVARA FP, 1995, J DEV BEHAV PEDIATR, V16, P362; Roberts I, 1995, Inj Prev, V1, P12, DOI 10.1136/ip.1.1.12; Sherrard J, 2001, Inj Prev, V7, P56; Strauss D, 1998, AM J EPIDEMIOL, V147, P855, DOI 10.1093/oxfordjournals.aje.a009539; STRUNK W, 1999, ELEMENTS STYLE, P13; *US DEP HHS, 1990, ICD 9 CM INT CLASS D, V1; *US DEP HHS, 1990, ICD 9 CM INT CLASS D, V2; World Health Organization, 1980, INT CLASS DIS	21	30	31	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	SEP	2003	9	3					226	230		10.1136/ip.9.3.226			5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	719QK	WOS:000185214900007	12966010	Green Published, Bronze			2021-06-18	
J	Hiraiwa, M; Liu, J; Lu, AG; Wang, CY; Misasi, R; Yamauchi, T; Hozumi, I; Inuzuka, T; O'Brien, JS				Hiraiwa, M; Liu, J; Lu, AG; Wang, CY; Misasi, R; Yamauchi, T; Hozumi, I; Inuzuka, T; O'Brien, JS			Regulation of gene expression in response to brain injury: Enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain	JOURNAL OF NEUROTRAUMA			English	Article						alternative splicing; cerebral ischemia; gene regulation; neurotrauma; neurotrophic factor; prosaposin; sphingolipid activator protein	SPHINGOLIPID ACTIVATOR PROTEINS; FOCAL CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; SCHWANN-CELLS; METACHROMATIC LEUKODYSTROPHY; NEUROTROPHIC FACTOR; STAB WOUNDS; IN-VIVO; DEFICIENCY; MUTATION	Prosaposin, the precursor of saposins or saps, is an injury-repair protein that acts on both neurons and glia. Previous studies identified the prosaposin gene as one of differentially expressed genes following nerve injury. In the present study, we investigated expression of prosaposin mRNA in injured brain utilizing rat models of focal cerebral ischemia and cortical stab wound in order to explore the significance of prosaposin in nerve injury. In ischemic brain, the level of prosaposin mRNA was elevated greater than 400% over controls within 5 days after ischemic insults. Importantly, this induction was accompanied by a 9-base splicing consistent with the alternative Exon-8 splicing of human prosaposin mRNA. In normal brain, two prosaposin mRNA species with and without the 9-base insertion were expressed at a ratio of 85:15; however, this equilibrium reverted to 5:95 following ischemic injury. Similar inductions were observed in stab wound brains. Immunohistochemical staining and in situ hybridization demonstrated an enhanced signal distribution of prosaposin mRNA and injury-induced prosaposin protein around the lesion. The data suggest the expression and processing of prosaposin mRNA may be crucially regulated not only for cerebral homeostasis but also during nerve regenerative and degenerative processes.	Univ Calif San Diego, Sch Med, Dept Neurosci, Ctr Mol Genet, La Jolla, CA 92093 USA; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Rome, Italy; Gifu Univ, Dept Neurol & Geriatr, Gifu, Japan	Hiraiwa, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, Ctr Mol Genet, 9500 Gilman Dr,CMG-115, La Jolla, CA 92093 USA.			Hozumi, Isao/0000-0003-0984-6291			Ashwal S, 1998, STROKE, V29, P1037, DOI 10.1161/01.STR.29.5.1037; Campana WM, 1998, FASEB J, V12, P307; Chambers CB, 1997, MOL BRAIN RES, V48, P115, DOI 10.1016/S0169-328X(97)00089-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOHERTY P, 1992, NATURE, V356, P791, DOI 10.1038/356791a0; FU Q, 1994, J MOL NEUROSCI, V5, P59, DOI 10.1007/BF02736694; Fujita N, 1998, J NEUROSCI, V18, P1970; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; GILLEN C, 1995, J NEUROSCI RES, V42, P159, DOI 10.1002/jnr.490420203; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; Henseler M, 1996, J BIOL CHEM, V271, P8416, DOI 10.1074/jbc.271.14.8416; HIRAIWA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P110, DOI 10.1006/abbi.1993.1328; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; Hiraiwa M, 1997, ARCH BIOCHEM BIOPHYS, V341, P17, DOI 10.1006/abbi.1997.9958; HOLTSCHMIDT H, 1991, J BIOL CHEM, V266, P7556; HOLTSCHMIDT H, 1991, FEBS LETT, V280, P267, DOI 10.1016/0014-5793(91)80308-P; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hozumi I, 1999, NEUROSCI LETT, V267, P73, DOI 10.1016/S0304-3940(99)00325-0; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; Igase K, 1999, J CEREBR BLOOD F MET, V19, P298, DOI 10.1097/00004647-199903000-00008; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kotani Y, 1996, J NEUROCHEM, V66, P2019; KREDA SM, 1994, DEV NEUROSCI-BASEL, V16, P90, DOI 10.1159/000112093; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; LAMONTAGNE S, 1994, J BIOL CHEM, V269, P20528; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LIU WK, 1993, AM J PATHOL, V142, P387; Lu AG, 2000, NEUROREPORT, V11, P1791, DOI 10.1097/00001756-200006050-00039; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; Madar-Shapiro L, 1999, BIOCHEM J, V337, P433, DOI 10.1042/0264-6021:3370433; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; OBRIEN JS, 1995, FASEB J, V9, P681; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; OBRIEN JS, 1991, FASEB J, V5, P301; Olivier B., 1998, BIOCHEMICA, P10; Oya Y, 1998, ACTA NEUROPATHOL, V96, P29, DOI 10.1007/s004010050857; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; RAFI MA, 1990, BIOCHEM BIOPH RES CO, V166, P1017, DOI 10.1016/0006-291X(90)90912-7; RAMSHAW AL, 1992, J CLIN PATHOL, V45, P1015, DOI 10.1136/jcp.45.11.1015; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; SUN Y, 1994, AM J PATHOL, V145, P1390; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TANIUCHI M, 1988, J NEUROSCI, V8, P664; Vouyiouklis DA, 2000, J NEUROCHEM, V74, P940, DOI 10.1046/j.1471-4159.2000.0740940.x; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Yokota N, 2001, STROKE, V32, P168, DOI 10.1161/01.STR.32.1.168; ZHANG XL, 1991, HUM GENET, V87, P211, DOI 10.1007/BF00204185; ZHANG XL, 1990, P NATL ACAD SCI USA, V87, P1426, DOI 10.1073/pnas.87.4.1426	56	30	32	0	7	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2003	20	8					755	765		10.1089/089771503767869980			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	712BU	WOS:000184777000006	12965054				2021-06-18	
J	Sarcia, PJ; Scumpia, PO; Moldawer, LL; DeMarco, VG; Skimming, JW				Sarcia, PJ; Scumpia, PO; Moldawer, LL; DeMarco, VG; Skimming, JW			Hypothermia induces interleukin-10 and attenuates injury in the lungs of endotoxemic rats	SHOCK			English	Article						anti-inflammatory; pro-inflammatory; LPS; GRO/CINC-1; IL-1 beta; IL-6; myeloperoxidase; normothermia	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN INJURY; TUMOR-NECROSIS-FACTOR; MODERATE HYPOTHERMIA; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; CYTOKINE PRODUCTION; HEMORRHAGIC-SHOCK; SKELETAL-MUSCLE; IN-VITRO	We recently reported that hypothermia protects against intrapulmonary nitric oxide overproduction and nitric oxide-mediated lung injury in endotoxemic rats. Few studies have been performed to investigate whether hypothermia reduces inflammation by affecting favorable changes in chemokine and pro- and anti-inflammatory cytokine profiles. In this study, we tested the hypothesis that hypothermia decreases concentrations of growth-related oncogene/cytokine-induced neutrophil chemoattractant-1 (GRO/CINC-1), interleukin (IL)-1beta, IL-6, and myeloperoxidase and increases concentration of IL-10 in the lungs endotoxemic rats. Twelve rats were anesthetized and randomized to treatment with either hypothermia (T = 18-24degreesC; n = 6) or normothermia (T = 36-38degreesC, n = 6). Endotoxin (15 mg/kg of Escherichia coli lipopolysaccharide) was administered intravascularly and lung tissue was harvested 150 min later. Three additional rats were sham instrumented and maintained as normothermic but not given endotoxin. Hematoxylin & eosin staining was performed for qualitative inspection of tissues. Quantitative analyses of lung homogenates were performed using enzyme-linked immunosorbent assays for IL-1beta, IL-6, IL-10, and GRO/CINC-1. Myeloperoxidase concentrations were determined using a colorimetric assay. Hypothermia attenuated the induction of intrapulmonary IL-1beta (P < 0.05), IL-6(P < 0.05), GRO/CINC-1 (P < 0.05), and myeloperoxidase (P < 0.05) caused by endotoxin. Inspection of the lungs revealed that hypothermia similarly attenuated histological signs of injury, such as interstitial edema and neutrophil accumulation. Hypothermia increased the intrapulmonary concentration of IL-10 more than 3-fold over that measured in the normothermia (endotoxin-exposed) group (P < 0.05). Hypothermia inhibits neutrophil recruitment in the lungs of endotoxemic rats in part by decreasing proinflammatory cytokine expression. Additionally, hypothermia induces intrapulmonary IL-10 expression. Further studies are needed to investigate whether IL-10 mediates the anti-inflammatory effects of hypothermia.	Univ Missouri, Dept Child Hlth, Columbia, MO 65211 USA; Univ Missouri, Dept Physiol, Columbia, MO 65211 USA; Univ Florida, Dept Pediat, Gainesville, FL USA; Univ Florida, Dept Surg, Gainesville, FL USA	Skimming, JW (corresponding author), Univ Missouri, Dept Child Hlth, 1 Hosp Dr, Columbia, MO 65211 USA.			DeMarco, Vincent/0000-0003-2092-9995	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000082] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5M01 RR000082-390655] Funding Source: Medline		Adams V, 2002, CARDIOVASC RES, V54, P95, DOI 10.1016/S0008-6363(02)00228-6; Ameredes BT, 2001, J LEUKOCYTE BIOL, V70, P730; Angstwurm K, 2000, J CEREBR BLOOD F MET, V20, P834, DOI 10.1097/00004647-200005000-00010; Biagas Katherine V., 1998, Current Opinion in Pediatrics, V10, P271, DOI 10.1097/00008480-199806000-00009; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; COX G, 1996, AM J PHYSIOL, V271, P566; CUNHA FQ, 1992, BIOCHEM BIOPH RES CO, V182, P1155, DOI 10.1016/0006-291X(92)91852-H; de Waal MR, 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gaines GC, 1999, J VASC SURG, V29, P370, DOI 10.1016/S0741-5214(99)70390-3; Gesser B, 1996, J LEUKOCYTE BIOL, V59, P407; Gui Y, 2000, AM J PHYSIOL-HEART C, V279, pH566; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Huang CJ, 2002, NITRIC OXIDE-BIOL CH, V6, P79, DOI 10.1006/niox.2001.0402; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lee SL, 2001, J SURG RES, V100, P150, DOI 10.1006/jsre.2001.6230; Lu MY, 2002, INTENS CARE MED, V28, P636, DOI 10.1007/s00134-002-1262-1; Olszyna DP, 2000, J INFECT DIS, V181, P613, DOI 10.1086/315275; Qing M, 2001, SHOCK, V15, P372, DOI 10.1097/00024382-200115050-00007; Schmidt M, 2000, EUR J IMMUNOL, V30, P1769, DOI 10.1002/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9; Scumpia PO, 2002, AM J PHYSIOL-LUNG C, V283, pL1231, DOI 10.1152/ajplung.00102.2002; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Tassani P, 2002, J THORAC CARDIOV SUR, V123, P648, DOI 10.1067/mtc.2002.121285; Thomassen MJ, 1996, CLIN IMMUNOL IMMUNOP, V80, P321, DOI 10.1006/clin.1996.0130; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; vanderPoll T, 1997, J IMMUNOL, V158, P1971; WATANABE K, 1991, EXP MOL PATHOL, V55, P30, DOI 10.1016/0014-4800(91)90016-Q; Wenzel RP, 1996, CLIN INFECT DIS, V22, P407, DOI 10.1093/clinids/22.3.407; Whalen MJ, 1997, ACT NEUR S, V70, P260; Wladis A, 2001, SHOCK, V15, P60, DOI 10.1097/00024382-200115010-00010	35	30	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	JUL	2003	20	1					41	45		10.1097/01.shk.0000071080.50028.f2			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	693FJ	WOS:000183706100008	12813367				2021-06-18	
J	Skokan, EG; Junkins, EP; Kadish, H				Skokan, EG; Junkins, EP; Kadish, H			Serious winter sport injuries in children and adolescents requiring hospitalization	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Academy-of-Pediatrics	OCT 19-25, 2001	SAN FRANCISCO, CA	Amer Acad Pediat		skiing; snowboarding; recreational injury; pediatric trauma; helmets; injury prevention	SNOWBOARDING INJURIES; HEAD-INJURIES; SEVERITY; SKIERS; RISK	To describe the epidemiology of serious winter sports-related injuries resulting in hospitalization in children and adolescents, we prospectively collected and analyzed records of all winter sports-related injuries requiring hospitalization at our respective institutions from 1996 to 2000. We identified 101 patients with a mean age of 10.7 years, of whom 68% were male and 32% female. Skiers accounted for 71% and snowboarders 26% of injuries; 3% of injuries were snowmobile-or luge-related. Leading mechanisms of injury were ground level falls (50%), crashes into trees, (18%), and falls from ski lift(13%). Approximately 26% of the patients met criteria for trauma-team activation. Leading diagnoses were head injury (20%), femur fracture (18%), and concussion (11%). Five patients required admission to the intensive care unit. The median injury severity score (ISS) was 7; 8% of patients had an ISS score > 15. Abbreviated Injury Scale-1990 scores of greater than or equal to 3 were noted in 34% of the patients. We conclude that Injuries sustained through participation in winter sports may be severe, especially in the case of injuries involving the head. Injury-prevention strategies should focus on head injuries. Copyright 2003, Elsevier Science (USA). All rights reserved.	Univ Utah, Sch Med, Dept Pediat, Div Pediat Emergency Med, Salt Lake City, UT USA; Intermt Injury Control Res Ctr, Salt Lake City, UT USA	Skokan, EG (corresponding author), Primary Childrens Med Ctr, Div Pediat Emergency Med, 100 Med Dr, Salt Lake City, UT 84113 USA.	eskokan@hsc.utah.edu					*AM MED ASS, HELM RECR SKIING OTH; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1992, INJURY FACT BOOK, P89; Bergstrom KA, 1999, SCAND J MED SCI SPOR, V9, P110; Bonnie R.J., 1999, REDUCING BURDEN INJU; *COMM INJ SCAL, 1990, ABBR INJ SCAL 1990 R; Diamond PT, 2001, BRAIN INJURY, V15, P429, DOI 10.1080/02699050010005922; Ferrera PC, 1999, AM J EMERG MED, V17, P575, DOI 10.1016/S0735-6757(99)90199-7; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; Hagel BE, 1999, CLIN J SPORT MED, V9, P9, DOI 10.1097/00042752-199901000-00003; Hennessey T, 2002, AM J PREV MED, V22, P110, DOI 10.1016/S0749-3797(01)00411-1; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; Josefson D, 1998, BRIT MED J, V316, P172; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Machold W, 2000, J TRAUMA, V48, P1109, DOI 10.1097/00005373-200006000-00018; Macnab A J, 1996, Inj Prev, V2, P286, DOI 10.1136/ip.2.4.286; Muller R, 2000, SPORTVERLETZ SPORTSC, V14, P121, DOI 10.1055/s-2000-8954; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; O'Neill DF, 1999, AM J SPORT MED, V27, P94; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Shorter NA, 1999, AM J EMERG MED, V17, P261, DOI 10.1016/S0735-6757(99)90121-3; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; WARME WJ, 1995, AM J SPORT MED, V23, P597, DOI 10.1177/036354659502300514	25	30	31	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2003	21	2					95	99		10.1053/ajem.2003.50032			5	Emergency Medicine	Emergency Medicine	663VQ	WOS:000182027400002	12671807				2021-06-18	
J	Hillary, FG; Schultheis, MT; Challis, BH; Millis, SR; Carnevale, GJ; Galshi, T; DeLuca, J				Hillary, FG; Schultheis, MT; Challis, BH; Millis, SR; Carnevale, GJ; Galshi, T; DeLuca, J			Spacing of repetitions improves learning and memory after moderate and severe TBI	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DEFICITS; RECALL; PERFORMANCE; RETRIEVAL; SCALE	Extensive research has determined that new learning in healthy individuals is significantly improved when trials are distributed over time (spaced presentation) compared to consecutive learning trials (massed presentation). This phenomenon known as the "spacing effect" (SE) has been shown to enhance verbal and nonverbal learning in healthy adults of different ages and in different memory paradigms (e.g., recognition, recall, etc.). The purpose of this study was to examine whether learning in adults with moderate and severe traumatic brain injury (TBI) is improved using a spacing-of-repetitions procedure. Using a within-groups design, participants with TBI (n = 20) were presented a list of 115 words that were presented either once (single condition), twice consecutively (massed condition), or twice with 11 words between presentations (spaced condition). Participants were required to rank each word from 1 to 10 according to their familiarity with the word; they were not asked to "memorize" words for a later test. Word list learning was measured with a free recall test immediately following list presentation and with free recall and recognition tests after a 30-min delay. Participants recalled and recognized significantly more spaced words than massed words during this word list learning task. These results strongly indicate that the spacing of repetitions improves learning and memory in individuals who have sustained moderate to severe TBI. Implications for rehabilitation are discussed.	Kessler Med Rehabil Res & Educ Corp, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Johnson & Johnson Pharmaceut Res & Dev LLC, New Brunswick, NJ USA; Kessler Inst Rehabil, W Orange, NJ USA	DeLuca, J (corresponding author), Kessler Med Rehabil Res & Educ Corp, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jdeluca@kmrrec.org	Hillary, Frank/AAN-8622-2021	Schultheis, Maria/0000-0002-6558-548X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07522] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133P970011] Funding Source: Medline		ALDENKAMP AP, 1991, J NEUROPSYCHOLOGICAL, V1, P199; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Berg I. J., 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI [DOI 10.1080/09602019108401384, 10.1080/09602019108401384]; BERGMAN MM, 1998, INT J COGNITIVE TECH, V3, P45; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Braun K, 1998, MEMORY, V6, P37; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Cermak LS, 1996, NEUROPSYCHOLOGY, V10, P219; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P115, DOI 10.1037/0278-7393.19.1.115; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P389, DOI 10.1037/0278-7393.19.2.389; CHIARAVALOTTI ND, IN PRESS CLIN REHABI; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dempster F. N., 1990, J RES DEV EDUC, V23, P97; DEMPSTER FN, 1988, AM PSYCHOL, V43, P627, DOI 10.1037/0003-066X.43.8.627; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Ebbinghaus H., 1964, MEMORY CONTRIBUTION; GAY LR, 1973, J EDUC PSYCHOL, V64, P171, DOI 10.1037/h0034595; GLENBERG AM, 1979, MEM COGNITION, V7, P95, DOI 10.3758/BF03197590; GREENE RL, 1989, J EXP PSYCHOL LEARN, V15, P371, DOI 10.1037/0278-7393.15.3.371; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hintzman D. L., 1974, THEORIES COGNITIVE P; KEARCOLWELL JJ, 1980, J CLIN PSYCHOL, V36, P782, DOI 10.1002/1097-4679(198007)36:3<782::AID-JCLP2270360334>3.0.CO;2-K; KRUG D, 1990, J EDUC PSYCHOL, V82, P366, DOI 10.1037/0022-0663.82.2.366; LEZAK MD, 1998, NEUROPSYCHOLOGICAL A; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; PRIGATANO GP, 1999, PRINCIPLES NEUROPSYC, P256; ROEDIGER HL, 1992, J EXP PSYCHOL LEARN, V18, P3, DOI 10.1037/0278-7393.18.1.3; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Russo R, 1998, J EXP PSYCHOL LEARN, V24, P161, DOI 10.1037/0278-7393.24.1.161; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	34	30	30	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2003	25	1					49	58		10.1076/jcen.25.1.49.13631			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	666YD	WOS:000182203300005	12607171				2021-06-18	
J	Jones, PA; Andrews, PJD; Easton, VJ; Minns, RA				Jones, PA; Andrews, PJD; Easton, VJ; Minns, RA			Traumatic brain injury in childhood: Intensive Care time series data and outcome	BRITISH JOURNAL OF NEUROSURGERY			English	Article						age-specific physiological derangements; cerebral perfusion pressure; children; intracranial pressure; outcome; secondary insults; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; INTRA-CRANICAL PRESSURE; PERFUSION-PRESSURE; SECONDARY INSULTS; YOUNG-CHILDREN; AGE; COMA; MANAGEMENT; SEVERITY	Age-specific norms are necessary to determine potential secondary brain insult after head injury in children. We describe and quantify the secondary physiological derangement recorded in children of different ages following traumatic brain injury, and relate it to outcome at 12 months post-injury. Prospective time-series data (including intracranial pressure, arterial blood pressure, cerebral perfusion pressure, oxygen saturation, temperature and heart rate) downloaded from ICU monitors, were examined to identify abnormal (i.e. outside normal age-specific limits) recordings lasting more than 5 min. Cumulated total duration of derangement was calculated for each parameter and as a percentage of the time that the ICP monitor was in situ. Univariate and multivariate logistic regression modelling was used to evaluate predictors of outcome. Age-specificity allows realistic comparisons of physiological data among children. Duration of age-specific derangement of CPP was found to predict outcome (dead v. alive: p = 0.003 and Glasgow Outcome Score 1-3 v. 4-5, i.e. poor v. independent outcome p = 0.004).	Univ Edinburgh, Dept Child Life & Hlth, Royal Hosp Sick Children, Edinburgh EH9 1UW, Midlothian, Scotland; Western Gen Hosp, Dept Clin & Surg Serv Anaesthet Pain Management &, Edinburgh EH4 2XU, Midlothian, Scotland; ICON Clin Res Ltd, Dublin 18, Ireland	Minns, RA (corresponding author), Univ Edinburgh, Dept Child Life & Hlth, Royal Hosp Sick Children, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	Robert.Minns@ed.ac.uk					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; *AM ASS AUT MED, 1995, ABBR INJ SCAL 1985 R; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; ANDREWS PJD, 1995, ACTA ANAESTH SCAND, V39, P112, DOI 10.1111/j.1399-6576.1995.tb04287.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; DONMALL MC, 1985, ACTA PAEDIAT SC S318, V74, P23; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Falkner B, 1996, PEDIATRICS, V98, P649; Horan M, 1987, PEDIATRICS, V79, P1; Hosmer D, 1989, APPL LOGISTIC REGRES; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; HOWELLS TP, 1997, P 10 INT S INTR PRES; HOWELLS TP, 1994, EDINBURGH MONITOR BR; JACKSON S, 1999, BRIT J NEUROSURG, V13, P104; JAMES HE, 1993, NEUROSURG QUART, V3, P272; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kirkpatrick PJ, 1996, J NEUROL NEUROSUR PS, V60, P131, DOI 10.1136/jnnp.60.2.131; Kollevold T, 1976, J Oslo City Hosp, V26, P99; LAM WH, 1999, CARE CRITICALLY 3, V15, P95; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MANN N, 1999, CARE CRITICALLY 3, V2, P143; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MAYER T, 1982, CLIN PEDIATR, V21, P391, DOI 10.1177/000992288202100701; MCLAURIN R L, 1989, Neurosurgical Review, V12, P219, DOI 10.1007/BF01790652; MINNS RA, 1991, PROBLEMS INTRACRANIA, P170; MORONT ML, 1994, PEDIATR CLIN N AM, V41, P1201; Nybo T, 1999, BRAIN INJURY, V13, P759; Ott R, 2000, J TRAUMA, V49, P729, DOI 10.1097/00005373-200010000-00023; PAYNE W, 1998, INTENS CARE WORLD, V15, P45; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; PIPER IR, 1991, BR J INTENS CARE, V1, P73; REILLY PL, 1988, CHILD NERV SYST, V4, P30; ROSNER B, 1993, J PEDIATR-US, V123, P871, DOI 10.1016/S0022-3476(05)80382-8; SETTERGREN G, 1980, ACTA PAEDIATR SCAND, V69, P457, DOI 10.1111/j.1651-2227.1980.tb07114.x; SHANN F, 1996, DRUG DOSES; SHAPIRO K, 1993, HEAD INJURY, P427; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Signorini DF, 1997, CRIT CARE MED, V25, P2048, DOI 10.1097/00003246-199712000-00024; SIGNORINI DF, 1997, J NEUROTRAUM, V14, P280; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; TEASDALE GM, 2000, 46 SIGN ROY COLL PHY; VANDER AJ, 1975, HUMAN PHYSL MECH BOD, P391; Verger K, 2000, BRAIN INJURY, V14, P495; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	63	30	31	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2003	17	1					29	39		10.1080/0268869031000093708			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	677GE	WOS:000182797900009	12779199				2021-06-18	
J	Martin, TA; Hoffman, NM; Donders, J				Martin, TA; Hoffman, NM; Donders, J			Clinical utility of the Trail Making Test ratio score	APPLIED NEUROPSYCHOLOGY			English	Article						Trail Making Test; ratio score; brain injury	RECOGNITION MEMORY TEST; MILD HEAD-INJURY	It has been suggested that a ratio score of part B to part A of the Trail Making Test (TMT) may have clinical utility as a measure of cognitive efficiency and/or dissimulation. We investigated the clinical utility of the TMT B/A ratio score in the evaluation of patients with traumatic brain injury. Part B of the TMT demonstrated a statistically significant difference between groups with mild (n = 59) versus moderate-severe (n = 41) injuries. However, the B/A ratio score did not demonstrate sensitivity to injury severity and also failed to discriminate reliably individuals who had independent psychometric indicators of possible dissimulation from those who did not. We conclude that in individuals with traumatic brain injury, the B/A ratio score does not appear to enhance the clinical utility of the TMT and that interpretation of performance on this test should instead involve comparing subtest completion times to established normative data.	Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, Grand Rapids, MI USA; Univ Missouri, Columbia, MO USA; Adler Sch Profess Psychol, Chicago, IL USA	Donders, J (corresponding author), Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI USA.	jdonders@mfbrc.com					Acker MB, 1989, NEUROPSYCHOLOGY, V3, P123, DOI 10.1037//0894-4105.3.3.123; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Golden C. J., 1981, INTERPRETATION HALST; Heaton R.K., 1991, COMPREHENSIVE NORMS; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P536; Miller A., 2000, CLIN NEUROPSYCHOLOGI, V2, P141; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis Scott R., 1996, P481; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MILLIS SR, 1997, CALIFORNIA VERBAL LE; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; TEASDALE G, 1974, LANCET, V2, P81; Warrington EK., 1984, RECOGNITION MEMORY T; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfson D., 1993, HALSTEAD REITAN NEUR	36	30	30	2	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	3					163	169		10.1207/S15324826AN1003_05			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	780NL	WOS:000189387500005	12890642				2021-06-18	
J	Wilson, BA; Scott, H; Evans, J; Emslie, H				Wilson, BA; Scott, H; Evans, J; Emslie, H			Preliminary report of a NeuroPage service within a health care system	NEUROREHABILITATION			English	Article						memory; brain injury; rehabilitation; external aids	MEMORY AID; REHABILITATION	NeuroPage, a paging service designed to reduce the everyday memory and/or planning problems of people with neurological deficits, is described. Following several research studies carried out to-evaluate the system, a British local health authority set up a nationwide commercial NeuroPage service. A report on the first 40 clients recruited to the service is provided. The age range was 14-81 years, the majority of clients were men and the most frequent diagnosis was traumatic brain injury although a number of different diagnostic groups were represented. The types of messages sent and the group's satisfaction with NeuroPage are considered. Three brief case studies to illustrate the different ways clients used the system are presented.	Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Cambridge CB2 2QQ, England; Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, Cambs, England	Wilson, BA (corresponding author), Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Box 58, Cambridge CB2 2QQ, England.						Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; EVANS JJ, IN PRESS J INT NEURO; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Inglis E, 2002, UNIVERSAL ACCESS AND ASSISTIVE TECHNOLOGY, P171; Robertson IH, 1999, CURR OPIN NEUROL, V12, P703, DOI 10.1097/00019052-199912000-00008; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WILSON BA, IN PRESS CLIN NEUROP; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161	12	30	32	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2003	18	1					3	8					6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	688EB	WOS:000183419400002	12719616				2021-06-18	
J	Chan, RCK; Manly, T				Chan, RCK; Manly, T			The application of "dysexecutive syndrome" measures across cultures: Performance and checklist assessment in neurologically healthy and traumatically brain-injured Hong Kong Chinese volunteers	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						assessment; dysexecutive syndromes; brain injury; cultures	COGNITIVE-FAILURES-QUESTIONNAIRE; TEMPORAL-LOBE LESIONS; FRONTAL-LOBE; EXECUTIVE FUNCTIONS; PLANNING ABILITY; MEMORY; DAMAGE; DISORGANIZATION; VALIDITY; HUMANS	Deficits in planning, self-regulation and attention are a relatively common consequence of traumatic brain injury (TBI). Such "dysexecutive" deficits tend to be most exposed in complex, real world situations. Consequently, clinicians often have to rely on interviews, questionnaires and observation in their assessments. While there is little doubt that dysexecutive symptoms occur across different cultures, the expression of those symptoms, the way in which they are experienced by others, and the propensity of friends/relatives to report negative features may vary considerably. The cross-cultural use of standardized checklists and measures that have predominantly been studied with English speaking, Western groups therefore requires empirical support. Here a group of 68 healthy Chinese speaking volunteers were asked to complete translations of 2 UK developed questionnaires (the Dysexecutive Questionnaire and Cognitive Failures Questionnaire) measures and to perform 2 "executive" tasks (The Six Elements Test and the Tower of Hanoi). Their self ratings and the ratings of close relatives were very close to those seen in the original UK standardization samples-as was their performance on the 2 tasks. Accordingly, the conditions for assessing their clinical sensitivity were met. Comparison between 30 Chinese patients with TBI and matched controls showed that both questionnaires and tests were sensitive to the deficits in this group.	Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; MRC, Cognit & Brain Sci Unit, Cambridge, England	Chan, RCK (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.						Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; DAUM I, 1995, CORTEX, V31, P413, DOI 10.1016/S0010-9452(13)80057-3; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Fuster J, 1989, PREFRONTAL CORTEX; GEOL V, 1995, NEUROPSYCHOLOGIA, V33, P623; Heaton R., 1993, WISCONSIN CARD SORTI; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; Larson GE, 1997, BRIT J PSYCHOL, V88, P29, DOI 10.1111/j.2044-8295.1997.tb02618.x; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; Luria A. R., 1966, HIGHER CORTICAL FUNC; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P52; Morris RG, 1997, COGN NEUROPSYCHOL, V14, P1007, DOI 10.1080/026432997381330; Morris RG, 1997, NEUROPSYCHOLOGIA, V35, P1147, DOI 10.1016/S0028-3932(97)00009-2; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman D. A, 1980, ATTENTION ACTION WIL; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sbordone R. J., 1996, ECOLOGICAL VALIDITY, P15; SCHWARTZ MF, 1991, COGN NEUROPSYCHOL, V8, P381, DOI 10.1080/02643299108253379; Schwartz MF, 1995, ANN NY ACAD SCI, V769, P321, DOI 10.1111/j.1749-6632.1995.tb38148.x; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T., 1988, NEUROPSYCHOLOGY MENT; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Stuss D.T., 1986, FRONTAL LOBES; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TEASDALE G, 1974, LANCET, V2, P81; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P2; Wilson BA, 1996, BEHAV ASSESSMENT DYS	35	30	31	1	7	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2002	8	6					771	780		10.1017/S1355617702860052			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	592CZ	WOS:000177920300005	12240741	Green Published			2021-06-18	
J	Donders, J; Axelrod, BN				Donders, J; Axelrod, BN			Two-subtest estimations of WAIS-III factor index scores	PSYCHOLOGICAL ASSESSMENT			English	Article							INTELLIGENCE SCALE-III; MEMORY MALINGERING TOMM; 7-SUBTEST SHORT FORMS; VALIDITY; SAMPLE	The reliability and validity of various short forms of the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III; D. Wechsler, 1997) were evaluated in a sample of 100 patients with traumatic brain injury and in a demographically matched subgroup from the standardization sample. All short forms were based on 2-subtest estimations of the respective factor indexes. Although acceptable estimates could be obtained from all short forms for Verbal Comprehension, none of the possible short forms for Perceptual Organization consistently met the minimum criterion regarding the percentage of cases that fell within the 90% confidence interval of the full-length index. It is concluded that short-form estimates of the WAIS-III are not appropriate for clinical use when the goal is to obtain factor indexes.	Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, Grand Rapids, MI 49503 USA; Dept Vet Affaris Med Ctr, Psychol Serv, Detroit, MI USA	Donders, J (corresponding author), Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						Abraham E, 1997, ASSESSMENT, V4, P409, DOI 10.1177/107319119700400411; Axelrod BN, 2000, ASSESSMENT, V7, P157, DOI 10.1177/107319110000700207; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P1; Axelrod BN, 2000, J CLIN PSYCHOL, V56, P807, DOI 10.1002/(SICI)1097-4679(200006)56:6<807::AID-JCLP9>3.0.CO;2-N; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Kaufman A.S., 1994, INTELLIGENT TESTING; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; MILLS SR, 1997, CALIFORNIA VERBAL LE; Nunnally J.C., 1978, PSYCHOMETRIC THEORY; Paolo A. M, 1993, PSYCHOL ASSESSMENT, V5, P425; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Ricker J H, 1998, Appl Neuropsychol, V5, P184, DOI 10.1207/s15324826an0504_3; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Ryan JJ, 1998, J PSYCHOEDUC ASSESS, V16, P315, DOI 10.1177/073428299801600403; Sattler J. M., 1992, ASSESSMENT CHILDREN; SATTLER JM, 1999, ASSESSMENT CHILDREN; SILVERSTEIN AB, 1990, PSYCHOL ASSESSMENT, V2, P3, DOI DOI 10.1037/1040-3590.2.1.3; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D, 1997, WAIS 3 ADM SCORING M; Williamson D. J. G., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [10.1037/10198-001, DOI 10.1037/10198-001]	32	30	32	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2002	14	3					360	364		10.1037//1040-3590.14.3.360			5	Psychology, Clinical	Psychology	586VK	WOS:000177606500014	12214442				2021-06-18	
J	Chan, RVP; Trobe, JD				Chan, RVP; Trobe, JD			Spasm of accommodation associated with closed head trauma	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article								Spasm of accommodation, creating pseudomyopia, is generally associated with miosis and excess convergence as part of spasm of the near reflex. It may also exist as an isolated entity, usually attributed to psychogenic causes. We present six cases of accommodative spasm associated with closed head injury. All patients were male, ranging in age between 16 and 37 years. The degree of pseudomyopia, defined as the difference between manifest and cycloplegic refraction, was 1.5 to 2 diopters. A 3-year trial of pharmacologically induced cycloplegia in one patient did not lead to reversal of the spasm when the cycloplegia was stopped. All patients required the manifest refraction to see clearly at distance. The pseudomyopia endured for at least 7 years following head trauma. This phenomenon may represent traumatic activation or disinhibition of putative brain stem accommodation centers in young individuals.	Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA	Trobe, JD (corresponding author), Kellogg Eye Ctr, Dept Ophthalmol, 1000 Wall St, Ann Arbor, MI 48105 USA.			Trobe, Jonathan/0000-0003-0728-6729			BANDO T, 1992, NEUROSCI RES, V15, P162, DOI 10.1016/0168-0102(92)90002-T; BOHLMANN BJ, 1987, J CLIN NEURO-OPHTHAL, V7, P129; COGAN DG, 1955, ARCH OPHTHALMOL-CHIC, V54, P752; GRIFFIN JF, 1976, NEUROLOGY, V26, P1018, DOI 10.1212/WNL.26.11.1018; SLOANE AE, 1973, DOC OPHTHALMOL, V34, P365, DOI 10.1007/BF00151823; THOMPSON HS, 1998, WALSH HOYTS CLIN NEU, V1, P1011	6	30	32	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022			J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	MAR	2002	22	1					15	17		10.1097/00041327-200203000-00005			3	Clinical Neurology; Ophthalmology	Neurosciences & Neurology; Ophthalmology	538GN	WOS:000174807200005	11937900				2021-06-18	
J	Garcia, LJ; Laroche, C; Barrette, J				Garcia, LJ; Laroche, C; Barrette, J			Work integration issues go beyond the nature of the communication disorder	JOURNAL OF COMMUNICATION DISORDERS			English	Article						work integration; quality of life; communication disorders; disability process model	TRAUMATIC BRAIN INJURY; QUALITY-OF-LIFE; DISABILITY MANAGEMENT; VOICE PROBLEMS; RETURN; OUTCOMES; STROKE; REINTEGRATION; PERCEPTIONS; PREDICTORS	The ability to obtain and maintain employment is one of society's most valued life participation events and is often considered in measurements of quality of life (QOL). Many work-places now require good communication skills and this may jeopardize the opportunity for persons with communication disorders (CD) to access interesting jobs. Sarno, Silverman, and Levita (1970) have long emphasized that functioning is a result of the interaction of psychosocial factors as well as conununication disorder characteristics. The current study gathered perceptions from different groups of persons with CID, from service providers and employers on the barriers towork integration. The results show that many barriers are corturion across types of CD. Such examples are noise, tasks requiring speed, having to speak to groups of persons and the attitudes of others. Although some common barriers were identified between the service providers and the persons with CID, service providers placed more emphasis on psychological adaptation aspects than did persons with CD. Employers generated an equivalently long list of barriers but were also very concerned about job market issues. Learning outcomes: As a result of this activity, the following learning outcomes will be realized: participants will be able to (1) identify barriers that service providers and persons with CD each perceive; (2) identify differences in the perceptions of each group concerning barriers; (3) learn ways to modify or eliminate barriers that interfere with successful employment among individuals with CD. (C) 2002 Elsevier Science Inc. All rights reserved.	Univ Ottawa, Inst Hlth Elderly, Ottawa, ON K1N 5C8, Canada; Univ Ottawa, Audiol & Speech Language Pathol Program, Ottawa, ON, Canada; Univ Ottawa, Fac Adm, Ottawa, ON K1N 6N5, Canada	Garcia, LJ (corresponding author), Univ Ottawa, Inst Hlth Elderly, 43 Bruyere St, Ottawa, ON K1N 5C8, Canada.	lgarcia@scohs.on.ca					ALGELERI R, 1993, STROKE, V10, P1478; BACKENROTH GAM, 1995, INT J REHABIL RES, V18, P76, DOI 10.1097/00004356-199501000-00012; BLACKSCHAFFER RM, 1990, ARCH PHYS MED REHAB, V71, P285; BROTHERSON MJ, 1994, TOP EARLY CHILD SPEC, V14, P101, DOI 10.1177/027112149401400110; BRUNELLE J, 1988, SUPERVISION INTERVEN, P179; CANELON MF, 1995, AM J OCCUP THER, V49, P461, DOI 10.5014/ajot.49.5.461; CAREY ML, 1992, BLS B, V2404; CARRIERO MR, 1987, CORTEX, V23, P667, DOI 10.1016/S0010-9452(87)80056-4; CASSAR MC, 1997, SEMINARS SPEECH LANG, V4, P371; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CRAIG AR, 1991, J SPEECH HEAR RES, V34, P279, DOI 10.1044/jshr.3402.279; DESANTO LW, 1995, ANN OTO RHINOL LARYN, V104, P763, DOI 10.1177/000348949510401003; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fougeyrollas P, 1997, ICIDH ENV FACTORS IN, V9, P32; FOUGEYROLLAS P, 1997, QUEBEC CLASSIFICATIO; FRITH C, 1985, J COMMUN DISORD, V18, P475, DOI 10.1016/0021-9924(85)90034-6; Garcia LJ, 2000, APHASIOLOGY, V14, P269, DOI 10.1080/026870300401478; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Isaki E, 2000, BRAIN INJURY, V14, P441; Jensen K., 1999, INT J DISABIL DEV ED, V46, P453, DOI DOI 10.1080/103491299100434; Kalina CM, 1999, ANN NY ACAD SCI, V888, P343, DOI 10.1111/j.1749-6632.1999.tb07969.x; Laroche C, 2000, J ACAD REHABILITATIV, V23, P63; Lunday AM, 1996, TOP LANG DISORD, V16, P23, DOI 10.1097/00011363-199605000-00004; MALMSBORG T, 1995, INT J TECHNOL ASSESS, V11, P235, DOI 10.1017/S0266462300006851; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MOHIDE EA, 1992, AM J SURG, V164, P619, DOI 10.1016/S0002-9610(05)80720-2; MORGAN DL, 1988, QUALITATIVE RES METH, V16; PARVING A, 1993, SCAND AUDIOL, V22, P133, DOI 10.3109/01050399309046029; RICE M, 1995, WORLD C INT FLUENC A; ROLLAND J, 1991, APHASIQUE, P195; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; RUMRILL PG, 1994, J LONG TERM CARE ADM, P7; Saeki S, 2000, DISABIL REHABIL, V22, P578, DOI 10.1080/09638280050138241; Sarno M, 1969, FUNCTIONAL COMMUNICA; SARNO MT, 1970, J AM GERIATR SOC, V18, P405, DOI 10.1111/j.1532-5415.1970.tb03673.x; SARNO MT, 1983, SCAND J REHABIL MED, P75; Sarno MT, 1997, APHASIOLOGY, V11, P665, DOI 10.1080/02687039708249414; SARNO MT, 1993, LIVING APHASIA PSYCH, P269; SCHLOSS PJ, 1987, J SPEECH HEAR DISORD, V52, P30, DOI 10.1044/jshd.5201.30; Shrey DE, 2000, OCCUP MED-STATE ART, V15, P789; Smith E, 1998, J VOICE, V12, P223, DOI 10.1016/S0892-1997(98)80042-8; Smith E, 1998, J VOICE, V12, P328, DOI 10.1016/S0892-1997(98)80022-2; Smith E, 1997, J VOICE, V11, P81, DOI 10.1016/S0892-1997(97)80027-6; Stewart MG, 1998, ARCH OTOLARYNGOL, V124, P143, DOI 10.1001/archotol.124.2.143; Target P, 1998, INT J REHABIL RES, V21, P41, DOI 10.1097/00004356-199803000-00004; THORNBURG L, 1994, J LONG TERM CARE ADM, P14; Titze IR, 1997, J VOICE, V11, P254, DOI 10.1016/S0892-1997(97)80002-1; *WHO, 2001, ICF INT CLASS FUNCT; World Health Organization, 1980, INT CLASS IMP DIS HA; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568; Zwerling C, 1998, J OCCUP ENVIRON MED, V40, P720, DOI 10.1097/00043764-199808000-00010	51	30	31	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAR-APR	2002	35	2					187	211	PII S0021-9924(02)00064-3	10.1016/S0021-9924(02)00064-3			25	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	553BE	WOS:000175655000007	12036151				2021-06-18	
J	Bolan, B; Foster, JK; Schmand, B; Bolan, S				Bolan, B; Foster, JK; Schmand, B; Bolan, S			A comparison of three tests to detect feigned amnesia: The effects of feedback and the measurement of response latency	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SIMULATED MEMORY IMPAIRMENT; DIGIT RECOGNITION TEST; FORCED-CHOICE METHOD; HEAD-INJURY; SYMPTOM VALIDITY; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGICAL-TESTS; MALINGERING TOMM; DEFICITS	Three experiments provided validation data for an English language version of the Amsterdam Short Term Memory Test (ASTM test) developed to detect feigned memory impairment. Using a simulation design, the ASTM test compared favourably with the Test of Memory Malingering (TOMM) and appeared better than a newly-devised Digit Recognition Test (DRT). Feedback on the correctness of responses had no significant effect on performance but notable trends were apparent. Simulators were significantly slower than controls on computerised versions of the ASTM test and the TOMM. Convergent findings indicate that the English language version of the ASTM test may be useful in detecting malingering.	Univ Western Australia, Dept Psychol, Perth, WA 6009, Australia; Univ Manchester, Dept Psychol, Manchester M13 9PL, Lancs, England; Acad Med Centrum, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Univ Manchester, Dept Comp Sci, Manchester M13 9PL, Lancs, England	Foster, JK (corresponding author), Univ Western Australia, Dept Psychol, Perth, WA 6009, Australia.						Back C., 1996, ASSESSMENT, V3, P449, DOI [10.1177/107319119600300411, DOI 10.1177/107319119600300411, DOI 10.1016/S0887-6177(01)00166-4]; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; CERCY SP, 1997, CLIN ASSESSMENT MALI; Christensen L.B., 1991, EXPT METHODOLOGY; Conover W.J., 1980, PRACTICAL NONPARAMET; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Heubrock D, 1998, EUR J PSYCHOL ASSESS, V14, P211, DOI 10.1027/1015-5759.14.3.211; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; Pankratz L., 1997, CLIN ASSESSMENT MALI; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SCHMAND B, UNPUB AMSTERDAM SHOR; Schmand B., 1999, AMSTERDAMSE KORTE TE; Schwartz SM, 1998, INT J LAW PSYCHIAT, V21, P261, DOI 10.1016/S0160-2527(98)00004-1; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]; Youngjohn J.R., 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	46	30	30	0	9	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2002	24	2					154	167		10.1076/jcen.24.2.154.1000			14	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	549MN	WOS:000175448100003	11992198				2021-06-18	
J	Comerford, VE; Geffen, GM; May, C; Medland, SE; Geffen, LB				Comerford, VE; Geffen, GM; May, C; Medland, SE; Geffen, LB			A rapid screen of the severity of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL SEQUELAE; STANDARDIZED ASSESSMENT; CONCUSSION; PLAYERS	This study investigated the sensitivity of information processing, recall and orientation tasks to the presence of mild Traumatic Brain Injury (mTBI). Fifty-six (40 male, 16 female) mTBI patients and 85 (57 male and 28 female) controls with orthopaedic injuries were tested within 24 hr of injury in the Department of Emergency Medicine. mTBI patients answered fewer orientation questions and recalled fewer words in delayed recall than orthopaedic patients. mTBI patients judged fewer sentences in 2 min than orthopaedic controls, and female mTBI patients judged fewer sentences than male mTBI patients. Male mTBI patients correctly recalled fewer words during immediate memory and learning than female mTBI patients and orthopaedic controls. Those mTBI patients with a history of previous head injuries did not perform more poorly than those mTBI patients without previous head injuries. These results indicate that tests of speed of information processing, word learning and orientation questions are sensitive to the acute effects of mTBI.	Univ Queensland, Cognit Psychophysiol Lab, Herston, Qld, Australia; Royal Brisbane Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia	Comerford, VE (corresponding author), Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.		Medland, Sarah/AAT-7595-2020; Medland, Sarah E/C-7630-2013	Medland, Sarah/0000-0003-1382-380X; Medland, Sarah E/0000-0003-1382-380X			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Baddeley A.D., 1992, SPEED CAPACITY LANGU; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P10; *CO MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hillier SL, 1997, BRAIN INJURY, V11, P649; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HINTONBAYRE AD, 1997, SPORT HLTH, V15, P4; HINTONBAYRE AD, 2000, THESIS U QUEENSLAND; Kelly JP, 1997, NEUROLOGY, V48, P581; Kolb B., 1996, FUNDAMENTALS HUMAN N; KRAUS JF, 1989, MILD HEAD INJURY, P8; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; National Health and Medical Research Council, 1992, IS THER SAF LEV DAIL; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Pols R G, 1992, Drug Alcohol Rev, V11, P339, DOI 10.1080/09595239200185461; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	27	30	30	0	6	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2002	24	4					409	419		10.1076/jcen.24.4.409.1044			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	568ZJ	WOS:000176574600001	12187455				2021-06-18	
S	Khaldi, A; Chiueh, CC; Bullock, MR; Woodward, JJ		Chiueh, CC; Hong, JS; Leong, SK		Khaldi, A; Chiueh, CC; Bullock, MR; Woodward, JJ			The significance of nitric oxide production in the brain after injury	NITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS AND CLINICAL POTENTIAL	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	30th Annual Meeting of the Society-for-Neuroscience	NOV 04-09, 2000	NEW ORLEANS, LOUISIANA	Soc Neurosci, Taiwanese Biosci Amer		nitric oxide production; brain injury; NMDA receptor	NMDA-RECEPTOR; CELL-DEATH; NEURONS; NEUROTOXICITY; ACTIVATION; NO; NITROSYLATION; MECHANISMS; CULTURES; DISEASE	Glutamate toxicity has been implicated in many aspects of brain injury including traumatic, ischemic, and hemorrhagic damage. We have used in vitro as well as in vivo methods to measure NO production and to examine the role of NO in glutamate toxicity. In building our recombinant system, we used human kidney embryonic cells, HEK 293, as host for transfection of nNOS and NMDA receptor proteins. Cells cotransfected with NMDA and nNOS were more resistant to glutamate toxicity. This resistance correlated with NO production as measured by citrulline assay. Meanwhile, the production of NO did not significantly change the response of the NMDA receptor as seen by calcium studies. Moreover, in vivo, NO production was directly correlated with brain tissue oxygen tension in subarachnoid hemorrhage patients. These data and others point toward the importance of NO production in the response of brain to injury.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; NIMH, Clin Sci Lab, NIH, Bethesda, MD 20892 USA; Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA	Khaldi, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, POB 980631, Richmond, VA 23298 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA009986] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA009986] Funding Source: Medline		ANEGAWA NJ, 1995, J NEUROCHEM, V64, P2004; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; Chandler LJ, 1997, MOL PHARMACOL, V51, P733; Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; CHIUEH CC, 1994, ANN NY ACAD SCI, V738, P279; DAWSON VL, 1993, J NEUROSCI, V13, P2651; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Fiorucci S, 2001, TRENDS IMMUNOL, V22, P232, DOI 10.1016/S1471-4906(01)01904-4; GARTHWAITE G, 1994, NEUROPHARMACOLOGY, V33, P1431, DOI 10.1016/0028-3908(94)90046-9; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GUNASEKAR PG, 1995, J NEUROCHEM, V65, P2016; HEWETT SJ, 1993, BRAIN RES, V625, P337, DOI 10.1016/0006-8993(93)91078-7; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Khaldi A, 2001, NEUROSURGERY, V49, P33; KHALDI A, 1995, THESIS VIRGINIA COMM; KOH JY, 1986, SCIENCE, V234, P73, DOI 10.1126/science.2875522; LIPTON SA, 1994, PROG BRAIN RES, V103, P359; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Pluta RM, 2001, NEUROSURGERY, V48, P884, DOI 10.1097/00006123-200104000-00039; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0	26	30	30	0	3	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-366-1	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2002	962						53	59		10.1111/j.1749-6632.2002.tb04055.x			7	Multidisciplinary Sciences; Pharmacology & Pharmacy	Science & Technology - Other Topics; Pharmacology & Pharmacy	BU76R	WOS:000176952400005	12076962				2021-06-18	
J	Kushimoto, S; Yamamoto, Y; Shibata, Y; Sato, H; Koido, Y				Kushimoto, S; Yamamoto, Y; Shibata, Y; Sato, H; Koido, Y			Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury	NEUROSURGERY			English	Article						alpha(2)-plasmin inhibitor; fibrinogenolysis; fibrinolysis; head injury; intravascular coagulation; plasmin	SOMATOSENSORY-EVOKED-POTENTIALS; TRAUMATIC BRAIN INJURY; ALPHA-2-PLASMIN INHIBITOR; DEGRADATION PRODUCTS; ENZYME-IMMUNOASSAY; MONOCLONAL-ANTIBODY; IN-VITRO; COAGULATION; ABNORMALITIES; PLASMA	OBJECTIVE: To evaluate the involvement of the fibrinolytic system, especially focused on alpha (2)-plasmin inhibitor, in patients with head injury. METHODS: This study consisted of 47 patients with isolated blunt head trauma in whom blood sampling could be initiated within 3 hours after injury. Patients were divided into two groups according to Glasgow Outcome Scale score status at 3 months after injury. In Group I patients (n = 26), the outcome was characterized as good recovery or moderate disability; in Group 2 patients (n = 21), the outcome was characterized as severe disability, vegetative state, or death. RESULTS: Concentrations of thrombin-antithrombin III complex were greater than 100 mug/L in 39 of 47 patients, and concentrations in Group 2 patients were elevated significantly beyond the concentrations in Group 1 patients. Activities of alpha (2)-plasmin inhibitor in Group 2 were significantly lower than in Group 1 (P < 0.0001). In Group 1 patients, alpha (2)-plasmin inhibitor activity was greater than 60%, while in all but four Group 2 patients, the inhibitor was reduced to less than 60% of normal activity within 3 hours of injury. All patients with alpha (2)-plasmin inhibitor activity less than 60% showed a marked bleeding tendency and/or severe brain edema. Using sandwich enzyme-linked immunosorbent assay, fibrinogen degradation product and fibrin degradation product were measured separately. A significant correlation was apparent between thrombin-antithrombin III complex and fibrinogen degradation product, as well as between the complex and fibrin degradation product. Marked decreases in alpha (2)-plasmin inhibitor were noted only in patients with thrombin-antithrombin III complex concentrations exceeding 500 mug/L. CONCLUSION: Fibrinolysis and fibrinogenolysis may be involved according to the degree of coagulation activation in the pathophysiology of severe head injury. Decreased activity of alpha (2)-plasmin inhibitor indicated poor prognosis and may be an exacerbating factor in the acute phase of head trauma.	Nippon Med Coll, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138603, Japan	Kushimoto, S (corresponding author), Nippon Med Coll, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P24, DOI 10.1055/s-2007-1004405; AOKI N, 1979, J CLIN INVEST, V63, P877, DOI 10.1172/JCI109387; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P42, DOI 10.1055/s-2007-1004406; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BENNETT B, 1972, MED CLIN N AM, V56, P95, DOI 10.1016/S0025-7125(16)32425-7; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CONFORTI G, 1994, BLOOD, V83, P994; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; FRANCIS CW, 1993, HEMOSTASIS THROMBOSI, P1076; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; ISOGAI N, 1993, JPN J CLIN PATHOL, V41, P1349; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; KOOPMAN J, 1987, J LAB CLIN MED, V109, P75; KOPPERT PW, 1988, THROMB HAEMOSTASIS, V59, P310; KOPPERT PW, 1987, THROMB HAEMOSTASIS, V57, P25; MOROI M, 1977, THROMB RES, V10, P851, DOI 10.1016/0049-3848(77)90142-6; OKAJIMA K, 1995, J LAB CLIN MED, V126, P377; OKAJIMA K, 1994, AM J HEMATOL, V45, P16, DOI 10.1002/ajh.2830450104; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; OWEN CA, 1979, J NEUROSURG, V51, P137, DOI 10.3171/jns.1979.51.2.0137; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RABBANI LE, 1993, THROMB RES, V70, P425, DOI 10.1016/0049-3848(93)90085-3; RUDD MA, 1991, CIRCULATION, V84, P2568, DOI 10.1161/01.CIR.84.6.2568; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; SORENSEN JV, 1993, SCAND J CLIN LAB INV, V53, P659, DOI 10.3109/00365519309092568; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357	40	30	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	NOV	2001	49	5					1084	1089		10.1097/00006123-200111000-00011			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	485NG	WOS:000171760000015	11846901				2021-06-18	
J	Verweij, BH; Muizelaar, JP; Vinas, FC				Verweij, BH; Muizelaar, JP; Vinas, FC			Hyperacute measurement of intracranial pressure, cerebral perfusion pressure, jugular venous oxygen saturation, and laser Doppler flowmetry, before and during removal of traumatic acute subdural hematoma	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; acute subdural hematoma; intracranial pressure; jugular venous oxygen saturation; laser Doppler flowmetry; cerebral oxygen metabolism	BRAIN INJURY; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; COMATOSE PATIENTS; BLOOD-FLOW; ISCHEMIA; MORTALITY; METABOLISM; ANTAGONIST; REVERSAL	Object. The poor prognosis for traumatic acute subdural hematoma (ASDH) might be due to underlying primary brain damage, ischemia, or both. Ischemia in ASDH is likely caused by increased intracranial pressure (ICP) leading to decreased cerebral perfusion pressure (CPP), but the degree to which these phenomena occur is unknown. The authors report data obtained before and during removal of ASDH in five cases. Methods. Five patients who underwent emergency evacuation of ASDH were monitored. In all patients, without delaying treatment, a separate surgical team (including the senior author) placed an ICP monitor and a jugular bulb catheter, and in two patients a laser Doppler probe was placed. The ICP prior to removing the bone flap in the five patients was 85, 85, 50, 59, and greater than 40 mm Hg, resulting in CPPs of 25, 3, 25, 56, and less than 50 mm Hg, respectively. Removing the bone flap as well as opening the dura and removing the blood clot produced a significant decrease in ICP and an increase in CPP. Jugular venous oxygen saturation (SjvO(2)) increased in four patients and decreased in the other during removal of the hematoma. Laser Doppler flow also increased, to 217% and 211% compared with preevacuation flow. Conclusions. Intracranial pressure is higher than previously suspected and CPP is very low in patients with ASDH. Removal of the bone flap yielded a significant reduction in ICR which was further decreased by opening the dura and evacuating the hematoma. The SjvO(2) as well as laser Doppler flow increased in all patients but one immediately after removal of the hematoma.	Univ Calif Davis, Med Ctr, Dept Neurosurg, Sacramento, CA 95817 USA; Wayne State Univ, Dept Neurosurg, Detroit, MI USA	Muizelaar, JP (corresponding author), Univ Calif Davis, Med Ctr, Dept Neurosurg, 4860 Y St,Room 3740, Sacramento, CA 95817 USA.						Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1992, J NEUROTRAUMA S1, V9, P333; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHAMBERS JW, 1951, J NEUROSURG, V8, P263, DOI 10.3171/jns.1951.8.3.0263; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; COLES JP, 2000, REST NEUROL NEUROSCI, V16, P215; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; RICHARDS T, 1974, SURGERY, V75, P253; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; 1996, J NEUROTRAUMAA, V13, P641	30	30	35	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2001	95	4					569	572		10.3171/jns.2001.95.4.0569			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	478NQ	WOS:000171352600005	11596950				2021-06-18	
J	Rovet, JF; Hepworth, S				Rovet, JF; Hepworth, S			Attention problems in adolescents with congenital hypothyroidism: A multicomponential analysis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						attention; congenital hypothyroidism; thyroid hormone; focus; concentrate	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; THYROID-HORMONE; NEUROLOGICAL DEVELOPMENT; THYROXINE THERAPY; CHILDREN; MOTOR; EXPRESSION; SKILLS; AGE	Even though early treatment of congenital hypothyroidism (CH) with newborn screening prevents the mental retardation previously seen in cretinism, affected children still exhibit subtle persisting neurocognitive deficits. One of their commonest problems is poor attention, which reflects both early disease severity and later (high) circulating thyroid hormone levels. While attention is currently regarded as multicomponential in nature, with different processing components supported by different brain regions, the specific components of attention affected by CH have not been identified. In light of animal evidence showing that neonatal thyroid hormone deficiencies impede the neurodevelopment of structures important for selective aspects of attention, we proposed a multicomponential approach to study attention in children with CH. This was accomplished via retrospective analysis of existing data on adolescents with CH whose attention was previously evaluated using multiple tests. Results showed significantly poorer overall attention in CH than controls with differences occurring mainly on focus and inhibit indices. However, performance on various indices was associated with different disease parameters. Poor encode and focus were correlated with more severe hypothyroidism and a longer period of thyroid hormone insufficiency and poor select and shift with higher thyroid hormone levels at testing. These results signify that thyroid hormone is important for the development and later regulation of brain structures supporting distinct aspects of attention.	Hosp Sick Children, Brain & Behav Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	Rovet, JF (corresponding author), Hosp Sick Children, Brain & Behav Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	joanne.rovet@sickkids.on.ca					Achenbach T, 1991, YOUTH SELF REPORT AG; Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Alvarez M, 1996, J PEDIATR ENDOCR MET, V9, P447; ALVAREZ MA, 1983, PSYCHONEUROENDOCRINO, V8, P451, DOI 10.1016/0306-4530(83)90026-4; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; [Anonymous], 1994, J Pediatr, V124, P383; BASS A, 1996, THYROID S1, V6, pS58; BERNAL J, 1995, EUR J ENDOCRINOL, V133, P390, DOI 10.1530/eje.0.1330390; Bhatara VS, 1998, PROG PSYCH, P187; BRADLEY DJ, 1989, P NATL ACAD SCI USA, V86, P7250, DOI 10.1073/pnas.86.18.7250; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Claustre J, 1996, NEUROCHEM INT, V28, P277, DOI 10.1016/0197-0186(95)00088-7; DerksenLubsen G, 1996, PEDIATR RES, V39, P561, DOI 10.1203/00006450-199603000-00028; DIAMOND L, 1998, P AM THYR ASS ANN M, P20; ERNST M, 1994, J AM ACAD CHILD ADOL, V34, P877; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; FUGGLE PW, 1991, EUR J PEDIATR, V150, P570, DOI 10.1007/BF02072209; Garfinkel BD., 1983, PSYCHIATR HOSP, V14, P163; GERMAK J, 1990, J PEDIAT, V126, P380; GOTTSCHALK B, 1994, DEV MED CHILD NEUROL, V36, P216; GOULD E, 1989, J NEUROSCI, V9, P3347; Hanukoglu A, 2001, J CLIN ENDOCR METAB, V86, P186, DOI 10.1210/jcem.86.1.7124; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEYERDAHL S, 1995, ACTA PAEDIATR, V84, P634, DOI 10.1111/j.1651-2227.1995.tb13716.x; HEYERDAHL S, 1991, J PEDIATR-US, V118, P850, DOI 10.1016/S0022-3476(05)82194-8; JASTAK S, 1984, MANUAL WIDE RANGE AC; KIMURA D, 1981, NEUROPSYCHOLOGIA, V19, P301, DOI 10.1016/0028-3932(81)90113-5; Kooistra L, 1996, ACTA PAEDIATR, V85, P425, DOI 10.1111/j.1651-2227.1996.tb14054.x; KOOISTRA L, 1994, J PEDIATR-US, V124, P903, DOI 10.1016/S0022-3476(05)83178-6; LaFranchi S, 1999, THYROID, V9, P735, DOI 10.1089/thy.1999.9.735; Leneman M, 2001, J INT NEUROPSYCH SOC, V7, P556, DOI 10.1017/S1355617701755038; Loss N, 1998, CHILD NEUROPSYCHOL, V4, P7, DOI 10.1076/chin.4.1.7.3192; MALONE MA, 1994, J CHILD NEUROL, V9, P181, DOI 10.1177/088307389400900216; Mano T, 1998, THYROID, V8, P353, DOI 10.1089/thy.1998.8.353; MEFFORD IN, 1989, MED HYPOTHESES, V29, P33, DOI 10.1016/0306-9877(89)90164-3; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Pliszka SR, 1996, J AM ACAD CHILD PSY, V35, P264, DOI 10.1097/00004583-199603000-00006; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; PORTERFIELD SP, 1994, ENDOCRINE REV MONOGR, V3, P357; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rovet J, 1997, DIABETES CARE, V20, P803, DOI 10.2337/diacare.20.5.803; Rovet J, 1996, J PEDIATR ENDOCR MET, V9, P63; Rovet J, 1998, PROG PSYCH, P163; Rovet J, 1996, J CHILD PSYCHOL PSYC, V37, P579, DOI 10.1111/j.1469-7610.1996.tb01444.x; Rovet J., 1980, J APPL DEV PSYCHOL, V1, P221, DOI [10.1016/0193-3973(80)90011-8, DOI 10.1016/0193-3973(80)90011-8]; ROVET J, 1997, THYROID S1, V7, P390; Rovet J. F., 1993, Pediatric Research, V33, pS91; ROVET JF, 1993, J PEDIATR-US, V122, P543, DOI 10.1016/S0022-3476(05)83533-4; ROVET JF, 1992, J PEDIATR PSYCHOL, V17, P187, DOI 10.1093/jpepsy/17.2.187; ROVET JF, 1995, J PEDIATR-US, V126, P380, DOI 10.1016/S0022-3476(95)70452-3; Rovet JF, 1999, THYROID, V9, P741, DOI 10.1089/thy.1999.9.741; Rovet JF, 1999, ACTA PAEDIATR, V88, P88, DOI 10.1080/080352599750029484; ROVET JF, 1990, PSYCHONEUROENDOCRINO, P273; Rozanov CB, 1996, NEUROSCIENCE, V74, P897, DOI 10.1016/0306-4522(96)00186-8; Salerno M, 1999, EUR J ENDOCRINOL, V141, P105, DOI 10.1530/eje.0.1410105; SAVARD P, 1983, NEUROSCIENCE, V10, P1399, DOI 10.1016/0306-4522(83)90121-5; SPENCER T, 1995, J CHILD PSYCHOL PSYC, V36, P879, DOI 10.1111/j.1469-7610.1995.tb01335.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; TUCKER DM, 1984, PSYCHOL REV, V91, P185, DOI 10.1037/0033-295X.91.2.185; Valentine J, 1997, J PAEDIATR CHILD H, V33, P117, DOI 10.1111/j.1440-1754.1997.tb01012.x; Van Vliet G, 1999, THYROID, V9, P79, DOI 10.1089/thy.1999.9.79; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VIRGILI M, 1991, EXP BRAIN RES, V83, P555; Wechsler D., 1974, MANUAL WECHSLER INTE; WEISS RE, 1993, J PEDIATR-US, V123, P539, DOI 10.1016/S0022-3476(05)80947-3; WHYBROW PC, 1969, ARCH GEN PSYCHIAT, V20, P48; Yeates KO, 1994, NEUROPSYCHOLOGY, V8, P65, DOI 10.1037/0894-4105.8.1.65	72	30	33	1	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2001	7	6					734	744		10.1017/S135561770176609X			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	471YE	WOS:000170955600009	11575595				2021-06-18	
J	Bennett, TL				Bennett, TL			Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychological assessment; ecological validity; rehabilitation planning; cognitive rehabilitation	TRAUMATIC BRAIN INJURY; EDUCATION; AGE; ATTENTION	This paper focuses on the benefits of neuropsychological assessment for evaluating a brain-injured person's functional abilities and rehabilitation needs. The importance of early assessment in addressing these goals is discussed. Strengths and weaknesses of neuropsychological assessment for predicting a person's ability to participate in normal activities of daily living are considered. Test data taken alone often lack ecological validity, but nevertheless, specific test findings can be used to predict functional skills. The ecological validity of neuropsychological testing can be extended by observing the patient's approach to tasks in the assessment environment and by observing the patient in his or her normal activities. Evaluation information obtained by allied rehabilitation professionals, including occupational and speech and language therapies, can be integrated with neuropsychological test data to both extend the generalizability of our findings and to validate hypotheses generated from our test data. The use of neuropsychological test data in planning a cognitive rehabilitation program is also considered. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Ctr Neurorehabil Serv, Ft Collins, CO 80524 USA; Colorado State Univ, Ft Collins, CO 80523 USA	Bennett, TL (corresponding author), Ctr Neurorehabil Serv, 1049 Robertson St, Ft Collins, CO 80524 USA.						[Anonymous], 1996, Neurology, V47, P592; [Anonymous], 1987, CLIN NEUROPSYCHOL, V1, P29; BENNETT TL, 1988, COGNITIVE REHABILITA, V6, P18; BENNETT TL, 1997, NEUROPSYCHOLOGY HDB, V2, P123; BENNETT TL, 1997, B NATL ACAD NEUROPSY, V13, P14; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BEWICK KC, 1995, NEUROREHABILITATION, V5, P367, DOI 10.3233/NRE-1995-5411; Goldstein K, 1942, EFFECTS BRAIN INJURY; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Johnstone B, 1997, ARCH CLIN NEUROPSYCH, V12, P523, DOI 10.1016/S0887-6177(97)00034-6; KAY T, 1989, ASSESSMENT BEHAV CON, P145; Long CJ., 1996, ECOLOGICAL VALIDITY; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Raskin S., 1992, NEUROREHABILITATION, V2, P38; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Reitan RM, 1996, CLIN NEUROPSYCHOL, V10, P293, DOI 10.1080/13854049608406691; Reitan RM, 1996, ARCH CLIN NEUROPSYCH, V11, P303, DOI 10.1016/0887-6177(95)00039-9; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Reitan RM, 2001, ARCH CLIN NEUROPSYCH, V16, P215; Saykin A J, 1995, Appl Neuropsychol, V2, P79, DOI 10.1207/s15324826an0202_5; Sbordone R. J., 1996, ECOLOGICAL VALIDITY, P15; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005	34	30	31	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2001	16	3					237	253		10.1016/S0887-6177(00)00082-2			17	Psychology, Clinical; Psychology	Psychology	424VU	WOS:000168255300005	14590176	Bronze			2021-06-18	
J	Allison, SC; Abraham, LD				Allison, SC; Abraham, LD			Sensitivity of qualitative and quantitative spasticity measures to clinical treatment with cryotherapy	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						ankle; Ashworth scale; cryotherapy; measurement; spasticity	MODIFIED ASHWORTH SCALE; TRAUMATIC BRAIN INJURY; ELBOW FLEXOR MUSCLES; CEREBRAL-PALSY; PRESYNAPTIC INHIBITION; HUMAN ANKLE; HYPERTONIA; REFLEXES; RELIABILITY; HEMIPARESIS	This study examined the extent to which a battery of tests could detect a reduction of plantarflexor spasticity resulting from cryotherapy. The tests included a traditional qualitative spasticity scale, three potential quantitative spasticity measures and a measure of voluntary ankle muscle function. Twenty-six adult traumatic-brain-injured subjects were examined; these included 22 males and 4 females. The mean age was 28.15 years (range: 18-57, SD 10.78). The five tests were performed in random sequence on both ankles of each subject, before and after a 20 minute cold pack application to the calf. Tests were: modified Ashworth scale (MAS) scoring; H-reflex testing with and without dorsiflexor contraction (Hdf/Hctrl ratio); H-reflex testing with and without Achilles tendon vibration (Hvib/Hctrl ratio); reflex threshold angle (RTA) and timed toe tapping (TTT). Cryotherapy resulted in lowered MAS scores consistent with a reduction in spasticity. Doubly multivariate repeated measures ANOVA revealed a significant difference (F = 24.16, P < 0.001) in test scores between the pre- and post-cryotherapy test batteries. Significant pre- and post-cryotherapy differences (P <less than or equal to> 0.03) for all dependent measures contributed to the main effect for cryotherapy. However, among the potential quantitative measures of spasticity only the RTA test demonstrated appropriate sensitivity to the reduction in spasticity. In spite of spasticity reduction, TTT performance was impaired following muscle cooling. Failure bf the H-reflex ratios to show a reduction consistent with reduced spasticity was attributed to competing alpha and gamma motoneuron effects resulting from peripheral cooling.	Acad Hlth Sci, Ft Sam Houston, TX 78234 USA; Univ Texas, Austin, TX 78712 USA	Allison, SC (corresponding author), AMEDD Ctr & Sch, Phys Therapy Branch, Ft Sam Houston, TX 78234 USA.						Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; ALLISON SC, 1995, J NEUROL, V242, P699, DOI 10.1007/BF00866923; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BASSETT S W, 1958, Phys Ther Rev, V38, P333; BELL KR, 1987, ARCH PHYS MED REHAB, V68, P490; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOORMAN GI, 1992, ABSTR SOC NEUROSCI, V18, P1408; Brouwer B, 1998, DEV MED CHILD NEUROL, V40, P168; Chiara T, 1998, ARCH PHYS MED REHAB, V79, P523, DOI 10.1016/S0003-9993(98)90066-1; DENYS EH, 1991, MUSCLE NERVE, V14, P795, DOI 10.1002/mus.880140902; Dewald J P, 1996, IEEE Trans Rehabil Eng, V4, P231, DOI 10.1109/86.547923; GILLIES JD, 1969, J PHYSIOL-LONDON, V205, P329, DOI 10.1113/jphysiol.1969.sp008968; Hagbarth K.-E., 1973, NEW DEV ELECTROMYOGR, V3, P428; HECOX B, 1994, PHYSICAL AGENTS COMP, P115; Hugon M., 1973, NEW DEVELOPMENTS ELE, P277; ILES JF, 1986, J NEUROL NEUROSUR PS, V49, P937, DOI 10.1136/jnnp.49.8.937; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J; KNUTSSON E, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P159; KNUTSSON E, 1969, Scandinavian Journal of Rehabilitation Medicine, V1, P126; LANCE JW, 1973, NEW DEVELOPMENTS ELE, V3, P444; Lehmann J., 1990, THERAPEUTIC HEAT COL; LEONARD CT, 1990, DEV MED CHILD NEUROL, V32, P974; LEVIN MF, 1993, J NEUROL, V240, P63, DOI 10.1007/BF00858718; MENSE S, 1978, PFLUG ARCH EUR J PHY, V374, P159, DOI 10.1007/BF00581297; MICHLOVITZ SL, 1990, THERMAL AGENTS REHAB, P63; MIGLIETTA O, 1973, AM J PHYS MED REHAB, V52, P198; MIGLIETTA OSVALDO, 1964, ARCH PHYS MED REHABIL, V45, P508; MILANOV I, 1992, J NEUROL, V239, P287; MILANOV IG, 1992, ACTA NEUROL SCAND, V85, P305; NANCE PW, 1989, PARAPLEGIA, V27, P296, DOI 10.1038/sc.1989.44; OTTOSON D, 1965, J PHYSIOL-LONDON, V180, P636, DOI 10.1113/jphysiol.1965.sp007721; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; PETAJAN J H, 1962, Am J Phys Med, V41, P240; PIERROTDESEILLI.E, 1990, NEW TRENDS ADV TECHN, P264; POWERS RK, 1988, ANN NEUROL, V23, P115, DOI 10.1002/ana.410230203; POWERS RK, 1989, ANN NEUROL, V25, P32, DOI 10.1002/ana.410250106; PRICE R, 1993, ARCH PHYS MED REHAB, V74, P300; PRICE R, 1990, ARCH PHYS MED REHAB, V71, P745; Urbscheit N, 1971, Phys Ther, V51, P983; Wolf SL, 1996, PHYS THER, V76, P586, DOI 10.1093/ptj/76.6.586	41	30	33	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2001	24	1					15	24		10.1097/00004356-200103000-00003			10	Rehabilitation	Rehabilitation	414XJ	WOS:000167691200003	11302460				2021-06-18	
J	Simbulan-Rosenthal, CM; Rosenthal, DS; Luo, RB; Li, JH; Zhang, J; Smulson, ME				Simbulan-Rosenthal, CM; Rosenthal, DS; Luo, RB; Li, JH; Zhang, J; Smulson, ME			Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy	NUCLEIC ACIDS RESEARCH			English	Article							FOCAL CEREBRAL-ISCHEMIA; ANTISENSE RNA EXPRESSION; DNA-DAMAGE; DEPENDENT TRANSCRIPTION; NICOTINAMIDE TREATMENT; GENE AMPLIFICATION; GENOMIC STABILITY; RIBOSE POLYMERASE; MAMMALIAN-CELLS; MICE RESISTANT	Poly(ADP-ribose) polymerase (PARP) knockout mice are resistant to murine models of human diseases such as cerebral and myocardial ischemia, traumatic brain injury, diabetes, Parkinsonism, endotoxic shock and arthritis, implicating PARP in the pathogenesis of these diseases. Potent selective PARP inhibitors are therefore being evaluated as novel therapeutic agents in the treatment of these diseases. Inhibition or depletion of PARP, however, increases genomic instability in cells exposed to genotoxic agents. We recently demonstrated the presence of a genomically unstable tetraploid population in PARP(-/-)fibroblasts and its loss after stable transfection with PARP cDNA. To elucidate whether the genomic instability is attributable to PARP deficiency or lack of PARP activity, we investigated the effects of PARP inhibition on development of tetraploidy. Immortalized wild-type and PARP(-/-) fibroblasts were exposed for 3 weeks to 20 muM GPI 6150 (1,11b-dihydro-[2H]benzopyrano[4,3,2-de]isoquinolin-3-one), a novel small molecule specific competitive inhibitor of PARP (Ki = 60 nM) and one of the most potent PARP inhibitors to date (1C(50) = 0.15 muM). Although GPI 6150 initially decreased cell growth in wild-type cells, there was no effect on cell growth or viability after 24 h, GPI 6150 inhibited endogenous PARP activity in wild-type cells by similar to 91%, to about the residual levels in PARP(-/-)cells. Flow cytometric analysis of unsynchronized wild-type cells exposed for 3 weeks to GPI 6150 did not induce the development of tetraploidy, suggesting that, aside from its catalytic function, PARP may play other essential roles in the maintenance of genomic stability.	Georgetown Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Guildford Pharmaceut Inc, Baltimore, MD 21224 USA	Smulson, ME (corresponding author), Georgetown Univ, Sch Med, Dept Biochem & Mol Biol, 3900 Reservoir Rd NW, Washington, DC 20007 USA.	smulson@bc.georgetown.edu	Rosenthal, Dean S/J-2360-2014; Simbulan-Rosenthal, Cynthia M./W-8429-2019	Rosenthal, Dean/0000-0002-7624-0209	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA025344, P01CA074175] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01 CA074175, 1PO1 CA74175, CA25344] Funding Source: Medline		Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Andreassen PR, 1996, MUTAT RES-FUND MOL M, V372, P181, DOI 10.1016/S0027-5107(96)00138-8; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; BANASIK M, 1994, MOL CELL BIOCHEM, V138, P185, DOI 10.1007/BF00928461; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; BURKLE A, 1990, CANCER RES, V50, P5756; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chatterjee PK, 2000, FASEB J, V14, P641; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; di Fagagna FD, 1999, NAT GENET, V23, P76; DING RC, 1994, CANCER RES, V54, P4627; DING RC, 1992, J BIOL CHEM, V267, P12804; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1998, EUR J PHARMACOL, V351, P377, DOI 10.1016/S0014-2999(98)00381-1; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; FERRO AM, 1983, J BIOL CHEM, V258, P6000; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; KUHULE S, 1999, BIOCHEM BIOPH RES CO, V263, P433; Kupper JH, 1996, CANCER RES, V56, P2715; LAPLACA M, 1999, NEUROTRAUMA, V16, P976; Lautar S., 1998, Society for Neuroscience Abstracts, V24, P1226; LIN MH, 1994, ORAL ONCOL, V30B, P252, DOI 10.1016/0964-1955(94)90007-8; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; MANDRUPPOULSEN T, 1993, DIABETES METAB REV, V9, P295, DOI 10.1002/dmr.5610090410; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; MORGAN WF, 1982, MUTAT RES, V104, P361, DOI 10.1016/0165-7992(82)90170-1; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; RAMEL S, 1995, PANCREAS, V11, P213, DOI 10.1097/00006676-199510000-00001; Robinson JK, 1996, CANCER-AM CANCER SOC, V77, P284, DOI 10.1002/(SICI)1097-0142(19960115)77:2<284::AID-CNCR10>3.0.CO;2-Y; Rosenthal DS, 1997, EXP CELL RES, V232, P313, DOI 10.1006/excr.1997.3536; Sallmann FR, 2000, J BIOL CHEM, V275, P15504, DOI 10.1074/jbc.275.20.15504; SCHREIBER V, 1995, P NATL ACAD SCI USA, V92, P4753, DOI 10.1073/pnas.92.11.4753; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; SIMBULAN CMG, 1993, J BIOL CHEM, V268, P93; Simbulan-Rosenthal CM, 1999, ONCOGENE, V18, P5015, DOI 10.1038/sj.onc.1202900; Simbulan-Rosenthal CM, 1998, J BIOL CHEM, V273, P13703, DOI 10.1074/jbc.273.22.13703; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Simbulan-Rosenthal CM, 1999, CANCER RES, V59, P2190; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Simbulan-Rosenthal CM, 1998, BIOCHEMISTRY-US, V37, P9363, DOI 10.1021/bi9731089; Simbulan-Rosenthal CM, 1999, P NATL ACAD SCI USA, V96, P13191, DOI 10.1073/pnas.96.23.13191; SimbulanRosenthal CM, 1996, BIOCHEMISTRY-US, V35, P11622, DOI 10.1021/bi953010z; SMULSON ME, 1995, J BIOL CHEM, V270, P119, DOI 10.1074/jbc.270.1.119; Sun AY, 1998, ACTA PHARMACOL SIN, V19, P104; Szabo C, 1998, P NATL ACAD SCI USA, V95, P3867, DOI 10.1073/pnas.95.7.3867; Takahashi K, 1997, J CEREBR BLOOD F MET, V17, P1137, DOI 10.1097/00004647-199711000-00001; Thiemermann C, 1997, P NATL ACAD SCI USA, V94, P679, DOI 10.1073/pnas.94.2.679; Tokime T, 1998, J CEREBR BLOOD F MET, V18, P991; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; VAGUE P, 1989, DIABETOLOGIA, V32, P316, DOI 10.1007/BF00265549; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; VINDELOV LL, 1983, CYTOMETRY, V3, P332, DOI 10.1002/cyto.990030505; WALDMAN AS, 1991, NUCLEIC ACIDS RES, V19, P5943, DOI 10.1093/nar/19.21.5943; Walles T, 1998, CIRCULATION, V98, P260; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Zhang J., 1999, Acta Physiologica Scandinavica, V167, P90; Zhang J, 2000, BIOCHEM BIOPH RES CO, V278, P590, DOI 10.1006/bbrc.2000.3816; Zingarelli B, 1999, GASTROENTEROLOGY, V116, P335, DOI 10.1016/S0016-5085(99)70130-7; Zingarelli B, 1998, CIRC RES, V83, P85, DOI 10.1161/01.RES.83.1.85	69	30	30	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	FEB 1	2001	29	3					841	849		10.1093/nar/29.3.841			9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	398ZL	WOS:000166786300031	11160908	Bronze, Green Published			2021-06-18	
J	Ishikawa, K; Tanaka, H; Shiozaki, T; Takaoka, M; Ogura, H; Kishi, M; Shimazu, T; Sugimoto, H				Ishikawa, K; Tanaka, H; Shiozaki, T; Takaoka, M; Ogura, H; Kishi, M; Shimazu, T; Sugimoto, H			Characteristics of infection and leukocyte count in severely head-injured patients treated with mild hypothermia	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						hypothermia; head injury; leukopenia; infection; pneumonia	TRAUMATIC BRAIN INJURY; T-CELL FUNCTION; NEUTROPHIL ACCUMULATION; MODERATE HYPOTHERMIA; CHEMI-LUMINESCENCE; THERAPY; RATS; COMPLICATIONS; CONSCIOUSNESS; TEMPERATURE	Objective: This study was designed to characterize the infectious complications and kinetics of leukocyte count in severely head-injured patients treated with mild hypothermia. Patients and Methods: We retrospectively analyzed the incidence and severity of infectious complications as well as daily changes in leukocyte count in 41 severely head-injured patients treated with mild hypothermia (group H), They were retrospectively compared with 25 severely head-injured patients treated with high-dose barbiturates (group B) and to 25 other severely head-injured patients treated with no barbiturates (group N), Results: initial intracranial pressure was significantly higher in group H than in the other groups, No significant differences existed in the incidence of pneumonia or meningitis among the three groups, whereas the incidence of bacteremia was significantly higher in group H than in the other two groups, Pneumonia was significantly more severe in group H than in the other groups, In six patients of group H, pneumonia spread fulminantly to become life threatening. Daily changes in total leukocyte count showed the same pattern, consisting of a peak, a nadir, and a second peak in all groups. Total leukocyte count was, however, significantly lower during the first 2 weeks in group H than in the other two groups. Lymphocyte and neutrophil counts were also lower in group H, Conclusion: Infectious. complications were more severe and leukocyte counts were lower in patients treated with mild hypothermia, who also had the highest initial intracranial pressures, than in patients treated with conventional therapies, Measures against increased susceptibility to infection and leukocyte suppression should be explored.	Osaka Univ, Sch Med, Dept Traumatol, Suita, Osaka 5650871, Japan; Osaka Prefectural Nakakawachi Med Ctr Acute Med, Suita, Osaka, Japan	Tanaka, H (corresponding author), Osaka Univ, Sch Med, Dept Traumatol, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.						Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; BIGGAR WD, 1986, J APPL PHYSIOL, V60, P1186; BIGGAR WD, 1984, INFECT IMMUN, V46, P857, DOI 10.1128/IAI.46.3.857-859.1984; BIGGAR WD, 1983, INFECT IMMUN, V40, P708, DOI 10.1128/IAI.40.2.708-712.1983; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; BULLOCK MR, 1996, J NEUROTRAUM, V13, P638; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Fagerli J, 1996, W V Med J, V92, P265; FREWEN TC, 1982, J PEDIATR-US, V100, P663, DOI 10.1016/S0022-3476(82)80782-8; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; HIRAIDE A, 1995, JPN J SURG METAB NUT, V29, P7; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Ishikawa K, 1998, J TRAUMA, V44, P1047, DOI 10.1097/00005373-199806000-00018; Ishikawa K, 1999, J TRAUMA, V46, P999, DOI 10.1097/00005373-199906000-00004; KRESS HG, 1989, ACTA ANAESTH SCAND, V33, P122, DOI 10.1111/j.1399-6576.1989.tb02873.x; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; RELLO J, 1992, CHEST, V102, P525, DOI 10.1378/chest.102.2.525; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SHENAQ SA, 1986, ANN CLIN LAB SCI, V16, P130; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; TEASDALE G, 1974, LANCET, V2, P81; vanEeden SF, 1997, AM J PHYSIOL-HEART C, V272, pH1717; VILLALOBOS TJ, 1955, P SOC EXP BIOL MED, V89, P192; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; Whalen MJ, 1997, ACT NEUR S, V70, P260; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; WHITE IWC, 1983, CAN ANAESTH SOC J, V30, P506, DOI 10.1007/BF03007085	45	30	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2000	49	5					912	922		10.1097/00005373-200011000-00020			11	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	372KA	WOS:000165231800020	11086785				2021-06-18	
J	Dewey, ME; Parker, CJ				Dewey, ME; Parker, CJ		Med Res Council Cognitive Function; Analysis Grp MRC-CFA Study	Survey into health problems of elderly people: a comparison of self-report with proxy information	INTERNATIONAL JOURNAL OF EPIDEMIOLOGY			English	Article						elderly; health problems; self report and proxy information	SURROGATE RESPONDENTS; ALZHEIMERS-DISEASE; FUNCTIONAL STATUS; AGREEMENT; COMPARABILITY	Background This study was conducted as part of the Medical Research Council Cognitive Function and Ageing Study. Objective To compare information given by elderly people on their past and current health and family history of illness with similar information obtained from a relative, friend or carer. Design Screening and assessment stages of a prevalence study. Setting Three urban and two rural areas of England and Wales. Participants A subsample weighted by age and cognitive status of random population samples of people greater than or equal to 65 years, living in their own home or in a residential or nursing home, interviewed between 1991 and 1994. A relative, friend or carer identified by each elderly person to provide proxy information. Interview Computerized schedules including items on demographic details, cognitive function, lifetime illnesses, current health problems and family history of illness. Results The rate of proxy 'don't know' responses and the agreement between the elderly person and their proxy were calculated for each item, both for the overall sample and for subgroups based on characteristics of the respondent and of the proxy and on the relationship between them. Higher 'don't know' rates were found to be particularly associated with more distant relationships, questions on family history, a shorter length of time known and a lack of co-residence. Agreement was strongly related to the nature of the question and less to co-residence, with other factors such as relationship having much smaller effects. Conclusions Proxy information on past and current health problems can be almost complete and in good agreement with self-report, particularly where the proxy lives with the respondent. On family history of illness, history of head injury or boxing and current sleep problems, proxy information is likely to be less complete and show poor agreement. A proxy who is not a close relative is likely to give less complete information but agreement will not be substantially lower.	Queens Med Ctr, Sch Med, Inst Hlth Serv Res, Nottingham NG7 2UH, England	Dewey, ME (corresponding author), Queens Med Ctr, Sch Med, Inst Hlth Serv Res, Nottingham NG7 2UH, England.		Dewey, Michael E/E-2049-2010	Dewey, Michael E/0000-0002-7522-3677			Brayne C, 1998, PSYCHOL MED, V28, P319; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; FLEISS JL, 1975, BIOMETRICS, V31, P651, DOI 10.2307/2529549; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HALABI S, 1992, INT J EPIDEMIOL, V21, P607, DOI 10.1093/ije/21.3.607; HERRMANN N, 1985, AM J EPIDEMIOL, V121, P937, DOI 10.1093/oxfordjournals.aje.a114064; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; KORTEN AE, 1992, INT J EPIDEMIOL, V21, P1121, DOI 10.1093/ije/21.6.1121; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; Magaziner J, 1987, Compr Gerontol B, V1, P118; PICKLE LW, 1983, AM J EPIDEMIOL, V118, P99, DOI 10.1093/oxfordjournals.aje.a113621; ROCCA WA, 1986, J CHRON DIS, V39, P907, DOI 10.1016/0021-9681(86)90039-1; RUBENSTEIN LZ, 1984, J GERONTOL, V39, P686, DOI 10.1093/geronj/39.6.686; VANDUIJN CM, 1993, INT J EPIDEMIOL, V22, P838	16	30	30	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0300-5771			INT J EPIDEMIOL	Int. J. Epidemiol.	AUG	2000	29	4					684	697					14	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	349WW	WOS:000089069400012	10922346				2021-06-18	
J	Kulkarni, M; Armstead, WM				Kulkarni, M; Armstead, WM			Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury	STROKE			English	Article						cerebral circulation; excitatory amino acids; newborn; opioids; oxygen free radicals; pigs	PIAL ARTERY VASODILATION; CEREBRAL ARTERIOLAR DILATION; OPIOID RECEPTOR FAMILY; ACTIVATION; NEWBORN; PIGLETS; CLONING; MEMBER; LOCALIZATION; RESPONSES	Background and Purpose-Although activation of the N-methyl-D-aspartate (NMDA) receptor is thought to contribute to altered cerebrovascular regulation after traumatic brain injury, the effects of such injury on the vascular response to NMDA itself has been less well appreciated. The newly described opioid nociceptin/orphanin FQ (NOC/oFQ) elicits pial artery dilation, at least in part, in a prostaglandin-dependent manner and is released into cerebrospinal fluid after fluid percussion brain injury (FPI). Generation of superoxide anion (O-2(-)) occurs after FPI, and a byproduct of cyclooxygenase metabolism is the generation of O-2(-). This study was designed to determine whether NOC/oFQ generates O-2(-), which in turn could link NOC/oFQ release to impaired NMDA-induced pi:ll :artery dilation after FPI. Methods-Injury of moderate severity (1.9 to 2.1 atm) was produced by the lateral FPI technique in anesthetized newborn pigs equipped with a closed cranial window. Superoxide dismutase-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O-2(-) generation. Results-Under non-brain injury conditions, topical NOC/oFQ (10(-10) mol/L, the concentration present in cerebrospinal fluid after FPI) increased superoxide dismutase-inhibitable NET reduction from 1+/-1 to 20+/-3 pmol/mm(2) but had no effect itself on pial artery diameter. Indomethacin (5 mg/kg IV) blunted such NET reduction (1 +/- 1 to 6+/-2 pmol/mm(2)), whereas the NOC/oFQ receptor antagonist [F/G] NOC/oFQ (1-13) NH2 (10(-6) mol/L) blocked NET reduction. [F/G] NOC/oFQ (1-13) NH2 and indomethacin also blunted the NET reduction observed after FPI (1+/-1 to 15+/-1 versus 1+/-1 to 4+/-1 versus 1+/-1 to 4+/-1 pmol/mm(2) for sham, NOC/oFQ antagonist, and indomethacin-treated animals, respectively). NMDA (10(-8) and 10(-6) mol/L)-induced pial artery dilation was reversed to vasoconstriction after FPI, and [F/G] NOC/oFQ (1-13) NH, attenuated such vasoconstriction (sham 9+/-1% and 16+/-1% versus Fm -7+/-1% and -12+/-1% versus FPI-[F/G] NOC/oFQ (1-13) NH2-pretreated animals -2+/-1% and -3+/-1%). Indomethacin and the free radical scavengers polyethylene glycol superoxide dismutase and catalase also partially restored NMDA-induced vasodilation. Conclusions-These data show that NOC/oFQ, in concentrations present in cerebrospinal fluid after FPI, increased O-2(-) production in a cyclooxygenase-dependent manner and contributes to such production after FPI, These data show that NOC/oFQ contributes to impaired NMDA-induced pial artery dilation after FPI, Therefore, these data suggest that cyclooxygenase-dependent O-2(-) generation links NOC/oFQ release to impaired NMDA-induced cerebrovasodilation after brain injury.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.	armsteaw@mail.med.upenn.edu					Armstead WM, 2000, BRAIN RES, V859, P104, DOI 10.1016/S0006-8993(00)01949-1; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH1272; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 1999, BRAIN RES, V835, P315, DOI 10.1016/S0006-8993(99)01623-6; Armstead WM, 1997, P SOC EXP BIOL MED, V214, P210; Bari F, 1998, BRAIN RES, V780, P237, DOI 10.1016/S0006-8993(97)01196-7; Bari F, 1996, STROKE, V27, P1634, DOI 10.1161/01.STR.27.9.1634; Busija DW, 1996, AM J PHYSIOL-HEART C, V270, pH1225; CHEN Y, 1994, FEBS LETT, V347, P279, DOI 10.1016/0014-5793(94)00560-5; Faber ESL, 1996, BRIT J PHARMACOL, V119, P189, DOI 10.1111/j.1476-5381.1996.tb15969.x; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; FUKUDA K, 1994, FEBS LETT, V343, P42, DOI 10.1016/0014-5793(94)80603-9; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Guerrini R, 1998, BRIT J PHARMACOL, V123, P163, DOI 10.1038/sj.bjp.0701640; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Kapusta DR, 1999, J PHARMACOL EXP THER, V289, P173; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; LESCOHIER I, 1993, PEDIATRICS, V91, P721; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MILLER JD, 1994, LANCET, V344, P421; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Nicol B, 1996, BRIT J PHARMACOL, V119, P1081, DOI 10.1111/j.1476-5381.1996.tb16007.x; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Thorogood MC, 1996, ANESTHESIOLOGY, V84, P614, DOI 10.1097/00000542-199603000-00017; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; Veltkamp R, 1999, STROKE, V30, P148, DOI 10.1161/01.STR.30.1.148; WEI EP, 1986, AM J PHYSIOL, V251, pH693; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; Zhao J, 1998, NEUROREPORT, V9, P631, DOI 10.1097/00001756-199803090-00013	36	30	30	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2000	31	8					1990	1996		10.1161/01.STR.31.8.1990			7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	340UP	WOS:000088553600039	10926968	Bronze			2021-06-18	
J	Li, GL; Farooque, M; Lewen, A; Lennmyr, F; Holtz, A; Olsson, Y				Li, GL; Farooque, M; Lewen, A; Lennmyr, F; Holtz, A; Olsson, Y			MAP2 and neurogranin as markers for dendritic lesions in CNS injury. An immunohistochemical study in the rat	APMIS			English	Article						dendrite; injury; MAP2; neurogranin; rat	MICROTUBULE-ASSOCIATED PROTEIN-2; MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; KINASE-C SUBSTRATE; SPINAL-CORD; ISCHEMIC DEGRADATION; SENSITIVE MARKER; LOCALIZATION; PHOSPHORYLATION; RC3	We compared two staining methods for the demonstration of dendrites under normal and pathological conditions of the rat central nervous system. MAP2- and neurogranin immunohistochemistry was applied to samples from normal tissue, spinal cord subjected to graded compression trauma, cerebral cortex following contusion trauma, and brains with focal ischemic lesions induced by occlusion of the middle cerebral artery (MCAO). Normal rats showed MAP2 immunoreactivity in nerve cell bodies and dendrites of brain and spinal cord. However, neurogranin staining was present only in nerve cell bodies and dendrites of the normal brain, and not in the spinal cord. Reduction of MAP2 immunoreactivity was seen in lesions of spinal cords subjected to compression trauma. Neurogranin staining was of no value in this experimental condition since it was not present under normal conditions. The brain contusions showed loss of both MAP2- and neurogranin immunoreactivity at the site of the lesion. MCAO resulted in an extensive loss of MAP2- and neurogranin staining in the ipsilateral hemisphere. In conclusion, our study shows that MAP2 immunostaining is a sensitive method for identifying dendritic lesions of various CNS injuries in the rat. Neurogranin immunostaining is an alternative method for investigations of dendritic pathology in the brain but not in the spinal cord.	Univ Uppsala Hosp, Neuropathol Lab, Dept Genet & Pathol, Res Grp Neuropathol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosci, Neurosurg Unit, Uppsala, Sweden; Univ Uppsala Hosp, Dept Med, Uppsala, Sweden	Li, GL (corresponding author), Univ Uppsala Hosp, Neuropathol Lab, Dept Genet & Pathol, Res Grp Neuropathol, S-75185 Uppsala, Sweden.		Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348			AlvarezBolado G, 1996, NEUROSCIENCE, V73, P565, DOI 10.1016/0306-4522(96)00061-9; BAUDIER J, 1991, J BIOL CHEM, V266, P229; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; CACERES A, 1984, J NEUROSCI, V4, P394; Camilli P.D., 1984, NEUROSCIENCE, V11, P819; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; Emery JA, 1997, J NEUROPATH EXP NEUR, V56, P1276, DOI 10.1097/00005072-199712000-00002; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; HOLTZ A, 1989, ACTA UNIVERSITATIS U, V209, P1; INUZUKA T, 1990, BRAIN RES, V526, P177, DOI 10.1016/0006-8993(90)90269-H; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KUWAKI T, 1989, STROKE, V20, P78, DOI 10.1161/01.STR.20.1.78; LENOMYR F, 1998, J NEUROPATHOL EXP NE, V57, P874; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li GL, 1997, FREE RADICAL RES, V27, P187, DOI 10.3109/10715769709097851; LI GL, 1995, RESTOR NEUROL NEUROS, V8, P189, DOI 10.3233/RNN-1995-8404; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MATUS A, 1994, TRENDS NEUROSCI, V17, P19, DOI 10.1016/0166-2236(94)90030-2; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/S0006-8993(96)00786-X; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P460, DOI 10.1111/j.1600-0404.1988.tb03688.x; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Prichard L, 1999, J BIOL CHEM, V274, P7689, DOI 10.1074/jbc.274.12.7689; REPRESA A, 1990, J NEUROSCI, V10, P3782; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; WATSON JB, 1992, P NATL ACAD SCI USA, V89, P8581, DOI 10.1073/pnas.89.18.8581; WATSON JB, 1994, MOL BRAIN RES, V27, P323, DOI 10.1016/0169-328X(94)90017-5; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yamanouchi H, 1998, ACTA NEUROPATHOL, V95, P466, DOI 10.1007/s004010050826; YANAGIHARA T, 1990, ACTA NEUROPATHOL, V80, P499, DOI 10.1007/BF00294610	33	30	39	0	4	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0903-4641			APMIS	APMIS	FEB	2000	108	2					98	106					9	Immunology; Microbiology; Pathology	Immunology; Microbiology; Pathology	292QR	WOS:000085807000002	10737454				2021-06-18	
J	Hutchinson, PJ; Al-Rawi, PG; O'Connell, MT; Gupta, AK; Pickard, JD; Kirkpatrick, PJ				Hutchinson, PJ; Al-Rawi, PG; O'Connell, MT; Gupta, AK; Pickard, JD; Kirkpatrick, PJ			Biochemical changes related to hypoxia during cerebral aneurysm surgery: Combined microdialysis and tissue oxygen monitoring: Case report	NEUROSURGERY			English	Article						brain metabolism; microdialysis; oxygen monitor; subarachnoid hemorrhage	CAROTID ENDARTERECTOMY; INTRACEREBRAL MICRODIALYSIS; SUBSTRATE DELIVERY; SUBARACHNOID HEMORRHAGE; NEUROSURGICAL PATIENTS; TRANSCRANIAL DOPPLER; INITIAL EXPERIENCE; HEAD-INJURY; BRAIN; PH	OBJECTIVE AND IMPORTANCE: The objective of this study was to monitor brain metabolism on-line during aneurysm surgery, by combining the use of a multiparameter (brain tissue oxygen, brain carbon dioxide, pH, and temperature) sensor with microdialysis (extracellular glucose, lactate, pyruvate, and glutamate). The case illustrates the potential value of these techniques by demonstrating the effects of adverse physiological events on brain metabolism and the ability to assist in both intraoperative and postoperative decision-making. CLINICAL PRESENTATION: A 41-year-old woman presented with a World Federation of Neurological Surgeons Grade 1 subarachnoid hemorrhage. Angiography revealed a basilar artery aneurysm that was not amenable to coiling, so the aneurysm was clipped. Before the craniotomy was performed, a multiparameter sensor and a microdialysis catheter were inserted to monitor brain metabolism. INTERVENTION: During the operation, the brain oxygen level decreased, in relation to biochemical changes, including the reduction of extracellular glucose and pyruvate and the elevation of lactate and glutamate. These changes were reversible. However, when the craniotomy was closed, a second decrease in brain oxygen occurred in association with brain swelling, which immediately prompted a postoperative computed tomographic scan. The scan demonstrated acute hydrocephalus, requiring external ventricular drainage. The patient made a full recovery. CONCLUSION: The monitoring techniques influenced clinical decision-making in the treatment of this patient. On-line measurement of brain tissue gases and extracellular chemistry has the potential to assist in the perioperative and postoperative management of patients under going complex cerebrovascular surgery and to establish the effects of intervention on brain homeostasis.	Univ Cambridge, Acad Dept Neurosurg, Cambridge, England; Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; Univ Cambridge, Dept Neuroanaesthesia, Cambridge, England; Univ Cambridge, MRC, Ctr Brain Repair, Cambridge, England	Hutchinson, PJ (corresponding author), Addenbrookes Hosp, Acad Dept Neurosurg, Box 167, Cambridge CB2 2QQ, England.			O'Connell, Mark/0000-0001-6272-8767	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		ALRAWI PG, 1999, BRIT J NEUROSURG, V13, P225; Bachli H, 1996, NEUROL RES, V18, P370; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BENVENISTE H, 1988, J CEREBR BLOOD F MET, V8, P713, DOI 10.1038/jcbfm.1988.118; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Charbel FT, 1997, SURG NEUROL, V48, P414, DOI 10.1016/S0090-3019(96)00473-9; CHIAPPA KH, 1979, STROKE, V10, P381, DOI 10.1161/01.STR.10.4.381; CHO I, 1986, ANN NEUROL, V20, P508, DOI 10.1002/ana.410200411; CLUTTONBROCK TH, 1994, J CLIN MONITOR, V10, P387, DOI 10.1007/BF01618420; Doppenberg EMR, 1997, J NEUROSURG, V87, P809, DOI 10.3171/jns.1997.87.6.0809; Goodman JC, 1996, ACT NEUR S, V67, P37; Hoffman WE, 1997, NEUROSURGERY, V40, P294, DOI 10.1097/00006123-199702000-00012; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Hutchinson PJ, 1999, NEUROL RES, V21, P352, DOI 10.1080/01616412.1999.11740943; Hutchinson PJ, 1999, NEUROREPORT, V10, pI; HUTCHINSON PJA, 1998, BRIT J NEUROSURG, V12, pP87; Jansen C, 1993, Ann Vasc Surg, V7, P95, DOI 10.1007/BF02042666; Kirkpatrick PJ, 1998, J NEUROSURG, V89, P389, DOI 10.3171/jns.1998.89.3.0389; MCDOWELL HA, 1992, ANN SURG, V215, P514, DOI 10.1097/00000658-199205000-00014; Mendelowitsch A, 1996, ACT NEUR S, V67, P48; NAYLOR AR, 1991, BRIT J SURG, V78, P1264, DOI 10.1002/bjs.1800781038; Nilsson OG, 1996, ACT NEUR S, V67, P45; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Plestis KA, 1997, J VASC SURG, V25, P620, DOI 10.1016/S0741-5214(97)70287-8; Ungerstedt U, 1984, MEASUREMENT NEUROTRA, P81; VENKATESH B, 1995, J CARDIOTHOR VASC AN, V9, P412, DOI 10.1016/S1053-0770(05)80096-5; VENKATESH B, 1994, CRIT CARE MED, V22, P588, DOI 10.1097/00003246-199404000-00013; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WHITTLE I R, 1990, British Journal of Neurosurgery, V4, P459, DOI 10.3109/02688699008993792; Whittle IR, 1998, NEUROREPORT, V9, P2821, DOI 10.1097/00001756-199808240-00025; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	34	30	32	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2000	46	1					201	205					5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	270MT	WOS:000084540200104	10626951				2021-06-18	
J	Leon-Carrion, J; Dominguez-Roldan, JM; Murillo-Cabezas, F; Dominguez-Morales, MD; Munoz-Sanchez, MA				Leon-Carrion, J; Dominguez-Roldan, JM; Murillo-Cabezas, F; Dominguez-Morales, MD; Munoz-Sanchez, MA			The role of citicholine in neuropsychological training after traumatic brain injury	NEUROREHABILITATION			English	Article; Proceedings Paper	International Conference on Recent Advances in Neurotraumatology (ICRAN 99)	NOV 20-23, 1999	TAIPEI, TAIWAN			citicholine; memory; neuropsychological rehabilitation; rCBF; traumatic brain injury	CITICOLINE; MEMORY	Objective: To report new strategies in the treatment of persistent memory deficits following traumatic brain injury (TBI) using a combination of pharmacology and neuropsychological training. Study design: Two studies were carried out. The first study measured the regional cerebral blood how (rCBF) of seven Patients with TBI with very severe memory deficits, once while resting and once one hour after the administration of citicholine (CDPc). In the second study, two groups of five patients of the same characteristics underwent an ecological neuropsychological memory rehabilitation program; during which time, one group was administered a placebo (Group A), and the other received CDPc (1 g/d v.o.) (Group B). Results: The results of Experiment 1 showed a hypoperfusion of the inferior left temporal cerebral blood flow during rest state while an induced normalization was observed after administration of the drug. Results of Experiment 2 showed no improvements in Group A's neuropsychological functions, while memory, learning processes and verbal fluency of Group B improved significantly after treatment. Conclusions: CDP-choline seems to be a drug with special affinity for cerebral areas associated with memory acting just where needed, normalizing blood flow in the hypoperfused left temporo-basal region, and making neuropsychological training effective. In general, data suggests that cognitive rehabilitation would follow the principle of first restoring and maintaining cerebral blood flow in the lesional site and then exercising function. In this study on memory rehabilitation, memory recuperation was made possible by first normalizing blood flow at the lesional site and at the same time applying neuropsychological training.	Fac Psicol, Human Neuropsychol Lab, Dept Expt Psychol, Seville 41018, Spain; Hosp Traumatol Virgen Rocio, Intens Care Unit, Seville, Spain; Ctr Brain Injury Rehabil C RE CER, Seville, Spain; Hosp Traumatol Virgen Rocio, Crit Care Dept, Seville, Spain	Leon-Carrion, J (corresponding author), Fac Psicol, Human Neuropsychol Lab, Dept Expt Psychol, Av San Francisco Javier S-N, Seville 41018, Spain.	jleon@cica.es	IBIS, NEUROCRITICOS/C-1805-2016; Dominguez-Roldan, Jose-Maria/M-1728-2016; Murillo-Cabezas, Francisco/AAO-3348-2021	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; 			AUBINEAU P, 1977, NEUROGENIC CONTROL B, P331; AZNERIC SP, 1998, BRAIN RES, V454, P11; Benton A, 1989, MULTILINGUAL APHASIA; Benton AL., 1974, REVISED VISUAL RETEN; BIEDERMAN GB, 1970, Q J EXP PSYCHOL, V22, P384, DOI 10.1080/14640747008401911; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; De Blas A., 1986, MED CLIN-BARCELONA, V87, P41; DUCKLES SP, 1986, NEURAL REGULATION BR, P235; FONLUPT P, 1985, NOVEL BIOCH PHARM CL, P169; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HEISTAD DD, 1980, AM J PHYSIOL, V239, P437; LADD SL, 1990, 95 ANN M AM PSYCH AS; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL; LEONCARRION J, 1994, 4 C PSYCH ASS SANT C, P73; LEONCARRION J, 1998, SEVILLA COMPUTERISED; LEVIN HS, 1992, NEUROPSYCHOLOGY MEMO; LEVIN HS, 1991, J NEUROL SCI S, V103, pS24; LOPEZ G, 1987, NEUROCHEM INT, V11, P293; LOPEZ G, 1992, J NEUROCHEM, V59, P338; LOPEZ G-COVIELLA I, 1992, Journal of Nutritional Biochemistry, V3, P313; LOZANO R, 1991, J NEUROL SCI S, V103, pS31; MAYES AR, 1998, HUMAN ORGANIC MEMORY; MILLER E, 1978, PRACTICAL ASPECTS ME; OBRIST WD, 1975, STROKE, V6, P301; OBRIST WD, 1988, HDB REGIONAL CEREBRA, P37; PETTIGREW LC, 1997, INT JOINT C STROK CE; RISBERG J, 1988, HDB REGIONAL CEREBRA; RISBERG J, 1975, STROKE, V6, P14; ROSENBERG GS, 1982, AM J CLIN NUTR, V36, P709; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; SCHACTER DL, 1986, CLIN NEUROPSYCHOLOGY; SIVAN AB, 1952, BENTON VISUAL RETENT; Spiers PA, 1996, ARCH NEUROL-CHICAGO, V53, P441, DOI 10.1001/archneur.1996.00550050071026; SQUIRE LR, 1971, J COMP PHYSIOL PSYCH, V74, P41, DOI 10.1037/h0030325; STANES MD, 1976, PSYCHOPHARMACOLOGIA, V46, P269, DOI 10.1007/BF00421113; *US WAR DEP, 1994, ARM IND TESTS MAN RE; WARRINGTON EK, 1986, DIS NERVOUS SYSTEM; WILSON BA, 1984, EVERYDAY MEMORY ACTI; WISHAW IQ, 1989, BRAIN RES B, V23, P247; WISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979; WOOD JL, 1982, FED PROC, V41, P3015	44	30	30	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2000	14	1					33	40					8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	323WV	WOS:000087588700005					2021-06-18	
J	Dirette, DK; Hinojosa, J; Carnevale, GJ				Dirette, DK; Hinojosa, J; Carnevale, GJ			Comparison of remedial and compensatory interventions for adults with acquired brain injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED-HEAD-INJURY; MODERATE	Objective: To examine the effects of a compensatory intervention versus a remedial intervention for deficits in visual processing of adults with acquired brain injuries (ABT). Setting: A cognitive rehabilitation program at a large comprehensive rehabilitation hospital in the New York City metropolitan area. Patients: Thirty adults with ABI were matched according to severity of injury, gender, age, and time post-injury, and randomly assigned to the remedial or compensatory group. Interventions: The remedial intervention consisted of four 45-minute sessions (once weekly) of participation in computer tasks without instruction in compensatory strategies. The compensatory intervention consisted of four 45-minute sessions of instruction in the use of three internal compensatory strategies, including verbalization, chunking, and pacing. Main Outcome Measures: Pretest/posttest measures included three functional computer tasks. Weekly measures included a computerized version of the Paced Auditory Serial Addition Task (PASAT) and two computerized matching tasks. Results: Both groups exhibited statistically significant improvement of comparable degree on posttests and weekly measures. Further analysis revealed that 80% of both groups used compensatory strategies, regardless of intervention method. Those who used strategies demonstrated better performance than those who did not. Conclusion: The ability to use internal compensatory strategies may be a significant confound in research examining the effects of the various cognitive rehabilitation intervention methods.	Western Michigan Univ, Occupat Therapy Dept, Kalamazoo, MI 49008 USA; NYU, Dept Occupat Therapy, New York, NY USA; Kessler Inst Rehabil, Dept Psychol & Neuropsychol, E Orange, NJ USA	Dirette, DK (corresponding author), Western Michigan Univ, Occupat Therapy Dept, 1201 Oliver St, Kalamazoo, MI 49008 USA.						AERO R, 1984, BRAIN GAME SOFTWARE; Anderson J. R., 1985, COGNITIVE PSYCHOL IT; ASINOVSKY V, 1992, IQ BUILDER SOFTWARE; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Diller L., 1993, AOTA SELF STUDY SERI, P7; GIANUTSOS R, 1987, HIGHER ORDER FUNCTIO; Gray J M, 1989, Brain Inj, V3, P163, DOI 10.3109/02699058909004548; Gray J. M., 1992, NEUROPSYCHOL REHABIL, V2, P97; Haase B., 1997, ASSESSMENT OCCUPATIO, P333; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; *LOF DEV CORP, 1986, LOT 1 2 3 SOFTW; MALEC J, 1984, COGNITIVE REHABILITA, V2, P18; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MOSEY AC, 1993, AOTA SELF STUDY SERI, P23; NEIMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811; Norusis M. J., 1994, SPSS ADV STAT 6 1; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; Parente R., 1989, J HEAD TRAUMA REHAB, V4, P53; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIMEL RW, 1982, NEUROSURGERY, V11, P334; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; *SPSS INC, 1995, SPSS 6 1 ADV VERS WI; STRACHE W, 1987, International Journal of Rehabilitation Research, V10, P141, DOI 10.1097/00004356-198700105-00028; Tabachnick B.G., 1989, USING MULTIVARIATE S; TEHAN G, 1995, MEM COGNITION, V23, P181, DOI 10.3758/BF03197220; Toglia JA., 1993, AOTA SELF STUDY SERI, P1; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Wood R L, 1987, Int Disabil Stud, V9, P149; WOOD RL, 1984, CLIN MANAGEMENT MEMO, P148	32	30	31	0	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1999	14	6					595	601		10.1097/00001199-199912000-00008			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	269AV	WOS:000084454300007	10671705				2021-06-18	
J	Zhang, C; Raghupathi, R; Saatman, KE; LaPlaca, MC; McIntosh, TK				Zhang, C; Raghupathi, R; Saatman, KE; LaPlaca, MC; McIntosh, TK			Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat	JOURNAL OF NEUROCHEMISTRY			English	Article						DNA fragmentation; DFF45/DFF40; fluid percussion; immunoblotting; traumatic brain injury	APOPTOTIC CELL-DEATH; CASPASE-ACTIVATED DNASE; DELAYED NEURONAL DEATH; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; GRANULE CELLS; SPINAL-CORD; INJURY; CLEAVAGE; CPP32	DNA fragmentation, an early event in neuronal death following traumatic brain injury, may be triggered by the 40-kDa subunit of DNA fragmentation factor (DFF40). DFF40 is typically bound to the 45-kDa subunit of DFF (DFF45), and activation of DFF40 may occur as a result of caspase-3-mediated cleavage of DFF45 into 30- and 11-kDa fragments. In this study, the intracellular distribution of DFF45 and DFF40 was examined following lateral fluid percussion brain injury of moderate severity (2.4-2.7 arm) in male Sprague-Dawley rats. In the cytosolic fraction (S1) of the injured cortex at 2 and 24 h postinjury, significant decreases in the intensities of DFF45-like proteins at 45- and 32-kDa bands and a concomitant increase in the 11-kDa bands were observed (p < 0.05 vs, uninjured controls). A significant decrease in the intensities of the 32-kDa band in the nuclear (P1) fraction of the injured cortex was observed at 30 min and 2 h postinjury (p < 0.01). Concomitantly, a decrease in DFF40 was observed in the cortical S1 fraction at 2 and 24 h (p < 0.05) and in the P1 fraction at 30 min and 2 h postinjury (p < 0.01). In the hippocampus, DFF45 decreased at 30 min in the P1 and 2 h in the S1 fraction (p < 0.05) and recovered by 24 h postinjury, whereas DFF40 was significantly decreased in the S1 and increased in the P1 fraction at both 2 and 24 h (p < 0.01), which indicated a translocation of DFF40 from cytosol to nucleus. These data are the first to demonstrate that changes in DFF proteins occur after brain trauma and suggest that these changes may play a role in apoptotic cell death via caspase-3-DFF45/DFF40-DNA cleavage observed following traumatic brain injury.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA	McIntosh, TK (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803, R01-NS26818] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P50NS008803] Funding Source: NIH RePORTER		Armstrong RC, 1997, J NEUROSCI, V17, P553; Barinaga M, 1998, SCIENCE, V281, P1303, DOI 10.1126/science.281.5381.1303; Barinaga M, 1998, SCIENCE, V281, P1302, DOI 10.1126/science.281.5381.1302; CARSON DA, 1993, LANCET, V341, P1251, DOI 10.1016/0140-6736(93)91154-E; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Chen J, 1998, J NEUROSCI, V18, P4914; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Enari M, 1998, NATURE, V391, P43; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MacFarlane M, 1997, J CELL BIOL, V137, P469, DOI 10.1083/jcb.137.2.469; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; Marks N, 1998, J NEUROSCI RES, V52, P334, DOI 10.1002/(SICI)1097-4547(19980501)52:3<334::AID-JNR9>3.0.CO;2-E; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mitamura S, 1998, BIOCHEM BIOPH RES CO, V243, P480, DOI 10.1006/bbrc.1998.8122; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Namura S, 1998, J NEUROSCI, V18, P3659; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; NITATORI T, 1995, J NEUROSCI, V15, P1001; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; PETITO CK, 1995, AM J PATHOL, V146, P1121; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/0006-8993(96)00222-3; RINK A, 1995, AM J PATHOL, V147, P1575; Sabol SL, 1998, BIOCHEM BIOPH RES CO, V253, P151, DOI 10.1006/bbrc.1998.9770; Sakahira H, 1998, NATURE, V391, P96; Samejima K, 1998, EXP CELL RES, V243, P453, DOI 10.1006/excr.1998.4212; Shah PT, 1997, NEUROSCIENCE, V79, P999, DOI 10.1016/S0306-4522(97)00013-4; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	54	30	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3042			J NEUROCHEM	J. Neurochem.	OCT	1999	73	4					1650	1659		10.1046/j.1471-4159.1999.0731650.x			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	236TZ	WOS:000082616200037	10501212				2021-06-18	
J	Wada, K; Alonso, OF; Busto, R; Panetta, J; Clemens, JA; Ginsberg, MD; Dietrich, WD				Wada, K; Alonso, OF; Busto, R; Panetta, J; Clemens, JA; Ginsberg, MD; Dietrich, WD			Early treatment with a novel inhibitor of lipid peroxidation (LY341122) improves histopathological outcome after moderate fluid percussion brain injury in rats	NEUROSURGERY			English	Article						fluid percussion brain injury; free radical scavenger; lipid peroxidation inhibitor; LY341122; rat	SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; CONJUGATED SUPEROXIDE-DISMUTASE; FREE-RADICAL PRODUCTION; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; REPERFUSION INJURY; SUBDURAL-HEMATOMA; NMDA RECEPTORS; GLUTAMATE	OBJECTIVE: Reactive oxygen species are thought to participate in the pathobiology of traumatic brain injury (TBI). This study determined whether treatment with LY341122, a potent inhibitor of lipid peroxidation and an antioxidant, would provide neuroprotection in a rat model of TBI. METHODS: To investigate the efficacy of LY341122 in this parasagittal fluid percussion model (1.8-2.1 atm), the rats received oval administration of LY341122 (100 mg/kg) or vehicle 2 hours before and 4 hours after TBI teach group, n = 7). To investigate the therapeutic window for treatment, rats were treated with LY341122 or vehicle for 20 hours by femoral vein infusion starting at 5 minutes, 30 minutes, or 3 hours after TBI teach group, n = 5). Three days after injury, analysis of contusion volumes and the frequency of damaged cortical neurons was conducted. RESULTS: Oral administration of LY341122 before and after TBI led to a significant reduction in overall contusion volume (3.28 mm(3) +/- 0.75 mm(3) [mean +/- standard error of the mean] versus 1.32 mm(3) +/- 0.33 mm(3); P < 0.05) and also reduced the frequency of damaged cortical neurons (1191.7 +/- 267.1 versus 474.6 +/- 80.2; P < 0.05). In the second experiment, rats treated with LY341122 at 5 minutes or 30 minutes after TBI also demonstrated a significant reduction (P < 0.05) in contusion volume (1.92 mm(3) +/- 0.64 mm(3) or 1.59 mm(3) +/- 0.50 mm(3), respectively) compared with vehicle-treated rats (4.32 mm(3) +/- 1.15 mm(3)). A significant reduction in total cortical necrotic neuron counts was also demonstrated in the 5-minute group (2243.8 +/- 265.3 versus 1457.8 +/- 265.3; P < 0.05). In contrast, histopathological outcome was not significantly improved when treatment was delayed until 3 hours after TBI. CONCLUSION: These data reinforce the hypothesis that lipid peroxidation and reactive oxygen species participate in the acute pathogenesis of TBI. Treatment delayed until 3 hours after TBI did not provide significant histopathological protection.	Univ Miami, Dept Neurol, Miami, FL 33101 USA; Univ Miami, Dept Neurol Surg, Neurotrauma Res Ctr, Miami, FL 33101 USA; Lilly Res Labs, Indianapolis, IN USA	Dietrich, WD (corresponding author), Univ Miami, Dept Neurol Surg & Neurol R48, POB 016960, Miami, FL 33101 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30291] Funding Source: Medline		Aldana P. R., 1998, Society for Neuroscience Abstracts, V24, P1732; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BONDY SC, 1993, BRAIN RES, V610, P229, DOI 10.1016/0006-8993(93)91405-H; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; CHAN PH, 1980, J NEUROCHEM, V35, P1004, DOI 10.1111/j.1471-4159.1980.tb07100.x; CLEMENS JA, 1999, J CEREB BLOOD FLO S1, V19, pS183; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DEMOPOULOS HB, 1982, PATHOLOGY OXYGEN, P127; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DEWITT DS, 1997, J NEUROTRAUM, V14, P219; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIETRICH WD, 1997, J CEREB BLOOD FLO S1, V17, pS25; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; DUCKROW RB, 1986, J NEUROSURG, V54, P607; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HAMMER B, 1993, NEUROREPORT, V5, P72, DOI 10.1097/00001756-199310000-00018; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KLEIHUES P, 1974, J NEUROCHEM, V23, P417, DOI 10.1111/j.1471-4159.1974.tb04374.x; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Lin SZ, 1996, STROKE, V27, P747, DOI 10.1161/01.STR.27.4.747; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCCORD JM, 1987, FASEB J, V46, P2402; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; RATAN RR, 1994, J NEUROCHEM, V62, P376; RINK A, 1995, AM J PATHOL, V147, P1575; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WELSH FA, 1984, CEREBRAL ISCHEMIA, P177; WILSON JT, 1995, J TRAUMA, V39, P473; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHIDA K, 1992, STROKE, V23, P865, DOI 10.1161/01.STR.23.6.865; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zilles K., 1985, CORTEX RAT STEREOTAX	64	30	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	SEP	1999	45	3					601	608		10.1097/00006123-199909000-00031			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	235MT	WOS:000082546000072	10493379				2021-06-18	
J	Brana, C; Benham, CD; Sundstrom, LE				Brana, C; Benham, CD; Sundstrom, LE			Calpain activation and inhibition in organotypic rat hippocampal slice cultures deprived of oxygen and glucose	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						calpain inhibition; hippocampus; MDL 28170; organotypic cultures; oxygen-glucose deprivation	CYTOSKELETAL PROTEOLYSIS; PROPIDIUM IODIDE; NEURONAL DAMAGE; IN-VITRO; BRAIN; ISCHEMIA; CALCIUM; NMDA; NEUROPROTECTION; CALPASTATIN	It has been suggested that, after ischaemia, activation of proteases such as calpains could be involved in cytoskeletal degradation leading to neuronal cell death. In vivo, calpain inhibitors at high doses have been shown to reduce ischaemic damage and traumatic brain injury, however, the relationship between calpain activation and cell death remains unclear. We have investigated the role of calpain activation in a model of ischaemia based on organotypic hippocampal slice cultures using the appearance of spectrin breakdown products (BDPs) as a measure of calpain I activation. Calpain I activity was detected on Western blot immediately after a 1-h exposure to ischaemia. Up to 4 h post ischaemia, BDPs were found mainly in the CA1 region and appeared before uptake of the vital dye propidium iodide (PI). 24 h after the insult, BDPs were detected extensively in CA1 and CA3 pyramidal cells, all of which was PI-positive. However, there were many more PI-positive cells that did not have BDPs, indicating that the appearance of BDPs does not necessarily accompany ischaemic cell death. Inhibition of BDP formation by the broad-spectrum protease inhibitor leupeptin was not accompanied by any neuroprotective effects. The more specific and more cell-permeant calpain inhibitor MDL 28170 had a clear neuroprotective effect when added after the ischaemic insult. In contrast, when MDL 28170 was present throughout the entire pre- and post-incubation phases, PI labelling actually increased, indicating a toxic effect. These results suggest that calpain activation is not always associated with cell death and that, while inhibition of calpains can be neuroprotective under some conditions, it may not always lead to beneficial outcomes in ischaemia.	Univ Southampton, Southampton Gen Hosp, Dept Clin Neurol Sci, Southampton SO16 6YD, Hants, England; SmithKline Beecham Pharmaceut, Harlow CM19 5AW, Essex, England	Brana, C (corresponding author), Univ Southampton, Southampton Gen Hosp, Dept Clin Neurol Sci, Level F,S Acad Block,Tremona Rd, Southampton SO16 6YD, Hants, England.						BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Faddis BT, 1997, J NEUROSCI, V17, P951; GOLL DE, 1992, BIOESSAYS, V14, P549, DOI 10.1002/bies.950140810; GOTO K, 1994, MOL BRAIN RES, V23, P40, DOI 10.1016/0169-328X(94)90209-7; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Kampfl A, 1996, J NEUROCHEM, V67, P1575; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; MALIK MN, 1981, LIFE SCI, V29, P795, DOI 10.1016/0024-3205(81)90035-7; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; OSWALD K, 1991, SOC NEUR ABSTR, V17, P185; Pringle AK, 1996, NEUROSCI LETT, V211, P203, DOI 10.1016/0304-3940(96)12745-2; Pringle AK, 1997, BRAIN RES, V755, P36, DOI 10.1016/S0006-8993(97)00089-9; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAIDO TC, 1994, FASEB J, V8, P814; SANDOVAL IV, 1978, EUR J BIOCHEM, V92, P463, DOI 10.1111/j.1432-1033.1978.tb12768.x; SCHLAEPFER WW, 1979, BRAIN RES, V168, P299, DOI 10.1016/0006-8993(79)90171-9; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Siman R, 1996, ADV NEUROL, V71, P167; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STRASSER U, 1995, J NEUROSCI METH, V57, P177, DOI 10.1016/0165-0270(94)00147-9; SUNDSTROM LE, 1995, J CEREBRAL BLOOD FLO, V15, pS11; VORNOV JJ, 1994, STROKE, V25, P457, DOI 10.1161/01.STR.25.2.457; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; WILDE GJC, 1994, NEUROSCI LETT, V180, P223, DOI 10.1016/0304-3940(94)90525-8	35	30	30	0	2	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	JUL	1999	11	7					2375	2384		10.1046/j.1460-9568.1999.00653.x			10	Neurosciences	Neurosciences & Neurology	211NT	WOS:000081175400019	10383627				2021-06-18	
J	Joseph, S; Masterson, J				Joseph, S; Masterson, J			Posttraumatic stress disorder and traumatic brain injury: Are they mutually exclusive?	JOURNAL OF TRAUMATIC STRESS			English	Article						PTSD; TBI	CLOSED-HEAD-INJURY; FOLLOW-UP; MEMORY; INFORMATION; INDIVIDUALS; ACCIDENTS; VICTIMS; MODEL; SCALE; PTSD	It has been suggested that posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) must be mutually incompatible disorders. However growing empirical evidence has begun to question this. Evidence suggests that although PTSD may be relatively rare among the TBI population, some TBI patients seem to develop PTSD. We suggest two theoretical routes through which PTSD might develop in TBI patients: through nonconscious processes in individuals who are subsequently amnesic, but who were conscious at the time of the traumatic episode and through subsequent appraisal processes in individuals who were unconscious during the traumatic episode.	Univ Essex, Colchester CO4 3SQ, Essex, England	Joseph, S (corresponding author), Univ Essex, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.			joseph, stephen/0000-0001-7171-3356; Masterson, Jackie/0000-0003-2869-6612			American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amick-McMullan A., 1989, J TRAUMATIC STRESS, V2, P21, DOI [DOI 10.1007/BF00975764, DOI 10.1002/JTS.2490020104]; BLEDIN K, 1994, BRIT J MED PSYCHOL, V67, P125, DOI 10.1111/j.2044-8341.1994.tb01778.x; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI DOI 10.1097/00001199-199602000-00011; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1996, J TRAUMA STRESS, V9, P223, DOI 10.1002/jts.2490090206; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; COCKBURN J, 1997, NEUROPSYCHOLOGICAL R, V7, P259; CREAMER M, 1992, J ABNORM PSYCHOL, V101, P452, DOI 10.1037/0021-843X.101.3.452; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIXON P, 1993, BRIT J MED PSYCHOL, V66, P193, DOI 10.1111/j.2044-8341.1993.tb01741.x; EVERLY GS, 1989, PERCEPT MOTOR SKILL, V68, P807, DOI 10.2466/pms.1989.68.3.807; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; FOA EB, 1991, J ABNORM PSYCHOL, V100, P156, DOI 10.1037/0021-843X.100.2.156; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; GERSONS BPR, 1992, BRIT J PSYCHIAT, V161, P742, DOI 10.1192/bjp.161.6.742; GILES GM, 1993, BRAIN INJURY REHABIL; GROSS Y, 1996, 2 WORLD C INT SOC TR; Horo-witz Milton J., 1976, STRESS RESPONSE SYND; HOROWITZ M, 1980, HUMAN STRESS COGNITI, P253; HOROWITZ MJ, 1975, ARCH GEN PSYCHIAT, V32, P1457; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; JOSEPH S, 1995, CLIN PSYCHOL REV, V15, P515, DOI 10.1016/0272-7358(95)00029-O; JOSEPH S, 1997, UNDERSTANDING POST T; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KING NS, 1997, J NEUROL NEUROSUR PS, V144, P989; KLAG E, 1996, P 2 WORLD C INT SOC; KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEVIN HS, 1989, MILD MODERATE HEAD I, P153; Levy A., 1996, 2 WORLD C INT SOC TR; LHEMKUHL LD, 1990, HEAD INJURY GLOSSARY; LITZ BT, 1989, CLIN PSYCHOL REV, V9, P243, DOI 10.1016/0272-7358(89)90030-5; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; MCNALLY RJ, 1993, J TRAUMA STRESS, V6, P33; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER L, 1993, J COGNITIVE REHABILI, V11, P18; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1992, P BRIT PSYCH SOC ANN; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; PARKER R, 1990, TRAUMATIC BRAIN INJU; Ponsford J., 1995, TRAUMATIC BRAIN INJU, P1; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; ROSEN GM, 1995, PROF PSYCHOL-RES PR, V26, P82, DOI 10.1037/0735-7028.26.1.82; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1991, NEUROPSYCHOLOGY ATTO; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SCHREIBER S, 1996, 2 WORLD C INT SOC TR; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Tate RL, 1998, NEUROPSYCHOL REHABIL, V8, P1, DOI 10.1080/713755554; TEASDALE G, 1974, LANCET, V2, P81; VARNEY NR, 1987, NEUROPSYCHOLOGY, V1, P79; WAKEFIELD JC, 1992, AM PSYCHOL, V47, P373, DOI 10.1037/0003-066X.47.3.373; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Wood R. L1., 1990, NEUROBEHAVIOURAL SEQ; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	71	30	31	0	0	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	JUL	1999	12	3					437	453		10.1023/A:1024762919372			17	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	227ZM	WOS:000082110100003	10467554				2021-06-18	
J	Wilson, BA; Evans, JJ; Emslie, H; Balleny, H; Watson, PC; Baddeley, AD				Wilson, BA; Evans, JJ; Emslie, H; Balleny, H; Watson, PC; Baddeley, AD			Measuring recovery from post traumatic amnesia	BRAIN INJURY			English	Article							HEAD-INJURY	Three groups of participants were assessed. Each participant was tested on 20 occasions. The groups comprised people (i) in post traumatic amnesia (PTA) following severe head injury (n = 9), (ii) with severe head injury but not in PTA (n = 10), and (iii) with no history of head injury or other neurological condition (n = 13). Subjects were given several tests of memory, attention and learning in order to determine which tests were good at (a) distinguishing people in PTA from those not in PTA, and (b) monitoring recovery over time. The results indicate that people in PTA have a wide range of deficits and their cognitive recovery is a gradual process rather than an all-or-none phenomenon In terms of measurement, the study suggests that a good test of PTA should include orientation questions, together with a reaction time measure, a visual recognition test and a speed of information processing measure. Most of the tests administered were good at distinguishing between brain-injured and non-brain-injured people, although only Mo tests distinguished between the: two brain-injured groups, i.e. those in PTA and those out of PTA. Almost all tests were good at monitoring recovery from PTA.	Lifespan Heathcare NHS Trust, Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, England; SW Mental Hlth Team, Ipswich, Suffolk, England; Univ Bristol, Dept Psychol, Bristol, Avon, England; MRC, Cognit & Brain Sci Unit, Cambridge, England	Wilson, BA (corresponding author), Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Box 58, Cambridge CB2 2QQ, England.			Watson, Peter/0000-0002-9436-0693			Baddeley A.D., 1992, SPEED CAPACITY LANGU; BADDELEY AD, 1992, CLIN MANAGEMENT MEMO, P1; BADDELEY AD, 1994, DOORS PEOPLE TEST VI; DUNN J, 1974, IRCS RES NEUROLOGY N, V2, P1497; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P819; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Rabbitt P. M. A., 1993, ATTENTION SELECTION, P188; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; SCHACHTER D, 1977, CORTEX, V13, P105; SHORES EA, 1986, MED J AUSTRALIA, V144, P596; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wilson B.A., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [10.1080/09602019208401410, DOI 10.1080/09602019208401410]	15	30	31	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1999	13	7					505	520		10.1080/026990599121412			16	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	215GT	WOS:000081374100004	10462148				2021-06-18	
J	Deb, S				Deb, S			ICD-10 codes detect only a proportion of all head injury admissions	BRAIN INJURY			English	Article								Despite criticism, the codes covering traumatic brain injury under the international Classification of Diseases have been widely used for sample collection in the epidemiological studies of head injury. Data have been collected from an Accident and Emergency department's (A&E's) case register on all head injury admissions to hospitals from a defined geographic area between 1 April 1996 and 31 March 1997, and compared with the list collected from the heath authority's central database by using the ICD-10 codes. Thirty seven per cent of the names in the A&E register appeared in the ICD-10 list, and 41% of the names in the ICD-10 list appeared in the list collected from the A&E department. The incidence of reported head injury was found to be three times higher among the 0-15 years age group compared with the 16-64 years age group (3.3% compared with 1% of the population). Among the 16-64 years age group, the peak rates of admission to hospital were in the months of February and August. Approximately 14% of all the head injury admissions stayed in hospital for more than 72 hours, another 14% stayed between 48 and 72 hours, and the rest (72%) stayed for less than 48 hours.	Cardiff Univ, Cardiff CF4 4XN, S Glam, Wales	Deb, S (corresponding author), Cardiff Univ, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.	Deb@Cardiff.ac.uk		Deb, Shoumitro/0000-0002-1300-8103			ANDERSON DW, 1980, J NEUROSURG, V53, pS11; Caveness W F, 1979, Adv Neurol, V22, P1; GRAVES E, 1989, VITAL HLTH STAT SER, V13; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; *OFF POP CENS SURV, 1987, HOSP IN PAT ENQ; *PHS HEALTHC FIN A, CLIN MOD, V1; World Health Organization, 1992, INT CLASS DIS 10 REV; World Health Organization (WHO), 1978, INT CLASS DIS 9 REV	8	30	30	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	1999	13	5					369	373		10.1080/026990599121557			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	200LE	WOS:000080541100005	10367147				2021-06-18	
J	Riese, H; Hoedemaeker, M; Brouwer, WH; Mulder, LJM; Cremer, R; Veldman, JBP				Riese, H; Hoedemaeker, M; Brouwer, WH; Mulder, LJM; Cremer, R; Veldman, JBP			Mental fatigue after very severe closed head injury: Sustained performance, mental effort, and distress at two levels of workload in a driving simulator	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; DIVIDED ATTENTION; RATE-VARIABILITY	In patients with very severe closed head injury (CHI), returning to work is often problematic. The present study focuses on a persistent complaint of these patients, viz. mental fatigue. To study this, the effect of sustained workload is assessed in a continuous dynamic divided attention task. Three types of measures are employed: performance loss with time-on-task, and subjective reports and cardiovascular measures of mental effort and distress. Eight very severe CHI patients (mean post-traumatic amnesia duration 51 days, mean age 23 years, (SD 6.4) and eight hospital controls (mean age 29 years, (SD 5.9) were tested. No differences were found between the patients and controls in the effects of task load on performance and the amount of mental effort, even in very demanding simulated work conditions. This parallels previous findings in less demanding laboratory tasks of sustained attention. Effects of CHI were found on both subjective and physiological indicators of distress. Compared to the controls, patients showed stronger effects on systolic blood pressure and subjectively experienced load.	Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 HV Amsterdam, Netherlands; Delft Univ Technol, Delft, Netherlands; Univ Groningen, Groningen, Netherlands; Inst TNO Work & Employment, Hoofddorp, Netherlands		h.riese@psy.vu.nl	Riese, Harriette/E-7234-2012	Riese, Harriette/0000-0003-3661-3151			AASMAN J, 1987, HUM FACTORS, V29, P161; AASMAN J, 1988, HUMAN MENTAL WORKLOA; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brouwer W, 1996, BRAIN COGNITION, V30, P380; Brouwer W.H., 1985, THESIS U GRONINGEN N; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; HELLINGA P, 1985, HEYMANS B U GRONINGE; KOORN R, 1995, GEDRAG ORG, V8, P318; Luria A. R., 1963, RESTORATION FUNCTION; Luteijn F., 1983, Handleiding Groninger Intelligentie Test [Manual Groningen Intelligence Test]; MANLY T, 1977, METHODOLOGY FRONTAL, P135; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Meijman TF, 1989, MENTALE BELASTING WE; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; MULDER G, 1981, PSYCHOPHYSIOLOGY, V18, P392, DOI 10.1111/j.1469-8986.1981.tb02470.x; MULDER G, 1986, ENERGETICS HUMAN INF; Mulder L. J. M., 1988, COMPUTERS PSYCHOL ME, P30; MULDER LJM, 1988, THESIS U GRONINGEN N; MULER B, 1992, BLOOD PRESSURE HEART, P153; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODDY M, 1984, CLOSED HEAD INJURY P, P108; PENAZ J, 1973, 10TH INT C MED BIOL, P104; PONSFORD JL, 1989, 1 BIANN C INT ASS ST; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; Schmidt I W, 1996, Appl Neuropsychol, V3, P155, DOI 10.1207/s15324826an0303&4_8; SETTELS JJ, 1985, PSYCHOPHYSIOLOGY CAR, P267; SNIJDERS JT, 1958, OPSTELLING EEN INTEL; THAYER RE, 1978, PSYCHOL REP, V42, P747, DOI 10.2466/pr0.1978.42.3.747; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANROON AM, 1998, THESIS U GRONINGEN N; VANWOLFFELAAR P, 1988, ROAD USER BEHAVIOUR, P302; VANWOLFFELAAR PC, 1991, COMPUTERS PSYCHOL AP; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VELDMAN JBP, 1992, THESIS U GRONINGEN N; VELDMAN JBP, IN PRESS J PSYCHOPHY; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; WESSELING KH, 1993, BLOOD PRESSURE HEART, P56; WESSELING KH, 1982, FUNKT BIOL MED, V1, P245; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Zijlstra FRH, 1985, CONSTRUCTION SUBJECT	46	30	31	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR	1999	9	2					189	205		10.1080/713755600			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	185ZJ	WOS:000079701300005					2021-06-18	
J	McKinely, BA; Parmley, CL; Tonneson, AS				McKinely, BA; Parmley, CL; Tonneson, AS			Standardized management of intracranial pressure: A preliminary clinical trial	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	25th Educational and Scientific Symposium of the Society-of-Critical-Care-Medicine	FEB 05-09, 1996	NEW ORLEANS, LA	Soc Crit Care Med		intracranial pressure (ICP); cerebral perfusion pressure (cpp); therapy algorithm; standardized protocol; computerized protocol; guidelines; severe head injury (SHI); traumatic brain injury (TBI); intensive care process	SEVERE HEAD-INJURY; MANNITOL	Objective: To test a standardized protocol for management of intracranial pressure (ICP) after severe head injury (i,e,, traumatic brain injury), consistent with published guidelines. Methods: We compared prospective use of a standardized protocol for ICP management in 12 patients with severe head injuries and retrospective ICP management using preprinted hospital orders in combination with ad hoc physician orders in 12 historical control patients with severe head injuries. With the standardized protocol, flow-chart decision logic diagrams were applied at patient bedside by critical care practitioners, with nursing shift review. Results: ICP and its variation during the first 6 intensive care unit days was less for the standardized protocol- than for the preprinted order-managed group (p <0.001), indicating better process control with the standardized protocol. ICP exceeded 25 mm Hg for less time for the standardized protocol group (182 hours; 15 +/- 23 hours/patient) than for prescribed order group (429 hours; 36 +/- 28 hours/patient) (p = 0.03). On average, ICP exceeded 20 mm Hg for 2.3 days for the standardized protocol-managed group and for 4.7 days for the prescribed order-managed group. Cerebral perfusion pressure was significantly greater and its variation less for the standardized protocol- than for the preprinted order-managed group, Fewer interventions were made for ICP management for the standardized protocol-than for the preprinted order-managed patients (601 vs. 876), suggesting more effective nursing time using the standardized protocol. Conclusion: ICP management was more consistent, and intracranial hypertension was better controlled, in patients managed according to a standardized, data-driven protocol for escalation and weaning of therapies in response to immediate patient needs, We recommend computerized implementation and a randomized clinical trial to compare the protocol with prescribed orders.	Univ Texas, Sch Med, Dept Anesthesiol, Houston, TX 77030 USA	McKinely, BA (corresponding author), Univ Texas, Sch Med, Dept Anesthesiol, 6431 Fannin,MSB 5-020, Houston, TX 77030 USA.	bmckinle@anes1.med.uth.tmc.edu					Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock MR, 1996, J NEUROTRAUM, V13, P719; Bullock R, 1995, New Horiz, V3, P448; Chesnut R M, 1995, New Horiz, V3, P581; Chesnut RM, 1998, CRIT CARE MED, V26, P210, DOI 10.1097/00003246-199802000-00009; EAST TD, 1991, INT J CLIN MONIT COM, V8, P263, DOI 10.1007/BF01739127; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GENTILELLO L, 1988, CRIT CARE MED, V16, P783, DOI 10.1097/00003246-198808000-00010; Ghajar J, 1995, New Horiz, V3, P395; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Granath P, 1997, J CONSTR STEEL RES, V42, P1, DOI 10.1016/S0143-974X(97)00021-7; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Lang E W, 1995, New Horiz, V3, P400; Marion D W, 1995, New Horiz, V3, P439; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Morris A H, 1996, Proc AMIA Annu Fall Symp, P418; MORRIS AH, 1997, PRINCIPLES PRACTICE, P1355; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Prielipp R C, 1995, New Horiz, V3, P456; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sailors R M, 1996, Proc AMIA Annu Fall Symp, P234; TILLETT JM, 1993, CRIT CARE MED, V21, P1005, DOI 10.1097/00003246-199307000-00014; Tonnesen A S, 1995, New Horiz, V3, P499; WALD SL, 1995, SURG CLIN N AM, V75, P225, DOI 10.1016/S0039-6109(16)46585-0; Wallace C J, 1995, Proc Annu Symp Comput Appl Med Care, P810; Wilberger J E, 1995, New Horiz, V3, P469; WILSON JA, 1994, J NEUROSURG ANESTH, V6, P139; Zornow M H, 1995, New Horiz, V3, P488	31	30	30	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	1999	46	2					271	279		10.1097/00005373-199902000-00013			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	166TT	WOS:000078593800015	10029033				2021-06-18	
J	Reitan, RM; Wolfson, D				Reitan, RM; Wolfson, D			The two faces of mild head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL DEFICIT SCALE; TRAUMATIC BRAIN INJURY; CROSS-VALIDATION; SEQUELAE; RECOVERY; ADULTS	The research literature indicates that the great majority of persons who sustain any initial neuropsychological impairment from a mild head injury recover in 1 to 3 months. Nevertheless, clinicians report that some persons with a mild head injury demonstrate signs and report symptoms suggesting that they have sustained permanent brain damage. Although this latter group contains the participants of principal clinical interest, our literature review did not identify any research that provided a comprehensive description of the neuropsychological characteristics of this important subgroup Of mild head-injured persons. The present investigation compared four groups: (1) controls, (2) persons with definite traumatic brain tissue damage, (3) persons with mild head injuries routinely accessed into a research study, and (4) persons with mild head injuries who had persisting clinical signs and symptoms. The same comprehensive neuropsychological test battery was used to evaluate all four groups. All pairs of groups differed significantly in neuropsychological status, with Group 3 showing only mild impairment (approaching the level of the controls) and Group 4 showing significant impairment (approaching the level of the group with definite brain tissue damage). The results emphasize the need for a comprehensive neuropsychological examination of persons with mild head injuries who have persisting clinical problems. (C) 1999 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Reitan Neuropsychol Lab, Tucson, AZ 85713 USA	Reitan, RM (corresponding author), Reitan Neuropsychol Lab, 2920 S 4th Ave, Tucson, AZ 85713 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DACEY RG, 1993, HEAD INJURY, P159; Devinsky O, 1996, J EPILEPSY, V9, P94, DOI 10.1016/0896-6974(95)00076-3; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin HS, 1989, MILD HEAD INJURY; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCCAFFREY RJ, 1997, PRACTICE FORENSIC NE; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; OESTREICHER JM, 1995, ARCH CLIN NEUROPSYCH, V10, P185; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; REITAN RM, 1997, MALINGERING DETECTIO; REITAN RM, 1998, MILD HEAD INJURY INT; Reitan RM, 1988, TRAUMATIC BRAIN INJU, VII; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; ROJAS DC, 1995, ARCH CLIN NEUROPSYCH, V10, P101, DOI 10.1016/0887-6177(94)E0038-Q; Ruff R.M., 1989, MILD HEAD INJURY, P176; SHERER M, 1993, ARCH CLIN NEUROPSYCH, V8, P429, DOI 10.1016/0887-6177(93)90006-M; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WOLFSON D, 1995, ARCH CLIN NEUROPSYCH, V10, P125, DOI 10.1016/0887-6177(94)E0037-P; Wolfson D., 1993, HALSTEAD REITAN NEUR; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	35	30	30	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	1999	14	2					191	202		10.1016/S0887-6177(98)00012-2			12	Psychology, Clinical; Psychology	Psychology	168EJ	WOS:000078678200003	14590602	Bronze			2021-06-18	
J	Pieter, W; Zemper, ED				Pieter, W; Zemper, ED			Incidence of reported cerebral concussion in adult taekwondo athletes	JOURNAL OF THE ROYAL SOCIETY OF HEALTH			English	Article						taekwondo; cerebral concussion; injury	CHRONIC BRAIN-DAMAGE; AMATEUR BOXING LEAD; INJURIES; KARATE	The purpose of the present study was to assess the exact conditions under which cerebral concussions occur in full-contact taekwondo competition. Injury data were collected by project staff and tournament medical personnel with simple check-off forms that describe the athlete and nature, site, circumstances and severity of the injury. The Mann-Whitney U test was used to determine the difference in injury rate between men and women. The men (7.04/1,000 athlete-exposures) sustained more cerebral concussions than the women (2.42/1,000 athlete-exposures) (p<0.001). The dominant injury mechanism in both the males and females was receiving a blow (6.46/1,000 athlete-exposures and 2.42/1,000 athlete-exposures for the men and women, respectively).	Univ N London, Sch Hlth & Sports Sci, London N7 8DB, England; Exercise Res Associates Oregon ExRA, Eugene, OR USA	Pieter, W (corresponding author), Univ N London, Sch Hlth & Sports Sci, 166-220 Holloway Rd, London N7 8DB, England.						Birrer R B, 1983, Br J Sports Med, V17, P131; BLIJD C, 1995, 1995 ICHPER SD 38 WO; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CHAPMAN PJ, 1989, AM J SPORT MED, V17, P690, DOI 10.1177/036354658901700518; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; Johannsen H V, 1988, Br J Sports Med, V22, P113; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; JORDAN BD, 1988, ARCH NEUROL-CHICAGO, V45, P1207, DOI 10.1001/archneur.1988.00520350045014; JORRITSMA LSM, 1987, VEILIGHEID BOKSEN; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; MCCLATCHIE GR, 1980, J TRAUMA, V20, P956; MCLATCHIE GR, 1976, BR J ACC SURG, V8, P132; MCLATCHIE GR, 1994, CLIN PRACTICE SPORTS, P609; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OLER M, 1991, J TRAUMA, V31, P251, DOI 10.1097/00005373-199131020-00017; Pieter F., 1995, BIOL SPORT, V12, P257; Pieter W., 1994, Journal of Sports Traumatology and Related Research, V16, P49; PIETER W, 1996, 199L INT PREOLYMP SC; PIETER W, 1997, SCI COACHING OLYMPIC; Pieter W, 1995, J HUM MOVEMENT STUD, V28, P1; PIETER W, 1996, EPIDEMIOLOGY SPORTS, P268; PIETER W, 1995, 1995 ICHPER SD 38 WO; PIETER W, 1995, SPORTGEZONDHEIDSZORG; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Ryan A J, 1983, Phys Sportsmed, V11, P49, DOI 10.1080/00913847.1983.11708702; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; SMITH PK, 1987, BIOMECHANICS, V3, P57; STRICEVIC MV, 1983, AM J SPORT MED, V11, P320, DOI 10.1177/036354658301100507; SYMONDS C, 1962, LANCET, V1, P1; WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207; Zemper E D, 1989, Br J Sports Med, V23, P161; Zemper E. D., 1991, INT C EXP SPORTS MED	37	30	32	0	6	ROYAL SOC OF HEALTH	LONDON	38A ST, GEORGES DR, LONDON SW1V 4BH, ENGLAND	0264-0325			J ROY SOC HEALTH	J. R. Soc. Health	OCT	1998	118	5					272	279		10.1177/146642409811800512			8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	230HN	WOS:000082245900012	10076687				2021-06-18	
J	Perry, VH; Bolton, SJ; Anthony, DC; Betmouni, S				Perry, VH; Bolton, SJ; Anthony, DC; Betmouni, S			The contribution of inflammation to acute and chronic neurodegeneration	RESEARCH IN IMMUNOLOGY			English	Article; Proceedings Paper	12th Macrophage Conference	SEP 17-19, 1998	PARIS, FRANCE	Inst Pasteur, European Macrophage Study Grp		CNS; neurodegeneration; Alzheimer's disease; Parkinson's disease; inflammation; review	INDUCED NEURONAL DEGENERATION; TISSUE-PLASMINOGEN ACTIVATOR; TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; MICROGLIAL RESPONSE; ISCHEMIC STROKE; NERVOUS-SYSTEM; RECRUITMENT; SCRAPIE; EXPRESSION		Univ Southampton, Sch Biol Sci, CNS Inflammat Grp, Southampton SO16 7PX, Hants, England	Perry, VH (corresponding author), Univ Southampton, Sch Biol Sci, CNS Inflammat Grp, Bassett Crescent E, Southampton SO16 7PX, Hants, England.		Perry, V. Hugh/Y-2935-2019; Anthony, Daniel C/F-7765-2010	Anthony, Daniel C/0000-0003-1380-6655; Bolton, Sarah/0000-0002-6098-6903			ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Anthony DC, 1998, CURR BIOL, V8, pR274, DOI 10.1016/S0960-9822(98)70171-X; Anthony DC, 1997, NEUROPATH APPL NEURO, V23, P406, DOI 10.1111/j.1365-2990.1997.tb01315.x; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Betmouni S, 1996, NEUROSCIENCE, V74, P1, DOI 10.1016/0306-4522(96)00212-6; BETMOUNI S, 1998, IN PRESS PSYCHOBIOLO; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BTMOUNI S, 1998, IN PRESS NEUROPATH A; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; CHOI DW, 1992, CEREBROVASC DIS, P187; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; Clark WM, 1996, CNS DRUGS, V6, P90, DOI 10.2165/00023210-199606020-00002; DEARMOND SJ, 1993, CURR OPIN NEUROL, V6, P872, DOI 10.1097/00019052-199312000-00008; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MCFARLIN DE, 1971, NATURE, V233, P336, DOI 10.1038/233336a0; MCGEER PL, 1992, NEUROLOGY, V42, P447, DOI 10.1212/WNL.42.2.447; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; PRUSINER SG, 1996, SCI AM, V272, P30; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Schnell L, 1997, EUR J NEUROSCI, V9, P1000, DOI 10.1111/j.1460-9568.1997.tb01450.x; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1997, J NEUROSCI, V17, P543; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; WILLIAMS AE, 1994, NEUROPATH APPL NEURO, V20, P47, DOI 10.1111/j.1365-2990.1994.tb00956.x; WILLIAMS AE, 1995, ACTA NEUROPATHOL, V90, P164, DOI 10.1007/BF00294316	34	30	30	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0923-2494			RES IMMUNOL	Res. Immunol.	SEP-OCT	1998	149	7-8					721	725		10.1016/S0923-2494(99)80046-7			5	Immunology	Immunology	141XG	WOS:000077169100021	9851531				2021-06-18	
J	Roddy, SP; Cohn, SM; Moller, BA; Duncan, CC; Gosche, JR; Seashore, JH; Touloukian, RJ				Roddy, SP; Cohn, SM; Moller, BA; Duncan, CC; Gosche, JR; Seashore, JH; Touloukian, RJ			Minimal head trauma in children revisited: Is routine hospitalization required?	PEDIATRICS			English	Article; Proceedings Paper	56th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 19-21, 1996	HOUSTON, TEXAS	Amer Assoc Surg Trauma		trauma; brain injury; CT scan; pediatric injuries	INJURY; MANAGEMENT; SCANS; SCORE; RISK	Objective. Children with a question of occult head injury are routinely hospitalized despite having both normal central nervous system (CNS) and computed tomographic (CT) scan examinations. We determined the incidence of significant CNS morbidity after occult head injury to determine whether or not hospital admission was necessary in children after minimal head trauma. Methods. We reviewed the records of children admitted to a level I trauma center with a question of closed head injury, an initial Glasgow Coma Scale equal to 15, a normal neurologic exam, and a normal head CT scan. Children with associated injuries requiring admission were excluded. The endpoints were deterioration in CNS exam, new CT findings, and the need for a prolonged hospital stay. Results. Sixty-two patients were studied with a mean age of 7 years (range, 1 month to 15 years), and 65% were male. The primary mechanisms of injury were fall (45%) and vehicular crash (23%). The mean injury severity score was 4 +/- 2. The mean length of stay was 1.2 days (range, 1 to 3 days). Prolonged hospitalization occurred in 9 patients (15%). No child developed significant CNS sequelae warranting hospital admission. Total charges for these hospitalizations were $177 874. Conclusions. Children undergoing emergency department work-up of occult head injury, who have a normal CNS exam and a normal head CT scan, do not seem to be at risk for significant CNS sequelae. These patients can be discharged home with parental supervision and avoid unnecessary and costly hospitalization.	Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA	Cohn, SM (corresponding author), Univ Miami, Sch Med, Dept Surg, Div Trauma & Surg Crit Care, Miami, FL 33101 USA.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRUCE DA, 1980, CLIN PEDIATR, V19, P719, DOI 10.1177/000992288001901101; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DUNCAN CC, 1990, PEDIAT TRAUMA, P222; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Goldstein B, 1994, Pediatr Rev, V15, P213, DOI 10.1542/pir.15-6-213; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8	17	30	32	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	APR	1998	101	4					575	577		10.1542/peds.101.4.575			3	Pediatrics	Pediatrics	ZE903	WOS:000072843200001	9521936				2021-06-18	
J	Moriarty, LJ; Duerstock, BS; Bajaj, CL; Lin, KN; Borgens, RB				Moriarty, LJ; Duerstock, BS; Bajaj, CL; Lin, KN; Borgens, RB			Two- and three-dimensional computer graphic evaluation of the subacute spinal cord injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						macrophage; spinal cord injury; cavitation; 3-D morphometry; neurotrauma; computer graphics	CENTRAL-NERVOUS-SYSTEM; MONONUCLEAR PHAGOCYTES; MACROPHAGES; RAT; INFLAMMATION	We have evaluated three-week-old compression lesions of the rat spinal cord using two-dimensional and three-dimensional morphometry, reconstruction, and visualization techniques. We offer a new computer assisted method to determine the number and density of macrophages within the spinal lesion using the macrophage specific monoclonal label ED1. We also provide quantitative information on pathological cyst formation and cavitation. This technique does not require: (1) subjective identification of the cell type, (2) human interaction with the data during the phase of quantification, and (3) can be applied to any sampling paradigm based on immunocytochemical labeling. Using novel algorithms based on solutions to 'correspondence' and 'branching' problems inherent in cross-sectional histological data, we provide three-dimensional reconstructions and visualizations of the macrophagic lesions and cysts imbedded within it. Our three-dimensional surface reconstructions can be interrogated to determine volumes and surface areas of structures within the data set. Using these methods we have learned that macrophage numbers approach the maximum density possible for such isodiametric cells (similar to 12 mu m diameter) in the central lesion ranging from 4000-7000 cells per mm(2) of lesion. At the time point studied, macrophage numbers would have peaked following the initial insult, and would not be expected to decline for several months. While the density of macrophages is highest in the region of most tissue damage, we show that the central regions of cavitated and cystic spinal parenchyma is not. We discuss how this density of cells may effect the secondary pathological responses of the spinal cord to injury. (C) 1998 Elsevier Science B.V.	Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA; Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA	Borgens, RB (corresponding author), Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, 1244 VCPR, W Lafayette, IN 47907 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR509137] Funding Source: Medline		Bajaj C., 1996, P 5 INT IM ROUNDT SA, P169; Bajaj CL, 1996, GRAPH MODEL IM PROC, V58, P524, DOI 10.1006/gmip.1996.0044; BLIGHT A R, 1984, Society for Neuroscience Abstracts, V10, P887; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Blight AR, 1991, J NEUROTRAUM, V8, P103, DOI 10.1089/neu.1991.8.103; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1991, J NEUROL SCI, V106, P158, DOI 10.1016/0022-510X(91)90253-4; BLIGHT AR, 1993, ADV NEUROL, V59, P91; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DAVID S, 1990, NEURON, V5, P463, DOI 10.1016/0896-6273(90)90085-T; DAVIES P, 1979, J RETICULOENDOTH SOC, V26, P37; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; KAO CC, 1977, J NEUROSURG, V46, P197, DOI 10.3171/jns.1977.46.2.0197; LazarovSpiegler O, 1996, FASEB J, V10, P1296; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; PERRY VH, 1992, BIOESSAYS, V14, P401, DOI 10.1002/bies.950140610; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; POLMAN CH, 1986, J NEUROIMMUNOL, V11, P215, DOI 10.1016/0165-5728(86)90005-6; Reier P J, 1988, Adv Neurol, V47, P87; Reier PJ, 1983, SPINAL CORD RECONSTR, P163; STOCUM DL, 1995, WOUND REPAIR REGENER; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Waibl H., 1973, TOPOGRAPHIE MEDULLA; YOUNG W, 1995, CONT MANAGEMENT SPIN, P27	33	30	31	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	MAR 5	1998	155	2					121	137		10.1016/S0022-510X(97)00203-7			17	Clinical Neurology; Neurosciences	Neurosciences & Neurology	ZD999	WOS:000072746900001	9562256				2021-06-18	
J	Engberg, A; Teasdale, TW				Engberg, A; Teasdale, TW			Traumatic brain injury in children in Denmark: A national 15-year study	EUROPEAN JOURNAL OF EPIDEMIOLOGY			English	Article						Denmark; disability pension; epidemiology; mortality; traumatic brain injury	HEAD-INJURY; ADOLESCENTS; CHILDHOOD; DEATH	Demographic trends are reported concerning three types of traumatic brain injury (concussions, cranial fractures, and intracranial contusions/haemorrhages) among children in Denmark of ages up to and including 14 years, for a fifteen pear period from 1979 through 1993. The data were derived from a national computer-based hospitalization register and include 49,594 children, of whom 60% were boys and 89% had suffered a concussion. Virtually all injuries were the result of accidents. A major finding was that there has been a general decline in the incidence of traumatic brain injuries, especially for boys from 5 to 14 years old, suggesting a degree of success in preventive measures, particularly regarding road safety. The incidence of fatal cases of intracranial contusions/haemorrhages approximately halved over the 15 year period. However, as a proportion of all diagnosed cases, mortality from intracranial contusions/haemorrhages remained fairly constant at about 22%, perhaps because there have been no markedly successful innovations in acute care. Among children surviving a intracranial contusions/haemorrhages, rather considerable numbers were found to have been awarded disability pension at ages under 30.	Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark	Teasdale, TW (corresponding author), Univ Copenhagen, Psychol Lab, Njalsgade 88, DK-2300 Copenhagen S, Denmark.	Teasdale@axp.psl.ku.dk					ALS E, 1958, Ugeskr Laeger, V120, P857; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; BARQUERO AV, 1990, NEUROLOGIA, V5, P155; BERNEY J, 1995, CHILD NERV SYST, V11, P256, DOI 10.1007/BF00301755; Caveness W F, 1979, Adv Neurol, V22, P1; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; ENGBERG A, 1995, ACTA NEUROL SCAND, V92, P5, DOI 10.1111/j.1600-0404.1995.tb01701.x; GUDMUNDSSON KR, 1986, ICELANDIC HLTH REC S, P43; Hansen T B, 1991, Ugeskr Laeger, V153, P2944; JORGENSEN IM, 1995, DAN MED BULL, V42, P285; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MacKenzie E J, 1989, Md Med J, V38, P725; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Mikkelsen S S, 1991, Ugeskr Laeger, V153, P3239; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; PITT WR, 1994, J PAEDIATR CHILD H, V30, P114, DOI 10.1111/j.1440-1754.1994.tb00593.x; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; *SUNDH, 1981, DODS DANM; *SUNDH, 1981, SYG; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	27	30	30	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0393-2990	1573-7284		EUR J EPIDEMIOL	Eur. J. Epidemiol.	FEB	1998	14	2					165	173		10.1023/A:1007492025190			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	ZG292	WOS:000072986400009	9556176				2021-06-18	
J	McMillan, TM				McMillan, TM			Minor head injury	CURRENT OPINION IN NEUROLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN INJURY; WHIPLASH INJURY; SYMPTOMS; RECOVERY; AMNESIA; HYPOTHESIS; DEFICITS; MEMORY; RISK	The relationship between brief loss of consciousness, subsequent cognitive and emotional complaints, and impact on daily functioning continues to be hotly debated. The weight of current evidence suggests that uncomplicated minor head injury can cause acute cognitive impairment that is organic in aetiology, but late onset or persisting symptoms result from a psychological response. Traditionally, loss of consciousness has been a prerequisite for the definition of minor head injury but this has been challenged in recent years, although evidence does no more than draw attention to this question. Evidence to support the view that post-traumatic stress disorder can develop after head injury continues to grow. Outcomes in unselected mild head injury patients who attend hospital are not improved by provision of early follow-up. (C) Rapid Science Publishers.	St Georges Healthcare Trust, Ctr Neurosci, Wolfson Rehabil Ctr, London SW20 0NE, England; Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England	McMillan, TM (corresponding author), St Georges Healthcare Trust, Ctr Neurosci, Wolfson Rehabil Ctr, London SW20 0NE, England.						*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P424; BARRETT K, 1995, J ACCID EMERG MED, V12, P173; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLEDIN K, 1994, BRIT J MED PSYCHOL, V67, P125, DOI 10.1111/j.2044-8341.1994.tb01778.x; BONTKE C, 1996, J HEAD TRAUMA REHAB, V15, P95; BROOKS DN, 1996, NEUROLAW LETT, V6, P101; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DIXON P, 1993, BRIT J MED PSYCHOL, V66, P193, DOI 10.1111/j.2044-8341.1993.tb01741.x; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Jacobs A, 1996, J NUCL MED, V37, P1605; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; JENKINS A, 1986, LANCET, V2, P445; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KOLB LC, 1987, AM J PSYCHIAT, V144, P989; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MALT U, 1988, BRIT J PSYCHIAT, V150, P431; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; PEARCE JMS, 1993, J NEUROL NEUROSUR PS, V56, P1328, DOI 10.1136/jnnp.56.12.1328-a; PEARCE JMS, 1995, CLIN NEUROLOGY, P134; Peterson L G, 1986, Adv Psychosom Med, V16, P84; Radanov BP, 1996, SPINE, V21, P392, DOI 10.1097/00007632-199602010-00029; Radanov BP, 1996, EUR NEUROL, V36, P48, DOI 10.1159/000117200; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1992, NEUROLAW LETT, V1, P3; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; SYMONDS C, 1962, LANCET, P1; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; VAMEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	61	30	30	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	1997	10	6					479	483		10.1097/00019052-199712000-00008			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	YQ035	WOS:000071340900008	9425562				2021-06-18	
J	Sander, AM; Kreutzer, JS; Fernandez, CC				Sander, AM; Kreutzer, JS; Fernandez, CC			Neurobehavioral functioning, substance abuse, and employment after brain injury: Implications for vocational rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SEVERE HEAD-INJURY; PREDICTING RETURN; FOLLOW-UP; WORK	Objective: To characterize neurobehavioral and substance abuse problems distinguishing between employed and unemployed persons with brain injury and to propose relevant vocational rehabilitation interventions. Design: A quasi-experimental, fixed effects factorial design was used. T-tests were used to compare employed and unemployed persons regarding neurobehavioral factor scale scares. Chi-square analyses were used to compare alcohol use and rate of mental health treatment for the two groups. Fisher's Exact Test was used to compare drug use for the two groups. Setting: Outpatient rehabilitation clinic at a large urban medical center. Participants: Patients with traumatic brain injury who received acute medical care and inpatient rehabilitation at a level I trauma center. Patients were evaluated an average of 16 months after injury. The employed (33%) and unemployed (67%) groups were similar regarding age and chronicity, but unemployed persons had more severe injuries. Main Outcome Measures: Neurobehavioral Functioning Inventory (NFI), Quantity Frequency Variability Index (QFVI), General Health and History Questionnaire. Results: Unemployed persons reported a greater frequency of difficulties on the NFI Depression, Attention/Memory, Aggression, Communication, and Motor scales. The most common difficulties among unemployed persons related to mood, personality, and slowness. Also, more unemployed persons had received mental health services. A substantially higher proportion of employed persons were classified as moderate or heavy drinkers, whereas there were more abstainers among the unemployed group: A low rate of drug use was reported and differences between groups were not observed. Conclusions: The unique neurobehavioral difficulties of unemployed persons should be carefully considered when developing empirically based preplacement training, job matching, and postplacement interventions. The high rate of alcohol use among employed persons indicates the need for follow-along that emphasizes education and prevention.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHYS MED & REHABIL, DIV NEUROL SURG, RICHMOND, VA 23298 USA							Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P642; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; GREENSPAN AI, 1996, ARCH PHYS MED REHAB, V10, P207; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Kreutzer J., 1987, GEN HLTH HIST QUESTI; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Mysiw W J, 1989, Brain Inj, V3, P27, DOI 10.3109/02699058909008070; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1984, CLOSED HEAD INJURY P; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SERIO CD, 1993, NEUROREHABILITATION, V4, P53; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	34	30	30	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1997	12	5					28	41		10.1097/00001199-199710000-00004			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YA515	WOS:A1997YA51500004					2021-06-18	
J	Teasdale, TW; Engberg, A				Teasdale, TW; Engberg, A			Duration of cognitive dysfunction after concussion, and cognitive dysfunction as a risk factor: a population study of young men	BRITISH MEDICAL JOURNAL			English	Article							MINOR HEAD-INJURY; SECULAR TRENDS; INTELLIGENCE; SYMPTOMS; SEQUELAE; RECOVERY	Objectives: To establish how long cognitive dysfunction lasts after concussion, and the extent to which it may be a predisposing risk factor for concussion, by examining the prevalence of cognitive dysfunction among young men who have sustained concussion. Design: Observational study. Setting: Denmark. Subjects: 1220 young men who had been admitted to hospital for concussion between the ages of 16 and 24 (identified in a national register of admissions) and who had also been cognitively tested by the Danish conscription draft board. Main outcome measure: Score on the draft board's cognitive screening test, dichotomised as dysfunctional or non-dysfunctional (20.4% of the general population of Danish men appearing before the draft board had a dysfunctional score). Results: 700 of the 1220 men had been tested after sustaining concussion; 520 had been tested before concussion. Four (50%) of the eight men who were tested less than seven days after the injury had a dysfunctional score. Among groups of the remaining 692 men who were tested at later time points after injury, the rates were only marginally raised (range 21.4% to 26.5%) above the population level. Among men tested before injury, the rate of dysfunctional scores was higher (30.4% (158/520)). Apart from suggesting cognitive dysfunction as a risk factor for concussion, this higher proportion seems to relate to the fact that they were typically injured as young adults, whereas those men who were tested after concussion had more often been injured as adolescents. The relative risk for concussion in the presence of cognitive dysfunction is estimated to be 1.57 (95% confidence interval 1.32 to 1.86). Conclusions: Cognitive dysfunction is not only a short term consequence of concussion but also a predisposing risk factor for concussion, more so for young adults than for adolescents.	ODENSE UNIV HOSP,DEPT NEUROL,DK-5000 ODENSE C,DENMARK	Teasdale, TW (corresponding author), UNIV COPENHAGEN,PSYCHOL LAB,NJALSGADE 88,DK-2300 COPENHAGEN S,DENMARK.						BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Duus B R, 1991, Ugeskr Laeger, V153, P2111; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; GRONWALL D, 1974, LANCET, V2, P605; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JENNETT B, 1989, MANAGEMENT HEAD INJU; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KRAUS JF, 1989, MILD HEAD INJURY; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lidvall H F, 1974, Acta Neurol Scand Suppl, V56, P3; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; TEASDALE TW, 1994, SCAND J PSYCHOL, V35, P328, DOI 10.1111/j.1467-9450.1994.tb00957.x; TEASDALE TW, 1987, NATURE, V325, P119, DOI 10.1038/325119a0	19	30	30	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 6	1997	315	7108					569	572					4	Medicine, General & Internal	General & Internal Medicine	XV717	WOS:A1997XV71700022	9302952				2021-06-18	
J	Manchester, D; Hodgkinson, A; Casey, T				Manchester, D; Hodgkinson, A; Casey, T			Prolonged, severe behavioural disturbance following traumatic brain injury: What can be done?	BRAIN INJURY			English	Article							HEAD-INJURY; REHABILITATION; RELATIVES; SERVICES	At the end of 1994 the New South Wales Department of Health identified the need for a specialized unit for people with a brain injury who exhibited aggressive and violent behaviour at such a level that they could not be cared for in standard rehabilitation programmes and who were not mentally ill as defined by the Mental Health Act. An interim unit based on the principles of neurobehavioural rehabilitation was opened in the grounds of Lidcombe Hospital, and in January 1995 the first patient (SA) was admitted. Following intervention weekly aggression decreased from a peak of 159 incidents to zero after ten months. Other maladaptive behaviours also decreased markedly. Simultaneous attempts to improve adaptive behaviours were successful. At 11 months follow-up in the community, these gains were all noted to have been maintained. This article discusses the need for specialized units dealing with severe behavioural problems following head injury, presents the case of SA for illustrative purposes, and addresses some of the more common criticisms of such environments.	STEPPING HILL HOSP,DEPT PSYCHOL,STOCKPORT,ENGLAND							ANDERSON DW, 1980, J NEUROSURGERY S, V53; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BULLARD H, 1988, MED SCI LAW, V28, P312, DOI 10.1177/002580248802800410; BURGESS PW, 1990, COGNITIVE REHABILITA; BURKE DC, 1995, BRAIN INJURY, V9, P735, DOI 10.3109/02699059509008229; COLOND JS, 1995, AM J MENT RETARD, V100, P201; DIRMEN S, 1993, BRAIN INJURY, V7, P113; Drinkwater J, 1989, CLIN APPROACHES VIOL, P287; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; EMERSON E, 1987, MENTAL HANDICAP, V15, P166; Gaskell GD, 1995, BRIT J SOC PSYCHOL, V34, P383; GILES GM, 1988, REHABILITATION SEVER; GLOAG D, 1985, BRIT MED J, V290, P913, DOI 10.1136/bmj.290.6472.913; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; LONDON PS, 1967, ANN ROY COLL SURG, V41, P479; MANCHESTER D, 1997, IN PRESS BRAIN INJUR; MANCHESTER D, 1993, BRIT MED J      0717, P384; MAROSSZEKY JE, 1994, BEHAV MANAGEMENT UNI; MARTIN MA, 1991, AUSTR NZ J DEV DISAB, V17, P201; MILLER L, 1990, COGNITIVE REHABI NOV, P14; MURPHY G, 1991, MENT HANDICAP RES, V4, P44; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; SACHDEV PS, 1991, MED J AUSTRALIA, V155, P75, DOI 10.5694/j.1326-5377.1991.tb142129.x; TATE RL, 1987, SCAND J REHABIL MED, V19, P13; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANMINNEN A, 1993, BRIT J DEV DISABIL, V39, P126, DOI 10.1179/bjdd.1993.015; WOOD J, 1989, MENT HANDICAP RES, V2, P3; Wood R. L. L., 1981, APPL CONDITIONING TH; Wood R. L. L., 1984, CLOSED HEAD INJURY P; WOOD RL, 1967, BRIAN INJURY REHABIL; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	32	30	31	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1997	11	8					605	617		10.1080/026990597123296			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	XL930	WOS:A1997XL93000005	9251868				2021-06-18	
J	Rubin, Y; Cecil, K; Wehrli, S; McIntosh, TK; Lenkinski, RE; Smith, DH				Rubin, Y; Cecil, K; Wehrli, S; McIntosh, TK; Lenkinski, RE; Smith, DH			High-resolution H-1 NMR spectroscopy following experimental brain trauma	JOURNAL OF NEUROTRAUMA			English	Article						acetate; brain injury; fluid percussion; N-acetyl aspartate; nuclear magnetic resonance	ACETYL-L-ASPARTATE; NUCLEAR-MAGNETIC-RESONANCE; H-1-NMR SPECTROSCOPY; N-ACETYLASPARTATE; INJURY; RAT; DISEASE; LACTATE; FLUID; METABOLISM	We investigated acute metabolic changes following parasagittal fluid-percussion brain injury in the rat, using high-resolution H-1 nuclear magnetic resonance (NMR) spectroscopy. Sixty minutes following brain injury or sham (surgery, no injury) treatment, brains were rapidly removed and the injured and control cortices were isolated (n = 5/group). Isolates of brain cortices were then placed in buffer and studied in a 400-MHz spectrometer with measurements taken every 15 min over a 145-min period. At the initial NMR evaluation (immediately following dissection), we observed significantly lower levels of N-acetyl aspartic acid (NAA) in the injured group compared to the sham group. Surprisingly, a reciprocal increase in the concentration of acetate, a major metabolic product of NAA, was not observed at this timepoint. At subsequent timepoints, a progressive loss of NAA was observed in both injured and sham cortices, presumably due to ischemic conditions of the ex vivo samples. However, this progressive loss of NAA was now accompanied by a commensurate accumulation of acetate. These results suggest that (I) a decrease in the concentration of NAA occurs by 1 h following experimental brain trauma, potentially marking traumatic neural injury; (2) the initial absence of an expected reciprocal increase in acetate concentration may signify rapid utilization of acetate following trauma, potentially for reparative processes; and (3) in contrast to trauma alone, post mortem ischemic conditions may induce an increase in acetate concentrations.	UNIV PENN,DEPT NEUROSURG,DIV NEUROSURG,PHILADELPHIA,PA 19104; HOSP UNIV PENN,DEPT RADIOL,PHILADELPHIA,PA 19104; CHILDRENS HOSP,NMR CORE FACIL,PHILADELPHIA,PA 19104			Lenkinski, Robert/F-9045-2014; smith, douglas/A-1321-2007	Cecil, Kim/0000-0001-8233-5485; Lenkinski, Robert/0000-0001-7371-5048	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R01NS026818, R55NS026818, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26818, NS08803] Funding Source: Medline		AUSTIN SJ, 1991, MAGNET RESON MED, V19, P439, DOI 10.1002/mrm.1910190235; BENUCK M, 1968, BIOCHIM BIOPHYS ACTA, V152, P611, DOI 10.1016/0005-2760(68)90101-X; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P799, DOI 10.1016/0730-725X(93)90197-L; COHEN Y, 1991, MAGNET RESON MED, V17, P225, DOI 10.1002/mrm.1910170125; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; DADAMO AF, 1973, J NEUROCHEM, V20, P1275, DOI 10.1111/j.1471-4159.1973.tb00097.x; DUNLOP DS, 1992, BRAIN RES, V580, P44, DOI 10.1016/0006-8993(92)90925-Y; HUGG JW, 1993, ANN NEUROL, V34, P788, DOI 10.1002/ana.410340606; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; KAUL M, 1991, J NEUROCHEM, V56, P192; KLUNK WE, 1992, NEUROLOGY, V42, P1578, DOI 10.1212/WNL.42.8.1578; KNIZLEY H, 1967, J BIOL CHEM, V242, P4619; KRIWACKI RW, 1989, PHARMACEUT RES, V6, P531, DOI 10.1023/A:1015941128608; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; MYERHOFF DJ, 1993, NEUROLOGY, V43, P509; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; PAULUS W, 1990, J NEUROL SCI, V95, P49, DOI 10.1016/0022-510X(90)90116-5; PEDEN CJ, 1993, DEV MED CHILD NEUROL, V35, P502; PETROFF OAC, 1988, J NEUROCHEM, V51, P163, DOI 10.1111/j.1471-4159.1988.tb04850.x; PLAITAKIS A, 1993, BRAIN RES BULL, V30, P381, DOI 10.1016/0361-9230(93)90269-H; PRICHARD JW, 1986, ANNU REV NEUROSCI, V9, P61; RICHARDS TL, 1991, AM J ROENTGENOL, V157, P1073, DOI 10.2214/ajr.157.5.1927795; Rothman DL, 1994, NMR PHYSL BIOMEDICIN, P353; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SUTTON LN, 1994, J NEUROSURG, V81, P443, DOI 10.3171/jns.1994.81.3.0443; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, MAGNET RESON MED, V7, P95, DOI 10.1002/mrm.1910070111	33	30	34	0	5	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	1997	14	7					441	449		10.1089/neu.1997.14.441			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	XP778	WOS:A1997XP77800002	9257662				2021-06-18	
J	Lee, ST; Lui, TN; Wong, CW; Yeh, YS; Tzaan, WC; Chen, TY; Hung, SY; Wu, CT				Lee, ST; Lui, TN; Wong, CW; Yeh, YS; Tzaan, WC; Chen, TY; Hung, SY; Wu, CT			Early seizures after severe closed head injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							PROGNOSIS; CONSCIOUSNESS; FEATURES; EPILEPSY; TRAUMA; MILD	Background: We studied the incidence and clinical significance of early post-traumatic seizures after severe closed head injury. Methods: This prospective study is based on clinical observation of 3340 adult patients with severe closed head injuries, each of them having a Glasgow Coma Scale (GCS) 3 to 8 after trauma. Anticonvulsant agents were not given to these patients unless there was evidence of seizure. Results: One hundred and twenty-one patients (3.6%) experienced seizures within 1 week after head injury; 42 of these (1.26% of the series) had seizures within 24 hours after trauma. The incidence of intracerebral parenchymal damage was found to be higher among those patients who developed seizures in the first week (66.1%) than in those who did not (62.7%). However this result did not reach statistical significance, The patients with early seizures had a lower mortality rate (p < 0.01). In patients who survived from the initial injury, the occurrence of early post-traumatic seizures did not appear to influence the neurological recovery at 6 months after injury. Conclusion: Presence of intracerebral parenchymal damage on CT scan after severe closed head injury does not increase the risk of early post-traumatic seizures. With proper treatment, patients presenting with early seizures may have a lower mortality rate. However, the occurrence of early seizures does not influence the neurological recovery in patients who survive the initial severe closed head injury.	CHANG GUNG MEM HOSP,CHANG GUNG MED COLL,TAYUAN 333,TAIWAN	Lee, ST (corresponding author), CHANG GUNG MEM HOSP,DEPT NEUROSURG,5 FU SHING ST,TAYUAN 333,TAIWAN.			Wu, Chieh-Tsai/0000-0002-8419-3764			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P2327; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CAVENESS WF, 1961, EPILEPSIA, V2, P123; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; DASILVA AM, 1990, ACT NEUR S, V50, P48; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; ELVIDGE AR, 1960, INJURIES BRAIN SPINA, P285; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Guidice M A, 1987, Brain Inj, V1, P61; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; Jennett B, 1979, Acta Neurochir Suppl (Wien), V28, P149; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; JENNETT B, 1981, MANAGEMENT HEAD INJU, P301; Jennett B, 1975, EPILEPSY NONMISSILE; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; MISES J, 1976, EPILEPSIA, V11, P37; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; TEASDALE G, 1974, LANCET, V2, P81; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	36	30	32	0	2	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	FEB	1997	24	1					40	43		10.1017/S0317167100021077			4	Clinical Neurology	Neurosciences & Neurology	WH812	WOS:A1997WH81200007	9043746	Bronze			2021-06-18	
J	Zapata, A; Capdevila, JL; Tarrason, G; Adan, J; Martinez, JM; Piulats, J; Trullas, R				Zapata, A; Capdevila, JL; Tarrason, G; Adan, J; Martinez, JM; Piulats, J; Trullas, R			Effects of NMDA-R1 antisense oligodeoxynucleotide administration: Behavioral and radioligand binding studies	BRAIN RESEARCH			English	Article						NMDA receptor; antisense oligodeoxynucleotide; elevated plus maze; anxiety; seizure	TRAUMATIC BRAIN INJURY; D-ASPARTATE ANTAGONIST; RECEPTOR COMPLEX; CEREBROCORTICAL NEURONS; FUNCTIONAL ANTAGONISTS; NANOMOLAR AFFINITY; RAT-BRAIN; ACID; EXCITOTOXICITY; PHENCYCLIDINE	The effects of an antisense phosphodiester oligodeoxynucleotide (ODN) directed to the NR1 subunit of the NMDA receptor mRNA and of its corresponding sense ODN were investigated in mice, Treatment with the antisense ODN significantly increased the time mice spent in the open arms of an elevated maze while the total number of arm entries was unaltered. Furthermore, seizure latencies after the administration of an ED100 dose of NMDA (150 mg/kg) were significantly higher in antisense treated animals compared to vehicle controls. At the same time, treatment with NR1 antisense ODN significantly reduced the B-max of [H-3]CGS-19755 binding (2101 fmol/mg protein) compared to both vehicle (2787 fmol/mg protein) and sense (2832+/-39 fmol/mg protein) controls without any significant change in K-D (33 nM). A corresponding reduction of [H-3]CGP-39653 binding was also observed after treatment with NR1 antisense compared to both sense and vehicle controls. In contrast, neither antisense nor sense ODNs altered the proportion of high affinity glycine sites or the potency of glycine at either high or low affinity glycine binding sites to inhibit [H-3]CGP-39653 binding. These results show that in vivo treatment with NR1 antisense ODNs to the NMDA receptor complex reduces antagonist binding al NMDA receptors and has pharmacological effects similar to those observed with some NMDA receptor antagonists. These results also suggest that treatment with antisense ODNs may provide another means to investigate allosteric modulation of receptor subtypes in vivo.	CSIC, INST INVEST BIOMED, DEPT BIOANALIT MED, UNITAT NEUROBIOL, ES-08034 BARCELONA, SPAIN; MERCK FARMA & QUIM SA, BARCELONA, SPAIN			Trullas, Ramon/D-2197-2016	Trullas, Ramon/0000-0001-7951-9881			ALLEN HL, 1990, SCIENCE, V247, P221, DOI 10.1126/science.2403696; BENNETT DA, 1990, PROG CLIN BIOL RES, V361, P519; BENNETT DA, 1986, LIFE SCI, V39, P2455, DOI 10.1016/0024-3205(86)90488-1; BENNETT DA, 1989, J PHARMACOL EXP THER, V250, P454; CHIASSON BJ, 1994, CELL MOL NEUROBIOL, V14, P507, DOI 10.1007/BF02088834; CROUCHER MJ, 1982, SCIENCE, V216, P899, DOI 10.1126/science.7079744; DANYSZ W, 1995, BEHAV PHARMACOL, V6, P455; DUNN RW, 1992, EUR J PHARMACOL, V214, P207, DOI 10.1016/0014-2999(92)90120-S; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HARGREAVES RJ, 1994, ACTA NEUROCHIR, P15; ISHII T, 1993, J BIOL CHEM, V268, P2836; KEHNE JH, 1991, EUR J PHARMACOL, V193, P283, DOI 10.1016/0014-2999(91)90141-C; KINDY MS, 1994, NEUROSCI RES COMMUN, V14, P175; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LAYER RT, 1995, PHARMACOL BIOCHEM BE, V52, P621, DOI 10.1016/0091-3057(95)00155-P; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maj J, 1993, Pol J Pharmacol, V45, P349; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723; MELDRUM BS, 1994, NEUROLOGY, V44, P14; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOTULSKY HJ, 1987, FASEB J, V1, P365; MURPHY DE, 1988, BRIT J PHARMACOL, V95, P932, DOI 10.1111/j.1476-5381.1988.tb11723.x; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PLAZNIK A, 1994, EUR NEUROPSYCHOPHARM, V4, P503, DOI 10.1016/0924-977X(94)90299-2; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; RUNDFELDT C, 1994, BRAIN RES, V653, P125, DOI 10.1016/0006-8993(94)90380-8; SILLS MA, 1991, EUR J PHARMACOL, V192, P19, DOI 10.1016/0014-2999(91)90063-V; SOLTESZ I, 1994, NEUROSCI LETT, V181, P5, DOI 10.1016/0304-3940(94)90547-9; SUN FY, 1995, BRAIN RES, V693, P163, DOI 10.1016/0006-8993(95)00731-5; TRULLAS R, 1989, PHARMACOL BIOCHEM BE, V34, P313, DOI 10.1016/0091-3057(89)90317-1; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WAHLESTEDT C, 1994, TRENDS PHARMACOL SCI, V15, P42, DOI 10.1016/0165-6147(94)90107-4; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; WINSLOW JT, 1990, EUR J PHARMACOL, V190, P11, DOI 10.1016/0014-2999(90)94107-9; YANG GY, 1994, NEUROSURGERY, V34, P339, DOI 10.1097/00006123-199402000-00018; YEE F, 1994, CELL MOL NEUROBIOL, V14, P475, DOI 10.1007/BF02088832	40	30	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 16	1997	745	1-2					114	120		10.1016/S0006-8993(96)01134-1			7	Neurosciences	Neurosciences & Neurology	WX974	WOS:A1997WX97400012	9037399				2021-06-18	
J	Chambers, J; Cohen, SS; Hemminger, L; Prell, JA; Nichols, JS				Chambers, J; Cohen, SS; Hemminger, L; Prell, JA; Nichols, JS			Mild traumatic brain injuries in low-risk trauma patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						mild traumatic brain injury; conclusion; screening; blunt trauma; cognitive deficit	MINOR HEAD-INJURY; POSTCONCUSSION SYMPTOMS; SEQUELAE	Background: Moderate or severe traumatic brain injury (TBI) resulting from cranial trauma is usually easily recognizable, Mild TBI (MTBI), however, may escape detection at presentation because of delayed symptoms and the absence of radiographic abnormalities, Despite its subtle or delayed presentation, the spectrum of symptoms often experienced after MTBI, collectively referred to as ''postconcussive syndrome,'' may cause serious psychosocial dysfunction. Methods/Results: To assess the sensitivity of emergency department screening for MTBI, a prospective follow-up study was conducted on a group of patients (N = 129) who had been evaluated at a regional trauma center after blunt trauma, None had symptoms or signs of TBI at presentation, nor any history of direct cranial trauma, All were discharged to home from the emergency department without a diagnosis of TBI, At 1 month after injury, 41 of 129 (32%) patients described an increase in symptoms consistent with MTBI. The most common symptoms were insomnia (62%), headaches (58%), irritability (56%) and fatigue (56%). At 2 months, most symptoms had decreased significantly, and none had increased in severity. Despite improvement in their symptoms over that time period, 11% of those with persistent symptoms remained unable to resume their premorbid daily activities, Conclusions: These data, obtained from a population of patients considered to be at extremely low risk for TBI, indicate that MTBI occurs more often among blunt trauma patients than is commonly appreciated, even in busy trauma centers. Because early recognition of MTBI may expedite referral of these patients for appropriate outpatient follow-up care, thereby avoiding potentially serious social and financial repercussions, emergency department personnel should have a high index of suspicion for MTBI in any patient sustaining blunt systemic trauma. Current measures that screen for MTBI appear to be inadequate; follow-up protocols may prove to be more sensitive screening tools.	UNIV COLORADO,HLTH SCI CTR,INTERMT NEUROSURG & NEUROSCI,DENVER,CO 80204; UNIV COLORADO,HLTH SCI CTR,PROVENANT ST ANTHONY CENT HOSP,DENVER,CO 80204; UNIV COLORADO,HLTH SCI CTR,DIV NEUROSURG,DENVER,CO 80204							ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BOLLOK I, 1983, NEUROPEPTIDES, V3, P263; CARTLIDGE NEF, 1978, INJURY, V10, P73; Colohan A. R. T., 1986, J HEAD TRAUMA REHAB, V1, P13; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; ENDERSON BL, 1991, SURG CLIN N AM, V71, P399; FISCHER RP, 1981, J TRAUMA, V21, P920, DOI 10.1097/00005373-198111000-00002; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1974, LANCET, V2, P604; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; Jennett B, 1978, Practitioner, V221, P77; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LONG CJ, 1986, SOUTHERN MED J, V79, P728, DOI 10.1097/00007611-198606000-00020; Mahon D, 1989, J Neurosci Nurs, V21, P382; Maio T, 1980, J Med Soc N J, V77, P637; Mattice C, 1994, J Emerg Nurs, V20, P48; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; *NATL HEAD INJ FDN, 1993, INT HEAD INJ TASK FO; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Veltman R H, 1993, J Neurosci Nurs, V25, P367; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	28	30	31	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	1996	41	6					976	980		10.1097/00005373-199612000-00006			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	VY407	WOS:A1996VY40700007	8970549				2021-06-18	
J	Ater, JL; Moore, BD; Francis, DJ; Castillo, R; Slopis, J; Copeland, DR				Ater, JL; Moore, BD; Francis, DJ; Castillo, R; Slopis, J; Copeland, DR			Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: Utilization of a neurological severity score	JOURNAL OF CHILD NEUROLOGY			English	Article							CENTRAL NERVOUS-SYSTEM; BRAIN-TUMOR PATIENTS; CLOSED HEAD-INJURY; CRANIAL IRRADIATION; CHILDHOOD; MEDULLOBLASTOMA; QUALITY; INFANTS; CANCER; CHEMOTHERAPY	Neuropsychological studies of children who have brain tumors have yielded diverse results with respect to identifying factors that contribute to poor intellectual outcome. The purpose of this study was to evaluate the relationship between pre- and perioperative events, tumor-related factors, and the neuropsychological status of children diagnosed with astrocytoma. Events that could potentially be detrimental to neuropsychological outcome were quantified utilizing a new ''neurological severity score.'' The Neurological Severity Score was developed as a research tool to test our hypothesis that ultimate intellectual outcome is a result of cumulative, interactive insults on the central nervous system. This study constitutes a first step in examining the predictive value of the Neurological Severity Score by evaluating its correlation with baseline neuropsychological status. Fifty-nine children who had astrocytoma (36 supratentorial and 23 infratentorial) received complete neurological and neuropsychological evaluations within 3 months of diagnosis. Each child's neurological history and examination results were scored by an independent observer using the Neurological Severity Score. Neuroimages obtained at diagnosis and at the time of neuropsychological testing were evaluated as well. For the group as a whole, memory, attention, and motor abilities were significantly below age-appropriate norms, whereas intelligence, language, and academic skills were preserved. Patterns of deficits were identified and related to tumor site. There were no significant differences in mean neuropsychological domain scores between groups based on gender, pre- versus post-operative status, ethnicity, tumor grade, or abnormalities on magnetic resonance imaging (MRI). The Neurological Severity Score was significantly inversely correlated with visual-spatial skills, memory, attention, performance IQ, and global IQ. Ln conclusion, among all the medical and neurological factors present at diagnosis, the neurological severity score had the highest correlation with neuropsychological scores. This instrument has promise as a research tool in investigations of the psychological effects of cancer and its treatment on children.	UNIV HOUSTON,DEPT PSYCHOL,HOUSTON,TX	Ater, JL (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PEDIAT,DIV PEDIAT,BOX 87,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.			Francis, David/0000-0003-3944-3274	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-33097] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA033097] Funding Source: NIH RePORTER		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; Ater Joann L., 1993, Cancer Bulletin (Houston), V45, P351; BARAM TZ, 1987, CANCER, V60, P173, DOI 10.1002/1097-0142(19870715)60:2<173::AID-CNCR2820600209>3.0.CO;2-F; Beery KE, 1967, DEV TEST VISUAL MOTO; BLEYER WA, 1990, CA-CANCER J CLIN, V40, P355, DOI 10.3322/canjclin.40.6.355; BROOKSHIRE B, 1991, NEUROSURGERY, V17, P887; BUSCHKE H, 1974, J EXP CHILD PSYCHOL, V18, P488, DOI 10.1016/0022-0965(74)90126-X; COPELAND DR, 1992, CA-CANCER J CLIN, V42, P283, DOI 10.3322/canjclin.42.5.283; DUNN LM, 1970, PEABODY INDIVIDUAL A; ELLENBERG L, 1987, NEUROSURGERY, V21, P638, DOI 10.1227/00006123-198711000-00006; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1987, J LEARN DISABIL, V20, P526, DOI 10.1177/002221948702000904; FLETCHER JM, 1988, J CLIN EXP NEUROPSYC, V10, P495, DOI 10.1080/01688638808408255; FLETCHER JM, 1985, J EXP CHILD PSYCHOL, V40, P244, DOI 10.1016/0022-0965(85)90088-8; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; HIRSCH JF, 1989, J NEUROSURG, V70, P568, DOI 10.3171/jns.1989.70.4.0568; HOCHBERG FH, 1980, NEUROLOGY, V30, P172, DOI 10.1212/WNL.30.2.172; Hollingshead A.B., 1957, 2 FACTOR INDEX SOCIA; HOPPEHIRSCH E, 1990, CHILD NERV SYST, V6, P60, DOI 10.1007/BF00307922; Jastak S, 1984, WIDE RANGE ACHIEVEME; KUN LE, 1983, J NEUROSURG, V58, P1, DOI 10.3171/jns.1983.58.1.0001; KUN LE, 1983, AM J CLIN ONCOL-CANC, V6, P651; LEBARON S, 1988, CANCER, V62, P1215, DOI 10.1002/1097-0142(19880915)62:6<1215::AID-CNCR2820620629>3.0.CO;2-C; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MADAMSWAIN A, 1991, CLIN PSYCHOL REV, V1, P267; McCarthy D., 1972, MCCARTHY SCALES CHIL; MOORE BD, 1992, J CHILD NEUROL, V7, P281, DOI 10.1177/088307389200700308; MOSTOW EN, 1991, J CLIN ONCOL, V9, P592, DOI 10.1200/JCO.1991.9.4.592; MULHERN RK, 1989, J CLIN ONCOL, V7, P1660, DOI 10.1200/JCO.1989.7.11.1660; MULHERN RK, 1992, MED PEDIATR ONCOL, V20, P181, DOI 10.1002/mpo.2950200302; MULHERN RK, 1988, J CHILD NEUROL, V3, P47, DOI 10.1177/088307388800300111; MULHERN RK, 1985, MED PEDIATR ONCOL, V13, P318, DOI 10.1002/mpo.2950130604; PACKER RJ, 1983, CHILD BRAIN, V10, P393; PACKER RJ, 1987, MED PEDIATR ONCOL, V15, P241, DOI 10.1002/mpo.2950150505; PACKER RJ, 1987, PEDIATR NEUROSCI, V13, P169, DOI 10.1159/000120325; RADCLIFFE J, 1992, ANN NEUROL, V32, P551, DOI 10.1002/ana.410320411; Reitan RM., 1969, MANUAL ADM NEUROPSYC; RIS MD, 1994, J CLIN EXP NEUROPSYC, V16, P21, DOI 10.1080/01688639408402615; Sattler J.M., 1988, ASSESSMENT CHILDRENS, V3rd; STEHBENS J A, 1991, Neuropsychology Review, V2, P147, DOI 10.1007/BF01109052; SUTTON LN, 1987, PEDIATR NEUROSCI, V13, P98, DOI 10.1159/000120311; THORNDIKE RL, 1986, STANFORDBINET INTELL; Wechsler D., 1974, MANUAL WECHSLER INTE	44	30	32	0	2	DECKER PERIODICALS INC	HAMILTON	4 HUGHSON STREET SOUTH PO BOX 620, LCD 1, HAMILTON ON L8N 3K7, CANADA	0883-0738			J CHILD NEUROL	J. Child Neurol.	NOV	1996	11	6					462	469		10.1177/088307389601100610			8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	VW886	WOS:A1996VW88600009	9120225				2021-06-18	
J	Balcer, LJ; Galetta, SL; Bagley, LJ; Pakola, SJ				Balcer, LJ; Galetta, SL; Bagley, LJ; Pakola, SJ			Localization of traumatic oculomotor nerve palsy to the midbrain exit site by magnetic resonance imaging	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article								PURPOSE: To present the magnetic resonance imaging findings for a patient with traumatic oculomotor nerve injury. METHODS: We examined a patient with a right pupil-involving oculomotor nerve palsy after severe closed head trauma. RESULTS: Magnetic resonance imaging of the brain demonstrated marked signal hypointensity on gradient-echo T-2*-weighted images consistent with hemorrhage at the midbrain exit site of the right oculomotor nerve. CONCLUSIONS: Distal fascicular damage or partial rootlet avulsion is a mechanism of injury in some traumatic oculomotor nerve palsies. Gradient echo T-2*-weighted magnetic resonance imaging is the most sensitive method to detect hemorrhagic changes associated with shearing injury.	UNIV PENN,SCH MED,DEPT NEURORADIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT OPHTHALMOL,PHILADELPHIA,PA 19104	Balcer, LJ (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,3 W GATES BLDG,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.						ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; ATLAS SW, 1991, MAGNETIC RESONANCE I, P439; HEINZE J, 1969, MED J AUSTRALIA, V2, P1246, DOI 10.5694/j.1326-5377.1969.tb103371.x; WALTER KA, 1994, NEUROLOGY, V44, P148, DOI 10.1212/WNL.44.1.148	4	30	31	0	2	OPHTHALMIC PUBL CO	CHICAGO	77 WEST WACKER DR, STE 660, CHICAGO, IL 60601	0002-9394			AM J OPHTHALMOL	Am. J. Ophthalmol.	SEP	1996	122	3					437	439		10.1016/S0002-9394(14)72078-1			3	Ophthalmology	Ophthalmology	VF620	WOS:A1996VF62000023	8794724				2021-06-18	
J	Bigler, ED; Blatter, DD; Johnson, SC; Anderson, CV; Russo, AA; Gale, SD; Ryser, DK; Macnamara, SE; Bailey, BJ				Bigler, ED; Blatter, DD; Johnson, SC; Anderson, CV; Russo, AA; Gale, SD; Ryser, DK; Macnamara, SE; Bailey, BJ			Traumatic brain injury, alcohol and quantitative neuroimaging: Preliminary findings	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; ATROPHY; DEFICITS; VOLUME; GRAY	Magnetic resonance (MR) quantitative neuroimaging analysis was undertaken with a large group of normal (n = 197) and traumatically brain injured (TBI, n = 99) adults. Of the TBI subjects 18 patients were identified with a history of substance-related abuse (TBI/Abuse group). Both the TBI/Abuse group and the remaining sample of TBI patients (n = 81, TBI/Non-abuse group) without a history of substance-related abuse differed significantly from the control group on most quantitative MR imaging analyses. The TBI/Abuse group displayed the greatest degree of atrophic change. However, the TBI/Abuse group had a significantly lower Glasgow Coma Scale (GCS) score, ostensibly suggesting that those with substance-related abuse suffered more severe brain injury than non-abuse TBI patients. When a subset (n = 18) of the TBI/Non-abuse group was matched by GCS, gender and age to the TBI/Abuse group, both groups differed significantly from the control group on most morphometric measures, but did not differ from one another. Results are discussed in terms of the potential adverse role that substance-related abuse, particularly alcohol, plays in the individual who sustains traumatic injury to the brain.	LDS HOSP,SALT LAKE CITY,UT	Bigler, ED (corresponding author), BRIGHAM YOUNG UNIV,DEPT PSYCHOL,POB 25543,PROVO,UT 84602, USA.						ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BADSBERGJENSEN G, 1993, LANCET, V342, P1201; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1994, FUNCTIONAL NEUROIMAG, P121; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; CHARNESS ME, 1993, ALCOHOL CLIN EXP RES, V17, P2, DOI 10.1111/j.1530-0277.1993.tb00718.x; CHICK JD, 1989, ALCOHOL CLIN EXP RES, V13, P512, DOI 10.1111/j.1530-0277.1989.tb00369.x; ECKARDT M J, 1988, Advances in Alcohol and Substance Abuse, V7, P59; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GALE SD, 1995, J INT NEUROPSYCH SOC, V1, P162; GALE SD, 1994, THESIS B YOUNG U PRO; GLUCKSMAN E, 1994, BRIT MED BULL, V50, P76, DOI 10.1093/oxfordjournals.bmb.a072886; Gronwall Dorothy, 1990, HEAD INJURY FACTS GU; JERNIGAN TL, 1991, NEUROPSYCHOPHARMACOL, V4, P175; JERNIGAN TL, 1991, ARCH GEN PSYCHIAT, V48, P881; JERNIGAN TL, 1982, PSYCHIAT RES, V7, P9, DOI 10.1016/0165-1781(82)90048-8; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; JOYCE EM, 1994, BRIT MED BULL, V50, P99, DOI 10.1093/oxfordjournals.bmb.a072888; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LOVINGER DM, 1993, ALCOHOL CLIN EXP RES, V17, P19, DOI 10.1111/j.1530-0277.1993.tb00720.x; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; Osborn AG, 1994, DIAGNOSTIC NEURORADI; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; ROSENTHAL M, 1993, J HEAD TRAUMA REHABI, V8; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; SALAZAR AM, CHALLENGES NEUROLOGY, P55; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SHEAR PK, 1994, ALCOHOL CLIN EXP RES, V18, P172, DOI 10.1111/j.1530-0277.1994.tb00899.x; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Wechsler D, 1981, WECHSLER MEMORY SCAL	40	30	30	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR	1996	10	3					197	206		10.1080/026990596124511			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UC765	WOS:A1996UC76500003	8777391				2021-06-18	
J	Rosomoff, HL; Kochanek, PM; Clark, R; DeKosky, ST; Ebmeyer, U; Grenvik, ANA; Marion, DW; Obrist, W; Palmer, AM; Safar, P; White, RJ				Rosomoff, HL; Kochanek, PM; Clark, R; DeKosky, ST; Ebmeyer, U; Grenvik, ANA; Marion, DW; Obrist, W; Palmer, AM; Safar, P; White, RJ			Resuscitation from severe brain trauma	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	International Resuscitation Research Conference (IRRC 94)	MAY 07-09, 1994	PITTSBURGH, PA			anoxia; trauma; brain injury; critical illness; hypothermia; ischemia; intracranial pressure; cerebral blood flow; cerebral edema	CEREBRAL BLOOD-FLOW; NERVE GROWTH-FACTOR; PROLONGED CARDIAC-ARREST; SEVERE HEAD-INJURIES; MODERATE HYPOTHERMIA; DOGS; RAT; METABOLISM; HYPOPERFUSION; INTERLEUKIN-1	Severe traumatic brain injuries are extremely heterogeneous. At least seven of the secondary derangements in the brain that have been identified as occurring after most traumatic brain injuries also occur after cardiac arrest. These secondary derangements include posttraumatic brain ischemia. In addition, traumatic brain injury causes insults not present after cardiac arrest, i.e., mechanical tissue injury (including axonal injury and hemorrhages), followed by inflammation, brain swelling, and brain herniation. Brain herniation, in the absence of a mass lesion, is due to a still-to-be-clarified mix of edema and increased cerebral blood flow and blood volume. Glutamate release immediately after traumatic brain injury is proven. Late excitotoxicity needs exploration. Inflammation is a trigger for repair mechanisms. In the 1950s and 1960s, traumatic brain injury with coma was treated empirically with prolonged moderate hypothermia and intracranial pressure monitoring and control. Moderate hypothermia (30 degrees to 32 degrees C), but not mild hypothermia, can help prevent increases in intracranial pressure. How to achieve optimized hypothermia and rewarming without delayed brain herniation remains a challenge for research. Deoxyribonucleic acid (DNA) damage and triggering of programmed cell death (apoptosis) by trauma de serve exploration. Rodent models of cortical contusion are being used effectively to clarify the molecular and cellular responses of brain tissue to trauma and to study axonal and dendritic injury. However, in order to optimize therapeutic manipulations of posttraumatic intracranial dynamics and solve the problem of brain herniation, it may be necessary to use traumatic brain injury models in large animals (e.g., the dog), with long-term intensive care. Stepwise measures to prevent lethal brain swelling after traumatic brain injury need experimental exploration, based on the multifactorial mechanisms of brain swelling. Novel treatments have so far influenced primarily healthy tissue; future explorations should benefit damaged tissue in the penumbra zones and in remote brain regions. The prehospital arena is unexplored territory for traumatic brain injury research.	UNIV PITTSBURGH, SAFAR CTR RESUSCITAT RES, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, WESTERN PSYCHIAT INST & CLIN, DEPT PSYCHIAT, PITTSBURGH, PA 15213 USA; UNIV MAGDEBURG, DEPT ANESTHESIOL & CRIT CARE MED, D-39120 MAGDEBURG, GERMANY; UNIV PITTSBURGH, MED CTR, MULTIDISCIPLINARY CRIT CARE TRAINING PROGRAM, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, PRESBYTERIAN UNIV HOSP, MED CTR, DEPT NEUROL SURG, PITTSBURGH, PA 15213 USA; UNIV PITTSBURGH, MED CTR, DEPT NEUROL SURG, PITTSBURGH, PA 15261 USA; WYETH RES UK, MAIDENHEAD, BERKS, ENGLAND; CASE WESTERN RESERVE UNIV, METROHLTH MED CTR, CLEVELAND, OH 44109 USA	Rosomoff, HL (corresponding author), UNIV MIAMI, SCH MED, DEPT NEUROL SURG, COMPREHENS PAIN & REHABIL CTR, 600 ALTON RD, MIAMI, FL 33139 USA.		Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021; Palmer, Alan/AAP-8650-2020	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758			AMES A, 1968, AM J PATHOL, V52, P437; BECKSTEAD JE, 1978, STROKE, V9, P569, DOI 10.1161/01.STR.9.6.569; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BOUMA GJ, 1992, INTRACRANIAL PRESSUR, V8, P529; BROWN GW, 1954, ARCH NEUROL-CHICAGO, V71, P77; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; Dekosky S. T., 1994, Society for Neuroscience Abstracts, V20, P193; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DEKOSKY ST, 1994, J NEUROTRAUMA, V11, P106; EBMEYER U, 1994, RESUSCITATION, V28, pS13; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; KUBOYAMA K, 1994, RESUSCITATION, V27, P231, DOI 10.1016/0300-9572(94)90037-X; LABORIT H, 1954, PRACTICE HIBERNATION; LEONOV Y, 1992, STROKE, V23, P45, DOI 10.1161/01.STR.23.1.45; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LILJA A, 1993, 45TH P ANN M SCAND N; Lind B, 1975, Resuscitation, V4, P97, DOI 10.1016/0300-9572(75)90071-4; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; LOVE JT, 1989, CRIT CARE MED, V17, pS146; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1993, J NEUROSURG, V78, pA347; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1993, J CEREB BLOOD FLO S1, V13, pS571; OKU K, 1994, RESUSCITATION, V27, P141, DOI 10.1016/0300-9572(94)90007-8; OKU K, 1993, STROKE, V24, P1590, DOI 10.1161/01.STR.24.10.1590; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; ROSOMOFF HL, 1957, ARCH NEURO PSYCHIATR, V78, P454, DOI 10.1001/archneurpsyc.1957.02330410018002; ROSOMOFF HL, 1960, SURG GYNECOL OBSTET, V110, P27; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; ROSOMOFF HL, 1956, J NEUROSURG, V13, P332; ROSOMOFF HL, 1959, ANN NY ACAD SCI, V80, P475, DOI 10.1111/j.1749-6632.1959.tb49225.x; ROSOMOFF HL, 1966, RESPIRATORY THERAPY, P243; SAFAR P, 1993, ANN EMERG MED, V22, P324, DOI 10.1016/S0196-0644(05)80463-9; SAFAR P, 1962, Arch Phys Med Rehabil, V43, P487; SAFAR P, 1988, CARDIOPULMONARY CERE; SAFAR P, 1995, CARDIAC ARREST, pCH49; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SNYDER JV, 1975, STROKE, V6, P21, DOI 10.1161/01.STR.6.1.21; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; STERZ F, 1992, RESUSCITATION, V24, P27, DOI 10.1016/0300-9572(92)90171-8; TSUBOKAWA T, 1994, NEUROCHEMICAL MONITO; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WOLFSON SK, 1992, RESUSCITATION, V23, P1, DOI 10.1016/0300-9572(92)90158-9; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	60	30	33	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	1996	24	2		S			S48	S56					9	Critical Care Medicine	General & Internal Medicine	TW260	WOS:A1996TW26000005	8608706				2021-06-18	
J	vanReekum, R; Links, PS; Finlayson, MAJ; Boyle, M; Boiago, I; Ostrander, LA; Moustacalis, E				vanReekum, R; Links, PS; Finlayson, MAJ; Boyle, M; Boiago, I; Ostrander, LA; Moustacalis, E			Repeat neurobehavioral study of borderline personality disorder	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Article						borderline personality disorder; etiology; brain injury; cognition; case-control study	DIAGNOSTIC INTERVIEW; SCHIZOPHRENIA; IMPAIRMENT; DEFICITS; INJURY	Previous research has tentatively identified a large subgroup of patients with borderline personality disorder (BPD) with histories of developmental or acquired brain insults. Similarly, these studies have demonstrated a possible biological correlation between the severity of BPD and the number of previous brain insults. The possibility of frontal system cognitive dysfunction in BPD has been raised. This single-blind, case-control study of BPD showed that 13 of 24 subjects with BPD had suffered a brain insult. Correlations between neurodevelopmental/acquired brain injury score and the diagnostic interview for borderline (DIB) score (r = 0.47), and between frontal system cognitive functioning and DIB score (r = -0.37) were seen. Neurocognitive testing and comparison with a cohort of subjects with traumatic brain injury (TBI) showed a pattern of similar cognitive functioning between the 2 groups, with the only differences on individual tests being in the direction of worse functioning in the group with BPD on 2 tasks. These results support the hypotheses described above. The main limitation reflects the low numbers of subjects.	UNIV TORONTO,DEPT PSYCHIAT,TORONTO,ON,CANADA; WELLESLEY HOSP,TORONTO,ON,CANADA; MCMASTER UNIV,DEPT PSYCHIAT,HAMILTON,ON,CANADA; HAMILTON CIV HOSP,HAMILTON,ON,CANADA; CHEDOKE MCMASTER HOSP,ACQUIRED BRAIN INJURY PROGRAM,HAMILTON,ON,CANADA	vanReekum, R (corresponding author), BAYCREST CTR GERIATR CARE,DEPT PSYCHIAT,3560 BATHURST ST,N YORK,ON M6A 2E1,CANADA.						AKHTAR S, 1986, J CLIN PSYCHIAT, V47, P196; Albert M., 1980, NEW DIRECTIONS MEMOR, P403; ANDRULONIS PA, 1982, J NERV MENT DIS, V170, P670, DOI 10.1097/00005053-198211000-00006; ANDRULONIS PA, 1984, BRIT J PSYCHIAT, V144, P358, DOI 10.1192/bjp.144.4.358; ANDRULONIS PA, 1980, PSYCHIATRIC CLIN N A, V4, P47; ARMITAGE SG, 1946, PSYCHOL MONOGR, V60, P277; Army Individual Test Battery, 1944, MAN DIR SCOR; BENSON DF, 1975, PSYCHIATRIC ASPECTS; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; BURGESS JW, 1991, PSYCHIAT RES, V38, P77, DOI 10.1016/0165-1781(91)90054-S; BURGESS JW, 1992, PSYCHIAT RES, V42, P283, DOI 10.1016/0165-1781(92)90120-R; CORNELIUS JR, 1989, J PERSONALITY DISORD, V3, P19; Cummings JL, 1985, CLIN NEUROPSYCHIATRY; DAHL AA, 1985, PSYCHIATR DEV, V2, P109; DREWE EA, 1975, NEUROPSYCHOLOGIA, V13, P421, DOI 10.1016/0028-3932(75)90065-2; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREEDMAN M, 1986, BEHAV NEUROSCI, V100, P337, DOI 10.1037/0735-7044.100.3.337; GARDNER D, 1987, J NERV MENT DIS, V175, P177, DOI 10.1097/00005053-198703000-00009; GUNDERSON JG, 1981, AM J PSYCHIAT, V138, P896; HAMBLIN KT, 1992, 1992 AM PSYCH ASS AN; Heaton R. K, 1981, WISCONSIN CARD SORTI; Jastak S, 1984, WIDE RANGE ACHIEVEME; LEWINSOHN PM, 1973, UNPUB PSYCHOL ASSESS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LINKS PS, 1988, CAN J PSYCHIAT, V33, P336, DOI 10.1177/070674378803300504; LINKS PS, 1994, IN PRESS J NERV MENT; Luria A. R., 1966, HIGHER CORTICAL FUNC; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; MILNER B, 1970, BIOL MEMORY; OLEARY KM, 1991, AM J PSYCHIAT, V148, P106; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Pfohl B., 1989, STRUCTURED INTERVIEW; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; SOLOFF PH, 1983, COMPR PSYCHIAT, V24, P574, DOI 10.1016/0010-440X(83)90026-3; SPREEN O, 1965, J NERV MENT DIS, V140, P323, DOI 10.1097/00005053-196505000-00002; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TUPPER D, 1987, SOFT NEUROLOGICAL SI; VANREEKUM R, 1993, CAN J PSYCHIAT, V38, pS4; VANREEKUM R, 1993, J PSYCHIATR NEUROSCI, V18, P121; VANREEKUM R, IN PRESS BRAIN INJUR; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; ZANARINI MC, 1994, BIOL NEUROBEHAVIORAL; ZIMMEMAN M, 1989, ARCH GEN PSYCHIAT, V42, P682	46	30	30	0	3	CANADIAN PSYCHIATRIC ASSOC	OTTAWA	SUITE 200, 237 ARGYLE AVE, OTTAWA ON K2P 1B8, CANADA	1180-4882			J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	JAN	1996	21	1					13	20					8	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	TP746	WOS:A1996TP74600003	8580113				2021-06-18	
J	Wallis, RA; Panizzon, KL				Wallis, RA; Panizzon, KL			Felbamate neuroprotection against CA1 traumatic neuronal injury	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						traumatic brain injury; felbamate; long-term potentiation; CA1; hippocampus	LONG-TERM POTENTIATION; BRAIN INJURY; HEAD-INJURY; HYPOXIC PROTECTION; HIPPOCAMPAL SLICE; AMINO-ACIDS; RAT; HYPOGLYCEMIA; RECEPTORS; CHILDREN	Traumatic brain injury is a leading cause of disability and death. Since the anticonvulsant felbamate provides hypoxic neuroprotection, we investigated whether felbamate would provide protection against traumatic neuronal injury as well. Traumatic injury to CA1 neurons in hippocampal slices was induced by fluid percussion, and CA1 evoked response was monitored. Pre-treatment with felbamate was strongly protective against neuronal injury, and permitted CA1 antidromic population spike recovery to a mean 94 +/- 1% (S.E.M.) of initial amplitude, compared to unmedicated slices which regained only 15 +/- 6%. The felbamate EC(50) for this protection was 136 mg/l, and significant protection was found at felbamate concentrations similar to those reported in felbamate monotherapy for seizures. Significant protection was also defected when felbamate was initiated 15 min after trauma. Slices given brief post-trauma felbamate treatment could demonstrate long-term potentiation when assessed 8 h after trauma. These studies indicate that felbamate is neuroprotective against CA1 traumatic neuronal injury.	UNIV CALIF LOS ANGELES,DEPT NEUROL,LOS ANGELES,CA 90024	Wallis, RA (corresponding author), SEPULVEDA VAMC,NEURONAL INJURY LAB,16111 PLUMMER ST,SEPULVEDA,CA 91343, USA.						BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; DODSON WE, 1993, EPILEPSIA, V34, pS18, DOI 10.1111/j.1528-1157.1993.tb04590.x; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAUGHT E, 1993, NEUROLOGY, V43, P688, DOI 10.1212/WNL.43.4.688; JENSEN PK, 1993, EPILEPSIA, V34, pS25, DOI 10.1111/j.1528-1157.1993.tb04591.x; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; MCCABE RT, 1993, J PHARMACOL EXP THER, V264, P1248; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; NELLGARD B, 1992, EXP BRAIN RES, V92, P259; NIGHTINGALE SL, 1994, JAMA-J AM MED ASSOC, V272, P995, DOI 10.1001/jama.272.13.995; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Olney J, 1978, KAINIC ACID TOOL NEU, P95; PANIZZON KL, 1993, NEUROLOGY, V43, pA312; PAPAGAPIOU MP, 1990, J CEREBR BLOOD F MET, V10, P270, DOI 10.1038/jcbfm.1990.44; SCHURR A, 1984, BRAIN RES, V297, P357, DOI 10.1016/0006-8993(84)90576-6; SUGIYAMA K, 1989, NEUROSCIENCE, V32, P770; TASKER RC, 1992, J NEUROSCI, V12, P4298; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; WAGNER ML, 1990, EPILEPSIA, V31, P642; WALLIS RA, 1992, STROKE, V23, P547, DOI 10.1161/01.STR.23.4.547; WALLIS RA, 1993, NEUROREPORT, V4, P951, DOI 10.1097/00001756-199307000-00029; WALLIS RA, 1994, BRAIN RES, V664, P115, DOI 10.1016/0006-8993(94)91961-5; WASTERLAIN CG, 1992, EUR J PHARMACOL, V212, P275, DOI 10.1016/0014-2999(92)90343-3	26	30	30	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	DEC 29	1995	294	2-3					475	482		10.1016/0014-2999(95)00568-4			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	TP560	WOS:A1995TP56000013	8750708				2021-06-18	
J	CORRIGAN, JD; LAMBHART, GL; RUST, E				CORRIGAN, JD; LAMBHART, GL; RUST, E			A PROGRAM OF INTERVENTION FOR SUBSTANCE-ABUSE FOLLOWING TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							ALCOHOLISM SCREENING-TEST	This article describes a pilot programme initiated in 1991 to address the problems of substance abuse among persons who have experienced traumatic brain injury (TBI). The model of treatment is community-based, using an interdisciplinary staff with expertise in TBI, vocational rehabilitation, and substance abuse treatment, to support and enhance existing services in the client's own community. The primary method of intervention is resource and service coordination. Six principles that serve as the underpinnings of the model are described, as are core and supplemental services and staffing patterns. Innovative components of the programme include the theoretical model of changing addictive behaviours used to guide treatment, and the development of community teams to facilitate a coordinated and integrated approach. The programme has relatively low start-up costs and can serve both urban and rural populations. Clinical experience and initial programme evaluation results suggest that substance abuse and vocational rehabilitation goals can be effectively attained using this model of service delivery.	OHIO STATE UNIV, DEPT PHYS MED & REHABIL, COLUMBUS, OH USA			Corrigan, John D./E-2921-2011				BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; CORRIGAN JD, IN PRESS ARCH PHYSIC; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P27; Falik M, 1993, J Case Manag, V2, P39; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; KREUTZER JS, 1987, GENERAL HLTH HIST QU; MCCONNAUGHY EA, 1989, PSYCHOTHER, V26, P494, DOI 10.1037/h0085468; MCLELLAN AT, 1990, ADDICTION SEVERITY I; MILLER WR, 1991, STAGES CHANGE READIN; OLSEN DH, 1985, FACES, V3; OLSEN DH, 1982, FAMILY SATISFACTION; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; POKORNY AD, 1972, AM J PSYCHIAT, V129, P342, DOI 10.1176/ajp.129.3.342; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Roberts-DeGennaro M, 1993, J Case Manag, V2, P106; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SKINNER HA, 1984, ANN INTERN MED, V101, P847, DOI 10.7326/0003-4819-101-6-847; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; WILLER BS, 1993, BRAIN INJURY REHABIL; 1987, DIAGNOSTIC STATISTIC; 1992, GUIDE INTERDISCIPLIN	25	30	30	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1995	9	3					221	236		10.3109/02699059509008195			16	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QR499	WOS:A1995QR49900002	7606236				2021-06-18	
J	MAITZ, EA; SACHS, PR				MAITZ, EA; SACHS, PR			TREATING FAMILIES OF INDIVIDUALS WITH TRAUMATIC BRAIN INJURY FROM A FAMILY SYSTEMS PERSPECTIVE	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AUTHORITY; FAMILY SYSTEMS; POWER; REHABILITATION; TRAUMATIC BRAIN INJURY	ADOLESCENTS	Research and clinical experience continue to demonstrate the impact of a traumatic brain injury on the entire family system and the importance of incorporating the family in the treatment process. Many authors have advocated for family education and support; however, there is less discussion of family therapy for families of individuals with traumatic brain injury. As a result, it has been difficult to apply research findings and clinical impressions to family treatment strategies. This article describes key treatment issues-specifically, power and authority-from a family systems perspective. Treatment recommendations are discussed that incorporate the special needs of families of individuals with traumatic brain injury within a family systems model.		MAITZ, EA (corresponding author), CLIN NEUROPSYCHOL ASSOCIATES,PHILADELPHIA,PA, USA.						BREUNLIN DC, 1992, METAFRAMEWORKS TRANS; BURR W, 1979, CONTEMPORARY THEORIE, V2; CAMPLER P, 1990, COMMUNITY INTEGRATIO; DEPOMPEI R, 1987, COGN REHABIL; EVANS RL, 1991, ARCH PHYS MED REHAB, V72, P144; FALICOV C, 1988, FAMILY T CONTINUITY; GLICK I, 1987, MARITAL FAMILY THERA; GURMAN AS, 1991, HDB FAMILY THERAPY, V2; Guttman H., 1991, HDB FAMILY THERAPY, VII; Haley J., 1976, PROBLEM SOLVING THER; Hill R., 1949, FAMILIES STRESS; HOFFMAN L, 1981, F FAMILY THERAPY; KAY T, 1994, NEUROPSYCHIATRY TRAU; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KUBLERROSS E, 1962, DEATH DYING; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON M, 1958, J HEAD TRAUMA REHABI, V3, P6; MALTZ E, 1991, HEAD INJURY FAMILY M; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McGoldrick, 1980, FAMILY LIFE CYCLE FR; MCLAUGHLIN AM, 1985, COGNITIVE REHABI JAN, P14; Minuchin S., 1974, FAMILIES FAMILY THER; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; Nichols M. P., 1984, FAMILY THERAPY CONCE; OLSON D, 1988, FAMILY T CONTINUITY; POWER PW, 1985, REHABIL LIT, V46, P78; Rolland JS, 1987, FAMILY SYSTEMS MED, V5, P482, DOI DOI 10.1037/H0089735; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; SACHS PR, 1991, TREATING FAMILIES BR; SAUBER SR, 1993, DICT FAMILY PSYCHOL; SLATER EJ, 1987, PSYCHIAT ANN, V17, P786, DOI 10.3928/0048-5713-19871201-08; TELSMANN M, 1982, J MARITAL FAM THER; WILLIAMS J, 1991, HEAD INJURY FAMILY M; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; ZARSKI JJ, 1987, AM J FAM THER, V15, P62	37	30	30	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					1	11		10.1097/00001199-199504000-00003			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900003					2021-06-18	
J	THEODOROS, DG; MURDOCH, BE; STOKES, P				THEODOROS, DG; MURDOCH, BE; STOKES, P			A PHYSIOLOGICAL ANALYSIS OF ARTICULATORY DYSFUNCTION IN DYSARTHRIC SPEAKERS FOLLOWING SEVERE CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							AMYOTROPHIC LATERAL SCLEROSIS; MOTOR CONTROL; TRAUMATIC DYSARTHRIA; VOWEL DISTORTION; POSITION CONTROL; FORCE; IMPAIRMENTS	A physiological analysis of the lip and tongue function of a group of 18 severely closed-head injured (CHI) subjects was performed using lip and tongue force transduction systems. Lip and tongue strength, endurance and rate of repetitive movements were assessed on four non-speech tasks: maximum strength, sustained maximum strength, repetition of 10 maximum strength compressions, and maximum repetition rate. The values recorded were compared to those achieved by a soup of 18 non-neurologically impaired subjects, matched for age and sex, who served as the controls. The results of the study indicated that the CHI subjects demonstrated a significant impairment of lip and tongue function based on strength, endurance and rate bf repetitive movements, compared to the controls. While lip function was found to be significantly impaired on several measures of strength and endurance, tongue function was noted to be more severely compromised. The CHI subjects were found to exhibit a significantly reduced rate of repetitive movements of the lips and tongue. The results are discussed in relation to the effects of CHI on neuromuscular function and differential subsystem impairment in dysarthria. The clinical implications of these findings are also discussed in relation to the treatment of articulatory disturbances following severe CHI.	UNIV QUEENSLAND,DEPT SPEECH & HEARING,MOTOR SPEECH RES UNIT,BRISBANE,QLD 4072,AUSTRALIA			Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012				Abbs J. H., 1983, CLIN DYSARTHRIA, P21; ABBS JH, 1987, NEUROLOGY, V37, P394, DOI 10.1212/WNL.37.3.394; ABBS JH, 1978, UNPUB LIP CLOSING FO; ABBS JH, 1982, SPEECH MOTOR CONTROL, P159; BARLOW SM, 1983, J SPEECH HEAR RES, V26, P616, DOI 10.1044/jshr.2604.616; BARLOW SM, 1986, EXP NEUROL, V94, P699, DOI 10.1016/0014-4886(86)90248-7; BARLOW SM, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P53; BARLOW SM, 1984, NEUROLOGY, V34, P145, DOI 10.1212/WNL.34.2.145; BARLOW SM, 1990, J SPEECH HEAR RES, V33, P660, DOI 10.1044/jshr.3304.660; BARLOW SM, 1988, ASS RES OT ABSTR, V218; BROOKE M, 1989, QUANTIFICATION NEURO, P101; Darley F., 1975, MOTOR SPEECH DISORDE; DEPAUL R, 1988, NEUROLOGY, V38, P281, DOI 10.1212/WNL.38.2.281; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828, DOI 10.1044/jshr.2304.828; GRIMBY L, 1981, J PHYSIOL-LONDON, V316, P545, DOI 10.1113/jphysiol.1981.sp013805; HUNKER CJ, 1982, NEUROLOGY NY, V32, P755; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; Marquardt TP, 1990, TRAUMATIC BRAIN INJU, P181; MCCLOSKEY DI, 1983, MOTOR CONTROL MECHAN, P151; MCNEIL MR, 1990, J SPEECH HEAR RES, V33, P255, DOI 10.1044/jshr.3302.255; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; Netsell R., 1985, SPEECH LANGUAGE EVAL, P363; NORUSIS MJ, 1990, SPSS PC PLUS STATIST; PORTNOY RA, 1982, J SPEECH HEAR DISORD, V47, P324, DOI 10.1044/jshd.4703.324; ROBIN DA, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P173; ROBIN DA, 1992, J SPEECH HEAR RES, V35, P1239, DOI 10.1044/jshr.3506.1239; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; STIERWALT JG, 1994, C MOTOR SPEECH SEDON; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; ZIEGLER W, 1983, PHONETICA, V40, P63; ZIEGLER W, 1983, PHONETICA, V40, P312, DOI 10.1159/000261698	34	30	31	0	1	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1995	9	3					237	254		10.3109/02699059509008196			18	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QR499	WOS:A1995QR49900003	7606237				2021-06-18	
J	MAX, JE; SMITH, WL; LINDGREN, SD; ROBIN, DA; MATTHEIS, P; STIERWALT, J; MORRISEY, M				MAX, JE; SMITH, WL; LINDGREN, SD; ROBIN, DA; MATTHEIS, P; STIERWALT, J; MORRISEY, M			CASE-STUDY - OBSESSIVE-COMPULSIVE DISORDER AFTER SEVERE TRAUMATIC BRAIN INJURY IN AN ADOLESCENT	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						OBSESSIVE-COMPULSIVE DISORDER; TRAUMATIC BRAIN INJURY; CHILDREN AND ADOLESCENTS	HEAD-INJURY; DEPRESSION	The neurological underpinnings of obsessive-compulsive disorder (OCD) are still largely undetermined. We report a prospective case study of a young subject who developed OCD and impulsive aggression after traumatic brain injury. The implications are that frontal and temporal lobe lesions may be sufficient to precipitate OCD in the absence of clear striatal injury and that compulsivity and impulsivity may represent different psychophysiological states.	UNIV IOWA,DEPT RADIOL,IOWA CITY,IA 52242; UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT SPEECH PATHOL & AUDIOL,IOWA CITY,IA 52242	MAX, JE (corresponding author), UNIV IOWA,DEPT PSYCHIAT,200 HAWKINS DR,1876 JPP,IOWA CITY,IA 52242, USA.		Robin, Donald/F-2109-2010				ADAMS W, 1990, WIDE RANGE ASSESSMEN; BAXTER LR, 1990, J CLIN PSYCHIAT, V51, P61; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Benton A, 1989, MULTILINGUAL APHASIA; Benton A.L., 1983, CONTRIBUTIONS NEUROP; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; Damasio H., 1989, LESION ANAL NEUROPSY; DONOVAN NJ, 1994, AM J PSYCHIAT, V151, P618; Dunn L., 1981, PEABODY PICTURE VOCA; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; German D.J., 1986, TEST WORD FINDING; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Goodman WK, 1991, CHILDRENS YALE BROWN; HILLBOM E, 1960, ACTA PSYCHIAT NEUROL, V6142, P35; INSEL TR, 1992, ARCH GEN PSYCHIAT, V49, P739; KETTL PA, 1986, BRIT J PSYCHIAT, V149, P315, DOI 10.1192/bjp.149.3.315; KROLL L, 1993, J NERV MENT DIS, V181, P457, DOI 10.1097/00005053-199307000-00011; LINDGREN SD, 1984, PEDIATRIC ASSESSMENT; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; McElroy S. L., 1993, DEPRESSION, V1, P121; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; Michael AJ, 1988, J ANXIETY DISORD, V4, P353, DOI DOI 10.1016/0887-6185(88)90030-8; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; TEASDALE G, 1974, LANCET, V2, P81; *US DEP HLTH HUM S, 1989, INT HEAD INJ TASK FO; Wechsler D., 1991, WECHSLER INTELLIGENC	29	30	30	0	4	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	JAN	1995	34	1					45	49		10.1097/00004583-199501000-00012			5	Psychology, Developmental; Pediatrics; Psychiatry	Psychology; Pediatrics; Psychiatry	QD725	WOS:A1995QD72500013	7860455				2021-06-18	
J	CARREL, M; MOESCHLER, O; RAVUSSIN, P; FAVRE, JB; BOULARD, G				CARREL, M; MOESCHLER, O; RAVUSSIN, P; FAVRE, JB; BOULARD, G			AEROMEDICAL PREHOSPITAL NEUROTRAUMA CARE AND SECONDARY SYSTEMIC INSULTS TO THE INJURED BRAIN	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article								Advanced supportive therapy at the site of the accident, associated with direct transfer to a trauma centre increases survival and reduces morbidity rates. Patients with severe head injury, especially those with multiple injuries, often arrive in the emergency department with potentially causes of serious secondary systemic insults to the already injured brain, such as acute anemia (Hematocrit less-than-or-equal-to 30%), hypotension (systolic arterial pressure (Pa(sys)) less-than-or-equal-to 95 mmHg, 12,7 kPa), hypercapnia (Paco2 greater-than-or-equal-to 45 mmHg, 6 kPa) and/or hypoxemia (Pao2 less-than-or-equal-to 65 mmHg, 8,7 kPa). The incidence of such insults and their impact on mortality were studied in a group of 51 consecutive adults suffering from non penetrating severe head injury (Glasgow score less-than-or-equal-to 8, mean age 31 +/- 17 yrs) rescued by a medicalised helicopter. Each patient received medical care on the site of the accident by an anaesthesiologist of a university hospital (UH) complying with an advanced trauma life support protocol including intubation, hyperventilation with FIO2 = 1, restoration of an adequate Pa(sys) and direct transportation to the UH. Mean delay from call to arrival of the rescue team on the site was 15 +/- 5 min. Mean scene time was 32 +/- 10 min in cases not requiring extrication. Nineteen patients (Group I) were admitted without secondary systemic insults to the brain, 13 with isolated head injury, and 6 with multiple injuries, with a low Glasgow Outcome Score (GOS 1-3) of 42 % at 3 months. In 32 patients (Group II), despite advanced supportive measures a the scene of the accident and during transportation, one or more secondary systemic insults to the brain were detected upon arrival at the emergency room, one with isolated head injury, 31 with multiple injuries, with a bad GOS of 72 % at 3 months. We conclude that : 1) advanced trauma life support prevents from secondary systemic insults in the great majority of isolated severe head injured patients, 2) secondary systemic insults to the already injured brain are frequent in patients with multiple injuries and are difficult to avoid despite rapid aeromedical trauma care, 3) secondary systemic insults to the brain have a catastrophic impact on the outcome of severely head injured patients.	CHU VAUDOIS,SERV ANESTHESIOL,CH-1011 LAUSANNE,SWITZERLAND			Moeschler, Olivier/B-1694-2008					0	30	30	0	0	EDITIONS SCIENTIFIQUES ELSEVIER	PARIS CEDEX 15	141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1994	13	3					326	335		10.1016/S0750-7658(94)80041-3			10	Anesthesiology	Anesthesiology	NX499	WOS:A1994NX49900009	7992940				2021-06-18	
J	VANLOON, J; SHIVALKAR, B; PLETS, C; GOFFIN, J; TJANDRAMAGA, TB; FLAMENG, W				VANLOON, J; SHIVALKAR, B; PLETS, C; GOFFIN, J; TJANDRAMAGA, TB; FLAMENG, W			CATECHOLAMINE RESPONSE TO A GRADUAL INCREASE OF INTRACRANIAL-PRESSURE	JOURNAL OF NEUROSURGERY			English	Article						INTRACRANIAL PRESSURE; CEREBRAL PERFUSION PRESSURE; BRAIN DEATH; CATECHOLAMINE	TRAUMATIC BRAIN INJURY; HEAD-INJURY; CIRCULATING CATECHOLAMINES; SUBARACHNOID HEMORRHAGE; CEREBROSPINAL-FLUID; CUSHING RESPONSE; BLOOD-FLOW; PLASMA; MASS	To determine the catecholamine response to progressive intracranial hypertension, intracranial pressure (ICP) was raised gradually by continuous expansion of an epidural balloon in seven dogs. Hemodynamic parameters, ICP, and cerebral perfusion pressure (CPP) were monitored continuously and serum catecholamine levels began to rise when CPP was in the low-positive range (20 to 30 mm Hg), reaching a peak just after brain death (CPP less-than-or-equal-to 0 mm Hg). There was no correlation between ICP and the catecholamine peak. Compared to control values, the mean increase was 286-fold for epinephrine and 78-fold for norepinephrine. Temporally, the catecholamine peak corresponded well with the observed hemodynamic changes. These results suggest that ischemia in certain parts of the brain stem is responsible for the hemodynamic changes observed in intracranial hypertension (such as the Cushing response), and they show that catecholamines play an important role in these hemodynamic changes.	CATHOLIC UNIV,UNIV HOSP GASTHUISBERG,DEPT CARDIAC SURG,LOUVAIN,BELGIUM; CATHOLIC UNIV,UNIV HOSP GASTHUISBERG,DEPT CLIN PHARMACOL,LOUVAIN,BELGIUM	VANLOON, J (corresponding author), CATHOLIC UNIV,UNIV HOSP GASTHUISBERG,DEPT NEUROSURG,HERESTR 49,B-3000 LOUVAIN,BELGIUM.		Shivalkar, Bharati/A-4416-2013				BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; BRASHEAR RE, 1971, ARCH INTERN MED, V127, P748, DOI 10.1001/archinte.127.4.748; CARPENTER MB, 1983, HUMAN NEUROANATOMY, P571; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cushing H, 1903, AM J MED SCI, V125, P1017, DOI 10.1097/00000441-190306000-00006; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; DILRAJ A, 1992, NEUROSURGERY, V31, P42, DOI 10.1227/00006123-199207000-00007; DUCKER TB, 1968, J NEUROSURG, V28, P118, DOI 10.3171/jns.1968.28.2.0118; EVANS DE, 1976, J NEUROSURG, V45, P609, DOI 10.3171/jns.1976.45.6.0609; GOLDFIEN A, 1962, AM J PHYSIOL, V202, P205; GRAF CJ, 1978, J NEUROSURG, V49, P862, DOI 10.3171/jns.1978.49.6.0862; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; KIM YI, 1980, ARCH INT PHARMACOD T, V245, P129; KORTEWEG GCJ, 1957, J NEUROPHYSIOL, V20, P100; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; LANGFITT TW, 1964, J NEUROSURG, V21, P998, DOI 10.3171/jns.1964.21.11.0998; LEVY MN, 1968, AM J PHYSIOL, V215, P169; LEYDEN E, 1866, VIRCHOWS ARCH, V37, P519; LORENZ R, 1976, INTRACRANIAL PRESSUR, V3, P270; MARION DW, 1986, NEUROSURGERY, V18, P101, DOI 10.1227/00006123-198601000-00019; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856; NATELSON BH, 1985, ARCH NEUROL-CHICAGO, V42, P178, DOI 10.1001/archneur.1985.04060020096022; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Norris JW, 1989, NEUROLOGY GENERAL ME, P159; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; ROSNER MJ, 1982, HEAD INJURY BASIC CL, P103; SCHRADER H, 1985, ACTA NEUROL SCAND, V72, P283; SCHRADER H, 1985, ACTA NEUROL SCAND, V71, P453; SHANLIN RJ, 1988, J AM COLL CARDIOL, V12, P727, DOI 10.1016/S0735-1097(88)80065-2; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	35	30	30	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1993	79	5					705	709		10.3171/jns.1993.79.5.0705			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	MD733	WOS:A1993MD73300009	8410249				2021-06-18	
J	DONDERS, J				DONDERS, J			MEMORY FUNCTIONING AFTER TRAUMATIC BRAIN INJURY IN CHILDREN	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; ADOLESCENTS	Immediate and 45-minute delayed recall of a paragraph-length story and of a complex geometric figure were investigated in a sample of 30 children with traumatic brain injury. There was no significant difference between children with mild to moderate injuries and children with severe injuries with regard to general level of verbal recall. However, there was a trend for children with mild to moderate injuries to have better recall of visual information than children with severe injuries. Recall of verbally presented information deteriorated significantly over the 45-minute delay, regardless of injury severity. No such deterioration was found for recall of visually presented information. Clinical and research implications are discussed.		DONDERS, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Denman S.B., 1987, DENMAN NEUROPSYCHOLO; Denman S.B, 1984, DENMAN NEUROPSYCHOLO; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; PARENTE R, 1991, COGNITIVE REHABILITA, P147; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Wechsler D., 1974, MANUAL WECHSLER INTE; Wilson B.A, 1987, REHABILITATION MEMOR; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	16	30	31	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP-OCT	1993	7	5					431	437		10.3109/02699059309029686			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	MA172	WOS:A1993MA17200006	8401485				2021-06-18	
J	DYWAN, J; SEGALOWITZ, SJ; HENDERSON, D; JACOBY, L				DYWAN, J; SEGALOWITZ, SJ; HENDERSON, D; JACOBY, L			MEMORY FOR SOURCE AFTER TRAUMATIC BRAIN INJURY	BRAIN AND COGNITION			English	Article									BROCK UNIV, FAC EDUC, ST CATHARINES L2S 3A1, ONTARIO, CANADA; MCMASTER UNIV, DEPT PSYCHOL, HAMILTON L8S 4L8, ONTARIO, CANADA	DYWAN, J (corresponding author), BROCK UNIV, DEPT PSYCHOL, ST CATHARINES L2S 3A1, ONTARIO, CANADA.						ADAMS JH, 1975, HDB CLINICAL NEUROLO, V23, P35; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; BENTON A, 1985, CLIN NEUROPSYCHOLOGY, P151; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BENTON AL, 1980, AM PSYCHOL, V35, P176, DOI 10.1037/0003-066X.35.2.176; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BURKE DM, 1981, PSYCHOL BULL, V90, P513, DOI 10.1037/0033-2909.90.3.513; COHEN G, 1989, PSYCHOL AGING, V4, P10, DOI 10.1037/0882-7974.4.1.10; Cohen J., 1983, APPL MULTIPLE REGRES; CRAIK FIM, 1990, PSYCHOL AGING, V5, P148, DOI 10.1037/0882-7974.5.1.148; DELIS D, 1987, CALIFORNIA VERBAL LE; Delis D. C., 1988, CLIN NEUROPSYCHOL, V2, P88, DOI [10.1080/13854048808520100, DOI 10.1080/13854048808520100]; DESIMONE R, 1989, HDB NEUROPSYCHOLOGY, V2, P267; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.1111/j.1467-8624.1985.tb00160.x; DREWE E A, 1974, Cortex, V10, P159; DYWAN J, 1990, PSYCHOL AGING, V5, P379, DOI 10.1037/0882-7974.5.3.379; DYWAN J, 1992, FEB INT NEUR SOC M S; EVANS FJ, 1966, INT J CLIN EXP HYP, V14, P162, DOI 10.1080/00207146608412959; FANTIE BD, 1991, NEUROPSYCHOLOGY LAW, P186; Fuster J, 1989, PREFRONTAL CORTEX; Fuster J. M., 1987, FRONTAL LOBES REVISI, P109; GARDINER JM, 1977, J VERB LEARN VERB BE, V16, P45, DOI 10.1016/S0022-5371(77)80006-6; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; HASHTROUDI S, 1989, PSYCHOL AGING, V4, P106, DOI 10.1037/0882-7974.4.1.106; Heaton R. K, 1981, WISCONSIN CARD SORTI; Hyvarinen J., 1982, PARIETAL CORTEX MONK; Jacoby L.L., 1989, VARIETIES MEMORY CON, P391, DOI DOI 10.1002/ACP.2350050509; JACOBY LL, 1989, J PERS SOC PSYCHOL, V56, P326, DOI 10.1037/0022-3514.56.3.326; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P115, DOI 10.1037/0096-3445.118.2.115; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Jennett B, 1975, Ciba Found Symp, P309; Jennett B, 1981, MANAGEMENT HEAD INJU; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; JOHNSTON WA, 1985, J EXP PSYCHOL LEARN, V11, P3, DOI 10.1037/0278-7393.11.1.3; KELLEY CM, 1989, J EXP PSYCHOL LEARN, V15, P1101, DOI 10.1037/0278-7393.15.6.1101; KOLB B, 1983, CAN J PSYCHOL, V37, P8, DOI 10.1037/h0080697; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MACMILLAN MB, 1986, BRAIN COGNITION, V5, P67, DOI 10.1016/0278-2626(86)90062-X; MCINTYRE JS, 1987, CAN J PSYCHOL, V41, P175, DOI 10.1037/h0084154; MESULAM MM, 1985, PRINCIPLES BEHAVIOUR; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P100, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PANDYA DN, 1985, CEREBRAL CORTEX ASS, V4; Pedhazur E.J., 1982, MULTIPLE REGRESSION, V2nd ed.; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RICHARDSONKLAVEHN A, 1988, ANNU REV PSYCHOL, V39, P475, DOI 10.1146/annurev.ps.39.020188.002355; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; SEGALOWITZ SJ, 1992, DEV NEUROPSYCHOL, V8, P279, DOI 10.1080/87565649209540528; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SHIMAMURA AP, 1987, J EXP PSYCHOL LEARN, V13, P464, DOI 10.1037/0278-7393.13.3.464; Stuss D.T., 1986, FRONTAL LOBES; TEASDALE G, 1974, LANCET, V2, P81; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; VARNEY NR, 1991, NEUROPSYCHOLOGY LAW, P24; Wechsler D., 1987, WECHSLER MEMORY SCAL; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114	65	30	29	0	5	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	JAN	1993	21	1					20	43		10.1006/brcg.1993.1002			24	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	KJ358	WOS:A1993KJ35800002	8424861				2021-06-18	
J	ZIMMERMAN, WD; GANZEL, TM; WINDMILL, IM; NAZAR, GB; PHILLIPS, M				ZIMMERMAN, WD; GANZEL, TM; WINDMILL, IM; NAZAR, GB; PHILLIPS, M			PERIPHERAL HEARING-LOSS FOLLOWING HEAD TRAUMA IN CHILDREN	LARYNGOSCOPE			English	Article							TEMPORAL BONE-FRACTURES; INJURY	The purpose of this prospective study was to determine the incidence and type of hearing loss occurring in children who suffered head injuries. Fifty children admitted to the neurosurgical service after sustaining head trauma were studied. Neurologic, otologic, and audiologic evaluations were performed. Diagnostic studies included skull roentgenograms and computerized tomography scans. A 32% incidence of conductive hearing loss and a 16% incidence of high-frequency sensorineural hearing loss was found in this group. All patients with temporal bone fractures had conductive hearing losses, but the presence of a skull vault fracture did not correlate with the presence, type, or degree of hearing loss. In addition, there was no correlation between either cause of injury, loss of consciousness, or Glasgow Coma Scale scores and the presence, type, or degree of hearing loss. There was a significant incidence of both sensorineural and conductive hearing loss in this series of patients, which indicates that close audiologic and otologic follow-up is necessary for all head injury patients.	UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT SURG,DIV SOCIAL WELF,550 S JACKSON ST,LOUISVILLE,KY 40202; UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT SURG,DIV COMMUNICAT DISORDERS,LOUISVILLE,KY 40202; UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT SURG,DIV NEUROL SURG,LOUISVILLE,KY 40202							BROWNING GG, 1982, ARCH OTOLARYNGOL, V108, P474; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; DOES IES, 1965, ARCHIV OTOLARYNGOL, V82, P331; GOODWIN WJ, 1983, OTOLARYNG CLIN N AM, V16, P651; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; HALL JW, 1982, LARYNGOSCOPE, V92, P883; HAWKINS JE, 1984, SEMIN HEAR, V5, P115; HEALY GB, 1982, NEW ENGL J MED, V17, P1029; HOUGH JVD, 1969, ANN OTO RHINOL LARYN, V78, P210, DOI 10.1177/000348946907800202; HOWE JR, 1975, NEUROLOGY, V25, P286, DOI 10.1212/WNL.25.3.286; JERGER J, 1981, AUDITORY DISORDERS, P169; KHAN AA, 1985, OTOLARYNG HEAD NECK, V93, P177, DOI 10.1177/019459988509300210; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P971, DOI 10.1288/00005537-197607000-00010; MOMOSE KJ, 1983, AM J NEURORADIOL, V4, P781; PEARSON BW, 1973, ARCH OTOLARYNGOL, V97, P81; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; Tos M, 1971, J Laryngol Otol, V85, P1147, DOI 10.1017/S0022215100074569; VARTIAINEN E, 1985, ACTA OTO-LARYNGOL, V99, P529, DOI 10.3109/00016488509182257; WILLSON GN, 1981, J LARYNGOL OTOL, V95, P1213, DOI 10.1017/S0022215100092057	21	30	30	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0023-852X			LARYNGOSCOPE	Laryngoscope	JAN	1993	103	1	1				87	91					5	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	KG364	WOS:A1993KG36400016	8421426				2021-06-18	
J	BJORNSTIG, U; OSTROM, M; ERIKSSON, A; SONNTAGOSTROM, E				BJORNSTIG, U; OSTROM, M; ERIKSSON, A; SONNTAGOSTROM, E			HEAD AND FACE INJURIES IN BICYCLISTS - WITH SPECIAL REFERENCE TO POSSIBLE EFFECTS OF HELMET USE	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SAFETY HELMETS; ACCIDENTS; CHILDREN; CRASHES; SWEDEN	Fatal and nonfatal head and face injuries to unhelmeted bicyclists were analyzed to assess the injury-reducing potential of bicycle helmet use. Of the fatally injured, 64% (median age, 55 years) had fatal head and face injuries compared with 38% (median age, 18 years) with head and face injuries in the nonfatal injury group. The fatally injured often had multiple impact points, mostly to the occipital and temporal regions. Brain contusions, most often to the frontal and temporal lobes, were the most common cause of fatal injury, followed by subdural hematomas. In the nonfatal injury group abrasions/lacerations were most common type of injury, followed by cerebral concussions/contusions and superficial contusions. If all types of injuries to bicyclists are taken into account a helmet might have had an injury-reducing effect in two of every five fatal cases and in one of every five nonfatal cases. To increase the helmet use among bicyclists, a law, as in Australia, would be an excellent instrument.	REG HOSP UMEA,UMEA,SWEDEN; UMEA UNIV,DEPT FORENS MED,S-90185 UMEA,SWEDEN; UMEA UNIV,UMEA ACCIDENT ANAL GRP,S-90185 UMEA,SWEDEN; UNIV MICHIGAN,TRANSPORTAT RES INST,ANN ARBOR,MI 48109							ALDMAN B, 1978, 3RD P INT IRCOBI C L, P118; [Anonymous], 1990, ABBREVIATED INJURY S; BADER M, 1990, JAMA-J AM MED ASSOC, V263, P1914, DOI 10.1001/jama.263.14.1914; BERGMAN AB, 1990, AM J DIS CHILD, V144, P727, DOI 10.1001/archpedi.1990.02150300127033; BJORNSTIG U, 1984, ACTA CHIR SCAND, V150, P353; BJORNSTIG UL, 1985, ACTA CHIR SCAND, V151, P577; BURG A, 1971, HUM FACTORS, V13, P79, DOI 10.1177/001872087101300110; DIGUISEPPI CG, 1990, AM J DIS CHILD, V144, P83, DOI 10.1001/archpedi.1990.02150250093041; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; EVANS L, 1991, TRAFFIC SAFETY DRIVE, P25; FIFE D, 1983, J TRAUMA, V23, P745, DOI 10.1097/00005373-198308000-00011; GENARELLI TA, 1984, BIOMECHANICS IMPACT, P103; GUICHON DMP, 1975, J TRAUMA, V15, P504, DOI 10.1097/00005373-197506000-00009; HOWLAND J, 1989, AM J DIS CHILD, V143, P741, DOI 10.1001/archpedi.1989.02150180123033; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; LEICESTER P, 1991, GR914REP; LIND MG, 1986, ACTA CHIR SCAND    S, P531; MILLS NJ, 1991, ACCIDENT ANAL PREV, V23, P153, DOI 10.1016/0001-4575(91)90045-7; MORGAN M, 1991, GR919; OMMAYA AK, 1984, BIOMECHANICS IMPACT, P117; OMMAYA AK, 1988, 32ND P ANN M ASS ADV; OSTROM M, IN PRESS INT J EPIDE; RIVARA FP, 1990, JAMA-J AM MED ASSOC, V263, P1915, DOI 10.1001/jama.1990.03440140034017; SANDELS S, 1972, SMA BARN TRAFIKEN; SCIALFA CT, 1987, 31ST P ANN M HUM FAC, P558; SJOGREN H, 1991, ACCIDENT ANAL PREV, V23, P77, DOI 10.1016/0001-4575(91)90037-6; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; STUTTS JC, 1990, ACCIDENT ANAL PREV, V22, P67, DOI 10.1016/0001-4575(90)90008-9; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1388, DOI 10.2105/AJPH.80.11.1388; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; WASSERMAN RC, 1988, AM J PUBLIC HEALTH, V78, P1220, DOI 10.2105/AJPH.78.9.1220; WESTMAN E, 1983, PEOPLE ROAD OFFICIAL, P11; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; WOOD T, 1988, ACCIDENT ANAL PREV, V20, P177, DOI 10.1016/0001-4575(88)90002-4; WORELL J, 1987, INJURY, V18, P5; 1982, INT STATISTICAL CLAS; 1982, ACCIDENT FACTS, P45; 1990, LIGHTWEIGHT PROTECTI; 1989, BICYCLE I AM BICYCLI; 1987, MORBIDITY MORTALITY, V32, P269; 1985, KONSUMENTVERKETS FOR; 1990, TRAFFIC INJURIES 198; 1984, ANSIZ9041984 AM NAT; 1990, FATAL ACCIDENT REPOR; 1982, LIGHTWEIGHT PROTECTI; 1982, NEISS DATA HIGHLIGHT, V6	47	30	32	0	6	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	1992	33	6					887	893					7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	KF879	WOS:A1992KF87900016	1474633				2021-06-18	
J	ROBERTS, WO				ROBERTS, WO			WHO PLAYS - WHO SITS - MANAGING CONCUSSIONS ON THE SIDELINES	PHYSICIAN AND SPORTSMEDICINE			English	Article								Allowing a player to return to competition too soon after a concussion may result in further injury or even death. By carefully evaluating and monitoring an athlete who sustains a concussion, then classifying the concussion by severity, the physician can determine whether the athlete can safely return to play.		ROBERTS, WO (corresponding author), MINNHEALTH PA,WHITE BEAR LAKE,MN, USA.			Roberts, William O/0000-0003-4517-4330				0	30	30	0	1	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	JUN	1992	20	6					66	72					7	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	HX590	WOS:A1992HX59000011	27438927				2021-06-18	
J	WEINSTABL, C; RICHLING, B; PLAINER, B; CZECH, T; SPISS, CK				WEINSTABL, C; RICHLING, B; PLAINER, B; CZECH, T; SPISS, CK			COMPARATIVE-ANALYSIS BETWEEN EPIDURAL (GAELTEC) AND SUBDURAL (CAMINO) INTRACRANIAL-PRESSURE PROBES	JOURNAL OF CLINICAL MONITORING			English	Article						MEASUREMENT TECHNIQUES-INTRACRANIAL PRESSURE; MONITORING-PRESSURE, INTRACRANIAL; EQUIPMENT-FIBEROPTIC ICP PROBE	MONITOR; DEVICE	The new fiberoptic Camino system has recently been introduced for clinical intracranial pressure (ICP) monitoring. We compared the subdural Camino system with the well-established epidural Gaeltec system in both in vitro and clinical conditions. In the in vitro experiments the intracranial vault was simulated by a tightly closed, fluid-filled box (0.9% sodium chloride) with the two probes inside. We simulated pulsating waveforms with a jet ventilator. No difference between the simulated curve patterns and values could be detected. In the clinical studies, both probes were implanted in 10 patients who had either head injuries, subarachnoid hemorrhage, or intracerebral hemorrhage. The in vivo comparison revealed no significant difference between the two systems in the recorded pressures in group 1 (ICP < 20 mm Hg). The subdurally placed Camino probe showed insignificantly lower ICP values than did the extradural Gaeltec probe. Although group 2 (ICP > 20 mm Hg) waveforms were nearly identical, significant differences (p < 0.01) in pressure measurements (systolic, diastolic, and mean) occurred (Camino, 18 +/- 3 mm Hg; Gaeltec, 27 +/- 3 mm Hg). Correlation coefficients for mean ICP values were 0.82 in group 1 and 0.49 in group 2. Problems with the Camino probe were usually mechanical and occurred in 2 patients. The problems were either easy to recognize or manifested as an ostensibly pathologic curve. No infection occurred with either system during or following implantation. The dissimilar characteristics of the two probes can be ascribed to their different extradural and subdural implantation sites. The Gaeltec probe was more durable over the period of implantation, which averaged 98 hours and ranged from 44 to 298 hours. Intracranial pressure values measured subdurally seemed to be more true to life in the high-pressure ranges. Both probes can be used for routine, continuous ICP monitoring. While subdural ICP probes can give correct values without delay and in vivo show more detail and change with ventilation, the epidural system was more durable.	UNIV VIENNA,DEPT NEUROSURG,A-1090 VIENNA,AUSTRIA	WEINSTABL, C (corresponding author), UNIV VIENNA,DEPT ANESTHESIA & GEN INTENS CARE,SPITALGASSE 23,A-1090 VIENNA,AUSTRIA.						BROCK M, 1972, INTRACRANIAL PRESSUR, V1, P1; CHEEK WR, 1979, NEUROSURGERY, V5, P666; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; DEARDEN NM, 1984, J NEUROSURG, V60, P123, DOI 10.3171/jns.1984.60.1.0123; DORSCH NWC, 1975, J NEUROSURG, V42, P249, DOI 10.3171/jns.1975.42.3.0249; GAAB MR, 1980, THESIS FM WURZBURG; GOBIET W, 1974, J NEUROSURG, V39, P272; LUNDBERG N, 1960, ACTA PSYCHIATRICA  S, V149, P1; MILLER JD, 1978, BRIT J HOSP MED, V19, P497; NORNES H, 1972, J NEUROSURG, V36, P537, DOI 10.3171/jns.1972.36.5.0537; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; POWELL MP, 1985, J NEUROSURG, V63, P745, DOI 10.3171/jns.1985.63.5.0745; SCHETTINI A, 1971, J NEUROSURG, V34, P38, DOI 10.3171/jns.1971.34.1.0038; VRIES JK, 1973, J NEUROSURG, V39, P416, DOI 10.3171/jns.1973.39.3.0416	14	30	30	0	1	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0748-1977			J CLIN MONITOR	J. Clin. Monit.	APR	1992	8	2					116	120		10.1007/BF01617429			5	Anesthesiology	Anesthesiology	HP095	WOS:A1992HP09500004	1583546				2021-06-18	
J	BASSETT, SS; SLATER, EJ				BASSETT, SS; SLATER, EJ			NEUROPSYCHOLOGICAL FUNCTION IN ADOLESCENTS SUSTAINING MILD CLOSED HEAD-INJURY	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article									UNIV MARYLAND,COLLEGE PK,MD 20742					PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-240510] Funding Source: Medline		BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benton A., 1976, MULTILINGUAL APHASIA; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; GAILBRAITH S, 1977, SCOTTISH MED J, V22, P129; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kirk RE, 1968, EXPT DESIGN; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENBERRY T L, 1980, Neurochemistry International, V2, P135, DOI 10.1016/0197-0186(80)90020-0; RUTTER M, 1983, DEV NEUROPSYCHIATRY; TEASDALE G, 1974, LANCET, V2, P81; TOTTEN J, 1979, LANCET, V1, P369; *US DEPT WAR, 1944, ARM IND TEST BATT MA; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1974, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	26	30	30	0	0	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0146-8693			J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	1990	15	2					225	236		10.1093/jpepsy/15.2.225			12	Psychology, Developmental	Psychology	DJ074	WOS:A1990DJ07400005	2374077				2021-06-18	
J	LEVIN, HS; AMPARO, EG; EISENBERG, HM; MINER, ME; HIGH, WM; EWINGCOBBS, L; FLETCHER, JM; GUINTO, FC				LEVIN, HS; AMPARO, EG; EISENBERG, HM; MINER, ME; HIGH, WM; EWINGCOBBS, L; FLETCHER, JM; GUINTO, FC			MAGNETIC-RESONANCE IMAGING AFTER CLOSED HEAD-INJURY IN CHILDREN	NEUROSURGERY			English	Article									UNIV TEXAS,MED BRANCH,DEPT RADIOL,GALVESTON,TX 77550; UNIV TEXAS,SCH MED,DIV NEUROSURG,HOUSTON,TX 77025; UNIV TEXAS,SCH MED,DEPT PSYCHIAT & BEHAV SCI,HOUSTON,TX 77025; UNIV HOUSTON,DEPT PSYCHOL,HOUSTON,TX 77004	LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,JOHN SEALY HOSP 9-112,DIV NEUROSURG,D-73,GALVESTON,TX 77550, USA.		fletcher, jack/Q-5975-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1986, J NEUROL NEUROSUR PS, V49, P1039, DOI 10.1136/jnnp.49.9.1039; Beery KE, 1967, VISUAL MOTOR INTEGRA; Benton AL, 1978, MULTILINGUAL APHASIA; BUSCHKE H, 1974, J EXP CHILD PSYCHOL, V18, P488, DOI 10.1016/0022-0965(74)90126-X; Dunn L., 1981, PEABODY PICTURE VOCA; GOLDMAN PS, 1977, NATURE, V267, P613, DOI 10.1038/267613a0; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; JENKINS A, 1986, LANCET, V2, P445; LEVIN HS, 1985, SEMIN NEUROL, V5, P221, DOI 10.1055/s-2008-1041519; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; TEASDALE G, 1974, LANCET, V2, P81; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011	18	30	30	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	FEB	1989	24	2					223	227		10.1227/00006123-198902000-00011			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	R9584	WOS:A1989R958400011	2918973				2021-06-18	
J	Wiedmann, KD; Wilson, JTL; Wyper, D; Hadley, DM; Teasdale, GM; Brooks, DN				Wiedmann, K. D.; Wilson, J. T. L.; Wyper, D.; Hadley, D. M.; Teasdale, G. M.; Brooks, D. N.			SPECT Cerebral Blood Flow, MR Imaging, and Neuropsychological Findings in Traumatic Head Injury	NEUROPSYCHOLOGY			English	Article						Single-photon emission computed tomography; magnetic resonance imaging; head injury; neuropsychology		Two groups of head injury patients were investigated 5 to 12 months (median 6 months) after injury employing single-photon emission computed tomography (SPECT) cerebral blood flow measurements and neuropsychological examination. The groups differed in primary clinical diagnosis: a group of 16 patients with a diagnosis of diffuse or contusional brain damage and a group of 8 patients with space-occupying lesions. The groups differed significantly on GCS admission score and on PTA, which indicated greater injury severity for the diffuse group. They also differed in neuropsychological test performance. Compared to a control group, the diffuse group showed statistically significant differences on 13 of 24 measures after correction for premorbid differences, whereas the focal group was significantly impaired on only three tests after correction. Regional analysis of SPECT-CBF abnormalities revealed consistent relationships, with impaired test performance for the diffuse group, but relationships were less clear for the focal group. The authors conclude that (1) patterns of CBF abnormalities were different for the focal and diffuse groups; (2) SPECT was able to identify abnormalities not demonstrated on MRI and vice versa; and (3) abnormal regional CBF was related to neuropsychological defects.	[Wiedmann, K. D.; Wilson, J. T. L.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Wyper, D.; Hadley, D. M.; Teasdale, G. M.] So Gen Hosp, Inst Neurol Sci, Dept Clin Phys, Glasgow G51 4TF, Lanark, Scotland; [Wyper, D.; Hadley, D. M.; Teasdale, G. M.] So Gen Hosp, Inst Neurol Sci, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland; [Wyper, D.; Hadley, D. M.; Teasdale, G. M.] So Gen Hosp, Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; [Brooks, D. N.] Univ Glasgow, Dept Psychol Med, Glasgow, Lanark, Scotland	Wiedmann, KD (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328	Medical Research Council of Great BritainUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This study was supported by the Medical Research Council of Great Britain.	ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; ANDERSEN AR, 1988, J CEREBR BLOOD F MET, V8, pS69, DOI 10.1038/jcbfm.1988.35; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bullock R., 1989, J CEREBRAL BLOOD S1, V9, pS204; ELL PJ, 1983, LANCET, V1, P1348; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; JENKINS A, 1986, LANCET, V2, P445; Langfitt T W, 1981, Prog Neurol Surg, V10, P14, DOI 10.1159/000384767; McKenna P.W.E., 1983, GRADED NAMING TEST; Nelson H, 1981, NATL ADULT READING T; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Rey A, 1941, ARCH PSYCHOL, V28; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wiedmann K. D., 1989, J CLIN EXPT NEUROPSY, V11, P58; Wilson J. T. L., 1990, PATTERNS LESIO UNPUB; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WILSON JTL, 1988, J CLIN EXP NEUROPSYC, V10, P222, DOI 10.1080/01688638808408237	24	30	30	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology		1989	3	4					267	281		10.1037//0894-4105.3.4.267			15	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	V44JW	WOS:000209746300006					2021-06-18	
J	LEVIN, HS; MADISON, CF; BAILEY, CB; MEYERS, CA; EISENBERG, HM; GUINTO, FC				LEVIN, HS; MADISON, CF; BAILEY, CB; MEYERS, CA; EISENBERG, HM; GUINTO, FC			MUTISM AFTER CLOSED HEAD-INJURY	ARCHIVES OF NEUROLOGY			English	Article									UNIV TEXAS,MED BRANCH,DIV NEURORADIOL,GALVESTON,TX 77550; UNIV TEXAS,SCH MED,DIV NEUROSURG,HOUSTON,TX 77025	LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550, USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BARAT M, 1981, REV NEUROL, V137, P343; BENSON DR, 1976, APHASIA ALEXIA AGRAP; Benton A. L., 1976, MANUAL MULTILINGUAL; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; BROWN JW, 1975, BRAIN LANG, V2, P18, DOI 10.1016/S0093-934X(75)80051-4; Cairns H, 1941, BRAIN, V64, P273, DOI 10.1093/brain/64.4.273; DAMASIO AR, 1982, ARCH NEUROL-CHICAGO, V39, P15, DOI 10.1001/archneur.1982.00510130017003; DEMOL J, 1979, ACTA NEUROL BELG, V79, P369; FISHER CM, 1979, ARCH NEUROL-CHICAGO, V36, P65, DOI 10.1001/archneur.1979.00500380035003; Geschwind Norman, 1974, SELECTED PAPERS LANG; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; MAKI Y, 1980, CHILD BRAIN, V7, P113; NAESER MA, 1982, ARCH NEUROL-CHICAGO, V39, P2, DOI 10.1001/archneur.1982.00510130004002; Plum F., 1980, DIAGNOSIS STUPOR COM, V3; SEGARRA JM, 1970, CEREBROVASCULAR DISE, P3; Spreen O, 1969, NEUROSENSORY CTR COM; TEASDALE G, 1974, LANCET, V2, P81	22	30	31	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.		1983	40	10					601	606		10.1001/archneur.1983.04050090037004			6	Clinical Neurology	Neurosciences & Neurology	RJ617	WOS:A1983RJ61700002	6615266				2021-06-18	
J	MANAKA, S; SANO, K				MANAKA, S; SANO, K			THYROTROPIN-RELEASING-HORMONE TARTRATE (TRH-T) SHORTENS CONCUSSION EFFECTS FOLLOWING HEAD IMPACT IN MICE	NEUROSCIENCE LETTERS			English	Article										MANAKA, S (corresponding author), UNIV TOKYO,FAC MED,DEPT NEUROSURG,TOKYO 113,JAPAN.						BREESE GR, 1974, LIFE SCI, V14, P1053, DOI 10.1016/0024-3205(74)90230-6; INANAGA K, 1975, Kurume Medical Journal, V22, P159; KASTIN AJ, 1972, LANCET, V2, P740; KELLER HH, 1974, NATURE, V248, P528, DOI 10.1038/248528a0; MANAKA S, 1977, BRAIN NERV, V29, P1075; MCCAUL JA, 1974, LANCET, V1, P735; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; PRANGE AJ, 1972, LANCET, V2, P999; PRANGE AJ, 1974, LIFE SCI, V14, P447, DOI 10.1016/0024-3205(74)90359-2; SAJI Y, 1977, Journal of Takeda Research Laboratories, V36, P39; SAJI Y, 1976, BASIC PHARM THERAP, V4, P515; WILSON IC, 1973, LANCET, V2, P43	12	30	30	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.		1978	8	3					255	258		10.1016/0304-3940(78)90131-3			4	Neurosciences	Neurosciences & Neurology	FL615	WOS:A1978FL61500013	19605168				2021-06-18	
J	Sanchez, EJ; Gabler, LF; Good, AB; Funk, JR; Crandall, JR; Panzer, MB				Sanchez, Erin J.; Gabler, Lee F.; Good, Ann B.; Funk, James R.; Crandall, Jeff R.; Panzer, Matthew B.			A reanalysis of football impact reconstructions for head kinematics and finite element modeling	CLINICAL BIOMECHANICS			English	Article						Laboratory reconstructions; Head kinematics; Finite element model; Brain strain; Concussion; Football	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; IN-VIVO; CONCUSSION; RESPONSES; STRAIN; ACCELERATIONS; PREDICTORS; PLAYERS	Background: Head kinematics generated by laboratory reconstructions of professional football helmet impacts have been applied to computational models to study the biomechanics of concussion. Since the original publication of this data, techniques for evaluating accelerometer consistency and error correction have been developed. This study applies these techniques to the original reconstruction data and reanalyzes the results given the current state of concussion biomechanics. Methods: Consistency checks were applied to the sensor data collected in the head of each test dummy. Inconsistent data were corrected using analytical techniques, and head kinematics were recalculated from the corrected data. Reconstruction videos were reviewed to identify artefactual impacts during the reconstruction to establish the region of applicability for simulations. Corrected head kinematics were input into finite element brain models to investigate strain response to the corrected dataset. Findings: Multiple reconstruction cases had inconsistent sensor arrays caused by a problematic sensor; corrections to the arrays caused changes in calculated rotational head motion. These corrections increased median peak angular velocity for the concussion cases from 35.6 to 41.5 rad/s. Using the original kinematics resulted in an average error of 20% in maximum principal strain results for each case. Simulations of the reconstructions also demonstrated that simulation lengths less than 40 ms did not capture the entire brain strain response and under-predicted strain. Interpretation This study corrects data that were used to determine concussion risk, and indicates altered head angular motion and brain strain response for many reconstructions. Conclusions based on the original data should be re-examined based on this new study.	[Sanchez, Erin J.; Gabler, Lee F.; Crandall, Jeff R.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Good, Ann B.; Funk, James R.; Crandall, Jeff R.] Biocore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA	Panzer, MB (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	mbp2q@virginia.edu			Football Research, Inc. (FRI)	Portions of the reanalysis presented in this paper were made possible by a grant from Football Research, Inc. (FRI). The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources. The authors would like to thank Biokinetics and Associates Ltd. for their assistance in providing data and discussing the reanalysis procedures.	BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bonita R., 2006, BASIC EPIDEMIOLOGY; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Chamouard F., 1987, SAE TECHNICAL PAPER; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fournier E., 2000, IRCOBI INT RES COUNC, V2000, P223; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kang HS, 1997, P STAPP CAR CRASH J, V41, P329; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A.I., 2003, IRCOBI C LISB PORT, P1; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Newman J, 1999, INT RES COUNC BIOM I, P17; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Sanchez E, 2017, J NEUROTRAUM, V34, pA30; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Siegmund G. P., 2015, ANN BIOMED ENG, P1; Takhounts E. G., 2009, P INT TECHN C ENH SA; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	43	29	29	1	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	APR	2019	64				SI		82	89		10.1016/j.clinbiomech.2018.02.019			8	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	HY6ON	WOS:000468249700011	29559201				2021-06-18	
J	Lochhead, JJ; Kellohen, KL; Ronaldson, PT; Davis, TP				Lochhead, Jeffrey J.; Kellohen, Kathryn L.; Ronaldson, Patrick T.; Davis, Thomas P.			Distribution of insulin in trigeminal nerve and brain after intranasal administration	SCIENTIFIC REPORTS			English	Article							ALZHEIMER-DISEASE; RAT-BRAIN; TRANSPORT; IMPAIRMENT; DELIVERY; MODEL; MECHANISMS; RESISTANCE; RECEPTORS; PATHOLOGY	In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficits in insulin signaling. Pre-clinical studies have shown that intranasal insulin is neuroprotective in models of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. Clinical trials have also shown that intranasal insulin elicits beneficial cognitive effects in patients with Alzheimer's disease. It is known that insulin can be detected in the CNS within minutes following intranasal administration. Despite these advances, the anatomical pathways that insulin utilizes to reach the CNS and the cellular CNS targets after intranasal administration are not fully understood. Here, we intranasally administered fluorescently labeled insulin and imaged its localization within the brain and trigeminal nerves. Our data indicates that intranasal insulin can reach cellular CNS targets along extracellular components of the trigeminal nerve. Upon CNS entry, we found insulin significantly increased levels of an activated form of the insulin receptor. These findings suggest that the intranasal route of administration is able to effectively deliver insulin to CNS targets in a biologically active form.	[Lochhead, Jeffrey J.; Kellohen, Kathryn L.; Ronaldson, Patrick T.; Davis, Thomas P.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA	Lochhead, JJ (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.	lochhead@email.arizona.edu	Lochhead, Jeffrey/Q-1295-2018	Lochhead, Jeffrey/0000-0001-5554-4812	National Institutes of Health: National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [042652]; American Heart AssociationAmerican Heart Association [18CDA34110454]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042652] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health: National Institute of Neurological Disorders and Stroke (042652) (T.P.D.) and the American Heart Association (18CDA34110454) (J.J.L.). The authors wish to thank James Averill and Madeline Martinez for technical assistance.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; ALEXANDERBRIDGES M, 1992, ADV ENZYME REGUL, V32, P149; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Athauda D, 2016, PROG NEUROBIOL, V145, P98, DOI 10.1016/j.pneurobio.2016.10.001; Banks WA, 1997, PEPTIDES, V18, P1257, DOI 10.1016/S0196-9781(97)00198-8; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; BASKIN DG, 1986, DIABETES, V35, P246, DOI 10.2337/diabetes.35.2.246; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Carpenter MC, 2014, BIOCHEMISTRY-US, V53, P1296, DOI 10.1021/bi4016567; Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dodd GT, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12513; DREJER K, 1992, DIABETIC MED, V9, P335, DOI 10.1111/j.1464-5491.1992.tb01792.x; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z; Gray SP, 2017, DIABETOLOGIA, V60, P927, DOI 10.1007/s00125-017-4215-5; Heni M, 2015, NAT REV ENDOCRINOL, V11, P701, DOI 10.1038/nrendo.2015.173; Hersom M, 2018, AM J PHYSIOL-ENDOC M, V315, pE531, DOI 10.1152/ajpendo.00350.2016; Hjorth CF, 2016, J PHARM SCI-US, V105, P1376, DOI 10.1016/j.xphs.2016.01.003; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kirshner ZZ, 2018, MOL CELL ENDOCRINOL, V473, P156, DOI 10.1016/j.mce.2018.01.015; Konishi M, 2017, P NATL ACAD SCI USA, V114, pE8478, DOI 10.1073/pnas.1710625114; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lioutas VA, 2015, TRANSL STROKE RES, V6, P264, DOI 10.1007/s12975-015-0409-7; Lochhead JJ, 2015, J CEREBR BLOOD F MET, V35, P371, DOI 10.1038/jcbfm.2014.215; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Mao YF, 2016, AGING CELL, V15, P893, DOI 10.1111/acel.12498; MCDANIEL ML, 1980, METABOLISM, V29, P762, DOI 10.1016/0026-0495(80)90200-0; MESSINA JL, 1992, EXP CELL RES, V200, P532, DOI 10.1016/0014-4827(92)90206-N; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nedelcovych MT, 2018, ACS CHEM NEUROSCI, V9, P809, DOI 10.1021/acschemneuro.7b00434; Pang Y, 2016, NEUROSCIENCE, V318, P157, DOI 10.1016/j.neuroscience.2016.01.020; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Pizzo ME, 2018, J PHYSIOL-LONDON, V596, P445, DOI 10.1113/JP275105; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Ramalingam M, 2014, J NEURAL TRANSM, V121, P611, DOI 10.1007/s00702-013-1147-1; Renner DB, 2012, J PHARM PHARMACOL, V64, P1709, DOI 10.1111/j.2042-7158.2012.01555.x; Rhea EM, 2018, J PHYSIOL-LONDON, V596, P4753, DOI 10.1113/JP276149; Rhea EM, 2017, J ALZHEIMERS DIS, V57, P241, DOI 10.3233/JAD-161095; Salameh TS, 2015, J ALZHEIMERS DIS, V47, P715, DOI 10.3233/JAD-150307; Schmid V, 2018, DIABETES OBES METAB, V20, P1563, DOI 10.1111/dom.13279; Spitzer N, 2011, J NEUROSCI METH, V197, P48, DOI 10.1016/j.jneumeth.2011.01.029; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tsakiridis T, 1999, MICROSC RES TECHNIQ, V47, P79, DOI 10.1002/(SICI)1097-0029(19991015)47:2<79::AID-JEMT1>3.0.CO;2-S; Tsuchiya A, 2014, J PHARMACOL SCI, V126, P337, DOI 10.1254/jphs.14182FP; Tsuchiya A, 2013, CELL PHYSIOL BIOCHEM, V32, P1451, DOI 10.1159/000356582; Wang C, 1992, Brain Res Mol Brain Res, V13, P289; Wang MH, 2017, J NEUROSCI, V37, P2870, DOI 10.1523/JNEUROSCI.2112-16.2017	51	29	29	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 22	2019	9								2621	10.1038/s41598-019-39191-5			9	Multidisciplinary Sciences	Science & Technology - Other Topics	HM3UI	WOS:000459399400090	30796294	DOAJ Gold, Green Published			2021-06-18	
J	Ledoux, AA; Tang, K; Yeates, KO; Pusic, MV; Boutis, K; Craig, WR; Gravel, J; Freedman, SB; Gagnon, I; Gioia, GA; Osmond, MH; Zemek, RL; McGahern, C; Sangha, G; Beer, D; Burns, E; Farion, KJ; Mikrogianakis, A; Barlow, K; Dubrovsky, AS; Meeuwisse, W; Meehan, WP; Kamil, Y; Beauchamps, MH; Hoshizaki, B; Anderson, P; Brooks, BL; Vassilyadi, M; Klassen, T; Keightley, M; Richer, L; DeMatteo, C				Ledoux, Andree-Anne; Tang, Ken; Yeates, Keith O.; Pusic, Martin, V; Boutis, Kathy; Craig, William R.; Gravel, Jocelyn; Freedman, Stephen B.; Gagnon, Isabelle; Gioia, Gerard A.; Osmond, Martin H.; Zemek, Roger L.; McGahern, Candice; Sangha, Gurinder; Beer, Darcy; Burns, Emma; Farion, Ken J.; Mikrogianakis, Angelo; Barlow, Karen; Dubrovsky, Alexander S.; Meeuwisse, Willem; Meehan, William P., III; Kamil, Yael; Beauchamps, Miriam H.; Hoshizaki, Blaine; Anderson, Peter; Brooks, Brian L.; Vassilyadi, Michael; Klassen, Terry; Keightley, Michelle; Richer, Lawrence; DeMatteo, Carol		Pediat Emergency Res Canada PERC	Natural Progression of Symptom Change and Recovery From Concussion in a Pediatric Population	JAMA PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; PROLONGED RECOVERY; CHILDREN; HEAD; PREDICTORS; GENDER; SEVERITY; VISITS	IMPORTANCE The natural progression of symptom change and recovery remains poorly defined in children after concussion. OBJECTIVES To describe the natural progression of symptom change by age group (5-7, 8-12, and 13-18 years) and sex, as well as to develop centile curves to inform families about children after injury recovery. DESIGN, SETTING, AND PARTICIPANTS Planned secondary analysis of a prospective multicenter cohort study (Predicting Persistent Postconcussive Problems in Pediatrics). The setting was 9 pediatric emergency departments within the Pediatric Emergency Research Canada (PERC) network. Participants were aged 5 to 18 years with acute concussion, enrolled from August 1, 2013, to May 31, 2015, and data analyses were performed between January 2018 and March 2018. EXPOSURES Participants had a concussion consistent with the Zurich Consensus Statement on Concussion in Sport diagnostic criteria and 85% completeness of the Postconcussion Symptom Inventory (PCSI) at each time point. MAIN OUTCOMES AND MEASURES The primary outcome was symptom change, defined as current rating minus preinjury rating (delta score), at presentation and 1, 2, 4, 8, and 12 weeks after injury, measured using the PCSI. Symptoms were self-rated for ages 8 to 18 years and rated by the child and parent for ages 5 to 7 years. The secondary outcome was recovery, defined as no change in symptoms relative to current preinjury PCSI ratings (delta score = 0). Mixed-effects models incorporated the total score, adjusting for random effects (site and participant variability), fixed-effects indicators (age, sex, time, age by time interaction, and sex by time interaction), and variables associated with recovery. Recovery centile curves by age and sex were computed. RESULTS A total of 3063 children (median age, 12.0 years [interquartile range, 9.2-14.6 years]; 60.7% male) completed the primary outcome; 2716 were included in the primary outcome analysis. For the group aged 5 to 7 years, symptom change primarily occurred the first week after injury; by 2 weeks, 75.6% of symptoms had improved (PCSI change between 0 and 2 weeks, -5.3; 95% CI, -5.5 to -5.0). For the groups aged 8 to 12 years and 13 to 18 years, symptom change was prominent the first 2 weeks but flattened between 2 and 4 weeks. By 4 weeks, 83.6% and 86.2% of symptoms, respectively, had improved for the groups aged 8 to 12 years (PCSI change between 0 and 4 weeks, -9.0; 95% CI, -9.6 to -8.4) and 13 to 18 years (PCSI change between 0 and 4 weeks, -28.6; 95% CI, -30.8 to -.26.3). Sex by time interaction was significant only for the adolescent group (beta = 0.32; 95% CI, 0.21-0.43; P < .001). Most adolescent girls had not recovered by week 12. CONCLUSIONS AND RELEVANCE Symptom improvement primarily occurs in the first 2 weeks after concussion in children and in the first 4 weeks after concussion in preadolescents and male adolescents. Female adolescents appear to have protracted recovery. The derived recovery curves may be useful for evidence-based anticipatory guidance.	[Ledoux, Andree-Anne; Tang, Ken; Osmond, Martin H.; Zemek, Roger L.] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith O.; Freedman, Stephen B.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Pusic, Martin, V] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Craig, William R.] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Hlth Ctr, Dept Pediat, Montreal Childrens Hosp, Montreal, PQ, Canada; [Gioia, Gerard A.] George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Rockville, MD USA; [Osmond, Martin H.; Zemek, Roger L.] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [McGahern, Candice; Kamil, Yael] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Sangha, Gurinder] London Childrens Hosp, Dept Pediat, London, ON, Canada; [Beer, Darcy; Klassen, Terry] Manitoba Childrens Hosp, Dept Pediat, Winnipeg, MB, Canada; [Burns, Emma] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Farion, Ken J.] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen] Albertas Childrens Hosp, Dept Pediat & Clin Neurosci, Calgary, AB, Canada; [Dubrovsky, Alexander S.] Montreal Childrens Hosp, Dept Pediat, Montreal, PQ, Canada; [Meeuwisse, Willem] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Beauchamps, Miriam H.] Univ Montreal, Ste Justine Res Ctr, Montreal, PQ, Canada; [Hoshizaki, Blaine] Univ Ottawa, Dept Kinesiol, Ottawa, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Dept Psychol, Ottawa, ON, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Neurosurg, Ottawa, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Richer, Lawrence] Stollery Childrens Hosp, Dept Neurol, Edmonton, AB, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada	Zemek, RL (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Yeates, Keith/AAJ-4223-2020; Barlow, Karen/I-6492-2019; Richer, Lawrence/D-3622-2009; Barlow, Karen/C-1323-2014; Freedman, Stephen/H-9102-2012	Richer, Lawrence/0000-0002-6897-8668; Pusic, Martin/0000-0001-5236-6598; Barlow, Karen/0000-0003-2612-8507; Osmond, Martin/0000-0001-8275-8381; Yeates, Keith/0000-0001-7680-2892; Craig, William/0000-0002-4804-194X; Freedman, Stephen/0000-0003-2319-6192	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team grant [TM1 127047]; CIHR planning grantCanadian Institutes of Health Research (CIHR) [MRP 119829]; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness; University of Ottawa Clinical Research Chair in pediatric concussion	This study was supported by a Canadian Institutes of Health Research (CIHR) operating grant (MOP 126197), a CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team grant (TM1 127047), and a CIHR planning grant (MRP 119829). Dr Freedman is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness. Dr Zemek is supported by a University of Ottawa Clinical Research Chair in pediatric concussion.	Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Box G.E.P., 1994, TIME SERIES ANAL FOR; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Faes C, 2009, AM STAT, V63, P389, DOI 10.1198/tast.2009.08196; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jones RH, 1993, LONGITUDINAL DATA SE, DOI [10.1007/978-1-4899-4489-4, DOI 10.1007/978-1-4899-4489-4]; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Verbeke G, 2009, SPRINGER SER STAT, P375; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P2624, DOI 10.1001/jama.2016.7407; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	52	29	29	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JAN	2019	173	1							e183820	10.1001/jamapediatrics.2018.3820			11	Pediatrics	Pediatrics	HG8OF	WOS:000455261300002	30398522	Green Published, Bronze			2021-06-18	
J	Hunter, A; Eastwood, JD				Hunter, Andrew; Eastwood, John D.			Does state boredom cause failures of attention? Examining the relations between trait boredom, state boredom, and sustained attention	EXPERIMENTAL BRAIN RESEARCH			English	Article						State boredom; Trait boredom; Attention; Cognition	TRAUMATIC BRAIN-INJURY; ANXIETY STRESS SCALES; RISKY DECISION-MAKING; VIGILANCE DECREMENT; COGNITIVE FAILURES; WORKING-MEMORY; DEPRESSION; PRONENESS; PERFORMANCE; AROUSAL	Boredom is an important personal and social problem, but the phenomena itself remains poorly understood. Recent work has shown that boredom is highly related to attention, and that this relationship may be instrumental in revealing boredom's causes and consequences. In this paper, experimental findings on trait boredom, state boredom, and sustained attention performance are presented. We demonstrate that trait boredom uniquely predicts sustained attention performance, over and above depression and self-report attention problems. We also present exploratory findings consistent with the claim that attention failures may cause boredom and that sustained attention tasks may themselves be boring. Discussion of each of these findings, and potential ramifications for cognitive research as a whole, is included.	[Hunter, Andrew; Eastwood, John D.] York Univ, Toronto, ON, Canada	Eastwood, JD (corresponding author), York Univ, Toronto, ON, Canada.	johneast@yorku.ca					Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Barkley RA, 2006, ATTENTION DEFICIT HY; Ben-Zeev D, 2012, PSYCHIAT RES, V197, P55, DOI 10.1016/j.psychres.2011.11.025; Berlyne D.E., 1960, CONFLICT AROUSAL CUR; BERNSTEIN HE, 1975, SOC RES, V42, P512; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Birnbaum MH, 2008, PSYCHOL REV, V115, P463, DOI 10.1037/0033-295X.115.2.463; BLASZCZYNSKI A, 1990, PSYCHOL REP, V67, P35, DOI 10.2466/PR0.67.5.35-42; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Csikszentmihalyi M., 1978, HIDDEN COSTS REWARD, P205; Cummings ML, 2016, HUM FACTORS, V58, P279, DOI 10.1177/0018720815609503; Dahlen ER, 2005, ACCIDENT ANAL PREV, V37, P341, DOI 10.1016/j.aap.2004.10.006; DAMRADFRYE R, 1989, J PERS SOC PSYCHOL, V57, P315; de Bont J, 1994, SPEED MOTION PICTURE; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Duque A, 2015, J BEHAV THER EXP PSY, V46, P107, DOI 10.1016/j.jbtep.2014.09.005; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; Fahlman SA, 2009, J SOC CLIN PSYCHOL, V28, P307, DOI 10.1521/jscp.2009.28.3.307; FARMER R, 1986, J PERS ASSESS, V50, P4, DOI 10.1207/s15327752jpa5001_2; Fisher CD, 1998, J ORGAN BEHAV, V19, P503, DOI 10.1002/(SICI)1099-1379(199809)19:5<503::AID-JOB854>3.3.CO;2-0; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; Gerritsen CJ, 2014, CONSCIOUS COGN, V27, P27, DOI 10.1016/j.concog.2013.10.001; Goldberg Y, 2013, BEHAV SCI-BASEL, V3, P434, DOI 10.3390/bs3030434; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; GRIFFIN JA, 1986, MOTIV EMOTION, V10, P195, DOI 10.1007/BF00992315; HAMILTON JA, 1984, PERS INDIV DIFFER, V5, P183, DOI 10.1016/0191-8869(84)90050-3; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; HOLLENBECK JR, 1995, J APPL PSYCHOL, V80, P685, DOI 10.1037/0021-9010.80.6.685; Hunter JA, 2016, EUR J PSYCHOL ASSESS, V32, P241, DOI 10.1027/1015-5759/a000251; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kass SJ, 2001, J BUS PSYCHOL, V16, P317, DOI 10.1023/A:1011121503118; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEARY MR, 1986, J PERS SOC PSYCHOL, V51, P968, DOI 10.1037/0022-3514.51.5.968; Lee CM, 2007, ADDICT BEHAV, V32, P1384, DOI 10.1016/j.addbeh.2006.09.010; LePera N., 2011, NEW SCH PSYCHOL B, V8, P15; Leventhal H., 1987, COGN EMOT, V1, P3, DOI [10.1080/02699938708408361, DOI 10.1080/02699938708408361]; London H., 1974, THOUGHT FEELING, P44, DOI [10.4324/9781315135656-8, DOI 10.4324/9781315135656-8]; Malkovsky E, 2012, EXP BRAIN RES, V221, P59, DOI 10.1007/s00221-012-3147-z; Martin M., 2006, QUAL RES PSYCHOL, V3, P193, DOI [DOI 10.1191/1478088706QRP0660A, 10.1191/1478088706qrp066oa, DOI 10.1191/1478088706QRP066OA]; MATTHEWS G, 1998, VIEWING PSYCHOL WHOL, P113; Matthies S, 2012, J BEHAV THER EXP PSY, V43, P938, DOI 10.1016/j.jbtep.2012.02.002; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mercer-Lynn KB, 2013, J SOC CLIN PSYCHOL, V32, P897; Merrifield C, 2014, EXP BRAIN RES, V232, P481, DOI 10.1007/s00221-013-3755-2; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rupp DE, 1997, J SOC BEHAV PERS, V12, P925; Sawin DA, 1995, HUM FACTORS, V37, P752, DOI 10.1518/001872095778995616; Scerbo M. W., 1998, VIEWING PSYCHOL WHOL, P145, DOI [10.1037/10290-006, DOI 10.1037/10290-006]; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Thackray RI, 1977, VIGILANCE THEORY OPE, P203; TROUTWINE R, 1981, PERCEPT MOTOR SKILL, V52, P865, DOI 10.2466/pms.1981.52.3.865; van Tilburg WAP, 2011, PERS SOC PSYCHOL B, V37, P1679, DOI 10.1177/0146167211418530; Video Tutor Inc., 1995, EAS ENGL US NUMB MON; Vodanovich SJ, 2005, J PERS ASSESS, V85, P295, DOI 10.1207/s15327752jpa8503_05; Wallace JC, 2003, PERS INDIV DIFFER, V34, P635, DOI 10.1016/S0191-8869(02)00050-8; Watt JD, 2010, J BUS PSYCHOL, V25, P163, DOI 10.1007/s10869-009-9138-9; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	68	29	31	6	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	SEP	2018	236	9			SI		2483	2492		10.1007/s00221-016-4749-7			10	Neurosciences	Neurosciences & Neurology	GP4FV	WOS:000440815700005	27510405				2021-06-18	
J	Martens, G; Lejeune, N; O'Brien, AT; Fregni, F; Martial, C; Wannez, S; Laureys, S; Thibaut, A				Martens, Geraldine; Lejeune, Nicolas; O'Brien, Anthony Terrence; Fregni, Felipe; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore			Randomized controlled trial of home-based 4-week tDCS in chronic minimally conscious state	BRAIN STIMULATION			English	Article						Transcranial direct current stimulation (tDCS); Consciousness; Minimally conscious state; Traumatic brain injury	DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VEGETATIVE STATE; MAJOR DEPRESSION; CLINICAL-TRIAL; LATE RECOVERY; DISORDERS; RECOMMENDATIONS; DEFINITION; AMANTADINE	Background: Patients with chronic disorders of consciousness face a significant lack of treatment options. Objective: We aimed at investigating the feasibility and the behavioral effects of home-based transcranial direct current stimulation (tDCS), applied by relatives or caregivers, in chronic patients in minimally conscious state (MCS). Methods: Each participant received, in a randomized order, 20 sessions of active and 20 sessions of sham tDCS applied over the prefrontal cortex for 4 weeks; separated by 8 weeks of washout. Level of consciousness was assessed using the Coma Recovery Scale-Revised before the first stimulation (baseline), at the end of the 20 tDCS sessions (direct effects) and 8 weeks after the end of each stimulation period (long-term effects). Reported adverse events and data relative to the adherence (i.e., amount of sessions effectively received) were collected as well. Results: Twenty-seven patients completed the study and 22 patients received at least 80% of the stimulation sessions. All patients tolerated tDCS well, no severe adverse events were noticed after real stimulation and the overall adherence (i.e., total duration of stimulation) was good. A moderate effect size (0.47 and 0.53, for modified intention to treat and per protocol analysis, respectively) was observed at the end of the 4 weeks of tDCS in favor of the active treatment. Conclusions: We demonstrated that home-based tDCS can be used adequately outside a research facility or hospital by patients' relatives or caregivers. In addition, 4 weeks of tDCS moderately improved the recovery of signs of consciousness in chronic MCS patients. (c) 2018 Elsevier Inc. All rights reserved.	[Martens, Geraldine; Lejeune, Nicolas; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore] Univ Liege, GIGA Consciousness, GIGA Res, Coma Sci Grp, Liege, Belgium; [Martens, Geraldine; Lejeune, Nicolas; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore] Univ Liege, Neurol Dept, Ave Hop 11, Liege, Belgium; [Martens, Geraldine; Lejeune, Nicolas; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore] Univ Hosp Liege, Ave Hop 11, Liege, Belgium; [Lejeune, Nicolas] Catholic Univ Louvain, St Luc Univ Clin, Ctr Hosp Neurol William Lennox, Louvain, Belgium; [O'Brien, Anthony Terrence; Fregni, Felipe; Thibaut, Aurore] Harvard Med Sch, Spaulding Rehabil Hosp, Neuromodulat Ctr, Boston, MA USA	Laureys, S (corresponding author), Univ Liege, GIGA Consciousness, GIGA Res, Coma Sci Grp, Liege, Belgium.; Martens, G (corresponding author), Univ Liege, Neurol Dept, Ave Hop 11, Liege, Belgium.; Martens, G (corresponding author), Univ Hosp Liege, Ave Hop 11, Liege, Belgium.; Martens, G (corresponding author), Univ Liege, GIGA Res Coma Sci Grp, Ave Hop 11, Liege, Belgium.	geraldine.martens@ulg.ac.be; coma@uliege.be	Laureys, Steven/AAN-2097-2021; Martens, Geraldine/ABF-1147-2020; Laureys, Steven/A-3349-2011; Thibaut, Aurore/U-8101-2019; Martial, Charlotte/O-6703-2016	Laureys, Steven/0000-0002-3096-3807; Martens, Geraldine/0000-0001-7038-7165; Martial, Charlotte/0000-0001-6291-3460; Fregni, Felipe/0000-0001-9359-8643; Lejeune, Nicolas/0000-0001-6059-606X	University and University Hospital of Liege (Belgium); Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; Human Brain ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [EU-H2020-fetflagshiphbp-sga1-ga720270]; Luminous project [EU-H2020-fetopenga686764]; Center-TBI project; James McDonnell Foundation; European Space AgencyEuropean Space AgencyEuropean Commission; BelspoBelgian Federal Science Policy Office; Fondazione Europea di Ricerca Biomedica; BIAL FoundationBial Foundation; Wallonia Brussels Federation Concerted Research Action; Cefaly Technology and Mind Science Foundation	This research was supported by University and University Hospital of Liege (Belgium), Belgian National Funds for Scientific Research (FRS-FNRS), Human Brain Project (EU-H2020-fetflagshiphbp-sga1-ga720270), Luminous project (EU-H2020-fetopenga686764), Center-TBI project, James McDonnell Foundation, European Space Agency, Belspo, Fondazione Europea di Ricerca Biomedica, the BIAL Foundation, Wallonia Brussels Federation Concerted Research Action, Cefaly Technology and Mind Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5651; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Brunoni AR, 2011, PROG NEURO-PSYCHOPH, V35, P96, DOI 10.1016/j.pnpbp.2010.09.010; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Castillo-Saavedra L, 2016, J PAIN, V17, P14, DOI 10.1016/j.jpain.2015.09.009; Charvet L, 2018, NEUROMODULATION, V21, P383, DOI 10.1111/ner.12583; Charvet LE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00026; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Dunlay SM, 2011, MAYO CLIN PROC, V86, P273, DOI 10.4065/mcp.2010.0732; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Ferrucci R, 2009, J AFFECT DISORDERS, P118; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2006, COGN BEHAV NEUROL, V19, P21, DOI 10.1097/00146965-200603000-00003; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Huang WS, 2017, BRAIN STIMUL, V10, P718, DOI 10.1016/j.brs.2017.02.001; Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514; Leuchter AF, 2015, BRAIN STIMUL, V8, P787, DOI 10.1016/j.brs.2015.05.005; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nair DG, 2011, RESTOR NEUROL NEUROS, V29, P411, DOI 10.3233/RNN-2011-0612; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Russo C, 2017, NEUROMODULATION, V20, P215, DOI 10.1111/ner.12574; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Saout V., 2010, Annals of Physical and Rehabilitation Medicine, V53, P96, DOI 10.1016/j.rehab.2010.01.002; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Simis M, 2014, NEUROMODULATION, V17, P497, DOI 10.1111/ner.12140; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Thibaut A, 2017, EXPERT REV MED DEVIC, V14, P633, DOI 10.1080/17434440.2017.1352470; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2015, BRAIN STIMUL, V8, P1116, DOI 10.1016/j.brs.2015.07.024; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962	41	29	33	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	SEP-OCT	2018	11	5					982	990		10.1016/j.brs.2018.04.021			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GR2QP	WOS:000442423400003	29759943	Green Published			2021-06-18	
J	Rehman, SU; Ahmad, A; Yoon, GH; Khan, M; Abid, MN; Kim, MO				Rehman, Shafiq Ur; Ahmad, Ashfaq; Yoon, Gwang-Ho; Khan, Mehtab; Abid, Muhammad Noman; Kim, Myeong Ok			Inhibition of c-Jun N-Terminal Kinase Protects Against Brain Damage and Improves Learning and Memory After Traumatic Brain Injury in Adult Mice	CEREBRAL CORTEX			English	Article						amyloidogenic and nonamyloidogeneic pathway; neurodegeneration; oxidative stress; SP600125; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; JNK PATHWAY; MOUSE MODEL; IN-VITRO; CANNABINOID RECEPTORS; TAU PHOSPHORYLATION; THERAPEUTIC TARGET	Traumatic brain injury (TBI) is a global risk factor that leads to long-term cognitive impairments. To date, the disease remains without effective therapeutics because of the multifactorial nature of the disease. Here, we demonstrated that activation of the c-Jun N-terminal kinase (JNK) is involved in multiple pathological features of TBI. Therefore, we investigated the disease-modifying therapeutic potential of JNK-specific inhibitor (SP600125) in TBI mice. Treating 2 different models of TBI mice with SP600125 for 7 days dramatically inhibited activated JNK, resulting in marked reductions of amyloid precursor protein (APP) expression level and in amyloid beta production and hyperphosphorylated tau and regulation of the abnormal expression of secretases. Furthermore, SP600125 strongly inhibited inflammatory responses, blood-brain barrier breakdown, apoptotic neurodegeneration, and synaptic protein loss, regulated prosurvival processes and improved motor function and behavioral outcomes in TBI mice. More interestingly, we found that SP600125 treatment ameliorated amyloidogenic APP processing and promoted the nonamyloidogenic pathway in TBI mouse brains. Our findings strongly suggest that active JNK is critically involved in disease development after TBI and that inhibition of JNK with SP600125 is highly efficient for slowing disease progression by reducing multiple pathological features in TBI mouse brains and regulating cognitive dysfunction.	[Rehman, Shafiq Ur; Ahmad, Ashfaq; Yoon, Gwang-Ho; Khan, Mehtab; Abid, Muhammad Noman; Kim, Myeong Ok] Gyeongsang Natl Univ, Coll Nat Sci, Dept Biol & Appl Life Sci BK21, Jinju 660701, South Korea	Kim, MO (corresponding author), Gyeongsang Natl Univ, Coll Nat Sci, Dept Biol & Appl Life Sci BK21, Jinju 660701, South Korea.	mokim@gnu.ac.kr	Bin Abid, Noman/AAP-2032-2021	Bin Abid, Noman/0000-0001-6929-8878	National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2016M3C7A1904391]	This research work was supported by the Brain Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1904391).	Abeti R, 2012, NEUROCHEM RES, V37, P2589, DOI 10.1007/s11064-012-0895-x; Ahmad A, 2017, MOL NEUROBIOL, V54, P2269, DOI 10.1007/s12035-016-9795-4; Ahn JH, 2016, BMB REP, V49, P376, DOI 10.5483/BMBRep.2016.49.7.246; Ando K, 2016, BIOCHEM BIOPH RES CO, V478, P929, DOI 10.1016/j.bbrc.2016.08.053; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Badshah H, 2016, J NEUROIMMUNE PHARM, V11, P48, DOI 10.1007/s11481-015-9623-z; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Chambers JW, 2013, J BIOL CHEM, V288, P1079, DOI 10.1074/jbc.M112.421354; Chang CP, 2016, MOL NEUROBIOL, V53, P7329, DOI 10.1007/s12035-015-9623-2; Chen C, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106248, 10.1371/journal.pone.0092271]; Chen D, 2012, ACTA NEUROCHIR, V154, P1469, DOI 10.1007/s00701-012-1328-y; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Graczyk PP, 2013, FUTURE MED CHEM, V5, P539, DOI [10.4155/FMC.13.34, 10.4155/fmc.13.34]; Guglielmotto M, 2011, J ALZHEIMERS DIS, V27, P871, DOI 10.3233/JAD-2011-110884; Han D, 2016, BRAIN BEHAV IMMUN, V51, P56, DOI 10.1016/j.bbi.2015.07.025; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kim BJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0093-4; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5; Repici M, 2006, ADV EXP MED BIOL, V588, P145; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shoji M, 2000, MOL BRAIN RES, V85, P221, DOI 10.1016/S0169-328X(00)00245-X; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vogel J, 2009, NEUROPHARMACOLOGY, V57, P539, DOI 10.1016/j.neuropharm.2009.07.021; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144; Zhou Q, 2015, ANN NEUROL, V77, P637, DOI 10.1002/ana.24361; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	72	29	30	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	AUG	2018	28	8					2854	2872		10.1093/cercor/bhx164			19	Neurosciences	Neurosciences & Neurology	GP6DH	WOS:000440966600016	29088310	Bronze			2021-06-18	
J	Boris, JR; Bernadzikowski, T				Boris, Jeffrey R.; Bernadzikowski, Thomas			Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program	CARDIOLOGY IN THE YOUNG			English	Article						Ehlers-Danlos; joint hypermobility; concussion; dysautonomia; autoimmune	JOINT HYPERMOBILITY; MANAGEMENT	Objective: The aim of this study was to identify and evaluate demographic and clinical features of paediatric patients with postural orthostatic tachycardia syndrome in a tertiary hospital speciality clinic. Method: This is a retrospective review of clinical data obtained during initial outpatient evaluation. Results: A total of 708 patients met the evaluation criteria. Female patients outnumbered males, 3.45:1. Caucasians were over-represented at 94.1% of patients. Median age at diagnosis was 15.7 years. Joint hypermobility occurred in 57.3% of patients; 22.4% had hypermobile Ehlers-Danlos syndrome; and 34.9% had hypermobility spectrum disorder. Median age of onset of symptoms was 12.6 years in patients with hypermobility versus 13.7 years in those without (p = 0.0001). Median duration of symptoms was 3.3 years with hypermobility versus 1.5 years without (p < 0.00001). Putative triggers included infection in 23.6% of patients, concussion in 11.4%, and surgery/trauma in 2.8%. Concurrent inflammatory disorders were noted in 5.2% of patients. Six symptoms comprised 80% of initial patient complaints. Overall, 66% of patients subsequently had at least 10 symptoms, 50% had at least 14 symptoms, and 30% reported at least 26 symptoms. Symptoms were largely cardiovascular, gastrointestinal, and neurological. Paediatric patients with postural orthostatic tachycardia syndrome seen in a large speciality clinic are predominantly female, are mostly Caucasian, have onset of symptoms in early adolescence, and have symptoms for over two years before diagnosis. Over half of patients have joint hypermobility. More than one-third of patients have a possible autoimmune or inflammatory trigger, including infection, concussion, or surgery/trauma. Patients experience symptoms that are highly variable and multi-system in origin over the course of illness.	[Boris, Jeffrey R.; Bernadzikowski, Thomas] Childrens Hosp Philadelphia, Div Cardiol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Boris, Jeffrey R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Boris, JR (corresponding author), Childrens Hosp Philadelphia, Div Cardiol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	borisj@email.chop.edu	Boris, Jeffrey/AAC-9942-2021; Boris, Jeffrey/L-5204-2019	Boris, Jeffrey/0000-0002-0428-7681	Division of Cardiology at the Children's Hospital of Philadelphia; Dysautonomia International	Students received financial support for their database work from the Division of Cardiology at the Children's Hospital of Philadelphia and from Dysautonomia International.	Burkhardt BEU, 2011, J PEDIATR-US, V158, P28, DOI 10.1016/j.jpeds.2010.07.020; Castori M, 2017, AM J MED GENET C, V175, P148, DOI 10.1002/ajmg.c.31539; Dida BC, 2002, E AFR MED J, V79, P80; Dysautonomia International, 2012, FIND DOCT EXP AUT DI; Fedorowski A, 2017, EUROPACE, V19, P1211, DOI 10.1093/europace/euw154; Friedman AW, 2003, LUPUS, V12, P274, DOI 10.1191/0961203303lu330oa; Gazit Y, 2003, AM J MED, V115, P33, DOI 10.1016/S0002-9343(03)00235-3; George SA, 2016, HEART RHYTHM, V13, P943, DOI 10.1016/j.hrthm.2015.12.012; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Henderson FC, 2017, AM J MED GENET C, V175, P195, DOI 10.1002/ajmg.c.31549; Hoeldtke RD, 2006, CLIN AUTON RES, V16, P390, DOI 10.1007/s10286-006-0373-0; Kanjwal K, 2011, CARDIOL J, V18, P527, DOI 10.5603/CJ.2011.0008; Kanjwal Khalil, 2010, Indian Pacing Electrophysiol J, V10, P173; Kovacic K, 2014, J PEDIATR-US, V164, P1104, DOI 10.1016/j.jpeds.2014.01.046; Li JW, 2014, CHINESE MED J-PEKING, V127, P3684, DOI 10.3760/cma.j.issn.0366-6999.20140244; Mar PL, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00220; Medes J., 1871, AM J MED SCI, P18; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Pianosi PT, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12122; Plash WB, 2013, CLIN SCI, V124, P109, DOI 10.1042/CS20120276; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Raj SR, 2005, CIRCULATION, V111, P2734, DOI 10.1161/CIRCULATIONAHA.104.497594; Robertson D, 1999, AM J MED SCI, V317, P75, DOI 10.1097/00000441-199902000-00001; Rowe PC, 1999, J PEDIATR-US, V135, P494, DOI 10.1016/S0022-3476(99)70173-3; Schondorf R, 1993, CLIN AUTONOMIC DISOR, P641; Sheldon RS, 2015, HEART RHYTHM, V12, pE41, DOI 10.1016/j.hrthm.2015.03.029; Venkatesan T, 2014, EXP BRAIN RES, V232, P2563, DOI 10.1007/s00221-014-3967-0; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067	29	29	29	2	5	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	MAY	2018	28	5					668	674		10.1017/S1047951117002888			7	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	GH6GN	WOS:000433542200007	29357955				2021-06-18	
J	Fuentes, MM; Wang, J; Haarbauer-Krupa, J; Yeates, KO; Durbin, D; Zonfrillo, MR; Jaffe, KM; Temkin, N; Tulsky, D; Bertisch, H; Rivara, FP				Fuentes, Molly M.; Wang, Jin; Haarbauer-Krupa, Juliet; Yeates, Keith Owen; Durbin, Dennis; Zonfrillo, Mark R.; Jaffe, Kenneth M.; Temkin, Nancy; Tulsky, David; Bertisch, Hilary; Rivara, Frederick P.			Unmet Rehabilitation Needs After Hospitalization for Traumatic Brain Injury	PEDIATRICS			English	Article							QUALITY-OF-LIFE; ITEM BANKS; CHILDREN; OUTCOMES; SERVICES; RECOVERY	OBJECTIVES: In this study, we describe unmet service needs of children hospitalized for traumatic brain injury (TBI) during the first 2 years after injury and examine associations between child, family, and injury-related characteristics and unmet needs in 6 domains (physical therapy, occupational therapy, speech therapy, mental health services, educational services, and physiatry). METHODS: Prospective cohort study of children age 8 to 18 years old admitted to 6 hospitals with complicated mild or moderate to severe TBI. Service need was based on dysfunction identified via parent-report compared with retrospective baseline at 6, 12, and 24 months. Needs were considered unmet if the child had no therapy services in the previous 4 weeks, no physiatry services since the previous assessment, or no educational services since injury. Analyses were used to compare met and unmet needs for each domain and time point. Generalized multinomial logit models with robust SEs were used to assess factors associated with change in need from pre-injury baseline to each study time point. RESULTS: Unmet need varied by injury severity, time since injury, and service domain. Unmet need was highest for physiatry, educational services, and speech therapy. Among children with service needs, increased time after TBI and complicated mild TBI were associated with a higher likelihood of unmet rather than met service needs. CONCLUSIONS: Children hospitalized for TBI have persistent dysfunction with unmet needs across multiple domains. After initial hospitalization, children with TBI should be monitored for functional impairments to improve identification and fulfillment of service needs.	[Fuentes, Molly M.; Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Wang, Jin; Jaffe, Kenneth M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Fuentes, Molly M.; Wang, Jin; Jaffe, Kenneth M.; Temkin, Nancy; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Durbin, Dennis] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Durbin, Dennis] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Dept Emergency Med, Providence, RI USA; [Zonfrillo, Mark R.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Tulsky, David] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA; [Tulsky, David] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Bertisch, Hilary; Rivara, Frederick P.] NYU, Sch Med, Rusk Rehabil, New York, NY USA	Fuentes, MM (corresponding author), Seattle Childrens Hosp, Dept Rehabil Med, CW8-6 POB 5371, Seattle, WA 98121 USA.	molly.fuentes@seattlechildrens.org	Yeates, Keith/AAJ-4223-2020; Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563; Yeates, Keith/0000-0001-7680-2892; Fuentes, Molly/0000-0001-8971-228X; Tulsky, David/0000-0002-4335-4509	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196]; Rehabilitation Medicine Scientist Training Program - National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD001097]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, T32HD057822] Funding Source: NIH RePORTER	This study was funded by the Centers for Disease Control and Prevention (CDC) (grant U01CE002196). Dr Fuentes was also supported by the Rehabilitation Medicine Scientist Training Program, funded by the National Institutes of Health (grant K12HD001097). This article does not reflect the official policy or opinions of the CDC or the US Department of Health and Human Services and does not constitute an endorsement of the individuals or their programs by CDC, Health and Human Services, or other components of the federal government and none should be inferred. Funded by the National Institutes of Health (NIH).	Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bertisch H, 2017, QUAL LIFE RES, V26, P1887, DOI 10.1007/s11136-017-1524-6; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon Richard C, 2010, J Appl Meas, V11, P304; Greenspan AI, 2000, BRAIN INJURY, V14, P417; HealthMeasures, 2017, PROMIS; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Lai JS, 2012, NEUROREHAB NEURAL RE, V26, P36, DOI 10.1177/1545968311412054; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rivara FP, 2011, PEDIATRICS, V128; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Steinberg AM, 2013, J TRAUMA STRESS, V26, P1, DOI 10.1002/jts.21780; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	23	29	29	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAY	2018	141	5							e20172859	10.1542/peds.2017-2859			10	Pediatrics	Pediatrics	GE5AV	WOS:000431231300011	29674358	Green Published, Bronze			2021-06-18	
J	Motamedi, V; Kanefsky, R; Matsangas, P; Mithani, S; Jeromin, A; Brock, MS; Mysliwiec, V; Gill, J				Motamedi, Vida; Kanefsky, Rebekah; Matsangas, Panagiotis; Mithani, Sara; Jeromin, Andreas; Brock, Matthew S.; Mysliwiec, Vincent; Gill, Jessica			Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea	SLEEP MEDICINE			English	Article						Tau; Interleukin-6 (IL-6); Obstructive sleep apnea (OSA); Biomarkers; Neurodegeneration; Inflammation	POSITIVE AIRWAY PRESSURE; C-REACTIVE PROTEIN; ALZHEIMERS-DISEASE; AMYLOID-BETA; INTERMITTENT HYPOXIA; COGNITIVE DECLINE; DISORDERS; RISK; BIOMARKERS; DYSFUNCTION	Obstructive sleep apnea (OSA) is characterized by apneas and hypopneas that result in hypoxia, cerebral hypoperfusion, endothelial dysfunction, inflammation, and oxidative stress. These pathophysiologic processes likely contribute to neuronal damage. Tau is a protein that stabilizes microtubules and, along with amyloid beta (A beta), is associated with neurodegenerative processes. We sought to determine if tau and other biomarkers of inflammation were related to OSA severity. Concentrations of tau, A beta 40, A beta 42, c-reactive protein (CRP), TNF-alpha, interleukin (IL)-6, and IL-10 were measured in blood and compared between participants with moderate-severe OSA (n = 28), those with mild OSA (n = 22), and healthy controls (n = 24). The cohort included relatively young, primarily male active duty military personnel without a history of traumatic brain injury or neurodegenerative disease. Total biomarker concentrations were determined from plasma samples using an ultra-sensitive detection method, Simoa (TM), and CRP was assayed by ELISA. Total tau and IL-6 concentrations were elevated in participants with moderate-severe OSA, with a mean apnea-hypopnea index (AHI) of 26.1/h, compared to those with mild OSA (mean AHI 8.6/h) and healthy controls (mean AHI 2.1/h). Tau concentrations were also significantly correlated with the AHI (r = 0.342, p = 0.004). Our findings show that tau is elevated in the blood of young patients with moderate-severe OSA, suggesting that this degree of sleep-disordered breathing is a contributing factor in the development of neurodegenerative disorders. The finding of increased IL-6 further suggests that inflammatory biomarkers are present early in the course of this chronic disease. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Motamedi, Vida; Kanefsky, Rebekah; Mithani, Sara; Gill, Jessica] NINR, NIH, 1 Cloisters Dr, Bethesda, MD 20892 USA; [Matsangas, Panagiotis] Naval Postgrad Sch, Dept Operat Res, Monterey, CA USA; [Jeromin, Andreas] Quanterix, 133 Hartwell Ave, Lexington, MA 02421 USA; [Brock, Matthew S.; Mysliwiec, Vincent] San Antonio Mil Med Ctr, Dept Sleep Med, 1100 Wilford Hall Loop,Bldg 4554, Jbsa Lackland, TX 78236 USA	Gill, J (corresponding author), NINR, 1 Cloister Court,Rm 256, Bethesda, MD 20892 USA.	vida.motamedi@nih.gov; rebekah.kanefsky@nih.gov; pmatsang@nps.edu; sara.mithani@nih.gov; ajeromin@quanterix.com; Matthew.s.brock.mil@mail.mil; vincent.mysliwiec.mil@mail.mil; gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; Matsangas, Panagiotis/L-1154-2015	Matsangas, Panagiotis/0000-0002-9829-4347	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; National Institutes of Health Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027, ZIENR000016] Funding Source: NIH RePORTER	No author has any conflicts of interest to disclose. This work was supported by the Center for Neuroscience and Regenerative Medicine (Grant 60855) and the National Institutes of Health Intramural Research Program.	Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Archontogeorgis K, 2014, PULM MED, V2014, DOI 10.1155/2014/930535; Arnardottir ES, 2012, SLEEP, V35, P921, DOI 10.5665/sleep.1952; Avci AY, 2017, SLEEP BREATH, V21, P703, DOI 10.1007/s11325-017-1486-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry R.B., 2012, AASM MANUAL SCORING; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1602/neurorx.1.2.213; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; Cardenas-Aguayo M.d.C., 2014, NEUROCHEMISTRY; Ciftci TU, 2004, CYTOKINE, V28, P87, DOI 10.1016/j.cyto.2004.07.003; Daulatzai MA, 2015, J NEUROSCI RES, V93, P1778, DOI 10.1002/jnr.23634; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Gharibeh T, 2010, NAT SCI SLEEP, V2, P233, DOI 10.2147/NSS.S6844; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Heeschen C, 2000, J AM COLL CARDIOL, V35, P1535, DOI 10.1016/S0735-1097(00)00581-7; Iber C, 2007, AASM MANUAL SCORING; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Kasasbeh E, 2006, SOUTH MED J, V99, P58, DOI 10.1097/01.smj.0000197705.99639.50; Kheirandish-Gozal L, 2016, SLEEP, V39, P1225, DOI 10.5665/sleep.5838; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lavie L, 2009, RESPIRATION, V78, P361, DOI 10.1159/000243552; Liguori C, 2017, SLEEP, V40; Lutsey PL, 2016, SLEEP, V39, P309, DOI 10.5665/sleep.5434; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Meston N, 2003, J INTERN MED, V254, P447, DOI 10.1046/j.1365-2796.2003.01212.x; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; Miller MA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00224; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Osorio RS, 2014, NEUROBIOL AGING, V35, P1318, DOI 10.1016/j.neurobiolaging.2013.12.030; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Schulz R, 2000, AM J RESP CRIT CARE, V162, P566, DOI 10.1164/ajrccm.162.2.9908091; Shekhar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159099; Shiota S, 2013, J ALZHEIMERS DIS, V37, P325, DOI 10.3233/JAD-130419; Sprecher KE, 2017, NEUROLOGY, V89, P445, DOI 10.1212/WNL.0000000000004171; Su DF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/726178; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Suzuki YJ, 2006, FREE RADICAL BIO MED, V40, P1683, DOI 10.1016/j.freeradbiomed.2006.01.008; Tam CS, 2007, SLEEP, V30, P723, DOI 10.1093/sleep/30.6.723; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thunstrom E, 2015, SLEEP, V38, P463, DOI 10.5665/sleep.4510; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Volpato S, 2001, CIRCULATION, V103, P947; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Yang QC, 2013, NEUROPSYCH DIS TREAT, V9, P1077, DOI 10.2147/NDT.S49868; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18	54	29	31	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAR	2018	43						71	76		10.1016/j.sleep.2017.11.1121			6	Clinical Neurology	Neurosciences & Neurology	FX3MO	WOS:000425976300014	29482817	Other Gold			2021-06-18	
J	Collins-Praino, LE; Arulsamy, A; Katharesan, V; Corrigan, F				Collins-Praino, Lyndsey E.; Arulsamy, Alina; Katharesan, Viythia; Corrigan, Frances			The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						mTBI; Post-concussion syndrome; Inflammation; Cognition; Depression	POST-CONCUSSION SYMPTOMS; ELEVATED PLUS-MAZE; COGNITIVE DEFICITS; ANIMAL-MODEL; MOUSE MODEL; HEAD-INJURY; MICROGLIA; RATS; NEUROINFLAMMATION; ACTIVATION	A small but significant proportion of mild traumatic brain injury (mTBI) sufferers will report persistent symptoms, including depression, anxiety and cognitive deficits, in the months, or even years, following the initial event. This is known as post-concussion syndrome and its pathogenesis is not yet known. This study sought to investigate the role of a peripheral inflammatory insult in the development of ongoing behavioral symptoms following a mTBI. To investigate, male Sprague-Dawley rats were administered a single mTBI using the diffuse impact -acceleration model to generate similar to 100 G of force. Sham animals underwent surgery only. At 5 days following surgery, rats were given either the TLR4 agonist, lipopolysaccharide (LPS, 0.1 mg/kg), or saline via an intraperitoneal injection. mTBI animals showed an exaggerated response to LPS, with an increase in the expression of pro-inflammatory cytokines within the hippocampus at 24 h post-dose, an effect not seen in sham animals. This was associated with the development of persistent behavioral deficits in the mTBI:LPS animals at 3 months post-injury. These behavioral deficits consisted of increased time spent immobile on the forced swim test, indicative of depressive like behavior, impaired cognitive performance on the Barnes Maze and decreased anxiety on the Elevated Plus Maze. In contrast, animals administered mTBI alone had no deficits. This study provides evidence that a peripheral inflammatory stimulus can facilitate ongoing symptoms following a mTBI. As such this provides a basis for further exploration of exogenous factors which promote immune system activation as potential targets for intervention to allow the resolution of symptoms following a mTBI.	[Collins-Praino, Lyndsey E.; Arulsamy, Alina; Katharesan, Viythia; Corrigan, Frances] Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA, Australia	Corrigan, F (corresponding author), Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Head Injury Grp, Adelaide, SA 5005, Australia.	frances.corrigan@adelaide.edu.au	Collins-Praino, Lyndsey/AAB-3318-2019	Collins-Praino, Lyndsey/0000-0002-4380-7600; Corrigan, Frances/0000-0001-6150-8893; Arulsamy, Alina/0000-0003-0993-5622	Neurosurgical Research Foundation	This work was supported by a grant from the Neurosurgical Research Foundation.	AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Bortolato M, 2009, NEUROPSYCHOPHARMACOL, V34, P2746, DOI 10.1038/npp.2009.118; Chongwatpol P, 2015, J INFLAMM RES, V8, P117, DOI 10.2147/JIR.S82261; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Connor TJ, 1997, PHARMACOL BIOCHEM BE, V58, P961, DOI 10.1016/S0091-3057(97)00028-2; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Couch Y, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0572-0; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Erridge C, 2007, AM J CLIN NUTR, V86, P1286; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Harrington ME, 2012, PROG NEUROBIOL, V99, P93, DOI 10.1016/j.pneurobio.2012.07.004; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindemann S, 2008, PHYSIOL BEHAV, V93, P415, DOI 10.1016/j.physbeh.2007.11.038; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Meyer JS, 2008, ANN NY ACAD SCI, V1139, P151, DOI 10.1196/annals.1432.029; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Selkirk GA, 2008, AM J PHYSIOL-REG I, V295, pR611, DOI 10.1152/ajpregu.00917.2007; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; TERMAN M, 1973, J EXP ANAL BEHAV, V20, P439, DOI 10.1901/jeab.1973.20-439; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Winstanley CA, 2011, BRIT J PHARMACOL, V164, P1301, DOI 10.1111/j.1476-5381.2011.01323.x; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	77	29	29	1	59	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 15	2018	336						22	31		10.1016/j.bbr.2017.08.035			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FK3JT	WOS:000413382100004	28855139				2021-06-18	
J	Stephens, JA; Liu, PY; Lu, HZ; Suskauer, SJ				Stephens, Jaclyn A.; Liu, Peiying; Lu, Hanzhang; Suskauer, Stacy J.			Cerebral Blood Flow after Mild Traumatic Brain Injury: Associations between Symptoms and Post-Injury Perfusion	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; arterial spin labeling; mild traumatic brain injury; sports-related concussion; symptomology	CONCUSSION; SPORT; CONNECTIVITY; NETWORKS	Arterial spin labeling (ASL) has emerged as a technique for assessing mild traumatic brain injury (mTBI), as it can noninvasively evaluate cerebrovascular physiology. To date, there is substantial variability in methodology and findings of ASL studies of mTBI. While both increased and decreased perfusion are reported after mTBI, more consistency is emerging when perfusion is examined with regard to symptomology. We evaluated 15 teenage athletes two and six weeks after sports-related concussion (SRC group) using pseudo-continuous ASL. We acquired comparison data from 15 matched controls from a single time point. At each time point, we completed whole-brain contrasts to evaluate differences between the SRC group and controls in relative cerebral blood flow (rCBF). Cluster-level findings directed region of interest (ROI) analyses to test for group differences in rCBF across the left dorsal anterior cingulate cortex (ACC) and left insula. Finally, we evaluated ROI rCBF and symptomology in the SRC group. At two weeks post-injury, the SRC group had significantly higher rCBF in the left dorsal ACC and left insula than controls; at six weeks post-injury, elevated rCBF persisted in the SRC group in the left dorsal ACC. Perfusion in the left dorsal ACC was higher in athletes reporting physical symptoms six weeks post-injury compared with asymptomatic athletes and controls. Overall, these findings are inconsistent with reports of reduced rCBF after mTBI but coherent with studies that report increased perfusion in persons with greater or persistent mTBI-related symptomology. Future work should continue to assess how CBF perfusion relates to symptomology and recovery after mTBI.	[Stephens, Jaclyn A.; Suskauer, Stacy J.] Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA; [Stephens, Jaclyn A.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Stephens, Jaclyn A.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Liu, Peiying; Lu, Hanzhang] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA.	Suskauer@kennedykrieger.org	Liu, Peiying/D-7512-2017	Liu, Peiying/0000-0003-0830-5960	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD007414, R01MH084021, P41 EB015909, R21HD080378]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084021] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health (J.S. 5T32HD007414); (H.L., R01MH084021, P41 EB015909); (S.S., R21HD080378).	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Borsook D, 2013, PROG NEUROBIOL, V104, P93, DOI 10.1016/j.pneurobio.2013.02.003; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Li Y., 2017, P INT SOC MAG RESON, V25, P3808; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Liu AA, 2011, NEUROLOGY, V77, P1518, DOI 10.1212/WNL.0b013e318233b229; Liu P., 2016, P INT SOC MAG RESON, V24, P2877; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mori S, 2016, COMPUT SCI ENG, V18, P21, DOI 10.1109/MCSE.2016.93; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Peng SP, 2016, NEURAL REGEN RES, V11, P257, DOI 10.4103/1673-5374.177733; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927	29	29	29	2	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					241	248		10.1089/neu.2017.5237			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000422918000004	28967326	Green Published			2021-06-18	
J	Broussard, JI; Acion, L; De Jesus-Cortes, H; Yin, T; Britt, JK; Salas, R; Costa-Mattioli, M; Robertson, C; Pieper, AA; Arciniegas, DB; Jorge, R				Broussard, John I.; Acion, Laura; De Jesus-Cortes, Hector; Yin, Terry; Britt, Jeremiah K.; Salas, Ramiro; Costa-Mattioli, Mauro; Robertson, Claudia; Pieper, Andrew A.; Arciniegas, David B.; Jorge, Ricardo			Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice	BRAIN INJURY			English	Article						Animal model; mild traumatic brain injury; spatial memory; anxiety; chronic traumatic encephalopathy	FLUID PERCUSSION INJURY; MOUSE MODEL; SYNAPTIC PLASTICITY; AXONAL INJURY; ANIMAL-MODEL; RAT MODEL; ENCEPHALOPATHY; IMPAIRMENTS; CONCUSSION; DEPRESSION	Primary Objective: Repeated traumatic brain injuries (rmTBI) are frequently associated with debilitating neuropsychiatric conditions such as cognitive impairment, mood disorders, and post-traumatic stress disorder. We tested the hypothesis that repeated mild traumatic brain injury impairs spatial memory and enhances anxiety-like behaviour. Research Design: We used a between groups design using single (smTBI) or repeated (rmTBI) controlled cranial closed skull impacts to mice, compared to a control group. Methods and Procedures: We assessed the effects of smTBI and rmTBI using measures of motor performance (Rotarod Test [RT]), anxiety-like behaviour (Elevated Plus Maze [EPM] and Open Field [OF] tests), and spatial memory (Morris Water Maze [MWM]) within 12 days of the final injury. In separate groups of mice, astrocytosis and microglial activation were assessed 24 hours after the final injury using GFAP and IBA-1 immunohistochemistry. Main Outcomes and Results: RmTBI impaired spatial memory in the MWM and increased anxiety-like behaviour in the EPM and OFT. In addition, rmTBI elevated GFAP and IBA-1 immunohistochemistry throughout the mouse brain. RmTBI produced astrocytosis and microglial activation, and elicited impaired spatial memory and anxiety-like behaviour. Conclusions: rmTBI produces acute cognitive and anxiety-like disturbances associated with inflammatory changes in brain regions involved in spatial memory and anxiety.	[Broussard, John I.; Acion, Laura; Salas, Ramiro; Arciniegas, David B.; Jorge, Ricardo] Baylor Coll Med, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Acion, Laura] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Calculo, CONICET, Buenos Aires, DF, Argentina; [De Jesus-Cortes, Hector; Yin, Terry; Britt, Jeremiah K.; Pieper, Andrew A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Salas, Ramiro; Jorge, Ricardo] Michael E DeBakey VA Med Ctr, Dept Vet Affairs, Houston, TX USA; [Costa-Mattioli, Mauro] Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Holden Comprehens Canc Ctr, Iowa City, IA USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Pieper, Andrew A.] Univ Iowa, Neurol, Iowa City, IA USA; [Pieper, Andrew A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Vet Affairs, Iowa City, IA USA; [Pieper, Andrew A.] Weill Cornell Med Coll, Cornell Autism Res Program, New York, NY USA	Jorge, R (corresponding author), 2002 Holcombe Blvd 2b-122, Houston, TX 77030 USA.	Ricardo.Jorge@bcm.edu	Salas, Ramiro/A-9602-2015; De Jesus-Cortes, Hector/ABC-9091-2020	De Jesus-Cortes, Hector/0000-0001-6983-6963; Pieper, Andrew/0000-0001-6299-6577; Acion, Laura/0000-0001-5213-6012; Broussard, John/0000-0001-7778-1747	Brain Injury Medicine Program; Beth K and Stuart C Yudofsky Division of Neuropsychiatry, Baylor College of Medicine; BCM IDDRC [U54HD083092]; University of Iowa Carver College of Medicine; Michael E DeBakey VA Medical Center	This work was supported by the Brain Injury Medicine Program; Beth K and Stuart C Yudofsky Division of Neuropsychiatry, Baylor College of Medicine [N/A]; BCM IDDRC [U54HD083092]; Brain Injury Medicine program; Beth K and Stuart C Yudofsky Division of Neuropsychiatry, Baylor College of Medicine [N/A]; Unrestricted funds to AAP from the University of Iowa Carver College of Medicine [N/A]; Anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research to A.A.P. [N/A]; Michael E DeBakey VA Medical Center.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avale ME, 2008, P NATL ACAD SCI USA, V105, P15991, DOI 10.1073/pnas.0807635105; Bailey KR, 2009, METHODS BEHAV ANAL M, V2; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McNamara CG, 2014, NAT NEUROSCI, V17, P1658, DOI 10.1038/nn.3843; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Salas R, 2008, MOL PHARMACOL, V74, P1641, DOI 10.1124/mol.108.048454; Salas R, 2007, NEUROPHARMACOLOGY, V53, P863, DOI 10.1016/j.neuropharm.2007.08.017; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Small KM, 2016, NEUROSCI LETT, V616, P80, DOI 10.1016/j.neulet.2016.01.057; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; WELKER WI, 1957, PSYCHOL REP, V3, P95, DOI 10.2466/pr0.1957.3.g.95; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yang KC, 2017, EUR J NEUROSCI, V45, P138, DOI 10.1111/ejn.13406	44	29	30	1	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					113	122		10.1080/02699052.2017.1380228			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300013	29156991				2021-06-18	
J	Kovacs, ZI; Tu, TW; Sundby, M; Qureshi, F; Lewis, BK; Jikaria, N; Burks, SR; Frank, JA				Kovacs, Zsofia I.; Tu, Tsang-Wei; Sundby, Maggie; Qureshi, Farhan; Lewis, Bobbi K.; Jikaria, Neekita; Burks, Scott R.; Frank, Joseph A.			MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain	THERANOSTICS			English	Article						pulsed focused ultrasound; microbubbles; sterile inflammation; blood-brain barrier; hyperphosphorylated Tau	CHRONIC TRAUMATIC ENCEPHALOPATHY; TUMOR BARRIER DISRUPTION; RAT GLIOMA MODEL; ALZHEIMERS-DISEASE; DRUG-DELIVERY; LIPOSOMAL DOXORUBICIN; BLOOD-TUMOR; IN-VIVO; STERILE INFLAMMATION; ANTIBODY DELIVERY	Magnetic resonance imaging (MRI)-guided pulsed focused ultrasound (pFUS) combined with microbubbles (MB) contrast agent infusion has been shown to transiently disrupt the blood-brain barrier (BBBD), increasing the delivery of neurotherapeutics to treat central nervous system (CNS) diseases. pFUS interaction with the intravascular MB results in acoustic cavitation forces passing through the neurovascular unit (NVU), inducing BBBD detected on contrast-enhanced MRI. Multiple pFUS+MB exposures in Alzheimer's disease (AD) models are being investigated as a method to clear amyloid plaques by activated microglia or infiltrating immune cells. Since it has been reported that pFUS+MB can induce a sterile inflammatory response (SIR) [1-5] in the rat, the goal of this study was to investigate the potential long-term effects of SIR in the brain following single and six weekly sonications by serial high-resolution MRI and pathology. Methods: Female Sprague Dawley rats weighing 217 +/- 16.6 g prior to sonication received bromo-deoxyuridine (BrdU) to tag proliferating cells in the brain. pFUS was performed at 548 kHz, ultrasound burst 10 ms and initial peak negative pressure of 0.3 MPa (in water) for 120 s coupled with a slow infusion of similar to 460 mu L/kg (5-8x10(7) MB) that started 30 s before and 30 s during sonication. Nine 2 mm focal regions in the left cortex and four regions over the right hippocampus were treated with pFUS+MB. Serial high-resolution brain MRIs at 3 T and 9.4 T were obtained following a single or during the course of six weekly pFUS+MB resulting in BBBD in the left cortex and the right hippocampus. Animals were monitored over 7 to 13 weeks and imaging results were compared to histology. Results: Fewer than half of the rats receiving a single pFUS+MB exposure displayed hypointense voxels on T2*-weighted (w) MRI at week 7 or 13 in the cortex or hippocampus without differences compared to the contralateral side on histograms of T2* maps. Single sonicated rats had evidence of limited microglia activation on pathology compared to the contralateral hemisphere. Six weekly pFUS+MB treatments resulted in pathological changes on T2* w images with multiple hypointense regions, cortical atrophy, along with 50% of rats having persistent BBBD and astrogliosis by MRI. Pathologic analysis of the multiple sonicated animals demonstrated the presence of metallophagocytic Prussian blue-positive cells in the parenchyma with significantly (p<0.05) increased areas of activated astrocytes and microglia, and high numbers of systemic infiltrating CD68(+) macrophages along with BrdU(+) cells compared to contralateral brain. In addition, multiple treatments caused an increase in the number of hyperphosphorylated Tau (pTau)-positive neurons containing neurofibrillary tangles (NFT) in the sonicated cortex but not in the hippocampus when compared to contralateral brain, which was confirmed by Western blot (WB) (p<0.04). Conclusions: The repeated SIR following multiple pFUS+MB treatments could contribute to changes on MR imaging including persistent BBBD, cortical atrophy, and hypointense voxels on T2w and T2*w images consistent with pathological injury. Moreover, areas of astrogliosis, activated microglia, along with higher numbers of CD68(+) infiltrating macrophages and BrdU(+) cells were detected in multiple sonicated areas of the cortex and hippocampus. Elevations in pTau and NFT were detected in neurons of the multiple sonicated cortex. Minimal changes on MRI and histology were observed in single pFUS+MB-treated rats at 7 and 13 weeks post sonication. In comparison, animals that received 6 weekly sonications demonstrated evidence on MRI and histology of vascular damage, inflammation and neurodegeneration associated with the NVU commonly observed in trauma. Further investigation is recommended of the long-term effects of multiple pFUS+MB in clinical trials.	[Kovacs, Zsofia I.; Tu, Tsang-Wei; Sundby, Maggie; Qureshi, Farhan; Lewis, Bobbi K.; Jikaria, Neekita; Burks, Scott R.; Frank, Joseph A.] NIH, Frank Lab, Clin Ctr, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Tu, Tsang-Wei] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Tu, Tsang-Wei] Howard Univ, Dept Radiol, Mol Imaging Lab, Washington, DC 20059 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	Kovacs, ZI; Frank, JA (corresponding author), Frank Lab, Bldg 10,Room B1N256,10 Ctr Dr,MSC 1074, Bethesda, MD 20854 USA.	zsofia.kovacs@nih.gov; jf5z@nih.gov	Frank, Joseph/W-2021-2019; frank, joseph/AAJ-6680-2020	Burks, Scott/0000-0003-2030-3845; Qureshi, Farhan/0000-0001-5541-1518	Intramural Research Program of the Clinical Center; Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health; Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award) [308049-10.01-60855, CNRM-89-3899]; CLINICAL CENTER [ZIACL040014] Funding Source: NIH RePORTER	This work was supported by the Intramural Research Programs of the Clinical Center and of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health. Dr. Tsang-Wei Tu was funded by the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award #308049-10.01-60855, USU Site No. CNRM-89-3899).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alecou T, 2017, J ULTRAS MED, V36, P2257, DOI 10.1002/jum.14256; Alkins RD, 2013, NEURO-ONCOLOGY, V15, P1225, DOI 10.1093/neuonc/not052; Alonso A, 2010, NEUROSCIENCE, V169, P116, DOI 10.1016/j.neuroscience.2010.04.001; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Amantea D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00147; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Aryal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166061; Aryal M, 2015, J CONTROL RELEASE, V204, P60, DOI 10.1016/j.jconrel.2015.02.033; Aryal M, 2015, PHYS MED BIOL, V60, P2511, DOI 10.1088/0031-9155/60/6/2511; Aryal M, 2013, J CONTROL RELEASE, V169, P103, DOI 10.1016/j.jconrel.2013.04.007; Aslund AKO, 2015, J CONTROL RELEASE, V220, P287, DOI 10.1016/j.jconrel.2015.10.047; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Baseri B, 2012, PHYS MED BIOL, V57, pN65, DOI 10.1088/0031-9155/57/7/N65; Bellucci A, 2011, NEURODEGENER DIS, V8, P221, DOI 10.1159/000322228; Burgess A, 2013, P SPIE, V8588; Burgess A, 2014, RADIOLOGY, V273, P736, DOI 10.1148/radiol.14140245; Burgess A, 2012, J CONTROL RELEASE, V163, P125, DOI 10.1016/j.jconrel.2012.08.012; Burgess A, 2011, THER DELIV, V2, P281, DOI 10.4155/TDE.11.5; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Caselli RJ, 2017, MAYO CLIN PROC, V92, P978, DOI 10.1016/j.mayocp.2017.02.011; Chai WY, 2014, J CONTROL RELEASE, V192, P1, DOI 10.1016/j.jconrel.2014.06.023; Chapman CD, 2013, PHARM RES-DORDR, V30, P2475, DOI 10.1007/s11095-012-0915-1; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen PY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0451-y; Cho H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31201; Chu PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33264; Chu PC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15477; Chu PC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627496; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Downs ME, 2015, SCI REP-UK, V5, DOI 10.1038/srep15076; Downs ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125911; Fix SM, 2018, ULTRASOUND MED BIOL, V44, P1266, DOI 10.1016/j.ultrasmedbio.2018.02.006; Fuger P, 2017, NAT NEUROSCI, V20, P1371, DOI 10.1038/nn.4631; Fung LK., 2017, SCI TRANSL MED, V9; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Goertz DE, 2015, INT J HYPERTHER, V31, P134, DOI 10.3109/02656736.2015.1009179; Gomez Diana, 2012, Front Biosci (Schol Ed), V4, P74; Gurlek A, 1998, J RECONSTR MICROSURG, V14, P337, DOI 10.1055/s-2007-1000187; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Head E, 2012, J ALZHEIMERS DIS, V32, P1029, DOI 10.3233/JAD-2012-120937; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Hong J.T., 2017, CNS NEUROL DISORD DR; Horodyckid C, 2017, J NEUROSURG, V126, P1351, DOI 10.3171/2016.3.JNS151635; Hynynen K, 2003, ACT NEUR S, V86, P555; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Itani M, 2012, MOL IMAGING BIOL, V14, P40, DOI 10.1007/s11307-011-0475-5; Jalali S, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-114; Jordao JF, 2013, EXP NEUROL, V248, P16, DOI 10.1016/j.expneurol.2013.05.008; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kobus T, 2016, J CONTROL RELEASE, V238, P281, DOI 10.1016/j.jconrel.2016.08.001; Kobus T, 2016, ULTRASOUND MED BIOL, V42, P481, DOI 10.1016/j.ultrasmedbio.2015.10.009; Kohler C, 2013, NEUROBIOL AGING, V34, P1369, DOI 10.1016/j.neurobiolaging.2012.11.010; Kovacs ZI, 2017, P NATL ACAD SCI USA; Kovacs Z, 2014, J CONTROL RELEASE, V187, P74, DOI 10.1016/j.jconrel.2014.05.033; Kovacs ZI, 2018, THERANOSTICS, V8, P2245, DOI 10.7150/thno.24181; Kovacs ZI, 2017, P NATL ACAD SCI USA, V114, pE75, DOI 10.1073/pnas.1614777114; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Lee DE, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0390-9; Leinenga G, 2016, NAT REV NEUROL, V12, P161, DOI 10.1038/nrneurol.2016.13; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Liu HL, 2008, ULTRASOUND MED BIOL, V34, P598, DOI 10.1016/j.ultrasmedbio.2008.01.011; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McConnell HL, 2017, J BIOL CHEM, V292, P762, DOI 10.1074/jbc.R116.760215; Mcdannold N, 2008, ULTRASOUND MED BIOL, V34, P930, DOI 10.1016/j.ultrasmedbio.2007.11.009; McDannold N, 2017, ULTRASOUND MED BIOL, V43, P469, DOI 10.1016/j.ultrasmedbio.2016.09.019; McDannold N, 2016, J NEUROSURG, V125, P1539, DOI 10.3171/2015.10.JNS151525; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon D, 2018, THERANOSTICS, V8, P2249, DOI 10.7150/thno.25468; McMahon D, 2017, THERANOSTICS, V7, P3989, DOI 10.7150/thno.21630; McMahon D, 2017, SCI REP-UK, V7, DOI 10.1038/srep45657; Mead BP, 2016, J CONTROL RELEASE, V223, P109, DOI 10.1016/j.jconrel.2015.12.034; Meng Y, 2017, ANN NEUROL, V81, P611, DOI 10.1002/ana.24933; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MOONEN CTW, 1990, SCIENCE, V250, P53, DOI 10.1126/science.2218514; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Mulik RS, 2016, BIOMATERIALS, V83, P257, DOI 10.1016/j.biomaterials.2016.01.021; Mullin L, 2011, CONTRAST MEDIA MOL I, V6, P126, DOI 10.1002/cmmi.414; Nance E, 2014, J CONTROL RELEASE, V189, P123, DOI 10.1016/j.jconrel.2014.06.031; National Research Council (U.S.), 2011, COMM UPD GUID CAR US; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Nisbet RM, 2017, BRAIN, V140, P1220, DOI 10.1093/brain/awx052; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; O'Reilly MA, 2017, J ULTRAS MED, V36, P475, DOI 10.7863/ultra.16.02005; O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417; O'Reilly MA, 2010, PHYS MED BIOL, V55, P5251, DOI 10.1088/0031-9155/55/18/001; O'Reilly MA, 2017, THERANOSTICS, V7, P3573, DOI 10.7150/thno.20621; Olumolade OO, 2016, ULTRASOUND MED BIOL, V42, P2270, DOI 10.1016/j.ultrasmedbio.2016.05.004; Park EJ, 2012, J CONTROL RELEASE, V163, P277, DOI 10.1016/j.jconrel.2012.09.007; Park J, 2017, J CONTROL RELEASE, V250, P77, DOI 10.1016/j.jconrel.2016.10.011; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Ruthirakuhan M, 2016, EXPERT OPIN PHARMACO, V17, P2417, DOI 10.1080/14656566.2016.1258060; Samiotaki G, 2013, IEEE T ULTRASON FERR, V60, P2257, DOI 10.1109/TUFFC.2013.6644731; Scarcelli T, 2014, BRAIN STIMUL, V7, P304, DOI 10.1016/j.brs.2013.12.012; Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x; Sierra C, 2017, J CEREBR BLOOD F MET, V37, P1236, DOI 10.1177/0271678X16652630; Silburt J, 2017, P NATL ACAD SCI USA; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Song KH, 2017, THERANOSTICS, V7, P144, DOI 10.7150/thno.15987; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Stumm RK, 2002, J NEUROSCI, V22, P5865; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Sun P, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7020021; Sun T, 2017, P NATL ACAD SCI USA, V114, pE10281, DOI 10.1073/pnas.1713328114; Suzuki Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00002; Nhan T, 2013, J CONTROL RELEASE, V172, P274, DOI 10.1016/j.jconrel.2013.08.029; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Treat LH, 2012, ULTRASOUND MED BIOL, V38, P1716, DOI 10.1016/j.ultrasmedbio.2012.04.015; Tu TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19094-z; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wei KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058995; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Wu SK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46689; Wu SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090107; Yulug B, 2017, BRAIN RES BULL, V131, P199, DOI 10.1016/j.brainresbull.2017.04.015; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	135	29	30	1	9	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2018	8	17					4837	4855		10.7150/thno.24512			19	Medicine, Research & Experimental	Research & Experimental Medicine	GT0FX	WOS:000444107300019	30279741	DOAJ Gold, Green Published			2021-06-18	
J	Schroll, R; Swift, D; Tatum, D; Couch, S; Heaney, JB; Llado-Farrulla, M; Zucker, S; Gill, F; Brown, G; Buffin, N; Duchesne, J				Schroll, Rebecca; Swift, David; Tatum, Danielle; Couch, Stuart; Heaney, Jiselle B.; Llado-Farrulla, Monica; Zucker, Shana; Gill, Frances; Brown, Griffin; Buffin, Nicholas; Duchesne, Juan			Accuracy of shock index versus ABC score to predict need for massive transfusion in trauma patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Shock index; ABC score; Massive transfusion; Trauma; Hemorrhagic shock; Resuscitation	DAMAGE CONTROL RESUSCITATION; MORTALITY; SURGERY; HEMORRHAGE; SEVERITY; SURVIVAL; UTILITY	Background: Various scoring systems have been developed to predict need for massive transfusion in traumatically injured patients. Assessments of Blood Consumption (ABC) score and Shock Index (SI) have been shown to be reliable predictors for Massive Transfusion Protocol (MTP) activation. However, no study has directly compared these two scoring systems to determine which is a better predictor for MTP activation. The primary objective was to determine whether ABC or SI better predicted the need for MTP in adult trauma patients with severe hemorrhage. Methods: This was a retrospective cohort study which included all injured patients who were trauma activations between January 1, 2009 and December 31, 2013 at an urban Level I trauma center. Patients <18 years old or with traumatic brain injury (TBI) were excluded. ABC and SI were calculated for each patient. MTP was defined as need for >10 units PRBC transfusion within 24 h of emergency department arrival. Sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC) were used to evaluate scoring systems' ability to predict effective MTP utilization. Results: A total of 645 patients had complete data for analysis. Shock Index >= 1 had sensitivity of 67.7% (95% CI 49.5%-82.6%) and specificity of 81.3% (95% CI 78.0%-84.3%) for predicting MTP, and ABC score >= 2 had sensitivity of 47.0% (95% CI 29.8%-64.9%) and specificity of 89.8% (95% CI 87.2%-92.1%). AUROC analyses showed SI to be the strongest predictor followed by ABC score with AUROC values of 0.83 and 0.74, respectively. SI had a significantly greater sensitivity (P = 0.035), but a significantly weaker specificity (P < 0.001) compared to ABC score. Conclusion: ABC score and Shock Index can both be used to predict need for massive transfusion in trauma patients, however SI is more sensitive and requires less technical skill than ABC score. (C) 2017 Elsevier Ltd. All rights reserved.	[Schroll, Rebecca; Swift, David; Couch, Stuart; Heaney, Jiselle B.; Llado-Farrulla, Monica; Zucker, Shana; Gill, Frances; Brown, Griffin; Buffin, Nicholas; Duchesne, Juan] Tulane Sch Med, New Orleans, LA 70112 USA; [Tatum, Danielle] Our Lady Lake Reg Med Ctr, Trauma Specialist Program, Baton Rouge, LA USA	Schroll, R (corresponding author), Tulane Sch Med, Dept Surg, 1430 Tulane Ave,8622, New Orleans, LA 70112 USA.	rschroll@tulane.edu	Zucker, Shana/AAL-3779-2020	Zucker, Shana/0000-0003-4090-3303			Barbosa RR, 2011, J TRAUMA, V71, pS364, DOI 10.1097/TA.0b013e318227f170; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brockamp T, 2012, CRIT CARE, V16, DOI 10.1186/cc11432; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Cantle PM, 2017, CRIT CARE CLIN, V33, P71, DOI 10.1016/j.ccc.2016.08.002; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2010, J TRAUMA, V69, pS33, DOI 10.1097/TA.0b013e3181e42411; DeMuro JP, 2013, AM J EMERG MED, V31, P1260, DOI 10.1016/j.ajem.2013.05.027; Duchesne JC, 2010, J TRAUMA, V69, P46, DOI 10.1097/TA.0b013e3181df91fa; Duchesne JC, 2009, J TRAUMA, V67, P33, DOI 10.1097/TA.0b013e31819adb8e; Era S, 2015, J OBSTET GYNAECOL RE, V41, P39, DOI 10.1111/jog.12480; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; King RW, 1996, ACAD EMERG MED, V3, P1041, DOI 10.1111/j.1553-2712.1996.tb03351.x; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Mcnab A, 2012, SURGERY, V152, P473, DOI 10.1016/j.surg.2012.07.010; Moffat B, 2013, CRIT CARE, V17, DOI 10.1186/cc13040; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; O'Reilly DJ, 2014, J TRAUMA ACUTE CARE, V77, pS66, DOI 10.1097/TA.0000000000000342; Ogura T, 2014, J TRAUMA ACUTE CARE, V76, P1243, DOI 10.1097/TA.0000000000000200; Ohmori T, 2017, INJURY, V48, P1006, DOI 10.1016/j.injury.2016.12.028; PHILLIPS TF, 1987, J TRAUMA, V27, P903, DOI 10.1097/00005373-198708000-00010; RADY MY, 1992, RESUSCITATION, V23, P227, DOI 10.1016/0300-9572(92)90006-X; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schuster KM, 2010, TRANSFUSION, V50, P1545, DOI 10.1111/j.1537-2995.2010.02587.x; Sumida M P, 2000, Air Med J, V19, P140, DOI 10.1016/S1067-991X(00)90007-5; Trajman A, 2008, SCAND J CLIN LAB INV, V68, P77, DOI 10.1080/00365510701666031; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a	31	29	33	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2018	49	1					15	19		10.1016/j.injury.2017.09.015			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FS9VT	WOS:000422767800003	29017765				2021-06-18	
J	Gracies, JM; Esquenazi, A; Brashear, A; Banach, M; Kocer, S; Jech, R; Khatkova, S; Benetin, J; Vecchio, M; McAllister, P; Ilkowski, J; Ochudlo, S; Catus, F; Grandoulier, AS; Vilain, C; Picaut, P				Gracies, Jean-Michel; Esquenazi, Alberto; Brashear, Allison; Banach, Marta; Kocer, Serdar; Jech, Robert; Khatkova, Svetlana; Benetin, Jan; Vecchio, Michele; McAllister, Peter; Ilkowski, Jan; Ochudlo, Stanislaw; Catus, France; Grandoulier, Anne Sophie; Vilain, Claire; Picaut, Philippe		Int AbobotulinumtoxinA Adult Lower	Efficacy and safety of abobotulinumtoxinA in spastic lower limb Randomized trial and extension	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; TOXIN TYPE-A; BOTULINUM TOXIN; DOUBLE-BLIND; HEMIPARETIC PATIENTS; STROKE; PLACEBO; PARESIS; GAIT; ADULTS	Objective: To demonstrate single abobotulinumtoxinA injection efficacy in lower limb vs placebo for adults with chronic hemiparesis and assess long-term safety and efficacy of repeated injections. Methods: In a multicenter, double-blind, randomized, placebo-controlled, single-cycle study followed by a 1-year open-label, multiple-cycle extension, adults >= 6 months after stroke/brain injury received one lower limb injection (abobotulinumtoxinA 1,000 U, abobotulinumtoxinA 1,500 U, placebo) followed by <= 4 open-label cycles (1,000, 1,500 U) at >= 12-week intervals. Efficacy measures included Modified Ashworth Scale (MAS) in gastrocnemius-soleus complex (GSC; double-blind primary endpoint), physician global assessment (PGA), and comfortable barefoot walking speed. Safety was the open-label primary endpoint. Results: After a single injection, mean (95% confidence interval) MAS GSC changes from baseline at week 4 (double-blind, n = 381) were as follows: -0.5 (-0.7 to -0.4) (placebo, n = 128), -0.6 (-0.8 to -0.5) (abobotulinumtoxinA 1,000 U, n = 125; p = 0.28 vs placebo), and -0.8 (-0.9 to -0.7) (abobotulinumtoxinA 1,500 U, n = 128; p = 0.009 vs placebo). Mean week 4 PGA scores were as follows: 0.7 (0.5, 0.9) (placebo), 0.9 (0.7, 1.1) (1,000 U; p = 0.067 vs placebo), and 0.9 (0.7, 1.1) (1,500 U; p = 0.067); walking speed was not significantly improved vs placebo. At cycle 4, week 4 (open-label), mean MAS GSC change reached -1.0. Incremental improvements in PGA and walking speed occurred across open-label cycles; by cycle 4, week 4, mean PGA was 1.9, and walking speed increased 125.3% (17.5, 33.2), with 16% of participants walking >0.8 m/s (associated with community mobility; 0% at baseline). Tolerability was good and consistent with the known abobotulinumtoxinA safety profile. Conclusions: In chronic hemiparesis, single abobotulinumtoxinA (Dysport Ipsen) administration reduced muscle tone. Repeated administration over a year was well-tolerated and improved walking speed and likelihood of achieving community ambulation.	[Gracies, Jean-Michel] Univ Paris Est, Hosp Albert Chenevier Henri Mondor, Serv Reeducat Neurolocomotrice, EA BIOTN 7377, Creteil, France; [Esquenazi, Alberto] Moss Rehab, Gait & Mot Anal Lab, Elkins Pk, PA USA; [Brashear, Allison] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA; [Banach, Marta] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland; [Kocer, Serdar] Ctr Reeducat Hop Jura, Porrentruy, Switzerland; [Jech, Robert] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; Gen Fac Hosp, Prague, Czech Republic; [Khatkova, Svetlana] Minist Hlth & Social Dev Russian Federat, Dept Neurol, Fed State Hosp, Treatments & Rehabil, Moscow, Russia; [Benetin, Jan] Slovak Med Univ Bratislava, Dept Neurol, Fac Med, Bratislava, Slovakia; Univ Hosp Bratislava, Bratislava, Slovakia; [Vecchio, Michele] AOU OVE Policlin, Dept Med Sci, UOC Phys Med & Rehabilitat, Catania, Italy; [McAllister, Peter] New England Inst Neurol & Headache, Stamford, CT USA; [Ilkowski, Jan] Nzoz Neuro Card, Ilkowski Partner, Poznan, Poland; [Ochudlo, Stanislaw] Cent Clin Hosp, Stroke Dept, Katowice, Poland; [Ochudlo, Stanislaw] Cent Clin Hosp, Dept Neurol, Katowice, Poland; [Catus, France] Assesoria Croissance, Santiago, Chile; [Grandoulier, Anne Sophie; Vilain, Claire; Picaut, Philippe] Ipsen Innovat, Les Ulis, France	Gracies, JM (corresponding author), Univ Paris Est, Hosp Albert Chenevier Henri Mondor, Serv Reeducat Neurolocomotrice, EA BIOTN 7377, Creteil, France.	jean-michel.gracies@aphp.fr	Kocer, Serdar/AAG-2708-2019; DECAVEL, Pierre/H-4032-2017	DECAVEL, Pierre/0000-0002-0567-7171; Vecchio, Michele/0000-0001-5254-3283; Jech, Robert/0000-0002-9732-8947; Ilkowski, Jan/0000-0002-9277-7532	IpsenIpsen	This study was sponsored by Ipsen. Jean-Michel Gracies wrote the first draft of the manuscript. Medical writing assistance (technical editing, preparation of figures and tables) was provided by Catherine Risebro of Mudskipper Business Ltd., funded by Ipsen. The clinical research organization responsible for the study was INC Research. The Article Processing Charge was funded by Ipsen.	Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P1558, DOI 10.1136/jnnp.2003.035139; Burbaud P, 1996, J NEUROL NEUROSUR PS, V61, P265, DOI 10.1136/jnnp.61.3.265; de Bruin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101038; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Esquenazi A, 2015, TOXICON S, V93, pS24; Gracies JM, 2015, ANN PHYS REHABIL MED, V58, P173, DOI 10.1016/j.rehab.2015.04.004; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Hesse S, 1995, NEUROSCI LETT, V201, P37, DOI 10.1016/0304-3940(94)12124-9; Hutin E, 2012, GAIT POSTURE, V36, P205, DOI 10.1016/j.gaitpost.2012.02.016; Kaji R, 2010, J NEUROL, V257, P1330, DOI 10.1007/s00415-010-5526-3; Kollen B, 2006, PHYS THER, V86, P618, DOI 10.1093/ptj/86.5.618; Martin A, 2014, NEUROPSYCH DIS TREAT, V10, P111, DOI 10.2147/NDT.S53913; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Perera S, 2016, J GERONTOL A-BIOL, V71, P63, DOI 10.1093/gerona/glv126; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360	23	29	35	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 28	2017	89	22					2245	2253		10.1212/WNL.0000000000004687			9	Clinical Neurology	Neurosciences & Neurology	FP5RI	WOS:000417678300012	29093068	Green Published			2021-06-18	
J	Zhu, XY; Frechou, M; Liere, P; Zhang, SD; Pianos, A; Fernandez, N; Denier, C; Mattern, C; Schumacher, M; Guennoun, R				Zhu, Xiaoyan; Frechou, Magalie; Liere, Philippe; Zhang, Shaodong; Pianos, Antoine; Fernandez, Neike; Denier, Christian; Mattern, Claudia; Schumacher, Michael; Guennoun, Rachida			A Role of Endogenous Progesterone in Stroke Cerebroprotection Revealed by the Neural-Specific Deletion of Its Intracellular Receptors	JOURNAL OF NEUROSCIENCE			English	Article						aging; endogenous; neuroprotection; progesterone receptors; sex differences; steroids	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; NERVOUS-SYSTEM; GABA(A) RECEPTORS; PERMANENT STROKE; ISCHEMIC-STROKE; INFARCT VOLUME; STEROID-LEVELS; TIME; NEUROSTEROIDS	Treatment with progesterone protects the male and female brain against damage after middle cerebral artery occlusion (MCAO). However, in both sexes, the brain contains significant amounts of endogenous progesterone. It is not known whether endogenously produced progesterone enhances the resistance of the brain to ischemic insult. Here, we used steroid profiling by gas chromatography-tandem mass spectrometry (GC-MS/ MS) for exploring adaptive and sex-specific changes in brain levels of progesterone and its metabolites after MCAO. Weshow that, in the male mouse brain, progesterone is mainly metabolized via 5 alpha-reduction leading to 5 alpha-dihydroprogesterone (5 alpha-DHP), also a progesterone receptor (PR) agonist ligand in neural cells, then to 3 alpha,5 alpha-tetrahydroprogesterone (3 alpha,5 alpha-THP). In the female mouse brain, levels of 5 alpha-DHP and 3 alpha,5 alpha-THP are lower and levels of 20 alpha-DHP are higher than in males. After MCAO, levels of progesterone and 5 alpha-DHP are upregulated rapidly to pregnancy-like levels in the male but not in the female brain. To assess whether endogenous progesterone and 5 alpha-DHPcontribute to the resistance of neural cells to ischemic damage, weinactivatedPRselectively in the CNS. Deletion of PR in the brain reduced its resistance to MCAO, resulting in increased infarct volumes and neurological deficits in both sexes. Importantly, endogenous PR ligands continue to protect the brain of aging mice. These results uncover the unexpected importance of endogenous progesterone and its metabolites in cerebroprotection. They also reveal that the female reproductive hormone progesterone is an endogenous cerebroprotective neurosteroid in both sexes.	[Zhu, Xiaoyan; Frechou, Magalie; Liere, Philippe; Zhang, Shaodong; Pianos, Antoine; Fernandez, Neike; Denier, Christian; Schumacher, Michael; Guennoun, Rachida] U1195 Inserm, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [Zhu, Xiaoyan; Frechou, Magalie; Liere, Philippe; Zhang, Shaodong; Pianos, Antoine; Fernandez, Neike; Denier, Christian; Schumacher, Michael; Guennoun, Rachida] Univ Paris Sud, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [Zhu, Xiaoyan; Frechou, Magalie; Liere, Philippe; Zhang, Shaodong; Pianos, Antoine; Fernandez, Neike; Denier, Christian; Schumacher, Michael; Guennoun, Rachida] Univ Paris Saclay, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [Zhang, Shaodong] Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Denier, Christian] Bicetre Hosp, Dept Neurol, F-94276 Le Kremlin Bicetre, France; [Denier, Christian] Bicetre Hosp, Stroke Ctr, F-94276 Le Kremlin Bicetre, France; [Mattern, Claudia] MetP Pharma AG, CH-6376 Emmetten, Switzerland; [Zhu, Xiaoyan] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China	Schumacher, M; Guennoun, R (corresponding author), U1195 Inserm, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.; Schumacher, M; Guennoun, R (corresponding author), Univ Paris Sud, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.; Schumacher, M; Guennoun, R (corresponding author), Univ Paris Saclay, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.	michael.schumacher@inserm.fr; rachida.guennoun@inserm.fr	Guennoun, Rachida/F-2420-2011; Schumacher, Michael/G-3581-2013; Frechou, Magalie/I-6598-2015	Guennoun, Rachida/0000-0002-9219-7300; Schumacher, Michael/0000-0001-6117-5371; Fernandez, Neike/0000-0001-9127-248X; Frechou, Magalie/0000-0001-8676-1000	China Scholarship CouncilChina Scholarship Council	X.Z. was funded by a Scholarship from the China Scholarship Council. We thank Pr. Pierre Chambon and the Mouse Clinical Institute (MCI, Illkirch, France) for the generous gift of the PR <SUP>+/loxP</SUP> mice and Brigitte Delespierre, Fanny Aprahamian, and Annie Cambourg for excellent technical assistance.	Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Belelli D, 1996, NEUROPHARMACOLOGY, V35, P1223, DOI 10.1016/S0028-3908(96)00066-4; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; BROWN TJ, 1987, J NEUROSCI, V7, P2529; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Carmichael ST, 2010, STROKE, V41, pS124, DOI 10.1161/STROKEAHA.110.597146; Carswell HVO, 2000, AM J PHYSIOL-HEART C, V278, pH290; CELOTTI F, 1992, FRONT NEUROENDOCRIN, V13, P163; Chen M, 2014, STEROIDS, V83, P17, DOI 10.1016/j.steroids.2014.01.013; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Espinosa-Garcia C, 2017, BRAIN BEHAV IMMUN; Fisher M, 2011, STROKE, V42, pS24, DOI 10.1161/STROKEAHA.110.592394; Franklin KB, 2008, MOUSE BRAIN STEREOTA; Frechou M, 2015, NEUROPHARMACOLOGY, V97, P394, DOI 10.1016/j.neuropharm.2015.06.002; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Gunn BG, 2015, FRONT NEUROENDOCRIN, V36, P28, DOI 10.1016/j.yfrne.2014.06.001; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hillisch A, 2003, STEROIDS, V68, P869, DOI 10.1016/j.steroids.2003.08.009; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Kumar N, 2017, ENDOCRINOLOGY, V158, P170, DOI 10.1210/en.2016-1426; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; LAMBERT JJ, 2009, PSYCHONEUROENDOCRINO, V34, P48; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Liere P, 2004, J LIPID RES, V45, P2287, DOI 10.1194/jlr.M400244-JLR200; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Melcangi RC, 2014, PROG NEUROBIOL, V113, P1, DOI 10.1016/j.pneurobio.2013.09.005; Mergenthaler P, 2011, J PHYSIOL-LONDON, V589, P4147, DOI 10.1113/jphysiol.2011.209718; MURR SM, 1974, ENDOCRINOLOGY, V94, P1209, DOI 10.1210/endo-94-4-1209; Nadeem L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11565; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pelletier G, 2010, STEROIDOGENIC ENZYME; Poletti A, 1998, STEROIDS, V63, P246, DOI 10.1016/S0039-128X(98)00018-X; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed I, 2009, PROGESTERONE NEUROPR; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Sitruk-Ware R, 2013, CLIMACTERIC, V16, P69, DOI 10.3109/13697137.2013.802556; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; TRAISH AM, 1990, ENDOCRINOLOGY, V127, P1167, DOI 10.1210/endo-127-3-1167; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Wali B, 2016, BEHAV BRAIN RES, V305, P46, DOI 10.1016/j.bbr.2016.02.024; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Waters EM, 2008, J COMP NEUROL, V511, P34, DOI 10.1002/cne.21826; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Wong R, 2013, J NEUROENDOCRINOL, V25, P1088, DOI 10.1111/jne.12042; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198	69	29	30	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	NOV 8	2017	37	45					10998	11020		10.1523/JNEUROSCI.3874-16.2017			23	Neurosciences	Neurosciences & Neurology	FM0MX	WOS:000414662100023	28986464	Bronze, Green Published			2021-06-18	
J	Haarbauer-Krupa, J; Ciccia, A; Dodd, J; Ettel, D; Kurowski, B; Lumba-Brown, A; Suskauer, S				Haarbauer-Krupa, Juliet; Ciccia, Angela; Dodd, Jonathan; Ettel, Deborah; Kurowski, Brad; Lumba-Brown, Angela; Suskauer, Stacy			Service Delivery in the Healthcare and Educational Systems for Children Following Traumatic Brain Injury: Gaps in Care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; education; healthcare; rehabilitation; traumatic brain injury	BEHAVIOR PROBLEMS; UNITED-STATES; INPATIENT REHABILITATION; EARLY-CHILDHOOD; YOUNG-CHILDREN; SHORT-TERM; PREDICTORS; OUTCOMES; PERFORMANCE; STUDENTS	Objective: To provide a review of evidence and consensus-based description of healthcare and educational service delivery and related recommendations for children with traumatic brain injury. Methods: Literature review and group discussion of best practices in management of children with traumatic brain injury (TBI) was performed to facilitate consensus-based recommendations from the American Congress on Rehabilitation Medicine's Pediatric and Adolescent Task Force on Brain Injury. This group represented pediatric researchers in public health, medicine, psychology, rehabilitation, and education. Results: Care for children with TBI in healthcare and educational systems is not well coordinated or integrated, resulting in increased risk for poor outcomes. Potential solutions include identifying at-risk children following TBI, evaluating their need for rehabilitation and transitional services, and improving utilization of educational services that support children across the lifespan. Conclusion: Children with TBI are at risk for long-term consequences requiring management as well as monitoring following the injury. Current systems of care have challenges and inconsistencies leading to gaps in service delivery. Further efforts to improve knowledge of the long-term TBI effects in children, child and family needs, and identify best practices in pathways of care are essential for optimal care of children following TBI.	[Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS-F62, Atlanta, GA 30341 USA; [Ciccia, Angela] Dept Psychol Sci, Program Commun Sci, Cleveland, OH USA; [Dodd, Jonathan] St Louis Childrens Hosp, Dept Psychol, St Louis, MO 63178 USA; [Dodd, Jonathan] Washington Univ, Sch Med, St Louis, MO USA; [Ettel, Deborah] Eugene Sch Dist 4J, Educ Support Serv, Eugene, OR USA; [Kurowski, Brad] Univ Cincinnati, Cincinnati Childrens HospitalMed Ctr, Div Phys Med & Rehabil, Dept Pediat & Neurol & Rehabil Med,Coll Med, Cincinnati, OH 45221 USA; [Lumba-Brown, Angela] Washington Univ, Sch Med, St Louis Childrens Hosp, Pediat Emergency Med, St Louis, MO 63130 USA; [Suskauer, Stacy] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA	Haarbauer-Krupa, J (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS-F62, Atlanta, GA 30341 USA.	JHaarbauerKrupa@cdc.gov	Ciccia, Angela/J-5967-2019	Lumba-Brown, Angela/0000-0002-9102-8791	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [L40 HD066480, K23 HD074683] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER		Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Ballard DW, 2013, ACAD EMERG MED, V20, P352, DOI 10.1111/acem.12109; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BEGALI V, 1992, HEAD INJURY CHILDREN; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Bulgren J.A., 2006, TEACHING ADOLESCENTS, P79; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2010, STUD NEUROPSYCHOL NE, P439; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crowe LM, 2005, HDB CLIN NEUROLOGY, V128, P661; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; [Division of Unintentional Injury National Center for Injury Prevention and Control Centers for Disease Control], RAT TBI REL HOSP AG; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2008, NEUROREHABILTIATION, V23, P13; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haarbauer-Krupa J., 2012, ASHA LEADER; Haarbauer-Krupa J, 2009, BRAIN INJURY PROFESS, V6; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Savage RC, 1995, PERSPECT NETW, V3; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schootman M, 2000, BRAIN INJURY, V14, P373; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 2015, J HEAD TRAUMA REHAB, V4, P1; Taylor HG., 2006, EXCEPTIONALITY, V14, P141, DOI [10.1207/s15327035ex1403_3, DOI 10.1207/S15327035EX1403_3, DOI 10.1207/S15327035EX1403_]; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P221; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	82	29	29	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					367	377		10.1097/HTR.0000000000000287			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100092	28060211	Green Accepted			2021-06-18	
J	Tavakoli, S; Peitz, G; Ares, W; Hafeez, S; Grandhi, R				Tavakoli, Samon; Peitz, Geoffrey; Ares, William; Hafeez, Shaheryar; Grandhi, Ramesh			Complications of invasive intracranial pressure monitoring devices in neurocritical care	NEUROSURGICAL FOCUS			English	Article						intracranial monitoring; infection; hemorrhage; complications; considerations; neurocritical care	EXTERNAL VENTRICULAR DRAIN; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC COMPLICATIONS; INTRACEREBRAL HEMORRHAGE; ANTIBIOTIC-PROPHYLAXIS; CATHETER PLACEMENT; CLINICAL-PRACTICE; INFECTION-RATES; RISK-FACTORS; ACCURACY	Intracranial pressure monitoring devices have become the standard of care for the management of patients with pathologies associated with intracranial hypertension. Given the importance of invasive intracranial monitoring devices in the modern neurointensive care setting, gaining a thorough understanding of the potential complications related to device placement- and misplacement-is crucial. The increased prevalence of intracranial pressure monitoring as a management tool for neurosurgical patients has led to the publication of a plethora of papers regarding their indications and complications. The authors aim to provide a concise review of key contemporary articles in the literature concerning important complications with the hope of elucidating practices that improve outcomes for neurocritically ill patients.	[Tavakoli, Samon; Peitz, Geoffrey; Hafeez, Shaheryar; Grandhi, Ramesh] Univ Texas Hlth San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Ares, William] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA	Grandhi, R (corresponding author), Univ Texas Hlth San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	grandhi@uthscsa.edu					Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; AlAzri A, 2017, ACTA NEUROCHIR, V159, P1399, DOI 10.1007/s00701-017-3201-5; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Baum GR, 2017, J NEUROSURG, V127, P1190, DOI 10.3171/2016.9.JNS16367; Bekar A, 1998, NEUROSURG REV, V21, P254, DOI 10.1007/BF01105781; Bergdal O, 2013, CLIN NEUROL NEUROSUR, V115, P1972, DOI 10.1016/j.clineuro.2013.05.026; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; BLOMSTEDT GC, 1985, J NEUROSURG, V62, P694, DOI 10.3171/jns.1985.62.5.0694; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatzi M, 2014, CRIT CARE MED, V42, P66, DOI 10.1097/CCM.0b013e31829a70a5; Citerio G, 2015, CRIT CARE MED, V43, P1630, DOI 10.1097/CCM.0000000000001019; Dandy WE, 1918, ANN SURG, V68, P5, DOI 10.1097/00000658-191807000-00002; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Ehtisham A, 2009, NEUROCRIT CARE, V10, P241, DOI 10.1007/s12028-008-9097-4; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Gard AP, 2017, NEUROCRIT CARE; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; GOPINATH SP, 1993, J NEUROSCI METH, V49, P11, DOI 10.1016/0165-0270(93)90104-Y; Gozal YM, 2014, NEUROCRIT CARE, V21, P147, DOI 10.1007/s12028-013-9936-9; Gray WP, 1996, NEUROSURGERY, V39, P927, DOI 10.1097/00006123-199611000-00008; Guyot LL, 1998, ACT NEUR S, V71, P47; Harrop JS, 2010, NEUROSURGERY, V67, P187, DOI 10.1227/01.NEU.0000370247.11479.B6; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Honda H, 2010, INFECT CONT HOSP EP, V31, P1078, DOI 10.1086/656377; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Jacobs DG, 1998, J NATL MED ASSOC, V90, P417; Jensen TS, 2016, ACTA NEUROCHIR, V158, P1491, DOI 10.1007/s00701-016-2863-8; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Krotz M, 2004, EUR RADIOL, V14, P227, DOI 10.1007/s00330-003-2134-y; Leschke JM, 2017, NEUROCRIT CARE, V27, P11, DOI 10.1007/s12028-016-0350-y; Lewis A, 2016, BRIT J NEUROSURG, V30, P49, DOI 10.3109/02688697.2015.1080222; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Mahan M, 2013, J CLIN NEUROSCI, V20, P1718, DOI 10.1016/j.jocn.2013.03.005; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Miller C, 2017, J NEUROSURG, V126, P289, DOI 10.3171/2015.12.JNS152341; Murthy SB, 2016, NEUROCRIT CARE, V24, P389, DOI 10.1007/s12028-015-0199-5; Naff N, 2011, STROKE, V42, P3009, DOI 10.1161/STROKEAHA.110.610949; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Poblete R, 2017, WORLD NEUROSURG, V99, P599, DOI 10.1016/j.wneu.2016.12.073; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Reyes MM, 2017, INFECT CONT HOSP EP, V38, P574, DOI 10.1017/ice.2017.21; ROSEGAY H, 1992, J NEUROSURG, V76, P1032, DOI 10.3171/jns.1992.76.6.1032; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Stoikes NF, 2008, SURG INFECT, V9, P503, DOI 10.1089/sur.2007.032; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Tanweer O, 2013, J NEUROSURG, V119, P1309, DOI 10.3171/2013.7.JNS13313; Tunkel AR, 2017, CLIN INFECT DIS, V64, P701, DOI 10.1093/cid/cix152; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	59	29	29	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E6	10.3171/2017.8.FOCUS17450			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800017	29088962	Bronze			2021-06-18	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, David B.; Pierrat, Baptiste; Murphy, Jeremiah G.; Gilchrist, Michael D.			Region and species dependent mechanical properties of adolescent and young adult brain tissue	SCIENTIFIC REPORTS			English	Article							P56 MOUSE-BRAIN; VISCOELASTIC PROPERTIES; NONNEURONAL CELLS; WHITE-MATTER; IN-VITRO; AGE; NEURONS; NUMBERS; MODELS; GRAY	Traumatic brain injuries, the leading cause of death and disability in children and young adults, are the result of a rapid acceleration or impact of the head. In recent years, a global effort to better understand the biomechanics of TBI has been undertaken, with many laboratories creating detailed computational models of the head and brain. For these models to produce realistic results they require accurate regional constitutive data for brain tissue. However, there are large differences in the mechanical properties reported in the literature. These differences are likely due to experimental parameters such as specimen age, brain region, species, test protocols, and fiber direction which are often not reported. Furthermore, there is a dearth of reported viscoelastic properties for brain tissue at large-strain and high rates. Mouse, rat, and pig brains are impacted at 10/s to a strain of similar to 36% using a custom-built micro-indenter with a 125 mu m radius. It is shown that the resultant mechanical properties are dependent on specimen-age, species, and region, under identical experimental parameters.	[MacManus, David B.; Pierrat, Baptiste; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Pierrat, Baptiste] Ecole Natl Super Mines, CIS EMSE, SAINBIOSE, F-42023 St Etienne, France; [Pierrat, Baptiste] INSERM, U1059, F-42000 St Etienne, France; [Murphy, Jeremiah G.] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland	Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	michael.gilchrist@ucd.ie		MacManus, David/0000-0003-2959-698X; Pierrat, Baptiste/0000-0001-8064-8496	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	The authors would like to acknowledge Dawn Pork & Bacon, Waterford, for supplying the porcine specimens. This work was made possible by Science Foundation Ireland (Grant No. 12/IP/1732).	Antona-Makoshi J, 2012, P 2012 INT IRCOBI C, V2012, P441; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Basso A., 2006, NEUR DIS PUBL HLTH C, P164; Brady S. T, 2012, BASIC NEUROCHEMISTRY; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Elkin B S, 2010, J BIOMECHANICAL ENG, V132, P1; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Li K., 2015, PLOS ONE, V10; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Maas S., 2015, FEBIO THEORY MANUAL, P94; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; REILAND S, 1978, ACTA RADIOL DIAGN, P15; Riederer BM, 2004, EUR J NEUROSCI, V19, P2039, DOI 10.1111/j.1460-9568.2004.03305.x; Rivlin R. S., 1948, PHILOS T ROYAL SOC A, V241; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sigaard RK, 2016, CEREB CORTEX, V26, P89, DOI 10.1093/cercor/bhu178; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	55	29	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 23	2017	7								13729	10.1038/s41598-017-13727-z			12	Multidisciplinary Sciences	Science & Technology - Other Topics	FK3QH	WOS:000413400500004	29061984	DOAJ Gold, Green Published			2021-06-18	
J	Viglione, DJ; Giromini, L; Landis, P				Viglione, Donald J.; Giromini, Luciano; Landis, Patricia			The Development of the Inventory of Problems-29: A Brief Self-Administered Measure for Discriminating Bona Fide From Feigned Psychiatric and Cognitive Complaints	JOURNAL OF PERSONALITY ASSESSMENT			English	Article							PERSONALITY-ASSESSMENT INVENTORY; MMPI-2; VALIDATION; PATTERNS; PSYCHOPATHOLOGY; SCALE; SIMS; PAI	This article describes the development of the Inventory of Problems-29 (IOP-29), a new, short, paper-and-pencil, self-administered measure of feigned mental and cognitive disorders. Four clinical comparison simulation studies were conducted. Study 1 (n = 451) selected the items and produced an index of potential feigning. Study 2 (n = 331) scaled this index to produce a probability score, and examined its psychometric properties. Study 3 tested the generalizability of Study 2's findings with 2 additional samples (ns = 128 and 90). Results supported the utility of the IOP-29 for discriminating bona fide from feigned psychiatric and cognitive complaints. Validity was demonstrated in feigning mild traumatic brain injury, psychosis, posttraumatic stress disorder, and depression. Within the independent samples of Studies 2 and 3, the brief IOP-29 performed similarly to the MMPI-2 and Personality Assessment Inventory, and perhaps better than the Test of Memory Malingering. Classifications within these samples with base rates of .5 produced sensitivity, specificity, positive predictive power, and negative predictive power statistics of about .80. Further research is needed testing the IOP-29 in ecologically valid field studies.	[Viglione, Donald J.; Landis, Patricia] Alliant Int Univ, Calif Sch Profess Psychol, 10455 Pomerado Rd, San Diego, CA 92131 USA; [Giromini, Luciano] Univ Turin, Dept Psychol, Turin, Italy	Viglione, DJ (corresponding author), Alliant Int Univ, Calif Sch Profess Psychol, 10455 Pomerado Rd, San Diego, CA 92131 USA.	dviglione@alliant.edu	Giromini, Luciano/AAF-9386-2019	Giromini, Luciano/0000-0002-9540-4803			Abramsky A. B, 2005, THESIS; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; BEABER RJ, 1985, AM J PSYCHIAT, V142, P1478; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Blanchard DD, 2003, J PERS ASSESS, V80, P197, DOI 10.1207/S15327752JPA8002_08; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Connell K, 2004, THESIS; Edens JF, 2007, J PERS ASSESS, V88, P33, DOI 10.1207/s15327752jpa8801_05; Elhai JD, 2000, J PERS ASSESS, V75, P449, DOI 10.1207/S15327752JPA7503_06; First M., 1995, STRUCTURED CLIN INTE; Gillard ND., 2010, STRUCTURED INTERVIEW; Green Lawrence C, 1999, THESIS; Green P., 1996, WORD MEMORY TEST USE; Green R.L., 1991, MMPI 2 MMPI INTERPRE; Hawes SW, 2009, PSYCHOL ASSESSMENT, V21, P112, DOI 10.1037/a0015036; Jansak D., 1996, THESIS; Lally SJ, 2003, PROF PSYCHOL-RES PR, V34, P491, DOI 10.1037/0735-7028.34.5.491; Landis P. E., 1996, THESIS; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; McCullaugh J. M, 2011, THESIS; McDougall A., 1996, THESIS; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Mellin D., 1996, THESIS; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Miller HA., 2001, M FAST MILLER FORENS; Morey L, 1996, INTERPRETIVE GUIDE P; Morey L. C., 1991, PERSONALITY ASSESSME; Morey LC., 2007, PERSONALITY ASSESSME; O'Brien S. M, 2004, THESIS; Peters L, 2012, PSYCHOL ASSESSMENT, V24, P66, DOI 10.1037/a0024544; Pizitz T. D, 2001, THESIS; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 1996, J PERS ASSESS, V67, P629, DOI 10.1207/s15327752jpa6703_15; Rogers R, 1998, BEHAV SCI LAW, V16, P147, DOI 10.1002/(SICI)1099-0798(199824)16:1<147::AID-BSL298>3.0.CO;2-3; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 1995, ASSESSMENT, V2, P81; Rogers R., 1991, PSYCHOL ASSESSMENT J, V3, P89, DOI DOI 10.1037/1040-3590.3.1.89; ROGERS R, 1988, CLIN ASSESSMENT MALI; Rogers R., 1991, PSYCHOL ASSESSMENT J, V3, P673, DOI [10.1037/1040-3590.3.4.673, DOI 10.1037/1040-3590.3.4.673]; Rogers R., 2008, CLIN ASSESSMENT MALI, P14; Rogers R., 2013, HDB PSYCHOL, V11, P517; Schaich D., 2000, THESIS; Sellbom M., 2008, CLIN ASSESSMENT MALI, P182; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; Tombaugh TN, 1996, TEST MEMORY MALINGER; Viglione D. J., 1994, BIENN M AM PSYCH LAW; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P; Weber K. A., 2008, THESIS; Widows M, 2004, SIMS STRUCTURED INVE; Wood S. M, 2008, THESIS	56	29	29	2	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3891	1532-7752		J PERS ASSESS	J. Pers. Assess.	SEP-OCT	2017	99	5					534	544		10.1080/00223891.2016.1233882			11	Psychology, Clinical; Psychology, Social	Psychology	FB4UB	WOS:000406136100011	27767344				2021-06-18	
J	Nguyen, S; McKay, A; Wong, DN; Rajaratnam, SM; Spitz, G; Williams, G; Mansfield, D; Ponsford, JL				Nguyen, Sylvia; McKay, Adam; Wong, Dana; Rajaratnam, Shantha M.; Spitz, Gershon; Williams, Gavin; Mansfield, Darren; Ponsford, Jennie L.			Cognitive Behavior Therapy to Treat Sleep Disturbance and Fatigue After Traumatic Brain Injury: A Pilot Randomized Controlled Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Mid-Year Meeting of the International-Neuropsychological-Society	JUL 06-08, 2016	London, ENGLAND	Int Neuropsychol Soc		Brain injuries; Cognitive therapy; Fatigue; Rehabilitation; Sleep; Traumatic	PLACEBO-CONTROLLED TRIAL; MULTIPLE-SCLEROSIS; CANCER-PATIENTS; COMORBID INSOMNIA; QUALITY INDEX; METAANALYSIS; DEPRESSION; SEVERITY; ANXIETY; SCALE	Objective: To evaluate the efficacy of adapted cognitive behavioral therapy (CBT) for sleep disturbance and fatigue in individuals with traumatic brain injury (TBI). Design: Parallel 2-group randomized controlled trial. Setting: Outpatient therapy. Participants: Adults (N=24) with history of TBI and clinically significant sleep and/or fatigue complaints were randomly allocated to an 8 session adapted CBT intervention or a treatment as usual (TAU) condition. Interventions: Cognitive behavior therapy. Main Outcome Measures: The primary outcome was the Pittsburgh Sleep Quality Index (PSQI) posttreatment and at 2-month follow-up. Secondary measures included the Insomnia Severity Index, Fatigue Severity Scale, Brief Fatigue Inventory (BFI), Epworth Sleepiness Scale, and Hospital Anxiety and Depression Scale. Results: At follow-up, CBT recipients reported better sleep quality than those receiving TAU (PSQI mean difference, 4.85; 95% confidence interval [CI], 2.56-7.14). Daily fatigue levels were significantly reduced in the CBT group (BFI difference, 1.54; 95% CI, 0.66-2.42). Secondary improvements were significant for depression. Large within-group effect sizes were evident across measures (Hedges g=1.14-1.93), with maintenance of gains 2 months after therapy cessation. Conclusions: Adapted CBT produced greater and sustained improvements in sleep, daily fatigue levels, and depression compared with TAU. These pilot findings suggest that CBT is a promising treatment for sleep disturbance and fatigue after TBI. (C) 2017 by the American Congress of Rehabilitation Medicine	[Nguyen, Sylvia; McKay, Adam; Wong, Dana; Rajaratnam, Shantha M.; Spitz, Gershon; Mansfield, Darren; Ponsford, Jennie L.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Nguyen, Sylvia; McKay, Adam; Wong, Dana; Rajaratnam, Shantha M.; Spitz, Gershon; Mansfield, Darren; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Nguyen, Sylvia; McKay, Adam; Wong, Dana; Spitz, Gershon; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Williams, Gavin] Epworth Healthcare, Melbourne, Vic, Australia	Nguyen, S (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	sylvia.nguyen@monash.edu	; McKay, Adam/M-6003-2017	Rajaratnam, Shantha/0000-0001-7527-8558; McKay, Adam/0000-0002-0479-7681; Williams, Gavin/0000-0003-2758-7473; Wong, Dana/0000-0001-9619-1929	Centre of Research Excellence for Brain Recovery [1023043]; Epworth Research Institute [80969]	Supported by the Centre of Research Excellence for Brain Recovery (grant no. 1023043) and the Epworth Research Institute (grant no. 80969).	Ashworth DK, 2015, J COUNS PSYCHOL, V62, P115, DOI 10.1037/cou0000059; Beaulieu-Bonneau Simon, 2017, Neuropsychol Rehabil, V27, P983, DOI 10.1080/09602011.2016.1162176; Beck A. T., 1979, COGNITIVE THERAPY DE; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castell BD, 2011, CLIN PSYCHOL-SCI PR, V18, P311, DOI 10.1111/j.1468-2850.2011.01262.x; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Delis D. C., 2000, MANUAL CALIFORNIAN V; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; First MB., 2002, STRUCTURED CLIN INTE; Fleming L, 2014, PSYCHO-ONCOLOGY, V23, P679, DOI 10.1002/pon.3468; Geiger-Brown JM, 2015, SLEEP MED REV, V23, P54, DOI 10.1016/j.smrv.2014.11.007; Gielissen MFM, 2006, J CLIN ONCOL, V24, P4882, DOI 10.1200/JCO.2006.06.8270; Heckler CE, 2016, SUPPORT CARE CANCER, V24, P2059, DOI 10.1007/s00520-015-2996-y; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Raina KD, 2016, J HEAD TRAUMA REHAB, V31, pE41, DOI 10.1097/HTR.0000000000000196; Roscoe JA, 2015, J CLIN ONCOL, V33, P165, DOI 10.1200/JCO.2014.57.6769; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Shekleton JA, 2014, SLEEP, V37, P107, DOI 10.5665/sleep.3318; Shekleton JA, 2010, SLEEP MED REV, V14, P47, DOI 10.1016/j.smrv.2009.06.001; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; van den Akker LE, 2016, J PSYCHOSOM RES, V90, P33, DOI 10.1016/j.jpsychores.2016.09.002; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Wilson, 1991, NATL ADULT READING T; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yun YH, 2012, J CLIN ONCOL, V30, P1296, DOI 10.1200/JCO.2011.37.2979; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	52	29	29	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2017	98	8					1508	1517		10.1016/j.apmr.2017.02.031			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FD1OF	WOS:000407305900002	28400181				2021-06-18	
J	Jiang, MQ; Zhao, YY; Cao, WY; Wei, ZZ; Gu, XH; Wei, L; Yu, SP				Jiang, Michael Qize; Zhao, Ying-Ying; Cao, Wenyuan; Wei, Zheng Zachory; Gu, Xiaohuan; Wei, Ling; Yu, Shan Ping			Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice	BRAIN PATHOLOGY			English	Article						cell survival; ischemic core; neurotrophic factors; neurovasculature; regeneration	FOCAL CEREBRAL-ISCHEMIA; PHARMACOLOGICALLY INDUCED HYPOTHERMIA; TRAUMATIC BRAIN-INJURY; WHISKER-BARREL CORTEX; ARTERY OCCLUSION; SPONTANEOUS REPERFUSION; BLOOD-FLOW; NESTIN EXPRESSION; TEMPORAL PROFILE; CORTICAL-NEURONS	Focal cerebral ischemia results in an ischemic core surrounded by the peri-infarct region (penumbra). Most research attention has been focused on penumbra while the pattern of cell fates inside the ischemic core is poorly defined. In the present investigation, we tested the hypothesis that, inside the ischemic core, some neuronal and vascular cells could survive the initial ischemic insult while regenerative niches might exist many days after stroke in the adult brain. Adult mice were subjected to focal cerebral ischemia induced by permanent occlusion of distal branches of the middle cerebral artery (MCA) plus transient ligations of bilateral common carotid artery (CCA). The ischemic insult uniformly reduced the local cerebral blood flow (LCBF) by 90%. Massive cell death occurred due to multiple mechanisms and a significant infarction was cultivated in the ischemic cortex 24 h later. Nevertheless, normal or even higher levels of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) persistently remained in the core tissue, some NeuN-positive and Glut-1/College IV-positive cells with intact ultrastructural features resided in the core 7-14 days post stroke. BrdU-positive but TUNEL-negative neuronal and endothelial cells were detected in the core where extensive extracellular matrix infrastructure developed. Meanwhile, GFAP-positive astrocytes accumulated in the penumbra and Iba-1-positive microglial/macrophages invaded the core several days after stroke. The long term survival of neuronal and vascular cells inside the ischemic core was also seen after a severe ischemic stroke induced by permanent embolic occlusion of the MCA. We demonstrate that a therapeutic intervention of pharmacological hypothermia could save neurons/endothelial cells inside the core. These data suggest that the ischemic core is an actively regulated brain region with residual and newly formed viable neuronal and vascular cells acutely and chronically after at least some types of ischemic strokes.	[Jiang, Michael Qize; Zhao, Ying-Ying; Cao, Wenyuan; Wei, Zheng Zachory; Gu, Xiaohuan; Wei, Ling; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Zhao, Ying-Ying; Wei, Ling] Capital Med Univ, Friendship Hosp, Dept Neurol, Beijing, Peoples R China; [Wei, Zheng Zachory; Gu, Xiaohuan; Yu, Shan Ping] Atlanta Vet Affair Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA	Yu, SP (corresponding author), Emory Univ, Sch Med, 101 Woodruff Circle,Suite 620, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS075338, NS062097, NS091585, NS073378]; VA National Merit grant [RX000666]; NIH S10 grant [S10 RR025679 01]; O. Wayne Rollins Endowment; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR025679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091585, R01NS062097, R41NS073378, R21NS075338, R44NS073378, R01NS085568, R42NS073378] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000666] Funding Source: NIH RePORTER	This work was supported by NIH grants NS075338 (LW/SPY), NS062097 (LW), NS091585 (LW), NS073378 (SPY) and VA National Merit grant RX000666 (SPY). We acknowledge the Emory Electron Microscope Core supported by NIH S10 grant (S10 RR025679 01). This study was also supported by the O. Wayne Rollins Endowment to SPY.	Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652, DOI 10.1097/00004647-199906000-00008; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; Barber PA, 1998, STROKE, V29, P2522, DOI 10.1161/01.STR.29.12.2522; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; BERECZKI D, 1993, J CEREBR BLOOD F MET, V13, P475, DOI 10.1038/jcbfm.1993.62; Bonova P, 2013, NEUROCHEM INT, V62, P8, DOI 10.1016/j.neuint.2012.10.015; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Cho YS, 2014, INT J MOL MED, V33, P1401, DOI 10.3892/ijmm.2014.1716; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Claus HL, 2013, NEUROPATHOLOGY, V33, P30, DOI 10.1111/j.1440-1789.2012.01322.x; Corbett D, 2000, BRAIN PATHOL, V10, P145; DEGIROLAMI U, 1984, J NEUROPATH EXP NEUR, V43, P57, DOI 10.1097/00005072-198401000-00005; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Garcia JH, 1996, STROKE, V27, P761, DOI 10.1161/01.STR.27.4.761; GARCIA JH, 1994, AM J PATHOL, V144, P188; GARCIA JH, 1974, J NEUROPATH EXP NEUR, V33, P408, DOI 10.1097/00005072-197407000-00007; GARCIA JH, 1993, AM J PATHOL, V142, P623; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Ghobrial GM, 2014, J CLIN NEUROSCI, V21, P2092, DOI 10.1016/j.jocn.2014.05.013; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; HAKIM AM, 1987, ANN NEUROL, V21, P279, DOI 10.1002/ana.410210310; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; JORGENSEN HS, 1994, ARCH NEUROL-CHICAGO, V51, P865, DOI 10.1001/archneur.1994.00540210037011; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kato H, 1999, CELL MOL NEUROBIOL, V19, P93, DOI 10.1023/A:1006920725663; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Koennecke HC, 2003, STROKE, V34, P2434, DOI 10.1161/01.STR.0000095162.75634.CE; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Li Y, 1997, J NEUROL SCI, V150, P93, DOI 10.1016/S0022-510X(97)00075-0; LITTLE JR, 1974, J NEUROSURG, V40, P186, DOI 10.3171/jns.1974.40.2.0186; Liu CL, 2004, NEUROSCIENCE, V127, P113, DOI 10.1016/j.neuroscience.2004.03.062; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Manabat C, 2003, STROKE, V34, P207, DOI 10.1161/01.STR.0000047101.87575.3C; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; Mennel HD, 2000, EXP TOXICOL PATHOL, V52, P395, DOI 10.1016/S0940-2993(00)80070-6; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Nagahiro Shinji, 1998, Journal of Medical Investigation, V45, P57; Nakashima K, 1999, J NEUROTRAUM, V16, P143, DOI 10.1089/neu.1999.16.143; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; Neumann-Haefelin T, 2004, STROKE, V35, P109, DOI 10.1161/01.STR.0000106482.31425.D1; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Ramos-Cejudo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052121; Sandu RE, 2016, NEUROBIOL AGING, V38, P127, DOI 10.1016/j.neurobiolaging.2015.11.006; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Shin YJ, 2013, CELL TISSUE RES, V351, P383, DOI 10.1007/s00441-012-1538-x; Shin YJ, 2013, ACTA HISTOCHEM, V115, P170, DOI 10.1016/j.acthis.2012.06.005; STEINBERG GK, 1986, STROKE, V17, P1193, DOI 10.1161/01.STR.17.6.1193; TOMKINS CE, 1994, J CELL SCI, V107, P1499; Wang LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087284; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Wei L, 1998, NEUROBIOL DIS, V5, P142, DOI 10.1006/nbdi.1998.0199; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Wei N, 2013, CNS NEUROSCI THER, V19, P753, DOI 10.1111/cns.12123; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2	78	29	30	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2017	27	4					480	498		10.1111/bpa.12425			19	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	EW9FF	WOS:000402821500007	27514013	Green Accepted			2021-06-18	
J	Robba, C; Bragazzi, NL; Bertuccio, A; Cardim, D; Donnelly, J; Sekhon, M; Lavinio, A; Duane, D; Burnstein, R; Matta, B; Bacigaluppi, S; Lattuada, M; Czosnyka, M				Robba, Chiara; Bragazzi, Nicola Luigi; Bertuccio, Alessandro; Cardim, Danilo; Donnelly, Joseph; Sekhon, Mypinder; Lavinio, Andrea; Duane, Derek; Burnstein, Rowan; Matta, Basil; Bacigaluppi, Susanna; Lattuada, Marco; Czosnyka, Marek			Effects of Prone Position and Positive End-Expiratory Pressure on Noninvasive Estimators of ICP: A Pilot Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intracranial pressure; optic nerve sheath diameter; positive end-expiratory pressure; prone position; pulsatility index; transcranial Doppler	CEREBRAL PERFUSION-PRESSURE; ELEVATED INTRACRANIAL-PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; NERVE SHEATH DIAMETER; OF-THE-LITERATURE; TRANSCRANIAL DOPPLER; OPTIC-NERVE; PULSATILITY INDEX; LUNG INJURY	Background: Prone positioning and positive end-expiratory pressure can improve pulmonary gas exchange and respiratory mechanics. However, they may be associated with the development of intracranial hypertension. Intracranial pressure (ICP) can be noninvasively estimated from the sonographic measurement of the optic nerve sheath diameter (ONSD) and from the transcranial Doppler analysis of the pulsatility (ICPPI) and the diastolic component (ICPFVd) of the velocity waveform. Methods: The effect of the prone positioning and positive endexpiratory pressure on ONSD, ICPFVd, and ICPPI was assessed in a prospective study of 30 patients undergoing spine surgery. One-way repeated measures analysis of variance, fixed-effect multivariate regression models, and receiver operating characteristic analyses were used to analyze numerical data. Results: The mean values of ONSD, ICPFVd, and ICPPI significantly increased after change from supine to prone position. Receiver operating characteristic analyses demonstrated that, among the noninvasive methods, the mean ONSD measure had the greatest area under the curve signifying it is the most effective in distinguishing a hypothetical change in ICP between supine and prone positioning (0.86 +/- 0.034 [0.79 to 0.92]). A cutoff of 0.43 cm was found to be a best separator of ONSD value between supine and prone with a specificity of 75.0 and a sensitivity of 86.7. Conclusions: Noninvasive ICP estimation may be useful in patients at risk of developing intracranial hypertension who require prone positioning.	[Robba, Chiara; Lavinio, Andrea; Duane, Derek; Burnstein, Rowan; Matta, Basil] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Cardim, Danilo; Donnelly, Joseph; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England; [Bertuccio, Alessandro] Univ London, S George Hosp, Dept Clin Neurosci, Div Neurosurg, London, England; [Bacigaluppi, Susanna] Univ Genoa, Galliera Hosp, Dept Neurosurg, Genoa, Italy; [Robba, Chiara; Lattuada, Marco] Univ Genoa, Galliera Hosp, Dept Intens Care, Genoa, Italy; [Bragazzi, Nicola Luigi] Univ Genoa, Sch Publ Hlth, Dept Hlth Sci DISSAL, Genoa, Italy; [Sekhon, Mypinder] Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada	Robba, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Neurosci Crit Care Unit, Hills Rd,Box 1, Cambridge CB2 0QQ, England.	kiarobba@gmail.com	Bacigaluppi, Susanna/AAK-3041-2020; Donnelly, Joseph/N-6803-2019; Burnstein, Rowan/AAF-3611-2021; Donnelly, Joseph/E-9235-2018; Bragazzi, Nicola Luigi/G-1672-2011; Cardim, Danilo Augusto/B-8447-2012; Robba, Chiara/AAS-7421-2020	Bacigaluppi, Susanna/0000-0002-5727-0728; Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Cardim, Danilo Augusto/0000-0002-9261-1321; Burnstein, Rowan/0000-0003-2107-1433	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK; Woolf Fisher Scholarship (NZ)	D.C. and M.C. are partially supported by NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK. J.D. is supported by a Woolf Fisher Scholarship (NZ). The remaining authors have no conflicts of interest to disclose.	Ab Rahman NHN, 2010, INT J EMERG MED, V3, P315, DOI 10.1007/s12245-010-0233-5; Albin MS, 2014, J NEUROSURG ANESTH, V26, P407, DOI 10.1097/ANA.0000000000000043; Artigas A, 1998, AM J RESP CRIT CARE, V157, P1332, DOI 10.1164/ajrccm.157.4.ats2-98; BECKER H, 1995, J SLEEP RES, V4, P125, DOI 10.1111/j.1365-2869.1995.tb00201.x; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Beuret P, 2002, INTENS CARE MED, V28, P564, DOI 10.1007/s00134-002-1266-x; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Budohoski Karol P, 2012, Acta Neurochir Suppl, V114, P121, DOI 10.1007/978-3-7091-0956-4_22; Cardim D, 2015, J NEUROTRAUMA; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; Gattinoni L, 2008, CAN MED ASSOC J, V178, P1174, DOI 10.1503/cmaj.080359; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Girden ER., 1992, ANOVA REPEATED MEASU; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Kristiansson H, 2014, J NEUROSURG ANESTH, V26, P407, DOI 10.1097/ANA.0000000000000044; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; LAMM WJE, 1994, AM J RESP CRIT CARE, V150, P184, DOI 10.1164/ajrccm.150.1.8025748; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Manzano F, 2008, CRIT CARE MED, V36, P2225, DOI 10.1097/CCM.0b013e31817b8a92; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; Moore F, 2002, J TRAUMA, V53, P492; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Pulitano S, 2013, J NEUROSURG ANESTH, V25, P330, DOI 10.1097/ANA.0b013e31828bac4d; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; Robba C, 2015, ACTA NEUROL SCAND; Robba C, 2015, J CLIN MONIT COMPUT; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; Roth C, 2014, NEUROCRIT CARE, V21, P186, DOI 10.1007/s12028-014-0004-x; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Smith R A, 1977, Respir Care, V22, P470; Sud S, 2014, CAN MED ASSOC J, V186, pE381, DOI 10.1503/cmaj.140081; Weil MH, 2001, CRIT CARE MED, V29, P460, DOI 10.1097/00003246-200102000-00056; Whiteley JR, 2015, J NEUROSURG ANESTH, V27, P155, DOI 10.1097/ANA.0000000000000106; Yiallourou TI, 2013, SLEEP BREATH, V17, P289, DOI 10.1007/s11325-012-0688-0; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	49	29	30	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2017	29	3					243	250		10.1097/ANA.0000000000000295			8	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	EX4UJ	WOS:000403230100006	26998650				2021-06-18	
J	Roy, A; Bernier, RA; Wang, JL; Benson, M; French, JJ; Good, DC; Hillary, FG				Roy, Arnab; Bernier, Rachel A.; Wang, Jianli; Benson, Monica; French, Jerry J., Jr.; Good, David C.; Hillary, Frank G.			The evolution of cost-efficiency in neural networks during recovery from traumatic brain injury	PLOS ONE			English	Article							DEFAULT MODE NETWORK; AMYLOID-BETA; FUNCTIONAL CONNECTIVITY; COMPONENT ANALYSIS; HIPPOCAMPAL; MEMORY; FMRI; SIGNAL; AXONS; ACCUMULATION	A somewhat perplexing finding in the systems neuroscience has been the observation that physical injury to neural systems may result in enhanced functional connectivity (i.e., hyperconnectivity) relative to the typical network response. The consequences of local or global enhancement of functional connectivity remain uncertain and this is particularly true for the overall metabolic cost of the network. We examine the hyperconnectivity hypothesis in a sample of 14 individuals with TBI with data collected at approximately 3, 6, and 12 months following moderate and severe TBI. As anticipated, individuals with TBI showed increased network strength and cost early after injury, but by one-year post injury hyperconnectivity was more circumscribed to frontal DMN and temporal-parietal attentional control regions. Cost in these subregions was a significant predictor of cognitive performance. Cost-efficiency analysis in the Power 264 data parcellation suggested that at 6 months post injury the network requires higher cost connections to achieve high efficiency as compared to the network 12 months post injury. These results demonstrate that networks self-organize to re-establish connectivity while balancing cost-efficiency trade-offs.	[Roy, Arnab; Bernier, Rachel A.; Benson, Monica; French, Jerry J., Jr.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Wang, Jianli] Hershey Med Ctr, Dept Radiol, Hershey, PA USA; [Good, David C.; Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Hillary, Frank G.] Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.; Hillary, FG (corresponding author), Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Bernier, Rachel/0000-0002-2759-9186	New Jersey Commission for Brain Injury Research [09.001.BIR1]; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); NIHUL through Penn State University's Clinical Translational Science Institute [Tr000127]; Social Life and Engineering Sciences Imaging Center; Hershey Medical Center and the Social Sciences Research Institute at the Pennsylvania State University, University Park [PA -16801]; NIHUL through the Clinical Translational Science Institute [Tr000127]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000127, UL1TR002014] Funding Source: NIH RePORTER	This work was funded in part by the New Jersey Commission for Brain Injury Research (09.001.BIR1) and the Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania. The research was also supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127, through Penn State University's Clinical Translational Science Institute. Work was supported by the Social Life and Engineering Sciences Imaging Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127 through the Clinical Translational Science Institute, Hershey Medical Center and the Social Sciences Research Institute at the Pennsylvania State University, University Park, PA -16801.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aerts H., 2016, BRAIN; Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Alexander-Bloch A. F., 2012, CEREB CORTEX; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bernal-Casas D, 2013, NEUROIMAGE, V82, P555, DOI 10.1016/j.neuroimage.2013.05.120; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Hahn A, 2014, BRAIN CONNECT, V20, P1; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Horvat S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002512; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Marchitelli R, 2016, HUM BRAIN MAPP, V37, P2114, DOI 10.1002/hbm.23157; Mazaika PK, 2009, HUM BRAIN MAPP; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Myers N, 2014, BRAIN, V137, P2052, DOI 10.1093/brain/awu103; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nugent AC, 2015, J CEREBR BLOOD F MET, V35, P583, DOI 10.1038/jcbfm.2014.228; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schroeter MS, 2015, J NEUROSCI, V35, P5459, DOI 10.1523/JNEUROSCI.4259-14.2015; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Venkatesan UM, 2014, J NEUROTRAUM, V13, P1; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379	71	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0170541	10.1371/journal.pone.0170541			26	Multidisciplinary Sciences	Science & Technology - Other Topics	ES9KK	WOS:000399875600003	28422992	DOAJ Gold, Green Published			2021-06-18	
J	Rubenstein, R; Chang, BG; Grinkina, N; Drummond, E; Davies, P; Ruditzky, M; Sharma, D; Wang, K; Wisniewski, T				Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Drummond, Eleanor; Davies, Peter; Ruditzky, Meir; Sharma, Deep; Wang, Kevin; Wisniewski, Thomas			Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Total Tau; Tau phosphorylation; GFAP; Cellular prion protein; Cognition; Immunohistochemistry	LONG-TERM POTENTIATION; NR2B-CONTAINING NMDA-RECEPTORS; AMYLOID-BETA OLIGOMERS; ALZHEIMERS-DISEASE; TYROSINE PHOSPHORYLATION; SYNAPTIC-TRANSMISSION; COGNITIVE IMPAIRMENTS; MOUSE MODELS; FYN; NEURODEGENERATION	Studies in vivo and in vitro have suggested that the mechanism underlying Alzheimer's disease (AD) neuropathogenesis is initiated by an interaction between the cellular prion protein (PrPC) and amyloid-beta oligomers (A beta o). This PrPC-A beta o complex activates Fyn kinase which, in turn, hyperphosphorylates tau (P-Tau) resulting in synaptic dysfunction, neuronal loss and cognitive deficits. AD transgenic mice lacking PrPC accumulate A beta, but show normal survival and no loss of spatial learning and memory suggesting that PrPC functions downstream of A beta o production but upstream of intracellular toxicity within neurons. Since AD and traumatic brain injury (TBI)linked chronic traumatic encephalopathy are tauopathies, we examined whether similar mechanistic pathways are responsible for both AD and TBI pathophysiologies. Using transgenic mice expressing different levels of PrPC, our studies investigated the influence and necessity of PrPC on biomarker (total-tau [T-Tau], P-Tau, GFAP) levels in brain and blood as measured biochemically following severe TBI in the form of severe closed head injury (sCHI). We found that following sCHI, increasing levels of T-Tau and P-Tau in the brain were associated with the PrPC expression levels. A similar relationship between PrPC expression and P-Tau levels following sCHI were found in blood in the absence of significant T-Tau changes. This effect was not seen with GFAP which increased within 24 h following sCHI and progressively decreased by the 7 day time point regardless of the PrPC expression levels. Changes in the levels of all biomarkers were independent of gender. We further enhanced and expanded the quantitation of brain biomarkers with correlative studies using immunohisochemistry. We also demonstrate that a TBI-induced calpain hyperactivation is not required for the generation of P-Tau. A relationship was demonstrated between the presence/absence of PrPC, the levels of P-Tau and cognitive dysfunction. Our studies suggest that PrPC is important in mediating TBI related pathology.	[Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Drummond, Eleanor; Wisniewski, Thomas] NYU, Ctr Cognit Neurol, Sch Med, Alexandria ERSP, 450 East 29th St, New York, NY 10016 USA; [Drummond, Eleanor; Wisniewski, Thomas] NYU, Dept Neurol, Sch Med, Alexandria ERSP, 450 East 29th St, New York, NY 10016 USA; [Davies, Peter] Feinstein Inst Med Res, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY 11030 USA; [Wang, Kevin] Univ Florida, Program Neurotrauma Neuroprote & Biomarker Res, Dept Psychiat, Gainesville, FL 32611 USA; [Wang, Kevin] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Wisniewski, Thomas] NYU, Sch Med, Alexandria ERSP, Dept Pathol, 450 East 29th St, New York, NY 10016 USA; [Wisniewski, Thomas] NYU, Sch Med, Alexandria ERSP, Dept Psychiat, 450 East 29th St, New York, NY 10016 USA	Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu	Wisniewski, Thomas/Q-6525-2019; Drummond, Eleanor/AAB-9731-2021	Wisniewski, Thomas/0000-0002-3379-8966; Wang, Kevin/0000-0002-9343-6473; Drummond, Eleanor/0000-0002-5466-4609	Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense (DoD) Broad Agency Announcement [W81XWH-11-2-0069 (RR), W81XWH-14-2-0166 (RR)]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG08051 (TW), NS73502 (TW)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051, R01AG022102] Funding Source: NIH RePORTER	This study is supported in part by the Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense (DoD) Broad Agency Announcement under Award numbers W81XWH-11-2-0069 (RR) and W81XWH-14-2-0166 (RR). Funding was also supplied by NIH awards AG08051 (TW) and NS73502 (TW). The DOD and NIH had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. For the DoD, the U. S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DoD.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Carleton A, 2001, PFLUG ARCH EUR J PHY, V442, P223, DOI 10.1007/s004240100523; Cavallini A, 2013, J BIOL CHEM, V288, P23331, DOI 10.1074/jbc.M113.463984; Chang BG, 2009, J VIROL METHODS, V159, P15, DOI 10.1016/j.jviromet.2009.02.019; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI [10.1586/ern.09.104, 10.1586/ERN.09.104]; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Kojima N, 1998, LEARN MEMORY, V5, P429; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lu YF, 1999, EUR J NEUROSCI, V11, P75, DOI 10.1046/j.1460-9568.1999.00407.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Noble W, 2013, FRONT NEUROL, V4, P88, DOI [10.3389/978-2-88919-261-8, DOI 10.3389/978-2-88919-261-8]; Petit CSV, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24377; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rubenstein R, 2018, BEHAV BRAIN RES, V340, P29, DOI 10.1016/j.bbr.2016.04.041; Rubenstein R, 2012, ELECTROPHORESIS, V33, P3720, DOI 10.1002/elps.201200384; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Suzuki T, 1995, BIOCHEM BIOPH RES CO, P216; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Xia M, 2016, MOL NEUROBIOL, V53, P455, DOI 10.1007/s12035-014-8994-0; Zeng L, 2015, INT J CLIN EXP MED, V8, P8042; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	61	29	29	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 18	2017	5								30	10.1186/s40478-017-0435-7			17	Neurosciences	Neurosciences & Neurology	ES4AM	WOS:000399471400002	28420443	DOAJ Gold, Green Published			2021-06-18	
J	Swanson, TM; Isaacson, BM; Cyborski, CM; French, LM; Tsao, JW; Pasquina, PF				Swanson, Thomas M.; Isaacson, Brad M.; Cyborski, Cherina M.; French, Louis M.; Tsao, Jack W.; Pasquina, Paul F.			Traumatic Brain Injury Incidence, Clinical Overview, and Policies in the US Military Health System Since 2000	PUBLIC HEALTH REPORTS			English	Article						blast injury; classification; military; TBI; traumatic brain injury	GLASGOW COMA SCALE; SERVICE MEMBERS; SUBARACHNOID HEMORRHAGE; COGNITIVE COMPLAINTS; ENDURING FREEDOM; IRAQI FREEDOM; HEAD-INJURY; MILD; MANAGEMENT; REHABILITATION	Exposure to explosive armaments during Operation Iraqi Freedom and Operation Enduring Freedom contributed to approximately 14% of the 352612 traumatic brain injury (TBI) diagnoses in the US military between 2000 and 2016. The US Department of Defense issued guidelines in 2009 to (1) standardize TBI diagnostic criteria; (2) classify TBI according to mechanism and severity; (3) categorize TBI symptoms as somatic, psychological, or cognitive; and (4) systematize types of care given during the acute and rehabilitation stages of TBI treatment. Polytrauma and associated psychological and neurologic conditions may create barriers to optimal rehabilitation from TBI. Given the completion of recent combat operations and the transition of TBI patients into long-term care within the US Department of Veterans Affairs system, a review of the literature concerning TBI is timely. Long-term follow-up care for patients who have sustained TBI will remain a critical issue for the US military.	[Swanson, Thomas M.; Isaacson, Brad M.; Cyborski, Cherina M.; French, Louis M.; Tsao, Jack W.; Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA; [Swanson, Thomas M.; Isaacson, Brad M.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Swanson, Thomas M.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed, Bethesda, MD USA; [Cyborski, Cherina M.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Tsao, Jack W.] US Navy, Bur Med & Surg Wounded Ill & Injured, Falls Church, VA USA; [Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD USA	Swanson, TM (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA.	tmswanson@live.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Center for Rehabilitation Science Research, Department of Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda, MD, USA [HU0001-11-1-0004, HU0001-15-2-0003]	This work is supported by the Center for Rehabilitation Science Research, Department of Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda, MD, USA, awards HU0001-11-1-0004 and HU0001-15-2-0003.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bagalman E., 2013, TRAUMATIC BRAIN INJU; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Centers for Disease Control and Prevention, 2008, EXPL BLAST INJ PRIM; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cifu D, 2011, OVERCOMING POSTDEPLO; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Dunn IF, 2008, ACUTE BRAIN SPINAL C, P1; Fischer H., 2014, GUIDE US MILITARY CA; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Isaacson BM, 2014, ORTHOP RES REV, V6, P27, DOI 10.2147/ORR.S56636; Isaacson Brad M, 2010, US Army Med Dep J, P31; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kim E, 2002, NEUROREHABILITATION, V17, P297; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Management of Concussion/mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Taber KH, 2010, PTSD RES Q, V21, P1; Taielian T, 2008, INVISIBLE WOUNDS WAR; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornton KE, 2008, APPL PSYCHOPHYS BIOF, V33, P101, DOI 10.1007/s10484-008-9056-z; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; US Department of Defense, 2016 DOD TBI WORLDW; US Department of Defense US Department of Veterans Affairs, TRAUM BRAIN INJ TBI; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Yang FPG, 2011, P INT SOC MAG RESON, V19, P346; Yuh EL, 2010, NEUROIMAG CLIN N AM, V20, P597, DOI 10.1016/j.nic.2010.07.012; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	85	29	30	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	MAR-APR	2017	132	2					251	259		10.1177/0033354916687748			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	EP5XU	WOS:000397453100018	28135424	Bronze, Green Published			2021-06-18	
J	Schurman, LD; Lichtman, AH				Schurman, Lesley D.; Lichtman, Aron H.			Endocannabinoids: A Promising Impact for Traumatic Brain Injury	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; cannabinoid; endocannabinoid; neuroprotection; phytocannabinoid	FATTY-ACID AMIDE; CLOSED-HEAD INJURY; CB1 CANNABINOID RECEPTORS; IMPROVES FUNCTIONAL RECOVERY; ACUTE LUNG INJURY; MOUSE MODEL; CELL-DEATH; MOLECULAR CHARACTERIZATION; DECOMPRESSIVE CRANIECTOMY; ISCHEMIC TOLERANCE	The endogenous cannabinoid (endocannabinoid) system regulates a diverse array of physiological processes and unsurprisingly possesses considerable potential targets for the potential treatment of numerous disease states, including two receptors (i.e., CB1 and CB2 receptors) and enzymes regulating their endogenous ligands N-arachidonoylethanolamine (anandamide) and 2-arachidonyl glycerol (2-AG). Increases in brain levels of endocannabinoids to pathogenic events suggest this system plays a role in compensatory repair mechanisms. Traumatic brain injury (TBI) pathology remains mostly refractory to currently available drugs, perhaps due to its heterogeneous nature in etiology, clinical presentation, and severity. Here, we review pre-clinical studies assessing the therapeutic potential of cannabinoids and manipulations of the endocannabinoid system to ameliorate TBI pathology. Specifically, manipulations of endocannabinoid degradative enzymes (e.g., fatty acid amide hydrolase, monoacylglycerol lipase, and a/b-hydrolase domain-6), CB1 and CB2 receptors, and their endogenous ligands have shown promise in modulating cellular and molecular hallmarks of TBI pathology such as; cell death, excitotoxicity, neuroinflammation, cerebrovascular breakdown, and cell structure and remodeling. TBI-induced behavioral deficits, such as learning and memory, neurological motor impairments, post-traumatic convulsions or seizures, and anxiety also respond to manipulations of the endocannabinoid system. As such, the endocannabinoid system possesses potential drugable receptor and enzyme targets for the treatment of diverse TBI pathology. Yet, full characterization of TBI-induced changes in endocannabinoid ligands, enzymes, and receptor populations will be important to understand that role this system plays in TBI pathology. Promising classes of compounds, such as the plant-derived phytocannabinoids, synthetic cannabinoids, and endocannabinoids, as well as their non-cannabinoid receptor targets, such as TRPV1 receptors, represent important areas of basic research and potential therapeutic interest to treat TBI.	[Schurman, Lesley D.; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA	Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	aron.lichtman@vcuhealth.org		O'Brien (nee Schurman), Lesley/0000-0002-5877-3976	Ruth L. Kirshchstein Institutional National Research [1F31NS095628]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DA032933, R01DA039942, P30DA033934]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS095628] Funding Source: NIH RePORTER	This research was funded by a Ruth L. Kirshchstein Institutional National Research Service Award 1F31NS095628 (LS), and NIH award R01 DA032933 (AL), R01DA039942 (AL), P30DA033934 (AL).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; ALVAREZ JM, 2015, PULM RES RESP MED OP, V2, P69; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Antoniou T, 2014, CAN MED ASSOC J, V186, P210, DOI [10.1503/cmaj.130510, 10.1097/MAJ.0000000000000466]; Arai Ken, 2009, Exp Transl Stroke Med, V1, P6, DOI 10.1186/2040-7378-1-6; Assaf F, 2011, BEHAV BRAIN RES, V220, P194, DOI 10.1016/j.bbr.2011.02.005; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Avraham Y, 2008, PROSTAG LEUKOTR ESS, V79, P35, DOI 10.1016/j.plefa.2008.07.003; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BELL RL, 1979, P NATL ACAD SCI USA, V76, P3238, DOI 10.1073/pnas.76.7.3238; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bequet F, 2007, EUR J NEUROSCI, V26, P3458, DOI 10.1111/j.1460-9568.2007.05900.x; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Brambrink AM, 1997, ANAESTHESIST, V46, P953, DOI 10.1007/s001010050492; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Casarejos MJ, 2013, J ALZHEIMERS DIS, V35, P525, DOI 10.3233/JAD-130050; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chu CJ, 2003, J BIOL CHEM, V278, P13633, DOI 10.1074/jbc.M211231200; Corcoran L, 2015, INT REV NEUROBIOL, V125, P203, DOI 10.1016/bs.irn.2015.10.003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Elsohly M. A., 2017, PHYTOCANNABINOIDS, DOI [10.1007/978-3-319-45541-9, DOI 10.1007/978-3-319-45541-9]; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gertsch J, 2010, BRIT J PHARMACOL, V160, P523, DOI 10.1111/j.1476-5381.2010.00745.x; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Gw Research Ltd, 2016, GWP42003P CBD; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hill AJ, 2014, NEUROSCI LETT, V566, P269, DOI 10.1016/j.neulet.2014.03.013; Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Hind WH, 2015, BRIT J PHARMACOL, V172, P3015, DOI 10.1111/bph.13106; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hu DE, 2005, BRIT J PHARMACOL, V146, P576, DOI 10.1038/sj.bjp.0706350; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Kwiatkoski M, 2012, NEUROTOX RES, V21, P271, DOI 10.1007/s12640-011-9273-8; Lambert DM, 1999, CURR MED CHEM, V6, P757; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Mackie K, 2006, INT J OBESITY, V30, pS19, DOI 10.1038/sj.ijo.0803273; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; Mayer S. A., 2010, MERRITTS NEUROLOGY; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Mazarati Andrey, 2006, Epilepsy Curr, V6, P213, DOI 10.1111/j.1535-7511.2006.00149.x; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; MECHOULAM R, 1967, FORT CHEM ORG NAT, V25, P175; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; Mestre L, 2005, J NEUROCHEM, V92, P1327, DOI 10.1111/j.1471-4159.2004.02979.x; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nguyen BM, 2014, AM SURGEON, V80, P979; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niphakis MJ, 2012, ACS CHEM NEUROSCI, V3, P418, DOI 10.1021/cn200089j; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; OKADA M, 1992, NEUROSCI LETT, V140, P55, DOI 10.1016/0304-3940(92)90680-6; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pelosi P, 2005, CURR OPIN CRIT CARE, V11, P37, DOI 10.1097/00075198-200502000-00006; Perez M, 2013, EUR J NEUROSCI, V38, P3424, DOI 10.1111/ejn.12341; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reggio PH, 2002, PROSTAG LEUKOTR ESS, V66, P143, DOI 10.1054/plef.2001.0343; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shiina G, 1998, AM J NEURORADIOL, V19, P297; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Siegel G.J., 1999, BASIC NEUROCHEMISTRY; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Staiano RI, 2016, J LEUKOCYTE BIOL, V99, P531, DOI 10.1189/jlb.3HI1214-584R; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sticht MA, 2016, NEUROPHARMACOLOGY, V102, P92, DOI 10.1016/j.neuropharm.2015.10.039; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stranahan AM, 2011, BEHAV NEUROSCI, V125, P791, DOI 10.1037/a0025133; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Titomanlio L, 2015, PEDIATR NEUROL, V52, P566, DOI 10.1016/j.pediatrneurol.2015.01.016; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Varga K, 1998, FASEB J, V12, P1035; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wallace MJ, 2001, EUR J PHARMACOL, V428, P51, DOI 10.1016/S0014-2999(01)01243-2; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang X, 2016, BRAIN RES, V1646, P174, DOI 10.1016/j.brainres.2016.05.055; Wiley JL, 2014, LIFE SCI, V97, P55, DOI 10.1016/j.lfs.2013.09.011; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zygmunt PM, 1999, NATURE, V400, P452	158	29	30	0	16	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	FEB 17	2017	8								69	10.3389/fphar.2017.00069			17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EK9VI	WOS:000394271600001	28261100	DOAJ Gold, Green Published			2021-06-18	
J	Tyburski, AL; Cheng, L; Assari, S; Darvish, K; Elliott, MB				Tyburski, Ashley L.; Cheng, Lan; Assari, Soroush; Darvish, Kurosh; Elliott, Melanie B.			Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-traumatic headache; Migraine; Concussion; Traumatic brain injury; Trigeminal; Microglia; Astrocytosis; Calcitonin gene-related peptide	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; POSTTRAUMATIC HEADACHE; MILITARY PERSONNEL; NERVE-STIMULATION; MOUSE MODEL; CONCUSSION; ALLODYNIA; MIGRAINE; RATS	Background: Frequent mild head injuries or concussion along with the presence of headache may contribute to the persistence of concussion symptoms. Methods: In this study, the acute effects of recovery between mild head injuries and the frequency of injuries on a headache behavior, trigeminal allodynia, was assessed using von Frey testing up to one week after injury, while histopathological changes in the trigeminal pain pathway were evaluated using western blot, ELISA and immunohistochemistry. Results: A decreased recovery time combined with an increased mild closed head injury (CHI) frequency results in reduced trigeminal allodynia thresholds compared to controls. The repetitive CHI group with the highest injury frequency showed the greatest reduction in trigeminal thresholds along with greatest increased levels of calcitonin gene-related peptide (CGRP) in the trigeminal nucleus caudalis. Repetitive CHI resulted in astrogliosis in the central trigeminal system, increased GFAP protein levels in the sensory barrel cortex, and an increased number of microglia cells in the trigeminal nucleus caudalis. Conclusions: Headache behavior in rats is dependent on the injury frequency and recovery interval between mild head injuries. A worsening of headache behavior after repetitive mild head injuries was concomitant with increases in CGRP levels, the presence of astrocytosis, and microglia proliferation in the central trigeminal pathway. Signaling between neurons and proliferating microglia in the trigeminal pain system may contribute to the initiation of acute headache after concussion or other traumatic brain injuries.	[Tyburski, Ashley L.; Cheng, Lan; Elliott, Melanie B.] Thomas Jefferson Univ, Dept Neurosurg, 1020 Locust St, Philadelphia, PA 19107 USA; [Assari, Soroush; Darvish, Kurosh] Temple Univ, Philadelphia, PA 19122 USA	Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, 1020 Locust St, Philadelphia, PA 19107 USA.	Melanie.elliott@jefferson.edu		CHENG, LAN/0000-0002-3620-3366	DoDUnited States Department of Defense [W81XWH-14-1-0594, W81WH-12-1-0326]	Research Support from DoD Awards W81XWH-14-1-0594, W81WH-12-1-0326 to MBE.	Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Edvinsson L, 1998, J AUTONOM NERV SYST, V70, P15, DOI 10.1016/S0165-1838(98)00033-2; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Grinberg YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019294; Gu N, 2016, CELL REP, V16, P605, DOI 10.1016/j.celrep.2016.06.018; Hazra A., 2014, J NEUROSCI RES; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Honore P, 2000, Prog Brain Res, V129, P357; Katiyar KS, 2017, J TISSUE ENG REGEN M, V11, P2737, DOI 10.1002/term.2168; Kirifides ML, 2001, J COMP NEUROL, V435, P325, DOI 10.1002/cne.1033; Kjeldgaard D, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-81; Kontos Anthony P, 2016, Pediatr Neurol Briefs, V30, P19, DOI 10.15844/pedneurbriefs-30-3-2; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Malhotra R, 2016, ANN INDIAN ACAD NEUR, V19, P175, DOI 10.4103/0972-2327.182302; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; MOUTON PR, 2002, PRINCIPLES PRACTICES; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Neelakantan H, 2012, EUR J PHARMACOL, V686, P55, DOI 10.1016/j.ejphar.2012.04.042; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky ML, 2014, PAIN, V155, P1037, DOI 10.1016/j.pain.2014.02.009; Oshinsky ML, 2012, HEADACHE, V52, P1336, DOI 10.1111/j.1526-4610.2012.02247.x; Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Recober A, 2010, DRUG NEWS PERSPECT, V23, P112, DOI 10.1358/dnp.2010.23.2.1475909; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Rossi HL, 2016, NEUROSCIENCE, V331, P99, DOI 10.1016/j.neuroscience.2016.06.022; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shimizu K, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-75; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Tao YX, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-30; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Ward SJ, 2014, BRIT J PHARMACOL, V171, P636, DOI 10.1111/bph.12439; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	64	29	29	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	FEB 7	2017	18								16	10.1186/s10194-017-0726-1			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EQ0DW	WOS:000397742900001	28176234	DOAJ Gold, Green Published			2021-06-18	
J	Ngo, KT; Varner, EL; Michael, AC; Weber, SG				Ngo, Khanh T.; Varner, Erika L.; Michael, Adrian C.; Weber, Stephen G.			Monitoring Dopamine Responses to Potassium Ion and Nomifensine by in Vivo Microdialysis with Online Liquid Chromatography at One-Minute Resolution	ACS CHEMICAL NEUROSCIENCE			English	Article						Capillary liquid chromatography; electrochemical detection; principal component analysis; dexamethasone; chronic implantation	FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; QUANTITATIVE MICRODIALYSIS; ELECTROCHEMICAL DETECTION; SPREADING DEPRESSION; FLUORESCENCE DETECTION; TEMPORAL RESOLUTION; BRAIN MICRODIALYSIS; PENETRATION INJURY; NUCLEUS-ACCUMBENS	Recently, our laboratory has demonstrated the technical feasibility of monitoring dopamine at 1 min temporal resolution with microdialysis and online liquid chromatography. Here, we monitor dopamine in the rat striatum during local delivery of high potassium/low sodium or nomifensine in awake behaving rats. Microdialysis probes were implanted and perfused continuously with or without dexamethasone in the perfusion fluid for 4 days. Dexamethasone is an anti-inflammatory agent that exhibits several positive effects on the apparent health of the 0 brain tissue surrounding microdialysis probes. Dopamine was monitored 1 or 4 days after implantation under basal conditions, during 10 min applications of 60 mM or 100 mM K+, and during 15 mM applications of 10 mu M nomifensine. High K+ and nomifensine were delivered locally by adding them to the microdialysis perfusion fluid using a computer-controlled, low-dead volume six-port valve. Each day/K+/dexamethasone combination elicited specific dopamine responses. Dexamethasone treatment increased dopamine levels in basal dialysates (i.e., in the absence of K+ or nomifensine). Applications of 60 mM K+ evoked distinct responses on days one and four after probe implantation, depending upon the presence or absence of dexamethasone, consistent with dexamethasone's ability to mitigate the traumatic effect of probe implantation. Applications of 100 mM evoked dramatic oscillations in dopamine levels that correlated with changes in the field potential at a metal electrode implanted adjacent to the microdialysis probe. This combination of results indicates the role of spreading depolarization in response to 100 mM K+. With 1 min temporal resolution, we find that it is possible to characterize the pharmacokinetics of the response to the local delivery of nomifensine. Overall, the findings reported here confirm the benefits arising from the ability to monitor dopamine via microdialysis at high sensitivity and at high temporal resolution.	[Ngo, Khanh T.; Varner, Erika L.; Michael, Adrian C.; Weber, Stephen G.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Weber, SG (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	sweber@pitt.edu	Weber, Stephen G/AAJ-9255-2020	/0000-0002-0101-0249; Ngo, Khanh/0000-0003-2325-5236; Weber, Stephen/0000-0002-7970-2632	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH104386]; National Science FoundationNational Science Foundation (NSF) [DGE-1247842]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH104386] Funding Source: NIH RePORTER	Funding for this work was provided by National Institutes of Health under award number R01 MH104386 (S.G.W.) and a Graduate Research Fellowship from the National Science Foundation, DGE-1247842 (E.L.V.).	Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Brimblecombe K. R., 2016, ACS CHEM NEUROSCI, DOI [10.1021/acschemneuro.6b00333, DOI 10.1021/ACSCHEMNEURO.6B00333.]; BUTCHER SP, 1988, J NEUROCHEM, V50, P346, DOI 10.1111/j.1471-4159.1988.tb02919.x; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; Chen KC, 2005, J NEUROCHEM, V92, P46, DOI 10.1111/j.1471-4159.2004.02848.x; CHURCH WH, 1989, ADV CHROMATOGR, V28, P165; COSFORD RJO, 1994, NEUROSCI LETT, V178, P175, DOI 10.1016/0304-3940(94)90753-6; Davies MI, 1999, ANAL CHIM ACTA, V379, P227, DOI 10.1016/S0003-2670(98)00633-3; DONZANTI BA, 1988, LIFE SCI, V43, P913, DOI 10.1016/0024-3205(88)90267-6; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Gu H, 2015, ANAL CHEM, V87, P6088, DOI 10.1021/acs.analchem.5b00633; Hauber W, 2000, BEHAV BRAIN RES, V111, P39, DOI 10.1016/S0166-4328(99)00197-7; Hows MEP, 2004, J NEUROSCI METH, V138, P123, DOI 10.1016/j.jneumeth.2004.03.021; HURD YL, 1989, LIFE SCI, V45, P283, DOI 10.1016/0024-3205(89)90137-9; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; JUSTICE JB, 1993, J NEUROSCI METH, V48, P263, DOI 10.1016/0165-0270(93)90097-B; KAMETANI H, 1995, NEUROBIOL AGING, V16, P639, DOI 10.1016/0197-4580(95)00047-I; Kehr J, 1998, J CHROMATOGR B, V708, P27, DOI 10.1016/S0378-4347(97)00677-4; Kennedy RT, 2013, CURR OPIN CHEM BIOL, V17, P860, DOI 10.1016/j.cbpa.2013.06.012; KIHARA T, 1993, J NEUROCHEM, V61, P1859, DOI 10.1111/j.1471-4159.1993.tb09827.x; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J; Nandi P, 2009, ANAL CHIM ACTA, V651, P1, DOI 10.1016/j.aca.2009.07.064; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Oyamada T, 1998, NEUROCHEM INT, V32, P171, DOI 10.1016/S0197-0186(97)00068-5; Perry M, 2009, ANAL CHIM ACTA, V653, P1, DOI 10.1016/j.aca.2009.08.038; Peters JL, 1998, J NEUROCHEM, V70, P594; Pusic KM, 2014, GLIA, V62, P1176, DOI 10.1002/glia.22672; Reinhoud NJ, 2013, ACS CHEM NEUROSCI, V4, P888, DOI 10.1021/cn400044s; Richter DW, 1999, J PHYSIOL-LONDON, V514, P567, DOI 10.1111/j.1469-7793.1999.567ae.x; Ripley TL, 1997, J NEUROSCI METH, V78, P7, DOI 10.1016/S0165-0270(97)00129-5; Saigusa T, 2001, J Oral Sci, V43, P129; Saylor RA, 2015, J CHROMATOGR A, V1382, P48, DOI 10.1016/j.chroma.2014.12.086; Shackman HM, 2007, J NEUROSCI METH, V159, P86, DOI 10.1016/j.jneumeth.2006.06.020; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Tang A, 2003, J NEUROSCI METH, V126, P1, DOI 10.1016/S0165-0270(03)00003-7; TELLEZ S, 1992, J CHROMATOGR-BIOMED, V581, P257, DOI 10.1016/0378-4347(92)80279-Y; TOSSMAN U, 1985, NEUROSCI LETT, V62, P231, DOI 10.1016/0304-3940(85)90360-X; TOSSMAN U, 1981, Neuroscience Letters, pS479; Varner EL, 2016, ACS CHEM NEUROSCI, V7, P728, DOI 10.1021/acschemneuro.5b00331; WAGES SA, 1986, ANAL CHEM, V58, P1649, DOI 10.1021/ac00121a012; WESTERINK BHC, 1989, J NEUROCHEM, V52, P722, DOI 10.1111/j.1471-4159.1989.tb02514.x; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Yang H, 2000, ANAL CHEM, V72, P2042, DOI 10.1021/ac991186r; Yang HY, 2015, ACS CHEM NEUROSCI, V6, P1487, DOI 10.1021/acschemneuro.5b00132; Yang HY, 2013, ACS CHEM NEUROSCI, V4, P790, DOI 10.1021/cn400072f; Yoshitake T, 2006, BIOMED CHROMATOGR, V20, P267, DOI 10.1002/bmc.560; Yoshitake T, 2003, ANAL BIOCHEM, V312, P125, DOI 10.1016/S0003-2697(02)00435-9; Zhang J, 2013, ANAL CHEM, V85, P9889, DOI 10.1021/ac4023605; Zhang J, 2012, J CHROMATOGR A, V1251, P54, DOI 10.1016/j.chroma.2012.06.002	52	29	29	2	25	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	FEB	2017	8	2			SI		329	338		10.1021/acschemneuro.6b00383			10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	EL2XH	WOS:000394483300015	28094974	Green Accepted			2021-06-18	
J	Wang, ZF; Pan, ZY; Xu, CS; Li, ZQ				Wang, Ze-Fen; Pan, Zhi-Yong; Xu, Cheng-Shi; Li, Zhi-Qiang			Activation of G-protein coupled estrogen receptor 1 improves early-onset cognitive impairment via PI3K/Akt pathway in rats with traumatic brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury; GPER; Apoptosis; Tau; Hippocampus	CONTROLLED CORTICAL IMPACT; GLOBAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; BLUNT HEAD-INJURY; HIPPOCAMPUS; MICE; GPR30; NEURODEGENERATION; NEUROPROTECTION; PATHOLOGY	Previous studies experimentally reveal that G-protein coupled estrogen receptor 1(GPER) has neuroprotection against ischemic injury. However, its effect on traumatic brain injury (TBI) is less well established. Cognitive impairment following human TBI is a common clinical observation, and TBI is considered as a risk factor for Alzheimer's disease (AD). This study aimed to observe the possible protective effect of GPER on early-onset cognitive impairment after a single TBI and investigate the cellular mechanism underlying its actions. We found that selective GPER agonist G-1 significantly reduced hippocampal CAl neuronal loss and improved cognitive impairment in TBI rats. Although previous studies have shown that AD-like tau pathology occurs many years after both repetitive and single TBI, accumulation of hyperphosphorylated tau was not observed within days (detected at 24 h and 7d) after TBI. Furthermore, tau phosphorylation was not altered by G-1 treatment. It was found that G-1 administration caused an increase in p-Akt level. However, the neuroprotective effects of G-1 on spatial cognition and neuronal death were attenuated by PI3K/Akt inhibitor LY294002. These findings indicate that GPER agonist G-1 had protection on cognitive function via activation of PI3K/Akt signaling. Early onset cognitive impairment following a single TBI was closely associated with acute hippocampal neuronal loss rather than tau pathology. This study suggests that early activation of GPER might be a promising therapeutic strategy for improvement of TBI-induced cognitive outcomes. (C) 2016 Elsevier Inc. All rights reserved.	[Wang, Ze-Fen; Li, Zhi-Qiang] Wuhan Univ, Sch Med, Cerebral Vasc Dis Ctr, Wuhan, Hubei, Peoples R China; [Pan, Zhi-Yong; Xu, Cheng-Shi; Li, Zhi-Qiang] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430071, Hubei, Peoples R China; [Wang, Ze-Fen] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan, Hubei, Peoples R China	Li, ZQ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430071, Hubei, Peoples R China.	lizhigiang@whu.edu.cn			Translational Medical Research Fund of Wuhan University School of Medicine; Innovation Seed Fund of Wuhan University School of Medicine [266078]	This study is supported by Translational Medical Research Fund of Wuhan University School of Medicine and Innovation Seed Fund of Wuhan University School of Medicine (266078). We thank Leyuan Jack Chen from School of Medicine, Texas Tech University Health Sciences Center, for proofreading the manuscript.	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Chakrabarti M, 2016, REV NEUROSCIENCE, V27, P271, DOI 10.1515/revneuro-2015-0032; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Djordjevic J, 2016, CURR ALZHEIMER RES, V13, P730, DOI 10.2174/1567205013666160222110320; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hill J.L., 2016, J NEUROCHEM; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jin-qiu Z., 2013, P WORLD C ENG, V3, P3, DOI DOI 10.3892/01.2012.991; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; lqbal K., 2009, ACTA NEUROPATHOL, V118, P53; Lu D, 2016, BIOCHEM BIOPH RES CO, V477, P209, DOI 10.1016/j.bbrc.2016.06.044; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Nag S, 2014, NEUROSCIENCE, V267, P122, DOI 10.1016/j.neuroscience.2014.02.040; Otto C, 2009, BIOL REPROD, V80, P34, DOI 10.1095/biolreprod.108.071175; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Su SH, 2016, BEHAV BRAIN RES, V313, P334, DOI 10.1016/j.bbr.2016.07.009; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Xu CS, 2015, J NEUROCHEM, V134, P566, DOI 10.1111/jnc.13134; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	37	29	30	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 22	2017	482	4					948	953		10.1016/j.bbrc.2016.11.138			6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EK1XB	WOS:000393720000065	27908726				2021-06-18	
J	Dieterich, AV; Andrade, RJ; Le Sant, G; Falla, D; Petzke, F; Hug, F; Nordez, A				Dieterich, Angela V.; Andrade, Ricardo J.; Le Sant, Guillaume; Falla, Deborah; Petzke, Frank; Hug, Francois; Nordez, Antoine			Shear wave elastography reveals different degrees of passive and active stiffness of the neck extensor muscles	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Muscle activation; Cervical spine; Ultrasound; Shear wave elastography; Neck; Shear modulus; Synergist	2000-2010 TASK-FORCE; LOW-BACK-PAIN; ELASTIC-MODULUS; SKELETAL-MUSCLE; CERVICAL-SPINE; ACTIVATION; CONTRACTION; DETERMINANTS; BIOMECHANICS; RELIABILITY	The neck extensor muscles contribute to spinal support and posture while performing head and neck motion. Muscle stiffness relates to passive elasticity (support) and active tensioning (posture and movement) of muscle. It was hypothesized that support and motion requirements are reflected in the distribution of stiffness between superficial and deep neck extensor muscles. In ten healthy participants, shear modulus (stiffness) of five neck extensor muscles was determined in prone at rest and during isometric head lift at three intensities using shear wave elastography. Shear modulus differed between muscles (P < 0.001), and was larger for the deeper muscles: (median (interquartile range)) trapezius 7.7 kPa (4.4), splenius capitis 6.5 kPa (2.5), semispinalis capitis 8.9 kPa (2.8), semispinalis cervicis 9.5 kPa (2.5), multifidus 14.9 kPa (1.4). Shear modulus differed between the resting condition and head lift (P < 0.001) but not between levels of head lift intensity. Shear wave elastography revealed highest passive and active stiffness of the deep neck extensor muscles most close to the spine. The highest active increase of stiffness during the head lift was found in the semispinalis cervicis muscle. The non-invasive, clinically applicable estimates of muscle stiffness have potential for the assessment of muscular changes associated with neck pain/injury.	[Dieterich, Angela V.; Petzke, Frank] Univ Med Ctr, Anasthesiol Klin, Schmerzmed, Robert Koch Str 40, D-37075 Gottingen, Germany; [Andrade, Ricardo J.; Le Sant, Guillaume; Hug, Francois; Nordez, Antoine] Univ Nantes, Fac Sport Sci, Lab Movement Interact Performance EA 4334, Nantes, France; [Andrade, Ricardo J.] Univ Lisbon, Fac Human Movement, Cruz Quebrada Dafundo, Portugal; [Le Sant, Guillaume] Sch Physiotherapy IFM3R, Nantes, France; [Falla, Deborah] Univ Birmingham, Coll Life & Environm Sci, Sch Sport Exercise & Rehabil Sci, Ctr Precis Rehabil Spinal Pain CPR Spine, Birmingham, W Midlands, England; [Hug, Francois] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia	Dieterich, AV (corresponding author), Univ Med Ctr, Anasthesiol Klin, Schmerzmed, Robert Koch Str 40, D-37075 Gottingen, Germany.	angela.dieterich@bccn.uni-goettingen.de	Andrade, Ricardo J./I-1792-2019	Andrade, Ricardo J./0000-0001-5316-7531; Le Sant, Guillaume/0000-0001-7614-6389; Falla, Deborah/0000-0003-1689-6190			Anderson JS, 2005, SPINE, V30, pE86, DOI 10.1097/01.brs.0000153700.97830.02; Bergmark A, 1989, ACTA ORTHOP SCAND S, V230, P20; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; Boudreau SA, 2014, EXP BRAIN RES, V232, P2011, DOI 10.1007/s00221-014-3891-3; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Boyd-Clark LC, 2001, J ANAT, V199, P709, DOI 10.1046/j.1469-7580.2001.19960709.x; Brandenburg JE, 2014, ARCH PHYS MED REHAB, V95, P2207, DOI 10.1016/j.apmr.2014.07.007; Chernak LA, 2013, PHYSIOL MEAS, V34, P713, DOI 10.1088/0967-3334/34/6/713; CLEMENS HJ, 1972, ARCH ORTHOPAD UNFALL, V73, P220, DOI 10.1007/BF01880731; Conley MS, 1997, J APPL PHYSIOL, V83, P2105; Cortez CD, 2016, DIAGN INTERV IMAG, V97, P71, DOI 10.1016/j.diii.2015.05.010; Deffieux T, 2012, IEEE T ULTRASON FERR, V59, P2390, DOI 10.1109/TUFFC.2012.2472; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Elliott JM, 2010, ARCH PHYS MED REHAB, V91, P1418, DOI 10.1016/j.apmr.2010.05.014; Falla D, 2007, EXP BRAIN RES, V182, P99, DOI 10.1007/s00221-007-0974-4; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Field A. P, 2009, DISCOVERING STAT USI; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gizzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137844; Herzog W, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00174; Hogg-Johnson S, 2009, J MANIP PHYSIOL THER, V32, pS46, DOI 10.1016/j.jmpt.2008.11.010; Holm LW, 2009, J MANIP PHYSIOL THER, V32, pS61, DOI 10.1016/j.jmpt.2008.11.011; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hug F, 2015, EXERC SPORT SCI REV, V43, P125, DOI 10.1249/JES.0000000000000049; Hug F, 2014, MED SCI SPORT EXER, V46, P2317, DOI 10.1249/MSS.0000000000000363; Hug F, 2013, J ELECTROMYOGR KINES, V23, P1413, DOI 10.1016/j.jelekin.2013.08.014; Juul Kristensen B, 2013, J REHABIL MED, V45, P376; Keshner EA, 1999, J VESTIBUL RES-EQUIL, V9, P423; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Kuo WH, 2013, ULTRASOUND MED BIOL, V39, P1356, DOI 10.1016/j.ultrasmedbio.2012.11.015; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lee JP, 2009, J ELECTROMYOGR KINES, V19, P391, DOI 10.1016/j.jelekin.2007.11.007; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; Lieber RL, 2013, AM J PHYSIOL-CELL PH, V305, pC241, DOI 10.1152/ajpcell.00173.2013; Lieber RL, 2010, SKELETAL MUSCLE STRU; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; MacDonald D, 2016, ULTRASOUND MED BIOL, V42, P1018, DOI 10.1016/j.ultrasmedbio.2015.12.002; Miyamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124311; NOLAN JP, 1988, SPINE, V13, P9, DOI 10.1097/00007632-198801000-00003; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; O'Leary S, 2011, ARCH PHYS MED REHAB, V92, P929, DOI 10.1016/j.apmr.2010.12.021; Panjabi MM, 2003, J ELECTROMYOGR KINES, V13, P371, DOI 10.1016/S1050-6411(03)00044-0; Peolsson A, 2010, MANUAL THER, V15, P567, DOI 10.1016/j.math.2010.06.007; PETIT J, 1990, J NEUROPHYSIOL, V63, P190; Rezasoltani A, 2013, J BODYW MOV THER, V17, P200, DOI 10.1016/j.jbmt.2012.07.001; Rezasoltani A, 2010, MANUAL THER, V15, P400, DOI 10.1016/j.math.2010.02.010; RICHMOND FJR, 1982, J NEUROPHYSIOL, V48, P49; Sakanaka TE, 2016, J PHYSIOL-LONDON, V594, P781, DOI 10.1113/JP271137; Siegmund GP, 2007, J BIOMECH ENG-T ASME, V129, P66, DOI 10.1115/1.2401185; Toursel T, 2002, J APPL PHYSIOL, V92, P1465, DOI 10.1152/japplphysiol.00621.2001; Valkeinen H, 2002, EUR J APPL PHYSIOL, V88, P247, DOI 10.1007/s00421-002-0709-y; Vasavada AN, 2002, EXP BRAIN RES, V147, P437, DOI 10.1007/s00221-002-1275-6; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Ward SR, 2009, J BIOMECH, V42, P1384, DOI 10.1016/j.jbiomech.2008.09.042; Yavuz A, 2015, MED ULTRASON, V17, P49, DOI 10.11152/mu.2013.2066.171.yvz; Yoshitake Y, 2014, MUSCLE NERVE, V50, P103, DOI 10.1002/mus.24104	59	29	30	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	JAN	2017	117	1					171	178		10.1007/s00421-016-3509-5			8	Physiology; Sport Sciences	Physiology; Sport Sciences	EL0LG	WOS:000394313300017	27913924				2021-06-18	
J	Goverover, Y; Genova, H; Smith, A; Chiaravalloti, N; Lengenfelder, J				Goverover, Yael; Genova, Helen; Smith, Angela; Chiaravalloti, Nancy; Lengenfelder, Jeanie			Changes in activity participation following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Activities of daily living; rehabilitation; quality of life	EXECUTIVE FUNCTION; OCCUPATIONAL PERFORMANCE; COMMUNITY INTEGRATION; ECOLOGICAL VALIDITY; LEISURE ACTIVITIES; UNITED-STATES; MODERATE; RELIABILITY; DEPRESSION; MILD	Traumatic brain injury (TBI) often results in impairments in cognitive skills as well as depression. As a result of these changes in cognition and mood, individuals with TBI may reduce their levels of participation and often report reduced health-related quality of life (HrQOL). The current study compares levels of past and present activity participation between healthy participants and persons with TBI using a client-centred approach in measurement. We additionally examine the relationship between activity participation, emotional functioning and HrQOL in persons with TBI. Fifty-two individuals with TBI who live in the community and 30 healthy age-matched controls performed a battery of cognitive tests and rated their affective symptomatology and activity participation (using the Activity Card Sort Test). Participants with TBI reported significantly lower current activity participation compared to controls. Current levels of activity and participation in the TBI sample were significantly related to age, time since injury, and HrQOL. Additionally, depressive symptomatology was significantly associated with HrQOL, but not with activity participation. Following TBI, levels of activity participation are reduced in most aspects of life, but more profoundly in social activities, high demand leisure activities and household activities. Additionally, high levels of depressive symptoms are associated with negative reports of HrQOL, regardless of current levels of activity participation.	[Goverover, Yael] NYU, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA; [Goverover, Yael; Genova, Helen; Smith, Angela; Chiaravalloti, Nancy; Lengenfelder, Jeanie] Kessler Fdn, W Orange, NJ USA; [Genova, Helen; Chiaravalloti, Nancy; Lengenfelder, Jeanie] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA	Goverover, Y (corresponding author), NYU, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [10-3218-BIR]	This research was supported by New Jersey Commission on Brain Injury Research [grant number 10-3218-BIR].	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Baum CM, 2001, ACS ACTIVITY CARD SO; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis D. C., 2000, CVLT 2 CALIFORNIA VE; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Douglas JM, 2006, BRAIN IMPAIR, V7, P107, DOI DOI 10.1375/BRIM.7.2.107; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Everard KM, 1999, J APPL GERONTOL, V18, P325, DOI 10.1177/073346489901800304; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2015, BRAIN INJURY, V29, P715, DOI 10.3109/02699052.2015.1004744; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Katz N, 2003, OTJR-OCCUP PARTICI H, V23, P10, DOI 10.1177/153944920302300102; Kobayashi LC, 2015, J EPIDEMIOL COMMUN H, V69, P278, DOI 10.1136/jech-2014-204733; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Martin RC, 2012, J HEAD TRAUMA REHAB, V27, pE81, DOI 10.1097/HTR.0b013e318273de49; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Singh-Manoux A, 2003, J EPIDEMIOL COMMUN H, V57, P907, DOI 10.1136/jech.57.11.907; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spitzer J, 2011, OTJR-OCCUP PART HEAL, V31, pS8, DOI 10.3928/15394492-20101108-03; Tabachnick B., 2001, USING MULTIVARIATE S; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; World Health Organization, 2001, INT CLASS FUNCT DIS; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	47	29	29	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	4					472	485		10.1080/09602011.2016.1168746			14	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	ES4KR	WOS:000399503600002	27043964				2021-06-18	
J	Phillips, NL; Mandalis, A; Benson, S; Parry, L; Epps, A; Morrow, A; Lah, S				Phillips, Natalie Lynette; Mandalis, Anna; Benson, Suzanne; Parry, Louise; Epps, Adrienne; Morrow, Angie; Lah, Suncica			Computerized Working Memory Training for Children with Moderate to Severe Traumatic Brain Injury: A Double-Blind, Randomized, Placebo-Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						cognitive training; pediatric; randomized controlled trial; traumatic brain injury; working memory	COGNITIVE REHABILITATION; ADHD; ADOLESCENTS; ATTENTION; DEFICITS; OUTCOMES; LIFE	Pediatric traumatic brain injury (TBI) places children at risk for deficits in working memory (WM; comprising a central executive [CE], and two storage systems: phonological loop [PL] and visuospatial sketchpad [VSSP]), which is strongly related to attention and academic skills in childhood. This study aimed to examine whether different components of WM can be improved following adaptive WM training (Cogmed) and whether improvements in WM generalize to other cognitive (attention) and academic skills (reading and mathematics) in children with TBI. Twenty-seven children with moderate to severe TBI were randomized to adaptive (Cogmed; n = 13) or non-adaptive training (active placebo; n = 14) and evaluated at baseline, post-training, and 3-months follow-up. Three children in the adaptive group and one child in the non-adaptive group withdrew from the study before completion of training. Complete case (CC) and intention-to-treat (ITT) analyses were conducted. Children in the adaptive group demonstrated significantly greater gains on select WM tasks (VSSP, but not PL or CE) from pre-to post-training (pre-post) and pre-training to follow-up (pre-follow-up; CC and ITT analyses). No gains were found on tests of attention. Adaptive training resulted in significantly greater gains on select academic skills (reading, but not mathematics): reading comprehension pre-post-training (ITT analyses) and reading accuracy pre-follow-up (CC and ITT analyses). This first, to our knowledge, study to examine the efficacy of adaptive WM training for children with TBI provides preliminary evidence of near and far transfer of training to WM and academic skills, respectively.	[Phillips, Natalie Lynette; Lah, Suncica] Univ Sydney, Sch Psychol, Brennan MacCallum Bldg A18, Sydney, NSW 2006, Australia; [Phillips, Natalie Lynette; Lah, Suncica] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Mandalis, Anna; Parry, Louise] Sydney Childrens Hosp Randwick, Dept Psychol, Sydney, NSW, Australia; [Parry, Louise; Epps, Adrienne] Sydney Childrens Hosp Randwick, Brain Injury Rehabil Program, Sydney, NSW, Australia; [Benson, Suzanne; Morrow, Angie] Childrens Hosp Westmead, Kids Rehab, Sydney, NSW, Australia	Lah, S (corresponding author), Univ Sydney, Sch Psychol, Brennan MacCallum Bldg A18, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au		Phillips, Natalie/0000-0001-7505-9670; Lah, Suncica/0000-0003-2282-4812	Australian Postgraduate Award scholarship from the Australian Government; University of Sydney Thompson Fellowship	Natalie Philips was supported by an Australian Postgraduate Award scholarship from the Australian Government. Suncica Lah was in part supported by the University of Sydney Thompson Fellowship.	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Alloway T. P., 2007, AUTOMATED WORKING ME; Alloway TP, 2013, J COGN PSYCHOL, V25, P84, DOI 10.1080/20445911.2012.748027; Alloway TP, 2010, BRIT J EDUC PSYCHOL, V80, P567, DOI 10.1348/000709910X494566; Astle DE, 2015, J NEUROSCI, V35, P6277, DOI 10.1523/JNEUROSCI.4517-14.2015; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Bergman-Nutley S, 2014, PSYCHOL RES-PSYCH FO, V78, P869, DOI 10.1007/s00426-014-0614-0; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; Catroppa C, 2015, BRAIN INJURY, V29, P1317, DOI 10.3109/02699052.2015.1043345; Chacko A, 2014, J CHILD PSYCHOL PSYC, V55, P247, DOI 10.1111/jcpp.12146; Dahlin K., 2013, J ED LEARNING, V2, P118, DOI [DOI 10.5539/JEL.V2N1P118, 10.5539/jel.v2n1p118]; Dunning DL, 2014, MEM COGNITION, V42, P854, DOI 10.3758/s13421-014-0410-5; Dunning DL, 2013, DEVELOPMENTAL SCI, V16, P915, DOI 10.1111/desc.12068; Efird J, 2011, INT J ENV RES PUB HE, V8, P15, DOI 10.3390/ijerph8010015; Egeland J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075660; Friso-van den Bos I, 2013, EDUC RES REV-NETH, V10, P29, DOI 10.1016/j.edurev.2013.05.003; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; Hellgren L., 2015, OPEN J THERAPY REHAB, V3, P46, DOI DOI 10.4236/OJTR.2015.32007; Holmes J, 2014, EDUC PSYCHOL-UK, V34, P440, DOI 10.1080/01443410.2013.797338; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Jarvis H. L., 2003, EDUC CHILD PSYCHOL, V20, P123; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Manly T., 1999, TEST EVERYDAY ATTENT; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Phillips N. L., 2015, CHILD NEUROPSYCHOL; Roberts G, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2015.4568; Sattler J. M., 2004, ASSESSMENT CHILDREN; Schuchardt K, 2008, J LEARN DISABIL-US, V41, P514, DOI 10.1177/0022219408317856; Shatil E, 2003, J EXP CHILD PSYCHOL, V86, P1, DOI 10.1016/S0022-0965(03)00106-1; Shipstead Z, 2015, ATTEN PERCEPT PSYCHO, V77, P1863, DOI 10.3758/s13414-015-0899-0; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Soderqvist S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01711; Spencer-Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119522; Stevens M. C., 2015, BRAIN IMAGING BEHAV, P3; Tabachnick BG, 2007, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; van Dongen-Boomsma M, 2014, J CHILD PSYCHOL PSYC, V55, P886, DOI 10.1111/jcpp.12218; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wechsler D., 2009, WECHSLER INDIVIDUAL; Wechsler D., 2003, WECHSLER INTELLIGENC; Weicker J., 2015, NEUROPSYCHOLOGIA, P3; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	56	29	31	1	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2097	2104		10.1089/neu.2015.4358			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800005	27050628				2021-06-18	
J	Gao, YY; Li, J; Wu, LY; Zhou, CH; Wang, Q; Li, X; Zhou, ML; Wang, HD				Gao, Yongyue; Li, Jie; Wu, Lingyun; Zhou, Chenhui; Wang, Qiang; Li, Xiang; Zhou, Mengliang; Wang, Handong			Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism	JOURNAL OF SURGICAL RESEARCH			English	Article						Tetrahydrocurcumin; Traumatic brain injury; Apoptosis; Autophagy; PI3K/AKT signaling pathway	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CELL-DEATH; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; OXIDATIVE STRESS; UP-REGULATION; APOPTOSIS; MICE; ACTIVATION; PROTECTS	Background: Tetrahydrocurcumin provides neuroprotection in multiple neurologic disorders by modulating oxidative stress, inflammatory responses, and autophagy. However, in traumatic brain injury (TBI), it is unclear whether a beneficial effect of tetrahydrocurcumin exists. In this study, we hypothesized that administration of tetrahydrocurcumin provides neuroprotection in a rat model of TBI. Material and methods: Behavioral studies were performed by recording and analyzing beam-walking scores. The role of tetrahydrocurcumin on neurons death was assessed via Nissl staining. We then performed Western blot analyses, terminal deoxynucleotidyl transferase 2'-deoxyuridine-5'-triphosphate (dUTP) nick end labeling assays and immunofluorescence staining to evaluate autophagy and apoptosis. Phospho-protein kinase B (p-AKT) was also assessed via Western blotting. Results: Our data indicated that administration of tetrahydrocurcumin alleviated brain edema, attenuated TBI-induced neuron cell death, decreased the degree of apoptosis and improved neurobehavioral function, which were accompanied by enhanced autophagy and phospho-AKT after TBI. Moreover, the autophagy inhibitor 3-methyladenine and the PI3K kinase inhibitor LY294002 partially reversed the neuroprotection of tetrahydrocurcumin after TBI. Conclusions: This study indicates that tetrahydrocurcumin protects neurons from TBI-induced apoptotic neuronal death, which may be through modulation autophagy and PI3K/AKT pathways. Thus, tetrahydrocurcumin may be an attractive therapeutic agent for TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Gao, Yongyue; Li, Jie; Wu, Lingyun; Zhou, Chenhui; Wang, Qiang; Li, Xiang; Zhou, Mengliang; Wang, Handong] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China	Li, J; Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njLijiepro@126.com; njhdwang@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489	Jinling Hospital of Nanjing, School of Medicine, Nanjing University [2010 M023]; Major Innovative Project of Medical Science and Technology of Nanjing Military Command [14ZX16]	This work was supported by grants from Jinling Hospital of Nanjing, School of Medicine, Nanjing University (no. 2010 M023) and the Major Innovative Project of Medical Science and Technology of Nanjing Military Command (no. 14ZX16).	Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Greeshma N, 2015, CHEM-BIOL INTERACT, V238, P118, DOI 10.1016/j.cbi.2015.06.025; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Ma LX, 2015, NEUROSCI LETT, V599, P1, DOI 10.1016/j.neulet.2015.05.004; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pari L, 2004, PHARMACOL RES, V49, P481, DOI 10.1016/j.phrs.2003.11.005; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tyagi N, 2012, J MOL NEUROSCI, V47, P128, DOI 10.1007/s12031-011-9695-z; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu JC, 2011, MOL NUTR FOOD RES, V55, P1646, DOI 10.1002/mnfr.201100454; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhou CH, 2015, BRAIN RES, V1629, P250, DOI 10.1016/j.brainres.2015.10.016; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	33	29	31	0	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2016	206	1					67	76		10.1016/j.jss.2016.07.014			10	Surgery	Surgery	EC2VR	WOS:000387982900012	27916377				2021-06-18	
J	Crair, MC; Mason, CA				Crair, Michael C.; Mason, Carol A.			Reconnecting Eye to Brain	JOURNAL OF NEUROSCIENCE			English	Article						axon; axon guidance; axon regeneration; eye; lateral geniculate nucleus; optic nerve; regeneration; retina; retinal ganglion cells; superior colliculus; traumatic brain injury; vision; visual cortex	OPTIC-NERVE REGENERATION; RETINAL GANGLION-CELLS; SPINAL-CORD-INJURY; LATERAL GENICULATE-NUCLEUS; INHIBITORY NEURON TRANSPLANTATION; PROMOTES AXON REGENERATION; PRIMARY VISUAL-CORTEX; IN-VIVO; GROWTH-CONE; RETINOGENICULATE SYNAPSE	Although much is known about the regenerative capacity of retinal ganglion cells, very significant barriers remain in our ability to restore visual function following traumatic injury or disease-induced degeneration. Here we summarize our current understanding of the factors regulating axon guidance and target engagement in regenerating axons, and review the state of the field of neural regeneration, focusing on the visual system and highlighting studies using other model systems that can inform analysis of visual system regeneration. This overview is motivated by a Society for Neuroscience Satellite meeting, "Reconnecting Neurons in the Visual System," held in October 2015 sponsored by the National Eye Institute as part of their " Audacious Goals Initiative" and co-organized by Carol Mason (Columbia University) and Michael Crair (Yale University). The collective wisdom of the conference participants pointed to important gaps in our knowledge and barriers to progress in promoting the restoration of visual system function. This article is thus a summary of our existing understanding of visual system regeneration and provides a blueprint for future progress in the field.	[Crair, Michael C.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA; [Crair, Michael C.] Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; [Mason, Carol A.] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Mason, Carol A.] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Neurosci, New York, NY 10032 USA; [Mason, Carol A.] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Ophthalmol, New York, NY 10032 USA	Crair, MC (corresponding author), Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St,SHM B301, New Haven, CT 06520 USA.; Mason, CA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St,14-509 P&S Bldg, New York, NY 10032 USA.	michael.crair@yale.edu; cam4@columbia.edu		Mason, Carol/0000-0001-6253-505X	Family of William Ziegler, III; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY015788, EY023105, EY012736, EY015290]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012736, R01EY023105, P30EY026878, R01EY015788, R01EY015290] Funding Source: NIH RePORTER	This work was supported by the Family of William Ziegler, III and the National Eye Institute Grants EY015788 and EY023105 to M.C.C. and EY012736 and EY015290 to C.A.M. We thank Paul Sieving, Tom Greenwell, and Steve Becker of the National Eye Institute for convening the Satellite meeting from which this article emanated and the conference panelists and participants for their enthusiastic participation.	Aktas O, 2016, CURR OPIN NEUROL, V29, P199, DOI 10.1097/WCO.0000000000000327; Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aralci M, 2014, NEURAL REGEN RES, V9, P2125, DOI 10.4103/1673-5374.147942; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baier H, 2013, ANNU REV CELL DEV BI, V29, P385, DOI 10.1146/annurev-cellbio-101011-155748; Balasubramanian R, 2014, GENE EXPR PATTERNS, V14, P1, DOI 10.1016/j.gep.2013.12.001; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Balmer TS, 2015, CEREB CORTEX, V25, P904, DOI 10.1093/cercor/bht281; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beazley LD, 2003, J NEUROTRAUM, V20, P1263, DOI 10.1089/089771503770802925; Becker CG, 2015, DEV CELL, V32, P516, DOI 10.1016/j.devcel.2015.01.001; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; Berardi N, 1999, J NEUROBIOL, V41, P119, DOI 10.1002/(SICI)1097-4695(199910)41:1<119::AID-NEU15>3.0.CO;2-N; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Bochner DN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010157; Brace EJ, 2014, J NEUROSCI, V34, P8398, DOI 10.1523/JNEUROSCI.4715-13.2014; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P413, DOI 10.1006/mcne.1995.1031; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Byrne AB, 2011, JOVE-J VIS EXP, DOI 10.3791/2707; Callahan A, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw040; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; CHAN SO, 1994, J COMP NEUROL, V344, P20, DOI 10.1002/cne.903440103; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chang WC, 2010, WIRES NANOMED NANOBI, V2, P151, DOI 10.1002/wnan.76; Chen LZ, 2016, ELIFE, V5, DOI 10.7554/eLife.16072; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Davis MF, 2015, NEURON, V86, P1055, DOI 10.1016/j.neuron.2015.03.062; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dell AL, 2013, J NEUROSCI, V33, P11076, DOI 10.1523/JNEUROSCI.0197-13.2013; Delloye-Bourgeois C, 2014, JOVE-J VIS EXP, DOI 10.3791/50883; Dhande OS, 2014, CURR BIOL, V24, pR155, DOI 10.1016/j.cub.2013.12.045; Diekmann H, 2013, EXP NEUROL, V248, P254, DOI 10.1016/j.expneurol.2013.06.021; Dilger EK, 2015, J NEUROSCI, V35, P3652, DOI 10.1523/JNEUROSCI.2343-14.2015; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; El-Danaf RN, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0046-6; Elsaeidi F, 2014, J NEUROSCI, V34, P2632, DOI 10.1523/JNEUROSCI.3898-13.2014; Endo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23976; Enes J, 2010, CURR BIOL, V20, P1154, DOI 10.1016/j.cub.2010.05.055; Erskine L, 2011, NEURON, V70, P951, DOI 10.1016/j.neuron.2011.02.052; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fabre PJ, 2010, J NEUROSCI, V30, P266, DOI 10.1523/JNEUROSCI.3778-09.2010; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FRASER SE, 1990, J EXP BIOL, V153, P61; Fu QL, 2011, INVEST OPHTH VIS SCI, V52, P8374, DOI 10.1167/iovs.11-7667; Furman M, 2013, J NEUROPHYSIOL, V110, P1441, DOI 10.1152/jn.01066.2012; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Garcia-Frigola C, 2010, EMBO J, V29, P3170, DOI 10.1038/emboj.2010.172; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; GUILLERY RW, 1987, J COMP NEUROL, V265, P203, DOI 10.1002/cne.902650205; Guy AT, 2015, SCIENCE, V349, P974, DOI 10.1126/science.aab3516; Hamid S, 2008, EUR SPINE J, V17, P1256, DOI 10.1007/s00586-008-0729-3; Hammarlund M, 2014, CURR OPIN NEUROBIOL, V27, P199, DOI 10.1016/j.conb.2014.04.001; HARRIS WA, 1987, DEVELOPMENT, V101, P123; He HY, 2007, NAT NEUROSCI, V10, P1134, DOI 10.1038/nn1965; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hong YK, 2014, NEURON, V84, P332, DOI 10.1016/j.neuron.2014.08.059; Hong YK, 2011, CURR OPIN NEUROBIOL, V21, P228, DOI 10.1016/j.conb.2011.02.007; Hooks BM, 2008, J NEUROSCI, V28, P4807, DOI 10.1523/JNEUROSCI.4667-07.2008; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Isaacman-Beck J, 2015, NEURON, V88, P691, DOI 10.1016/j.neuron.2015.10.004; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Jaworski A, 2015, SCIENCE, V350, P961, DOI 10.1126/science.aad2615; Jia ZQ, 2016, NEURAL REGEN RES, V11, P137, DOI 10.4103/1673-5374.175061; Jin KX, 2016, DEV NEUROBIOL, V76, P900, DOI 10.1002/dneu.22365; Jin XM, 2016, J BIOCHEM, V159, P491, DOI 10.1093/jb/mvw009; Kalia A, 2014, P NATL ACAD SCI USA, V111, P2035, DOI 10.1073/pnas.1311041111; KALIL K, 1986, J NEUROSCI, V6, P2563; Kaneko M, 2014, ELIFE, V3, DOI 10.7554/eLife.02798; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; King C, 2004, EXP NEUROL, V187, P380, DOI 10.1016/j.expneurol.2004.02.006; Kobayashi Y, 2015, NEURON, V86, P264, DOI 10.1016/j.neuron.2015.02.036; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kurup N, 2015, CURR BIOL, V25, P1594, DOI 10.1016/j.cub.2015.04.061; Kuwajima T, 2012, NEURON, V74, P676, DOI 10.1016/j.neuron.2012.03.025; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Li H, 2016, CELL REP, V16, P545, DOI 10.1016/j.celrep.2016.06.013; Li RW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001135; Li S, 2015, NAT NEUROSCI, V18, P1737, DOI 10.1038/nn.4146; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Lom B, 1999, J NEUROSCI, V19, P9928; Lorenzana AO, 2015, NEURON, V86, P947, DOI 10.1016/j.neuron.2015.03.061; Lu DC, 2016, NEUROREHAB NEURAL RE, V30, P951, DOI 10.1177/1545968316644344; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Luo XT, 2016, CELL REP, V15, P398, DOI 10.1016/j.celrep.2016.03.029; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MASON C, 2014, VISUAL NEUROSCIENCES, P1317; Mason CA, 1997, CURR OPIN NEUROBIOL, V7, P647, DOI 10.1016/S0959-4388(97)80084-0; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Niemi JP, 2016, EXP NEUROL, V275, P25, DOI 10.1016/j.expneurol.2015.09.018; Nikolaou N, 2015, NEURON, V88, P999, DOI 10.1016/j.neuron.2015.10.020; Nishiyama A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00133; Nix P, 2014, J NEUROSCI, V34, P629, DOI 10.1523/JNEUROSCI.3859-13.2014; Ozel MN, 2015, ELIFE, V4, DOI 10.7554/eLife.10721; Omura T, 2015, NEURON, V86, P1215, DOI 10.1016/j.neuron.2015.05.005; Osterhout JA, 2015, NEURON, V86, P985, DOI 10.1016/j.neuron.2015.04.005; Osterhout JA, 2014, CELL REP, V8, P1006, DOI 10.1016/j.celrep.2014.06.063; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Peng SS, 2016, EXP EYE RES, V148, P90, DOI 10.1016/j.exer.2016.06.001; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plas DT, 2005, J COMP NEUROL, V491, P305, DOI 10.1002/cne.20694; Poliak S, 2016, CELL, V164, P512, DOI 10.1016/j.cell.2015.12.049; Prins D, 2016, ACTA OPHTHALMOL, V94, P113, DOI 10.1111/aos.12825; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reichman S, 2014, P NATL ACAD SCI USA, V111, P8518, DOI 10.1073/pnas.1324212111; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Robles E, 2014, CURR BIOL, V24, P2085, DOI 10.1016/j.cub.2014.07.080; Rodger J, 2004, MOL CELL NEUROSCI, V25, P56, DOI 10.1016/j.mcn.2003.09.010; Rodger J, 2001, EUR J NEUROSCI, V14, P1929, DOI 10.1046/j.0953-816x.2001.01822.x; Rousso DL, 2016, CELL REP, V15, P1930, DOI 10.1016/j.celrep.2016.04.069; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Ruthazer ES, 2010, TRENDS NEUROSCI, V33, P183, DOI 10.1016/j.tins.2010.01.003; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Sanchez-Arrones L, 2013, J NEUROSCI, V33, P8596, DOI 10.1523/JNEUROSCI.2083-12.2013; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Schwab ME, 1996, PHYSIOL REV, V76, P319; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Shanks JA, 2016, J NEUROSCI, V36, P5252, DOI 10.1523/JNEUROSCI.4599-15.2016; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076347; Shigeoka T, 2016, CELL, V166, P181, DOI 10.1016/j.cell.2016.05.029; Shirkey NJ, 2012, DEV NEUROBIOL, V72, P628, DOI 10.1002/dneu.20967; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Song YQ, 2015, NAT NEUROSCI, V18, P817, DOI 10.1038/nn.4019; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Sridhar A, 2016, STEM CELL TRANSL MED, V5, P417, DOI 10.5966/sctm.2015-0093; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Suetterlin P, 2014, NEURON, V84, P740, DOI 10.1016/j.neuron.2014.09.023; Sugitani K, 2016, ADV EXP MED BIOL, V854, P671, DOI 10.1007/978-3-319-17121-0_89; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Symonds ACE, 2007, EUR J NEUROSCI, V25, P744, DOI 10.1111/j.1460-9568.2007.05321.x; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Tan LM, 2015, CELL, V163, P1756, DOI 10.1016/j.cell.2015.11.021; Tang YS, 2014, P NATL ACAD SCI USA, V111, P18339, DOI 10.1073/pnas.1421844112; Tedeschi A, 2016, NEURON IN PRESS; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; TORREALBA F, 1982, J COMP NEUROL, V211, P377, DOI 10.1002/cne.902110405; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Ueki Y, 2015, P NATL ACAD SCI USA, V112, P13717, DOI 10.1073/pnas.1510595112; Vagge A, 2016, CURR OPIN OPHTHALMOL, V27, P380, DOI 10.1097/ICU.0000000000000293; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Vigneswara V, 2015, MOL CELL NEUROSCI, V68, P212, DOI 10.1016/j.mcn.2015.08.001; Wada F, 2016, CELL REP, V15, P1329, DOI 10.1016/j.celrep.2016.04.021; Wang JC, 2016, INT WORKS DISCRETE, P291, DOI 10.1109/WODES.2016.7497862; Wang XX, 2015, INVEST OPHTH VIS SCI, V56, P1357, DOI 10.1167/iovs.14-15472; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Weth F, 2014, SEMIN CELL DEV BIOL, V35, P126, DOI 10.1016/j.semcdb.2014.07.010; Williams RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118918; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Yan B, 2016, VISION RES, V121, P57, DOI 10.1016/j.visres.2016.01.006; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yoshimatsu T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10590; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010; Zou YX, 2015, J NEUROSCI, V35, P10429, DOI 10.1523/JNEUROSCI.1718-15.2015	199	29	30	2	23	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 19	2016	36	42					10707	10722		10.1523/JNEUROSCI.1711-16.2016			16	Neurosciences	Neurosciences & Neurology	EE1BK	WOS:000389315300001	27798125	Green Published, Bronze			2021-06-18	
J	Padayachy, LC; Padayachy, V; Galal, U; Pollock, T; Fieggen, AG				Padayachy, Llewellyn C.; Padayachy, Vaishali; Galal, Ushma; Pollock, Travis; Fieggen, A. Graham			The relationship between transorbital ultrasound measurement of the optic nerve sheath diameter (ONSD) and invasively measured ICP in children.	CHILDS NERVOUS SYSTEM			English	Article						Non-invasive; ICP monitoring; Optic nerve sheath diameter; Ultrasound	RAISED INTRACRANIAL-PRESSURE; TRAUMATIC-BRAIN-INJURY; SONOGRAPHIC EVALUATION; NONINVASIVE METHODS; ULTRASONOGRAPHY	Purpose To analyse the diagnostic accuracy of age-related optic nerve sheath diameter (ONSD) cut-off values in children for detecting raised intracranial pressure (ICP) and to assess the benefit of using patency of the anterior fontanelle in describing a different set of cut-off values. Methods The ONSD measurement was performed prior to invasive ICP measurement in children under general anesthesia. The diagnostic accuracy of the ONSD measurement was compared to ICP at thresholds of 20, 15, 10, and 5 mmHg. This was further analysed in children above and below the age of 1 year, with a subgroup analysis of age at 4 years, and assessment of the anterior fontanelle (AF) as a reliable physiological marker in part II of this study. Results Data from 174 children were analysed. In children <= 1 year old, the ONSD measurement with the best diagnostic accuracy for detecting ICP >= 20 mmHg was 5.16 mm, compared to 5.75 mm in children > 1 year old (p < 0.001). In addition, patency of the anterior fontanelle (AF) was found to be a useful clinical marker for defining different ONSD cutoff values at ICP thresholds of 20, 15, 10 and 5 mmHg. Conclusion Transorbital ultrasound measurement of the ONSD is a reliable non-invasive marker of ICP particularly at higher thresholds of 20 and 15 mmHg. Patency of the AF is a useful clinical marker for defining different ONSD cut-off values in children.	[Padayachy, Llewellyn C.; Fieggen, A. Graham] Univ Cape Town, Red Cross War Mem Childrens Hosp, Fac Hlth Sci, Paediat Neurosurg Unit,Div Neurosurg, Cape Town, South Africa; [Padayachy, Vaishali] Univ Cape Town, Red Cross War Mem Childrens Hosp, Trauma Unit, Cape Town, South Africa; [Galal, Ushma] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa; [Pollock, Travis] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Opthalmol Unit, Cape Town, South Africa	Padayachy, LC (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Fac Hlth Sci, Paediat Neurosurg Unit,Div Neurosurg, Cape Town, South Africa.	llewesp@yahoo.com	Padayachy, Llewellyn/AAD-3821-2019				Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Beare NAV, 2008, TROP MED INT HEALTH, V13, P1400, DOI 10.1111/j.1365-3156.2008.02153.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bruce BB, 2014, J NEURO-OPHTHALMOL, V34, P288, DOI 10.1097/WNO.0000000000000153; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc6893; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; McAuley D, 2009, CHILD NERV SYST, V25, P87, DOI 10.1007/s00381-008-0713-6; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Padayachy L, 2016, NEUROSURGERY, V79, P100, DOI 10.1227/NEU.0000000000001200; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Steinborn M, 2015, ULTRASCHALL MED, V36, P54, DOI 10.1055/s-0034-1385012; Steinborn M, 2011, ULTRASCHALL MED, V32, P608, DOI 10.1055/s-0029-1245822; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x	24	29	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2016	32	10					1779	1785		10.1007/s00381-016-3068-4			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	DY1UG	WOS:000384879300004	27659820				2021-06-18	
J	de Koning, ME; Gareb, B; El Moumni, M; Scheenen, ME; van der Horn, HJ; Timmerman, ME; Spikman, JM; van der Naalt, J				de Koning, M. E.; Gareb, B.; El Moumni, M.; Scheenen, M. E.; van der Horn, H. J.; Timmerman, M. E.; Spikman, J. M.; van der Naalt, J.			Subacute posttraumatic complaints and psychological distress in trauma patients with or without mild traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Mild traumatic brain injury; Trauma; Posttraumatic complaints; Symptom checklist; Anxiety; Depression	POST-CONCUSSION SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; CONSTRUCT-VALIDITY; BASE-RATE; QUESTIONNAIRE; PREDICTORS; ILLNESS; ANXIETY	Objective: To identify the frequency, nature and profile of complaints for trauma patients with and without mild traumatic brain injury (mTBI), and to assess their relation to anxiety and depression. Methods: A prospective cohort study in a level-one trauma centre was conducted. Mild traumatic brain injury patients and trauma controls were approached for participation. Two weeks after injury, The Head Injury Symptom Checklist (HISC) and the Hospital Anxiety and Depression Scale (HADS) were administered. Results: Two-hundred seventy two patients with mTBI and 125 TC patients completed the questionnaires. Differences were demonstrated between the two trauma populations on frequency and nature of reported complaints. Ordinal common factor analysis on the mTBI scores yielded three factors: mental distress, physical discomfort, and sensory disbalance, which were all significantly correlated to anxiety and depression scores. Discriminant analyses identified a subset of complaints which could allocate almost 80% of patients to the correct group. Conclusions: Patients with mTBI showed a different pattern of complaints than orthopaedic control patients. A mental distress factor consisting of both somatic and cognitive complaints proved to be most discriminating and showed high correlations with anxiety and depression. (C) 2016 Elsevier Ltd. All rights reserved.	[de Koning, M. E.; van der Horn, H. J.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands; [Gareb, B.; El Moumni, M.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, NL-9700 AB Groningen, Netherlands; [Scheenen, M. E.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neuropsychol, NL-9700 AB Groningen, Netherlands; [Timmerman, M. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychometr & Stat, NL-9700 AB Groningen, Netherlands	van der Naalt, J (corresponding author), Univ Med Ctr Groningen, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl	Gareb, Barzi/AAK-5393-2020	Gareb, Barzi/0000-0003-3534-9176; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps 2012-06]	This work was funded by a grant of the Dutch Brain Foundation (grant nr. Ps 2012-06).	Association AP, 2013, DIAGN STAT MAN MENT; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Losoi H, 2015, NEUROTRAUMA; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Visser-Keizer AC, 2015, ARCH PHYS MED REHAB, V96, P1056, DOI 10.1016/j.apmr.2014.12.010; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	29	29	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47	9					2041	2047		10.1016/j.injury.2016.04.036			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DU5QG	WOS:000382265800029	27297705				2021-06-18	
J	Cariou, A; Deye, N; Vivien, B; Richard, O; Pichon, N; Bourg, A; Huet, L; Buleon, C; Frey, J; Asfar, P; Legriel, S; Narcisse, S; Mathonnet, A; Cravoisy, A; Dequin, PF; Wiel, E; Razazi, K; Daubin, C; Kimmoun, A; Lamhaut, L; Marx, JS; de la Garanderie, DP; Ecollan, P; Combes, A; Spaulding, C; Barat, F; Ben Boutieb, M; Coste, J; Chiche, JD; Pene, F; Mira, JP; Treluyer, JM; Hermine, O; Carli, P				Cariou, Alain; Deye, Nicolas; Vivien, Benoit; Richard, Olivier; Pichon, Nicolas; Bourg, Angele; Huet, Loic; Buleon, Clement; Frey, Jerome; Asfar, Pierre; Legriel, Stephane; Narcisse, Sophie; Mathonnet, Armelle; Cravoisy, Aurelie; Dequin, Pierre-Francois; Wiel, Eric; Razazi, Keyvan; Daubin, Cedric; Kimmoun, Antoine; Lamhaut, Lionel; Marx, Jean-Sebastien; de la Garanderie, Didier Payen; Ecollan, Patrick; Combes, Alain; Spaulding, Christian; Barat, Florence; Ben Boutieb, Myriam; Coste, Joel; Chiche, Jean-Daniel; Pene, Frederic; Mira, Jean-Paul; Treluyer, Jean-Marc; Hermine, Olivier; Carli, Pierre		Epo-ACR-02 Study Grp	Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest A Multicenter, Randomized Controlled Trial	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY			English	Article						For a supplemental figure; please see the online version of this article	PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; TRAUMATIC BRAIN-INJURY; COMATOSE SURVIVORS; RESUSCITATION; ISCHEMIA; RATS; CARE; CARDIOPULMONARY; NEUROPROTECTION	BACKGROUND Preliminary data suggested a clinical benefit in treating out-of-hospital cardiac arrest (OHCA) patients with a high dose of erythropoietin (Epo) analogs. OBJECTIVES The authors aimed to evaluate the efficacy of epoetin alfa treatment on the outcome of OHCA patients in a phase 3 trial. METHODS The authors performed a multicenter, single-blind, randomized controlled trial. Patients still comatose after a witnessed OHCA of presumed cardiac origin were eligible. In the intervention group, patients received 5 intravenous injections spaced 12 h apart during the first 48 h (40,000 units each, resulting in a maximal dose of 200,000 total units), started as soon as possible after resuscitation. In the control group, patients received standard care without Epo. The main endpoint was the proportion of patients in each group reaching level 1 on the Cerebral Performance Category (CPC) scale (survival with no or minor neurological sequelae) at day 60. Secondary endpoints included all-cause mortality rate, distribution of patients in CPC levels at different time points, and side effects. RESULTS In total, 476 patients were included in the primary analysis. Baseline characteristics were similar in the 2 groups. At day 60, 32.4% of patients (76 of 234) in the intervention group reached a CPC 1 level, as compared with 32.1% of patients (78 of 242) in the control group (odds ratio: 1.01; 95% confidence interval: 0.68 to 1.48). The mortality rate and proportion of patients in each CPC level did not differ at any time points. Serious adverse events were more frequent in Epo-treated patients as compared with controls (22.6% vs. 14.9%; p = 0.03), particularly thrombotic complications (12.4% vs. 5.8%; p = 0.01). CONCLUSIONS In patients resuscitated from an OHCA of presumed cardiac cause, early administration of erythropoietin plus standard therapy did not confer a benefit, and was associated with a higher complication rate. (High Dose of Erythropoietin Analogue After Cardiac Arrest [Epo-ACR-02]; NCT00999583) (C) 2016 by the American College of Cardiology Foundation.	[Cariou, Alain; Chiche, Jean-Daniel; Pene, Frederic; Mira, Jean-Paul] Cochin Hosp, AP HP, Med Intens Care Unit, 27 Rue Faubourg St Jacques, F-75679 Paris 1, France; [Cariou, Alain; Vivien, Benoit; Spaulding, Christian; Coste, Joel; Chiche, Jean-Daniel; Pene, Frederic; Mira, Jean-Paul; Treluyer, Jean-Marc; Hermine, Olivier; Carli, Pierre] Paris Descartes Univ, Paris, France; [Cariou, Alain; Lamhaut, Lionel; Spaulding, Christian] Paris Descartes Univ, Parisian Cardiovasc Res Ctr, INSERM, U970,Team 4, Paris, France; [Deye, Nicolas] Lariboisiere Hosp, AP HP, Med Intens Care Unit, Paris, France; [Deye, Nicolas] INSERM, U942, Paris, France; [Vivien, Benoit; Lamhaut, Lionel; Marx, Jean-Sebastien; Carli, Pierre] Hop Necker Enfants Malad, AP HP, SAMU 75, Paris, France; [Richard, Olivier] Ctr Hosp Versailles, SAMU 78, Versailles, France; [Pichon, Nicolas] CHU Dupuytren, Med ICU, Limoges, France; [Bourg, Angele] SAMU 87, Limoges, France; [Bourg, Angele] CHU Dupuytren, Limoges, France; [Huet, Loic] Henri Mondor Hosp, AP HP, SAMU 94, Creteil, France; [Buleon, Clement] CHU Caen, SAMU, Pole Reanimat, Anesthesie, F-14000 Caen, France; [Frey, Jerome] CHU Nancy, SAMU 54, Nancy, France; [Asfar, Pierre] CHU Angers, Reanimat Med & Med Hyperbare, Angers, France; [Legriel, Stephane] Ctr Hosp Versailles, Med ICU, Versailles, France; [Narcisse, Sophie] Hop La Source, SAMU 45, Orleans, France; [Mathonnet, Armelle] Ctr Hosp Reg Orleans, Hop La Source, Med Surg Intens Care Unit, Orleans, France; [Cravoisy, Aurelie] CHU Nancy, Med ICU, Nancy, France; [Dequin, Pierre-Francois] Univ Tours, INSERM, Med ICU, U1100, Tours, France; [Dequin, Pierre-Francois] CRICS Grp, Tours, France; [Wiel, Eric] Lille Univ Hosp, Emergency Dept, Lille, France; [Wiel, Eric] Lille Univ Hosp, SAMU 59, Lille, France; [Razazi, Keyvan] Hop Henri Mondor, AP HP, Med ICU, F-94010 Creteil, France; [Daubin, Cedric] CHU Caen, Dept Med Intens Care, F-14000 Caen, France; [Kimmoun, Antoine] CHU Nancy, Serv Reanimat Med Brabois, Vandoeuvre Les Nancy, France; [Lamhaut, Lionel] Necker Univ Hosp, AP HP, Intens Care Unit, Paris, France; [de la Garanderie, Didier Payen] Lariboisiere Univ Hosp, AP HP, SMUR Surg Intens Care, Paris, France; [de la Garanderie, Didier Payen] Univ Paris 07, Univ Denis Diderot, Paris, France; [Ecollan, Patrick] AP HP, SMUR Pitie Salpetriere, Paris, France; [Combes, Alain] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr,INSERM,iCAN,UMRS 1166,Med, Paris, France; [Spaulding, Christian] Cochin Univ Hosp, AP HP, Dept Cardiol, Paris, France; [Barat, Florence] AP HP, Cent Pharm, Clin Trial Unit, Paris, France; [Ben Boutieb, Myriam; Coste, Joel] Hop Hotel Dieu, AP HP, Biostat & Epidemiol Unit, Paris, France; [Treluyer, Jean-Marc] Paris Ctr, Clin Res Unit, Paris, France; [Treluyer, Jean-Marc] Paris Descartes Univ, Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, INSERM, CNRS,Imagine Inst,U1123,Erl 8654,Dept Hematol, Paris, France	Cariou, A (corresponding author), Cochin Hosp, AP HP, Med Intens Care Unit, 27 Rue Faubourg St Jacques, F-75679 Paris 1, France.	alain.cariou@aphp.fr	Lamhaut, Lionel/AAM-8449-2021; Legriel, Stephane/J-1307-2017; Chiche, Jean-Daniel/P-5220-2017	Lamhaut, Lionel/0000-0003-4160-9456; Legriel, Stephane/0000-0003-4782-6734; Chiche, Jean-Daniel/0000-0002-6433-6254; Hermine, Olivier/0000-0003-2574-3874; Pene, Frederic/0000-0003-3639-3849	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [PHRC-AOM P 071217]; Baxter [NCT02068287]	This work was funded by a research grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique PHRC-AOM P 071217). Dr. Kimmoun has received a grant from Baxter for the Esmosepsis clinical trial (NCT02068287) and fees for a consultancy activity. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Carli and Hermine contributed equally to this work. Previous presentations: Annual Meeting of the European Society of Intensive Care Medicine, Barcelona, Spain, October 2014.	ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bottiger BW, 2008, NEW ENGL J MED, V359, P2651, DOI 10.1056/NEJMoa070570; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cariou A, 2008, RESUSCITATION, V76, P397, DOI 10.1016/j.resuscitation.2007.10.003; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Genc S, 2004, RESTOR NEUROL NEUROS, V22, P105; Grmec S, 2009, RESUSCITATION, V80, P631, DOI 10.1016/j.resuscitation.2009.03.010; Joffre J, 2014, RESUSCITATION, V85, P769, DOI 10.1016/j.resuscitation.2014.02.013; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Leuchter RHV, 2014, JAMA-J AM MED ASSOC, V312, P817, DOI 10.1001/jama.2014.9645; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Noguchi Constance Tom, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000860; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Olsen NV, 2003, CLIN INFECT DIS, V37, pS323, DOI 10.1086/376912; Ott I, 2010, CIRC-CARDIOVASC INTE, V3, P408, DOI 10.1161/CIRCINTERVENTIONS.109.904425; Popp E, 2007, RESUSCITATION, V74, P344, DOI 10.1016/j.resuscitation.2007.01.019; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Suh JW, 2011, INT J CARDIOL, V149, P216, DOI 10.1016/j.ijcard.2010.02.002	32	29	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0735-1097	1558-3597		J AM COLL CARDIOL	J. Am. Coll. Cardiol.	JUL 5	2016	68	1					40	49		10.1016/j.jacc.2016.04.040			10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	DP5IB	WOS:000378528400007	27364049	Bronze			2021-06-18	
J	Baugh, CM; Kroshus, E; Stamm, JM; Daneshvar, DH; Pepin, MJ; Meehan, WP				Baugh, Christine M.; Kroshus, Emily; Stamm, Julie M.; Daneshvar, Daniel H.; Pepin, Michael J.; Meehan, William P.			Clinical Practices in Collegiate Concussion Management	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; clinical practice; best practices; health policy; college	ATHLETIC TRAINERS; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PRACTICE PATTERNS; SPORT HELD; POSITION; SYMPTOMS; ZURICH	Background: In recent years, sports leagues and sports medicine experts have developed guidelines for concussion management. The extent to which current clinical practice is consistent with guideline recommendations is unclear. At the collegiate level, there have been few examinations of concussion management practices and the extent to which meaningful differences across divisions of competition exist. Purpose: The purposes of this study were to (1) examine current practices in concussion diagnosis and management at National Collegiate Athletic Association (NCAA) member colleges, (2) explore the extent to which current practices reflect current recommendations for concussion diagnosis and management, and (3) determine whether there are differences in management patterns across divisions of competition. Design: Descriptive epidemiology study. Methods: An electronic questionnaire was sent to sports medicine clinicians at all NCAA member colleges during September and October 2013. Clinicians were asked about baseline assessments, diagnosis and management practices, return-to-play protocols, the perceived prevalence of underdiagnosis, and basic demographic information. Results: Approximately 30% (n = 866) of contacted clinicians, representing nearly 50% (n = 527) of NCAA member colleges, responded to the questionnaire. Preparticipation baseline examinations were administered at the majority of schools (95%), but most (87.5%) administered baseline assessments only to selected high-risk athletes. Computerized neurocognitive testing and balance assessments were most commonly used as preseason baseline and postinjury assessments. Multimodal examination in line with NCAA and other guidance was used only at a minority of institutions. Athletic trainers most commonly administered and interpreted the preseason baseline examination. Most clinicians reported that their institutions' practices were in line with NCAA guidelines during the first 24 hours of an athlete's concussion diagnosis, with exact percentages varying across measures. Differences across divisions of competition included shorter return-to-play time at Division I schools than Division III schools (9.13 vs 10.31 days, respectively) and more frequently referring concussed athletes to a physician within 24 hours of diagnosis at Division I schools. Conclusion: Concussion management at many colleges in the United States incorporates elements recommended by current guidelines; however, there is room to improve. Increasing the use of a multimodal baseline and postinjury examination will elevate the concussion care provided to college athletes and better align with best practice guidance.	Harvard Univ, Cambridge, MA 02138 USA; Boston Univ, Boston, MA 02215 USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA; [Baugh, Christine M.; Pepin, Michael J.; Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Micheli Ctr Sport Injury Prevent, Boston, MA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Stamm, Julie M.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Daneshvar, Daniel H.] Boston Univ, Sch Med, Chron Traumat Encephalopathy Ctr, Boston, MA 02118 USA	Baugh, CM (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA.	cbaugh@g.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513	NCAA; National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; National Football League Players' Association; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: C.M.B. is an NCAA Graduate Student Research Grant award winner; no funds from that grant were used toward the conduct of this project. C.M.B.'s doctoral education and related research is supported by the National Institute of Mental Health of the National Institutes of Health under award number T32MH019733. E.K. was a postdoctoral research fellow with the National Collegiate Athletic Association Sport Science Institute from 2014 to 2015 and is currently a consultant with the institute. C.M.B. and E.K. both have research funded by the National Football League Players' Association. W.P.M. receives royalties from ABC-Clio publishing for the sale of his book Kids, Sports, and Concussion: A Guide for Coaches and Parents and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled Concussions and with Springer International publishing for a future book entitled Head and Neck Injuries in Young Athletes. His research is funded in part by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.	Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; NCAA, 2014, CONC GUID DIAGN MAN; NCAA, 2013, 2013 2014 NCAA SPORT, P56; NCAA, 2012 2013 NCAA SPORT; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	24	29	29	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2016	44	6					1391	1399		10.1177/0363546516635639			9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	DO5KJ	WOS:000377821700011	27037282	Green Accepted			2021-06-18	
J	Hendrickson, CM; Howard, BM; Kornblith, LZ; Conroy, AS; Nelson, MF; Zhuo, HJ; Liu, KD; Manley, GT; Matthay, MA; Calfee, CS; Cohen, MJ				Hendrickson, Carolyn M.; Howard, Benjamin M.; Kornblith, Lucy Z.; Conroy, Amanda S.; Nelson, Mary F.; Zhuo, Hanjing; Liu, Kathleen D.; Manley, Geoffrey T.; Matthay, Michael A.; Calfee, Carolyn S.; Cohen, Mitchell J.			The acute respiratory distress syndrome following isolated severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury (TBI); acute respiratory distress syndrome (ARDS); platelet transfusion; crystalloid	ACUTE LUNG INJURY; MULTIPLE ORGAN FAILURE; PLATELET TRANSFUSION; BLOOD-TRANSFUSION; BLUNT TRAUMA; COAGULOPATHY; PLASMA; RISK; DYSFUNCTION; MORTALITY	BACKGROUND Acute respiratory distress syndrome (ARDS) is common after traumatic brain injury (TBI) and is associated with worse neurologic outcomes and longer hospitalization. However, the incidence and associated causes of ARDS in isolated TBI have not been well studied. METHODS We performed a subgroup analysis of 210 consecutive patients with isolated severe TBI enrolled in a prospective observational cohort at a Level 1 trauma center between 2005 and 2014. Subjects required endotracheal intubation and had isolated severe TBI defined by a head Abbreviated Injury Scale (AIS) score of 3 or greater and AIS score lower than 3 in all other categories. ARDS within the first 8 days of admission was rigorously adjudicated using Berlin criteria. Regression analyses were used to test the association between predictors of interest and ARDS. RESULTS The incidence of ARDS in the first 8 days after severe isolated TBI was 30%. Patients who developed ARDS were administered more crystalloids (4.3 L vs. 3.5 L, p = 0.005) and blood products in the first 12 hours of admission. Patients with ARDS had significantly worse clinical outcomes measured at 28 days, including longer median intensive care unit and hospital stays (4 days vs. 13 days, p < 0.001, and 7.5 days vs. 14.5 days, p < 0.001, respectively). In unadjusted logistic regression analyses, the odds of developing ARDS were significantly associated with head AIS score (odds ratio [OR], 1.8; p = 0.018), male sex (OR, 2.9; p = 0.012), and early transfusion of platelets (OR, 2.8; p = 0.003). These associations were similar in a multivariate logistic regression model. CONCLUSION In the era of balanced hemostatic resuscitation practices, severity of head injury, male sex, early crystalloids, and early transfusion of platelets are associated with a higher risk of ARDS after severe isolated TBI. Early transfusion of platelets after severe TBI may be a modifiable risk factor for ARDS, and these findings invite further investigation into causal mechanisms driving this observed association. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level III.	[Hendrickson, Carolyn M.; Zhuo, Hanjing; Matthay, Michael A.; Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit CareMedicine, San Francisco, CA USA; [Hendrickson, Carolyn M.; Zhuo, Hanjing; Matthay, Michael A.; Calfee, Carolyn S.] Univ Calif San Francisco, Dept Anesthesia, Div Pulm & Crit CareMedicine, San Francisco, CA USA; [Liu, Kathleen D.] Univ Calif San Francisco, Dept Med, Div Nephrol & Crit Care Med, San Francisco, CA USA; [Liu, Kathleen D.] Univ Calif San Francisco, Dept Anesthesia, Div Nephrol & Crit Care Med, San Francisco, CA USA; [Howard, Benjamin M.; Kornblith, Lucy Z.; Conroy, Amanda S.; Nelson, Mary F.; Cohen, Mitchell J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	Cohen, MJ (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave, San Francisco, CA 94110 USA.	mcohen@sfghsurg.ucsf.edu		Liu, Kathleen/0000-0003-4891-8649	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM-085689, HL090833, HL110969, 5T32HL007185-37, 1F32HL124911-01]; DoDUnited States Department of Defense [W911NF-10-1-0384]; PICORI [ME-1306-02735, R37 HL51856]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL110969, K23HL090833, R37HL051856, T32HL007185, F32HL124911, K23HL133495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM085689] Funding Source: NIH RePORTER	This study was supported by NIH GM-085689 and DoD W911NF-10-1-0384 (to M.J.C.), NIH HL090833 and HL110969 (to C.S.C.), PICORI ME-1306-02735 (to G.M.), R37 HL51856 (M.A.M. and K.D.L.), as well as NIH 5T32HL007185-37 and 1F32HL124911-01 (to C.M.H.)	Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chaiwat O, 2009, ANESTHESIOLOGY, V110, P351, DOI 10.1097/ALN.0b013e3181948a97; Chi X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044829; Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Croce MA, 2005, J TRAUMA, V59, P19, DOI 10.1097/01.TA.0000171459.21450.DC; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Hendrickson CM, 2015, J TRAUMA ACUTE CARE, V79, P417, DOI 10.1097/TA.0000000000000760; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holena DN, 2012, J TRAUMA ACUTE CARE, V73, P825, DOI 10.1097/TA.0b013e318256de38; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Howard BM, 2015, J TRAUMA ACUTE CARE, V78, P735, DOI 10.1097/TA.0000000000000583; Injury Prevention and Control, INJ PREV CONTR TRAUM; Kemp CD, 2008, AM SURGEON, V74, P866; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Larsen AM, 2015, TRANSFUSION MED, V25, P174, DOI 10.1111/tme.12209; Lingappan K, 2013, TOXICOL APPL PHARM, V272, P281, DOI 10.1016/j.taap.2013.06.007; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Marik PE, 2008, CRIT CARE MED, V36, P3080, DOI 10.1097/CCM.0b013e31818c3801; Mascia L, 1998, INTENS CARE MED, V24, P1115, DOI 10.1007/s001340050727; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Miller PR, 2002, AM SURGEON, V68, P845; Miller PR, 2002, AM SURGEON, V68, P50; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Plurad D, 2007, J TRAUMA, V63, P1, DOI 10.1097/TA.0b013e318068b1ed; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Schmidt ME, 1997, NEUROPSYCHOPHARMACOL, V16, P298, DOI 10.1016/S0893-133X(96)00264-3; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; Vlaar APJ, 2010, BLOOD, V116, P1360, DOI 10.1182/blood-2009-10-248732; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wu B, 2014, TRANSFUSION MED, V24, P400, DOI 10.1111/tme.12162; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	51	29	29	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2016	80	6					989	997		10.1097/TA.0000000000000982			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DO5MX	WOS:000377828300028	26881489	Green Accepted			2021-06-18	
J	Oliver, JM; Jones, MT; Kirk, KM; Gable, DA; Repshas, JT; Johnson, TA; Andreasson, U; Norgren, N; Blennow, K; Zetterberg, H				Oliver, Jonathan M.; Jones, Margaret T.; Kirk, K. Michele; Gable, David A.; Repshas, Justin T.; Johnson, Torie A.; Andreasson, Ulf; Norgren, Niklas; Blennow, Kaj; Zetterberg, Henrik			Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; HEAD TRAUMA; NEUROFILAMENT LIGHT; DHA	DIFFUSE AXONAL INJURY; IMPACT EXPOSURE; BRAIN-INJURY; BODY-COMPOSITION; SPORTS-MEDICINE; DIVISION-I; EXERCISE; BLOOD; SIZE	Purpose American football athletes are exposed to subconcussive impacts over the course of the season resulting in elevations in serum neurofilament light (NFL), a biomarker of axonal injury. Docosahexaenoic acid (DHA) has been reported to reduce axonal trauma associated with traumatic brain injury in rodent models. However, the optimal dose in American football athletes is unknown. This study examined the effect of differing doses of DHA on serum NFL over the course of a season of American football. Methods In a randomized, double-blind, placebo-controlled, parallel design, 81 National Collegiate Athletic Association Division I American football athletes were assigned to ingest either 2, 4, 6 gd(-1) of DHA or placebo. Blood was sampled at specific times over the course of 189 d, coincident with changes in intensity, hours of contact, and likely changes in head impacts. Standardized magnitude-based inference was used to define outcomes. Results DHA supplementation increased plasma DHA in a dose-dependent manner (2 gd(-1): mean difference from baseline; 90% CL; 2 gd(-1): 1.3; +/- 0.6; 4 gd(-1): 1.6; +/- 0.7%; 6 gd(-1): 2.8; +/- 1.2%). Serum NFL increased to a greater extent in starters (area under the curve, 1995 +/- 1383 pgmL(-1)) versus nonstarters (1398 +/- 581 pgmL(-1); P = 0.024). Irrespective of dose, supplemental DHA likely attenuated serum NFL coincident with increases in serum NFL by likely small and moderate magnitude (effect size = 0.4-0.7). Conclusions Findings from this study, the first large-scale study examining potential prophylactic use of DHA in American football athletes, include identification of optimal dose of DHA, suggesting a neuroprotective effect of DHA supplementation.	[Oliver, Jonathan M.; Kirk, K. Michele; Gable, David A.; Repshas, Justin T.; Johnson, Torie A.] Texas Christian Univ, Dept Kinesiol, Sports Concuss Res Grp, TCU Box 297730, Ft Worth, TX 76129 USA; [Jones, Margaret T.] George Mason Univ, Div Hlth & Human Performance, Manassas, VA USA; [Kirk, K. Michele; Gable, David A.] Texas Christian Univ, Dept Sport Med, Ft Worth, TX 76129 USA; [Kirk, K. Michele] John Peter Smith Hosp, Dept Sport Med, Ft Worth, TX 76104 USA; [Norgren, Niklas] UmanDiagnostics, Umea, Sweden; [Andreasson, Ulf; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England	Oliver, JM (corresponding author), Texas Christian Univ, Dept Kinesiol, Sports Concuss Res Grp, TCU Box 297730, Ft Worth, TX 76129 USA.	jonathan.oliver@tcu.edu			DSM Nutritional Products; Office of the Provost for Texas Christian University; College of Education and Human Development at George Mason University; Swedish Research CouncilSwedish Research CouncilEuropean Commission; VINNOVAVinnova; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Frimurarestiftelsen	Supplements were provided by DSM Nutritional Products. Support for this study was received from the following: DSM Nutritional Products, Office of the Provost for Texas Christian University, the College of Education and Human Development at George Mason University, Swedish Research Council, VINNOVA, the Knut and Alice Wallenberg Foundation, Frimurarestiftelsen.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams TH, 2010, BRIT J NUTR, V103, P91, DOI 10.1017/S0007114509991516; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ervin R Bethene, 2004, Adv Data, P1; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Melvin MN, 2014, J STRENGTH COND RES, V28, P3320, DOI 10.1519/JSC.0000000000000651; Mori TA, 1999, HYPERTENSION, V34, P253, DOI 10.1161/01.HYP.34.2.253; Mori TA, 2000, AM J CLIN NUTR, V71, P1085; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nikolaidis MG, 2004, SPORTS MED, V34, P1051, DOI 10.2165/00007256-200434150-00004; Oliver JM, 2012, J ATHL TRAINING, V47, P257, DOI 10.4085/1062-6050-47.3.12; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schober ME, 2015, J NEUROTRAUM, V32, P1; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tuor UI, 2014, NEUROIMAGE-CLIN, V6, P32, DOI 10.1016/j.nicl.2014.08.003; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Yamamoto Joelle B, 2008, Res Sports Med, V16, P111, DOI 10.1080/15438620802103320; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	40	29	29	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2016	48	6					974	982		10.1249/MSS.0000000000000875			9	Sport Sciences	Sport Sciences	DM8MO	WOS:000376617900002	26765633				2021-06-18	
J	Tsukamoto, H; Suga, T; Takenaka, S; Tanaka, D; Takeuchi, T; Hamaoka, T; Isaka, T; Ogoh, S; Hashimoto, T				Tsukamoto, Hayato; Suga, Tadashi; Takenaka, Saki; Tanaka, Daichi; Takeuchi, Tatsuya; Hamaoka, Takafumi; Isaka, Tadao; Ogoh, Shigehiko; Hashimoto, Takeshi			Repeated high-intensity interval exercise shortens the positive effect on executive function during post-exercise recovery in healthy young males	PHYSIOLOGY & BEHAVIOR			English	Article						Brain; Cognitive function; Glycogen depletion; Neuronal activation; Psychological arousal	TRAUMATIC BRAIN-INJURY; LACTATE OXIDATION COMPLEX; COGNITIVE PERFORMANCE; MODERATE EXERCISE; GLUCOSE; METABOLISM; STROOP; INTERFERENCE; CONSUMPTION; ACTIVATION	A single bout of aerobic exercise improves executive function (EF), but only for a short period. Compared with a single bout of aerobic exercise, we recently found that high-intensity interval exercise (HIIE) could maintain a longer improvement in EF. However, the mechanism underlying the effect of different exercise modes on the modifications of EF remains unclear. The purpose of the current investigation was to test our hypothesis that the amount of exercise-induced lactate production and its accumulation affects human brain function during and after exercise, thereby affecting post-exercise EF: Ten healthy male subjects performed cycle ergometer exercise. The HIIE protocol consisted of four 4-min bouts at 90% peak VO2 with a 3-min active recovery period at 60% peak VO2. The amount of lactate produced during exercise was manipulated by repeating the HIIE twice with a resting period of 60 min between the 1st HIIE and 2nd HIIE. To evaluate EF, a color-word Stroop task was performed, and reverse-Stroop interference scores were obtained. EF immediately after the 1st HIIE was significantly improved compared to that before exercise, and the improved EF was sustained during 40 min of the post-exercise recovery. However, for the 2nd HIIE, the improved EF was sustained for only 10 min of the post-exercise recovery period, despite the performance of the same exercise. In addition, during and following HIIE, the glucose and lactate accumulation induced by the 2nd HIIE was significantly lower than that induced by the 1st HIIE. Furthermore, there was an inverse relationship between lactate and EF by plotting the changes in lactate levels against changes in EF from pre-exercise during the late phase of post-exercise recovery. These findings suggested the possibility that repeated bouts of HIIE, which decreases lactate accumulation, may dampen the positive effect of exercise on EF during the post-exercise recovery. (C) 2016 The Authors. Published by Elsevier Inc.	[Tsukamoto, Hayato; Suga, Tadashi; Takenaka, Saki; Tanaka, Daichi; Takeuchi, Tatsuya; Hamaoka, Takafumi; Isaka, Tadao; Hashimoto, Takeshi] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kyoto, Shiga, Japan; [Tsukamoto, Hayato] Japan Soc Promot Sci, Tokyo, Japan; [Hamaoka, Takafumi] Tokyo Med Univ, Sch Med, Tokyo 1608402, Japan; [Ogoh, Shigehiko] Toyo Univ, Grad Sch Engn, Saitama, Japan	Hashimoto, T (corresponding author), Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kyoto, Shiga, Japan.	thashimo@fc.ritsumei.ac.jp	Meijer, Anna/K-5118-2016; Tsukamoto, Hayato/AAE-9348-2019	Tsukamoto, Hayato/0000-0001-5512-0497; Ogoh, Shigehiko/0000-0001-5297-6468	Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [26702029, 25560344]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26702029, 15H03077, 15KK0358, 25560344] Funding Source: KAKEN	We thank all of the subjects who participated in the study. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology - Grant-in-Aid for Young Scientists (A) for TH (no. 26702029); Grant-in-Aid for Exploratory Research for TH (no. 25560344).	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Ando S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063630; Angadi SS, 2015, J APPL PHYSIOL, V119, P753, DOI 10.1152/japplphysiol.00518.2014; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Casanova F, 2013, MED SCI SPORT EXER, V45, P1610, DOI 10.1249/MSS.0b013e31828b2ce9; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Dalsgaard MK, 2004, AM J PHYSIOL-REG I, V287, pR534, DOI 10.1152/ajpregu.00256.2004; Dalsgaard MK, 2003, EXP PHYSIOL, V88, P297, DOI 10.1113/eph8802469; Dalsgaard MK, 2002, J PHYSIOL-LONDON, V540, P681, DOI 10.1113/jphysiol.2001.013062; Febbraio MA, 1999, J APPL PHYSIOL, V87, P2341; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Grego F, 2005, INT J SPORTS MED, V26, P27, DOI 10.1055/s-2004-817915; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/mss.0b013e31815fcb04, 10.1249/MSS.0b013e31815fcb04]; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Ikeda Y, 2010, PERCEPT MOTOR SKILL, V110, P654, DOI 10.2466/PMS.110.2.654-660; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Lucas S.J., 2015, J CEREB BLOOD FLOW M; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Newington Jordan T, 2013, J Neurodegener Dis, V2013, P234572, DOI 10.1155/2013/234572; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Nybo L, 2003, J APPL PHYSIOL, V95, P1125, DOI 10.1152/japplphysiol.00241.2003; Ogoh S, 2005, AM J PHYSIOL-HEART C, V288, pH1461, DOI 10.1152/ajpheart.00948.2004; Ogoh S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12163; Puhan MA, 2006, ANN INTERN MED, V145, P816, DOI 10.7326/0003-4819-145-11-200612050-00006; Rasmussen P, 2011, FASEB J, V25, P2865, DOI 10.1096/fj.11-183822; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; Schurr A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00170; SEGAL SS, 1979, J APPL PHYSIOL, V47, P514; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thompson C, 2015, EUR J APPL PHYSIOL, V115, P1825, DOI 10.1007/s00421-015-3166-0; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tsukamoto H, 2016, PHYSIOL BEHAV, V155, P224, DOI 10.1016/j.physbeh.2015.12.021; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023	52	29	30	2	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JUN 1	2016	160						26	34		10.1016/j.physbeh.2016.03.029			9	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	DM7ME	WOS:000376543900005	27060507	Other Gold			2021-06-18	
J	Wu, X; Kirov, II; Gonen, O; Ge, YL; Grossman, RI; Lui, YW				Wu, Xin; Kirov, Ivan I.; Gonen, Oded; Ge, Yulin; Grossman, Robert I.; Lui, Yvonne W.			MR Imaging Applications in Mild Traumatic Brain Injury: An Imaging Update	RADIOLOGY			English	Article							DEFAULT-MODE NETWORK; MAGNETIC-RESONANCE-SPECTROSCOPY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; APPEARING WHITE-MATTER; DIFFUSE AXONAL INJURY; WORKING-MEMORY; CEREBRAL AUTOREGULATION; FUNCTIONAL CONNECTIVITY; POSTCONCUSSION SYNDROME	Mild traumatic brain injury (mTBI), also commonly referred to as concussion, affects millions of Americans annually. Although computed tomography is the first-line imaging technique for all traumatic brain injury, it is incapable of providing long-term prognostic information in mTBI. In the past decade, the amount of research related to magnetic resonance (MR) imaging of mTBI has grown exponentially, partly due to development of novel analytical methods, which are applied to a variety of MR techniques. Here, evidence of subtle brain changes in mTBI as revealed by these techniques, which are not demonstrable by conventional imaging, will be reviewed. These changes can be considered in three main categories of brain structure, function, and metabolism. Macrostructural and microstructural changes have been revealed with three-dimensional MR imaging, susceptibility-weighted imaging, diffusion-weighted imaging, and higher order diffusion imaging. Functional abnormalities have been described with both task-mediated and resting-state blood oxygen level-dependent functional MR imaging. Metabolic changes suggesting neuronal injury have been demonstrated with MR spectroscopy. These findings improve understanding of the true impact of mTBI and its pathogenesis. Further investigation may eventually lead to improved diagnosis, prognosis, and management of this common and costly condition. (C) RSNA, 2016	[Wu, Xin; Kirov, Ivan I.; Gonen, Oded; Ge, Yulin; Grossman, Robert I.; Lui, Yvonne W.] NYU, Sch Med, Dept Radiol, Ctr Biomed Imaging, 660 First Ave,4th Floor, New York, NY 10016 USA	Lui, YW (corresponding author), NYU, Sch Med, Dept Radiol, Ctr Biomed Imaging, 660 First Ave,4th Floor, New York, NY 10016 USA.	yvonne.lui@nyumc.org	Kirov, Ivan/I-2792-2019; Ge, Yulin/D-9060-2019; Wu, Xin/AAF-4276-2019; Ge, Yulin/L-7052-2019	Kirov, Ivan/0000-0001-5641-8578; Ge, Yulin/0000-0002-2320-6031; Gonen, Oded/0000-0002-3148-2028; Wu, Xin/0000-0001-5952-3402	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UL1 TR000038]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS039135-11]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB017183]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER	Y.W.L. supported by the National Institute of Neurological Disorders and Stroke (UL1 TR000038), National Institutes of Health (R01 NS039135-11), and National Institute of Biomedical Imaging and Bioengineering (P41 EB017183). R.I.G. supported by the National Institutes of Health (grant R01 NS039135-11).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Campbell A, 2001, BRAIN RES BULL, V55, P125, DOI 10.1016/S0361-9230(01)00455-5; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Chung HW, 2011, AM J NEURORADIOL, V32, P3, DOI 10.3174/ajnr.A2041; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Connor JR, 2003, J NEUROL SCI, V207, P112, DOI 10.1016/S0022-510X(02)00436-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Davenport ND, 2012, NEUROIMAGE, V59, P2017; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Ding X, 2014, NEUROSCIENCE, V277, P637, DOI 10.1016/j.neuroscience.2014.07.060; Disbrow EA, 2014, J PARKINSON DIS, V4, P453, DOI 10.3233/JPD-130341; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Graham R, 2013, SPORTS RELATED CONCU; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jensen JH, 2006, MAGN RESON MED, V55, P1350, DOI 10.1002/mrm.20907; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kim SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102229; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; LEXA FJ, 1994, AM J NEURORADIOL, V15, P201; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; LOEVNER LA, 1995, RADIOLOGY, V196, P511, DOI 10.1148/radiology.196.2.7617869; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Park JY, 2014, EUR J NEUROSCI, V40, P2715, DOI 10.1111/ejn.12640; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Schlosser RGM, 2006, NEUROSCIENCE, V139, P91, DOI 10.1016/j.neuroscience.2005.06.037; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P353, DOI 10.1007/s11682-014-9310-3; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Uruma G, 2013, ANN NUCL MED, V27, P187, DOI 10.1007/s12149-012-0674-4; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vidal-Pineiro D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00256; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	181	29	29	0	16	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2016	279	3					693	707		10.1148/radiol.16142535			15	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DP8AG	WOS:000378719700006	27183405	Green Published, Bronze			2021-06-18	
J	Barekat, A; Gonzalez, A; Mauntz, RE; Kotzebue, RW; Molina, B; El-Mecharrafie, N; Conner, CJ; Garza, S; Melkani, GC; Joiner, WJ; Lipinski, MM; Finley, KD; Ratliff, EP				Barekat, Ayeh; Gonzalez, Arysa; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Molina, Brandon; El-Mecharrafie, Nadja; Conner, Catherine J.; Garza, Shannon; Melkani, Girish C.; Joiner, William J.; Lipinski, Marta M.; Finley, Kim D.; Ratliff, Eric P.			Using Drosophila as an integrated model to study mild repetitive traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MOUSE MODEL; CELL-DEATH; AUTOPHAGY; SLEEP; CONSEQUENCES; MELANOGASTER; CONCUSSION; GUIDELINES; LONGEVITY; PROTEINS	Traumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. In addition, there has been a growing appreciation that even repetitive, milder forms of TBI (mTBI) can have long-term deleterious consequences to neural tissues. Hampering our understanding of genetic and environmental factors that influence the cellular and molecular responses to injury has been the limited availability of effective genetic model systems that could be used to identify the key genes and pathways that modulate both the acute and long-term responses to TBI. Here we report the development of a severe and mild-repetitive TBI model using Drosophila. Using this system, key features that are typically found in mammalian TBI models were also identified in flies, including the activation of inflammatory and autophagy responses, increased Tau phosphorylation and neuronal defects that impair sleep-related behaviors. This novel injury paradigm demonstrates the utility of Drosophila as an effective tool to validate genetic and environmental factors that influence the whole animal response to trauma and to identify prospective therapies needed for the treatment of TBI.	[Barekat, Ayeh; Gonzalez, Arysa; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Molina, Brandon; El-Mecharrafie, Nadja; Finley, Kim D.; Ratliff, Eric P.] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Barekat, Ayeh; Kotzebue, Roxanne W.; Molina, Brandon; El-Mecharrafie, Nadja; Conner, Catherine J.; Garza, Shannon; Melkani, Girish C.; Finley, Kim D.; Ratliff, Eric P.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Joiner, William J.] San Diego State Univ, Dept Pharmacol, San Diego, CA 92182 USA; [Lipinski, Marta M.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Finley, Kim D.; Ratliff, Eric P.] San Diego State Univ, Dept Chem, San Diego, CA 92182 USA	Finley, KD; Ratliff, EP (corresponding author), San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA.; Finley, KD; Ratliff, EP (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Finley, KD; Ratliff, EP (corresponding author), San Diego State Univ, Dept Chem, San Diego, CA 92182 USA.	kfinley@mail.sdsu.edu; eratliff@mail.sdsu.edu		Lipinski, Marta/0000-0002-7537-9014	NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG039628]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG039628] Funding Source: NIH RePORTER	We would like to thank Dr. James Atwood, TJ Gray, and Shari Garrett at Omni International for generating high speed videos and providing kinetic energy calculations of the flies undergoing traumatic injury using the Bead Ruptor system. We would also like to thank Dr. Natalie A. Gude and Dr. Mark A. Sussman for use of and expert assistance with the Leica SP8 confocal microscope and Dr. Sanford I. Bernstein and Dr. Greg L. Harris for helpful discussions. This work was supported by R01AG039628 from NIH/NIA (KDF).	Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Blake MR, 2015, NEUROBIOL DIS, V77, P117, DOI 10.1016/j.nbd.2015.02.012; DeVorkin Lindsay, 2014, Cold Spring Harb Protoc, V2014, P959, DOI 10.1101/pdb.prot080333; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Laskowski R. A., 2015, BRAIN NEUROTRAUMA MO; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lipinski MM, 2015, NEURAL REGEN RES, V10, P892, DOI 10.4103/1673-5374.158344; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; Nagy P, 2015, METHODS, V75, P151, DOI 10.1016/j.ymeth.2014.11.016; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nezis Ioannis P, 2012, Int J Cell Biol, V2012, P146767, DOI 10.1155/2012/146767; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Ratliff EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132768; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178	55	29	29	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 4	2016	6								25252	10.1038/srep25252			14	Multidisciplinary Sciences	Science & Technology - Other Topics	DL1YC	WOS:000375428200002	27143646	DOAJ Gold, Green Published			2021-06-18	
J	Agrawal, R; Noble, E; Vergnes, L; Ying, Z; Reue, K; Gomez-Pinilla, F				Agrawal, Rahul; Noble, Emily; Vergnes, Laurent; Ying, Zhe; Reue, Karen; Gomez-Pinilla, Fernando			Dietary fructose aggravates the pathobiology of traumatic brain injury by influencing energy homeostasis and plasticity	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cognition; energy homeostasis; metabolic syndrome; mitochondria; plasticity; traumatic brain injury	MITOCHONDRIAL TRANSCRIPTION FACTOR; METABOLIC SYNDROME; NEUROLOGICAL DISORDERS; SIGNALING PATHWAY; COPY NUMBER; MEMORY; PGC-1-ALPHA; DAMAGE; EPIDEMIOLOGY; DYSFUNCTION	Fructose consumption has been on the rise for the last two decades and is starting to be recognized as being responsible for metabolic diseases. Metabolic disorders pose a particular threat for brain conditions characterized by energy dysfunction, such as traumatic brain injury. Traumatic brain injury patients experience sudden abnormalities in the control of brain metabolism and cognitive function, which may worsen the prospect of brain plasticity and function. The mechanisms involved are poorly understood. Here we report that fructose consumption disrupts hippocampal energy homeostasis as evidenced by a decline in functional mitochondria bioenergetics (oxygen consumption rate and cytochrome C oxidase activity) and an aggravation of the effects of traumatic brain injury on molecular systems engaged in cell energy homeostasis (sirtuin 1, peroxisome proliferator-activated receptor gamma coactivator-1alpha) and synaptic plasticity (brain-derived neurotrophic factor, tropomyosin receptor kinase B, cyclic adenosine monophosphate response element binding, synaptophysin signaling). Fructose also worsened the effects of traumatic brain injury on spatial memory, which disruption was associated with a decrease in hippocampal insulin receptor signaling. Additionally, fructose consumption and traumatic brain injury promoted plasma membrane lipid peroxidation, measured by elevated protein and phenotypic expression of 4-hydroxynonenal. These data imply that high fructose consumption exacerbates the pathology of brain trauma by further disrupting energy metabolism and brain plasticity, highlighting the impact of diet on the resilience to neurological disorders.	[Agrawal, Rahul; Noble, Emily; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu		vergnes, laurent/0000-0002-8804-589X; Noble, Emily/0000-0002-7483-031X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465]; NIH NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR026744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by National Institutes of Health Grant NS050465 (F.G-P.), and instrument grant NIH NCRR S10RR026744 (K.R.).	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Creavin ST, 2012, J ALZHEIMERS DIS, V28, P931, DOI 10.3233/JAD-2011-111550; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Eakins James, 2009, J Diabetes Sci Technol, V3, P1373; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Farooqui AA, 2012, CELL MOL LIFE SCI, V69, P741, DOI 10.1007/s00018-011-0840-1; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Grasselli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020791; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mowery NT, 2009, J TRAUMA, V66, P145, DOI 10.1097/TA.0b013e3181938c5e; Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Padwal RS, 2014, CAN J CARDIOL, V30, P467, DOI 10.1016/j.cjca.2013.11.004; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	50	29	29	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2016	36	5					941	953		10.1177/0271678X15606719			13	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	DK9OX	WOS:000375261800009	26661172	Green Published, Bronze			2021-06-18	
J	Pogoda, TK; Stolzmann, KL; Iverson, KM; Baker, E; Krengel, M; Lew, HL; Amara, JH; Meterko, M				Pogoda, Terri K.; Stolzmann, Kelly L.; Iverson, Katherine M.; Baker, Errol; Krengel, Maxine; Lew, Henry L.; Amara, Jomana H.; Meterko, Mark			Associations Between Traumatic Brain Injury, Suspected Psychiatric Conditions, and Unemployment in Operation Enduring Freedom/Operation Iraqi Freedom Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; employment; neurobehavioral symptoms; posttraumatic stress disorder; substance use disorder; traumatic brain injury; unemployment; veterans	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; AFGHANISTAN WAR VETERANS; SUBSTANCE USE DISORDERS; MENTAL-HEALTH PROBLEMS; CLOSED-HEAD-INJURY; DISABILITY COMPENSATION; EMPLOYMENT STATUS; COMBAT VETERANS; FOLLOW-UP	Objective: To examine the relations among demographic characteristics, traumatic brain injury (TBI) history, suspected psychiatric conditions, current neurobehavioral health symptoms, and employment status in Veterans evaluated for TBI in the Department of Veterans Affairs. Study Design: Retrospective cross-sectional database review of comprehensive TBI evaluations documented between October 2007 and June 2009. Participants: Operation Enduring Freedom/Operation Iraqi Freedom Veterans (n=11 683) who completed a comprehensive TBI evaluation. Main Measures: Veterans Affairs clinicians use the comprehensive TBI evaluations to obtain information about TBI-related experiences, current neurobehavioral symptoms, and to identify suspected psychiatric conditions. Results: Approximately one-third of Veterans in this sample were unemployed, and of these, the majority were looking for work. After simultaneously adjusting for health and deployment-related variables, significant factors associated with unemployment included one or more suspected psychiatric conditions (eg, posttraumatic stress disorder, anxiety, depression), neurobehavioral symptom severity (ie, affective, cognitive, vestibular), former active duty status, injury etiology, age, lower education, and marital status. The associations of these factors with employment status varied by deployment-related TBI severity. Conclusions: Simultaneously addressing health-related, educational, and/or vocational needs may fill a critical gap for helping Veterans readjust to civilian life and achieve their academic and vocational potential.	[Pogoda, Terri K.; Stolzmann, Kelly L.; Iverson, Katherine M.; Baker, Errol; Meterko, Mark] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Boston, MA USA; [Krengel, Maxine] VA Boston Healthcare Syst, Res & Dev Serv, Boston, MA USA; [Pogoda, Terri K.; Meterko, Mark] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02130 USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02130 USA; [Krengel, Maxine] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02130 USA; [Lew, Henry L.] Virginia Commonwealth Univ, Def & Vet Brain Injury Ctr, Dept Phys Med & Rehabil, Richmond, VA USA; [Lew, Henry L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA; [Amara, Jomana H.] Naval Postgrad Sch, Def Resources Management Inst, Monterey, CA USA	Pogoda, TK (corresponding author), Ctr Healthcare Org & Implementat Res, 150 South Huntington Ave 152M, Boston, MA 02130 USA.; Pogoda, TK (corresponding author), Boston Univ, Sch Publ Hlth, VA Boston Healthcare Syst, 150 South Huntington Ave 152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780	Office of Research and Development, Health Services Research & Development (HSR&D) Service, Department of Veterans Affairs [SDR 08-405]; HSR&D Career Development Award [CDA-2, 10-029]	This paper is based on work supported by the Office of Research and Development, Health Services Research & Development (HSR&D) Service, Department of Veterans Affairs, through SDR 08-405. Dr. Iverson's contribution to this manuscript was supported by a HSR&D Career Development Award (CDA-2; 10-029). The opinions expressed in this article are the authors' and do not reflect those of the Department of Veterans Affairs, the Veterans Health Administration, Health Services Research and Development Service, the Defense and Veterans Brain Injury Center, or the Department of Defense. Some of the findings were presented at the 2014 Academy Health Annual Research Meeting, San Diego, California.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI 10.1089/neu.2008-0849; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Council NR, 2013, RET HOM IR AFGH ASS; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; [Department of Veterans Affairs VHA Veterans Health Administration], 2010, SCREEN EV POSS TRAUM; Department of Veterans Affairs VHA, 2011, VHA HDB; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Drew D, 2001, PSYCHIATR SERV, V52, P1479, DOI 10.1176/appi.ps.52.11.1479; Elbogen EB, 2012, MIL MED, V177, P669, DOI 10.7205/MILMED-D-11-00388; Epidemiology Program P-DHG Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2014, AN VA HLTH CAR UT OP, P1; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Greenberg GA, 2007, MIL MED, V172, P162, DOI 10.7205/MILMED.172.2.162; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Nazareth I, 2006, J PSYCHOSOM RES, V60, P395, DOI 10.1016/j.jpsychores.2005.07.011; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Olson-Madden JH, 2012, J HEAD TRAUMA REHAB, V27, P370, DOI 10.1097/HTR.0b013e318268d496; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; ROSS CE, 1995, J HEALTH SOC BEHAV, V36, P230, DOI 10.2307/2137340; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tsai J, 2013, J OCCUP REHABIL, V23, P504, DOI 10.1007/s10926-013-9419-z; U.S. General Accounting Office, 2008, GAO08276; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wong ES, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-96; Zivin K, 2011, PSYCHIAT SERV, V62, P35, DOI 10.1176/ps.62.1.pss6201_0035	84	29	29	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					191	203		10.1097/HTR.0000000000000092			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800011	25310289				2021-06-18	
J	Silverberg, ND; Berkner, PD; Atkins, JE; Zafonte, R; Iverson, GL				Silverberg, Noah D.; Berkner, Paul D.; Atkins, Joseph E.; Zafonte, Ross; Iverson, Grant L.			Relationship Between Short Sleep Duration and Preseason Concussion Testing	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sleep deprivation; sleep initiation and maintenance disorders; cognition; athletes; brain concussion	COGNITIVE PERFORMANCE; SEX-DIFFERENCES; POOR SLEEP; DEPRIVATION; ADOLESCENTS; SYMPTOMS; HEADACHE; METAANALYSIS; VARIABLES; STUDENTS	Objective: Baseline, preseason assessment of cognition, symptoms, and balance has been recommended as part of a comprehensive sport concussion management program. We examined the relationship between sleep and baseline test results. We hypothesized that adolescents who slept fewer hours the night before would report more symptoms and perform more poorly on cognitive testing than students who had a full night sleep. Design: Cross-sectional observation study. Setting: Preseason concussion testing for high school athletes. Participants: A large sample (n = 2928) of student athletes from Maine, USA, between the ages of 13 and 18 years completed preseason testing. Participants with developmental problems, a history of treatment for neurological or psychiatric problems, recent concussion, or 3 or more prior concussions were excluded. Assessment of Risk Factors: Athletes were divided into 4 groups based on their sleep duration the night before testing. Main Outcome Measures: Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT; ImPACT Applications, Inc, Pittsburgh, PA) cognitive composite scores and the embedded Post-Concussion Symptom Scale. Results: Sleep was not related to any ImPACT cognitive composite score, after covarying for age and controlling for multiple comparisons. In contrast, there were sleep duration, sex, and sleep duration by sex effects on the Post-Concussion Symptom Scale. The effect of sleep duration on symptom reporting was more pronounced in girls. Supplementary analyses suggested that sleep insufficiency was associated with a diverse array of postconcussion-like symptoms. Conclusions: Poor sleep the night before baseline or postinjury testing may be an important confound when assessing postconcussion symptoms. Girls may be more vulnerable to experiencing and reporting symptoms following insufficient sleep. Clinical Relevance: Clinicians should routinely ask how the athlete slept the night before preseason baseline testing and consider deferring the symptom assessment or later retesting athletes who slept poorly.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, Vancouver, BC V5Z 1M9, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC V5Z 1M9, Canada; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Atkins, Joseph E.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Brigham & Womens Hosp,Sch Med, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Zafonte, Ross; Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Zafonte, Ross; Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA	Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca	Meijer, Anna/K-5118-2016	Iverson, Grant/0000-0001-7348-9570	Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; Vancouver Coastal Health Research Institute	Supported in part by the Goldfarb Center for Public Policy and Civic Engagement/Colby College, and the Bill and Joan Alfond Foundation. R. Zafonte was supported in part by the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members. N.D. Silverberg receives salary support from the Vancouver Coastal Health Research Institute.	Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; BLAU JN, 1990, CEPHALALGIA, V10, P157, DOI 10.1046/j.1468-2982.1990.1004157.x; Bruni O, 2008, SLEEP MED, V9, P542, DOI 10.1016/j.sleep.2007.08.010; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-2005-867080; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Hillman DR, 2013, MED J AUSTRALIA, V199, pS7, DOI 10.5694/mja13.10620; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Kamphuis J, 2012, SLEEP MED, V13, P327, DOI 10.1016/j.sleep.2011.12.006; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; Lee KA, 1999, J ADOLESCENT HEALTH, V24, P16, DOI 10.1016/S1054-139X(98)00074-3; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Minkel JD, 2012, EMOTION, V12, P1015, DOI 10.1037/a0026871; Miyata S, 2013, J SLEEP RES, V22, P535, DOI 10.1111/jsr.12054; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; O'Brien MJ, 2012, J BONE JOINT SURG AM, V94A, P1975, DOI 10.2106/JBJS.K.00958; Oginska H, 2014, J SLEEP RES, V23, P339, DOI 10.1111/jsr.12115; Owens JA, 2005, J DEV BEHAV PEDIATR, V26, P312, DOI 10.1097/00004703-200508000-00011; PENETAR D, 1993, PSYCHOPHARMACOLOGY, V112, P359, DOI 10.1007/BF02244933; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Pilcher JJ, 1997, J AM COLL HEALTH, V46, P121, DOI 10.1080/07448489709595597; Ratcliff R, 2009, PSYCHON B REV, V16, P742, DOI 10.3758/PBR.16.4.742; Tran DP, 2013, CRANIO, V31, P165, DOI 10.1179/crn.2013.026; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Vikram M, 2012, CLIN TER, V163, P383; Wilkinson R.T., 1966, PSYCHON SCI, V5, P471; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	38	29	29	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2016	26	3					226	231		10.1097/JSM.0000000000000241			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	DL4KX	WOS:000375605800012	26247549				2021-06-18	
J	Daiutolo, BV; Tyburski, A; Clark, SW; Elliott, MB				Daiutolo, Brittany V.; Tyburski, Ashley; Clark, Shannon W.; Elliott, Melanie B.			Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						trigeminovascular system; traumatic brain injury; post-traumatic headache; pain; post-traumatic migraine	GENE-RELATED PEPTIDE; NITRIC-OXIDE SYNTHASE; TRIGEMINOVASCULAR SYSTEM; PROSTAGLANDIN E-2; SELECTIVE-INHIBITION; RECEPTOR ANTAGONISTS; GLIAL ACTIVATION; LIGHT AVERSION; MIGRAINE; CGRP	The pain-signaling molecules, nitric oxide synthase (NOS) and calcitonin gene-related peptide (CGRP), are implicated in the pathophysiology of post-traumatic headache (PTH) as they are for migraine. This study assessed the changes of inducible NOS (iNOS) and its cellular source in the trigeminal pain circuit, as well as the relationship between iNOS and CGRP after controlled cortical impact (CCI) injury in mice. The effects of a CGRP antagonist (MK8825) and sumatriptan on iNOS messenger RNA (mRNA) and protein were compared to vehicle at 2 weeks postinjury. Changes in CGRP levels in the trigeminal nucleus caudalis (TNC) in iNOS knockouts with CCI were compared to wild-type (WT) mice at 3 days and 2 weeks post injury. Trigeminal allodynia and photosensitivity were measured. MK8825 and sumatriptan increased allodynic thresholds in CCI groups compared to vehicle (p < 0.01), whereas iNOS knockouts were not different from WT. Photosensitivity was attenuated in MK8825 mice and iNOS knockouts compared to WT (p < 0.05). MK8825 and sumatriptan reduced levels of iNOS mRNA and iNOS immunoreactivity in the TNC and ganglia (p < 0.01). Differences in iNOS cellular localization were found between the trigeminal ganglia and TNC. Although the knockout of iNOS attenuated CGRP at 3 days (p < 0.05), it did not reduce CGRP at 2 weeks. CGRP immunoreactivity was found in the meningeal layers post-CCI, while negligible in controls. Findings support the importance of interactions between CGRP and iNOS in mediating allodynia, as well as the individual roles in photosensitivity. Mitigating prolonged increases in CGRP may be a promising intervention for treating acute PTH.	[Daiutolo, Brittany V.; Tyburski, Ashley; Clark, Shannon W.; Elliott, Melanie B.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA	Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, 1020 Locust St,Jefferson Alumni Hall,Room 236, Philadelphia, PA 19107 USA.	melanie.elliott@jefferson.edu					Akerman S, 2002, BRIT J PHARMACOL, V137, P62, DOI 10.1038/sj.bjp.0704842; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Antonova M, 2012, CEPHALALGIA, V32, P822, DOI 10.1177/0333102412451360; Bartfai T, 2001, NATURE, V410, P425, DOI 10.1038/35068663; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Bechade C, 2014, GLIA, V62, P956, DOI 10.1002/glia.22652; Bell IM, 2012, BIOORG MED CHEM LETT, V22, P3941, DOI 10.1016/j.bmcl.2012.04.105; Bellamy J, 2006, EUR J NEUROSCI, V23, P2057, DOI 10.1111/j.1460-9568.2006.04742.x; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 1998, J NEUROPHYSIOL, V79, P964; Burstein R, 2014, CEPHALALGIA, V34, P853, DOI 10.1177/0333102414527648; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; De Alba J, 2006, PAIN, V120, P170, DOI 10.1016/j.pain.2005.10.028; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Dieterle A, 2011, CEPHALALGIA, V31, P31, DOI 10.1177/0333102410375725; Dobson CF, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00647.x; Dussor G, 2014, ACS CHEM NEUROSCI, V5, P1085, DOI 10.1021/cn500083e; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Edvinsson L, 1998, J AUTONOM NERV SYST, V70, P15, DOI 10.1016/S0165-1838(98)00033-2; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Feistel S, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-93; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fischer MJM, 2010, EXPERT OPIN INV DRUG, V19, P815, DOI 10.1517/13543784.2010.490829; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2012, CEPHALALGIA, V32, P3, DOI 10.1177/0333102411430267; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hoffmann J, 2012, CURR TREAT OPTION NE, V14, P50, DOI 10.1007/s11940-011-0155-4; Hughes FJ, 1999, J BIOL CHEM, V274, P1776, DOI 10.1074/jbc.274.3.1776; Kaiser EA, 2012, J NEUROSCI, V32, P15439, DOI 10.1523/JNEUROSCI.3265-12.2012; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Lennerz JK, 2008, J COMP NEUROL, V507, P1277, DOI 10.1002/cne.21607; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Levy D, 2011, ANN NEUROL, V69, P600, DOI 10.1002/ana.22422; Li J, 2008, BRAIN RES, V1196, P22, DOI 10.1016/j.brainres.2007.12.028; Liu Y, 2008, BRAIN RES, V1208, P103, DOI 10.1016/j.brainres.2008.02.078; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Maihofner C, 2000, NEUROSCI LETT, V290, P71, DOI 10.1016/S0304-3940(00)01302-1; May A, 1999, J CEREBR BLOOD F MET, V19, P115; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; MOUTON PR, 2002, PRINCIPLES PRACTICES; Neeb L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017360; Noseda R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103929; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Olesen J, 2010, NEUROTHERAPEUTICS, V7, P183, DOI 10.1016/j.nurt.2010.03.006; Olesen J, 2008, PHARMACOL THERAPEUT, V120, P157, DOI 10.1016/j.pharmthera.2008.08.003; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Recober A, 2010, DRUG NEWS PERSPECT, V23, P112, DOI 10.1358/dnp.2010.23.2.1475909; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Recober A, 2009, CURR OPIN NEUROL, V22, P241, DOI 10.1097/WCO.0b013e32832b2427; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Russo Andrew F, 2009, Mol Cell Pharmacol, V1, P264; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Seiler K, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-74; Shivanand K, 2011, DARU, V19, P224; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Thompson S, 2010, BEHAV NEUROSCI, V124, P821, DOI 10.1037/a0021568; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang XJ, 2010, HEADACHE, V50, P579, DOI 10.1111/j.1526-4610.2010.01632.x; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	86	29	29	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2016	33	8					748	760		10.1089/neu.2015.4087			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DJ0ZM	WOS:000373932900005	26472135	Green Published			2021-06-18	
J	Amorini, AM; Lazzarino, G; Di Pietro, V; Signoretti, S; Lazzarino, G; Belli, A; Tavazzi, B				Amorini, Angela Maria; Lazzarino, Giacomo; Di Pietro, Valentina; Signoretti, Stefano; Lazzarino, Giuseppe; Belli, Antonio; Tavazzi, Barbara			Metabolic, enzymatic and gene involvement in cerebral glucose dysmetabolism after traumatic brain injury	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Traumatic brain injury; Glucose dysmetabolism; Glycolysis; Pentose phosphate pathway; Energy metabolism; Mitochondrial dysfunction	PENTOSE-PHOSPHATE PATHWAY; ENERGY-METABOLISM; OXIDATIVE STRESS; WHITE-MATTER; MITOCHONDRIAL DYSFUNCTION; MULTIPLE-SCLEROSIS; UP-REGULATION; BLOOD-FLOW; IN-VITRO; MICRODIALYSIS	In this study, the metabolic, enzymatic and gene changes causing cerebral glucose dysmetabolism following graded diffuse traumatic brain injury (TBI) were evaluated. TBI was induced in rats by dropping 450 g from 1 (mild TBI: mTBI) or 2 m height (severe TBI; sTBI). After 6, 12, 24, 48, and 120 h gene expressions and enzymatic activities of glycolysis and pentose phosphate pathway (PPP) enzymes, and levels of lactate, ATP, ADP, ATP/ADP (indexing mitochondrial phosphorylating capacity), NADP+, NADPH and GSH were determined in whole brain extracts (n = 9 rats at each time for both TBI levels). Sham-operated animals (n = 9) were used as controls. Results demonstrated that mTBI caused a late increase (48-120 h post injury) of glycolytic gene expression and enzymatic activities, concomitantly with mitochondrial functional recovery (ATP and ATP/ADP normalization). No changes in lactate and PPP genes and enzymes, were accompanied by transient decrease in GSH, NADP(+), NADPH and NADPH/NADP(+). Animals following sTBI showed early increase (6-24 h post injury) of glycolytic gene expression and enzymatic activities, occurring during mitochondrial malfunctioning (50% decrease in ATP and ATP/ADP). Higher lactate and lower GSH, NADP(+), NADPH, NADPH/NADP(+) than controls were recorded at anytime post injury (p < 0.01). Both TBI levels caused metabolic and gene changes affecting glucose metabolism. Following mTBI, increased glucose flux through glycolysis is coupled to mitochondrial glucose oxidation. "True" hyperglycolysis occurs only after sTBI, where metabolic changes, caused by depressed mitochondrial phosphorylating capacity, act on genes causing net glycolytic flux increase uncoupled from mitochondrial glucose oxidation. (C) 2016 Elsevier B.V. All rights reserved.	[Amorini, Angela Maria; Lazzarino, Giacomo; Tavazzi, Barbara] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy; [Di Pietro, Valentina; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neurobiol, Birmingham B15 2TT, W Midlands, England; [Signoretti, Stefano] San Camillo Hosp, Dept Neurosci Head & Neck Surg, Div Neurosurg, Circonvallaz Gianicolense 87, I-00152 Rome, Italy; [Lazzarino, Giuseppe] Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Bldg 2,3 Floor,Viale A Doria 6, I-95125 Catania, Italy; [Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct, Birmingham B15 2TH, W Midlands, England; [Belli, Antonio] Queen Elizabeth Hosp, Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England	Lazzarino, G (corresponding author), Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Bldg 2,3 Floor,Viale A Doria 6, I-95125 Catania, Italy.	angela.amorini@rm.unicatt.it; g.lazzarino@libero.it; v.dipietro@bham.ac.uk; stefano.signoretti@tiscali.it; lazzarig@unict.it; a.belli@bham.ac.uk; btavazzi@rm.unicatt.it	Belli, Antonio/I-3799-2015; TAVAZZI, BARBARA/AAB-9830-2019; Signoretti, stefano/AAL-5631-2020; lazzarino, giuseppe/K-2277-2015	Belli, Antonio/0000-0002-3211-9933; TAVAZZI, BARBARA/0000-0001-8743-0895; Signoretti, stefano/0000-0002-8086-1622; Di Pietro, Valentina/0000-0001-9430-4723; AMORINI, Angela Maria/0000-0003-3525-9955; lazzarino, giuseppe/0000-0002-5917-7279; Lazzarino, Giacomo/0000-0003-1639-0966	Catholic University of Rome; University of Catania (FIR funds); University of Birmingham	This work was partly funded by research grants awarded by the Catholic University of Rome, the University of Catania (FIR funds) and the University of Birmingham.	Amemiya S, 2012, NEUROIMAGE, V61, P579, DOI 10.1016/j.neuroimage.2012.04.001; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Arnorini AM, 2014, BBA-MOL BASIS DIS, V1842, P1137, DOI 10.1016/j.bbadis.2014.04.005; Artiss JD, 2000, AM J CLIN PATHOL, V114, P139; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caravas J, 2014, DIABETES OBES METAB, V16, P21, DOI 10.1111/dom.12333; Carpenter K.L., 2015, FRONT NEUROSCI; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Frye R.E., 2014, EPILEPSY BEHAV; Gjedde A, 2005, J CEREBR BLOOD F MET, V25, P1183, DOI 10.1038/sj.jcbfm.9600113; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kawamata T., 1995, J CEREB BLOOD FLOW M, V12, P12; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pundik S, 2012, NEUROLOGY, V79, pS44, DOI 10.1212/WNL.0b013e3182695a14; Regenold WT, 2008, J NEUROL SCI, V275, P106, DOI 10.1016/j.jns.2008.07.032; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sahuquillo J., 2014, PLOS ONE; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Steen C, 2013, MULT SCLER J, V19, P1282, DOI 10.1177/1352458513477228; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2001, J BIOL CHEM, V276, P48083, DOI 10.1074/jbc.M101715200; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Ye CY, 2015, NEUROPHARMACOLOGY, V95, P29, DOI 10.1016/j.neuropharm.2015.02.020; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805	51	29	29	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	APR	2016	1862	4					679	687		10.1016/j.bbadis.2016.01.023			9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	DH3KO	WOS:000372686100018	26844378	Bronze			2021-06-18	
J	Huang, CS; Sakry, D; Menzel, L; Dangel, L; Sebastiani, A; Kramer, T; Karram, K; Engelhard, K; Trotter, J; Schafer, MKE				Huang, Changsheng; Sakry, Dominik; Menzel, Lutz; Dangel, Larissa; Sebastiani, Anne; Kraemer, Tobias; Karram, Khalad; Engelhard, Kristin; Trotter, Jacqueline; Schaefer, Michael K. E.			Lack of NG2 Exacerbates Neurological Outcome and Modulates Glial Responses After Traumatic Brain Injury	GLIA			English	Article						astrocytes; microglia; macrophages; gliosis; CNS inflammation; Cxcl13	CHONDROITIN SULFATE PROTEOGLYCANS; OLIGODENDROCYTE PRECURSOR CELLS; CORTICAL IMPACT INJURY; SPINAL-CORD-INJURY; ACTIVATED MICROGLIA; LYMPHOID CHEMOKINE; NG2-POSITIVE CELLS; UP-REGULATION; PROLIFERATION; MACROPHAGES	Traumatic brain injury (TBI) is a major cause of death and disability. The underlying pathophysiology is characterized by secondary processes including neuronal death and gliosis. To elucidate the role of the NG2 proteoglycan we investigated the response of NG2-knockout mice (NG2-KO) to TBI. Seven days after TBI behavioral analysis, brain damage volumetry and assessment of blood brain barrier integrity demonstrated an exacerbated response of NG2-KO compared to wild-type (WT) mice. Reactive astrocytes and expression of the reactive astrocyte and neurotoxicity marker Lcn2 (Lipocalin-2) were increased in the perilesional brain tissue of NG2-KO mice. In addition, microglia/macrophages with activated morphology were increased in number and mRNA expression of the M2 marker Arg1 (Arginase 1) was enhanced in NG2-KO mice. While TBI-induced expression of pro-inflammatory cytokine genes was unchanged between genotypes, PCR array screening revealed a marked TBI-induced up-regulation of the C-X-C motif chemokine 13 gene Cxcl13 in NG2-KO mice. CXCL13, known to attract immune cells to the inflamed brain, was expressed by activated perilesional microglia/macrophages seven days after TBI. Thirty days after TBI, NG2-KO mice still exhibited more pronounced neurological deficits than WT mice, up-regulation of Cxcl13, enhanced CD45+ leukocyte infiltration and a relative increase of activated Iba-1+/CD45+ microglia/macrophages. Our study demonstrates that lack of NG2 exacerbates the neurological outcome after TBI and associates with abnormal activation of astrocytes, microglia/macrophages and increased leukocyte recruitment to the injured brain. These findings suggest that NG2 may counteract neurological deficits and adverse glial responses in TBI.	[Huang, Changsheng; Menzel, Lutz; Dangel, Larissa; Sebastiani, Anne; Kraemer, Tobias; Engelhard, Kristin; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55131 Mainz, Germany; [Sakry, Dominik; Karram, Khalad; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55131 Mainz, Germany; [Engelhard, Kristin; Trotter, Jacqueline; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55131 Mainz, Germany	Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Univ Med Ctr, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Changsheng, Huang/M-6033-2018	Huang, Changsheng/0000-0003-0535-1865; Kramer, Tobias/0000-0001-6900-3486; Sakry, Dominik/0000-0002-7144-7243; Menzel, Lutz/0000-0002-3816-6255	Naturwissenschaftlich-Medizinisches Forschungszentrum (NMFZ) of the Johannes Gutenberg-University Mainz; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [CRC 1080, CRC TR 128]	Grant sponsor: Naturwissenschaftlich-Medizinisches Forschungszentrum (NMFZ) of the Johannes Gutenberg-University Mainz; Grant sponsor: Deutsche Forschungsgemeinschaft; Grant numbers: CRC 1080 Project B6, CRC TR 128 Project B7.	Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Bagaeva LV, 2006, J IMMUNOL, V176, P7676, DOI 10.4049/jimmunol.176.12.7676; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Claus HL, 2013, NEUROPATHOLOGY, V33, P30, DOI 10.1111/j.1440-1789.2012.01322.x; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dehn D, 2006, GLIA, V53, P491, DOI 10.1002/glia.20307; Esen N, 2014, GLIA, V62, P1452, DOI 10.1002/glia.22692; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gunn MD, 1998, NATURE, V391, P799; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Levine J, 2016, BRAIN RES, V1638, P199, DOI 10.1016/j.brainres.2015.07.026; Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Petrosyan HA, 2013, J NEUROSCI, V33, P4032, DOI 10.1523/JNEUROSCI.4702-12.2013; Rainey-Barger EK, 2011, BRAIN BEHAV IMMUN, V25, P922, DOI 10.1016/j.bbi.2010.10.002; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sakry D, 2015, BRAIN RES, DOI [10.1016/j.brainres.2015.06.003, DOI 10.1016/J.BRAINRES.201506.003]; Sakry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127222; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stegmuller J, 2002, J NEUROCYTOL, V31, P497, DOI 10.1023/A:1025743731306; Sugimoto K, 2014, GLIA, V62, P185, DOI 10.1002/glia.22598; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tirotta E, 2011, GLIA, V59, P1518, DOI 10.1002/glia.21195; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Ughrin YM, 2003, J NEUROSCI, V23, P175; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; You WK, 2014, ANGIOGENESIS, V17, P61, DOI 10.1007/s10456-013-9378-1; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	64	29	29	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	APR	2016	64	4					507	523		10.1002/glia.22944			17	Neurosciences	Neurosciences & Neurology	DD8CX	WOS:000370153300004	26638112				2021-06-18	
J	Rizzo, JR; Hudson, TE; Dai, WW; Desai, N; Yousefi, A; Palsana, D; Selesnick, I; Balcer, LJ; Galetta, SL; Rucker, JC				Rizzo, John-Ross; Hudson, Todd E.; Dai, Weiwei; Desai, Ninad; Yousefi, Arash; Palsana, Dhaval; Selesnick, Ivan; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.			Objectifying eye movements during rapid number naming: Methodology for assessment of normative data for the King-Devick test	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Brain concussion; Eye movements; Eye movement measurements; Saccades	DORSOLATERAL PREFRONTAL CORTEX; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; OCULAR MOTOR BEHAVIOR; SCREENING TOOL; MICROSACCADES; ATTENTION; SACCADES	Objective: Concussion is a major public health problem and considerable efforts are focused on sideline-based diagnostic testing to guide return-to-play decision-making and clinical care. The King-Devick (K-D) test, a sensitive sideline performance measure for concussion detection, reveals slowed reading times in acutely concussed subjects, as compared to healthy controls; however, the normal behavior of eye movements during the task and deficits underlying the slowing have not been defined. Methods: Twelve healthy control subjects underwent quantitative eye tracking during digitized K-D testing. Results: The total K-D reading time was 51.24 (+/- 9.7) seconds. A total of 145 saccades (+/- 15) per subject were generated, with average peak velocity 299.5 degrees/s and average amplitude 8.2. The average inter-saccadic interval was 248.4 ms. Task-specific horizontal and oblique saccades per subject numbered, respectively, 102 (+/- 10) and 17 (+/- 4). Subjects with the fewest saccades tended to blink more, resulting in a larger amount of missing data; whereas, subjects with the most saccades tended to make extra saccades during line transitions. Conclusions: Establishment of normal and objective ocular motor behavior during the K-D test is a critical first step towards defining the range of deficits underlying abnormal testing in concussion. Further, it sets the groundwork for exploration of K-D correlations with cognitive dysfunction and saccadic paradigms that may reflect specific neuroanatomic deficits in the concussed brain. (C) 2016 Elsevier B.V. All rights reserved.	[Rizzo, John-Ross; Hudson, Todd E.; Yousefi, Arash] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Rizzo, John-Ross; Hudson, Todd E.; Desai, Ninad; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Dai, Weiwei; Selesnick, Ivan] NYU, Tandon Sch Engn, Dept Elect & Comp Engn, New York, NY USA; [Palsana, Dhaval] NYU, Tandon Sch Engn, Dept Mech Engn, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA	Rucker, JC (corresponding author), Ctr Ambulatory Care, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.	janet.rucker@nyumc.org		Rizzo, John-Ross/0000-0002-4084-0085; Rucker, Janet/0000-0002-0397-0999	NYU School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG042379] Funding Source: NIH RePORTER	NYU School of Medicine.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Choi W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01024; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEUROOPHTHALMOL; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Roos JCP, 2008, EXP BRAIN RES, V187, P283, DOI 10.1007/s00221-008-1304-1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	24	29	29	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2016	362						232	239		10.1016/j.jns.2016.01.045			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DH1PW	WOS:000372558400047	26944155	Green Accepted			2021-06-18	
J	Fu, TS; Jing, R; McFaull, SR; Cusimano, MD				Fu, Terence S.; Jing, Rowan; McFaull, Steven R.; Cusimano, Michael D.			Health & Economic Burden of Traumatic Brain Injury in the Emergency Department	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Concussion; cost of illness; epidemiology; prevention; traumatic brain injury	UNITED-STATES; CARE; TRENDS; POPULATION; ONTARIO; VISITS; COSTS; US; PROGRAM; TBI	Objective: To evaluate epidemiological patterns and lifetime costs of traumatic brain injury (TBI) identified in the emergency department (ED) within a publicly insured population in Ontario, Canada, in 2009. Methods: A nationally representative, population-based database was used to identify TBI cases presenting to Ontario EDs between April 2009 and March 2010. We calculated unit costs for medical treatment and productivity loss, and multiplied these by corresponding incidence estimates to determine the lifetime costs of identified TBI cases across age group, sex, and mechanism of injury. Results: In 2009, there were more than 133,000 ED visits for TBI in Ontario, resulting in a conservative estimate of $945 million in lifetime costs. Lifetime cost estimates ranged from $279 million to $1.22 billion depending on the diagnostic criteria used to define TBI. Peak rates of TBI occurred among young children (ages 0-4 year) and the elderly (ages 85+ years). Males experienced a 53% greater rate of TBI and incurred two-fold higher costs compared with females. Falls, sports/bicyclist-related injuries, and motor vehicle crashes represented 47%, 12%, and 10% of TBI presenting to ED, respectively, and accounted for a significant proportion of costs. Conclusions: This study revealed an enormous health and economic burden associated with TBI identified in the ED setting. Our findings underscore the importance of ongoing surveillance and prevention efforts targeted to vulnerable populations. More research is needed to fully appreciate the burden of TBI across a variety of health care settings.	[Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Univ Toronto, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [McFaull, Steven R.] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Cusimano, MD (corresponding author), St Michaels Hosp, Keenan Res Ctr, Injury Prevent Res Off, Dept Surg,Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation.	[Anonymous], 1999, JAMA, V282, P974; Berkowitz M, 1987, PERMANENT DISABILITY; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Canadian Institute of Health Information (CIHI), 2008, DAT QUAL STUD EM DEP, VII; Canadian Institute of Health Information (CIHI), 2006, HEAD INJ CAN DEC CHA; Centers for Disease Control and Prevention, 2010, EXT CAUS INJ MORT MA; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; CIHI, 2007, BURD NEUR DIS DIS IN; CIHI, 2011, NAT HLTH EXP TRENDS; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corso A.C., 2003, PREVENTION EFFECTIVE; Cusimano MD, 2008, INJURY PREV, V14, P113, DOI 10.1136/ip.2007.017533; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Dutton RP, 2011, J TRAUMA, V70, P554, DOI 10.1097/TA.0b013e31820d1062; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; Lawrence BA, 2011, MED WORK LOSS COST E; Lawrence BA, 2000, INJURY CONTROL SAFET, V7, P97; Mahyr C, 2014, COSTS ASS DEATH INVE; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayhew D.R., 2005, BEST PRACTICES GRADU; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Miller T.R., 1995, DATABOOK NONFATAL IN; Miller TR ZE, 2009, NEUROTRAUMA CRITICAL, P445; Ministry of Health and Long-Term Care Health Data Branch, AMB SERV BILL; Ministry of Health and Long-Term Care Health Data Branch, DAT QUAL REV EM TOT; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; Simniceanu A, 2014, TRAFFIC INJ PREV, V15, P734, DOI 10.1080/15389588.2013.867483; Statistics Canada, 2014, TABL 326 0021 CONS P; Statistics Canada, 2013, LIF TABL CAN PROV TE; Statistics Canada, 2013, TABL 202 0407 INC IN; Thurman DKJRC, 1995, STANDARDS SURVEILLAN; US Department of Health and Human Services, 2010, TRAUMATIC BRAIN INJU; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; World Health Organization, 2006, NEUR DIS PUBL HLTH C	51	29	29	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAR	2016	43	2					238	247		10.1017/cjn.2015.320			10	Clinical Neurology	Neurosciences & Neurology	DH5GS	WOS:000372814900003	26842131	Bronze			2021-06-18	
J	Shein, SL; Ferguson, NM; Kochanek, PM; Bayir, H; Clark, RSB; Fink, EL; Tyler-Kabara, EC; Wisniewski, SR; Tian, Y; Balasubramani, GK; Bell, MJ				Shein, Steven L.; Ferguson, Nikki M.; Kochanek, Patrick M.; Bayir, Huelya; Clark, Robert S. B.; Fink, Ericka L.; Tyler-Kabara, Elizabeth C.; Wisniewski, Stephen R.; Tian, Ye; Balasubramani, G. K.; Bell, Michael J.			Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury-Results From an Automated Data Collection System Time-Synched to Drug Administration	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						intracranial hypertension; pediatrics; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; PEDIATRIC HEAD-INJURY; DEXAMETHASONE THERAPY; HYPERTONIC SALINE; BLOOD-PRESSURE; FENTANYL; METABOLISM	Objectives: To describe acute cerebral hemodynamic effects of medications commonly used to treat intracranial hypertension in children with traumatic brain injury. Currently, data supporting the efficacy of these medications are insufficient. Design: In this prospective observational study, intracranial hypertension (intracranial pressure 20 mm Hg for > 5 min) was treated by clinical protocol. Administration times of medications for intracranial hypertension (fentanyl, 3% hypertonic saline, mannitol, and pentobarbital) were prospectively recorded and synchronized with an automated database that collected intracranial pressure and cerebral perfusion pressure every 5 seconds. Intracranial pressure crises confounded by external stimulation or mechanical ventilator adjustments were excluded. Mean intracranial pressure and cerebral perfusion pressure from epochs following drug administration were compared with baseline values using Kruskal-Wallis analysis of variance and Dunn test. Frailty modeling was used to analyze the time to intracranial pressure crisis resolution. Mixed-effect models compared intracranial pressure and cerebral perfusion pressure 5 minutes after the medication versus baseline and rates of treatment failure. Setting: A tertiary care children's hospital. Patients: Children with severe traumatic brain injury (Glasgow Coma Scale score 8). Interventions: None. Measurements and Main Results: We analyzed 196 doses of fentanyl, hypertonic saline, mannitol, and pentobarbital administered to 16 children (median: 12 doses per patient). Overall, intracranial pressure significantly decreased following the administration of fentanyl, hypertonic saline, and pentobarbital. After controlling for administration of multiple medications, intracranial pressure was decreased following hypertonic saline and pentobarbital administration; cerebral perfusion pressure was decreased following fentanyl and was increased following hypertonic saline administration. After adjusting for significant covariates (including age, Glasgow Coma Scale score, and intracranial pressure), hypertonic saline was associated with a two-fold faster resolution of intracranial hypertension than either fentanyl or pentobarbital. Fentanyl was significantly associated with the most frequent treatment failure. Conclusions: Intracranial pressure decreased after multiple drug administrations, but hypertonic saline may warrant consideration as the first-line drug for treating intracranial hypertension, as it was associated with the most favorable cerebral hemodynamics and fastest resolution of intracranial hypertension.	[Shein, Steven L.; Ferguson, Nikki M.; Kochanek, Patrick M.; Bayir, Huelya; Clark, Robert S. B.; Fink, Ericka L.; Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Shein, Steven L.; Ferguson, Nikki M.; Kochanek, Patrick M.; Bayir, Huelya; Clark, Robert S. B.; Fink, Ericka L.; Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.; Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.; Tian, Ye; Balasubramani, G. K.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Ferguson, Nikki Miller/AAA-4548-2020; Shein, Steven/I-7763-2019; Tyler-Kabara, Elizabeth/H-4930-2013	Shein, Steven/0000-0003-3382-5159; Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Wisniewski, Stephen/0000-0002-3877-9860; Goundappa K, Balasubramani/0000-0001-7221-1825	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD 040686]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD 040686, NS 081041]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); PCORIPatient-Centered Outcomes Research Institute - PCORI; Laerdal Foundation;  [K23 NS065132]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041, K23NS065132] Funding Source: NIH RePORTER	Drs. Shein and Ferguson were supported by the National Institutes of Health (NIH) training grant (T32 HD 040686). Dr. Kochanek received salary support by an NIH grant (NS 081041). Dr. Fink was supported by K23 NS065132. Drs. Wisniewski and Bell received salary support by an NIH grant (NS 081041).; Dr. Bell received support for article research from the National Institutes of Health (NIH). His institution received funding: Drs. Shein and Ferguson were supported by NIH training grant (T32 HD 040686). Drs. Bell, Kochanek, and Wisniewski received salary support by an NIH grant (NS 081041). Dr. Fink was supported by K23 NS065132. Dr. Shein received support for article research from the NIH. His institution received funding from the NIH (T32 HD040686). Dr. Ferguson received support for article research from the NIH. Her institution received funding from the NIH/NICHD. Dr. Kochanek has multiple grants from federal agencies including the NIH and the U.S. Army, receives a stipend for serving as editor of Pediatric Critical Care Medicine, served as an expert witness on several cases over the past 36 months, received honoraria for numerous lectures at national meetings and/or as a guest professor at various institutions of higher education, and received support for article research from the NIH. His institution received funding from the NIH. Dr. Bayir received support for article research from the NIH. Dr. Clark received royalties from Elsevier. His institution received funding from NIH grants. Dr. Fink received support for article research from the NIH. Her institution received funding from the NIH, PCORI, and the Laerdal Foundation. Dr. Tyler-Kabara disclosed other support: TK Group LLC, member, consulting group for computer security, occasional medical legal work related to pediatric neurosurgery (none related to severe traumatic head injuries in the last 36 months). Dr. Wisniewski received support for article research from the Department of Defense. His institution received funding from the Department of Defense. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; CARLSSON C, 1982, ANESTHESIOLOGY, V57, P375, DOI 10.1097/00000542-198211000-00005; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; FANCONI S, 1988, INTENS CARE MED, V14, P163; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Hager H, 2009, OBES SURG, V19, P717, DOI 10.1007/s11695-008-9607-7; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; MICHENFELDER JD, 1971, BRIT J ANAESTH, V43, P630, DOI 10.1093/bja/43.7.630; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da	28	29	30	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2016	17	3					236	245		10.1097/PCC.0000000000000610			10	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	DG0IC	WOS:000371747500008	26673840	Green Accepted			2021-06-18	
J	Berger, M; Nadler, JW; Friedman, A; McDonagh, DL; Bennett, ER; Cooter, M; Qi, WJ; Laskowitz, DT; Ponnusamy, V; Newman, MF; Shaw, LM; Warner, DS; Mathew, JP; James, ML				Berger, Miles; Nadler, Jacob W.; Friedman, Allan; McDonagh, David L.; Bennett, Ellen R.; Cooter, Mary; Qi, Wenjing; Laskowitz, Daniel T.; Ponnusamy, Vikram; Newman, Mark F.; Shaw, Leslie M.; Warner, David S.; Mathew, Joseph P.; James, Michael L.		MAD-PIA Investigators	The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Amyloid-beta; anesthesia; cerebrospinal fluid; isoflurane; propofol; surgery; tau protein	NEUROIMAGING INITIATIVE SUBJECTS; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; TOTAL TAU; BIOMARKERS; SURGERY; BETA; ASSOCIATION; PROTEIN; RISK	Background: Preclinical studies have found differential effects of isoflurane and propofol on the Alzheimer's disease (AD)-associated markers tau, phosphorylated tau (p-tau) and amyloid-beta (A beta). Objective: We asked whether isoflurane and propofol have differential effects on the tau/A beta ratio (the primary outcome), and individual AD biomarkers. We also examined whether genetic/intraoperative factors influenced perioperative changes in AD biomarkers. Methods: Patients undergoing neurosurgical/otolaryngology procedures requiring lumbar cerebrospinal fluid (CSF) drain placement were prospectively randomized to receive isoflurane (n = 21) or propofol (n = 18) for anesthetic maintenance. We measured perioperative CSF sample AD markers, performed genotyping assays, and examined intraoperative data from the electronic anesthesia record. A repeated measures ANOVA was used to examine changes in AD markers by anesthetic type over time. Results: The CSF tau/A beta ratio did not differ between isoflurane-versus propofol-treated patients (p = 1.000). CSF tau/A beta ratio and tau levels increased 10 and 24 h after drain placement (p = 2.002x10(-6) and p = 1.985x10(-6), respectively), mean CSF p-tau levels decreased (p = 0.005), and A beta levels did not change (p = 0.152). There was no interaction between anesthetic treatment and time for any of these biomarkers. None of the examined genetic polymorphisms, including ApoE4, were associated with tau increase (n = 9 polymorphisms, p > 0.05 for all associations). Conclusion: Neurosurgery/otolaryngology procedures are associated with an increase in the CSF tau/A beta ratio, and this increase was not influenced by anesthetic type. The increased CSF tau/A beta ratio was largely driven by increases in tau levels. Future work should determine the functional/prognostic significance of these perioperative CSF tau elevations.	[Berger, Miles; Cooter, Mary; Laskowitz, Daniel T.; Newman, Mark F.; Warner, David S.; Mathew, Joseph P.; James, Michael L.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Nadler, Jacob W.] Univ Rochester, Postanesthesia Care Unit, Rochester, NY USA; [Nadler, Jacob W.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA; [Friedman, Allan; Bennett, Ellen R.; Warner, David S.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA; [McDonagh, David L.] Univ Texas Dallas, Dept Anesthesiol & Pain Management, Neurol Surg Neurol & Neurotherapeut, Dallas, TX 75230 USA; [Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA; [Qi, Wenjing] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Laskowitz, Daniel T.; Warner, David S.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Ponnusamy, Vikram] Duke Univ, Coll Arts & Sci, Durham, NC 27710 USA; [Newman, Mark F.] Duke Univ, Med Ctr, Private Diagnost Clin, Durham, NC 27710 USA; [Shaw, Leslie M.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	Berger, M (corresponding author), Duke Univ, Med Ctr, Room 4317, Durham, NC 27710 USA.	miles.berger@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Sampson, John/0000-0002-0104-7658; Berger, Miles/0000-0002-2386-5061; Li, Yi-Ju/0000-0001-6996-4834	Department of Anesthesiology, Duke University Medical Center; NIH T32 grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM08600]; International Anesthesia Research Society Mentored Research Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG050918]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG050918, K76AG057022] Funding Source: NIH RePORTER	This work was supported by the Department of Anesthesiology, Duke University Medical Center. MB also acknowledges support from NIH T32 grant #GM08600, an International Anesthesia Research Society Mentored Research Award, and NIH R03 #AG050918.	Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Anckarsater R, 2014, J NEURAL TRANSM, V121, P649, DOI 10.1007/s00702-013-1156-0; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Berger M, 2014, J CARDIOTHOR VASC AN, V28, P1609, DOI 10.1053/j.jvca.2014.04.014; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; Carrillo MC, 2013, ALZHEIMERS DEMENT, V9, P137, DOI 10.1016/j.jalz.2012.11.003; Chen SY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-21; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Hampel H, 1999, BRAIN RES, V823, P104, DOI 10.1016/S0006-8993(99)01146-4; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Mulder C, 2010, CLIN CHEM, V56, P248, DOI 10.1373/clinchem.2009.130518; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Palotas A, 2010, J ALZHEIMERS DIS, V21, P1153, DOI 10.3233/JAD-2010-100702; Papon MA, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00272; Perret-Liaudet A, 2012, J ALZHEIMERS DIS, V31, P13, DOI 10.3233/JAD-2012-120361; Pica-Mendez AM, 2010, CLIN CHIM ACTA, V411, P1833, DOI 10.1016/j.cca.2010.07.019; Pomara N, 2011, NEUROCHEM RES, V36, P1124, DOI 10.1007/s11064-011-0459-5; Reinsfelt B, 2012, ANN THORAC SURG, V94, P549, DOI 10.1016/j.athoracsur.2012.04.044; Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sotiropoulos I, 2008, J NEUROCHEM, V107, P385, DOI 10.1111/j.1471-4159.2008.05613.x; Su X, 2012, MOL MED, V18, P1481, DOI 10.2119/molmed.2012.00351; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Terrando N, 2015, ANESTH ANALG, V120, P649, DOI 10.1213/ANE.0000000000000624; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Vanderstichele H, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt142; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Ye XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052887; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang B, 2013, ANESTHESIOLOGY, V119, P52, DOI 10.1097/ALN.0b013e31828ce55d; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019; Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2; Zschocke J, 2013, CNS NEUROL DISORD-DR, V12, P1194	44	29	30	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2016	52	4					1299	1310		10.3233/JAD-151190			12	Neurosciences	Neurosciences & Neurology	DP9BQ	WOS:000378792100013	27079717	Green Accepted			2021-06-18	
J	Harvey, L; Mitchell, R; Brodaty, H; Draper, B; Close, J				Harvey, Lara; Mitchell, Rebecca; Brodaty, Henry; Draper, Brian; Close, Jacqueline			The influence of dementia on injury-related hospitalisations and outcomes in older adults	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury; Hospitalisations; Dementia; Prevalence; Mortality; Probabilistic data linkage	TRAUMATIC BRAIN-INJURY; HIP FRACTURE; PEOPLE; POPULATION; MORTALITY; COMMUNITY; SURVIVAL; DISEASE	Introduction: Injury is the most common reason for admission to hospital in people with dementia in Australia. However relatively little is known about the temporal trends and the hospital experience of people with dementia hospitalised for an injury. This population-based data linkage study compared the causes, temporal trends and health outcomes for injury-related hospitalisations in people with and without dementia. Methods: Hospitalisation and death data for 235,612 individuals aged 65 years and over admitted to hospital for an injury over the ten year period (2003-2012) in New South Wales, Australia were probabilistically linked. Descriptive statistics including chi square tests, observed and age-standardised admission rates and rate ratios (RRs) were calculated. Trends over time were analysed using negative binomial regression. Results: There were 331,432 injury-related hospitalisations over the study period. Both the observed (RR 3.16; 95% CI 3.13-3.19) and age-standardised admission rate ratios (RR 1.78; 95% CI 1.77-1.79) were higher for people with dementia. Age-standardised rates increased by 3.5% (95% CI 3.1-3.9) per annum over the study period for people without dementia. In contrast, for people with dementia, rates increased by 2.4% (95% CI 1.8-3.1) per annum until 2007 and then decreased by 3.1% (95% CI -4.4 to -1.7) per annum from 2007 onwards. Compared to people without dementia, a higher proportion of people with dementia were hospitalised as a result of a fall (90.9% vs 75.2%, p < 0.0001), sustained a fracture (57.2% vs 52.1%, p < 0.0001), notably hip fracture (30.7% vs 14.7%, p < 0.0001), had longer mean hospital lengths of stay (LOS) (16.5 vs 13.6 days), and higher 30-day mortality (8.7% vs 3.6% p < 0.0001), although this pattern was not consistent across all injury types. Conclusions: People with dementia are disproportionately represented in injury-related hospitalisations, experience longer hospital LOS and have poorer outcomes. Ninety percent of hospitalisations for people with dementia were as a result of a fall, highlighting the importance of developing and implementing effective fall-related preventive strategies in this high risk population. (C) 2015 Elsevier Ltd. All rights reserved.	[Harvey, Lara; Mitchell, Rebecca; Close, Jacqueline] UNSW, Neurosci Res Australia, Falls & Injury Prevent Grp, Sydney, NSW, Australia; [Mitchell, Rebecca] Macquarie Univ, Australian Inst Hlth Innovat, N Ryde, NSW 2109, Australia; [Brodaty, Henry; Draper, Brian] UNSW, Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW, Australia; [Brodaty, Henry; Draper, Brian] UNSW, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Close, Jacqueline] UNSW, Prince Wales Clin Sch, Sydney, NSW, Australia	Harvey, L (corresponding author), Neurosci Res Australia, Barker St, Sydney, NSW 2031, Australia.	l.harvey@neura.edu.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761	Dementia Collaborative Research Centres-Assessment and Better Care, University of New South Wales	This study was funded by the Dementia Collaborative Research Centres-Assessment and Better Care, University of New South Wales. The authors would like to thank the NSW Ministry of Health and the NSW Registry of Birth Deaths and Marriages for the provision of the hospitalisation and death data extracts, and the Centre for Health Record Linkage (CHeReL) for the provision of the unique patient identifiers used to link the datasets.	Abrahamsen B, 2010, OSTEOPOROSIS INT, V21, P373, DOI 10.1007/s00198-009-0957-3; *ACC EC, 2005, DEM EST PROJ AUSTR S; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Australian Bureau of Statistics, 2018, AUSTR DEM STAT, V2019; Australian Health Performance Authority, 2013, HOSP PERF LENGTH S S; Australian Institute of Health and Welfare, 2009, NAT HLTH PERF FRAM; Berry J., 2006, GUIDE STAT METHODS I; Centre for Health Record Linkage, 2012, MAST LINK KEY QUAL A; Cummings E, 2011, HEALTH INF MANAG J, V40, P5, DOI 10.1177/183335831104000301; Deloitte Access Economics, 2011, DEM AUSTR 2011 2050; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Fong TG, 2012, ANN INTERN MED, V156, P848, DOI 10.7326/0003-4819-156-12-201206190-00005; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Knopp-Sihota JA, 2014, GERIATR GERONTOL INT, V14, P121, DOI 10.1111/ggi.12069; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; National Centre for Classification in Health N, 2010, AUSTR COD STAND ICD; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; SAS Institute, 2013, SAS ENT GUID 6 1 64; Scandol JP, 2013, INJURY, V44, P776, DOI 10.1016/j.injury.2012.11.023; Stevens JA, 2013, OSTEOPOROSIS INT, V24, P2725, DOI 10.1007/s00198-013-2375-9; Toson B, 2015, J CLIN EPIDEMIOL, V68, P44, DOI 10.1016/j.jclinepi.2014.09.017; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25	30	29	29	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					226	234		10.1016/j.injury.2015.09.021			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900040	26534784				2021-06-18	
J	Lawrence, T; Helmy, A; Bouamra, O; Woodford, M; Lecky, F; Hutchinson, PJ				Lawrence, T.; Helmy, A.; Bouamra, O.; Woodford, M.; Lecky, F.; Hutchinson, P. J.			Traumatic brain injury in England and Wales: prospective audit of epidemiology, complications and standardised mortality	BMJ OPEN			English	Article							GLASGOW COMA SCALE; HEAD-INJURY; IMPACT; PERFORMANCE; MANAGEMENT; COHORT; CARE	Objectives: To provide a comprehensive assessment of the management of traumatic brain injury (TBI) relating to epidemiology, complications and standardised mortality across specialist units. Design: The Trauma Audit and Research Network collects data prospectively on patients suffering trauma across England and Wales. We analysed all data collected on patients with TBI between April 2014 and June 2015. Setting: Data were collected on patients presenting to emergency departments across 187 hospitals including 26 with specialist neurosurgical services, incorporating factors previously identified in the Ps14 multivariate logistic regression (Ps14(n)) model multivariate TBI outcome prediction model. The frequency and timing of secondary transfer to neurosurgical centres was assessed. Results: We identified 15 820 patients with TBI presenting to neurosurgical centres directly (6258), transferred from a district hospital to a neurosurgical centre (3682) and remaining in a district general hospital (5880). The commonest mechanisms of injury were falls in the elderly and road traffic collisions in the young, which were more likely to present in coma. In severe TBI (Glasgow Coma Score (GCS) <= 8), the median time from admission to imaging with CT scan is 0.5 hours. Median time to craniotomy from admission is 2.6 hours and median time to intracranial pressure monitoring is 3 hours. The most frequently documented complication of severe TBI is bronchopneumonia in 5% of patients. Risk-adjusted W scores derived from the Ps14(n) model indicate that no neurosurgical unit fell outside the 3 SD limits on a funnel plot. Conclusions: We provide the first comprehensive report of the management of TBI in England and Wales, including data from all neurosurgical units. These data provide transparency and suggests equity of access to high-quality TBI management provided in England and Wales.	[Lawrence, T.; Bouamra, O.; Woodford, M.] Univ Manchester, Salford Royal Hosp, Manchester Med Acad Hlth Sci Ctr, Trauma Audit & Res Network,Inst Populat Hlth, Salford, Lancs, England; [Helmy, A.; Hutchinson, P. J.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Helmy, A.; Hutchinson, P. J.] Addenbrookes Hosp, Dept Neurosurg, Cambridge, England; [Lecky, F.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Serv Res Sect, Ctr Urgent & Emergency Care Res CURE, Sheffield, S Yorkshire, England	Helmy, A (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England.; Helmy, A (corresponding author), Addenbrookes Hosp, Dept Neurosurg, Cambridge, England.	adelhelmy@cantab.net	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Lawrence, Thomas/0000-0003-3648-7634; bouamra, omar/0000-0002-3155-4634	University of Cambridge, UKUniversity of Cambridge; Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship [G0802251]; National Institute for Health Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0802251] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 13/15/02, 12/35/57, ACF-2006-14-004] Funding Source: researchfish	AH is supported by the University of Cambridge, UK and Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (grant number G0802251). PJH is supported by National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge.	[Anonymous], 2007, GUIDELINES MANAGEMEN; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Fuller G, 2015, EUR J EMERG MED, V22, P42, DOI 10.1097/MEJ.0000000000000117; HOLLIS S, 1995, J TRAUMA, V38, P763, DOI 10.1097/00005373-199505000-00015; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Lecky F, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20010; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; NICE, 2014, TRIAG ASS INV EARL M; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955	20	29	29	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	11							e012197	10.1136/bmjopen-2016-012197			8	Medicine, General & Internal	General & Internal Medicine	EG8JQ	WOS:000391303400109	27884843	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Savitsky, B; Givon, A; Rozenfeld, M; Radomislensky, I; Peleg, K				Savitsky, B.; Givon, A.; Rozenfeld, M.; Radomislensky, I.; Peleg, K.			Traumatic brain injury: It is all about definition	BRAIN INJURY			English	Article						Glasgow Coma Scale (GCS); Abbreviated Injury Score (AIS); Traumatic Brain Injury (TBI); brain injury severity assessment	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; ENDOTRACHEAL INTUBATION; MORTALITY PREDICTIONS; POLYTRAUMA; AGREEMENT; TRIPLETS; IMPACT; ISS	Background: TBI may be defined by different methods. Some may be most useful for immediate clinical purposes, however less optimal for epidemiologic research. Other methods, such as the Abbreviated Injury Score (AIS), may prove more beneficial for this task, if the cut-off-points for their categories are defined correctly.Objective: To reveal the optimal cut-off-points for AIS in definition of severity of TBI in order to ensure uniformity between future studies of TBI.Results: Mortality of patients with TBI AIS 3, 4 was 1.9% and 2.9% respectively, comparing with 31.1% among TBI AIS 5+. Predictive discrimination ability of the model with cut-off-points of 5+ for TBI AIS (in comparison with other cut-off-points) was better. Patients with missing Glasgow Coma Scale (GCS) in the ED had an in-hospital mortality rate of 11.5%. In this group, 25% had critical TBI according to AIS. Normal GCS didn't indicate an absence of head injury, as, among patients with GCS 15 in the ED, 26% had serious/critical TBI injury. Moreover, 7% of patients with multiple injury and GCS 3-8 had another reason than head injury for unconsciousness.Conclusions: This study recommends the adoption of an AIS cut-off 5 as a valid definition of severe TBI in epidemiological studies, while AIS 3-4 may be defined as moderate' TBI and AIS 1-2 as mild'.	[Savitsky, B.; Givon, A.; Rozenfeld, M.; Radomislensky, I.; Peleg, K.] Israel Natl Ctr Trauma & Emergency Med Res, Gertner Inst Epidemiol & Hlth Policy Res, IL-52621 Ramat Gan, Israel; [Rozenfeld, M.; Peleg, K.] Tel Aviv Univ, Sch Publ Hlth, Fac Med, Tel Aviv, Israel	Peleg, K (corresponding author), Israel Natl Ctr Trauma & Emergency Med Res, Gertner Inst Epidemiol & Hlth Policy Res, IL-52621 Ramat Gan, Israel.	kobip@gertner.health.gov.il		Savitsky, Bella/0000-0001-8917-8419			Aharonson-Daniel L, 2006, J TRAUMA, V61, P711, DOI 10.1097/01.ta.0000235294.32326.e6; Bellner J, 2003, J NEUROL NEUROSUR PS, V74, P351, DOI 10.1136/jnnp.74.3.351; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Butcher NE, 2013, J TRAUMA ACUTE CARE, V74, P884, DOI 10.1097/TA.0b013e31827e1bad; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Dinh MM, 2013, EMERG MED AUSTRALAS, V25, P457, DOI 10.1111/1742-6723.12126; Faul M, 2012, PREHOSP EMERG CARE, V16, P222, DOI 10.3109/10903127.2011.615013; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Kraus JF, NEUROLOGY; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rozenfeld M, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041042; Russell R, 2004, J TRAUMA, V56, P1321, DOI 10.1097/01.TA.0000062763.21379.D9; Sanossian N, 2014, STROKE S1, V45, pA32; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; The Association for the Advancement of Automotive Medicine (AAAM), ABBR INJ SCAL AIS; Tuma M., 2014, CRITICAL CARE RES PR, V2014, DOI DOI 10.1155/2014/105386; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Zehtabchi S, 2011, ACAD EMERG MED, V18, P637, DOI 10.1111/j.1553-2712.2011.01083.x	25	29	30	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1194	1200		10.1080/02699052.2016.1187290			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300004	27466967				2021-06-18	
J	Garner, AA; Mann, KP; Fearnside, M; Poynter, E; Gebski, V				Garner, Alan A.; Mann, Kristy P.; Fearnside, Michael; Poynter, Elwyn; Gebski, Val			The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by paramedics only	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; MORTALITY; CARE	Background Advanced prehospital interventions for severe brain injury remains controversial. No previous randomised trial has been conducted to evaluate additional physician intervention compared with paramedic only care. Methods Participants in this prospective, randomised controlled trial were adult patients with blunt trauma with either a scene GCS score <9 (original definition), or GCS<13 and an Abbreviated Injury Scale score for the head region >= 3 (modified definition). Patients were randomised to either standard ground paramedic treatment or standard treatment plus a physician arriving by helicopter. Patients were evaluated by 30-day mortality and 6-month Glasgow Outcome Scale (GOS) scores. Due to high non-compliance rates, both intention-to-treat and as-treated analyses were preplanned. Results 375 patients met the original definition, of which 197 was allocated to physician care. Differences in the 6-month GOS scores were not significant on intention-to-treat analysis (OR 1.11, 95% CI 0.74 to 1.66, p=0.62) nor was the 30-day mortality (OR 0.91, 95% CI 0.60 to 1.38, p=0.66). As-treated analysis showed a 16% reduction in 30-day mortality in those receiving additional physician care; 60/195 (29%) versus 81/180 (45%), p<0.01, Number needed to treat =6. 338 patients met the modified definition, of which 182 were allocated to physician care. The 6-month GOS scores were not significantly different on intention-to-treat analysis (OR 1.14, 95% CI 0.73 to 1.75, p=0.56) nor was the 30-day mortality (OR 1.05, 95% CI 0.66 to 1.66, p=0.84). As-treated analyses were also not significantly different. Conclusions This trial suggests a potential mortality reduction in patients with blunt trauma with GCS<9 receiving additional physician care (original definition only). Confirmatory studies which also address noncompliance issues are needed.	[Garner, Alan A.; Poynter, Elwyn] CareFlight, Wentworthville, NSW 2145, Australia; [Mann, Kristy P.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Fearnside, Michael] Westmead Hosp, Dept Surg, Sydney, NSW, Australia; [Gebski, Val] Univ Sydney, NHMRC Clin Trials Ctr, Biostat & Res Methodol, Sydney, NSW 2006, Australia	Garner, AA (corresponding author), CareFlight, Locked Bag 2002, Wentworthville, NSW 2145, Australia.	alang@careflight.org	Garner, Alan/AAN-1513-2020	Garner, Alan/0000-0002-4010-9137; Gebski, Val/0000-0001-8748-1844	Insurance Australia Group, NSW Motor Accident Authority	Insurance Australia Group, NSW Motor Accident Authority.	BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Early Management of Severe Trauma course content, 2013, EARL MAN SEV TRAUM C; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Garner AA, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-69; JENNETT B, 1975, LANCET, V1, P480; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marshall LF, 1987, NEUROBEHAVIORAL RECO, P206; RICE WR, 1988, BIOMETRICS, V44, P1, DOI 10.2307/2531892; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; WHITEHEAD J, 1993, STAT MED, V12, P2257, DOI 10.1002/sim.4780122404; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	15	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	NOV	2015	32	11					869	875		10.1136/emermed-2014-204390			7	Emergency Medicine	Emergency Medicine	CU4CK	WOS:000363473600010	25795741	Green Published, Other Gold			2021-06-18	
J	Zhao, QC; Hu, JX; Xiang, J; Gu, YM; Jin, PS; Hua, F; Zhang, ZS; Liu, YH; Zan, K; Zhang, ZH; Zu, J; Yang, XX; Shi, HJ; Zhu, JN; Xu, Y; Cui, GY; Ye, XC				Zhao, Qiuchen; Hu, Jinxia; Xiang, Jie; Gu, Yuming; Jin, Peisheng; Hua, Fang; Zhang, Zunsheng; Liu, Yonghai; Zan, Kun; Zhang, Zuohui; Zu, Jie; Yang, Xinxin; Shi, Hongjuan; Zhu, Jienan; Xu, Yun; Cui, Guiyun; Ye, Xinchun			Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke	BRAIN RESEARCH			English	Article						Intranasal administration; Human umbilical cord mesenchymal stem cells; Conditioned medium; Angiopoietin; Vascular remodeling	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MYOCARDIAL-INFARCTION; IN-VITRO; ANGIOGENESIS; EXPRESSION; ANGIOPOIETIN-1; PROMOTE; ACTIVATION; RECOVERY	Stem cell-based treatments have been reported to be a potential strategy for stroke. However, tumorigenic potential and low survival rates of transplanted cells could attenuate the efficacy of the stem cell-based treatments. The application of stem cell-condition medium (CM) may be a practicable approach to conquer these limitations. In this study, we investigated whether intranasal administration of human umbilical cord mesenchymal stem cells (hUCMSCs)-CM has the therapeutic effects in rats after stroke. Adult male rats were subjected to middle cerebral artery occlusion (MCAo) and were treated by intranasal routine with or without hUCMSCs-CM (1 ml/kg/d), starting 24 h after MCAo and daily for 14 days. Neurological functional tests, blood brain barrier (BBB) leakage, were measured. Angiogenesis and angiogenic factor expression were measured by immunohistochemistry, and Western blot, respectively. hUCMSCs-CM treatment of stroke by intranasal routine starting 24 h after MCAo in rats significantly enhances BBB functional integrity and promotes functional outcome but does not decrease lesion volume compared to rats in DMEM/F12 medium control group and saline control group. Treatment of ischemic rats with hUCMSCs-CM by intranasal routine also significantly decreases the levels of Ang2 and increases the levels of both Ang1 and Tie2 in the ischemic brain. To take together, increased expression of Ang1 and Tie2 and decreased expression of Ang2, induced by hUCMSCs-CM treatment, contribute to vascular remodeling in the ischemic brain which plays an important role in functional outcome after stroke. (c) 2015 Elsevier B.V. All rights reserved.	[Zhao, Qiuchen; Xu, Yun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Hu, Jinxia; Hua, Fang; Zhang, Zunsheng; Liu, Yonghai; Zan, Kun; Zhang, Zuohui; Zu, Jie; Yang, Xinxin; Shi, Hongjuan; Zhu, Jienan; Cui, Guiyun; Ye, Xinchun] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China; [Xiang, Jie] Xuzhou Med Coll, Affiliated Hosp, Dept Rehabil Med, Xuzhou, Jiangsu, Peoples R China; [Gu, Yuming] Xuzhou Med Coll, Affiliated Hosp, Dept Intervent Radiol, Xuzhou, Jiangsu, Peoples R China; [Jin, Peisheng] Xuzhou Med Coll, Affiliated Hosp, Dept Plast Surg, Xuzhou, Jiangsu, Peoples R China	Xu, Y (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.	xinchunye@gmail.com	Zhang, Zuohui/AAQ-6728-2021	Zhang, Zuohui/0000-0002-8486-4767	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201025, 81271344, 81571155]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131118, BL2014031]; Summit of Six Top Talents Program of Jiangsu Province [2013-WSN-081]; Mayor Program of Public Health of Jiangsu Province [Z201208]	This work was supported by the National Natural Science Foundation of China (Nos. 81201025, 81271344 and 81571155), the National Natural Science Foundation of Jiangsu Province (Nos. BK20131118 and BL2014031), the Summit of Six Top Talents Program of Jiangsu Province (No. 2013-WSN-081), and the Mayor Program of Public Health of Jiangsu Province (No. Z201208).	Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Chen JL, 2011, STROKE, V42, P3551, DOI 10.1161/STROKEAHA.111.627174; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Cui GY, 2013, NEUROSCI LETT, V554, P82, DOI 10.1016/j.neulet.2013.08.065; Cui GY, 2013, NEUROSCI LETT, V548, P101, DOI 10.1016/j.neulet.2013.02.072; Cui X, 2011, NEUROBIOL DIS, V43, P285, DOI 10.1016/j.nbd.2011.04.005; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Inoue T, 2013, TISSUE ENG PT A, V19, P24, DOI [10.1089/ten.tea.2011.0385, 10.1089/ten.TEA.2011.0385]; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Koh SH, 2008, BRAIN RES, V1229, P233, DOI 10.1016/j.brainres.2008.06.087; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Lin YC, 2011, STROKE, V42, P2045, DOI 10.1161/STROKEAHA.110.603621; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0000000000000152, 10.1161/CIR.0b013e31828124ad]; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Perin EC, 2009, CATHETER CARDIO INTE, V73, P281, DOI 10.1002/ccd.21807; Sandhu R, 2004, CARDIOVASC RES, V64, P115, DOI 10.1016/j.cardiores.2004.05.013; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Ye X, 2011, NEUROSCIENCE, V190, P339, DOI 10.1016/j.neuroscience.2011.06.004; Ye XC, 2011, EXP NEUROL, V232, P299, DOI 10.1016/j.expneurol.2011.09.022; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhu JH, 2012, HISTOL HISTOPATHOL, V27, P537, DOI 10.14670/HH-27.537; Zhu SF, 2013, NEUROSCI LETT, V541, P77, DOI 10.1016/j.neulet.2013.03.018	39	29	32	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 22	2015	1624						489	496		10.1016/j.brainres.2015.08.003			8	Neurosciences	Neurosciences & Neurology	CW5PY	WOS:000365050100049	26279113				2021-06-18	
J	Cincotta, M; Giovannelli, F; Chiaramonti, R; Bianco, G; Godone, M; Battista, D; Cardinali, C; Borgheresi, A; Sighinolfi, A; D'Avanzo, AM; Breschi, M; Dine, Y; Lino, M; Zaccara, G; Viggiano, MP; Rossi, S				Cincotta, Massimo; Giovannelli, Fabio; Chiaramonti, Roberta; Bianco, Giovanni; Godone, Marco; Battista, Donato; Cardinali, Consuelo; Borgheresi, Alessandra; Sighinolfi, Antonella; D'Avanzo, Anna Maria; Breschi, Marco; Dine, Ylli; Lino, Mario; Zaccara, Gaetano; Viggiano, Maria Pia; Rossi, Simone			No effects of 20 Hz-rTMS of the primary motor cortex in vegetative state: A randomised, sham-controlled study	CORTEX			English	Article						Vegetative state; Disorders of consciousness; Transcranial magnetic stimulation; rTMS	TRANSCRANIAL MAGNETIC STIMULATION; MINIMALLY CONSCIOUS STATE; UNRESPONSIVE WAKEFULNESS SYNDROME; DEEP BRAIN-STIMULATION; COMA RECOVERY; EXCITABILITY; DISORDERS	We assessed the effects of a non-invasive neuromodulatory intervention with repetitive transcranial magnetic stimulation (rTMS) of the motor cortex in patients with vegetative state (VS) by a randomised, sham-controlled study with a cross-over design. Eleven patients classified as being in VS (9 post-anoxic, 2 post-traumatic, time elapsed from the injury 9-85 months) were included in the study. Real or sham 20 Hz rTMS were applied to the left primary motor cortex (M1) for 5 consecutive days. Primary outcome measures were changes in the JFK Coma Recovery Scale-Revised (CRS-R) scale total score and Clinical Global Impression Improvement (CGI-I) scale. Additional measures were EEG changes and impression of the patients relatives using the CGI-I scale. Evaluations were blindly performed at baseline, after the first day of treatment, immediately after the end of the 5-days treatment, 1 week and 1 month later. Slight changes observed in the CRS-R and CGI-I scores did not significantly differ between real or sham stimulation conditions. EEG was not significantly changed on average, although spots of brain reactivity were occasionally found underneath the stimulation point. Findings did not provide evidence of therapeutic effect of 20 Hz rTMS of the M1 in chronic VS, at least with conventional coils and current safety parameters. Therefore, they might be useful to better allocate human and financial resources in future trials. (C) 2015 Elsevier Ltd. All rights reserved.	[Cincotta, Massimo; Giovannelli, Fabio; Chiaramonti, Roberta; Battista, Donato; Cardinali, Consuelo; Borgheresi, Alessandra; Zaccara, Gaetano] Azienda Sanit Firenze, Neurol Unit, Florence, Italy; [Giovannelli, Fabio; Viggiano, Maria Pia] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy; [Bianco, Giovanni; Godone, Marco; Rossi, Simone] Azienda Osped Univ Senese, Brain Invest & Neuromodulat Lab, UOC Neurol & Clin Neurophysiol, Dept Neurosci,Si BIN Lab, Siena, Italy; [Sighinolfi, Antonella; D'Avanzo, Anna Maria; Breschi, Marco; Dine, Ylli; Lino, Mario] Casa Cura Villa Terme, Florence, Italy	Cincotta, M (corresponding author), Osped San Giovanni di Dio, Azienda Sanit Firenze, UO Neurol, Via Torregalli 3, I-50143 Florence, Italy.	cincotta@unifi.it	Giovannelli, Fabio/AAC-1571-2019; Cincotta, Massimo/AAA-7532-2019; Borgheresi, Alessandra/AAA-7582-2019; Viggiano, Mariapia/AAC-1556-2019	Giovannelli, Fabio/0000-0003-1059-9945; Cincotta, Massimo/0000-0001-5223-646X; Borgheresi, Alessandra/0000-0002-1513-8665; Viggiano, Mariapia/0000-0002-3230-0935; rossi, simone/0000-0001-6697-9459	'Ente Cassa di Risparmio di Firenze', Florence, ItalyFondazione Cassa Risparmio Firenze [2013.0193]	The Unit of Neurology, Azienda Sanitaria di Firenze, was supported by a grant from 'Ente Cassa di Risparmio di Firenze' (Grant no. 2013.0193), Florence, Italy.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Denslow S, 2005, BIOL PSYCHIAT, V57, P752, DOI 10.1016/j.biopsych.2004.12.017; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Guy W., 1976, ECDEU ASSESSMENT MAN, P76; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Naro A, 2015, NEUROREHAB NEURAL RE, V29, P603, DOI 10.1177/1545968314562114; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Ragazzoni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057069; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rossi S, 2007, CLIN NEUROPHYSIOL, V118, P709, DOI 10.1016/j.clinph.2006.11.005; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini P. M., 2015, CLIN NEUROPHYSIOLOGY; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sommer J, 2006, CLIN NEUROPHYSIOL, V117, P440, DOI 10.1016/j.clinph.2005.09.025; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Yamamoto T, 2002, ACT NEUR S, V79, P79; Yamamoto T, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.04.010	27	29	32	0	5	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	OCT	2015	71						368	376		10.1016/j.cortex.2015.07.027			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	CS5PV	WOS:000362131300033	26301875				2021-06-18	
J	Johnson, B; Hallett, M; Slobounov, S				Johnson, Brian; Hallett, Mark; Slobounov, Semyon			Follow-up evaluation of oculomotor performance with fMRI in the subacute phase of concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; EYE-MOVEMENT	Objective:To expand on our previous study by performing a follow-up testing session in the subacute phase of injury for participants recently diagnosed with a concussion.Methods:A battery of oculomotor tests were administered to participants 30 days postconcussion while simultaneous fMRI was performed.Results:Three of the 7 oculomotor tasks (antisaccade, self-paced saccade, and memory-guided saccade) administered showed significant differences between the recently concussed group compared with normal volunteers. However, performance in these 3 tasks did show improvement from the acute phase of injury. The fMRI analysis revealed significant differences in brain activation patterns compared with normal volunteers, with the concussed group still demonstrating increased and larger areas of activation. Similar to the oculomotor performance, the fMRI analysis showed that at 30 days postinjury, the concussed group more closely mirrored that of the normal volunteer group compared with at 7 days following insult.Conclusions:Even at 30 days postinjury, and despite being clinically asymptomatic, advanced techniques are able to detect subtle lingering alterations in the concussed brain. Therefore, progressive neuroimaging techniques such as fMRI in conjunction with assessment of oculomotor performance may be beneficial in clinical management of concussion.	[Johnson, Brian; Slobounov, Semyon] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Slobounov, Semyon] Penn State Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA USA; [Hallett, Mark; Slobounov, Semyon] NINDS, NIH, Bethesda, MD 20892 USA	Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	sms18@psu.edu					Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Johnson B, 2014, BRAIN IMAGING BEHAV; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Wade NJ, 2010, PERCEPTION, V39, P1150	10	29	29	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 29	2015	85	13					1163	1166		10.1212/WNL.0000000000001968			4	Clinical Neurology	Neurosciences & Neurology	CX4CF	WOS:000365645100002	26320202	Green Published			2021-06-18	
J	Abbasi, SH; Mohammadinejad, P; Shahmansouri, N; Salehiomran, A; Beglar, AA; Zeinoddini, A; Forghani, S; Akhondzadeh, S				Abbasi, Seyed Hesameddin; Mohammadinejad, Payam; Shahmansouri, Nazila; Salehiomran, Abbas; Beglar, Akram Arjmandi; Zeinoddini, Atefeh; Forghani, Saeedeh; Akhondzadeh, Shahin			Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Atorvastatin; Coronary artery bypass; Depression; Simvastatin	TRAUMATIC BRAIN-INJURY; CLINICAL-TRIAL; HEART-DISEASE; STATIN USE; MYOCARDIAL-INFARCTION; COGNITIVE FUNCTION; MAJOR DEPRESSION; RISK-FACTOR; DISORDER; FLUOXETINE	Background: A decreased risk of developing depression has been reported among statin users. Aside from their lipid-lowering effects, statins are considered immunomodulatory agents and have protective effects against oxidative stress and inflammation which are well known for their association with depression. The aim of the present study was to compare the probable antidepressant effects of simvastatin and atorvastatin among post-coronary artery bypass graft (CABG) surgery patients with high and low potentials for blood-brain-barrier penetration, respectively. Method: Forty-six outpatients who had undergone CABG in the last 6 months and suffered from mild to moderate depression participated in a parallel, double-blind, placebo-controlled trial, and were randomized to undergo 6 weeks of treatment with either simvastatin (20 mg/day) or atorvastatin (20 mg/day). Participants were evaluated using Hamilton depression rating scale (HDRS) at baseline and weeks 3 and 6. The primary outcome was to evaluate the efficacy of simvastatin in improving the depressive symptoms. Result: General linear model repeated measures demonstrated significant effect for time x treatment interaction on the HDRS scores IF (1.62, 71.06)=3.41, P=0.048]. There was no significant difference between the treatment groups regarding the adverse events. No one experienced serious adverse event. Limitation: The limitations of the present study were its small sample size and the short-term follow-up period. Conclusion: Treatment with simvastatin seems to be well tolerated with superior antidepressant effects compared to atorvastatin in post-CABG patients. Long-term outcomes of this practice and its probable influence on other psychological aspects are yet to be investigated in future studies. (C) 2015 Elsevier B.V. All rights reserved.	[Abbasi, Seyed Hesameddin; Shahmansouri, Nazila; Salehiomran, Abbas; Beglar, Akram Arjmandi] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran; [Abbasi, Seyed Hesameddin] Iranian Petr Ind Hlth Res Inst, Family Hlth Res Ctr, Tehran, Iran; [Mohammadinejad, Payam; Zeinoddini, Atefeh; Akhondzadeh, Shahin] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Psychiat Res Ctr, Tehran, Iran; [Forghani, Saeedeh] Razi Vaccine & Serum Res Inst, Karaj, Iran	Akhondzadeh, S (corresponding author), Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Psychiat Res Ctr, Tehran, Iran.	s.akhond@neda.net	Mohammadinejad, Payam/N-8138-2015; Forghani, Saeedeh/M-9792-2017; Abbasi, Seyed Hesameddin/D-5420-2009; Akhondzadeh, Shahin/F-2914-2018	Abbasi, Seyed Hesameddin/0000-0002-1068-8860; Akhondzadeh, Shahin/0000-0002-2277-5101	Tehran University of Medical SciencesTehran University of Medical Sciences [19164]	This trial was supported by a grant from Tehran University of Medical Sciences (Grant no: 19164).	Abbasi SH, 2012, J AFFECT DISORDERS, V141, P308, DOI 10.1016/j.jad.2012.03.033; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; Bush D E, 2005, Evid Rep Technol Assess (Summ), P1; Carney RM, 2003, BIOL PSYCHIAT, V54, P241, DOI 10.1016/S0006-3223(03)00111-2; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Dang YH, 2014, CURR PHARM DESIGN, V20, P5151, DOI 10.2174/1381612819666140110120435; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Frasure-Smith N, 2005, PSYCHOSOM MED, V67, pS19, DOI 10.1097/01.psy.0000162253.07959.db; Ghanizadeh A, 2013, DEPRESS ANXIETY, V30, P1084, DOI 10.1002/da.22195; Gougol A, 2015, J PSYCHOPHARMACOL, V29, P575, DOI 10.1177/0269881115578160; Haghighi M, 2014, J PSYCHIATR RES, V58, P109, DOI 10.1016/j.jpsychires.2014.07.018; Hajjar L, 2002, J GERONTOL A-BIOL, V57, pM414, DOI 10.1093/gerona/57.7.M414; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hayashi T, 2005, BRAIN RES, V1037, P52, DOI 10.1016/j.brainres.2004.12.051; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; Khajavi D, 2012, J CLIN PSYCHIAT, V73, P1428, DOI 10.4088/JCP.12m07706; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lin PY, 2014, PHARMACOL BIOCHEM BE, V124, P174, DOI 10.1016/j.pbb.2014.06.006; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Ludka FK, 2013, EUR NEUROPSYCHOPHARM, V23, P400, DOI 10.1016/j.euroneuro.2012.05.005; Maany I, 2004, JAMA-J AM MED ASSOC, V292, P2833, DOI 10.1001/jama.292.23.2833-b; Machado-Vieira R, 2008, J CLIN PSYCHIAT, V69, P946, DOI 10.4088/JCP.v69n0610; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Mandas A, 2014, NEUROL RES, V36, P247, DOI 10.1179/1743132813Y.0000000287; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Modabbernia A, 2012, PSYCHOPHARMACOLOGY, V223, P381, DOI 10.1007/s00213-012-2729-6; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Otte C, 2012, J CLIN PSYCHIAT, V73, P610, DOI 10.4088/JCP.11m07038; Parsaik AK, 2014, J AFFECT DISORDERS, V160, P62, DOI 10.1016/j.jad.2013.11.026; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Santos T, 2012, NEUROPSYCH DIS TREAT, V8, P413, DOI 10.2147/NDT.S31714; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Shahmansouri N, 2014, J AFFECT DISORDERS, V155, P216, DOI 10.1016/j.jad.2013.11.003; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Stafford L, 2011, J CLIN PSYCHIAT, V72, P1229, DOI 10.4088/JCP.09m05825blu; Stewart RA, 2000, ARCH INTERN MED, V160, P3144, DOI 10.1001/archinte.160.20.3144; Trivedi Madhukar H, 2009, J Clin Psychiatry, V70, pe01; Tsai SJ, 2007, MED HYPOTHESES, V68, P1296, DOI 10.1016/j.mehy.2006.09.043; Vuletic S, 2006, DEMENT GERIATR COGN, V22, P392, DOI 10.1159/000095679; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weidner G, 2009, PSYCHOL HEALTH MED, V14, P255, DOI 10.1080/13548500902730101; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x; Young-Xu Y, 2003, J AM COLL CARDIOL, V42, P690, DOI 10.1016/S0735-1097(03)00785-X; Zeinoddini A, 2015, DEPRESS ANXIETY, V32, P167, DOI 10.1002/da.22340	51	29	30	0	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	SEP 1	2015	183						149	155		10.1016/j.jad.2015.04.049			7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CK6TQ	WOS:000356361500020	26005776				2021-06-18	
J	Hu, T; Zhou, FJ; Chang, YF; Li, YS; Liu, GC; Hong, Y; Chen, HL; Xiyang, YB; Bao, TH				Hu, Tao; Zhou, Feng-Jie; Chang, Ye-Fei; Li, Ya-Shan; Liu, Guang-Cai; Hong, Ying; Chen, Hong-Lan; Xiyang, Yan-Bin; Bao, Tian-Hao			miR21 is Associated with the Cognitive Improvement Following Voluntary Running Wheel Exercise in TBI Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						miR21; Voluntary running wheel; Traumatic brain injury; Learning and memory	TRAUMATIC BRAIN-INJURY; TREADMILL EXERCISE; EXPRESSION; HIPPOCAMPUS; TARGETS; MEMORY; RATS; RNAS	Recent evidences revealed that the alteration of microRNAs (miRNAs) might be associated with neuroplasticity induced by voluntary running wheel (RW) exercise in mice suffered from traumatic brain injury (TBI). In the present study, we explored the possible role of miR21 involved in the cognitive improvement following voluntary RW in TBI mice. Firstly, in situ hybridization and quantitative real-time PCR (qRT-PCR) were employed to determine the hippocampal expression and location of miR21 in TBI mice with or without spontaneous RW. Either miR21-mimics/plenti-miR21 or miR21-agomir/miR21-sponge was employed to regulate the miR21 expression in vivo and in vitro. Acquisition of spatial learning and memory retention was assessed by Morris Water Maze (MWM) test. Golgi stain was also performed to evaluate the alteration of hippocampal dendrite. Our finding confirmed that the elevated miR21 level in hippocampal post-TBI was significantly reduced by spontaneous RW. Overexpression of miR21 in TBI mice with spontaneous RW induced deteriorations in spatial learning and memory retention by significant decreases in the somata size and branch points of the hippocampus neurons. In vitro transduction with miR21 also reduced the neurite extension and the area of cultured hippocampal neuron. However, miR21 down-regulation reversed these effects. The present data strongly suggest that miR21 is an important molecule that has been involved in neuroprotection induced by voluntary RW exercise post-TBI.	[Hu, Tao; Chang, Ye-Fei; Li, Ya-Shan; Liu, Guang-Cai; Hong, Ying; Chen, Hong-Lan] Third Peoples Hosp Yunnan Prov, Dept Lab Med, Kunming, Yunnan Province, Peoples R China; [Zhou, Feng-Jie] First Peoples Hosp XianTao, XianTao, Hubei Province, Peoples R China; [Xiyang, Yan-Bin] Kunming Med Univ, Inst Neurosci, Kunming 650500, Yunnan Province, Peoples R China; [Bao, Tian-Hao] Kunming Med Univ, Affiliated Hosp 2, Dept Neurol, Kunming 650500, Yunnan Province, Peoples R China	Xiyang, YB (corresponding author), Kunming Med Univ, Inst Neurosci, 1168 West Chunrong Rd,Yuhua Ave, Kunming 650500, Yunnan Province, Peoples R China.	xiyang_neuro@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100911]; Special Fund of the Applied Basic Research Programs of Yunnan Province; Kunming Medical University in China [2013FB116]	We thank Dr. Kevin J. Wells for his valuable comments during the preparation of this manuscript. This work is supported by National Natural Science Foundation of China (Grant NO.81100911, http://isisn.nsfc.gov.cn/egrantweb/), the Special Fund of the Applied Basic Research Programs of Yunnan Province associated with Kunming Medical University in China (Grant NO.2013FB116, http://61.166.241.213/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SS, 2012, BRAIN DEV-JPN, V34, P45, DOI 10.1016/j.braindev.2011.01.011; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Heo YM, 2014, INT NEUROUROL J, V18, P16, DOI 10.5213/inj.2014.18.1.16; Hoffman AN, 2011, EUR J NEUROSCI, V34, P1023, DOI 10.1111/j.1460-9568.2011.07820.x; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; JASLOVE SW, 1992, NEUROSCIENCE, V47, P495, DOI 10.1016/0306-4522(92)90161-T; Kim SE, 2013, MOL MED REP, V7, P31, DOI 10.3892/mmr.2012.1160; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Long JM, 2011, CURR MED CHEM, V18, P3314, DOI 10.2174/092986711796504592; Ntanasis-Stathopoulos J, 2013, J MUSCULOSKEL NEURON, V13, P133; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; VanLeeuwen JE, 2010, J NEUROSCI RES, V88, P650, DOI 10.1002/jnr.22216; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x	22	29	30	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2015	57	1					114	122		10.1007/s12031-015-0584-8			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP7MW	WOS:000360073300013	26018937				2021-06-18	
J	Jovanovic, B; Milan, Z; Markovic-Denic, L; Djuric, O; Radinovic, K; Doklestic, K; Velickovi, J; Ivancevic, N; Gregoric, P; Pandurovic, M; Bajec, D; Bumbasirevic, V				Jovanovic, Bojan; Milan, Zoka; Markovic-Denic, Ljiljana; Djuric, Olivera; Radinovic, Kristina; Doklestic, Krstina; Velickovi, Jelena; Ivancevic, Nenad; Gregoric, Pavle; Pandurovic, Milena; Bajec, Djordje; Bumbasirevic, Vesna			Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre	INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES			English	Article						Injury; Neurotrauma; Pneumonia; Predictors	HEAD-INJURY; EARLY-ONSET; SCALE; SCORE; CARE; ASPIRATION	Introduction: The aims of this study were (1) to assess the incidence of ventilator-associated pneumonia (VAP) in patients with traumatic brain injury (TBI), (2) to identify risk factors for developing VAP, and (3) to assess the prevalence of the pathogens responsible. Patients and methods: The following data were collected prospectively from patients admitted to a 24bed intensive care unit (ICU) during 2013/14: the mechanism of injury, trauma distribution by system, the Acute Physiology and Chronic Health Evaluation (APACHE) II score, the Abbreviated Injury Scale (AIS) score, the Injury Severity Score (ISS), underlying diseases, Glasgow Coma Scale (GCS) score, use of vasopressors, need for intubation or cardiopulmonary resuscitation upon admission, and presence of pulmonary contusions. All patients were managed with a standardized protocol if VAP was suspected. The Sequential Organ Failure Assessment (SOFA) score and the Clinical Pulmonary Infection Score (CPIS) were measured on the day of VAP diagnosis. Results: Of the 144 patients with TBI who underwent mechanical ventilation for >48 h, 49.3% did not develop VAP, 24.3% developed early-onset VAP, and 26.4% developed late-onset VAP. Factors independently associated with early-onset VAP included thoracic injury (odds ratio (OR) 8.56, 95% confidence interval (CI) 2.05-35.70; p = 0.003), ISS (OR 1.09, 95% CI 1.03-1.15; p = 0.002), and coma upon admission (OR 13.40, 95% CI 3.12-57.66; p < 0.001). Age (OR 1.04, 95% CI 1.02-1.07; p = 0.002), ISS (OR 1.09, 95% CI 1.04-1.13; p < 0.001), and coma upon admission (OR 3.84, 95% CI 1.44-10.28; p = 0.007) were independently associated with late-onset VAP (Nagelkerke r(2) = 0.371, area under the curve (AUC) 0.815, 95% CI 0.733-0.897; p < 0.001). The 28-day survival rate was 69% in the non-VAP group, 45.7% in the early-onset VAP group, and 31.6% in the late-onset VAP group. Acinetobacter spp was the most common pathogen in patients with early-and late-onset VAP. Conclusions: These results suggest that the extent of TBI and trauma of other organs influences the development of early VAP, while the extent of TBI and age influences the development of late VAP. Patients with early-and late-onset VAP harboured the same pathogens. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.	[Jovanovic, Bojan; Doklestic, Krstina; Velickovi, Jelena; Ivancevic, Nenad; Gregoric, Pavle; Pandurovic, Milena; Bajec, Djordje; Bumbasirevic, Vesna] Univ Belgrade, Fac Med, Belgrade, Serbia; [Jovanovic, Bojan; Radinovic, Kristina; Velickovi, Jelena; Pandurovic, Milena; Bumbasirevic, Vesna] Clin Ctr Serbia, Ctr Anaesthesiol, Belgrade, Serbia; [Milan, Zoka] Kings Coll Hosp London, London SE5 9RS, England; [Markovic-Denic, Ljiljana; Djuric, Olivera] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Doklestic, Krstina; Ivancevic, Nenad; Gregoric, Pavle] Clin Ctr Serbia, Clin Emergency Surg, Belgrade, Serbia; [Pandurovic, Milena] Medigrp Hosp, Belgrade, Serbia; [Bajec, Djordje] Clin Ctr Serbia, Clin Digest Surg, Belgrade, Serbia	Milan, Z (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	zoka.milan@kcl.ac.uk	Djuric, Olivera/H-8580-2019	Djuric, Olivera/0000-0002-8574-5938; Velickovic, Jelena/0000-0001-7862-5420	Ministry of Science and Technological Development of Serbia [175046]	This work was supported by the Ministry of Science and Technological Development of Serbia (contract number 175046, 2011-2014).	Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Browne E, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000066; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Garnacho-Montero J, 2005, INTENS CARE MED, V31, P649, DOI 10.1007/s00134-005-2598-0; Garnacho-Montero Jose, 2014, BMC Infect Dis, V14, P135, DOI 10.1186/1471-2334-14-135; Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08; Giantsou E, 2005, INTENS CARE MED, V31, P1488, DOI 10.1007/s00134-005-2697-y; Hedrick TL, 2008, J TRAUMA, V64, P714, DOI 10.1097/TA.0b013e31811ec18e; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; Martin-Loeches I, 2013, INTENS CARE MED, V39, P672, DOI 10.1007/s00134-012-2808-5; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Nair GB, 2015, INTENS CARE MED, V41, P34, DOI 10.1007/s00134-014-3564-5; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tilahun B, 2015, AM J CRIT CARE, V24, P8, DOI 10.4037/ajcc2015102; Zarzaur BL, 2013, J TRAUMA ACUTE CARE, V75, P234, DOI 10.1097/TA.0b013e3182924c18; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	30	29	41	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1201-9712	1878-3511		INT J INFECT DIS	Int. J. Infect. Dis.	SEP	2015	38						46	51		10.1016/j.ijid.2015.07.005			6	Infectious Diseases	Infectious Diseases	CV0OJ	WOS:000363949900010	26166697	DOAJ Gold			2021-06-18	
J	Konigs, M; Heij, HA; van der Sluijs, JA; Vermeulen, J; Goslings, JC; Luitse, JSK; Poll-The, BT; Beelen, A; van der Wees, M; Kemps, RJJK; Catsman-Berrevoets, CE; Oosterlaan, J				Konigs, Marsh; Heij, Hugo A.; van der Sluijs, Johannes A.; Vermeulen, Jeroen; Goslings, J. Carel; Luitse, Jan S. K.; Poll-The, Bwee Tien; Beelen, Anita; van der Wees, Marleen; Kemps, Rachel J. J. K.; Catsman-Berrevoets, Coriene E.; Oosterlaan, Jaap			Pediatric Traumatic Brain Injury and Attention Deficit	PEDIATRICS			English	Article							CHILDREN; RECOVERY; SKILLS; ADOLESCENTS; VARIABILITY; DISORDERS; OUTCOMES	BACKGROUND: We investigated the impact of pediatric traumatic brain injury (TBI) on attention, a prerequisite for behavioral and neurocognitive functioning. METHODS: Children aged 6 to 13 years who were diagnosed with TBI (n = 113; mean 1.7 years postinjury) were compared with children with a trauma control injury (not involving the head) (n = 53). TBI severity was defined as mild TBI with or without risk factors for complicated TBI (mild(RF+) TBI, n = 52; mild(RF-) TBI, n = 24) or moderate/severe TBI (n = 37). Behavioral functioning was assessed by using parent and teacher questionnaires, and the Attention Network Test assessed alerting, orienting, and executive attention. Ex-Gaussian modeling determined the contribution of extremely slow responses (lapses of attention) to mean reaction time (MRT). RESULTS: The TBI group showed higher parent and teacher ratings of attention and internalizing problems, higher parent ratings of externalizing problems, and lower intelligence than the control group (P < .05, >= 0.34). No effect of TBI on alerting, orienting, and executive attention was observed (P >= .55). MRT was slower in the TBI group (P = .008, d = 0.45), traced back to increased lapses of attention (P = .002, d = 0.52). The mild(RF-) TBI group was unaffected, whereas the mild(RF+) TBI and moderate/severe TBI groups showed elevated parent ratings of behavior problems, lower intelligence, and increased lapses of attention (P <= .03, d >= 0.48). Lapses of attention fully explained the negative relation between intelligence and parent-rated attention problems in the TBI group (P = .02). CONCLUSIONS: Lapses of attention represent a core attention deficit in children with mild(RF+) TBI (even in the absence of intracranial pathology) or moderate/severe TBI, and relate to daily life problems after pediatric TBI.	[Konigs, Marsh; Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands; [Heij, Hugo A.] Emma Childrens Hosp, Acad Med Ctr, Pediat Surg Ctr Amsterdam, Amsterdam, Netherlands; [Heij, Hugo A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van der Sluijs, Johannes A.] Vrije Univ Amsterdam Med Ctr, Dept Pediat Orthoped, Amsterdam, Netherlands; [Vermeulen, Jeroen] Vrije Univ Amsterdam Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands; [Luitse, Jan S. K.] Univ Amsterdam, Acad Med Ctr, Dept Emergency Med, NL-1105 AZ Amsterdam, Netherlands; [Poll-The, Bwee Tien] Univ Amsterdam, Acad Med Ctr, Dept Pediat Neurol, NL-1105 AZ Amsterdam, Netherlands; [Beelen, Anita] Merem Rehabil Ctr De Trappenberg, Huizen, Netherlands; [Beelen, Anita] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [van der Wees, Marleen] Libra Rehabil Med & Audiol Blixembosch, Eindhoven, Netherlands; [Kemps, Rachel J. J. K.] Libra Rehabil Med & Audiol Leijpk, Tilburg, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus MC, Dept Pediat Neurol, Rotterdam, Netherlands; [Oosterlaan, Jaap] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands	Konigs, M (corresponding author), Vrije Univ Amsterdam, Clin Neuropsychol, Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	m.konigs@vu.nl		Vermeulen, R. Jeroen/0000-0002-3503-3625	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [022.003.010]	This work was supported by the Netherlands Organization for Scientific Research, grant number 022.003.010.	American College of Surgeons, 2004, ATLS ADV TRAUM LIF S; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barriga AQ, 2002, J EMOT BEHAV DISORD, V10, P233, DOI 10.1177/10634266020100040501; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conklin HM, 2010, J CLIN ONCOL, V28, P4465, DOI 10.1200/JCO.2010.28.4026; de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010; Epstein JN, 2011, NEUROPSYCHOPHARMACOL, V36, P1060, DOI 10.1038/npp.2010.243; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Geurts HM, 2008, NEUROPSYCHOLOGIA, V46, P3030, DOI 10.1016/j.neuropsychologia.2008.06.013; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hussain-Gambles M, 2004, HEALTH SOC CARE COMM, V12, P382, DOI 10.1111/j.1365-2524.2004.00507.x; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; LOGAN GD, 1994, J EXP PSYCHOL LEARN, V20, P1022, DOI 10.1037/0278-7393.20.5.1022; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Statistics Netherlands, STAND OND 2006; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tabachnick B.G., 2012, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Verhulst F.C., 2013, HANDLEIDING ASEBA VR; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Winslade WJ, 1999, CONFRONTING TRAUMATI	35	29	29	0	16	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2015	136	3					534	541		10.1542/peds.2015-0437			8	Pediatrics	Pediatrics	CQ6IN	WOS:000360708100042	26240208				2021-06-18	
J	Mitchell, LA; Hirdes, J; Poss, JW; Slegers-Boyd, C; Caldarelli, H; Martin, L				Mitchell, Lori A.; Hirdes, John; Poss, Jeff W.; Slegers-Boyd, Caroline; Caldarelli, Hilary; Martin, Lynn			Informal caregivers of clients with neurological conditions: profiles, patterns and risk factors for distress from a home care prevalence study	BMC HEALTH SERVICES RESEARCH			English	Article							PARKINSONS-DISEASE; FAMILY CAREGIVERS; BRAIN-INJURY; BURDEN; DEMENTIA; DEPRESSION; SUPPORT; PEOPLE; INTERVENTION; EXPERIENCES	Background: Individuals living in the community with neurological conditions receive the majority of their care from informal caregivers. The purpose of this project was to provide a profile of caregivers of home care clients with neurological conditions. The study also examined prevalence of caregiver distress and the association between neurological conditions and other client and caregiver characteristics with distress. Methods: The study population included Canadian home care clients in the Winnipeg Regional Health Authority in Manitoba and in the province of Ontario. Clients with RAI-Home Care (RAI-HC) assessment data from 2003 to 2010 were examined. Neurological conditions of interest included Alzheimer's disease and related dementias, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Huntington disease, epilepsy, muscular dystrophy, cerebral palsy, traumatic brain injury, spinal cord injury, and stroke. Descriptive statistics were analyzed to describe home care client characteristics and caregiver characteristics for each neurological condition. Logistic regression analysis was used to identify risk factors associated with caregiver distress. Results: A substantial proportion of home care clients were found to have one or more of the neurological conditions (38.8 % to 41.9 %). Caregiver distress was twice as prevalent among caregivers of clients with neurological conditions (28.0 %). The largest associations with caregiver distress were the amount of informal care hours provided in a week and the MAPLe algorithm, an indicator of a client's level of priority for care. After adjustment for client characteristics, Huntington disease was the neurological condition most strongly associated with caregiver distress. However, clients' clinical characteristics and informal care hours had a stronger association with caregiver distress than the presence of a neurological condition. Provision of formal home care services provided a protective effect from caregiver distress. Conclusions: Neurological conditions are common among home care clients and a significant proportion of informal caregivers providing care to these clients experience distress. The complexity of clients with neurological conditions suggests the need for multicomponent support strategies for informal caregivers.	[Mitchell, Lori A.; Slegers-Boyd, Caroline] Winnipeg Reg Hlth Author, Home Care Program, Winnipeg, MB, Canada; [Hirdes, John; Poss, Jeff W.; Caldarelli, Hilary] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Martin, Lynn] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada	Mitchell, LA (corresponding author), Winnipeg Reg Hlth Author, Home Care Program, Winnipeg, MB, Canada.	lmitchell3@wrha.mb.ca			Public Health Agency of Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	Funding for the study was provided by the Public Health Agency of Canada. The opinions expressed in this publication are those of the authors/researchers, and do not necessarily reflect the official views of the Public Health Agency of Canada. In addition, JPH holds the Ontario Home Care Research and Knowledge Exchange Chair funded by the Ontario Ministry of Health and Long-Term Care. The authors would like to thank Hal Loewen, Medical Rehabilitation Librarian at the University of Manitoba's Neil John Maclean Health Sciences Library in Winnipeg Manitoba for his literature search services.	Aarsland D, 2007, J NEUROL NEUROSUR PS, V78, P36, DOI 10.1136/jnnp.2005.083113; Alshubaili AF, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-206; Aubeeluck A, 2007, CLIN GENET, V71, P434, DOI 10.1111/j.1399-0004.2007.00784.x; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Boeije HR, 2003, COMMUNITY WORK FAMIL, V6, P223, DOI DOI 10.1080/136688003200014343810.1080/1366880032000143438; Bogard CL, 2010, THESIS U MINNESOTA M; Bostrom Katrin, 2006, Clin Nurs Res, V15, P86, DOI 10.1177/1054773805285706; Bowes A, 2003, HEALTH SOC CARE COMM, V11, P387, DOI 10.1046/j.1365-2524.2003.00440.x; Buchanan R, 2010, DISABIL REHABIL, V32, P500, DOI 10.3109/09638280903171485; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Chappell NL, 2002, GERONTOLOGIST, V42, P772, DOI 10.1093/geront/42.6.772; Cifu DX, 2006, J REHABIL RES DEV, V43, P499, DOI 10.1682/JRRD.2005.08.1365; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Finlayson M, 2008, DISABIL REHABIL, V30, P1848, DOI 10.1080/09638280701707324; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; Grant I, 2003, AM J GERIAT PSYCHIAT, V11, P62, DOI 10.1176/appi.ajgp.11.1.62; Health Council of Canada, 2012, SEN NEED CAR DISTR W; Hirdes JP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-9; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Ho Samuel M. Y., 2008, Hong Kong Medical Journal, V14, P286; Isaksson G, 2008, SCAND J OCCUP THER, V15, P236, DOI 10.1080/11038120802194265; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Kenneson A, 2010, HEALTH SOC CARE COMM, V18, P520, DOI 10.1111/j.1365-2524.2010.00930.x; Kramer BJ, 2000, HEALTH SOC WORK, V25, P97, DOI 10.1093/hsw/25.2.97; Kumamoto K, 2006, INT J GERIATR PSYCH, V21, P163, DOI 10.1002/gps.1445; Martinez-Martin P, 2008, MOVEMENT DISORD, V23, P1673, DOI 10.1002/mds.22106; McConaghy Ronelle, 2005, Nurs Health Sci, V7, P81, DOI 10.1111/j.1442-2018.2005.00213.x; McEwan L, 2007, EPILEPSY BEHAV, V11, P13, DOI 10.1016/j.yebeh.2007.02.019; Morris JN, 2000, CAN J AGING, V19, P87, DOI 10.1017/S071498080001391X; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; MORRIS JN, 2002, RAI HOME CARE RAI HC; O'Connor EJ, 2011, QUAL LIFE RES, V20, P703, DOI 10.1007/s11136-010-9804-4; Pagnini F, 2010, PSYCHOL HEALTH MED, V15, P685, DOI 10.1080/13548506.2010.507773; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Rabkin JG, 2009, AMYOTROPH LATERAL SC, V10, P448, DOI [10.3109/17482960802459889, 10.1080/17482960802459889]; Roscoe LA, 2009, HEALTH COMMUN, V24, P239, DOI 10.1080/10410230902804133; Shaw WS, 2003, J PSYCHOSOM RES, V54, P293, DOI 10.1016/S0022-3999(02)00412-9; World Health Organization, 2006, NEUR DIS PUBL HLTH C	40	29	30	0	30	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	AUG 28	2015	15								350	10.1186/s12913-015-1010-1			12	Health Care Sciences & Services	Health Care Sciences & Services	CP7YS	WOS:000360106700005	26315104	DOAJ Gold, Green Published			2021-06-18	
J	Scholten, AC; Polinder, S; Panneman, MJM; van Beeck, EF; Haagsma, JA				Scholten, Annemieke C.; Polinder, Suzanne; Panneman, Martien J. M.; van Beeck, Ed F.; Haagsma, Juanita A.			Incidence and costs of bicycle-related traumatic brain injuries in the Netherlands	ACCIDENT ANALYSIS AND PREVENTION			English	Article; Proceedings Paper	2nd International Conference on Transportation Information and Safety (ICTIS)	JUN 29-JUL 02, 2013	Wuhan, PEOPLES R CHINA			Bicycle; Bicycle-related injury; Traumatic brain injury; Risk groups; Prevention	QUALITY-OF-LIFE; HELMET LEGISLATION; NEW-ZEALAND; POPULATION; EPIDEMIOLOGY; EUROPE; TRENDS; RETURN; WORK	The main cause of death and serious disability in bicycle accidents is traumatic brain injury (TBI). The aim of this population-based study was to assess the incidence and costs of bicycle-related TBI across various age groups, and in comparison to all bicycle-related injuries, to identify main risk groups for the development of preventive strategies. Data from the National Injury Surveillance System and National Medical Registration were used for all patients with bicycle-related injuries and TBI who visited a Dutch emergency department (ED) between 1998 and 2012. Demographics and national, weighted estimates of injury mechanism, injury severity and costs were analysed per age group. Direct healthcare costs and indirect costs were determined using the incidence-based Dutch Burden of Injury Model. Between 1998 and 2012, the incidence of ED treatments due to bicycle-related TBI strongly increased with 54%, to 43 per 100,000 persons in 2012. However, the incidence of all bicycle-related injuries remained stable, from 444 in 1998 to 4561100,000 in 2012. Incidence of hospital admission increased in both TBI (92%) and all injuries from cycling (71%). Highest increase in incidence of both ED treatments and hospital admissions was seen in adults aged 55+. The injury rate of TBI per kilometre travelled increased (44%) except in children, but decreased (-4%) for all injuries, showing a strong decrease in children (-36%) but an increase in men aged 25+, and women aged 15+. Total costs of bicycle-related TBI were (sic)74.5 million annually. Although bicycle-related TBI accounted for 9% of the incidence of all ED treatments due to cycling, it accounted for 18% of the total costs due to all bicycle-related injuries ((sic)410.7 million). Children and adolescents (aged 0-24) had highest incidence of ED treatments due to bicycle-related injuries. Men in the working population (aged 15-64) had highest indirect costs following injuries from cycling, including TBI. Older cyclists (aged 55+) were identified as main risk group for TBI, as they had highest ED attendance, injury rate, injury severity, admission to hospital or intensive care unit, and costs. Incidence of ED treatments due to cycling are high and often involve TBI, imposing a high burden on individuals and society. Older cyclists aged 55+ were identified as main risk group for TBI to be targeted in preventive strategies, due to their high risk for (serious) injuries and ever-increasing share of ED visits and hospital admissions. (C) 2015 Elsevier Ltd. All rights reserved.	[Scholten, Annemieke C.; Polinder, Suzanne; van Beeck, Ed F.; Haagsma, Juanita A.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Res Dept, Amsterdam, Netherlands	Scholten, AC (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	a.scholten@erasmusmc.nl					Aertsens J, 2010, ACCIDENT ANAL PREV, V42, P2149, DOI 10.1016/j.aap.2010.07.008; Airaksinen Noora, 2010, Ann Adv Automot Med, V54, P267; Amoros Emmanuelle, 2011, BMC Public Health, V11, P653, DOI 10.1186/1471-2458-11-653; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; BOVAG RAI Foundation, 2013, MOBILITY IN FIGURES; Buehler R., 2012, TR NEWS, V280, P34; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Consumer and Safety Institute, 2011, FACT SHEET BICYCLE A; Consumer and Safety Institute, 2005, THE DUTCH BURDEN OF; Consumer and Safety Institute, 2013, FACT SHEET NATIONAL; Consumer and Safety Institute and Institute for Road Safety Research (SWOV), 2012, FACTSH COOL KOP HELM; de Putter CE, 2012, J BONE JOINT SURG AM, V94A, DOI 10.2106/JBJS.K.00561; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; EilertPetersson E, 1997, ACCIDENT ANAL PREV, V29, P363, DOI 10.1016/S0001-4575(97)00002-X; Godefrooij T., 1997, GREENING URBAN TRANS, P229; Goldenbeld C., 2003, TIJDSCHRIFT VOOR GEZ, V81, P18; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hansen P, 1995, AUST J PUBLIC HEALTH, V19, P450; Hefny AF, 2012, INJURY, V43, P1547, DOI 10.1016/j.injury.2011.05.016; Hendriksen I., 2008, ELECTRIC BICYCLES MA; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Institute for Health Metrics and Evaluation, 2013, GBD COMPARE FROM INS; Karkhaneh M, 2008, ACCIDENT ANAL PREV, V40, P192, DOI 10.1016/j.aap.2007.05.006; Karkhaneh M, 2013, ACCIDENT ANAL PREV, V59, P206, DOI 10.1016/j.aap.2013.05.027; Konkin DE, 2006, AM J SURG, V191, P615, DOI 10.1016/j.amjsurg.2006.02.012; Kopjar B, 2000, PREV MED, V30, P401, DOI 10.1006/pmed.2000.0645; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; Kuhn M., 2012, SAFETY ASPECTS OF HI; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Meerding WJ, 2010, INT J INJ CONTROL SA, V17, P13, DOI 10.1080/17457300903523237; Ministry of Transport and Fietsberaad, 2009, CYCLING IN THE NETHE; Mulder S, 2002, INJURY PREV, V8, P74, DOI 10.1136/ip.8.1.74; OECD, 2012, CLOSING THE GENDER G; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Papoutsi S, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/850236; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Pucher J, 2008, TRANSPORT RES REC, P58, DOI 10.3141/2074-08; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Rivara F P, 1997, Inj Prev, V3, P110, DOI 10.1136/ip.3.2.110; Scheiman S, 2010, ACCIDENT ANAL PREV, V42, P758, DOI 10.1016/j.aap.2009.11.005; Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Statistics Netherlands (CBS), 2013, POPULATION DATA; Stone M, 2003, ACCIDENT ANAL PREV, V35, P549, DOI 10.1016/S0001-4575(02)00032-5; SWOV Institute for Road Safety Research, 2014, MOBILITY OF PERSONS; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor M, 2002, INJ PREV, V8, P317, DOI 10.1136/ip.8.4.317; Thompson D.C., 2000, COCHRANE DATABASE SY; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1388, DOI 10.2105/AJPH.80.11.1388; Van der Stegen R.H.M., 2009, DISCRIPTION OF METHO; Veisten K, 2007, ACCIDENT ANAL PREV, V39, P1162, DOI 10.1016/j.aap.2007.03.002; Villamor E, 2008, CHILD CARE HLTH DEV, V34, P743, DOI 10.1111/j.1365-2214.2008.00882.x; Zimmerman K, 2012, ACCIDENT ANAL PREV, V45, P204, DOI 10.1016/j.aap.2011.06.018	55	29	29	0	24	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	AUG	2015	81						51	60		10.1016/j.aap.2015.04.022			10	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CM2YR	WOS:000357548800006	25939135				2021-06-18	
J	Khan, M; Dhammu, TS; Matsuda, F; Singh, AK; Singh, I				Khan, Mushfiquddin; Dhammu, Tajinder S.; Matsuda, Fumiyo; Singh, Avtar K.; Singh, Inderjit			Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy	BMC NEUROSCIENCE			English	Article						AMP-activated protein kinase; Neuronal nitric oxide synthase; Neuroprotection; Peroxynitrite; S-nitrosoglutathione; Stroke; Cerebral ischemia reperfusion	NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; RAT MODEL; NEUROPROTECTIVE EFFICACY; PEROXYNITRITE FORMATION; NEUROVASCULAR UNIT; BLOOD-FLOW; LIFE-SPAN	Background: Stroke immediately sets into motion sustained excitotoxicity and calcium dysregulation, causing aberrant activity in neuronal nitric oxide synthase (nNOS) and an imbalance in the levels of nitric oxide (NO). Drugs targeting nNOS-originated toxicity may therefore reduce stroke-induced damage. Recently, we observed that a redox-modulating agent of the NO metabolome, S-nitrosoglutathione (GSNO), confers neurovascular protection by reducing the levels of peroxynitrite, a product of aberrant NOS activity. We therefore investigated whether GSNO-mediated neuroprotection and improved neurological functions depend on blocking nNOS/peroxynitrite-associated injurious mechanisms using a rat model of cerebral ischemia reperfusion (IR). Results: IR increased the activity of nNOS, the levels of neuronal peroxynitrite and phosphorylation at Ser(1412) of nNOS. GSNO treatment of IR animals decreased IR-activated nNOS activity and neuronal peroxynitrite levels by reducing nNOS phosphorylation at Ser(1412). The Ser(1412) phosphorylation is associated with increased nNOS activity. Supporting the notion that nNOS activity and peroxynitrite are deleterious following IR, inhibition of nNOS by its inhibitor 7-nitroindazole or reducing peroxynitrite by its scavenger FeTPPS decreased IR injury. GSNO also decreased the activation of AMP Kinase (AMPK) and its upstream kinase LKB1, both of which were activated in IR brain. AMPK has been implicated in nNOS activation via Ser(1412) phosphorylation. To determine whether AMPK activation is deleterious in the acute phase of IR, we treated animals after IR with AICAR (an AMPK activator) and compound c (an AMPK inhibitor). While AICAR potentiated, compound c reduced the IR injury. Conclusions: Taken together, these results indicate an injurious nNOS/peroxynitrite/AMPK cycle following stroke, and GSNO treatment of IR inhibits this vicious cycle, resulting in neuroprotection and improved neurological function. GSNO is a natural component of the human body, and its exogenous administration to humans is not associated with any known side effects. Currently, the FDA-approved thrombolytic therapy suffers from a lack of neuronal protective activity. Because GSNO provides neuroprotection by ameliorating stroke's initial and causative injuries, it is a candidate of translational value for stroke therapy.	[Khan, Mushfiquddin; Dhammu, Tajinder S.; Matsuda, Fumiyo; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Matsuda, Fumiyo] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan; [Singh, Avtar K.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson VA Med Ctr, Charleston, SC USA	Khan, M (corresponding author), Med Univ S Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA.	khanm@musc.edu; singhi@musc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-72511]; VA merit awardUS Department of Veterans Affairs [BX001062, BX002829]; NIH, National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06 RR018823, C06 RR015455]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26350615] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072511] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002829, I01BX001062] Funding Source: NIH RePORTER	This work was supported by grants from NIH (NS-72511) and VA merit award (BX001062 and BX002829). This work was also supported by the NIH, Grants C06 RR018823 and No C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. We thank Ms. Joyce Bryan and Ms. Terry Hope for their technical help and secretarial assistance. We are grateful to Drs. Harutoshi Sakakima and Yoshihiro Yoshida for their scientific input and to Ms. Danielle Lowe (MD/PhD student at the MUSC) for statistical analysis. We also acknowledge Dr. Tom Smith from the MUSC Writing Center for his valuable editing of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; Coert BA, 2003, AM J PHYSIOL-HEART C, V284, pH151, DOI 10.1152/ajpheart.00580.2002; Colagiovanni DB, 2011, INT J TOXICOL, V30, P466, DOI 10.1177/1091581811412084; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; DEBELDER AJ, 1994, CARDIOVASC RES, V28, P691; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Garcia-Bonilla L, 2014, J IMMUNOL, V193, P2531, DOI 10.4049/jimmunol.1400918; Gingerich S, 2008, NEUROPHARMACOLOGY, V55, P878, DOI 10.1016/j.neuropharm.2008.06.058; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Gursoy-Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI 10.1111/j.1471-4159.2012.07938.x; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Komeima K, 2000, J BIOL CHEM, V275, P28139; Komeima K, 2001, FEBS LETT, V497, P65, DOI 10.1016/S0014-5793(01)02389-4; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lo EH, 2004, NAT MED, V10, P1295, DOI 10.1038/nm1204-1295; Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Manwani B, 2013, J NEUROSCI RES; Matsuda F, 2011, ACTA PHYSIOL, V201, P275, DOI [10.1111/j.1748-1716.2010.02174.x, 10.1111/j.1748-1708.2010.02174.x]; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0000000000000152, 10.1161/CIR.0b013e31828124ad]; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Qu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052788; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Sakakima H, 2012, RESTOR NEUROL NEUROS, V30, P383, DOI 10.3233/RNN-2012-110209; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Sun J, 2008, ARCH BIOCHEM BIOPHYS, V471, P126, DOI 10.1016/j.abb.2008.01.003; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thiyagarajan M, 2004, BRIT J PHARMACOL, V142, P899, DOI 10.1038/sj.bjp.0705811; WANG Q, 1995, J CEREBR BLOOD F MET, V15, P774, DOI 10.1038/jcbfm.1995.97; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; Weisova P, 2011, ANTIOXID REDOX SIGN, V14, P1863, DOI 10.1089/ars.2010.3544; Willmot M, 2005, FREE RADICAL BIO MED, V39, P412, DOI 10.1016/j.freeradbiomed.2005.03.028; Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	62	29	30	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	JUL 15	2015	16								42	10.1186/s12868-015-0179-x			12	Neurosciences	Neurosciences & Neurology	CM7CM	WOS:000357848000001	26174015	DOAJ Gold, Green Published			2021-06-18	
J	Schofield, PW; Malacova, E; Preen, DB; D'Este, C; Tate, R; Reekie, J; Wand, H; Butler, T				Schofield, Peter W.; Malacova, Eva; Preen, David B.; D'Este, Catherine; Tate, Robyn; Reekie, Joanne; Wand, Handan; Butler, Tony			Does Traumatic Brain Injury Lead to Criminality? A Whole-Population Retrospective Cohort Study Using Linked Data	PLOS ONE			English	Article							HEAD-INJURY; PSYCHIATRIC-ILLNESS; AFGHANISTAN; DISORDERS; PRISONERS; IRAQ; TBI	Background Traumatic brain injury (TBI) may be a risk factor for criminal behaviour however multiple factors potentially confound the association. Methods Record linkage and Cox proportional hazards regression analyses were used to examine the association between hospital-recorded TBI (n = 7,694) and subsequent first criminal conviction in a retrospective cohort matched 1: 3 with 22,905 unaffected community controls and full-sibling controls (n = 2,397). Aboriginality, substance abuse, social disadvantage, and mental illness were included in analyses as potential confounders Results In multivariable models, relative to general population controls, TBI was associated with any conviction (males: Hazard Ratio (HR) = 1.58 (95% CI 1.46 to 1.72); females: HR = 1.52 (95% CI 1.28 to 1.81)); and similar Hazard Ratios were obtained for the sibling analyses in males (HR = 1.68 (95% CI 1.31-2.18)) and females (HR 1.27 (95% CI 0.71-2.29)). TBI was also associated with violent convictions relative to the general population, (males: HR = 1.65 (95% CI 1.42 to 1.92); females HR = 1.73 (95% CI 1.21 to 2.47)), and in analyses with sibling controls in men (HR = 1.89 (95% CI 1.20-3.00)), but not in women (HR 0.73, 95% CI 0.29-1.81)). Conclusion The results support a modest causal link between TBI and criminality after comprehensive adjustment for confounding. Reducing the rate of TBI, a major public health imperative, might have benefits in terms of crime reduction.	[Schofield, Peter W.] Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia; [Schofield, Peter W.] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Malacova, Eva; Preen, David B.] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [D'Este, Catherine] Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; [Tate, Robyn] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Reekie, Joanne; Wand, Handan; Butler, Tony] UNSW Australia, Kirby Inst, Sydney, NSW, Australia	Schofield, PW (corresponding author), Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia.	peter.schofield@hnehealth.nsw.gov.au	Preen, David/H-5663-2014	Preen, David/0000-0002-2982-2169; Butler, Tony/0000-0002-2679-2769; Schofield, Peter/0000-0001-8298-8590	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [533504]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006525/1] Funding Source: researchfish	Funding was supplied by the National Health and Medical Research Council (grant # 533504) to TB, PWS, RT, DBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, AUSTR VERS INT CLASS, V1; [Anonymous], 2010, INT STAT CLASS DIS R; Australian Bureau of Statistics, 2006, SOC IND AR SEIFA TEC; BIJUR PE, 1990, PEDIATRICS, V86, P337; Briffa TG, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-111; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Frisell T, 2012, BEHAV GENET, V42, P3, DOI 10.1007/s10519-011-9483-0; Hodgins S, 1996, ARCH GEN PSYCHIAT, V53, P489, DOI 10.1001/archpsyc.1996.01830060031004; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hosmer D.W, 1999, APPL SURVIVAL ANAL R; Institute for Digital Research and Education, INTR TO SAS; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mayhew P, 2003, TRENDS ISS CRIME CRI, V247, P1; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Mulder E, 2011, INT J OFFENDER THER, V55, P118, DOI 10.1177/0306624X09356683; Preen D, 2003, AUST EPIDEMIOL, V10, P24; Rowe DC, 1997, CRIMINOLOGY, V35, P177, DOI 10.1111/j.1745-9125.1997.tb00874.x; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sourander A, 2011, SOC PSYCH PSYCH EPID, V46, P1211, DOI 10.1007/s00127-010-0292-1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017	37	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132558	10.1371/journal.pone.0132558			12	Multidisciplinary Sciences	Science & Technology - Other Topics	CN1QN	WOS:000358194900058	26172545	DOAJ Gold, Green Published			2021-06-18	
J	Margulies, SS; Kilbaugh, T; Sullivan, S; Smith, C; Propert, K; Byro, M; Saliga, K; Costine, BA; Duhaime, AC				Margulies, Susan S.; Kilbaugh, Todd; Sullivan, Sarah; Smith, Colin; Propert, Kathleen; Byro, Melissa; Saliga, Kristen; Costine, Beth A.; Duhaime, Ann-Christine			Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study	BRAIN PATHOLOGY			English	Article						brain injury; pediatric; preclinical trials; treatment; TBI	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; MATURATION-DEPENDENT RESPONSE; HIGH-DOSE CYCLOSPORINE; DIFFUSE AXONAL INJURY; MITOCHONDRIAL DYSFUNCTION; NEONATAL PIG; CELL-DEATH; PERMEABILITY TRANSITION; CEREBRAL-ISCHEMIA	We have developed the first immature large animal translational treatment trial of a pharmacologic intervention for traumatic brain injury (TBI) in children. The preclinical trial design includes multiple doses of the intervention in two different injury types (focal and diffuse) to bracket the range seen in clinical injury and uses two post-TBI delays to drug administration. Cyclosporin A (CsA) was used as a case study in our first implementation of the platform because of its success in multiple preclinical adult rodent TBI models and its current use in children for other indications. Tier 1 of the therapy development platform assessed the short-term treatment efficacy after 24h of agent administration. Positive responses to treatment were compared with injured controls using an objective effect threshold established prior to the study. Effective CsA doses were identified to study in Tier 2. In the Tier 2 paradigm, agent is administered in a porcine intensive care unit utilizing neurological monitoring and clinically relevant management strategies, and intervention efficacy is defined as improvement in longer term behavioral endpoints above untreated injured animals. In summary, this innovative large animal preclinical study design can be applied to future evaluations of other agents that promote recovery or repair after TBI.	[Margulies, Susan S.; Sullivan, Sarah; Propert, Kathleen; Byro, Melissa] Univ Penn, Philadelphia, PA 19104 USA; [Kilbaugh, Todd] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Saliga, Kristen; Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02115 USA	Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 210 S 33rd St,240 Skirkanich Hall, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu		Kilbaugh, Todd/0000-0002-4959-3092; Smith, Colin/0000-0002-4507-5132; Costine-Bartell, Beth/0000-0001-7559-9378	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS069545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545] Funding Source: NIH RePORTER	The preclinical study was supported by the NIH grant U01NS069545. We thank our NIH partners Drs Ramona Hicks and Linda McGavern for their insightful questions that shaped our study design and their long-standing support for the project. We are grateful for the expert technical assistance, many long hours of participation and deep dedication to the project by Courtney Robertson, Athena Zuppa, Jill Ralston, Ashley Bebee, Kortne Hudick, Sabrina Taylor, Christopher Seufert, Carter Dodge, Marissa Fiorello and Jamie Rose. We appreciate the long, tedious hours contributed by Erica Hummel, Jesi Kim, Peter Chhour, Susie Cha and Rachel Margulies digitizing photographs of injured brain sections to determine lesion volume pathology values.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BATES TE, 1994, DEV NEUROSCI-BASEL, V16, P321, DOI 10.1159/000112126; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care AANS/CNS, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9976; Cannistra SA, 2009, J CLIN ONCOL, V27, P3073, DOI 10.1200/JCO.2009.23.1811; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cibulskyte D, 2007, PHARMACOL RES, V56, P311, DOI 10.1016/j.phrs.2007.07.010; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; DELMAESTRO R, 1987, MECH AGEING DEV, V41, P29, DOI 10.1016/0047-6374(87)90051-0; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Duhaime AC, 2006, J NEUROSURG, V104, P259, DOI 10.3171/ped.2006.104.4.259; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; FINN WF, 1989, RENAL FAILURE, V11, P3, DOI 10.3109/08860228909066940; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Fukui S, 2003, ACT NEUR S, V86, P301; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Ghafari A, 2007, TRANSPL P, V39, P1219, DOI 10.1016/j.transproceed.2007.03.014; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hall Edward D., 2009, V25, P10, DOI 10.1159/000209470; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Karlsson M, 2013, INT J BIOCHEM CELL B, V45, P151, DOI 10.1016/j.biocel.2012.08.008; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lum BL, 2000, CANCER CHEMOTH PHARM, V45, P305, DOI 10.1007/s002800050045; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saito A, 2005, MOL NEUROBIOL, V31, P105, DOI 10.1385/MN:31:1-3:105; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SULLIVAN BA, 1984, TRANSPLANT P, V17, P145; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TSAO PW, 1992, DEV PHARMACOL THERAP, V18, P20, DOI 10.1159/000480594; Turner MS, 2003, ACT NEUR S, V87, P81; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	96	29	29	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	MAY	2015	25	3					289	303		10.1111/bpa.12247			15	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CG6CX	WOS:000353384200007	25904045	Green Published, Green Accepted			2021-06-18	
J	Gunther, M; Plantman, S; Davidsson, J; Angeria, M; Mathiesen, T; Risling, M				Gunther, Mattias; Plantman, Stefan; Davidsson, Johan; Angeria, Maria; Mathiesen, Tiit; Risling, Marten			COX-2 regulation and TUNEL-positive cell death differ between genders in the secondary inflammatory response following experimental penetrating focal brain injury in rats	ACTA NEUROCHIRURGICA			English	Article						TBI; COX-2; iNOS; Sex; Gender; Secondary inflammation	NITRIC-OXIDE; CYCLOOXYGENASE-2; MECHANISMS; EXPRESSION; INDUCTION; ESTROGEN; STROKE	Traumatic brain injury is followed by secondary neuronal degeneration, largely dependent on an inflammatory response. This response is probably gender specific, since females are better protected than males in experimental models. The reasons are not fully known. We examined aspects of the inflammatory response following experimental TBI in male and female rats to explore possible gender differences at 24 h and 72 h after trauma, times of peak histological inflammation and neuronal degeneration. A penetrating brain injury model was used to produce penetrating focal TBI in 20 Sprague-Dawley rats, 5 males and 5 females for each time point. After 24 and 72 h the brains were removed and subjected to in situ hybridization and immunohistochemical analyses for COX-2, iNOS, osteopontin, glial fibrillary acidic protein, 3-nitrotyrosine, TUNEL and Fluoro-Jade. COX-2 mRNA and protein levels were increased in the perilesional area compared to the uninjured contralateral side and significantly higher in males at 24 h and 72 h (p < 0.05). iNOS mRNA was significantly increased in females at 24 h (p < 0.05) although protein was not. TUNEL was increased in male rats after 24 h (p < 0.05). Glial fibrillary acidic protein, osteopontin, 3-nitrotyrosine and Fluoro-Jade stained degenerating neurons were increased in the perilesional area, showing no difference between genders. COX-2 regulation differed between genders after TBI. The increased COX-2 expression in male rats correlated with increased apoptotic cell death detected by increased TUNEL staining at 24 h, but not with neuronal necrosis measured by Flouro-Jade. Astrogliosis and microgliosis did not differ, confirming a comparable level of trauma. The gender-specific trait of the secondary inflammatory response may be connected to prostaglandin regulation, which may partially explain gender variances in outcome after TBI.	[Gunther, Mattias; Plantman, Stefan; Angeria, Maria; Risling, Marten] Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, SE-17177 Stockholm, Sweden; [Gunther, Mattias] Karolinska Inst, Dept Neurosci, Sect Expt Traumatol, SE-17177 Stockholm, Sweden; [Davidsson, Johan] Chalmers Univ Technol, Dept Appl Mech, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg, SE-17177 Stockholm, Sweden	Gunther, M (corresponding author), Karolinska Inst, Dept Neurosci, Sect Expt Traumatol, Retzius Vag 8,B1 5, SE-17177 Stockholm, Sweden.	mattias.gunther@ki.se	Davidsson, Johan/A-3229-2016; , Mattias/A-4442-2013	Davidsson, Johan/0000-0002-1717-1514; , Mattias/0000-0003-2372-6114; Mathiesen, Tiit/0000-0001-9463-1919	ALF Stockholms Lans Landsting; Swedish Defense	This study was funded by ALF Stockholms Lans Landsting and The Swedish Defense.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gahm C, 2000, NEUROSURGERY, V46, P169; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gunther M, 2012, ACTA NEUROCHIR, V154, P689, DOI 10.1007/s00701-012-1297-1; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Manabe Y, 2004, ANN NEUROL, V55, P668, DOI 10.1002/ana.20078; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Park EM, 2006, J CEREBR BLOOD F MET, V26, P392, DOI 10.1038/sj.jcbfm.9600194; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rose JW, 2004, J NEUROIMMUNOL, V149, P40, DOI 10.1016/j.jneuroim.2003.12.021; Schank JC, 2001, PHYSIOL BEHAV, V72, P129, DOI 10.1016/S0031-9384(00)00395-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	44	29	34	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2015	157	4					649	659		10.1007/s00701-014-2331-2			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE0RD	WOS:000351511300018	25597483				2021-06-18	
J	Mazza, M; Tempesta, D; Pino, MC; Nigri, A; Catalucci, A; Guadagni, V; Gallucci, M; Iaria, G; Ferrara, M				Mazza, Monica; Tempesta, Daniela; Pino, Maria Chiara; Nigri, Anna; Catalucci, Alessia; Guadagni, Veronica; Gallucci, Massimo; Iaria, Giuseppe; Ferrara, Michele			Neural activity related to cognitive and emotional empathy in post-traumatic stress disorder	BEHAVIOURAL BRAIN RESEARCH			English	Article						Explicit emotional empathy; Implicit emotional empathy; Cognitive empathy; Post-traumatic stress disorder	BORDERLINE PERSONALITY-DISORDER; TRAUMATIC BRAIN-INJURY; SOCIAL COGNITION; FUNCTIONING AUTISM; ASPERGER-SYNDROME; PTSD; FMRI; MIND; ALEXITHYMIA; QUOTIENT	The aim of this study is to evaluate the empathic ability and its functional brain correlates in posttraumatic stress disorder subjects (PTSD). Seven PTSD subjects and ten healthy controls, all present in the L'Aquila area during the earthquake of the April 2009, underwent fMRI during which they performed a modified version of the Multifaceted Empathy Test. PTSD patients showed impairments in implicit and explicit emotional empathy, but not in cognitive empathy. Brain responses during cognitive empathy showed an increased activation in patients compared to controls in the right medial frontal gyrus and the left inferior frontal gyrus. During implicit emotional empathy responses patients with PTSD, compared to controls, exhibited greater neural activity in the left pallidum and right insula; instead the control group showed an increased activation in right inferior frontal gyrus. Finally, in the explicit emotional empathy responses the PTSD group showed a reduced neural activity in the left insula and the left inferior frontal gyrus. The behavioral deficit limited to the emotional empathy dimension, accompanied by different patterns of activation in empathy related brain structures, represent a first piece of evidence of a dissociation between emotional and cognitive empathy in PTSD patients. The present findings support the idea that empathy is a multidimensional process, with different facets depending on distinct anatomical substrates. (C) 2014 Elsevier B.V. All rights reserved.	[Mazza, Monica; Tempesta, Daniela; Pino, Maria Chiara; Ferrara, Michele] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Nigri, Anna] Fdn IRCCS Neurol Inst Carlo Besta, Dept Neuroradiol, Milan, Italy; [Catalucci, Alessia; Gallucci, Massimo] San Salvatore Hosp, Dept Neuroradiol, Laquila, Italy; [Guadagni, Veronica; Iaria, Giuseppe] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Guadagni, Veronica; Iaria, Giuseppe] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Guadagni, Veronica; Iaria, Giuseppe] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada	Mazza, M (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Via Vetoio, I-67100 Laquila, Italy.	monica.mazza@cc.univaq.it	Nigri, Anna/AAM-9827-2021	Nigri, Anna/0000-0002-1197-5458; Tempesta, Daniela/0000-0002-6942-5336; Mazza, Monica/0000-0003-4050-2243; Guadagni, Veronica/0000-0002-9309-0652; Pino, Maria Chiara/0000-0003-2657-2122; Iaria, Giuseppe/0000-0002-5987-6491; Ferrara, Michele/0000-0003-2304-7576			American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, V5th; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bandelow B, 2012, EUR ARCH PSY CLIN N, V262, P459, DOI 10.1007/s00406-012-0289-8; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, ESSAY AUTISM THEORY; Beck JG, 2009, J ANXIETY DISORD, V23, P443, DOI 10.1016/j.janxdis.2008.09.001; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; DAVIS MH, 1994, J PERS, V62, P369, DOI 10.1111/j.1467-6494.1994.tb00302.x; Decety J, 2013, FRONT HUM NEUROSCI, P7; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; Decety J, 2011, NEUROPSYCHOLOGIA, V49, P2994, DOI 10.1016/j.neuropsychologia.2011.06.024; Devinsky O, 2000, EPILEPSY BEHAV, V1, P60, DOI 10.1006/ebeh.2000.0025; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; Elliot TJ, 2006, COST CARING EXAMINAT; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Farrow TFD, 2005, PSYCHIAT RES-NEUROIM, V140, P45, DOI 10.1016/j.pscychresns.2005.05.012; Frewen PA, 2008, J ABNORM PSYCHOL, V117, P171, DOI 10.1037/0021-843X.117.1.171; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gazzaniga Michael S., 1985, THE SOCIAL BRAIN; Gelhaus P, 2012, MED HEALTH CARE PHIL, V15, P103, DOI 10.1007/s11019-011-9366-4; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Guadagni V, 2014, J SLEEP RES, V23, P657, DOI 10.1111/jsr.12192; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hooker CI, 2010, BRAIN RES, V1308, P100, DOI 10.1016/j.brainres.2009.10.006; HOPPE KD, 1977, PSYCHOTHER PSYCHOSOM, V28, P148, DOI 10.1159/000287057; Kashdan TB, 2007, PERS INDIV DIFFER, V43, P725, DOI 10.1016/j.paid.2007.01.013; Klimecki OM, 2013, CEREB CORTEX, V23, P1552, DOI 10.1093/cercor/bhs142; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Mazza M, 2013, EUR ARCH PSY CLIN N, V263, P575, DOI 10.1007/s00406-013-0394-3; Mazza M, 2012, PSYCHIAT RES, V198, P248, DOI 10.1016/j.psychres.2011.11.027; Moroni L, 2006, Monaldi Arch Chest Dis, V66, P255; Nietlisbach G, 2010, PSYCHOL REP, V106, P832, DOI 10.2466/PR0.106.3.832-844; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Porto PR, 2009, J NEUROPSYCH CLIN N, V21, P114, DOI 10.1176/appi.neuropsych.21.2.114; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Seitz RJ, 2008, NEUROSCIENCE, V152, P713, DOI 10.1016/j.neuroscience.2007.10.066; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; SPIELBERGER CD, 1984, J PERS ASSESS, V48, P95; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirioux B, 2014, NEUROSCIENCE; Wellman HM, 1990, MIT PRESS SERIES LEA; Whiten A., 1991, NATURAL THEORIES MIN	64	29	30	1	59	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR	2015	282						37	45		10.1016/j.bbr.2014.12.049			9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CC2PB	WOS:000350186000005	25555525				2021-06-18	
J	Piitulainen, JM; Posti, JP; Aitasalo, KMJ; Vuorinen, V; Vallittu, PK; Serlo, W				Piitulainen, Jaakko M.; Posti, Jussi P.; Aitasalo, Kalle M. J.; Vuorinen, Ville; Vallittu, Pekka K.; Serlo, Willy			Paediatric cranial defect reconstruction using bioactive fibre-reinforced composite implant: early outcomes	ACTA NEUROCHIRURGICA			English	Article; Proceedings Paper	15th European Congress of Neurosurgery	OCT 12-17, 2014	Prague, CZECH REPUBLIC			Cranioplasty; Craniectomy; Craniofacial bone reconstruction; Fibre-reinforced composite; FRC; Bioactive glass; Paediatric; Skull bone defect	TRAUMATIC BRAIN-INJURY; AUTOGENOUS BONE-GRAFT; DECOMPRESSIVE CRANIECTOMY; GLASS S53P4; IN-VITRO; CLINICAL ARTICLE; CHRONIC OSTEOMYELITIS; FLAP RESORPTION; RISK-FACTORS; CRANIOPLASTY	In children, approximately half of cryopreserved allograft bone flaps fail due to infection and resorption. Synthetic materials offer a solution for allograft bone flap resorption. Fibre-reinforced composite with a bioactive glass particulate filling is a new synthetic material for bone reconstruction. Bioactive glass is capable of chemically bonding with bone and is osteoinductive, osteoconductive and bacteriostatic. Fibre-reinforced composite allows for fabricating thin (0.8 mm) margins for implant, which are designed as onlays on the existing bone. Bioactive glass is dissolved over time, whereas the fibre-reinforced composite serves as a biostable part of the implant, and these have been tested in preclinical and adult clinical trials. In this study, we tested the safety and other required properties of this composite material in large skull bone reconstruction with children. Eight cranioplasties were performed on seven patients, aged 2.5-16 years and having large (> 16 cm(2)) skull bone defects. The implant used in this study was a patient-specific, glass-fibre-reinforced composite, which contained a bioactive glass particulate compound, S53P4. During follow-up (average 35.1 months), one minor complication was observed and three patients needed revision surgery. Two surgical site infections were observed. After treatment of complications, a good functional and cosmetic outcome was observed in all patients. The implants had an onlay design and fitted the defect well. In clinical and imaging examinations, the implants were in the original position with no signs of implant migration, degradation or mechanical breakage. Here, we found that early cranioplasty outcomes with the fibre-reinforced composite implant were promising. However, a longer follow-up time and a larger group of patients are needed to draw firmer conclusions regarding the long-term benefits of the proposed novel biomaterial and implant design. The glass-fibre-reinforced composite implant incorporated by particles of bioactive glass may offer an original, non-metallic and bioactive alternative for reconstruction of large skull bone defects in a paediatric population.	[Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku 20521, Finland; [Posti, Jussi P.; Vuorinen, Ville] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku 20521, Finland; [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland; [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, TCBC, Turku, Finland; [Vallittu, Pekka K.] Oral Hlth Care, City Turku Welf Div, Turku, Finland; [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland	Piitulainen, JM (corresponding author), Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, POB 52, Turku 20521, Finland.	jaakko.piitulainen@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Piitulainen, Jaakko/0000-0001-9788-8904			Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370; Ballo AM, 2009, CLIN ORAL IMPLAN RES, V20, P608, DOI 10.1111/j.1600-0501.2008.01700.x; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; DeLuca L, 1997, PLAST RECONSTR SURG, V99, P1324, DOI 10.1097/00006534-199704001-00019; Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Engstrand T, 2014, J NEUROSURG, V120, P273, DOI 10.3171/2013.6.JNS1360; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Goldstein JA, 2013, CURR OPIN OTOLARYNGO, V21, P400, DOI 10.1097/MOO.0b013e328363003e; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309; Kamdar MR, 2009, PLAST RECONSTR SURG, V124, P2072, DOI 10.1097/PRS.0b013e3181bcefc4; KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212; Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5; Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876; Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5; Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1; Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003; Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Ritter L, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130088; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Rogers GF, 2012, J CRANIOFAC SURG, V23, P323, DOI 10.1097/SCS.0b013e318241dcba; Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898; Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813; Wang DY, 2013, CLIN ORAL INVEST, V17, P1601, DOI 10.1007/s00784-012-0841-y; Yli-Urpo H, 2003, ACTA ODONTOL SCAND, V61, P241, DOI 10.1080/00016350310004719; Zehnder M, 2006, ORAL SURG ORAL MED O, V101, P530, DOI 10.1016/j.tripleo.2005.03.014; Zehnder M, 2004, J ENDODONT, V30, P220, DOI 10.1097/00004770-200404000-00009; Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564	41	29	29	1	24	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2015	157	4					681	687		10.1007/s00701-015-2363-2			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE0RD	WOS:000351511300024	25663141				2021-06-18	
J	Sullivan, KA; Edmed, SL; Allan, AC; Karlsson, LJE; Smith, SS				Sullivan, Karen A.; Edmed, Shannon L.; Allan, Alicia C.; Karlsson, Lina J. E.; Smith, Simon S.			Characterizing Self-Reported Sleep Disturbance after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						insomnia; concussion; post-concussion syndrome; excessive daytime sleepiness	INSOMNIA SEVERITY INDEX; OUTCOME MEASURES; DISORDERS; RECOMMENDATIONS; PREVALENCE; ADULTS; VALIDATION; COMPLAINTS; LATENCY; SCALE	Sleep disturbance after mild traumatic brain injury (mTBI) is commonly reported as debilitating and persistent. However, the nature of this disturbance is poorly understood. This study sought to characterize sleep after mTBI compared with a control group. A cross-sectional matched case control design was used. Thirty-three persons with recent mTBI (1-6 months ago) and 33 age, sex, and ethnicity matched controls completed established questionnaires of sleep quality, quantity, timing, and sleep-related daytime impairment. The mTBI participants were compared with an independent sample of close-matched controls (CMCs; n=33) to allow partial internal replication. Compared with controls, persons with mTBI reported significantly greater sleep disturbance, more severe insomnia symptoms, a longer duration of wake after sleep onset, and greater sleep-related impairment (all medium to large effects, Cohen's d>0.5). No differences were found in sleep quantity, timing, sleep onset latency, sleep efficiency, or daytime sleepiness. All findings except a measure of sleep timing (i.e., sleep midpoint) were replicated for CMCs. These results indicate a difference in the magnitude and nature of perceived sleep disturbance after mTBI compared with controls, where persons with mTBI report poorer sleep quality and greater sleep-related impairment. Sleep quantity and timing did not differ between the groups. These preliminary findings should guide the provision of clearer advice to patients about the aspects of their sleep that may change after mTBI and could inform treatment selection.	[Sullivan, Karen A.; Edmed, Shannon L.; Allan, Alicia C.; Karlsson, Lina J. E.; Smith, Simon S.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Brisbane, Qld 4059, Australia; [Sullivan, Karen A.; Edmed, Shannon L.; Allan, Alicia C.; Karlsson, Lina J. E.; Smith, Simon S.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Brisbane, Qld 4059, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, O Block B Wing Room B523, Kelvin Grove Campus, Brisbane, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045	School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1300000224) approved this research. This project was granted an occupational workplace health and safety clearance. Funding was contributed by the School of Psychology and Counselling, Queensland University of Technology.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnedt JT, 2012, BEHAV SLEEP MED, V10, P25, DOI 10.1080/15402002.2012.636267; Augner C, 2011, CENT EUR J PUBL HEAL, V19, P115, DOI 10.21101/cejph.a3647; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barclay NL, 2013, SLEEP MED REV, V17, P29, DOI 10.1016/j.smrv.2012.01.008; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Burgess Helen J, 2003, Behav Sleep Med, V1, P102, DOI 10.1207/S15402010BSM0102_3; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chandra P. S., 2007, SLEEP MED, V8, pS92; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conway A, 2013, RES NURS HEALTH, V36, P320, DOI 10.1002/nur.21536; Drotar D, 2010, J PEDIATR PSYCHOL, V35, P801, DOI 10.1093/jpepsy/jsq049; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Field A., 2013, DISCOVERING STAT USI, V4; Gander PH, 2005, SLEEP, V28, P249, DOI 10.1093/sleep/28.2.249; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hedman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061713; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Lagos L., 2012, BIOFEEDBACK, V40, P150, DOI [10.5298/1081-5937-40.4.05, DOI 10.5298/1081-5937-40.4.05]; Levin Kate Ann, 2006, Evid Based Dent, V7, P83, DOI 10.1038/sj.ebd.6400436; LINDSAY RM, 1993, AM STAT, V47, P217, DOI 10.2307/2684982; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Niven D. J., 2013, CLIN EPIDEMIOL, V4, P99; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P707; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Patient-Reported Outcomes Information System, 2011, PROMIS SCORING GUIDE; Ponsford J., 2012, 9 WORLD C INT BRAIN; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Steele DL, 2005, CHRONOBIOL INT, V22, P89, DOI 10.1081/CBI-200042428; Tabachnick BG, 2007, USING MULTIVARIATE S; Weber M, 2013, J SLEEP DISORDERS TH, V2, P2; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; World Health Organization, 1992, ICD 10 INT STAT CLAS; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	68	29	29	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2015	32	7					474	486		10.1089/neu.2013.3284			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CE4YV	WOS:000351837400007	25275933	Green Published			2021-06-18	
J	Moenninghoff, C; Kraff, O; Maderwald, S; Umutlu, L; Theysohn, JM; Ringelstein, A; Wrede, KH; Deuschl, C; Altmeppen, J; Ladd, ME; Forsting, M; Quick, HH; Schlamann, M				Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Ringelstein, Adrian; Wrede, Karsten H.; Deuschl, Cornelius; Altmeppen, Jan; Ladd, Mark E.; Forsting, Michael; Quick, Harald H.; Schlamann, Marc			Diffuse Axonal Injury at Ultra-High Field MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CEREBRAL MICROBLEEDS; INTRACEREBRAL HEMORRHAGE; WHITE-MATTER; PROGNOSTIC VALUE; 1.5 TESLA; 7 T; LESIONS; DEMENTIA	Objective Diffuse axonal injury (DAI) is a specific type of traumatic brain injury caused by shearing forces leading to widespread tearing of axons and small vessels. Traumatic microbleeds (TMBs) are regarded as a radiological marker for DAI. This study aims to compare DAIassociated TMBs at 3 Tesla (T) and 7 T susceptibility weighted imaging (SWI) to evaluate possible diagnostic benefits of ultra-high field (UHF) MRI. Material and Methods 10 study participants (4 male, 6 female, age range 20-74 years) with known DAI were included. All MR exams were performed with a 3 T MR system (Magnetom Skyra) and a 7 T MR research system (Magnetom 7 T, Siemens AG, Healthcare Sector, Erlangen, Germany) each in combination with a 32-channel-receive coil. The average time interval between trauma and imaging was 22 months. Location and count of TMBs were independently evaluated by two neuroradiologists on 3 T and 7 T SWI images with similar and additionally increased spatial resolution at 7 T. Inter-and intraobserver reliability was assessed using the interclass correlation coefficient (ICC). Count and diameter of TMB were evaluated with Wilcoxon signed rank test. Results Susceptibility weighted imaging revealed a total of 485 TMBs (range 1-190, median 25) at 3 T, 584 TMBs (plus 20%, range 1-262, median 30.5) at 7 T with similar spatial resolution, and 684 TMBs (plus 41%, range 1-288, median 39.5) at 7 T with 10-times higher spatial resolution. Hemorrhagic DAI appeared significantly larger at 7 T compared to 3 T (p = 0.005). Inter-and intraobserver correlation regarding the counted TMB was high and almost equal 3 T and 7 T. Conclusion 7 T SWI improves the depiction of small hemorrhagic DAI compared to 3 T and may be supplementary to lower field strengths for diagnostic in inconclusive or medicolegal cases.	[Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Ringelstein, Adrian; Deuschl, Cornelius; Altmeppen, Jan; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Wrede, Karsten H.; Deuschl, Cornelius; Ladd, Mark E.; Forsting, Michael; Quick, Harald H.; Schlamann, Marc] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Wrede, Karsten H.] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Schlamann, Marc] Univ Hosp Giessen, Inst Neuroradiol, Giessen, Germany	Moenninghoff, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	christoph.moenninghoff@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Maderwald, Stefan/B-4241-2011; Kraff, Oliver/AAE-2238-2020	Wrede, Karsten/0000-0001-7076-3503; Kraff, Oliver/0000-0002-6006-8934			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Allkemper T, 2004, EUR RADIOL, V14, P1000, DOI 10.1007/s00330-004-2241-4; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Conijn MMA, 2011, AM J NEURORADIOL, V32, P1043, DOI 10.3174/ajnr.A2450; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hilal S, 2014, ALZ DIS ASSOC DIS, V28, P106, DOI 10.1097/WAD.0000000000000015; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Lupo Janine M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P747; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MONACO EA, 2013, NEUROSURGERY, V72, DOI DOI 10.1227/01.NEU; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; Schlamann M, 2010, ACAD RADIOL, V17, P3, DOI 10.1016/j.acra.2009.10.001; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Tatsumi S, 2008, AJNR Am J Neuroradiol, V29, pe13, DOI 10.3174/ajnr.A0908; Theysohn JM, 2011, J MAGN RESON IMAGING, V33, P782, DOI 10.1002/jmri.22513; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vernooij MW, 2009, ARCH NEUROL-CHICAGO, V66, P714, DOI 10.1001/archneurol.2009.42; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wargo CJ, 2013, MAGN RESON IMAGING, V31, P810, DOI 10.1016/j.mri.2013.01.013; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107	47	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122329	10.1371/journal.pone.0122329			14	Multidisciplinary Sciences	Science & Technology - Other Topics	CE8HY	WOS:000352083900177	25793614	DOAJ Gold, Green Published			2021-06-18	
J	Jaja, BNR; Lingsma, H; Schweizer, TA; Thorpe, KE; Steyerberg, EW; Macdonald, RL				Jaja, Blessing N. R.; Lingsma, Hester; Schweizer, Tom A.; Thorpe, Kevin E.; Steyerberg, Ewout W.; Macdonald, R. Loch		SAHIT Collaboration	Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; prognostic factors; hypertension; neurological status; meta-analysis; outcomes; vascular disorders	TRAUMATIC BRAIN-INJURY; INTRACRANIAL ANEURYSMS; RISK-FACTORS; CEREBRAL INFARCTION; GRADING SCALES; CASE-FATALITY; PREDICTION; IMPACT; MANAGEMENT; SURVIVAL	OBJECT The literature has conflicting reports about the prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to investigate the prognostic value of premorbid hypertension and neurological status in the SAH International Trialists repository. METHODS Patient-level meta-analyses were conducted to investigate univariate associations between premorbid hypertension (6 studies; n = 7249), admission neurological status measured on the World Federation of Neurosurgical Societies (WFNS) scale (10 studies; n = 10,869), and 3-month Glasgow Outcome Scale (GOS) score. Multivariable analyses were performed to sequentially adjust for the effects of age, CT clot burden, aneurysm location, aneurysm size, and modality of aneurysm repair. Prognostic associations were estimated across the ordered categories of the GOS using proportional odds models. Nagelkerke's R-2 statistic was used to quantify the added prognostic value of hypertension and neurological status beyond those of the adjustment factors. RESULTS Premorbid hypertension was independently associated with poor outcome, with an unadjusted pooled odds ratio (OR) of 1.73 (95% confidence interval [Cl] 1.50-2.00) and an adjusted OR of 1.38 (95% 01 1.25-1.53). Patients with a premorbid history of hypertension had higher rates of cardiovascular and renal comorbidities, poorer neurological status (p <= 0.001), and higher odds of neurological complications including cerebral infarctions, hydrocephalus, rebleeding, and delayed ischemic neurological deficits. Worsening neurological status was strongly independently associated with poor outcome, including WFNS Grades II (OR 1.85, 95% 01 1.68-2.03), III (OR 3.85, 95% Cl 3.32-4.47), IV (OR 5.58, 95% Cl 4.91-6.35), and V (OR 14.18, 95% CI 12.20-16.49). Neurological status had substantial added predictive value greater than the combined value of other prognostic factors (R-2 increase > 10%), while the added predictive value of hypertension was marginal (R-2 increase < 0.5%). CONCLUSIONS This study confirmed the strong prognostic effect of neurological status as measured on the WFNS scale and the independent but weak prognostic effect of premorbid hypertension. The effect of premorbid hypertension could involve multifactorial mechanisms, including an increase in the severity of initial bleeding, the fate of comorbid events, and neurological complications.	[Jaja, Blessing N. R.; Schweizer, Tom A.; Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Jaja, Blessing N. R.; Schweizer, Tom A.; Thorpe, Kevin E.; Macdonald, R. Loch] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Jaja, Blessing N. R.; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Inst Med Sci, Toronto, ON M5B 1W8, Canada; [Thorpe, Kevin E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Lingsma, Hester; Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Macdonald, RL (corresponding author), Univ Toronto, Dept Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca		hasan, david/0000-0002-8335-5442; Thorpe, Kevin/0000-0002-7586-3893; Noble, Adam/0000-0002-8070-4352; Singh, Jeffrey/0000-0003-3499-574X	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario; Physicians Services Incorporated Foundation; Brain Aneurysm Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by a grant from the Canadian Institutes for Health Research, a Personnel Award from the Heart and Stroke Foundation of Canada, and an Early Researcher Award from the Ontario Ministry of Research and Innovation to Dr. Schweizer. Dr. Macdonald receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Canada; and is Chief Scientific Officer of Edge Therapeutics, Inc., for which he has direct stock ownership. The remaining authors have no conflicts of interest to declare.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Caranci F, 2013, EUR J RADIOL, V82, P1598, DOI 10.1016/j.ejrad.2012.12.026; Chiang VLS, 2000, NEUROSURGERY, V46, P28; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; De Marchis GM, 2014, J NEUROL NEUROSUR PS, V85, P56, DOI 10.1136/jnnp-2013-305051; Degen LAR, 2011, STROKE, V42, P1546, DOI 10.1161/STROKEAHA.110.601211; Eskesen V, 1987, Br J Neurosurg, V1, P455, DOI 10.3109/02688698708999636; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Germanson TP, 1998, SURG NEUROL, V49, P155, DOI 10.1016/S0090-3019(97)00337-6; Giraldo EA, 2012, J NEUROSURG, V117, P15, DOI 10.3171/2012.3.JNS11706; Heinze G, 2003, COMPUT METH PROG BIO, V71, P155, DOI 10.1016/S0169-2607(02)00077-9; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Jaja BNR, 2014, NEUROCRIT CARE, V21, P551, DOI 10.1007/s12028-014-9990-y; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Julien JS, 2008, NEUROSURGERY, V63, P204, DOI 10.1227/01.NEU.0000316857.80632.9A; Juvela S, 2005, J NEUROSURG, V102, P998, DOI 10.3171/jns.2005.102.6.0998; Juvela S, 2003, STROKE, V34, P1852, DOI 10.1161/01.STR.0000080380.56799.DD; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KELLER AZ, 1970, AM J EPIDEMIOL, V91, P139, DOI 10.1093/oxfordjournals.aje.a121121; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Mitchell P, 2006, SURG NEUROL, V66, P574, DOI 10.1016/j.surneu.2006.06.063; Mocco J, 2006, NEUROSURGERY, V59, P529, DOI 10.1227/01.NEU.0000228680.22550.A2; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Pobereskin LH, 2001, J NEUROSURG, V95, P555, DOI 10.3171/jns.2001.95.4.0555; Pobereskin LH, 2001, J NEUROL NEUROSUR PS, V70, P340, DOI 10.1136/jnnp.70.3.340; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Rosen DS, 2004, NEUROSURGERY, V54, P566, DOI 10.1227/01.NEU.0000108862.32404.A5; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Sadasivan C, 2013, ANN BIOMED ENG, V41, P1347, DOI 10.1007/s10439-013-0800-z; Schemper M, 2003, STAT MED, V22, P2299, DOI 10.1002/sim.1486; Starke RM, 2009, J CLIN NEUROSCI, V16, P894, DOI 10.1016/j.jocn.2008.10.010; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Toftdahl D B, 1997, Ugeskr Laeger, V159, P1434; van den Bergh WM, 2006, ACTA NEUROCHIR, V148, P1065, DOI 10.1007/s00701-006-0863-9; van Heuven AW, 2008, STROKE, V39, P1347, DOI 10.1161/STROKEAHA.107.498345; Wostrack M, 2013, ACTA NEUROCHIR, V155, P579, DOI 10.1007/s00701-013-1634-z	43	29	30	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					644	652		10.3171/2014.10.JNS132694			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600023	25554825	Bronze			2021-06-18	
J	Kutcher, ME; Howard, BM; Sperry, JL; Hubbard, AE; Decker, AL; Cuschieri, J; Minei, JP; Moore, EE; Brownstein, BH; Maier, RV; Cohen, MJ				Kutcher, Matthew E.; Howard, Benjamin M.; Sperry, Jason L.; Hubbard, Alan E.; Decker, Anna L.; Cuschieri, Joseph; Minei, Joseph P.; Moore, Ernest E.; Brownstein, Bernard H.; Maier, Ronald V.; Cohen, Mitchell Jay			Evolving beyond the vicious triad: Differential mediation of traumatic coagulopathy by injury, shock, and resuscitation	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Coagulopathy; acute traumatic coagulopathy; vicious triad	STANDARD OPERATING PROCEDURES; DAMAGE CONTROL RESUSCITATION; SCALE COLLABORATIVE PROJECT; PROTEIN-C; INCREASED MORTALITY; CLINICAL CARE; HOST RESPONSE; ORGAN FAILURE; BRAIN-INJURY; COAGULATION	BACKGROUND: A subset of trauma patients with critical injury present with coagulopathy, portending markedly worse outcomes. Clinical practice is evolving to treat the classical risk factors of hypothermia, hemodilution, and acidosis; however, coagulopathy persists even in the absence of these factors. We sought to determine the relative importance of injury- and shock-specific factors compared with resuscitation-associated factors in coagulopathy after trauma. METHODS: Comprehensive demographic data, laboratory data, and outcomes data were prospectively collected from seven trauma centers over 8 years (November 2003 to August 2011) as part of the Inflammation and the Host Response to Injury Large-Scale Collaborative Program. A total of 1,537 critically injured patients with blunt trauma and hemorrhagic shock were analyzed to evaluate predictors of admission coagulopathy (international normalized ratio [INR] >= 1.3), multiorgan failure, and mortality. RESULTS: Of 1,537 patients, 578 (37.6%) had admission INR of 1.3 or greater. Coagulopathic patients had more severe injury, more severe base deficit and lactate levels, as well as lower admission temperature, lower pH, and higher prehospital crystalloid volume (all p < 0.001). Coagulopathic patients required more blood products and mechanical ventilation and had higher rates of nosocomial infection, multiorgan failure, and mortality (all p < 0.02). Injury severity, temperature, and acidosis (all p < 0.02) independently predicted coagulopathy in multivariate analysis, with a significant interaction between lactate and prehospital crystalloid. In Cox regression models, however, coagulopathy itself remained an independent predictor of both multiorgan failure and mortality (p < 0.02) even when adjusted for injury severity, shock, and elements of the vicious triad. CONCLUSION: Most patients with coagulopathy after trauma have mixed risk factors; however, coagulopathy has deleterious effects independent of injury severity, shock, and the vicious triad. Better understanding of the biochemical mechanisms of acute traumatic coagulopathy may facilitate biochemically targeted resuscitation strategies and improve outcomes. (Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Kutcher, Matthew E.; Howard, Benjamin M.; Cohen, Mitchell Jay] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Kutcher, Matthew E.; Howard, Benjamin M.; Cohen, Mitchell Jay] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Hubbard, Alan E.; Decker, Anna L.] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA; [Hubbard, Alan E.; Decker, Anna L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sperry, Jason L.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Sperry, Jason L.] Presbyterian Univ Hosp, Pittsburgh, PA 15213 USA; [Cuschieri, Joseph; Maier, Ronald V.] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA; [Cuschieri, Joseph; Maier, Ronald V.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Minei, Joseph P.] Parkland Hlth & Hosp Syst, Dallas, TX USA; [Moore, Ernest E.] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Denver, CO USA; [Brownstein, Bernard H.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Cohen, MJ (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave,Room 3C-38, San Francisco, CA 94110 USA.	mcohen@sfghsurg.ucsf.edu		Kutcher, Matthew/0000-0003-4566-5359	Inflammation and the Host Response to Injury Large-Scale Collaborative Research Grant from the National Institute of General Medical Sciences [2-U54-GM062119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM062119] Funding Source: NIH RePORTER	This study was supported by the Inflammation and the Host Response to Injury Large-Scale Collaborative Research Grant from the National Institute of General Medical Sciences, 2-U54-GM062119.	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; Biffl WL, 2001, ANN SURG, V233, P843, DOI 10.1097/00000658-200106000-00015; Brandt C A, 2003, AMIA Annu Symp Proc, P794; Brazil EV, 2000, J ROY SOC MED, V93, P507, DOI 10.1177/014107680009301003; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown JB, 2013, J TRAUMA ACUTE CARE, V74, P1207, DOI 10.1097/TA.0b013e31828c44fd; Coats TJ, 2006, EMERG MED J, V23, P546, DOI 10.1136/emj.2005.032334; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Duchesne JC, 2010, J TRAUMA, V69, P46, DOI 10.1097/TA.0b013e3181df91fa; Duchesne JC, 2009, BRIT J HOSP MED, V70, P22, DOI 10.12968/hmed.2009.70.1.37690; Evans HL, 2009, J TRAUMA, V67, P384, DOI 10.1097/TA.0b013e3181ad66a7; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hirshberg A, 2003, J TRAUMA, V54, P454, DOI 10.1097/01.TA.0000053245.08642.1F; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Hook EB, 1997, AM J EPIDEMIOL, V145, P1138; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; KASHUK JL, 1982, J TRAUMA, V22, P672, DOI 10.1097/00005373-198208000-00004; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; Moore EE, 2014, SHOCK, V41, P35, DOI 10.1097/SHK.0000000000000110; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; STONE HH, 1983, ANN SURG, V197, P532, DOI 10.1097/00000658-198305000-00005; Subramanian J, 2011, STAT MED, V30, P642, DOI 10.1002/sim.4106; Trentzsch H, 2012, SHOCK, V37, P131, DOI 10.1097/SHK.0b013e318245f6b2; West MA, 2006, J TRAUMA, V61, P436, DOI 10.1097/01.ta.0000232517.83039.c4; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; WILSON RF, 1987, AM SURGEON, V53, P410; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC	45	29	33	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2015	78	3					516	523		10.1097/TA.0000000000000545			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CE8DQ	WOS:000352072000016	25710421				2021-06-18	
J	Sebastiano, DR; Panzica, F; Visani, E; Rotondi, F; Scaioli, V; Leonardi, M; Sattin, D; D'Incerti, L; Parati, E; Strambi, LF; Franceschetti, S				Sebastiano, Davide Rossi; Panzica, F.; Visani, E.; Rotondi, F.; Scaioli, V.; Leonardi, M.; Sattin, D.; D'Incerti, L.; Parati, E.; Strambi, Luigi Ferini; Franceschetti, S.			Significance of multiple neurophysiological measures in patients with chronic disorders of consciousness	CLINICAL NEUROPHYSIOLOGY			English	Article						Disorders of consciousness; Evoked potentials; EEG; Relative power; Sleep score; Cluster analysis	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; EVOKED-POTENTIALS; PROGNOSTIC VALUE; WAKEFULNESS SYNDROME; POSTTRAUMATIC COMA; CRS-R; EEG; SLEEP; RECOVERY	Objective: The aim of this study was to verify the value of multiple neurophysiological tests in classifying disorders of consciousness (DOCs) in patients in a chronic vegetative or minimal consciousness state categorised on the basis of the Coma Recovery Scale (CRS). Methods: The study included 142 patients, all of whom underwent long (18 h) EEG-polygraphic recordings including one night. The EEG was scored using the Synek scale and sleep patterns using an arbitrary scale. Absolute total power and relative EEG power were evaluated in different frequency bands. Multimodal evoked potentials (EPs), including auditory event-related potentials, were also evaluated and scored. Results: The most information came from the combined multimodal EPs and sleep EEG scores. A two-step cluster analysis based on the collected information allowed a satisfactory evaluation of DOC severity. Spectral EEG properties seemed to be significantly related to DOC classes and CRS scores, but did not seem to make any significant additional contribution to DOC classification. Conclusions: Multiple electrophysiological evaluations based on EEG, sleep polygraphic recordings and multimodal EPs are helpful in assessing DOC severity and residual functioning in patients with chronic DOCs. Significance: Simple electrophysiological measures that can be easily applied at patients' bedsides can significantly contribute to the recognition of DOC severity in chronic patients surviving a severe brain injury. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Sebastiano, Davide Rossi; Panzica, F.; Visani, E.; Rotondi, F.; Scaioli, V.; Franceschetti, S.] C Besta Fdn Neurol Inst, Dept Neurophysiol, Epilepsy Ctr, I-20133 Milan, Italy; [Leonardi, M.; Sattin, D.] C Besta Fdn Neurol Inst, Disabil Unit, Neurol Unit, I-20133 Milan, Italy; [D'Incerti, L.] C Besta Fdn Neurol Inst, Dept Neuroradiol, I-20133 Milan, Italy; [Parati, E.] C Besta Fdn Neurol Inst, Dept Cerebrovasc Dis, I-20133 Milan, Italy; [Strambi, Luigi Ferini] Univ Vita Salute San Raffaele, Sleep Disorders Ctr, Milan, Italy; [Rotondi, F.] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy	Franceschetti, S (corresponding author), C Besta Fdn Neurol Inst, Via Celoria 11, I-20133 Milan, Italy.	franceschetti@istituto-besta.it	Franceschetti, Silvana/K-3438-2016; Krutofal, Alina/AAD-6768-2019; Sattin, Davide/AAX-4083-2020; Panzica, Ferruccio/K-6711-2016; Sattin, Davide/K-5963-2016; STRAMBI, Luigi FERINI/K-3620-2018; Parati, Eugenio Agostino/AAN-5893-2021; leonardi, matilde/J-9997-2018; Sebastiano, Davide Rossi/G-8541-2016; Visani, Elisa/J-2331-2016	Franceschetti, Silvana/0000-0002-1921-6755; Sattin, Davide/0000-0001-7736-4337; Panzica, Ferruccio/0000-0002-0105-943X; Sattin, Davide/0000-0001-7736-4337; STRAMBI, Luigi FERINI/0000-0003-2867-5424; Parati, Eugenio Agostino/0000-0001-5020-6523; leonardi, matilde/0000-0003-0552-8923; Sebastiano, Davide Rossi/0000-0003-3698-8615; Visani, Elisa/0000-0002-1399-2630; D'Incerti, Ludovico/0000-0002-4092-9290	healthcare grant from Regione Lombardia [IX/000407-05/08/2010]	None of the authors have any potential conflicts of interest to disclose. The start-up Coma Research Centre (CRC) project was funded by a healthcare grant (No. IX/000407-05/08/2010) from Regione Lombardia.	Babiloni C, 2006, CEREB CORTEX, V16, P37, DOI 10.1093/cercor/bhi082; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; BERGAMASCO B, 1968, ELECTROEN CLIN NEURO, V25, P87; Boccagni C, 2011, J CLIN NEUROPHYSIOL, V28, P489, DOI 10.1097/WNP.0b013e318231c8c8; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; de Biase S, 2014, SLEEP MED, V15, P393, DOI 10.1016/j.sleep.2013.09.026; De Salvo S, 2012, FUNCT NEUROL, V27, P155; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Fingelkurts Alexander A, 2013, Suppl Clin Neurophysiol, V62, P81; Fingelkurts AA, 2012, CONSCIOUS COGN, V21, P149, DOI 10.1016/j.concog.2011.10.004; Fingelkurts AA, 2013, NEUROREHAB NEURAL RE, V27, P345, DOI 10.1177/1545968312469836; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Guerit J M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P117; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 2010, CURR OPIN CRIT CARE, V16, P98, DOI 10.1097/MCC.0b013e328337541a; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Kaplan PW, 2006, SEMIN NEUROL, V26, P403, DOI 10.1055/s-2006-948321; Koenig MA, 2013, SEMIN NEUROL, V33, P121, DOI 10.1055/s-0033-1348962; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kulkarni VP, 2007, J CLIN NEUROPHYSIOL, V24, P433, DOI 10.1097/WNP.0b013e31815c2810; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Lombardi F, 2007, FUNCT NEUROL, V22, P47; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Malinowska U, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-109; Morlet D, 2013, BRAIN TOPOGR; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SYNEK VM, 1988, CLIN ELECTROENCEPHAL, V19, P160, DOI 10.1177/155005948801900310; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Varotto G, 2014, CLIN NEUROPHYSIOL, V125, P63, DOI 10.1016/j.clinph.2013.06.016; Xu WW, 2012, J TRAUMA ACUTE CARE, V72, P1024, DOI 10.1097/TA.0b013e31824475cc	44	29	29	1	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2015	126	3					558	564		10.1016/j.clinph.2014.07.004			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB4RX	WOS:000349616700019	25082091				2021-06-18	
J	Skopin, MD; Kabadi, SV; Viechweg, SS; Mong, JA; Faden, AI				Skopin, Mark D.; Kabadi, Shruti V.; Viechweg, Shaun S.; Mong, Jessica A.; Faden, Alan I.			Chronic Decrease in Wakefulness and Disruption of Sleep-Wake Behavior after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; lateral fluid percussion; sleep-wake disturbances; orexin; electroencephalography	LIMITS MICROGLIAL ACTIVATION; DAYTIME SLEEPINESS; OREXIN; DISTURBANCES; PATTERNS; IMPACT; MEMORY; MODEL; RATS; MICE	Traumatic brain injury (TBI) can cause sleep-wake disturbances and excessive daytime sleepiness. The pathobiology of sleep disorders in TBI, however, is not well understood, and animal models have been underused in studying such changes and potential underlying mechanisms. We used the rat lateral fluid percussion (LFP) model to analyze sleep-wake patterns as a function of time after injury. Rapid-eye movement (REM) sleep, non-REM (NREM) sleep, and wake bouts during light and dark phases were measured with electroencephalography and electromyography at an early as well as chronic time points after LFP. Moderate TBI caused disturbances in the ability to maintain consolidated wake bouts during the active phase and chronic loss of wakefulness. Further, TBI resulted in cognitive impairments and depressive-like symptoms, and reduced the number of orexin-A-positive neurons in the lateral hypothalamus.	[Skopin, Mark D.; Kabadi, Shruti V.; Viechweg, Shaun S.; Mong, Jessica A.; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA	Faden, AI (corresponding author), Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Organized Res, 20 Penn St Suite 247,Hlth Sci Facil HSF 2, Baltimore, MD 21201 USA.	afaden@anes.umm.edu		Faden, Alan I./0000-0003-0128-2348	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 T32 GM 75767-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075767] Funding Source: NIH RePORTER	We thank Michael Makley, Adam Puche, and Cecilia Diniz Behn for their help with the sleep-wake analysis and the National Institutes of Health (5 T32 GM 75767-5) for their support.	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Fujiki Nobuhiro, 2007, CNS & Neurological Disorders-Drug Targets, V6, P45, DOI 10.2174/187152707779940781; Gerashchenko D, 2003, NEUROSCIENCE, V116, P223, DOI 10.1016/S0306-4522(02)00575-4; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Marr AL., 2004, CENTRAL NERVOUS SYST; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mihara Y, 2011, J MOL NEUROSCI, V43, P162, DOI 10.1007/s12031-010-9438-6; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Wiseman-Hakes C, 2011, BRAIN INJURY, V25, P1256, DOI 10.3109/02699052.2011.608215; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	45	29	31	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					289	296		10.1089/neu.2014.3664			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700001	25242371	Green Published			2021-06-18	
J	Su, CY; Wuang, YP; Lin, YH; Su, JH				Su, Chwen-Yng; Wuang, Yee-Pay; Lin, Yueh-Hsien; Su, Jui-Hsing			The Role of Processing Speed in Post-Stroke Cognitive Dysfunction	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Stroke; Processing speed; Cognitive impairment	MINI-MENTAL-STATE; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; SUBARACHNOID HEMORRHAGE; NEUROPSYCHOLOGICAL PROFILES; CLINICAL DETERMINANTS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; AGE-DIFFERENCES	The association between speed of information processing and cognition has been extensively validated in normal aging and other neurocognitive disorders. Our aim was to determine whether such a relationship exists in stroke. Thirty patients and 30 age-and education-matched healthy individuals were administered a comprehensive battery of neuropsychological tests divided into the following six cognitive domains: processing speed (PS), verbal memory, visual memory, visuoperceptual function, language, and cognitive flexibility. The results demonstrate that stroke patients were characterized by cognitive deficits in almost all of these domains, but have the most pronounced deficits in PS. After adjusting for symbol digit modalities test score, all significant group differences in cognitive functioning disappeared. However, group differences remained significant after controlling for the influence of other cognitive factors. These findings suggest that decreased PS appears to underlie post-stroke cognitive dysfunction and may serve as a potential target for intervention.	[Su, Chwen-Yng; Wuang, Yee-Pay] Kaohsiung Med Univ, Coll Hlth Sci, Dept Occupat Therapy, Kaohsiung, Taiwan; [Lin, Yueh-Hsien] Natl Taiwan Normal Univ, Special Educ Ctr, Taipei, Taiwan; [Su, Jui-Hsing] Kaohsiung Municipal Hsiaokang Hosp, Dept Rehabil Med, Kaohsiung 812, Taiwan	Su, JH (corresponding author), Kaohsiung Municipal Hsiaokang Hosp, Dept Rehabil Med, 482 Shanming Rd, Kaohsiung 812, Taiwan.	cysu@cc.kmu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 97-2314-B-037-046-MY3]	This study was supported by the National Science Council of Taiwan under grant NSC 97-2314-B-037-046-MY3.	Allan LM, 2011, BRAIN, V134, P3713, DOI 10.1093/brain/awr273; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Apostolova LG, 2006, ALZ DIS ASSOC DIS, V20, P224, DOI 10.1097/01.wad.0000213857.89613.10; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Barker-Collo S, 2013, INT J STROKE, V8, pE14, DOI 10.1111/j.1747-4949.2012.00959.x; Barker-Collo S, 2012, STROKE, V43, P50, DOI 10.1161/STROKEAHA.111.627182; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Brand C, 2014, BRIT J NEUROSURG, V28, P68, DOI 10.3109/02688697.2013.815314; Bronnick K, 2010, COGNITIVE IMPAIRMENT, P27; Bugg JM, 2006, BRAIN COGNITION, V62, P9, DOI 10.1016/j.bandc.2006.02.006; Butters MA, 2004, ARCH GEN PSYCHIAT, V61, P587, DOI 10.1001/archpsyc.61.6.587; Cepeda NJ, 2013, DEVELOPMENTAL SCI, V16, P269, DOI 10.1111/desc.12024; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P263, DOI 10.1001/archneur.1985.04060030081013; Diamond BJ, 2008, ARCH CLIN NEUROPSYCH, V23, P189, DOI 10.1016/j.acn.2007.10.002; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Elgamal SA, 2011, CAN GERIATR J, V14, P66, DOI 10.5770/cgj.v14i3.17; Ferrer E, 2013, DEVELOPMENTAL SCI, V16, P941, DOI 10.1111/desc.12088; Fjell AM, 2009, DEMENT GERIATR COGN, V28, P252, DOI 10.1159/000241878; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerritsen MJJ, 2003, J CLIN EXP NEUROPSYC, V25, P1, DOI 10.1076/jcen.25.1.1.13622; Gillespie DC, 2006, CLIN NEUROPSYCHOL, V20, P59, DOI 10.1080/13854040500203308; Gold J. M., 2007, INFORM PROCESSING SP, P125; GOLDEN CJ, 1985, MANUAL LURIA NEBRASK; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gottesman RF, 2010, LANCET NEUROL, V9, P895, DOI 10.1016/S1474-4422(10)70164-2; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Hannay HJ, 2004, NEUROPSYCHOLOGICAL A; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; Hurford R, 2013, J NEUROL, V260, P237, DOI 10.1007/s00415-012-6625-0; Jaillard A, 2010, CEREBROVASC DIS, V29, P415, DOI 10.1159/000289344; Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kaplan E., 2001, Boston naming test; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Knowles EEM, 2010, SCHIZOPHR RES, V117, P324, DOI 10.1016/j.schres.2010.02.552; Kongs SK, 2000, WISCONSIN CARD SORTI; Lee T, 2012, NEUROPSYCHOLOGY, V26, P776, DOI 10.1037/a0030053; Leeson VC, 2010, SCHIZOPHRENIA BULL, V36, P400, DOI 10.1093/schbul/sbn100; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lovell M. R., 1997, HDB NEUROPSYCHOLOGY; Lyden PD, 2001, STROKE, V32, P1310, DOI 10.1161/01.STR.32.6.1310; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Mantyla R, 1999, STROKE, V30, P2053, DOI 10.1161/01.STR.30.10.2053; Rodriguez-Sanchez JM, 2007, BRIT J PSYCHIAT, V191, pS107, DOI 10.1192/bjp.191.51.s107; McGrath LM, 2011, J CHILD PSYCHOL PSYC, V52, P547, DOI 10.1111/j.1469-7610.2010.02346.x; McKinlay A, 2009, EUR J COGN PSYCHOL, V21, P330, DOI 10.1080/09541440802281266; Meyers J., 1995, REY COMPLEX FIGURE T; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; Moroney JT, 1997, NEUROLOGY, V48, P1317, DOI 10.1212/WNL.48.5.1317; Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671; NINDS Common Data Elements, MULTIPLE SCLEROSIS; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Rao S. M., 2014, MULT SCLER INT, V2014, DOI [10.1155/2014/975803, DOI 10.1155/2014/975803]; Rasquin S, 2005, CEREBROVASC DIS, V19, P309, DOI 10.1159/000084499; Ravnik J, 2006, CROAT MED J, V47, P253; Reed BR, 2007, BRAIN, V130, P731, DOI 10.1093/brain/awl385; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; SWIRSKYSACCHETTI T, 1992, J CLIN PSYCHOL, V48, P779, DOI 10.1002/1097-4679(199211)48:6<779::AID-JCLP2270480612>3.0.CO;2-B; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; van der Ham IJM, 2011, NEUROPSYCHOLOGIA, V49, P999, DOI 10.1016/j.neuropsychologia.2011.02.024; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; VERNON PA, 1986, INTELLIGENCE, V10, P315, DOI 10.1016/0160-2896(86)90002-4; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; *WEST PSYCH SERV, 1983, HOOP VIS ORG TEST VO; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Winkens I, 2006, CLIN REHABIL, V20, P827, DOI 10.1177/0269215506070813; Zhu YC, 2012, J NEUROL, V259, P530, DOI 10.1007/s00415-011-6218-3; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	84	29	29	0	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2015	30	2					148	160		10.1093/arclin/acu057			13	Psychology, Clinical; Psychology	Psychology	CF0JP	WOS:000352230000007	25618135	Bronze			2021-06-18	
J	Yang, ST; Hsiao, IT; Hsieh, CJ; Chiang, YH; Yen, TC; Chiu, WT; Lin, KJ; Hu, CJ				Yang, Shun-Tai; Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Chiang, Yung-Hsiao; Yen, Tzu-Chen; Chiu, Wen-Ta; Lin, Kun-Ju; Hu, Chaur-Jong			Accumulation of amyloid in cognitive impairment after mild traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Mild traumatic brain injury; Amyloid PET; Alzheimer disease; Cognitive impairment; Genetics; Neurodegenerative diseases	APOLIPOPROTEIN-E GENOTYPE; ALZHEIMERS-DISEASE; BETA DEPOSITION; HEAD TRAUMA; ASSOCIATION; POPULATION; RISK; PRESENILIN-1; TAUOPATHY; TAIWAN	Recent epidemiology studies have indicated that traumatic brain injury (TBI) can increase the risk of developing neurodegenerative diseases such as Alzheimer's disease (AD). Amyloid-beta (A beta) plaques and neurofibrillary tangles are pathological indicators of AD. The accumulation of A beta is considered the first step of AD pathophysiology. Compelling studies have supported the hypothesis that TBI accelerates the formation and accumulation of A beta. These findings could link TBI with AD, although the research that reported these findings had limitations, particularly regarding mild TBI (mTBI) patients. The effects of mTBI on A beta accumulation remain uncertain because of a lack of mTBI pathology data. Using amyloid-positron emission tomography (amyloid-PET), researchers can help to determine whether mTBI increases the accumulation of A beta, which might be involved in the pathophysiological mechanisms of mTBI in AD, and could be a target for the treatment of neurodegenerative diseases associated with TBI. In this study, we recruited 27 mTBI patients with mTBI in mean 6 years before this study (21 mTBI patients without cognitive impairment, 6 mTBI patients with cognitive impairment,) and 10 controls. All of them underwent mini-mental state examination, apolipoprotein E (APOE) genotyping, and amyloid-PET. The results show an increase of amyloid accumulation and allele frequency of APOE4 in the mTBI patients with cognitive impairment. These findings indicate that amyloid accumulation is an important indicator of cognitive impairment, and amyloid-PET should be a safe and useful tool for diagnosing amyloid-related cognitive impairment. APOE allele might play a role in the occurrence of cognitive impairment after mTBL The contribution of mTBI to the amyloid accumulation requires further study, and mTBI patients should be recruited for longitudinal research with repeated amyloid-PET studies. (C) 2014 Elsevier B.V. All rights reserved.	[Yang, Shun-Tai; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taipei, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Univ, Healthy Aging Res Ctr, Taoyuan, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Mem Hosp, Dept Nucl Med, Taipei, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Mem Hosp, Mol Imaging Ctr, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei Med Univ Hosp, Dept Neurosur,Program Neural Regenerat Med, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Hu, Chaur-Jong] Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan	Lin, KJ (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Taipei, Taiwan.	lin4857@cgmh.org.tw; chaurjongh@tmu.edu.tw	Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564; Hsiao, Ing-Tsung/0000-0002-5255-7498	Ministry of Science and Technology, Taiwan, ROCMinistry of Science and Technology, Taiwan [NSC 100-2314-B-182A-091-MY3]; Ministry of Health and Welfare, Taiwan, ROC [DOH101-TD-PB-111-NSC017]	This study was supported by Ministry of Science and Technology, Taiwan, ROC, NSC 100-2314-B-182A-091-MY3 (KJ Lin) and Ministry of Health and Welfare, Taiwan, ROC, DOH101-TD-PB-111-NSC017 (CJ Hu).	Basso A., 2006, NEUROL DISORD PUBLIC, P164; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Chiu WT, 2011, JAMA-J AM MED ASSOC, V306, P267, DOI 10.1001/jama.2011.989; Chuang YF, 2010, DEMENT GERIATR COGN, V29, P248, DOI 10.1159/000285166; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Galimberti D, 2011, CNS NEUROL DISORD-DR, V10, P163, DOI 10.2174/187152711794480438; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Hu CJ, 1998, J NEUROL SCI, V157, P158, DOI 10.1016/S0022-510X(98)00052-5; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Koivunen J, 2008, DEMENT GERIATR COGN, V26, P378, DOI 10.1159/000163927; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lin JW, 2008, ACT NEUR S, V101, P113; Lin KJ, 2010, NUCL MED BIOL, V37, P497, DOI 10.1016/j.nucmedbio.2010.02.003; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Takeda M, 2010, PSYCHIAT CLIN NEUROS, V64, P592, DOI 10.1111/j.1440-1819.2010.02148.x; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Yao CH, 2010, APPL RADIAT ISOTOPES, V68, P2293, DOI 10.1016/j.apradiso.2010.07.001; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	38	29	29	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	FEB 15	2015	349	1-2					99	104		10.1016/j.jns.2014.12.032			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CC6YZ	WOS:000350516200017	25586534				2021-06-18	
J	Rao, V; Koliatsos, V; Ahmed, F; Lyketsos, C; Kortte, K				Rao, Vani; Koliatsos, Vassilis; Ahmed, Faizi; Lyketsos, Constantine; Kortte, Kathleen			Neuropsychiatric Disturbances Associated with Traumatic Brain Injury: A Practical Approach to Evaluation and Management	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; neuropsychiatry; postconcussion; depression; posttraumatic stress disorder; chronic traumatic encephalopathy; anxiety; mood; mania; behavior; psychosis; apathy; sleep	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; DEPRESSION FOLLOWING MILD; II PSYCHIATRIC-DISORDERS; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; MAJOR DEPRESSION; RISK-FACTORS; AXIS-I; POSTCONCUSSIVE SYMPTOMS	Traumatic brain injury (TBI) causes a wide variety of neuropsychiatric disturbances associated with great functional impairments and low quality of life. These disturbances include disorders of mood, behavior, and cognition, and changes in personality. The diagnosis of specific neuropsychiatric disturbances can be difficult because there is significant symptom overlap. Systematic clinical evaluations are necessary to make the diagnosis and formulate a treatment plan that often requires a multipronged approach. Management of TBI-associated neuropsychiatric disorders should always include nonpharmacological interventions, including education, family involvement, supportive and behavioral psychotherapies, and cognitive rehabilitation. Pharmacological treatments include antidepressants, anticonvulsants, antipsychotics, dopaminergic agents, and cholinesterase inhibitors. However, evidence-based treatments are extremely limited, and management relies on clinical empiricism and resemblance of TBI neuropsychiatric symptom profiles with those of idiopathic psychiatric disorders. Although the understanding of TBI-associated neuropsychiatric disorders has improved in the last decade, further research is needed including prospective, longitudinal studies to explore biomarkers that will assist with management and prognosis as well as randomized-controlled studies to validate pharmacological and nonpharmacological treatments. The current review summarizes the available literature in support of a structured, systematic evaluation approach and treatment options as well as recommendations for further research directions.	[Rao, Vani; Koliatsos, Vassilis; Ahmed, Faizi; Lyketsos, Constantine] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21224 USA; [Koliatsos, Vassilis] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21224 USA; [Koliatsos, Vassilis] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neuropathol, Baltimore, MD 21224 USA; [Kortte, Kathleen] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Div Rehabil Psychol & Neuropsychol, Baltimore, MD USA	Rao, V (corresponding author), Johns Hopkins Univ, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr,4th Floor,Suite 425, Baltimore, MD 21224 USA.	vrao@jhmi.edu					American Psychiatric Association, 2013, DIAGN STAT UAL MENT; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; [Anonymous], 2010, RIM CARE COMPANION J; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bedard Michel, 2012, Adv Mind Body Med, V26, P14; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1046/j.1440-1614.2000.00758.x; CAMPBELL JJ, 1994, J NEUROPSYCH CLIN N, V6, P411; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; EPSTEIN NB, 1981, HDB FAMILY THERAPY, P444; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fann JR, 2014, J NEUROTRAUMA; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; GRAY BG, 1992, J NUCL MED, V33, P52; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Haskins EC, 2012, COGNITIVE REHABILITA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 2002, NEUROREHABILITATION, V17, P325; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koliatsos V. E., 2015, BRAIN NEUROTRAUMA MO; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kortte KB, 2004, REHABIL PSYCHOL, V49, P187, DOI 10.1037/0090-5550.49.3.187; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Meyer A, 2000, J NEUROPSYCH CLIN N, V12, P407, DOI 10.1176/appi.neuropsych.12.3.407; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Omalu BI, NEUROSURGERY, P1092; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Rao V, 2007, AM J PSYCHIAT, V164, P728, DOI 10.1176/appi.ajp.164.5.728; Rao V, 2006, EUR J PSYCHIAT, V20, P65, DOI 10.4321/s0213-61632006000200002; Rao V, 2013, PSYCHOSOMATICS, V54, P403, DOI 10.1016/j.psym.2013.01.001; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Shan RSLP, 2004, AM J PHYS MED REHAB, V83, P421, DOI 10.1097/00002060-200406000-00003; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Sigurdardottir S, 2014, J HEAD TRAUMA REHABI; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Takayanagi Y, 2013, J NEUROPSYCH CLIN N, V25, P292, DOI 10.1176/appi.neuropsych.12040093; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; van Reekum R, 2013, MANAGEMENT ADULTS TR, P283; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218	146	29	29	0	30	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					64	82		10.1055/s-0035-1544241			19	Clinical Neurology	Neurosciences & Neurology	CC4AP	WOS:000350293300010	25714869				2021-06-18	
J	Zaleski, A; Bogle, J; Starling, A; Zapala, DA; Davis, L; Wester, M; Cevette, M				Zaleski, Ashley; Bogle, Jamie; Starling, Amaal; Zapala, David A.; Davis, Laurie; Wester, Matthew; Cevette, Michael			Vestibular Evoked Myogenic Potentials in Patients With Vestibular Migraine	OTOLOGY & NEUROTOLOGY			English	Article						Migraine; Otolith; oVEMP; cVEMP	BONE-CONDUCTED VIBRATION; MENIERES-DISEASE; COLLIC REFLEX; FOLLOW-UP; VERTIGO; DIZZINESS; HEADACHE; RECOVERY; CLASSIFICATION; DISORDERS	Objective Literature investigating otolith reflexes in patients with vestibular migraine (VM) is variable and primarily describes the descending saccular pathway. This research aimed to study ocular vestibular evoked myogenic potential (oVEMP) and cervical vestibular evoked myogenic potential (cVEMP) prevalence and response characteristics in patients with suspected VM and in control patients. The purpose is to assess vulnerabilities within the ascending utricular and descending saccular pathways in the VM population. Study Design Retrospective study Setting Tertiary academic referral center Patients 39 adults with VM, 29 control patients Main Outcome Measure(s) Air conducted oVEMPs and cVEMPs measured with 500 Hz tone burst stimuli Results Age of headache onset was most often in childhood or adolescence, with dizziness onset occurring later. The rate of bilaterally absent oVEMPs was significantly higher (28%, p < 0.01) in the VM group compared with the control group (0%). oVEMP amplitude asymmetry ratios were significantly higher for the definite VM (p < 0.01) and probable VM (p = 0.023) groups than the control group. Eleven patients also had history of concussion; they were significantly more likely to demonstrate bilaterally absent oVEMPs (p < 0.01) in comparison to the control patients. When VM patients with a history of concussion were omitted from analysis, differences in oVEMP amplitude asymmetry (p < 0.01) and bilateral oVEMP absence remained significant (p = 0.015). There were no differences in the rate of bilateral cVEMP presence or response parameters between VM and control groups. Conclusion VEMP presentation differs for some patients diagnosed with VM. The higher rates of abnormal oVEMPs may suggest greater vulnerability within the ascending utricular-ocular pathway in patients with VM.	[Zaleski, Ashley; Bogle, Jamie; Davis, Laurie; Wester, Matthew; Cevette, Michael] Mayo Clin Arizona, Audiol Sect, Scottsdale, AZ USA; [Starling, Amaal] Mayo Clin Arizona, Neurol Sect, Scottsdale, AZ USA; [Zapala, David A.] Mayo Clin Florida, Audiol Sect, Jacksonville, FL USA	Bogle, J (corresponding author), Mayo Clin Scottsdale, Audiol Sect, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	bogle.jamie@mayo.edu					Allena M, 2007, CEPHALALGIA, V27, P1150, DOI 10.1111/j.1468-2982.2007.01414.x; Bahmad F, 2009, ANN OTO RHINOL LARYN, V118, P670, DOI 10.1177/000348940911800912; Baier B, 2009, J NEUROL, V256, P1447, DOI 10.1007/s00415-009-5132-4; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI 10.1586/ERN.11.19; Baloh RW, 1997, HEADACHE, V37, P615, DOI 10.1046/j.1526-4610.1997.3710615.x; BARABAS G, 1983, PEDIATRICS, V72, P188; Bergenius J, 1999, ACTA OTO-LARYNGOL, V119, P895; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Boldingh MI, 2011, CEPHALALGIA, P31; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Celebisoy N, 2008, CEPHALALGIA, V28, P72, DOI 10.1111/j.1468-2982.2007.01474.x; Cha YH, 2013, CEPHALALGIA, V33, P1160, DOI 10.1177/0333102413487999; Chihara Y, 2007, CLIN NEUROPHYSIOL, V118, P2745, DOI 10.1016/j.clinph.2007.08.005; Curthoys IS, 2012, ACTA OTORHINOLARYNGO, V32, P41; CUTRER FM, 1992, HEADACHE, V32, P300, DOI 10.1111/j.1526-4610.1992.hed3206300.x; Dieterich M, 1999, J NEUROL, V246, P883, DOI 10.1007/s004150050478; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-8; Furman JM, 2003, CURR OPIN NEUROL, V16, P5, DOI 10.1097/00019052-200302000-00002; Zuniga MG, 2012, OTOLARYNG HEAD NECK, V146, P788, DOI 10.1177/0194599811434073; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Hamel E, 2007, CEPHALALGIA, V27, P1295; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; Johnson GD, 1998, LARYNGOSCOPE, V108, P1, DOI 10.1097/00005537-199801001-00001; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; Kim HA, 2008, NEUROLOGY, V70, P449, DOI 10.1212/01.wnl.0000297554.21221.a0; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; KURITZKY A, 1981, HEADACHE, V21, P227, DOI 10.1111/j.1526-4610.1981.hed2105227.x; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lee H, 2002, NEUROL RES, V24, P663, DOI 10.1179/016164102101200726; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Manzari L, 2012, J LARYNGOL OTOL, V126, P683, DOI 10.1017/S0022215112000692; Marano E, 2005, HEADACHE, V45, P325, DOI 10.1111/j.1526-4610.2005.05069.x; Marcelli V, 2010, HEADACHE, V50, P71, DOI 10.1111/j.1526-4610.2009.01454.x; Murofushi T, 2009, CEPHALALGIA, V29, P1259, DOI 10.1111/j.1468-2982.2009.01860.x; Murofushi T, 1997, ACTA OTO-LARYNGOL, V117, P66, DOI 10.3109/00016489709117994; Neff BA, 2012, OTOL NEUROTOL, V33, P1235, DOI 10.1097/MAO.0b013e31825d644a; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Obermann M, 2012, NEUROLOGY, V78; Oh SY, 2015, CLIN NEUROPHYSIOL, V126, P180, DOI 10.1016/j.clinph.2014.03.030; Olesen J, 2005, REV NEUROL-FRANCE, V161, P689; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Piker EG, 2011, J AM ACAD AUDIOL, V22, P222, DOI 10.3766/jaaa.22.4.5; Polensek SH, 2010, AUDIOL NEURO-OTOL, V15, P241, DOI 10.1159/000255440; Radtke A, 2012, NEUROLOGY, V79, P1607, DOI 10.1212/WNL.0b013e31826e264f; Radtke A, 2011, CEPHALALGIA, V31, P906, DOI 10.1177/0333102411405228; Roceanu A, 2008, CEPHALALGIA, V28, P988, DOI 10.1111/j.1468-2982.2008.01641.x; Sharon JD, 2014, LARYNGOSCOPE, V124, P969, DOI 10.1002/lary.24285; Shin JE, 2013, ACTA OTO-LARYNGOL, V133, P154, DOI 10.3109/00016489.2012.727469; Taylor RL, 2012, CEPHALALGIA, V32, P213, DOI 10.1177/0333102411434166; Thakar A, 2001, J LARYNGOL OTOL, V115, P782; Vass Z, 2004, NEUROSCIENCE, V124, P919, DOI 10.1016/j.neuroscience.2003.12.030; von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351; Vukovic V, 2007, HEADACHE, V47, P1427, DOI 10.1111/j.1526-4610.2007.00939.x; Young YH, 2003, ARCH OTOLARYNGOL, V129, P815, DOI 10.1001/archotol.129.8.815; Zapala David A, 2004, J Am Acad Audiol, V15, P198, DOI 10.3766/jaaa.15.3.3	55	29	31	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	FEB	2015	36	2					295	302		10.1097/MAO.0000000000000665			8	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AZ8IQ	WOS:000348459300028	25415464				2021-06-18	
J	Hadanny, A; Golan, H; Fishlev, G; Bechor, Y; Volkov, O; Suzin, G; Ben-Jacob, E; Efrati, S				Hadanny, A.; Golan, H.; Fishlev, G.; Bechor, Y.; Volkov, O.; Suzin, G.; Ben-Jacob, E.; Efrati, S.			Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Anoxic brain damage; rehabilitation; cognitive symptoms; hyperbaric oxygen therapy; SPECT	CEREBRAL-PALSY; INJURY; THERAPY; CHILDREN; SEQUELAE; CORTEX; REHABILITATION; SURVIVORS	Purpose: Cognitive impairment may occur in 42-50% of cardiac arrest survivors. Hyperbaric oxygen therapy (HBO2) has recently been shown to have neurotherapeutic effects in patients suffering from chronic cognitive impairments (CCI) consequent to stroke and mild traumatic brain injury. The objective of this study was to assess the neurotherapeutic effect of HBO2 in patients suffering from CCI due to cardiac arrest. Methods: Retrospective analysis of patients with CCI caused by cardiac arrest, treated with 60 daily sessions of HBO2. Evaluation included objective computerized cognitive tests (NeuroTrax), Activity of Daily Living (ADL) and Quality of life questionnaires. The results of these tests were compared with changes in brain activity as assessed by single photon emission computed tomography (SPECT) brain imaging. Results: The study included 11 cases of CCI patients. Patients were treated with HBO2, 0.5-7.5 years (mean 2.6 +/- 0.6 years) after the cardiac arrest. HBO2 was found to induce modest, but statistically significant improvement in memory, attention and executive function (mean scores) of 12%, 20% and 24% respectively. The clinical improvements were found to be well correlated with increased brain activity in relevant brain areas as assessed by computerized analysis of the SPECT imaging. Conclusions: Although further research is needed, the results demonstrate the beneficial effects of HBO2 on CCI in patients after cardiac arrest, even months to years after the acute event.	[Hadanny, A.; Fishlev, G.; Bechor, Y.; Suzin, G.; Efrati, S.] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel; [Hadanny, A.; Golan, H.; Fishlev, G.; Volkov, O.; Efrati, S.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Golan, H.; Volkov, O.] Assaf Harofeh Med Ctr, Nucl Imaging Div, IL-70300 Zerifin, Israel; [Ben-Jacob, E.; Efrati, S.] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Ben-Jacob, E.; Efrati, S.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Ben-Jacob, E.] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Hadanny, A (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel.	Amir.had@gmail.com; efratishai@013.net	Golan, Haim/K-2831-2019		Assaf HaRofeh Medical Center research fund	The study was funded by the Assaf HaRofeh Medical Center research fund.	Achiron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071058; Allen BS, 2012, EUR J CARDIO-THORAC, V41, P1132, DOI 10.1093/ejcts/ezr315; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Barrett KF, 1998, NEUROLOGY, V50, pA178; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Doniger GA, 2006, BEHAV NEUROSCI, V120, P804, DOI 10.1037/0735-7044.120.4.804; Doniger GM, 2014, GUIDE NORMATIVE DATA; Donker SCV, 2001, SAMJ S AFR MED J, V91, P909; Donker SCV, 1999, S AFR MED J, V89, P360; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; FitzGerald A, 2010, BRAIN INJURY, V24, P1311, DOI 10.3109/02699052.2010.506864; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Guo MF, 2011, FOLIA NEUROPATHOL, V49, P79; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; Hopkins RO, 2012, NEUROREHABILITATION, V31, P319, DOI 10.3233/NRE-2012-0799; JACOBS EA, 1969, NEW ENGL J MED, V281, P753, DOI 10.1056/NEJM196910022811402; Jain K, 2009, TXB HYPERBARIC MED, VFifth; JASZCZAK RJ, 1979, PHYS MED BIOL, V24, P1123, DOI 10.1088/0031-9155/24/6/003; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Lim C, 2014, J REHABIL MED, V46, P691, DOI 10.2340/16501977-1816; Melton J.L., 2005, PSYCHOMETRIC EVALUAT; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Montgomery D, 1999, UNDERSEA HYPERBAR M, V26, P235; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Neubauer RA, 1998, NEUROL RES, V20, pS33; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rossignol Daniel A, 2007, BMC Pediatr, V7, P36, DOI 10.1186/1471-2431-7-36; Schweiger A., 2003, ACTA NEUROPSYCHOLOGI, V1, P407, DOI DOI 10.5604/17307503/9168; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Tapeantong Toungrat, 2009, Journal of the Medical Association of Thailand, V92, P1374; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; van Alem AP, 2004, AM HEART J, V148, P416, DOI 10.1016/j.ahj.2004.01.031; Zur D, 2015, J NEURO-OPHTHALMOL, V35, P26, DOI 10.1097/WNO.0000000000000199	47	29	34	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	4					471	486		10.3233/RNN-150517			16	Neurosciences	Neurosciences & Neurology	CQ1IP	WOS:000360350900006	26409406	Green Published			2021-06-18	
J	Moser, RS; Schatz, P; Glenn, M; Kollias, KE; Iverson, GL				Moser, Rosemarie Scolaro; Schatz, Philip; Glenn, Megan; Kollias, Kelly E.; Iverson, Grant L.			Examining prescribed rest as treatment for adolescents who are slow to recover from concussion	BRAIN INJURY			English	Article						Concussion; baseline testing; comprehensive rest; concussion management	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; INTERPRETING CHANGE; VOLUNTARY EXERCISE; FOOTBALL PLAYERS; CLINICAL-SAMPLES; TEMPORAL WINDOW; UP-REGULATION	Objective: Rest is a widely recommended treatment for concussion, but its utility is unclear following the acute stage of recovery. This study examined the effects of 1-week of prescribed rest in concussed adolescent athletes. Method: Participants were 13 adolescent athletes with persistent symptoms following a concussion. More than three-quarters (77%) had self-reported ADHD, learning disability or two prior concussions. All completed ImPACT (R) at another facility, but none completed a period of comprehensive rest prior to examination at a specialty practice. Three time points of test data were compared, to control for possible spontaneous recovery: Test 1 (external facility), Test 2 (before prescribed rest) and Test 3 (following prescribed rest). Results: Repeated measures ANOVAs revealed a significant effect of prescribed rest on all ImPACT (R) composite scores and the total symptom score. Post-hoc analyses revealed no significant differences between Time 1 and Time 2, whereas significant differences were present after prescribed rest. Following prescribed rest, having two or more reliably improved cognitive test scores or having improved symptoms was present in eight of the 13 patients (61.5%). Conclusions: A substantial percentage of adolescents with persistent symptoms following concussion showed improvement in symptoms and cognitive functioning following education, reassurance and 1-week of prescribed rest.	[Moser, Rosemarie Scolaro; Glenn, Megan; Kollias, Kelly E.] RSM Psychol Ctr LLC, Sports Concuss Ctr New Jersey, Lawrenceville, NJ USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Sport Concuss Clin, Boston, MA 02114 USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA	Moser, RS (corresponding author), Sports Concuss Ctr NJ, 3131 Princeton Pike,Bldg 5 Ste 110, Lawrenceville, NJ 08648 USA.	rmoser@sportsconcussionnj.com	Meijer, Anna/K-5118-2016	Iverson, Grant/0000-0001-7348-9570	ImPACT Applications, Inc.; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc.)	Data were collected at the Sports Concussion Center of New Jersey (SCCNJ). Dr Rosemarie Moser is the owner of SCCNJ and some of the authors are employees or consultants at the Center. There were no other study sponsors. In the past, Dr Moser has served as a consultant to the International Brain Research Foundation, ImPACT Applications, Inc. and Pearson. These organizations had no role in the conceptualization or content of the current manuscript or the decision to submit for publication. In addition, she receives royalties from a book on youth concussion and special journal issue on mild traumatic brain injury. Philip Schatz, PhD, is a consultant to the Sports Concussion Center of New Jersey. He has also served as a consultant to the International Brain Research Foundation and to ImPACT Applications, Inc. to study the effects of concussion in high school and collegiate athletes. However, the latter two entities had no role in the conceptualization or content of the current manuscript or the decision to submit for publication. Grant Iverson, PhD has been reimbursed by the government, professional scientific bodies and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including professional athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs and Psychological Assessment Resources (PAR, Inc.). He has not received research support from ImPACT Applications, Inc. in the past 3 years. He receives royalties from two books relating to neuropsychology and one test (WCST-64).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Iverson GL, BRAIN INJUR IN PRESS; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2004, BRIT J SPORT MED, V29, P196; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2013, AM J SPORTS MED, V39, P2325; Schatz P, 2009, ARCH CLIN NEUROPSYCH, V24, P502; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8	37	29	29	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					58	63		10.3109/02699052.2014.964771			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000008	25279423				2021-06-18	
J	Ryan, NP; Catroppa, C; Cooper, JM; Beare, R; Ditchfield, M; Coleman, L; Silk, T; Crossley, L; Rogers, K; Beauchamp, MH; Yeates, KO; Anderson, VA				Ryan, Nicholas P.; Catroppa, Cathy; Cooper, Janine M.; Beare, Richard; Ditchfield, Michael; Coleman, Lee; Silk, Timothy; Crossley, Louise; Rogers, Kirrily; Beauchamp, Miriam H.; Yeates, Keith O.; Anderson, Vicki A.			Relationships between acute imaging biomarkers and theory of mind impairment in post-acute pediatric traumatic brain injury: A prospective analysis using susceptibility weighted imaging (SWI)	NEUROPSYCHOLOGIA			English	Article						Child; Brain injuries; Magnetic resonance imaging; Theory of Mind; Neurobiology	DIFFUSE AXONAL INJURY; SOCIAL BRAIN; CLINICAL-APPLICATIONS; CHILDREN; DEFICITS; EMOTION; LESIONS; ADOLESCENTS; COMPETENCE; OUTCOMES	Theory of Mind (ToM) forms an integral component of socially skilled behavior, and is critical for attaining developmentally appropriate goals. The protracted development of ToM is mediated by increasing connectivity between regions of the anatomically distributed 'mentalizing network', and may be vulnerable to disruption from pediatric traumatic brain injury (TBI). The present study aimed to evaluate the post-acute effects of TBI on first-order ToM, and examine relations between ToM and both local and global indices of macrostructural damage detected using susceptibility-weighted imaging (SWI). 104 children and adolescents with TB! and 43 age-matched typically developing (TD) controls underwent magnetic resonance imaging including a susceptibility-weighted imaging (SWI) sequence 2-8 weeks post-injury and were assessed on cognitive ToM tasks at 6-months after injury. Compared to TD controls and children with mild-moderate injuries, children with severe TBI showed significantly poorer ToM. Moreover, impairments in ToM were related to diffuse neuropathology, and parietal lobe lesions. Our findings support the vulnerability of the immature social brain network to disruption from TBI, and suggest that global macrostructural damage commonly associated with traumatic axonal injury (TAI) may contribute to structural disconnection of anatomically distributed regions that underlie ToM. This study suggests that SWI may be a valuable imaging biomarker to predict outcome and recovery of social cognition after pediatric TBI. (C) 2014 Elsevier Ltd. All rights reserved.	[Ryan, Nicholas P.; Catroppa, Cathy; Cooper, Janine M.; Beare, Richard; Silk, Timothy; Crossley, Louise; Rogers, Kirrily; Anderson, Vicki A.] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic 3052, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Rogers, Kirrily; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Hlth, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Univ, Melbourne, Vic 3004, Australia; [Coleman, Lee] Royal Childrens Hosp, Dept Radiol, Melbourne, Vic 3052, Australia; [Silk, Timothy] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada	Ryan, NP (corresponding author), Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Flemington Rd, Melbourne, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au; cathy.catroppa@mcri.edu.au; janine.cooper@mcri.edu.au; richard.beare@mcri.edu.au; michael.ditchfield@southemhealth.org.au; lee.coleman@rch.org.au; tim.silk@mcri.edu.au; louise.crossley@mcri.edu.au; kirrilyrogers@gmail.com; Miriam.beauchamp@umontreal.ca; kyeates@ucalgary.ca; vicki.anderson@rch.org.au	Ryan, Nicholas/K-5445-2019; Silk, Tim/K-4295-2019; Yeates, Keith/AAJ-4223-2020	Ryan, Nicholas/0000-0002-0878-8889; Yeates, Keith/0000-0001-7680-2892; Rogers, Kirrily/0000-0001-8282-537X; Beare, Richard/0000-0002-7530-5664; Silk, Tim/0000-0002-7290-512X	Victoria Neuro-trauma Initiative, Australia; Victorian Government Operational Infrastructure Support Program [CO6E1]	This work was supported by a grant from the Victoria Neuro-trauma Initiative, Australia and the Victorian Government Operational Infrastructure Support Program (No. CO6E1).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Coffey C., 1991, Psychopathology and the Brain, V3, P243; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Dal Monte O, 2014, CORTEX, V58, P9, DOI 10.1016/j.cortex.2014.05.002; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tabachnick B., 2001, USING MULTIVARIATE S; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Walz NC, 2009, DEV NEUROPSYCHOL, V34, P507, DOI 10.1080/87565640902964490; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zaitchik D, 2010, NEUROPSYCHOLOGIA, V48, P2528, DOI 10.1016/j.neuropsychologia.2010.04.031	60	29	29	0	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN	2015	66						32	38		10.1016/j.neuropsychologia.2014.10.040			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	CA0SG	WOS:000348626200004	25445779				2021-06-18	
J	Smith, PH; Potenza, MN; Mazure, CM; Mckee, SA; Park, CL; Hoff, RA				Smith, Philip H.; Potenza, Marc N.; Mazure, Carolyn M.; Mckee, Sherry A.; Park, Crystal L.; Hoff, Rani A.			Compulsive sexual behavior among male military veterans: Prevalence and associated clinical factors	JOURNAL OF BEHAVIORAL ADDICTIONS			English	Article						compulsive sexual behavior; military; PTSD; child abuse; veterans; trauma	IMPULSE-CONTROL DISORDERS; PSYCHIATRIC COMORBIDITY; BRAIN-INJURY; STRESS; CHILDHOOD; HISTORY; PTSD; MEN; PARAPHILIAS; EXPERIENCES	Background and aims: Compulsive sexual behavior (CSB) is highly prevalent among men, often co-occurring with psychiatric disorders and traumatic experiences. Psychiatric disorders and trauma are highly prevalent among military veterans, yet there is a paucity of research on CSB among military samples. The aim of this study was to examine the prevalence of and factors associated with CSB among male military veterans. Methods: Surveys were administered to veterans of Operations Iraqi Freedom, Enduring Freedom, or New Dawn at baseline (n = 258), 3 months (n= 194), and 6 months (n= 136). Bivariate analyses and Generalized Estimating Equations were utilized to estimate associations between CSB and the following variables: psychiatric co-morbidity, childhood physical or sexual trauma, pre- and post-deployment experiences, TV/ Internet usage, and sociodemographics. Associations between CSB and specific PTSD symptom clusters were also examined. Results: CSB was reported by 16.7% of the sample at baseline. Several variables were associated with CSB in bivariate analyses; however, only PTSD severity, childhood sexual trauma, and age remained significant in multivariable GEE models. The PTSD symptom cluster re-experiencing was most strongly associated with CSB. Discussion: This exploratory study suggests that CSB is prevalent amongst veterans returning from combat and is associated with childhood trauma and PTSD, particularly re-experiencing. Conclusions: Further study is needed to identify the mechanisms linking PTSD and CSB, define the context and severity of CSB in veterans, and examine the best ways to assess and treat CSB in VA clinical settings.	[Smith, Philip H.] Yale Univ, New Haven, CT 06520 USA; [Potenza, Marc N.; Mazure, Carolyn M.; Mckee, Sherry A.; Hoff, Rani A.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Park, Crystal L.] Univ Connecticut, Dept Psychol, Storrs, CT USA; [Hoff, Rani A.] VISN 1 Mental Illness Res Educ & Clin Care Ctr MI, Dept Psychol, Los Angeles, CA USA	Hoff, RA (corresponding author), NEPEC 182,950 Campbell Ave, West Haven, CT 06416 USA.	Rani.hoff@va.gov			U.S. Department of Veteran Affairs Office of Research and Development; Clinical Science Research and Development [ZDA1]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [RL1 AA017539]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH01423539]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [RL1AA017539] Funding Source: NIH RePORTER	This study was funded by the U.S. Department of Veteran Affairs Office of Research and Development, Clinical Science Research and Development (ZDA1, PI: Hoff), NIAAA (RL1 AA017539, PI: Potenza), and NIMH (T32MH01423539, PI: Zhang)	Bancroft J, 2004, J SEX RES, V41, P225, DOI 10.1080/00224490409552230; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Black DW, 1997, AM J PSYCHIAT, V154, P243; Blain LM, 2012, CHILD ABUSE NEGLECT, V36, P413, DOI 10.1016/j.chiabu.2012.03.003; Carnes PJ., 1991, DONT CALL IT LOVE RE; Carnes PJ, 1996, SEXUAL ADDICTION COM, V3, P258, DOI DOI 10.1080/1072016; Carpenter BN, 2013, SEX ADDICT COMPULS, V20, P79, DOI 10.1080/10720162.2013.772873; Cloitre M, 2005, BEHAV THER, V36, P119, DOI 10.1016/S0005-7894(05)80060-7; COLEMAN E, 1992, PSYCHIAT ANN, V22, P320, DOI 10.3928/0048-5713-19920601-09; Dodge B, 2004, J SEX RES, V41, P343, DOI 10.1080/00224490409552241; Drummet AR, 2003, FAM RELAT, V52, P279, DOI 10.1111/j.1741-3729.2003.00279.x; Grant B. F., 2000, ALCOHOL USE DISORDER; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant J. E., 2008, IMPULSE CONTROL DISO; Grant JE, 2005, AM J PSYCHIAT, V162, P2184, DOI 10.1176/appi.ajp.162.11.2184; Grant JE, 2007, J CLIN PSYCHIAT, V68, P1584, DOI 10.4088/JCP.v68n1018; Greenberg JB, 2012, PSYCHOL ADDICT BEHAV, V26, P89, DOI 10.1037/a0024328; Hansen NB, 2012, J TRAUMA DISSOCIATIO, V13, P345, DOI 10.1080/15299732.2011.641710; Howard MD, 2007, SEX ADDICT COMPULS, V14, P77, DOI 10.1080/10720160701310443; Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7; Kafka MP, 2003, INT J OFFENDER THER, V47, P439, DOI 10.1177/0306624X03253845; KAFKA MP, 1994, J CLIN PSYCHIAT, V55, P481; KAFKA MP, 1992, J CLIN PSYCHIAT, V53, P345; Katichman SC, 2004, J SEX RES, V41, P235, DOI 10.1080/00224490409552231; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kingston DA, 2013, SEX ADDICT COMPULS, V20, P91, DOI 10.1080/10720162.2013.768131; Kor A, 2013, SEX ADDICT COMPULS, V20, P27, DOI 10.1080/10720162.2013.768132; Kuzma JM, 2008, PSYCHIAT CLIN N AM, V31, P603, DOI 10.1016/j.psc.2008.06.005; McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121; Miner MH, 2013, SEX ADDICT COMPULS, V20, P127, DOI 10.1080/10720162.2013.768133; Orsillo SM, 1996, J TRAUMA STRESS, V9, P235, DOI 10.1007/BF02110658; Pincus S. H., 2001, US ARMY MED DEP J, V4, P6; Raymond NC, 2003, COMPR PSYCHIAT, V44, P370, DOI 10.1016/S0010-440X(03)00110-X; Raymond NC, 2002, INT CLIN PSYCHOPHARM, V17, P201, DOI 10.1097/00004850-200207000-00008; Reid RC, 2010, J COUPLE RELATSH THE, V9, P203, DOI 10.1080/15332691.2010.491782; Reid RC, 2010, J SEX MARITAL THER, V37, P45, DOI 10.1080/0092623X.2011.533585; Reid RC, 2007, SEX ADDICT COMPULS, V14, P167, DOI 10.1080/10720160701480204; Schmied EA, 2013, MIL MED, V178, P1051, DOI 10.7205/MILMED-D-13-00135; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Simpson JA, 2012, DEV PSYCHOL, V48, P674, DOI 10.1037/a0027293; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	43	29	29	0	8	AKADEMIAI KIADO ZRT	BUDAPEST	BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY	2062-5871	2063-5303		J BEHAV ADDICT	J. Behav. Addict.	DEC	2014	3	4					214	222		10.1556/JBA.3.2014.4.2			9	Psychiatry	Psychiatry	AY6FK	WOS:000347662500002	25592306	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Virji-Babul, N; Hilderman, CGE; Makan, N; Liu, AP; Smith-Forrester, J; Franks, C; Wang, ZJ				Virji-Babul, Naznin; Hilderman, Courtney G. E.; Makan, Nadia; Liu, Aiping; Smith-Forrester, Jenna; Franks, Chris; Wang, Z. J.			Changes in Functional Brain Networks following Sports-Related Concussion in Adolescents	JOURNAL OF NEUROTRAUMA			English	Article						graph theory; mild traumatic brain injury; concussion; adolescents; resting-state EEG	GRAPH-THEORETICAL ANALYSIS; WHITE-MATTER; HEAD-INJURY; CONNECTIVITY; ATTENTION; DEFICITS; FMRI; AGE	Sports-related concussion is a major public health issue; however, little is known about the underlying changes in functional brain networks in adolescents following injury. Our aim was to use the tools from graph theory to evaluate the changes in brain network properties following concussion in adolescent athletes. We recorded resting state electroencephalography (EEG) in 33 healthy adolescent athletes and 9 adolescent athletes with a clinical diagnosis of subacute concussion. Graph theory analysis was applied to these data to evaluate changes in brain networks. Global and local metrics of the structural properties of the graph were calculated for each group and correlated with Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) scores. Brain networks of both groups showed small-world topology with no statistically significant differences in the global metrics; however, significant differences were found in the local metrics. Specifically, in the concussed group, we noted: 1) increased values of betweenness and degree in frontal electrode sites corresponding to the (R) dorsolateral prefrontal cortex and the (R) inferior frontal gyrus and 2) decreased values of degree in the region corresponding to the (R) frontopolar prefrontal cortex. In addition, there was significant negative correlation between degree and hub value, with total symptom score at the electrode site corresponding to the (R) prefrontal cortex. This preliminary report in adolescent athletes shows for the first time that resting-state EEG combined with graph theoretical analysis may provide an objective method of evaluating changes in brain networks following concussion. This approach may be useful in identifying individuals at risk for future injury.	[Virji-Babul, Naznin; Hilderman, Courtney G. E.; Makan, Nadia] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada; [Liu, Aiping; Wang, Z. J.] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada; [Smith-Forrester, Jenna] Univ British Columbia, Neurosci Program, Vancouver, BC V6T 1Z3, Canada; [Virji-Babul, Naznin] Child & Family Res Inst, Vancouver, BC, Canada	Virji-Babul, N (corresponding author), Univ British Columbia, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	naznin.virji-babul@ubc.ca	Meijer, Anna/K-5118-2016	Hilderman, Courtney G E/0000-0003-0209-4939; Virji-Babul, Naznin/0000-0002-8984-5848	University of British Columbia; Brain Research Center, University of British Columbia; Whitecaps Residency program; Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR)	This research was supported by the University of British Columbia and the Brain Research Center, University of British Columbia. The authors thank the Whitecaps Residency program for their support and all the participants, trainers, and coaches who took part in this study. Jenna Smith-Forrester is supported by a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarship. Dr. Naznin Virji-Babul had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Coronado VG, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Keightley M. L., 2013, J NEUROTRAUM, V15, P1; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li JN, 2009, J MACH LEARN RES, V10, P475; Martinez A, 1999, NAT NEUROSCI, V2, P364; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.69.066133]; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Rotem-Kohavi N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00209; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Sun JF, 2012, AGING DIS, V3, P181; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	45	29	29	2	37	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2014	31	23					1914	1919		10.1089/neu.2014.3450			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AT6US	WOS:000345075500003	24956041				2021-06-18	
J	Causin, P; Guidoboni, G; Harris, A; Prada, D; Sacco, R; Terragni, S				Causin, Paola; Guidoboni, Giovanna; Harris, Alon; Prada, Daniele; Sacco, Riccardo; Terragni, Samuele			A poroelastic model for the perfusion of the lamina cribrosa in the optic nerve head	MATHEMATICAL BIOSCIENCES			English	Article						Biological tissues; Eye; Optic nerve head; Lamina cribrosa; Poroelastic models; Finite element method	BLOOD-FLOW AUTOREGULATION; INTRAOCULAR-PRESSURE; MATHEMATICAL-MODEL; HUMAN SCLERA; GLAUCOMA; BIOMECHANICS; TOMOGRAPHY; HEMODYNAMICS; MECHANISMS; PARADIGM	In this work we present a mathematical model for the coupling between biomechanics and hemodynamics in the lamina cribrosa, a thin porous tissue at the base of the optic nerve head which is thought to be the site of injury in ocular neurodegenerative diseases such as glaucoma. In this exploratory two-dimensional investigation, the lamina cribrosa is modeled as a poroelastic material where blood vessels are viewed as pores in a solid elastic matrix. The model is used to investigate the influence on the distributions of stress, blood volume fraction (or vascular porosity) and blood velocity within the lamina cribrosa due to the application of different levels of the intraocular pressure (IOP) and the enforcement of different mechanical constraints at the lamina's boundary. The model simulations suggest that the degree of fixity of the boundary constraint strongly influences the lamina's response to IOP elevation. Specifically, when the boundary is mechanically clamped, KW elevation leads to an increase in stress close to the lamina's boundary, making it more susceptible to tissue damage. On the other hand, when rotations are allowed at the boundary, the most vulnerable region appears to be located at the lamina's central axis, in proximity of the eye globe, where increased stress and reduced vascular porosity and blood velocity are predicted for increased levels of IOP. Published by Elsevier Inc.	[Causin, Paola] Univ Milan, Dipartimento Matemat F Enriques, I-20133 Milan, Italy; [Guidoboni, Giovanna; Prada, Daniele] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; [Guidoboni, Giovanna] Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA; [Guidoboni, Giovanna] Inst Rech Math Interact & Applicat, F-67084 Strasbourg, France; [Sacco, Riccardo] Politecn Milan, Dipartimento Matemat F Brioschi, I-20133 Milan, Italy; [Terragni, Samuele] Politecn Milan, I-20133 Milan, Italy	Guidoboni, G (corresponding author), Indiana Univ Purdue Univ, Dept Math Sci, N Blackford St,LD270, Indianapolis, IN 46202 USA.			GUIDOBONI, Giovanna/0000-0001-7470-0171; Prada, Daniele/0000-0002-8498-0928	NSF/DMSNational Science Foundation (NSF) [1134731, 1224195]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21EY022101-01A1]; Direct For Mathematical & Physical ScienNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1224195] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R21EY022101] Funding Source: NIH RePORTER	This work was partially supported by the NSF/DMS Grants 1134731 and 1224195, the NIH Grant 1R21EY022101-01A1.	Arciero J, 2013, INVEST OPHTH VIS SCI, V54, P5584, DOI 10.1167/iovs.12-11543; Balaratnasingam C, 2014, EXP EYE RES, V121, P11, DOI 10.1016/j.exer.2014.02.008; Bhole AP, 2009, PHILOS T R SOC A, V367, P3339, DOI 10.1098/rsta.2009.0093; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Camp RJ, 2011, J AM CHEM SOC, V133, P4073, DOI 10.1021/ja110098b; Campbell IC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026286; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Chapelle D, 2010, COMPUT MECH, V46, P91, DOI 10.1007/s00466-009-0452-x; Coussy O., 2004, POROMECHANICS; Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4; Detournay E., 1993, ANAL DESIGN METHOD, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; Flynn BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012337; Girard M.J.A., 2014, CURR EYE RES, P1, DOI http://dx.doi.org/10.3109/02713683.2014.914543; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Grytz R, 2014, J MECH BEHAV BIOMED, V29, P602, DOI 10.1016/j.jmbbm.2013.03.027; Grytz R, 2012, MECH RES COMMUN, V42, P92, DOI 10.1016/j.mechrescom.2012.01.007; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; Guidoboni G, 2014, INVEST OPHTH VIS SCI, V55, P4105, DOI 10.1167/iovs.13-13611; Guidoboni G, 2013, J COUPLED SYST MULTI, V1, P1, DOI 10.1166/jcsmd.2013.1004; Guidoboni G, 2014, MATH BIOSCI ENG, V11, P523, DOI 10.3934/mbe.2014.11.523; Harris A., 2009, OCULAR BLOOD FLOW GL; Harris A, 2013, EUR J OPHTHALMOL, V23, P139, DOI 10.5301/ejo.5000255; Hatch WV, 1997, BRIT J OPHTHALMOL, V81, P871, DOI 10.1136/bjo.81.10.871; He DQ, 1999, J BIOMECH, V32, P579, DOI 10.1016/S0021-9290(99)00025-1; HERRMANN LR, 1965, AIAA J, V3, P1896, DOI 10.2514/3.3277; HUYGHE JM, 1992, AM J PHYSIOL, V262, pH1256; Jerome J.W., 1996, ANAL CHARGE TRANSPOR; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pe273, DOI 10.1111/aos.12324; Krieglstein, 2003, ATLAS OCULAR BLOOD F; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Li XG, 2013, COMPUT METHOD BIOMEC, V16, P1330, DOI 10.1080/10255842.2012.670853; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; Newson T, 2006, J BIOMECH ENG-T ASME, V128, P496, DOI 10.1115/1.2205372; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Showalter RE, 2000, J MATH ANAL APPL, V251, P310, DOI 10.1006/jmaa.2000.7048; Sigal IA, 2014, IEEE T MED IMAGING, V33, P1381, DOI 10.1109/TMI.2014.2312133; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; WOO SLY, 1972, EXP EYE RES, V14, P29, DOI 10.1016/0014-4835(72)90139-X; Yan DB, 1998, CURR EYE RES, V17, P903, DOI 10.1076/ceyr.17.9.903.5143; Yoon YJ, 2012, J BIOMECH, V45, P716, DOI 10.1016/j.jbiomech.2011.12.007	44	29	31	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-5564	1879-3134		MATH BIOSCI	Math. Biosci.	NOV	2014	257				SI		33	41		10.1016/j.mbs.2014.08.002			9	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	AU2ZP	WOS:000345483200005	25149561				2021-06-18	
J	Mayer, AR; Bedrick, EJ; Ling, JM; Toulouse, T; Dodd, A				Mayer, Andrew R.; Bedrick, Edward J.; Ling, Josef M.; Toulouse, Trent; Dodd, Andrew			Methods for Identifying Subject-Specific Abnormalities in Neuroimaging Data	HUMAN BRAIN MAPPING			English	Article						mild traumatic brain injury; diffusion tensor imaging; neuroimaging; subject-specific abnormalities	TRAUMATIC BRAIN-INJURY; WHITE-MATTER ABNORMALITIES; MULTIPLE-SCLEROSIS; ANISOTROPY; SCHIZOPHRENIA; INFERENCE; MAPS	Algorithms that are capable of capturing subject-specific abnormalities (SSA) in neuroimaging data have long been an area of focus for diverse neuropsychiatric conditions such as multiple sclerosis, schizophrenia, and traumatic brain injury. Several algorithms have been proposed that define SSA in patients (i.e., comparison group) relative to image intensity levels derived from healthy controls (HC) (i.e., reference group) based on extreme values. However, the assumptions underlying these approaches have not always been fully validated, and may be dependent on the statistical distributions of the transformed data. The current study evaluated variations of two commonly used techniques (pothole method and standardization with an independent reference group) for identifying SSA using simulated data (derived from normal, t and chi-square distributions) and fractional anisotropy maps derived from 50 HC. Results indicated substantial group-wise bias in the estimation of extreme data points using the pothole method, with the degree of bias being inversely related to sample size. Statistical theory was utilized to develop a distribution-corrected z-score (DisCo-Z) threshold, with additional simulations demonstrating elimination of the bias and a more consistent estimation of extremes based on expected distributional properties. Data from previously published studies examining SSA in mild traumatic brain injury were then re-analyzed using the DisCo-Z method, with results confirming the evidence of group-wise bias. We conclude that the benefits of identifying SSA in neuropsychiatric research are substantial, but that proposed SSA approaches require careful implementation under the different distributional properties that characterize neuroimaging data. Hum Brain Mapp 35:5457-5470, 2014. (c) 2014 Wiley Periodicals, Inc.	[Mayer, Andrew R.; Ling, Josef M.; Toulouse, Trent; Dodd, Andrew] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Bedrick, Edward J.] Univ Colorado, Dept Biostat & Informat, Aurora, CO USA	Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org					Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Bulmer M. G., 1979, PRINCIPLES STAT; Cook R.D., 1982, RESIDUALS INFLUENCE; Cox R, 2006, EFFICIENT ROBUST NON; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Ehrlich S, 2013, SCHIZOPHR B, V40, P665; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Geisser S, 1993, PREDICTIVE INTERFERE; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Monnig MA, 2013, ADDICT BIOL, V18, P581, DOI 10.1111/j.1369-1600.2012.00441.x; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Patel SA, 2007, J MAGN RESON IMAGING, V26, P552, DOI 10.1002/jmri.21076; POLINE JB, 1993, J CEREBR BLOOD F MET, V13, P425, DOI 10.1038/jcbfm.1993.57; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Scheel M, 2013, BRAIN STRUCT FUNCT, V218, P151, DOI 10.1007/s00429-012-0389-2; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Viviani R, 2007, HUM BRAIN MAPP, V28, P1075, DOI 10.1002/hbm.20332; Watts R, 2014, RADIOLOGY; White T, 2013, SCHIZOPHRENIA BULL, V39, P1077, DOI 10.1093/schbul/sbs106; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014	37	29	29	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2014	35	11					5457	5470		10.1002/hbm.22563			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS3KK	WOS:000344176100010	24931496	Green Published			2021-06-18	
J	Sinopoli, KJ; Chen, JK; Wells, G; Fait, P; Ptito, A; Taha, T; Keightley, M				Sinopoli, Katia J.; Chen, Jen-Kai; Wells, Greg; Fait, Philippe; Ptito, Alain; Taha, Tim; Keightley, Michelle			Imaging "Brain Strain" in Youth Athletes with Mild Traumatic Brain Injury during Dual-Task Performance	JOURNAL OF NEUROTRAUMA			English	Article						dual-task; fMRI; mild TBI; working memory	SPORTS-RELATED CONCUSSION; STABILITY FOLLOWING CONCUSSION; WORKING-MEMORY DYSFUNCTION; EVENT-RELATED FMRI; MINOR HEAD-INJURY; PREFRONTAL CORTEX; FUNCTIONAL MRI; DIVIDED ATTENTION; POSTCONCUSSIVE SYMPTOMS; ANTERIOR CINGULATE	Mild traumatic brain injury (mTBI) is a common cause of injury in youth athletes. Much of what is known about the sequelae of mTBI is yielded from the adult literature, and it appears that it is mainly those with persistent post-injury symptoms who have ongoing cognitive and neural abnormalities. However, most studies have employed single-task paradigms, which may not be challenging enough to uncover subtle deficits. We sought to examine the neural correlates of dual-task performance in male athletes aged 9-15 years using a functional neuroimaging protocol. Participants included 13 youths with a history of mTBI three to six months prior to testing and 14 typically-developing controls. All participants completed a working memory task in isolation (single-task) and while completing a concurrent motor task (dual-task); neural activity during performance was then compared between groups. Although working memory performance was similar during the single-task condition, increased working memory load resulted in an altered pattern of neural activation in key working memory areas (i.e., dorsolateral prefrontal and parietal cortices) in youth with mTBI relative to controls. During the dual-task condition, accuracy was similar between groups but injured youth performed slower than typically-developing controls, suggesting a speed-accuracy tradeoff in the mTBI group only. The injured youths also exhibited abnormal recruitment of brain structures involved in both working memory and dual-tasking. These data show that the dual-task paradigm can uncover functional impairments in youth with mTBI who are not highly symptomatic and who do not exhibit neuropsychological dysfunction. Moreover, neural recruitment abnormalities were noted in both task conditions, which we argue suggests mTBI-related disruptions in achieving efficient cognitive control and allocation of processing resources.	[Sinopoli, Katia J.] Hosp Sick Children, Div Neurol, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Wells, Greg] Hosp Sick Children, Dept Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Wells, Greg; Taha, Tim] Univ Toronto, Dept Kinesiol & Phys Educ, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci & Psychol, Toronto, ON M5S 1A1, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Phys Act Sci, Trois Rivieres, PQ GA9 5H7, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Res Grp Neuromusculoskeletal Dysfunct, Trois Rivieres, PQ GA9 5H7, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada	Keightley, M (corresponding author), 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	michelle.keightley@utoronto.ca	Sinopoli, Katia/AAO-7803-2020; Meijer, Anna/K-5118-2016	Fait, Philippe/0000-0002-2554-9273	Ontario Neurotrauma Foundation [ONF 2009-ABI-IMAGING-750]; Rita G. Rudel Early Career Award	This project was funded by the Ontario Neurotrauma Foundation (ONF 2009-ABI-IMAGING-750) awarded to Drs. Keightley and Wells and the Rita G. Rudel Early Career Award awarded to Dr. Sinopoli.	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Adelson P D, 2000, Clin Neurosurg, V47, P319; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A, 2001, J EXP PSYCHOL GEN, V130, P641, DOI 10.1037//0096-3445.130.4.641; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; CHEN JK, 2007, PSYCHIATRY, V78, P1231; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dennis M., 2013, NEUROSCI BIOBEHAV RE; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellenbogen R, 2008, MEM COGNITION, V36, P968, DOI 10.3758/MC.36.5.968; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Fait PE, 2011, PERCEPT MOTOR SKILL, V112, P29, DOI 10.2466/05.10.23.25.PMS.112.1.29-43; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GARDNER A, 2010, ARCH CLIN NEUROPSYCH, V64, P25; Gazes Y, 2010, BEHAV BRAIN RES, V210, P229, DOI 10.1016/j.bbr.2010.02.036; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goldberg TE, 1998, NEUROIMAGE, V7, P296, DOI 10.1006/nimg.1998.0338; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Hartley AA, 2011, BRAIN COGNITION, V75, P281, DOI 10.1016/j.bandc.2011.01.004; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jaeggi SM, 2007, COGN AFFECT BEHAV NE, V7, P75, DOI 10.3758/CABN.7.2.75; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koechlin E, 1999, NATURE, V399, P148; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lien MC, 2010, J EXP PSYCHOL HUMAN, V36, P1, DOI 10.1037/a0015875; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marois R, 2006, PSYCHOL RES-PSYCH FO, V70, P436, DOI 10.1007/s00426-005-0022-6; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Miller EK, 1996, J NEUROSCI, V16, P5154; Mochizuki H, 2007, BRAIN RES, V1172, P82, DOI 10.1016/j.brainres.2007.07.046; Muller NG, 2002, J COGNITIVE NEUROSCI, V14, P673, DOI 10.1162/08989290260138582; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Reed N., 2013, NEUROL NEUROPHYSIOL, V4, P171, DOI DOI 10.4172/2155-9562.1000171; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; Russo RN, 2012, DEV NEUROREHABIL, V15, P13, DOI 10.3109/17518423.2011.625558; Sander MC, 2012, NEUROSCI BIOBEHAV R, V36, P2007, DOI 10.1016/j.neubiorev.2012.06.004; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.3.CO;2-I; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	119	29	29	1	32	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2014	31	22					1843	1859		10.1089/neu.2014.3326			17	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CB4ZO	WOS:000349637400004	24902051				2021-06-18	
J	Zemek, R; Eady, K; Moreau, K; Farion, KJ; Solomon, B; Weiser, M; Dematteo, C				Zemek, Roger; Eady, Kaylee; Moreau, Katherine; Farion, Ken J.; Solomon, Beverly; Weiser, Margaret; Dematteo, Carol			Knowledge of paediatric concussion among front-line primary care providers	PAEDIATRICS & CHILD HEALTH			English	Article						Adolescent; Concussion; Guidelines; Multidisciplinary; Practice variation; Youth	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SYMPTOM INVENTORY; CHILDREN; MANAGEMENT; SCALE; PHYSICIANS; CLINICIAN; CONSENSUS	Objective: To assess the knowledge of paediatric concussion diagnosis and management among front-line primary care providers. Methods: Experts from the Concussions Ontario Diagnosis and Early Education Working Group developed a 34-item survey incorporating case vignettes with the collaboration of experts in medical education. Electronic surveys were distributed via FluidSurveys using a modified version of Dillman's tailored design method. The survey was distributed to five Ontario professional associations. The target participants were front-line health care providers (family physicians, emergency medicine physicians, general paediatricians, nurse practitioners and physician assistants) in Ontario; only providers who diagnose and/or manage paediatric concussions were eligible to participate. Results: The survey was fully completed by 577 health care providers who treat paediatric concussion. Of the respondents, 78% (95% CI 74% to 81%) reported diagnosing >= 5 concussions annually. Physicians and nonphysicians equally recognized concussion (90% [95% CI 86% to 92%]; 85% [95% CI 77% to 90%], respectively). Only 37% (95% CI 32% to 41%) of physicians correctly applied graduated return to play guidelines. Return to learn recommendations were also insufficient: 53% (95% CI 49% to 58%) neglected to recommend school absence and 40% (95% CI (35% to 44%) did not recommend schoolwork accommodations. Only 26% (95% CI 22% to 30%) of physicians reported regular use of concussion scoring scales. Conclusions: Considerable gaps in knowledge exist in front-line primary care providers with inadequate application of graduated return to play and return to learn following concussion, as demonstrated by the present broad population-based survey. Consistent application of best evidence-based management using comprehensive guidelines may help to reduce the impact of concussion and persistent postconcussive problems in children and adolescents.	[Zemek, Roger; Moreau, Katherine; Farion, Ken J.] Univ Ottawa, Dept Paediat, Ottawa, ON, Canada; [Zemek, Roger; Farion, Ken J.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Zemek, Roger; Eady, Kaylee; Moreau, Katherine; Farion, Ken J.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Solomon, Beverly] Univ Toronto, Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Weiser, Margaret] Western Univ, Acquired Brain Injury Rehabil Program, London, ON, Canada; [Dematteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada	Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Zemek, Roger/H-1039-2018		Ontario Neurotrauma Foundation, Toronto, Ontario	The authors thank Corinne Kagan from the Concussions Ontario/mTBI strategy for her assistance with this project, as well as Alia Busuttil and Hoang Pham for their assistance with manuscript editing. This project was funded by a grant from the Ontario Neurotrauma Foundation, Toronto, Ontario. This work originated at the Children's Hospital of Eastern Ontario (Ottawa, Ontario). The Research Ethics Board of the Children's Hospital of Eastern Ontario approved this study before initiation (file number: 12/88X).	[Anonymous], 2013, BR J SPORTS MED, V47, P259; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carroll L J, 2011, CONCUSSION CRISIS AN; Dillman D.A., 2000, MAIL INTERNET SURVEY; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hill CA, 2006, WESTERN J NURS RES, V28, P322, DOI 10.1177/0193945905284723; IBM, 2012, SPSS SOFTW VERS 20 A; Inc C, 2012, FLUID SURV; Nguyen K, 2013, CAN FAM PHYSICIAN, V59, pE330; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; LECLERC S, 2004, ASSESSMENT CONCUSSIO; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Piland SG, 2003, J ATHL TRAINING, V38, P104; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wiebe ER, 2012, CAN FAM PHYSICIAN, V58, pE225; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R., 2014, GUIDELINES DIAGNOSIN; Zemek R, 2014, CJEM IN PRESS; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	41	29	29	0	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	NOV	2014	19	9					474	479		10.1093/pch/19.9.475			6	Pediatrics	Pediatrics	AT0OQ	WOS:000344635600010	25414583	Green Published			2021-06-18	
J	Lin, CY; Shih, CC; Yeh, CC; Chou, WH; Chen, TL; Liao, CC				Lin, Chiao-Yi; Shih, Chun-Chuan; Yeh, Chun-Chieh; Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang			Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: Two nationwide retrospective cohort studies	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Myocardial infarction; Mortality; Systemic lupus erythematosus	TRAUMATIC BRAIN-INJURY; FATTY LIVER-DISEASE; CARDIOVASCULAR-DISEASE; ADVERSE OUTCOMES; UNITED-STATES; EVENTS; WOMEN; INDEX; RATES; ATHEROSCLEROSIS	Background: This study evaluated the risk of acute myocardial infarction (AMI) and mortality among patients with systemic lupus erythematosus (SLE) in two nationwide retrospective cohort studies. Methods: Using Taiwan's National Health Insurance Research Database, we conducted a retrospective cohort study and identified 1207 adults newly diagnosed with SLE in 2000-2004. Non-SLE cohort consisted of 9656 adults without SLE, frequency-matched for age and sex and randomly selected from the same data set. Events of AMI were considered as outcome during the follow-up period between 2000 and 2008. Another nested cohort study of 6900 patients with AMI receiving cardiac surgeries was conducted to analyze the impact of SLE on post-AMI mortality. Results: During the follow-up period, there were 52 newly diagnosed AMI cases. The incidences of AMI for SLE cohort and non-SLE cohort were 2.10 and 0.49 per 1000 person-years, respectively, with an adjusted hazard ratio (HR) of 5.11 (95% confidence interval [CI] 2.63-9.92). For females, the adjusted HR of AMI associated with SLE was as high as 6.28 (95% CI 2.67-14.7). Further analyses in the nested cohort showed that SLE was significantly associated with post-AMI mortality (odds ratio, 2.60; 95% CI 1.09-6.19). Conclusion: Patients with SLE had higher risk of AMI compared with non-SLE control, and this risk was more significant in females. In addition, SLE is an independent risk factor for post-AMI mortality. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Lin, Chiao-Yi] Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	National Science Council TaiwanMinistry of Science and Technology, Taiwan [NSC102-2314-B-038-021-MY3]	This study was supported in part by a grant from the National Science Council Taiwan (NSC102-2314-B-038-021-MY3).	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; ASHERSON RA, 1989, Q J MED, V73, P1103; Bengtsson C, 2012, LUPUS, V21, P452, DOI 10.1177/0961203311425524; Bessant R, 2006, ARTHRIT RHEUM-ARTHR, V55, P892, DOI 10.1002/art.22343; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Brea A, 2013, INT J CARDIOL, V167, P1109, DOI 10.1016/j.ijcard.2012.09.085; Camtbell R, 2008, ARTHRIT RHEUM-ARTHR, V59, P458, DOI 10.1002/art.23539; Cooper GS, 2007, ARTHRIT RHEUM-ARTHR, V57, P993, DOI 10.1002/art.22894; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; ETTINGER WH, 1987, AM J MED, V83, P503, DOI 10.1016/0002-9343(87)90762-5; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Feng WW, 2010, NEUROLOGY, V74, P588, DOI 10.1212/WNL.0b013e3181cff776; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Herzog CA, 2007, CIRCULATION, V116, P1465, DOI 10.1161/CIRCULATIONAHA.107.696765; HOWELL WL, 1960, AM HEART J, V60, P341, DOI 10.1016/0002-8703(60)90192-7; Jakobsen AH, 2008, J AFFECT DISORDERS, V109, P177, DOI 10.1016/j.jad.2007.10.012; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lu LJ, 2010, LUPUS, V19, P119, DOI 10.1177/0961203309350755; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mosca M, 2000, LUPUS, V9, P445, DOI 10.1191/096120300678828640; Mosca M, 2010, ANN RHEUM DIS, V69, P1269, DOI 10.1136/ard.2009.117200; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Scalzi LV, 2010, ARTHRITIS RHEUM-US, V62, P2767, DOI 10.1002/art.27551; Schanberg LE, 2009, ARTHRITIS RHEUM-US, V60, P1496, DOI 10.1002/art.24469; Schattner A, 2003, ARCH INTERN MED, V163, P1507, DOI 10.1001/archinte.163.13.1507; Vidovich MI, 2009, INT J CARDIOL, V137, P302, DOI 10.1016/j.ijcard.2008.05.077; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Wells DK, 2010, CLIN EXP RHEUMATOL, V28, P223; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu LS, 2014, AM J MED SCI, V347, P42, DOI 10.1097/MAJ.0b013e318278707f; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	29	31	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	OCT 20	2014	176	3					847	851		10.1016/j.ijcard.2014.08.006			5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AR9KT	WOS:000343893300067	25156834				2021-06-18	
J	Nguyen, BM; Kim, D; Bricker, S; Bongard, F; Neville, A; Putnam, B; Smith, J; Plurad, D				Nguyen, Brian M.; Kim, Dennis; Bricker, Scott; Bongard, Fred; Neville, Angela; Putnam, Brant; Smith, Jennifer; Plurad, David			Effect of Marijuana Use on Outcomes in Traumatic Brain Injury	AMERICAN SURGEON			English	Article							CLOSED-HEAD INJURY; DEXANABINOL HU-211; CANNABINOIDS	Traumatic brain injury (TBI) is associated with significant morbidity and mortality. Several studies have demonstrated neuroprotective effects of cannabinoids. The objective of this study was to establish a relationship between the presence of a positive toxicology screen for tetrahydrocannabinol (THC) and mortality after TBI. A 3-year retrospective review of registry data at a Level I center of patients sustaining TBI having a toxicology screen was performed. Pediatric patients (younger than 15 years) and patients with a suspected nonsurvivable injury were excluded. The THC(+) group was compared with the THC(-) group with respect to injury mechanism, severity, disposition, and mortality. Logistic regression was used to determine independent associations with mortality. There were 446 cases meeting all inclusion criteria. The incidence of a positive THC screen was 18.4 per cent (82). Overall mortality was 9.9 per cent (44); however, mortality in the THC(+) group (2.4% [two]) was significantly decreased compared with the THC(-) group (11.5% [42]; P = 0.012). After adjusting for differences between the study cohorts on logistic regression, a THC(+) screen was independently associated with survival after TBI (odds ratio, 0.224; 95% confidence interval, 0.051 to 0.991; P = 0.049). A positive THC screen is associated with decreased mortality in adult patients sustaining TBI.	[Nguyen, Brian M.; Kim, Dennis; Bricker, Scott; Bongard, Fred; Neville, Angela; Putnam, Brant; Smith, Jennifer; Plurad, David] Harbor UCLA Med Ctr, Torrance, CA 90509 USA	Plurad, D (corresponding author), Harbor UCLA Med Ctr, 1000 W Carson St,Box 42, Torrance, CA 90509 USA.	dsplurad@yahoo.com					Allegretti JR, 2013, INFLAMM BOWEL DIS, V19, P2809, DOI 10.1097/01.MIB.0000435851.94391.37; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Borgelt LM, 2013, PHARMACOTHERAPY, V33, P195, DOI 10.1002/phar.1187; Brewster ME, 1997, INT J CLIN PHARM TH, V35, P361; Center for Behavioral Health Statistics and Quality, 2012, GUID DAWN TREND TABL; Durmaz R, 2008, NEUROSURG REV, V31, P215, DOI 10.1007/s10143-007-0119-z; Goodwin RS, 2008, J ANAL TOXICOL, V32, P562, DOI 10.1093/jat/32.8.562; Gowran A, 2011, CNS NEUROSCI THER, V17, P637, DOI 10.1111/j.1755-5949.2010.00195.x; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Sagredo O, 2011, J NEUROSCI RES, V89, P1509, DOI 10.1002/jnr.22682; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Tomida I, 2006, J GLAUCOMA, V15, P349, DOI 10.1097/01.ijg.0000212260.04488.60; Yoles E, 1996, J NEUROTRAUM, V13, P49, DOI 10.1089/neu.1996.13.49	16	29	29	0	29	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2014	80	10					979	983					5	Surgery	Surgery	AP7SV	WOS:000342277900015	25264643				2021-06-18	
J	Rincon, F; Hunter, K; Schorr, C; Dellinger, RP; Zanotti-Cavazzoni, S				Rincon, Fred; Hunter, Krystal; Schorr, Christa; Dellinger, R. Philip; Zanotti-Cavazzoni, Sergio			The epidemiology of spontaneous fever and hypothermia on admission of brain injury patients to intensive care units: a multicenter cohort study	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; ischemic stroke; mortality rate; subarachnoid hemorrhage; intracerebral hemorrhage; outcomes; vascular disorders	SUBARACHNOID HEMORRHAGE; TEMPERATURE ALTERATIONS; IMPACT; RESUSCITATION; STATES; RISK; HYPERTHERMIA; GUIDELINES; STROKE	Object. Fever and hypothermia (dysthermia) are associated with poor outcomes in patients with brain injuries. The authors sought to study the epidemiology of dysthermia on admission to the intensive care unit (ICU) and the effect on in-hospital case fatality in a mixed cohort of patients with brain injuries. Methods. The authors conducted a multicenter retrospective cohort study in 94 ICUs in the United States. Critically ill patients with neurological injuries, including acute ischemic stroke (AIS), aneurysmal subarachnoid hemorrhage (aSAH), intracerebral hemorrhage (ICH), and traumatic brain injury (TBI), who were older than 17 years and consecutively admitted to the ICU from 2003 to 2008 were selected for analysis. Results. In total, 13,587 patients were included in this study; AIS was diagnosed in 2973 patients (22%), ICH in 4192 (31%), aSAH in 2346(17%), and TBI in 4076(30%). On admission to the ICU, fever was more common among TBI and aSAH patients, and hypothermia was more common among ICH patients. In-hospital case fatality was more common among patients with hypothermia (OR 12.7, 95% CI 8.4-19.4) than among those with fever (OR 1.9, 95% 01 1.7-2.1). Compared with patients with ICH (OR 2.0,95% 01 1.8-2.3), TBI (OR 1.5,95% 01 1.3-1.8), and aSAH (OR 1.4, 95% 01 1.2-1.7), patients with AIS who developed fever had the highest risk of death (OR 3.1, 95% CI 2.5-3.7). Although all hypothermic patients had an increased mortality rate, this increase was not significantly different across subgroups. In a multivariable analysis, when adjusted for all other confounders, exposure to fever (adjusted OR 1.3,95% 01 1.1-1.5) or hypothermia (adjusted OR 7.8,95% 01 3.9-15.4) on admission to the ICU was found to be significantly associated with in-hospital case fatality. Conclusions. Fever is frequently encountered in the acute phase of brain injury, and a small proportion of patients with brain injuries may also develop spontaneous hypothermia. The effect of fever on mortality rates differed by neurological diagnosis. Both early spontanecius fever and hypothermia conferred a higher risk of in-hospital death after brain injury.	[Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurol, Philadelphia, PA 19107 USA; [Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurosurg, Div Crit Care & Neurotrauma, Philadelphia, PA 19107 USA; [Hunter, Krystal] Cooper Univ Hosp, Dept Biostat, Camden, NJ USA; [Schorr, Christa; Dellinger, R. Philip; Zanotti-Cavazzoni, Sergio] Cooper Univ Hosp, Dept Med, Div Cardiovasc Dis & Crit Care Med, Camden, NJ USA	Rincon, F (corresponding author), Thomas Jefferson Univ, Dept Neurol Surg, 909 Walnut St,3rd Floor, Philadelphia, PA 19107 USA.	fred.rincon@jefferson.edu		Schorr, Christa/0000-0001-7777-4280; Rincon, Fred/0000-0002-8510-118X	American Heart Association (AHA)American Heart Association [12CRP12050342]	Dr. Rincon has received salary support from the American Heart Association (AHA 12CRP12050342). Drs. Rincon and Zanotti-Cavazzoni and Mrs. Hunter had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bota DP, 2004, INTENS CARE MED, V30, P811, DOI 10.1007/s00134-004-2166-z; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; den Hartog AW, 2010, CRIT CARE, V14, DOI 10.1186/cc9077; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Frosini M, 1999, EXP BRAIN RES, V126, P252, DOI 10.1007/s002210050734; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; HAYWARD JN, 1968, AM J PHYSIOL, V215, P389; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Laupland KB, 2012, CRIT CARE MED, V40, P145, DOI 10.1097/CCM.0b013e31822f061d; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Rincon F, 2013, J INTENSIVE CARE MED; Rincon F, 2012, STROKE, V43, pA3658; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rincon F, 2010, NEUROCRIT CARE, V13, P75, DOI 10.1007/s12028-010-9347-0; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rubiano AM, 2013, INJURY, V44, P1219, DOI 10.1016/j.injury.2012.11.026; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Shibata M, 1998, MED HYPOTHESES, V50, P185, DOI 10.1016/S0306-9877(98)90016-0; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80	38	29	32	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2014	121	4					950	960		10.3171/2014.7.JNS132470			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AQ7DR	WOS:000342973300029	25105701				2021-06-18	
J	Dela Pena, I; Sanberg, PR; Acosta, S; Tajiri, N; Lin, SZ; Borlongan, CV				Dela Pena, I.; Sanberg, P. R.; Acosta, S.; Tajiri, N.; Lin, S-Z; Borlongan, C. V.			Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Stem cells; Aging	COLONY-STIMULATING FACTOR; RANDOMIZED CONTROLLED-TRIAL; MYOCARDIAL-INFARCTION; FUNCTIONAL RECOVERY; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; MOTOR FUNCTION; BLOOD-CELLS; AGED RATS; REPAIR	Traumatic brain injury (TBI), often called the signature wound of Iraq and Afghanistan wars, is characterized by a progressive histopathology and long-lasting behavioral deficits. Treatment options for TBI are limited and patients are usually relegated to rehabilitation therapy and a handful of experimental treatments. Stem cell-based therapies offer alternative treatment regimens for TBI, and have been intended to target the delayed therapeutic window post-TBI, in order to promote "neuroregeneration," in lieu of "neuroprotection" which can be accomplished during acute TBI phase. However, these interventions may require adjunctive pharmacological treatments especially when aging is considered as a comorbidity factor for post-TBI health outcomes. Here, we put forward the concept that a combination therapy of human umbilical cord blood cell (hUCB) and granulocyte-colony stimulating factor (G-CSF) attenuates neuroinflammation in TBI, in view of the safety and efficacy profiles of hUCB and G-CSF, their respective mechanisms of action, and efficacy of hUCB+G-CSF combination therapy in TBI animal models. Further investigations on the neuroinflammatory pathway as a key pathological hallmark in acute and chronic TBI and also as a major therapeutic target of hUCB+G-CSF are warranted in order to optimize the translation of this combination therapy in the clinic.	[Dela Pena, I.; Sanberg, P. R.; Acosta, S.; Tajiri, N.; Borlongan, C. V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA; [Lin, S-Z] China Med Univ & Hosp, Ctr Neuropsychiat, Taichung, Taiwan	Borlongan, CV (corresponding author), 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Lin, Shinn-Zong/AAX-2379-2020; Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	This study was funded by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. P. R. Sanberg and C. V. Borlongan have patents and patent applications on stem cell therapy and serve as founder and consultant, respectively, of Saneron CCEL Therapeutics, Inc. C. V. Borlongan is funded by the National Institutes of Health 1R01NS071956-01A1, and James and Esther King Biomedical Research Foundation 1KG01-33966. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S. A., 2013, J STEM CELL RES T S4, V1, pS004; Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Boltze J, 2012, CELL TRANSPLANT, V21, P723, DOI 10.3727/096368911X586783; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Copeland N, 2009, CLIN MED, V9, P342, DOI 10.7861/clinmedicine.9-4-342; Dietel B, 2012, EXP NEUROL, V237, P379, DOI 10.1016/j.expneurol.2012.06.019; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; Henning RJ, 2008, STEM CELLS DEV, V17, P1207, DOI 10.1089/scd.2008.0023; Herranz AS, 2010, CURR STEM CELL RES T, V5, P17, DOI 10.2174/157488810790442822; Huang HY, 2012, CELL TRANSPLANT, V21, pS3, DOI 10.3727/096368912X633725; Ilic D, 2012, BRIT MED BULL, V102, P43, DOI 10.1093/bmb/lds008; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee EJ, 2012, MOL THER, V20, P155, DOI 10.1038/mt.2011.202; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li T, 2014, MOL CELL BIOCHEM, V387, P91, DOI 10.1007/s11010-013-1874-5; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2003, NEUROSURGERY, V53, P702; Morita Y, 2007, NEUROSCI RES, V58, P356, DOI 10.1016/j.neures.2007.04.006; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Newman MB, 2003, NEUROTOX RES, V5, P355, DOI 10.1007/BF03033155; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Ou YL, 2010, BRAIN RES, V1366, P217, DOI 10.1016/j.brainres.2010.09.098; Pimentel-Coelho PM, 2012, PEDIATR RES, V71, P464, DOI 10.1038/pr.2011.59; Rasouli J, 2011, Einstein J Biol Med, V27, P74; Rolan Terry, 2013, J Spec Oper Med, V13, P45; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sehara Y, 2007, J NEUROSCI RES, V85, P2167, DOI 10.1002/jnr.21341; Shahaduzzaman M, 2013, AGE, V35, P2071, DOI 10.1007/s11357-012-9496-5; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Verina T, 2013, PEDIATR NEUROL, V48, P346, DOI 10.1016/j.pediatrneurol.2012.10.010; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yang M, 2003, CELL MOL NEUROBIOL, V23, P851, DOI 10.1023/A:1025017423102; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Zhao Li R, 2013, Recent Pat CNS Drug Discov, V8, P2	71	29	30	0	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2014	58	3					145	149					5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR1XH	WOS:000343377400002	24844175				2021-06-18	
J	Kerr, ZY; Collins, CL; Mihalik, JP; Marshall, SW; Guskiewicz, KM; Comstock, RD				Kerr, Zachary Y.; Collins, Christy L.; Mihalik, Jason P.; Marshall, Stephen W.; Guskiewicz, Kevin M.; Comstock, R. Dawn			Impact Locations and Concussion Outcomes in High School Football Player-to-Player Collisions	PEDIATRICS			English	Article						epidemiology; injury surveillance; traumatic brain injury	SPORT-RELATED CONCUSSION; STATES HIGH-SCHOOL; UNITED-STATES; ATHLETIC-TRAINERS; HEAD IMPACTS; BRAIN-INJURY; COLLEGIATE; EPIDEMIOLOGY; BIOMECHANICS	BACKGROUND: Little research has examined concussion outcomes in terms of impact location (ie, the area on the head in which the impact occurred). This study describes the epidemiology of concussions resulting from player-to-player collision in high school football by impact location. METHODS: National High School Sports-Related Injury Surveillance Study data (2008/2009-2012/2013) were analyzed to calculate rates and describe circumstances of football concussion (eg, symptomology, symptom resolution time, return to play) resulting from player-to-player collisions by impact location (ie, front-, back-, side-, and top-of-the-head). RESULTS: Most concussions resulting from player-to-player collisions occurred from front-of-the-head (44.7%) and side-of-the-head (22.3%) impacts. Number of symptoms reported, prevalence of reported symptoms, symptom resolution time, and length of time to return to play were not associated with impact location. However, a larger proportion of football players sustaining concussions from top-of-the-head impacts experienced loss of consciousness (8.0%) than those sustaining concussions from impacts to other areas of the head (3.5%) (injury proportion ratio 2.3; 95% confidence interval 1.2-4.2; P = .008). Players had their head down at the time of impact in a higher proportion of concussions caused by top-of-the-head impacts (86.4%) than concussions from impacts to other areas of the head (24.0%) (injury proportion ratio 3.6; 95% confidence interval 3.2-4.0; P < .001). CONCLUSIONS: Among high school football players who sustained concussions due to player-to-player collisions, concussion outcomes were generally independent of impact location. Recommended strategies for reducing the proportion of top-of-the-head impacts include improved education regarding tackling with proper "head-up" technique.	[Kerr, Zachary Y.; Mihalik, Jason P.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Chapel Hill, NC USA; [Collins, Christy L.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Collins, Christy L.] Ohio State Univ, Columbus, OH 43210 USA; [Comstock, R. Dawn] Univ Denver, Aurora, CO USA	Comstock, RD (corresponding author), Univ Colorado Denver, PIPER Program, 13001 East 17th Pl,Mailstop B119, Aurora, CO 80045 USA.	Comstock@UCDenver.edu		Mihalik, Jason/0000-0001-6085-8322; Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Kerr, Zachary/0000-0003-1423-1259	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER	The content of this report was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01. We acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention or any of the other institutions that provided financial support for this research.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dick R, 2007, J ATHL TRAINING, V42, P173; Gabbett TJ, 2006, J STRENGTH COND RES, V20, P215; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heck JF, 2004, J ATHL TRAINING, V39, P101; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; MUELLER FO, 1994, AM SOC TEST MATER, V1229, P20, DOI 10.1520/STP12800S; Mueller FO, 2012, ANN SURVEY FOOTBALL; National Federation of State High School Associations, 2013, HIGH SCH SPORTS PART; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Pryor RR, 2014, 2014 YOUTH SPORTS SA; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sosin DM, 1996, BRAIN INJURY, V10, P47; US Census Bureau, 2009, CENS REG US; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645	29	29	29	0	34	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2014	134	3					489	496		10.1542/peds.2014-0770			8	Pediatrics	Pediatrics	AO5DN	WOS:000341362600048	25113292	Bronze			2021-06-18	
J	Shivers, KY; Nikolopoulou, A; Machlovi, SI; Vallabhajosula, S; Figueiredo-Pereira, ME				Shivers, Kai-Yvonne; Nikolopoulou, Anastasia; Machlovi, Saima Ishaq; Vallabhajosula, Shankar; Figueiredo-Pereira, Maria E.			PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Prostaglandin J2; PET; Microglia; PACAP; Parkinson; PK11195	TRAUMATIC BRAIN-INJURY; CYCLOPENTENONE PROSTAGLANDINS; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); UBIQUITIN/PROTEASOME PATHWAY; ENDOGENOUS ELECTROPHILE; MOUSE MODEL; WILD-TYPE; J-SERIES	Neuroinflammation is a major risk factor in Parkinson's disease (PD). Alternative approaches are needed to treat inflammation, as anti-inflammatory drugs such as NSAIDs that inhibit cyclooxygenase-2 (COX-2) can produce devastating side effects, including heart attack and stroke. New therapeutic strategies that target factors downstream of COX-2, such as prostaglandin J2 (PGJ2), hold tremendous promise because they will not alter the homeostatic balance offered by COX-2 derived prostanoids. In the current studies, we report that repeated microinfusion of PGJ2 into the substantia nigra of non-transgenic mice, induces three stages of pathology that mimic the slow-onset cellular and behavioral pathology of PD: mild (one injection) when only motor deficits are detectable, intermediate (two injections) when neuronal and motor deficits as well as microglia activation are detectable, and severe (four injections) when dopaminergic neuronal loss is massive accompanied by microglia activation and motor deficits. Microglia activation was evaluated in vivo by positron emission tomography (PET) with [C-11(R)PK11195 to provide a regional estimation of brain inflammation. PACAP27 reduced dopaminergic neuronal loss and motor deficits induced by PGJ2, without preventing microglia activation. The latter could be problematic in that persistent microglia activation can exert long-term deleterious effects on neurons and behavior. In conclusion, this PGJ2-induced mouse model that mimics in part chronic inflammation, exhibits slow-onset PD-like pathology and is optimal for testing diagnostic tools such as PET, as well as therapies designed to target the integrated signaling across neurons and microglia, to fully benefit patients with PD. (C) 2014 Elsevier B.V. All rights reserved.	[Shivers, Kai-Yvonne; Machlovi, Saima Ishaq; Figueiredo-Pereira, Maria E.] CUNY, Grad Sch, Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Shivers, Kai-Yvonne; Machlovi, Saima Ishaq; Figueiredo-Pereira, Maria E.] CUNY, Univ Ctr, New York, NY 10065 USA; [Nikolopoulou, Anastasia; Vallabhajosula, Shankar] Cornell Univ, Weill Cornell Med Coll, Citigrp Biomed Imaging Ctr, Dept Radiol, New York, NY 10065 USA	Figueiredo-Pereira, ME (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, 695 Pk Ave,Room 827N, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu			CTSC GRANT [UL1-RR024996]; Hunter College [1R25GM097634];  [NIH: AG028847/NIA];  [NS041073/NINDS (SNRP)];  [MD007599/NIMHD/RCMI]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM097634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS080686, U54NS041073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R24DA012136] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007599] Funding Source: NIH RePORTER	The authors thank Dalila Ordonez, Carolyn Diaz, Vanessa Jacob (Hunter College), Michael Synan and Dr. Bin He (Weill Cornell Medical College) for their excellent technical assistance. Supported by NIH: AG028847/NIA to M.F.-P.; and NS041073/NINDS (SNRP) to M.F.-P. (head of subproject); CTSC GRANT UL1-RR024996 (TL1 training award to K.-Y.S.); and MD007599/NIMHD/RCMI to Hunter College; and Training Program at Hunter College (BP-Endure Grant 1R25GM097634 to S.I.M.). The authors declare no competing financial interests.	ABDELHALIM MS, 1977, PROSTAGLANDINS, V14, P633, DOI 10.1016/0090-6980(77)90190-3; Anglade P, 1996, NEURODEGENERATION, V5, P121, DOI 10.1006/neur.1996.0018; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Atlasz T, 2010, BRAIN RES BULL, V81, P497, DOI 10.1016/j.brainresbull.2009.09.004; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Becker C, 2010, PARKINSONISM RELAT D, V16, P31, DOI 10.1016/j.parkreldis.2009.06.005; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Betarbet R, 2004, EXP NEUROL, V187, P76, DOI 10.1016/j.expneurol.2003.12.012; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carvalho MM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-14; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; CHIU EKY, 1985, GEN PHARMACOL-VASC S, V16, P163, DOI 10.1016/0306-3623(85)90064-3; COX HM, 1992, BRIT J PHARMACOL, V106, P498, DOI 10.1111/j.1476-5381.1992.tb14363.x; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Dejda A, 2011, PEPTIDES, V32, P1207, DOI 10.1016/j.peptides.2011.04.003; Deleidi M, 2013, CELL MOL LIFE SCI, V70, P4259, DOI 10.1007/s00018-013-1352-y; Dogrukol-Ak D, 2004, CURR PHARM DESIGN, V10, P1325, DOI 10.2174/1381612043384934; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Esposito E, 2007, EXP NEUROL, V205, P295, DOI 10.1016/j.expneurol.2007.02.008; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Feng ZH, 2003, NEUROREPORT, V14, P1927, DOI 10.1097/00001756-200310270-00009; Golovko MY, 2008, NEUROSCI LETT, V432, P243, DOI 10.1016/j.neulet.2007.12.031; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Henderson JM, 1999, EUR J NEUROSCI, V11, P2749, DOI 10.1046/j.1460-9568.1999.00692.x; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Higdon AN, 2012, ANTIOXID REDOX SIGN, V17, P1580, DOI 10.1089/ars.2012.4523; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Huang H, 2013, CELL BIOCHEM BIOPHYS, V67, P55, DOI 10.1007/s12013-013-9628-2; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Klivenyi P, 2003, J MOL NEUROSCI, V21, P191, DOI 10.1385/JMN:21:3:191; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Liu H, 2013, NEUROTOXICOLOGY, V39, P35, DOI 10.1016/j.neuro.2013.08.001; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Martinez B, 2005, J LIPID RES, V46, P736, DOI 10.1194/jlr.M400392-JLR200; McGeer EG, 2007, CNS DRUGS, V21, P789, DOI 10.2165/00023210-200721100-00001; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Metcalfe MJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.70; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Moody TW, 2011, CURR OPIN ENDOCRINOL, V18, P61, DOI 10.1097/MED.0b013e328342568a; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Myeku N, 2012, NEUROSCI LETT, V527, P126, DOI 10.1016/j.neulet.2012.08.051; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Ogburn KD, 2006, NEUROBIOL DIS, V22, P294, DOI 10.1016/j.nbd.2005.11.006; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; Ohtaki H, 2010, J MOL NEUROSCI, V42, P397, DOI 10.1007/s12031-010-9350-0; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Pierre SR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-18; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Reglodi D, 2004, BEHAV BRAIN RES, V151, P303, DOI 10.1016/j.bbr.2003.09.007; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rodriguez-Grande B, 2013, BRAIN BEHAV IMMUN, V29, P51, DOI 10.1016/j.bbi.2012.11.017; Satoh T, 2007, TRENDS NEUROSCI, V30, P37, DOI 10.1016/j.tins.2006.11.004; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shih AY, 2006, J NEUROSCI, V26, P3887, DOI 10.1523/JNEUROSCI.0936-06.2006; Silveira MS, 2006, ADV EXP MED BIOL, V557, P164; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Tan YV, 2011, ASN NEURO, V3, P195, DOI 10.1042/AN20110024; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Uchida H, 2010, INT J EXP PATHOL, V91, P256, DOI 10.1111/j.1365-2613.2010.00712.x; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357; Wang G, 2008, NEUROPEPTIDES, V42, P267, DOI 10.1016/j.npep.2008.03.002; Wang ZY, 2006, J BIOL CHEM, V281, P21377, DOI 10.1074/jbc.M601201200; Warraich ST, 2009, BRAIN RES BULL, V78, P85, DOI 10.1016/j.brainresbull.2008.08.023; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002	92	29	29	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	SEP	2014	1842	9					1707	1719		10.1016/j.bbadis.2014.06.020			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AO0BZ	WOS:000340975400042	24970746	Green Accepted			2021-06-18	
J	Tanriverdi, F; Dokmetas, HS; Kebapci, N; Kilicli, F; Atmaca, H; Yarman, S; Ertorer, ME; Erturk, E; Bayram, F; Tugrul, A; Culha, C; Cakir, M; Mert, M; Aydin, H; Taskale, M; Ersoz, N; Canturk, Z; Anaforoglu, I; Ozkaya, M; Oruk, G; Hekimsoy, Z; Kelestimur, F; Erbas, T				Tanriverdi, F.; Dokmetas, H. S.; Kebapci, N.; Kilicli, F.; Atmaca, H.; Yarman, S.; Ertorer, M. E.; Erturk, E.; Bayram, F.; Tugrul, A.; Culha, C.; Cakir, M.; Mert, M.; Aydin, H.; Taskale, M.; Ersoz, N.; Canturk, Z.; Anaforoglu, I.; Ozkaya, M.; Oruk, G.; Hekimsoy, Z.; Kelestimur, F.; Erbas, T.			Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database	ENDOCRINE			English	Article						Hypopituitarism; Pituitary; Sheehan's syndrome; Pituitary tumors	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; REPLACEMENT THERAPY; SHEEHANS-SYNDROME; PREMATURE MORTALITY; GH REPLACEMENT; ACUTE-PHASE; HIGH-RISK; DYSFUNCTION	Hypopituitarism in adult life is commonly acquired and the main causes are known as pituitary tumors and/or their treatments. Since there are new insights into the etiology of hypopituitarism and presence of differences in various populations, more studies regarding causes of hypopituitarism are needed to be done in different ethnic groups with sufficient number of patients. Therefore, we performed a multi-center database study in Turkish population investigating the etiology of hypopituitarism in 773 patients in tertiary care institutions. The study was designed and coordinated by the Pituitary Study Group of SEMT (The Society of Endocrinology and Metabolism of Turkey). Nineteen tertiary reference centers (14 university hospitals and 5 training hospitals) from the different regions of Turkey participated in the study. It is a cross-sectional database study, and the data were recorded for 18 months. We mainly classified the causes of hypopituitarism as pituitary tumors (due to direct effects of the pituitary tumors and/or their treatments), extra-pituitary tumors and non-tumoral causes. Mean age of 773 patients (49.8 % male, 50.2 % female) was 43.9 +/- 16.1 years (range 16-84 years). The most common etiology of pituitary dysfunction was due to non-tumoral causes (49.2 %) among all patients. However, when we analyze the causes according to gender, the most common etiology in males was pituitary tumors, but the most common etiology in females was non-tumoral causes. According to the subgroup analysis of the causes of hypopituitarism in all patients, the most common four causes of hypopituitarism which have frequencies over 10 % were as follows: nonsecretory pituitary adenomas, Sheehan's syndrome, lactotroph adenomas and idiopathic. With regard to the type of hormonal deficiencies; FSH/LH deficiency was the most common hormonal deficit (84.9 % of the patients). In 33.8 % of the patients, 4 anterior pituitary hormone deficiencies (FSH/LH, ACTH, TSH, and GH) were present. Among all patients, the most frequent cause of hypopituitarism was non-secretory pituitary adenomas. However, in female patients, present study clearly demonstrates that Sheehan's syndromeis still one of the most important causes of hypopituitarism in Turkish population. Further, population-based prospective studies need to be done to understand the prevalence and incidence of the causes of hypopituitarism in different countries.	[Tanriverdi, F.; Bayram, F.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Dokmetas, H. S.; Kilicli, F.] Cumhuriyet Univ, Sch Med, Dept Endocrinol, Sivas, Turkey; [Kebapci, N.] Osmangazi Univ, Fac Med, Dept Endocrinol, Eskisehir, Turkey; [Atmaca, H.] Karaelmas Univ, Dept Endocrinol, Zonguldak, Turkey; [Yarman, S.] Istanbul Univ, Fac Med, Dept Endocrinol, Istanbul, Turkey; [Ertorer, M. E.] Baskent Univ, Fac Med, Div Endocrinol, Adana, Turkey; [Erturk, E.] Uludag Univ, Sch Med, Dept Endocrinol, Bursa, Turkey; [Tugrul, A.] Trakya Univ, Fac Med, Endocrinol Sect, Edirne, Turkey; [Culha, C.] Ankara Res & Training Hosp, Dept Endocrinol, Ankara, Turkey; [Cakir, M.] Selcuk Univ, Meram Sch Med, Div Endocrinol, Konya, Turkey; [Mert, M.] Okmeydani Training & Res Hosp, Dept Endocrinol, Istanbul, Turkey; [Aydin, H.] Yeditepe Univ, Sch Med, Dept Endocrinol, Istanbul, Turkey; [Taskale, M.] Dr Sadi Konuk Res Hosp, Dept Endocrinol, Istanbul, Turkey; [Ersoz, N.; Erbas, T.] Hacettepe Univ, Sch Med, Dept Endocrinol, Ankara, Turkey; [Canturk, Z.] Kocaeli Univ, Sch Med, Dept Endocrinol, Izmit, Kocaeli, Turkey; [Anaforoglu, I.] Trabzon Numune Educ & Res Hosp, Dept Endocrinol, Trabzon, Turkey; [Ozkaya, M.] Maras Sutcuimam Sch Med, Dept Endocrinol, Kahramanmaras, Turkey; [Oruk, G.] Ataturk Training & Res Hosp, Dept Endocrinol, Izmir, Turkey; [Hekimsoy, Z.] Celal Bayar Univ, Fac Med, Dept Internal Med, Div Endocrinol & Metab, Manisa, Turkey	Tanriverdi, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fatihtan@erciyes.edu.tr	ANAFOROGLU, INAN/AAG-8413-2021; ERTORER, MELEK EDA/ABI-3705-2020; Erturk, Erdinc/AAJ-6536-2021; Erbas, Tomris/AAF-7765-2019; Yarman, Sema/AAS-7526-2020; Oruk, Gonca/AAJ-7303-2020	ANAFOROGLU, INAN/0000-0001-8990-3713; ERTORER, MELEK EDA/0000-0001-7357-8709; 			Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; ARAFAH B M, 1986, Journal of Clinical Endocrinology and Metabolism, V62, P1173; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Benvenga S, 2004, AM J MED, V116, P767, DOI 10.1016/j.amjmed.2003.12.038; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; De Marinis L, 2006, J ENDOCRINOL INVEST, V29, P516, DOI 10.1007/BF03344141; Elumir-Mamba L.A.S., 2010, PHILIPP J INTERN MED, V48, P23; Fernandez-Rodriguez E, 2013, CLIN ENDOCRINOL, V78, P278, DOI 10.1111/j.1365-2265.2012.04516.x; Kelestimur F, 2005, EUR J ENDOCRINOL, V152, P581, DOI 10.1530/eje.1.01881; Kelestimur Fahrettin, 2003, Pituitary, V6, P181, DOI 10.1023/B:PITU.0000023425.20854.8e; Kurtulmus N, 2006, AGING CLIN EXP RES, V18, P536; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; SHEEHAN H L, 1965, J Obstet Gynaecol Br Commonw, V72, P103; SONKSEN PH, 1990, HORM RES, V33, P45, DOI 10.1159/000181583; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Stochholm K, 2008, EUR J ENDOCRINOL, V158, P447, DOI 10.1530/EJE-07-0523; Tanriverdi F, 2005, GROWTH HORM IGF RES, V15, P231, DOI 10.1016/j.ghir.2005.03.005; Tanriverdi F, 2012, PITUITARY, V15, P579, DOI 10.1007/s11102-011-0371-7; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TOOGOOD AA, 1995, CLIN ENDOCRINOL, V43, P97, DOI 10.1111/j.1365-2265.1995.tb01898.x; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306	34	29	29	0	18	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	SEP	2014	47	1					198	205		10.1007/s12020-013-0127-4			8	Endocrinology & Metabolism	Endocrinology & Metabolism	AS2CS	WOS:000344087600025	24366641				2021-06-18	
J	Xiang, J; Collins, CL; Liu, D; McKenzie, LB; Comstock, RD				Xiang, Joe; Collins, Christy L.; Liu, Daniel; McKenzie, Lara B.; Comstock, R. Dawn			Lacrosse Injuries Among High School Boys and Girls in the United States Academic Years 2008-2009 Through 2011-2012	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						lacrosse; epidemiology; injury prevention	WOMENS LACROSSE; DESCRIPTIVE EPIDEMIOLOGY; COLLEGIATE LACROSSE; SURVEILLANCE SYSTEM; HEAD-INJURIES; CONCUSSIONS; SPORTS; MENS; SYMPTOMS	Background: Lacrosse is a fast growing youth sport in the United States. Although there have been published studies examining injuries associated with lacrosse, significantly less research has been conducted in high school lacrosse players than in older lacrosse players. The objective of this study was to compare high school lacrosse injury rates and patterns by type of athletic activity (ie, competition vs practice) and sex. Hypothesis: Lacrosse injury rates and patterns differ by type of athletic activity and sex. Study Design: Descriptive epidemiology study. Methods: Using the High School RIO (Reporting Information Online) database, lacrosse exposure and injury data were collected during 4 academic years, 2008-2012, from a large sample of high schools in the United States. Schools' certified athletic trainers submitted exposure and injury information weekly. Results: During the study period, 1406 injuries occurred during 716,812 athlete exposures, for an injury rate of 1.96 per 1000 athlete exposures (AEs). Injury rates were higher in competition than in practice (3.61 vs 1.23 per 1000 AEs, respectively; rate ratio [RR], 2.94; 95% CI, 2.65-3.27). Boys had a higher injury rate than girls (2.26 vs 1.54 per 1000 AEs, respectively; RR, 1.47; 95% CI, 1.32-1.64). The most common injury diagnoses among both boys and girls were sprains/strains (boys: 35.6%; girls: 43.9%) and concussions (boys: 21.9%; girls: 22.7%). The most commonly injured body sites in competition were the head/face (32.0%), lower leg/ankle/foot (17.8%), and knee (12.2%), while in practice, the most commonly injured body sites were the lower leg/ankle/foot (34.9%), head/face (16.4%), and knee (12.7%). Among boys, the most common mechanisms of injury were contact with another person (40.9%) and no contact (21.1%). Among girls, the most common mechanisms of injury were no contact (26.2%), contact with a playing apparatus (24.0%), and overuse/chronic (17.7%). Most injured athletes (71.8%) returned to activity in 21 days, but 6.9% of all injuries required surgery. Conclusion: Lacrosse injury rates and patterns among high school athletes in the United States differ by type of athletic activity and sex. Future studies should continue to compare differences in injury rates and patterns in high school lacrosse, with particular emphasis placed on high-risk plays in competition and the prevention and management of concussions in both boys and girls.	[Xiang, Joe; Collins, Christy L.; Liu, Daniel; McKenzie, Lara B.; Comstock, R. Dawn] Nationwide Childrens Hosp, Columbus, OH 43205 USA	McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, RBIII, 700 Childrens Dr, Columbus, OH 43205 USA.	Lara.McKenzie@nationwidechildrens.org		McKenzie, Lara/0000-0003-2889-0001	National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack	The authors acknowledge the generous research funding contributions of the National Federation of State High School Associations, National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. This research would not be possible without the dedication of the certified athletic trainers across the United States who have generously shared their professional expertise and their time to report data to the High School RIO.	Bowers AL, 2010, AM J SPORT MED, V38, P527, DOI 10.1177/0363546509348754; Carter EA, 2010, INT J INJ CONTROL SA, V17, P111, DOI 10.1080/17457300903524888; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hall C, 2013, RES SPORTS MED, V21, P229, DOI 10.1080/15438627.2013.792085; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matz SO, 2004, AM J SPORT MED, V32, P608, DOI 10.1177/0363546503262172; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; National Federation of State High School Association, 2011 12 HIGH SCH ATH; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; United States Census Bureau, CENS REG DIV US; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	30	29	29	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2014	42	9					2082	2088		10.1177/0363546514539914			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	AP9GQ	WOS:000342387400006	25053695				2021-06-18	
J	Boye, NDA; Mattace-Raso, FUS; Van der Velde, N; Van Lieshout, EMM; De Vries, OJ; Hartholt, KA; Kerver, AJH; Bruijninckx, MMM; Van der Cammen, TJM; Patka, P; Van Beeck, EF				Boye, Nicole D. A.; Mattace-Raso, Francesco U. S.; Van der Velde, Nathalie; Van Lieshout, Esther M. M.; De Vries, Oscar J.; Hartholt, Klaas A.; Kerver, Albert J. H.; Bruijninckx, Milko M. M.; Van der Cammen, Tischa J. M.; Patka, Peter; Van Beeck, Ed F.		IMPROveFALL Trial Collaborators	Circumstances leading to injurious falls in older men and women in the Netherlands	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Falls; Hip fractures; TBI; Circumstances; Indoor; Outdoor; Season; Activity; Elderly	ELDERLY-PEOPLE; HIP FRACTURE; OUTDOOR FALLS; RISK; CONSEQUENCES; ADULTS; LOCATION; INDOOR; COSTS	Background: Fall-induced injuries in persons aged 65 years and older are a major public health problem. Data regarding circumstances leading to specific injuries, such as traumatic brain injury (TBI) and hip fractures in older adults are scarce. Objective: To investigate the activity distributions leading to indoor and outdoor falls requiring an emergency department (ED) visit, and those resulting in TBIs and hip fractures. Participants: 5880 older adults who visited the ED due to a fall. Methods: Data is descriptive and stratified by age and gender. Results: Two-thirds of all falls occurred indoors. However, there were higher proportions of outdoor falls at ages 65-79 years (48%). Walking up or down stairs (51%) and housekeeping (17%) were the most common indoor activities leading to a TBIs. Walking (42%) and sitting or standing (16%) was the most common indoor activities leading to a hip fracture. The most common outdoor activities were walking (61% for TBIs and 57% for hip fractures) and cycling (10% for TBIs and 24% for hip fractures). Conclusion: In the present study we found that the indoor activities distribution leading to TBIs and hip fractures differed. Notably, about half of the traumatic brain injuries and hip fractures in men and women aged 65-79 years occurred outdoors. This study provides new insights into patterns leading to injurious falls by age, gender and injury type, and may guide the targeting of falls prevention at specific activities and risk groups, including highly functional older men and women. (C) 2014 Elsevier Ltd. All rights reserved.	[Boye, Nicole D. A.; Mattace-Raso, Francesco U. S.; Van der Velde, Nathalie; Hartholt, Klaas A.; Van der Cammen, Tischa J. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Geriatr Med Sect, NL-3000 CA Rotterdam, Netherlands; [Boye, Nicole D. A.; Van Lieshout, Esther M. M.; Hartholt, Klaas A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg Traumatol, NL-3000 CA Rotterdam, Netherlands; [Patka, Peter] Univ Med Ctr Rotterdam, Erasmus MC, Dept Accid & Emergency Med, NL-3000 CA Rotterdam, Netherlands; [Van Beeck, Ed F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Van der Velde, Nathalie; De Vries, Oscar J.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Kerver, Albert J. H.] St Franciscus Gasthuis, Dept Surg, Rotterdam, Netherlands; [Bruijninckx, Milko M. M.] IJsselland Hosp, Dept Surg, Capelle Aan Den Ijssel, Netherlands	Boye, NDA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.boye@erasmusmc.nl	Hartholt, Klaas A/Q-1782-2016; Mattace- Raso, Francesco/L-2541-2015	Hartholt, Klaas A/0000-0001-5019-9239; van der Velde, Nathalie/0000-0002-6477-6209	Netherlands Organisation for Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development [170.885.607]	This work was supported by a research grant from the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 170.885.607].	Abolhassani F, 2006, BONE, V39, P408, DOI 10.1016/j.bone.2006.01.144; Aharonoff GB, 1998, CLIN ORTHOP RELAT R, P10; Allander E, 1998, ACCIDENT ANAL PREV, V30, P607, DOI 10.1016/S0001-4575(98)00016-5; ASHLEY M J, 1977, Age and Ageing, V6, P211, DOI 10.1093/ageing/6.4.211; Bath PA, 1999, EUR J EPIDEMIOL, V15, P65, DOI 10.1023/A:1007531101765; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bergland A, 1998, Physiother Res Int, V3, P164, DOI 10.1002/pri.138; Bleijlevens MHC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-40; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Close JC, 2011, EMERG MED J; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Coutinho ESF, 2009, CAD SAUDE PUBLICA, V25, P455, DOI 10.1590/S0102-311X2009000200024; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Greenspan AI, 2006, J TRAUMA, V61, P1234, DOI 10.1097/01.ta.0000231558.71696.1a; Hartholt KA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-48; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Jensen J, 2002, SCAND J PUBLIC HEALT, V30, P54, DOI 10.1177/14034948020300011201; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kelsey JL, 2012, J AM GERIATR SOC, V60, P517, DOI 10.1111/j.1532-5415.2011.03834.x; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kochanek KD, 2011, VOL NATL VITAL STAT, V59; Kojima S, 2008, GERIATR GERONTOL INT, V8, P272, DOI 10.1111/j.1447-0594.2008.00476.x; Lai PC, 2011, J MED SYST, V35, P1543, DOI 10.1007/s10916-010-9431-1; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Nachreiner NM, 2007, J WOMENS HEALTH, V16, P1437, DOI 10.1089/jwh.2006.0245; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; Rapp K., 2012, J AM MED DIR ASSOC, V13, pe181; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; World Health Organization (WHO), 2008, ICD 10 INT STAT CLAS; Yasumura S, 1996, ARCH GERONTOL GERIAT, V23, P95, DOI 10.1016/0167-4943(96)00711-X	44	29	29	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2014	45	8					1224	1230		10.1016/j.injury.2014.03.021			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AN0MU	WOS:000340279500015	24818642				2021-06-18	
J	McNett, M; Amato, S; Gianakis, A; Grimm, D; Philippbar, SA; Belle, J; Moran, C				McNett, Molly; Amato, Shelly; Gianakis, Anastasia; Grimm, Dawn; Philippbar, Sue Ann; Belle, Josie; Moran, Cristina			The FOUR Score and GCS as Predictors of Outcome After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Coma Scale; Outcome prediction; Traumatic brain injury	GLASGOW COMA SCALE; FUNCTIONAL INDEPENDENCE MEASURE; INTERRATER RELIABILITY; EMERGENCY-DEPARTMENT; IMPAIRED CONSCIOUSNESS; NATIONAL-SURVEY; HEAD-INJURY; VALIDATION; MEMORY	The Glasgow Coma Scale (GCS) is a routine component of a neurological exam for critically ill traumatic brain injury (TBI) patients, yet has been criticized for not accurately depicting verbal status among intubated patients or including brain stem reflexes. Preliminary research on the Full Outline of UnResponsiveness (FOUR) Scale suggests it overcomes these limitations. Research is needed to determine correlations with patient outcomes. The aims of this study were to: (1) examine correlations between 24 and 72 h FOUR and GCS scores and functional/cognitive outcomes; (2) determine relationship between 24 and 72 h FOUR scores and mortality. Prospective cohort study. Data gathered on adult TBI patients at a Level I trauma center. FOUR scores assigned at 24, 72 h. Functional outcome measured by functional independence measure scores at rehabilitation discharge; cognitive status measured by Weschler Memory Scale scores 3 months post-injury. n = 136. Mean age 53.1. 72 h FOUR and GCS scores correlated with functional outcome (r (s) = 0.34, p = 0.05; r (s) = 0.39, p = 0.02), but not cognitive status. Receiver operating characteristic curves were comparable for FOUR and GCS at 24 and 72 h for functional status (24 h FOUR, GCS = 0.625, 0.602, respectively; 72 h FOUR, GCS = 0.640, 0.688), cognitive status (24 h FOUR, GCS = 0.703, 0.731; 72 h FOUR, GCS = 0.837, 0.674), and mortality (24 h FOUR, GCS = 0.913, 0.935; 72 h FOUR, GCS = 0.837, 0.884). FOUR is comparable to GCS in terms of predictive ability for functional status, cognitive outcome 3 months post-injury, and in-hospital mortality.	[McNett, Molly] MetroHlth Syst, Dept Nursing Res, Cleveland, OH 44109 USA; [Amato, Shelly] MetroHlth Rehabil Inst Ohio, Dept Nursing, Cleveland, OH USA; [Gianakis, Anastasia; Grimm, Dawn] MetroHlth Syst, Dept Nursing, Trauma Crit Care Burns, Cleveland, OH USA; [Philippbar, Sue Ann] Case Western Reserve Univ, Dept Phys Med & Rehabil, MetroHlth Rehabil Inst Ohio, Cleveland, OH 44106 USA; [Belle, Josie; Moran, Cristina] MetroHlth Syst, Dept Nursing, Trauma Crit Care, Cleveland, OH USA	McNett, M (corresponding author), MetroHlth Syst, Dept Nursing Res, Cleveland, OH 44109 USA.	mmcnett@metrohealth.org			Sigma Theta Tau International	This study received partial funding from Sigma Theta Tau International.	BHATTY GB, 1993, ACTA NEUROCHIR, V120, P132, DOI 10.1007/BF02112031; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Franzen MD, 2000, RELIABILITY VALIDITY, V2nd; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Hinkle JL, 2010, REHABIL NURS, V35, P23, DOI 10.1002/j.2048-7940.2010.tb00027.x; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Iverson G, 1999, J COGNITIVE REHABILI, V17, P16; Juarez V J, 1995, J Neurosci Nurs, V27, P283; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marolf M., 1996, CLIN REHABIL, V10, P309; MCHORNEY CA, 1995, MED CARE, V33, P15, DOI 10.1097/00005650-199501000-00002; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; Roh DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	34	29	34	0	12	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2014	21	1					52	57		10.1007/s12028-013-9947-6			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AL7XP	WOS:000339350500008	24408147				2021-06-18	
J	Levy, AS; Orlando, A; Salottolo, K; Mains, CW; Bar-Or, D				Levy, Andrew Stewart; Orlando, Alessandro; Salottolo, Kristin; Mains, Charles W.; Bar-Or, David			Outcomes of a Nontransfer Protocol for Mild Traumatic Brain Injury with Abnormal Head Computed Tomography in a Rural Hospital Setting	WORLD NEUROSURGERY			English	Article						Brain injuries; Hemorrhage; Neurosurgery; Outcome assessment	NEW-ORLEANS CRITERIA; INTRACRANIAL INJURY; CT; RULE; VALIDATION; MANAGEMENT; PREDICTORS; CARE	OBJECTIVE: This study sought to investigate outcomes after a novel nontransfer protocol for mild traumatic brain injuries patients with small intracranial hemorrhage (ICH) in a rural trauma center without neurosurgical capabilities. METHODS: This was a retrospective cohort study. In 2007, a nontransfer protocol was implemented at a Level III Trauma Center. It included adult patients from April 2007 through December 2012 with mild traumatic brain injury (mTBI) (Glasgow Coma Scale score 13 to 15) and computed tomography (CT) showing small ICH and no coagulopathy. The following ICHs were allowed: 1) minimal or small traumatic subarachnoid hemorrhage, 2) punctuate or minimal superficial cerebral contusion, 3) punctuate or minimal intraparenchymal hemorrhage, or 4) very small subdural hemorrhage (SDH) without mass effect (a very thin smear SDH along the tentorium or falx). CT scans were reviewed by the on-call neurosurgeon at an affiliated Level I Trauma Center, and consensus was obtained on the suitability for nontransfer. RESULTS: A total of 76 patients were included. The median hospital length of stay was 1 day (interquartile range = 1 day). No patient required a neurosurgical intervention or postadmission transfer to a Level I facility. There were no in-hospital deaths, and all patients were discharged with stable head CTs and in good neurologic condition. Two patients were readmitted for nonprotocol-related reasons: 1 acute-on-chronic SDH 6 weeks postdischarge, and 1 visual eye change with normal CT 2 days postdischarge. CONCLUSIONS: Our 6-year study corroborates the low neurosurgical rate reported in the literature for mTBI with small ICH. Nontransfer protocols may lead to a more efficient use of hospital resources while providing safe, effective and economical health care.	[Levy, Andrew Stewart] St Antonius Hosp, InterMountain Neurosurg, Lakewood, CO USA; [Orlando, Alessandro; Salottolo, Kristin; Bar-Or, David] St Antonius Hosp, Trauma Res Dept, Lakewood, CO 80228 USA; [Mains, Charles W.] St Antonius Hosp, Trauma Serv Dept, Lakewood, CO USA; [Mains, Charles W.; Bar-Or, David] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA	Bar-Or, D (corresponding author), St Antonius Hosp, Trauma Res Dept, Lakewood, CO 80228 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Clement CM, 2006, ANN EMERG MED, V48, P245, DOI 10.1016/j.annemergmed.2006.04.008; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Livingston DH, 1991, J TRAUMA, V31, P487; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	20	29	29	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL-AUG	2014	82	1-2					E319	E323		10.1016/j.wneu.2013.11.008			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AQ6HM	WOS:000342911400076	24240025				2021-06-18	
J	Sajja, VSSS; Ereifej, ES; VandeVord, PJ				Sajja, Venkata Siva Sai Sujith; Ereifej, Evon S.; VandeVord, Pamela J.			Hippocampal vulnerability and subacute response following varied blast magnitudes	NEUROSCIENCE LETTERS			English	Article						Hippocampus; Blast; Magnitude; Oxidative stress; Piezo2	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; INFLAMMATION; NEURONS; LEADS; MODEL; PCR	Clinical outcomes from blast neurotrauma are associated with higher order cognitive functions such as memory, problem solving skills and attention. Current literature is limited to a single overpressure exposure or repeated exposures at the same level of overpressure and is focused on the acute response (<3 days). In an attempt to expand the understanding of neuropathological and molecular changes of the subacute response (7 days post injury), we used an established rodent model of blast neurotrauma. Three pressure magnitudes (low, moderate and high) were used to evaluate molecular injury thresholds. Immunohistochemical analysis demonstrated increased cleaved caspase-3 levels and loss of neuronal population (NeuN +) within the hippocampus of all pressure groups. On the contrary, selective activation of microglia was observed in the low blast group. In addition, increased astrocytes (GFAP), membrane signal transduction protein (Map2k1) and calcium regulator mechanosensitive protein (Piezo 2) were observed in the moderate blast group. Results from gene expression analysis suggested ongoing neuro-protection, as brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF) and Mn and CuZn superoxide dismutases (SOD) all increased in the low and moderate blast groups. Ongoing neuroprotection was further supported by increased SOD levels observed in the moderate group using immunohistochemistry. The gene expression level of glutamate aspartate transporter (GLAST) was upregulated in the low, but downregulated in the high blast group, while no changes were found in the moderate group. Overall, the data shown here provides evidence of a diverse neuroprotective and glial response to various levels of blast exposure. This mechanistic role of neuroprotection is vital in understanding ongoing cellular stress, both at the gene and protein levels, in order to develop interventional studies for the prognosis of injury. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Sajja, Venkata Siva Sai Sujith; Ereifej, Evon S.; VandeVord, Pamela J.] Virginia Polytech & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Res & Dev Serv, Salem, VA USA	VandeVord, PJ (corresponding author), 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	sujith.srm@gmail.com; pvord@vt.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0207]	This project was supported by a Department of Defense contract to Pamela J VandeVord, W81XWH-08-2-0207. We would also like to thank Hyung Joon Cho for the technical assistance provided in this project.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rauh MJ, 2013, J REHABIL RES DEV, V50, P161, DOI 10.1682/JRRD.2011.11.0212; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	23	29	33	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 6	2014	570						33	37		10.1016/j.neulet.2014.03.072			5	Neurosciences	Neurosciences & Neurology	AI6VM	WOS:000337015100008	24726403				2021-06-18	
J	He, BR; Xie, ST; Wu, MM; Hao, DJ; Yang, H				He, Bao-Rong; Xie, Song-Tao; Wu, Ming-Mei; Hao, Ding-Jun; Yang, Hao			Phagocytic Removal of Neuronal Debris by Olfactory Ensheathing Cells Enhances Neuronal Survival and Neurite Outgrowth via p38MAPK Activity	MOLECULAR NEUROBIOLOGY			English	Article						Olfactory ensheathing cells; Phagocytosis; Neuron; Survival; p38MAPK	SPINAL-CORD-INJURY; IN-VITRO; SCHWANN-CELLS; WALLERIAN DEGENERATION; AXONAL REGENERATION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; NOGO RECEPTOR; RAT-BRAIN; GLIA	Compelling evidence from animal models and clinical studies suggest that transplantation of olfactory ensheathing cells (OECs), specialized glia in the olfactory system, combined with specific training may be therapeutically useful in the central nervous system (CNS) injuries and neurodegenerative diseases. The unique function of OECs could mainly attribute to both production of cell adhesion molecules and secretion of growth factors in OECs, which support neuron survival and neurite outgrowth. However, little is known about whether engulfment of neuronal degenerative debris by OECs also equally contributes to neuronal survival and neurite outgrowth. Furthermore, the molecular mechanisms responsible for neuronal degenerative corpses' removal remain elusive. Here, we used an in vitro model of primary culture of spinal cord neurons to investigate the effect of engulfment of degenerative neuron debris by OECs on neuronal survival and neurite outgrowth and the possible molecular mechanisms. Our results showed that OECs can engulf an amount of degenerated neuron debris, and this phagocytosis can make a substantial contribution to neuron growth, as demonstrated by increased number of neurons with longer neurite length and richer neurite branches when compared with the combination of neuron debris and OEC conditioned medium (OECCM). Moreover, p38 mitogen-activated protein kinase (p38MAPK) signaling pathway may mediate the OEC engulfment of debris because the p38MAPK-specific inhibitor, SB203580, can abrogate all the positive effects of OECs, including clearance of degenerated neuron debris and generation of bioactive molecules, indicating that p38MAPK is required for the process of phagocytosis of the neuron debris. In addition, the OEC phagocytic activity had no influence on its generation of bioactive molecules. Therefore, these findings provide new insight into further investigations on the OEC role in the repair of traumatic CNS injury and neurodegenerative diseases.	[He, Bao-Rong] Xi An Jiao Tong Univ, Coll Med, Hong Hui Hosp, Dept Spine Surg, Xian 710054, Shaanxi, Peoples R China; [Xie, Song-Tao] Fourth Mil Med Univ, Dept Burns & Cutaneous Surg, Xijing Hosp, Xian 710032, Peoples R China; [Wu, Ming-Mei] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; [Hao, Ding-Jun] Xi An Jiao Tong Univ, Coll Med, Hong Hui Hosp, Dept Orthopaed, Xian 710054, Shaanxi, Peoples R China; [Yang, Hao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Clin Stem Cell Res Ctr, Shanghai 200217, Peoples R China	Hao, DJ (corresponding author), Xi An Jiao Tong Univ, Coll Med, Hong Hui Hosp, Dept Orthopaed, Xian 710054, Shaanxi, Peoples R China.	haodingjun@163.com; yanghao.71_99@yahoo.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371411, 81071486, 81171137, 81372056]	This work was supported by the Natural Science Foundation of China (grant nos. 81371411, 81071486, 81171137, and 81372056).	Aldskogius H, 2001, MICROSC RES TECHNIQ, V54, P40, DOI 10.1002/jemt.1119; Bhat NR, 1998, J NEUROSCI, V18, P1633; Buss A, 2005, BRAIN, V128, P356, DOI 10.1093/brain/awh355; Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Gudino-Cabrera G, 2000, GLIA, V30, P49, DOI 10.1002/(SICI)1098-1136(200003)30:1<49::AID-GLIA6>3.0.CO;2-M; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harris JA, 2009, GLIA, V57, P1848, DOI 10.1002/glia.20899; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930; Kafitz KW, 1999, GLIA, V25, P99, DOI 10.1002/(SICI)1098-1136(19990115)25:2<99::AID-GLIA1>3.0.CO;2-V; Kocsis JD, 2009, NEUROSCI LETT, V456, P137, DOI 10.1016/j.neulet.2008.08.093; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Leung JYK, 2008, CELL MOL LIFE SCI, V65, P2732, DOI 10.1007/s00018-008-8184-1; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; Li YB, 1998, NEUROSCI RES, V32, P137, DOI 10.1016/S0168-0102(98)00077-7; Liu Y, 2010, MOL VIS, V16, P2903; Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011; Ma YH, 2010, CELL TRANSPLANT, V19, P167, DOI 10.3727/096368910X492634; MIRAGALL F, 1989, DEV BIOL, V135, P272, DOI 10.1016/0012-1606(89)90179-6; Mitchell PJ, 2007, J NEUROSCI METH, V164, P350, DOI 10.1016/j.jneumeth.2007.04.021; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nacher J, 1999, HISTOL HISTOPATHOL, V14, P89, DOI 10.14670/HH-14.89; Navarro X, 1999, ANN NEUROL, V45, P207, DOI 10.1002/1531-8249(199902)45:2<207::AID-ANA11>3.0.CO;2-K; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Pastrana E, 2007, NEUROCHEM INT, V50, P491, DOI 10.1016/j.neuint.2006.10.004; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Pellitteri R, 2007, NEUROSCI LETT, V417, P24, DOI 10.1016/j.neulet.2007.02.065; Raisman G, 2007, NAT REV NEUROSCI, V8, P312, DOI 10.1038/nrn2099; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2; RAMONCUETO A, 1995, GLIA, V14, P163, DOI 10.1002/glia.440140302; Ruitenberg MJ, 2005, BRAIN, V128, P839, DOI 10.1093/brain/awh424; Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Vincent AJ, 2007, GLIA, V55, P905, DOI 10.1002/glia.20512; Vincent AJ, 2005, J NEUROCYTOL, V34, P65, DOI 10.1007/s11068-005-5048-6; Vincent AJ, 2005, GLIA, V51, P132, DOI 10.1002/glia.20195; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Williams SK, 2004, J COMP NEUROL, V470, P50, DOI 10.1002/cne.11045; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y; Yang H, 2011, NEUROCHEM INT, V59, P1010, DOI 10.1016/j.neuint.2011.08.021; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Yang Hao, 2003, Shi Yan Sheng Wu Xue Bao, V36, P5	55	29	30	3	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2014	49	3					1501	1512		10.1007/s12035-013-8588-2			12	Neurosciences	Neurosciences & Neurology	AG8KE	WOS:000335666500028	24258406				2021-06-18	
J	Mannix, R; Iverson, GL; Maxwell, B; Atkins, JE; Zafonte, R; Berkner, PD				Mannix, Rebekah; Iverson, Grant L.; Maxwell, Bruce; Atkins, Joseph E.; Zafonte, Ross; Berkner, Paul D.			Multiple prior concussions are associated with symptoms in high school athletes	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article								Objectives: The purpose of this study was to evaluate the association of prior concussion on baseline computerized neurocognitive testing in a large cohort of high school athletes. Methods: This is a retrospective cohort study of student athletes from 49 Maine High Schools in 2010 who underwent baseline computerized neurocognitive evaluation with Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT (R)). As part of the ImPACT (R), subjects reported a prior history of concussion as well as demographic information and a symptom questionnaire. We used linear regression to evaluate the association of prior concussion with baseline: (1) ImPACT (R) composite scores; and (2) symptom scores. Results: Six thousand seventy-five subjects were included in the study, of whom 57% were boys. The majority of student athletes (85.3%) reported no prior history of concussion while 4.6% reported having sustained two or more prior concussions. On simple linear regression, increasing number of concussions was related to worse performance in verbal memory (P = 0.039) and greater symptoms scores (P < 0.001). On multivariate modeling, only the association with baseline symptoms remained (P < 0.001). Other factors associated with baseline symptom reporting in the multivariate model included mental health history, headache/migraine history, gender, developmental and/or learning problems, and number of prior concussions. Interpretation: In this large-scale, retrospective survey study, history of multiple prior concussions was associated with higher symptom burden but not baseline computerized neurocognitive testing. The association between baseline symptom reporting and clinical and demographic factors was greater than the association with a history of multiple concussions.	[Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Mannix, Rebekah; Iverson, Grant L.; Zafonte, Ross] Harvard Med Sch, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.; Zafonte, Ross] Spaulding Rehabil Hosp, Boston, MA USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Atkins, Joseph E.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA	Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	rebekah.mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Iverson, Grant/0000-0001-7348-9570			Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P254, DOI 10.1080/09084280903297594; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Rosenthal JA, 2014, AM J SPORTS MED; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	24	29	29	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JUN	2014	1	6					433	438		10.1002/acn3.70			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V45KI	WOS:000209815100006	25356413	DOAJ Gold, Green Published			2021-06-18	
J	Kamnaksh, A; Budde, MD; Kovesdi, E; Long, JB; Frank, JA; Agoston, DV				Kamnaksh, Alaa; Budde, Matthew D.; Kovesdi, Erzsebet; Long, Joseph B.; Frank, Joseph A.; Agoston, Denes V.			Diffusion Tensor Imaging Reveals Acute Subcortical Changes after Mild Blast-Induced Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							LONG-TERM CONSEQUENCES; AXONAL INJURY; MILITARY; CONCUSSION; BIOMARKERS; VETERANS; COMBAT; MODEL; RATS; MRI	Mild blast-induced traumatic brain injury (mbTBI) poses special diagnostic challenges due to its overlapping symptomatology with other neuropsychiatric conditions and the lack of objective outcome measures. Diffusion tensor imaging (DTI) can potentially provide clinically relevant information toward a differential diagnosis. In this study, we aimed to determine if single and repeated (5 total; administered on consecutive days) mild blast overpressure exposure results in detectable structural changes in the brain, especially in the hippocampus. Fixed rat brains were analyzed by ex vivo DTI at 2 h and 42 days after blast (or sham) exposure(s). An anatomy-based region of interest analysis revealed significant interactions in axial and radial diffusivity in a number of subcortical structures at 2 h only. Differences between single-and multiple-injured rats were largely in the thalamus but not the hippocampus. Our findings demonstrate the value and the limitations of DTI in providing a better understanding of mbTBI pathobiology.	[Kamnaksh, Alaa; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Kamnaksh, Alaa] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Budde, Matthew D.; Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD 20892 USA; [Kovesdi, Erzsebet] US Dept Vet Affairs, Vet Affairs Cent Off, Washington, DC 20420 USA; [Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA	Agoston, DV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	denes.agoston@usuhs.edu	Frank, Joseph/W-2021-2019		Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G1703F]; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	We thank the Neurotrauma Team at the Walter Reed Army Institute of Research for their technical help during the exposures, along with Eric Gold and Lindsay Janes for assistance with the MRI experiments. This work was supported by the Center for Neuroscience and Regenerative Medicine grant number G1703F.	Adluru N, 2012, NEUROIMAGE, V59, P306, DOI 10.1016/j.neuroimage.2011.07.029; Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Crestani CC, 2013, CURR NEUROPHARMACOL, V11, P141, DOI 10.2174/1570159X11311020002; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu HB, 2010, MAGN RESON IMAGING, V28, P146, DOI 10.1016/j.mri.2009.05.019; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Paxinos G., 2007, RAT BRAIN STEREOTACT; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rodrigo J, 2002, HISTOL HISTOPATHOL, V17, P973, DOI 10.14670/HH-17.973; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	59	29	30	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 2	2014	4								4809	10.1038/srep04809			6	Multidisciplinary Sciences	Science & Technology - Other Topics	AG1ZZ	WOS:000335216000001	24786839	DOAJ Gold, Green Published			2021-06-18	
J	Laribi, S; Kansao, J; Borderie, D; Collet, C; Deschamps, P; Ababsa, R; Mouniam, L; Got, L; Leon, A; Thoannes, H; Santin, A; Kouyoumdjian, JC; Dahyot-Fizelier, C; Millet, C; Golmard, JL; Beaudeux, JL				Laribi, Said; Kansao, Jamal; Borderie, Didier; Collet, Corinne; Deschamps, Patrick; Ababsa, Redha; Mouniam, Leonard; Got, Laurence; Leon, Alain; Thoannes, Henri; Santin, Aline; Kouyoumdjian, Jean-Claude; Dahyot-Fizelier, Claire; Millet, Catherine; Golmard, Jean-Louis; Beaudeux, Jean-Louis		Stic-S100 Study Grp	S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						biomarker; cranial computed tomography; liquid-phase immunoassay; minor head injury; S100B protein	TRAUMATIC-BRAIN-INJURY; S-100 PROTEIN MEASUREMENTS; COMPUTED-TOMOGRAPHY; SERUM-LEVELS; EMERGENCY-DEPARTMENT; MANAGEMENT; MARKER; DAMAGE; ALCOHOL; ELIMINATION	Background: S100B protein measurement in blood is proposed to exclude the presence of computed tomography (CT) lesions after minor head injury (MHI). We aimed to validate S100B as an accurate and valuable screening tool for MHI diagnosis in a large multicenter study, as well as: 1) to evaluate whether a second S100B blood level determination 3 h after the first one would be informative; 2) to compare the bioclinical performances of the two commercially available automated methods of measurement of S100B for the screening of patients. Methods: Four thousand and thirty MHI subjects were enrolled in a prospective observational multicenter study; results for serum S100B measurement determined within 3 h after the clinical event (H0) then at H3 were compared to that of cranial CT scans performed with 6 h following the presentation to emergency department. Both the Diasorin and the Roche Diagnostics assays were systematically performed. Results: Cerebral lesions on CT scan were identified with sensitivity and negative-predictive value (NPV) of 96.3% and 99.4% (Diasorin, 1 dissonant case), and of 100% and 100% (Roche Diagnostics, no dissonant case). Sensitivity and NPV at H3 appeared lower than those at H0, due to the rapid decrease in S100B levels. Conclusions: Serum S100B level on admission of patients with MHI is an accurate and useful screening tool to exclude intracranial lesions. Performing a second late S100B level determination is not informative. The two automated immunoassays appear usable in a similar manner, although the two methods are not interchangeable.	[Beaudeux, Jean-Louis] APHP, Dept Clin Chem, F-75015 Paris, France; [Laribi, Said] CHU Lariboisiere, APHP, Emergency Dept, Paris, France; [Kansao, Jamal] CHU Cochin, APHP, Emergency Dept, Paris, France; [Borderie, Didier] CHU Cochin, APHP, Dept Biol Clin, Paris, France; [Collet, Corinne] CHU Lariboisiere, APHP, Dept Biol Clin, Paris, France; [Deschamps, Patrick] CHG Pontoise, Emergency Dept, Pontoise, France; [Ababsa, Redha] CHG Pontoise, Dept Biol Clin, Pontoise, France; [Mouniam, Leonard] CHG Orleans, Emergency Dept, Orleans, France; [Got, Laurence] CHG Orleans, Dept Biol Clin, Orleans, France; [Leon, Alain] CHU Reims, Emergency Dept, Reims, France; [Thoannes, Henri] CHU Reims, Dept Biol Clin, Reims, France; [Santin, Aline] CHU Henri Mondor, APHP, Emergency Dept, F-94010 Creteil, France; [Kouyoumdjian, Jean-Claude] CHU Henri Mondor, APHP, Dept Biol Clin, F-94010 Creteil, France; [Dahyot-Fizelier, Claire] CHU Poitiers, Emergency Dept, Poitiers, France; [Millet, Catherine] CHU Poitiers, Dept Biol Clin, Poitiers, France; [Golmard, Jean-Louis] CHU Pitie Salpetriere, APHP, Dept Clin Res, Paris, France	Beaudeux, JL (corresponding author), APHP, Dept Clin Chem, 149 Rue Sevres, F-75015 Paris, France.	jean-louis.beaudeux@parisdescartes.fr	Laribi, said/S-3693-2016; Laribi, Said/D-5229-2014	collet, corinne/0000-0001-6990-863X			Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Einav S, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-9; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Erickson JA, 2011, CLIN CHIM ACTA, V412, P2122, DOI 10.1016/j.cca.2011.07.020; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P123, DOI 10.1097/HTR.0b013e31820e6840; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	29	31	0	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	APR	2014	52	4					527	536		10.1515/cclm-2013-0621			10	Medical Laboratory Technology	Medical Laboratory Technology	AC1AO	WOS:000332226800018	24225131				2021-06-18	
J	Luo, P; Chen, T; Zhao, Y; Zhang, L; Yang, Y; Liu, W; Li, S; Rao, W; Dai, S; Yang, J; Fei, Z				Luo, P.; Chen, T.; Zhao, Y.; Zhang, L.; Yang, Y.; Liu, W.; Li, S.; Rao, W.; Dai, S.; Yang, J.; Fei, Z.			Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors	CELL DEATH & DISEASE			English	Article						excitotoxicity; metabotropic glutamate receptor; postsynaptic density; scaffold protein; traumatic brain injury	NEURONAL INJURY; ACTIVATION; MGLUR5; VITRO; INHIBITION; PSD-95; FAMILY; MODEL; VIVO; RAT	Traumatic brain injury (TBI) produces excessive glutamate, leading to excitotoxicity via the activation of glutamate receptors. Postsynaptic density scaffold proteins have crucial roles in mediating signal transduction from glutamate receptors to their downstream mediators. Therefore, studies on the mechanisms underlying regulation of excitotoxicity by scaffold proteins can uncover new treatments for TBI. Here, we demonstrated that the postsynaptic scaffold protein Homer 1a was neuroprotective against TBI in vitro and in vivo, and this neuroprotection was associated with its effects on group I metabotropic glutamate receptors (mGluRs). Upon further study, we found that Homer 1a mainly affected neuronal injury induced by mGluR1 activation after TBI and also influenced mGluR5 function when its activity was restored. The ability of Homer 1a to disrupt mGluR-ERK signaling contributed to its ability to regulate the functions of mGluR1 and mGluR5 after traumatic injury. Intracellular Ca2+ and PKC were two important factors involved in the mediation of mGluR-ERK signaling by Homer 1a. These results define Homer 1a as a novel endogenous neuroprotective agent against TBI.	[Luo, P.; Chen, T.; Zhao, Y.; Zhang, L.; Yang, Y.; Liu, W.; Li, S.; Rao, W.; Dai, S.; Fei, Z.] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Yang, J.] Boston Univ, Sch Med, Boston Vet Affairs Healthcare Syst, Dept Surg, Boston, MA 02130 USA	Yang, J (corresponding author), Boston Univ, Sch Med, Boston Vet Affairs Healthcare Syst, Dept Surg, 150 South Huntington Ave, Boston, MA 02130 USA.	jyang@bu.edu		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30930093, 81301037, 81200949]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2012SF2-01-4]; Research Foundation of PLA [2010gxjs078, AWS11J008]	The work was supported by National Natural Science Foundation of China (Nos. 30930093, 81301037 and 81200949), National Science and Technology Major Project of China (2013ZX 09J13109-02C); National Science and Technology Pillar Program of China (No. 2012BAI11B02), Science and Technology Project of Shaanxi (No. 2012SF2-01-4), and Research Foundation of PLA (Nos. 2010gxjs078 and AWS11J008).	Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Berent-Spillson A, 2004, J NEUROCHEM, V89, P90, DOI 10.1111/j.1471-4159.2003.02321.x; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Camon L, 1998, J NEUROSCI RES, V51, P339, DOI 10.1002/(SICI)1097-4547(19980201)51:3<339::AID-JNR7>3.0.CO;2-H; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei Z, 2003, J CLIN NEUROSCI, V10, P684, DOI 10.1016/j.jocn.2003.04.001; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Kammermeier PJ, 2007, P NATL ACAD SCI USA, V104, P6055, DOI 10.1073/pnas.0608991104; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	39	29	32	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	APR	2014	5								e1174	10.1038/cddis.2014.116			13	Cell Biology	Cell Biology	AG5HP	WOS:000335450400020	24722299	DOAJ Gold, Green Published			2021-06-18	
J	Pischiutta, F; D'Amico, G; Dander, E; Biondi, A; Biagi, E; Citerio, G; De Simoni, MG; Zanier, ER				Pischiutta, Francesca; D'Amico, Giovanna; Dander, Erica; Biondi, Andrea; Biagi, Ettore; Citerio, Giuseppe; De Simoni, Maria Grazia; Zanier, Elisa R.			Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain	NEUROPHARMACOLOGY			English	Article						Traumatic brain injury; Stem cell transplantation; Mesenchymal stromal cells; Cyclosporin A; Immunosuppression; Brain protection	UMBILICAL-CORD BLOOD; STEM-CELLS; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTORS; INJURY; EXPRESSION; CYCLOSPORINE; THERAPY; STROKE	The need for immunosuppression after allo/xenogenic mesenchymal stromal cell (MSC) transplantation is debated. This study compared the long-term effects of human (h) bone marrow MSC transplant in immunocompetent or immunosuppressed traumatic brain injured (TBI) mice. C57Bl/6 male mice were subjected to TBI or sham surgery followed 24 h later by an intra-cerebroventricular infusion of phosphate buffer saline (PBS, control) or hMSC (150,000/5 mu l). Immunocompetent and cyclosporin A immunosuppressed (CsA) mice were analyzed for gene expression at 72 h, functional deficits and histological analysis at five weeks. Gene expression analysis showed the effectiveness of immunosuppression (INF gamma reduction in CsA treated groups), with no evidence of early rejection (no changes of MHCII and CD86 in all TBI groups) and selective induction of T-reg (increase of Foxp3) only in the TBI hMSC group. Five weeks after TBI, hMSC had comparable efficacy, with functional recovery (on both sensorimotor and cognitive deficits) and structural protection (contusion volume, vessel rescue effect, gliotic scar reduction, induction of neurogenesis) in immunosuppressed and immunocompetent mice. Therefore, long-term hMSC efficacy in TBI is not dependent on immunosuppressive treatment. These findings could have important clinical implication since immunosuppression in acute TBI patients may increase their risk of infection and not be tolerated. (C) 2013 Elsevier Ltd. All rights reserved.	[Pischiutta, Francesca; De Simoni, Maria Grazia; Zanier, Elisa R.] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy; [D'Amico, Giovanna; Dander, Erica; Biondi, Andrea] Univ Milano Bicocca, Osped San Gerardo, Fdn MBBM, Ctr Ric Tettamanti,Clin Pediat, Monza, Italy; [Biagi, Ettore] Univ Milano Bicocca, San Gerardo Hosp, Dept Paediat, Lab Cell Therapy Stefano Verri, Monza, Italy; [Citerio, Giuseppe] San Gerardo Hosp, Dept Perioperat Med & Intens Care, Neuroanesthesia & Neurointens Care Unit, Monza, Italy	De Simoni, MG (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Lab Inflammat & Nervous Syst Dis, I-20156 Milan, Italy.	desimoni@marionegri.it	Zanier, Elisa/AAA-8095-2020; Biondi, Andrea/K-9997-2016; De Simoni, Maria Grazia/I-6021-2012; D'Amico, Giovanna/AAL-3334-2020; Citerio, Giuseppe/B-1839-2015; Biondi, Andrea/AAX-1865-2020; Dander, Erica/AAA-9485-2019; Pischiutta, Francesca/AAA-7927-2020	De Simoni, Maria Grazia/0000-0001-6695-5297; D'Amico, Giovanna/0000-0001-7809-7269; Citerio, Giuseppe/0000-0002-5374-3161; Biondi, Andrea/0000-0002-6757-6173; Dander, Erica/0000-0002-2810-1263; Pischiutta, Francesca/0000-0002-7151-0812; Zanier, Elisa/0000-0002-3011-8718	association "Esserci con Cate per i Bimbi"; association "Fondazione Matilde Tettamanti"; association "Comitato Maria Letizia Verga"; association "Comitato Stefano Verri"	We would like to thank the associations "Esserci con Cate per i Bimbi", "Fondazione Matilde Tettamanti", "Comitato Maria Letizia Verga" and "Comitato Stefano Verri" for their generous and continuous support.	Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Atoui R, 2012, STEM CELL TRANSL MED, V1, P200, DOI 10.5966/sctm.2011-0012; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Brophy GM, 2013, J NEUROTRAUM, V30, P1484, DOI 10.1089/neu.2012.2524; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Cho GW, 2010, BRAIN RES, V1353, P1, DOI 10.1016/j.brainres.2010.06.013; Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413; Coyne TM, 2007, TRANSPLANTATION, V84, P1507, DOI 10.1097/01.tp.0000288185.09601.4d; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gatto F, 2012, STEM CELLS DEV, V21, P1466, DOI 10.1089/scd.2011.0555; Grinnemo KH, 2006, ANN MED, V38, P144, DOI 10.1080/07853890500422982; Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Kaltsas A, 2012, CURR OPIN INFECT DIS, V25, P423, DOI 10.1097/QCO.0b013e328355660b; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pietila M, 2012, STEM CELLS DEV, V21, P575, DOI 10.1089/scd.2011.0023; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Salvade A, 2010, TISSUE ENG PART C-ME, V16, P201, DOI [10.1089/ten.tec.2008.0572, 10.1089/ten.TEC.2008.0572]; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Stocchetti N, 2005, ANESTH ANALG, V101, P1463, DOI 10.1213/01.ANE.0000181337.03655.0C; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Xiao Z, 2013, AM J NEPHROL, V37, P30, DOI 10.1159/000345988; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zanier ER, 2013, CNS NEUROSCI THER, V19, P695, DOI 10.1111/cns.12128; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	58	29	29	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	APR	2014	79						119	126		10.1016/j.neuropharm.2013.11.001			8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AE1ZX	WOS:000333774200014	24246661				2021-06-18	
J	Wojcik, SM				Wojcik, Susan M.			Predicting mild traumatic brain injury patients at risk of persistent symptoms in the Emergency Department	BRAIN INJURY			English	Article						Closed head injury; emergency care; head injury	POST-CONCUSSION SYMPTOMS; MINOR HEAD-INJURY; COMA SCALE SCORE; POSTCONCUSSION-SYNDROME; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; HIGH-SCHOOL; SPORTS; MANAGEMENT; RECOVERY	Objective: To identify factors that can predict which emergency department (ED) patients with mTBI are likely to develop persistent post-concussion symptoms (PPCS). Design: A matched case-control study was conducted at a Level 1 trauma centre between June 2006 and July 2009. Patients diagnosed with mTBI in the ED and diagnosed at a concussion management programme with at least one PPCS (85 cases) were compared to patients diagnosed with mTBI in the ED (340 controls) to determine if factors assessed at the time of ED presentation could predict patients likely to develop persistent symptoms. Results: Multivariable hierarchical logistic regression with variables indicating increased risk for PPCS (prior mTBI, history of depression, history of anxiety, multiple injury, forgetfulness/poor memory, noise sensitivity, or light sensitivity) resulted in a final predictive model including prior mTBI, history of anxiety, forgetfulness/poor memory and light sensitivity. The final model had a specificity of 87.9% and a sensitivity of 69.9%. Conclusions: A strong prediction model to identify those ED patients with mTBI at risk for PPCS was developed and could be easily implemented in the ED; therefore, helping to target those patients who would potentially benefit from close follow-up.	[Wojcik, Susan M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA	Wojcik, SM (corresponding author), 550 E Genesee St, Syracuse, NY 13202 USA.	wojciks@upstate.edu					Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Bay Esther, 2007, J Neurosci Nurs, V39, P43; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Hsiang John N K, 2005, J Long Term Eff Med Implants, V15, P153, DOI 10.1615/JLongTermEffMedImplants.v15.i2.40; Hulley S, 2007, DESIGNING CLIN RES, P112; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lovell M, 2005, OPER TECHN SPORT MED, V13, P212, DOI 10.1053/j.otsm.2006.01.005; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McMillan TM, 2009, BRAIN INJURY, V23, P509, DOI 10.1080/02699050902970729; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 1999, BRAIN INJURY, V13, P943; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tellier A, 1999, BRAIN INJURY, V13, P463; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543	75	29	29	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					422	430		10.3109/02699052.2014.884241			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900004	24564636				2021-06-18	
J	Myer, GD; Smith, D; Foss, KDB; Dicesare, CA; Kiefer, AW; Kushner, AM; Thomas, SM; Sucharew, H; Khoury, JC				Myer, Gregory D.; Smith, David; Foss, Kim D. Barber; Dicesare, Christopher A.; Kiefer, Adam W.; Kushner, Adam M.; Thomas, Staci M.; Sucharew, Heidi; Khoury, Jane C.			Rates of Concussion Are Lower in National Football League Games Played at Higher Altitudes	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						concussion-mitigation strategies; injury prevention; mild traumatic brain injury; professional football	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; CAVITATION; PRESSURE	STUDY DESIGN: Retrospective epidemiologic investigation. OBJECTIVE: To investigate the relationship between altitude and concussion rate in the National Football League (NFL). Because of the physiologic responses that occur during acclimatization to altitude, it was hypothesized that games played on fields at a higher altitude would have reduced concussion rates compared to games played on. fields at a lower altitude. BACKGROUND: Recent research indicates that the elevation above sea level at which football games are played may be associated with the likelihood of a concussion in high school football athletes. METHODS: Data on incident concussions and athlete exposures for the first 16 weeks of the NFL 2012 and 2013 regular seasons were obtained from publicly available web-based sources and used to calculate competition concussion rates for each NFL stadium. Concussion rates were analyzed in relation to game elevation. RESULTS: During the first 16 weeks of the 2012 and 2013 NFL regular seasons, 300 concussions, involving 284 players, were reported (64.3 primary cases per 10 000 game exposures). The odds of a concussion were 30% lower when playing at a higher elevation (equal to or greater than 644 ft [196.3 m] above sea level) compared to a lower elevation (odds ratio = 0.70; 95% confidence interval: 0.53, 0.94). A multivariable generalized linear model controlling for season, week, and clustering of team at home and away confirmed these results, showing that the odds of at least 1 concussion were reduced by 32% in games played at higher elevation. CONCLUSION: The results of this epidemiological investigation indicate that increased altitude was associated with a reduction in the odds of a sport-related concussion in NFL athletes. The reported relationship of concussion incidence and field elevation should be further investigated, and, if verified, further work will be needed to understand why that relationship exists.	[Myer, Gregory D.; Smith, David; Foss, Kim D. Barber; Dicesare, Christopher A.; Kiefer, Adam W.; Kushner, Adam M.; Thomas, Staci M.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Human Performance Lab, Cincinnati, OH 45229 USA; [Myer, Gregory D.; Kiefer, Adam W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Ohio State Univ, Wexner Med Ctr, OSU Sports Med, Sports Hlth & Performance Inst, Columbus, OH 43210 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Kiefer, Adam W.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Sucharew, Heidi; Khoury, Jane C.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Khoury, Jane C.] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA	Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	greg.myer@chmcc.org	Kiefer, Adam/F-1756-2018; Khoury, Jane/O-2068-2015; DiCesare, Christopher/ABH-9573-2020; Sucharew, Heidi/M-4338-2015; DiCesare, Christopher/AAA-3327-2021; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422			Associated Press, GOODELL ISSUES MEMO; Associated Press, CONCUSSIONS REPORTED; Associated Press, RESULTS OF CONCUSSIO; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brooks MA, 2013, AMERICAN ACADEMY OF; CHURCH CC, 1989, J ACOUST SOC AM, V86, P215, DOI 10.1121/1.398328; Courtney M, SHEEP COLLISIONS THE; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; de Lench B, HIGH SCHOOL FOOTBALL; Fainaru S, INSIDE THE NUMBERS C; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Kraemer W. J., 1989, PEDIATR EXERC SCI, V1, P336, DOI DOI 10.1123/PES.1.4.336; Kurosawa Y, 2009, IEEE ENG MED BIO, P7224, DOI 10.1109/IEMBS.2009.5335260; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P575; Moiseyev NN, 1968, DYNAMIC STABILITY OF; National Football League, NFL ANNOUNCES NEW SI; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith MD, NFL OFFICIATING VIDE; Sporting News, SN CONCUSSION REPORT; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Volin B, 2013, BOSTON GLOBE; Ward T, 2012, FDA ISSUES WARNING L; Wilson MH, 2008, NEUROSURGERY, V63, P970, DOI 10.1227/01.NEU.0000327885.15132.CA; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81; Wilson MH, 2008, J ACOUST SOC AM, V63, P974; Zhong P, 1997, J ACOUST SOC AM, V101, P2940, DOI 10.1121/1.418522; Zhong P, 1998, J ACOUST SOC AM, V104, P3126, DOI 10.1121/1.423905	36	29	29	0	19	J O S P T,	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011			J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	MAR	2014	44	3					164	172		10.2519/jospt.2014.5298			9	Orthopedics; Rehabilitation; Sport Sciences	Orthopedics; Rehabilitation; Sport Sciences	AD3LC	WOS:000333139600005	24471872	Bronze			2021-06-18	
J	Reznik, JE; Biros, E; Marshall, R; Jelbart, M; Milanese, S; Gordon, S; Galea, MP				Reznik, J. E.; Biros, E.; Marshall, R.; Jelbart, M.; Milanese, S.; Gordon, S.; Galea, M. P.			Prevalence and risk-factors of neurogenic heterotopic ossification in traumatic spinal cord and traumatic brain injured patients admitted to specialised units in Australia	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Brain Injury; Spinal Cord Injury; Traumatic; Neurogenic Heterotopic Ossification	PATHOPHYSIOLOGY	Objectives: To identify the prevalence and risk factors in the development of Neurogenic Heterotopic Ossification (NHO) in traumatic brain and spinal cord injured patients admitted to specialised units. Methods: An audit protocol was used to gather all clinically relevant data, in specific patient groups, relating to the prevalence of NHO, and was statistically analysed to identify traumatic brain injury (TBI) and traumatic spinal cord injury (TSCI) patients at high risk of developing NHO. Results: 262 TBI and 151 TSCI patients were identified. NHO was diagnosed in 10 and 16 patients with TBI and TSCI, respectively; 18 clinically relevant characteristics were analysed for association with NHO in these patient groups. The only common variables associated with NHO in both neurological conditions were deep vein thrombosis and/or pulmonary emboli (DVT/PE). Conclusions: The prevalence of NHO in TBI patients is less than one-third of that found in TSCI patients, similar to 4% and 11%, respectively. This study also suggests that the risk factors associated with NHO in TBI patients are distinct from those identified as risk factors in TSCI patients.	[Reznik, J. E.; Milanese, S.; Gordon, S.; Galea, M. P.] James Cook Univ, Townsville, Qld 4811, Australia; [Biros, E.] Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia; [Marshall, R.] Royal Adelaide Hosp, Hampstead Rehabil Ctr, Amputee & Spinal Injury Rehabil Serv, Adelaide, SA 5000, Australia; [Jelbart, M.] Hampstead Rehabil Ctr, Brain Injury Rehabil Serv, Adelaide, SA, Australia; [Milanese, S.] Univ S Australia, Adelaide, SA 5001, Australia; [Galea, M. P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia	Reznik, JE (corresponding author), James Cook Univ, POB 165, Townsville, Qld 4811, Australia.	jackie.reznik@jcu.edu.au	Galea, Mary/F-4242-2010; Milanese, Steve/F-3898-2013	Galea, Mary/0000-0003-0045-7978; Milanese, Steve/0000-0002-6470-3296; Gordon, Susan/0000-0002-4760-1212; Reznik, Jacqueline/0000-0002-7324-9531			Beilby J, 2008, NZ J PHYSIOTHERAPY, V36, P7; BRADLEIGH LH, 1992, ARCH PHYS MED REHAB, V73, P293; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; Coelho CVC, 2009, ARQ NEURO-PSIQUIAT, V67, P382, DOI 10.1590/S0004-282X2009000300002; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286; Dejerine, 1919, REV NEUROL-FRANCE, V35, P399; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Geschickter CF, 1938, J BONE JOINT SURG, V20, P661; Goldman J, 1980, Physiotherapy, V66, P219; Hitzig SL, 2008, AM J PHYS MED REHAB, V87, P545, DOI 10.1097/PHM.0b013e31817c16d6; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Martinelli I, 2010, CRIT CARE MED, V38, pS3, DOI 10.1097/CCM.0b013e3181c9cbd9; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Reznik JE, 2013, PHYS THER REV, V18, P300, DOI 10.1179/1743288X13Y.0000000084; Reznik JE, 2013, BRAIN INJURY, V27, P242, DOI 10.3109/02699052.2012.729293; Roberts PH, 1968, J BONE JOINT SURG BR, V50B, P70; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Seipel R, 2012, SKELETAL RADIOL, V41, P61, DOI 10.1007/s00256-011-1115-5; Silver J R, 1969, Paraplegia, V7, P220; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	29	29	34	1	3	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	MAR	2014	14	1					19	28					10	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AF2YV	WOS:000334579300003	24583537				2021-06-18	
J	Starkstein, SE; Pahissa, J				Starkstein, Sergio E.; Pahissa, Jaime			Apathy Following Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Apathy; Traumatic brain injury; Depression; Cognitive deficits; Psychotropic medication; Psychotherapy	NOSOLOGICAL POSITION; ALZHEIMERS-DISEASE; EVALUATION SCALE; DEPRESSION; VALIDITY; RELIABILITY; DISORDERS; INVENTORY; DAMAGE	Traumatic brain injury (TBI) may result in significant emotional and behavioral changes, such as depression, impulsivity, anxiety, aggressive behavior, and posttraumatic stress disorder. Apathy has been increasingly recognized as a relevant sequela of TBI, with a negative impact on the patients' quality of life as well as their participation in rehabilitation activities. This article reviews the nosologic and phenomenological aspects of apathy in TBI, diagnostic issues, frequency and prevalence, relevant comorbid conditions, potential mechanisms, and treatment.	[Starkstein, Sergio E.] Univ Western Australia, Fremantle Hosp T 7, Sch Psychiat & Clin Neurosci, Fremantle, WA 6959, Australia; [Pahissa, Jaime] CEMIC Univ, Dept Psychiat, RA-1430 Buenos Aires, DF, Argentina	Starkstein, SE (corresponding author), Univ Western Australia, Fremantle Hosp T 7, Sch Psychiat & Clin Neurosci, Fremantle, WA 6959, Australia.	sergio.starkstein@uwa.edu.au					Al-Adawi S, 2004, J NEUROPSYCH CLIN N, V16, P435, DOI 10.1176/appi.neuropsych.16.4.435; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Finset A, 2000, BRAIN INJURY, V14, P887; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Goldfine AM, 2011, CURR OPIN NEUROL, V24, P564, DOI 10.1097/WCO.0b013e32834cd4f5; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Habib M, 2004, J NEUROPSYCH CLIN N, V16, P509, DOI 10.1176/appi.neuropsych.16.4.509; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 2002, NEUROREHABILITATION, V17, P325; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Laplane D, 2001, MOVEMENT DISORD, V16, P810, DOI 10.1002/mds.1185; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Rao V, 2013, PSYCHOSOMATICS, V54, P403, DOI 10.1016/j.psym.2013.01.001; Raymont V, 2013, HUM BRAIN MAPP; Ribot TH, 1904, MALADES VOLONTE; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Sims A, 2003, SYMPTOMS MIND; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Spalletta G, 2013, HUM BRAIN MAPP, V34, P3193, DOI 10.1002/hbm.22137; STARKSTEIN S, 2002, PSYCHIAT COGNITIVE D; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Starkstein SE, 2000, INT PSYCHOGERIATR, V12, P135, DOI 10.1017/S1041610200006918; STARKSTEIN SE, 1989, INT J PSYCHIAT MED, V19, P155; Starkstein SE, 2009, MOVEMENT DISORD, V24, P1211, DOI 10.1002/mds.22577; Strauss ME, 2002, NEUROPSY NEUROPSY BE, V15, P176, DOI 10.1097/01.WNN.0000020010.79870.C3; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	50	29	30	2	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					103	+		10.1016/j.psc.2013.10.002			11	Psychiatry	Psychiatry	AD8UM	WOS:000333541200008	24529426				2021-06-18	
J	Cheng, PL; Lin, HY; Lee, YK; Hsu, CY; Lee, CC; Su, YC				Cheng, Po-Liang; Lin, Hsin-Yi; Lee, Yi-Kung; Hsu, Chen-Yang; Lee, Ching-Chih; Su, Yung-Cheng			Higher mortality rates among the elderly with mild traumatic brain injury: a nationwide cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Mortality; Traumatic brain injury	OLDER-ADULTS; OUTCOMES; MODEL; AGE	Background: It is known that the risk of death in elderly patients with moderate to severe traumatic brain injury is increased. However, the relationship between mild traumatic brain injury and death has never been established. We investigated the mortality rates of older patients with mild traumatic brain injury in Taiwan to evaluate if there is a higher risk of death compared with the general population. Methods: We utilized a sampled National Health Insurance claims database containing one million beneficiaries. We followed all adult beneficiaries older than 65 years from January 1, 2005 till December 31, 2009 to see if they died. We further identified patients with mild traumatic brain injury and compared their risk of death with the general population. Results: We identified 5997 patients with mild traumatic brain injury and 84,117 patients without mild traumatic brain injury. After controlling for age, gender, urbanization level, socioeconomic status, diabetes, hypertension, history of alcohol intoxication, history of ischemic stroke, history of intracranial hemorrhage, malignancies, dementia and Charlson Comorbidity Index score, the adjusted hazard ratio was 1.25 (95% confidence interval, 1.16-1.34). Conclusions: Mild traumatic brain injury is an independent significant risk factor for death in the elderly.	[Cheng, Po-Liang; Lin, Hsin-Yi; Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Med Fdn, Emergency Dept, Dalin Tzu Chi Hosp, Dalin Township 622, Chiayi County, Taiwan; [Cheng, Po-Liang; Lin, Hsin-Yi; Lee, Yi-Kung; Lee, Ching-Chih; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Ctr Canc, Dalin Tzu Chi Hosp, Chiayi, Taiwan	Su, YC (corresponding author), Buddhist Tzu Chi Med Fdn, Emergency Dept, Dalin Tzu Chi Hosp, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan.	drsu119@gmail.com					Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou YC, 2013, J HEAD TRAUMA REHABI; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hou SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071801; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Lee YK, 2013, EMERG MED J, V30, P620, DOI 10.1136/emermed-2012-201440; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Selassie AW, 2013, J HEAD TRAUMA REHABI; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; Thompson Hilaire J, 2006, Crit Care Nurs Clin North Am, V18, P419, DOI 10.1016/j.ccell.2006.05.008; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	21	29	29	1	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JAN 28	2014	22								7	10.1186/1757-7241-22-7			7	Emergency Medicine	Emergency Medicine	AB3VY	WOS:000331719500001	24468114	DOAJ Gold, Green Published			2021-06-18	
J	Bertisch, H; Rath, J; Long, C; Ashman, T; Rashid, T				Bertisch, Hilary; Rath, Joseph; Long, Coralynn; Ashman, Teresa; Rashid, Tayyab			Positive psychology in rehabilitation medicine: A brief report	NEUROREHABILITATION			English	Article						Rehabilitation; brain injury; positive psychology; resilience; function; positive psychotherapy inventory	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SPINAL-CORD-INJURY; SELF-EFFICACY; COGNITIVE REHABILITATION; EXECUTIVE DYSFUNCTION; DEPRESSIVE SYMPTOMS; THE-LITERATURE; RATING-SCALE; HEAD-INJURY	BACKGROUND: The field of positive psychology has grown exponentially within the last decade. To date, however, there have been few empirical initiatives to clarify the constructs within positive psychology as they relate to rehabilitation medicine. Character strengths, and in particular resilience, following neurological trauma are clinically observable within rehabilitation settings, and greater knowledge of the way in which these factors relate to treatment variables may allow for enhanced treatment conceptualization and planning. OBJECTIVE: The goal of this study was to explore the relationships between positive psychology constructs (character strengths, resilience, and positive mood) and rehabilitation-related variables (perceptions of functional ability post-injury and beliefs about treatment) within a baseline data set, a six-month follow-up data set, and longitudinally across time points. METHODS: Pearson correlations and supplementary multiple regression analyses were conducted within and across these time points from a starting sample of thirty-nine individuals with acquired brain injury (ABI) in an outpatient rehabilitation program. RESULTS: Positive psychology constructs were related to rehabilitation-related variables within the baseline data set, within the follow-up data set, and longitudinally between baseline positive psychology variables and follow-up rehabilitation-related data. CONCLUSIONS: These preliminary findings support relationships between character strengths, resilience, and positive mood states with perceptions of functional ability and expectations of treatment, respectively, which are primary factors in treatment success and quality of life outcomes in rehabilitation medicine settings. The results suggest the need for more research in this area, with an ultimate goal of incorporating positive psychology constructs into rehabilitation conceptualization and treatment planning.	[Bertisch, Hilary; Rath, Joseph; Long, Coralynn] NYU, Langone Med Ctr, Ctr Ambulatory Care, Rusk Inst Rehabil Med, New York, NY 10016 USA; [Ashman, Teresa] Shepherd Ctr, Nw Atlanta, GA USA; [Rashid, Tayyab] Univ Toronto, Scarborough Student Ctr, Hlth & Wellness Ctr, Toronto, ON, Canada	Bertisch, H (corresponding author), NYU, Langone Med Ctr, Ctr Ambulatory Care, Rusk Inst Rehabil Med, 240 East 38th St,17th Floor, New York, NY 10016 USA.	Hilary.bertisch@nyumc.org	Rath, Joseph F./C-4823-2008	Rath, Joseph F./0000-0003-2933-6299			Arruda JE, 1999, ARCH PHYS MED REHAB, V80, P676, DOI 10.1016/S0003-9993(99)90171-5; Azar B, 2011, APA MONITOR, V42, P32; Bados A, 2007, J CLIN PSYCHOL, V63, P585, DOI 10.1002/jclp.20368; Ben-Yishay Y., 2011, HDB HOLISTIC NEUROPS, P7; Bertisch H., REHABILITATION PSYCH; Bertisch H, 2011, J SPEC GROUP WORK, V36, P264, DOI 10.1080/01933922.2011.613901; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Breier JI, 1998, ARCH NEUROL-CHICAGO, V55, P660, DOI 10.1001/archneur.55.5.660; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Chan IWS, 2006, PSYCHOL HEALTH, V21, P335, DOI 10.1080/14768320500215137; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Dunn DS, 2005, REHABIL PSYCHOL, V50, P305, DOI 10.1037/0090-5550.50.3.305; Edlund MJ, 2002, AM J PSYCHIAT, V159, P845, DOI 10.1176/appi.ajp.159.5.845; Eilander HJ, 2009, NEUROPSYCHOL REHABIL, V19, P1, DOI 10.1080/09602010701694822; Elliott T. R., 2009, OXFORD HDB POSITIVE, V2, P651, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0062; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Guney S, 2011, PROCD SOC BEHV, V29, DOI 10.1016/j.sbspro.2011.11.209; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hampton NZ, 2000, REHABIL COUNS BULL, V43, P66; Hart T, 2009, NEUROPSYCHOLOGY, V23, P729, DOI 10.1037/a0016153; Heppner PP, 2001, J COUNS PSYCHOL, V48, P330, DOI 10.1037/0022-0167.48.3.330; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kortte KB, 2012, REHABIL PSYCHOL, V57, P248, DOI 10.1037/a0029004; Langenbahn DM, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P167; Lester P. B., 2013, PSYCHOTHERAPEUTIC IN; Lorr M, 2003, PROFILE MOOD STATES; Lucas SE, 2005, AUST OCCUP THER J, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Magee WL, 2002, J MUSIC THER, V39, P20, DOI 10.1093/jmt/39.1.20; Majani Giuseppina, 2011, G Ital Med Lav Ergon, V33, pA64; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; May Institute for Neurorehabilitation, 2013, ENR DEM STUD TEACH R; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Memorial Hermann Rehabilitation and Research, 2013, PROGR SPEC; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Perlman LM, 2010, PROF PSYCHOL-RES PR, V41, P120, DOI 10.1037/a0018800; Peterson C., 2004, CHARACTER STRENGTHS; Pierini D, 2010, REHABIL NURS, V35, P167, DOI 10.1002/j.2048-7940.2010.tb00043.x; Prigatano GP, 2009, CURR OPIN NEUROL, V22, P606, DOI 10.1097/WCO.0b013e328332a1e7; Prigatano GP, 2003, ARCH CLIN NEUROPSYCH, V18, P811, DOI 10.1016/S0887-6177(02)00205-6; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Rashid T., 2008, POSITIVE PSYCHOL EXP; Rashid T, 2008, THERAPISTS GUIDE POS; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Robinson-Smith G, 2000, ARCH PHYS MED REHAB, V81, P460, DOI 10.1053/mr.2000.3863; Robottom BJ, 2012, PARKINSONISM RELAT D, V18, P174, DOI 10.1016/j.parkreldis.2011.09.021; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Schutz LE, 2007, BRAIN INJURY, V21, P545, DOI 10.1080/02699050701426923; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Sharf J., 2008, DISS ABSTR INT B, V68, P6336; SHERR RL, 1992, NEUROPSYCHOLOGY, V6, P417, DOI DOI 10.1037/0894-4105.6.4.417; Shin JC, 2012, ANN REHABIL MED-ARM, V36, P119, DOI 10.5535/arm.2012.36.1.119; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tallman B, 2010, REHABIL PSYCHOL, V55, P204, DOI 10.1037/a0019541; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tsai M, 2014, CLIN PSYCHOL PSYCHOT, V21, P97, DOI 10.1002/cpp.1831; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Vogel DL, 2005, J COUNS PSYCHOL, V52, P459, DOI 10.1037/0022-0167.52.4.459; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; White B, 2010, REHABIL PSYCHOL, V55, P23, DOI 10.1037/a0018451; Wijesuriya N., 2011, PSYCHOL RES, V5, P369; Wilson BA, 2005, J INT NEUROPSYCH SOC, V11, P488, DOI 10.1017/S1355617705050599	85	29	29	0	30	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	3					573	585		10.3233/NRE-141059			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AJ7YQ	WOS:000337918400018	24448878				2021-06-18	
J	Forslund, MV; Arango-Lasprilla, JC; Roe, C; Perrin, PB; Sigurdardottir, S; Andelic, N				Forslund, Marit V.; Arango-Lasprilla, Juan C.; Roe, Cecilie; Perrin, Paul B.; Sigurdardottir, Solrun; Andelic, Nada			Multi-level modelling of employment probability trajectories and employment stability at 1, 2 and 5 years after traumatic brain injury	BRAIN INJURY			English	Article						Employment trajectories; job stability; prospective study; return to work; traumatic brain injury	RETURN; WORK; PREDICTION; DISABILITY; MODERATE	Primary objectives: To examine trajectories of employment probability and stability over the first 5 years after traumatic brain injury (TBI) by using multi-level modelling and multinomial logistic regressions. Research design: A longitudinal cohort study. Methods and procedures: One hundred and five individuals with moderate-to-severe TBI who had been admitted to the Trauma Referral Centre for the Southeast region of Norway were followed up at 1, 2 and 5 years after the injury. Main outcomes and results: Employment status was dichotomized into employed and unemployed, while employment stability was categorized into stably employed, unstably employed and unemployed at 1, 2 and 5 years after injury. Being single, unemployment prior to injury, blue collar occupation, lower Glasgow Coma Scale (GCS) score at hospital admission and greater length of post-traumatic amnesia (PTA) were significantly associated with being unemployed at 1, 2 and 5 years post-injury. Further, younger patients, those with a lower GCS, greater length of PTA and greater length of hospital stay were negatively associated with employment stability. Conclusions: It could be wise to target patient population with these demographic and injury characteristics for more extensive follow-ups and vocational rehabilitation to help improve employment outcomes following injury.	[Forslund, Marit V.; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Forslund, Marit V.; Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Arango-Lasprilla, Juan C.] Univ Deusto, IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Perrin, Paul B.] Virginia Commonwealth Univ, Richmond, VA USA; [Sigurdardottir, Solrun; Andelic, Nada] Univ Oslo, Fac Med, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Inst Hlth & Soc, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp Trust, Akershus, Norway	Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	nadand@ous-hf.no	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X; Andelic, Nada/0000-0002-3719-4406			Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Fleming J, 1999, BRAIN INJURY, V13, P417; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Johnson R, 1987, Int Disabil Stud, V9, P49; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	28	29	29	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					980	986		10.3109/02699052.2014.888770			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600013	24655118				2021-06-18	
J	Post, A; Oeur, A; Walsh, E; Hoshizaki, B; Gilchrist, MD				Post, Andrew; Oeur, Anna; Walsh, Evan; Hoshizaki, Blaine; Gilchrist, Michael D.			A centric/non-centric impact protocol and finite element model methodology for the evaluation of American football helmets to evaluate risk of concussion	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						concussion; impact biomechanics; American football; standards; finite element modelling	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; INTRACRANIAL-PRESSURE; AXONAL DAMAGE; HEAD IMPACTS; ENCEPHALOPATHY; RECONSTRUCTION; ACCELERATION; BIOMECHANICS; PREDICTION	American football reports high incidences of head injuries, in particular, concussion. Research has described concussion as primarily a rotation dominant injury affecting the diffuse areas of brain tissue. Current standards do not measure how helmets manage rotational acceleration or how acceleration loading curves influence brain deformation from an impact and thus are missing important information in terms of how concussions occur. The purpose of this study was to investigate a proposed three-dimensional impact protocol for use in evaluating football helmets. The dynamic responses resulting from centric and non-centric impact conditions were examined to ascertain the influence they have on brain deformations in different functional regions of the brain that are linked to concussive symptoms. A centric and non-centric protocol was used to impact an American football helmet; the resulting dynamic response data was used in conjunction with a three-dimensional finite element analysis of the human brain to calculate brain tissue deformation. The direction of impact created unique loading conditions, resulting in peaks in different regions of the brain associated with concussive symptoms. The linear and rotational accelerations were not predictive of the brain deformation metrics used in this study. In conclusion, the test protocol used in this study revealed that impact conditions influences the region of loading in functional regions of brain tissue that are associated with the symptoms of concussion. The protocol also demonstrated that using brain deformation metrics may be more appropriate when evaluating risk of concussion than using dynamic response data alone.	[Post, Andrew; Oeur, Anna; Walsh, Evan; Hoshizaki, Blaine; Gilchrist, Michael D.] Univ Ottawa, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland	Post, A (corresponding author), Univ Ottawa, Ottawa, ON, Canada.	apost@uottawa.ca; aoeur016@uottawa.ca; ewals056@uottawa.ca; thoshiza@uottawa.ca; Michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, 38 STAPP CAR CRASH C, P145; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T, 1971, P 15 STAPP CAR CRASH; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Kendall M, 2012, P IRCOBI SEPT 10 14; King AI, 2003, IRCOBI C SEPT 25 26; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Madsen DP, 2008, EUR J ORTHODONT, V30, P102; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller RT, 1998, P 42 STAPP CAR CRASH; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Nahum A. M., 1977, P 21 STAPP CAR CRASH; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ommaya AK, 1967, P 11 STAPP CAR CRASH, P670906; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Purves D., 2001, NEUROSCIENCE; RUAN JS, 1994, THESIS WAYNE STATE U; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Schreiber DI, 1997, P 41 STAPP CAR CRASH; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; Singh A, 2006, STAPP CAR CRASH J, V2006, P602; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhou C, 1995, P 39 STAPP CAR CRASH, V39, P121, DOI DOI 10.4271/952714	64	29	29	1	40	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2014	17	16					1785	1800		10.1080/10255842.2013.766724			16	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Computer Science; Engineering	AJ2YM	WOS:000337531300004	23477767				2021-06-18	
J	Raj, SP; Wade, SL; Cassedy, A; Taylor, HG; Stancin, T; Brown, TM; Kirkwood, MW				Raj, Stacey P.; Wade, Shari L.; Cassedy, Amy; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Kirkwood, Michael W.			Parent Psychological Functioning and Communication Predict Externalizing Behavior Problems After Pediatric Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						externalizing behavior problems; parent-adolescent interaction; protective factors; traumatic brain injury	PSYCHIATRIC-DISORDERS; FAMILY-INTERACTION; HEAD-INJURY; CHILDREN; ADOLESCENTS; ADAPTATION; QUALITY; BURDEN; YOUTH	Objective Adolescents sustaining traumatic brain injury (TBI) show increased prevalence of behavior problems. This study investigated the associations of parent mental health, family functioning, and parent-adolescent interaction with adolescent externalizing behavior problems in the initial months after TBI, and examined whether injury severity moderated these associations. Methods 117 parent-adolescent dyads completed measures of family functioning, adolescent behavior, and parent mental health an average of 108 days post-TBI. Dyads also engaged in a 10-min video-recorded problem-solving activity coded for parent behavior and tone of interaction. Results Overall, higher ratings of effective parent communication were associated with fewer externalizing behavior problems, whereas poorer caregiver psychological functioning was associated with greater adolescent externalizing behaviors. Results failed to reveal moderating effects of TBI severity on the relationship between socio-environmental factors and behavior problems. Conclusions Interventions targeting parent communication and/or improving caregiver psychological health may ameliorate potential externalizing behavior problems after adolescent TBI.	[Raj, Stacey P.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil, Cincinnati, OH 45229 USA; [Raj, Stacey P.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado Denver, Sch Med, Denver, CO USA	Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764, R01 MH073764] Funding Source: Medline		Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Alderfer MA, 2008, J PEDIATR PSYCHOL, V33, P1046, DOI 10.1093/jpepsy/jsm083; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Celano M, 2008, FAM PROCESS, V47, P7, DOI 10.1111/j.1545-5300.2008.00236.x; Collins W.A., 2008, CHILD ADOLESCENT DEV, P551; Collins WA, 2004, J EARLY ADOLESCENCE, V24, P55, DOI 10.1177/0272431603260882; Deater-Deckard K, 1998, DEV PSYCHOPATHOL, V10, P469, DOI 10.1017/S0954579498001709; DeLambo KE, 2004, J PEDIATR PSYCHOL, V29, P343, DOI 10.1093/jpepsy/jsh038; Dunn MJ, 2011, J PEDIATR PSYCHOL, V36, P565, DOI 10.1093/jpepsy/jsq062; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Maruish M.E., 1994, USE PSYCHOL TESTING, P217; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Melby J., 1998, IOWA FAMILY INTERACT; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pettit GS, 2008, J ABNORM CHILD PSYCH, V36, P711, DOI 10.1007/s10802-008-9242-8; PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade S. L., 2012, COUNSELOR ASSISTED P; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson HC, 2011, J FAM PSYCHOL, V25, P993, DOI 10.1037/a0025903	35	29	29	2	27	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JAN-FEB	2014	39	1					84	95		10.1093/jpepsy/jst075			12	Psychology, Developmental	Psychology	300EG	WOS:000330446600009	24065551	Bronze, Green Published			2021-06-18	
J	Wood, RL; O'Hagan, G; Williams, C; McCabe, M; Chadwick, N				Wood, Rodger Ll.; O'Hagan, Geraldine; Williams, Claire; McCabe, Michael; Chadwick, Nicole			Anxiety Sensitivity and Alexithymia as Mediators of Postconcussion Syndrome Following Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						psychological distress; anxiety sensitivity; postconcussion symptoms; postconcussion syndrome; mild traumatic brain injury; alexithymia	DEPRESSION INVENTORY-II; MINOR HEAD-INJURY; POSTTRAUMATIC AMNESIA; STRESS-DISORDER; PANIC ATTACKS; PERCEPTION; SYMPTOMS; SCALE; PAIN; CONSCIOUSNESS	Objective: To examine the influence of anxiety sensitivity (AS) and alexithymia as potential mediators for the development of psychological distress and postconcussion syndrome after mild traumatic brain injury (mTBI). Participants: Sixty-one patients with mTBI assessed at a mean of 2.38 weeks after injury and demographically matched healthy controls (n = 61). Measures: Twenty-item Toronto Alexithymia Scale, Anxiety Sensitivity Index, State-Trait Anxiety Inventory, and Rivermead Post Concussion Questionnaire. Results: The mTBI group reported significantly higher levels of AS, alexithymia, psychological distress, and postconcussion (PC) symptom scores than controls. High AS and alexithymia in the mTBI group were associated with a greater number of PC symptoms and higher levels of psychological distress than patients scoring low on these measures and controls. In the mTBI group, a combination of AS and low mood explained 52.6% of the variance in PC symptom reporting. A combination of trait-anxiety, alexithymia, and PC symptoms explained 77.2% of the variance in levels of mood. Conclusion: A combination of low mood and high AS may act as a psychological diathesis for the development of persisting PC symptoms. Early identification could provide a focus for early intervention to prevent the development of postconcussion syndrome after mTBI.	[Wood, Rodger Ll.; O'Hagan, Geraldine; Williams, Claire; Chadwick, Nicole] Swansea Univ, Coll Human & Hlth Sci, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales; [Wood, Rodger Ll.; McCabe, Michael] Morriston Hosp, Dept Accid & Emergency, Swansea, W Glam, Wales	Wood, RL (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk		Williams, Claire/0000-0002-0791-744X			Asmundson GJG, 2001, EUR J PAIN, V5, P23, DOI 10.1053/eujp.2000.0211; Asmundson GJG, 1999, BEHAV RES THER, V37, P703, DOI 10.1016/S0005-7967(98)00172-7; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; BARRETT K, 1994, J ACCID EMERG MED, V11, P79; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Beck AT., 1996, BECK DEPRESSION INVE, V2; Benton FA, 1996, J ANXIETY DISORD, V10, P267, DOI 10.1016/0887-6185(96)00011-4; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cochrane A, 2008, PSYCHOL REC, V58, P585, DOI 10.1007/BF03395639; Cohen J, 1998, STAT POWER ANAL BEHA; COX BJ, 1994, J PSYCHOSOM RES, V38, P523, DOI 10.1016/0022-3999(94)90049-3; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Deacon BJ, 2001, J PSYCHOPATHOL BEHAV, V23, P25, DOI 10.1023/A:1011087322899; DONNELL CD, 1990, BEHAV RES THER, V28, P83, DOI 10.1016/0005-7967(90)90058-Q; EVANS RW, 1992, NEUROL CLIN, V10, P815; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; MALLER RG, 1992, J ANXIETY DISORD, V6, P241, DOI 10.1016/0887-6185(92)90036-7; Marchesi C, 2000, J PSYCHOSOM RES, V49, P43, DOI 10.1016/S0022-3999(00)00084-2; McCrea M, 2008, MILD TRAUMATIC BRAIN; McDonald S, 2011, BRAIN IMPAIR, V12, P165; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; Mueller J, 2006, COMPR PSYCHIAT, V47, P489, DOI 10.1016/j.comppsych.2006.03.001; Nelson EA, 2006, J ANXIETY DISORD, V20, P1071, DOI 10.1016/j.janxdis.2006.02.001; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; Pevalin J.D., 2002, SOC CONT, V45-46, P75, DOI [10.3917/soco.045.0075, DOI 10.3917/SOCO.045.0075]; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Poole H, 2006, CLIN J PAIN, V22, P790, DOI 10.1097/01.ajp.0000210930.20322.93; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Reiss S., 1992, ANXIETY SENSITIVITY; Reiss S., 1985, THEORETICAL ISSUES B, P107; Richards JC, 2000, J ANXIETY DISORD, V14, P413, DOI 10.1016/S0887-6185(00)00031-1; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Schmidt NB, 1998, BEHAV RES THER, V36, P165, DOI 10.1016/S0005-7967(98)00011-4; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Spielberger CD, 1989, STATE TRAIT ANXIETY; Steer RA, 1998, J PSYCHOPATHOL BEHAV, V20, P127, DOI 10.1023/A:1023091529735; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Taylor G. J., 1997, DISORDERS AFFECT REG; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; Taylor S., 1999, ANXIETY SENSITIVITY; TEASDALE G, 1974, LANCET, V2, P81; Tellier A, 1999, BRAIN INJURY, V13, P463; Vanheule S, 2007, PSYCHOPATHOLOGY, V40, P14, DOI 10.1159/000096385; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Wood RL, 2011, INJURY, V42, P1214, DOI 10.1016/j.injury.2010.07.245; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zahradnik M, 2009, J TRAUMA STRESS, V22, P131, DOI 10.1002/jts.20397; ZEITLIN SB, 1993, AM J PSYCHIAT, V150, P658	74	29	30	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					E9	E17		10.1097/HTR.0b013e31827eabba			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400003	23381020				2021-06-18	
J	Cannizzaro, MS; Coelho, CA				Cannizzaro, Michael S.; Coelho, Carl A.			Analysis of Narrative Discourse Structure as an Ecologically Relevant Measure of Executive Function in Adults	JOURNAL OF PSYCHOLINGUISTIC RESEARCH			English	Article						Narrative discourse; Executive function; Age; Story grammar	TRAUMATIC BRAIN-INJURY; AGE-DIFFERENCES; PREFRONTAL CORTEX; YOUNG-OLD; LANGUAGE; COMPREHENSION; METHODOLOGY; IMPAIRMENTS; DISRUPTION; ACTIVATION	This study examined the narrative discourse production and executive function (EF) abilities of 46 neuro-typical adults (18-98 years old). Two questions were addressed: Is the analysis of narrative structure sensitive to changes associated with aging? & What is the relationship between measures of narrative structure and EF? Narratives were elicited under two conditions and narrative structure was analyzed for the presence of organizing story grammar elements. Narrative structure was significantly correlated with age as well as linguistic and non-linguistic measures of EF. Factor analysis of story structure and EF variables yielded two factors reflecting constructs of output-fluidity and organizational-efficiency. These data suggest that narrative structure and EF represent aspects of goal-directed knowledge that are not bound by a traditional linguistic and non-linguistic division. Thus, narrative structure may represent a global and ecologically valid measure of goal-directed executive function knowledge that is also sensitive to changes associated with typical aging.	[Cannizzaro, Michael S.] Univ Vermont, Dept Commun Sci & Disorders, Burlington, VT 05405 USA; [Coelho, Carl A.] Univ Connecticut, Dept Commun Sci, Storrs, CT 06269 USA	Cannizzaro, MS (corresponding author), Univ Vermont, Dept Commun Sci & Disorders, 401 Pomeroy Hall,489 Main St, Burlington, VT 05405 USA.	mcannizz@uvm.edu					Alexander MP, 2006, J INT NEUROPSYCH SOC, V12, P236, DOI 10.1017/S1355617706060309; Arkin S, 2001, APHASIOLOGY, V15, P533, DOI 10.1080/02687040143000032; Ash S, 2006, NEUROLOGY, V66, P1405, DOI 10.1212/01.wnl.0000210435.72614.38; Ash S, 2009, J NEUROLINGUIST, V22, P370, DOI 10.1016/j.jneuroling.2008.12.001; Blair M, 2007, J INT NEUROPSYCH SOC, V13, P237, DOI 10.1017/S1355617707070269; Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255; BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cannizzaro M. S., 2012, PERSPECTIVE IN PRESS; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1990, J PSYCHOLINGUIST RES, V19, P405, DOI 10.1007/BF01068887; COELHO CA, 1998, ANAL DISCOURSE COMMU, P115; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COOPER PV, 1990, J GERONTOL, V45, pP210, DOI 10.1093/geronj/45.5.P210; Crozier S, 1999, NEUROPSYCHOLOGIA, V37, P1469, DOI 10.1016/S0028-3932(99)00054-8; Day A., 1985, GOOD DOG CARL; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Fleming V., 2009, CLIN APH C CO MAY 26; Gaesser B., 2010, CHARACTERIZING AGE R; GLOSSER G, 1992, J GERONTOL, V47, pP266, DOI 10.1093/geronj/47.4.P266; GORDON PC, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P23; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; Grafman J., 1989, INTEGRATING THEORY P, P93; Grafman J., 2008, OXFORD HDB HUMAN ACT, V2; Grafman J, 2006, SER INT NEUROPSYCHOL, P69, DOI 10.1017/CBO9780511545917.005; HELLER RB, 1993, PSYCHOL AGING, V8, P443, DOI 10.1037/0882-7974.8.3.443; Juncos-Rabadan O, 2005, BRAIN LANG, V95, P423, DOI 10.1016/j.bandl.2005.04.001; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LeDorze G, 1998, J COMMUN DISORD, V31, P53, DOI 10.1016/S0021-9924(97)00051-8; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, P611; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1995, J SPEECH HEAR RES, V38, P415, DOI 10.1044/jshr.3802.415; LILES BZ, 1985, J COMMUN DISORD, V18, P409, DOI 10.1016/0021-9924(85)90030-9; Mackenzie C, 2000, INT J LANG COMM DIS, V35, P269, DOI 10.1080/136828200247188; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; MCCABE A, 1984, J PSYCHOLINGUIST RES, V13, P457, DOI 10.1007/BF01068179; McCabe A, 2006, IMAGINATION COGNITIO, V25, P321; McGinnis D, 2008, APPL COGNITIVE PSYCH, V22, P171, DOI 10.1002/acp.1367; McGinnis D, 2009, J GERONTOL B-PSYCHOL, V64, P202, DOI 10.1093/geronb/gbp005; MERRITT DD, 1989, J SPEECH HEAR DISORD, V54, P438, DOI 10.1044/jshd.5403.438; Miller LMS, 2009, PSYCHOL AGING, V24, P63, DOI 10.1037/a0014586; MILLIGAN GW, 1987, APPL PSYCH MEAS, V11, P329, DOI 10.1177/014662168701100401; Motes MA, 2011, COGN NEUROSCI-UK, V2, P1, DOI 10.1080/17588928.2010.512974; Murphy DR, 2006, PSYCHOL AGING, V21, P49, DOI 10.1037/0882-7974.21.1.49; Murray LL, 1999, AM J SPEECH-LANG PAT, V8, P137, DOI 10.1044/1058-0360.0802.137; Noh SR, 2007, INT J BEHAV DEV, V31, P133, DOI 10.1177/0165025407073581; Noh SR, 2009, MEM COGNITION, V37, P769, DOI 10.3758/MC.37.6.769; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; Obler L. K., 1994, DISCOURSE ANAL APPL, P15; Partiot A, 1996, NEUROREPORT, V7, P761, DOI 10.1097/00001756-199602290-00020; Peelle JE, 2008, LANG LINGUIST COMPAS, V2, P18, DOI 10.1111/j.1749-818x.2007.00047.x; Roelofs A, 2002, COGNITIVE BRAIN RES, V15, P85, DOI 10.1016/S0926-6410(02)00218-5; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Salkind n, 2003, USING SPSS WINDOWS M; SAS J., 2007, JMP SOFTW REL 7 0 1; Schneider P, 2002, J SPEECH LANG HEAR R, V45, P372, DOI 10.1044/1092-4388(2002/029); Shadden B.B., 1998, ANAL DISCOURSE COMMU, P35; SHEWAN CM, 1988, J COMMUN DISORD, V21, P139, DOI 10.1016/0021-9924(88)90002-0; Sirigu A, 1998, CORTEX, V34, P771, DOI 10.1016/S0010-9452(08)70780-9; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; Ska Bernadette, 2009, Psychol. Neurosci., V2, P101, DOI 10.3922/j.psns.2009.2.002; Stein N., 1979, NEW DIRECTIONS DISCO; Stemmer B, 1999, BRAIN LANG, V68, P402, DOI 10.1006/brln.1999.2120; Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Tye-Murray N, 2008, INT J AUDIOL, V47, pS31, DOI 10.1080/14992020802301662; ULATOWSKA HK, 1986, BRAIN LANG, V28, P24, DOI 10.1016/0093-934X(86)90088-X; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wlotko EW, 2010, LANG LINGUIST COMPAS, V4, P623, DOI 10.1111/j.1749-818x.2010.00224.x; Wood JN, 2005, CEREB CORTEX, V15, P1155, DOI 10.1093/cercor/bhh215; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Wright HH, 2011, J SPEECH LANG HEAR R, V54, P900, DOI 10.1044/1092-4388(2010/09-0253); Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [10.1375/brim.4.1.1.27031, DOI 10.1375/brim.4.1.1.27031]; Ylvisaker M., 2008, LANGUAGE INTERVENTIO, P879; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Zalla T, 1998, CORTEX, V34, P621, DOI 10.1016/S0010-9452(08)70519-7	85	29	31	1	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6905	1573-6555		J PSYCHOLINGUIST RES	J. Psycholinguist. Res.	DEC	2013	42	6					527	549		10.1007/s10936-012-9231-5			23	Linguistics; Psychology, Experimental	Linguistics; Psychology	238MA	WOS:000325949500003	23192423				2021-06-18	
J	Greco, T; Hovda, D; Prins, M				Greco, Tiffany; Hovda, David; Prins, Mayumi			The Effects of Repeat Traumatic Brain Injury on the Pituitary in Adolescent Rats	JOURNAL OF NEUROTRAUMA			English	Article						adolescent; GH; mild TBI; pituitary; RTBI	GROWTH-HORMONE DEFICIENCY; HEAD TRAUMA; FOOTBALL PLAYERS; SOCIAL PHOBIA; GH DEFICIENCY; HIGH-SCHOOL; FACTOR-I; HYPOPITUITARISM; DYSFUNCTION; CONCUSSION	Adolescents are one of the highest groups at risk for sustaining both traumatic brain injury (TBI) and repeat TBI (RTBI). Consequences of endocrine dysfunction following TBI have been routinely explored in adults, but studies in adolescents are limited, and show an incidence rate of endocrine dysfunction in 16-61% in patients, 1-5 years after injury. Similar to in adults, the most commonly affected axis is growth hormone (GH) and insulin-like growth hormone 1 (IGF-1). Despite TBI being the primary cause of morbidity and mortality among the pediatric population, there are currently no experimental studies specifically addressing the occurrence of pituitary dysfunction in adolescents. The present study investigated whether a sham, single injury or four repeat injuries (24 h interval) delivered to adolescent rats resulted in disruption of the GH/IGF-1 axis. Circulating levels of basal GH and IGF-1 were measured at baseline, 24 h, 72 h, 1 week, and 1 month after injury, and vascular permeability of the pituitary gland was quantified via Evans Blue dye extravasation. Changes in weight and length of animals were measured as a potential consequence of GH and IGF-1 disruption. The results from the current study demonstrate that RTBI results in significant acute and chronic decreases in circulation of GH and IGF-1, reduction in weight gain and growth, and an increase in Evans Blue dye extravasation in the pituitary compared with sham and single injury animals. RTBI causes significant disruption of the GH/IGF-1 axis that may ultimately affect normal cognitive and physical development during adolescence.	[Greco, Tiffany; Hovda, David; Prins, Mayumi] Semel Inst, Dept Neurosurg, Los Angeles, CA 90095 USA; [Greco, Tiffany; Hovda, David; Prins, Mayumi] Semel Inst, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hovda, David; Prins, Mayumi] Semel Inst, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Hovda, David] Semel Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Greco, T (corresponding author), Semel Inst, UCLA Dept Neurosurg, 10833 Le Conte Ave,Room 18-212, Los Angeles, CA 90095 USA.	tgreco@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NFL Charities; UCLA Brain Injury Research Center, Marilyn; Austin Anderson Fellowship [NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by NFL Charities, UCLA Brain Injury Research Center, Marilyn and Austin Anderson Fellowship, NS058489.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; ALFOLDI P, 1990, AM J PHYSIOL, V258, pR634; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Becu-Villalobos D, 1997, CELL MOL NEUROBIOL, V17, P699, DOI 10.1023/A:1022542221535; Bellone S., 2012, PITUITARY; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Blakemore SJ, 2012, J ROY SOC MED, V105, P111, DOI 10.1258/jrsm.2011.110221; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Cameron JL, 2004, ANN NY ACAD SCI, V1021, P110, DOI 10.1196/annals.1308.012; Chambers RA, 1996, NEUROPSYCHOPHARMACOL, V15, P587, DOI 10.1016/S0893-133X(96)00132-7; Choi SJ, 1997, DEV BRAIN RES, V98, P134, DOI 10.1016/S0165-3806(96)00179-4; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; De Sanctis V, 2008, Georgian Med News, P18; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GABRIEL SM, 1992, NEUROENDOCRINOLOGY, V56, P619, DOI 10.1159/000126284; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Galdiero M, 2012, J ENDOCRINOL INVEST, V35, P782, DOI 10.1007/BF03345805; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GRONWALL D, 1975, LANCET, V2, P995; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hua K, 2009, GLIA, V57, P1062, DOI 10.1002/glia.20829; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Ives JC, 2007, J ATHL TRAINING, V42, P431; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lauzier F., 2012, CRIT CARE S1, V16, pP299; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Loche S, 1996, Br J Clin Pract Suppl, V85, P1; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; McHugh T, 2006, BRAIN COGNITION, V60, P209; Molina DP, 2012, NEUROBIOL AGING, V33, P1938, DOI 10.1016/j.neurobiolaging.2011.09.014; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; NANCE DM, 1983, NEUROSCI BIOBEHAV R, V7, P189, DOI 10.1016/0149-7634(83)90015-5; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Noguchi T, 1996, HORM RES, V45, P5, DOI 10.1159/000184752; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Nussey, 2001, ENDOCRINOLOGY INTEGR; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; PELTON EW, 1977, NEUROLOGY, V27, P282, DOI 10.1212/WNL.27.3.282; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; PRIMUS RJ, 1989, DEV PSYCHOBIOL, V22, P633, DOI 10.1002/dev.420220608; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ramsey MM, 2004, NEUROSCIENCE, V129, P119, DOI 10.1016/j.neuroscience.2004.08.001; Rizzoti K, 2010, EUR J NEUROSCI, V32, P2053, DOI 10.1111/j.1460-9568.2010.07524.x; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schaeffer M, 2011, J MOL ENDOCRINOL, V47, pR59, DOI 10.1530/JME-11-0035; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider M., 2013, CELL TISSUE RES; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPEAR LP, 1980, PSYCHOPHARMACOLOGY, V70, P47, DOI 10.1007/BF00432369; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Stabler B, 1996, ANXIETY, V2, P86, DOI 10.1002/(SICI)1522-7154(1996)2:2<86::AID-ANXI4>3.0.CO;2-B; Stabler B, 1996, HORM RES, V45, P30, DOI 10.1159/000184755; STABLER B, 1992, CLIN ENDOCRINOL, V36, P467, DOI 10.1111/j.1365-2265.1992.tb02247.x; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; van Dam PS, 2004, EUR J PHARMACOL, V490, P87, DOI 10.1016/j.ejphar.2004.02.047; VANEDEN CG, 1990, PROG BRAIN RES, V85, P169; Veldhuis JD, 2006, ENDOCR REV, V27, P101, DOI 10.1210/er.2005-0006; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Verrillo E, 2011, NEUROENDOCRINOLOGY, V94, P66, DOI 10.1159/000326818; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200	86	29	29	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1983	1990		10.1089/neu.2013.2990			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400007	23862570	Green Published			2021-06-18	
J	Schatz, P; Maerlender, A				Schatz, Philip; Maerlender, Arthur			A Two-Factor Theory for Concussion Assessment Using ImPACT: Memory and Speed	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						concussion; neurocognitive testing; reliability; validity; ImPACT	TEST-RETEST RELIABILITY; CONSTRUCT-VALIDITY; CLINICAL UTILITY; SPORT; BATTERY	We present the initial validation of a two-factor structure of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) using ImPACT composite scores and document the reliability and validity of this factor structure. Factor analyses were conducted for baseline (N 21,537) and post-concussion (N 560) data, yielding Memory (Verbal and Visual) and Speed (Visual Motor Speed and Reaction Time) Factors; inclusion of Total Symptom Scores resulted in a third discrete factor. Speed and Memory z-scores were calculated, and testretest reliability (using intra-class correlation coefficients) at 1 month (0.88/0.81), 1 year (0.85/0.75), and 2 years (0.76/0.74) were higher than published data using Composite scores. Speed and Memory scores yielded 89 sensitivity and 70 specificity, which was higher than composites (80/62) and comparable with subscales (91/69). This emergent two-factor structure has improved testretest reliability with no loss of sensitivity/specificity and may improve understanding and interpretability of ImPACT test results.	[Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Maerlender, Arthur] Geisel Sch Med Dartmouth, Hanover, NH USA	Schatz, P (corresponding author), St Josephs Univ, 222 Post Hall,5600 City Ave, Philadelphia, PA 19131 USA.	pschatz@sju.edu			International Brain Research Foundation; Sports Concussion Center of New Jersey	P.S. has received funding to study the effects of concussion in high school and collegiate athletes from the International Brain Research Foundation, the Sports Concussion Center of New Jersey. He has also served as a consultant to ImPACT Applications Inc. A. M. has no conflict to declare.	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; American Psychological Association (APA), 1986, GUID COMP BAS TESTS; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Chicchetti D. V., 1994, PSYCHOL ASSESSMENT, V6, P294, DOI DOI 10.1037//1040-3590.6.4.284; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell M., 2004, IMPACT VERSION 2 0 C; Lovell M. R., 2005, IMPACT VERSION 4 0 C; Lovell MR, 2006, J ATHL TRAINING, V41, P137; Lovell MR, 2007, IMPACT VERSION 6 0 C; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nakayama Y., 2013, THESIS MICHIGAN STAT; Randolph C, 2006, J ATHL TRAINING, V41, P138; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, PM&R, V3, pS433, DOI 10.1016/j.pmrj.2011.08.002; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	31	29	29	0	19	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2013	28	8					791	797		10.1093/arclin/act077			7	Psychology, Clinical; Psychology	Psychology	262FC	WOS:000327718700006	24123401	Green Published, Bronze			2021-06-18	
J	Svider, PF; Pashkova, AA; Folbe, AJ; Eloy, JD; Setzen, M; Baredes, S; Eloy, JA				Svider, Peter F.; Pashkova, Anna A.; Folbe, Adam J.; Eloy, Jean Daniel; Setzen, Michael; Baredes, Soly; Eloy, Jean Anderson			Obstructive Sleep Apnea: Strategies for Minimizing Liability and Enhancing Patient Safety	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						obstructive sleep apnea; medical malpractice; litigation; physician liability; informed consent; OSA; OSA liability; otolaryngology litigation; sleep apnea malpractice; otolaryngology malpractice	ENDOSCOPIC SINUS SURGERY; READABILITY ASSESSMENT; EDUCATION MATERIALS; MEDICAL MALPRACTICE; OTOLARYNGOLOGY-HEAD; AMERICAN ACADEMY; INFORMED-CONSENT; UNITED-STATES; LITIGATION; INJURY	Objective To characterize malpractice litigation regarding obstructive sleep apnea (OSA) and educate physicians on frequently cited factors. Study Design and Setting Analysis of the Westlaw legal database Methods Jury verdict and settlement reports were examined for outcome, awards, patient demographic factors, defendant specialty, and alleged causes of malpractice Results Out of 54 identified cases, 33 (61.1%) cases were resolved in favor of defendants, 12 (22.2%) via settlement, and 9 (16.7%) through jury award. Median settlement and jury awards did not significantly differ ($750,000 vs $550,000, P > .50). Age and gender did not affect outcome. Otolaryngologists and anesthesiologists were the most frequently named defendants. Forty-seven cases (87.1%) stemmed from OSA patients who underwent procedures with resultant perioperative adverse events. Common alleged factors included death (48.1%), permanent deficits (42.6%), intraoperative complications (35.2%), requiring additional surgery (25.9%), anoxic brain injury (24.1%), inadequate informed consent (24.1%), inappropriate medication administration (22.2%), and inadequate monitoring (20.4%). Conclusion Litigation related to OSA is frequently associated with perioperative complications more than nonoperative issues such as a failure to diagnose this disorder. Nonetheless, OSA is considerably underdiagnosed, and special attention should be paid to at-risk patients, including close monitoring of their clinical status and the medications they receive. For patients with diagnosed or suspected OSA with planned operative intervention, whether for OSA or an unrelated issue, a comprehensive informed consent process detailing the factors outlined in this analysis is an effective strategy to increase communication and improve the physician-patient relationship, minimize liability, and ultimately improve patient safety.	[Svider, Peter F.; Baredes, Soly; Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ 07103 USA; [Svider, Peter F.; Folbe, Adam J.] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA; [Pashkova, Anna A.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Eloy, Jean Daniel] Rutgers New Jersey Med Sch, Dept Anesthesiol, Newark, NJ 07103 USA; [Setzen, Michael] N Shore Univ Hosp, Rhinol Sect, Manhasset, NY USA; [Setzen, Michael] NYU, Sch Med, Dept Otolaryngol, New York, NY USA; [Baredes, Soly; Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Ctr Skull Base & Pituitary Surg, Newark, NJ 07103 USA; [Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA	Eloy, JA (corresponding author), Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, 90 Bergen St,Suite 8100, Newark, NJ 07103 USA.	jean.anderson.eloy@gmail.com		Eloy, Jean/0000-0002-3555-9432			Anderson GF, 2005, HEALTH AFFAIR, V24, P903, DOI 10.1377/hlthaff.24.4.903; Annas GJ, 2012, NEW ENGL J MED, V367, P445, DOI 10.1056/NEJMra1108646; Blaivas M, 2012, AM J EMERG MED, V30, P338, DOI 10.1016/j.ajem.2010.12.016; Blake DM, OTOLARYNGOL HEAD NEC, DOI 10.1177/0194599813498696; Brooks RG, 2004, ARCH INTERN MED, V164, P2217, DOI 10.1001/archinte.164.20.2217; Cherla DV, 2012, LARYNGOSCOPE, V122, P1649, DOI 10.1002/lary.23309; Choudhry AJ, J GASTROINTEST SURG, DOI 10.1007/s11605-013-2248-8; Chung SA, 2008, ANESTH ANALG, V107, P1543, DOI 10.1213/ane.0b013e318187c83a; Colaco M, 2013, J UROLOGY, V189, P1048, DOI 10.1016/j.juro.2012.08.255; de Serres LM, 2000, ARCH OTOLARYNGOL, V126, P1423, DOI 10.1001/archotol.126.12.1423; Eloy JA, J NEUROSURG IN PRESS; Eloy JA, INT FORUM ALLERGY RH, DOI 10.1177/0194599813498696; Eloy JA, OTO HEAD NE IN PRESS; Eloy JA, 2013, OTOLARYNG HEAD NECK, V148, P764, DOI 10.1177/0194599813481943; Eloy JA, 2012, OTOLARYNG HEAD NECK, V147, P848, DOI 10.1177/0194599812456152; Erichsen D, 2012, CLIN PEDIATR, V51, P1125, DOI 10.1177/0009922812464548; Fink AS, 2010, ANN SURG, V252, P27, DOI 10.1097/SLA.0b013e3181e3ec61; Finkel KJ, 2009, SLEEP MED, V10, P753, DOI 10.1016/j.sleep.2008.08.007; Frank-Stromborg Marilyn, 2002, Semin Oncol Nurs, V18, P128, DOI 10.1053/sonu.2002.32510; General Accounting Office, 1995, MED LIAB IMP HOSP PH; Hansberry DR, LARYNGOSCOPE, DOI 10.1002/lary.24261; Hong SS, 2013, OTOLARYNG HEAD NECK, V148, P589, DOI 10.1177/0194599813475566; Kasabwala K, 2013, INT FORUM ALLERGY RH, V3, P325, DOI 10.1002/alr.21097; Kasabwala K, 2012, OTOLARYNG HEAD NECK, V147, P466, DOI 10.1177/0194599812442783; Kezirian EJ, 2010, OTOLARYNG HEAD NECK, V143, P441, DOI 10.1016/j.otohns.2010.05.009; Kovalerchik O, INT FORUM ALLERGY RH, DOI 10.1002/alr.21169; Lekovic GP, 2007, NEUROSURGERY, V60, P516, DOI 10.1227/01.NEU.0000255337.80285.39; Lydiatt DD, 2003, ARCH OTOLARYNGOL, V129, P50, DOI 10.1001/archotol.129.1.50; Lynn-Macrae AG, 2004, LARYNGOSCOPE, V114, P1492, DOI 10.1097/00005537-200408000-00032; Mehlman MJ, 2006, J LEGAL MED, V27, P17, DOI 10.1080/01947640500533218; Mello MM, 2011, SYNTH PROJ RES SY S1, V21, P72097; Misra P, 2013, LARYNGOSCOPE, V123, P90, DOI 10.1002/lary.23574; MITNICK JS, 1995, J AM COLL SURGEONS, V181, P315; Moffett P, 2011, WEST J EMERG MED, V12, P109; Morris LGT, 2008, ARCH OTOLARYNGOL, V134, P102, DOI 10.1001/archotol.134.1.102; Nash JJ, 2011, OTOLARYNG HEAD NECK, V144, P10, DOI 10.1177/0194599810390470; Paik AM, AESTHET SUR IN PRESS; Patel CR, HEAD NECK, DOI 10.1002/hed.23157; Reilly BK, 2013, LARYNGOSCOPE, V123, P112, DOI 10.1002/lary.23608; Sanghvi S, 2012, LARYNGOSCOPE, V122, P1943, DOI 10.1002/lary.23424; Seabury SA, 2013, HEALTH AFFAIR, V32, P111, DOI 10.1377/hlthaff.2012.0967; Sohn H, 2003, OTOLARYNG HEAD NECK, V128, P344, DOI 10.1067/mhn.2003.4; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2004, NEW ENGL J MED, V350, P283, DOI 10.1056/NEJMhpr035470; Svider PF, 2013, LARYNGOSCOPE, V123, P2099, DOI 10.1002/lary.24000; Svider PF, 2013, LARYNGOSCOPE, V123, P1849, DOI 10.1002/lary.23905; Svider PF, 2013, LARYNGOSCOPE, V123, P1754, DOI 10.1002/lary.23997; Svider PF, 2013, LARYNGOSCOPE, V123, P1156, DOI 10.1002/lary.23995; Svider PF, 2013, AM J OTOLARYNG, V34, P31, DOI 10.1016/j.amjoto.2012.08.001; Svider PF, J GASTROINTEST SURG, DOI 10.1007/s11605-013-2261-y; Svider PF, OPHTHAL PLA IN PRESS; Svider PF, AM J OTOLAR IN PRESS; Wegman B, 2012, CLIN ORTHOP RELAT R, V470, P1379, DOI 10.1007/s11999-012-2244-4; Wolf JS, 2002, LARYNGOSCOPE, V112, P774, DOI 10.1097/00005537-200205000-00002	54	29	30	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	DEC	2013	149	6					947	953		10.1177/0194599813504074			7	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	255ND	WOS:000327245700023	24025916				2021-06-18	
J	Ning, YL; Yang, N; Chen, X; Xiong, RP; Zhang, XZ; Li, P; Zhao, Y; Chen, XY; Liu, P; Peng, Y; Wang, ZG; Chen, JF; Zhou, YG				Ning, Ya-Lei; Yang, Nan; Chen, Xing; Xiong, Ren-Ping; Zhang, Xiu-Zhu; Li, Ping; Zhao, Yan; Chen, Xing-Yun; Liu, Ping; Peng, Yan; Wang, Zheng-Guo; Chen, Jiang-Fan; Zhou, Yuan-Guo			Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						adenosine; brain trauma; cognitive impairment; experimental; neuroprotection	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; BONE-MARROW-CELLS; A(2A) RECEPTORS; SELECTIVE INACTIVATION; WORKING-MEMORY; BLOCKADE; INVOLVEMENT	Traumatic brain injury (TBI), particularly explosive blast-induced TBI (bTBI), has become the most prevalent injury among military personnel. The disruption of cognitive function is one of the most serious consequences of bTBI because its long-lasting effects prevent survivors fulfilling their active duty and resuming normal civilian life. However, the mechanisms are poorly understood and there is no treatment available. This study investigated the effects of adenosine A2A receptor (A2AR) on bTBI-induced cognitive deficit, and explored the underlying mechanisms. After being subjected to moderate whole-body blast injury, mice lacking the A2AR (A2AR knockout (KO)) showed less severity and shorter duration of impaired spatial reference memory and working memory than wild-type mice did. In addition, bTBI-induced cortical and hippocampal lesions, as well as proinflammatory cytokine expression, glutamate release, edema, cell loss, and gliosis in both early and prolonged phases of the injury, were significantly attenuated in A2AR KO mice. The results suggest that early injury and chronic neuropathological damages are important mechanisms of bTBI-induced cognitive impairment, and that the impairment can be attenuated by preventing A2AR activation. These findings suggest that A2AR antagonism is a potential therapeutic strategy for mild-to-moderate bTBI and consequent cognitive impairment.	[Ning, Ya-Lei; Yang, Nan; Chen, Xing; Xiong, Ren-Ping; Li, Ping; Zhao, Yan; Chen, Xing-Yun; Liu, Ping; Peng, Yan; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, Chongqing 400042, Peoples R China; [Ning, Ya-Lei; Yang, Nan; Chen, Xing; Xiong, Ren-Ping; Zhang, Xiu-Zhu; Li, Ping; Zhao, Yan; Chen, Xing-Yun; Liu, Ping; Peng, Yan; Wang, Zheng-Guo; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Zhang, Xiu-Zhu; Wang, Zheng-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 4, Chongqing 400042, Peoples R China; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Zhou, YG (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	yuanguo.zhou@gmail.com	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022, 81201461]; Key Project of Medicine and Health of PLA [08G098]	This work was supported by grants from the National Natural Science Foundation of China (No. 31171022 and No. 81201461) and Key Project of Medicine and Health of PLA (No. 08G098).	Brambilla R, 2003, GLIA, V43, P190, DOI 10.1002/glia.10243; Bura SA, 2008, PAIN, V140, P95, DOI 10.1016/j.pain.2008.07.012; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cunha GMA, 2008, EXP NEUROL, V210, P776, DOI 10.1016/j.expneurol.2007.11.013; Cunha RA, 2008, CURR PHARM DESIGN, V14, P1512, DOI 10.2174/138161208784480090; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gui L, 2009, BRAIN RES, V1297, P185, DOI 10.1016/j.brainres.2009.08.050; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Kensinger EA, 2003, NEUROPSYCHOLOGY, V17, P230, DOI 10.1037/0894-4105.17.2.230; Kochanek PM, 2005, J CEREBR BLOOD F MET, V25, P1596, DOI 10.1038/sj.jcbfm.9600154; Kusano Y, 2010, J CEREBR BLOOD F MET, V30, P808, DOI 10.1038/jcbfm.2009.244; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Minghetti L, 2007, J NEUROPATH EXP NEUR, V66, P363, DOI 10.1097/nen.0b013e3180517477; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Popoli P., 2003, Neurology, V61, pS69; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Shen HY, 2010, J NEUROTRAUM, V27, P373, DOI 10.1089/neu.2009.0926; Takahashi RN, 2008, FRONT BIOSCI-LANDMRK, V13, P2614, DOI 10.2741/2870; Wang Z G, 1989, Zhonghua Yi Xue Za Zhi, V69, P7; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103; Zhou SJ, 2009, BRAIN RES, V1303, P74, DOI 10.1016/j.brainres.2009.09.082	40	29	32	0	31	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2013	33	11					1789	1798		10.1038/jcbfm.2013.127			10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	246SL	WOS:000326559300016	23921902	Green Published, Bronze			2021-06-18	
J	Bazarian, JJ; Blyth, BJ; He, H; Mookerjee, S; Jones, C; Kiechle, K; Moynihan, R; Wojcik, SM; Grant, WD; Secreti, LM; Triner, W; Moscati, R; Leinhart, A; Ellis, GL; Khan, J				Bazarian, Jeffrey J.; Blyth, Brian J.; He, Hua; Mookerjee, Sohug; Jones, Courtney; Kiechle, Karin; Moynihan, Ryan; Wojcik, Susan M.; Grant, William D.; Secreti, LaLainia M.; Triner, Wayne; Moscati, Ronald; Leinhart, August; Ellis, George L.; Khan, Jawwad			Classification Accuracy of Serum Apo A-I and S100B for the Diagnosis of Mild Traumatic Brain Injury and Prediction of Abnormal Initial Head Computed Tomography Scan	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; CT scanning; head trauma; human studies; traumatic brain injury	OPERATING CHARACTERISTIC CURVES; PROTEIN; MANAGEMENT; AREAS	The objective of the current study was to determine the classification accuracy of serum S100B and apolipoprotein (apoA-I) for mild traumatic brain injury (mTBI) and abnormal initial head computed tomography (CT) scan, and to identify ethnic, racial, age, and sex variation in classification accuracy. We performed a prospective, multi-centered study of 787 patients with mTBI who presented to the emergency department within 6h of injury and 467 controls who presented to the outpatient laboratory for routine blood work. Serum was analyzed for S100B and apoA-I. The outcomes were disease status (mTBI or control) and initial head CT scan. At cutoff values defined by 90% of controls, the specificity for mTBI using S100B (0.899 [95% confidence interval (CI): 0.78-0.92]) was similar to that using apoA-I (0.902 [0.87-0.93]), and the sensitivity using S100B (0.252 [0.22-0.28]) was similar to that using apoA-I (0.249 [0.22-0.28]). The area under the receiver operating characteristic curve (AUC) for the combination of S100B and apoA-I (0.738, 95% CI: 0.71, 0.77), however, was significantly higher than the AUC for S100B alone (0.709, 95% CI: 0.68, 0.74, p=0.001) and higher than the AUC for apoA-I alone (0.645, 95% CI: 0.61, 0.68, p<0.0001). The AUC for prediction of abnormal initial head CT scan using S100B was 0.694 (95%CI: 0.62, 0.77) and not significant for apoA-I. At a S100B cutoff of <0.060g/L, the sensitivity for abnormal head CT was 98%, and 22.9% of CT scans could have been avoided. There was significant age and race-related variation in the accuracy of S100B for the diagnosis of mTBI. The combined use of serum S100B and apoA-I maximizes classification accuracy for mTBI, but only S100B is needed to classify abnormal head CT scan. Because of significant subgroup variation in classification accuracy, age and race need to be considered when using S100B to classify subjects for mTBI.	[Bazarian, Jeffrey J.; Blyth, Brian J.; Jones, Courtney; Khan, Jawwad] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14642 USA; [He, Hua] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.; Mookerjee, Sohug] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; [Kiechle, Karin] Univ Munich, Chirurg Klin Innenstadt, Munich, Germany; [Moynihan, Ryan] SUNY Coll Geneseo, Geneseo, NY 14454 USA; [Wojcik, Susan M.; Grant, William D.; Secreti, LaLainia M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA; [Triner, Wayne] Albany Med Coll, Dept Emergency Med, Albany, NY 12208 USA; [Moscati, Ronald] SUNY Buffalo, Dept Emergency Med, Buffalo, NY 14260 USA; [Leinhart, August] Bassett Med Ctr, Dept Family Med, Cooperstown, NY USA; [Ellis, George L.] Guthrie Clin, Dept Emergency Med, Sayre, PA USA	Bazarian, JJ (corresponding author), Univ Rochester, Sch Med & Dent, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu			New York State Department of Health; Academic Health Center Consortium; Emergency Research Network of the Empire State (ERNIES); Pilot Research Collaborative Program of the Foundation for Healthy Living; University of Rochester's Clinical and Translational Science Award; Upstate New York Translational Research Network (UNYTRN); Upstate New York Consortium for Healthcare Research and Quality (UNYCHRQ)	This study was supported by funds from the New York State Department of Health, the Academic Health Center Consortium, and the Emergency Research Network of the Empire State (ERNIES). ERNIES is supported by the Pilot Research Collaborative Program of the Foundation for Healthy Living, the University of Rochester's Clinical and Translational Science Award, the Upstate New York Translational Research Network (UNYTRN), and the Upstate New York Consortium for Healthcare Research and Quality (UNYCHRQ).	ALLMAN RM, 1985, JAMA-J AM MED ASSOC, V254, P246, DOI 10.1001/jama.254.2.246; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blyth B. J., 2010, J NEUROTRAUM, V26, P25; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Faul M., 2002, TRAUMATIC BRAIN INJU; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rutland-Brown W, 2008, J HEAD TRAUMA REHAB, V23, P84, DOI 10.1097/01.HTR.0000314527.78134.70; Tang W., 2012, APPL CATEGORICAL COU; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TAPE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P295, DOI 10.1016/0005-2760(90)90030-2; Towend W, 2006, J NEUROTRAUM, V23, P149; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Van Lenten BJ, 2006, ARTERIOSCL THROM VAS, V26, P1687, DOI 10.1161/01.ATV.0000232522.47018.a6; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	29	29	29	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1747	1754		10.1089/neu.2013.2853			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000007	23758329	Green Published			2021-06-18	
J	Avesani, R; Roncari, L; Khansefid, M; Formisano, R; Boldrini, P; Zampolini, M; Ferro, S; De Tanti, A; Dambruoso, F				Avesani, R.; Roncari, L.; Khansefid, M.; Formisano, R.; Boldrini, P.; Zampolini, M.; Ferro, S.; De Tanti, A.; Dambruoso, F.			The Italian National Registry of severe acquired brain injury: epidemiological, clinical and functional data of 1469 patients	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Rehabilitation; Outcome assessment; Hypoxia, brain; Cerebrovascular disorders; Brain injuries	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; LENGTH-OF-STAY; CARDIAC-ARREST; MODEL SYSTEMS; REHABILITATION; DISCHARGE; RECOVERY; MODERATE; OUTCOMES	Background. The lack of knowledge about epidemiological and clinical data of patients with Acquired Brain Injury (ABI) admitted to Rehabilitation facilities in Italy led to the creation, in June 2008, of a data collection on-line registry. Aim. To collect epidemiological and clinical data and to evaluate functional outcome of patients with severe traumatic and non-traumatic ABI admitted to Rehabilitation facilities in Italy between June 2008 and December 2011 and to compare data of patients with ABI of different aetiologies. Design. Observational retrospective study. Setting. The study involved 29 Italian Rehabilitation facilities. Population. The study enrolled 1469 patients with severe traumatic (TBI) and non-traumatic ABI (NTBI). Methods. Data collected included demographic (number of patients with TBI and NTBI, gender, age) and clinical characteristics (provenience, number of days elapsed between onset and rehabilitation admission, rehabilitation length of stay, discharge destination, death and vegetative state diagnosis, presence of percutaneous endoscopic gastrostomy, tracheostomy, pressure sores and paraosteoarthropathies). Functional outcome was evaluated using the Disability Rating Scale. Results. Of the whole population studied, 44.31% and 55.69% patients had suffered a TBI and a NTBI, respectively. In the NTBI group 40.09% had a cerebrovascular injury, 12.04% an anoxic brain damage, 3.6% had a brain injury of other causes. The mean age was 43.67 and 56.68 for subjects with TBI and NTBI, respectively. Patients with TBI showed a lower onset-admission interval (OAI), compared with NTBI group; no difference in rehabilitation length of stay (LOS) was recorded between groups. Patients with TBI presented a lower DRS score at admission and discharge and returned home more frequently than NTBI group. Conclusions. The creation of a National registry allows the collection of data about patients with ABI in order to study the clinical course, the functional outcome and to establish a basis for comparison with other data sources. Clinical Rehabilitation Impact. Data collection could be useful in the evaluation and planning of rehabilitation pathways, and to assess the allocation of healthcare and rehabilitative resources.	[Avesani, R.; Khansefid, M.; Dambruoso, F.] Sacro Cuore Don Calabria Hosp, Dept Rehabil, I-37024 Verona, Italy; [Roncari, L.; Dambruoso, F.] Univ Verona, Dept Rehabil Med, I-37100 Verona, Italy; [Formisano, R.] S Lucia IRCCS Hosp, Dept Rehabil, Rome, Italy; [Boldrini, P.] Ca Foncello Hosp, Dept Rehabil, Treviso, Italy; [Zampolini, M.] ASL 3, Dept Rehabil, Umbria, Trevi Perugia, Italy; [Ferro, S.] Agenzia Sanitaria Reg Emilia Romagna, Serv Presidi Osped, Bologna, Italy; [De Tanti, A.] Cardinal Ferrari Hosp, Dept Rehabil, Fontanellato Parma, Italy	Avesani, R (corresponding author), Sacro Cuore Don Calabria Hosp, Dept Rehabil, Via Don A Sempreboni 5, I-37024 Verona, Italy.	renato.avesani@sacrocuore.it			National Health Services funds [502/92]	The work has been supported with National Health Services funds of research project in accordance with art. 12 of Italian Legislative Decree 502/92. Neither financial nor material support was required for the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation, review or approval of the manuscript.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Avesani R, 2012, EUR J PHYS REHAB MED, V48, P433; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Boldrini P, 2004, EUROPA MEDICOPHYS S1, V40, P9; Boldrini P, 2002, GIORNALE ITALIANO ME, V16, P61; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Gazzellini S, 2012, EUR J PHYS REHAB MED, V48, P423; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hakkennes S, 2012, INT J REHABIL RES, V35, P323, DOI 10.1097/MRR.0b013e328355dd00; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reinier K, 2011, CAN MED ASSOC J, V183, P1705, DOI 10.1503/cmaj.101512; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Smania N, 2012, J HEAD TRAUMA REHABI; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taricco M, 2007, ITAL J REHAB MED MR, V21, P53; Tarrico M, 2004, EUROPA MEDICOPHYS S1, P73; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Toigo G, 2005, G GERONTOL, VLIII, P603; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zampolini M, 2012, EUR J PHYS IN PRESS; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	36	29	29	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	OCT	2013	49	5					611	618					8	Rehabilitation	Rehabilitation	283TA	WOS:000329268700001	23558700				2021-06-18	
J	Hansen, K; Dau, N; Feist, F; Deck, C; Willinger, R; Madey, SM; Bottlang, M				Hansen, Kirk; Dau, Nathan; Feist, Florian; Deck, Caroline; Willinger, Remy; Madey, Steven M.; Bottlang, Michael			Angular Impact Mitigation system for bicycle helmets to reduce head acceleration and risk of traumatic brain injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Helmet; Bicycle; Traumatic brain injury; Impact mitigation; Rotational acceleration; Concussion	BIOMECHANICS; PERFORMANCE; ABSORPTION; RESPONSES; FRICTION; DAMAGE; STATE; SIMON	Angular acceleration of the head is a known cause of traumatic brain injury (TBI), but contemporary bicycle helmets lack dedicated mechanisms to mitigate angular acceleration. A novel Angular Impact Mitigation (AIM) system for bicycle helmets has been developed that employs an elastically suspended aluminum honeycomb liner to absorb linear acceleration in normal impacts as well as angular acceleration in oblique impacts. This study tested bicycle helmets with and without AIM technology to comparatively assess impact mitigation. Normal impact tests were performed to measure linear head acceleration. Oblique impact tests were performed to measure angular head acceleration and neck loading. Furthermore, acceleration histories of oblique impacts were analyzed in a computational head model to predict the resulting risk of TBI in the form of concussion and diffuse axonal injury (DAI). Compared to standard helmets, AIM helmets resulted in a 14% reduction in peak linear acceleration (p < 0.001), a 34% reduction in peak angular acceleration (p < 0.001), and a 22-32% reduction in neck loading (p < 0.001). Computational results predicted that AIM helmets reduced the risk of concussion and DAI by 27% and 44%, respectively. In conclusion, these results demonstrated that AIM technology could effectively improve impact mitigation compared to a contemporary expanded polystyrene-based bicycle helmet, and may enhance prevention of bicycle-related TBI. Further research is required. (C) 2013 Elsevier Ltd. All rights reserved.	[Hansen, Kirk; Dau, Nathan; Madey, Steven M.; Bottlang, Michael] Legacy Res Inst, Biomech Lab, Portland, OR 97232 USA; [Feist, Florian] Graz Univ Technol, Vehicle Safety Inst, A-8010 Graz, Austria; [Deck, Caroline; Willinger, Remy] Univ Strasbourg, Inst Mecan Fluides & Solides, Strasbourg, France	Bottlang, M (corresponding author), Legacy Biomech Lab, 1225 NE 2nd Ave, Portland, OR 97215 USA.	mbottlan@lhs.org	Augat, Peter/A-2051-2011	Augat, Peter/0000-0003-4805-2128; DECK, Caroline/0000-0003-2289-1222	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS074734, R41 NS074734] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS074734] Funding Source: NIH RePORTER		Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Abu-Zidan FM, 2007, EMERG MED AUSTRALAS, V19, P366, DOI 10.1111/j.1742-6723.2007.00967.x; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; British Standards Institute, 1997, HELMETS FOR PEDAL CY; Camacho DLA, 1999, J BIOMECH, V32, P293, DOI 10.1016/S0021-9290(98)00178-X; Caserta G, 2010, MECH ADV MATER STRUC, V17, P366, DOI 10.1080/15376494.2010.488612; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Consumer Product Safety Commission, 2011, NATIONAL ELECTRONIC; Consumer Product Safety Commission, 1998, SAFETY STANDARD FOR; Cook A, 2003, INJURY PREV, V9, P266, DOI 10.1136/ip.9.3.266; Dau N., 2012, NORTH WEST BIOMECHAN; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deck C., 2012, INTERNATIONAL CRASHW; Deck C., 2007, P IRCOBI C MAASTR NE, P185; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Fredriksson R, 2007, STAPP CAR CRASH JO, V51, P155; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ivarsson J, 2003, J BIOMECH ENG-T ASME, V125, P523, DOI 10.1115/1.1590360; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P274, DOI 10.1177/1754337111435294; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; Society of Automotive Engineers, 2007, INSTRUMENTATION FOR; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Zarei H, 2008, MATER DESIGN, V29, P193, DOI 10.1016/j.matdes.2006.10.013; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	48	29	29	1	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	OCT	2013	59						109	117		10.1016/j.aap.2013.05.019			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	261SX	WOS:000327686000013	23770518	Green Accepted			2021-06-18	
J	Bedi, SS; Walker, PA; Shah, SK; Jimenez, F; Thomas, CP; Smith, P; Hetz, RA; Xue, HS; Pati, S; Dash, PK; Cox, CS				Bedi, Supinder S.; Walker, Peter A.; Shah, Shinil K.; Jimenez, Fernando; Thomas, Chelsea P.; Smith, Philippa; Hetz, Robert A.; Xue, Hasen; Pati, Shibani; Dash, Pramod K.; Cox, Charles S., Jr.			Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Behavior (rodent); blood-brain barrier; brain trauma; microglia; rats	MOUSE SPINAL-CORD; TIME-COURSE; MICROGLIA; RATS; INFLAMMATION; EXPRESSION	BACKGROUND: Autologous bone marrow-derived mononuclear cells (AMNCs) have shown therapeutic promise for central nervous system insults such as stroke and traumatic brain injury (TBI). We hypothesized that intravenous injection of AMNC provides neuroprotection, which leads to cognitive improvement after TBI. METHODS: A controlled cortical impact (CCI) rodent TBI model was used to examine blood-brain barrier (BBB) permeability, neuronal and glial apoptosis, as well as cognitive behavior. Two groups of rats underwent CCI with AMNC treatment (CCI-autologous) or without AMNC treatment (CCI-alone), consisting of 2 million AMNC per kilogram body weight harvested from the tibia and intravenously injected 72 hours after injury. CCI-alone animals underwent sham harvests and received vehicle injections. RESULTS: Ninety-six hours after injury, AMNC significantly reduced the BBB permeability in injured animals, and there was an increase in apoptosis of proinflammatory activated microglia in the ipsilateral hippocampus. At 4 weeks after injury, we observed significant improvement in probe testing of CCI-Autologous group in comparison to CCI-Alone in the Morris Water Maze paradigm. CONCLUSION: Our data demonstrate that the intravenous injection of AMNC after TBI leads to neuroprotection by preserving early BBB integrity, increasing activated microglial apoptosis and improving cognitive function. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Bedi, Supinder S.; Walker, Peter A.; Shah, Shinil K.; Jimenez, Fernando; Thomas, Chelsea P.; Smith, Philippa; Hetz, Robert A.; Xue, Hasen; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Walker, Peter A.; Shah, Shinil K.; Hetz, Robert A.; Xue, Hasen; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Shah, Shinil K.] Texas A&M Univ, Michael E DeBakey Inst Comparat Cardiovasc Sci &, College Stn, TX USA; [Pati, Shibani] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Pati, Shibani] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cox, CS (corresponding author), Univ Texas Med Sch Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-236, Houston, TX 77030 USA.	Charles.s.cox@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	Brown Foundation, Inc.; Children's Memorial Hermann Hospital Foundation;  [NIH T32 GM 08 79201];  [M01 RR 02558]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	This study was supported by grants NIH T32 GM 08 79201, and M01 RR 02558; Brown Foundation, Inc., Children's Memorial Hermann Hospital Foundation.	Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Porter AG, 1999, TRENDS CELL BIOL, V9, P394, DOI 10.1016/S0962-8924(99)01624-4; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Smith HS, 2010, PAIN PHYSICIAN, V13, P295; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Terry A.V., 2009, SPATIAL NAVIGATION W; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker Peter A, 2011, World J Stem Cells, V3, P9, DOI 10.4252/wjsc.v3.i2.9	29	29	30	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2013	75	3					410	416		10.1097/TA.0b013e31829617c6			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	300GZ	WOS:000330453700009	23928737	Green Accepted			2021-06-18	
J	Husby, IM; Skranes, J; Olsen, A; Brubakk, AM; Evensen, KAI				Husby, Ingrid Marie; Skranes, Jon; Olsen, Alexander; Brubakk, Ann-Mari; Evensen, Kari Anne I.			Motor skills at 23 years of age in young adults born preterm with very low birth weight	EARLY HUMAN DEVELOPMENT			English	Article						Fine motor skills; Gross motor skills; Grooved Pegboard test; High-level Mobility Assessment Tool; Long-term outcome; Motor speed; Movement Assessment Battery for Children-2; Prematurity; Trail Making Test-5	MOBILITY ASSESSMENT-TOOL; TRAUMATIC BRAIN-INJURY; NEURODEVELOPMENTAL DISABILITY; NEUROLOGICAL CONDITIONS; CHILDREN BORN; MRI FINDINGS; FOLLOW-UP; INFANTS; ADOLESCENTS; OUTCOMES	Background: Motor skills have previously not been reported in young adults born with very low birth weight (VLBW), although they are commonly reported in children and adolescents. Aim: To compare fine and gross motor skills in VLBW young adults with matched term-born controls, and to study longitudinal changes in the VLBW group. Study design: A geographically based follow-up study of a VLBW group and a control group. Subjects: Thirty-six VLBW (birth weight <= 1500 g) young adults, including four participants with cerebral palsy (CP), and 37 matched controls (birth weight >= 10th centile) were examined at 14 and 23 years of age. Outcome measures: Fine and gross motor skills were assessed using Grooved Pegboard test (GP), Trail Making Test-5 (TMT-5), Movement Assessment Battery for Children-2 (Movement ABC-2) and High-level Mobility Assessment Tool (HiMAT). Results: VLBW young adults were slower than controls on GP (p = 0.026) and TMT-5 (p < 0.001). Mean total Movement ABC-2 score was 69.7 +/- 20.2 in the VLBW group compared with 74.1 +/- 14.4 in the control group (p = 0.017). Differences were also seen in manual dexterity and balance. Additionally, HiMAT showed reduced balance and speed in gross motor skills in the VLBW group. The proportion of participants with motor problems did not change between age 14 and 23. After exclusion of participants with CP, scores were essentially the same. Conclusion: VLBW young adults had overall poorer fine and gross motor skills compared with controls. Reduced speed seemed to be an underlying problem. Longitudinal findings indicate that VLBW children have not outgrown their motor problems when entering adulthood. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Husby, Ingrid Marie; Skranes, Jon; Brubakk, Ann-Mari; Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Skranes, Jon] Sorlandet Hosp, Dept Pediat, Arendal, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, MI Lab, N-7491 Trondheim, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Olsen, Alexander] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Brubakk, Ann-Mari] Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7491 Trondheim, Norway; [Evensen, Kari Anne I.] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway	Husby, IM (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med Childrens & Womens Hlth, POB 8905, N-7491 Trondheim, Norway.	ingrihu@stud.ntnu.no	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Research Council of NorwayResearch Council of Norway	The study was funded by the Research Council of Norway and was independent of commercial interest.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barnett, 2007, MOVEMENT ASSESSMENT; Bracewell M, 2002, MENT RETARD DEV D R, V8, P241, DOI 10.1002/mrdd.10049; Bruininks R. H., 1978, BRUININKS OSERETSKY; Davies PS, 2000, BIOL PHILOS, V15, P19, DOI 10.1023/A:1006525318699; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Delis D, 2005, NORSK MANUAL S; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Evensen KAI, 2004, ARCH DIS CHILD-FETAL, V89, pF451, DOI 10.1136/adc.2003.037788; Evensen KAI, 2009, EARLY HUM DEV, V85, P511, DOI 10.1016/j.earlhumdev.2009.04.007; Evensen KAI, 2009, EUR J PAEDIATR NEURO, V13, P47, DOI 10.1016/j.ejpn.2008.02.009; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Gaddlin PO, 2008, EARLY HUM DEV, V84, P343, DOI 10.1016/j.earlhumdev.2007.09.013; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Henderson S. E., 1992, MOVEMENT ASSESSMENT; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOLLINGSHEAD AB, 1958, 2 FACTOR INDEX SOCIA; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Lafayette I., 2002, LAFAYETTE INSTRUMENT; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; McCormick MC, 2011, ANNU REV PUBL HEALTH, V32, P367, DOI 10.1146/annurev-publhealth-090810-182459; McCormick MC, 1997, PEDIATRICS, V99, P869, DOI 10.1542/peds.99.6.869; Moen KT, 2011, HIMAT HIGH LEVEL MOB, P12; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; O'Brien F, 2004, ARCH DIS CHILD, V89, P207, DOI 10.1136/adc.2002.006676; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Rademaker KJ, 2005, ARCH DIS CHILD-FETAL, V90, pF489, DOI 10.1136/adc.2005.073908; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Skranes J, 2012, EARLY HUM DEV, V88, P103, DOI 10.1016/j.earlhumdev.2011.07.017; Skranes JS, 2005, PEDIATR RADIOL, V35, P758, DOI 10.1007/s00247-005-1446-2; Skranes JS, 1997, NEUROPEDIATRICS, V28, P149, DOI 10.1055/s-2007-973692; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Volpe J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2004, HIGH LEVEL MOBILITY; Williams G, 2012, CLIN REHABIL, V26, P741, DOI 10.1177/0269215511429163; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Wuang YP, 2012, DEV MED CHILD NEUROL, V54, P160, DOI 10.1111/j.1469-8749.2011.04177.x	49	29	31	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	SEP	2013	89	9					747	754		10.1016/j.earlhumdev.2013.05.009			8	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	210ZT	WOS:000323874600023	23810435				2021-06-18	
J	Son, S; Yoo, CJ; Lee, SG; Kim, EY; Park, CW; Kim, WK				Son, Seong; Yoo, Chan Jong; Lee, Sang Gu; Kim, Eun Young; Park, Chan Woo; Kim, Woo Kyung			Natural Course of Initially Non-Operated Cases of Acute Subdural Hematoma : The Risk Factors of Hematoma Progression	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Acute subdural hematoma; Chronic subdural hematoma; X-ray computed tomography	TRAUMATIC SUBARACHNOID HEMORRHAGE; EXTERNAL HYDROCEPHALUS; RAPID RESOLUTION; BRAIN-INJURY; HEAD TRAUMA; HYGROMA; MANAGEMENT; PATHOGENESIS; ADULTS; FATE	Objective : The objectives of the present study were to characterize the natural course of initially non-operated traumatic acute subdural hematoma (ASDH) and to identify the risk factors of hematoma progression. Methods : Retrospective analysis was performed using sequential computed tomography (CT) images maintained in a prospective observational database containing 177 ASDH cases treated from 2005 to 2011. Patients were allocated to four groups as followings; 136 (76.8%) patients to the spontaneous resolution group, 12 (6.8%) who underwent operation between 4 hours and 7 days to the rapid worsening group (RWG), 24 (13.6%) who experienced an increase of hematoma and that underwent operation between 7 and 28 days to the subacute worsening group (SWG), and 5 (2.8%) who developed delayed aggravation requiring surgery from one month after onset to the delayed worsening group (DWG). Groups were compared with respect to various factors. Results : No significant intergroup difference was found with respect to age, mechanism of injury, or initial Glasgow Coma Scale. The presence of combined cerebral contusion or subarachnoid hemorrhage was found to be a significant prognostic factor. Regarding CT findings, mixed density was common in the RWG and the SWG. Mid line shifting, hematoma thickness, and numbers of CT slices containing hematoma were significant prognostic factors of the RWG and the SWG. Brain atrophy was more severe in the SWG and the DWG. Conclusion : A large proportion of initially non-operated ASDHs worsen in the acute or subacute phase. Patients with risk factors should be monitored carefully for progression by repeat CT imaging.	[Son, Seong; Yoo, Chan Jong; Lee, Sang Gu; Kim, Eun Young; Park, Chan Woo; Kim, Woo Kyung] Gachon Univ, Gil Med Ctr, Dept Neurosurg, Inchon 405760, South Korea	Yoo, CJ (corresponding author), Gachon Univ, Gil Med Ctr, Dept Neurosurg, 1198 Guwol Dong, Inchon 405760, South Korea.	nschan@gilhospital.com					AOKI N, 1990, ACTA NEUROCHIR, V103, P76, DOI 10.1007/BF01420196; BARKLEY JM, 2007, BRAIN INJURY MED PRI, P129; BULLOCK MR, 2006, NEUROSURGERY S, V58; Cardoso ER, 1996, J NEUROSURG, V85, P1143, DOI 10.3171/jns.1996.85.6.1143; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Feliciano CE, P R HLTH SCI J, V27, p[220, 200]; Gean A, 1994, IMAGING HEAD TRAUMA; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Izumihara A, 1997, NEUROL SURG TOKYO, V25, P307; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Kim H, 1999, J KOREAN NEUROSURG S, V28, P1636; Lee CH, 2009, J KOREAN MED SCI, V24, P1224, DOI 10.3346/jkms.2009.24.6.1224; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee KS, 2011, J KOREAN NEUROSURG S, V50, P512, DOI 10.3340/jkns.2011.50.6.512; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Matsuyama T, 1997, SURG NEUROL, V47, P423, DOI 10.1016/S0090-3019(96)00398-9; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Okumura Y, 1998, NEUROL SURG TOKYO, V26, P691; Park SH, 2011, CLIN NEUROL NEUROSUR, V113, P272, DOI 10.1016/j.clineuro.2010.11.014; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Servadei F, 2002, ACT NEUR S, V81, P81; Soltys SG, 2007, NEUROSURGERY, V61, P235; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Wu Ming-can, 2004, Chin J Traumatol, V7, P96; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc; Zwienenberg-Lee M, 2011, YOUMANS NEUROLOGICAL, P3335	34	29	32	0	8	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2013	54	3					211	219		10.3340/jkns.2013.54.3.211			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	241YZ	WOS:000326205900009	24278650	DOAJ Gold, Green Published			2021-06-18	
J	Dvorkin, AY; Ramaiya, M; Larson, EB; Zollman, FS; Hsu, N; Pacini, S; Shah, A; Patton, JL				Dvorkin, Assaf Y.; Ramaiya, Milan; Larson, Eric B.; Zollman, Felise S.; Hsu, Nancy; Pacini, Sonia; Shah, Amit; Patton, James L.			A "virtually minimal" visuo-haptic training of attention in severe traumatic brain injury	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Virtual reality; Robotics; Attention; Rehabilitation; TBI	COGNITIVE REHABILITATION; ONLINE CONTROL; MOTOR CONTROL; REALITY; INTERVENTION; REMEDIATION; ENVIRONMENT; PROGRAMS; BENEFITS; DEFICITS	Background: Although common during the early stages of recovery from severe traumatic brain injury (TBI), attention deficits have been scarcely investigated. Encouraging evidence suggests beneficial effects of attention training in more chronic and higher functioning patients. Interactive technology may provide new opportunities for rehabilitation in inpatients who are earlier in their recovery. Methods: We designed a "virtually minimal" approach using robot-rendered haptics in a virtual environment to train severely injured inpatients in the early stages of recovery to sustain attention to a visuo-motor task. 21 inpatients with severe TBI completed repetitive reaching toward targets that were both seen and felt. Patients were tested over two consecutive days, experiencing 3 conditions (no haptic feedback, a break-through force, and haptic nudge) in 12 successive, 4-minute blocks. Results: The interactive visuo-haptic environments were well-tolerated and engaging. Patients typically remained attentive to the task. However, patients exhibited attention loss both before (prolonged initiation) and during (pauses during motion) a movement. Compared to no haptic feedback, patients benefited from haptic nudge cues but not break-through forces. As training progressed, patients increased the number of targets acquired and spontaneously improved from one day to the next. Conclusions: Interactive visuo-haptic environments could be beneficial for attention training for severe TBI patients in the early stages of recovery and warrants further and more prolonged clinical testing.	[Dvorkin, Assaf Y.; Larson, Eric B.; Zollman, Felise S.; Hsu, Nancy; Pacini, Sonia; Patton, James L.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Dvorkin, Assaf Y.; Larson, Eric B.; Zollman, Felise S.; Patton, James L.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Ramaiya, Milan; Shah, Amit; Patton, James L.] Univ Illinois, Chicago, IL USA	Dvorkin, AY (corresponding author), Rehabil Inst Chicago, 345 E Super St, Chicago, IL 60611 USA.	sasaf@vms.huji.ac.il	Larson, Eric/AAD-9567-2021		US Department of Education, National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133A080045A]	We gratefully acknowledge Kathleen Beck and Lindsay Davitt for assisting with initial study design and data collection. This work was supported by the US Department of Education, National Institute on Disability and Rehabilitation Research (Grant #H133A080045A). The opinions expressed here do not necessarily represent the policy of the Department of Education.	Ariff G, 2002, J NEUROSCI, V22, P7721; Bluteau J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001775; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Brewer BR, 2008, BRAIN RES BULL, V75, P804, DOI 10.1016/j.brainresbull.2008.01.006; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Driver J., 2004, CROSSMODAL SPACE CRO; Dvorkin Assaf Y, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P962, DOI 10.1109/ICORR.2009.5209629; Dvorkin AY, 2013, BRAIN INJURY, V27, P957, DOI 10.3109/02699052.2013.793399; Dvorkin AY, 2009, EXP BRAIN RES, V193, P95, DOI 10.1007/s00221-008-1598-z; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gray R, 2002, EXP BRAIN RES, V145, P50, DOI 10.1007/s00221-002-1085-x; Hagen C, 1979, REHABILITATION HEAD, P87; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Huang FC, 2007, J MOTOR BEHAV, V39, P179, DOI 10.3200/JMBR.39.3.179-193; Jones CM, 2008, EXP BRAIN RES, V186, P659, DOI 10.1007/s00221-008-1277-0; Larson EB, 2011, BRAIN INJURY, V25, P274, DOI 10.3109/02699052.2010.551648; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Merlo JL, 2010, AM J PSYCHOL, V123, P413, DOI 10.5406/amerjpsyc.123.4.0413; Michel J A, 2006, Eura Medicophys, V42, P59; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; Palmese CA, 2000, BRAIN INJURY, V14, P535; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Patton J, 2006, ASSIST TECHNOL, V18, P181, DOI 10.1080/10400435.2006.10131917; Pero S, 2006, BRAIN INJURY, V20, P1207, DOI 10.1080/02699050600983271; Pittenger DJ, 2002, GENET SOC GEN PSYCH, V128, P237; Plotnik M, 1998, J NEUROL NEUROSUR PS, V65, P328, DOI 10.1136/jnnp.65.3.328; Potter GG, 2007, NEUROPSYCHOPHARMACOL, V32, P2135, DOI 10.1038/sj.npp.1301339; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Sturm W, 2003, Z NEUROPSYCHOL, V14, P283, DOI [DOI 10.1024/1016-264X.14.4.283, 10.1024/1016-264X.14.4.283]; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Weiss PL, 2003, CYBERPSYCHOL BEHAV, V6, P335, DOI 10.1089/109493103322011650; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zoccolotti P, 2011, EUR J PHYS REHAB MED, V47, P123	42	29	31	0	36	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	AUG 9	2013	10								92	10.1186/1743-0003-10-92			9	Engineering, Biomedical; Neurosciences; Rehabilitation	Engineering; Neurosciences & Neurology; Rehabilitation	199NE	WOS:000323000800001	23938101	DOAJ Gold, Green Published			2021-06-18	
J	Bryer, EJ; Medaglia, JD; Rostami, S; Hillary, FG				Bryer, E. J.; Medaglia, J. D.; Rostami, S.; Hillary, Frank G.			Neural Recruitment after Mild Traumatic Brain Injury Is Task Dependent: A Meta-analysis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Functional magnetic resonance imaging; Working memory; Cognitive control; Hypoactivation; Hyperactivation	WORKING-MEMORY DYSFUNCTION; SUSTAINED ATTENTION; COGNITIVE-CONTROL; PERFORMANCE; DEFICITS; NETWORK; CORTEX; FMRI; ABNORMALITIES; CONNECTIVITY	Individuals with mild traumatic brain injury (TBI) often have deficits in processing speed and working memory (WM) and there is a growing literature using functional imaging studies to document these deficits. However, divergent results from these studies revealed both hypoactivation and hyperactivation of neural resources after injury. We hypothesized that at least part of this variance can be explained by distinct demands between WM tasks. Notably, in this literature some WM tasks use discrete periods of encoding, maintenance, and retrieval, whereas others place continuous demands on WM. The purpose of this meta-analysis is to examine the differences in neural recruitment after mTBI to determine if divergent findings can be explained as a function of task demand and cognitive load. A comprehensive literature review revealed 14 studies using functional magnetic resonance imaging to examine brain activity of individuals with mTBI during working memory tasks. Three of the fourteen studies included reported hypoactivity, five reported hyperactivity, and the remaining six reported both hypoactivity and hyperactivity. Studies were grouped according to task type and submitted to GingerALE maximum likelihood meta-analyses to determine the most consistent brain activation patterns. The primary findings from this meta-analysis suggest that the discrepancy in activation patterns is at least partially attributable to the classification of WM task, with hyperactivation being observed in continuous tasks and hypoactivation being observed during discrete tasks. We anticipate that differential task load expressed in continuous and discrete WM tasks contributes to these differences. Implications for the interpretation of fMRI signals in clinical samples are discussed.	[Bryer, E. J.; Medaglia, J. D.; Rostami, S.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, Bruce V Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Commission on Brain Injury Research [0120090178]	Dr. Jen-Khai Chen (cf., Chen et al., 2008) provided data upon request. The authors declare that there are no conflicts of interest, either financial or otherwise, associated with this study and the resulting manuscript. This study was funded in part by a grant from the New Jersey Commission on Brain Injury Research (grant number 0120090178).	Baddeley A. D., 1994, Neuropsychology, V8, P485, DOI [10.1037/0894-4105.8.4.485., 10.1037/0894-4105.8.4.485]; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Courtney Susan M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P501, DOI 10.3758/CABN.4.4.501; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Goldman-Rakic P.S., 1987, CIRCUITRY PRIMATE PR; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hillary F. G., 2013, BRAIN IMAGING BEHAV; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kosslyn SM, 1999, PHILOS T ROY SOC B, V354, P1283, DOI 10.1098/rstb.1999.0479; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Research Imaging Institute UTHSCSA, MULT AN GUI VERS 2 6; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2004, BRAIN INJURY, V18, P219; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; TEASDALE G, 1974, LANCET, V2, P81; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	55	29	30	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2013	19	7					751	762		10.1017/S1355617713000490			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	186CI	WOS:000322018900002	23656706				2021-06-18	
J	Garringer, JA; Niyonkuru, C; McCullough, EH; Loucks, T; Dixon, CE; Conley, YP; Berga, S; Wagner, AK				Garringer, Julie A.; Niyonkuru, Christian; McCullough, Emily H.; Loucks, Tammy; Dixon, C. Edward; Conley, Yvette P.; Berga, Sarah; Wagner, Amy K.			Impact of Aromatase Genetic Variation on Hormone Levels and Global Outcome after Severe TBI	JOURNAL OF NEUROTRAUMA			English	Article						aromatase; estradiol; genetics CYP19A1; testosterone; traumatic brain injury	SERUM ESTROGEN-LEVELS; TESTOSTERONE INCREASES; GENDER-DIFFERENCES; BRAIN-INJURY; LESION SIZE; SEX; CYP19; POLYMORPHISMS; ORGANIZATION; ASSOCIATION	Although experimental traumatic brain injury (TBI) studies support estradiol as a neuroprotectant and potent stimulator of neuroplasticity, clinical studies suggest a negative association between endogenous estradiol profiles and mortality/poor outcomes. However, no studies have evaluated associations with cerebral spinal fluid (CSF) hormone profiles and aromatase gene (cytochrome P450 [CYP] 19A1) variability on clinical TBI outcomes. We evaluated 110 adults with severe TBI. Average and daily estradiol, testosterone, and estradiol/testosterone ratios (E2:T) were measured using CSF and serum samples and compared to healthy controls. Eighteen tagging and four functional single-nucleotide polymorphisms (SNPs) for CYP19A1 were genotyped and compared to hormones, acute mortality, and Glasgow Outcome Scale (GOS) scores 6 months post-TBI. TBI subjects had lower CSF estradiol over time versus controls. CSF testosterone was initially high, but declined over time. E2/T ratios were initially low, compared to controls, but rose over time. Higher mean E2/T ratio in bivariate analysis was associated with lower mortality (p = 0.019) and better GOS-6 scores (p = 0.030). rs2470152 influenced CSF E2/T ratio and also serumand CSF testosterone (p <= 0.05 all comparisons). Multiple-risk SNPs rs2470152, rs4646, and rs2470144 were associated with worse GOS-6 scores (p <= 0.05, all comparisons), and those with > 1 risk SNP variant had a higher risk for poor outcome, compared with those with <= 1 risk variant. TBI results in low CSF estradiol and dynamic CSF testosterone and E2/T ratio. In contrast to clinical serum hormone studies, higher CSF E2/T ratio was associated with better outcome. Further, genetic variation in CYP19A1 influences both hormone dynamics and outcome post-TBI.	[Garringer, Julie A.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Niyonkuru, Christian; McCullough, Emily H.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [McCullough, Emily H.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Loucks, Tammy] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Berga, Sarah] Wake Forest Univ, Dept Obstet & Gynecol, Winston Salem, NC 27109 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Loucks, Tammy/N-8223-2019	Loucks, Tammy/0000-0001-7651-7602; Conley, Yvette/0000-0002-1784-6067	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR323155]; Department of DefenseUnited States Department of Defense [W81XWH-071-0701]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01NS030318, R01NR008424, R01 HD048162]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors thank Sandra Deslouches for her technical support and the Brain Trauma Research Center for some elements of data collection. This work was supported by the Centers for Disease Control and Prevention (R49 CCR323155), the Department of Defense (W81XWH-071-0701), and the National Institutes of Health (5P01NS030318, R01NR008424, and R01 HD048162).	Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Azcoitia I, 2011, NEUROSCIENCE, V191, P139, DOI 10.1016/j.neuroscience.2011.02.012; Balthazart J, 2006, ENDOCRINOLOGY, V147, P359, DOI 10.1210/en.2005-0845; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bulun SE, 2004, SEMIN REPROD MED, V22, P5; Cheng J, 2007, J CEREBR BLOOD F MET, V27, P1553, DOI 10.1038/sj.jcbfm.9600457; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Eriksson AL, 2009, J CLIN ENDOCR METAB, V94, P1033, DOI 10.1210/jc.2008-1283; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Garcia-Casado Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-36; Gibson CL, 2006, J CEREBR BLOOD F MET, V26, P1103, DOI 10.1038/sj.jcbfm.9600270; Guo Y, 2006, HUM MOL GENET, V15, P2401, DOI 10.1093/hmg/ddl155; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Hawk T, 1998, BRAIN RES, V796, P296, DOI 10.1016/S0006-8993(98)00327-8; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; HOBBS CJ, 1992, J STEROID BIOCHEM, V42, P629, DOI 10.1016/0960-0760(92)90455-R; Hojo Y, 2008, MOL CELL ENDOCRINOL, V290, P31, DOI 10.1016/j.mce.2008.04.017; HONDA S, 1994, BIOCHEM BIOPH RES CO, V198, P1153, DOI 10.1006/bbrc.1994.1163; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2010, CLIN CHIM ACTA, V411, P53, DOI 10.1016/j.cca.2009.09.039; Koudu Y, 2012, BIOCHEM GENET, V50, P389, DOI 10.1007/s10528-011-9483-z; MacLusky NJ, 2006, NEUROSCIENCE, V138, P957, DOI 10.1016/j.neuroscience.2005.12.054; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; McCullough LD, 2003, J NEUROSCI, V23, P8701; Mendelowitsch A, 2001, BRAIN RES, V901, P230, DOI 10.1016/S0006-8993(01)02359-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pennypacker KR, 2000, ACTA NEUROBIOL EXP, V60, P515; Prange-Kiel J, 2006, NEUROSCIENCE, V138, P765, DOI 10.1016/j.neuroscience.2005.05.061; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Sebastian S, 2001, J CLIN ENDOCR METAB, V86, P4600, DOI 10.1210/jc.86.10.4600; Simpson ER, 2004, SEMIN REPROD MED, V22, P11; Sofi M, 2003, BREAST CANCER RES TR, V79, P399, DOI 10.1023/A:1024038632570; Sowers MR, 2006, AM J MED, V119, P1, DOI 10.1016/j.amjmed.2006.07.005; Spratt DI, 2006, AM J PHYSIOL-ENDOC M, V291, pE631, DOI 10.1152/ajpendo.00467.2005; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xu WH, 2007, AM J EPIDEMIOL, V166, P1420, DOI 10.1093/aje/kwm242; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Yang SH, 2002, J APPL PHYSIOL, V92, P195; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	48	29	29	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1415	1425		10.1089/neu.2012.2565			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500005	23540392	Green Published			2021-06-18	
J	Man, DWK; Poon, WS; Lam, C				Man, David Wai Kwong; Poon, Wai Sang; Lam, Chow			The effectiveness of artificial intelligent 3-D virtual reality vocational problem-solving training in enhancing employment opportunities for people with traumatic brain injury	BRAIN INJURY			English	Article						Artificial intelligence; cognitive rehabilitation; employment; technology; traumatic brain injury; virtual reality	CARD SORTING TEST; SELF-AWARENESS; COGNITIVE REHABILITATION; MEMORY; MANAGEMENT; OUTCOMES; ADULTS; SKILLS; RETURN	Background: People with traumatic brain injury (TBI) often experience cognitive deficits in attention, memory, executive functioning and problem-solving. The purpose of the present research study was to examine the effectiveness of an artificial intelligent virtual reality (VR)-based vocational problem-solving skill training programme designed to enhance employment opportunities for people with TBI. Method: This was a prospective randomized controlled trial (RCT) comparing the effectiveness of the above programme with that of the conventional psycho-educational approach. Forty participants with mild (n = 20) or moderate (n = 20) brain injury were randomly assigned to each training programme. Comparisons of problem-solving skills were performed with the Wisconsin Card Sorting Test, the Tower of London Test and the Vocational Cognitive Rating Scale. Results: Improvement in selective memory processes and perception of memory function were found. Across-group comparison showed that the VR group performed more favourably than the therapist-led one in terms of objective and subjective outcome measures and better vocational outcomes. Conclusions: These results support the potential use of a VR-based approach in memory training in people with MCI. Further VR applications, limitations and future research are described.	[Man, David Wai Kwong] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Poon, Wai Sang] Chinese Univ Hong Kong, Dept Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Lam, Chow] IIT, Coll Psychol, Chicago, IL 60616 USA	Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Yuk Choi Rd, Kowloon, Hong Kong, Peoples R China.	david.man@polyu.edu.hk	Poon, Wai Sang/F-1558-2011		National Institute on Disability and Rehabilitation Research (NIDRR), US [H133F100025]; General Research Fund, Hong Kong [562710]	This study was partially supported by the National Institute on Disability and Rehabilitation Research (NIDRR) H133F100025 grant, US, and the General Research Fund (562710), Hong Kong. The content is solely the responsibility of the authors and does not necessarily reflect the views of the funding bodies. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Anderson K, 2008, J SPINAL CORD MED, V31, P133, DOI 10.1080/10790268.2008.11760704; Axelrod Bradley N, 1992, Clin Neuropsychol, V6, P143, DOI 10.1080/13854049208401851; Brown L., 1997, TEST NONVERBAL INTEL; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHAN F, 1990, REHABIL COUNS BULL, V33, P212; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chiu H.F., 1994, HONG KONG J PSYCHIAT, V4, P25; Computerised Wisconsin card sort task, 2003, COMP WISC CARD SORT; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; DREWE E A, 1974, Cortex, V10, P159; Fleming JM, 1996, BRAIN INJURY, V10, P1; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1207/s15516709cog0702_3; Gilworth G, 2006, BRAIN INJURY, V20, P835, DOI 10.1080/02699050600832221; GREIG TC, 2004, J VOCATIONAL REHABIL, V21, P71; Heaton R., 1993, WISCONSIN CARD SORTI; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Keane M.T., 1988, ANALOGICAL PROBLEM S; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Lam C. S., 2005, ENCY DISABILITY, VII, P583; Lam CS, 1991, REHABILITATION ED, V5, P242; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Lemaire ED, 2003, J TELEMED TELECARE, V9, P17, DOI 10.1258/135763303321159648; Leung K L, 2005, Work, V25, P333; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Man DWK, 2006, BRAIN INJURY, V20, P981, DOI 10.1080/13561820600909852; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; Medalia A, 2010, SCHIZOPHRENIA BULL, V36, P912, DOI 10.1093/schbul/sbq073; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Poon WS, 2007, HONG KONG MED J, V13, P21; Revheim N, 2006, SCHIZOPHR RES, V83, P237, DOI 10.1016/j.schres.2005.12.849; Rizzo AA, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199712000-00002; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shum D, 2000, BRAIN COGNITION, V44, P59; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Soong W, 2005, INT J REHABIL RES, V28, P341, DOI 10.1097/00004356-200512000-00006; Soong W, 2003, BRAIN INJURY S1, V17, P51; Tam SF, 2005, REHABIL PSYCHOL, V50, P285, DOI 10.1037/0090-5550.50.3.285; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412	54	29	29	3	59	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1016	1025		10.3109/02699052.2013.794969			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100005	23662639				2021-06-18	
J	Williamson, MLC; Elliott, TR; Berry, JW; Underhill, AT; Stavrinos, D; Fine, PR				Williamson, Meredith L. C.; Elliott, Timothy R.; Berry, Jack W.; Underhill, Andrea T.; Stavrinos, Despina; Fine, Philip R.			Predictors of health-related quality-of-life following traumatic brain injury	BRAIN INJURY			English	Article						Depression; family satisfaction; pain; sructural equation modelling	1ST 5 YEARS; REHABILITATION; SATISFACTION; VALIDATION; PAIN; TRAJECTORIES; ADJUSTMENT; STRATEGIES; IMPACT; SCALE	Primary objective: To examine the predictive associations of family satisfaction, functional impairment, pain, and depression on health-related quality-of-life (HRQoL) among persons with traumatic brain injury (TBI) through structural equation modelling (SEM). Research design: Participants were part of a larger longitudinal study of adjustment following TBI. Direct and indirect effects of predictor variables on HRQoL were analyzed through SEM. Methods and procedures: The sample included 131 participants with TBI (89 men, 42 women) who had been discharged from an acute care hospital. The Sickness Impact Profile was administered to measure HRQoL at or beyond 24 months post-discharge. Predictor variable measures included the Functional Independence Measure, Family Satisfaction Scale and single items assessing the presence of pain and depression. Main outcomes and results: SEM revealed direct effects of functional impairment (p<0.001), family satisfaction (p<0.01), depression (p<0.05) and pain (p<0.01) on HRQoL. Indirect effects from functional impairment (p<0.05) and pain (p<0.05) to HRQoL through depression were also present. Conclusions: The presence of pain and depression, greater functional impairment and lower family satisfaction were predictively associated with lower HRQoL. Depression further mediated the effects of pain and functional impairment on HRQoL. The present study advances understanding of the ways in which pain, depression and functional impairment predict HRQoL.	[Williamson, Meredith L. C.; Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Berry, Jack W.] Samford Univ, Birmingham, AL USA; [Underhill, Andrea T.; Stavrinos, Despina; Fine, Philip R.] Univ Alabama Birmingham, Injury Res Control Ctr, Birmingham, AL USA	Williamson, MLC (corresponding author), 2902 B Silver Spur Circle, Bryan, TX 77801 USA.	mcmeredithcampbell@gmail.com	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dunn D. S., OXFORD HDB IN PRESS; Elliott T. R., 2002, HDB POSITIVE PSYCHOL, P687; Elliott T. R., 2009, OXFORD HDB POSITIVE, V2, P651, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0062; Elliott TR, 2007, PSYCHOL MANAGEMENT P, P14; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hutchinson SR, 1998, STRUCT EQU MODELING, V5, P344, DOI 10.1080/10705519809540111; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kline R. B., 2011, PRINCIPLES PRACTICES; Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Muthen L. K., 2010, MPLUS USERS GUIDE; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olson D.H., 1982, FAMILY INVENTORIES I, P25; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Thompson, 2006, FDN BEHAV STAT INSIG; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Yu C.Y., 2002, EVALUATION MODEL FIT	40	29	29	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					992	999		10.3109/02699052.2013.801512			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100002	23781905				2021-06-18	
J	Shelat, PB; Plant, LD; Wang, JC; Lee, E; Marks, JD				Shelat, Phullara B.; Plant, Leigh D.; Wang, Janice C.; Lee, Elizabeth; Marks, Jeremy D.			The Membrane-Active Tri-Block Copolymer Pluronic F-68 Profoundly Rescues Rat Hippocampal Neurons from Oxygen-Glucose Deprivation-Induced Death through Early Inhibition of Apoptosis	JOURNAL OF NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; PEO TRIBLOCK COPOLYMERS; CYTOCHROME-C RELEASE; PURIFIED POLOXAMER-188; MITOCHONDRIAL-MEMBRANE; CEREBRAL-ISCHEMIA; INTRACELLULAR MECHANISMS; SEALANT POLOXAMER; BAX TRANSLOCATION; PROTEIN-KINASE	Pluronic F-68, an 80% hydrophilic member of the Pluronic family of polyethylene-polypropylene-polyethylene tri-block copolymers, protects non-neuronal cells from traumatic injuries and rescues hippocampal neurons from excitotoxic and oxidative insults. F-68 interacts directly with lipid membranes and restores membrane function after direct membrane damage. Here, we demonstrate the efficacy of Pluronic F-68 in rescuing rat hippocampal neurons from apoptosis after oxygen-glucose deprivation (OGD). OGD progressively decreased neuronal survival over 48 h in a severity-dependent manner, the majority of cell death occurring after 12 h after OGD. Administration of F-68 for 48 h after OGD rescued neurons from death in a dose-dependent manner. At its optimal concentration (30 mu M), F-68 rescued all neurons that would have died after the first hour after OGD. This level of rescue persisted when F-68 administration was delayed 12 h after OGD. F-68 did not alter electrophysiological parameters controlling excitability, NMDA receptor-activated currents, or NMDA-induced increases in cytosolic calcium concentrations. However, F-68 treatment prevented phosphatidylserine externalization, caspase activation, loss of mitochondrial membrane potential, and BAX translocation to mitochondria, indicating that F-68 alters apoptotic mechanisms early in the intrinsic pathway of apoptosis. The profound neuronal rescue provided by F-68 after OGD and the high level of efficacy with delayed administration indicate that Pluronic copolymers may provide a novel, membrane-targeted approach to rescuing neurons after brain ischemia. The ability of membrane-active agents to block apoptosis suggests that membranes or their lipid components play prominent roles in injury-induced apoptosis.	[Shelat, Phullara B.; Plant, Leigh D.; Wang, Janice C.; Lee, Elizabeth; Marks, Jeremy D.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	Marks, JD (corresponding author), Univ Chicago, 900 East 57th St,Room 130, Chicago, IL 60637 USA.	jmarks@uchicago.edu	Marks, Jeremy/W-2087-2019	Marks, Jeremy/0000-0002-2644-5257; Lee, Elizabeth/0000-0001-8071-6786	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS056313, T32 HL 094282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL094282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056313] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health Grants R01 NS056313 (J.D.M.) and T32 HL 094282 (P.B.S.).	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bajaj S, 2010, J ORTHOP TRAUMA, V24, P571, DOI 10.1097/BOT.0b013e3181ec4712; Ballas SK, 2004, HEMOGLOBIN, V28, P85, DOI 10.1081/HEM-120035919; Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307; Behrens MM, 1999, NEUROSCIENCE, V94, P917, DOI 10.1016/S0306-4522(99)00212-2; Bhola PD, 2009, BIOPHYS J, V97, P2222, DOI 10.1016/j.bpj.2009.07.056; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Duvinage C., 1996, TOXICOL LETT, V88, P101; Fan J, 2012, INT J NEUROSCI, V122, P665, DOI 10.3109/00207454.2012.707714; Firestone MA, 2003, BIOMACROMOLECULES, V4, P1539, DOI 10.1021/bm034134r; Garcia-Perez C, 2012, P NATL ACAD SCI USA, V109, P4497, DOI 10.1073/pnas.1118244109; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Gelperina S, 2010, EUR J PHARM BIOPHARM, V74, P157, DOI 10.1016/j.ejpb.2009.09.003; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Goldstein JC, 2000, NAT CELL BIOL, V2, P156; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Grindel JM, 2002, BIOPHARM DRUG DISPOS, V23, P87, DOI 10.1002/bdd.297; Grindel JM, 2002, J PHARM SCI-US, V91, P1936, DOI 10.1002/jps.10190; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Jewell RC, 1997, J PHARM SCI, V86, P808, DOI 10.1021/js960491e; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kanno T, 2011, J CELL PHYSIOL, V226, P2329, DOI 10.1002/jcp.22571; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; Khodjakov A, 2004, MITOCHONDRION, V3, P217, DOI 10.1016/j.mito.2003.10.002; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lehman E.L., 2006, NONPARAMETRICS STAT; Liu W, 2011, FREE RADICAL BIO MED, V50, P166, DOI 10.1016/j.freeradbiomed.2010.10.709; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Plataki M, 2011, AM J RESP CRIT CARE, V184, P939, DOI 10.1164/rccm.201104-0647OC; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Sahay G, 2008, BIOCONJUGATE CHEM, V19, P2023, DOI 10.1021/bc8002315; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shanta SR, 2012, J LIPID RES, V53, P1823, DOI 10.1194/jlr.M022558; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Soeda S, 2004, NEUROCHEM INT, V45, P619, DOI 10.1016/j.neuint.2004.04.001; Spurney CF, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-20; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanaka E, 1999, J NEUROPHYSIOL, V81, P1872; Townsend D, 2010, J CLIN INVEST, V120, P1140, DOI 10.1172/JCI41329; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Tymianski M, 1997, CELL CALCIUM, V21, P175, DOI 10.1016/S0143-4160(97)90042-7; Wang HK, 2008, J NEUROSCI, V28, P1721, DOI 10.1523/JNEUROSCI.4973-07.2008; Wang JY, 2012, BIOMACROMOLECULES, V13, P2616, DOI 10.1021/bm300847x; Wang JY, 2010, LANGMUIR, V26, P12953, DOI 10.1021/la101841a; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WILLCOX ML, 1978, J SURG RES, V25, P349, DOI 10.1016/0022-4804(78)90130-0; Wu GH, 2005, BIOPHYS J, V89, P3159, DOI 10.1529/biophysj.104.052290; Wu GH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028101; Yang Z, 2008, BIOCONJUGATE CHEM, V19, P1987, DOI 10.1021/bc800144a; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zhu S, 2004, J NEUROSCI, V24, P5909, DOI 10.1523/JNEUROSCI.1278-04.2004; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120	81	29	30	0	21	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 24	2013	33	30					12287	12299		10.1523/JNEUROSCI.5731-12.2013			13	Neurosciences	Neurosciences & Neurology	188CF	WOS:000322168600014	23884935	Bronze, Green Published			2021-06-18	
J	Budinich, CS; Tucker, LB; Lowe, D; Rosenberger, JG; McCabe, JT				Budinich, Craig S.; Tucker, Laura B.; Lowe, Dennell; Rosenberger, John G.; McCabe, Joseph T.			Short and long-term motor and behavioral effects of diazoxide and dimethyl sulfoxide administration in the mouse after traumatic brain injury	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Diazoxide; TBI; DMSO; Open field; Morris water maze	DEPENDENT POTASSIUM CHANNELS; CONTROLLED CORTICAL IMPACT; CEREBRAL HYPOPERFUSION; OPEN-FIELD; OXIDATIVE STRESS; NERVOUS-SYSTEM; WATER-MAZE; RAT; DEFICITS; MITOCHONDRIAL	Traumatic brain injury (TBI) is a worldwide phenomenon that affects all ages and socioeconomic classes and results in varying degrees of immediate and delayed motor, cognitive, and emotional deficiencies. A plethora of pharmacologic interventions that target recognized initiators and propagators of pathology are being investigated in an attempt to ameliorate secondary injury processes that follow primary injury. Diazoxide (DZ), a K-ATP channel activator, has been shown to provide short- and long-term protective effects in a variety of in vitro and in vivo cerebral ischemia models. However, the effects of DZ on behavioral outcome following TBI have not been investigated. TBI was induced in male C57BL/6J mice by controlled cortical impact (CCI) and followed by intraperitoneal administration of either normal saline, dimethyl sulfoxide (DMSO), or 2.5 mg/kg DZ in DMSO, 30 min post-injury and daily for three days. Open field and beam walk performances were used to assess motor and behavioral function 1, 7, and 14 days following injury. Spatial learning and memory were assessed three weeks following injury using the Morris water maze. Injured mice were significantly impaired on the beam-walk and Morris water maze tasks, and were hyperactive and anxious in an open field environment. On post-injury days 1 and 14, mice treated with DMSO exhibited an increase in the amount of time required to perform the beam walk task. In addition, animals exposed to DMSO or DZ + DMSO exhibited slower swimming speed in the Morris water maze on the final day of testing. There was no therapeutic effect, however, of the treatment or vehicle on open field behavior or learning and memory function in the Morris water maze. In summary, CCI produced significant long-term impairment of motor, memory, and behavioral performance measures, and DZ administration, under the conditions used, provided no functional benefits following injury. Published by Elsevier Inc.	[Budinich, Craig S.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Grad Program Neurosci, Bethesda, MD 20814 USA; [Tucker, Laura B.; Lowe, Dennell; Rosenberger, John G.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Tucker, Laura B.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu		Tucker, Laura/0000-0002-5984-6399	TriService Nursing Research Program grant [N10-P09]; USUHS Intramural grant [RO704B]	This work was supported by TriService Nursing Research Program grant N10-P09 to C.S.B. and USUHS Intramural grant RO704B to J.T.M. The experiments were conducted according to the principles set forth in the Guide for Care and Use of Laboratory Animals, ILAR, National Research Council, DHEW Publ. # (NIH) 73-23. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, Department of Defense, the U.S. Government, or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of such reagents or commercial hardware or software. This document may not be cited for purposes of advertisement. The investigators appreciated utilization of the Pre-Clinical Core facilities of the Center for Neuroscience and Regenerative Medicine, USUHS.	Abe E, 2010, BRAIN RES, V1330, P151, DOI 10.1016/j.brainres.2010.02.074; Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Ali BH, 2001, VET HUM TOXICOL, V43, P228; Arnoux JB, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-63; Arras M, 2001, COMPARATIVE MED, V51, P443; Authier N, 2002, TOXICOL LETT, V132, P117, DOI 10.1016/S0378-4274(02)00052-8; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Cavaletti G, 2000, TOXICOL LETT, V118, P103, DOI 10.1016/S0378-4274(00)00269-1; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; de Arriba SG, 1999, NEUROSCI LETT, V273, P13, DOI 10.1016/S0304-3940(99)00603-5; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Domoki F, 2005, AM J PHYSIOL-HEART C, V289, pH368, DOI 10.1152/ajpheart.00887.2004; Farkas E, 2006, BRAIN RES, V1087, P168, DOI 10.1016/j.brainres.2006.02.134; Farkas E, 2005, NEUROSCI LETT, V387, P168, DOI 10.1016/j.neulet.2005.06.036; Farkas E, 2005, NEUROSCI LETT, V373, P195, DOI 10.1016/j.neulet.2004.10.007; Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; He XM, 2008, J NEUROL SCI, V268, P18, DOI 10.1016/j.jns.2007.10.029; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Lei J, 2012, CHIN J TRAUMATOL, V15, P17, DOI 10.3760/cma.j.issn.1008-1275.2012.01.004; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagy K, 2004, J NEUROSCI RES, V76, P697, DOI 10.1002/jnr.20120; Nasrallah FA, 2008, J NEUROSCI RES, V86, P208, DOI 10.1002/jnr.21477; O'Sullivan JC, 2007, J NEUROTRAUM, V24, P532, DOI 10.1089/neu.2006.0128; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rajapakse N, 2003, J NEUROSCI RES, V73, P206, DOI 10.1002/jnr.10657; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shake JG, 2001, ANN THORAC SURG, V72, P1849, DOI 10.1016/S0003-4975(01)03192-7; Shimizu K, 2002, AM J PHYSIOL-HEART C, V283, pH1005, DOI 10.1152/ajpheart.00054.2002; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang H, 2010, J BIOCHEM, V148, P413, DOI 10.1093/jb/mvq074; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	53	29	29	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	JUL	2013	108						66	73		10.1016/j.pbb.2013.04.001			8	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	175LS	WOS:000321232800008	23583443				2021-06-18	
J	Wu, JF; Raver, C; Piao, CS; Keller, A; Faden, AI				Wu, Junfang; Raver, Charles; Piao, Chunshu; Keller, Asaf; Faden, Alan I.			Cell Cycle Activation Contributes to Increased Neuronal Activity in the Posterior Thalamic Nucleus and Associated Chronic Hyperesthesia after Rat Spinal Cord Contusion	NEUROTHERAPEUTICS			English	Article						Cell cycle activation; Posterior thalamic nucleus; Neuronal hyperexcitability; Pain; Hyperalgesia; Inflammation	PRIMARY SOMATOSENSORY CORTEX; CENTRAL NEUROPATHIC PAIN; INFLAMMATORY RESPONSE; LIMITS NEUROINFLAMMATION; REMOTE ACTIVATION; DEPENDENT KINASES; SCAR FORMATION; VPL NEURONS; HUMAN BRAIN; INJURY	Spinal cord injury (SCI) causes not only sensorimotor and cognitive deficits, but frequently also severe chronic pain that is difficult to treat (SCI pain). We previously showed that hyperesthesia, as well as spontaneous pain induced by electrolytic lesions in the rat spinothalamic tract, is associated with increased spontaneous and sensory-evoked activity in the posterior thalamic nucleus (PO). We have also demonstrated that rodent impact SCI increases cell cycle activation (CCA) in the injury region and that post-traumatic treatment with cyclin dependent kinase inhibitors reduces lesion volume and motor dysfunction. Here we examined whether CCA contributes to neuronal hyperexcitability of PO and hyperpathia after rat contusion SCI, as well as to microglial and astroglial activation (gliopathy) that has been implicated in delayed SCI pain. Trauma caused enhanced pain sensitivity, which developed weeks after injury and was correlated with increased PO neuronal activity. Increased CCA was found at the thoracic spinal lesion site, the lumbar dorsal horn, and the PO. Increased microglial activation and cysteine-cysteine chemokine ligand 21 expression was also observed in the PO after SCI. In vitro, neurons co-cultured with activated microglia showed up-regulation of cyclin D1 and cysteine-cysteine chemokine ligand 21 expression. In vivo, post-injury treatment with a selective cyclin dependent kinase inhibitor (CR8) significantly reduced cell cycle protein induction, microglial activation, and neuronal activity in the PO nucleus, as well as limiting chronic SCI-induced hyperpathia. These results suggest a mechanistic role for CCA in the development of SCI pain, through effects mediated in part by the PO nucleus. Moreover, cell cycle modulation may provide an effective therapeutic strategy to improve reduce both hyperpathia and motor dysfunction after SCI.	[Wu, Junfang; Piao, Chunshu; Faden, Alan I.] Univ Maryland, Sch Med, Natl Study Ctr Trauma & EMS, Dept Anesthesiol, Baltimore, MD 21201 USA; [Wu, Junfang; Piao, Chunshu; Faden, Alan I.] Univ Maryland, Sch Med, Natl Study Ctr Trauma & EMS, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Raver, Charles; Keller, Asaf] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Keller, Asaf; Faden, Alan I.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Wu, JF (corresponding author), Univ Maryland, Sch Med, Natl Study Ctr Trauma & EMS, Dept Anesthesiol, Bressler Res Bldg,655 W Baltimore St,Room 6-009, Baltimore, MD 21201 USA.	jwu@anes.umm.edu		Keller, Asaf/0000-0001-8727-663X; Raver, Charles/0000-0003-3042-3234; Faden, Alan I./0000-0003-0128-2348	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS054221, R01 NS066965]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054221, R01NS066965] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health Grants R01 NS054221 (AIF) and R01 NS066965 (AK). We thank Michael Dinizo, Kelsey Guanciale, Rainier Cabatbat, Katherine Cardiff, Marie Hanscom, Angela Pan, and Aicha Moutanni for expert technical support.	Abramson CE, 2008, SPINAL CORD, V46, P320, DOI 10.1038/sj.sc.3102136; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baastrup C, 2008, CNS DRUGS, V22, P455, DOI 10.2165/00023210-200822060-00002; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; de Jong EK, 2005, J NEUROSCI, V25, P7548, DOI 10.1523/JNEUROSCI.1019-05.2005; Defrin R, 2002, SPINAL CORD, V40, P96, DOI 10.1038/sj.sc.3101245; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5; Falci S, 2002, J NEUROSURG, V97, P193, DOI 10.3171/spi.2002.97.2.0193; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gerke MB, 2003, NEUROSCIENCE, V117, P715, DOI 10.1016/S0306-4522(02)00961-2; Greenspan JD, 2004, PAIN, V109, P357, DOI 10.1016/S0304-3959(04)00068-5; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Gwak YS, 2010, J PHYSIOL SCI, V60, P59, DOI 10.1007/s12576-009-0066-2; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2006, J NEUROPHYSIOL, V95, P3343, DOI 10.1152/jn.01009.2005; Hall BJ, 2010, J PAIN, V11, P864, DOI 10.1016/j.jpain.2009.12.008; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hubscher CH, 2006, EXP NEUROL, V197, P177, DOI 10.1016/j.expneurol.2005.09.007; Hubscher CH, 2010, NEUROSCI LETT, V477, P153, DOI 10.1016/j.neulet.2010.04.053; Hulsebosch CE, 2008, EXP NEUROL, V214, P6, DOI 10.1016/j.expneurol.2008.07.016; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; Liu DZ, 2010, NEUROBIOL DIS, V37, P549, DOI 10.1016/j.nbd.2009.11.013; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Masri R, 2012, ADV EXP MED BIOL, V760, P74; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Moulton EA, 2005, J NEUROPHYSIOL, V93, P2183, DOI 10.1152/jn.01025.2004; NOTHIAS F, 1988, BRAIN RES, V447, P169, DOI 10.1016/0006-8993(88)90980-8; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Persu C, 2009, J Med Life, V2, P296; POGGIO GF, 1960, B JOHNS HOPKINS HOSP, V106, P266; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Quiton RL, 2010, J NEUROPHYSIOL, V104, P1717, DOI 10.1152/jn.00161.2010; Rintala DH, 2005, J REHABIL RES DEV, V42, P573, DOI 10.1682/JRRD.2005.02.0033; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; Schmitt AB, 2000, ACTA NEUROPATHOL, V100, P528, DOI 10.1007/s004010000221; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Stormer S, 1997, SPINAL CORD, V35, P446, DOI 10.1038/sj.sc.3100411; TASKER RR, 1992, J NEUROSURG, V77, P373, DOI 10.3171/jns.1992.77.3.0373; TASKER RR, 1991, J NEUROSURG, V75, P168; Tator C H, 1999, Neurosurg Focus, V6, pe8; Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005; Trageser JC, 2006, J NEUROPHYSIOL, V96, P1456, DOI 10.1152/jn.00423.2006; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Vierck CJ, 2000, PAIN, V89, P1, DOI 10.1016/S0304-3959(00)00463-2; Wang CH, 2005, ACTA PHARMACOL SIN, V26, P46, DOI 10.1111/j.1745-7254.2005.00007.x; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang GX, 2008, J NEUROSCI, V28, P11959, DOI 10.1523/JNEUROSCI.3296-08.2008; Waxman SG, 2006, TRENDS NEUROSCI, V29, P207, DOI 10.1016/j.tins.2006.02.003; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitt JL, 2013, J NEUROSCI, V33, P3915, DOI 10.1523/JNEUROSCI.2639-12.2013; Widerstrom-Noga EG, 2007, ARCH PHYS MED REHAB, V88, P1628, DOI 10.1016/j.apmr.2007.09.013; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Wu JF, 2012, CELL CYCLE, V11, P1782, DOI 10.4161/cc.20153; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; Wu JF, 2010, GLIA, V58, P315, DOI 10.1002/glia.20925; Wu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044027; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Yezierski R P, 2000, Prog Brain Res, V129, P429; Yezierski RP, 2009, J REHABIL RES DEV, V46, P95, DOI 10.1682/JRRD.2008.06.0074; Zhang XJ, 2005, J NEUROPHYSIOL, V93, P2552, DOI 10.1152/jn.01237.2004; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007	87	29	33	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	JUL	2013	10	3					520	538		10.1007/s13311-013-0198-1			19	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	180CF	WOS:000321569800015	23775067	Green Published			2021-06-18	
J	Chu, WH; Li, M; Li, F; Hu, R; Chen, Z; Lin, JK; Feng, H				Chu, Weihua; Li, Mei; Li, Fei; Hu, Rong; Chen, Zhi; Lin, Jiangkai; Feng, Hua			Immediate splenectomy down-regulates the MAPK-NF-kappa B signaling pathway in rat brain after severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; splenectomy; microglia; inflammation; MAPK-NF-kappa B	INNATE IMMUNITY; MICROGLIA; INFLAMMATION; ASTROCYTES; CHEMOKINES; EXPRESSION	BACKGROUND: The treatment of severe traumatic brain injury (TBI) remains a difficult process. One key to improving treatment efficacy is to reduce secondary brain injury. Local and systemic inflammatory responses play an important role in secondary injury after TBI, which if unchecked can lead to fatal cerebral edema. Previous studies focused mainly on local brain tissue, whereas little is known about the contribution of peripheral organs in the pathogenesis of TBI. We previously showed that immediate splenectomy decreases mortality and improves cognitive function in rats after severe TBI by inhibiting the release of proinflammatory cytokines both systematically and locally in the injured brain. In this study, we further investigated the molecular mechanisms responsible for the effect of the spleen on local brain inflammation after TBI. METHODS: We established a severe TBI model with rats and performed splenectomy to study the effect of the spleen on mitogen-activated protein kinase (MAPK)-NF-kappa B activation in the brain tissue. The expression of p38 MAPK, extracellular regulated protein kinases (ERK), and NF-kappa B protein in the trauma region was examined by Western blotting. The neuron-like PC-12 cell line and microglia-like BV-2 cell line were used for in vitro experiments to test the effects of spleen supernatant after TBI. Cell apoptosis (annexin V/propidium iodide staining), NF-kappa B nuclear translocation (immunofluorescence microscopy), and MAPK signaling (phosphorylation of p-p38 and p-ERK) were examined. RESULTS: We found that TBI significantly up-regulated MAPK signaling in the injured brain region, whereas immediate splenectomy suppressed MAPK activation. In vitro, the spleen supernatant from rats after TBI also resulted in increased MAPK activation and NF-kappa B nuclear translocation in microglia-like BV-2 cells, whereas the application of interleukin (IL)-1R antagonist (IL-1Ra) significantly reduced the expression of p-p38 and p-ERK as well as NF-kappa B nuclear translocation. In addition, spleen supernatant after TBI induced apoptosis in neuron-like PC-12 cells, and IL-1Ra could effectively reduce apoptosis. CONCLUSION: Our study demonstrates that immediate splenectomy down-regulates the MAPK-NF-kappa B signaling pathway in rat brain after severe TBI. We also provide experimental evidence for the potential use of IL-1Ra to alleviate brain inflammation after TBI. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Chu, Weihua; Li, Mei; Li, Fei; Hu, Rong; Chen, Zhi; Lin, Jiangkai; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China	Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.	fenghua8888@yahoo.com.cn			Health Sector Public Welfare Fund of China [200802017]; State Natural Science Fund of China [81000531]	This study was supported by the Health Sector Public Welfare Fund of China (grant no. 200802017) and the State Natural Science Fund of China (grant no. 81000531).	Biber K, 2008, J NEUROIMMUNOL, V198, P69, DOI 10.1016/j.jneuroim.2008.04.012; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gibbons LJ, 2009, BIODRUGS, V23, P111, DOI 10.2165/00063030-200923020-00004; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kraft A, 2009, NEUROTOXICOLOGY, P30; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Sarov-Blat L, 2010, ARTERIOSCL THROM VAS, V30, P2256, DOI 10.1161/ATVBAHA.110.209205; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027; Xie NC, 2010, NEUROSCI LETT, V482, P51, DOI 10.1016/j.neulet.2010.07.004; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	23	29	32	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2013	74	6					1446	1453		10.1097/TA.0b013e31829246ad			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AB4DO	WOS:000331739800010	23694871				2021-06-18	
J	Failla, MD; Burkhardt, JN; Miller, MA; Scanlon, JM; Conley, YP; Ferrell, RE; Wagner, AK				Failla, Michelle D.; Burkhardt, Josh N.; Miller, Megan A.; Scanlon, Joelle M.; Conley, Yvette P.; Ferrell, Robert E.; Wagner, Amy K.			Variants of SLC6A4 in depression risk following severe TBI	BRAIN INJURY			English	Article						5-HTTLPR; depression; gene variation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; TRANSCRIPTION FACTOR AP-2; MESSENGER-RNA LEVELS; MAJOR DEPRESSION; PROMOTER REGION; 5-HTTLPR; POLYMORPHISM; ASSOCIATION	Background: Post-traumatic depression (PTD) may be a result of several factors like secondary injury chemical cascades as well as psycho-social factors following traumatic brain injury (TBI). While the role of serotonin in the pathology and treatment of idiopathic major depression may be somewhat controversial, it is unclear what role serotonin may play in PTD following a TBI. Objective: To assess serotonergic function and genetic risk for PTD development over 1 year following TBI. Research design: Examination of variation in the serotonin transporter gene [SLC6A4 (5-HTTLPR, rs25331, and a variable number of tandem repeats variant in Intron 2)] in 109 subjects with moderate-severe injury. Depression was assessed using the Patient Health Questionnaire (PHQ-9) at 6 and/or 12 months post-injury. Main outcomes and results: At 6 months post-injury, subjects with a history of pre-morbid mood disorders and 5-HTTLPR L-homozygotes were at greater risk for PTD. Contrary to major depression, subjects without pre-morbid mood disorders (n = 80) and S-carriers were 2.803-times less likely to be depressed compared to L-homozygotes. At 12 months postinjury, LG-carriers were also less likely to experience PTD. Temporal analysis also showed 5-HTTLPR associations in PTD development across recovery. Conclusions: This study suggests a unique injury-and temporally-specific interaction between TBI and genetic risk for depression.	[Failla, Michelle D.; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Failla, Michelle D.; Burkhardt, Josh N.; Miller, Megan A.; Scanlon, Joelle M.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Sch Med, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Ferrell, Robert E.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, 3471 5th Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Conley, Yvette/0000-0002-1784-6067	CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR323155]; DODUnited States Department of Defense [W81XWH-071-0701]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NR008424, R01 HD048162]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	Sources of Support: CDC: R49 CCR323155; DOD: W81XWH-071-0701; NIH R01NR008424, and R01 HD048162.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Damberg M, 2005, J NEURAL TRANSM, V112, P1281, DOI 10.1007/s00702-005-0325-1; Edenberg HJ, 1998, PSYCHIATR GENET, V8, P193, DOI 10.1097/00041444-199800830-00011; Erritzoe D, 2010, J NEUROSCI, V30, P3391, DOI 10.1523/JNEUROSCI.2852-09.2010; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Frodl T, 2004, ARCH GEN PSYCHIAT, V61, P177, DOI 10.1001/archpsyc.61.2.177; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Garcia MA, 1996, J NEUROSCI, V16, P7550; Gelernter J, 1999, AM J MED GENET, V88, P61, DOI 10.1002/(SICI)1096-8628(19990205)88:1<61::AID-AJMG11>3.0.CO;2-K; Gould KR, PSYCHOL MED, V201, P1; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Heils A, 1996, J NEUROCHEM, V66, P2621; Ho P-S, PSYCHIAT RES NEUROIM; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kenna GA, 2012, PHARMACOGN PERS MED, V5, P19, DOI 10.2147/PGPM.S23462; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kobiella A., 2011, TRANSL PSYCHIAT, V1, P1; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Little KY, 1998, AM J PSYCHIAT, V155, P207; Lotrich Francis E, 2003, Am J Pharmacogenomics, V3, P145, DOI 10.2165/00129785-200303020-00007; Mak KK, 2013, J NEUROL NEUROSUR PS, V84, P322, DOI 10.1136/jnnp-2012-303791; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Ogilvie AD, 1996, LANCET, V347, P731, DOI 10.1016/S0140-6736(96)90079-3; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Praschak-Rieder N, 2007, BIOL PSYCHIAT, V62, P327, DOI 10.1016/j.biopsych.2006.09.022; Rees M, 1997, MOL PSYCHIATR, V2, P398, DOI 10.1038/sj.mp.4000256; Reimold M, 2007, J NEURAL TRANSM, V114, P635, DOI 10.1007/s00702-006-0609-0; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Van Dyck CH, 2004, AM J PSYCHIAT, V161, P525, DOI 10.1176/appi.ajp.161.3.525; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Wozniak G, 2010, NEUROSURG QUART, V20, P297, DOI 10.1097/WNQ.0b013e3181732399; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153; Zafonte RD, 2002, J HEAD TRAUMA REHAB, V17, P322, DOI 10.1097/00001199-200208000-00006; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	60	29	29	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					696	706		10.3109/02699052.2013.775481			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500009	23672445				2021-06-18	
J	Kolias, AG; Scotton, WJ; Belli, A; King, AT; Brennan, PM; Bulters, DO; Eljamel, MS; Wilson, MH; Papadopoulos, MC; Mendelow, AD; Menon, DK; Hutchinson, PJ				Kolias, A. G.; Scotton, W. J.; Belli, A.; King, A. T.; Brennan, P. M.; Bulters, D. O.; Eljamel, M. S.; Wilson, M. H.; Papadopoulos, M. C.; Mendelow, A. D.; Menon, D. K.; Hutchinson, P. J.		UK Neurosurgical Res Network; RESCUE-ASDH Collaborative Grp	Surgical management of acute subdural haematomas: current practice patterns in the United Kingdom and the Republic of Ireland	BRITISH JOURNAL OF NEUROSURGERY			English	Article						craniotomy; decompressive craniectomy; intracranial pressure; randomised trial; traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; HINGE CRANIOTOMY; BRAIN-INJURY; MORTALITY	Introduction. Uncertainty remains as to the role of decompressive craniectomy (DC) for primary evacuation of acute subdural haematomas (ASDH). In 2011, a collaborative group was formed in the UK with the aim of answering the following question: "What is the clinical- and cost-effectiveness of decompressive craniectomy, in comparison with craniotomy for adult patients undergoing primary evacuation of an ASDH?" The proposed RESCUE-ASDH trial (Randomised Evaluation of Surgery with Craniectomy for patients Undergoing Evacuation of Acute Subdural Haematoma) is a multicentre, pragmatic, parallel group randomised trial of DC versus craniotomy for adult head-injured patients with an ASDH. In this study, we used an online questionnaire to assess the current practice patterns in the management of ASDH in the UK and the Republic of Ireland, and to gauge neurosurgical opinion regarding the proposed RESCUE-ASDH trial. Materials and methods. A questionnaire survey of full members of the Society of British Neurological Surgeons and members of the British Neurosurgical Trainees Association was undertaken between the beginning of May and the end of July 2012. Results. The online questionnaire was answered by 95 neurosurgeons representing 31 of the 32 neurosurgical units managing adult head-injured patients in the UK and the Republic of Ireland. Forty-five percent of the respondents use primary DC in at least 25% of patients with ASDH. In addition, of the 22 neurosurgical units with at least two Consultant respondents, only three units (14%) showed intradepartmental agreement regarding the proportion of their patients receiving a primary DC for ASDH. Conclusion. The survey results demonstrate that there is significant uncertainty as to the optimal surgical technique for primary evacuation of ASDH. The fact that the majority of the respondents are willing to become collaborators in the planned RESCUE-ASDH trial highlights the relevance of this important subject to the neurosurgical community in the UK and Ireland.	[Kolias, A. G.; Scotton, W. J.; Hutchinson, P. J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Kolias, A. G.; Scotton, W. J.; Menon, D. K.; Hutchinson, P. J.] Univ Cambridge, Cambridge, England; [Belli, A.] Queen Elizabeth Hosp, NIHR Ctr Surg Reconstruct & Microbiol, Birmingham B15 2TH, W Midlands, England; [Belli, A.] Univ Birmingham, Birmingham, W Midlands, England; [King, A. T.] Salford Royal Hosp, Div Neurosurg, Manchester, Lancs, England; [King, A. T.] Univ Manchester, Manchester, Lancs, England; [Brennan, P. M.] Western Gen Hosp, Dept Clin Neurosci, Div Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland; [Brennan, P. M.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Bulters, D. O.] Southampton Univ Hosp, Div Neurosurg, Southampton, Hants, England; [Bulters, D. O.] Univ Southampton, Southampton, Hants, England; [Eljamel, M. S.] Ninewells Hosp, Div Neurosurg, Dundee DD1 9SY, Scotland; [Eljamel, M. S.] Univ Dundee, Dundee, Scotland; [Wilson, M. H.] St Marys Hosp, Div Neurosurg, London, England; [Wilson, M. H.] Univ London Imperial Coll Sci Technol & Med, London, England; [Papadopoulos, M. C.] Univ London St Georges Hosp, Div Neurosurg, London, England; [Papadopoulos, M. C.] St Georges Univ London, London, England; [Mendelow, A. D.] Royal Victoria Infirm, Div Neurosurg, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Mendelow, A. D.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Menon, D. K.] Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 0QQ, England	Kolias, AG (corresponding author), Addenbrookes Hosp, Div Neurosurg, Box 167,Level 3,A Block, Cambridge CB2 0QQ, England.	angeloskolias@gmail.com	King, Andrew/AAR-1656-2020; Bulters, Diederik/ABH-3573-2020; Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; King, Andrew/0000-0002-6546-7248; Kolias, Angelos/0000-0003-3992-0587; Corteen, Elizabeth/0000-0002-3069-9655; Eljamel, Muftah Salem (Sam)/0000-0002-1491-0094; Bulters, Diederik/0000-0001-9884-9050; Wilson, Mark/0000-0002-2346-4911; Scotton, William/0000-0003-0607-3190; Papadopoulos, Marios/0000-0001-9174-4176	Academic Foundation Programme (Neurosciences), Cambridge Academic Training Office, School of Clinical Medicine, University of Cambridge; Royal College of Surgeons of England Research Fellowship; Freemasons; Rosetrees TrustRosetrees Trust; NIHR Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, ACF-2011-14-003] Funding Source: researchfish	WJS is supported by an Academic Foundation Programme (Neurosciences), Cambridge Academic Training Office, School of Clinical Medicine, University of Cambridge. AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), an NIHR Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. DKM is an NIHR Senior Investigator. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the NIHR Cambridge Biomedical Research Centre.	[Anonymous], 2007, HEAD INJ TRIAG ASS I; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Marion DW, 2006, NEUROSURGERY, V58, P655; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; SHIGEMORI M, 1980, ACTA NEUROCHIR, V54, P61, DOI 10.1007/BF01401944; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	11	29	29	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2013	27	3					330	333		10.3109/02688697.2013.779365			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	136HR	WOS:000318353500008	23530712				2021-06-18	
J	Melmed, S				Melmed, Shlomo			Idiopathic Adult Growth Hormone Deficiency	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							GH REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; BODY-MASS INDEX; PHYSICAL PERFORMANCE; PITUITARY-ADENOMAS; RADIATION-THERAPY; ENDOCRINE-SOCIETY; CONTROLLED-TRIAL; CHILDHOOD-ONSET; HEALTHY-ADULTS	GH secretion is controlled by hypothalamic as well as intrapituitary and peripheral signals, all of which converge upon the somatotroph, resulting in integrated GH synthesis and secretion. Enabling an accurate diagnosis of idiopathic adult GH deficiency (IAGHD) is challenged by the pulsatility of GH secretion, provocative test result variability, and suboptimal GH assay standardization. The spectrum between attenuated GH secretion associated with the normal aging process and with obesity and truly well-defined IAGHD is not distinct and may mislead the diagnosis. Adult-onset GHD is mainly caused by an acquired pituitary deficiency, commonly including prior head/neck irradiation, or an expanding pituitary mass causing functional somatotroph compression. To what extent rare cryptic causes account for those patients seemingly classified as IAGHD is unclear. About 15% of patients with adult GHD and receiving GH replacement in open-label surveillance studies are reported as being due to an idiopathic cause. These patients may also reflect a pool of subjects with an as yet to be determined occult defect, or those with unclear or incomplete medical histories (including forgotten past sports head injury or motor vehicle accident). Therefore, sub-maximal diagnostic evaluation likely leads to an inadvertent diagnosis of IAGHD. In these latter cases, adherence to rigorous biochemical diagnostic criteria and etiology exclusion may result in reclassification of a subset of these patients to a distinct known acquired etiology, or as GH-replete. Accordingly, rigorously verified IAGHD likely comprises less than 10% of adult GHD patients, an already rare disorder. Regardless of etiology, patients with adult GHD, including those with IAGHD, exhibit a well-defined clinical phenotype including increased fat mass, loss of lean muscle mass, decreased bone mass, and enhanced cardiac morbidity. Definition of unique efficacy and dosing parameters for GH replacement and resultant therapeutic efficacy markers in true IAGHD requires prospective study.	[Melmed, Shlomo] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA	Melmed, S (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Room 2015, Los Angeles, CA 90048 USA.	melmed@csmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA 75979]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA075979] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant CA 75979.	Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Aimaretti G, 2001, EUR J ENDOCRINOL, V145, P267, DOI 10.1530/eje.0.1450267; Aimaretti G, 2000, J CLIN ENDOCR METAB, V85, P3693, DOI 10.1210/jc.85.10.3693; Alatzoglou KS, 2010, NAT REV ENDOCRINOL, V6, P562, DOI 10.1038/nrendo.2010.147; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Attanasio AF, 2011, J CLIN ENDOCR METAB, V96, P2255, DOI 10.1210/jc.2011-0448; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Bellastella G, 2010, J CLIN ENDOCR METAB, V95, P3750, DOI 10.1210/jc.2010-0551; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Birzniece V, 2011, TRENDS ENDOCRIN MET, V22, P171, DOI 10.1016/j.tem.2011.02.005; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Brabant G, 2009, EUR J ENDOCRINOL, V161, pS25, DOI 10.1530/EJE-09-0273; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Bulow B, 1999, 81 ANN M END SOC JUN; Casanueva FF, 2008, P NATL ACAD SCI USA, V105, P20452, DOI 10.1073/pnas.0811680106; Chanson P, 2010, J CLIN ENDOCR METAB, V95, P3684, DOI 10.1210/jc.2010-0295; Chipman JJ, 1997, CLIN ENDOCRINOL, V46, P473, DOI 10.1046/j.1365-2265.1997.1660984.x; Cittadini A, 2002, J CLIN ENDOCR METAB, V87, P1654, DOI 10.1210/jc.87.4.1654; Clasey JL, 2001, J CLIN ENDOCR METAB, V86, P3845, DOI 10.1210/jc.86.8.3845; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; De Bellis A, 2011, CLIN ENDOCRINOL, V75, P361, DOI 10.1111/j.1365-2265.2011.04056.x; Fleetwood MR, 2012, J BIOL CHEM, V287, P25454, DOI 10.1074/jbc.M112.365825; FROHMAN LA, 1972, ENDOCRINOLOGY, V91, P262, DOI 10.1210/endo-91-1-262; Gasco V, 2008, PITUITARY, V11, P121, DOI 10.1007/s11102-008-0110-x; Gasperi M, 2002, J CLIN ENDOCR METAB, V87, P1961, DOI 10.1210/jc.87.5.1961; Gasperi M, 2002, J ENDOCRINOL INVEST, V25, P329, DOI 10.1007/BF03344013; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Gleeson HK, 2004, J CLIN ENDOCR METAB, V89, P662, DOI 10.1210/jc.2003-031224; Goldenberg N, 2007, ENDOCRIN METAB CLIN, V36, P37, DOI 10.1016/j.ecl.2006.11.003; Gotherstrom G, 2009, J CLIN ENDOCR METAB, V94, P809, DOI 10.1210/jc.2008-1538; Graham MR, 2008, HORM RES, V69, P343, DOI 10.1159/000117390; Harman H, 2011, EVE ON TOP: WOMENS EXPERIENCE OF SUCCESS IN THE PUBLIC SECTOR, P115, DOI 10.1210/jc.2010-1669; Hartman ML, 2013, J CLIN ENDOCR METAB, V98, P980, DOI 10.1210/jc.2012-2684; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOLMES SJ, 1995, CLIN ENDOCRINOL, V42, P613, DOI 10.1111/j.1365-2265.1995.tb02688.x; Holt RIG, 2009, GROWTH HORM IGF RES, V19, P320, DOI 10.1016/j.ghir.2009.04.009; Karges B, 2004, HORM RES, V61, P165, DOI 10.1159/000076007; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lipworth WL, 2012, MED J AUSTRALIA, V197, P204, DOI 10.5694/mja11.11572; LITTLEY MD, 1989, Q J MED, V70, P145; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; Meinhardt U, 2010, ANN INTERN MED, V152, P568, DOI 10.7326/0003-4819-152-9-201005040-00007; Melmed S, 2006, NAT CLIN PRACT ENDOC, V2, P119, DOI 10.1038/ncpendmet0138; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI20401; Melmed S, 2010, WILLIAMS TXB ENDOCRI; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Monson JP, 2003, EUR J ENDOCRINOL, V148, pS9, DOI 10.1530/eje.0.148S009; Murray RD, 2007, J CLIN ENDOCR METAB, V92, P1705, DOI 10.1210/jc.2006-2055; Nystrom HF, 2011, PITUITARY, V14, P208, DOI 10.1007/s11102-010-0278-8; Olshansky SJ, 2008, JAMA-J AM MED ASSOC, V299, P2792, DOI 10.1001/jama.299.23.2792; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Shalet SM, 2010, CLIN ENDOCRINOL, V73, P432, DOI 10.1111/j.1365-2265.2010.03809.x; SNYDER PJ, 1986, AM J MED, V81, P457, DOI 10.1016/0002-9343(86)90299-8; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Thorner MO, 2009, J GERONTOL A-BIOL, V64, P1039, DOI 10.1093/gerona/glp091; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; van Nieuwpoort IC, 2011, EUR J ENDOCRINOL, V164, P491, DOI 10.1530/EJE-10-0914; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Webb SM, 2009, J CLIN ENDOCR METAB, V94, P392, DOI 10.1210/jc.2008-0713; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; YAMASHITA S, 1987, J CLIN INVEST, V79, P449, DOI 10.1172/JCI112832; Young J, 2007, BRIT J SPORT MED, V41, P335, DOI 10.1136/bjsm.2006.030585; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	83	29	29	0	5	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	JUN	2013	98	6					2187	2197		10.1210/jc.2012-4012			11	Endocrinology & Metabolism	Endocrinology & Metabolism	155GS	WOS:000319736500018	23539718	Bronze, Green Published			2021-06-18	
J	Johnstone, VPA; Yan, EB; Alwis, DS; Rajan, R				Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh			Cortical Hypoexcitation Defines Neuronal Responses in the Immediate Aftermath of Traumatic Brain Injury	PLOS ONE			English	Article							RAT BARREL CORTEX; FLUID-PERCUSSION INJURY; SPREADING DEPRESSION; INTRATHECAL BACLOFEN; PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPSY; SOMATOSENSORY CORTEX; RECEPTOR AGONISTS; WHISKER VIBRATION; HIPPOCAMPAL CA1	Traumatic brain injury (TBI) from a blow to the head is often associated with complex patterns of brain abnormalities that accompany deficits in cognitive and motor function. Previously we reported that a long-term consequence of TBI, induced with a closed-head injury method modelling human car and sporting accidents, is neuronal hyper-excitation in the rat sensory barrel cortex that receives tactile input from the face whiskers. Hyper-excitation occurred only in supra-granular layers and was stronger to complex than simple stimuli. We now examine changes in the immediate aftermath of TBI induced with same injury method. At 24 hours post-trauma significant sensorimotor deficits were observed and characterisation of the cortical population neuronal responses at that time revealed a depth-dependent suppression of neuronal responses, with reduced responses from supragranular layers through to input layer IV, but not in infragranular layers. In addition, increased spontaneous firing rate was recorded in cortical layers IV and V. We postulate that this early post-injury suppression of cortical processing of sensory input accounts for immediate post-trauma sensory morbidity and sets into train events that resolve into long-term cortical hyper-excitability in upper sensory cortex layers that may account for long-term sensory hyper-sensitivity in humans with TBI.	[Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh] Monash Univ, Dept Physiol, Monash, Vic, Australia	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Monash, Vic, Australia.	ramesh.rajan@monash.edu	Johnstone, Victoria/B-5083-2015; rajan, ramesh/L-4842-2019	Johnstone, Victoria/0000-0001-9885-3607; Rajan, Ramesh/0000-0001-9862-0520	National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1029311]	This study was funded by the National Health & Medical Research Council of Australia (grant no. APP1029311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; Brands DWA, 2002, PREDICTING BRAIN MEC; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golarai G, 2001, J NEUROSCI, V21, P8523; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; KELLER A, 1985, BRAIN RES, V343, P159, DOI 10.1016/0006-8993(85)91171-0; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerner C, 2004, NEUROSCI LETT, V361, P21, DOI 10.1016/j.neulet.2003.12.074; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Larsen DD, 2006, J COMP NEUROL, V494, P398, DOI 10.1002/cne.20754; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Nance ML, 2006, ANN SURG, V243, P121, DOI 10.1097/01.sla.0000193838.11102.56; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; NEUMANNHAEFELIN T, 1995, NEUROSCI LETT, V193, P101, DOI 10.1016/0304-3940(95)11677-O; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Reinert M, 2000, Neurosurg Focus, V8, pe10; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salin P, 1995, J NEUROSCI, V15, P8234; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Turner MS, 2003, ACT NEUR S, V87, P81; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Ydenius A, 2010, TRAFFIC INJ PREV, V11, P526, DOI 10.1080/15389588.2010.492053; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao H, 2010, INT J CRASHWORTHINES, V15, P313, DOI 10.1080/13588260903335290; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728	105	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63454	10.1371/journal.pone.0063454			15	Multidisciplinary Sciences	Science & Technology - Other Topics	154EP	WOS:000319654700150	23667624	DOAJ Gold, Green Published			2021-06-18	
J	Asher, SR; Curry, P; Sharma, D; Wang, J; O'Keefe, GE; Daniel-Johnson, J; Vavilala, MS				Asher, Shyamal R.; Curry, Parichat; Sharma, Deepak; Wang, Jin; O'Keefe, Grant E.; Daniel-Johnson, Jennifer; Vavilala, Monica S.			Survival Advantage and PaO2 Threshold in Severe Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; hyperoxemia; hyperoxia; cerebral oxygenation	SEVERE HEAD-INJURY; HYPEROXIA; ARTERIAL; OXYGENATION; THERAPY	Background: Hypoxemia can adversely affect outcome after traumatic brain injury (TBI). However, the effect of high PaO2 on TBI outcomes is controversial. The primary aim of this study was to identify the optimal PaO2 range early after severe TBI. Methods: In this single-center retrospective study conducted at a level-1 trauma center, patients with severe TBI (head Abbreviated Injury Scale score > 3, admission Glasgow Coma Scale score <= 8) were included. The crude and adjusted (including chest injuries and acute respiratory distress syndrome) effects of 50 mm Hg incremental PaO2 thresholds during the first 72 hours on discharge survival were examined. Results: Data from 193 patients (44 +/- 18 y; 77% male; admission Glasgow Coma Scale score 4 +/- 2) were reviewed. Overall survival was 57%. PaO2 thresholds in increments of 50 mm Hg between 250 and 486 mm Hg (68%) were associated with discharge survival in patients with severe TBI compared with PaO2 60 mm Hg < PaO2 < threshold. This association between PaO2 thresholds and survival was sustained until a PaO2 of 486 mm Hg (adjusted odds ratio 3.4; 95% confidence interval, 1.5-7.7). Although most patients had at least 1 PaO2 >= 250 mm Hg during the first 72 hours, in-hospital hypoxemia was common (24%) and was associated with mortality (survival adjusted odds ratio 0.46; 95% confidence interval, 0.22-0.95). Conclusions: In this series, a PaO2 threshold between 250 and 486 mm Hg during the first 72 hours after injury was associated with improved all-cause survival in patients with severe TBI, independent of hypocarbia or hypercarbia.	[Asher, Shyamal R.; Curry, Parichat; Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Sharma, Deepak; O'Keefe, Grant E.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [O'Keefe, Grant E.] Univ Washington, Dept Gen Surg, Seattle, WA 98104 USA; [Daniel-Johnson, Jennifer] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Wang, Jin; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA	Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Ahn Edward S, 2005, Clin Neurosurg, V52, P348; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2008, J NEUROSURG, V109, P421, DOI 10.3171/JNS/2008/109/9/0421; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Neumar RW, 2011, CURR OPIN CRIT CARE, V17, P236, DOI 10.1097/MCC.0b013e3283454c8c; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; Singhal AB, 2007, NEUROL RES, V29, P173, DOI 10.1179/016164107X181815; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasman W, 2006, AM J OPHTHALMOL, V141, P167, DOI 10.1016/j.ajo.2005.07.034; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	23	29	31	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2013	25	2					168	173		10.1097/ANA.0b013e318283d350			6	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	103XN	WOS:000315952900008	23343758				2021-06-18	
J	Chibbaro, S; Vallee, F; Beccaria, K; Poczos, P; Makiese, O; Fricia, M; Mateo, J; Gobron, C; Guichard, JP; Romano, A; Levy, B; George, B; Vicaut, E				Chibbaro, S.; Vallee, F.; Beccaria, K.; Poczos, P.; Makiese, O.; Fricia, M.; Mateo, J.; Gobron, C.; Guichard, J-P; Romano, A.; Levy, B.; George, B.; Vicaut, E.			The impact of early cranioplasty on cerebral blood flow and its correlation with neurological and cognitive outcome. Prospective multi-centre study on 24 patients	REVUE NEUROLOGIQUE			French	Article						Brain perfusion; CT perfusion; Severe head injury; Neurology and cognitive outcome; Cranioplasty	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; SINKING SKIN-FLAP; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; MANAGEMENT; PRESSURE; EXPERIENCE; PERFUSION	Introduction. - Cranioplasty after decompressive craniectomy in patients suffering from severe head injury often leads to a functional improvement although, to date, the pathophysiology of this phenomenon remains unclear. A few hypotheses have been proposed. The impact of cranioplasty on cerebral perfusion could be one explanation. We have evaluated the impact of cranioplasty on the functional status of patients undergoing decompressive craniectomy for severe head injury with its influence on cerebral perfusion. Materials and methods. - Twenty-four patients undergoing craniectomy for severe head injury were included in this multi-centric and prospective study. All of them had a cranioplasty within 12 weeks following decompressive craniectomy. A clinical and radiological evaluation was performed prior to and after cranioplasty. Neurological and cognitive evaluation was performed with the Glasgow Outcome Score (GOS), the Frontal Assessment Battery (FAB) and the Mini Mental State Examination (MMSE). Radiological evaluation was performed by perfusion CT scan and transcranial Doppler. Results. - A statistically significant neurological and cognitive improvement was observed in 92% of patients at 6 months follow-up (F-U). Brain perfusion was improved at 6 weeks F-U, predominantly in the affected hemisphere. Systolic and diastolic blood velocity flow were improved in both middle cerebral arteries. Conclusion. - Cranioplasty after decompressive craniectomy for patients suffering from severe head injury probably improves the functional outcome of these patients, thanks to a global improvement of cerebral perfusion. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Chibbaro, S.; Beccaria, K.; Poczos, P.; Makiese, O.; George, B.] Hop Univ Lariboisiere, Serv Neurochirurg, F-75010 Paris, France; [Fricia, M.] Hop Univ Cannizzaro, Serv Neurochirurg, I-95126 Catania, Italy; [Vallee, F.; Mateo, J.] Hop Univ Lariboisiere, Serv Anesthesie Reanimat, F-75010 Paris, France; [Romano, A.] Hop Univ Parme, Serv Neurochirurg, I-43100 Parma, Italy; [Guichard, J-P] Hop Univ Lariboisiere, Serv Neuroradiol, F-75010 Paris, France; [Gobron, C.; Levy, B.] Hop Univ Lariboisiere, Serv Neurol, F-75010 Paris, France; [Vicaut, E.] Hop Univ Lariboisiere, Unite Rech Clin, F-75010 Paris, France	Chibbaro, S (corresponding author), Hop Univ Lariboisiere, Serv Neurochirurg, 2 Rue Ambroise Pare, F-75010 Paris, France.	schibbaro@hotmail.com	BECCARIA, Kevin/AAL-5122-2021; Chibbaro, Salvatore/AAI-6368-2020; Poczos, Pavel/E-9906-2017	Poczos, Pavel/0000-0002-1456-3010; chibbaro, salvatore/0000-0003-1318-1245			BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Chibbaro S, 2009, J NEUROSURG, V111, P884; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Cooper DJ, 2011, NEW ENGL J MED, V365, P2040; DeWitt D S, 1995, New Horiz, V3, P376; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GAAB MR, 1990, ACT NEUR S, V51, P326; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hodozuka A, 2000, NEUROL SURG TOKYO, V28, P245; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kawaguchi T, 2003, NEUROL MED-CHIR, V43, P320, DOI 10.2176/nmc.43.320; Kunze E, 1998, ACT NEUR S, V71, P16; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maekawa M, 1999, NEUROL SURG TOKYO, V27, P717; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Munch E, 2000, NEUROSURGERY, V47, P315; Nabavi DG, 1999, RADIOLOGY, V213, P141, DOI 10.1148/radiology.213.1.r99oc03141; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STULA D, 1982, J MAXILLOFAC SURG, V10, P142, DOI 10.1016/S0301-0503(82)80030-1; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	37	29	32	0	4	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.	MAR	2013	169	3					240	248		10.1016/j.neurol.2012.06.016			9	Clinical Neurology	Neurosciences & Neurology	127OH	WOS:000317707800008	23084153				2021-06-18	
J	Li, HP; Komuta, Y; Kimura-Kuroda, J; van Kuppevelt, TH; Kawano, H				Li, Hong-Peng; Komuta, Yukari; Kimura-Kuroda, Junko; van Kuppevelt, Toin H.; Kawano, Hitoshi			Roles of Chondroitin Sulfate and Dermatan Sulfate in the Formation of a Lesion Scar and Axonal Regeneration after Traumatic Injury of the Mouse Brain	JOURNAL OF NEUROTRAUMA			English	Article						axonal regeneration; extracellular matrix; glial response to injury; in vitro study; traumatic brain injury	GROWTH-FACTOR-BETA; NIGROSTRIATAL DOPAMINERGIC AXONS; ADULT-RAT BRAIN; EMBRYONIC PIG BRAIN; HYBRID CHAINS; FIBROTIC SCAR; SPINAL-CORD; CNS INJURY; NEURITOGENIC ACTIVITY; BINDING ACTIVITIES	Dermatan sulfate (DS) is synthesized from chondroitin sulfate (CS) by epimerization of glucuronic acid of CS to yield iduronic acid. In the present study, the role of CS and DS was examined in mice that received transection of nigrostriatal dopaminergic pathway followed by injection of glycosaminoglycan degrading enzymes into the lesion site. Two weeks after injury, fibrotic and glial scars were formed around the lesion, and transected axons did not regenerate beyond the fibrotic scar. Injection of chondroitinase ABC (ChABC), which degrades both CS and DS, completely suppressed the fibrotic scar formation, reduced the glial scar, and promoted the regeneration of dopaminergic axons. Injection of the DS-degrading enzyme chondroitinase B (ChB) also yielded similar results. By contrast, injection of chondroitinase AC (ChAC), a CS-degrading enzyme, did not suppress the fibrotic and glial scar formation, but reduced CS immunoreactivity and promoted the axonal regeneration. Addition of transforming growth factor-beta 1 (TGF-beta 1) to a co-culture of meningeal fibroblasts and cerebral astrocytes induces a fibrotic scar-like cell cluster. The effect of TGF-beta 1 on cluster formation was suppressed by treatment with ChABC or ChB, but not by ChAC. TGF-beta 1-induced cell cluster repelled neurites of neonatal cerebellar neurons, but addition of ChABC or ChAC suppressed the inhibitory property of clusters on neurite outgrowth. The present study is the first to demonstrate that DS and CS play different functions after brain injury: DS is involved in the lesion scar formation, and CS inhibits axonal regeneration.	[Li, Hong-Peng; Komuta, Yukari; Kimura-Kuroda, Junko; Kawano, Hitoshi] Tokyo Metropolitan Inst Med Sci, Lab Neural Regenerat, Setagaya City, Tokyo 1568506, Japan; [Li, Hong-Peng] China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, NL-6525 ED Nijmegen, Netherlands	Kawano, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Neural Regenerat, 2-1-6 Kamikitazawa, Setagaya City, Tokyo 1568506, Japan.	kawano-ht@igakuken.or.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015		Ministry of Education, Culture, Sports, Science and Technology in Japan Contract (Mext)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [23500422]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC-81171248]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23500422] Funding Source: KAKEN	We thank Dr. G. Raisman for reviewing the manuscript. This study was supported by grants from Grant-in-Aid for Scientific Research (C) from Ministry of Education, Culture, Sports, Science and Technology in Japan Contract (Mext) (23500422) and from The National Natural Science Foundation of China (NSFC-81171248).	Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Denholm EM, 2000, EUR J PHARMACOL, V400, P145, DOI 10.1016/S0014-2999(00)00381-2; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Hashiguchi T, 2010, GLYCOCONJUGATE J, V27, P49, DOI 10.1007/s10719-009-9253-x; HIERCK BP, 1994, J HISTOCHEM CYTOCHEM, V42, P1499, DOI 10.1177/42.11.7930532; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kimura-Kuroda J, 2010, MOL CELL NEUROSCI, V43, P177, DOI 10.1016/j.mcn.2009.10.008; Komuta Y, 2010, CELL MOL NEUROBIOL, V30, P101, DOI 10.1007/s10571-009-9435-x; Kozma EM, 2011, GLYCOBIOLOGY, V21, P1301, DOI 10.1093/glycob/cwr065; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lensen JFM, 2006, MATRIX BIOL, V25, P457, DOI 10.1016/j.matbio.2006.06.003; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li HP, 2007, J NEUROSCI RES, V85, P536, DOI 10.1002/jnr.21141; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Moon C, 2004, NEUROSCI LETT, V367, P133, DOI 10.1016/j.neulet.2004.05.101; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Moon LDF, 2001, NAT NEUROSCI, V4, P465; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nagata I, 2006, J COMP NEUROL, V499, P274, DOI 10.1002/cne.21102; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; ROMARIS M, 1991, BIOCHIM BIOPHYS ACTA, V1093, P229, DOI 10.1016/0167-4889(91)90127-J; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8; Stylli SS, 2000, J CLIN NEUROSCI, V7, P137, DOI 10.1054/jocn.1999.0187; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Teng X, 2008, J NEUROSCI RES, V86, P3140, DOI 10.1002/jnr.21767; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; VERNA JM, 1989, INT J DEV NEUROSCI, V7, P389, DOI 10.1016/0736-5748(89)90060-9; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; WESTERGRENTHORSSON G, 1992, EUR J BIOCHEM, V205, P277, DOI 10.1111/j.1432-1033.1992.tb16778.x; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoshioka N, 2011, J NEUROSCI RES, V89, P381, DOI 10.1002/jnr.22552; Yoshioka N, 2010, J COMP NEUROL, V518, P3867, DOI 10.1002/cne.22431; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951	56	29	30	0	24	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	5					413	425		10.1089/neu.2012.2513			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	103CI	WOS:000315891600011	23438307	Green Published			2021-06-18	
J	Weckbach, S; Hohmann, C; Braumueller, S; Denk, S; Klohs, B; Stahel, PF; Gebhard, F; Huber-Lang, MS; Perl, M				Weckbach, Sebastian; Hohmann, Christoph; Braumueller, Sonja; Denk, Stephanie; Klohs, Bettina; Stahel, Philip F.; Gebhard, Florian; Huber-Lang, Markus S.; Perl, Mario			Inflammatory and apoptotic alterations in serum and injured tissue after experimental polytrauma in mice: Distinct early response compared with single trauma or "double-hit" injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Experimental polytrauma; inflammation; apoptosis; multiple injury; mice	ACUTE LUNG INJURY; BLUNT CHEST TRAUMA; ALVEOLAR MACROPHAGES; PULMONARY APOPTOSIS; FAS LIGAND; HEMORRHAGE; MORTALITY; DEATHS; NEUTROPHILS; FRACTURE	BACKGROUND: The exact alterations of the immune system after polytrauma leading to sepsis and multiple-organ failure are poorly understood. Thus, the early local and systemic inflammatory and apoptotic response was characterized in a new polytrauma model and compared with the alterations seen after single or combined injuries. METHODS: Anesthetized C57BL/6 mice were subjected to either blunt bilateral chest trauma (Tx), closed head injury, right femur fracture including contralateral soft tissue injury, or a combination of injuries (PTx). After 2 hours or 6 hours, animals were sacrificed, and the systemic as well as the local pulmonary immune response (bronchoalveolar lavage [BAL]/plasma cytokines, lung myeloperoxidase [MPO] activity, and alveolocapillary barrier dysfunction) were evaluated along with lung/brain apoptosis (lung caspase 3 Western blotting, immunohistochemistry, and polymorphonuclear leukocytes [PMN] Annexin V). RESULTS: Hemoglobin, Po-2 saturation, and pH did not differ between the experimental groups. Local BAL cytokines/chemokines were significantly increased in almost all groups, which included Tx. There was no further enhancement of this local inflammatory response in the lungs in case of PTx. At 2 hours, all groups except sham and closed head injury alone revealed an increased activity of lung MPO. However, 6 hours after injury, lung MPO remained increased only in the PTx group. Increased BAL protein levels were found, reflecting enhanced lung leakage in all groups with Tx 6 hours after trauma. Only after PTx was neutrophil apoptosis significantly decreased, whereas lung caspase 3 and plasma interleukin 6/keratinocyte chemoattractant (KC) were substantially increased. CONCLUSION: The combination of different injuries leads to an earlier systemic inflammatory response when compared with the single insults. Interestingly, only after PTx but not after single or double hits was lung apoptosis increased, and PMN apoptosis was decreased along with a prolonged presence of neutrophils in the lungs, which may therefore represent a possible pathomechanism for lung injury after polytrauma. (J Trauma Acute Care Surg. 2013; 74: 489-498. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Weckbach, Sebastian; Hohmann, Christoph; Braumueller, Sonja; Denk, Stephanie; Klohs, Bettina; Gebhard, Florian; Huber-Lang, Markus S.; Perl, Mario] Univ Ulm, Dept Trauma Hand Plast & Reconstruct Surg, D-89075 Ulm, Germany; [Stahel, Philip F.] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Orthopaed & Neurosurg, Denver, CO USA	Perl, M (corresponding author), Univ Ulm, Dept Trauma Hand Plast & Reconstruct Surg, Steinhoevelstr 9, D-89075 Ulm, Germany.	mario.perl@uniklinik-ulm.de	Huber-Lang, Markus/AAJ-2209-2020		Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [PE 908/2-1]; University of Ulm [LSPZ.0003.05, HU 823/3-2]	This study was supported by grants from the Deutsche Forschungsgemeinschaft PE 908/2-1 (to M.P.) and HU 823/3-2 (to M.S.H.-L. and M.P.) from the University of Ulm LSPZ.0003.05 (to M.P.)	Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; [Anonymous], 2011, TRAUM REG DGU ANN RE; Ayala A, 2002, AM J PATHOL, V161, P2283, DOI 10.1016/S0002-9440(10)64504-X; Biffl WL, 1999, SURGERY, V126, P198, DOI 10.1016/S0039-6060(99)70155-8; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Claes L, 2006, J ORTHOP RES, V24, P1178, DOI 10.1002/jor.20173; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Frutos-Vivar Fernando, 2004, Curr Opin Crit Care, V10, P1, DOI 10.1097/00075198-200402000-00001; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Giannoudis PV, 2008, INJURY, V39, P705, DOI 10.1016/j.injury.2008.02.016; Hwang PF, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-92; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Knoferl MW, 2004, SHOCK, V22, P51, DOI 10.1097/01.shk.0000127684.64611.5c; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Liener UC, 2011, LANGENBECK ARCH SURG, V396, P251, DOI 10.1007/s00423-010-0645-y; Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Mommsen P, 2011, CYTOKINE, V53, P60, DOI 10.1016/j.cyto.2010.09.005; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0; Perl M, 2007, AM J RESP CRIT CARE, V176, P591, DOI 10.1164/rccm.200611-1743OC; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Qvick B, 2012, UNFALLCHIRURG, V115, P892, DOI 10.1007/s00113-010-1920-7; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Seitz DH, 2011, SHOCK, V36, P621, DOI 10.1097/SHK.0b013e318234f8a0; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Trupka A, 1998, UNFALLCHIRURG, V101, P244, DOI 10.1007/s001130050265; Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df; Wu JS, 2012, J EMERG MED, V43, P407, DOI 10.1016/j.jemermed.2009.05.024; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC	39	29	31	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2013	74	2					489	498		10.1097/TA.0b013e31827d5f1b			10	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	108UH	WOS:000316321200037	23354243				2021-06-18	
J	Golub, A; Vazan, P; Bennett, AS; Liberty, HJ				Golub, Andrew; Vazan, Peter; Bennett, Alexander S.; Liberty, Hilary J.			Unmet Need for Treatment of Substance Use Disorders and Serious Psychological Distress Among Veterans: A Nationwide Analysis Using the NSDUH	MILITARY MEDICINE			English	Article							COMORBIDITY SURVEY REPLICATION; MENTAL-HEALTH PROBLEMS; AFGHANISTAN VETERANS; IRAQ; CARE; SERVICES; BARRIERS; ILLNESS; ONSET	Many veterans returning from Afghanistan and Iraq experience serious mental health (MH) concerns including substance use disorders (SUD), post-traumatic stress disorder, traumatic brain injury, depression, or serious psychological distress (SPD). This article uses data from the 2004 to 2010 National Survey on Drug Use and Health to examine the prevalence of unmet MH needs among veterans aged 21 to 34 in the general population. The prevalence of untreated SUD among veterans (16%) was twice as high as untreated SPD (8%), a nonspecific diagnosis of serious MH concerns. Surprisingly, similar rates of untreated SUD and SPD were found among a nonveteran comparison sample matched on gender and age. These findings suggest that reducing unmet need for MH treatment for veterans in the general population may require improving outreach to all Americans and creating greater acceptance for MH treatment. The need for further analyses of reasons for not obtaining treatment is discussed.	[Golub, Andrew; Vazan, Peter; Bennett, Alexander S.; Liberty, Hilary J.] Natl Dev & Res Inst, New York, NY 10010 USA	Golub, A (corresponding author), Natl Dev & Res Inst, 71 West 23rd St,8th Floor, New York, NY 10010 USA.				National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [NIAAA R01 AA020178]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020178] Funding Source: NIH RePORTER	This research was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA R01 AA020178).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychological Association, 2007, PSYCH NEEDS US MIL S; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; [Anonymous], 2008, 2007 NAT SURV DRUG U; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Ender M.G., 2009, AM SOLDIERS IRAQ MCS; Finley Erin, 2011, FIELDS COMBAT UNDERS; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hosmer D, 1989, APPL LOGISTIC REGRES; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2001, HEALTH SERV RES, V36, P987; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, J GEN INTERN MED, V26, P1160, DOI 10.1007/s11606-011-1746-1; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; *SUBST AB MENT HLT, 2006, 2005 NAT SURV DRUG U; *SUBST AB MENT HLT, 2005, 2004 NAT SURV DRUG U; *SUBST AB MENT HLT, 2007, 2006 NAT SURV DRUG U; Substance Abuse and Mental Health Data Archive, 2011, 2010 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration, 2008, 2009 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration, 2009, 2008 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration, 2005, NSDUH REP SUBST US D; Substance Abuse and Mental Health Services Administration, 2010, 2009 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2008, NSDUH REP SER PSYCH; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2007, NSDUH REP SER PSYCH; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR, VI; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; WAGNER TH, 2007, PSYCHOL SERVICES, V0004; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Watkins KE, 2011, HEALTH AFFAIR, V30, P2194, DOI 10.1377/hlthaff.2011.0509	37	29	29	0	11	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2013	178	1					107	114		10.7205/MILMED-D-12-00131			8	Medicine, General & Internal	General & Internal Medicine	AN7TV	WOS:000340804800023	23356128	Green Accepted, Bronze			2021-06-18	
J	Lannsjo, M; Backheden, M; Johansson, U; af Geijerstam, JL; Borg, J				Lannsjo, M.; Backheden, M.; Johansson, U.; af Geijerstam, J. L.; Borg, J.			Does head CT scan pathology predict outcome after mild traumatic brain injury?	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						brain concussion; head CT scan; mild traumatic brain injury; prediction	POST-CONCUSSION SYMPTOMS; CONSTRUCT-VALIDITY; FOLLOW-UP; QUESTIONNAIRE; RECOVERY; TRIAL; RELIABILITY; UPDATE; COHORT; ADULTS	Background and purpose: More evidence is needed to forward our understanding of the key determinants of poor outcome after mild traumatic brain injury (MTBI). A large, prospective, national cohort of patients was studied to analyse the effect of head CT scan pathology on the outcome. Methods: One-thousand two-hundred and sixty-two patients with MTBI (Glasgow Coma Scale score 15) at 39 emergency departments completed a study protocol including acute head CT scan examination and follow-up by the Rivermead Post Concussion Symptoms Questionnaire and the Glasgow Outcome Scale Extended (GOSE) at 3 months after MTBI. Binary logistic regression was used for the assessment of prediction ability. Results: In 751 men (60%) and 511 women (40%), with a mean age of 30 years (median 21, range 6-94), we observed relevant or suspect relevant pathologic findings on acute CT scan in 52 patients (4%). Patients aged below 30 years reported better outcome both with respect to symptoms and GOSE as compared to patients in older age groups. Men reported better outcome than women as regards symptoms (OR 0.64, CI 0.49-0.85 for >= 3 symptoms) and global function (OR 0.60, CI 0.39-0.92 for GOSE 1-6). Conclusions: Pathology on acute CT scan examination had no effect on self-reported symptoms or global function at 3 months after MTBI. Female gender and older age predicted a less favourable outcome. The findings support the view that other factors than brain injury deserve attention to minimize long-term complaints after MTBI.	[Lannsjo, M.] Uppsala Univ, Dept Rehabil Med, Inst Neurosci, Uppsala, Sweden; [Lannsjo, M.; Johansson, U.] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavleborg, Sweden; [Backheden, M.] Karolinska Inst, Dept LIME, Med Stat Unit, Stockholm, Sweden; [af Geijerstam, J. L.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Borg, J.] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden	Lannsjo, M (corresponding author), Sandviken Hosp, SE-81189 Sandviken, Sweden.	marianne.lannsjo@lg.se		Borg, Jorgen/0000-0002-2372-7478; Lannsjo, Marianne/0000-0001-8792-3796	Centre for Research and Development Uppsala University/County Council of Gavleborg; Stockholm County CouncilStockholm County Council; AFA Insurance	Grants from the Centre for Research and Development Uppsala University/County Council of Gavleborg, the Stockholm County Council and AFA Insurance. Authors declare no conflicts of interest.	af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Gonzales PG, 2011, AM ACAD PHYS MED REH, V3, P413; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; National Institute for Clinical Excellence Head Injury, 2007, TRIAG ASS INV EARL M; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	39	29	29	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JAN	2013	20	1					124	129		10.1111/j.1468-1331.2012.03813.x			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	090RG	WOS:000314996200019	22812542				2021-06-18	
J	VanItallie, TB				VanItallie, Theodore B.			Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Neuroimaging biomarkers; Apolipoprotein E epsilon 4; Fluorodeoxyglucose-positron emission tomography; Cerebral metabolic rate of glucose; Personalized medicine	POSITRON-EMISSION-TOMOGRAPHY; APOE EPSILON-4 ALLELE; FAMILY-HISTORY; MOUSE MODEL; CLEARANCE; DEMENTIA; DEFICIT	The most opportune time for preventive intervention in sporadic Alzheimer's disease (spAD) is early in its preclinical stage (pcAD), when the odds of preventing or minimizing later disabling neurodegeneration are most favorable. The efficacy of promising preventive interventions should be assessed in patients in the earliest discernible phase of pcAD. This will require application of personalized medicine techniques, with use of suitable biomarkers to detect pcAD in individuals believed to be spAD-prone. This review focuses on the genetic biomarker, apolipoprotein E (apoE) epsilon 4, and on certain neuroimaging biomarkers, such as structural MRI (sMRI), fluorodeoxyglucose-positron emission tomography (FDG-PET), and PET-amyloid tracers capable of delineating the extent and distribution of amyloid-beta (A beta) deposits in the brain, that can be useful in identifying cognitively normal people who are at enhanced risk of developing spAD. Many years before AD symptoms appear, such neuroimaging procedures can disclose signature abnormalities of brain structure, function, and amyloid levels in cognitively normal apoE epsilon 4 allele carriers and/or individuals with a family history of spAD. Although no effective treatment for spAD is yet available, there is evidence that, by taking a proactive personalized-medicine approach, the practicing physician may be able to reduce risk in AD-prone patients by attending to such modifiable AD risk factors as hypertension, obesity, type 2 diabetes, insulin resistance, hypercholesterolemia, sedentary lifestyle, and current cigarette smoking. Young patients who are epsilon 4 positive should be advised to avoid participation in contact sports or other activities that expose them to risk of traumatic brain injury. (C) 2013 Elsevier Inc. All rights reserved.	Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Med, Div Endocrinol Diabet & Nutr, New York, NY 10025 USA	VanItallie, TB (corresponding author), Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Med, Div Endocrinol Diabet & Nutr, New York, NY 10025 USA.				College International de Recherche Servier (CIRS)	Publication of this article was supported by the College International de Recherche Servier (CIRS).	Alzheimers Assoc, 2011, ALZHEIMERS DEMENT, V7, P208, DOI 10.1016/j.jalz.2011.02.004; Berti V, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.01.001; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Fennema-Notestine C, 2011, J ALZHEIMERS DIS, V26, P49, DOI 10.3233/JAD-2011-0002; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; Fleisher AS, 2012, NEUROBIOL A IN PRESS; Gandy S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004274; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Lee SH, 2012, J NEUROSCI, V32, P5953, DOI 10.1523/JNEUROSCI.0465-12.2012; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; Martin LJ, 2012, PROG MOL BIOL TRANSL, V107, P355, DOI 10.1016/B978-0-12-385883-2.00005-9; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2011, ADV ALZH DIS, V2, P219, DOI 10.3233/978-1-60750-793-2-219; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Sabuncu MR, 2011, ARCH NEUROL-CHICAGO, V68, P1040, DOI 10.1001/archneurol.2011.167; Sadowsky CH, 2012, J AM BOARD FAM MED, V25, P350, DOI 10.3122/jabfm.2012.03.100183; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Varghese M, 2011, TRANSL NEUROSCI, V2, P1, DOI 10.2478/s13380-011-0011-8; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; Vlassenko AG, 2011, ANN NEUROL, V70, P857, DOI 10.1002/ana.22608; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506; Wu Z, 1998, ALZ DIS ASSOC DIS, V12, P190, DOI 10.1097/00002093-199809000-00011; Xiong CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1313, DOI 10.1001/archneurol.2011.208; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106	33	29	29	0	53	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	JAN	2013	62	1		1			S30	S33		10.1016/j.metabol.2012.08.024			4	Endocrinology & Metabolism	Endocrinology & Metabolism	056PZ	WOS:000312504700008	23021038				2021-06-18	
J	Ersahin, M; Cevik, O; Akakin, D; Sener, A; Ozbay, L; Yegen, BC; Sener, G				Ersahin, Mehmet; Cevik, Ozge; Akakin, Dilek; Sener, Azize; Ozbay, Latif; Yegen, Berrak C.; Sener, Goksel			Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury	PROSTAGLANDINS & OTHER LIPID MEDIATORS			English	Article						Oxidative stress; Spinal cord injury; Caspase-3; Bladder; Leukotriene; Montelukast	RECEPTOR BLOCKER MONTELUKAST; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NEUROLOGICAL DYSFUNCTION; SECONDARY INJURY; CELL-DEATH; INFILTRATION; INFLAMMATION; ANTAGONIST; APOPTOSIS	Spinal cord injury (SCI) leads to an inflammatory response that generates substantial secondary damage within the tissue besides the primary damage. Leukotrienes are biologically active 5-lipoxygenase products of arachidonic acid metabolism that are involved in the mediation of various inflammatory disorders including SCI. In this study, we investigated the possible protective effects of montelukast, a leukotriene receptor blocker, on SCI-induced oxidative damage. Wistar albino rats (n = 24) were divided randomly as control, vehicle- or montelukast (10 mg/kg, ip)-treated SCI groups. To induce SCI, a standard weight-drop method that induced a moderately severe injury at T10 was used. Vehicle or montelukast were administered to the injured animals 15 min after injury. At seven days post-injury, neurological examination was performed and rats were decapitated. Blood samples were taken to evaluate leukotriene 134 levels, and pro-inflmamatory cytokines (TNF-alpha, IL-1 beta) while in spinal cord and urinary bladder samples malondialdehyde (MDA), glutathione (GSH), luminol chemiluminescence (CL) levels and myeloperoxidase (MPO) and caspase-3 activities were determined. Tissues were also evaluated histologically. SCI caused significant decreases in tissue GSH, which were accompanied with significant increases in luminol CL and MDA levels and MPO and caspase-3 activities, while pro-inflammatory cytokines in the plasma were elevated. On the other hand. montelukast treatment reversed these parameters and improved histological findings. In conclusion, SCI caused oxidative tissue injury through the activation of pro-inflammatory mediators and by neutrophil infiltration into tissues, and the neuroprotective and antiapoptotic effects of montelukast are mediated by the inhibition of lipid peroxidation, neutrophil accumulation and proinflammatory cytokine release. Moreover, montelukast does not only exert antioxidant and antiapoptotic effects on the spinal cord, but it has a significant impact on the bladder tissue damage secondary to SCI. (C) 2012 Elsevier Inc. All rights reserved.	[Sener, Goksel] Marmara Univ, Sch Pharm, Dept Pharmacol, Istanbul, Turkey; [Yegen, Berrak C.] Marmara Univ, Sch Med, Dept Physiol, Istanbul, Turkey; [Ersahin, Mehmet] Istanbul Medeniyet Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Cevik, Ozge] Cumhuriyet Univ, Sch Pharm, Dept Biochem, Sivas, Turkey; [Akakin, Dilek] Marmara Univ, Sch Med, Dept Histol & Embryol, Istanbul, Turkey; [Sener, Azize] Marmara Univ, Sch Pharm, Dept Biochem, Istanbul, Turkey; [Ozbay, Latif] Yeditepe Univ, Sch Pharm, Dept Pharmacol, Istanbul, Turkey	Sener, G (corresponding author), Marmara Univ, Sch Pharm, Dept Pharmacol, Istanbul, Turkey.	gsener@marmara.edu.tr	Sener, Goksel/AAN-4461-2021; Yegen, Berrak C./ABA-1986-2020; Yegen, Berrak/O-6652-2017; Cevik, Ozge/Z-2790-2019; Yegen, Berrak/ABA-3274-2020; Cevik, Ozge/F-1326-2014	Sener, Goksel/0000-0001-7444-6193; Yegen, Berrak C./0000-0003-0791-0165; Yegen, Berrak/0000-0003-0791-0165; Cevik, Ozge/0000-0002-9325-3757			Allen A.R., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BALENTINE JD, 1978, LAB INVEST, V39, P236; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bao F, 2006, NEUROSCIENCE, V140, P1011, DOI 10.1016/j.neuroscience.2006.02.061; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Beutler E., 1975, MANUAL BIOCH METHODS, P112, DOI DOI 10.3892/MMR.2015.3648; BISGAARD H, 1985, PROSTAGLANDINS, V30, P791, DOI 10.1016/0090-6980(85)90007-3; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Chen J, 1998, J NEUROSCI, V18, P4914; Chu LS, 2006, ACTA PHARMACOL SIN, V27, P282, DOI 10.1111/j.1745-7254.2006.00290.x; Craggs MD, 2006, AUTON NEUROSCI-BASIC, V126, P355, DOI 10.1016/j.autneu.2006.03.010; DAMON M, 1983, BIOCHEM BIOPH RES CO, V111, P518, DOI 10.1016/0006-291X(83)90337-6; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Ersahin M, 2012, J PINEAL RES, V52, P340, DOI 10.1111/j.1600-079X.2011.00948.x; Fehlings MG, 2010, J CLIN IMMUNOL, V30, pS109, DOI 10.1007/s10875-010-9404-7; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Genovese T, 2008, BRIT J PHARMACOL, V153, P568, DOI 10.1038/sj.bjp.0707577; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Han X, 2012, NEUROSCI LETT, V511, P28, DOI 10.1016/j.neulet.2012.01.030; Herrera JJ, 2010, J NEUROTRAUM, V27, P423, DOI 10.1089/neu.2009.0997; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Impellizzeri D, 2012, BIOCHEM PHARMACOL, V83, P1413, DOI 10.1016/j.bcp.2012.02.001; Jiang Q, 2003, FASEB J, V17, P816, DOI 10.1096/fj.02-0877com; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Kabasakal L, 2005, PROSTAG LEUKOTR ESS, V72, P431, DOI 10.1016/j.plefa.2005.02.008; Knoblach SM, 2005, J NEUROSCI RES, V80, P369, DOI 10.1002/jnr.20465; KROL W, 1990, BIOCHEM INT, V21, P593; Kyung KS, 2006, EUR J NEUROSCI, V24, P1042, DOI 10.1111/j.1460-9568.2006.04908.x; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Mohamadin Ahmed M, 2011, Pathophysiology, V18, P235, DOI 10.1016/j.pathophys.2011.02.003; Moon YJ, 2012, J NEUROSCI RES, V90, P243, DOI 10.1002/jnr.22734; MORELAND DB, 1989, SURG NEUROL, V31, P277, DOI 10.1016/0090-3019(89)90052-9; Ni BH, 1998, J CEREBR BLOOD F MET, V18, P248, DOI 10.1097/00004647-199803000-00003; Ozkan E, 2010, PANCREAS, V39, P1041, DOI 10.1097/MPA.0b013e3181db2dfd; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rong W, 2012, NEUROCHEM RES, V37, P1615, DOI 10.1007/s11064-012-0756-7; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Samson Gregory, 2007, Phys Med Rehabil Clin N Am, V18, P255; Sener G, 2005, PROSTAG LEUKOTR ESS, V73, P453, DOI 10.1016/j.plefa.2005.07.008; Sener G, 2007, PROSTAG OTH LIPID M, V83, P257, DOI 10.1016/j.prostaglandins.2007.01.013; Sener G, 2007, J PHARM PHARMACOL, V59, P837, DOI 10.1211/jpp.59.6.0009; Sener G, 2006, PHARMACOL RES, V54, P65, DOI 10.1016/j.phrs.2006.02.007; Taoka Y, 1998, J NEUROSCI, V18, P1393; Toklu HZ, 2010, J SPINAL CORD MED, V33, P401, DOI 10.1080/10790268.2010.11689719; Virchow JC, 2001, CLIN EXP ALLERGY, V31, P836, DOI 10.1046/j.1365-2222.2001.01051.x; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; WILLIAMS JD, 1984, J IMMUNOL, V132, P3034; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yilmaz ER, 2012, ACTA NEUROCHIR, V154, P1037, DOI 10.1007/s00701-012-1298-0; Zhao R, 2011, J PHARM PHARMACOL, V63, P550, DOI 10.1111/j.2042-7158.2010.01238.x	64	29	34	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-8823	2212-196X		PROSTAG OTH LIPID M	Prostaglandins Other Lipid Mediat.	DEC	2012	99	3-4					131	139		10.1016/j.prostaglandins.2012.09.002			9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	056SN	WOS:000312511800009	22986158				2021-06-18	
J	Ji, XT; Tian, Y; Xie, KL; Liu, WP; Qu, Y; Fei, Z				Ji, Xituan; Tian, Ye; Xie, Keliang; Liu, Weiping; Qu, Yan; Fei, Zhou			Protective effects of hydrogen-rich saline in a rat model of traumatic brain injury via reducing oxidative stress	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury (TBI); Reactive oxygen species (ROS); Oxidative stress; Hydrogen-rich saline (HS)	INTESTINAL ISCHEMIA/REPERFUSION; REPERFUSION INJURY; GAS; MICE; ISCHEMIA; IMPACT; INHALATION; BIOMARKERS; MARKERS; DAMAGE	Background: Hydrogengas (H-2) has beenconsidered as a novel antioxidant to selectively reduce the toxic reactive oxygen species (ROS) such as hydroxyl radical (center dot OH) without affecting the other signal ROS. Our recent study shows that H-2 inhalation is beneficial to traumatic brain injury (TBI) via reducing oxidative stress. In contrast to H-2, hydrogen-rich saline (HS) may be more suitable for clinical application. The present study was designed to investigate whether HS has a protective effect against TBI via reducing oxidative stress in rats. Methods: TBI model was induced by controlled cortical impact injury. Different dosages of HS were intraperitoneally administered at 5 min after TBI operation. We then measured the brain edema, blood-brain barrier (BBB) breakdown, neurological dysfunction and injury volume in all animals. In addition, the oxidative products and antioxidant enzymes in brain tissues were detected. Results: TBI-challenged rats exhibited significant brain injuries characterized by the increase of BBB permeability, brain edema, and lesion volume as well as neurological dysfunction, which were dose-dependently ameliorated by HS treatment. Moreover, we found that HS treatment increased the endogenous antioxidant enzymatic activities and decreased the oxidative product levels in brain tissues of TBI-challenged rats. Conclusion: Hydrogen-rich saline can exert a protective effect against TBI via reducing oxidative stress. Molecular hydrogen may be a more effective therapeutic strategy for TBI patients. (C) 2012 Elsevier Inc. All rights reserved.	[Ji, Xituan; Liu, Weiping; Qu, Yan; Fei, Zhou] Fourth Mil Med Univ, Xiing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China; [Tian, Ye] Xian Cent Hosp, Dept Neurol, Xian, Shaanxi Provinc, Peoples R China; [Xie, Keliang] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China	Fei, Z (corresponding author), Fourth Mil Med Univ, Xiing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China.	Tougaozy2011@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30930093, 81101409, 81071533]	This work was supported by research grants from the National Natural Science Foundation of China (nos. 30930093, 81101409, 81071533). The authors thank Professor Xuejun Sun for his kind help with information.	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Cai JM, 2009, BRAIN RES, V1256, P129, DOI 10.1016/j.brainres.2008.11.048; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; George JF, 2010, KIDNEY INT, V77, P85, DOI 10.1038/ki.2009.432; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kumar A, 2008, NEONATOLOGY, V94, P96, DOI 10.1159/000116633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu DD, 2008, CRIT CARE MED, V36, P565, DOI 10.1097/01.CCM.0000299737.24338.5C; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Mao YF, 2009, BIOCHEM BIOPH RES CO, V381, P602, DOI 10.1016/j.bbrc.2009.02.105; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Matchett GA, 2009, BRAIN RES, V1259, P90, DOI 10.1016/j.brainres.2008.12.066; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta Shigeo, 2008, Nihon Ronen Igakkai Zasshi, V45, P355; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020; Satpute RM, 2009, FOOD CHEM TOXICOL, V47, P2689, DOI 10.1016/j.fct.2009.06.007; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Xie KL, 2010, SHOCK, V34, P495, DOI 10.1097/SHK.0b013e3181def9aa; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603	40	29	30	0	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	NOV	2012	178	1					E9	E16		10.1016/j.jss.2011.12.038			8	Surgery	Surgery	028UV	WOS:000310450300002	22475349				2021-06-18	
J	Xydakis, MS; Ling, GSF; Mulligan, LP; Olsen, CH; Dorlac, WC				Xydakis, Michael S.; Ling, Geoffrey S. F.; Mulligan, Lisa P.; Olsen, Cara H.; Dorlac, Warren C.			Epidemiologic aspects of traumatic brain injury in acute combat casualties at a major military medical center: A cohort study	ANNALS OF NEUROLOGY			English	Article							MINOR HEAD-INJURY; SEVERITY SCORE; CONSCIOUSNESS; IRAQ; AFGHANISTAN; SYMPTOMS; VETERANS; LENGTH; STAY	Objective: From the ongoing military conflicts in Iraq and Afghanistan, an understanding of the neuroepidemiology of traumatic brain injury (TBI) has emerged as requisite for further advancements in neurocombat casualty care. This study reports population-specific incidence data and investigates TBI identification and grading criteria with emphasis on the role of loss of consciousness (LOC) in the diagnostic rubric. Methods: This is a cohort study of all consecutive troops acutely injured during combat operationssustaining body-wide injuries sufficient to require immediate stateside evacuationand admitted sequentially to our medical center during a 2-year period. A prospective exploration of the TBI identification and grading system was performed in a homogeneous population of blast-injured polytrauma inpatients. Results: TBI incidence was 54.3%. Structural neuroimaging abnormalities were identified in 14.0%. Higher Injury Severity Score (ISS) was associated with abnormal neuroimaging, longer length of stay (LOS), and elevated TBI statusprimarily based on autobiographical LOC. Mild TBI patients had normal neuroimaging, higher ISS, and comparable LOS to TBI-negative patients. Patients who reported LOC had a lower incidence of abnormal neuroimaging. Interpretation: This study demonstrates that the methodology used to assign the diagnosis of a mild TBI in troops with complex combat-related injuries is crucial to an accurate accounting. The detection of incipient mild TBI, based on an identification system that utilizes LOC as the principal diagnostic criterion to discern among patients with outcomes of interest, misclassifies patients whose LOC may not reflect actual brain injury. Attempts to identify high-risk battlefield casualties within the current point-of-injury mild TBI case definition, which favors high sensitivity, will be at the expense of specificity. ANN NEUROL 2012;72:673681	[Xydakis, Michael S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Traumat Brain Injury Surg Res Program, Div Otolaryngol, Bethesda, MD 20814 USA; [Xydakis, Michael S.; Ling, Geoffrey S. F.; Mulligan, Lisa P.] Uniformed Serv Univ Hlth Sci, Walter Reed Army Med Ctr, Bethesda, MD 20814 USA; [Ling, Geoffrey S. F.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Mulligan, Lisa P.] Uniformed Serv Univ Hlth Sci, Dept Neurosurg, Bethesda, MD 20814 USA; [Olsen, Cara H.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA	Xydakis, MS (corresponding author), Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA.	Michael.Xydakis@usuhs.edu			Sanofi; Bristol-MyersBristol-Myers Squibb; Squibb	G.S.F.L.: speaking fees, Sanofi, Bristol-Myers, Squibb (not active); stock/stock options, Merck.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Casscells SW, 2007, TRAUMATIC BRAIN INJU; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Defense and Veterans Brain Injury Center, 2011, VA DOD CLIN PRACT GU; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Jaffee M, 2010, MIL MED, V175, P37, DOI 10.7205/MILMED-D-10-00170; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kulinskaya E., 2005, IMA Journal of Management Mathematics, V16, P369, DOI 10.1093/imaman/dpi015; LINN S, 1993, INT J EPIDEMIOL, V22, P905, DOI 10.1093/ije/22.5.905; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU, P1; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toschlog EA, 2003, AM SURGEON, V69, P491; VA Health Care, 2008, GAO08276 VA HLTH CAR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	38	29	29	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	NOV	2012	72	5					673	681		10.1002/ana.23757			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	062RV	WOS:000312940300007	23060246				2021-06-18	
J	Debray, TPA; Koffijberg, H; Vergouwe, Y; Moons, KGM; Steyerberg, EW				Debray, Thomas P. A.; Koffijberg, Hendrik; Vergouwe, Yvonne; Moons, Karel G. M.; Steyerberg, Ewout W.			Aggregating published prediction models with individual participant data: a comparison of different approaches	STATISTICS IN MEDICINE			English	Article						prediction research; prediction models; meta-analysis; logistic regression; multivariable; Bayesian inference	DEEP-VEIN THROMBOSIS; TRAUMATIC BRAIN-INJURY; LOGISTIC-REGRESSION ANALYSIS; SEVERE HEAD-INJURY; PROGNOSTIC MODELS; VENOUS THROMBOSIS; PATIENT DATA; EXTERNAL VALIDATION; PRIMARY-CARE; ROC CURVE	During the recent decades, interest in prediction models has substantially increased, but approaches to synthesize evidence from previously developed models have failed to keep pace. This causes researchers to ignore potentially useful past evidence when developing a novel prediction model with individual participant data (IPD) from their population of interest. We aimed to evaluate approaches to aggregate previously published prediction models with new data. We consider the situation that models are reported in the literature with predictors similar to those available in an IPD dataset. We adopt a two-stage method and explore three approaches to calculate a synthesis model, hereby relying on the principles of multivariate meta-analysis. The former approach employs a naive pooling strategy, whereas the latter accounts for within-study and between-study covariance. These approaches are applied to a collection of 15 datasets of patients with traumatic brain injury, and to five previously published models for predicting deep venous thrombosis. Here, we illustrated how the generally unrealistic assumption of consistency in the availability of evidence across included studies can be relaxed. Results from the case studies demonstrate that aggregation yields prediction models with an improved discrimination and calibration in a vast majority of scenarios, and result in equivalent performance (compared with the standard approach) in a small minority of situations. The proposed aggregation approaches are particularly useful when few participant data are at hand. Assessing the degree of heterogeneity between IPD and literature findings remains crucial to determine the optimal approach in aggregating previous evidence into new prediction models. Copyright (C) 2012 John Wiley & Sons, Ltd.	[Debray, Thomas P. A.; Koffijberg, Hendrik; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Vergouwe, Yvonne; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands	Debray, TPA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Stratenum 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	T.Debray@umcutrecht.nl	Debray, Thomas/J-7413-2012; Steyerberg, Ewout W/C-1509-2018	Debray, Thomas/0000-0002-1790-2719; Steyerberg, Ewout W/0000-0002-7787-0122; Koffijberg, Hendrik/0000-0002-1753-0652	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [9120.8004, 918.10.615, 916.11.126]	We would like to thank Stan Buckens for his input and comments during the review process, and Netherlands Organization for Scientific Research (9120.8004, 918.10.615 and 916.11.126).	Abu-Hanna A, 2001, METHOD INFORM MED, V40, P1; Altman DG, 2009, CANCER INVEST, V27, P235, DOI 10.1080/07357900802572110; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Balazs K, 2006, APPL PSYCH MEAS, V30, P322, DOI 10.1177/0146621605286315; Becker BJ, 2007, STAT SCI, V22, P414, DOI 10.1214/07-STS243; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Brier G.W., 1950, MONTHLY WEATHER REV, V78, P1, DOI 2.0.CO;2; Buller HR, 2009, ANN INTERN MED, V150, P229, DOI 10.7326/0003-4819-150-4-200902170-00003; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; de Leeuw CA, 2010, THESIS UTRECHT U UTR; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gagne P, 2009, PRESSE MED, V38, P525, DOI 10.1016/j.lpm.2008.09.022; Geersing GJ, 2010, BRIT J GEN PRACT, V60, P742, DOI 10.3399/bjgp10X532387; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishak KJ, 2008, STAT MED, V27, P670, DOI 10.1002/sim.2913; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; JENNETT B, 1976, LANCET, V1, P1031; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Development Core Team, 2011, R LANG ENV STAT COMP; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2000, STAT MED, V19, P141, DOI 10.1002/(SICI)1097-0258(20000130)19:2<141::AID-SIM334>3.0.CO;2-O; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subramaniam RM, 2006, ANN EMERG MED, V48, P678, DOI 10.1016/j.annemergmed.2006.04.010; Sutton AJ, 2008, STAT MED, V27, P651, DOI 10.1002/sim.2916; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURGERY, V80, P797; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Toll DB, 2008, FAM PRACT, V25, P3, DOI 10.1093/fampra/cmm075; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; VANHOUWELINGEN HC, 1995, STAT MED, V14, P1999, DOI 10.1002/sim.4780141806; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	52	29	29	0	23	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715			STAT MED	Stat. Med.	OCT 15	2012	31	23					2697	2712		10.1002/sim.5412			16	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	007FP	WOS:000308874500009	22733546				2021-06-18	
J	Pauli, C; Thais, MED; Claudino, LS; Bicalho, MAH; Bastos, AC; Guarnieri, R; Nunes, JC; Lin, K; Linhares, MN; Walz, R				Pauli, Carla; de Oliveira Thais, Maria Emilia; Claudino, Lucia Sukys; Horta Bicalho, Maria Alice; Bastos, Alexandre Cunha; Guarnieri, Ricardo; Nunes, Jean Costa; Lin, Katia; Linhares, Marcelo Neves; Walz, Roger			Predictors of quality of life in patients with refractory mesial temporal lobe epilepsy	EPILEPSY & BEHAVIOR			English	Article						Health-related quality of life; QOLIE-31; Mesial temporal lobe epilepsy; Psychiatric disorders	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; ILAE COMMISSION; DEPRESSION; INVENTORY; SYMPTOMS; HEADACHE; SEIZURES; PROPOSAL; SURGERY	Purpose: The identification of variables associated with health-related quality of life (HRQoL) in patients with mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) would improve surgical decision-making and post-operatory follow-up in this group of patients. Methods: We analyzed the independent association between the Quality of Life in Epilepsy Inventory-31 (QOLIE-31) of 81 consecutive patients with refractory MTLE-HS. The clinical, demographic, radiological and electrophysiological variables were analyzed by multiple linear regression analysis. Key findings: Approximately 36% (adjusted R-2 = 0.36; R coefficient = 0.66) of the QOLIE-31 overall score variance was explained by the history of initial precipitant injury, family history of epilepsy, disease duration, age of epilepsy onset, seizure frequency and presence of psychiatric axis-II diagnosis. The variance of QOLIE-31 sub-scales was: seizure worry = 7%; overall QOL = 11%; emotional well-being = 32%; energy/fatigue = 38%; cognitive function = 13%; medication effects = 7%; social function = 13% (R coefficient between 0.30 and 0.65). Significance: The pre-surgical variables studied had relatively low prediction capacity for the overall QOLIE-31 score and its sub-scales in this set of Brazilian patients with refractory MTLE-HS. (C) 2012 Elsevier Inc. All rights reserved.	[Lin, Katia; Walz, Roger] Univ Fed Santa Catarina, Dept Clin Med, HU, BR-88040970 Florianopolis, SC, Brazil; [Linhares, Marcelo Neves] Univ Fed Santa Catarina, Dept Cirurgia, HU, BR-88040970 Florianopolis, SC, Brazil; [Claudino, Lucia Sukys; Lin, Katia] Univ Fed Santa Catarina, Serv Neurol, HU, BR-88040970 Florianopolis, SC, Brazil; [Nunes, Jean Costa] Univ Fed Santa Catarina, Serv Patol, HU, BR-88040970 Florianopolis, SC, Brazil; [Pauli, Carla; Claudino, Lucia Sukys; Horta Bicalho, Maria Alice; Guarnieri, Ricardo; Nunes, Jean Costa; Lin, Katia; Linhares, Marcelo Neves; Walz, Roger] Univ Fed Santa Catarina, Ctr Neurociencias Aplicadas CeNAp, HU, BR-88040970 Florianopolis, SC, Brazil; [Pauli, Carla; de Oliveira Thais, Maria Emilia; Claudino, Lucia Sukys; Horta Bicalho, Maria Alice; Bastos, Alexandre Cunha; Guarnieri, Ricardo; Linhares, Marcelo Neves; Walz, Roger] HGCR, Ctr Epilepsia Santa Catarina CEPESC, Florianopolis, SC, Brazil	Walz, R (corresponding author), Univ Fed Santa Catarina, Dept Clin Med, HU, 3 Andar, BR-88040970 Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Lin, Katia/G-4891-2012; Walz, Roger/K-9096-2013; Neurociencia, Inct/I-1011-2013	Lin, Katia/0000-0002-5401-7524; Walz, Roger/0000-0002-9875-6687; SUKYS CLAUDINO, LUCIA/0000-0002-4735-2703	PRPe/FUNPESQUISA-UFSC; FAPESC/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); PPSUS-FAPESC [2.456/2011-2]	This work was supported by the PRPe/FUNPESQUISA-UFSC, PRONEX program of the FAPESC/CNPq (NENASC Project) and the PPSUS-FAPESC (Project 2.456/2011-2).	Alexandre V, 2011, EPILEPTIC DISORD, V13, P56, DOI 10.1684/epd.2011.0411; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Araujo D, 2006, EPILEPSIA, V47, P1354, DOI 10.1111/j.1528-1167.2006.00605.x; Cramer JA, 2003, EPILEPSY BEHAV, V4, P515, DOI 10.1016/j.yebeh.2003.07.009; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dickens C, 2011, J CARDIOPULM REHABIL, V31, P105, DOI 10.1097/HCR.0b013e318207d32b; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; First M.B., 1996, STRUCTURED CLIN INTE; Guarnieri R, 2005, PSYCHIAT RES-NEUROIM, V138, P75, DOI 10.1016/j.pscychresns.2004.10.003; Guarnieri R, 2009, EPILEPSY BEHAV, V14, P529, DOI 10.1016/j.yebeh.2009.01.002; da Silva TI, 2007, EPILEPSY BEHAV, V10, P234, DOI 10.1016/j.yebeh.2006.08.022; Jacobson AM, 1997, QUAL LIFE RES, V6, P11; Jehi L, 2011, EPILEPSY BEHAV, V22, P723, DOI 10.1016/j.yebeh.2011.08.039; Johnson EK, 2004, EPILEPSIA, V45, P544, DOI 10.1111/j.0013-9580.2004.47003.x; Karaivazoglou K, 2010, ANN HEPATOL, V9, P419, DOI 10.1016/S1665-2681(19)31618-7; Krishnamoorthy ES, 2007, EPILEPSY BEHAV, V10, P349, DOI 10.1016/j.yebeh.2006.10.002; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Luoni C, 2011, EPILEPSIA, V52, P2181, DOI 10.1111/j.1528-1167.2011.03325.x; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Nunes JC, 2011, SEIZURE-EUR J EPILEP, V20, P480, DOI 10.1016/j.seizure.2011.02.014; Nunes JC, 2011, J NEUROL SCI, V306, P20, DOI 10.1016/j.jns.2011.04.006; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perucca E, 2011, LANCET NEUROL, V10, P446, DOI 10.1016/S1474-4422(11)70047-3; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Tavares M, 1996, ENTREVISTA CLIN ESTR; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x; Terra-Bustamante VC, 2005, J NEUROL NEUROSUR PS, V76, P1080, DOI 10.1136/jnnp.2004.048934; Velasco TR, 2011, NEUROSURGERY, V68, P431, DOI 10.1227/NEU.0b013e318201c293; Vickrey BG, 1993, QUALITY LIFE EPILEPS, P9; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	31	29	30	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050			EPILEPSY BEHAV	Epilepsy Behav.	OCT	2012	25	2					208	213		10.1016/j.yebeh.2012.06.037			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	028WZ	WOS:000310457100016	23032134				2021-06-18	
J	Christensen, J				Christensen, Jakob			Traumatic brain injury: Risks of epilepsy and implications for medicolegal assessment	EPILEPSIA			English	Article						Antiepileptic drugs; Early seizures; Epidemiology; Prevention; Treatment	ACUTE SYMPTOMATIC SEIZURE; POSTTRAUMATIC SEIZURES; HOSPITALIZATION; PREVENTION; CHILDHOOD; MORTALITY; CHILDREN; ADULTS; TRIAL; AGE	Traumatic brain injury (TBI) is a potentially preventable cause of epilepsy. Increasing incidence among army personnel and the high incidence among children and young people raise concern. This article presents a review of selected studies dealing with the risks of TBI and the risk of posttraumatic epilepsy in humans. The incidence of persons admitted to hospital with TBI has decreased in developed countries in recent years. However, there is little change in TBI-associated deaths, and the decrease in hospitalization may merely reflect that more people with head injury are cared for on an outpatient basis. It is clear that epilepsy is a frequent consequence of brain injury, even many years after the injury. However, several well-controlled studies have been unable to identify therapies that prevent the development of epilepsy after TBI. Posttraumatic epilepsy has significant implications for the affected individuals, family, and society. Despite several interventions used to prevent posttraumatic epilepsy, the only proven intervention to date is to prevent TBI from occurring.	[Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ, Dept Clin Pharmacol, Aarhus, Denmark	Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk		Christensen, Jakob/0000-0002-9385-6435	Danish Epilepsy Association; UCB NordicUCB Pharma SA	Dr. Jakob Christensen received research support from the Danish Epilepsy Association.; Dr. Jakob Christensen received honoraria from serving on the scientific advisory board of UCB Nordic and Eisai AB, received honoraria from giving lectures from UCB Nordic and Eisai AB, and received funding for a trip from UCB Nordic. The author confirms that he has read the Journal's position on issues involved in ethical publication and affirms that this report is consistent with those guidelines.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Centers for Disease Control and Prevention, 2012, TRAUMATIC BRAIN INJU, P2002; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Sun YL, 2010, EPIDEMIOLOGY, V21, P650, DOI 10.1097/EDE.0b013e3181e94253; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	26	29	31	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580			EPILEPSIA	Epilepsia	SEP	2012	53			4	SI		43	47		10.1111/j.1528-1167.2012.03612.x			5	Clinical Neurology	Neurosciences & Neurology	000RG	WOS:000308404700006	22946720				2021-06-18	
J	Giannakopoulos, GF; Saltzherr, TP; Beenen, LFM; Reitsma, JB; Bloemers, FW; Goslings, JC; Bakker, FC				Giannakopoulos, G. F.; Saltzherr, T. P.; Beenen, L. F. M.; Reitsma, J. B.; Bloemers, F. W.; Goslings, J. C.; Bakker, F. C.		REACT Study Grp	Missed injuries during the initial assessment in a cohort of 1124 level-1 trauma patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Missed injuries; Trauma; Diagnosis; Tertiary survey; Risk factors	MAJOR TRAUMA; BLUNT TRAUMA; TERTIARY	Introduction: Despite the presence of diagnostic guidelines for the initial evaluation in trauma, the reported incidence of missed injuries is considerable. The aim of this study was to assess the missed injuries in a large cohort of trauma patients originating from two European Level-1 trauma centres. Methods: We analysed the 1124 patients included in the randomised REACT trial. Missed injuries were defined as injuries not diagnosed or suspected during initial clinical and radiological evaluation in the trauma room. We assessed the frequency, type, consequences and the phase in which the missed injuries were diagnosed and used univariate analysis to identify potential contributing factors. Results: Eight hundred and three patients were male, median age was 38 years and 1079 patients sustained blunt trauma. Overall, 122 injuries were missed in 92 patients (8.2%). Most injuries concerned the extremities. Sixteen injuries had an AIS grade of >= 3. Patients with missed injuries had significantly higher injury severity scores (ISSs) (median of 15 versus 5, p < 0.001). Factors associated with missed injuries were severe traumatic brain injury (GCS <= 8) and multitrauma (ISS >= 16). Seventy-two missed injuries remained undetected during tertiary survey (59%). In total, 31 operations were required for 26 initially missed injuries. Conclusion: Despite guidelines to avoid missed injuries, this problem is hard to prevent, especially in the severely injured. The present study showed that the rate of missed injuries was comparable with the literature and their consequences not severe. A high index of suspicion remains warranted, especially in multitrauma patients. (C) 2011 Elsevier Ltd. All rights reserved.	[Giannakopoulos, G. F.; Bloemers, F. W.; Bakker, F. C.] Vrije Univ Amsterdam Med Ctr, Dept Trauma Surg, NL-1007 MB Amsterdam, Netherlands; [Saltzherr, T. P.; Goslings, J. C.] Univ Amsterdam, Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands; [Beenen, L. F. M.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Reitsma, J. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	Giannakopoulos, GF (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Trauma Surg, Room 7F-004,POB 7057, NL-1007 MB Amsterdam, Netherlands.	gf.giannakopoulos@gmail.com	Bloemers, Frank/P-5436-2019; Beenen, Ludo F/AAA-3114-2021	Bloemers, Frank/0000-0002-8393-4946; Beenen, Ludo F/0000-0001-9204-1026	ZonMw, the Netherlands Organization for Health Research and DevelopmentNetherlands Organization for Health Research and DevelopmentNetherlands Government [3920.0005]	This study was part of the REACT trial which was sponsored by an unrestricted grant from ZonMw, the Netherlands Organization for Health Research and Development (Grant number 3920.0005).	Agostini C, 2008, J RADIOL, V89, P325, DOI 10.1016/S0221-0363(08)93007-9; *AM ASS AUT MED, 1985, ABBR INJ SCAL 1985 R; American College of Surgeons Committee on Trauma, 1994, ADV TRAUM LIF SUPP R, P17; Biffl WL, 2003, J TRAUMA, V54, P38, DOI 10.1097/00005373-200301000-00005; Brink M, 2008, AM J ROENTGENOL, V190, P1591, DOI 10.2214/AJR.07.3277; Brooks A, 2004, INJURY, V35, P407, DOI 10.1016/S0020-1383(03)00219-5; Buduhan G, 2000, J TRAUMA, V49, P600, DOI 10.1097/00005373-200010000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; ENDERSON BL, 1990, J TRAUMA, V30, P666, DOI 10.1097/00005373-199006000-00002; Goslings JC, 2006, J TRAUMA, V61, P111, DOI 10.1097/01.ta.0000222704.86560.ac; Hoff WS, 2004, J TRAUMA, V56, P291, DOI 10.1097/01.TA.0000105924.37441.31; Houshian S, 2002, J TRAUMA, V52, P715, DOI 10.1097/00005373-200204000-00018; Janjua KJ, 1998, J TRAUMA, V44, P1000, DOI 10.1097/00005373-199806000-00012; Jin PHFK, 2008, INJURY, V39, P83, DOI 10.1016/j.injury.2007.07.022; Kalemoglu M, 2006, MIL MED, V171, P598, DOI 10.7205/MILMED.171.7.598; Pfeifer R, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-20; REID DC, 1987, J TRAUMA, V27, P980, DOI 10.1097/00005373-198709000-00005; RIZOLI SB, 1994, ACCIDENT ANAL PREV, V26, P681, DOI 10.1016/0001-4575(94)90030-2; Robertson R, 1996, AM J SURG, V172, P564, DOI 10.1016/S0002-9610(96)00247-4; Saltzherr TP, 2008, BMC EMERG MED, V22, P8; Vles WJ, 2003, J AM COLL SURGEONS, V197, P596, DOI 10.1016/S1072-7515(03)00601-X	21	29	29	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2012	43	9					1517	1521		10.1016/j.injury.2011.07.012			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	977MK	WOS:000306666100034	21820114				2021-06-18	
J	Jerusalem, A; Dao, M				Jerusalem, Antoine; Dao, Ming			Continuum modeling of a neuronal cell under blast loading	ACTA BIOMATERIALIA			English	Article						Continuum model; Neuron; Blast; Cell damage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HUMAN HEAD; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; SHOCK HUGONIOT; IN-SITU; PRESSURE; IMPACT; DEFORMATION; BIOMECHANICS	Traumatic brain injuries have recently been put under the spotlight as one of the most important causes of accidental brain dysfunctions. Significant experimental and modeling efforts are thus underway to study the associated biological, mechanical and physical mechanisms. In the field of cell mechanics, progress is also being made at the experimental and modeling levels to better characterize many of the cell functions, including differentiation, growth, migration and death. The work presented here aims to bridge both efforts by proposing a continuum model of a neuronal cell submitted to blast loading. In this approach, the cytoplasm, nucleus and membrane (plus cortex) are differentiated in a representative cell geometry, and different suitable material constitutive models are chosen for each one. The material parameters are calibrated against published experimental work on cell nanoindentation at multiple rates. The final cell model is ultimately subjected to blast loading within a complete computational framework of fluid-structure interaction. The results are compared to the nanoindentation simulation, and the specific effects of the blast wave on the pressure and shear levels at the interfaces are identified. As a conclusion, the presented model successfully captures some of the intrinsic intracellular phenomena occurring during the cellular deformation under blast loading that potentially lead to cell damage. It suggests, more particularly, that the localization of damage at the nucleus membrane is similar to what has already been observed at the overall cell membrane. This degree of damage is additionally predicted to be worsened by a longer blast positive phase duration. In conclusion, the proposed model ultimately provides a new three-dimensional computational tool to evaluate intracellular damage during blast loading. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Jerusalem, Antoine] IMDEA Mat Inst, Madrid 28040, Spain; [Dao, Ming] MIT, Cambridge, MA 02139 USA	Jerusalem, A (corresponding author), IMDEA Mat Inst, C Prof Aranguren S-N, Madrid 28040, Spain.	antoine.jerusalem@imdea.org; mingdao@mit.edu	Dao, Ming/B-1602-2008	Dao, Ming/0000-0001-5372-385X; Jerusalem, Antoine/0000-0001-5026-8038	Spanish Ministry of Science and InnovationSpanish Government; European UnionEuropean Commission; Madrid Regional Government [ESTRUMAT-S2009/MAT-1585]; Cajal Blue Brain Project; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL094270]; Infectious Disease Interdisciplinary Research Group of the SMART Center; Singapore-MIT Alliance (SMA)Singapore-MIT Alliance for Research & Technology Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL094270] Funding Source: NIH RePORTER	The authors thank Prof. Subra Suresh for his insightful guidance and suggestions. The authors are also grateful to Javier Rodriguez, of Principia, for his immeasurable help with Abaqus. A.J. acknowledges support from the Juan de la Cierva grant from the Spanish Ministry of Science and Innovation, from the Amarout grant from the European Union, from the ESTRUMAT-S2009/MAT-1585 grant (Madrid Regional Government), and from the Cajal Blue Brain Project. M.D. acknowledges support from the National Institutes of Health (NIH) Grant R01HL094270, Infectious Disease Interdisciplinary Research Group of the SMART Center, and the Computational Systems Biology Programme of the Singapore-MIT Alliance (SMA).	Abolfathi N, 2008, International Journal of Modelling and Simulation, V28, P470; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; Alley Matthew David, 2009, THESIS PURDUE U; Ayton GS, 2010, SEMIN CELL DEV BIOL, V21, P357, DOI 10.1016/j.semcdb.2009.11.011; Barnes PD, 2008, SEMIN PEDIATR NEUROL, V15, P178, DOI 10.1016/j.spen.2008.10.009; Barron T. H. K., 1999, HEAT CAPACITY THERMA; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; BETT KE, 1965, NATURE, V207, P620, DOI 10.1038/207620a0; BOEHLER R, 1977, J APPL PHYS, V48, P4183, DOI 10.1063/1.323455; Caille N, 2002, J BIOMECH, V35, P177, DOI 10.1016/S0021-9290(01)00201-9; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Christou G, 2010, INT J IMPACT ENG, V47, P48; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Dao M, 2006, MAT SCI ENG C-BIO S, V26, P1232, DOI 10.1016/j.msec.2005.08.020; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deriu MA, J BIOMECH IN PRESS; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Dintwa E, 2011, J FOOD ENG, V103, P265, DOI 10.1016/j.jfoodeng.2010.10.023; Drumheller D.S., 1998, INTRO WAVE PROPAGATI; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Flaherty B, 2007, CELL BIOCHEM BIOPHYS, V49, P14, DOI 10.1007/s12013-007-0045-2; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Gladilin E, 2007, PHYS BIOL, V4, P104, DOI 10.1088/1478-3975/4/2/004; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360; Guillaume AI, 2002, AVIAT SPACE ENVIR MD, V73, P171; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Holzapfel G., 2000, NONLINEAR SOLID MECH; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hu LL, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356107; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Jean RP, 2005, J BIOMECH ENG-T ASME, V127, P594, DOI 10.1115/1.1933997; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaliske M, 1997, COMPUT MECH, V19, P228, DOI 10.1007/s004660050171; Kamm RD, 2000, ASME INT C MECH BIOL, V242, P1; Karcher H, 2003, BIOPHYS J, V85, P3336, DOI 10.1016/S0006-3495(03)74753-5; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lee KYK, 2011, NEUROIMAGE, V54, pS30, DOI 10.1016/j.neuroimage.2010.05.042; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li J, 2007, P NATL ACAD SCI USA, V104, P4937, DOI 10.1073/pnas.0700257104; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mandadapu KK, 2008, J BIOMECH, V41, P1467, DOI 10.1016/j.jbiomech.2008.02.014; Marc A.M., 1994, DYNAMIC BEHAV MAT; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McGarry J G, 2004, Eur Cell Mater, V7, P27; McGarry JP, 2009, ANN BIOMED ENG, V37, P2317, DOI 10.1007/s10439-009-9772-4; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; Miller P, 2010, J MECH BEHAV BIOMED, V3, P268, DOI 10.1016/j.jmbbm.2009.11.001; Mofrad M. R., 2006, CYTOSKELETAL MECH MO; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moreo P, 2008, ACTA BIOMATER, V4, P613, DOI 10.1016/j.actbio.2007.10.014; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Motherway J, 2009, Leg Med (Tokyo), V11 Suppl 1, pS220, DOI 10.1016/j.legalmed.2009.01.072; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Nagayama K, 2006, SHOCK WAVES, V15, P267, DOI 10.1007/s00193-006-0030-5; Nagayama K, 2002, J APPL PHYS, V91, P476, DOI 10.1063/1.1421630; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ofek G, 2009, J BIOMECH, V42, P873, DOI 10.1016/j.jbiomech.2009.01.024; Peeters EAG, 2005, J BIOMECH ENG-T ASME, V127, P237, DOI 10.1115/1.1865198; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Quinn DJ, 2011, ANN BIOMED ENG, V39, P1041, DOI 10.1007/s10439-010-0232-y; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Salvador-Silva M, 2004, GLIA, V45, P364, DOI 10.1002/glia.10342; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Simulia, 2010, AB 6 10; Slomka N, 2010, J BIOMECH, V43, P1806, DOI 10.1016/j.jbiomech.2010.02.011; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suzuki H, 2007, J MAMMAL OVA RES, V24, P107; Taylor RL, 1970, INT J NUMER METH ENG, V2, P45, DOI [10.1002/nme.1620020106, DOI 10.1002/NME.1620020106]; Vaziri A, 2006, J MATER RES, V21, P2126, DOI 10.1557/JMR.2006.0262; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Willinger R, 2000, J SOUND VIB, V235, P611, DOI 10.1006/jsvi.1999.2931; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Willinger R, 2001, INT J CRASHWORTHINES, V6, P281, DOI 10.1533/cras.2001.0178; Yan KC, 2010, J BIOMECH, V43, P1031, DOI 10.1016/j.jbiomech.2009.12.018; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017; Young J, 2010, J BIOMECH, V43, P210, DOI 10.1016/j.jbiomech.2009.09.025; Zhang CY, 2007, PHILOS MAG, V87, P3415, DOI 10.1080/14786430701288094; Zhang CY, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021912; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Ziegler L, 2010, EXP NEUROL, V223, P119, DOI 10.1016/j.expneurol.2009.09.019	111	29	29	2	44	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	SEP	2012	8	9					3360	3371		10.1016/j.actbio.2012.04.039			12	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	990JD	WOS:000307625900018	22562014	Green Accepted			2021-06-18	
J	Youn, YA; Kim, SJ; Sung, IK; Chung, SY; Kim, YH; Lee, IG				Youn, Y. A.; Kim, S. J.; Sung, I. K.; Chung, S. Y.; Kim, Y. H.; Lee, I. G.			Serial Examination of Serum IL-8, IL-10 and IL-1Ra Levels is Significant in Neonatal Seizures Induced by Hypoxic-Ischaemic Encephalopathy	SCANDINAVIAN JOURNAL OF IMMUNOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; RECEPTOR ANTAGONIST; INTERLEUKIN-6; CYTOKINES; CHILDREN; EPILEPSY; PLASMA	We investigated changes in the levels of significant cytokines in relation to neonatal seizures, a pattern of cytokine concentrations serially and the severity of brain insult. The hypoxicischaemic encephalopathy-induced seizure group consisted of 13 patients, and another 15 normal newborns were enrolled as a control group. All of the initial samples were obtained within the first 24 h of admission, and the second samples were obtained between 48 and 72 h in both groups. Only the third samples were taken in the seizure group on the 5th day. During neonatal seizures, the levels of most cytokines increased within 24 h, and, in particular, the levels of interleukin (IL)-8 significantly increased (P < 0.05). After 4872 h of seizure onset, the levels of most cytokines decreased, especially, IL-1Ra; however, IL-8 and IL-10 remained increased (P < 0.05). During the prognosis, one patient who was diagnosed with quadriplegic cerebral palsy at 6 months of age presented extreme elevation of IL-1beta, IL-1Ra, IL-6, IL-8, IL-10 and tumor necrosis factor-alpha in the initial sample, reflecting the severity of brain damage. A significant increase in IL-8 may serve as a biomarker for earlier detection of brain damage in neonatal seizure, if detected within 24 and 4872 h of the seizure.	[Lee, I. G.] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Pediat, Seoul 137701, South Korea; [Chung, S. Y.] Catholic Univ Korea, Incheon St Marys Hosp, Dept Pediat, Kyonggi Do, South Korea; [Chung, S. Y.; Kim, Y. H.] Catholic Univ Korea, Coll Med, Kyonggi Do, South Korea; [Kim, Y. H.] Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Pediat, Kyonggi Do, South Korea	Lee, IG (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Pediat, 505 Banpo Dong, Seoul 137701, South Korea.	lea732@hanmail.net					Alapirtti T, 2009, J NEUROL SCI, V280, P94, DOI 10.1016/j.jns.2009.02.355; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Asano T, 2010, SCAND J IMMUNOL, V71, P447, DOI 10.1111/j.1365-3083.2010.02391.x; Bartha AI, 2004, PEDIATR RES, V56, P960, DOI 10.1203/01.PDR.0000144819.45689.BB; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Ergenekon E, 2004, BRAIN DEV-JPN, V26, P283, DOI 10.1016/S0387-7604(03)00166-9; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Giulian D, 2004, NEUROBIOLOGY CENTRAL; Godukhin O V, 2009, Neurosci Behav Physiol, V39, P625, DOI 10.1007/s11055-009-9187-6; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Jeannin P, 1996, J IMMUNOL, V156, P3159; KIMELBERG HK, 1994, NEUROBIOLOGY CENTRAL, P193; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MULLER R, 1979, J MED, V10, P307; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; PANAYIOTOPOULOS CP, 2005, EPILEPSIES SEIZURE S; Peltola J, 1998, EPILEPSY RES, V31, P129, DOI 10.1016/S0920-1211(98)00024-2; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Silveira RC, 2003, J PEDIATR-US, V143, P625, DOI 10.1067/S0022-3476(03)00531-6; Sinha S, 2008, EPILEPSY RES, V82, P171, DOI 10.1016/j.eplepsyres.2008.07.018; Soares HD, 1995, J NEUROSCI, V15, P8223; Swaiman KF, 2006, PEDIAT NEUROLOGY PRI; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; VOLPE JJ, 2008, NEONATAL SEIZURES NE; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	33	29	33	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-9475			SCAND J IMMUNOL	Scand. J. Immunol.	SEP	2012	76	3					286	293		10.1111/j.1365-3083.2012.02710.x			8	Immunology	Immunology	996MV	WOS:000308094200011	22537067	Bronze			2021-06-18	
J	Ahmad, A; Khan, MM; Javed, H; Raza, SS; Ishrat, T; Khan, MB; Safhi, MM; Islam, F				Ahmad, Ajmal; Khan, Mohd. Moshahid; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, M. Badruzzaman; Safhi, Mohammed M.; Islam, Fakhrul			Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Oxidative stress; Cerebral ischemia; Antioxidant; Apoptosis; Neuroprotection	TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; NEUROCHEMICAL CHANGES; ANTIOXIDANT; STROKE; DAMAGE; REPERFUSION; PROTECTS; NEURONS; MICE	Stroke is a life-threatening disease with major cause of mortality and morbidity worldwide. The neuronal damage following cerebral ischemia is a serious risk to stroke patients. Oxidative stress and apoptotic damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The objective of this study was to test the hypothesis that administration of edaravone (Edv) maintains antioxidant status in brain, improves the cholinergic dysfunction and suppresses the progression of apoptosis response in rat. To test this hypothesis, male Wistar rats were subjected to middle cerebral artery occlusion (MCAO) of 2 h followed by reperfusion for 22 h. Edv was administered (10 mg/kg bwt) intraperitoneally 30 min before the onset of ischemia and 1 h after reperfusion. After reperfusion, rats were tested for neurobehavioral activities and were sacrificed for the infarct volume, estimation of oxidative damage markers. Edv treatment significantly reduced ischemic lesion volume, improved neurological deficits, contended oxidative loads, and suppressed apoptotic damage. In conclusion, treatment with Edv ameliorated the neurological and histological outcomes with elevated endogenous anti-oxidants status as well as reduced induction of apoptotic responses in MCA occluded rat. We theorized that Edv is among the pharmacological agents that reduce free radicals and its associated cholinergic dysfunction and apoptotic damage and have been found to limit the extent of brain damage following stroke.	[Ahmad, Ajmal; Khan, Mohd. Moshahid; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, M. Badruzzaman; Islam, Fakhrul] Jamia Hamdard, Neurotoxicol Lab, Dept Med Elementol & Toxicol, Fund Improvement Sci & Technology DST, New Delhi 110062, India; [Ahmad, Ajmal; Khan, Mohd. Moshahid; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, M. Badruzzaman; Islam, Fakhrul] Jamia Hamdard, Special Assistance Programme UGC Sponsored, New Delhi 110062, India; [Ahmad, Ajmal] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA; [Khan, Mohd. Moshahid] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Ishrat, Tauheed] Univ Georgia, Dept Clin & Adm Pharm, Augusta, GA 30912 USA; [Safhi, Mohammed M.; Islam, Fakhrul] Jazan Univ, Fac Pharm, Neurosci & Toxicol Unit, Jazan, Saudi Arabia	Islam, F (corresponding author), Jamia Hamdard, Neurotoxicol Lab, Dept Med Elementol & Toxicol, Fund Improvement Sci & Technology DST, New Delhi 110062, India.	fislam2001@yahoo.co.in	Ahmad, Ajmal/AAY-6018-2020; Raza, Syed Shadab/AAE-5185-2019	Raza, Syed Shadab/0000-0002-6147-9399; Javed, Hayate/0000-0003-0767-2830; Khan, Mohammad Moshahid/0000-0003-4679-294X	Department of Ayurveda, Yoga and Naturalpathy, Unani, Siddha and Homeopath (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi	Authors are thankful to the Department of Ayurveda, Yoga and Naturalpathy, Unani, Siddha and Homeopath (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi for financial assistance. The authors wish to thanks Mr. Dharamvir Singh for his assistance.	Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chang Chia-Yu, 2009, Acta Neurol Taiwan, V18, P231; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; Cheung RTF, 2003, J PINEAL RES, V34, P153, DOI 10.1034/j.1600-079X.2003.00034.x; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Faraci FM, 2006, J APPL PHYSIOL, V100, P739, DOI 10.1152/japplphysiol.01044.2005; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Imam SZ, 2000, BRAIN RES, V855, P186, DOI 10.1016/S0006-8993(99)02249-0; Ishrat T, 2009, EUR NEUROPSYCHOPHARM, V19, P636, DOI 10.1016/j.euroneuro.2009.02.002; Islam F, 2002, BIOL TRACE ELEM RES, V90, P203, DOI 10.1385/BTER:90:1-3:203; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jiao L, 2011, NEUROSCIENCE, V182, P177, DOI 10.1016/j.neuroscience.2011.01.017; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Khan MM, 2010, CHEM-BIOL INTERACT, V183, P255, DOI 10.1016/j.cbi.2009.10.003; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; LEVINE S, 1960, AM J PATHOL, V36, P1; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masuo Y, 1997, BRAIN RES PROTOC, V1, P321, DOI 10.1016/S1385-299X(97)00005-6; MOHANDAS J, 1984, CANCER RES, V44, P5086; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Racay P, 2009, CELL MOL NEUROBIOL, V29, P901, DOI 10.1007/s10571-009-9373-7; Saleem S, 2006, J MED FOOD, V9, P246, DOI 10.1089/jmf.2006.9.246; Sarkar S, 2006, MECH AGEING DEV, V127, P391, DOI 10.1016/j.mad.2005.12.010; Sasaki T, 2006, J NEUROSCI RES, V84, P1187, DOI 10.1002/jnr.21036; SCHWARTING RKW, 1991, BRAIN RES, V554, P46, DOI 10.1016/0006-8993(91)90170-Z; Shah MK, 2010, J MAGN RESON IMAGING, V32, P796, DOI 10.1002/jmri.22302; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Utley HC, 1967, ARCH BIOCHEM BIOPHYS, V260, P521; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Yamamoto Y, 2009, REDOX REP, V14, P251, DOI 10.1179/135100009X12525712409779; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; ZAHEER N, 1965, ARCH BIOCHEM BIOPHYS, V109, P646; Zeevalk GD, 1998, DEV NEUROSCI-BASEL, V20, P444, DOI 10.1159/000017342; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117	45	29	40	0	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	AUG	2012	367	1-2					215	225		10.1007/s11010-012-1335-6			11	Cell Biology	Cell Biology	964GX	WOS:000305683100022	22648734				2021-06-18	
J	Bajor, M; Michaluk, P; Gulyassy, P; Kekesi, AK; Juhasz, G; Kaczmarek, L				Bajor, Malgorzata; Michaluk, Piotr; Gulyassy, Peter; Kekesi, Adrienna Katalin; Juhasz, Gabor; Kaczmarek, Leszek			Synaptic cell adhesion molecule-2 and collapsin response mediator protein-2 are novel members of the matrix metalloproteinase-9 degradome	JOURNAL OF NEUROCHEMISTRY			English	Article						CRMP-2; degradome; MMP-9; proteolysis; synaptoneurosomes; SynCAM-2	LONG-TERM POTENTIATION; MATRIX METALLOPROTEINASE-2 AND-9; GENE KNOCK-OUT; RAT-BRAIN; EPILEPTIC SEIZURES; NEURONAL DEATH; RECEPTOR; CRMP-2; MMP-9; PHOSPHORYLATION	J. Neurochem. (2012) 122, 775788. Abstract The elucidation of entire sets of protease substrates (proteodegradomes) is important for understanding proteolytic pathways, their networks, and their role in the regulation of cell function. Matrix metalloproteinase-9 (MMP-9) is an extracellularly operating protease that is expressed and released in the brain in response to enhanced neuronal activity. Under physiological conditions, MMP-9 is involved in neuronal plasticity, including long-term potentiation, learning, and memory. This function may be related to its activity at the synapse. Under pathological conditions (e.g., during excitotoxicity, stroke, and traumatic brain injury), when the concentration of glutamate is persistently increased, MMP-9 is detrimental to brain tissue. To assess the MMP-9 degradome, we used synaptoneurosomal fractions isolated from the hippocampus of wildtype and MMP-9 knockout mice. To induce MMP-9 activity, the synaptoneurosomal fractions were treated with 50 mu M glutamate for 30 min at 37 degrees C. To investigate MMP-9 targets, two-dimensional fluorescence difference gel electrophoresis was performed. This approach enabled the accurate analysis of differences in protein abundance between samples. The differential spots that contained potential MMP-9 substrates were excised from the gel, and proteins of interest were identified using mass spectrometry. Two novel MMP-9 targets were identified: synaptic cell adhesion molecule-2 and collapsin response mediator protein-2. The MMP-9-driven processing of the newly identified substrates was confirmed by western blot in primary hippocampal neurons after stimulation with either N-methyl-D-aspartate or glutamate or incubation with recombinant autoactivating MMP-9 and use of a specific inhibitor.	[Bajor, Malgorzata; Michaluk, Piotr; Kaczmarek, Leszek] Nencki Inst, Neurobiol Lab, Warsaw, Poland; [Gulyassy, Peter; Kekesi, Adrienna Katalin; Juhasz, Gabor] Eotvos Lorand Univ, Lab Prote, Budapest, Hungary	Bajor, M (corresponding author), Nencki Inst, Neurobiol Lab, Warsaw, Poland.	m.bajor@nencki.gov.pl; l.kaczmarek@nencki.gov.pl	Kekesi, Katalin Adrienna A/H-3484-2017; Juhasz, Gabor/I-7781-2017; Michaluk, Piotr/AAR-5238-2021; Kaczmarek, Leszek/B-6171-2008	Kekesi, Katalin Adrienna A/0000-0003-3042-4878; Juhasz, Gabor/0000-0002-0849-6931; Michaluk, Piotr/0000-0003-2306-3314; Kaczmarek, Leszek/0000-0002-7207-3490; Bajor, Malgorzata/0000-0001-5778-0165	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [HEALTH-F2-2009-223524]; International Brain Research Organization	We thank Adam Gorlewicz for help preparing the electron microscopy specimens, Attila Simor and Jewgeni Nikolaev for help with the statistical analysis, and Emilia Rejmak for help with synaptoneurosome preparation. We also thank Prof. Czeslaw Cierniewski who provided substantial support during the initial stage of the project. This work was supported by the European Commission's Seventh Framework Programme (FP7) through project "Plasticise: Promotion of plasticity as a treatment for neurodegenerative conditions'' (grant agreement HEALTH-F2-2009-223524) to L. K. and an InEurope Short Stay Grant from the International Brain Research Organization to M. B. The authors have no conflict of interest to declare.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Asahi M, 2001, J NEUROSCI, V21, P7724; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; BENAVIDES J, 1988, J NEUROSCI, V8, P3607; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cauwe B, 2009, INTEGR BIOL-UK, V1, P404, DOI 10.1039/b904701h; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; Czech T, 2004, NEUROCHEM RES, V29, P2189, DOI 10.1007/s11064-004-7025-3; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Dominguez R, 2007, J NEUROCHEM, V101, P232, DOI 10.1111/j.1471-4159.2006.04360.x; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Emes RD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00044; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Franken S, 2003, J BIOL CHEM, V278, P3241, DOI 10.1074/jbc.M210181200; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010; Klemmer P, 2009, J PROTEOMICS, V72, P82, DOI 10.1016/j.jprot.2008.10.005; Kovacs Z, 2011, NEUROCHEM INT, V59, P563, DOI 10.1016/j.neuint.2011.06.016; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Mizoguchi H, 2008, J PHARMACOL SCI, V106, P9, DOI 10.1254/jphs.FM0070139; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Noble LJ, 2002, J NEUROSCI, V22, P7526; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Shinomura T, 1999, ANESTH ANALG, V88, P1401, DOI 10.1097/00000539-199906000-00037; Takacs E, 2010, NEUROCHEM INT, V56, P799, DOI 10.1016/j.neuint.2010.03.003; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Troca-Marin JA, 2010, MOL CELL NEUROSCI, V43, P308, DOI 10.1016/j.mcn.2009.12.004; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wright JW, 2009, BEHAV BRAIN RES, V203, P27, DOI 10.1016/j.bbr.2009.04.014; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	79	29	30	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2012	122	4					775	788		10.1111/j.1471-4159.2012.07829.x			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	974ZH	WOS:000306475700012	22694054	Bronze			2021-06-18	
J	Lehto, LJ; Sierra, A; Corum, CA; Zhang, JJ; Idiyatullin, D; Pitkanen, A; Garwood, M; Grohn, O				Lehto, Lauri Juhani; Sierra, Alejandra; Corum, Curtis Andrew; Zhang, Jinjin; Idiyatullin, Djaudat; Pitkanen, Asla; Garwood, Michael; Grohn, Olli			Detection of calcifications in vivo and ex vivo after brain injury in rat using SWIFT	NEUROIMAGE			English	Article						SWIFT; Phase contrast; Brain calcification; Ultra short echo-time	LATERAL FLUID-PERCUSSION; MAGNETIC-RESONANCE; INTRACRANIAL CALCIFICATION; MRI; ACCUMULATION; LESIONS; IMAGES; DIFFERENTIATION; RECONSTRUCTION; MICROBLEEDS	Calcifications represent one component of pathology in many brain diseases. With MRI, they are most often detected by exploiting negative contrast in magnitude images. Calcifications are more diamagnetic than tissue, leading to a magnetic field disturbance that can be seen in phase MR images. Most phase imaging studies use gradient recalled echo based pulse sequences. Here, the phase component of SWIFT, a virtually zero acquisition delay sequence, was used to detect calcifications ex vivo and in vivo in rat models of status epilepticus and traumatic brain injury. Calcifications were detected in phase and imaginary SWIFT images based on their dipole like magnetic field disturbances. In magnitude SWIFT images, calcifications were distinguished as hypointense and hyperintense. Hypointense calcifications showed large crystallized granules with few surrounding inflammatory cells, while hyperintense calcifications contained small granules with the presence of more inflammatory cells. The size of the calcifications in SWIFT magnitude images correlated with that in Alizarin stained histological sections. Our data indicate that SWIFT is likely to better preserve signal in the proximity of a calcification or other field perturber in comparison to gradient echo due to its short acquisition delay and broad excitation bandwidth. Furthermore, a quantitative description for the phase contrast near dipole magnetic field inhomogeneities for the SWIFT pulse sequence is given. In vivo detection of calcifications provides a tool to probe the progression of pathology in neurodegenerative diseases. In particular, it appears to provide a surrogate marker for inflammatory cells around the calcifications after brain injury. (C) 2012 Elsevier Inc. All rights reserved.	[Corum, Curtis Andrew; Zhang, Jinjin; Idiyatullin, Djaudat; Garwood, Michael] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Sch Med, Minneapolis, MN 55455 USA; [Lehto, Lauri Juhani; Sierra, Alejandra; Pitkanen, Asla; Grohn, Olli] Univ Eastern Finland, Dept Neurobiol, Biomed Imaging Unit, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Corum, CA (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Sch Med, 2021 6th St SE, Minneapolis, MN 55455 USA.	corum@cmrr.umn.edu	Idiyatullin, Djaudat/J-5994-2012; Corum, Curtis/A-7520-2016	Idiyatullin, Djaudat/0000-0002-0942-3208; Sierra Lopez, Alejandra/0000-0001-5399-2056; Corum, Curtis/0000-0002-4994-6206	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41 RR008079, P30 NS057091, R21 CA139688, S10 RR023730]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA139688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR008079, S10RR023730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS057091] Funding Source: NIH RePORTER	We thank Maarit Pulkkinen for her invaluable help in handling the histology, Jarmo Hartikainen for his help with the disease models, and Ryan Chamberlain and Rajesh Venkataraman for the use of high performance gridding code for image reconstruction. We would also like to thank Doctoral Program in Molecular Medicine at University of Eastern Finland, Emil Aaltonen Foundation, Academy of Finland and the strategic funding of the University of Eastern Finland (UEF-Brain). Additional funds were provided by NIH grants, P41 RR008079, P30 NS057091, R21 CA139688, and S10 RR023730.	ANSARI MQ, 1990, PEDIATR NEUROL, V6, P94, DOI 10.1016/0887-8994(90)90041-X; ARNOLD MM, 1991, POSTGRAD MED J, V67, P147, DOI 10.1136/pgmj.67.784.147; AVRAHAMI E, 1994, J NEUROL, V241, P381, DOI 10.1007/BF02033355; Beatty PJ, 2005, IEEE T MED IMAGING, V24, P799, DOI 10.1109/TMI.2005.848376; BERGIN CJ, 1991, RADIOLOGY, V179, P777, DOI 10.1148/radiology.179.3.2027991; Caldemeyer KS, 1997, AM J NEURORADIOL, V18, P107; Carl M, 2012, MAGN RESON MED, V67, P991, DOI 10.1002/mrm.23075; Cervos-Navarro J., 1991, J NEUROL SCI, V103, P3; Chan CF, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-17; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Corum C.A., 2005, NUCL MAGNETIC RESONA; Corum C.A., 2010, P 18 ANN M ISMRM STO, P5113; DEMER LL, 1994, TRENDS CARDIOVAS MED, V4, P45, DOI 10.1016/1050-1738(94)90025-6; Du JA, 2011, MAGN RESON MED, V65, P1013, DOI 10.1002/mrm.22682; Gayoso MJ, 2003, HISTOL HISTOPATHOL, V18, P855, DOI 10.14670/HH-18.855; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gupta RK, 2001, J COMPUT ASSIST TOMO, V25, P698, DOI 10.1097/00004728-200109000-00006; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HAFNER S, 1994, MAGN RESON IMAGING, V12, P1047, DOI 10.1016/0730-725X(94)91236-P; HENKELMAN RM, 1991, RADIOLOGY, V179, P199, DOI 10.1148/radiology.179.1.1848714; Idiyatullin D, 2008, J MAGN RESON, V193, P267, DOI 10.1016/j.jmr.2008.05.009; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; Idiyatullin D, 2011, J ENDODONT, V37, P745, DOI 10.1016/j.joen.2011.02.022; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LAFRENIERE GF, 1992, BRAIN RES BULL, V28, P825, DOI 10.1016/0361-9230(92)90268-3; Lauzon ML, 1996, MAGNET RESON MED, V36, P940, DOI 10.1002/mrm.1910360617; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; MACDONALD HL, 1986, BRIT J RADIOL, V59, P355, DOI 10.1259/0007-1285-59-700-355; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Nissi M., 2010, P 18 ANN M ISMRM STO, P5113; NITSCH C, 1992, ACTA NEUROPATHOL, V85, P55, DOI 10.1007/BF00304634; OKUCHI K, 1992, NEURORADIOLOGY, V34, P328, DOI 10.1007/BF00588194; Oliveira A, 2003, EXP NEUROL, V179, P127, DOI 10.1016/S0014-4886(02)00012-2; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PARISI J, 1988, CAN J NEUROL SCI, V15, P152, DOI 10.1017/S0317167100027530; Park JY, 2012, MAGN RESON MED, V67, P428, DOI 10.1002/mrm.23026; Park JY, 2009, MAGN RESON MED, V61, P175, DOI 10.1002/mrm.21822; Park JY, 2006, MAGN RESON MED, V55, P848, DOI 10.1002/mrm.20821; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rahmer J, 2006, MAGN RESON MED, V55, P1075, DOI 10.1002/mrm.20868; Rauscher A, 2003, J MAGN RESON IMAGING, V18, P175, DOI 10.1002/jmri.10346; Rodriguez MJ, 2001, NEUROBIOL DIS, V8, P59, DOI 10.1006/nbdi.2000.0332; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Sandner G, 2010, NEUROIMAGE, V53, P44, DOI 10.1016/j.neuroimage.2010.06.007; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Seevinck PR, 2011, MAGN RESON MED, V65, P146, DOI 10.1002/mrm.22594; SHIROTANI T, 1994, J CEREBR BLOOD F MET, V14, P831, DOI 10.1038/jcbfm.1994.104; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; SILVER MS, 1985, PHYS REV A, V31, P2753, DOI 10.1103/PhysRevA.31.2753; Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010.abs; Watanabe H, 1998, J CEREBR BLOOD F MET, V18, P686, DOI 10.1097/00004647-199806000-00011; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373; Zhou R, 2010, MAGN RESON MED, V63, P1154, DOI 10.1002/mrm.22378; Zhu WZ, 2008, CHINESE MED J-PEKING, V121, P2021, DOI 10.1097/00029330-200810020-00014	59	29	29	0	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUL 16	2012	61	4					761	772		10.1016/j.neuroimage.2012.03.002			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	967PP	WOS:000305920600002	22425671	Green Accepted			2021-06-18	
J	Lucca, JJD; Chavko, M; Dubick, MA; Adeeb, S; Falabella, MJ; Slack, JL; McCarron, R; Li, YS				Lucca, Jurandir J. Dalle; Chavko, Mikulas; Dubick, Michael A.; Adeeb, Saleena; Falabella, Michael J.; Slack, Jessica L.; McCarron, Richard; Li, Yansong			Blast-induced moderate neurotrauma (BINT) elicits early complement activation and tumor necrosis factor alpha (TNF alpha) release in a rat brain	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Blast overpressure; Blast-induced neurotrauma; Complement activation; Edema; Inflammatory cytokine; Leukocyte infiltration	MEMBRANE ATTACK; INJURY; EXPRESSION; CONTUSION; INCREASE; EDEMA; CELLS; FLUID; C3	Blast-induced neurotrauma (BINT) is a major medical concern yet its etiology is largely undefined. Complement activation may play a role in the development of secondary injury following traumatic brain injury; however, its role in BINT is still undefined. The present study was designed to characterize the complement system and adaptive immune-inflammatory responses in a rat model of moderate BINT. Anesthetized rats were exposed to a moderate blast (120 kPa) using an air-driven shock tube. Brain tissue injury, systemic and local complement, cerebral edema, inflammatory cell infiltration, and pro-inflammatory cytokine production were measured at 0.5, 3, 48, 72, 120, and 168 h. Injury to brain tissue was evaluated by histological evaluation. Systemic complement was measured via ELSIA. The remaining measurements were determined by immunohistoflourescent staining. Moderate blast triggers moderate brain injuries, elevated levels of local brain C3/C5b-9 and systemic C5b-9, increased leukocyte infiltration, unregulated tumor necrosis factor alpha (TNF alpha), and aquaporin-4 in rat brain cortex at 3- and 48-hour post blast. Early immune-inflammatory response to BINT involves complement and TNF alpha, which correlates with hippocampus and cerebral cortex damage. Complement and TNF alpha activation may be a novel therapeutic target for reducing the damaging effects of BINT inflammation. Published by Elsevier B.V.	[Lucca, Jurandir J. Dalle; Dubick, Michael A.; Falabella, Michael J.; Slack, Jessica L.; Li, Yansong] USA, Inst Surg Res, Immunomodulat Trauma Program, Ft Sam Houston, TX 78234 USA; [Chavko, Mikulas; Adeeb, Saleena; McCarron, Richard] USN, Dept Trauma & Resuscitat Med, Med Res Ctr, Silver Spring, MD 20910 USA	Lucca, JJD (corresponding author), USA, Inst Surg Res, Immunomodulat Trauma Program, 3650 Chambers Pass,BHT2,Bldg 3610, Ft Sam Houston, TX 78234 USA.	Jurandir.dallelucca@us.army.mil			Defense Medical Research and Development Program (DMRDP); US Army Medical Research and Materiel Command Combat Casualty Care Research ProgramU.S. Army Medical Research & Materiel Command (USAMRMC); Office of Naval ResearchOffice of Naval Research	This study was funded by the Defense Medical Research and Development Program (DMRDP) and US Army Medical Research and Materiel Command Combat Casualty Care Research Program and the Office of Naval Research.	Alexander JJ, 2003, BBA-MOL BASIS DIS, V1639, P169, DOI 10.1016/j.bbadis.2003.09.005; Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Arumugam TV, 2009, NEUROSCIENCE, V158, P1074, DOI 10.1016/j.neuroscience.2008.07.015; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Defense Manpower Data Center [internet], 2008, GLOB WAR TERR CAS RE; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ingersoll SA, 2010, MOL IMMUNOL, V48, P219, DOI 10.1016/j.molimm.2010.08.007; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mellor SG, 1998, BR J HOSP MED, V39, P536; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Schmidt OI., 2004, EUR J TRAUMA, V30, P135, DOI [10.1007/s00068-004-1394-9, DOI 10.1007/S00068-004-1394-9]; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Surbatovic M, 2007, MIL MED, V172, P190, DOI 10.7205/MILMED.172.2.190; Tenuta Joachim J, 2006, J Am Acad Orthop Surg, V14, pS45; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-24; Weeks C, 2007, CLIN IMMUNOL, V124, P311, DOI 10.1016/j.clim.2007.05.010; WOOD A, 1993, J NEUROSCI, V13, P3319	35	29	29	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUL 15	2012	318	1-2					146	154		10.1016/j.jns.2012.02.002			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	964BK	WOS:000305668500025					2021-06-18	
J	Kim, J; Whyte, J; Patel, S; Europa, E; Wang, JJ; Coslett, HB; Detre, JA				Kim, Junghoon; Whyte, John; Patel, Sunil; Europa, Eduardo; Wang, Jiongjiong; Coslett, H. Branch; Detre, John A.			Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study	PSYCHOPHARMACOLOGY			English	Article						Methylphenidate; Traumatic brain injury; CBF; fMRI; Sustained attention; Working memory	CEREBRAL-BLOOD-FLOW; DIFFEOMORPHIC IMAGE REGISTRATION; DEFICIT HYPERACTIVITY DISORDER; POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY; COGNITIVE TASK; ORAL METHYLPHENIDATE; MAGNETIC-RESONANCE; CONTROLLED-TRIAL; VISUAL-CORTEX	Methylphenidate (MPH), the most widely prescribed psychostimulant to treat many neuropsychiatric conditions, is reported to improve attention and speed of processing in survivors of traumatic brain injury (TBI). The neural correlate of this efficacy, however, remains unclear. Using perfusion functional magnetic resonance imaging (fMRI) as a biomarker of regional neural activity, the current study aimed to examine the neural correlates of single-dose (0.3 mg/kg) MPH administration in a randomized double-blind placebo-controlled crossover study design. Twenty-three individuals with moderate to severe TBI were tested on two occasions approximately 1 week apart. Perfusion fMRI scanning was carried out at rest and while participants performed cognitive tasks requiring sustained attention and working memory. Behaviorally, MPH significantly improved both accuracy and reaction time (RT) in the sustained attention task but only RT in the working memory task. A trend of global reduction of cerebral blood flow by MPH was observed in all task conditions including resting. Voxel-wise whole-brain analysis revealed an interaction effect of drug by condition (MPH-placebo X task-rest) for the sustained attention task in the left posterior superior parietal cortex and parieto-occipital junction (BA 7/19). The magnitude of drug-related deactivation of this area during task performance was correlated with improvement in RT. Suppression of activity in this area during task performance may reflect a compensatory mechanism by which MPH ameliorates attention impairments in TBI.	[Kim, Junghoon; Whyte, John; Patel, Sunil; Europa, Eduardo] Moss Rehabil Res Inst, Albert Einstein Healthcare Network, Elkins Pk, PA 19027 USA; [Wang, Jiongjiong] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Coslett, H. Branch; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA	Kim, J (corresponding author), Moss Rehabil Res Inst, Albert Einstein Healthcare Network, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	kimj@einstein.edu	Kim, Junghoon John/I-6702-2019; Wang, Danny JJ/O-2482-2018; Kim, Junghoon/A-6669-2012	Kim, Junghoon John/0000-0001-5729-8993; Wang, Danny JJ/0000-0002-0840-7062; Whyte, John/0000-0002-4381-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24HD39621, R24HD050836, P30NS045839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039621, R24HD050836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045839] Funding Source: NIH RePORTER	The authors wish to thank Kathy Z. Tang, B. A.; John Slattery, B. A.; Geoffrey K. Aguirre, MD, Ph.D.; Daniel Kimberg, Ph.D.; John Pluta, B. S.; and Allen Osman, Ph.D. for their help with subject recruitment, data analysis, and manuscript review. The assistance of MRI technicians Doris Cain, Patricia O'Donnell, and Norman Butler is also gratefully acknowledged. This study was supported by grant R24HD39621 (to J.W.), R24HD050836 (to J.W.; www.ncrrn.org), and P30NS045839 (to J.A.D.) from the NIH.	Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; AMAN MG, 1984, AUST NZ J PSYCHIAT, V18, P86, DOI 10.3109/00048678409161040; Auriel E, 2006, CLIN NEUROPHARMACOL, V29, P15, DOI 10.1097/00002826-200601000-00005; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2006, MED IMAGE ANAL, V10, P397, DOI 10.1016/j.media.2005.03.005; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Berridge CW, 2006, BIOL PSYCHIAT, V60, P1111, DOI 10.1016/j.biopsych.2006.04.022; Bullmore ET, 2003, CEREB CORTEX, V13, P144, DOI 10.1093/cercor/13.2.144; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dodds CM, 2008, J NEUROSCI, V28, P5976, DOI 10.1523/JNEUROSCI.1153-08.2008; Epstein JN, 2007, J CHILD PSYCHOL PSYC, V48, P899, DOI 10.1111/j.1469-7610.2007.01761.x; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Goldstein RZ, 2011, NEUROPSYCHOPHARMACOL, V36, P366, DOI 10.1038/npp.2010.145; Goldstein RZ, 2010, P NATL ACAD SCI USA, V107, P16667, DOI 10.1073/pnas.1011455107; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Li CSR, 2010, P NATL ACAD SCI USA, V107, P14455, DOI 10.1073/pnas.1002467107; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mai J.K., 2004, ATLAS HUMAN BRAIN; Mehta MA, 2000, J NEUROSCI, V20; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2003, MED HYPOTHESES, V61, P282, DOI 10.1016/S0306-9877(03)00175-0; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palmer SM, 2006, EUR J NEUROSCI, V24, P2389, DOI 10.1111/j.1460-9568.2006.05113.x; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Portin K, 1999, P ROY SOC B-BIOL SCI, V266, P981, DOI 10.1098/rspb.1999.0733; Rahman S, 2006, NEUROPSYCHOPHARMACOL, V31, P651, DOI 10.1038/sj.npp.1300886; Rapoport J L, 2002, J Atten Disord, V6 Suppl 1, pS57; Rhodes SM, 2004, PSYCHOPHARMACOLOGY, V175, P319, DOI 10.1007/s00213-004-1833-7; Rubia K, 2011, BIOL PSYCHIAT, V70, P255, DOI 10.1016/j.biopsych.2011.04.018; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schwartz MF, 2005, ARCH PHYS MED REHAB, V86, P1807, DOI 10.1016/j.apmr.2005.03.009; Shafritz KM, 2004, AM J PSYCHIAT, V161, P1990, DOI 10.1176/appi.ajp.161.11.1990; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; STRAUSS J, 1984, PSYCHOPHYSIOLOGY, V21, P609, DOI 10.1111/j.1469-8986.1984.tb00247.x; Swanson J, 2011, NEUROPSYCHOPHARMACOL, V36, P207, DOI 10.1038/npp.2010.160; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; Turner DC, 2005, PSYCHOPHARMACOLOGY, V178, P286, DOI 10.1007/s00213-004-1993-5; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wang DJJ, 2011, PSYCHIAT RES-NEUROIM, V191, P60, DOI 10.1016/j.pscychresns.2010.09.011; WANG GJ, 1994, LIFE SCI, V54, pPL143, DOI 10.1016/0024-3205(94)00873-6; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J., 2004, REHABILITATION MED P, P1677; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	82	29	29	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUL	2012	222	1					47	57		10.1007/s00213-011-2622-8			11	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	954FN	WOS:000304932100005	22203319	Green Accepted			2021-06-18	
J	Laxe, S; Tschiesner, U; Zasler, N; Lopez-Blazquez, R; Tormos, JM; Bernabeu, M				Laxe, Sara; Tschiesner, Uta; Zasler, Nathan; Lopez-Blazquez, Raquel; Tormos, Jose M.; Bernabeu, Montserrat			What domains of the International Classification of Functioning, Disability and Health are covered by the most commonly used measurement instruments in traumatic brain injury research?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						ICF Core Set; Neurorehabilitation; Traumatic brain injury; Linking; Outcome measures; International classification of functioning; Disability and health	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; ICF CORE SETS; HEAD-INJURY; RATING-SCALE; REHABILITATION; COMMUNITY; SETTINGS; RECOVERY; UPDATE	Objective: To identify the most frequently used outcome measurement instruments reported in clinical studies on TBI and to provide a content comparison in the framework of the International Classification of Functioning, Disability and Health (ICF). Patients and methods: A systematic literature review of clinical studies in TBI was performed using Medline, EMBASE and PsychINFO. The items of the measurement instruments present in more than 20% of the studies were linked to the ICF language. Results: 193 papers fulfilled the eligibility criteria. The frequency analysis identified six instruments: Functional Independence Measure (50%), Glasgow Outcome Scale (34%), Disability Rating Scale (32%), Wechsler Adult Intelligence Scale (29%), Trail Making Test (26%) and Community Integration Questionnaire (22%). The analysed instruments focus on different aspects of body functions (especially DRS, WAIS and TMT) and aspects of activities and participation in life (especially CIQ and FIM). Inter-researcher agreement for the ICF linking process was 0.83. Conclusions: Translating the items of different measurement instruments into the ICF language provides a practical tool to facilitate content comparisons among different outcome measures. The comparison can assist clinical researchers to integrate information acquired from different studies and different tools. (C) 2012 Elsevier B.V. All rights reserved.	[Laxe, Sara; Bernabeu, Montserrat] Univ Autonoma Barcelona, Brain Injury Unit, Guttmann Inst Hosp Neurorehabil, Badalona 08916, Spain; [Tschiesner, Uta] Univ Munich, Dept Otorhinolaryngol, D-80539 Munich, Germany; [Tschiesner, Uta] Univ Munich, ICF Res Branch, Dept Biopsychosocial Hlth, D-80539 Munich, Germany; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA 23233 USA; [Lopez-Blazquez, Raquel; Tormos, Jose M.] Univ Autonoma Barcelona, Res Dept, Guttmann Inst Hosp Neurorehabil, Badalona 08916, Spain	Laxe, S (corresponding author), Univ Autonoma Barcelona, Brain Injury Unit, Guttmann Inst Hosp Neurorehabil, Cami de Can Run Sn, Badalona 08916, Spain.	slaxe@guttmann.com; Uta.Tschiesner@med.uni-muenthen.de; nzasler@cccv-ltd.com; rlopez@guttmann.com; jmtormos@guttmann.com; mbernabeu@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Aringer M, 2006, LUPUS, V15, P248, DOI 10.1191/0961203306lu2298xx; Axelrod BN, 1999, J CLIN EXP NEUROPSYC, V21, P368, DOI 10.1076/jcen.21.3.368.916; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cieza A, 2009, J CLIN EPIDEMIOL, V62, P899, DOI 10.1016/j.jclinepi.2009.01.019; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Ewert T, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410015362; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Grill E, 2005, DISABIL REHABIL, V27, P361, DOI 10.1080/09638280400013974; Haigh R, 2001, J REHABIL MED, V33, P273; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Koskinen S, 2011, DISABIL REHABIL  MAY; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Linden A, 2010, SCAND J OCCUP THER, V17, P267, DOI 10.3109/11038120903265022; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; REITAN RM, 1994, J CLIN PSYCHOL, V50, P47, DOI 10.1002/1097-4679(199401)50:1<47::AID-JCLP2270500106>3.0.CO;2-X; Reitan RM., 1985, HALSTEAD REITAN NEUR; Ryan JJ, 2006, J CLIN PSYCHOL, V62, P1319, DOI 10.1002/jclp.20307; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Schepers VPM, 2007, DISABIL REHABIL, V29, P221, DOI 10.1080/09638280600756257; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thonnard J L, 2007, Eura Medicophys, V43, P525; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tschiesner U, 2008, EUR ARCH OTO-RHINO-L, V265, P627, DOI 10.1007/s00405-008-0641-9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Xie F, 2007, J RHEUMATOL, V34, P2301	48	29	31	0	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2012	114	6					645	650		10.1016/j.clineuro.2011.12.038			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	969GY	WOS:000306044900021	22245447				2021-06-18	
J	Mommsen, P; Zeckey, C; Andruszkow, H; Weidemann, J; Fromke, C; Puljic, P; van Griensven, M; Frink, M; Krettek, C; Hildebrand, F				Mommsen, Philipp; Zeckey, Christian; Andruszkow, Hagen; Weidemann, Juergen; Froemke, Cornelia; Puljic, Patrik; van Griensven, Martijn; Frink, Michael; Krettek, Christian; Hildebrand, Frank			Comparison of Different Thoracic Trauma Scoring Systems in Regards to Prediction of Post-Traumatic Complications and Outcome in Blunt Chest Trauma	JOURNAL OF SURGICAL RESEARCH			English	Article						multiple trauma; thoracic trauma; scoring systems; post-traumatic complications; association	INTENSIVE-CARE-UNIT; COMPUTED-TOMOGRAPHY; PULMONARY CONTUSION; MULTIPLE TRAUMA; FLAIL CHEST; PROGNOSTIC-FACTORS; ORGAN DYSFUNCTION; TRISS METHOD; HEAD TRAUMA; INJURIES	Background. As accurate assessment of thoracic injury severity in the early phase after trauma is difficult, we compared different thoracic trauma scores regarding their predictive ability for the development of post-traumatic complications and mortality. Materials and Methods. Two hundred seventy-eight multiple trauma patients (ISS >= 16) age > 16 y with severe blunt chest trauma (AIS(chest) >= 3) admitted between 2000 and 2009 to Level I Trauma center were included. Exclusion criteria were severe traumatic brain injury (AIS(head) >= 3) and penetrating thoracic trauma. The association between AIS(chest), Pulmonary Contusion score (PCS), Wagner-score and Thoracic Trauma Severity score (TTS), and duration of ventilation, length of ICU stay, development of post-traumatic complications, and mortality was investigated. Statistical analysis was performed with chi(2)-test, ANOVA, logistic regression, and receiver operating characteristic (ROC) curve. Results. Patients' mean age was 42.7 +/- 17.0 y, the mean injury severity score was 28.7 +/- 9.3 points. Overall, 60 patients (21.6%) developed ARDS, 143 patients (51.4%) SIRS, 110 patients (39.6%) sepsis, and 36 patients (13.0%) MODS. Twenty-two patients (7.9%) died. Among the examined thoracic trauma scores only the TTS was an independent predictor of mortality. With the TTS showing the best prediction power, the TTS, PCS, and Wagner-score were independent predictors of ventilation time, length of ICU stay, and the development of post-traumatic ARDS and MODS. Conclusions. Thoracic trauma scores combining anatomical and physiologic parameters like the TTS seem to be most suitable for severity assessment and prediction of outcome in multiple trauma patients with concomitant blunt chest trauma. (C) 2012 Elsevier Inc. All rights reserved.	[Mommsen, Philipp; Zeckey, Christian; Andruszkow, Hagen; Puljic, Patrik; Frink, Michael; Krettek, Christian; Hildebrand, Frank] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany; [Weidemann, Juergen] Hannover Med Sch, Inst Diagnost Radiol, D-30625 Hannover, Germany; [Froemke, Cornelia] Hannover Med Sch, Inst Biometry, D-30625 Hannover, Germany; [van Griensven, Martijn] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Mommsen, P (corresponding author), Hannover Med Sch, Trauma Dept, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mommsen.philipp@mh-hannover.de	van Griensven, Martijn/F-5808-2012; Hildebrand, Frank/J-3176-2017; Mommsen, Philipp/ABC-3510-2020	van Griensven, Martijn/0000-0001-5104-9881; Krettek, Christian/0000-0001-9807-0020			Athanassiadi K, 2004, EUR J CARDIO-THORAC, V26, P373, DOI 10.1016/j.ejcts.2004.04.011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blostein PA, 1997, J TRAUMA, V43, P13, DOI 10.1097/00005373-199707000-00006; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CLARK GC, 1988, J TRAUMA, V28, P298, DOI 10.1097/00005373-198803000-00004; Eren S, 2003, EUR J CARDIO-THORAC, V23, P888, DOI 10.1016/S1010-7940(03)00143-X; ERICKSON DR, 1971, J TRAUM, V11, P689, DOI 10.1097/00005373-197108000-00007; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Exadaktylos AK, 2001, J TRAUMA, V51, P1173, DOI 10.1097/00005373-200112000-00025; FULTON RL, 1970, SURGERY, V67, P499; GAILLARD M, 1990, J TRAUMA, V30, P93, DOI 10.1097/00005373-199001000-00015; Greene R, 1987, J Thorac Imaging, V2, P1, DOI 10.1097/00005382-198707000-00004; Guerrero-Lopez F, 2000, CRIT CARE MED, V28, P1370, DOI 10.1097/00003246-200005000-00018; HOFF SJ, 1994, AM SURGEON, V60, P138; Inthorn D, 1992, Anasthesiol Intensivmed Notfallmed Schmerzther, V27, P498, DOI 10.1055/s-2007-1000347; Ivatury RR, 2000, CRIT CARE MED, V28, P1234, DOI 10.1097/00003246-200004000-00062; JOHNSON JA, 1986, J TRAUMA, V26, P695, DOI 10.1097/00005373-198608000-00002; Joosse P, 2001, J TRAUMA, V51, P134, DOI 10.1097/00005373-200107000-00021; Karaaslan T, 1995, J TRAUMA, V39, P1081, DOI 10.1097/00005373-199512000-00012; LEWIS FR, 1982, SURG CLIN N AM, V62, P97; Lotfipour S, 2009, WEST J EMERG MED, V10, P79; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MARTS B, 1994, AM J SURG, V168, P688, DOI 10.1016/S0002-9610(05)80146-1; MCGONIGAL MD, 1990, J TRAUMA, V30, P1431, DOI 10.1097/00005373-199012000-00001; NELSON JB, 1992, J TRAUMA, V33, P722, DOI 10.1097/00005373-199211000-00022; Oestern HJ, 1997, CHIRURG, V68, P1059, DOI 10.1007/s001040050323; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; PERRY JF, 1965, J THORAC CARDIOV SUR, V49, P684, DOI 10.1016/S0022-5223(19)33266-0; PILLGRAMLARSEN J, 1993, INJURY, V24, P182, DOI 10.1016/0020-1383(93)90289-I; PINILLA JC, 1982, J TRAUMA, V22, P221, DOI 10.1097/00005373-198203000-00008; REGEL G, 1990, SURG ENDOSC-ULTRAS, V4, P31, DOI 10.1007/BF00591411; RHEA JT, 1989, J TRAUMA, V29, P502, DOI 10.1097/00005373-198904000-00015; RICHARDSON JD, 1982, ANN SURG, V196, P481, DOI 10.1097/00000658-198210000-00012; RIZZO AG, 1995, J TRAUMA, V38, P338, DOI 10.1097/00005373-199503000-00005; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; SCHILD HH, 1989, J COMPUT ASSIST TOMO, V13, P417, DOI 10.1097/00004728-198905000-00008; Sharma B R, 2005, J Clin Forensic Med, V12, P21, DOI 10.1016/j.jcfm.2004.08.002; STELLIN G, 1991, AM SURGEON, V57, P780; Talmor M, 1999, ARCH SURG-CHICAGO, V134, P81, DOI 10.1001/archsurg.134.1.81; TOCINO IM, 1984, AM J ROENTGENOL, V143, P987, DOI 10.2214/ajr.143.5.987; Trupka A, 1997, UNFALLCHIRURG, V100, P469, DOI 10.1007/s001130050144; Trupka A, 1998, UNFALLCHIRURG, V101, P244, DOI 10.1007/s001130050265; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011; WAGNER RB, 1989, SURG CLIN N AM, V69, P31; Wang SH, 2007, J FORMOS MED ASSOC, V106, P444, DOI 10.1016/S0929-6646(09)60293-X	49	29	33	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	JUL	2012	176	1					239	247		10.1016/j.jss.2011.09.018			9	Surgery	Surgery	958BD	WOS:000305210100043	22099585				2021-06-18	
J	von Reyn, CR; Mott, RE; Siman, R; Smith, DH; Meaney, DF				von Reyn, Catherine R.; Mott, Rosalind E.; Siman, Robert; Smith, Douglas H.; Meaney, David F.			Mechanisms of calpain mediated proteolysis of voltage gated sodium channel alpha-subunits following in vitro dynamic stretch injury	JOURNAL OF NEUROCHEMISTRY			English	Article						axon; calpain; NMDA receptor; proteolysis; sodium channel; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EXCITATORY AMINO-ACIDS; D-ASPARTATE RECEPTORS; NMDA RECEPTOR; CORTICAL-NEURONS; CYTOSKELETAL PROTEOLYSIS; CALCIUM INFLUX; CNS INJURY; MU-CALPAIN; RAT	J. Neurochem. (2012) 121, 793805. Abstract Although enhanced calpain activity is well documented after traumatic brain injury (TBI), the pathways targeting specific substrate proteolysis are less defined. Our past work demonstrated that calpain cleaves voltage gated sodium channel (NaCh) a-subunits in an in vitro TBI model. In this study, we investigated the pathways leading to NaCh cleavage utilizing our previously characterized in vitro TBI model, and determined the location of calpain activation within neuronal regions following stretch injury to micropatterned cultures. Calpain specific breakdown products of a-spectrin appeared within axonal, dendritic, and somatic regions 6 h after injury, concurrent with the appearance of NaCh a-subunit proteolysis in both whole cell or enriched axonal preparations. Direct pharmacological activation of either NMDA receptors (NMDArs) or NaChs resulted in NaCh proteolysis. Likewise, a chronic (6 h) dual inhibition of NMDArs/NaChs but not L-type voltage gated calcium channels significantly reduced NaCh proteolysis 6 h after mechanical injury. Interestingly, an early, transient (30 min) inhibition of NMDArs alone significantly reduced NaCh proteolysis. Although a chronic inhibition of calpain significantly reduced proteolysis, a transient inhibition of calpain immediately after injury failed to significantly attenuate NaCh proteolysis. These data suggest that both NMDArs and NaChs are key contributors to calpain activation after mechanical injury, and that a larger temporal window of sustained calpain activation needs consideration in developing effective treatments for TBI.	[von Reyn, Catherine R.; Mott, Rosalind E.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Siman, Robert; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122; von Reyn, Catherine/0000-0002-5753-2134	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-NS-015202, NS 35712, HD41699]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS035712] Funding Source: NIH RePORTER	Funds were provided by grants from the National Institutes of Health, P01-NS-015202, NS 35712 and HD41699.	Araujo IM, 2004, J NEUROCHEM, V91, P1322, DOI 10.1111/j.1471-4159.2004.02811.x; Araujo IM, 2010, NEUROCHEM RES, V35, P1966, DOI 10.1007/s11064-010-0323-z; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; BERMUDEZRATTONI F, 1991, P NATL ACAD SCI USA, V88, P5379, DOI 10.1073/pnas.88.12.5379; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Cochilla AJ, 1999, J NEUROSCI, V19, P193; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Golshani P, 1998, J NEUROPHYSIOL, V80, P143; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jette N, 2006, J CEREBR BLOOD F MET, V26, P777, DOI 10.1038/sj.jcbfm.9600226; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Nguyen TH, 1999, J NEUROCHEM, V73, P1995; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Peng TI, 1998, MOL PHARMACOL, V53, P974; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Smith DH, 1999, J NEUROSCI, V19, P4263; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Vanderklish P, 1996, LEARN MEMORY, V3, P209, DOI 10.1101/lm.3.2-3.209; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	65	29	29	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	JUN	2012	121	5					793	805		10.1111/j.1471-4159.2012.07735.x			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	933UE	WOS:000303387800012	22428606	Bronze, Green Accepted			2021-06-18	
J	Kelley, AM; Athy, JR; Cho, TH; Erickson, B; King, M; Cruz, P				Kelley, Amanda M.; Athy, Jeremy R.; Cho, Timothy H.; Erickson, Bradley; King, Melody; Cruz, Pedro			Risk propensity and health risk behaviors in U.S. army soldiers with and without psychological disturbances across the deployment cycle	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Risk propensity; Combat deployment; Health risk behaviors	POSTTRAUMATIC-STRESS-DISORDER; VENTROMEDIAL PREFRONTAL CORTEX; BECK DEPRESSION INVENTORY; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; MILITARY PERSONNEL; PERSONALITY; COMBAT; AFGHANISTAN; IRAQ	Anecdotal and preliminary evidence suggests that Soldiers returning from a combat deployment engage in an increased number of health risk behaviors. Three potential factors driving this change were examined in this study; posttraumatic stress disorder (PTSD), concussion and traumatic brain injury (TBI), and perceived invincibility. We studied members of a combat arms brigade one month prior to a deployment to Iraq and approximately one month after their return (N = 319). Participants anonymously completed surveys characterizing attitudes about risk, risk propensity, invincibility, engagement in health risk behaviors, and personality. Using standardized screening instruments, participants were categorized with respect to PTSD and probable TBI. Results suggest that Soldiers engage in more alcohol use and reckless driving behaviors post-deployment. These changes were exaggerated in those who screened positive for PTSD. Perception of one's invincibility and survival skills increased post-deployment thus suggesting that participants felt less susceptible to adverse consequences and more adept at surviving dangerous situations. This study provides documentation of the pattern of health behavior in Soldiers engaged in the deployment cycle. Our findings suggest increases in the number of risks Soldiers' engage in post-deployment are not limited to those with PTSD symptomtotology. This study has implications for not only adjustment to life post-deployment at the individual level but also operational readiness. Published by Elsevier Ltd.	[Kelley, Amanda M.; Athy, Jeremy R.; Cho, Timothy H.; Erickson, Bradley; King, Melody; Cruz, Pedro] USA, Aeromed Res Lab, Ft Rucker, AL 36362 USA	Kelley, AM (corresponding author), USA, Aeromed Res Lab, Bldg 6901,Farrel Rd,POB 620577, Ft Rucker, AL 36362 USA.	amanda.m.kelley@us.army.mil			Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [633002.800C5, 622787.869P1]	This project was funded by the Medical Research and Material Command under program element numbers 633002.800C5 and 622787.869P1. The funding source had no further role in study and statistical design, data collection, analysis, interpretation of findings, or writing of the report.	Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bell N S, 2001, Inj Prev, V7, P4, DOI 10.1136/ip.7.1.4; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Byrnes JP, 2005, DEV JUDGMENT DECISIO; Centers for Disease Control and Prevention, 2009, YOUTH BEH RISK SURV; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hewitt P. L., 1993, PSYCHOL ASSESS, V5, P408, DOI DOI 10.1037/1040-3590.5.4.408; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; Killgore WDS, 2006, MIL MED, V171, P233, DOI 10.7205/MILMED.171.3.233; Killgore WDS, 2008, J PSYCHIATR RES, V42, P58; Killgore WDS, 2010, MIL MED, V175, P499, DOI 10.7205/MILMED-D-09-00240; King DW, 2003, MANUAL DEPLOYMENT RI; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; MCCRAE RR, 1994, CURR DIR PSYCHOL SCI, V3, P173, DOI 10.1111/1467-8721.ep10770693; MOLINA ME, 2007, WORLD J BIOL PSYCHIA, V13, P1; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; PARKER D, 1995, ERGONOMICS, V38, P1036, DOI 10.1080/00140139508925170; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sharkansky EJ, 2000, J ABNORM PSYCHOL, V109, P188, DOI 10.1037/0021-843X.109.2.188; Sicard B, 2001, MIL MED, V166, P871; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Thomsen CJ, 2011, J PSYCHIATR RES, V45, P1321, DOI 10.1016/j.jpsychires.2011.04.003; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	36	29	29	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956			J PSYCHIATR RES	J. Psychiatr. Res.	MAY	2012	46	5					582	589		10.1016/j.jpsychires.2012.01.017			8	Psychiatry	Psychiatry	939VF	WOS:000303846500003	22305118				2021-06-18	
J	Larson, MJ; South, M; Clayson, PE; Clawson, A				Larson, Michael J.; South, Mikle; Clayson, Peter E.; Clawson, Ann			Cognitive control and conflict adaptation in youth with high-functioning autism	JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article						N2; event-related potential; autism; conflict adaptation; cognitive control	DEVELOPMENTAL LANGUAGE DISORDER; ERROR-RELATED NEGATIVITY; TRAUMATIC BRAIN-INJURY; SPECTRUM DISORDERS; ANTERIOR CINGULATE; STROOP TASK; ERP; CHILDREN; DEFICITS; ADJUSTMENTS	Background: Youth diagnosed with autism spectrum disorders (ASD) often show deficits in cognitive control processes, potentially contributing to characteristic difficulties monitoring and regulating behavior. Modification of performance following conflict can be measured by examining conflict adaptation, the adjustment of cognitive resources based on previous-trial conflict. The electrophysiological correlates of these processes can be measured using the N2, a stimulus-locked component of the event-related potential (ERP). Methods: High-density ERPs and behavioral data [ i. e. response times (RTs) and error rates] were acquired while 28 youth with ASD and 36 typically developing controls completed a modified Eriksen flanker task. Results: Behaviorally, groups showed similar conflict adaptation effects; youth with ASD showed larger RT slowing on switch trials. For electrophysiology, controls demonstrated larger N2 amplitudes for incongruent (high-conflict) trials following congruent (low-conflict) trials than for incongruent trials following incongruent trials. Importantly, youth with ASD showed no such differences in N2 amplitude based on previous-trial conflict. Conclusions: Lack of electrophysiological conflict adaptation effects in youth with ASD indicates irregular neural processing associated with conflict adaptation. Individuals with ASD show declines in level of conflict evaluation and adaptation. Future research is necessary to accurately characterize and understand the behavioral implications of these cognitive control deficits relative to diagnostic severity, anxiety, and personality.	[Larson, Michael J.; South, Mikle; Clayson, Peter E.; Clawson, Ann] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.; South, Mikle] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Clayson, Peter E/F-5438-2011; Larson, Michael J/C-8543-2012; Clayson, Peter/AAC-9207-2019; South, Mikle/H-4978-2013	Clayson, Peter E/0000-0003-4437-6598; Larson, Michael J/0000-0002-8199-8065; Clayson, Peter/0000-0003-4437-6598; South, Mikle/0000-0003-0152-1257; Clawson, Ann/0000-0002-8669-0086	Brigham Young University College of Family, Home, and Social Sciences; Brigham Young University	We gratefully acknowledge the assistance of Annahir Cariello, Oliver Johnston, Jaime Ballard, Adrian Rockwell, Ryan Hunsaker, Sarah Van Tassell, Kyle Jamison, and Tiffani Newton. This study was supported by funds from the Brigham Young University College of Family, Home, and Social Sciences and a Brigham Young University Mentored Environment Grant.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Barnea-Goraly N, 2010, ARCH GEN PSYCHIAT, V67, P1052, DOI 10.1001/archgenpsychiatry.2010.123; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Bogte H, 2007, NEUROPSYCHOLOGIA, V45, P1707, DOI 10.1016/j.neuropsychologia.2006.12.020; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; COURCHESNE E, 1989, J AUTISM DEV DISORD, V19, P1, DOI 10.1007/BF02212714; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Griebling J, 2010, J CHILD NEUROL, V25, P856, DOI 10.1177/0883073809351313; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Henderson H, 2006, BRAIN COGNITION, V61, P96, DOI 10.1016/j.bandc.2005.12.009; Henderson HA, 2010, DEV NEUROPSYCHOL, V35, P177, DOI 10.1080/87565640903526538; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Ladouceur CD, 2010, DEV NEUROPSYCHOL, V35, P194, DOI 10.1080/87565640903526553; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Levitt JG, 2003, BIOL PSYCHIAT, V54, P1355, DOI 10.1016/S0006-3223(03)00688-7; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Ozonoff S., 2007, NEW DEV AUTISM FUTUR; Salmond CH, 2007, CORTEX, V43, P686, DOI 10.1016/S0010-9452(08)70498-2; Solomon M, 2008, INT J DEV NEUROSCI, V26, P239, DOI 10.1016/j.ijdevneu.2007.11.001; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; South M, 2010, BIOL PSYCHOL, V85, P242, DOI 10.1016/j.biopsycho.2010.07.009; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vlamings PHJM, 2008, EUR J NEUROSCI, V28, P399, DOI 10.1111/j.1460-9568.2008.06336.x; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x	41	29	30	2	34	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0021-9630			J CHILD PSYCHOL PSYC	J. Child Psychol. Psychiatry	APR	2012	53	4					440	448		10.1111/j.1469-7610.2011.02498.x			9	Psychology, Developmental; Psychiatry; Psychology	Psychology; Psychiatry	895LT	WOS:000300498400013	22176206				2021-06-18	
J	Medeiros, FA; Weinreb, RN; Boer, ER; Rosen, PN				Medeiros, Felipe A.; Weinreb, Robert N.; Boer, Erwin R.; Rosen, Peter N.			Driving Simulation as a Performance-based Test of Visual Impairment in Glaucoma	JOURNAL OF GLAUCOMA			English	Article						driving; simulation; glaucoma; functional impairment; quality of life	OPEN-ANGLE GLAUCOMA; QUALITY-OF-LIFE; VEHICLE COLLISION INVOLVEMENT; INCREASED DEPRESSIVE SYMPTOMS; LATERAL GENICULATE-NUCLEUS; TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; ALZHEIMER-DISEASE; RISK-FACTORS; FIELD LOSS	The fundamental goal of glaucoma management is to prevent patients from developing visual impairments sufficient to produce disability in their daily lives and impair their quality of life. Ultimately, patients are interested in how their vision will impact their ability to perform daily activities, such as driving. Although technologic advancements such as automated perimetry and devices for optic nerve imaging have resulted in great improvement in our ability to quantify structural and functional damage in glaucoma, the impact on vision-related quality of life of some of the information acquired from these tests remain elusive. In contrast, performance-based measures may be better correlated to traditional measures of vision health and, more importantly, they provide a more direct measure of disability. Driving simulators can be used as a performance-based test for evaluation of functional impairment in glaucoma. Their use can potentially help in the evaluation of driving safety and performance of diseased subjects and provide insight into the different mechanisms involved in causing driving impairment in this disease. The ability to do this in an experimentally controlled and standardized setting enables testing of a much larger number of hypotheses compared with on-road evaluations. Besides evaluating driver fitness, simulators could also potentially be used as a sophisticated test to evaluate cognitive impairment in the context of an everyday task (driving) that has not been available through traditional neuropsychologic assessment.	[Medeiros, Felipe A.; Weinreb, Robert N.; Boer, Erwin R.; Rosen, Peter N.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA	Medeiros, FA (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	fmedeiros@glaucoma.ucsd.edu			National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY08208]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY021818, R01EY008208] Funding Source: NIH RePORTER	Supported in part by the National Eye Institute grant EY08208 (F.A.M.).	Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; Aspinall PA, 2008, INVEST OPHTH VIS SCI, V49, P1907, DOI 10.1167/iovs.07-0559; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K, 1993, J Am Optom Assoc, V64, P71; Bedard M, 2010, AM J OCCUP THER, V64, P336, DOI 10.5014/ajot.64.2.336; Biederman Joseph, 2007, Ann Gen Psychiatry, V6, P4, DOI 10.1186/1744-859X-6-4; BLAAUW GJ, 1982, HUM FACTORS, V24, P473, DOI 10.1177/001872088202400408; BOYDSTUN LE, 1980, P HUM FACT SOC 24 AN, P111; Brooks JO, 2010, ACCIDENT ANAL PREV, V42, P788, DOI 10.1016/j.aap.2009.04.013; Chisholm CM, 2008, BRIT J OPHTHALMOL, V92, P225, DOI 10.1136/bjo.2007.129726; Coeckelbergh TRM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1509, DOI 10.1001/archopht.120.11.1509; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; Cross JM, 2009, BRIT J OPHTHALMOL, V93, P400, DOI 10.1136/bjo.2008.144584; de Winter JCF, 2009, ERGONOMICS, V52, P137, DOI 10.1080/00140130802277521; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; DECINA LE, 1993, ACCIDENT ANAL PREV, V25, P267, DOI 10.1016/0001-4575(93)90021-N; Devos H, 2007, NEUROLOGY, V69, P1434, DOI 10.1212/01.wnl.0000277640.58685.fc; DRANCE SM, 1981, ARCH OPHTHALMOL-CHIC, V99, P829, DOI 10.1001/archopht.1981.03930010829007; Fildes Brian, 2007, Annu Proc Assoc Adv Automot Med, V51, P559; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Freeman EE, 2006, AM J PUBLIC HEALTH, V96, P1254, DOI 10.2105/AJPH.2005.069146; Freund B., 2006, ADV TRANSPORTATION S, P71; Garway-Heath DF, 2008, PROG BRAIN RES, V173, P47, DOI 10.1016/S0079-6123(08)01105-9; GAWRON VJ, 1988, ERGONOMICS, V31, P1219, DOI 10.1080/00140138808966764; Gilhotra JS, 2001, CLIN EXP OPHTHALMOL, V29, P104, DOI 10.1046/j.1442-9071.2001.00411.x; Girkin CA, 2004, INVEST OPHTH VIS SCI, V45, P2272, DOI 10.1167/iovs.03-0996; Girkin CA, 2010, ARCH OPHTHALMOL-CHIC, V128, P541, DOI 10.1001/archophthalmol.2010.49; Godley ST, 2002, ACCIDENT ANAL PREV, V34, P589, DOI 10.1016/S0001-4575(01)00056-2; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Gupta N, 2007, SURV OPHTHALMOL, V52, pS122, DOI 10.1016/j.survophthal.2007.08.006; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hills BL, 1977, REANALYSIS CALIFORNI, P1; Horswill MS, 2008, PERCEPTION, V37, P1269, DOI 10.1068/p5821; HUGHES DTD, 1967, MED SCI LAW, V7, P200, DOI 10.1177/002580246700700407; Janz NK, 2009, INVEST OPHTH VIS SCI, V50, P1718, DOI 10.1167/iovs.08-2575; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Klimkeit EI, 2009, NEUROSCI BIOBEHAV R, V33, P223, DOI 10.1016/j.neubiorev.2008.08.005; Lee GCH, 1997, COMPUT IND ENG, V33, P533, DOI 10.1016/S0360-8352(97)00186-1; Lee HC, 2005, AM J OCCUP THER, V59, P97, DOI 10.5014/ajot.59.1.97; Lee HC, 2003, J SAFETY RES, V34, P453, DOI 10.1016/j.jsr.2003.09.007; Lee HC, 2003, AM J OCCUP THER, V57, P324, DOI 10.5014/ajot.57.3.324; Lee HC., 2003, T ENG AUST, V8, P89, DOI DOI 10.3389/FNHUM.2014.00772; Lee JD, 2002, HUM FACTORS, V44, P314, DOI 10.1518/0018720024497844; LEE JD, 2004, SIMULATOR FIDELITY L; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Lorenzana L, 2009, OPHTHAL EPIDEMIOL, V16, P107, DOI 10.1080/09286580902738142; Loughman J, 2007, BRIT J OPHTHALMOL, V91, P1493, DOI 10.1136/bjo.2006.108084; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; MCCLOSKEY LW, 1994, AGE AGEING, V23, P267, DOI 10.1093/ageing/23.4.267; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P89, DOI 10.1001/archopht.123.1.89; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; McGwin G, 1998, ACCIDENT ANAL PREV, V30, P781, DOI 10.1016/S0001-4575(98)00031-1; McKendrick AM, 2007, INVEST OPHTH VIS SCI, V48, P2115, DOI 10.1167/iovs.06-1208; McKendrick AM, 2005, INVEST OPHTH VIS SCI, V46, P3693, DOI 10.1167/iovs.04-1406; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Medeiros FA, 2004, AM J OPHTHALMOL, V137, P863, DOI 10.1016/j.ajo.2003.12.009; Medeiros FA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1250, DOI 10.1001/archophthalmol.2009.276; Owen VMF, 2008, INVEST OPHTH VIS SCI, V49, P2449, DOI 10.1167/iovs.07-0877; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Owsley C, 2001, OPTOMETRY VISION SCI, V78, P350, DOI 10.1097/00006324-200105000-00019; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; Reed MP, 1999, ERGONOMICS, V42, P1015, DOI 10.1080/001401399185117; Reimer B, 2007, J SAFETY RES, V38, P563, DOI 10.1016/j.jsr.2007.07.002; Reimer B, 2006, BEHAV RES METHODS, V38, P314, DOI 10.3758/BF03192783; Reinach SJ, 1997, ALZ DIS ASSOC DIS, V11, P21, DOI 10.1097/00002093-199706001-00006; Richman J, 2010, OPHTHAL EPIDEMIOL, V17, P144, DOI 10.3109/09286581003734878; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Rizzo M, 1997, ARCH NEUROL-CHICAGO, V54, P545, DOI 10.1001/archneur.1997.00550170027011; Rizzo M, 2004, ARCH OPHTHALMOL-CHIC, V122, P641, DOI 10.1001/archopht.122.4.641; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; SAMPLE PA, 1990, INVEST OPHTH VIS SCI, V31, P1869; Sample PA, 2000, INVEST OPHTH VIS SCI, V41, P1783; Schappert S. M., 1995, ADV DATA, V262, p[1, 1991]; Shechtman O, 2009, TRAFFIC INJ PREV, V10, P379, DOI 10.1080/15389580902894989; SILVERMAN SE, 1990, INVEST OPHTH VIS SCI, V31, P722; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Szlyk JP, 2002, J REHABIL RES DEV, V39, P467; Thibos LN, 1998, OPTOMETRY VISION SCI, V75, P399, DOI 10.1097/00006324-199806000-00024; Uc EY, 2009, NEUROLOGY, V73, P1103, DOI 10.1212/WNL.0b013e3181bacf6e; Warrian KJ, 2010, SURV OPHTHALMOL, V55, P146, DOI 10.1016/j.survophthal.2009.06.006; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yan X, 2008, ACCIDENT ANAL PREV, V40, P274, DOI 10.1016/j.aap.2007.06.007; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1	98	29	29	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1057-0829	1536-481X		J GLAUCOMA	J. Glaucoma	APR-MAY	2012	21	4					221	227		10.1097/IJG.0b013e3182071832			7	Ophthalmology	Ophthalmology	920DK	WOS:000302382100003	21467952	Green Accepted			2021-06-18	
J	Berger, RP; Beers, SR; Papa, L; Bell, M				Berger, Rachel P.; Beers, Sue R.; Papa, Linda; Bell, Michael			Common Data Elements for Pediatric Traumatic Brain Injury: Recommendations from the Biospecimens and Biomarkers Workgroup	JOURNAL OF NEUROTRAUMA			English	Article						best practices; biomarkers; common data elements; pediatrics; standardization; traumatic brain injury	URINARY S100B PROTEIN; SERUM; INFANTS	Biospecimens represent a critically important resource in pediatric brain injury research. Data from these specimens can be used to identify and classify injury, understand the molecular mechanisms underlying different types of brain injury, and ultimately identify therapeutic targets to tailor treatments for individual patient needs. To realize the full potential of biospecimens in pediatric traumatic brain injury (TBI), standardization and adoption of best practice guidelines are needed to ensure the quality and consistency of specimens. Multiple groups, including the National Cancer Institute (NCI), the International Society for Biological and Environmental Repositories (ISBER), and the Organisation for Economic Co-operation and Development (OECD), have previously published best practice guidelines for biospecimen resources. Recommendations have also been provided by the Biospecimens and Biomarkers Workgroup of the interagency TBI Common Data Elements (CDE) initiative. The recommendations from all of these sources, however, focus exclusively on adult biospecimen collection. There are no published pediatric-specific biospecimen collection guidelines. An additional workgroup was formed to specifically address this gap. The aim of the Pediatric TBI CDE Biospecimens and Biomarkers Workgroup was to provide recommendations for best practice guidelines to standardize the quality and accessibility of biospecimens for pediatric brain injury research in general, and for pediatric TBI research in particular. Consensus recommendations were developed by review of previously published adult-specific recommendations, including the recommendations of the original TBI Common Data Elements Biospecimens and Biomarkers Workgroup, and by participation in the interagency workshop "Common Data Elements for TBI Research: Pediatric Considerations," held in Houston, Texas in March of 2010. These recommendations represent expert opinion on this subject. The authors of this article were members of the Biospecimens Workgroup. We hope that with adoption of these best practices, future investigators will be able to obtain biospecimens in a consistent way that meets the needs of pediatric patients, and helps to accelerate acquisition of pediatric-specific biomarker data.	[Berger, Rachel P.; Bell, Michael] Univ Pittsburgh, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15224 USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15224 USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL USA; [Beers, Sue R.] Univ Pittsburgh, Inst Review Board, Pittsburgh, PA 15224 USA	Berger, RP (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh UPMC, 4427 Penn Ave, Pittsburgh, PA 15224 USA.	rachel.berger@chp.edu			National Institutes of Health-National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); U.S. Department of Education/National Institute on Disability and Rehabilitation ResearchUS Department of Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	This project was jointly supported by the National Institutes of Health-National Institute of Neurological Disorders and Stroke, and the U.S. Department of Education/National Institute on Disability and Rehabilitation Research.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; [Anonymous], 2007, NIH PUB; Berger R, 2009, PEDIATR CRIT CARE ME, V10, P260, DOI 10.1097/PCC.0b013e31819a376d; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Eiseman E., 2003, CASE STUDIES EXISTIN; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goncalves CA, 2010, CARDIOVASC PSYCHIAT, V2010, P790431, DOI DOI 10.1155/2010/790431; Holtkamp K, 2008, J NEURAL TRANSM, V115, P937, DOI 10.1007/s00702-008-0041-8; International Society for Biological and Environmental Repositories, 2005, CHIN TAIW UN DET, P5; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Miller A., 2011, J NEUROTRAU IN PRESS; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Portela LVC, 2002, CLIN CHEM, V48, P950; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034	22	29	29	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	4					672	677		10.1089/neu.2011.1861			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	901SQ	WOS:000300987500006	22106839	Green Published			2021-06-18	
J	Gasco, V; Prodam, F; Pagano, L; Grottoli, S; Belcastro, S; Marzullo, P; Beccuti, G; Ghigo, E; Aimaretti, G				Gasco, Valentina; Prodam, Flavia; Pagano, Loredana; Grottoli, Silvia; Belcastro, Sara; Marzullo, Paolo; Beccuti, Guglielmo; Ghigo, Ezio; Aimaretti, Gianluca			Hypopituitarism following brain injury: when does it occur and how best to test?	PITUITARY			English	Article						Brain Injuries; Hypopituitarism; Diagnosis	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY DYSFUNCTION; LONG-TERM; NEUROENDOCRINE DYSFUNCTION; HIGH-RISK; PREVALENCE; LESIONS; TBI; DEFICIENCY; SURVIVORS	Aim of this review is to highlight how and when Traumatic Brain Injury (TBI) as well as Subarachnoid Haemorrhage (SAH) and primary Brain Tumours (pBT) of the Central Nervous System (CNS) can induce hypopituitarism, an under-diagnosed clinical problem. Moreover, this review aims to clarify, on the basis of the recent evidences, how these patients have to be tested for pituitary-function. Both retrospective and prospective studies recommended that patients with more severe form of Brain Injuries (BI) and in particular, those with fractures of the base of the skull or early diabetes insipidus, have to be closely monitored for signs and symptoms of endocrine dysfunction. Further studies will be crucial to raise awareness and remind physicians on the prevalence of hypopituitarism in patients with BI and to elucidate any incremental benefits these patients may receive from hormone replacement.	[Gasco, Valentina; Grottoli, Silvia; Beccuti, Guglielmo; Ghigo, Ezio] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, I-10126 Turin, Italy; [Prodam, Flavia; Pagano, Loredana; Belcastro, Sara; Marzullo, Paolo; Aimaretti, Gianluca] Univ Eastern Piedmont Amedeo Avogadro, Dept Clin & Expt Med, Div Endocrinol, Novara, Italy; [Marzullo, Paolo] San Giuseppe Hosp, Oggebbio, Verbania, Italy	Gasco, V (corresponding author), Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Cso Dogliotti 14, I-10126 Turin, Italy.	valentina.gasco@unito.it	Beccuti, Guglielmo/AAI-5452-2021; Marzullo, Paolo/K-6371-2016; Prodam, Flavia/B-8844-2013; Pagano, Loredana/AAK-9139-2020	Beccuti, Guglielmo/0000-0003-3163-2361; Marzullo, Paolo/0000-0003-3215-5747; Prodam, Flavia/0000-0001-9660-5335; 			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Ceballos R, 1966, Ala J Med Sci, V3, P185; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; EDWARDS OM, 1986, MEDICINE, V65, P281; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; PIERUCCI G, 1971, Pathologica (Genoa), V63, P71; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	38	29	33	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X			PITUITARY	Pituitary	MAR	2012	15	1					20	24		10.1007/s11102-010-0235-6			5	Endocrinology & Metabolism	Endocrinology & Metabolism	904IG	WOS:000301187500003	20526744				2021-06-18	
J	Hart, T; Vaccaro, MJ; Hays, C; Maiuro, RD				Hart, Tessa; Vaccaro, Monica J.; Hays, Christina; Maiuro, Roland D.			Anger Self-Management Training for People With Traumatic Brain Injury: A Preliminary Investigation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger management; emotional regulation; traumatic brain injury	CAREGIVER BURDEN; AGGRESSION; DEFICITS; PROGRAM; PSYCHOTHERAPY; IRRITABILITY; GUIDELINES; SYMPTOMS; THERAPY; PATIENT	Objective: To examine the feasibility and gather preliminary data on the efficacy of a fully manualized, 8-session, psychoeducational treatment for irritability and anger after traumatic brain injury (TBI), called anger self-management training (ASMT). Participants: A total of 10 persons with moderate to severe, chronic TBI with significant cognitive impairment and elevated levels of anger and irritability participated in the study; 8 had significant others (SOs) who participated in portions of the treatment and provided pre- and posttreatment measures; 1 SO provided only data. Main Outcome Measure: Two subscales of the State-Trait Anger Expression Scale-Revised and Brief Anger-Aggression Questionnaire. Design: Pre- to posttreatment pilot study. Results: There was significant improvement on all 3 measures of self-reported anger, with large effect sizes (>1.0), and on 1 of 3 SO-reported scales. Qualitative feedback from participants was positive and dropout rate was low (1 of 11). Conclusions: The treatment model represented by the ASMT appears worthy of further study in persons with TBI who have both problematic anger and cognitive impairment.	[Hart, Tessa; Vaccaro, Monica J.; Hays, Christina; Maiuro, Roland D.] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA	Hart, T (corresponding author), Moss Rehabil Res Inst, Med Arts Bldg,50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu			Moss Rehabilitation Research Institute; TBI Clinical Trials Network, National Institutes of Health [UO1 HD042738]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042738] Funding Source: NIH RePORTER	This research was supported by a seed grant from the Moss Rehabilitation Research Institute and by the TBI Clinical Trials Network, National Institutes of Health grant UO1 HD042738. Jo Ann Brockway, PhD, contributed to the development of the treatment manual described in this project. Christianne Hopwood, PsyD, served as a research therapist and Megan Bartlett, MA, assisted with manuscript preparation. We thank the clinicians at the Drucker Brain Injury Center, Moss Rehabilitation Hospital for referring participants. We also owe a debt of gratitude to the people with TBI and their friends and family members who participated in this study.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Blanco J. M., 2001, ANSIEDAD ESTRES, V7, P247; Burgess PW, 1996, BRIXTON SPATIAL ANTI; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Deffenbacher JL, 2002, COUNS PSYCHOL, V30, P262, DOI 10.1177/0011000002302004; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Derogatis LR., 2000, BRIEF SYMPTOM INVENT, V18; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eames P., 1990, NEUROBEHAVIORAL SEQU, P410; Eames PG, 2001, BRAIN DAM B, P29; Fassino S, 2002, EUR NEUROPSYCHOPHARM, V12, P453, DOI 10.1016/S0924-977X(02)00058-5; Greve KW, 2001, BRAIN INJURY, V15, P255; GUALTIERI T, 1990, J HEAD TRAUMA REHAB, V5, P32; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Levy M, 2005, NEUROREHABILITATION, V20, P279; LIRA FT, 1983, INT J CLIN NEUROPSYC, V5, P159; MAIURO RD, 1987, J INTERPERS VIOLENCE, V2, P166, DOI DOI 10.1177/088626087002002003; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Novaco R.W., 1975, ANGER CONTROL DEV EV; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; O'Leary CA, 2000, BEHAV INTERVENT, V15, P205, DOI 10.1002/1099-078X(200007/09)15:3<205::AID-BIN56>3.3.CO;2-B; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1964, EXAMEN CLIN PSYCHOL; Schnurr PR, 2007, J TRAUMA STRESS, V20, P779, DOI 10.1002/jts.20292; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver J, 2007, BRAIN INJURY MED PRI, P963; Spielberger C.D., 1999, STATE TRAIT ANGER EX; Stevenson CS, 2002, AUST NZ J PSYCHIAT, V36, P610, DOI 10.1046/j.1440-1614.2002.01052.x; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; UOMOTO JM, 1992, ARCH PHYS MED REHAB, V73, P674; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 2011, WECHLSER ABBREVIATED; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J., 2004, REHABILITATION MED P, P1677; Whyte J, 2009, ARCH PHYS MED REHAB, V90, pS3, DOI 10.1016/j.apmr.2009.07.008; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	49	29	29	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2012	27	2					113	122		10.1097/HTR.0b013e31820e686c			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	912LI	WOS:000301799100004	21407088				2021-06-18	
J	McDonald, S				McDonald, Skye			New Frontiers in Neuropsychological Assessment: Assessing Social Perception Using a Standardised Instrument, The Awareness of Social Inference Test	AUSTRALIAN PSYCHOLOGIST			English	Article						assessment; clinical disorders; neuropsychology; social perception	TRAUMATIC BRAIN-INJURY; FACIAL AFFECT RECOGNITION; CLOSED HEAD-INJURY; RIGHT-HEMISPHERE; EMOTION RECOGNITION; FRONTOTEMPORAL DEMENTIA; UNDERSTANDING SARCASM; IMPAIRED RECOGNITION; NONVERBAL CUES; MIND	Many clinical disorders lead to impairments in social perception that are not easily detected using standard neuropsychological instruments. In this article, The Awareness of Social Inference Test (TASIT) is described, and evidence for its reliability and validity is reviewed. TASIT was designed to assess the ability to interpret emotional expressions and paralinguistic cues in order to make judgements about speakers' mental states and their conversational meanings, especially when these diverge from the literal meaning of what they say (as in the case of sarcasm). TASIT has three parts: (1) the Emotion Evaluation Test (six basic emotions); (2) Test of Social Inference (Minimal), assessing the ability to understand emotions, mental states, and conversational inferences in sincere and sarcastic interchanges; and (3) Test of Social Inference (Enriched), assessing comprehension of lies and sarcasm, each with alternate forms for re-testing. TASIT has adequate testretest and alternate forms reliability. Evidence for construct validity is derived from its relationship to conventional neuropsychological tests, experimental tests of social perception, and real-world performance. In addition, research using TASIT to examine deficits in social perception in traumatic brain injury, schizophrenia, frontotemporal dementia, Alzheimer's disease, and stroke attest to its sensitivity as a clinical assessment tool.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; ARCHER D, 1977, J PERS SOC PSYCHOL, V35, P443, DOI 10.1037/0022-3514.35.6.443; Backman L, 2004, J INTERN MED, V256, P195, DOI 10.1111/j.1365-2796.2004.01386.x; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; BIHRLE AM, 1986, BRAIN COGNITION, V5, P399, DOI 10.1016/0278-2626(86)90042-4; Blake ML, 2009, J SPEECH LANG HEAR R, V52, P359, DOI 10.1044/1092-4388(2009/07-0012); BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; BROWNELL HH, 1992, BRAIN LANG, V43, P121, DOI 10.1016/0093-934X(92)90025-A; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Burnham H, 2004, DEMENT GERIATR COGN, V18, P75, DOI 10.1159/000077813; Cadieux NL, 1997, J INT NEUROPSYCH SOC, V3, P411, DOI 10.1017/S1355617797004116; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Combs DR, 2007, SCHIZOPHR RES, V91, P112, DOI 10.1016/j.schres.2006.12.010; Combs DR, 2006, SCHIZOPHR RES, V87, P340, DOI 10.1016/j.schres.2006.05.003; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; EDINGER JA, 1983, PSYCHOL BULL, V93, P30; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Ekman P., 1973, DARWIN FACIAL EXPRES, P169; Ekman P., 1976, PICTURES FACIAL AFFE; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Fournier NM, 2008, EPILEPSY BEHAV, V12, P460, DOI 10.1016/j.yebeh.2007.12.009; Frommann N, 2003, PSYCHIAT RES, V117, P281, DOI 10.1016/S0165-1781(03)00039-8; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/jnp.14.1.64; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton R., 1993, WISCONSIN CARD SORTI; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Henry JD, 2008, NEUROPSYCHOLOGIA, V46, P1363, DOI 10.1016/j.neuropsychologia.2007.12.012; HIER DB, 1980, APPL PSYCHOLINGUIST, V1, P279, DOI 10.1017/S0142716400000564; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jahshan CS, 2007, SCHIZOPHR RES, V89, P278, DOI 10.1016/j.schres.2006.09.004; KAGAN C, 1984, BRIT J CLIN PSYCHOL, V23, P161, DOI 10.1111/j.2044-8260.1984.tb00643.x; KAHN M, 1970, FAM PROCESS, V9, P449, DOI 10.1111/j.1545-5300.1970.00449.x; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; KAPLAN JA, 1990, BRAIN LANG, V38, P315, DOI 10.1016/0093-934X(90)90117-Y; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kohler CG, 2005, AM J GERIAT PSYCHIAT, V13, P926, DOI 10.1176/appi.ajgp.13.11.926; Kosmidis MH, 2008, BEHAV NEUROL, V19, P65, DOI 10.1155/2008/157356; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCALPINE C, 1992, BEHAV MODIF, V16, P559, DOI 10.1177/01454455920164007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McKenzie K., 2000, BRIT J LEARN DISABIL, V28, P143; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; MUEHLENHARD CL, 1986, BEHAV THER, V17, P404, DOI 10.1016/S0005-7894(86)80071-5; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Palermo MT, 2006, AUTISM, V10, P353, DOI 10.1177/1362361306064431; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Penn DL, 2000, SCHIZOPHR RES, V46, P217, DOI 10.1016/S0920-9964(00)00005-0; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Prodan CI, 2001, NEUROPSY NEUROPSY BE, V14, P206; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rapp A. M., 2011, J INT NEUROPSYCH SOC, V17, P1; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shamay SG, 2002, BRAIN COGNITION, V48, P558, DOI 10.1006/brcg.2001.1417; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Solomon M, 2004, J AUTISM DEV DISORD, V34, P649, DOI 10.1007/s10803-004-5286-y; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss D. T., 2002, PRINCIPLES FRONTAL L; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; TROWER P, 1980, J CONSULT CLIN PSYCH, V48, P327, DOI 10.1037/0022-006X.48.3.327; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; van der Gaag M, 2002, SCHIZOPHRENIA BULL, V28, P167, DOI 10.1093/oxfordjournals.schbul.a006919; VANLANCKER DR, 1987, BRAIN LANG, V32, P265, DOI 10.1016/0093-934X(87)90128-3; WALLANDER JL, 1985, BEHAV ASSESS, V7, P137; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; WINNER E, 1977, BRAIN, V100, P717, DOI 10.1093/brain/100.4.717; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wolwer W, 2005, SCHIZOPHR RES, V80, P295, DOI 10.1016/j.schres.2005.07.018; Young A., 2002, FACIAL EXPRESSIONS E	128	29	29	1	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	MAR	2012	47	1			SI		39	48		10.1111/j.1742-9544.2011.00054.x			10	Psychology, Multidisciplinary	Psychology	879MQ	WOS:000299334300006		Bronze			2021-06-18	
J	Tang, CY; Eaves, E; Dams-O'Connor, K; Ho, L; Leung, E; Wong, E; Carpenter, D; Ng, J; Gordon, W; Pasinetti, G				Tang, Cheuk Ying; Eaves, Emily; Dams-O'Connor, Kristen; Ho, Lap; Leung, Eric; Wong, Edmund; Carpenter, David; Ng, Johnny; Gordon, Wayne; Pasinetti, Giulio			DIFFUSE DISCONNECTIVITY IN TBI: A RESTING STATE FMRI AND DTI STUDY	TRANSLATIONAL NEUROSCIENCE			English	Article						Traumatic Brain Injury (TBI); Functional magnetic resonance imaging (fMRI); DTI; Cognitive Function	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; LATE-LIFE DEPRESSION; AXONAL INJURY; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; MRI; TASK; ABNORMALITIES	Diffuse axonal injury is a common pathological consequence of Traumatic Brain Injury (TBI). Diffusion Tensor Imaging is an ideal technique to study white matter integrity using the Fractional Anisotropy (FA) index which is a measure of axonal integrity and coherence. There have been several reports showing reduced FA in individuals with TBI, which suggest demyelination or reduced fiber density in white matter tracts secondary to injury. Individuals with TBI are usually diagnosed with cognitive deficits such as reduced attention span, memory and executive function. In this study we sought to investigate correlations between brain functional networks, white matter integrity, and TBI severity in individuals with TBI ranging from mild to severe. A resting state functional magnetic resonance imaging protocol was used to study the default mode network in subjects at rest. FA values were decreased throughout all white matter tracts in the mild to severe TBI subjects. FA values were also negatively correlated with TBI injury severity ratings. The default mode network showed several brain regions in which connectivity measures were higher among individuals with TBI relative to control subjects. These findings suggest that, subsequent to TBI, the brain may undergo adaptation responses at the cellular level to compensate for functional impairment due to axonal injury.	[Tang, Cheuk Ying; Eaves, Emily; Leung, Eric; Wong, Edmund; Carpenter, David; Ng, Johnny] Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA; [Tang, Cheuk Ying; Pasinetti, Giulio] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Dams-O'Connor, Kristen; Gordon, Wayne] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Pasinetti, Giulio] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Pasinetti, Giulio] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA	Tang, CY (corresponding author), Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu		Pasinetti, Giulio/0000-0002-1524-5196	National Center for Research Resources (NCRR), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR029887]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG029310] Funding Source: NIH RePORTER	The study was supported by discretionary funding to GMP and Grant Number #UL1RR029887, National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The authors would also like to thank the Image Analysis Core of the Mount Sinai Translational and Molecular Imaging Institute.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2011, NEUROBIOL AGING; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Haler R. J., 1993, BIOL APPROACHES STUD, P317; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; MacDonald CL, 2008, NEUROLOGY, V71, P1199, DOI 10.1212/01.wnl.0000327521.69520.7f; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	38	29	31	0	16	VERSITA	WARSAW	SOLIPSKA 14A-1, 02-482 WARSAW, POLAND	2081-3856			TRANSL NEUROSCI	Transl. Neurosci.	MAR	2012	3	1					9	14		10.2478/s13380-012-0003-3			6	Neurosciences	Neurosciences & Neurology	951CN	WOS:000304698400002	23459252	Green Accepted			2021-06-18	
J	van Bregt, DR; Thomas, TC; Hinzman, JM; Cao, TX; Liu, M; Bing, GY; Gerhardt, GA; Pauly, JR; Lifshitz, J				van Bregt, Daniel R.; Thomas, Theresa Currier; Hinzman, Jason M.; Cao, Tuoxin; Liu, Mei; Bing, Guoying; Gerhardt, Greg A.; Pauly, James R.; Lifshitz, Jonathan			Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Substantia nigra; PCR; Concussion; Parkinsons; Brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL-LEAGUE PLAYER; PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; CELL-DEATH; HEAD-INJURY; DOPAMINERGIC-NEURONS; FISCHER-344 RATS; GENE DELIVERY; MICE	Dementia and parkinsonism are late-onset symptoms associated with repetitive head injury, as documented in multiple contact-sport athletes. Clinical symptomatology is the likely phenotype of chronic degeneration and circuit disruption in the substantia nigra (SN). To investigate the initiating neuropathology, we hypothesize that a single diffuse brain injury is sufficient to initiate SN neuropathology including neuronal loss, vascular disruption and microglial activation, contributing to neurodegeneration and altered dopamine regulation. Adult, male Sprague-Dawley rats were subjected to sham or moderate midline fluid percussion brain injury. Stereological estimates indicated a significant 44% loss of the estimated total neuron number in the SN at 28-days post-injury, without atrophy of neuronal nuclear volumes, including 25% loss of tyrosine hydroxylase positive neurons by 28-days post-injury. Multi-focal vascular compromise occurred 1-2 days post-injury, with ensuing microglial activation (significant 40% increase at 4-days). Neurodegeneration (silver-stain technique) encompassed on average 21% of the SN by 7-days post-injury and increased to 29% by 28-days compared to sham (1%). Whole tissue SN, but not striatum, dopamine metabolism was altered at 28-days post-injury, without appreciable gene or protein changes in dopamine synthesis or regulation elements. Together, single moderate diffuse brain injury resulted in SN neurovascular pathology potentially associated with neuroinflammation or dopamine dysregulation. Compensatory mechanisms may preserve dopamine signaling acutely, but subsequent SN damage with aging or additional injury may expose clinical symptomatology of motor ataxias and dementia. (C) 2011 Elsevier Inc. All rights reserved.	[Lifshitz, Jonathan] Univ Kentucky, Albert B Chandler Med Ctr, SCoBIRC, Off B463,Coll Med, Lexington, KY 40536 USA; [van Bregt, Daniel R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Thomas, Theresa Currier; Hinzman, Jason M.; Liu, Mei; Bing, Guoying; Gerhardt, Greg A.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Hinzman, Jason M.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Morris K Udall Parkinsons Dis Res Ctr Excellence, Lexington, KY 40536 USA; [Hinzman, Jason M.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Ctr Microelectrode Technol, Lexington, KY 40536 USA; [Pauly, James R.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY 40536 USA	Lifshitz, J (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, SCoBIRC, Off B463,Coll Med, Biomed & Biol Sci Res Bldg,741 S Limestone St, Lexington, KY 40536 USA.	JLifshitz@uky.edu	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Bing, Guoying/0000-0003-0609-8152	University of Kentucky College of Medicine; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS065052, F31 NS067899, P30 NS051220]; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG000242]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [7-11, 11-2a]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 NS039787]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, P30NS051220, P50NS039787, F31NS067899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000242] Funding Source: NIH RePORTER	With generous thanks to Amanda Lisembee, Deanne Hopkins, Kelley Hall and Stewart Surgener without whose technical expertise and insightful support this study would not have been possible. Supported, in part, by University of Kentucky College of Medicine, NIH NINDS R01 NS065052, NIH NIA T32 AG000242, NIH NINDS F31 NS067899, Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) 7-11, KSCHIRT 11-2a, NIH P50 NS039787 and NIH NINDS P30 NS051220.	Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; BERNHEIM.H, 1965, KLIN WOCHENSCHR, V43, P711, DOI 10.1007/BF01707066; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Breit S, 2007, EXP NEUROL, V205, P36, DOI 10.1016/j.expneurol.2006.12.016; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Di Monte DA, 2000, MOVEMENT DISORD, V15, P459, DOI 10.1002/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3; Dick AD, 2001, INVEST OPHTH VIS SCI, V42, P170; Duke DC, 2007, NEUROGENETICS, V8, P83, DOI 10.1007/s10048-006-0077-6; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Gash D M, 1998, Adv Pharmacol, V42, P911; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; GUILARTE TR, 1995, NEUROTOXICOLOGY, V16, P441; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hall ED, 1996, BRAIN RES, V742, P80, DOI 10.1016/S0006-8993(96)00968-7; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hebert MA, 1998, BRAIN RES, V797, P42, DOI 10.1016/S0006-8993(98)00370-9; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hornykiewicz O, 1987, Adv Neurol, V45, P19; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; KOPIN IJ, 1994, J NEURAL TRANSM-SUPP, P57; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuhlmann AC, 1997, BRAIN RES, V751, P281, DOI 10.1016/S0006-8993(96)01409-6; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J., 2011, BRAIN STRUCT FUNCT; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Little KY, 1998, AM J PSYCHIAT, V155, P207; Litvan I, 2007, J NEUROPATH EXP NEUR, V66, P251, DOI 10.1097/nen.0b013e3180415e42; Liu M, 2008, J NEUROSCI RES, V86, P2792, DOI 10.1002/jnr.21725; Liu M, 2010, J NEUROCHEM, V112, P773, DOI 10.1111/j.1471-4159.2009.06497.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lotharius J, 1999, J NEUROSCI, V19, P1284; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ JS, 1975, J NEUROSURG, V42, P166, DOI 10.3171/jns.1975.42.2.0166; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; MOKRY J, 1995, PHYSIOL RES, V44, P143; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pedrosa R, 2002, BRIT J PHARMACOL, V137, P1305, DOI 10.1038/sj.bjp.0704982; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Przedborski S, 2010, MOVEMENT DISORD, V25, pS55, DOI 10.1002/mds.22638; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Shih Ming Chi, 2006, Sao Paulo Med. J., V124, P168, DOI 10.1590/S1516-31802006000300014; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Smith L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S2; SMITH RD, 1993, NEUROSCIENCE, V52, P7, DOI 10.1016/0306-4522(93)90176-G; Stanford JA, 2003, NEUROBIOL AGING, V24, P259, DOI 10.1016/S0197-4580(02)00083-0; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Surmeier D.J., 2010, ANTIOXID REDOX SIGNA; Surmeier DJ, 2010, PROG BRAIN RES, V183, P59, DOI 10.1016/S0079-6123(10)83004-3; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Thiffault C, 2000, BRAIN RES, V885, P283, DOI 10.1016/S0006-8993(00)02960-7; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Unterharnscheidt F, 1995, Rev Neurol, V23, P847; Unterharnscheidt F, 1995, Rev Neurol, V23, P661; Unterharnscheidt F, 1995, Rev Neurol, V23, P1013; Unterharnscheidt F, 1995, Rev Neurol, V23, P833; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; West MJ, 1996, J COMP NEUROL, V370, P11; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zigmond MJ, 1997, NEUROBIOL DIS, V4, P247, DOI 10.1006/nbdi.1997.0157	104	29	29	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2012	234	1					8	19		10.1016/j.expneurol.2011.12.003			12	Neurosciences	Neurosciences & Neurology	910DN	WOS:000301617500003	22178300	Green Accepted			2021-06-18	
J	Hoesch, RE; Lin, E; Young, M; Gottesman, RF; Altaweel, L; Nyquist, PA; Stevens, RD				Hoesch, Robert E.; Lin, Eric; Young, Mark; Gottesman, Rebecca F.; Altaweel, Laith; Nyquist, Paul A.; Stevens, Robert D.			Acute lung injury in critical neurological illness	CRITICAL CARE MEDICINE			English	Article						acute lung injury; acute respiratory distress syndrome; cough reflex; gag reflex; mechanical ventilation; pulmonary edema	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; NEUROGENIC PULMONARY-EDEMA; SUBARACHNOID HEMORRHAGE; TIDAL VOLUME; CONSENSUS CONFERENCE; HEART-FAILURE; COUGH REFLEX; RISK-FACTORS; VENTILATION	Objective: Acute lung injury and acute respiratory distress syndrome have been reported in a significant proportion of patients with critical neurologic illness. Our aim was to identify risk factors for acute lung injury/acute respiratory distress syndrome in this population. Design: Prospective, observational study. Setting: A 22-bed, adult neurosciences critical care unit at a tertiary care hospital. Patients: Primary neurologic disorder, mechanical ventilation >48 hrs. Interventions: None. Measurements and Main Results: A total of 192 patients were enrolled with a range of neurologic disorders. Among these, 68 (35%) were diagnosed with acute lung injury/acute respiratory distress syndrome. In a multivariate logistic regression analysis, independent risk factors for acute lung injury/acute respiratory distress syndrome were pneumonia (odds ratio [95% confidence interval] 3.12 [1.5-6.0], p = .002), circulatory shock (2.2 [1.07-4.57], p = .03), and absence of a gag or cough reflex (3.41 [1.34-8.68], p = .01). Neither neurologic diagnosis nor neurologic severity, assessed with the Glasgow Coma Scale, was significantly associated with the development of acute lung injury/acute respiratory distress syndrome. Conclusion: Acute lung injury/acute respiratory distress syndrome occurred in more than one third of mechanically ventilated neurosciences critical care unit patients. Loss of the cough or gag reflex is strongly predictive of acute lung injury/acute respiratory distress syndrome, while neurologic diagnosis and Glasgow Coma Scale are not. Lower brainstem dysfunction, a clinical marker of neurologic injury not captured by the Glasgow Coma Scale, is a risk factor for acute lung injury/acute respiratory distress syndrome and could inform decisions regarding airway protection and mechanical ventilation. (Crit Care Med 2012; 40:587-593)	[Hoesch, Robert E.; Gottesman, Rebecca F.; Altaweel, Laith; Nyquist, Paul A.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hoesch, Robert E.; Lin, Eric; Young, Mark; Nyquist, Paul A.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol Surg, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	rstevens@jhmi.edu	Gottesman, Rebecca/ABA-8468-2020				Addington WR, 1999, STROKE, V30, P1203, DOI 10.1161/01.STR.30.6.1203; [Anonymous], 2000, N ENGL J MED, V342, P1301; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Hammond CAS, 2001, NEUROLOGY, V56, P502, DOI 10.1212/WNL.56.4.502; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Kahn JM, 2005, CRIT CARE MED, V33, P766, DOI 10.1097/01.CCM.0000157786.41506.24; Koenig MA, 2007, INTENS CARE MED, V33, P1587, DOI 10.1007/s00134-007-0704-1; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; MILNE ENC, 1984, RADIOLOGY, V152, P1; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Sedy J, 2008, PHYSIOL RES, V57, P499, DOI 10.33549/physiolres.931432; Sharshar T, 2011, CRIT CARE MED, V39, P1960, DOI 10.1097/CCM.0b013e31821b843b; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Widdicombe J, 2006, RESP PHYSIOL NEUROBI, V150, P105, DOI 10.1016/j.resp.2005.04.013	29	29	29	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	FEB	2012	40	2					587	593		10.1097/CCM.0b013e3182329617			7	Critical Care Medicine	General & Internal Medicine	879EW	WOS:000299313500030	21946655				2021-06-18	
J	Sakurai, A; Atkins, CM; Alonso, OF; Bramlett, HM; Dietrich, WD				Sakurai, Atsushi; Atkins, Coleen M.; Alonso, Ofelia F.; Bramlett, Helen M.; Dietrich, W. Dalton			Mild Hyperthermia Worsens the Neuropathological Damage Associated with Mild Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						concussion; dentate hilus; fluid-percussion brain injury; hyperthermia; temperature; traumatic brain injury	FLUID-PERCUSSION INJURY; CENTRAL-NERVOUS-SYSTEM; DIFFUSE AXONAL INJURY; CEREBRAL-BLOOD-FLOW; INTRAVASCULAR COAGULATION; TEMPERATURE; HYPOTHERMIA; COAGULOPATHY; EXERCISE; MODEL	The effects of slight variations in brain temperature on the pathophysiological consequences of acute brain injury have been extensively described in models of moderate and severe traumatic brain injury (TBI). In contrast, limited information is available regarding the potential consequences of temperature elevations on outcome following mild TBI (mTBI) or concussions. One potential confounding variable with mTBI is the presence of elevated body temperature that occurs in the civilian or military populations due to hot environments combined with exercise or other forms of physical exertion. We therefore determined the histopathological effects of pre- and post-traumatic hyperthermia (39 degrees C) on mTBI. Adult male Sprague-Dawley rats were divided into 3 groups: pre/post-traumatic hyperthermia, post-traumatic hyperthermia alone for 2 h, and normothermia (37 degrees C). The pre/post-hyperthermia group was treated with hyperthermia starting 15 min before mild parasagittal fluid-percussion brain injury (1.4-1.6 atm), with the temperature elevation extending for 2h after trauma. At 72h after mTBI, the rats were perfusion-fixed for quantitative histopathological evaluation. Contusion areas and volumes were significantly larger in the pre/post-hyperthermia treatment group compared to the post-hyperthermia and normothermic groups. In addition, pre/post-traumatic hyperthermia caused the most severe loss of NeuN-positive cells in the dentate hilus compared to normothermia. These neuropathological results demonstrate that relatively mild elevations in temperature associated with pen-traumatic events may affect the long-term functional consequences of mTBI. Because individuals exhibiting mildly elevated core temperatures may be pre-disposed to aggravated brain damage after mTBI or concussion, precautions should be introduced to target this important physiological variable.	Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	Dietrich, WD (corresponding author), Univ Miami, Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis, 1095 NW 14th Terrace R-48, Miami, FL 33136 USA.	ddietrich@miami.edu		Atkins, Coleen/0000-0003-4718-7493	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 042133, R01 NS 056072, P50 NS 030291]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS056072, R01NS042133] Funding Source: NIH RePORTER	The authors wish to thank Jeremy Lytle for editorial assistance and David Sequeira and Yuan Kang for technical support. This study was supported in part by NIH grants R01 NS 042133, R01 NS 056072, and P50 NS 030291.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALMASHHADANI SA, 1994, BLOOD COAGUL FIBRIN, V5, P731, DOI 10.1097/00001721-199410000-00009; Atkins C.M., 2010, EUR J NEUROSCI, V28, P35; Avignone E, 2005, EUR J NEUROSCI, V22, P3077, DOI 10.1111/j.1460-9568.2005.04497.x; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bouchama A, 2005, J APPL PHYSIOL, V98, P697, DOI 10.1152/japplphysiol.00461.2004; Bouchama A, 1996, THROMB HAEMOSTASIS, V76, P909; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CABANAC M, 1975, ANNU REV PHYSIOL, V37, P415, DOI 10.1146/annurev.ph.37.030175.002215; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CARLSSON C, 1976, J NEUROCHEM, V26, P1001, DOI 10.1111/j.1471-4159.1976.tb06484.x; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Chinevere TD, 2008, EUR J APPL PHYSIOL, V103, P307, DOI 10.1007/s00421-008-0707-9; CHOPP M, 1988, STROKE, V19, P1521, DOI 10.1161/01.STR.19.12.1521; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Goosey-Tolfrey V, 2008, J APPL PHYSIOL, V105, P37, DOI 10.1152/japplphysiol.01084.2007; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAYWARD JN, 1968, AM J PHYSIOL, V215, P389; Hermstad Erik, 2010, J Emerg Trauma Shock, V3, P66, DOI 10.4103/0974-2700.58660; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KATSUMURA H, 1995, ACTA NEUROCHIR, V135, P62, DOI 10.1007/BF02307416; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer A.R., 2011, HUM BRAIN M IN PRESS; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Ohmoto Y, 1996, INT J HYPERTHER, V12, P321, DOI 10.3109/02656739609022521; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Rasmussen P, 2010, ACTA PHYSIOL, V199, P63, DOI 10.1111/j.1748-1716.2010.02084.x; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Sukstanskii AL, 2006, P NATL ACAD SCI USA, V103, P12144, DOI 10.1073/pnas.0604376103; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561	77	29	32	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					313	321		10.1089/neu.2011.2152			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300010	22026555	Green Published			2021-06-18	
J	Bashir, S; Vernet, M; Yoo, WK; Mizrahi, I; Theoret, H; Pascual-Leone, A				Bashir, Shahid; Vernet, Marine; Yoo, Woo-Kyoung; Mizrahi, Ilan; Theoret, Hugo; Pascual-Leone, Alvaro			Changes in cortical plasticity after mild traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Theta burst stimulation; motor cortex; excitability; EEG	HUMAN MOTOR CORTEX; STIMULATION; INHIBITION; CONCUSSION; SPORTS	Purpose: Even after a mild traumatic brain injury (TBI) symptoms may be long lasting and never resolve completely. The neurophysiologic substrate for such lasting deficits remains unclear. There is a lack of objective measures of early brain abnormalities following mild TBI, which could shed light on the genesis of these lasting impairments. Methods: Here we report findings in a previously healthy man tested 2 and 6 weeks after a well-documented concussion. Findings were compared with 12 control subjects. All subjects underwent brain magnetic resonance imaging (MRI) and diffusion-tensor imaging (DTI). Testing included neuropsychological evaluation and physiological assessment with TMS and EEG, excitatory/inhibitory balance and brain plasticity. Results: While the MRI, DTI and neuropsychological evaluations showed no abnormalities, neurophysiologic tests revealed subclinical abnormalities in our patient: (1) Significantly higher intracortical facilitation than the control group at both time points; (2) Intracortical inhibition presumably mediated by GABA(B) receptors was absent at week 2, but returned to normal value at week 6; (3) Abnormal mechanisms of plasticity at week 2, that normalize at week 6. Conclusions: These findings demonstrate a transient alteration of brain cortical physiology following concussion independent of anatomical findings and neuropsychological function. This case study suggests that TMS measures may serve as sensitive biomarkers of physiologic brain abnormalities after concussion.	[Bashir, Shahid; Vernet, Marine; Yoo, Woo-Kyoung; Mizrahi, Ilan; Pascual-Leone, Alvaro] Harvard Univ, Berenson Allen Ctr Noninvas Brain Stimulat, Beth Israel Deaconess Med Ctr, Dept Neurol,Med Sch, Boston, MA 02215 USA; [Bashir, Shahid] King Saud Univ, Fac Med, Dept Physiol, Autism Res & Treatment Ctr, Riyadh, Saudi Arabia; [Bashir, Shahid] King Saud Univ, Fac Med, Dept Physiol, AL Amodi Autism Res Chair, Riyadh, Saudi Arabia; [Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Guttmann, E-08193 Barcelona, Spain	Pascual-Leone, A (corresponding author), Harvard Univ, Berenson Allen Ctr Noninvas Brain Stimulat, Beth Israel Deaconess Med Ctr, Dept Neurol,Med Sch, 330 Brookline Ave, Boston, MA 02215 USA.	apleone@bidmc.harvard.edu	Bashir, Shahid/E-7212-2014; Yoo, Woo-Kyoung/B-6356-2013; Bashir, Shahid/N-3031-2019; Pascual-Leone, Alvaro/AAC-5101-2019	Yoo, Woo-Kyoung/0000-0002-1273-0647; Bashir, Shahid/0000-0001-6286-6895; Pascual-Leone, Alvaro/0000-0001-8975-0382; Theoret, Hugo/0000-0002-7458-8797; Vernet, Marine/0000-0001-7331-3567	CIMIT; National Center for Research Resources: Harvard Clinical and Translational Science CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025758]; Fyssen Foundation (France); National Research Foundation of KoreaNational Research Foundation of Korea; Korean Government MESTMinistry of Education, Science and Technology, Republic of KoreaKorean Government [NRF-013-2010-1-E00018]; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758, KL2RR025757] Funding Source: NIH RePORTER	This work was supported in part by grants from CIMIT (Dr. Pascual-Leone), the National Center for Research Resources: Harvard Clinical and Translational Science Center (UL1 RR025758). Dr. Pascual-Leone serves on the scientific advisory boards for Nexstim, Neuronix, Starlab Neuroscience, Allied Mind, Neosync, and Novavision, and holds intellectual property on the real-time integration of transcranial magnetic stimulation (TMS) with electroencephalography (EEG) and magnetic resonance imaging (MRI). Dr. Vernet was supported by the Fyssen Foundation (France). Dr. Yoo was supported by a National Research Foundation of Korea grant funded by the Korean Government MEST, Basic Research Promotion Fund (NRF-013-2010-1-E00018). Mr. Mizrahi was supported by the Doris Duke Charitable Foundation. The authors thank Andrea Vatulas, Cara Burzynski and Ann Connor for their administrative support.	De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Landi D, 2010, RESTOR NEUROL NEUROS, V28, P349, DOI 10.3233/RNN-2010-0538; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	19	29	29	0	26	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	4					277	282		10.3233/RNN-2012-110207			6	Neurosciences	Neurosciences & Neurology	973OA	WOS:000306368300001	22596356	Green Accepted			2021-06-18	
J	Chiang, YH; Chao, DP; Chu, SF; Lin, HW; Huang, SY; Yeh, YS; Lui, TN; Binns, CW; Chiu, WT				Chiang, Yung-Hsiao; Chao, Dan-Ping; Chu, Shu-Fen; Lin, Hui-Wen; Huang, Shih-Yi; Yeh, Yi-Shian; Lui, Tai-Ngar; Binns, Colin W.; Chiu, Wen-Ta			Early Enteral Nutrition and Clinical Outcomes of Severe Traumatic Brain Injury Patients in Acute Stage: A Multi-Center Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						early enteral feeding; GCS; initial severity; sTBI; survival rate	TOTAL PARENTERAL-NUTRITION; METABOLIC-RESPONSE; NITROGEN-EXCRETION; HEAD-TRAUMA; THERAPY; SUPPORT; BENEFITS	Guidelines for patients with severe traumatic brain injury (sTBI) published in 2007 recommend providing early nutrition after trauma. Early enteral nutrition (EN) started within 48 h post-injury reduces clinical malnutrition, prevents bacterial translocation from the gastrointestinal tract, and improves outcome in sTBI patients sustaining hypermetabolism and hypercatabolism. The aim of this study was to examine the effect of early EN support on survival rate, Glasgow Coma Scale (GCS) score, and clinical outcome of sTBI patients. Medical records of sTBI patients with GCS scores 4-8 were recruited from 18 hospitals in Taiwan, excluding patients with GCS scores <= 3. During 2002-2010, data from 145 EN patients receiving appropriate calories and nutrients within 48 h post-trauma were collected and compared with 152 non-EN controls matched for gender, age, body weight, initial GCS score, and operative status. The EN patients had a greater survival rate and GCS score on the 7th day in the intensive care unit (ICU), and a better outcome at 1 month post-injury. After adjusting for age, gender, initial GCS score, and recruitment period, the non-EN patients had a hazard ratio of 14.63 (95% CI 8.58-24.91) compared with EN patients. The GCS score during the first 7 ICU days was significantly improved among EN patients with GCS scores of 6-8 compared with EN patients with GCS scores of 4-5 and non-EN patients with GCS scores of 6-8. This finding demonstrates that EN within 48 h post-injury is associated with better survival, GCS recovery, and outcome among sTBI patients, particularly in those with a GCS score of 6-8.	[Lui, Tai-Ngar; Chiu, Wen-Ta] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 11696, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Sch Med, Taipei 11696, Taiwan; [Chao, Dan-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 11696, Taiwan; [Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Taipei 11696, Taiwan; [Lin, Hui-Wen] Taipei Med Univ, Biostat & Res Consultat Ctr, Taipei 11696, Taiwan; [Huang, Shih-Yi] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei 11696, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Med Sci, Taipei 11696, Taiwan; [Yeh, Yi-Shian] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei 11696, Taiwan; [Binns, Colin W.] Curtin Univ Technol, Sch Publ Hlth, Perth, WA, Australia	Lui, TN (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, 111,Sec 3,Hsing Long Rd, Taipei 11696, Taiwan.	cgmh604082@gmail.com; wtchiu@tmu.edu.tw	Binns, Colin W/A-6012-2008; Huang, Shih-Yi/R-3495-2018	Binns, Colin W/0000-0002-6220-3933; Huang, Shih-Yi/0000-0003-2914-5513	National Health Research InstitutesNational Health Research Institutes, Japan [NHRI-EX100-9707PI]; Department of Health, Executive Yuan [DOH100-TD-B-111-003]; National Science Council, Executive Yuan from the Taiwanese government [NSC98-2321-B-038-003-MY3]	This study was supported by the National Health Research Institutes grant NHRI-EX100-9707PI, the Department of Health, Executive Yuan grant DOH100-TD-B-111-003, and the National Science Council, Executive Yuan grant NSC98-2321-B-038-003-MY3 from the Taiwanese government.	BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; Chen W.L., 2007, CLIN PRACTICE GUIDEL, P167; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Aguilar-Nascimento JE, 2008, CURR OPIN CLIN NUTR, V11, P255, DOI 10.1097/MCO.0b013e3282fba5c6; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Hadley MN, 1996, NUTRITION, V12, P125, DOI 10.1016/S0899-9007(97)85050-3; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HAUSMANN D, 1985, INTENS CARE MED, V11, P80; Kattelmann KK, 2006, J AM DIET ASSOC, V106, P1226, DOI 10.1016/j.jada.2006.05.320; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Lewis SJ, 2001, BRIT MED J, V323, P773, DOI 10.1136/bmj.323.7316.773; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; MOORE EE, 1986, J TRAUMA, V26, P874, DOI 10.1097/00005373-198610000-00003; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Roberts P.R., 1999, CRIT CARE MED, V27, P135; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	35	29	46	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					75	80		10.1089/neu.2011.1801			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300008	21534720				2021-06-18	
J	Epstein, DR; Babcock-Parziale, JL; Haynes, PL; Herb, CA				Epstein, Dana R.; Babcock-Parziale, Judith L.; Haynes, Patricia L.; Herb, Christine A.			Insomnia treatment acceptability and preferences of male Iraq and Afghanistan combat Veterans and their healthcare providers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cognitive-behavioral treatment; healthcare providers; insomnia; OIF/OEF Veterans; pharmacotherapy; polytrauma; sleep; traumatic brain injury; treatment acceptability; treatment preference	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; SLEEP DISTURBANCE; INVENTORY-II; DEPRESSION; INTERVENTION; NIGHTMARES; EFFICACY	Sleep difficulty is a prevalent problem among returning Veterans. Although there is strong evidence for the efficacy and durability of cognitive-behavioral treatment for insomnia (CBT-I) in the general population, the interventions require motivation, attention, and adherence from patients to achieve successful outcomes. Given the unique characteristics of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans who have experienced blast-related injuries and other trauma, CBT-I for these patients may require modification, including alternative delivery methods, to ensure effective implementation and positive outcomes. We interviewed 18 OIF/OEF Veterans who screened positive for mild traumatic brain injury and 19 healthcare providers to determine the acceptability of insomnia treatments and preferences for the interventions and treatment delivery. Veterans and providers had distinct preferences for insomnia treatment and its delivery. The treatments the Veterans found most acceptable were also the ones they preferred: relaxation treatment and pharmacotherapy. The providers identified relaxation therapy as the most acceptable treatment. Veterans preferred the individual treatment format as well as electronic methods of treatment delivery. Despite some differences between patients and providers, a compromise through modification of empirically supported behavioral treatments is feasible, and implications for preference-based insomnia intervention development and testing are discussed.	[Epstein, Dana R.; Herb, Christine A.] Phoenix Dept Vet Affairs VA Hlth Care Syst, Phoenix, AZ USA; [Epstein, Dana R.] Arizona State Univ, Phoenix, AZ USA; [Babcock-Parziale, Judith L.; Haynes, Patricia L.] Southern Arizona VA Healthcare Syst, Tucson, AZ USA; [Haynes, Patricia L.] Univ Arizona, Tucson, AZ USA	Epstein, DR (corresponding author), Phoenix VA Hlth Care Syst, 650 Indian Sch Rd RS-151, Phoenix, AZ 85012 USA.	dana.epstein@va.gov			VA Health Services Research and Development's Quality Enhancement Research Initiative (QUERI) [RRP 07-309]	This material was based on work supported by the VA Health Services Research and Development's Quality Enhancement Research Initiative (QUERI) (grant RRP 07-309).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bootzin RR, 2011, ANNU REV CLIN PSYCHO, V7, P435, DOI 10.1146/annurev.clinpsy.3.022806.091516; Bootzin RR, 1978, PROGR BEHAV MODIFICA, V6, P1; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Calohan J, 2010, J TRAUMA STRESS, V23, P645, DOI 10.1002/jts.20570; Carter PA, 2006, CANCER NURS, V29, P95, DOI 10.1097/00002820-200603000-00003; Cook JM, 2010, J TRAUMA STRESS, V23, P553, DOI 10.1002/jts.20569; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; Edinger JD, 2003, SLEEP, V26, P177, DOI 10.1093/sleep/26.2.177; Epstein D, 2009, SLEEP, V32, pA272; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Goodie JL, 2009, J CLIN PSYCHOL, V65, P294, DOI 10.1002/jclp.20548; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jungquist CR, 2010, SLEEP MED, V11, P302, DOI 10.1016/j.sleep.2009.05.018; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; McCrae CS, 2007, AM J GERIAT PSYCHIAT, V15, P979, DOI 10.1097/JGP.0b013e31813547e6; Moldofsky H, 2001, SLEEP MED REV, V5, P387, DOI 10.1053/smrv.2001.0179; Morin CM, 2006, SLEEP MED, V7, pS15, DOI 10.1016/j.sleep.2006.03.005; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; MORIN CM, 1992, SLEEP, V15, P302, DOI 10.1093/sleep/15.4.302; National Center for PTSD, 2007, PTSD CHECKL PCL; National Institutes of Health, 2005, SLEEP, V28, P1049; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ong J, 2010, J CLIN PSYCHOL, V66, P1175, DOI 10.1002/jclp.20736; Ong JC, 2008, BEHAV THER, V39, P171, DOI 10.1016/j.beth.2007.07.002; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sidani S, 2006, WORLDV EVID-BASED NU, V3, P116, DOI 10.1111/j.1741-6787.2006.00060.x; Sidani S, 2009, RES NURS HEALTH, V32, P419, DOI 10.1002/nur.20329; Smith S, 2001, J SLEEP RES, V10, P229, DOI 10.1046/j.1365-2869.2001.00262.x; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Spielman AJ, 2010, MED PSYCHIATRY, P277; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Ulmer CS, 2011, J CLIN SLEEP MED, V7, P57; Vincent N, 2001, SLEEP, V24, P411, DOI 10.1093/sleep/24.4.411; Zayfert C, 2004, J TRAUMA STRESS, V17, P69, DOI 10.1023/B:JOTS.0000014679.31799.e7	54	29	30	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	6					867	878		10.1682/JRRD.2011.06.0114			12	Rehabilitation	Rehabilitation	149EX	WOS:000319302900005	23299258	Bronze			2021-06-18	
J	Riganello, F; Garbarino, S; Sannita, WG				Riganello, Francesco; Garbarino, Sergio; Sannita, Walter G.			Heart Rate Variability, Homeostasis, and Brain Function A Tutorial and Review of Application	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						heart rate variability; central autonomic network; methods; homeostasis; cognition; emotions; clinical application	RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC NERVOUS-SYSTEM; MEDIAL PREFRONTAL NETWORKS; POWER SPECTRUM ANALYSIS; POSTTRAUMATIC-STRESS-DISORDER; BAROREFLEX CARDIAC CONTROL; CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; VAGAL TONE; ANXIETY DISORDERS	Measures of heart rate variability (HRV) are major indices of the sympathovagal balance in cardiovascular research. These measures are thought to reflect complex patterns of brain activation as well and HRV is now emerging as a descriptor thought to provide information on the nervous system organization of homeostatic responses in accordance with the situational requirements. Current models of integration equate HRV to the affective states as parallel outputs of the central autonomic network, with HRV reflecting its organization of affective, physiological, "cognitive,'' and behavioral elements into a homeostatic response. Clinical application is in the study of patients with psychiatric disorders, traumatic brain injury, impaired emotion-specific processing, personality, and communication disorders. HRV responses to highly emotional sensory inputs have been identified in subjects in vegetative state and in healthy or brain injured subjects processing complex sensory stimuli. In this respect, HRV measurements can provide additional information on the brain functional setup in the severely brain damaged and would provide researchers with a suitable approach in the absence of conscious behavior or whenever complex experimental conditions and data collection are impracticable, as it is the case, for example, in intensive care units.	[Garbarino, Sergio; Sannita, Walter G.] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Riganello, Francesco] S Anna Inst, Crotone, Italy; [Sannita, Walter G.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Sannita, WG (corresponding author), Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy.	wgs@dism.unige.it	Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020; Garbarino, Sergio/X-5368-2018	Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; Garbarino, Sergio/0000-0002-8508-552X			AASMAN J, 1987, HUM FACTORS, V29, P161; Abdullah H, 2009, IEEE ENG MED BIO, P5014, DOI 10.1109/IEMBS.2009.5334607; Abrams DA, 2011, CEREB CORTEX, V21, P1507, DOI 10.1093/cercor/bhq198; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Adjei P, 2009, EPILEPSY RES, V87, P281, DOI 10.1016/j.eplepsyres.2009.08.011; Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Ahs F, 2009, NEUROIMAGE, V47, P815, DOI 10.1016/j.neuroimage.2009.05.091; Ahsberg E, 2000, ERGONOMICS, V43, P252, DOI 10.1080/001401300184594; Ako M, 2003, PSYCHIAT CLIN NEUROS, V57, P59, DOI 10.1046/j.1440-1819.2003.01080.x; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Anders D, 2010, CHRONOBIOL INT, V27, P1609, DOI 10.3109/07420528.2010.504317; Aoki K, 2001, AM J PHYSIOL-REG I, V281, pR591; APELBAUM H, 2001, DISS ABSTR INT B, V61, P6742; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; AstonJones G, 1996, PROG BRAIN RES, V107, P379; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Aysin B, 2007, P ANN INT IEEE EMBS, P5047, DOI 10.1109/IEMBS.2007.4353474; Aysin Benhur, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1776; BACKS RW, 1994, INT J PSYCHOPHYSIOL, V16, P57, DOI 10.1016/0167-8760(94)90042-6; BACKS RW, 1991, P HUM FACT SOC 35, P1495; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Badra LJ, 2001, AM J PHYSIOL-HEART C, V280, pH2674; Bar KJ, 2008, PSYCHIAT RES, V157, P255, DOI 10.1016/j.psychres.2007.04.021; Bar KJ, 2006, ALCOHOL CLIN EXP RES, V30, P1592, DOI 10.1111/j.1530-0277.2006.00191.x; Bai XP, 2009, AM J PHYSIOL-HEART C, V297, pH765, DOI 10.1152/ajpheart.01283.2008; BALOGH S, 1993, PSYCHOPHARMACOL BULL, V29, P201; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Bar KJ, 2005, J PSYCHIATR RES, V39, P519, DOI 10.1016/j.jpsychires.2004.12.007; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Barbieri R, 2002, AM J PHYSIOL-REG I, V283, pR1210, DOI 10.1152/ajpregu.00127.2002; Bartels MN, 2003, CHEST, V124, P863, DOI 10.1378/chest.124.3.863; Bassi A, 2010, EUR NEUROL, V63, P279, DOI 10.1159/000287583; Beauchaine T, 2001, DEV PSYCHOPATHOL, V13, P183, DOI 10.1017/S0954579401002012; Beda A, 2007, PSYCHOPHYSIOLOGY, V44, P767, DOI 10.1111/j.1469-8986.2007.00542.x; Benarroch EE, 2006, NEUROL SCI, V27, pS130, DOI 10.1007/s10072-006-0587-x; Benarroch E.E., 2007, CONTINUUM LIFELONG L, V13, P13, DOI [10.1212/01.CON.0000299964.20642.9a, DOI 10.1212/01.CON.0000299964.20642.9A]; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bentley M. T., 2003, Medicine & Science in Sports & Exercise, V35, pS254, DOI 10.1097/00005768-200305001-01413; BERNE C, 1992, DIABETOLOGIA, V35, P873, DOI 10.1007/BF00399935; Berntson G. G., 1999, CARD ELECTROPHYSIOL, V3, P279, DOI [10.1023/A:1009920002142, DOI 10.1023/A:1009920002142]; Berntson GG, 2007, BIOL PSYCHOL, V74, P295, DOI 10.1016/j.biopsycho.2006.08.006; BERNTSON GG, 1993, PSYCHOL BULL, V114, P296, DOI 10.1037/0033-2909.114.2.296; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Berntson GG, 1998, BEHAV BRAIN RES, V94, P225, DOI 10.1016/S0166-4328(98)00041-2; Berntson GG, 2004, PSYCHOPHYSIOLOGY, V41, P333, DOI 10.1111/j.1469-8986.2004.00156.x; Berntson GG, 2003, EUR J NEUROSCI, V18, P2103, DOI 10.1046/j.1460-9568.2003.02967.x; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P572, DOI 10.1111/j.1469-8986.1994.tb02350.x; Bianchi AM, 2010, METHOD INFORM MED, V49, P479, DOI 10.3414/ME09-02-0037; Bilgin S, 2010, J MED SYST, V34, P155, DOI 10.1007/s10916-008-9227-8; Blom EH, 2010, ACTA PAEDIATR, V99, P604, DOI 10.1111/j.1651-2227.2009.01657.x; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; BOOTSMA M, 1994, AM J PHYSIOL, V266, pH1565; Braga ANG, 2002, AM J PHYSIOL-REG I, V282, pR1663, DOI 10.1152/ajpregu.00583.2001; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Britton A, 2008, NEUROEPIDEMIOLOGY, V31, P115, DOI 10.1159/000148257; BROWN HN, 1981, PSYCHOSOMATICS, V22, P907; Buchanan TW, 2010, PSYCHONEUROENDOCRINO, V35, P56, DOI 10.1016/j.psyneuen.2009.09.006; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Cadeddu C, 2010, EPILEPSY RES, V92, P145, DOI 10.1016/j.eplepsyres.2010.08.012; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; Cain KC, 2007, NEUROGASTROENT MOTIL, V19, P110, DOI 10.1111/j.1365-2982.2006.00877.x; Camacho, 2001, NONLINEAR BIOMEDICAL, V2, P1; Cameron OG, 2009, NEUROIMAGE, V47, P787, DOI 10.1016/j.neuroimage.2009.05.010; Campana LM, 2010, J APPL PHYSIOL, V108, P1668, DOI 10.1152/japplphysiol.00013.2010; Carrasco S, 2001, J MED ENG TECHNOL, V25, P240, DOI 10.1080/03091900110086651; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Chang CS, 2010, NEUROGASTROENT MOTIL, V22, P546, DOI 10.1111/j.1365-2982.2009.01455.x; Chellakumar PJ, 2005, PHYSIOL MEAS, V26, P979, DOI 10.1088/0967-3334/26/6/008; Chen CL, 2006, SCAND J GASTROENTERO, V41, P1001, DOI 10.1080/00365520600575688; Chen JL, 2006, CLIN ENDOCRINOL, V64, P611, DOI 10.1111/j.1365-2265.2006.02514.x; Chen QH, 2003, NEUROSCIENCE, V118, P797, DOI 10.1016/S0306-4522(03)00033-2; Clark KB, 1999, NAT NEUROSCI, V2, P94; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 1998, BIOL PSYCHIAT, V44, P1054, DOI 10.1016/S0006-3223(97)00475-7; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Cohen H, 2006, AUTON NEUROSCI-BASIC, V128, P1, DOI 10.1016/j.autneu.2005.06.007; Conte V, 2009, J NEUROSURG ANESTH, V21, P242, DOI 10.1097/ANA.0b013e31819b61df; Cooke WH, 1998, AM J PHYSIOL-HEART C, V274, pH709, DOI 10.1152/ajpheart.1998.274.2.H709; Craig AD, 2004, J COMP NEUROL, V477, P119, DOI 10.1002/cne.20240; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DALACK GW, 1990, J CLIN PSYCHIAT, V51, P4; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; de Bruyne MC, 1999, AM J EPIDEMIOL, V150, P1282; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; de Zambotti M, 2011, J SLEEP RES, V20, P318, DOI 10.1111/j.1365-2869.2010.00871.x; DEBOER RW, 1984, IEEE T BIO-MED ENG, V31, P384, DOI 10.1109/TBME.1984.325351; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Dekker JM, 1997, AM J EPIDEMIOL, V145, P899, DOI 10.1093/oxfordjournals.aje.a009049; Dolce G, 2008, J PSYCHOPHYSIOL, V22, P150, DOI 10.1027/0269-8803.22.3.150; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dringenberg HC, 1997, EXP BRAIN RES, V116, P160, DOI 10.1007/PL00005736; Dringenberg HC, 1998, NEUROSCI BIOBEHAV R, V22, P243, DOI 10.1016/S0149-7634(97)00012-2; Dringenberg HC, 2002, EUR J PHARMACOL, V447, P43, DOI 10.1016/S0014-2999(02)01829-0; Dumont M, 2004, CLIN NEUROPHYSIOL, V115, P2031, DOI 10.1016/j.clinph.2004.04.007; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; DWORKIN BR, 1994, P NATL ACAD SCI USA, V91, P6329, DOI 10.1073/pnas.91.14.6329; Earnest CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002288; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1983, J APPL PHYSIOL, V54, P961; Edwards L, 2002, PSYCHOPHYSIOLOGY, V39, P678, DOI 10.1017/S0048577202011770; Egizio VB, 2008, PSYCHOPHYSIOLOGY, V45, P1046, DOI 10.1111/j.1469-8986.2008.00698.x; Eibe F., 2004, MACHINE LEARNING WEK; Ellis RJ, 2010, MUSIC PERCEPT, V27, P317, DOI 10.1525/MP.2010.27.4.317; Ermis N, 2010, AUTON NEUROSCI-BASIC, V152, P84, DOI 10.1016/j.autneu.2009.08.018; ESLER M, 1993, PHARMACOL TOXICOL, V73, P243, DOI 10.1111/j.1600-0773.1993.tb00579.x; Eustatia-Rutten CFA, 2008, J CLIN ENDOCR METAB, V93, P2835, DOI 10.1210/jc.2008-0080; Faith M, 2001, SCAND J PSYCHOL, V42, P121, DOI 10.1111/1467-9450.00221; Faye PM, 2010, CLIN J PAIN, V26, P777, DOI 10.1097/AJP.0b013e3181ed1058; Field T, 2008, INFANT BEHAV DEV, V31, P361, DOI 10.1016/j.infbeh.2007.12.008; Flouris AD, 2009, J SPORT MED PHYS FIT, V49, P382; Fojt O, 1998, IEEE ENG MED BIOL, V17, P96, DOI 10.1109/51.664037; Fournier GN, 2004, NEUROSCIENCE, V123, P785, DOI 10.1016/j.neuroscience.2003.10.021; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; Friedman BH, 1996, CLIN AUTON RES, V6, P147, DOI 10.1007/BF02281901; Friedman BH, 1998, J PSYCHOSOM RES, V44, P133, DOI 10.1016/S0022-3999(97)00202-X; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Fujibayashi M, 2009, AM J HUM BIOL, V21, P828, DOI 10.1002/ajhb.20899; Fukusaki C, 2000, CLIN AUTON RES, V10, P123, DOI 10.1007/BF02278016; Fulbright RK, 2001, AM J ROENTGENOL, V177, P1205, DOI 10.2214/ajr.177.5.1771205; FULLER BF, 1992, INT J PSYCHOPHYSIOL, V12, P81, DOI 10.1016/0167-8760(92)90045-D; Fusheng Y, 2001, NONLINEAR BIOMEDICAL, V11, P72; Galluzzi S, 2009, J GERONTOL A-BIOL, V64, P1312, DOI 10.1093/gerona/glp105; Ge DF, 2002, BIOMED ENG ONLINE, V1, DOI 10.1186/1475-925X-1-5; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; GELSEMA AJ, 1989, J AUTONOM NERV SYST, V27, P91, DOI 10.1016/0165-1838(89)90091-X; Giagkoudaki F, 2010, J SPORT REHABIL, V19, P173, DOI 10.1123/jsr.19.2.173; Gianaros PJ, 2005, PSYCHOSOM MED, V67, P553, DOI 10.1097/01.psy.0000170335.92770.7a; Gianaros PJ, 2004, PSYCHOPHYSIOLOGY, V41, P521, DOI 10.1111/1469-8986.2004.00179.x; Goedhart AD, 2008, PSYCHOPHYSIOLOGY, V45, P1086, DOI 10.1111/j.1469-8986.2008.00710.x; Goldstein David S, 2010, Cleve Clin J Med, V77 Suppl 3, pS34, DOI 10.3949/ccjm.77.s3.06; Gorman JM, 2000, AM HEART J, V140, P577; Grant CC, 2009, AUTON NEUROSCI-BASIC, V151, P186, DOI 10.1016/j.autneu.2009.08.015; Gray MA, 2009, J NEUROSCI, V29, P1817, DOI 10.1523/JNEUROSCI.3363-08.2009; Grippo AJ, 2002, NEUROSCI BIOBEHAV R, V26, P941, DOI 10.1016/S0149-7634(03)00003-4; Gross J. J., 1998, REV GEN PSYCHOL VOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Han J., 2006, DATA MINING CONCEPTS; Hansen A. L., 2003, INT J PSYCHOPHYSIOL, V40, P306; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hansen AL, 2009, ANXIETY STRESS COPIN, V22, P77, DOI 10.1080/10615800802272251; Harnod T, 2009, SEIZURE-EUR J EPILEP, V18, P21, DOI 10.1016/j.seizure.2008.05.013; Harper R M, 1996, Semin Pediatr Neurol, V3, P13, DOI 10.1016/S1071-9091(96)80024-6; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Hassert DL, 2004, BEHAV NEUROSCI, V118, P79, DOI 10.1037/0735-7044.118.1.79; HAYANO J, 1991, AM J CARDIOL, V67, P199, DOI 10.1016/0002-9149(91)90445-Q; Henderson LA, 2002, J NEUROPHYSIOL, V88, P3477, DOI 10.1152/jn.00107.2002; Holdstock L, 2001, ALCOHOL CLIN EXP RES, V25, P540, DOI 10.1097/00000374-200104000-00010; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Houtveen JH, 2002, PSYCHOPHYSIOLOGY, V39, P427, DOI 10.1017/S0048577202394022; Hsu DT, 2007, J COMP NEUROL, V504, P89, DOI 10.1002/cne.21440; Hynynen E, 2010, INT J SPORTS MED, V31, P428, DOI 10.1055/s-0030-1249625; Hynynen E, 2011, EUR J APPL PHYSIOL, V111, P733, DOI 10.1007/s00421-010-1698-x; Inagaki H, 2004, EXP ANIM TOKYO, V53, P373, DOI 10.1538/expanim.53.373; Ingjaldsson JT, 2003, BIOL PSYCHIAT, V54, P1427, DOI 10.1016/S0006-3223(02)01926-1; INUI K, 1995, J PHYSIOL-LONDON, V488, P521, DOI 10.1113/jphysiol.1995.sp020987; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Jansen K, 2010, SEIZURE-EUR J EPILEP, V19, P455, DOI 10.1016/j.seizure.2010.07.008; Jeanne M, 2009, AUTON NEUROSCI-BASIC, V147, P91, DOI 10.1016/j.autneu.2009.01.005; Jehi Lara, 2010, Cleve Clin J Med, V77 Suppl 3, pS51, DOI 10.3949/ccjm.77.s3.09; Jianling S., 2010, CELL BIOCHEM BIOPHYS, V59, P165; Johnsen BH, 2003, J ANXIETY DISORD, V17, P75, DOI 10.1016/S0887-6185(02)00178-0; Jonsson P, 2007, INT J PSYCHOPHYSIOL, V63, P48, DOI 10.1016/j.ijpsycho.2006.08.002; KAMADA T, 1992, PSYCHOSOM MED, V54, P462, DOI 10.1097/00006842-199207000-00008; Karasulu L, 2010, LUNG, V188, P315, DOI 10.1007/s00408-010-9237-4; Karthik S, 2009, Indian J Physiol Pharmacol, V53, P243; Katoh K, 2002, ALIMENT PHARM THERAP, V16, P180, DOI 10.1046/j.1365-2036.16.s2.27.x; KATONA PG, 1975, J APPL PHYSIOL, V39, P801; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; KAWACHI I, 1995, AM J CARDIOL, V75, P882, DOI 10.1016/S0002-9149(99)80680-8; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.12.012, 10.1016/j.biopsych.2009.11.019]; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Khaykin Y, 1998, CAN J PSYCHIAT, V43, P183, DOI 10.1177/070674379804300209; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kimmerly DS, 2005, J PHYSIOL-LONDON, V569, P331, DOI 10.1113/jphysiol.2005.091637; King AB, 1999, J COMP NEUROL, V413, P572; King ML, 1997, BRAIN INJURY, V11, P445; Kitzlerova E, 2007, NEUROENDOCRINOL LETT, V28, P832; Kiviniemi AM, 2010, MED SCI SPORT EXER, V42, P1355, DOI 10.1249/MSS.0b013e3181cd5f39; KLEIGER RE, 1991, AM J CARDIOL, V68, P626, DOI 10.1016/0002-9149(91)90355-O; KOIZUMI K, 1981, J AUTONOM NERV SYST, V3, P483, DOI 10.1016/0165-1838(81)90082-5; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; Kondo H, 2003, J COMP NEUROL, V465, P499, DOI 10.1002/cne.10842; Kotchoubey B, 2006, J NEUROL, V253, P1374, DOI 10.1007/s00415-006-0221-0; Krittayaphong R, 1997, PSYCHOSOM MED, V59, P231, DOI 10.1097/00006842-199705000-00004; Kuo TBJ, 2009, EXP NEUROL, V217, P38, DOI 10.1016/j.expneurol.2009.01.012; Kuusela Tom A, 2003, BMC Physiol, V3, P11, DOI 10.1186/1472-6793-3-11; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lane RD, 2001, BRAIN COGNITION, V47, P97; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lanfranchi PA, 2002, AM J PHYSIOL-REG I, V283, pR815, DOI 10.1152/ajpregu.00051.2002; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; Liao DP, 1999, ENVIRON HEALTH PERSP, V107, P521, DOI 10.2307/3434393; Liao DP, 2004, AM J EPIDEMIOL, V159, P768, DOI 10.1093/aje/kwh109; Liao DP, 1997, AM J EPIDEMIOL, V145, P696, DOI 10.1093/aje/145.8.696; Licht C. M., 2011, BIOL PSYCHIAT, V67, P1067; Licht CMM, 2010, BIOL PSYCHIAT, V68, P861, DOI 10.1016/j.biopsych.2010.06.032; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; LITVACK DA, 1995, PSYCHOPHYSIOLOGY, V32, P492, DOI 10.1111/j.1469-8986.1995.tb02101.x; Loewy AD, 1990, CENTRAL REGULATION A, P168; Lombardi F, 1996, CARDIOVASC RES, V32, P208, DOI 10.1016/0008-6363(96)00116-2; Lombardi F, 2001, CARDIOVASC RES, V50, P210, DOI 10.1016/S0008-6363(01)00221-8; Lombardi Federico, 2002, Card Electrophysiol Rev, V6, P245, DOI 10.1023/A:1016329008921; Longin E, 2005, EARLY HUM DEV, V81, P663, DOI 10.1016/j.earlhumdev.2005.03.015; Looser RR, 2010, PSYCHOSOM MED, V72, P281, DOI 10.1097/PSY.0b013e3181d35065; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; Lunt HC, 2010, J PHYSIOL-LONDON, V588, P3605, DOI 10.1113/jphysiol.2010.193458; Machado C, 2011, CLIN NEUROPHYSIOL, V122, P1059, DOI 10.1016/j.clinph.2010.08.022; Malarvili MB, 2008, IEEE ENG MED BIO, P4756, DOI 10.1109/IEMBS.2008.4650276; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6; Martinmaki K, 2008, EUR J APPL PHYSIOL, V102, P353, DOI 10.1007/s00421-007-0594-5; Mashin VA, 2000, HUMAN PHYSL, V26, P420, DOI [10.1007/BF02760270, DOI 10.1007/BF02760270]; Mativo P, 2010, EPILEPTIC DISORD, V12, P212, DOI 10.1684/epd.2010.0325; May O, 2011, ACTA DIABETOL, V48, P55, DOI 10.1007/s00592-010-0222-4; McCraty R, 2001, BIOL PSYCHOL, V56, P131, DOI 10.1016/S0301-0511(01)00074-6; MCGRADY A, 1994, BIOFEEDBACK SELF-REG, V19, P51, DOI 10.1007/BF01720670; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Mendonca GV, 2010, APPL PHYSIOL NUTR ME, V35, P439, DOI 10.1139/H10-028; Monk C, 2001, INT J NEUROPSYCHOPH, V4, P199, DOI 10.1017/S146114570100236X; Montano N, 1998, CIRCULATION, V98, P1394, DOI 10.1161/01.CIR.98.14.1394; Monteiro WD, 2011, EUR J APPL PHYSIOL, V111, P1017, DOI 10.1007/s00421-010-1720-3; Moodithaya Shailaja S, 2009, Indian J Physiol Pharmacol, V53, P227; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Mulder G., 1986, ENERGETICS HUMAN INF, P175, DOI DOI 10.1007/978-94-009-4448-0_12; Mulder L. J. M., 2002, HUMAN FACTORS TRANSP, P297; Murakami H, 2007, PERCEPT MOTOR SKILL, V105, P299, DOI 10.2466/PMS.105.5.299-308; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Mylonopoulou M, 2010, NEPHROL DIAL TRANSPL, V25, P3749, DOI 10.1093/ndt/gfq226; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147; Nickel P, 2003, HUM FACTORS, V45, P575, DOI 10.1518/hfes.45.4.575.27094; Nickel P, 2003, J PSYCHOPHYSIOL, V17, P94; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Nobili L, 1997, VISION RES, V37, P3559, DOI 10.1016/S0042-6989(97)00076-X; O'Connor MF, 2007, NEUROPSYCHOPHARMACOL, V32, P2184, DOI 10.1038/sj.npp.1301342; Ohtake Yuka, 2007, Rinsho Byori, V55, P1075; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; PAGANI M, 1992, TRENDS PHARMACOL SCI, V13, P50, DOI 10.1016/0165-6147(92)90022-X; Pal G. K., 2007, TXB PHYSL, P6; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Park Mi-Kyong, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P601, DOI 10.2114/jpa.24.601; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Patra S, 2010, APPL PSYCHOPHYS BIOF, V35, P135, DOI 10.1007/s10484-009-9114-1; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENISTON EG, 1986, PSYCHOL REC, V36, P471, DOI 10.1007/BF03394967; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Pereira EAC, 2010, EXP NEUROL, V223, P574, DOI 10.1016/j.expneurol.2010.02.004; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Persson H, 2007, SEIZURE-EUR J EPILEP, V16, P504, DOI 10.1016/j.seizure.2007.03.010; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Philippu A, 2001, DRUG NEWS PERSPECT, V14, P523, DOI 10.1358/dnp.2001.14.9.858409; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Piccirillo G, 1997, INT J CARDIOL, V60, P121, DOI 10.1016/S0167-5273(97)00088-0; Pichon A, 2010, AUTON NEUROSCI-BASIC, V156, P117, DOI 10.1016/j.autneu.2010.03.019; Pieper S, 2010, PSYCHOSOM MED, V72, P570, DOI 10.1097/PSY.0b013e3181dbc0e9; Ponomarenko V. I., 2009, WORLD ACAD SCI ENG T, V56, P581; Porges SW, 2007, BIOL PSYCHOL, V74, P301, DOI 10.1016/j.biopsycho.2006.08.007; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Pu J, 2010, BIOL PSYCHOL, V84, P531, DOI 10.1016/j.biopsycho.2009.07.006; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rasic-Milutinovic ZR, 2010, SAUDI MED J, V31, P650; RECHLIN T, 1994, J AFFECT DISORDERS, V32, P271, DOI 10.1016/0165-0327(94)90091-4; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RICHTER A, 1990, INT J PSYCHOPHYSIOL, V10, P75, DOI 10.1016/0167-8760(90)90048-I; Rickard NS, 2004, PSYCHOL MUSIC, V32, P371, DOI DOI 10.1177/0305735604046096; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Riganello F, 2008, J PSYCHOPHYSIOL, V22, P166, DOI 10.1027/0269-8803.22.4.166; Riganello F, 2011, CLIN NEUROPHYSIOL, V122, P1061, DOI 10.1016/j.clinph.2010.09.006; Riganello F, 2009, J PSYCHOPHYSIOL, V23, P18, DOI 10.1027/0269-8803.23.1.18; RIMOLDI O, 1990, AM J PHYSIOL, V258, pH967; Ross DC, 2002, J CLIN PSYCHOPHARM, V22, P414, DOI 10.1097/00004714-200208000-00013; Rottenberg J, 2007, BIOL PSYCHOL, V74, P200, DOI 10.1016/j.biopsycho.2005.08.010; Roumelioti ME, 2010, NEPHROL DIAL TRANSPL, V25, P3733, DOI 10.1093/ndt/gfq234; Roy RA, 2009, J MANIP PHYSIOL THER, V32, P277, DOI 10.1016/j.jmpt.2009.03.003; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sala Michela, 2009, Ther Adv Cardiovasc Dis, V3, P29, DOI 10.1177/1753944708096282; Santucci AK, 2000, PSYCHOPHYSIOLOGY, V37, pS86; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; SAUL JP, 1990, NEWS PHYSIOL SCI, V5, P32; Sauvet F, 2009, AVIAT SPACE ENVIR MD, V80, P862, DOI 10.3357/ASEM.2531.2009; Sayar K., 2002, B CLIN PSYCHOPHARMAC, V12, P130; Schneider U, 2010, EARLY HUM DEV, V86, P319, DOI 10.1016/j.earlhumdev.2010.05.018; Scholten MRM, 2006, J PSYCHIAT RES, V40, P638, DOI 10.1016/j.jpsychires.2006.03.005; Schroeder EB, 2005, DIABETES CARE, V28, P668, DOI 10.2337/diacare.28.3.668; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Schwerdtfeger A, 2010, PSYCHOPHYSIOLOGY, V47, P786, DOI 10.1111/j.1469-8986.2010.00965.x; Sequeira H, 2000, BRAIN RES BULL, V53, P87, DOI 10.1016/S0361-9230(00)00312-9; Serpiello FR, 2011, EUR J APPL PHYSIOL, V111, P669, DOI 10.1007/s00421-010-1687-0; Servant D, 2009, ENCEPHALE, V35, P423, DOI 10.1016/j.encep.2008.06.016; Sevcencu C, 2010, EPILEPSIA, V51, P725, DOI 10.1111/j.1528-1167.2009.02479.x; Sevoz-Couche C, 2003, J NEUROPHYSIOL, V90, P2521, DOI 10.1152/jn.00275.2003; Shafqat K, 2007, P ANN INT IEEE EMBS, P299; SHIH CD, 1995, AM J PHYSIOL-HEART C, V269, pH46; Shinba T, 2008, PSYCHIAT CLIN NEUROS, V62, P603, DOI 10.1111/j.1440-1819.2008.01855.x; SIEVER L, 1994, AM J PSYCHIAT, V142, P1017; SNIDMAN N, 1995, PSYCHOPHYSIOLOGY, V32, P199, DOI 10.1111/j.1469-8986.1995.tb02949.x; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; Song HS, 2003, APPL PSYCHOPHYS BIOF, V28, P13, DOI 10.1023/A:1022312815649; Spiegelhalder K, 2011, J SLEEP RES, V20, P137, DOI 10.1111/j.1365-2869.2010.00863.x; Stein PK, 2009, AGE AGEING, V38, P212, DOI 10.1093/ageing/afn292; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Stephens CL, 2010, BIOL PSYCHOL, V84, P463, DOI 10.1016/j.biopsycho.2010.03.014; STUMPF WE, 1990, EXPERIENTIA, V46, P13, DOI 10.1007/BF01955408; Su SY, 2010, TWIN RES HUM GENET, V13, P1, DOI 10.1375/twin.13.1.1; SUN MK, 1985, AM J PHYSIOL, V249, pR672; Tak LM, 2010, PSYCHOTHER PSYCHOSOM, V79, P179, DOI 10.1159/000296136; Tak LM, 2009, BIOL PSYCHOL, V82, P101, DOI 10.1016/j.biopsycho.2009.05.002; Takahashi T, 2005, INT J PSYCHOPHYSIOL, V55, P199, DOI 10.1016/j.ijpsycho.2004.07.004; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Tattersall AJ, 1995, HUM FACTORS, V37, P682, DOI 10.1518/001872095778995517; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Thayer JF, 2002, SCAND J PSYCHOL, V43, P123, DOI 10.1111/1467-9450.00277; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; TIBBLIN G, 1975, IRCS (International Research Communications System) Medical Science Library Compendium, V3, P95; TOGASHI H, 1992, J PHARMACOL EXP THER, V262, P343; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Uijtdehaage SHJ, 2000, CLIN AUTON RES, V10, P107, DOI 10.1007/BF02278013; Urakawa K, 2005, TOHOKU J EXP MED, V206, P213, DOI 10.1620/tjem.206.213; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; Valkonen-Korhonen M, 2003, PSYCHOPHYSIOLOGY, V40, P716, DOI 10.1111/1469-8986.00072; VALLBO AB, 1979, PHYSIOL REV, V59, P919; van Dixhoorn J, 2005, EUR J CARDIOV PREV R, V12, P193, DOI 10.1097/00149831-200506000-00002; van Leeuwen P, 2000, HERZSCHR ELEKTROPHYS, V11, P127; van Orshoven NP, 2004, J PHYSIOL-LONDON, V555, P573, DOI 10.1113/jphysiol.2003.056580; Varadhan R, 2009, J GERONTOL A-BIOL, V64, P682, DOI 10.1093/gerona/glp013; Vaschillo EG, 2008, PSYCHOPHYSIOLOGY, V45, P847, DOI 10.1111/j.1469-8986.2008.00673.x; Veltman JA, 1996, BIOL PSYCHOL, V42, P323, DOI 10.1016/0301-0511(95)05165-1; Veltman JA, 1998, ERGONOMICS, V41, P656, DOI 10.1080/001401398186829; Verkuil B, 2009, INT J PSYCHOPHYSIOL, V74, P220, DOI 10.1016/j.ijpsycho.2009.09.003; Vernieri F, 2010, STROKE, V41, P2087, DOI 10.1161/STROKEAHA.110.583088; Villa F, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P37, DOI 10.1109/CIC.2008.4748971; Virtanen R, 2003, PSYCHOSOM MED, V65, P751, DOI 10.1097/01.PSY.0000088760.65046.CF; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; WALLACE DM, 1992, BRAIN RES BULL, V28, P447, DOI 10.1016/0361-9230(92)90046-Z; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Watkins LL, 1998, PSYCHOSOM MED, V60, P498, DOI 10.1097/00006842-199807000-00018; Watkins LL, 1999, PSYCHOSOM MED, V61, P334, DOI 10.1097/00006842-199905000-00012; Watkins LL, 2002, AM HEART J, V143, P460, DOI 10.1067/mhj.2002.120404; Wheat AL, 2010, APPL PSYCHOPHYS BIOF, V35, P229, DOI 10.1007/s10484-010-9133-y; WIENTJES CJE, 1992, BIOL PSYCHOL, V34, P179, DOI 10.1016/0301-0511(92)90015-M; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; WILLIAMS CL, 2001, MEMORY CONSOLIDATION, P141, DOI DOI 10.1037/10413-008; Williamson JB, 2010, AUTON NEUROSCI-BASIC, V156, P60, DOI 10.1016/j.autneu.2010.03.009; Wise V, 2011, INT J PSYCHOPHYSIOL, V79, P155, DOI 10.1016/j.ijpsycho.2010.10.002; Wise V, 2009, INT J PSYCHOPHYSIOL, V74, P34, DOI 10.1016/j.ijpsycho.2009.07.001; Witten IH, 2005, DATA MINING PRACTICA; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Yasui H, 2010, AUTON NEUROSCI-BASIC, V156, P96, DOI 10.1016/j.autneu.2010.03.011; YERAGANI VK, 1991, PSYCHIAT RES, V37, P35, DOI 10.1016/0165-1781(91)90104-W; Yeragani VK, 2002, BIOL PSYCHIAT, V51, P733, DOI 10.1016/S0006-3223(01)01347-6; Yeragani VK, 2001, DEPRESS ANXIETY, V13, P72, DOI 10.1002/da.1019; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011; ZARDETTOSMITH AM, 1995, BRAIN RES BULL, V38, P253, DOI 10.1016/0361-9230(95)00097-X; Zhang JL, 2011, ARCH GERONTOL GERIAT, V53, P95, DOI 10.1016/j.archger.2010.06.010; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004; Zhuang Z, 2005, INT J NEUROSCI, V115, P315, DOI 10.1080/00207450590520911; Ziegler G, 2009, EUR J NEUROSCI, V30, P2205, DOI 10.1111/j.1460-9568.2009.07008.x	377	29	29	0	66	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	MERKELSTR 3, D-37085 GOTTINGEN, GERMANY	0269-8803	2151-2124		J PSYCHOPHYSIOL	J. Psychophysiol.		2012	26	4					178	203		10.1027/0269-8803/a000080			26	Psychology, Biological; Neurosciences	Psychology; Neurosciences & Neurology	031WY	WOS:000310674500004					2021-06-18	
J	Arango-Lasprilla, JC; Nicholls, E; Cabrera, TV; Drew, A; Jimenez-Maldonado, M; Martinez-Cortes, ML				Arango-Lasprilla, Juan Carlos; Nicholls, Elizabeth; Villasenor Cabrera, Teresita; Drew, Alison; Jimenez-Maldonado, Miriam; Luisa Martinez-Cortes, Maria			HEALTH-RELATED QUALITY OF LIFE IN CAREGIVERS OF INDIVIDUALS WITH TRAUMATIC BRAIN INJURY FROM GUADALAJARA, MEXICO	JOURNAL OF REHABILITATION MEDICINE			English	Article						quality of life; traumatic brain injury; caregivers	FAMILY CAREGIVERS; HEAD-INJURY; OUTCOMES; CARERS; SF-36; NEEDS	Objective: The goal of the present study was to assess the health-related quality of life of a group of family caregivers of individuals with traumatic brain injury from Guadalajara, Mexico. Patients and methods: Ninety family caregivers of individuals with traumatic brain injury and 83 healthy controls completed the Short-Form 36, a self-report health-related quality of life measure composed of 8 component areas: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, mental health, and role-emotional. The samples were statistically similar with respect to age, gender, marital status, and education. However, caregivers had significantly lower household income than controls. Results: After controlling for income, results showed significantly lower scores for traumatic brain injury caregivers compared with healthy controls on 6 Short-Form 36 subscales: role-emotional, vitality, mental health, social functioning, bodily pain, and general health. Conclusion: Caregivers of individuals with traumatic brain injury living in Guadalajara, Mexico report having poorer health-related quality of life across various domains including mental and general health. Future studies should be conducted to determine which specific factors (e.g. lack of services, physical strain of providing care) are responsible for reduced health-related quality of life in these areas. It is likely that resources, such as respite services, adult day-care, aides, outpatient rehabilitation, psycho-educational programs, and support groups would increase health-related quality of life for these individuals.	[Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Rehabil Psychol & Neuropsychol Sch Med, Richmond, VA 23219 USA; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Luisa Martinez-Cortes, Maria] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico	Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Rehabil Psychol & Neuropsychol Sch Med, Theater Row Bldg,730 E Broad St, Richmond, VA 23219 USA.	jcarangolasp@vcu.edu					ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Barraza-Llorens M, 2002, HEALTH AFFAIR, V21, P47, DOI 10.1377/hlthaff.21.3.47; Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; BROOKS DN, 1984, CLOSED HEAD INJURY P, P148; Cunningham JM, 1999, HLTH CARE DISABILITY, P475; Grant JS, 2000, BRAIN INJURY, V14, P1089; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hickey AM, 1997, PSYCHOL HEALTH, V12, P827, DOI 10.1080/08870449708406743; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Lynch R. T., 1986, APPL REHABILITATION, P262; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Molloy M., 1983, AUSTR REHABILITATION, V7, P34; Moules S, 1999, BRAIN INJURY, V13, P983; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Nanda U, 1998, EVAL HEALTH PROF, V21, P179, DOI 10.1177/016327879802100204; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Smith L.M., 1995, FAMILY SUPPORT PROGR; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zitnay GA, 2005, ACT NEUR S, V93, P131	27	29	33	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	NOV	2011	43	11					983	986		10.2340/16501977-0883			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	856QN	WOS:000297658600004	22031343	DOAJ Gold			2021-06-18	
J	Avraham, Y; Davidi, N; Lassri, V; Vorobiev, L; Kabesa, M; Dayan, M; Chernoguz, D; Berry, E; Leker, RR				Avraham, Y.; Davidi, N.; Lassri, V.; Vorobiev, L.; Kabesa, M.; Dayan, M.; Chernoguz, D.; Berry, E.; Leker, R. R.			Leptin Induces Neuroprotection Neurogenesis and Angiogenesis after Stroke	CURRENT NEUROVASCULAR RESEARCH			English	Article						Angiogenesis; cerebrovascular disease; leptin; neurogenesis; neuroprotection; stroke	ACTIVATED PROTEIN-KINASE; CLOSED-HEAD-INJURY; VEGF EXPRESSION; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; IN-VIVO; RECEPTOR; INCREASES; INHIBITION; ISCHEMIA	Leptin is a potent AMP kinase (AMPK) inhibitor that is central to cell survival. Hence, we explored the effects of leptin on neurogenesis and angiogenesis after stroke. Neural stem cells (NSC) were grown as neurospheres in culture and treated with vehicle or leptin and neurosphere size and terminal differentiation were then determined. We then explored the effects of leptin on endogenous repair mechanisms in vivo. Sabra mice underwent photothrombotic stroke, were given vehicle or leptin and newborn cells were labeled with Bromo-deoxy-Uridine. Functional outcome was studied with the neurological severity score for 90 days post stroke and the brains were then evaluated with immunohistochemistry. In a subset of animals the brains were also evaluated for changes in the expression of leptin receptor and AMPK. In vitro, leptin led to a 2-fold increase in neurosphere size but did not change the differentiation of newborn cells. Following stroke, exogenous leptin led to a 4-fold increase in the number of NSC in the cortex abutting the lesion. There was a 1.5-fold increase in the number of newborn neurons and glia in leptin treated animals. Leptin also significantly increased the number of blood vessels in the peri-lesioned cortex. Leptin treated mice had increased expression of leptin receptor and increased phosphorylated AMPK concentration. Animals treated with leptin also had significantly better functional states. In conclusion, leptin induces neurogenesis and angiogenesis after stroke and leads to increased leptin receptor and pAMPK concentrations. This may explain at least in part the better functional outcome observed in leptin treated animals after stroke.	[Avraham, Y.; Davidi, N.; Vorobiev, L.; Kabesa, M.; Dayan, M.; Berry, E.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel	Avraham, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurol, Stroke Serv, POB 12000, IL-91120 Jerusalem, Israel.	yosefa@md.huji.ac.il; leker@hadassah.org.il	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334	Israel Science FoundationIsrael Science Foundation [1327/07]; Peritz and Chantal Scheinberg Cerebrovascular Research Fund; Sol Irwin Juni Trust	This work was supported in part by a grant from the Israel Science Foundation (Grant No. 1327/07), by the Peritz and Chantal Scheinberg Cerebrovascular Research Fund and by the Sol Irwin Juni Trust Fund.	Abe Y, 2007, AM J PHYSIOL-HEART C, V292, pH2387, DOI 10.1152/ajpheart.00579.2006; Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Anagnostoulis S, 2008, CYTOKINE, V42, P353, DOI 10.1016/j.cyto.2008.03.009; Avraham Y, 2010, CURR NEUROVASC RES, V7, P136, DOI 10.2174/156720210791184943; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Ben-Hur T, 2007, J NEUROL SCI; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Dagon Y, 2005, J BIOL CHEM, V280, P42142, DOI 10.1074/jbc.M507607200; Eichenbaum JW, 2002, J PHARMACOL TOXICOL, V47, P67, DOI 10.1016/S1056-8719(02)00215-0; Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313; Forsberg-Nilsson K, 1998, J NEUROSCI RES, V53, P521, DOI 10.1002/(SICI)1097-4547(19980901)53:5<521::AID-JNR2>3.0.CO;2-B; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Heida NM, ARTERIOSCLER THROMB, V200-206; Hou N, 2011, CLIN EXP PHARM  0929; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Liapakis IE, 2007, IN VIVO, V21, P797; Matsui H, 2007, LIFE SCI, V80, P672, DOI 10.1016/j.lfs.2006.10.027; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Neurath KM, 2006, GLIA, V53, P733, DOI 10.1002/glia.20326; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Purdham DM, 2008, AM J PHYSIOL-HEART C, V295, pH441, DOI 10.1152/ajpheart.91537.2007; Ribatti D, 2008, PEPTIDES, V29, P1596, DOI 10.1016/j.peptides.2008.05.011; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Tajmir P, 2004, ENDOCRINOLOGY, V145, P1550, DOI 10.1210/en.2003-1128; Talavera-Adame D, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3028010; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073	44	29	30	0	12	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	NOV	2011	8	4					313	322		10.2174/156720211798120954			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	883FE	WOS:000299618800006	22023616				2021-06-18	
J	Zafar, SN; Millham, FH; Chang, YC; Fikry, K; Alam, HB; King, DR; Velmahos, GC; de Moya, MA				Zafar, Syed Nabeel; Millham, Frederick H.; Chang, Yuchiao; Fikry, Karim; Alam, Hasan B.; King, David R.; Velmahos, George C.; de Moya, Marc A.			Presenting Blood Pressure in Traumatic Brain Injury: A Bimodal Distribution of Death	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Mortality; Blood pressure	PREHOSPITAL HYPOTENSION; BLUNT TRAUMA; PROGNOSTIC VALUE; TEAM ACTIVATION; HEAD-INJURY; PREDICTOR; MORTALITY; CRITERIA; INSULTS	Background: Recent research explores the relationship between vital signs on arrival to the emergency department and early outcomes. This work has not included traumatic brain injury (TBI). We aimed to evaluate the relationship of the initial emergency department systolic blood pressure (EDSBP) with outcome. Methods: By using the National Trauma Data Bank (v7), we analyzed patients older than 16 years with isolated moderate to severe blunt TBI. TBI was defined by International Classification of Diseases-9th Rev diagnosis codes and Abbreviated Injury Scale scores. We determined mortality rates while controlling for age, gender, race, payment type, and injury severity using logistic regression. Survival analysis was performed to determine 3-day survival rates. Scores and rates were plotted against EDSBP. Results: A total of 7,238 patients were included in the analysis. Plots of adverse outcomes versus EDSBP demonstrated bimodal distributions. The mortality curve had one inflection point at EDSBP 120 mm Hg, indicating higher mortality when blood pressures were lower than this threshold. Another inflection began at EDSBP 140 mm Hg. The mortality rate was 21% when EDSBP was <120 mm Hg, 9% when it was between 120 mm Hg and 140 mm Hg, and 19% when EDSBP was >= 140 mm Hg. Multivariate analysis demonstrated that patients presenting with an EDSBP of <120 mm Hg and >= 140 mm Hg were 2.7 (95% confidence interval = 2.13,3.48) and 1.6 (95% confidence interval = 1.32,1.96) times more likely to die, respectively, than those who presented with a EDSBP of 120 mm Hg to 140 mm Hg. Conclusions: Mortality in moderate to severe TBI has a bimodal distribution. Like hypotension, hypertension at hospital admission seems to be associated with increased mortality in TBI, even after controlling for other factors.	[Fikry, Karim; Alam, Hasan B.; King, David R.; Velmahos, George C.; de Moya, Marc A.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Zafar, Syed Nabeel] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Millham, Frederick H.] Newton Wellesley Hosp, Dept Surg, Newton, MA USA; [Chang, Yuchiao] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA	de Moya, MA (corresponding author), Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	mdemoya@partners.org		Zafar, Syed Nabeel/0000-0003-3843-9687; King, David/0000-0003-1028-1478			Agarwal SK, 2008, J TRAUMA, V65, P1250; Bjerke HS, 2000, J TRAUMA, V48, P1037; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chan L, 1997, ACAD EMERG MED, V4, P785, DOI 10.1111/j.1553-2712.1997.tb03785.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; Franklin GA, 2007, J TRAUMA, V63, P297; Kiening KL, 2005, ACT NEUR S, V95, P293; KNUDSON MM, 1994, ARCH SURG-CHICAGO, V129, P448; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehmann R, 2009, ARCH SURG-CHICAGO, V144, P853, DOI 10.1001/archsurg.2009.153; Lehmann RK, 2007, AM J SURG, V193, P630, DOI 10.1016/j.amjsurg.2007.01.017; Lipsky AM, 2006, J TRAUMA, V61, P1228, DOI 10.1097/01.ta.0000196694.52615.84; MACKERSIE RC, 1989, ARCH SURG-CHICAGO, V124, P809; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NASSOURA Z, 1991, J TRAUMA, V31, P1596, DOI 10.1097/00005373-199112000-00005; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shapiro MJ, 2008, J TRAUMA, V65, P1245, DOI 10.1097/TA.0b013e31818c262f; Shapiro NI, 2003, J EMERG MED, V25, P175, DOI 10.1016/S0736-4679(03)00167-7; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0	30	29	29	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1179	1184		10.1097/TA.0b013e3182140d38			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	849IG	WOS:000297118600021	21502878				2021-06-18	
J	Cantu, RC; Register-Mihalik, JK				Cantu, Robert C.; Register-Mihalik, Johna K.			Considerations for Return-to-Play and Retirement Decisions After Concussion	PM&R			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; RECURRENT CONCUSSION; SEX-DIFFERENCES; EPIDEMIOLOGY; ASSOCIATION; INJURY; SPORTS; IMPACT; RISK	Return-to-play and retirement decisions after concussion are often difficult and complex. The complexity of these decisions may be influenced by many factors, including the number, proximity, and severity of previous concussions; gender; age; sport played; exposure to head impacts; and predisposing or pre-existing conditions. These circumstances and conditions can confound the decisions concerning return to play and retirement. Clinicians should carefully weigh how these circumstances and conditions influence quality of life and how they interact with the effects of concussion. Furthermore, clinicians should consider past and potential exposures to both subconcussive and concussive impacts during the athlete's lifetime when deliberating a return to play or retirement. The purpose of this overview is to highlight and discuss these issues as they factor into the return-to-play and retirement decisions after a concussive injury in an effort to provide clinicians with evidence-based information that can be used in the decision-making process. PM R 2011;3:S440-S444	[Cantu, Robert C.] Emerson Hosp, Dept Surg, Concord, MA 01742 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cantu, Robert C.; Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Register-Mihalik, Johna K.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA	Cantu, RC (corresponding author), Emerson Hosp, Dept Surg, 131 ORNAC,Suite 820, Concord, MA 01742 USA.	rcantu@emersonhosp.org		Register-Mihalik, Johna/0000-0002-4229-4743			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920	27	29	29	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S440	S444		10.1016/j.pmrj.2011.07.013			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	966YK	WOS:000305873100012	22035687				2021-06-18	
J	Finnoff, JT; Jelsing, EJ; Smith, J				Finnoff, Jonathan T.; Jelsing, Elena J.; Smith, Jay			Biomarkers, Genetics, and Risk Factors for Concussion	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; S-100 PROTEIN MEASUREMENTS; APOLIPOPROTEIN-E POLYMORPHISM; AMYLOID PRECURSOR PROTEIN; BIOCHEMICAL SERUM MARKERS; ICE HOCKEY INJURIES; HIGH-SCHOOL; DESCRIPTIVE EPIDEMIOLOGY	It is estimated that between 1.6 and 3.8 million concussions occur annually in the United States. Although frequently regarded as benign, concussions can lead to multiple different adverse outcomes, including prolonged postconcussive symptoms, chronic traumatic encephalopathy, cognitive impairment, early onset dementia, movement disorders, psychiatric disorders, motor neuron disease, and even death. Therefore it is important to identify individuals with concussion to provide appropriate medical care and minimize adverse outcomes. Furthermore, it is important to identify individuals who are predisposed to sustaining a concussion or to having an adverse outcome after concussion. This article will discuss the current research on serum biomarkers for concussion, genetic influence on concussion, risk factors associated with concussion predisposition and poor outcome, and practical suggestions for the application of this information in clinical practice. PM R 2011;3:S452-S459	[Finnoff, Jonathan T.; Smith, Jay] Mayo Clin Sports Med Ctr, Mayo Clin Coll Med, Rochester, MN 55905 USA; [Jelsing, Elena J.] Mayo Clin, Mayo Clin Coll Med, Rochester, MN USA	Finnoff, JT (corresponding author), Mayo Clin Sports Med Ctr, Mayo Clin Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	finnoff.jonathan@mayo.edu					Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P202; Agel J, 2007, J ATHL TRAINING, V42, P249; Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P194; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lambert JC, 1998, HUM MOL GENET, V7, P1511, DOI 10.1093/hmg/7.9.1511; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; LUCOTTE G, 1994, AM J MED GENET, V54, P286, DOI 10.1002/ajmg.1320540319; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCMORRIS T, 1994, PERCEPT MOTOR SKILL, V78, P123, DOI 10.2466/pms.1994.78.1.123; Missler U, 1997, ACTA NEUROL SCAND, V96, P142; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Poorkaj, 1998, ANN NEUROL, V44, P428; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Townend W, 2002, J NEUROL NEUROSUR PS, V65, P177; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; Williamson I, 2006, BRIT J SPORT MED, V40, P128; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	107	29	29	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S452	S459		10.1016/j.pmrj.2011.07.014			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	966YK	WOS:000305873100014	22035689				2021-06-18	
J	Hannon, MJ; Sherlock, M; Thompson, CJ				Hannon, M. J.; Sherlock, M.; Thompson, C. J.			Pituitary dysfunction following traumatic brain injury or subarachnoid haemorrhage - In "Endocrine Management in the Intensive Care Unit"	BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article						pituitary; TBI; subarachnoid haemorrhage; glucocorticoid insufficiency; DI; SIADH	LEYDIG-CELL STEROIDOGENESIS; CRITICALLY-ILL PATIENTS; ANTI-DIURETIC HORMONE; SPECIAL WRITING GROUP; HUMAN GROWTH-HORMONE; ANTIDIURETIC-HORMONE; NEUROENDOCRINE DYSFUNCTION; INAPPROPRIATE SECRETION; ADRENAL INSUFFICIENCY; DIABETES-INSIPIDUS	Traumatic brain injury and subarachnoid haemorrhage are important causes of morbidity and mortality in the developed world. There is a large body of evidence that demonstrates that both conditions may adversely affect pituitary function in both the acute and chronic phases of recovery. Diagnosis of hypopituitarism and accurate treatment of pituitary disorders offers the opportunity to improve mortality and outcome in both traumatic brain injury and subarachnoid haemorrhage. In this article, we will review the history and pathophysiology of pituitary function in the acute phase following traumatic brain injury and subarachnoid haemorrhage, and we will discuss in detail three key aspects of pituitary dysfunction which occur in the early course of TBI; acute cortisol deficiency, diabetes insipidus and SIAD. (C) 2011 Elsevier Ltd. All rights reserved.	[Hannon, M. J.; Sherlock, M.; Thompson, C. J.] Beaumont Hosp RCSI Med Sch, Acad Dept Endocrinol, Dublin 9, Ireland	Thompson, CJ (corresponding author), Beaumont Hosp RCSI Med Sch, Acad Dept Endocrinol, Beaumont Rd, Dublin 9, Ireland.	christhompson@beaumont.ie					Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Audibert G, 2009, ANESTH ANALG, V108, P1922, DOI 10.1213/ane.0b013e31819a85ae; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; BECKER RM, 1973, J TRAUMA, V13, P112, DOI 10.1097/00005373-197302000-00003; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Boughey JC, 2004, AM SURGEON, V70, P500; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; CALKINS JH, 1988, ENDOCRINOLOGY, V123, P1605, DOI 10.1210/endo-123-3-1605; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; CARTLIDGE NE, 1972, J NEUROSURG, V36, P640, DOI 10.3171/jns.1972.36.5.0640; CATALANO RD, 1984, ARCH SURG-CHICAGO, V119, P145; Ceballos R, 1966, Ala J Med Sci, V3, P185; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Crowley RK, 2007, CLIN ENDOCRINOL, V66, P475, DOI 10.1111/j.1365-2265.2007.02754.x; CYRAN E, 1918, DEUT MED WOCHENSCHR, P1; DEJONG FH, 1984, J CLIN ENDOCR METAB, V59, P1143, DOI 10.1210/jcem-59-6-1143; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; DONG Q, 1992, CLIN ENDOCRINOL, V36, P399, DOI 10.1111/j.1365-2265.1992.tb01466.x; EDWARDS OM, 1986, MEDICINE, V65, P281; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; GUO H, 1990, ENDOCRINOLOGY, V127, P1234, DOI 10.1210/endo-127-3-1234; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HANNON MJ, 2011, AM END SOC ANN M JUN; HANNON MJ, 2011, AM END SOC ANN M; HERNDON DN, 1990, ANN SURG, V212, P424, DOI 10.1097/00000658-199010000-00005; Hoff R, 2009, STROKE, V40, P2575, DOI 10.1161/STROKEAHA.108.538116; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; ISOTANI E, 1994, STROKE, V25, P2198, DOI 10.1161/01.STR.25.11.2198; JEEVANANDAM M, 1995, JPEN-PARENTER ENTER, V19, P137, DOI 10.1177/0148607195019002137; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; KNOX J, 1995, J TRAUMA, V39, P526; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Koo DJ, 2001, CRIT CARE MED, V29, P618, DOI 10.1097/00003246-200103000-00026; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; LEVITAN D, 1984, AM J NEPHROL, V4, P99, DOI 10.1159/000166785; Ligtenberg JJM, 2001, INTENS CARE MED, V27, P1567, DOI 10.1007/s001340101050; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Marik PE, 2002, CRIT CARE MED, V30, P1267, DOI 10.1097/00003246-200206000-00018; Mauduit C, 1998, ENDOCRINOLOGY, V139, P2863, DOI 10.1210/en.139.6.2863; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; MCIVER B, 1991, BRIT MED J, V303, P1465, DOI 10.1136/bmj.303.6815.1465; Mebis L, 2006, ENDOCRIN METAB CLIN, V35, P807, DOI 10.1016/j.ecl.2006.09.009; Meduri GU, 2002, AM J RESP CRIT CARE, V165, P983, DOI 10.1164/ajrccm.165.7.2106014; Michalaki M, 2001, J CLIN ENDOCR METAB, V86, P4198, DOI 10.1210/jc.86.9.4198; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Oh MS, 1999, NEPHRON, V82, P110, DOI 10.1159/000045385; OSTERMAN PO, 1975, ACTA NEUROL SCAND, V52, P56, DOI 10.1111/j.1600-0404.1975.tb02827.x; Palmer BF, 2000, NEPHROL DIAL TRANSPL, V15, P262, DOI 10.1093/ndt/15.2.262; PARENTI G, 2010, J ENDOCRINOLOGI 0831; Peeters RP, 2005, J CLIN ENDOCR METAB, V90, P4559, DOI 10.1210/jc.2005-0535; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; PERLMUTTER D, 1976, J NEUROSURG, V45, P259, DOI 10.3171/jns.1976.45.3.0259; PIERUCCI G, 1971, Pathologica (Genoa), V63, P71; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.physiol.54.1.885; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Rap Z, 1971, Pol Med J, V10, P188; Rinkel GJ, 2004, COCHRANE DB SYST REV, V4; RUDMAN D, 1977, J CLIN ENDOCR METAB, V45, P747, DOI 10.1210/jcem-45-4-747; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; SECKL J, 1998, BMJ-BRIT MED J, V298, P2; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Sherlock M, 2010, EUR J ENDOCRINOL, V162, pS13, DOI 10.1530/EJE-09-1057; Sobey CG, 1998, CLIN EXP PHARMACOL P, V25, P867, DOI 10.1111/j.1440-1681.1998.tb02337.x; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; SPRATT DI, 1992, J CLIN ENDOCR METAB, V75, P1562, DOI 10.1210/jc.75.6.1562; TAKAKU A, 1979, SURG NEUROL, V11, P349; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; THOMPSON CJ, 1986, CLIN SCI, V71, P651, DOI 10.1042/cs0710651; TWIJNSTRA A, 1980, CLIN NEUROL NEUROSUR, V82, P263, DOI 10.1016/0303-8467(80)90018-9; Van den Berghe G H, 1998, Verh K Acad Geneeskd Belg, V60, P487; VandenBerghe G, 1997, J CLIN ENDOCR METAB, V82, P590, DOI 10.1210/jc.82.2.590; VANDENBERGHE GH, 1998, VERHANDELINGEN KONIN, V60, P520; Vanhorebeek I, 2006, CRIT CARE CLIN, V22, P1, DOI 10.1016/j.ccc.2005.09.004; VANTHOFF W, 1961, BMJ-BRIT MED J, V2, P1190, DOI 10.1136/bmj.2.5261.1190; Vermes I, 2001, BEST PRACT RES CL EN, V15, P495, DOI 10.1053/beem.2001.0166; VOERMAN HJ, 1992, NETH J MED, V41, P229; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; WANG C, 1978, CLIN ENDOCRINOL, V9, P249, DOI 10.1111/j.1365-2265.1978.tb02207.x; WEBSTER J E, 1960, Arch Neurol, V2, P19; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; WIJDICKS EFM, 1985, ANN NEUROL, V17, P137, DOI 10.1002/ana.410170206; Wijesurendra RS, 2009, NEUROCRIT CARE, V11, P158, DOI 10.1007/s12028-009-9217-9; Witkowska AM, 2009, ARCH IMMUNOL THER EX, V57, P137, DOI 10.1007/s00005-009-0010-4; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083; 1998, NIH CONSENS STATEMEN, V16, P1	126	29	29	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1521-690X	1532-1908		BEST PRACT RES CL EN	Best Pract. Res. Clin. Endoc. Metab.	OCT	2011	25	5					783	798		10.1016/j.beem.2011.06.001			16	Endocrinology & Metabolism	Endocrinology & Metabolism	833CQ	WOS:000295859800008	21925078				2021-06-18	
J	Hirsh, AT; Braden, AL; Craggs, JG; Jensen, MP				Hirsh, Adam T.; Braden, Alan L.; Craggs, Jason G.; Jensen, Mark P.			Psychometric Properties of the Community Integration Questionnaire in a Heterogeneous Sample of Adults With Physical Disability	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Disabled persons; Outcome assessment (health care); Psychometrics; Quality of life; Rehabilitation	FORM HEALTH SURVEY; TRAUMATIC BRAIN INJURY; SPINAL-CORD-INJURY; SELF-RATED HEALTH; QUALITY-OF-LIFE; PSYCHOSOCIAL FACTORS; SURVEY SF-36; PARTICIPATION; RELIABILITY; OUTCOMES	Hirsh AT, Braden AL, Craggs JG, Jensen MP. Psychometric properties of the Community Integration Questionnaire in a heterogeneous sample of adults with physical disability. Arch Phys Med Rehabil 2011;92:1602-10. Objective: To investigate the psychometric properties of the Community Integration Questionnaire (CIQ) in a mixed sample of adults with physical disabilities. Design: Cross-sectional, survey study. Setting: Academic and community medical clinics, national registry, and self-referral. Participants: Community-dwelling adults with spinal cord injury (n=146), multiple sclerosis (n=174), limb loss (n=158), or muscular dystrophy (n=273). Interventions: Not applicable. Main Outcome Measures: CIQ, General Health item from the Medical Outcomes Study 36-Item Short-Form Health Survey, and Mental Health Scale from the Medical Outcomes Study 36-Item Short-Form Health Survey. Results: Based on the original scoring procedures, the CIQ Total scale and Home Integration subscale demonstrated acceptable internal consistency; however, reliability indices for the Social Integration and Productive Activities subscales were suboptimal. The exploratory factor analysis yielded a 4-factor solution (accounting for approximately 63% of the variance) that did not replicate the original factor structure of the CIQ. The results of the confirmatory factor analyses indicated that a modified 3-factor solution provided the best fit to the data from our samples. Using a revised scoring system based on these findings, the CIQ demonstrated improved reliability relative to the original scoring and good concurrent validity. Conclusions: The results provide general support for the validity of the CIQ as a measure of participation in adults with physical disabilities. However, our results indicate that some small modifications to the original scoring system are needed to optimize its use in this patient group. Additional research is needed to refine the measurement of participation in these and other populations.	[Hirsh, Adam T.] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46202 USA; [Braden, Alan L.; Jensen, Mark P.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Craggs, Jason G.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA	Hirsh, AT (corresponding author), Indiana Univ Purdue Univ, Dept Psychol, 402 N Blackford St,LD 124, Indianapolis, IN 46202 USA.	athirsh@iupui.edu		Craggs, Jason/0000-0002-9531-0559	National Institutes of Health, National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Center for Medical Rehabilitation Research [T32 HD007424, PO1 HD33988]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007424, P01HD033988] Funding Source: NIH RePORTER	Supported in part by the National Institutes of Health, National Institute of Child Health and Human Development, and the National Center for Medical Rehabilitation Research (grant nos. T32 HD007424, PO1 HD33988).	Allen K, 1996, JAMA-J AM MED ASSOC, V275, P1001, DOI 10.1001/jama.275.13.1001; Archibald CJ, 1999, AM J RESP CRIT CARE, V160, P523, DOI 10.1164/ajrccm.160.2.9808109; Balkrishnan R, 2001, AM J MANAG CARE, V7, P145; BERWICK DM, 1991, JAMA-J AM MED ASSOC, V266, P841, DOI 10.1001/jama.266.6.841; Beusterien KM, 1996, J GERIATR PSYCH NEUR, V9, P13, DOI 10.1177/089198879600900103; Bollen K.A., 1989, STRUCTURAL EQUATIONS, P514, DOI 10.1002/9781118619179; Bollen K.A., 1993, TESTING STRUCTURAL E; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Chrispin PS, 1997, ANAESTHESIA, V52, P15, DOI 10.1111/j.1365-2044.1997.015-az014.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113; Crossley TF, 2002, J HEALTH ECON, V21, P643, DOI 10.1016/S0167-6296(02)00007-3; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; FERKETICH S, 1991, RES NURS HEALTH, V14, P165, DOI 10.1002/nur.4770140211; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; GORDON WA, 1999, REHABILITATION ADULT, P312; Hair J.F., 2009, MULTIVARIATE DATA AN, V7th; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hirsh AT, 2010, J PAIN, V11, P79, DOI 10.1016/j.jpain.2009.06.004; Johnston Mark, 2002, J Spinal Cord Med, V25, P11; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Kennedy BP, 1998, BRIT MED J, V317, P917; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; Miro J, 2009, AM J HOSP PALLIAT ME, V26, P308, DOI 10.1177/1049909109335146; Molton IR, 2009, J REHABIL RES DEV, V46, P31, DOI 10.1682/JRRD.2008.03.0044; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Renwick R, 2003, INT J REHABIL RES, V26, P279, DOI 10.1097/00004356-200312000-00005; Salter KL, 2007, INT J REHABIL RES, V30, P339, DOI 10.1097/MRR.0b013e3282f144b7; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Schafer JL., 1997, ANAL INCOMPLETE MULT; Streiner DL, 1989, HLTH MEASUREMENT SCA; Tate DG, 2001, REHABIL PSYCHOL, V46, P125, DOI 10.1037/0090-5550.46.2.125; Tate R. L., 2010, COMPENDIUM TESTS SCA; Turner-Bowker DM, 2002, SF 36 HLTH SURVEY SF; van de Ven L, 2005, DISABIL SOC, V20, P311, DOI 10.1080/09687590500060778; Van der Mei SF, 2007, DISABIL REHABIL, V29, P473, DOI 10.1080/09638280600841257; van der Slot WMA, 2007, DISABIL REHABIL, V29, P179, DOI 10.1080/09638280600747686; Wagner AK, 1998, J CLIN EPIDEMIOL, V51, P925, DOI 10.1016/S0895-4356(98)00083-3; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE., 2000, SF 36 HLTH SURVEY MA; Ware JE., 1993, SF 36 HLTH SURVEY MA; Ware JE., 1994, SF 36 PHYS MENTAL HL, V1st; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1994, BRAIN INJURY REHABIL, P355; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 2001, INT CLASS FUNCT DIS; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638	63	29	29	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2011	92	10					1602	1610		10.1016/j.apmr.2011.05.004			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	833DE	WOS:000295861200011	21851927	Green Accepted			2021-06-18	
J	Podvin, S; Gonzalez, AM; Miller, MC; Dang, XT; Botfield, H; Donahue, JE; Kurabi, A; Boissaud-Cooke, M; Rossi, R; Leadbeater, WE; Johanson, CE; Coimbra, R; Stopa, EG; Eliceiri, BP; Baird, A				Podvin, Sonia; Gonzalez, Ana-Maria; Miller, Miles C.; Dang, Xitong; Botfield, Hannah; Donahue, John E.; Kurabi, Arwa; Boissaud-Cooke, Matthew; Rossi, Ryan; Leadbeater, Wendy E.; Johanson, Conrad E.; Coimbra, Raul; Stopa, Edward G.; Eliceiri, Brian P.; Baird, Andrew			Esophageal Cancer Related Gene-4 Is a Choroid Plexus-Derived Injury Response Gene: Evidence for a Biphasic Response in Early and Late Brain Injury	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; SQUAMOUS-CELL CARCINOMA; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; RAT; EXPRESSION; ECRG4; HYPERMETHYLATION; PROLIFERATION; TRAFFICKING	By virtue of its ability to regulate the composition of cerebrospinal fluid (CSF), the choroid plexus (CP) is ideally suited to instigate a rapid response to traumatic brain injury (TBI) by producing growth regulatory proteins. For example, Esophageal Cancer Related Gene-4 (Ecrg4) is a tumor suppressor gene that encodes a hormone-like peptide called augurin that is present in large concentrations in CP epithelia (CPe). Because augurin is thought to regulate senescence, neuroprogenitor cell growth and differentiation in the CNS, we evaluated the kinetics of Ecrg4 expression and augurin immunoreactivity in CPe after CNS injury. Adult rats were injured with a penetrating cortical lesion and alterations in augurin immunoreactivity were examined by immunohistochemistry. Ecrg4 gene expression was characterized by in situ hybridization. Cell surface augurin was identified histologically by confocal microscopy and biochemically by sub-cellular fractionation. Both Ecrg4 gene expression and augurin protein levels were decreased 24-72 hrs post-injury but restored to uninjured levels by day 7 post-injury. Protein staining in the supraoptic nucleus of the hypothalamus, used as a control brain region, did not show a decrease of auguin immunoreactivity. Ecrg4 gene expression localized to CPe cells, and augurin protein to the CPe ventricular face. Extracellular cell surface tethering of 14 kDa augurin was confirmed by cell surface fractionation of primary human CPe cells in vitro while a 6-8 kDa fragment of augurin was detected in conditioned media, indicating release from the cell surface by proteolytic processing. In rat CSF however, 14 kDa augurin was detected. We hypothesize the initial release and proteolytic processing of augurin participates in the activation phase of injury while sustained Ecrg4 down-regulation is dysinhibitory during the proliferative phase. Accordingly, augurin would play a constitutive inhibitory function in normal CNS while down regulation of Ecrg4 gene expression in injury, like in cancer, dysinhibits proliferation.	[Podvin, Sonia; Dang, Xitong; Kurabi, Arwa; Coimbra, Raul; Eliceiri, Brian P.; Baird, Andrew] Univ Calif San Diego, Dept Surg, Sch Med, San Diego, CA 92103 USA; [Gonzalez, Ana-Maria; Botfield, Hannah; Boissaud-Cooke, Matthew; Leadbeater, Wendy E.] Univ Birmingham, Sch Clin & Expt Med, Dept Neuropharmacol & Neurobiol, Birmingham, W Midlands, England; [Miller, Miles C.; Donahue, John E.; Rossi, Ryan; Johanson, Conrad E.; Stopa, Edward G.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02903 USA; [Miller, Miles C.; Donahue, John E.; Rossi, Ryan; Johanson, Conrad E.; Stopa, Edward G.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pathol, Providence, RI 02903 USA	Podvin, S (corresponding author), Univ Calif San Diego, Dept Surg, Sch Med, San Diego, CA 92103 USA.	anbaird@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Donahue, John E/A-3000-2008	Coimbra, Raul/0000-0002-3759-6851; Donahue, John E/0000-0001-7186-2562; Johanson, Conrad/0000-0002-1297-5484; Eliceiri, Brian/0000-0003-1811-1916; Baird, Andrew/0000-0003-0027-9905	Hydrocephalus Association; United States National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; United States National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM078421]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY018479, HL073396, AG027910]; American Recovery and Reinvestment Act (ARRA); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R21EY018479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM078421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027910] Funding Source: NIH RePORTER	Dr. Podvin is supported by a Mentored Young Investigator Award from the Hydrocephalus Association (www.hydroassoc.org). Dr. Baird, Dr. Eliceiri and Dr. Coimbra are supported by a United States National Institutes of Health (www.nih.gov) P20 Exploratory Center Grant for Would Healing Research from the United States National Institute of General Medical Sciences (www.nigms.nih.gov; P20 GM078421) and are also supported by the National Institutes of Health (NIH) EY018479 (Dr. Baird), (NIH) HL073396 (Dr. Eliceiri) and by supplemental funding through the American Recovery and Reinvestment Act (ARRA). No external funding was received for these studies for Dr. Miller, Dr. Dang, Dr. Donahue, Dr. Rossi or Dr. Stopa. Conrad Johanson is supported by NIH AG027910. All of the studies conducted at the University of Birmingham by Dr. Gonzalez, Dr. Botfield, Dr. Boissaud-Cooke and Dr. Leadbeater were funded by a grant from the School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (www.medicine.bham.ac.uk). The funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allen Brain Atlas Resources, 2009, ALL BRAIN ATL RES; Baird A, 2011, METHODS MOL BIOL, V686, P483, DOI 10.1007/978-1-60761-938-3_25; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Ennis SR, 2006, J CEREBR BLOOD F MET, V26, P675, DOI 10.1038/sj.jcbfm.9600224; Ghabriel MN, 2010, ACTA NEUROCHIR SUPPL, V106, P239, DOI 10.1007/978-3-211-98811-4_45; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Johanson CE, 2000, CELL MOL NEUROBIOL, V20, P197, DOI 10.1023/A:1007097622590; Johanson C, 2011, TOXICOL PATHOL, V39, P186, DOI 10.1177/0192623310394214; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kujuro Y, 2010, P NATL ACAD SCI USA, V107, P8259, DOI 10.1073/pnas.0911446107; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Mori Y, 2007, ONCOL REP, V18, P981; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Ozawa A, 2011, MOL ENDOCRINOL, V25, P776, DOI 10.1210/me.2010-0389; PALM D, 1995, AM J PHYSIOL-REG I, V269, pR73; Popovic Matija, 2011, J Mol Recognit, V24, P245, DOI 10.1002/jmr.1042; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1316, DOI 10.1001/archneurol.2010.275; ROBERTON A, 2009, SOC END BES 2009 HAR, V15, pS82; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Su Tao, 1998, Zhonghua Zhongliu Zazhi, V20, P254; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tadross JA, 2010, BRIT J PHARMACOL, V159, P1663, DOI 10.1111/j.1476-5381.2010.00655.x; Trudel C, 2000, J CELL PHYSIOL, V185, P260, DOI 10.1002/1097-4652(200011)185:2<260::AID-JCP11>3.0.CO;2-X; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	39	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24609	10.1371/journal.pone.0024609			9	Multidisciplinary Sciences	Science & Technology - Other Topics	822JC	WOS:000295039700031	21935431	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Karetko-Sysa, M; Skangiel-Kramska, J; Nowicka, D				Karetko-Sysa, Magdalena; Skangiel-Kramska, Jolanta; Nowicka, Dorota			Disturbance of perineuronal nets in the perilesional area after photothrombosis is not associated with neuronal death	EXPERIMENTAL NEUROLOGY			English	Article						Perineuronal net; Photothrombotic stroke; CAT-315; Brevican; Cerebral cortex; Cell death; Rat	CHONDROITIN-SULFATE PROTEOGLYCANS; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; PARVALBUMIN-CONTAINING NEURONS; PROMOTES FUNCTIONAL RECOVERY; OCULAR DOMINANCE PLASTICITY; TRAUMATIC BRAIN-INJURY; ADULT VISUAL-CORTEX; EXTRACELLULAR-MATRIX	Perineuronal nets (PNNs) are a condensed form of extracellular matrix that covers the surface of a subset of neurons. Their presence limits neuronal plasticity and may protect neurons against harmful agents. Here we analyzed the relationship between spatiotemporal changes in PNN expression and cell death markers after focal cortical photothrombotic stroke in rats. We registered a substantial decrease in PNN density using Wisteria floribunda agglutinin staining and CAT-315 and brevican immunoreactivity; the decrease occurred not only in the lesion core but also in the perilesional and remote cortex as well as in homotopic contralateral cortical regions. Fluor Jade C and TUNEL staining in perilesional and remote areas, however, showed a low density of dying cells. Our results suggest that the PNN reduction was not a result of cellular death and could be considered an attempt to create conditions favorable for synaptic remodeling. (C) 2011 Elsevier Inc. All rights reserved.	[Karetko-Sysa, Magdalena; Skangiel-Kramska, Jolanta; Nowicka, Dorota] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland	Nowicka, D (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, 3 Pasteur St, PL-02093 Warsaw, Poland.	d.nowicka@nencki.gov.pl		Nowicka, Dorota/0000-0001-9999-0793	Nencki Institute	This work was supported by statutory funds of the Nencki Institute. We thank Dr Katarzyna Lukasiuk and Professor Malgorzata Kossut for critical reading of the manuscript.	Ajmo JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-14; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bano D, 2007, STROKE, V38, P674, DOI 10.1161/01.STR.0000256294.46009.29; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bertolotto A, 1996, CELL TISSUE RES, V283, P283, DOI 10.1007/s004410050538; Bidmon HJ, 1998, NEUROSCIENCE, V82, P397; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Bruckner G, 2004, J MOL HISTOL, V35, P115; BRUCKNER G, 1994, BRAIN RES, V658, P67; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; BuchkremerRatzmann I, 1997, NEUROREPORT, V8, P519, DOI 10.1097/00001756-199701200-00028; Cafferty WBJ, 2008, J NEUROSCI, V28, P11998, DOI 10.1523/JNEUROSCI.3877-08.2008; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; DeGracia DJ, 2008, J NEUROCHEM, V106, P2288, DOI 10.1111/j.1471-4159.2008.05561.x; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Farkas T, 2003, NEUROSCI LETT, V342, P49, DOI 10.1016/S0304-3940(03)00230-1; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; FOSANG AJ, 1991, J BIOL CHEM, V266, P15579; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Fox K, 2002, SCIENCE, V298, P1187, DOI 10.1126/science.1079224; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Golgi C, 1873, GAZZ MED ITAL LOMBAR, V33, P244; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Haunso A, 2000, BRAIN RES, V864, P142, DOI 10.1016/S0006-8993(00)02173-9; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; Hoff EI, 2005, J NEUROSCI METH, V141, P135, DOI 10.1016/j.jneumeth.2004.06.004; Karetko M, 2009, ACTA NEUROBIOL EXP, V69, P564; Katsman D, 2003, J CEREBR BLOOD F MET, V23, P997, DOI 10.1097/01.WCB.0000084252.20114.BE; Kilinc M, 2010, NEUROBIOL DIS, V40, P293, DOI 10.1016/j.nbd.2010.06.003; Kim GW, 2001, NEUROSCIENCE, V105, P1007, DOI 10.1016/S0306-4522(01)00237-8; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Lander C, 1997, J NEUROSCI, V17, P1928; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Matthews RT, 2002, J NEUROSCI, V22, P7536; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Morawski M, 2010, NEUROSCIENCE, V169, P1347, DOI 10.1016/j.neuroscience.2010.05.022; Morawski M, 2010, NEUROBIOL AGING, V31, P1254, DOI 10.1016/j.neurobiolaging.2008.07.023; Nagel S, 2005, BRAIN RES, V1056, P43, DOI 10.1016/j.brainres.2005.07.036; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nakamura M, 2009, BRAIN RES, V1252, P117, DOI 10.1016/j.brainres.2008.11.022; NEUFELD EF, 1970, SCIENCE, V169, P141, DOI 10.1126/science.169.3941.141; Nowicka D, 2008, ACTA NEUROBIOL EXP, V68, P155; Nowicka D, 2009, EUR J NEUROSCI, V30, P2053, DOI 10.1111/j.1460-9568.2009.06996.x; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; OJIMA H, 1995, NEUROREPORT, V6, P617, DOI 10.1097/00001756-199503000-00008; Park KP, 2009, STROKE, V40, P2836, DOI 10.1161/STROKEAHA.109.554824; Passini MA, 2002, J NEUROSCI, V22, P6437; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; SZELE FG, 1995, J NEUROSCI, V15, P4429; TAYLOR RM, 1994, EXP CELL RES, V214, P606, DOI 10.1006/excr.1994.1298; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Wegner F, 2003, EXP NEUROL, V184, P705, DOI 10.1016/S0014-4886(03)00313-3; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	91	29	29	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2011	231	1					113	126		10.1016/j.expneurol.2011.05.022			14	Neurosciences	Neurosciences & Neurology	810DX	WOS:000294106700014	21683696				2021-06-18	
J	Lohani, S; Devkota, UP				Lohani, Subash; Devkota, Upendra Prasad			Hyponatremia in Patients with Traumatic Brain Injury: Etiology, Incidence, and Severity Correlation	WORLD NEUROSURGERY			English	Article						Cerebral salt wasting syndrome; Fractional excretion of uric acid; Hyponatremia; Syndrome of inappropriate antidiuretic hormone; Traumatic brain injury	DIURETIC HORMONE SIADH; SALT-WASTING SYNDROME; HEAD-INJURY; INAPPROPRIATE SECRETION; ANTIDIURETIC-HORMONE; PRACTICAL SCALE; CLASSIFICATION; DISEASE	BACKGROUND: Hyponatremia is common in patients with traumatic brain injury (TBI). This study aims at ascertaining the incidence of hyponatremia in TBI with its etiologic diagnosis, biochemical confirmation, and severity correlation with initial Glasgow Coma Scale (GCS) score and computed tomography (CT) abnormality. METHODS: All patients more than 20 years old with severe and moderate TBI and the mild ones with CT abnormality were included. Daily sodium level was monitored for 14 days. Central venous pressure (CVP) was measured for assessment of volume status. Fractional excretion of uric acid (FEUA) was measured in all patients with hyponatremia, both before and after its correction. RESULTS: Of 40 consecutive patients, 33 remained for analysis. Hyponatremia was seen in 9 (27.2%) patients, of whom 6 developed it within the first week. Mean duration of hyponatremia was 1.78 days. We found that 5 patients had an elevated CVP consistent with the syndrome of inappropriate antidiuretic hormone (SIADH), whereas 3 had low CVP consistent with cerebral salt wasting syndrome (CSWS) and 1 had an equivocal reading. Measurement of FEUA did not show consistent pattern to suggest a biochemical distinction. There were 33.3% each of mild and moderate, and 16.6% of severe TBI among hyponatremic patients. Hyponatremia was seen in Rotterdam CT scores I to IV in increasing incidence (r = 0.983, P = 0.017), whereas it had no significant correlation with initial GCS (r = 0.756, P = 0.455). CONCLUSIONS: Hyponatremia due to SIADH is more common in TBI. FEUA measurement is not consistent enough to make a distinction between SIADH and CSWS. CT scoring of severity is more predictive of hyponatremia than initial GCS.	[Lohani, Subash; Devkota, Upendra Prasad] Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal	Lohani, S (corresponding author), Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal.	subash.lohani@gmail.com					Abdel-Latif Mohamed El-Amin, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.06.2008.0135; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; DAVISON C, 1998, OXFORD TXB CLIN NEPH, P1156; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; Fukagawa M., 2008, CURRENT MED DIAGNOSI, P757; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Ishibashi Akira, 1999, Kurume Medical Journal, V46, P123; JENNETT B, 1975, LANCET, V1, P480; Kawajiri Katsuhisa, 1992, Neurological Surgery, V20, P1003; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kumar PD, 2001, ANN INTERN MED, V135, P932, DOI 10.7326/0003-4819-135-10-200111200-00027; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maesaka JK, 1999, NEPHRON, V82, P100, DOI 10.1159/000045384; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; NELSON PB, 1981, J NEUROSURG, V55, P938, DOI 10.3171/jns.1981.55.6.0938; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; SIVAKUMAR V, 1994, NEUROSURGERY, V34, P269, DOI 10.1227/00006123-199402000-00010; TEASDALE G, 1974, LANCET, V2, P81	22	29	35	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	SEP-OCT	2011	76	3-4					355	360		10.1016/j.wneu.2011.03.042			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	836VU	WOS:000296145700031	21986437				2021-06-18	
J	Miyake, J; Masatomi, T				Miyake, Junichi; Masatomi, Takashi			Arthroscopic Debridement of the Humeral Capitellum for Osteochondritis Dissecans: Radiographic and Clinical Outcomes	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Arthroscopic debridement; elbow; humeral capitellum; osteochondritis dissecans	FOLLOW-UP; BASEBALL PLAYERS; ELBOW; CLASSIFICATION; MANAGEMENT; AUTOGRAFT	Purpose Although arthroscopic debridement of the humeral capitellum is an accepted procedure for osteochondritis dissecans, some patients develop radial head enlargement or osteoarthritic lesions after the procedure. The aim of this study was to investigate the radiographic and clinical outcomes of arthroscopic debridement and consider its indications. Methods We retrospectively evaluated 106 patients who had arthroscopic debridement between 1997 and 2007. Surgery was performed after closure of the capitellar physis. We categorized the patients into 4 groups by lesion size and by whether the proximal radial physis was open or closed. The average patient age at surgery was 15 years (range, 12-18 y), and the average follow-up period was 13 months (range, 8-46 mo). Results In patients with large lesions and open proximal radial physes, radiographic and clinical outcomes were poor. Three of 4 patients developed early osteoarthritic lesions of the radiohumeral joint, secondary to radial head enlargement. Radial head resection was required in 2 of 3 patients. Conversely, osteoarthritic lesions did not occur, and we observed noteworthy improvement in elbow pain routinely after the procedure in the other 3 groups. For range of motion, clinically important changes were not observed. Overall, postoperative elbow pain was absent in 89 patients. Mild pain was present in 15 patients and moderate or severe pain in 2 patients. A total of 90 patients returned to sports at pre-injury levels. Time of return to sports varied from 1 month to 5 months (mean, 2.4 mo). Conclusions Arthroscopic debridement of the capitellum can provide excellent short-term results for the treatment of osteochondritis dissecans. However, it is contraindicated in cases with large lesions when the proximal radial physis remains open. (J Hand Surg 2011;36A:1333-1338. Copyright (C) 2011 by the American Society for Surgery of the Hand. All rights reserved.) Type of study/level of evidence Therapeutic IV.	[Miyake, Junichi] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; Yukioka Hosp, Dept Orthopaed Surg, Osaka, Japan	Miyake, J (corresponding author), Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	miyake-osk@umin.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23592185] Funding Source: KAKEN		BAUER M, 1992, CLIN ORTHOP RELAT R, P156; Baumgarten TE, 1998, AM J SPORT MED, V26, P520, DOI 10.1177/03635465980260040801; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Byrd JWT, 2002, AM J SPORT MED, V30, P474, DOI 10.1177/03635465020300040401; Iwasaki N, 2006, AM J SPORT MED, V34, P1233, DOI 10.1177/0363546506286343; Jones KJ, 2010, J PEDIATR ORTHOPED, V30, P8, DOI 10.1097/BPO.0b013e3181c3be83; Mihara K, 2010, J SHOULDER ELB SURG, V19, P31, DOI 10.1016/j.jse.2009.04.007; Mihara K, 2009, AM J SPORT MED, V37, P298, DOI 10.1177/0363546508324970; Miyake J, 2010, J SHOULDER ELB SURG, V19, P958, DOI 10.1016/j.jse.2010.03.002; Oka Y, 2001, J BONE JOINT SURG BR, V83B, P738, DOI 10.1302/0301-620X.83B5.11767; Ruch DS, 1998, ARTHROSCOPY, V14, P797, DOI 10.1016/S0749-8063(98)70013-1; Schoch B, 2010, ARTHROSCOPY, V26, P1469, DOI 10.1016/j.arthro.2010.03.008; Shimada K, 2005, CLIN ORTHOP RELAT R, P140, DOI 10.1097/01.blo.0000160025.14363.f9; Takahara M, 1999, CLIN ORTHOP RELAT R, P108; Takahara M, 2007, J BONE JOINT SURG AM, V89A, P1205, DOI 10.2106/JBJS.F.00622; Toh S, 2002, J BONE JOINT SURG AM, V84A, P593, DOI 10.2106/00004623-200204000-00013; Yamamoto Y, 2006, AM J SPORT MED, V34, P714, DOI 10.1177/0363546505282620	17	29	31	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023			J HAND SURG-AM	J. Hand Surg.-Am. Vol.	AUG	2011	36A	8					1333	1338		10.1016/j.jhsa.2011.05.024			6	Orthopedics; Surgery	Orthopedics; Surgery	804QP	WOS:000293669400013	21705155				2021-06-18	
J	New, PW; Simmonds, F; Stevermuer, T				New, P. W.; Simmonds, F.; Stevermuer, T.			Comparison of patients managed in specialised spinal rehabilitation units with those managed in non-specialised rehabilitation units	SPINAL CORD			English	Article						spinal cord injury; non-traumatic spinal cord injury; outcomes; epidemiology; rehabilitation; specialisation	FUNCTIONAL INDEPENDENCE MEASURE; AROC ANNUAL-REPORT; CORD-INJURY; AUSTRALIA; CARE; CENTERS; LENGTH; STATE	Study design: Prospective open cohort study. Objective: Compare the demographic characteristics and rehabilitation outcomes for both non-traumatic SCI (NT-SCI) and traumatic SCI (T-SCI) patients admitted into either specialist spinal cord injury rehabilitation units (SCIRUs) or non-specialist rehabilitation units (NSRUs). Setting: Rehabilitation units in Australia. Methods: The Australasian Rehabilitation Outcomes Centre maintains a national database on inpatients admitted to most (130/145) public and private rehabilitation units in Australia. Patients were included if they had a diagnosis of spinal cord injury (SCI) and were discharged between 1 January 2006 and 31 December 2006. Patients were excluded if admitted for <7 days, only for assessment, or were a readmission following a previous SCI. Results: There were 668 patients with confirmed SCI admitted (NT-SCI n = 361, 54.0%; T-SCI n = 307, 46.0%). NT-SCI patients were much less likely to be admitted into a specialist SCIRU (30.5%) compared with T-SCI patients (70.4%). For both NT-SCI and T-SCI patients, those admitted to a specialist SCIRU tended to be younger (P = 0.000), have a longer length of stay in rehabilitation (P = 0.000), and lower Functional Independence Measure (FIM) motor subscale score on admission (P = 0.000) than those admitted to a NSRU. For NT-SCI patients, after adjusting for covariates, those admitted into specialist SCIRU had greater improvement in their FIM motor score during rehabilitation. This finding was not demonstrated in T-SCI patients. Conclusions: There are differences in the characteristics of SCI patients admitted to SCIRU compared with NSRU. NT-SCI patients admitted to SCIRU have greater functional gain. Sponsorship: This project was made possible by a major research grant from the Victorian Neurotrauma Initiative. A minor research grant was also provided by the Australasian Faculty of Rehabilitation Medicine 2007 Ipsen research scholarship. The authors would like to thank these organisations for their support. These organisations had no role in the design, analysis or preparation of this manuscript. Spinal Cord (2011) 49, 909-916; doi:10.1038/sc.2011.29; published online 5 April 2011	[New, P. W.] Caulfield Hosp, Spinal Rehabil Unit, Caulfield, Vic 3162, Australia; [New, P. W.] Monash Univ, Epworth Monash Rehabil Med Unit, So Med Sch, Melbourne, Vic 3004, Australia; [Simmonds, F.; Stevermuer, T.] Univ Wollongong, Australasian Rehabil Outcome Ctr, Ctr Hlth Serv Dev, Wollongong, NSW, Australia	New, PW (corresponding author), Caulfield Hosp, Spinal Rehabil Unit, 260 Kooyong Rd, Caulfield, Vic 3162, Australia.	p.new@cgmc.org.au			Victorian Neurotrauma Initiative; Australasian Faculty of Rehabilitation Medicine	The authors would like to thank the assistance of all the hospitals contributing data to AROC, and especially those who participated in the data quality review undertaken as part of this project. Some of the results described here were presented at the 49th International Spinal Cord Society Annual Scientific Meeting, Florence, Italy, 21-24 October 2009. This project was made possible by a major research grant from the Victorian Neurotrauma Initiative. A minor research grant was also provided by the Australasian Faculty of Rehabilitation Medicine 2007 Ipsen research scholarship. We thank these organizations for their support. These organizations had no role in the design, analysis or preparation of this paper.	[Anonymous], 1997, GUID UN DAT SET MED; BEDBROOK GM, 1985, LIFETIME CARE PARAPL; Celani MG, 2001, ARCH PHYS MED REHAB, V82, P589, DOI 10.1053/apmr.2001.21948; CHARLES ED, 1977, PARAPLEGIA, V15, P302; Cripps R, 2008, INJURY RES STAT SERI, V48; DONOVAN WH, 1984, PARAPLEGIA, V22, P282, DOI 10.1038/sc.1984.46; FRANKEL H, 1987, PARAPLEGIA, V25, P239, DOI 10.1038/sc.1987.42; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Guttmann L., 1976, SPINAL CORD INJURIES, V2nd ed; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Hamilton B B, 1976, Paraplegia, V14, P87; HEINEMANN AW, 1989, ARCH NEUROL-CHICAGO, V46, P1098, DOI 10.1001/archneur.1989.00520460084017; Marino RJ, 2002, J SPINAL CORD MED S1, V26, pS50; National Health and Hospitals Reform Commission, 2009, HEALTH FUT ALL AUSTR; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; New Peter W, 2006, Aust Health Rev, V30, P353; NEW PW, SPINAL CORD, V49, P397; O'Connor PJ, 2000, SPINAL CORD, V38, P597, DOI 10.1038/sj.sc.3101048; Osterthun R, 2009, SPINAL CORD, V47, P339, DOI 10.1038/sc.2008.127; Simmonds F, 2007, AUST HEALTH REV, V31, pS31; Simmonds F, 2008, AUST HEALTH REV, V32, P85, DOI 10.1071/AH080085; Smith M, 2002, SPINAL CORD, V40, P11, DOI 10.1038/sj.sc.3101226; TATOR CH, 1995, PARAPLEGIA, V33, P254, DOI 10.1038/sc.1995.58; Wallace D, 2002, J CLIN EPIDEMIOL, V55, P922, DOI 10.1016/S0895-4356(02)00410-9; Wolfe DL, 2007, TOP SPINAL CORD INJ, V13, P11; YARKONY GM, 1985, PARAPLEGIA, V23, P265, DOI 10.1038/sc.1985.43	26	29	29	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	AUG	2011	49	8					909	916		10.1038/sc.2011.29			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	803HS	WOS:000293573000011	21468042	Bronze			2021-06-18	
J	Classen, S; Levy, C; Meyer, DL; Bewernitz, M; Lanford, DN; Mann, WC				Classen, Sherrilene; Levy, Charles; Meyer, Dustin L.; Bewernitz, Megan; Lanford, Desiree N.; Mann, William C.			Simulated Driving Performance of Combat Veterans With Mild Tramatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						automobile driving; brain injuries; computer simulation; stress disorders, post-traumatic; veterans	VALIDITY	OBJECTIVE. We determined differences in driving errors between combat veterans with mild traumatic brain injury and posttraumatic stress disorder and healthy control participants. METHOD. We compared 18 postdeployed combat veterans with 20 control participants on driving errors in a driving simulator. RESULTS. Combat veterans were more likely to be male; were younger; and had more racial diversity, less formal education, and lower cognitive scores than control participants. Control participants made more signaling errors (t [19] = 2.138, p = .046, SE = 0.395), but combat veterans made more overspeeding (t[17.3] = 4.095, p = .001, SE = 0.708) and adjustment-to-stimuli (t[17] = 2.380, p = .029, SE = 0.140) errors. Young age was related to overspeeding. CONCLUSION. Combat veterans made more critical driving errors than did control participants. Such errors made on the road may lead to crashes or injuries. Although limited in generalizability, these findings provide early support for developing safe driving interventions for combat veterans.	[Classen, Sherrilene] Univ Florida, Inst Mobil Act & Participat, Gainesville, FL 32610 USA; [Classen, Sherrilene; Bewernitz, Megan; Lanford, Desiree N.; Mann, William C.] Univ Florida, Occupat Therapy Dept, Gainesville, FL 32610 USA; [Levy, Charles] Malcom Randall VA Vet Affairs Med Ctr, Phys Med & Rehabil Serv, Gainesville, FL USA; [Mann, William C.] Vet Affairs Rehabil Outcomes Res Ctr, Gainesville, FL USA; [Meyer, Dustin L.] Univ Florida, Hlth Sci Program, Gainesville, FL 32610 USA	Classen, S (corresponding author), Univ Florida, Inst Mobil Act & Participat, POB 100164, Gainesville, FL 32610 USA.	sclassen@phhp.ufl.edu	Bewernitz, Megan/D-3151-2019				*AM OCC THER ASS, 2005, AM J OCCUPATIONAL TH, V59, P666, DOI DOI 10.5014/AJOT.59.6.666; American Occupational Therapy Association, 2008, AM J OCCUPATIONAL TH, V62, P625, DOI DOI 10.5014/AJOT.62.6.625; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BROWN ID, 1988, ERGONOMICS, V31, P585, DOI 10.1080/00140138808966701; Classen Sherrilene, 2007, Traffic Inj Prev, V8, P69, DOI 10.1080/15389580600994339; Classen S, 2010, AM J OCCUP THER, V64, P233, DOI 10.5014/ajot.64.2.233; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDMAN M, PTSD 101; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; *I MED, 2007, GLOB WAR  HLTH LONGT; Justiss MD, 2006, TOP GERIATR REHABIL, V22, P121; KENNEDY RS, 1992, AVIAT SPACE ENVIR MD, V63, P588; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Radloff L.S., 1986, COMMUNITY MENTAL HLT; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SHECHTMAN, 2010, THERAPY, V64, P242, DOI DOI 10.5014/AJ0T.64.2.242; Shechtman Oritz, 2007, Traffic Inj Prev, V8, P78, DOI 10.1080/15389580600994321; Staplin L, 2003, J SAFETY RES, V34, P389, DOI 10.1016/j.jsr.2003.09.002	24	29	29	0	9	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2011	65	4					419	427		10.5014/ajot.2011.000893			9	Rehabilitation	Rehabilitation	792YY	WOS:000292787500009	21834457	Bronze			2021-06-18	
J	Liu, L; Wei, HJ; Chen, FL; Wang, JH; Dong, JF; Zhang, JN				Liu, Li; Wei, Huijie; Chen, Fanglian; Wang, Jinghua; Dong, Jing-fei; Zhang, Jianning			Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						endothelial progenitor cells; traumatic brain injury; clinical outcome; prognostic marker	ACTIVATED PLATELETS; PRECURSOR CELLS; CD34(+) CELLS; STEM-CELLS; DIFFERENTIATION; MOBILIZATION; ANGIOGENESIS; REPAIR; STROKE	Objective: Endothelial progenitor cells play an active role in vascular repair and revascularization of tissue damaged by traumatic, inflammatory, and ischemic injures. We correlate the changes in circulating endothelial progenitor cells with the severity of traumatic brain injury. The study is designed to investigate the endothelial progenitor cell mobilization after injury and a potential use of circulating endothelial progenitor cells as a prognostic marker for evaluating trauma severity and clinical outcomes. Design: A prospective cohort study conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Tianjin Huanhu Hospital (Tianjin, China). Patients: Patients with traumatic brain injury and age-and gender-matched healthy controls. Interventions: None. Measurements and Main Results: Changes in the levels of circulating endothelial progenitor cells were monitored for up to 21 days in 84 patients with traumatic brain injury. Results were correlated with the clinical assessment of injury severity as determined by the Glasgow Coma Scale. The level of circulating endothelial progenitor cells was found to be suppressed 24-48 hrs after injury but rapidly increased, reaching the highest at days 5-7 post-trauma. Circulating endothelial progenitor cells in patients with improved Glasgow Coma Scale scores were significantly higher than those with deteriorated conditions and remained persistently low in patients who died of trauma. Conclusions: The results suggest that the level of circulating endothelial progenitor cells correlates with the clinical severity and outcome of traumatic brain injury and may offer potential as a prognostic marker for traumatic brain injury. A long-term follow-up of these patients is ongoing. (Crit Care Med 2011; 39: 1760-1765)	[Liu, Li; Wei, Huijie; Chen, Fanglian; Wang, Jinghua; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China; Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Dong, Jing-fei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA	Liu, L (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China.	jfdong@bcm.tmc.edu; jianningzhang@hotmail.com			Chinese Science Foundation (Beijing, China) [2005CB522600, 30772229]; National Institutes of Health (Bethesda, MD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER	Supported, in part, by grants 2005CB522600 (JZ) and 30772229 (JZ) from the Chinese Science Foundation (Beijing, China) and grant HL71895 (JFD) from the National Institutes of Health (Bethesda, MD).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Gehling UM, 2000, BLOOD, V95, P3106; Gill M, 2001, CIRC RES, V88, P167; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Langer HF, 2007, SEMIN THROMB HEMOST, V33, P136, DOI 10.1055/s-2007-969026; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401	20	29	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JUL	2011	39	7					1760	1765		10.1097/CCM.0b013e3182186cee			6	Critical Care Medicine	General & Internal Medicine	778RF	WOS:000291721800019	21460712	Green Accepted			2021-06-18	
J	Umeda, S; Kurosaki, Y; Terasawa, Y; Kato, M; Miyahara, Y				Umeda, Satoshi; Kurosaki, Yoshiko; Terasawa, Yuri; Kato, Motoichiro; Miyahara, Yasuyuki			Deficits in prospective memory following damage to the prefrontal cortex	NEUROPSYCHOLOGIA			English	Article						Prospective memory; Prefrontal cortex; Medial temporal lobe; Neuropsychological test; Executive function; Traumatic brain injury	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; REGIONS; INTENTIONS; REALIZATION; INVOLVEMENT; HYPOTHESIS; POSTERIOR; DEMANDS; DISEASE	Neuropsychological investigations of prospective memory (PM), representing memory of future intentions or plans, have evolved over the past two decades. The broadly accepted divisions involved in PM consist of a prospective memory component (PMC), a process for remembering to remember, and a retrospective memory component, a process for remembering the content of the intended action. Previous functional neuroimaing studies have provided some evidence that the rostral prefrontal cortex (BA10) is one of areas that is critical for prospective remembering. However, the question of whether damage to part of the prefrontal cortex affects attenuated performance for PMC remains unresolved. In this study, 74 participants with traumatic brain injury (TBI) including focal damage to frontal or temporal lobe areas were administered thirteen standard neuropsychological tests and the PM task. To identify influential areas contributing to PM performance, discriminant function analysis was conducted. The results indicated that the following three areas are highly contributory to PM performance: the right dorsolateral prefrontal cortex; the right ventromedial prefrontal cortex; and the left dorsomedial prefrontal cortex. Comparing differences in neuropsychological test scores showed that orientation scores were significantly higher in the greater PM performance group, suggesting that PMC represents an integrated memory function associated with awareness of current status. These data contribute to our understanding of the neural substrates and functional characteristics of the PMC. (C) 2011 Elsevier Ltd. All rights reserved.	[Umeda, Satoshi; Terasawa, Yuri] Keio Univ, CARLS, Dept Psychol, Minato Ku, Tokyo 1088345, Japan; [Kurosaki, Yoshiko] Ohtawara Red Cross Hosp, Dept Rehabil, Ohtawara, Tochigi 3248686, Japan; [Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Miyahara, Yasuyuki] Ohtawara Red Cross Hosp, Dept Neurosurg, Ohtawara, Tochigi 3248686, Japan	Umeda, S (corresponding author), Keio Univ, CARLS, Dept Psychol, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	umeda@flet.keio.ac.jp		Terasawa, Yuri/0000-0002-2812-0544	Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [21530770]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21530770, 21330168] Funding Source: KAKEN	This study was supported by a Grant-in-Aid for Scientific Research (No. 21530770) from the Japan Society for the Promotion of Science (JSPS). We are grateful to the patients who participated in our study.	BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Brandimonte M., 1996, PROSPECTIVE MEMORY T; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Costa A, 2010, NEUROPSYCHOLOGY, V24, P327, DOI 10.1037/a0018015; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; EINSTEIN GO, 2008, PSYCHOL LEARN MOTIV, P145; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gupta S, 2010, J CLIN EXP NEUROPSYC, V32, P898, DOI 10.1080/13803391003596470; Handa T., 1989, J KEIO MED SOC, V66, P153; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Hayashi C, 1951, ANN I STAT MATH, V3, P69, DOI [10.1007/BF02949778, DOI 10.1007/BF02949778]; Heaton R. K, 1981, WISCONSIN CARD SORTI; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Imai Y., 1994, J HONG KONG COLL PSY, V4, P20; Isaacs EB, 2003, P NATL ACAD SCI USA, V100, P13060, DOI 10.1073/pnas.1233825100; Jones CRG, 2011, J AUTISM DEV DISORD, V41, P455, DOI 10.1007/s10803-010-1067-y; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kinkingnehun S, 2007, NEUROIMAGE, V37, P1237, DOI 10.1016/j.neuroimage.2007.06.027; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kohs SC, 1923, INTELLIGENCE MEASURE; Kumar D, 2005, J CLIN EXP NEUROPSYC, V27, P867, DOI 10.1080/13803390490919100; Livner A, 2009, J NEUROL SCI, V283, P235, DOI 10.1016/j.jns.2009.02.377; Maylor EA, 1995, NEUROCASE, V1, P285, DOI 10.1093/neucas/1.3.285; McDaniel M. A., 2007, PROSPECTIVE MEMORY O; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; MCKITRICK LA, 1992, J GERONTOL, V47, pP337, DOI 10.1093/geronj/47.5.P337; Morris AL, 2008, CONSCIOUS COGN, V17, P1378, DOI 10.1016/j.concog.2008.04.005; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Raven J. C., 1990, COLOURED PROGRESSIVE; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Umeda S, 2006, REV NEUROSCIENCE, V17, P267; Umeda S, 2005, NEUROIMAGE, V26, P932, DOI 10.1016/j.neuroimage.2005.03.004; UMEDA S, 2000, JAPANESE J NEUROPSYC, V16, P193; Umeda S, 2010, SOC NEUROSCI-UK, V5, P19, DOI 10.1080/17470910902990584; Volle E, 2008, CEREB CORTEX, V18, P2460, DOI 10.1093/cercor/bhn010; Wechsler D., 1987, WECHSLER MEMORY SCAL; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 2005, PSYCHOPHYSIOLOGY, V42, P698, DOI 10.1111/j.1469-8986.2005.00361.x; West R, 2007, NEUROCASE, V13, P115, DOI 10.1080/13554790701399247; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Worthington A, 1999, NEUROCASE, V5, P47	77	29	31	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUL	2011	49	8			SI		2178	2184		10.1016/j.neuropsychologia.2011.03.036			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	793FL	WOS:000292805700005	21477605				2021-06-18	
J	Davidson, JRT; Crawford, C; Ives, JA; Jonas, WB				Davidson, Jonathan R. T.; Crawford, Cindy; Ives, John A.; Jonas, Wayne B.			Homeopathic Treatments in Psychiatry: A Systematic Review of Randomized Placebo-Controlled Studies	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							MAJOR DEPRESSIVE DISORDER; CONTROLLED-TRIALS; DOUBLE-BLIND; FIBROMYALGIA SYNDROME; ALTERNATIVE MEDICINE; CLINICAL-TRIAL; METAANALYSIS; COMPLEMENTARY; EFFICACY; FIBROSITIS	Objective: To systematically review placebo-controlled randomized trials of homeopathy for psychiatric conditions. Data Sources: Eligible studies were identified using the following databases from database inception to April 2010: PubMed, CINAHL, PsycINFO, Horn-Inform, Cochrane CENTRAL, National Center for Complementary and Alternative Medicine grantee publications database, and ClinicalTrials.gov. Gray literature was also searched using Google, Google Scholar, the European Committee for Homeopathy, inquiries with homeopathic experts and manufacturers, and the bibliographic lists of included published studies and reviews. Search terms were as follows: (homeopath* or homoeopath*) and (placebo or sham) and (anxiety or panic or phobia or post-traumatic stress or PTSD or obsessive-compulsive disorder or fear or depress* or dysthym* or attention deficit hyperactivity or premenstrual syndrome or premenstrual disorder or premenstrual dysphoric disorder or traumatic brain injury or fibromyalgia or chronic fatigue syndrome or myalgic encephalitis or insomnia or sleep disturbance). Searches included only English-language literature that reported randomized controlled trials in humans. Study Selection: Trials were included if they met 7 criteria and were assessed for possible bias using the Scottish Intercollegiate Guidelines Network (SIGN) 50 guidelines. Overall assessments were made using the Grading of Recommendations Assessment, Development and Evaluation procedure. Identified studies were grouped into anxiety or stress, sleep or circadian rhythm complaints, premenstrual problems, attention-deficit/hyperactivity disorder, mild traumatic brain injury, and functional somatic syndromes. Results: Twenty-five eligible studies were identified from an initial pool of 1,431. Study quality according to SIGN 50 criteria varied, with 6 assessed as good, 9 as fair, and 10 as poor. Outcome was unrelated to SIGN quality. Effect size could be calculated in 16 studies, and number needed to treat, in 10 studies. Efficacy was found for the functional somatic syndromes group (fibromyalgia and chronic fatigue syndrome), but not for anxiety or stress. For other disorders, homeopathy produced mixed effects. No placebo-controlled studies of depression were identified. Meaningful safety data were lacking in the reports, but the superficial findings suggested good tolerability of homeopathy. A funnel plot in 13 studies did not support publication bias (chi(2)(1)=1.923, P=.166). Conclusions: The database on studies of homeopathy and placebo in psychiatry is very limited, but results do not preclude the possibility of some benefit. J Clin Psychiatry 2011;72(6):795-805 (C) Copyright 2011 Physicians Postgraduate Press, Inc.	[Davidson, Jonathan R. T.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Crawford, Cindy; Ives, John A.; Jonas, Wayne B.] Samueli Inst, Alexandria, VA USA	Davidson, JRT (corresponding author), 3068 Baywood Dr, Seabrook Isl, SC 29455 USA.	jonathan.davidson@duke.edu	Crawford, Cindy/AAI-3891-2021		AstraZenecaAstraZeneca; Euthymics Bioscience; United States Army Medical Research Acquisition Activity [W81XWH-08-1-0615-P00001]	In the last 12 months, Dr Davidson has received consulting fees from AstraZeneca and Euthymics Bioscience and royalties from the Davidson Trauma Scale, Social Phobia Inventory, Connor-Davidson Resilience Scale, Guilford Publications, and American Psychiatric Press. Ms Crawford and Drs Ives and Jonas report no potential conflict of interest.; This project was partially supported by award number W81XWH-08-1-0615-P00001 (United States Army Medical Research Acquisition Activity).	Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; AWDRY R, 1996, INT J ALTERN COMPLEM, V14, P12; Baker DG, 2003, COMPLEMENT THER MED, V11, P65, DOI 10.1016/S0965-2299(03)00059-1; Bell IR, 2004, INT J NEUROSCI, V114, P1195, DOI 10.1080/00207450490475724; Bell IR, 2004, RHEUMATOLOGY, V43, P577, DOI 10.1093/rheumatology/keh111; Bell IR, 2004, J ALTERN COMPLEM MED, V10, P285, DOI 10.1089/107555304323062275; BELL IR, SLEEP MED; Bonne O, 2003, J CLIN PSYCHIAT, V64, P282, DOI 10.4088/JCP.v64n0309; Chapman EH, 1999, J HEAD TRAUMA REHAB, V14, P521, DOI 10.1097/00001199-199912000-00002; CHAPMAN EH, 1994, J AM I HOM, V87, P14; COLE CL, 1998, THESIS TECHNIKON WIT, P1; COLQUHOUN D, 1990, LANCET, V336, P441, DOI 10.1016/0140-6736(90)91989-N; Cooper KL, 2010, SLEEP MED REV, V14, P329, DOI 10.1016/j.smrv.2009.11.005; Cucherat M, 2000, EUR J CLIN PHARMACOL, V56, P27, DOI 10.1007/s002280050716; Davidson JRT, 1998, COMPR PSYCHIAT, V39, P16, DOI 10.1016/S0010-440X(98)90027-X; De Silva V, 2010, RHEUMATOLOGY, V49, P1063, DOI 10.1093/rheumatology/keq025; Ernst E, 2010, MED J AUSTRALIA, V192, P458, DOI 10.5694/j.1326-5377.2010.tb03585.x; FISHER P, 1989, BRIT MED J, V299, P365, DOI 10.1136/bmj.299.6695.365; FISHER P, 1990, LANCET, V336, P954, DOI 10.1016/0140-6736(90)92334-E; FISHER P, 1986, BR HOM J, V75, P142; Freeman MP, 2010, J CLIN PSYCHIAT, V71, P669, DOI 10.4088/JCP.10cs05959blu; Freeman MP, 2010, J CLIN PSYCHIAT, V71, P682, DOI 10.4088/JCP.10r05976blu; Frei H, 2005, EUR J PEDIATR, V164, P758, DOI 10.1007/s00431-005-1735-7; Grabia S, 2003, Homeopathy, V92, P92, DOI 10.1016/S1475-4916(03)00007-9; Hauser W, 2009, PAIN, V145, P69, DOI 10.1016/j.pain.2009.05.014; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Hedges L.V., 1985, STAT METHODS META AN; HEIRS M, 2007, COCHRANE DB SYST REV, V4; Jacobs BP, 2009, ACP EVIDENCE BASED G; Jacobs J, 2005, J ALTERN COMPLEM MED, V11, P799, DOI 10.1089/acm.2005.11.799; JACOBS J, 1991, BR HOMEOPATH J, V80, P57; Jonas WB, 2003, ANN INTERN MED, V138, P393, DOI 10.7326/0003-4819-138-5-200303040-00009; KIRTLAND KA, 1994, THESIS TECHNIKON NAT; Kolia-Adam N, 2008, SIMILLIMUM, VXXI, P91; KOLIAADAM N, 2010, EFFICACY COFFEA CRUD; KUMAR K, NO JET LAG SCI TEST; La Pine MP, 2006, DIMENS CRIT CARE NUR, V25, P130, DOI 10.1097/00003465-200605000-00015; LAISTER CA, EFFICACY HOMOEOPATHI; Lewith G, 2009, J EVAL CLIN PRACT, V15, P1236, DOI 10.1111/j.1365-2753.2009.01261.x; Linde K, 1998, J ALTERN COMPLEM MED, V4, P371, DOI 10.1089/acm.1998.4.371; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; Lipman Derek, 1999, Sleep Breath, V3, P53, DOI 10.1007/s11325-999-0053-0; Ludtke R, 2008, J CLIN EPIDEMIOL, V61, P1197, DOI 10.1016/j.jclinepi.2008.06.015; MAHARAJ A, 2005, THESIS DURBAN I TECH; McCarney RW, 2003, COCHRANE DB SYST REV; MCCUTCHEON LE, 1996, J APPL NUTR, V48, P2; Naude DF, 2010, HOMEOPATHY, V99, P63, DOI 10.1016/j.homp.2009.11.001; NGOBESE JC, 2006, THEIS DURBAN U TECHN; Perry R, 2010, CLIN RHEUMATOL, V29, P457, DOI 10.1007/s10067-009-1361-2; Pilkington K, 2006, HOMEOPATHY, V95, P151, DOI 10.1016/j.homp.2006.05.005; Relton C, 2009, HOMEOPATHY, V98, P77, DOI 10.1016/j.homp.2008.12.004; SAUL W, 2005, THESIS TECHNIKON NAT; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; *SIGN NETW, 2001, GUID DEV HDB; STRAUSS LC, 2000, BIOMED THER, V18, P197; TRAUB G, 2000, THESIS TECHNIKON WIT; VAITHILINGAM H, 2005, THESIS DURBAN U TECH; Weatherley-Jones E, 2004, J PSYCHOSOM RES, V56, P189, DOI 10.1016/S0022-3999(03)00377-5; Yakir M, 2001, Br Homeopath J, V90, P148, DOI 10.1054/homp.1999.0491	59	29	29	0	45	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	JUN	2011	72	6					795	805		10.4088/JCP.10r06580			11	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	786XJ	WOS:000292340900009	21733480				2021-06-18	
J	Fuller, G; Bouamra, O; Woodford, M; Jenks, T; Patel, H; Coats, TJ; Oakley, P; Mendelow, AD; Pigott, T; Hutchinson, PJ; Lecky, F				Fuller, G.; Bouamra, O.; Woodford, M.; Jenks, T.; Patel, H.; Coats, T. J.; Oakley, P.; Mendelow, A. D.; Pigott, T.; Hutchinson, P. J.; Lecky, F.			Temporal trends in head injury outcomes from 2003 to 2009 in England and Wales	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Critical care; neurosurgery; craniocerebral trauma; cohort studies; patient transfer	TRAUMATIC BRAIN-INJURY; CARE; MORTALITY; GENDER; EPIDEMIOLOGY; IMPROVEMENT; IMPACT	Background: Case fatality rates after blunt head injury (HI) did not improve in England and Wales between 1994 and 2003. The United Kingdom National Institute of Clinical Excellence subsequently published HI management guidelines, including the recommendation that patients with severe head injuries (SHIs) should be treated in specialist neuroscience units (NSU). The aim of this study was to investigate trends in case fatality and location of care since the introduction of national HI clinical guidelines. Methods: We conducted a retrospective cohort study using prospectively recorded data from the Trauma and Audit Research Network (TARN) database for patients presenting with blunt trauma between 2003 and 2009. Temporal trends in log odds of death adjusted for case mix were examined for patients with and without HI. Location of care for patients with SHI was also studied by examining trends in the proportion of patients treated in non-NSUs. Results: Since 2003, there was an average 12% reduction in adjusted log odds of death per annum in patients with HI (n=15,173), with a similar but smaller trend in non-HI trauma mortality (n=48,681). During the study period, the proportion of patients with HI treated entirely in non-NSUs decreased from 31% to 19%, (p < 0.01). Interpretation: The reduction in odds of death following HI since 2003 is consistent with improved management following the introduction of national HI guidelines and increased treatment of SHI in NSUs.	[Fuller, G.; Bouamra, O.; Woodford, M.; Jenks, T.; Lecky, F.] Univ Manchester, Trauma Audit & Res Network, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp,Hlth Sci Res Grp, Salford M6 8HD, Lancs, England; [Patel, H.] Salford Royal Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England; [Coats, T. J.] Univ Leicester, Leicester Royal Infirm, Dept Accid & Emergency, Emergency Med Acad Grp, Leicester LE1 5WW, Leics, England; [Oakley, P.] N Staffordshire Hosp, Dept Intens Care & Anaesthesia, N Staffordshire NHS Trust Stoke On Trent, Stoke On Trent ST4 7LN, Staffs, England; [Mendelow, A. D.] Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Pigott, T.] Walton Ctr NHS Fdn Trust, Dept Neurosurg, Liverpool L9 7LJ, Merseyside, England; [Hutchinson, P. J.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge CB2 2QQ, England	Fuller, G (corresponding author), Univ Manchester, Trauma Audit & Res Network, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp,Hlth Sci Res Grp, Clin Sci Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	gordonwfuller@doctors.net.uk		Fuller, Gordon Ward/0000-0001-8532-3500; Coats, Timothy/0000-0003-2736-2784; bouamra, omar/0000-0002-3155-4634	Academy of Medical Sciences/Health Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2008-06-001] Funding Source: researchfish	We declare that we have no conflicts of interest in relation to publication of this paper. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship. TARN is part of the University of Manchester and is self funding through contributions from participating hospitals.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; *COMM INJ SCAL ASS, 1990, ABBR INJ SCAL 1990 R; Cooper RJ, 2006, ANN EMERG MED, V47, P19, DOI 10.1016/j.annemergmed.2005.11.030; *DEP HLTH, HLTH PAT INF ADV GRO; DEPARTMENT OF, 2010, GROUP DFDF, P1; Domino KB, 2010, J NEUROSURG ANESTH, V22, P360, DOI 10.1097/ANA.0b013e3181f0db15; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; George RL, 2003, J TRAUMA, V54, P464, DOI 10.1097/01.TA.0000051939.95039.E6; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lecky FE, 2002, EMERG MED J, V19, P520, DOI 10.1136/emj.19.6.520; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; *NAT CONF ENQ PAT, 2007, NCEPOD TRAUM WHO CAR; *NAT I CLIN EXC, 2003, 56 NAT I CLIN EXC NA; *NAT I CLIN EXC, 2003, 4 NAT I CLIN EXC NAT; Nissen Stephen W, 2010, J Pharm Pract, V23, P61, DOI 10.1177/0897190009356555; Office for National Statistics, 2005, MORT STAT CAUS SEX A; PEREL P, 2006, BMC MED INFORM DECIS, V14, P6; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rubin DB., 1987, MULTIPLE IMPUTATION; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SMITH M, 2004, BJ ANAESTHESIA, V93, P754; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; TWEEDIE IE, 2008, CARE CRITICALLY ILL, V24, P143; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; WESTABY S, 2007, BMJ-BRIT MED J, V335, P795; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; NEUROCRITICAL CARE C	38	29	29	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2011	25	3					414	421		10.3109/02688697.2011.570882			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	769QR	WOS:000291033800026	21513451				2021-06-18	
J	Honeybul, S				Honeybul, Stephen			Sudden death following cranioplasty: a complication of decompressive craniectomy for head injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Decompressive craniectomy; complications; neurotrauma		This report details three cases of massive post-operative cerebral swelling following autologous cranioplasty. All three patients had a bifrontal decompressive craniectomy for intractably raised intracranial pressure following severe neurotrauma, developed hydrocephalus necessitating shunt insertion and were making a poor neurological recovery.	Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au					Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Kelly AG, 2010, NEUROLOGY, V75, P682, DOI 10.1212/WNL.0b013e3181eee273; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	3	29	30	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2011	25	3					343	345		10.3109/02688697.2011.568643			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	769QR	WOS:000291033800012	21501058				2021-06-18	
J	Frugier, T; Crombie, D; Conquest, A; Tjhong, F; Taylor, C; Kulkarni, T; McLean, C; Pebay, A				Frugier, Tony; Crombie, Duncan; Conquest, Alison; Tjhong, Frisca; Taylor, Caroline; Kulkarni, Tejal; McLean, Catriona; Pebay, Alice			Modulation of LPA Receptor Expression in the Human Brain Following Neurotrauma	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Autotaxin; Human; Lysophosphatidic acid; Traumatic brain injury human brain	CENTRAL-NERVOUS-SYSTEM; LYSOPHOSPHATIDIC ACID; PHOSPHODIESTERASE-I; AUTOTAXIN; PROLIFERATION; LOCALIZATION; ACTIVATION; INITIATION; SIGNALS; GROWTH	Lysophosphatidic acid (LPA) is involved in physiological and pathological states, including in neural development and inflammation. We assessed the expression pattern of the LPA receptors 1-3 and of LPA-producing enzyme autotaxin in post-mortem human brain tissue, both in normal individuals and in individuals who died following traumatic brain injury. We found that LPA receptors and autotaxin are weakly expressed in the normal control adult brain. Quantitative PCR for the LPA receptors and autotaxin mRNA showed an increase of LPAR(2) and a decrease of autotaxin mRNA expression in the cortex following brain injury. Immunohistochemical analysis showed that LPAR(1) colocalized with astrocytes and that LPAR(2) is present on the ependymal cells lining the lateral ventricle in the brain samples from individuals who died following severe head injury. This work shows for the first time that key components of the LPA pathway are modulated following TBI in humans.	[Pebay, Alice] Univ Melbourne, Ctr Neurosci, Dept Pharmacol, Parkville, Vic 3010, Australia; [McLean, Catriona] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3004, Australia; [Crombie, Duncan; Tjhong, Frisca; Taylor, Caroline; Kulkarni, Tejal; Pebay, Alice] OBrien Inst, Fitzroy, Vic 3065, Australia; [Frugier, Tony; Conquest, Alison] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Frugier, Tony; Conquest, Alison] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia	Pebay, A (corresponding author), Univ Melbourne, Ctr Neurosci, Dept Pharmacol, Parkville, Vic 3010, Australia.	apebay@unimelb.edu.au		Frugier, Tony/0000-0002-1275-5158; Taylor, Caroline/0000-0003-2151-8709; Pebay, Alice/0000-0002-7408-9453; Crombie, Duncan/0000-0002-4718-1967	NHMRCNational Health and Medical Research Council of Australia [454723]; NHMRC/Victorian Neurotrauma Initiative Career Development AwardNational Health and Medical Research Council of Australia; Victorian State Government's Department of Innovation; Industry and Regional Development's Operational Infastructure Support Program; National Trauma Research Institute; University of MelbourneUniversity of Melbourne; Mental Health Research Institute of Victoria; Victorian Institute of Forensic Medicine; Victorian Neurotrauma Initiative, Neurosciences Australia	This work was supported by a NHMRC Project Grant 454723, a NHMRC/Victorian Neurotrauma Initiative Career Development Award (to AP) and the Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infastructure Support Program. Tissues were received from the Victorian Brain Bank Network, supported by The National Trauma Research Institute, The University of Melbourne, The Mental Health Research Institute of Victoria, The Victorian Institute of Forensic Medicine and funded by the Victorian Neurotrauma Initiative, Neurosciences Australia and the NHMRC. The authors wish to thank the Histology Facility, Department of Anatomy and Cell Biology, University of Melbourne and J. Palmer for their technical assistance.	Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dennis J, 2005, J NEUROSCI RES, V82, P737, DOI 10.1002/jnr.20686; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Elmes SJR, 2004, BRAIN RES, V1022, P205, DOI 10.1016/j.brainres.2004.07.005; Frohnert PW, 2003, J NEUROPATH EXP NEUR, V62, P520, DOI 10.1093/jnen/62.5.520; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujita R, 2007, NEUROCHEM INT, V50, P351, DOI 10.1016/j.neuint.2006.09.003; Fuss B, 1997, J NEUROSCI, V17, P9095; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Keller JN, 1997, J NEUROCHEM, V69, P1073; Keller JN, 1996, J NEUROCHEM, V67, P2300; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Liszewska E, 2009, ENDOCRINOLOGY, V150, P422, DOI 10.1210/en.2008-0749; Moller T, 1999, NEUROREPORT, V10, P2929; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; NARITA M, 1994, J BIOL CHEM, V269, P28235; Pebay A, 1999, GLIA, V28, P25, DOI 10.1002/(SICI)1098-1136(199910)28:1<25::AID-GLIA3>3.0.CO;2-D; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Renback K, 1999, NEUROSCI LETT, V270, P59, DOI 10.1016/S0304-3940(99)00464-4; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Stankoff B, 2002, MOL CELL NEUROSCI, V20, P415, DOI 10.1006/mcne.2002.1129; Takuwa Y, 2002, J BIOCHEM, V131, P767, DOI 10.1093/oxfordjournals.jbchem.a003163; TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weiner JA, 1998, J COMP NEUROL, V398, P587; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; Yu NC, 2004, GLIA, V45, P17, DOI 10.1002/glia.10297; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	41	29	29	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2011	31	4					569	577		10.1007/s10571-011-9650-0			9	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	755AC	WOS:000289898000009	21234797				2021-06-18	
J	Lescot, T; Reina, V; Le Manach, Y; Boroli, F; Chauvet, D; Boch, AL; Puybasset, L				Lescot, Thomas; Reina, Vincent; Le Manach, Yannick; Boroli, Filippo; Chauvet, Dorian; Boch, Anne-Laure; Puybasset, Louis			In vivo accuracy of two intraparenchymal intracranial pressure monitors	INTENSIVE CARE MEDICINE			English	Article						Intracranial pressure; Cerebrospinal fluid pressure; Transducers; Pressure monitor; Traumatic brain injury; Subarachnoid hemorrhage	EXPERIENCE; AGREEMENT	To evaluate the in vivo accuracy of the new Pressio(A (R)) device for intraparenchymal monitoring of intracranial pressure (ICP) versus the Codman(A (R)) device and intraventricular measurement external ventricular drainage (EVD). Data were collected retrospectively for 30 consecutive patients admitted into a 25-bed neurosurgical intensive care unit of a university hospital between January and December 2009. Patients received both intraventricular and intraparenchymal ICP monitoring with Pressio(A (R)) (n = 15) or Codman(A (R)) (n = 15). We obtained 3,089 data points from the 30 patients. Mean difference between intraparenchymal and EVD pressure (bias) was -0.6 mmHg, and limits of agreement (1.96 SD of the bias) were -8.1 to 6.9 mmHg with Pressio(A (R)) and 0.3 mmHg with limits of agreement of -6.7 to 7.1 mmHg with Codman(A (R)) (NS). The temporal difference was -0.7 +/- A 1.6 mmHg/100 h of monitoring with Pressio(A (R)) and 0.1 +/- A 1.6 mmHg/100 h of monitoring with Codman(A (R)) over the study period (NS). Intraparenchymal pressure measured with both transducers approximates intraventricular cerebrospinal fluid pressure with an accuracy of +/- 7 mmHg.	[Lescot, Thomas] Grp Hosp Pitie Salpetriere, AP HP, Unite Neuroreanimat, Dept Anesthesia Reanimat, F-75651 Paris 13, France; [Lescot, Thomas; Reina, Vincent; Le Manach, Yannick; Boroli, Filippo; Chauvet, Dorian; Boch, Anne-Laure; Puybasset, Louis] Univ Paris 06, F-75651 Paris 13, France; [Lescot, Thomas; Le Manach, Yannick; Boroli, Filippo; Puybasset, Louis] Grp Hosp Pitie Salpetriere, AP HP, Anaesthesiol & Crit Care Dept, F-75651 Paris 13, France; [Reina, Vincent; Chauvet, Dorian; Boch, Anne-Laure] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurosurg, F-75651 Paris 13, France	Lescot, T (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Unite Neuroreanimat, Dept Anesthesia Reanimat, 47-83 Blvd Hop, F-75651 Paris 13, France.	thomas.lescot@psl.aphp.fr	Le Manach, Yannick/AAE-5700-2019	Le Manach, Yannick/0000-0003-0474-8545			Al-Tamimi YZ, 2009, NEUROSURGERY, V64, P94, DOI 10.1227/01.NEU.0000328392.98602.5A; Allin D, 2008, NEUROSURGERY, V62, P1158, DOI 10.1227/01.neu.0000325878.67752.eb; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; COURTOIS M, 1995, CIRCULATION, V92, P1994, DOI 10.1161/01.CIR.92.7.1994; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Schaller B, 2005, J TRAUMA, V59, P1521, DOI 10.1097/01.ta.0000197402.20180.6b; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9	16	29	29	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2011	37	5					875	879		10.1007/s00134-011-2182-8			5	Critical Care Medicine	General & Internal Medicine	747AG	WOS:000289291900021	21359608				2021-06-18	
J	Parenti, G; Cecchi, PC; Ragghianti, B; Schwarz, A; Ammannati, F; Mennonna, P; Di Rita, A; Gallina, P; Di Lorenzo, N; Innocenti, P; Forti, G; Peri, A				Parenti, G.; Cecchi, P. C.; Ragghianti, B.; Schwarz, A.; Ammannati, F.; Mennonna, P.; Di Rita, A.; Gallina, P.; Di Lorenzo, N.; Innocenti, P.; Forti, G.; Peri, A.			Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Hypopituitarism; subarachnoid hemorrhage; pituitary; hypocortisolism; cerebral aneurysm	TRAUMATIC BRAIN-INJURY; LONG-TERM; HIGH-RISK; HYPOPITUITARISM; DEFICIENCY; DYSFUNCTION; PREVALENCE; DIAGNOSIS	Background: Subarachnoid hemorrhage (SAH) is a potential cause of hypopituitarism. Most of the studies regarding the relationship between SAH and anterior pituitary function were retrospective and hormonal assessment was performed several months after SAH. Aim: To prospectively evaluate the prevalence of anterior pituitary hormone deficiencies in the acute phase after spontaneous SAH and their possible correlation with clinical and radiological parameters. Methods: Pituitary function was tested in 60 patients within 72 h after spontaneous SAH. Results: 56.9% of the patients showed at least one anterior pituitary hormone deficiency: gonadotropin and GH secretion failure represented the most prevalent hormonal deficiencies (33.3 and 22.0%, respectively), whereas ACTH and TSH deficiency was less frequent (7.1 and 1.8%, respectively). With the exception of secondary hypogonadism, the prevalence of other pituitary hormone deficiencies is in agreement with previous studies, which evaluated pituitary function on long-term follow up after SAH. No correlation was found between hypopituitarism and clinical status, as assessed with Hunt-Hess and Glascow Coma Scales. Moreover, no correlation was found between hypopituitarism and bleeding severity evaluated with Fisher's scale. Conclusions: We demonstrated a high prevalence of anterior pituitary hormone deficiencies acutely after SAH. Although part of GH and gonadotropin deficiencies might be a consequence of functional alteration due to SAH itself, the finding of low cortisol levels in this stressful condition strongly suggests the presence of true hypocortisolism. Therefore, an evaluation of pituitary function shortly after SAH might be useful to identify a subset of patients who deserve a more accurate follow-up. (J. Endocrinol. Invest. 34: 361-365, 2011) (c) 2011, Editrice Kurtis	[Parenti, G.; Ragghianti, B.; Forti, G.; Peri, A.] Univ Florence, Dept Clin Physiopathol, Endocrine Unit, I-50139 Florence, Italy; [Cecchi, P. C.; Schwarz, A.] Reg Gen Hosp, Operat Unit Neurosurg, Bolzano, Italy; [Ammannati, F.; Mennonna, P.] Careggi Univ Hosp, Operat Unit Neurosurg, Florence, Italy; [Di Rita, A.; Gallina, P.; Di Lorenzo, N.] Univ Florence, Dept Neurosurg, I-50139 Florence, Italy; [Innocenti, P.] Univ Florence, Dept Neurol & Psychiat Sci, I-50139 Florence, Italy	Peri, A (corresponding author), Univ Florence, Dept Clin Physiopathol, Endocrine Unit, Via Pieraccini 6, I-50139 Florence, Italy.	a.peri@dfc.unifi.it	Parenti, Gabriele/AAX-9932-2020				Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Mangieri P, 2003, ARQ NEURO-PSIQUIAT, V61, P14, DOI 10.1590/S0004-282X2003000100003; Mesotten D, 2008, NAT CLIN PRACT ENDOC, V4, P496, DOI 10.1038/ncpendmet0921; Nieschlag E, 2005, EUR UROL, V48, P1, DOI 10.1016/j.eururo.2005.04.027; SCHNEIDER HJ, 2007, JAMA-J AM MED ASSOC, V12, P1429; STRATAKIS CA, 1995, ANN NY ACAD SCI, V29, P1; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Young R, 2004, Crit Care Resusc, V6, P295	22	29	31	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0391-4097	1720-8386		J ENDOCRINOL INVEST	J. Endocrinol. Invest.	MAY	2011	34	5					361	365		10.1007/BF03347460			5	Endocrinology & Metabolism	Endocrinology & Metabolism	784QD	WOS:000292172400006	20811167				2021-06-18	
J	Waldron-Perrine, B; Rapport, LJ; Hanks, RA; Lumley, M; Meachen, SJ; Hubbarth, P				Waldron-Perrine, Brigid; Rapport, Lisa J.; Hanks, Robin A.; Lumley, Mark; Meachen, Sarah-Jane; Hubbarth, Paul			Religion and Spirituality in Rehabilitation Outcomes Among Individuals With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; CONGREGATIONAL SUPPORT; OVARIAN-CANCER; HEAD-INJURY; SATISFACTION; INVOLVEMENT; DISABILITY; ADJUSTMENT; BELIEFS	Objective: The long-term consequences of traumatic brain injury affect millions of Americans, many of whom report using religion and spirituality to cope. Little research, however, has investigated how various elements of the religious and spiritual belief systems affect rehabilitation outcomes. The present study sought to assess the use of specifically defined elements of religion and spirituality as psychosocial resources in a sample of traumatically brain injured adults. Participants: The sample included 88 adults with brain injury from 1 to 20 years post injury and their knowledgeable significant others (SOs). The majority of the participants with brain injury were male (76%), African American (75%) and Christian (76%). Measures: Participants subjectively reported on their religious/spiritual beliefs and psychosocial resources as well as their current physical and psychological status. Significant others reported objective rehabilitation outcomes. Analyses: Hierarchical multiple regression analyses were used to determine the proportion of variance in outcomes accounted for by demographic, injury related, psychosocial and religious/spiritual variables. Results: The results indicate that religious well-being (a sense of connection to a higher power) was a unique predictor for life satisfaction, distress and functional ability whereas public religious practice and existential well-being were not. Conclusions: The findings of this project indicate that specific facets of religious and spiritual belief systems do play direct and unique roles in predicting rehabilitation outcomes whereas religious activity does not. Notably, a self-reported individual connection to a higher power was an extremely robust predictor of both subjective and objective outcome.	[Waldron-Perrine, Brigid; Rapport, Lisa J.; Lumley, Mark; Meachen, Sarah-Jane; Hubbarth, Paul] Wayne State Univ, Dept Psychol, Detroit, MI 48201 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48201 USA	Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, Detroit, MI 48201 USA.	rapport@sun.science.wayne.edu					Brillhart Barbara, 2005, Rehabil Nurs, V30, P31; BUFFORD RK, 1991, J PSYCHOL THEOL, V19, P56; Canada AL, 2006, GYNECOL ONCOL, V101, P102, DOI 10.1016/j.ygyno.2005.09.045; Canada AL, 2005, GYNECOL ONCOL, V99, pS125, DOI 10.1016/j.ygyno.2005.07.057; Carone DA, 2001, CLIN PSYCHOL REV, V21, P989, DOI 10.1016/S0272-7358(00)00078-7; *CDC INJ CTR, 2006, TRAUM BRAIN INJ US E; Chally PS, 2004, ARCH PHYS MED REHAB, V85, pS60, DOI 10.1016/j.apmr.2004.03.013; Cohen, 2002, LINK RELIG HLTH PSYC; Cohen D, 2009, INT J PSYCHOL RELIG, V19, P121, DOI 10.1080/10508610802711335; Contrada RJ, 2004, HEALTH PSYCHOL, V23, P227, DOI 10.1037/0278-6133.23.3.227; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cutrona CE., 1987, ADV PERSONAL RELATIO, V1, P37; Derogatis L, 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ellison CG, 2001, SOC FORCES, V80, P215, DOI 10.1353/sof.2001.0063; ELLISON CG, 1994, J SCI STUD RELIG, V33, P46, DOI 10.2307/1386636; ELLISON CW, 1983, J PSYCHOL THEOL, V11, P330; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fetzer Institute, 1999, MULT MEAS REL SPIR U; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Hill PC, 2003, AM PSYCHOL, V58, P64, DOI 10.1037/0003-066X.58.1.64; Idler EL, 1997, J GERONTOL B-PSYCHOL, V52, pS306, DOI 10.1093/geronb/52B.6.S306; Ironson G, 2002, ANN BEHAV MED, V24, P34, DOI 10.1207/S15324796ABM2401_05; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Johnstone B, 2009, BRAIN INJURY, V23, P411, DOI 10.1080/02699050902788501; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Karademas EC, 2010, J HEALTH PSYCHOL, V15, P239, DOI 10.1177/1359105309347585; Keefe FJ, 2001, J PAIN, V2, P101, DOI 10.1054/jpai.2001.19296; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Koenig H.G., 2001, HDB RELIG HLTH; Koenig HG, 1998, J NERV MENT DIS, V186, P513, DOI 10.1097/00005053-199809000-00001; Landis B J, 1996, Issues Ment Health Nurs, V17, P217, DOI 10.3109/01612849609049916; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Makros J, 2003, J RELIG HEALTH, V42, P143, DOI 10.1023/A:1023681830716; Matheis EN, 2006, REHABIL PSYCHOL, V51, P265, DOI 10.1037/0090-5550.51.3.265; MATON KI, 1989, J SCI STUD RELIG, V28, P310, DOI 10.2307/1386742; McColl MA, 2000, ARCH PHYS MED REHAB, V81, P817, DOI 10.1053/apmr.2000.5567; Pargament KI., 1997, PSYCHOL RELIG COPING; Prigatano G., 1986, PATIENT COMPETENCY R; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Riley BB, 1998, ARCH PHYS MED REHAB, V79, P258, DOI 10.1016/S0003-9993(98)90004-1; Rippentrop AE, 2005, REHABIL PSYCHOL, V50, P278, DOI 10.1037/0090-5550.50.3.278; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Saunders SM, 2010, PROF PSYCHOL-RES PR, V41, P355, DOI 10.1037/a0020953; Sheldon KM, 2001, AM PSYCHOL, V56, P216, DOI 10.1037//0003-066X.56.3.216; Smith A., 1973, SYMBOL DIGITS MODALI; Soderback I, 1992, Disabil Rehabil, V14, P30; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tabachnick B. G., 2006, USING MULTIVARIATE S; Tate DG, 2002, AM J PHYS MED REHAB, V81, P400, DOI 10.1097/00002060-200206000-00002; Thoresen CE, 2002, ANN BEHAV MED, V24, P3, DOI 10.1207/S15324796ABM2401_02; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	58	29	29	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2011	56	2					107	116		10.1037/a0023552			10	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	769KL	WOS:000291011800004	21574729				2021-06-18	
J	Ertmer, C; Kampmeier, T; Rehberg, S; Lange, M				Ertmer, Christian; Kampmeier, Tim; Rehberg, Sebastian; Lange, Matthias			Fluid resuscitation in multiple trauma patients	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						fluid therapy; hemorrhagic shock; permissive hypotension; traumatic brain injury	UNCONTROLLED HEMORRHAGIC-SHOCK; HYPERTONIC SALINE-DEXTRAN; HYDROXYETHYL STARCH 130/0.4; RANDOMIZED CLINICAL-TRIAL; LACTATED RINGERS SOLUTION; 753 CONSECUTIVE DEATHS; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; BRAIN-INJURY; CARDIAC-SURGERY	Purpose of review Fluid resuscitation in trauma patients with hemorrhagic shock is controversially discussed in the literature. The coincidence of brain injury complicates management of these patients. This article summarizes the current knowledge on nonblood component fluid resuscitation and choice of fluids in patients with multiple trauma. Recent findings Whereas current evidence suggests the efficacy of fluid therapy in hemorrhagic shock without active bleeding, experimental and clinical data demonstrate that aggressive volume challenge may be futile or even deleterious in the setting of uncontrolled hemorrhage. Large amounts of isotonic crystalloids may be associated with hypothermia, acidosis and inflammation. In patients with traumatic brain injury hypertonic solutions may positively influence inflammation and intracranial pressure without affecting neurologic outcome or mortality. Summary To date no large-scale clinical studies exist to either support or refute the use of nonblood component fluid resuscitation of hemorrhagic shock in trauma patients. The optimal choice of fluid remains to be determined, but existing evidence suggests avoiding crystalloids in favor of hypertonic solutions. The role of modern, iso-oncotic colloids in the treatment of hemorrhagic shock has not yet been sufficiently defined. In patients with concomitant brain injury, arterial hypotension must be avoided and infusion of hypotonic solutions is obsolete, whereas administration of hypertonic solutions may exert beneficial effects beyond hemodynamic stabilization.	[Ertmer, Christian; Kampmeier, Tim; Rehberg, Sebastian; Lange, Matthias] Univ Munster, Dept Anesthesiol & Intens Care, Munster, Germany	Lange, M (corresponding author), Univ Hosp Muenster, Dept Anesthesiol & Intens Care, D-48129 Munster, Germany.	lange-m@anit.uni-muenster.de	Rehberg, Sebastian/AAD-5191-2019	Kampmeier, Tim/0000-0003-4329-7521			Alam HB, 2009, J TRAUMA, V67, P856, DOI 10.1097/TA.0b013e3181b5ae75; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; *AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP A; Attuwaybi B, 2004, J TRAUMA, V56, P749, DOI 10.1097/01.TA.0000119686.33487.65; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Balkamou X, 2010, ANESTHESIOLOGY, V113, P1092, DOI 10.1097/ALN.0b013e3181f56029; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BICKELL WH, 1992, ANN EMERG MED, V21, P1077, DOI 10.1016/S0196-0644(05)80648-1; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CAREY JS, 1970, SURG GYNECOL OBSTETR, V131, P679; Chen SY, 2009, J TRAUMA, V66, P676, DOI 10.1097/TA.0b013e318173e7da; CHUDNOFSKY CR, 1989, ANN EMERG MED, V18, P122, DOI 10.1016/S0196-0644(89)80099-X; Constable PD, 2003, ANESTH ANALG, V96, P919, DOI 10.1213/01.ANE.0000053256.77500.9D; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Dar DE, 2010, SHOCK, V34, P75, DOI 10.1097/SHK.0b013e3181ce2cbc; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; Dubick MA, 2006, SHOCK, V25, P321, DOI 10.1097/01.shk.0000209525.50990.28; Dubniks M, 2007, INTENS CARE MED, V33, P2192, DOI 10.1007/s00134-007-0756-2; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Dunser MW, 2009, CRIT CARE, V13, DOI 10.1186/cc8167; Ertmer C, 2009, BEST PRACT RES-CLIN, V23, P193, DOI 10.1016/j.bpa.2008.11.001; Flaherty S, 2003, J TRAUMA, V54, P70; GROSS D, 1990, SURG GYNECOL OBSTET, V170, P106; Huet RCGG, 2000, CAN J ANAESTH, V47, P1207; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Kelman G R, 1969, Int Anesthesiol Clin, V7, P739, DOI 10.1097/00004311-196907040-00003; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; KRAUSZ MM, 1992, J TRAUMA, V33, P6, DOI 10.1097/00005373-199207000-00002; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; KWAN I, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002245; Liang L, 2010, J TRAUMA, V68, P655, DOI 10.1097/TA.0b013e3181a8b286; Lier H, 2008, J TRAUMA, V65, P951, DOI 10.1097/TA.0b013e318187e15b; Ljungstrom K G, 1988, Acta Chir Scand Suppl, V543, P26; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MAZZONI MC, 1988, AM J PHYSIOL, V255, pH629; MOSS GS, 1974, NEW ENGL J MED, V290, P724, DOI 10.1056/NEJM197403282901307; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NAGY KK, 1993, CIRC SHOCK, V40, P289; OWENS TM, 1995, J TRAUMA, V39, P200, DOI 10.1097/00005373-199508000-00004; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Schortgen F, 2004, INTENS CARE MED, V30, P2222, DOI 10.1007/s00134-004-2415-1; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Sharma RM, 2005, ANESTH ANALG, V101, P833, DOI 10.1213/01.ANE.0000175209.61051.7F; SHATNEY CH, 1983, ARCH SURG-CHICAGO, V118, P804; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; SIMMONS RS, 1987, AM REV RESPIR DIS, V135, P924, DOI 10.1164/arrd.1987.135.4.924; SMITH JP, 1985, J TRAUMA, V25, P65, DOI 10.1097/00005373-198501000-00011; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stahel PF, 2009, INJURY, V40, pS27, DOI 10.1016/j.injury.2009.10.034; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Sung KC, 2006, ACTA ANAESTH SCAND, V50, P108, DOI 10.1111/j.1399-6576.2005.00881.x; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; Vincenzi R, 2009, AM J SURG, V198, P407, DOI 10.1016/j.amjsurg.2009.01.017; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; WILLIAMS LF, 1968, SURG CLIN N AM, V48, P263; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6	69	29	36	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2011	24	2					202	208		10.1097/ACO.0b013e3283445326			7	Anesthesiology	Anesthesiology	732AS	WOS:000288154100014	21293262				2021-06-18	
J	Li, LA; Jiang, QA; Qu, CS; Ding, GL; Li, QJ; Wang, SY; Lee, JH; Lu, M; Mahmood, A; Chopp, M				Li, Lian; Jiang, Quan; Qu, Chang Sheng; Ding, Guang Liang; Li, Qing Jiang; Wang, Shi Yang; Lee, Ji Hyun; Lu, Mei; Mahmood, Asim; Chopp, Michael			Transplantation of Marrow Stromal Cells Restores Cerebral Blood Flow and Reduces Cerebral Atrophy in Rats with Traumatic Brain Injury: In vivo MRI Study	JOURNAL OF NEUROTRAUMA			English	Article						cerebral atrophy; cerebral blood flow; marrow stromal cells; MRI; ventricular expansion	VOLUME; MODERATE; MILD; PERFUSION; ISCHEMIA; DAMAGE; DEATH	Cell therapy promotes brain remodeling and improves functional recovery after various central nervous system disorders, including traumatic brain injury (TBI). We tested the hypothesis that treatment of TBI with intravenous administration of human marrow stromal cells (hMSCs) provides therapeutic benefit in modifying hemodynamic and structural abnormalities, which are detectable by in vivo MRI. hMSCs were labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Male Wistar rats (300-350 g, n = 18) subjected to controlled cortical impact TBI were intravenously injected with 1 mL of saline (n = 9) or hMSCs in suspension (n = 9, approximately 3 x 10(6) SPIO-labeled hMSCs) 5 days post-TBI. In vivo MRI measurements consisting of cerebral blood flow (CBF), T2-weighted imaging, and 3D gradient echo imaging were performed for all animals 2 days post-TBI and weekly for 6 weeks. Functional outcome was evaluated with modified neurological severity score and Morris water maze test. Cell engraftment was detected in vivo by 3D MRI and confirmed by double staining. Ventricle and lesion volumetric alterations were measured using T2 maps, and hemodynamic abnormality was tracked by MRI CBF measurements. Our data demonstrate that treatment with hMSCs following TBI diminishes hemodynamic abnormalities by early restoration and preservation of CBF in the brain regions adjacent to and remote from the impact site, and reduces generalized cerebral atrophy, all of which may contribute to the observed improvement of functional outcome.	[Li, Lian; Jiang, Quan; Ding, Guang Liang; Li, Qing Jiang; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Qu, Chang Sheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Wang, Shi Yang; Lee, Ji Hyun] Oakland Univ, Dept Phys, Rochester, MI USA	Jiang, QA (corresponding author), Henry Ford Hosp, Dept Neurol, Educ & Res Bldg,B126,2799 W Grand Blvd, Detroit, MI 48202 USA.	QJIANG1@hfhs.org	Wang, Shiyang/C-1729-2012	LEE, JI HYUN/0000-0003-0450-2879; Ding, Guangliang/0000-0003-1286-5901	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS23393, PO1 NS42345, RO1 NS48349, RO1 NS38292, RO1 NS43324, HL64766]; Mort and Brigitte Harris Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038292, R01NS064134, P01NS042345, R01NS048349, P50NS023393] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (grants P50 NS23393, PO1 NS42345, RO1 NS48349, RO1 NS38292, RO1 NS43324, HL64766) and the Mort and Brigitte Harris Foundation.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; HOSSMANN KA, 1993, RESUSCITATION, V26, P225, DOI 10.1016/0300-9572(93)90143-E; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Li L, 2005, J MAGN RESON IMAGING, V21, P726, DOI 10.1002/jmri.20318; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; MORRIS PP, 2002, MAGNETIC RESONANCE I, P773; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILKINS A, 2009, CELL RES IN PRESS; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	29	30	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2011	28	4					535	545		10.1089/neu.2010.1619			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	746IW	WOS:000289240200005	21275806	Green Published			2021-06-18	
J	Minor, KH; Bournat, JC; Toscano, N; Giger, RJ; Davies, SJA				Minor, Kenneth H.; Bournat, Juan C.; Toscano, Nicole; Giger, Roman J.; Davies, Stephen J. A.			Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue	BRAIN			English	Article						decorin; scar; semaphorin; ErbB4; STAT3	GROWTH-FACTOR RECEPTOR; COLLAPSIN-1 MESSENGER-RNA; ALPHA-CONVERTING-ENZYME; SPINAL-CORD; ADULT-RAT; PROTEOGLYCANS DECORIN; NUCLEAR-LOCALIZATION; CELL-PROLIFERATION; III COLLAPSIN-1; DOWN-REGULATION	Scar tissue at sites of traumatic injury in the adult central nervous system presents a combined physical and molecular impediment to axon regeneration. Of multiple known central nervous system scar associated axon growth inhibitors, semaphorin 3A has been shown to be strongly expressed by invading leptomeningeal fibroblasts. We have previously demonstrated that infusion of the small leucine-rich proteoglycan decorin results in major suppression of several growth inhibitory chondroitin sulphate proteoglycans and growth of adult sensory axons across acute spinal cord injuries. Furthermore, decorin treatment of leptomeningeal fibroblasts significantly increases their ability to support neurite growth of co-cultured adult dorsal root ganglion neurons. In the present study we show that decorin has the ability to suppress semaphorin 3A expression within adult rat cerebral cortex scar tissue and in primary leptomeningeal fibroblasts in vitro. Infusion of decorin core protein for eight days resulted in a significant reduction of semaphorin 3A messenger RNA expression within injury sites compared with saline-treated control animals. Both in situ hybridization and immunostaining confirmed that semaphorin 3A messenger RNA expression and protein levels are significantly reduced in decorin-treated animals. Similarly, decorin treatment decreased the expression of semaphorin 3A messenger RNA in cultured rat leptomeningeal fibroblasts compared with untreated cells. Mechanistic studies revealed that decorin-mediated suppression of semaphorin 3A critically depends on erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 function. Collectively, our studies show that in addition to suppressing the levels of inhibitory chondroitin sulphate proteoglycans, decorin has the ability to suppress semaphorin 3A in the injured central nervous system. Our findings provide further evidence for the use of decorin as a potential therapy for promoting axonal growth and repair in the injured adult mammalian brain and spinal cord.	[Minor, Kenneth H.; Davies, Stephen J. A.] Univ Colorado Denver, Dept Neurosurg, Aurora, CO 80045 USA; [Bournat, Juan C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Toscano, Nicole; Giger, Roman J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48105 USA; [Giger, Roman J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48105 USA	Davies, SJA (corresponding author), Univ Colorado Denver, Dept Neurosurg, Bldg RC 1 N,Room P18-9100,12800 E 19th Ave, Aurora, CO 80045 USA.	stephen.davies@ucdenver.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [7NS047333]; David Van Wagener Spinal Cord Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS047333, R01NS047333] Funding Source: NIH RePORTER	Supported by NIH 7NS047333, the David Van Wagener Spinal Cord Fund and private donations by the international spinal cord injury community.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Arakawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3418, DOI 10.1093/ndt/gfn314; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Blaskovich MA, 2003, CANCER RES, V63, P1270; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Davies SJA, 1997, NATURE, V390, P680; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DE WF, 2002, EXP NEUROL, V175, P61; De Winter F, 2006, MOL CELL NEUROSCI, V32, P102, DOI 10.1016/j.mcn.2006.03.002; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Eastwood SL, 2003, MOL PSYCHIATR, V8, P148, DOI 10.1038/sj.mp.4001233; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Fukushima K, 2001, AM J SPORT MED, V29, P394, DOI 10.1177/03635465010290040201; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Grisanti S, 2005, INVEST OPHTH VIS SCI, V46, P191, DOI 10.1167/iovs.04-0902; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hou ST, 2008, BIOCHEM BIOPH RES CO, V367, P109, DOI 10.1016/j.bbrc.2007.12.103; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Krebs DL, 2000, J CELL SCI, V113, P2813; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lindholm T, 2004, NEUROREPORT, V15, P649, DOI 10.1097/00001756-200403220-00015; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Minor K, 2008, NEUROBIOL DIS, V32, P88, DOI 10.1016/j.nbd.2008.06.009; Mire E, 2008, MOL CELL NEUROSCI, V37, P222, DOI 10.1016/j.mcn.2007.09.009; Montolio M, 2009, CHEM BIOL, V16, P691, DOI 10.1016/j.chembiol.2009.05.006; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Ni CY, 2003, J BIOL CHEM, V278, P4561, DOI 10.1074/jbc.M210504200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Niclou SP, 2003, MOL CELL NEUROSCI, V24, P902, DOI 10.1016/S1044-7431(03)00243-4; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Ortiz-Munoz G, 2010, J AM SOC NEPHROL, V21, P763, DOI 10.1681/ASN.2009060625; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Pasterkamp RJ, 2001, EUR J NEUROSCI, V13, P457, DOI 10.1046/j.0953-816X.2000.01398.x; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567; Puricelli L, 2002, INT J CANCER, V100, P642, DOI 10.1002/ijc.10533; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Rewcastle GW, 1998, J MED CHEM, V41, P742, DOI 10.1021/jm970641d; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shibata N, 2009, NEURODEGENER DIS, V6, P118, DOI 10.1159/000213762; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Su ZD, 2010, GLIA, V58, P901, DOI 10.1002/glia.20972; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamamaki N, 2001, NEUROREPORT, V12, P775, DOI 10.1097/00001756-200103260-00032; Tamamaki N, 2003, J COMP NEUROL, V455, P238, DOI 10.1002/cne.10476; Thiel KW, 2006, BIOCHEM BIOPH RES CO, V350, P629, DOI 10.1016/j.bbrc.2006.09.095; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Wang HJ, 2005, EXP MOL PATHOL, V78, P17, DOI 10.1016/j.yexmp.2004.07.006; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Williams G, 2005, J NEUROCHEM, V92, P1180, DOI 10.1111/j.1471-4159.2004.02950.x; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P244, DOI 10.1080/03008200802147746; Zhou W, 2002, INFLAMM RES, V51, P91, DOI 10.1007/BF02684009	101	29	31	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	APR	2011	134		4				1140	1155		10.1093/brain/awq304			16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	745KC	WOS:000289163300026	21115466	Bronze, Green Published			2021-06-18	
J	Andersson, EE; Bedics, BK; Falkmer, T				Andersson, Elisabeth Elgmark; Bedics, Beate Karrdahl; Falkmer, Torbjorn			MILD TRAUMATIC BRAIN INJURIES: A 10-YEAR FOLLOW-UP	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain concussion; brain injuries; traumatic; post-concussion symptoms; quality of life; rehabilitation; intervention studies; RCT	CENTER-TASK-FORCE; HEAD-INJURY; HEALTH; ASSOCIATION; DISABILITY; SYMPTOMS; VALIDITY; ADULTS; SF-36	Objective and design: Long-term consequences of mild traumatic brain injuries were investigated based on a 10-year follow-up of patients from a previously-published randomized controlled study of mild traumatic brain injuries. One aim was to describe changes over time after mild traumatic brain injuries in terms of the extent of persisting post-concussion symptoms, life satisfaction, perceived health, activities of daily living, changes in life roles and sick leave. Another aim was to identify differences between the intervention and control groups. Patients: The intervention group comprised 142 persons and the control group 56 persons. Methods: Postal questionnaires with a response rate of 56%. Results: No differences over time were found for the intervention and control groups in terms of post-concussion symptoms. In the intervention group some variables in life satisfaction, perceived health and daily life were decreased. Some roles had changed over the years for both groups. No other differences between the intervention and control groups were found. However, in both groups sick leave decreased. Conclusion: Early individual intervention by a qualified rehabilitation team does not appear to impact on the long-term outcome for persons with symptoms related to mild traumatic brain injuries. The status after approximately 3 weeks is indicative of the status after 10 years.	[Andersson, Elisabeth Elgmark; Falkmer, Torbjorn] Jonkoping Univ, Dept Rehabil, Sch Hlth Sci, SE-55111 Jonkoping, Sweden; [Bedics, Beate Karrdahl] Koping Hosp, Rehabil Unit, Koping, Sweden; [Falkmer, Torbjorn] Curtin Univ, CHIRI, Curtin Hlth Innovat Res Inst, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, S-58183 Linkoping, Sweden; [Falkmer, Torbjorn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia	Andersson, EE (corresponding author), Jonkoping Univ, Dept Rehabil, Sch Hlth Sci, Box 1026, SE-55111 Jonkoping, Sweden.	elisabeth.elgmark@hhj.hj.se			ForeningsSparbankens; Sjuharad Foundation, Boras, Sweden; Axel Linder Foundation, Alingsas, Sweden; Selma Anderssons Foundation; Uppsala University, Sweden	This study was supported by the ForeningsSparbankens, Sjuharad Foundation, Boras, Sweden, the Axel Linder Foundation, Alingsas, Sweden and the Selma Anderssons Foundation, Uppsala University, Sweden. We thank secretaries Margareta Olsson, Marianne Hjalmarsson and Birgitta Hallberg. We are grateful for the support of Sven-Erik Roslin, Head of the physiotherapy department, all at the Rehabilitation Centre, Sodra Alvsborgs Sjukhus, Boras, Sweden and Associate Professor Matthew Molineux at the School of Occupational Therapy and Social Work, Curtin University, Perth, WA, Australia.	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Andersson EE, 2006, J REHABIL MED, V38, P26, DOI 10.1080/16501970500310564; ANDREN E, 1998, THESIS GOTEBORG U GO; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BRANHOLM IB, 1994, DISABIL REHABIL, V16, P205; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; KARLOWSKI TR, 1975, JAMA-J AM MED ASSOC, V231, P1038, DOI 10.1001/jama.231.10.1038; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pocock SJ, 1983, CLIN TRIALS PRACTICA; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; QUELLET MC, 2006, REHABIL PSYCHOL, V5, P140; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; The Swedish Council on techonolgy assessment (SBU), 2006, 153 SBU; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	35	29	29	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2011	43	4					323	329		10.2340/16501977-0666			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	743ID	WOS:000289011000008	21271211	DOAJ Gold, Green Published			2021-06-18	
J	Eckner, JT; Kutcher, JS; Richardson, JK				Eckner, James T.; Kutcher, Jeffrey S.; Richardson, James K.			Effect of Concussion on Clinically Measured Reaction Time in 9 NCAA Division I Collegiate Athletes: A Preliminary Study	PM&R			English	Article							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; UNITED-STATES; RECOVERY; SYMPTOMS; HISTORY; PREDICTORS	Objectives: To evaluate the effect of concussion on clinically measured reaction time (RTclin) and in comparison to a computerized reaction time measure (RTcomp). Design: Prospective, repeated measures observational study. Setting: Athletic training clinic at a National Collegiate Athletic Association (NCAA) Division I university. Participants: Data are reported for 9 collegiate athletes with acute concussion who were part of a larger cohort of 209 athletes recruited from the university's football, women's soccer, and wrestling teams before the start of their respective athletic seasons. Methods: Baseline RTclin and RTcomp were measured during preparticipation physical examinations. RTclin measured the time required to catch a suspended vertical shaft by hand closure after its release by the examiner. RTcomp was derived from the simple RI component of the Cog State-Sport computerized neurocognitive test battery. Athletes who subsequently sustained a physician-diagnosed concussion underwent repeated RTclin and RTcomp testing within 72 hours of injury. A Wilcoxon signed rank test was used to compare baseline and after-injury RTs. Main Outcome Measurements: After-injury changes in RTclin and RTcomp were calculated with respect to each athlete's own preseason baseline value. Results: After-injury RTclin was prolonged in 8 of the 9 athletes with concussions, whereas RTcomp was prolonged in 5 of the 9 athletes with concussions. The mean (standard deviation) RTclin increased from 193 +/- 21 ms to 219 +/- 31 ms (P = .050), and mean RTcomp increased from 247 +/- 75 to 462 +/- 120 ms (P = .214). Conclusions: We concluded that RTclin appears to be sensitive to the known prolongation of RT after concussion and compares favorably with an accepted computerized RI measure. This study supports the potential utility of RTclin as part of a multifaceted concussion assessment battery. PM R 2011;3:212-218	[Eckner, James T.; Richardson, James K.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA	Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001097] Funding Source: Medline		Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Eckner JT, 2010, MED SCI SPORTS  0802; Eckner JT, 2011, J ATHL TRAI IN PRESS; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell M., 2001, BRIT J SPORT MED, V35, P373; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	42	29	29	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	MAR	2011	3	3					212	218		10.1016/j.pmrj.2010.12.003			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	961AX	WOS:000305437400005	21402367	Green Published, Green Accepted			2021-06-18	
J	Fitzgerald, PB; Hoy, KE; Maller, JJ; Herring, S; Segrave, R; McQueen, S; Peachey, A; Hollander, Y; Anderson, JF; Daskalakis, ZJ				Fitzgerald, Paul B.; Hoy, Kate E.; Maller, Jerome J.; Herring, Sally; Segrave, Rebecca; McQueen, Susan; Peachey, Amy; Hollander, Yitzchak; Anderson, Jacqueline F.; Daskalakis, Zafiris J.			Transcranial Magnetic Stimulation for Depression After a Traumatic Brain Injury A Case Study	JOURNAL OF ECT			English	Article						transcranial magnetic stimulation; major depression; traumatic brain injury		Depression after a traumatic brain injury (TBI) is very common, yet there is a lack of evidence-based treatment options for people who experience depression after a TBI. Traditionally, a history of TBI has been considered an exclusion criterion for transcranial magnetic stimulation trials because of the increased risk of seizure after a TBI. We present what we believe to be the first case of a patient with depression after a TBI treated with transcranial magnetic stimulation.	[Fitzgerald, Paul B.] Monash Univ, Monash Alfred Psychiat Res Ctr, Dept Psychiat, Alfred Hosp, Prahran, Vic 3181, Australia; [Fitzgerald, Paul B.; Hoy, Kate E.; Maller, Jerome J.; Herring, Sally; Segrave, Rebecca; McQueen, Susan; Peachey, Amy] Monash Univ, Sch Psychol & Psychiat, Prahran, Vic 3181, Australia; [Hollander, Yitzchak] Alfred Hosp, Dept Psychiat, Melbourne, Vic, Australia; [Anderson, Jacqueline F.] Univ Melbourne, Melbourne, Vic, Australia; [Daskalakis, Zafiris J.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada	Fitzgerald, PB (corresponding author), Monash Univ, Monash Alfred Psychiat Res Ctr, Dept Psychiat, Alfred Hosp, Commercial Rd, Prahran, Vic 3181, Australia.	Paul.fitzgerald@alfred.org.au	Segrave, Rebecca/H-4554-2014; Maller, Jerome J/H-4963-2014; Fitzgerald, Paul B/A-1225-2008; Daskalakis, Zafiris J/J-5503-2013	Segrave, Rebecca/0000-0002-1839-0794; Maller, Jerome J/0000-0003-4685-1508; Fitzgerald, Paul B/0000-0003-4217-8096; Daskalakis, Zafiris J/0000-0001-9502-0538; Herring, Sally/0000-0003-0996-7413; Anderson, Jacqueline/0000-0003-4996-8189; Hoy, Kate/0000-0003-0694-9674			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676	4	29	30	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1095-0680			J ECT	J. ECT	MAR	2011	27	1					38	40		10.1097/YCT.0b013e3181eb30c6			3	Behavioral Sciences; Psychiatry	Behavioral Sciences; Psychiatry	726CU	WOS:000287697100026	20938348				2021-06-18	
J	Luo, JA; Bo, XN; Wu, DS; Yeh, J; Richardson, PM; Zhang, Y				Luo, Juan; Bo, Xuenong; Wu, Dongsheng; Yeh, John; Richardson, Peter M.; Zhang, Yi			Promoting Survival, Migration, and Integration of Transplanted Schwann Cells by Over-Expressing Polysialic Acid	GLIA			English	Article						polysialyltransferase; astrocyte; cell therapy; spinal cord injury; neurotrauma; lentiviral vector	CENTRAL-NERVOUS-SYSTEM; OLFACTORY ENSHEATHING CELLS; ADHESION MOLECULE NCAM; SPINAL-CORD-INJURY; IN-VITRO; AXONAL REGENERATION; FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; SENSORY AXONS; PSA-NCAM	The poor survival and migration of transplanted Schwann cells (SCs) are major drawbacks for their clinical application in cell therapy for neurotrauma. To overcome such drawbacks we genetically modified SCs to over-express polysialic acid (PSA) by lentiviral delivery of polysialyltransferase (PST) to study whether over-expression of PSA could enhance their survival, migration, and integration when transplanted into the spinal cord. It was found that more PSA-expressing SCs (PST/SCs) survived than GFP-expressing SCs (GFP/SCs) after transplantation, although cell loss was still quite significant. PSA expression did not enhance the motility of transplanted SCs in uninjured spinal cord. However, in a spinal cord crush injury model PST/SCs transplanted caudal to the lesion showed that increased number of PST/SCs migrated to the injury site compared with that of GFP/SCs. Induced expression of PSA in spinal cord can further facilitate the infiltration of PST/SCs into the lesion site. PST/SCs were also shown to intermingle well with host spinal cells while GFP/SCs formed boundaries with host tissue. This was confirmed by an in vitro confrontation assay showing that more PST/SCs crossed over to astrocyte territory than GFP/SCs. Furthermore, PST/SCs induced much less expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycan in the surrounding tissues than GFP/SCs, indicating that expression of PSA on SCs do not cause significant stress response of astrocytes. These results demonstrate that expression of PSA on SCs significantly changes their biological properties and makes them more feasible for neural repair after neurotrauma. (C)2010 Wiley-Liss, Inc.	[Luo, Juan; Bo, Xuenong; Wu, Dongsheng; Zhang, Yi] Univ London, Ctr Neurosci & Trauma, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London E1 2AT, England; [Yeh, John; Richardson, Peter M.] Univ London, Barts & London Sch Med & Dent, Dept Neurosurg, London E1 2AT, England	Zhang, Y (corresponding author), Univ London, Ctr Neurosci & Trauma, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, 4 Newark St, London E1 2AT, England.	yi.zhang@qmul.ac.uk	Bo, Xuenong/E-9845-2012	Bo, Xuenong/0000-0002-9202-3562	International Spinal Research Trust	Grant sponsor: Nathalie Rose Barr PhD Studentship from International Spinal Research Trust.	ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970; Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Bachelin C, 2010, BRAIN, V133, P406, DOI 10.1093/brain/awp256; Barral-Moran MJ, 2003, J NEUROSCI RES, V72, P679, DOI 10.1002/jnr.10627; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Decker L, 2000, MOL CELL NEUROSCI, V16, P422, DOI 10.1006/mcne.2000.0885; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Fairless R, 2005, MOL CELL NEUROSCI, V28, P253, DOI 10.1016/j.mcn.2004.09.009; Fewou SN, 2007, J BIOL CHEM, V282, P16700, DOI 10.1074/jbc.M610797200; Franceschini I, 2004, MOL CELL NEUROSCI, V27, P151, DOI 10.1016/j.mcn.2004.05.006; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Gascon E, 2007, DEVELOPMENT, V134, P1181, DOI 10.1242/dev.02808; Gregoriadis G, 2000, CELL MOL LIFE SCI, V57, P1964, DOI 10.1007/PL00000676; HEKMAT A, 1990, J COMP NEUROL, V291, P457, DOI 10.1002/cne.902910311; Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; JANCIK JM, 1978, CELL TISSUE RES, V186, P209, DOI 10.1007/BF00225532; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kiss JZ, 1998, MOL CELL ENDOCRINOL, V140, P89; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Levi ADO, 1996, J NEUROSCI METH, V68, P21, DOI 10.1016/0165-0270(96)00055-6; Li YW, 2003, J BIOL CHEM, V278, P9585, DOI 10.1074/jbc.M213244200; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Papastefanaki F, 2007, BRAIN, V130, P2159, DOI 10.1093/brain/awm155; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Plant GW, 2001, MOL CELL NEUROSCI, V17, P471, DOI 10.1006/mcne.2000.0948; RAISMAN G, EXP NEUROL IN PRESS; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Santos-Silva A, 2007, J NEUROSCI, V27, P7154, DOI 10.1523/JNEUROSCI.1184-07.2007; Seidenfaden R, 2001, J NEUROBIOL, V46, P11, DOI 10.1002/1097-4695(200101)46:1<11::AID-NEU2>3.0.CO;2-#; Storms SD, 1998, J BIOL CHEM, V273, P27124, DOI 10.1074/jbc.273.42.27124; TETZLAFF W, 2010, J NEUROTRAU IN PRESS; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Vutskits L, 2006, NEUROCHEM RES, V31, P215, DOI 10.1007/s11064-005-9021-7; YANG PF, 1994, J BIOL CHEM, V269, P23039; Yoshida K, 1999, J NEUROSCI, V19, P794; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827; Zhang Y, 2008, RESTOR NEUROL NEUROS, V26, P81; Zhang Y, 2007, MOL THER, V15, P1796, DOI 10.1038/sj.mt.6300220; Zhang Y, 2007, MOL CELL NEUROSCI, V35, P109, DOI 10.1016/j.mcn.2007.02.011; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x	61	29	34	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAR	2011	59	3					424	434		10.1002/glia.21111			11	Neurosciences	Neurosciences & Neurology	718ZT	WOS:000287166500007	21264949				2021-06-18	
J	Pardini, M; Krueger, F; Hodgkinson, C; Raymont, V; Ferrier, C; Goldman, D; Strenziok, M; Guida, S; Grafman, J				Pardini, M.; Krueger, F.; Hodgkinson, C.; Raymont, V.; Ferrier, C.; Goldman, D.; Strenziok, M.; Guida, S.; Grafman, J.			Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury	NEUROLOGY			English	Article							MONOAMINE-OXIDASE-A; BORDERLINE PERSONALITY-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; CHILDHOOD SEXUAL-ABUSE; NEURAL MECHANISMS; HEAD-INJURY; BEHAVIOR; VIOLENCE; GENE; INVENTORY	Objective: This study investigates the interaction between brain lesion location and monoamine oxidase A (MAO-A) in the genesis of aggression in patients with penetrating traumatic brain injury (PTBI). Methods: We enrolled 155 patients with PTBI and 42 controls drawn from the Vietnam Head Injury Study registry. Patients with PTBI were divided according to lesion localization (prefrontal cortex [PFC] vs non-PFC) and were genotyped for the MAO-A polymorphism linked to low and high transcriptional activity. Aggression was assessed with the aggression/agitation subscale of the Neuropsychiatric Inventory (NPI-a). Results: Patients with the highest levels of aggression preferentially presented lesions in PFC territories. A significant interaction between MAO-A transcriptional activity and lesion localization on aggression was revealed. In the control group, carriers of the low-activity allele demonstrated higher aggression than high-activity allele carriers. In the PFC lesion group, no significant differences in aggression were observed between carriers of the 2 MAO-A alleles, whereas in the non-PFC lesion group higher aggression was observed in the high-activity allele than in the low-activity allele carriers. Higher NPI-a scores were linked to more severe childhood psychological traumatic experiences and posttraumatic stress disorder symptomatology in the control and non-PFC lesion groups but not in the PFC lesion group. Conclusions: Lesion location and MAO-A genotype interact in mediating aggression in PTBI. Importantly, PFC integrity is necessary for modulation of aggressive behaviors by genetic susceptibilities and traumatic experiences. Potentially, lesion localization and MAO-A genotype data could be combined to develop risk-stratification algorithms and individualized treatments for aggression in PTBI. Neurology (R) 2011;76:1038-1045	[Pardini, M.; Krueger, F.; Raymont, V.; Strenziok, M.; Grafman, J.] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, NIH, Bethesda, MD USA; [Pardini, M.; Guida, S.] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Pardini, M.] Univ Genoa, Magnet Resonance Res Ctr Nervous Syst Dis, Genoa, Italy; [Krueger, F.] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Hodgkinson, C.; Ferrier, C.; Goldman, D.] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Raymont, V.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	Grafman, J (corresponding author), Kessler Fdn Res Ctr, Brain Injury Res Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jgrafman@kesslerfoundation.org	Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Grafman, Jordan H./0000-0001-8645-4457	US National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); National Naval Medical Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Henry M. Jackson Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000306, Z01AA000306, ZIAAA000301] Funding Source: NIH RePORTER	Supported by the US National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the US Army Medical Research and Material Command administered by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year postinjury follow-up study).; The authors thank the Vietnam veterans who participated in this study. Without their long-term commitment to improving the health care of veterans, this study could not have been completed. The authors thank the National Naval Medical Center for their support and provision of their facilities and S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for their help with the testing of participants and organization of this study.; Dr. Pardini and Dr. Krueger report no disclosures. Dr. Hodgkinson receives intramural research support from the NIH. Dr. Raymont and C. Ferrier report no disclosures. Dr. Goldman serves on the editorial boards of Biological Psychiatry and Addictions Biology. Dr. Strenziok and Dr. Guida report no disclosures. Dr. Grafman serves as Co-editor of Cortex and receives research support from the Intramural Research Program NIH/NINDS and the Henry M. Jackson Foundation.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ducci F, 2008, MOL PSYCHIATR, V13, P334, DOI 10.1038/sj.mp.4002034; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Manor I, 2002, MOL PSYCHIATR, V7, P626, DOI 10.1038/sj.mp.4001037; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Ni XQ, 2007, PSYCHIAT GENET, V17, P153, DOI 10.1097/YPG.0b013e328016831c; Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027; Pietrini P, 2000, AM J PSYCHIAT, V157, P1772, DOI 10.1176/appi.ajp.157.11.1772; Pritchard AL, 2009, INT J GERIATR PSYCH, V24, P1020, DOI 10.1002/gps.2214; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Schmahl CG, 2004, BIOL PSYCHIAT, V55, P759, DOI 10.1016/j.biopsych.2003.11.007; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Strenziok M, 2009, SOC COGN AFFECT 0921; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Vollm BA, 2009, CRIM BEHAV MENT HEAL, V19, P64, DOI 10.1002/cbm.716	32	29	31	0	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR	2011	76	12					1038	1045		10.1212/WNL.0b013e318211c33e			8	Clinical Neurology	Neurosciences & Neurology	741GW	WOS:000288853200007	21422455	Green Published			2021-06-18	
J	de la Plata, CDM; Yang, FG; Wang, JY; Krishnan, K; Bakhadirov, K; Paliotta, C; Aslan, S; Devous, MD; Moore, C; Harper, C; McColl, R; Cullum, CM; Diaz-Arrastia, R				de la Plata, Carlos D. Marquez; Yang, Fanpei Gloria; Wang, Jun Yi; Krishnan, Kamini; Bakhadirov, Khamid; Paliotta, Christopher; Aslan, Sina; Devous, Michael D., Sr.; Moore, Carol; Harper, Caryn; McColl, Roderick; Cullum, C. Munro; Diaz-Arrastia, Ramon			Diffusion Tensor Imaging Biomarkers for Traumatic Axonal Injury: Analysis of Three Analytic Methods	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						DTI; TAI; Traumatic Brain injury; Memory; Tractography; Cognitive outcomes	WHITE-MATTER INJURY; BRAIN-INJURY; CORPUS-CALLOSUM; FIBER TRACKING; HEAD-INJURY; MILD; TRACTOGRAPHY; MODERATE; DAMAGE; ATLAS	Traumatic axonal injury (TAI) is a common mechanism of traumatic brain injury not readily identified using conventional neuroimaging modalities. Novel imaging modalities such as diffusion tensor imaging (DTI) can detect microstructural compromise in white matter (WM) in various clinical populations including TAI. DTI-derived data can be analyzed using global methods (i.e.. WM histogram or voxel-based approaches) or a regional approach (i.e., tractography). While each of these methods produce qualitatively comparable results, it is not clear which is most useful in clinical research and ultimately in clinical practice. This study compared three methods of analyzing DTI-derived data with regard to detection of WM injury and their association with clinical outcomes. Thirty patients with TAI and 19 demographically similar normal controls were scanned using a 3 Tesla magnet. Patients were scanned approximately eight months postinjury,and underwent an outcomes assessment at that time. Histogram analysis of fractional anisotropy (FA) and mean diffusivity showed global WM integrity differences between patients and controls. Voxel-based and tractography analyses showed significant decreases in FA within centroaxial structures involved in TAI. All three techniques were associated with functional and cognitive outcomes. DTI measures of microstructural integrity appear robust, as the three analysis techniques studied showed adequate utility for detecting WM injury. (JINS, 2011,17, 24-35)	[Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [de la Plata, Carlos D. Marquez; Yang, Fanpei Gloria; Wang, Jun Yi; Krishnan, Kamini; Bakhadirov, Khamid] Univ Texas Dallas, Ctr Brain Hlth, Richardson, TX 75083 USA	Diaz-Arrastia, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ramon.diaz-arrastia@utsouthwestern.edu	Cullum, C. Munro/AAC-2496-2019; Kennedy, Kristen M/B-4699-2008	Cullum, C. Munro/0000-0001-9706-5465; Kennedy, Kristen M/0000-0001-5373-9026; McColl, Roderick/0000-0001-7022-100X; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS060827, R01 HD48179, U01 HD42652]; Department of EducationUS Department of Education [H133 A020526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827] Funding Source: NIH RePORTER	This research was supported by funding to C. Marquez de la Plata (NIH K23 NS060827) and R. Diaz-Arrastia (NIH R01 HD48179, U01 HD42652 and Department of Education H133 A020526). We thank Evelyn Babcock, PhD, of the University of Texas Southwestern Medical Center for her assistance with image acquisition. We also thank Ana Arenivas, Carlee Culver, and Matthew Warner for their assistance with data analysis.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benton A., 1976, MULTILINGUAL APHASIA; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Catheline G, 2010, NEUROBIOL AGING, V31, P1582, DOI 10.1016/j.neurobiolaging.2008.08.012; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Delis DC, 2000, CALIFORNIA VERBAL LE; Diaz-Marchan P.G., 1996, NEUROTRAUMA, P137; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Hagler DJ, 2009, HUM BRAIN MAPP, V30, P1535, DOI 10.1002/hbm.20619; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lee JS, 2005, NEUROIMAGE, V26, P771, DOI 10.1016/j.neuroimage.2005.02.036; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; MARK LP, 1995, AM J NEURORADIOL, V16, P1303; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Pannek K, 2010, NEUROIMAGE, V50, P1044, DOI 10.1016/j.neuroimage.2010.01.020; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saindane AM, 2007, AM J NEURORADIOL, V28, P767; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Thurnher MM, 2005, AM J NEURORADIOL, V26, P2275; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu Y, 2006, AM J NEURORADIOL, V27, P656; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100; Zhang WH, 2008, NEUROIMAGE, V42, P771, DOI 10.1016/j.neuroimage.2008.04.241	49	29	29	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2011	17	1					24	35		10.1017/S1355617710001189			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	702KX	WOS:000285894700004	21070694	Green Accepted			2021-06-18	
J	Fontainhas, AM; Townes-Anderson, E				Fontainhas, Aurora Maria; Townes-Anderson, Ellen			RhoA Inactivation Prevents Photoreceptor Axon Retraction in an In Vitro Model of Acute Retinal Detachment	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CYCLIC-AMP; ACTIN CYTOSKELETON; PIGMENT EPITHELIUM; PROTEIN-KINASES; BINDING-PROTEIN; VISUAL RECOVERY; CNS NEURONS; LIM-KINASE	PURPOSE. An early injury response to retinal detachment is disruption of synaptic connectivity between photoreceptors and second-order neurons. Most dramatic is the retraction of rod cell axons and their terminals away from the outer synaptic layer and toward their cell bodies. This study tested whether axonal retraction in detached retina was due to the activation of the small GTPase RhoA and was preventable using RhoA antagonists. METHODS. Retinal detachments were created in in vitro preparations of porcine eyecups. RhoA activation was determined with a Rhotekin binding assay. To block axon retraction, drugs were applied to neural retinal explants either before or after detachment from the retinal pigment epithelium. Presynaptic movement was quantified by image analysis of double-labeled retinas examined with confocal microscopy. RESULTS. Active RhoA increases transiently after detachment followed by morphologic evidence of axonal retraction over the next 24 hours. Pretreating the retina with a RhoA antagonist, CT-04, or a Rho kinase inhibitor, Y27632, at multiple concentrations significantly inhibited axonal retraction. Reducing calcium influx through L-type calcium channels with nicardipine also blocked retraction. To create a more plausible therapeutic scenario, drug treatments were delayed and applied after retinal detachment. The Rho kinase inhibitor, but not nicardipine, significantly blocked rod axonal retraction when applied up to 6 hours after detachment. CONCLUSIONS. Thus, RhoA and downstream Rho kinase activity constitute part of the mechanism that produces rod axonal retraction in retinal explants. Treatments that manipulate RhoA signaling may promote synaptic stability after retinal detachment. (Invest Ophthalmol Vis Sci. 2011;52:579-587) DOI:10.1167/iovs.10-5744	[Townes-Anderson, Ellen] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Fontainhas, Aurora Maria; Townes-Anderson, Ellen] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Integrat Neurosci Program, Newark, NJ 07103 USA	Townes-Anderson, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, 185 S Orange Ave, Newark, NJ 07103 USA.	andersel@umdnj.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY 012031]; F. M. Kirby Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012031] Funding Source: NIH RePORTER	Supported by National Institutes of Health Grant EY 012031 and an award from the F. M. Kirby Foundation.	Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Couvillon AD, 2006, CELL SIGNAL, V18, P715, DOI 10.1016/j.cellsig.2005.06.012; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Emmert DA, 2004, AM J PHYSIOL-CELL PH, V286, pC8, DOI 10.1152/ajpcell.00428.2002; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Fontainhas AM, 2008, INVEST OPHTH VIS SCI, V49, P4177, DOI 10.1167/iovs.07-1580; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; GUERIN CJ, 1993, INVEST OPHTH VIS SCI, V34, P175; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hiraga A, 2006, J PERIPHER NERV SYST, V11, P217, DOI 10.1111/j.1529-8027.2006.00091.x; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Ishibashi H, 1997, NEUROREPORT, V8, P853, DOI 10.1097/00001756-199703030-00009; Khodair MA, 2005, INVEST OPHTH VIS SCI, V46, P967, DOI 10.1167/iovs.04-0579; Khodair MA, 2003, INVEST OPHTH VIS SCI, V44, P4976, DOI 10.1167/iovs.03-0036; Kitaoka Y, 2004, BRAIN RES, V1018, P111, DOI 10.1016/j.brainres.2004.05.070; KROLL AJ, 1968, AM J OPHTHALMOL, V66, P410, DOI 10.1016/0002-9394(68)91524-9; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leung T, 2002, FEBS LETT, V532, P445, DOI 10.1016/S0014-5793(02)03736-5; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; Lewis GP, 2003, MOL NEUROBIOL, V28, P159, DOI 10.1385/MN:28:2:159; Lewis GP, 2002, EYE, V16, P375, DOI 10.1038/sj.eye.6700202; Linberg KA, 2009, MOL VIS, V15, P10; Lu Q, 2009, CURR MED CHEM, V16, P1355, DOI 10.2174/092986709787846569; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MACHEMER R, 1968, AM J OPHTHALMOL, V66, P396, DOI 10.1016/0002-9394(68)91523-7; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Matsuoka T, 1997, BIOCHEM BIOPH RES CO, V240, P484, DOI 10.1006/bbrc.1997.7624; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; McKerracher L, 2004, NAT MED, V10, P1052, DOI 10.1038/nm1004-1052; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Nakai K, 1997, BLOOD, V90, P3936, DOI 10.1182/blood.V90.10.3936; Nakamura S, 1966, Nihon Ganka Kiyo, V17, P920; Niederost B, 2002, J NEUROSCI, V22, P10368; Ozgur S, 2007, RETINA-J RET VIT DIS, V27, P358; Pai KS, 2002, J NEUROCHEM, V80, P715, DOI 10.1046/j.0022-3042.2001.00761.x; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rex TS, 2002, INVEST OPHTH VIS SCI, V43, P1234; Sakai T, 2001, INVEST OPHTH VIS SCI, V42, pS446; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Stella SL, 2000, EUR J NEUROSCI, V12, P3537, DOI 10.1046/j.1460-9568.2000.00235.x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wickham L, 2006, ARCH OPHTHALMOL-CHIC, V124, P1779, DOI 10.1001/archopht.124.12.1779; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yatani A, 2005, AM J PHYSIOL-HEART C, V288, pH650, DOI 10.1152/ajpheart.00268.2004; Zadro-Lamoureux LA, 2009, INVEST OPHTH VIS SCI, V50, P1448, DOI 10.1167/iovs.08-2855	61	29	30	0	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	JAN	2011	52	1					579	587		10.1167/iovs.10-5744			9	Ophthalmology	Ophthalmology	718CL	WOS:000287097400030	20861490	Green Published			2021-06-18	
J	Hashimoto, T; Umeda, S; Kojima, S				Hashimoto, Teruo; Umeda, Satoshi; Kojima, Shozo			Neural substrates of implicit cueing effect on prospective memory	NEUROIMAGE			English	Article						BA10; Caudal ACC; fMRI; Prospective memory; Subliminal cue	ANTERIOR CINGULATE CORTEX; ROSTRAL PREFRONTAL CORTEX; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; MEDIAL FRONTAL-CORTEX; ALZHEIMERS-DISEASE; TASK; PERFORMANCE; DEFICITS; REGIONS	Functional magnetic resonance imaging was used to examine the maintenance of intentions during an ongoing task involving implicit cues. Participants were required to detect target words while engaging in the ongoing task. Cues matched to the target category and cues matched to the action for targets were presented implicitly during the ongoing task. Implicit categorical target cues were found to enhance prospective memory performance, and implicit action cues accelerated responses more than irrelevant implicit cues in the prospective memory task. We found increased caudal anterior cingulate cortex (cACC) activity during the ongoing task with both implicit target and action cues, suggesting that alertness or preparatory attentional processes were strengthened by implicit cues. Implicit target cues elicited enhanced activity in the lateral anterior prefrontal cortex (Brodmann's area 10), which may be involved in dual processing of the ongoing task and the maintained intention. These results suggest that implicit cues may boost primitive attention toward an intended action and may be accessible to off-line maintenance. The facilitation of prospective target detection and the action execution by target cues were associated with increased supplementary motor area (SMA) activity. In contrast, we found enhanced premotor cortex (PMC) activation with action cue during the prospective memory task, suggesting that the PMC may be involved in stimulus-induced and rather automatic action. These results demonstrate the effectiveness of implicit cues for examining the maintenance of intention. Overall, we found that implicit target cues can facilitate prospective memory performance, and implicit action cues can accelerate responses. The above-mentioned neural underpinnings suggest that attentional and motor control processes are involved in the enhancement of prospective memory. (C) 2010 Elsevier Inc. All rights reserved.	[Hashimoto, Teruo] Riken BSI Symbol Cognit Dev, Wako, Saitama 3510198, Japan; [Hashimoto, Teruo; Umeda, Satoshi; Kojima, Shozo] Keio Univ, Dept Psychol, Tokyo, Japan	Hashimoto, T (corresponding author), Riken BSI Symbol Cognit Dev, 21-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-hashimoto@brain.riken.jp	Hashimoto, Teruo/C-4196-2013	Hashimoto, Teruo/0000-0002-5327-0667	Keio University;  [21830174]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21830174, 21530770] Funding Source: KAKEN	This work was supported by Grant-in-Aid for Scientific Research (21830174 to T.H.) and the Global Center Of Excellence Program (Keio University).	AMANO S, 2002, NTT DATABASE SERIES; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cohen AL, 2001, AGING NEUROPSYCHOL C, V8, P1, DOI 10.1076/anec.8.1.1.845; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dumontheil I, 2008, DEV MED CHILD NEUROL, V50, P168, DOI 10.1111/j.1469-8749.2008.02026.x; Einstein GO, 1998, PSYCHOL SCI, V9, P284, DOI 10.1111/1467-9280.00056; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; Haupt S, 2009, HUM BRAIN MAPP, V30, P3043, DOI 10.1002/hbm.20731; Heinzel A, 2008, CONSCIOUS COGN, V17, P699, DOI 10.1016/j.concog.2008.01.008; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hintzman DL, 1998, MEM COGNITION, V26, P449, DOI 10.3758/BF03201155; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Ikehara S., 1999, GOI TAIKEI JAPANESE; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kliegel M, 2007, INT J PSYCHOPHYSIOL, V64, P226, DOI 10.1016/j.ijpsycho.2006.09.007; Kliegel M, 2006, CHILD NEUROPSYCHOL, V12, P407, DOI 10.1080/09297040600696040; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Mantyla T, 1993, Memory, V1, P203, DOI 10.1080/09658219308258233; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marsh RL, 2005, J EXP PSYCHOL LEARN, V31, P68, DOI 10.1037/0278-7393.31.1.68; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel MA, 1998, MEM COGNITION, V26, P121, DOI 10.3758/BF03211375; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; MCDANIEL MA, 1992, ADV LEARNING BEHAVIO, V7, P87; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Postle N, 2008, NEUROIMAGE, V43, P634, DOI 10.1016/j.neuroimage.2008.08.006; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ratcliff R, 2009, PSYCHOL REV, V116, P59, DOI 10.1037/a0014086; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Salimpoor VN, 2010, J COGNITIVE NEUROSCI, V22, P790, DOI 10.1162/jocn.2009.21234; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith R, 2007, NEUROIMAGE, V36, P1387, DOI 10.1016/j.neuroimage.2007.04.032; Smith RE, 2005, EXP PSYCHOL, V52, P243, DOI 10.1027/1618-3169.52.4.243; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor K. S., 2008, HUM BRAIN MAPP; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Tyler LK, 2008, J COGNITIVE NEUROSCI, V20, P1381, DOI 10.1162/jocn.2008.20095; Umeda S, 2006, REV NEUROSCIENCE, V17, P267; Ursu S, 2009, BIOL PSYCHOL, V80, P279, DOI 10.1016/j.biopsycho.2008.10.008; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476	68	29	30	0	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN 1	2011	54	1					645	652		10.1016/j.neuroimage.2010.07.047			8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	675IY	WOS:000283825000066	20673802				2021-06-18	
J	Hong, MS; Feezor, RJ; Lee, WA; Nelson, PR				Hong, Michael S.; Feezor, Robert J.; Lee, W. Anthony; Nelson, Peter R.			The advent of thoracic endovascular aortic repair is associated with broadened treatment eligibility and decreased overall mortality in traumatic thoracic aortic injury	JOURNAL OF VASCULAR SURGERY			English	Article							STENT GRAFT REPAIR; AMERICAN-ASSOCIATION; TRANSECTIONS; SURGERY	Background: Aortic injury is the second leading cause of death in trauma. Thoracic endovascular aortic repair (TEVAR) has recently been applied to traumatic thoracic aortic injuries (TTAIs) as a minimally invasive alternative to open surgery. We sought to determine the impact of TEVAR on national trends in the management of TTAL Methods: We queried the Nationwide Inpatient Sample from the years 2001 to 2007 to select patients diagnosed with TTAI (International Classification of Disease-9 code 901.0). Patients were evaluated based on open surgical repair, TEVAR, or nonoperative management, before and after widespread adoption of TEVAR (2001-2005 and 2006-2007). Outcomes of interest were inpatient mortality, length of stay (LOS), and major complications. Results: An estimated 1180 annual admissions occurred for TTAI in the United States. Comparing the two time periods, there was an increase in TEVAR (P<.001) with a simultaneous decrease in open repair (P<.001) in 2006 to 2007. The overall number of interventions also increased (P<.001). Overall mortality decreased (25.0% vs 19.0%;P<.001), corresponding to improved survival in the nonoperative grouP(28.0% vs 23.2%; P<.001). There was no improvement in open repair mortality rates between the two time periods. Comparing intervention types, the TEVAR group had a higher percentage of patients with brain injury (26.1% vs 20.6%; P=.008), lung injury (25.0% vs 17.7%; P<.001), and hemothorax (32.5% vs 21.7%; P<.001) than the open surgery group. There were no differences in the number of intra-abdominal injuries or major orthopedic fractures. The open surgery group had more respiratory complications (43.9% vs 54.2%; P<.001), whereas TEVAR had a higher stroke rate (1.9% vs 0.7%; P=.021). There were no differences in paraplegia or renal failure. Overall in-hospital mortality was 23.2% (nonoperative group 26.7%, open repair 12.4%, and TEVAR 10.6%). Mortality between open repair and TEVAR groups were not significantly different. LOS was shorter among the TEVAR group vs open (15.7 vs 22.9 days; P<.001). Conclusion: TEVAR has replaced open repair as the primary operative treatment for TTAI and has extended operative treatment to those patients not previously considered candidates for repair. Increased utilization of TEVAR is associated with improved overall mortality. There is no difference in mortality between TEVAR and open repair groups in our study, which likely reflects the multisystem nature of injury and greater preoperative risk in the TEVAR group. (J Vasc Surg 2011;53:36-43.)	[Hong, Michael S.; Feezor, Robert J.; Lee, W. Anthony; Nelson, Peter R.] Univ Florida, Coll Med, Div Vasc Surg & Endovasc Therapy, Dept Surg, Gainesville, FL 32610 USA	Nelson, PR (corresponding author), Univ Florida, Coll Med, Div Vasc Surg & Endovasc Therapy, Dept Surg, POB 100128, Gainesville, FL 32610 USA.	peter.nelson@surgery.ufl.edu	Nelson, Peter R/B-2055-2009	Nelson, Peter R/0000-0003-0398-2962			Arthurs ZM, 2009, J VASC SURG, V49, P988, DOI 10.1016/j.jvs.2008.11.052; Broux C, 2006, INTENS CARE MED, V32, P770, DOI 10.1007/s00134-006-0115-8; Clark DE, 2004, J TRAUMA, V57, P130, DOI 10.1097/01.TA.0000114240.58834.84; Demetriades D, 2008, J TRAUMA, V64, P1415, DOI 10.1097/TA.0b013e3181715e32; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Feezor RJ, 2009, J AM COLL SURGEONS, V208, P510, DOI 10.1016/j.jamcollsurg.2009.01.012; Hannan EL, 2007, J TRAUMA, V62, P964, DOI 10.1097/01.ta.0000215375.07314.bd; Hemmila MR, 2004, J TRAUMA, V56, P13, DOI 10.1097/01.TA.0000108634.15989.07; Internet Citation: HCUP Databases, 2009, INT CIT HCUP DAT HEA; Mattox KL, 2008, J TRAUMA, V64, P570; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Pate JW, 1997, ANN THORAC SURG, V64, P387; Schulman CI, 2007, J TRAUMA, V62, P664, DOI 10.1097/TA.0b013e318031b58c; Sweeney MS, 1997, ANN THORAC SURG, V64, P384, DOI 10.1016/S0003-4975(97)00561-4; Tang GL, 2008, J VASC SURG, V47, P671, DOI 10.1016/j.jvs.2007.08.031; Verdant A, 2010, J VASC SURG, V51, P294, DOI 10.1016/j.jvs.2009.05.066	17	29	30	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JAN	2011	53	1					36	43		10.1016/j.jvs.2010.08.009			8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	704WB	WOS:000286085200006	20961728				2021-06-18	
J	Jacobsson, LJ; Westerberg, M; Malec, JF; Lexell, J				Jacobsson, L. J.; Westerberg, M.; Malec, J. F.; Lexell, J.			Sense of coherence and disability and the relationship with life satisfaction 6-15 years after traumatic brain injury in northern Sweden	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Long-term outcome; Outcome assessment; Traumatic brain injury; Quality of life; Questionnaires	QUALITY-OF-LIFE; ANTONOVSKYS SENSE; COMMUNITY INTEGRATION; MULTIPLE TRAUMA; HEAD-INJURY; SCALE; HEALTH; INDIVIDUALS; VALIDITY; DEPRESSION	The objective of the study was to assess sense of coherence (SOC) many years after traumatic brain injury (TBI) and explore the relationship between SOC and self-rated life satisfaction (LS) as well as measures of functioning and disability, sex, age at injury, injury severity and time post-injury. Sixty-six individuals (aged 18-65 years) who were 6-15 years post-injury were interviewed. Data on SOC (SOC-13 item scale), measures of functioning and disability (Mayo-Portland Adaptability Inventory, MPAI-4), LS (Satisfaction with Life Scale, SWLS), and sex, age at injury, injury severity and time post-injury were analysed with hierarchical multiple regression analyses. The results showed that SOC in the study group did not differ from the general population and was strongly associated with LS. Regression analyses revealed that emotional factors, social participation, SOC, and time since injury, were more influential than sex, age at injury, and injury severity in explaining LS. It was concluded that SOC in this group of individuals with TBI who were many years post-injury was similar to nondisabled individuals. SOC, together with emotional factors, social participation and injury-related factors, were determinants of LS. These results confirm that LS after TBI is a complex phenomenon dependent on several factors that are important targets for rehabilitation professionals.	[Jacobsson, L. J.] Kalix Hosp, Dept Gen Med, Med Rehabil Sect, SE-95282 Kalix, Sweden; [Jacobsson, L. J.] Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden; [Westerberg, M.] Lulea Univ Technol, Dept Business Adm & Social Sci, S-95187 Lulea, Sweden; [Malec, J. F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Malec, J. F.] Indiana Univ Sch Med, Indianapolis, IN USA; [Lexell, J.] Skane Univ Hosp, Dept Rehabil Med, Lund, Sweden; [Jacobsson, L. J.; Lexell, J.] Lund Univ, Dept Hlth Sci, Lund, Sweden	Jacobsson, LJ (corresponding author), Kalix Hosp, Dept Gen Med, Med Rehabil Sect, SE-95282 Kalix, Sweden.	lars_j@glocalnet.net	Westerberg, Mats/C-3300-2012	Westerberg, Mats/0000-0001-5464-9292; Lexell, Jan/0000-0001-5294-3332; Jacobsson, Lars/0000-0002-1127-1178	Norrbacka-Eugenia Foundation; Cancer and Traffic Injury Fund; Norrbotten County Council; Swedish Association of Brain Injured and their Families; Skane county council's research and development foundation	This study was supported by grants from the Norrbacka-Eugenia Foundation, the Cancer and Traffic Injury Fund, Norrbotten County Council, the Swedish Association of Brain Injured and their Families and Skane county council's research and development foundation.	Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1987, UNRAVELING MYSTERY H; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Feldt T, 2007, QUAL LIFE RES, V16, P483, DOI 10.1007/s11136-006-9130-z; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hendrikx T, 2008, SCAND J PUBLIC HEALT, V36, P340, DOI 10.1177/1403494808089560; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Kaiser CF, 1996, J SOC BEHAV PERS, V11, P459; Kivimaki M, 2000, SOC SCI MED, V50, P583, DOI 10.1016/S0277-9536(99)00326-3; Klang B, 1996, QUAL LIFE RES, V5, P109, DOI 10.1007/BF00435975; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Langius A, 1993, Scand J Caring Sci, V7, P3; Langius A, 1992, Scand J Caring Sci, V6, P165; Larsson G, 1999, EUR J PERSONALITY, V13, P51, DOI 10.1002/(SICI)1099-0984(199901/02)13:1<51::AID-PER321>3.0.CO;2-P; Lindmark U, 2010, SCAND J PUBLIC HEALT, V38, P1, DOI 10.1177/1403494809351654; Linley PA, 2003, J TRAUMA STRESS, V16, P601, DOI 10.1023/B:JOTS.0000004086.64509.09; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Pallant JF, 2002, PERS INDIV DIFFER, V33, P39, DOI 10.1016/S0191-8869(01)00134-9; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; PETRIE K, 1992, BRIT J CLIN PSYCHOL, V31, P293, DOI 10.1111/j.2044-8260.1992.tb00996.x; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Schnyder U, 2000, PSYCHOTHER PSYCHOSOM, V69, P296, DOI 10.1159/000012411; Skarsater I, 2009, ARCH PSYCHIAT NURS, V23, P119, DOI 10.1016/j.apnu.2008.04.007; Smith J, 1998, CANADIAN J REHABILIT, V11, P131; Snekkevik H, 2003, CLIN REHABIL, V17, P443, DOI 10.1191/0269215503cr630oa; Tabachnick BG, 2007, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; Ying YW, 1997, AM J COMMUN PSYCHOL, V25, P839, DOI 10.1023/A:1022217330005	52	29	30	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	3					383	400	PII 936108151	10.1080/09602011.2011.566711			18	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	761ND	WOS:000290403800005	21480050				2021-06-18	
J	Kramer, AH; Diringer, MN; Suarez, JI; Naidech, AM; Macdonald, LR; Le Roux, PD				Kramer, Andreas H.; Diringer, Michael N.; Suarez, Jose I.; Naidech, Andrew M.; Macdonald, Loch R.; Le Roux, Peter D.			Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL OXYGENATION; INTENSIVE-CARE; COMPLICATIONS; METABOLISM; PRESSURE; DELIVERY; TENSION; FLOW	Introduction: Anemia is associated with poor outcomes in patients with aneurysmal subarachnoid hemorrhage (SAH). It remains unclear whether this association can be modified with more aggressive use of red blood cell (RBC) transfusions. The degree to which restrictive thresholds have been adopted in neurocritical care patients remains unknown. Methods: We performed a survey of North American academic neurointensivists, vascular neurosurgeons and multidisciplinary intensivists who regularly care for patients with SAH to determine hemoglobin (Hb) concentrations which commonly trigger a decision to initiate transfusion. We also assessed minimum and maximum acceptable Hb goals in the context of a clinical trial and how decision-making is influenced by advanced neurological monitoring, clinician characteristics and patient-specific factors. Results: The survey was sent to 531 clinicians, of whom 282 (53%) responded. In a hypothetical patient with high-grade SAH (WFNS 4), the mean Hb concentration at which clinicians administered RBCs was 8.19 g/dL (95% CI, 8.07 to 8.30 g/dL). Transfusion practices were comparatively more restrictive in patients with low-grade SAH (mean Hb 7.85 g/dL (95% CI, 7.73 to 7.97 g/dL)) (P < 0.0001) and more liberal in patients with delayed cerebral ischemia (DCI) (mean Hb 8.58 g/dL (95% CI, 8.45 to 8.72 g/dL)) (P < 0.0001). In each setting, there was a broad range of opinions. The majority of respondents expressed a willingness to study a restrictive threshold of = 8 g/dL (92%) and a liberal goal of = 10 g/dl (75%); in both cases, the preferred transfusion thresholds were significantly higher for patients with DCI (P < 0.0001). Neurosurgeons expressed higher minimum Hb goals than intensivists, especially for patients with high-grade SAH (b = 0.46, P = 0.003), and were more likely to administer two rather than one unit of RBCs (56% vs. 19%; P < 0.0001). Institutional use of transfusion protocols was associated with more restrictive practices. More senior clinicians preferred higher Hb goals in the context of a clinical trial. Respondents were more likely to transfuse patients with brain tissue oxygen tension values < 15 mmHg and lactate-to-pyruvate ratios > 40. Conclusions: There is widespread variation in the use of RBC transfusions in SAH patients. Practices are heavily influenced by the specific dynamic clinical characteristics of patients and may be further modified by clinician specialty and seniority, the use of protocols and advanced neurological monitoring.	[Kramer, Andreas H.] Univ Calgary, Dept Crit Care Med, Hotchkiss Brain Inst, Foothills Med Ctr, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Foothills Med Ctr, Calgary, AB T2N 2T9, Canada; [Diringer, Michael N.] Washington Univ, Sch Med, Dept Neurol & Neurol Surg, Neurol Neurosurg Intens Care Unit, St Louis, MO 63110 USA; [Suarez, Jose I.] Baylor Coll Med, Dept Neurol, Div Vasc Neurol, Houston, TX 77030 USA; [Suarez, Jose I.] Baylor Coll Med, Dept Neurol, Div Neurocrit Care, Houston, TX 77030 USA; [Naidech, Andrew M.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Macdonald, Loch R.] Univ Toronto, Div Neurosurg, Dept Surg, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19106 USA	Kramer, AH (corresponding author), Univ Calgary, Dept Crit Care Med, Hotchkiss Brain Inst, Foothills Med Ctr, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	andreas.kramer@calgaryhealthregion.ca	Diringer, Michael N/C-1165-2008	Diringer, Michael N/0000-0003-2337-5537			Bendel P, 2008, RADIOLOGY, V246, P543, DOI 10.1148/radiol.2461061915; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Cummings SM, 2001, HEALTH SERV RES, V35, P1347; Deans KJ, 2007, CRIT CARE MED, V35, P1509, DOI 10.1097/01.CCM.0000266584.40715.A6; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2009, NEUROCRIT CARE, V10, P20, DOI 10.1007/s12028-008-9137-0; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; KURTZ P, 2010, CRITICAL CARE, V14, P341; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Leece P, 2004, J MED INTERNET RES, V6, P26, DOI 10.2196/jmir.6.4.e39; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Naidech AM, 2006, NEUROSURGERY, V59, P775, DOI 10.1227/01.NEU.0000232662.86771.A9; Ramakrishna R, 2008, J NEUROSURG, V109, P1075, DOI 10.3171/JNS.2008.109.12.1075; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stevens RD, 2009, INTENS CARE MED, V35, P1556, DOI 10.1007/s00134-009-1533-1; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22; BRAIN TISSUE OXYGEN	31	29	30	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2011	15	1							R30	10.1186/cc9977			11	Critical Care Medicine	General & Internal Medicine	742RJ	WOS:000288961900030	21244675	DOAJ Gold, Green Published			2021-06-18	
J	Sedney, CL; Orphanos, J; Bailes, JE				Sedney, Cara L.; Orphanos, John; Bailes, Julian E.			When to Consider Retiring an Athlete After Sports-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Mild traumatic brain injury; Athletes	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; RECURRENT CONCUSSION; ASSOCIATION; TAU	The pathophysiology of concussion may lead to a variety of both short-and long-term effects, which may lead to a decision to retire from contact sports. These effects follow a recognizable progression and may cause an athlete to opt out of play at any point along this progression. To elucidate the effect of concussion or mild traumatic brain injury and weigh in on a decision to retire, the treating physician needs to take into account the history, neurologic examination, brain imaging, and neuropsychological testing. In addition, myriad social factors surrounding play must be taken into consideration.	[Sedney, Cara L.] W Virginia Univ, Dept Neurosurg, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Orphanos, John; Bailes, Julian E.] W Virginia Univ, Dept Neurosurg, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26505 USA	Sedney, CL (corresponding author), W Virginia Univ, Dept Neurosurg, Robert C Byrd Hlth Sci Ctr, POB 9183, Morgantown, WV 26506 USA.	csedney@hsc.wvu.edu		Sedney, Cara/0000-0003-1290-7083			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Callaway GH, 1996, MED SCI SPORT EXER, V28, P1218, DOI 10.1097/00005768-199610000-00002; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1111/j.1365-2990.1996.tb00840.x; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; ILKONOMOVIC M, 2004, EXP NEUROL, V190, P192; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; OMALU B, J NEUROSURG IN PRESS; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Osborne B, 2001, J ATHL TRAINING, V36, P316; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Schneider R., 1973, HEAD NECK INJURIES F; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Torg JS., 1991, ATHLETIC INJURIES HE; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	32	29	30	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					189	+		10.1016/j.csm.2010.08.005			13	Sport Sciences	Sport Sciences	691XR	WOS:000285114800017	21074092				2021-06-18	
J	Struchen, MA; Pappadis, MR; Sander, AM; Burrows, CS; Myszka, KA				Struchen, Margaret A.; Pappadis, Monique R.; Sander, Angelle M.; Burrows, Christina S.; Myszka, Katherine A.			Examining the Contribution of Social Communication Abilities and Affective/Behavioral Functioning to Social Integration Outcomes for Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						craniocerebral trauma; social communication; social integration; traumatic brain injury	CLOSED-HEAD-INJURY; COMMUNITY INTEGRATION; FOLLOW-UP; CLINICAL TOOL; QUESTIONNAIRE; COMPETENCE; SKILLS; REHABILITATION; PERSPECTIVES; PERCEPTIONS	Objective: To evaluate the contribution of social communication abilities and affective/behavioral functioning to social integration outcomes for persons with traumatic brain injury (TBI). Design: Prospective cohort study. Participants: A total of 184 adults with TBI (72.8% men) evaluated at least 6 months postdischarge from acute care or inpatient rehabilitation hospitals and after living at least 3 months in the community postdischarge (Mean = 7.84 months postinjury). Measures: La Trobe Communication Questionnaire (LCQ), Assessment of Interpersonal Problem-Solving Skills (AIPSS), Affective Behavioral subscale From the Problem Checklist of the Head Injury Family Interview (AB-HIFI), Craig Handicap Assessment and Reporting Technique-Short Form Social Integration subscale (CHART-SF-SI), Community Integration Questionnaire Social Integration subscale (CIQ-SI). Results: Social communication measures (LCQ, AIPSS) and self-reported behavioral functioning (AB-HIFI) contributed significantly to concurrently measured social integration outcomes after controlling for demographic and injury-related variables. Separate hierarchical multiple regression analyses revealed that social communication and behavioral variables accounted for 11.3% of variance in CIQ-SI and 16.3% of variance in CHART-SF-SI. Conclusions: Social communication abilities and affective/ behavioral functioning make a substantial contribution to social integration outcomes after TBI. The implications of such evidence for clinical assessment and intervention are discussed.	[Struchen, Margaret A.; Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Struchen, Margaret A.; Pappadis, Monique R.; Sander, Angelle M.; Burrows, Christina S.] TIRR Mem Hermann Hosp, Brain Injury Res Ctr, Houston, TX USA; [Pappadis, Monique R.] Univ Houston, Grad Coll Social Work, Houston, TX USA; [Burrows, Christina S.; Myszka, Katherine A.] Univ Houston, Dept Psychol, Houston, TX USA; [Sander, Angelle M.] Harris Cty Hosp Dist, Dept Phys Med & Rehabil, Quentin Mease Community Hosp, Houston, TX USA	Struchen, MA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1 Baylor Plaza, Houston, TX 77030 USA.	struchen@bcm.edu	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380; O'Brien, Katherine/0000-0002-1416-4124	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133B031117, H133B090023, H133A070043]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grant H133B031117, Rehabilitation Research and Training Center on Community Integration of Persons with Traumatic Brain Injury; H133B090023, Rehabilitation Research and Training Center on Developing Strategies to Foster Community Integration and Participation for Individuals With Traumatic Brain Injury; and H133A070043, Texas Traumatic Brain Injury Model System of TIRR).	BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; BOWERS D, 1991, BRAIN, V114, P2593, DOI 10.1093/brain/114.6.2593; Bowers D., 1991, FLORIDA AFFECT BATTE; Brooks DN, 1979, REHABILITATION HEAD, P107; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BRUININKS RH, 1992, RES DEV DISABIL, V13, P463, DOI 10.1016/0891-4222(92)90003-O; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; *CRAIG HOSP RES DE, 1999, CRAIG HAND ASS REP T; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Damico JS, 1985, COMMUNICATION SKILLS, P165; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DONAHOE CP, 1990, PSYCHIATRY, V53, P329; Donahoe CP, 1996, SOCIAL INDEPENDENT L; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Gage M, 1997, AM J OCCUP THER, V51, P96, DOI 10.5014/ajot.51.2.96; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KARPMAN T, 1985, J APPL REHABILITATIO, V17, P28; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MARSH NV, 1999, BRAIN DAM B, P175; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCFALL RM, 1982, BEHAV ASSESS, V4, P1; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Mooney GF, 1988, COGNITIVE REHABI SEP, P14; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P18; PRUTTING CA, 1982, J SPEECH HEAR DISORD, V47, P123, DOI 10.1044/jshd.4702.123; Sale P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, 10.1097/00001199-199109000-00004.]; SALZBERG CL, 1981, MENT RETARD, V19, P127; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SPSS, 2009, PASW STAT 18 REL VER; Struchen M.A., 2005, REHABILITATION TRAUM, P88; Struchen MA, 2003, J INT NEUROPSYCH SOC, V9, P255; Struchen MA, 2002, ASSESSMENT INTERPERS; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiteneck GG, 1992, GUIDE USE CHART CRAI; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	68	29	29	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2011	26	1					30	42		10.1097/HTR.0b013e3182048f7c			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	703GA	WOS:000285965200004	21209561				2021-06-18	
J	Bigler, ED; McCauley, SR; Wu, TC; Yallampalli, R; Shah, S; MacLeod, M; Chu, ZL; Hunter, JV; Clifton, GL; Levin, HS; Wilde, EA				Bigler, Erin D.; McCauley, Stephen R.; Wu, Trevor C.; Yallampalli, Ragini; Shah, Sanjeev; MacLeod, Marianne; Chu, Zili; Hunter, Jill V.; Clifton, Guy L.; Levin, Harvey S.; Wilde, Elisabeth A.			The temporal stem in traumatic brain injury: preliminary findings	BRAIN IMAGING AND BEHAVIOR			English	Article						Temporal stem; White matter pathways; Traumatic brain injury; Diffusion tensor imaging (DTI); Memory; Neurobehavioral sequelae	DIFFUSION TENSOR TRACTOGRAPHY; VERBAL MEMORY; UNCINATE FASCICULUS; LOBE; WHITE; MRI; HIPPOCAMPUS; CORTEX; DAMAGE; TRACTS	The temporal stem (TS) of the temporal lobe is a major white matter (WM) region containing several major pathways that connect the temporal lobe with the rest of the brain. Because of its location, it may be particularly vulnerable to shear-strain effects resulting from traumatic brain injury (TBI). A case vignette is presented in a patient with severe brain injury and focal TS pathology. Also, 12 severe TBI subjects unselected for TS pathology were compared to demographically matched, neurologically-intact controls using diffusion tensor imaging (DTI) to examine white matter tracts associated with the TS, including the inferior fronto-occipital fasciculus (IFOF), inferior longitudinal fasciculus (ILF), arcuate fasciculus (AF), cingulum bundle (CB) and the uncinate fasciculus (UF). For each tract, fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were computed and compared between the two groups and also examined in relationship to memory performance in the TBI subjects. Significant FA and ADC differences were observed in all tracts in the TBI patients compared to controls, with several relationships with memory outcome noted in the IFOF, ILF and AF. Based on these preliminary findings, the potential role of TBI-induced WM disconnection involving the TS is discussed as well as the relationship of TS damage to neurobehavioral outcome. The need for future studies specifically examining the role of TS injury in TBI is emphasized.	[Bigler, Erin D.; Wu, Trevor C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [McCauley, Stephen R.; MacLeod, Marianne; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Chu, Zili; Hunter, Jill V.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Shah, Sanjeev; Chu, Zili; Hunter, Jill V.] Texas Childrens Hosp, EB Singleton Dept Diagnost Imaging, Houston, TX 77030 USA; [Yallampalli, Ragini] Univ Houston, Dept Psychol, Houston, TX USA; [Clifton, Guy L.] Univ Texas Houston, Sch Med, Dept Surg, Vivian L Smith Ctr Neurol Res, Houston, TX USA	Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu			NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS43353]; Dana Foundation; Brigham Young University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	Parts of this were funded by grants from the NIH (NINDS) NS43353 (G.L.C.) and the Dana Foundation (E.A.W.) along with a grant from the College of Family, Home and Social Science from Brigham Young University (E.D.B.). The technical assistance of Tracy Abildskov for various facets of the DTI analyses and illustration preparation and Jo Ann Petrie for manuscript preparation are also gratefully acknowledged.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Andersen P., 2006, HIPPOCAMPUS BOOK; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bird CM, 2007, NEUROPSYCHOLOGIA, V45, P1160, DOI 10.1016/j.neuropsychologia.2006.10.011; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bracht T, 2009, PSYCHIAT RES-NEUROIM, V174, P217, DOI 10.1016/j.pscychresns.2009.05.001; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Choi CY, 2010, J KOREAN NEUROSURG S, V47, P365, DOI 10.3340/jkns.2010.47.5.365; Corkin S, 1997, J NEUROSCI, V17, P3964; Delis DC, 2000, CALIFORNIA VERBAL LE; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; DUCKWORTH JL, 2010, CURRENT OPINION 0212; Eslinger PJ, 1996, CEREB CORTEX, V6, P530, DOI 10.1093/cercor/6.3.530; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gaffan D, 2001, NEUROPSYCHOLOGIA, V39, P51, DOI 10.1016/S0028-3932(00)00097-X; Gaffan D, 2005, SCIENCE, V309, P2172, DOI 10.1126/science.1119445; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Govindan RM, 2008, EPILEPSY RES, V80, P30, DOI 10.1016/j.eplepsyres.2008.03.011; Helmstaedter C, 2008, EPILEPSIA, V49, P88, DOI 10.1111/j.1528-1167.2007.01386.x; HOOGENRAAD F, 2002, MULTICENTER EVALUATI; HOREL JA, 1994, CORTEX, V30, P269, DOI 10.1016/S0010-9452(13)80198-0; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Lavenex P, 2007, DEV NEUROSCI-BASEL, V29, P179, DOI 10.1159/000096222; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; MacDonald CL, 2008, NEUROLOGY, V71, P1199, DOI 10.1212/01.wnl.0000327521.69520.7f; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; NETSCH T, 2001, INT C COMP VIS; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Peltier J, 2010, J NEUROSURG, V112, P1033, DOI 10.3171/2009.6.JNS08132; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Rempel-Clower NL, 2007, ANN NY ACAD SCI, V1121, P72, DOI 10.1196/annals.1401.026; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robertson G.J., 2007, WIDE RANGE ACHIEVEME; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schoene-Bake JC, 2009, NEUROIMAGE, V46, P569, DOI 10.1016/j.neuroimage.2009.03.013; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; SHAMY JL, 2010, HIPPOCAMPUS     0121; Sheslow D, 2004, WIDE RANGE ASSESSMEN; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang F, 2008, J NEUROSURG, V108, P775, DOI 10.3171/JNS/2008/108/4/0775; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 1991, WECHSLER INTELLIGENC; Wen HT, 1999, NEUROSURGERY, V45, P549, DOI 10.1097/00006123-199909000-00028; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	68	29	29	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2010	4	3-4					270	282		10.1007/s11682-010-9105-0			13	Neuroimaging	Neurosciences & Neurology	658SB	WOS:000282508600007	20835782				2021-06-18	
J	Mao, HJ; Yang, KH; King, AI; Yang, K				Mao, Haojie; Yang, King H.; King, Albert I.; Yang, Kai			Computational neurotrauma-design, simulation, and analysis of controlled cortical impact model	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain injury; Controlled cortical impact; Finite element	TRAUMATIC BRAIN-INJURY; OLDER ADULTS; BIOMECHANICS; MILD; TBI; RAT	The controlled cortical impact (CCI) model is widely used in many laboratories to study traumatic brain injury (TBI). Although external impact parameters during CCI tests could be clearly defined, little is known about the internal tissue-level mechanical responses of the rat brain. Furthermore, the external impact parameters tend to vary considerably among different labs making the comparison of research findings difficult if not impossible. In this study, a design of computer experiments was performed with typical external impact parameters commonly found in the literature. An anatomically detailed finite element (FE) rat brain model was used to simulate the CCI experiments to correlate external mechanical parameters (impact depth, impact velocity, impactor shape, impactor size, and craniotomy pattern) with rat brain internal responses, as predicted by the FE model. Systematic analysis of the results revealed that impact depth was the leading factor affecting the predicted brain internal responses. Interestingly, impactor shape ranked as the second most important factor, surpassing impactor diameter and velocity which were commonly reported in the literature as indicators of injury severity along with impact depth. The differences in whole brain response due to a unilateral or a bilateral craniotomy were small, but those of regional intracranial tissue stretches were large. The interaction effects of any two external parameters were not significant. This study demonstrates the potential of using numerical FE modeling to engineer better experimental TBI models in the future.	[Mao, Haojie; Yang, King H.; King, Albert I.] Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA; [Yang, Kai] Wayne State Univ, Dept Ind & Mfg Engn, Detroit, MI 48201 USA	Mao, HJ (corresponding author), Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA.	hmao@wayne.edu	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	Injury Control Research Center at University of Alabama at Birmingham	The authors would like to acknowledge Dr. Cheng-Tang Wu from LSTC for his help in post-processing of simulation results. The authors also acknowledge Chris Anderson for his help in preparing the manuscript. This study is partially supported by the Injury Control Research Center at University of Alabama at Birmingham.	Antony J., 2003, DESIGN EXPT ENG SCI; Arbogast K., 1997, P 41 STAPP CAR CRASH; Bain A.C., 1999, 43 STAPP CAR CRASH C; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Fearnside MR, 1997, HEAD INJURY PATHOPHY, P3; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; Hoffmann B, 2002, ACT NEUR S, V79, P33; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KRAUS JF, 1996, NEUROTRAUMA, P13; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; LENTH RV, 1989, TECHNOMETRICS, V31, P469, DOI 10.2307/1269997; MAO H, 2009, BIOMEDICAL ENG; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Roy R.K., 2001, DESIGN EXPT USING TA; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Takhounts EG, 2008, STAPP CAR C, V52, P1; Vink R, 1990, Magnes Res, V3, P163; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15	34	29	29	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	DEC	2010	9	6					763	772		10.1007/s10237-010-0212-z			10	Biophysics; Engineering, Biomedical	Biophysics; Engineering	684AA	WOS:000284518200009	20372960	Other Gold			2021-06-18	
J	Siegel, JA; Craytor, MJ; Raber, J				Siegel, Jessica A.; Craytor, Michael J.; Raber, Jacob			Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice	BEHAVIOURAL PHARMACOLOGY			English	Article						acetylcholine; apolipoprotein E; cognition; hippocampus; methamphetamine; mouse	VENTRAL TEGMENTAL AREA; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E GENE; BASAL FOREBRAIN; ALZHEIMERS-DISEASE; CHOLINERGIC RECEPTORS; PREPULSE INHIBITION; OBJECT RECOGNITION; SPATIAL NAVIGATION; BENZILATE BINDING	Exposure to methamphetamine during brain development impairs cognition in humans and rodents. In mice, these impairments are more severe in females than males. Genetic factors, such as apolipoprotein E genotype, may modulate the cognitive effects of methamphetamine. Methamphetamine-induced alterations in the brain acetylcholine system may contribute to the cognitive effects of methamphetamine and may also be modulated by apolipoprotein E isoform. We assessed the long-term effects of methamphetamine exposure during brain development on cognitive function and muscarinic acetylcholine receptors in mice, and whether apolipoprotein E isoform modulates these effects. Mice expressing human apolipoprotein E3 or E4 were exposed to methamphetamine (5 mg/kg) or saline once a day from postnatal days 11-20 and behaviorally tested in adulthood. Muscarinic acetylcholine receptor binding was measured in the hippocampus and cortex. Methamphetamine exposure impaired novel location recognition in female, but not male, mice. Methamphetamine-exposed male and female mice	[Siegel, Jessica A.; Craytor, Michael J.; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci ONPRC, Portland, OR 97239 USA	Raber, J (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, 8131 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	raberj@ohsu.edu			NIH, NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 MH77647, T32-DA007262]; NASANational Aeronautics & Space Administration (NASA) [NNJ05HE63G]; Alzheimer's AssociationAlzheimer's Association [IIRG-05-14021]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH077647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007262] Funding Source: NIH RePORTER	The authors would like to acknowledge Ted Benice, Laura Villasana, Jenna Rosenberg, Tim Pfankuch, and Anthony Bader for their help with injections and behavioral testing of mice for this study. This study was supported by NIH R01 MH77647, T32-DA007262 NIDA Institutional Training Grant, NASA NNJ05HE63G, and Alzheimer's Association IIRG-05-14021.	ACEVEDO S, 2008, NEUR ANN M WASH DC U; Acevedo SF, 2008, J NEUROCHEM, V107, P976, DOI 10.1111/j.1471-4159.2008.05673.x; Acevedo SF, 2007, NEUROPSYCHOPHARMACOL, V32, P665, DOI 10.1038/sj.npp.1301091; Acevedo SF, 2010, PEDIATR RES, V67, P293, DOI 10.1203/PDR.0b013e3181cb8e68; Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Allen SJ, 1997, NEUROSCI LETT, V239, P33, DOI 10.1016/S0304-3940(97)00872-0; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Arendt T, 1997, J NEUROSCI, V17, P516; Arnold HM, 2002, NEUROSCIENCE, V114, P451, DOI 10.1016/S0306-4522(02)00292-0; Arters J, 1998, J NEUROBIOL, V37, P582, DOI 10.1002/(SICI)1097-4695(199812)37:4<582::AID-NEU7>3.0.CO;2-5; Aubert I, 1996, J COMP NEUROL, V369, P31; Bacciottini L, 2001, BEHAV BRAIN RES, V124, P183, DOI 10.1016/S0166-4328(01)00230-3; Ballmaier M, 2002, NEUROSCIENCE, V114, P91, DOI 10.1016/S0306-4522(02)00234-8; Bartres-Faz D, 2002, ADDICT BIOL, V7, P227, DOI 10.1080/135562102200120451; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bechtholt AJ, 2004, PHARMACOL BIOCHEM BE, V77, P783, DOI 10.1016/j.pbb.2004.02.002; Benice TS, 2008, J NEUROSCI METH, V168, P422, DOI 10.1016/j.jneumeth.2007.11.002; Berlanga ML, 2005, J COMP NEUROL, V492, P34, DOI 10.1002/cne.20684; Bitner RS, 2002, BRAIN RES, V938, P45, DOI 10.1016/S0006-8993(02)02485-X; Bleich S, 2003, J NEURAL TRANSM, V110, P401, DOI 10.1007/s00702-002-0789-1; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Bussey TJ, 1999, J NEUROSCI, V19, P495; Buttini M, 1999, J NEUROSCI, V19, P4867; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chang L, 2004, PSYCHIAT RES-NEUROIM, V132, P95, DOI 10.1016/j.pscychresns.2004.06.004; Chang L, 2009, NEUROIMAGE, V48, P391, DOI 10.1016/j.neuroimage.2009.06.062; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Crawford CA, 2003, SYNAPSE, V48, P131, DOI 10.1002/syn.10197; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; DAY J, 1992, SYNAPSE, V12, P281, DOI 10.1002/syn.890120405; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dobbs LK, 2008, NEUROSCIENCE, V156, P700, DOI 10.1016/j.neuroscience.2008.07.052; Forrester MB, 2007, J TOXICOL ENV HEAL A, V70, P7, DOI 10.1080/15287390600748799; Garcia-Rates S, 2007, TOXICOL APPL PHARM, V223, P195, DOI 10.1016/j.taap.2007.05.015; Gaykema RP, 1996, J COMP NEUROL, V374, P555; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Guangda Xiang, 1999, Atherosclerosis, V147, P293, DOI 10.1016/S0021-9150(99)00198-7; Heller A, 2001, J PHARMACOL EXP THER, V298, P769; Heller A, 2001, DEV BRAIN RES, V130, P139, DOI 10.1016/S0165-3806(01)00222-X; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; HORTNAGL H, 1993, BRAIN RES BULL, V31, P129, DOI 10.1016/0361-9230(93)90019-8; Hruba L, 2010, DEV PSYCHOBIOL, V52, P71, DOI 10.1002/dev.20414; Jones CK, 2000, J PHARMACOL EXP THER, V294, P1017; Kenny PJ, 2000, J NEUROCHEM, V75, P2409, DOI 10.1046/j.1471-4159.2000.0752409.x; Kish SJ, 1999, MOL PSYCHIATR, V4, P26, DOI 10.1038/sj.mp.4000462; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Lai MKP, 2006, NEUROBIOL DIS, V22, P555, DOI 10.1016/j.nbd.2005.12.016; Lin L, 1998, NEUROREPORT, V9, P547, DOI 10.1097/00001756-199802160-00030; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Masuda J, 2005, NEUROSCIENCE, V132, P537, DOI 10.1016/j.neuroscience.2005.01.010; MCCABE RT, 1987, BRAIN RES BULL, V19, P551; Mirza NR, 2000, PSYCHOPHARMACOLOGY, V148, P243, DOI 10.1007/s002130050048; MUIR JL, 1994, J NEUROSCI, V14, P2313; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Murai T, 2007, PHYSIOL BEHAV, V90, P116, DOI 10.1016/j.physbeh.2006.09.013; Muramatsu T, 1997, J NEURAL TRANSM, V104, P913, DOI 10.1007/BF01285559; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Pike CJ, 2001, BRAIN RES, V919, P160, DOI 10.1016/S0006-8993(01)03024-4; PIPER BJ, 2010, PSYCHOPHARM IN PRESS; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Raber Jacob, 2004, Sci Aging Knowledge Environ, V2004, pre2, DOI 10.1126/sageke.2004.11.re2; RAVIKUMAR BV, 1985, J NEUROCHEM, V44, P240, DOI 10.1111/j.1471-4159.1985.tb07136.x; Ricceri L, 2002, BRAIN RES, V954, P160, DOI 10.1016/S0006-8993(02)03172-4; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Salehi A, 1998, P NATL ACAD SCI USA, V95, P11445, DOI 10.1073/pnas.95.19.11445; Sambeth A, 2007, EUR J PHARMACOL, V572, P151, DOI 10.1016/j.ejphar.2007.06.018; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Schaefer TL, 2008, J NEUROCHEM, V104, P1674, DOI 10.1111/j.1471-4159.2007.05112.x; Siegal D, 2004, SYNAPSE, V52, P223, DOI 10.1002/syn.20020; SIEGEL JA, 2009, NEUROBIOL AGING; Skelton MR, 2007, PSYCHONEUROENDOCRINO, V32, P734, DOI 10.1016/j.psyneuen.2007.05.004; Smith LM, 2008, NEUROTOXICOL TERATOL, V30, P20, DOI 10.1016/j.ntt.2007.09.005; Smith LM, 2006, PEDIATRICS, V118, P1149, DOI 10.1542/peds.2005-2564; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; STRUTHERS JM, 1992, J DEV BEHAV PEDIATR, V13, P108, DOI 10.1097/00004703-199204000-00005; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Terplan M, 2009, OBSTET GYNECOL, V113, P1285, DOI 10.1097/AOG.0b013e3181a5ec6f; Timofeeva OA, 2008, NEUROTOXICOL TERATOL, V30, P38, DOI 10.1016/j.ntt.2007.10.002; van Meer P, 2007, BEHAV BRAIN RES, V176, P372, DOI 10.1016/j.bbr.2006.10.024; VANHEST A, 1990, PHARMACOL BIOCHEM BE, V35, P903, DOI 10.1016/0091-3057(90)90378-U; Vaucher E, 2002, NEUROBIOL AGING, V23, P87, DOI 10.1016/S0197-4580(01)00250-0; Vorhees CV, 2007, BEHAV PHARMACOL, V18, P549, DOI 10.1097/FBP.0b013e3282ee2abe; Vorhees CV, 2000, J NEUROSCI, V20, P4732, DOI 10.1523/JNEUROSCI.20-12-04732.2000; VOYTKO ML, 1994, J NEUROSCI, V14, P167; WATSON M, 1986, J PHARMACOL EXP THER, V237, P419; WEISSMAN AD, 1993, SYNAPSE, V13, P241, DOI 10.1002/syn.890130307; Whiteaker P, 2000, BRIT J PHARMACOL, V131, P729, DOI 10.1038/sj.bjp.0703616; Wilhelm J, 2007, J PSYCHIATR RES, V41, P871, DOI 10.1016/j.jpsychires.2006.07.011; Williams MT, 2004, EUR J NEUROSCI, V19, P3165, DOI 10.1111/j.0953-816X.2004.03405.x; Williams MT, 2003, PSYCHOPHARMACOLOGY, V168, P329, DOI 10.1007/s00213-003-1433-y; Williams MT, 2003, SYNAPSE, V48, P138, DOI 10.1002/syn.10159; Williams MT, 2002, BRAIN RES, V958, P312, DOI 10.1016/S0006-8993(02)03620-X; Winzer-Serhan UH, 2008, FRONT BIOSCI-LANDMRK, V13, P636, DOI 10.2741/2708; Won L, 2002, SYNAPSE, V43, P139, DOI 10.1002/syn.10026; WON L, 1992, BRAIN RES, V575, P6, DOI 10.1016/0006-8993(92)90416-7	106	29	29	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	OCT	2010	21	7					602	614		10.1097/FBP.0b013e32833e7e44			13	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	650AG	WOS:000281817900002	20729719	Green Accepted			2021-06-18	
J	Walker, PA; Jimenez, F; Gerber, MH; Aroom, KR; Shah, SK; Harting, MT; Gill, BS; Savitz, SI; Cox, CS				Walker, Peter A.; Jimenez, Fernando; Gerber, Michael H.; Aroom, Kevin R.; Shah, Shinil K.; Harting, Matthew T.; Gill, Brijesh S.; Savitz, Sean I.; Cox, Charles S., Jr.			Effect of Needle Diameter and Flow Rate on Rat and Human Mesenchymal Stromal Cell Characterization and Viability	TISSUE ENGINEERING PART C-METHODS			English	Article							TRAUMATIC BRAIN-INJURY	Introduction: Current mesenchymal stromal cell (MSC) delivery methods require infusion/implantation through needles and/or catheters. Little investigation into the effect of delivery via catheter injection has been completed. We hypothesize that injection of rat and human MSCs through various clinically relevant-sized catheters and flow rates will not affect cell viability, characterization, or function. Methods: Both rat and human MSCs were injected through 20-, 25-, and 30-gauge needles, as well through an SL-10 microcatheter at rates of 60, 120, 240, and 500 mL/h. MSC viability and apoptotic fraction was measured. MSCs were characterized 24 h after injection with flow cytometric immunophenotyping, and multilineage differentiation was completed. Results: Catheter diameter or flow rate did not affect rat MSC viability. No clinically significant decrease in human MSC viability was observed immediately after injection; however, a delayed decrease in viability was observed at 24 h. No difference in the surface markers CD11b, CD45, CD29, CD49e, CD73, CD90, CD105, and Stro-1 or the capacity for multilineage differentiation (adipogenesis, osteogenesis, and chondrogenesis) was observed for either rat or human MSCs. Conclusion: The injection of human and rat MSCs through various clinically relevant catheters and flow rates did not have a clinically significant effect on viability immediately after injection, indicating compliance with recently published Food and Drug Administration guidelines (viability >70%). Further, no changes in cell characterization or function were observed via measurement of cell surface markers and the capacity for multilineage differentiation, respectively. These results ensure the biocompatibility of MSCs with commonly used delivery methods.	[Walker, Peter A.; Jimenez, Fernando; Aroom, Kevin R.; Shah, Shinil K.; Harting, Matthew T.; Gill, Brijesh S.; Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Walker, Peter A.; Gerber, Michael H.; Shah, Shinil K.; Gill, Brijesh S.; Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Dept Surg, Houston, TX 77030 USA; [Savitz, Sean I.] Univ Texas Med Sch Houston, Dept Neurol, Houston, TX 77030 USA	Cox, CS (corresponding author), Univ Texas Med Sch Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-236, Houston, TX 77030 USA.	charles.s.cox@uth.tmc.edu		Aroom, Kevin/0000-0003-1504-0585; Harting, Matthew/0000-0002-8929-8311	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM 08 79201, M01 RR 02558]; Texas Higher Education Coordinating Board; Children's Memorial Hermann Hospital Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	Supported by grants from NIH T32 GM 08 79201, M01 RR 02558, Texas Higher Education Coordinating Board, and Children's Memorial Hermann Hospital Foundation.	Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; *FDA, 2009, GUID FDA REV SPONS C; *FDA, 2009, DRAFT GUID IND SOM C; Fellous TG, 2007, DIABETES-METAB RES, V23, P87, DOI 10.1002/dmrr.692; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; LEVERETT LB, 1972, BIOPHYS J, V12, P257, DOI 10.1016/S0006-3495(72)86085-5; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Sharp MK, 1998, ANN BIOMED ENG, V26, P788, DOI 10.1114/1.65; SUTERA SP, 1977, CIRC RES, V41, P2, DOI 10.1161/01.RES.41.1.2; Tol M, 2008, CYTOTHERAPY, V10, P98, DOI 10.1080/14653240701762356; Truskey G. A., 2004, TRANSPORT PHENOMENA	16	29	29	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384			TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	OCT	2010	16	5					989	997		10.1089/ten.tec.2009.0423			9	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Cell Biology; Engineering; Materials Science	655DN	WOS:000282223800019	20001789	Green Published			2021-06-18	
J	Staniloiu, A; Markowitsch, HJ; Brand, M				Staniloiu, Angelica; Markowitsch, Hans J.; Brand, Matthias			Psychogenic amnesia - A malady of the constricted self	CONSCIOUSNESS AND COGNITION			English	Article						Dissociative amnesia; Inferolateral prefrontal cortex; Self-consciousness; Emotion; Autobiographical-episodic memory (AEM)	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PERSISTENT ANTEROGRADE AMNESIA; TEMPORAL-LOBE EPILEPSY; INFERIOR FRONTAL GYRUS; MENTAL TIME-TRAVEL; THEORY-OF-MIND; AUTOBIOGRAPHICAL MEMORY; EPISODIC MEMORY; RETROGRADE-AMNESIA	Autobiographical-episodic memory is the conjunction of subjective time. autonoetic consciousness and the experiencing self Understanding the neural correlates of autobiographical-episodic memory might therefore be essential for shedding light on the neurobiology underlying the experience of being an autonoetic self In this contribution we illustrate the intimate relationship between autobiographical-episodic memory and self by reviewing the clinical and neuropsychological features and brain functional imaging correlates of psychogenic amnesia - a condition that is usually characterized by severely impaired retrograde memory functioning, in absence of structural brain damage as detected by standard imaging We demonstrate that in this disorder the autobiographical-episodic memory deficits do not exist in isolation, but occur with impairments of the autonoetic self-consciousness, emotional processing, and theory of mind or executive functions Furthermore functional and metabolic brain alterations involving regions that are agreed upon to exert crucial roles in memory processes were frequently found to accompany the psychogenic memory "loss" (C) 2010 Elsevier Inc. All rights reserved.	[Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Alfried Krupp Inst Adv Study, Greifswald, Germany; [Brand, Matthias] Univ Duisburg Essen, Duisburg, Germany; [Brand, Matthias] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany	Staniloiu, A (corresponding author), Univ Bielefeld, POB 100131, D-33501 Bielefeld, Germany.		Brand, Matthias/B-1109-2011				Addis DR, 2010, CORTEX, V46, P425, DOI 10.1016/j.cortex.2009.04.011; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; ADLER G, 1981, AM J PSYCHIAT, V138, P46; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Allman JM, 2010, BRAIN STRUCT FUNCT, V214, P495, DOI 10.1007/s00429-010-0254-0; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Anterion CT, 2008, REV NEUROL-FRANCE, V164, P271, DOI 10.1016/j.neurol.2007.06.004; Arzy S, 2009, EUR J NEUROSCI, V30, P2009, DOI 10.1111/j.1460-9568.2009.06974.x; Augustine, 2001, CONFESSIONS; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bach I., 1998, COGNITIVE NEUROPSYCL, V3, P139, DOI [10.1080/135468098396215, DOI 10.1080/135468098396215]; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bass C, 2007, J ROY SOC MED, V100, P81, DOI 10.1258/jrsm.100.2.81; Batson CD, 1996, PERS SOC PSYCHOL B, V22, P474, DOI 10.1177/0146167296225005; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Becker-Blease KA, 2004, J CHILD PSYCHOL PSYC, V45, P522, DOI 10.1111/j.1469-7610.2004.00242.x; Bedny M, 2009, P NATL ACAD SCI USA, V106, P11312, DOI 10.1073/pnas.0900010106; Ben Shalom D, 2003, CORTEX, V39, P1129; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Boria S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005596; Borsci G, 2009, J AFFECT DISORDERS, V114, P208, DOI 10.1016/j.jad.2008.07.013; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P469; Brand M, 2003, PRINCIPLES OF LEARNING AND MEMORY, P171; BRAND M, 2009, FESTSCHRIFT HONOR LG, P229; Brand M, 2008, HBK BEHAV NEUROSCI, V18, P317, DOI 10.1016/S1569-7339(08)00218-X; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brandt J, 2006, SEMIN NEUROL, V26, P331, DOI 10.1055/s-2006-945519; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bright-Paul A, 2008, DEV PSYCHOL, V44, P1055, DOI 10.1037/0012-1649.44.4.1055; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; BUIE DH, 1981, J AM PSYCHOANAL ASS, V29, P281, DOI 10.1177/000306518102900201; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Burgl G., 1900, MUNCHEN MED WOCHEN, P1270; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Carlson EA, 1998, CHILD DEV, V69, P1107, DOI 10.1111/j.1467-8624.1998.tb06163.x; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Colvert E, 2008, J ABNORM CHILD PSYCH, V36, P1057, DOI 10.1007/s10802-008-9232-x; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Coons PM, 1992, DISSOCIATION, V5, P73; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Corballis MC, 2009, EXP BRAIN RES, V192, P553, DOI 10.1007/s00221-008-1491-9; Corcoran R, 2003, PSYCHOL MED, V33, P897, DOI 10.1017/S0033291703007529; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Dam~asio A., 1999, FEELING WHAT HAPPENS; Daniel R, 2010, J NEUROSCI, V30, P47, DOI 10.1523/JNEUROSCI.2205-09.2010; Darwin C., 2004, DESCENT MAN SELECTIO; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; DIFIORINO M, 2003, BRIDGING E W PSYCH, V1, P56; Donaldson W., 1972, ORG MEMORY, P381, DOI [DOI 10.1016/B978-0-12-809324-5.21037-7, DOI 10.1017/S0140525X00047257]; Dorahy M. J., 2007, TRAUMATIC DISSOCIATI, P55; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eliot T. S., 1969, COMPLETE POEMS PLAYS; Fink GR, 1996, J NEUROSCI, V16, P4275; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Freud Sigmund, 1901, MONATSSCHRIFT PSYCHI, V4, P436; FUJIWARA E, 2008, J NEUROSCI, V26, P10935; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Ganser, 1903, ARCH PSYCHIAT NERVEN, V38, P34, DOI 10.1007/BF02173461; Ganser SJ, 1898, ARCH PSYCHIATRIE NER, V30:, P633; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Glisky EL, 2004, NEUROPSYCHOLOGIA, V42, P1132, DOI 10.1016/j.neuropsychologia.2003.08.016; Govindan RM, 2010, CEREB CORTEX, V20, P561, DOI 10.1093/cercor/bhp122; GRASBY PM, 1994, BRAIN, V117, P1271, DOI 10.1093/brain/117.6.1271; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Hacking I., 1995, REWRITING SOUL MULTI; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Harpaz-Rotem I, 2005, MEMORY, V13, P51, DOI 10.1080/09658210344000567; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Henke K, 2003, NEUROREPORT, V14, P1197, DOI 10.1097/00001756-200307010-00002; Hennig-Fast K, 2008, NEUROPSYCHOLOGIA, V46, P2993, DOI 10.1016/j.neuropsychologia.2008.06.014; HERING E, 1895, MEMORY GENERAL FUNCT; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; HOWE ML, 1993, PSYCHOL BULL, V113, P305, DOI 10.1037/0033-2909.113.2.305; Huntjens RJC, 2005, CONSCIOUS COGN, V14, P377, DOI 10.1016/j.concog.2004.10.001; Hurlemann R, 2005, J NEUROSCI, V25, P6343, DOI 10.1523/JNEUROSCI.0228-05.2005; HYMAN IE, 1992, NATO ADV SCI INST SE, V65, P207; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Inoue Y, 2004, J AFFECT DISORDERS, V82, P403, DOI 10.1016/j.jad.2004.04.004; James W., 1950, PRINCIPLES PSYCHOL, V1; Janet P., 1907, MAJOR SYMPTOMS HYSTE, V2nd; Janet P., 1920, MAJOR SYMPTOMS HYSTE; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kanzer M, 1939, AM J PSYCHIAT, V96, P711, DOI 10.1176/ajp.96.3.711; Kapur N, 1997, BRAIN COGNITION, V35, P58, DOI 10.1006/brcg.1997.0927; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kessler J, 1997, J CLIN EXP NEUROPSYC, V19, P604, DOI 10.1080/01688639708403746; Klein SB, 2010, ANN NY ACAD SCI, V1191, P1, DOI 10.1111/j.1749-6632.2010.05441.x; Kleinman A., 1980, PATIENTS HEALERS CON, V3; Kobayashi C, 2007, BRAIN RES, V1164, P95, DOI 10.1016/j.brainres.2007.06.022; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Kopelman Michael D, 2008, Handb Clin Neurol, V88, P185, DOI 10.1016/S0072-9752(07)88008-0; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Krahn LE, 2008, PSYCHOSOMATICS, V49, P277, DOI 10.1176/appi.psy.49.4.277; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kuehnel S, 2008, BRAIN IMAGING BEHAV, V2, P163, DOI 10.1007/s11682-008-9026-3; Kumar S, 2007, PSYCHIAT CLIN NEUROS, V61, P583, DOI 10.1111/j.1440-1819.2007.01735.x; Kundera Milan, 1991, UNBEARABLE LIGHTNESS; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lanius RA, 2005, BIOL PSYCHIAT, V57, P873, DOI 10.1016/j.biopsych.2005.01.011; Lanius RA, 2003, AM J PSYCHIAT, V160, P667, DOI 10.1176/appi.ajp.160.4.667; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Lemogne C, 2009, MEMORY, V17, P1, DOI 10.1080/09658210802438466; Lennox WG, 1943, AM J PSYCHIAT, V99, P732, DOI 10.1176/ajp.99.5.732; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2009, NEUROPSYCHOLOGIA, V47, P2188, DOI 10.1016/j.neuropsychologia.2008.12.026; Lind SE, 2009, J AUTISM DEV DISORD, V39, P1231, DOI 10.1007/s10803-009-0735-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; LOEWENSTEIN RJ, 1991, AM PSYCHIATRIC PRESS, V10, P189; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Luria A. R., 1987, MIND MNEMONIST LITTL; Maldonado J.R., 2008, AM PSYCHIAT PUBLISHI, P665; Maldonado JR, 2002, J TRAUMA STRESS, V15, P401, DOI 10.1023/A:1020137409097; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch H.J., 1992, INTELLECTUAL FUNCTIO; Markowitsch H. J., 2010, DEV AUTOBIOGRAPHICAL; Markowitsch HJ, 2010, CURR ISS MEM, P23; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; Markowitsch HJ, 1999, CORTEX, V35, P243, DOI 10.1016/S0010-9452(08)70797-4; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 1999, NEUROCASE, V5, P189, DOI 10.1093/neucas/5.3.189; Markowitsch HJ, 1999, CORTEX, V35, P219, DOI 10.1016/S0010-9452(08)70795-0; Markowitsch HJ, 1997, NEUROCASE, V3, P445, DOI 10.1080/13554799708405020; MARKOWITSCH HJ, 1988, BRAIN RES REV, V13, P351, DOI 10.1016/0165-0173(88)90012-4; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P627, DOI 10.1080/01688639308402586; MARKOWITSCH HJ, 1984, CORTEX, V20, P27, DOI 10.1016/S0010-9452(84)80021-0; Markowitsch HJ, 2003, SELF IN NEUROSCIENCE AND PSYCHIATRY, P180, DOI 10.1017/CBO9780511543708.010; Markowitsch HJ, 2003, CORTEX, V39, P643, DOI 10.1016/S0010-9452(08)70858-X; MARKOWITSCH HJ, 1985, J COMP NEUROL, V242, P425, DOI 10.1002/cne.902420310; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; MARKOWITSCH HJ, 1994, NEUROREPORT, V5, P1349, DOI 10.1097/00001756-199406270-00013; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; MARKOWITSCH HJ, 1990, CORTEX, V26, P597, DOI 10.1016/S0010-9452(13)80309-7; MARKOWITSCH HJ, 1994, TRENDS NEUROSCI, V17, P513, DOI 10.1016/0166-2236(94)90150-3; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; Markowitsch HJ, 1999, MEMORY, V7, P561, DOI 10.1080/096582199387751; Markowitsch HJ, 1999, CURR OPIN PSYCHIATR, V12, P331, DOI 10.1097/00001504-199905000-00014; MARKOWITSCH HJ, 2005, ENDOPHYSICS TIME QUA, P131; MARKOWITSCH HJ, 2000, OXFORD HDB MEMORY, P465; Masson J, 1985, COMPLETE LETT S FREU; Mattila AK, 2009, PSYCHOSOMATICS, V50, P59, DOI 10.1176/appi.psy.50.1.59; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; McCullough JP., 2000, TREATMENT CHRONIC DE; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McKay GCM, 2009, ADV PSYCHIAT TREAT, V15, P152, DOI DOI 10.1192/APT.BP.105.001586; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Mishkin M., 1984, NE UR OPS YCHOL MEMO, P287; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mitchell S. A., 1995, FREUD HIST MODERN PS; Modell AH, 2006, IMAGINATION MEANINGF; Modestin J, 2002, PSYCHOL PSYCHOTHER-T, V75, P53, DOI 10.1348/147608302169544; Mondadori CRA, 2006, BRAIN, V129, P2908, DOI 10.1093/brain/awl266; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moriguchi Y, 2009, HUM BRAIN MAPP, V30, P2063, DOI 10.1002/hbm.20653; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Morin A, 2009, CONSCIOUS COGN, V18, P524, DOI 10.1016/j.concog.2008.09.008; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nelson K, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P3; Nelson K., 2005, ORIGINS SOCIAL MIND, P319; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Newen A, 2003, CONSCIOUS COGN, V12, P529, DOI 10.1016/S1053-8100(03)00080-1; Newen A, 2009, GRAZER PHILOS STUDIE, V79, P209; NIEUWENHUYS R, 1978, HUMAN CENTRAL NERVOU; OBrien JT, 1997, BRIT J PSYCHIAT, V170, P199; OConnor M, 1997, BRAIN COGNITION, V35, P71, DOI 10.1006/brcg.1997.0928; Oddo S, 2010, CORTEX, V46, P29, DOI 10.1016/j.cortex.2008.07.003; Ouellet J, 2008, BEHAV NEUROL, V20, P27, DOI [10.3233/BEN-2008-0213, 10.1155/2008/520328]; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Pearce JMS, 2007, EUR NEUROL, V57, P126, DOI 10.1159/000098103; Peigneux P, 2010, CURR ISS MEM, P165; Perner J, 2001, SELF IN TIME: DEVELOPMENTAL PERSPECTIVES, P181; Perner J., 2000, OXFORD HDB MEMORY, P297; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pfeifer J. H., 2010, DEV SOCIAL COGNITIVE, P141; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Plaza M, 2009, NEUROCASE, V15, P294, DOI 10.1080/13554790902729473; Post RM, 1995, ANN NY ACAD SCI, V771, P677, DOI 10.1111/j.1749-6632.1995.tb44720.x; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.1111/j.1467-8624.1996.tb01813.x; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Putnam F.W., 1997, DISSOCIATION CHILDRE; Rabin JS, 2010, J COGNITIVE NEUROSCI, V22, P1095, DOI 10.1162/jocn.2009.21344; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106; Rathbone CJ, 2009, NEUROCASE, V15, P405, DOI 10.1080/13554790902849164; Ray RD, 2010, SOC COGN AFFECT NEUR, V5, P318, DOI 10.1093/scan/nsp039; Reinhold N, 2006, CURR MED IMAGING, V2, P35, DOI 10.2174/157340506775541668; REINHOLD N, 2008, COMMUNICATION; Reinhold N, 2007, J NEUROPSYCHOL, V1, P53, DOI 10.1348/174866407X180819; Rinne T., 2007, TRAUMATIC DISSOCIATI, P139; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014; Romei V, 2008, PSYCHOTHER PSYCHOSOM, V77, P175, DOI 10.1159/000119737; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rosenbaum RS, 2007, SCIENCE, V318, P1257, DOI 10.1126/science.1148763; Rosenbaum RS, 2009, NEUROPSYCHOLOGIA, V47, P2181, DOI 10.1016/j.neuropsychologia.2008.11.028; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schneider K, 1912, Z GESAMTE NEUROL PSY, V8, P553, DOI 10.1007/BF02866053; Schneider K., 1928, HDB GEISTESKRANKHEIT, V1, P508; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Seeley WW, 2008, CURR OPIN NEUROL, V21, P701, DOI 10.1097/WCO.0b013e3283168e2d; Seligman R, 2008, CULT MED PSYCHIAT, V32, P31, DOI 10.1007/s11013-007-9077-8; SEMON R, 1904, MNEME ERTHALTENDES P; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Serra L, 2007, BEHAV NEUROL, V18, P53, DOI 10.1155/2007/193140; Shamay-Tsoory S, 2009, J NEUROPSYCH CLIN N, V21, P59, DOI 10.1176/appi.neuropsych.21.1.59; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shaw P, 2004, BRAIN, V127, P1535, DOI 10.1093/brain/awh168; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; SIEGEL DJ, 2004, J AM ACAD CHILD ADOL, V40, P997; SMITH CN, 2010, NEUROPSYCHOLOGIA; Spiegel D, 2006, AM J PSYCHIAT, V163, P566, DOI 10.1176/appi.ajp.163.4.566; Spitzer C, 2008, BUNDESGESUNDHEITSBLA, V51, P46, DOI 10.1007/s00103-008-0418-8; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; St Jacques PL, 2009, J INT NEUROPSYCH SOC, V15, P819, DOI 10.1017/S1355617709990439; Staniloiu A., 2010, ASCS09, P316; STANILOIU A, J PSYCHOL IN PRESS; Staniloiu A, 2010, BEHAV BRAIN SCI, V33, P170, DOI 10.1017/S0140525X10000804; Staniloiu Angelica, 2009, Cogn Neuropsychiatry, V14, P180, DOI 10.1080/13546800902931036; STEINBERG M, 2000, COMPREHENSIVE TXB PS, P1544; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Thomas-Anterion C, 2010, J NEUROL NEUROSUR PS, V81, P468, DOI 10.1136/jnnp.2008.163808; Tomasello M, 2008, JEAN NICOD LECT, P1; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; Tranel D, 2009, NEUROCASE, V15, P217, DOI 10.1080/13554790902775492; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E, 1983, ELEMENTS EPISODIC ME; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [DOI 10.1093/ACPROF:OSO/9780195161564.003.0001, 10.1093/acprof:oso/9780195161564.003.0001]; Tulving E, 2007, BEHAV BRAIN SCI, V30, P334, DOI 10.1017/S0140525X07002208; Tulving Endel, 1995, P839; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valentino K, 2009, J CHILD PSYCHOL PSYC, V50, P1029, DOI 10.1111/j.1469-7610.2009.02072.x; van der Hart O, 2001, AUST NZ J PSYCHIAT, V35, P589; Van der Hart O, 2006, AM J PSYCHIAT, V163, P1646, DOI 10.1176/appi.ajp.163.9.1646-a; Vann SD, 2009, BRAIN, V132, P2372, DOI 10.1093/brain/awp175; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VERCAMMEN A, 2010, SCHIZOPHRENIA B, V8, P4; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vogeley K, 2007, SCHIZOPHRENIA BULL, V33, P157, DOI 10.1093/schbul/sbl056; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang F, 2009, BIOL PSYCHIAT, V66, P516, DOI 10.1016/j.biopsych.2009.03.023; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; WelchRoss MK, 1997, DEV PSYCHOL, V33, P43, DOI 10.1037/0012-1649.33.1.43; Welzer H, 2005, MEMORY, V13, P63, DOI 10.1080/09658210344000576; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; *WHO, 1992, CLASS MENT BEH DIS C; WILLIAMS JMG, 1988, PSYCHOL MED, V18, P689, DOI 10.1017/S0033291700008370; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wood H, 2003, NAT REV NEUROSCI, V4, P774; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Yehuda R, 1997, J TRAUMA STRESS, V10, P453, DOI 10.1023/A:1024845422065; Zanarini MC, 2008, ACTA PSYCHIAT SCAND, V118, P291, DOI 10.1111/j.1600-0447.2008.01247.x	309	29	29	0	37	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	SEP	2010	19	3			SI		778	801		10.1016/j.concog.2010.06.024			24	Psychology, Experimental	Psychology	660FM	WOS:000282625500010	20655759				2021-06-18	
J	Wu, HT; Mahmood, A; Lu, DY; Jiang, H; Xiong, Y; Zhou, D; Chopp, M				Wu, Hongtao; Mahmood, Asim; Lu, Dunyue; Jiang, Hao; Xiong, Ye; Zhou, Dong; Chopp, Michael			Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						simvastatin; epidermal growth factor receptor; lipid raft; astrocyte; traumatic brain injury	PROSTATE-CANCER CELLS; SPINAL-CORD-INJURY; REACTIVE ASTROCYTES; NEURAL INJURY; ACTIVATION; RATS; ATORVASTATIN; NEUROPROTECTION; NEUROGENESIS; MICRODOMAINS	Object. The authors' previous studies have demonstrated that simvastatin treatment promotes neuronal survival and reduces inflammatory cytokine release from astrocytes after traumatic brain injury (TBI) in rats. Since reactive astrocytes produce inflammation mediators, in the current study the authors investigated the effect of simvastatin on astrocyte activation after TBI and its underlying signaling mechanisms. Methods. Saline or simvastatin (1 mg/kg) was orally administered to rats starting at Day 1 after TBI and then daily for 14 days. Rats were killed at 1, 3, 7, and 14 days after treatment. Brain sections and tissues were prepared for immunohistochemical staining and Western blot analysis, respectively. Cultured astrocytes were subjected to oxygen-glucose deprivation (OGD) and followed by immunocytochemical staining with glial fibrillary acidic protein/caveolin-1 and Western blot analysis. Lipid rafts were isolated from the cell lysate and Western blotting was carried out to detect the changes in epidermal growth factor receptor (EGFR) expression and phosphorylation in the lipid rafts. Results. Simvastatin significantly promoted neuronal survival after TBI and attenuated activation of astrocytes. Simvastatin modified the caveolin-1 expression in lipid rafts in astrocyte cell membrane, suppressed the phosphorylation of EGFR in lipid rafts of astrocytes after OGD, and inhibited the OGD-induced interleukin-1 production. Conclusions. These data suggest that simvastatin reduces reactive astrogliosis and rescues neuronal cells after TBI. These beneficial effects of simvastatin may be mediated by inhibiting astrocyte activation after TBI through modifying the caveolin-1 expression in lipid rafts and the subsequent modulation of EGFR phosphorylation in lipid rafts. (DOI: 10.3171/2009.9.JNS09859)	[Jiang, Hao; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Wu, Hongtao; Mahmood, Asim; Lu, Dunyue; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Wu, Hongtao; Zhou, Dong] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Chopp, M (corresponding author), Henry Ford Hosp, Dept Neurol, E&R Bldg 3056,2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu	Wu, Hongtao/A-8602-2011	Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS052280-01A1, PO1NS23345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052280, R01NS023345] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant Nos. R01NS052280-01A1 (to Asim Mahmood, M.D., primary investigator) and PO1NS23345 (to Michael Chopp, Ph.D., primary investigator).	Arnbrosini A, 2005, J NEUROSCI METH, V144, P183, DOI 10.1016/j.jbeumeth.2004.11.002; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Freeman MR, 2007, STEROIDS, V72, P210, DOI 10.1016/j.steroids.2006.11.012; Jin KL, 2002, J NEUROSCI, V22, P5365; JUNIER MP, 1993, J NEUROSCI, V13, P703; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Liu B, 2004, GLIA, V46, P153, DOI 10.1002/glia.10358; Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Oh HY, 2007, PROSTATE, V67, P1061, DOI 10.1002/pros.20593; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Ushio-Fukai M, 2001, J BIOL CHEM, V276, P48269, DOI 10.1074/jbc.M105901200; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zhuang LY, 2005, J CLIN INVEST, V115, P959	29	29	30	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2010	113	3					591	597		10.3171/2009.9.JNS09859			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	641FV	WOS:000281111100024	19895202	Green Accepted			2021-06-18	
J	Ibrahim, NG; Margulies, SS				Ibrahim, Nicole G.; Margulies, Susan S.			Biomechanics of the toddler head during low-height falls: an anthropomorphic dummy analysis Laboratory investigation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						anthropomorphic surrogate; low-height fall; toddler; head impact; pediatric head injury	PEDIATRIC INJURY RISK; SHORT-DISTANCE FALLS; FETAL CRANIAL BONE; CHILDHOOD FALLS; CERVICAL-SPINE; INFANT SKULL; BRAIN-INJURY; CHILDREN; CONCUSSION; IMPACTS	Object. Falls are the most common environmental setting for closed head injuries in children between 2 and 4 years of age. The authors previously found that toddlers had fewer skull fractures and scalp/facial soft-tissue injuries, and more frequent altered mental status than infants for the same low-height falls (<= 3 ft). Methods. To identify potential age-dependent mechanical load factors that may be responsible for these clinical findings, the authors created an instrumented dummy representing an 18-month-old child using published toddler anthropometry and mechanical properties of the skull and neck, and they measured peak angular acceleration during low-height falls (1,2, and 3 ft) onto carpet pad and concrete. They compared these results from occiput-first impacts to previously obtained values measured in a 6-week-old infant dummy. Results. Peak angular acceleration of the toddler dummy head was largest in the sagittal and horizontal directions and increased significantly (around 2-fold) with fall height between I and 2 ft. Impacts onto concrete produced larger peak angular accelerations and smaller impact durations than those onto carpet pad. When compared with previously measured infant drops, toddler head accelerations were more than double those of the infant from the same height onto the same surface, likely contributing to the higher incidence of loss of consciousness reported in toddlers. Furthermore, the toddler impact forces were larger than those in the infant, but because of the thicker toddler skull, the risk of skull fracture from low-height falls is likely lower in toddlers compared with infants. Conclusions. If similar fracture limits and brain tissue injury thresholds between infants and toddlers are assumed, it is expected that for impact events, the toddler is likely less vulnerable to skull fracture but more vulnerable to neurological impairment compared with the infant. (DOI: 10.3171/2010.3.PEDS09357)	[Ibrahim, Nicole G.; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, R01NS039679] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32-NS-043126, R01-NS-39679] Funding Source: Medline		ADELOYE A, 1975, AM J PHYS ANTHROPOL, V43, P23, DOI 10.1002/ajpa.1330430105; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; AISENSON MR, 1950, PEDIATRICS, V6, P223; ANDERSON RN, 2004, DEATHS INJURIES 2001, V52; BAGNALL KM, 1977, J ANAT, V124, P791; BAGNALL KM, 1977, J ANAT, V123, P777; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Chang LT, 2007, J TRAUMA, V63, P70, DOI 10.1097/01.ta.0000219142.15584.b8; Coats B., 2007, THESIS U PENNSYLVANI; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Deemer E, 2005, MED ENG PHYS, V27, P31, DOI 10.1016/j.medengphy.2004.09.005; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Demetriades D, 2005, J TRAUMA, V58, P342, DOI 10.1097/01.TA.0000135161.44100.D8; Egan J. P., 1975, SIGNAL DETECTION THE; Emily Sun R.S, 1998, DEV IMPROVED INJURY; EPPINGER R, 2000, DEV IMPROVED INJURY; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hennrikus WL, 2003, CLIN ORTHOP RELAT R, P148, DOI 10.1097/01.blo.0000043059.62337.97; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; HUBBARD RP, 1971, J BIOMECH, V4, P491, DOI 10.1016/0021-9290(71)90039-X; IBRAHIM NG, 2009, THESIS U PENNSYLVANI; Irwin AL, 1997, P 41 STAPP CAR CRASH; Johnson K, 2005, CLIN RADIOL, V60, P464, DOI 10.1016/j.crad.2004.09.013; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; Kapoor T, 2008, ACCIDENT ANAL PREV, V40, P1880, DOI 10.1016/j.aap.2008.07.008; Kim K A, 2000, Neurosurg Focus, V8, pe3; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; KRIEWALL TJ, 1981, J BIOMECH, V14, P73, DOI 10.1016/0021-9290(81)90166-4; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; LEHMAN D, 1993, PEDIATRICS, V92, P121; LEVENE S, 1991, ARCH DIS CHILD, V66, P1047, DOI 10.1136/adc.66.9.1047; LYONS TJ, 1993, PEDIATRICS, V92, P125; Macgregor D M, 2000, Inj Prev, V6, P291, DOI 10.1136/ip.6.4.291; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Murray JA, 2000, AM SURGEON, V66, P863; *NHTSA, 2000, NHTSA PUBL; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Nuckley DJ, 2006, J BIOMECH, V39, P3045, DOI 10.1016/j.jbiomech.2005.10.014; Nuckley DJ, 2004, BONE, V35, P720, DOI 10.1016/j.bone.2004.04.015; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; Oehmichen M, 2005, NEUROPEDIATRICS, V36, P240, DOI 10.1055/s-2005-872812; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1966, P 10 STAPP CAR CRASH, P191; OMMAYA AK, 1967, P 11 STAPP CAR CRASH, P73; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Phelan KJ, 2001, AMBUL PEDIATR, V1, P227, DOI 10.1367/1539-4409(2001)001<0227:TAPOPI>2.0.CO;2; Pincemaille Y., 1988, INVESTIGATION RELATI; Pintar F A, 2000, Stapp Car Crash J, V44, P77; Pitone ML, 2006, PEDIATR EMERG CARE, V22, P470, DOI 10.1097/01.pec.0000226869.41803.50; PRANGE M, 2002, THESIS U PENNSYLVANI; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Reed MP, 2009, ACCIDENT ANAL PREV, V41, P598, DOI 10.1016/j.aap.2009.02.009; RIVARA FP, 1993, PEDIATRICS, V92, P61; ROOT I, 1992, AM J FOREN MED PATH, V13, P85, DOI 10.1097/00000433-199203000-00017; Sances A, 2000, CRIT REV BIOMED ENG, V28, P213; Schneider Lawrence, 1986, SIZE SHAPE HEAD NECK; Sherwood C P, 2003, Traffic Inj Prev, V4, P206, DOI 10.1080/15389580309885; Smith GA, 1996, PEDIATRICS, V97, P161; Snyder R. G., 1977, ANTHROPOMETRY INFANT; Timoshenko S., 1940, THEORY PLATES SHELLS; Vilke GM, 2004, PEDIATR EMERG CARE, V20, P660, DOI 10.1097/01.pec.0000142949.81135.3d; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; ZITELLI BJ, 1992, ATLAS PEDIAT PHYS DI	78	29	29	1	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2010	6	1					57	68		10.3171/2010.3.PEDS09357			12	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	615BV	WOS:000279107100010	20593989				2021-06-18	
J	Jia, F; Pan, YH; Mao, Q; Liang, YM; Jiang, JY				Jia, Feng; Pan, Yao-hua; Mao, Qing; Liang, Yu-min; Jiang, Ji-yao			Matrix Metalloproteinase-9 Expression and Protein Levels after Fluid Percussion Injury in Rats: The Effect of Injury Severity and Brain Temperature	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; matrix metalloproteinase-9; mild hypothermia; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; INTRACEREBRAL HEMORRHAGE; POSTTRAUMATIC HYPOTHERMIA; MATRIX METALLOPROTEINASES; THERAPEUTIC HYPOTHERMIA; HOUSEKEEPING GENES; MILD HYPOTHERMIA; NEURONAL DEATH; CELL-DEATH; MECHANISMS	The temporal and regional expression profiles of matrix metalloproteinase-9 (MMP-9), after moderate or severe traumatic brain injury (TBI) were measured to investigate the effects of post-traumatic hypothermia (33 degrees C) or hyperthermia (39 degrees C). In the first phase of this study, adult male Sprague-Dawley rats were randomly assigned to groups of moderate TBI (1.8-2.2 atm), severe TBI (2.4-2.7 atm), and sham-injured control. The rats were killed at 4, 6, 12, 24, 48, and 72 h, or 1 week after TBI, for mRNA and protein analysis. In the second phase, rats underwent moderate fluid percussion brain injury, followed immediately by 4 h of post-traumatic normothermia (37 degrees C), hyperthermia (39 degrees C), or hypothermia (32 degrees C). The rats were killed at 12 and 48 h after TBI for mRNA expression analyses, or killed at 24 and 72 h after TBI for protein expression analyses. Brain samples, including the cerebral cortex and hippocampus (both ipsilateral and contralateral hemispheres of each group), were assayed using RT-PCR and Western blot techniques. MMP-9 levels in both the ipsilateral and contralateral hemispheres were significantly increased after TBI compared with those of sham injured animals (p < 0.01). Two expression peaks of MMP-9 were observed in the ipsilateral cortex and hippocampus. An increase in injury severity was associated with an increase in mRNA (12 and 48 h), and protein (24 and 72 h) levels of MMP-9. Posttraumatic hypothermia attenuated the increase in both the mRNA and protein levels of MMP-9, compared with normothermia and hyperthermia (p < 0.01). In contrast, hyperthermia had no significant effect on mRNA (at 12 h) and protein levels (at 24 h) of MMP-9, compared with normothermic values (p > 0.05), but resulted in a significant increase in the levels of MMP-9 mRNA and protein at 24 and 72 h, respectively (p < 0.01). Increases in MMP-9 mRNA and protein after TBI were proportional to injury severity in this model. The effects of post-traumatic hypothermia on the expression of MMP-9 may partially explain the observed effects of post-traumatic temperature on secondary injury after TBI.	[Jia, Feng; Pan, Yao-hua; Mao, Qing; Liang, Yu-min; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Jia, Feng] Jiangsu Univ, Affiliated Hosp, Yixing Peoples Hosp, Dept Neurosurg, Yixing City, Jiangsu, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	jiangjyb@online.sh.cn					Aswal APS, 2008, ANIM REPROD SCI, V103, P164, DOI 10.1016/j.anireprosci.2007.04.012; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Burk J, 2008, BRAIN RES, V1226, P248, DOI 10.1016/j.brainres.2008.06.015; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Jia F, 2009, J NEUROTRAUMA; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; JIANG C, 2009, INFLAMM RES     0409; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; JOHANSEN KS, 1983, ACTA PATH MICRO IM C, V91, P355; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203; Noble LJ, 2002, J NEUROSCI, V22, P7526; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; UTOH J, 1992, ARTIF ORGANS, V16, P377; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wallace JA, 2002, J CEREBR BLOOD F MET, V22, P1303, DOI 10.1097/01.WCB.0000040943.89393.c1; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whalen MJ, 1997, ACT NEUR S, V70, P260; Yamashita A, 2007, ARCH HISTOL CYTOL, V70, P197, DOI 10.1679/aohc.70.197; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	52	29	31	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					1059	1068		10.1089/neu.2009.1067			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300009	20233042				2021-06-18	
J	Mellergard, P; Sjogren, F; Hillman, J				Mellergard, Pekka; Sjogren, Florence; Hillman, Jan			Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Intensive care; microdialysis; monitoring; VEGF; FGF2; subarachnoidal hemorrhage; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; NEUROSURGICAL INTENSIVE-CARE; BRAIN-INJURY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; INTRACEREBRAL MICRODIALYSIS; CYTOKINE EXPRESSION; INFLAMMATION; RECOVERY; ANGIOGENESIS	Microdialysate fluid from 145 severely injured NSICU-patients, 88 with subarachnoidal haemorrage (SAH), and 57 with traumatic brain injury (TBI), was collected by microdialysis during the first 7 days following impact, and levels of the neurotrophins fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (VEGF) were analysed. The study illustrates both similarities and differences in the reaction patterns of the 2 inflammatory proteins. The highest concentrations of both FGF2 and VEGF were measured on Day 2 (mean (+/- SE) values being 47.1 +/- 15.33 and 116.9 +/- 41.85 pg/ml, respectively, in the pooled patient material). The VEGF concentration was significantly higher in TBI-patients, while the FGF2 showed a tendency to be higher in SAH-patients. This is the first report presenting in some detail the human cerebral response of FGF2 and VEGF following SAH and TBI. Apart from increasing the understanding of the post-impact inflammatory response of the human brain, the study identifies potential threshold values for these chemokines that may serve as monitoring indicators in the NSICU.	[Mellergard, Pekka; Hillman, Jan] Linkoping Univ Hosp, Dept Neurosurg, S-58185 Linkoping, Sweden; [Sjogren, Florence] Linkoping Univ Hosp, Dept Dermatol, S-58185 Linkoping, Sweden	Mellergard, P (corresponding author), Linkoping Univ Hosp, Dept Neurosurg, S-58185 Linkoping, Sweden.	pekka.mellergard@lio.se					Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Croll SD, 2004, ADV EXP MED BIOL, V548, P57; Fulwyler M J, 1990, Methods Cell Biol, V33, P613; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Johansson A, 2003, NEUROREPORT, V14, P1867, DOI 10.1097/00001756-200310060-00022; KEMENY DM, 1992, J IMMUNOL METHODS, V150, P57, DOI 10.1016/0022-1759(92)90065-2; Kriz Jasna, 2006, Critical Reviews in Neurobiology, V18, P145; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; Mellergard P, 2008, NEUROSURGERY, V62, P151, DOI 10.1227/01.NEU.0000311072.33615.3A; Minami M, 2006, J PHARMACOL SCI, V100, P461, DOI 10.1254/jphs.CRJ06005X; Monfils MH, 2005, NEUROSCIENCE, V134, P1, DOI 10.1016/j.neuroscience.2005.04.006; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Ornitz DM, 2001, GENOME BIOL, V2; Peles E, 2004, NEUROSURGERY, V55, P562, DOI 10.1227/01.NEU.0000134383.27713.9A; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Skold MK, 2008, CURR NEUROVASC RES, V5, P246, DOI 10.2174/156720208786413451; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Sturnegk P, 2007, BRIT J NEUROSURG, V21, P332, DOI 10.1080/02688690701411574; Suzuki R, 2003, ACTA NEUROCHIR SUPPL, V86, P277; Waelgaard L, 2006, SCAND J IMMUNOL, V64, P345, DOI 10.1111/j.1365-3083.2006.01826.x; Weickert CS, 2005, NEUROSCIENCE, V131, P219, DOI 10.1016/j.neuroscience.2004.09.070; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	41	29	29	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2010	24	3					261	267		10.3109/02688690903521605			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	625OR	WOS:000279905200007	20465454				2021-06-18	
J	Pollonini, L; Pophale, S; Situ, N; Wu, MH; Frye, RE; Leon-Carrion, J; Zouridakis, G				Pollonini, Luca; Pophale, Swaroop; Situ, Ning; Wu, Meng-Hung; Frye, Richard E.; Leon-Carrion, Jose; Zouridakis, George			Information Communication Networks in Severe Traumatic Brain Injury	BRAIN TOPOGRAPHY			English	Article; Proceedings Paper	Workshop on Cortical Network Analysis with Neuroelectromagnetic and Hemodynamic Signals	MAY, 2009	Univ Rome Sapienza, Rome, ITALY		Univ Rome Sapienza	Severe neurocognitive disorder; Minimally conscious state; Vegetative state; Granger causality; Functional connectivity analysis		In this study we explored the use of coherence and Granger causality (GC) to separate patients in minimally conscious state (MCS) from patients with severe neurocognitive disorders (SND) that show signs of awareness. We studied 16 patients, 7 MCS and 9 SND with age between 18 and 49 years. Three minutes of ongoing electroencephalographic (EEG) activity was obtained at rest from 19 standard scalp locations, while subjects were alert but kept their eyes closed. GC was formulated in terms of linear autoregressive models that predict the evolution of several EEG time series, each representing the activity of one channel. The entire network of causally connected brain areas can be summarized as a graph of incompletely connected nodes. The 19 channels were grouped into five gross anatomical regions, frontal, left and right temporal, central, and parieto-occipital, while data analysis was performed separately in each of the five classical EEG frequency bands, namely delta, theta, alpha, beta, and gamma. Our results showed that the SND group consistently formed a larger number of connections compared to the MCS group in all frequency bands. Additionally, the number of connections in the delta band (0.1-4 Hz) between the left temporal and parieto-occipital areas was significantly different (P < 0.1%) in the two groups. Furthermore, in the beta band (12-18 Hz), the input to the frontal areas from all other cortical areas was also significantly different (P < 0.1%) in the two groups. Finally, classification of the subjects into distinct groups using as features the number of connections within and between regions in all frequency bands resulted in 100% classification accuracy of all subjects. The results of this study suggest that analysis of brain connectivity networks based on GC can be a highly accurate approach for classifying subjects affected by severe traumatic brain injury.	[Pollonini, Luca; Pophale, Swaroop; Situ, Ning; Wu, Meng-Hung; Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Engn Technol, Houston, TX 77204 USA; [Pollonini, Luca; Pophale, Swaroop; Situ, Ning; Wu, Meng-Hung; Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Comp Sci, Houston, TX 77204 USA; [Pollonini, Luca; Pophale, Swaroop; Situ, Ning; Wu, Meng-Hung; Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Elect & Comp Engn, Houston, TX 77204 USA; [Frye, Richard E.] Univ Texas Hlth Sci Ctr, Dept Pediat, Div Child & Adolescent Neurol, Houston, TX USA; [Frye, Richard E.] Univ Texas Hlth Sci Ctr, Childrens Learning Inst, Houston, TX USA; [Leon-Carrion, Jose] Univ Seville, Human Neuropsychol Lab, Seville, Spain; [Leon-Carrion, Jose] Ctr Brain Injury Rehabil CRECER, Seville, Spain	Zouridakis, G (corresponding author), Univ Houston, Biomed Imaging Lab, Dept Engn Technol, 218 Philip G Hoffman Hall, Houston, TX 77204 USA.	zouridakis@uh.edu	Frye, Richard/AAB-5543-2020; Zouridakis, George/R-8876-2019; Pollonini, Luca/J-9274-2014	Zouridakis, George/0000-0002-7770-9857; Pollonini, Luca/0000-0003-2955-6355			Box G.E.P., 2008, TIME SERIES ANAL FOR; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; FALLANI FD, J BIFURCAT IN PRESS; FRYE RE, 2007, SOC NEUR M SAN DIEG; FRYE RE, 2009, COMPARISON IN PRESS; FRYE RE, 2007, P WSEAS INT C COMP C; Gonzalez R. C., 1977, DIGITAL IMAGE PROCES; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; POPHALE S, 2008, THESIS U HOUSTON; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81	19	29	29	0	9	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0896-0267	1573-6792		BRAIN TOPOGR	Brain Topogr.	JUN	2010	23	2			SI		221	226		10.1007/s10548-010-0139-9			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	599TI	WOS:000277935900015	20224956				2021-06-18	
J	Piland, SG; Ferrara, MS; Macciocchi, SN; Broglio, SP; Gould, TE				Piland, Scott G.; Ferrara, Michael S.; Macciocchi, Stephen N.; Broglio, Steven P.; Gould, Trenton E.			Investigation of Baseline Self-Report Concussion Symptom Scores	JOURNAL OF ATHLETIC TRAINING			English	Article						baseline evaluation; factorial validity; Postconcussion Symptom Scale	POSTCONCUSSION-LIKE SYMPTOMS; COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; CEREBRAL CONCUSSION; SPORTS; MANAGEMENT; STATEMENT; VALIDITY; RETURN	Context: Self-reported symptoms (SRS) scales comprise one aspect of a multifaceted assessment of sport-related concussion. Obtaining SRS assessments before a concussion occurs assists in determining when the injury is resolved. However, athletes may present with concussion-related symptoms at baseline. Thus, it is important to evaluate such reports to determine if the variables that are common to many athletic environments are influencing them. Objective: To evaluate the influence of a history of concussion, sex, acute fatigue, physical illness, and orthopaedic injury on baseline responses to 2 summative symptom scales; to investigate the psychometric properties of all responses; and to assess the factorial validity of responses to both scales in the absence of influential variables. Design: Cross-sectional study. Setting: Athletic training facilities of 6 National Collegiate Athletic Association institutions. Patients or Other Participants: The sample of 1065 was predominately male (n = 805) collegiate athletes with a mean age of 19.81 +/- 1.53 years. Main Outcome Measure(s): Participants completed baseline measures for duration and severity of concussion-related SRS and a brief health questionnaire. Results: At baseline, respondents reporting a previous concussion had higher composite scores on both scales (P <= .01), but no sex differences were found for concussion-related symptoms. Acute fatigue, physical illness, and orthopaedic injury increased composite SRS scores on both duration and severity measures (P <= .01). Responses to both scales were stable and internally consistent. Confirmatory factor analysis provided strong evidence for the factorial validity of the responses of participants reporting no fatigue, physical illness, or orthopaedic injury on each instrument. Conclusions: A history of concussion, acute fatigue, physical illness, and orthopaedic injury increased baseline SRS scores. These conditions need to be thoroughly investigated and controlled by clinicians before baseline SRS measures are collected.	[Piland, Scott G.; Gould, Trenton E.] Univ So Mississippi, Hattiesburg, MS 39406 USA; [Ferrara, Michael S.] Univ Georgia, Athens, GA 30602 USA; [Macciocchi, Stephen N.] Shepherd Spinal Inst, Atlanta, GA USA; [Broglio, Steven P.] Univ Illinois, Champaign, IL 61820 USA	Piland, SG (corresponding author), Univ So Mississippi, 118 Coll Dr,Box 5142, Hattiesburg, MS 39406 USA.	scott.piland@usm.edu			National Athletic Trainers' Association Research & Education Foundation [303DGP0007]; Department of Kinesiology, The University of Georgia	This project was funded by a National Athletic Trainers' Association Research & Education Foundation Doctoral Dissertation Grant (303DGP0007) and the Kindig Research Award from the Department of Kinesiology, The University of Georgia.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bollen K.A., 1989, STRUCTURAL EQUATIONS, P514, DOI 10.1002/9781118619179; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cantu RC, 2000, NEUROSURGERY, V47, P669; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Joreskog KG., 1993, SAGE FOCUS EDITIONS, V154, P294; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	40	29	29	0	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2010	45	3					273	278		10.4085/1062-6050-45.3.273			6	Sport Sciences	Sport Sciences	599PI	WOS:000277925200010	20446841	Green Published			2021-06-18	
J	Stancin, T; Wade, SL; Walz, NC; Yeates, KO; Taylor, HG				Stancin, Terry; Wade, Shari L.; Walz, Nicolay C.; Yeates, Keith Owen; Taylor, H. Gerry			Family Adaptation 18 Months After Traumatic Brain Injury in Early Childhood	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						traumatic brain injury; family impact; parent coping; early childhood	OUTCOME 30 MONTHS; FUNCTIONAL RECOVERY; INITIAL YEAR; SHORT-TERM; PREDICTORS; CHILDREN; RELIABILITY; BURDEN; CAREGIVER; SEVERITY	Objective: The purpose of this study was to examine family adaptation to a traumatic brain injury (TBI) in young children during the first 18-month postinjury, when compared with children who had an orthopedic injury. Methods: A concurrent cohort/prospective research design was used with repeated assessments of children aged 3 to 6 years with TBI or orthopedic injury requiring hospitalization and their families. Shortly after injury and at 6-, 12-, and 18-month postinjury, parents of 99 children with TBI (20 severe, 64 moderate, 15 mild) and 117 with orthopedic injury completed standardized assessments of family functioning, parental distress and coping, injury-related burden, and noninjury-related parent stressors and resources. Mixed models analyses examined group differences in parental burden and distress adjusted for race and social demographic factors. Results: Both moderate and severe TBI were associated with higher levels of injury-related stress than orthopedic injury, with stress levels diminishing over time in all groups. Severe TBI was also associated with greater psychological distress on the Brief Symptom Inventory but not with more depressive symptoms. Family functioning and social resources moderated the relationship of TBI severity to injury-related burden and caregiver distress, respectively. Lower child adaptive skills were associated with poorer family outcome but group differences remained even when controlling for this effect. Conclusions: Severe TBI in young children has adverse consequences for parents and families during the first 18-month postinjury. The consequences lessen over time for many families and vary as a function of social resources.	[Stancin, Terry] Metrohlth Med Ctr, Dept Psychiat, Div Pediat Psychol, Cleveland, OH 44109 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Rehabil, Cincinnati, OH USA; [Wade, Shari L.; Walz, Nicolay C.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Walz, Nicolay C.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA	Stancin, T (corresponding author), Metrohlth Med Ctr, Dept Psychiat, Div Pediat Psychol, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	tstancin@metrohealth.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; USPHS NIHUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1UL1RR026314]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314, M01RR008084] Funding Source: NIH RePORTER	Supported by grant R01 HD42729 from NICHD, in part by USPHS NIH Grant M01 RR 08084, and by Trauma Research grants from the State of Ohio Emergency Medical Services (to S. L. W.).; This publication was supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Derogatis L., 1982, BRIEF SYMPTOM INVENT; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; HARRISON PL, 2003, MANUAL ADAPTIVE BEHA, V2; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moos R, 1994, LIFE STRESSORS SOCIA; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; SAS Institute, 1990, SAS STAT US GUID VER; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TAYLOR HG, 2008, J INT NEUROPSYCH SOC, V14, P1; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WADE SL, 2006, TREATING NEURODEVELO, P170; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	38	29	30	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	MAY	2010	31	4					317	325		10.1097/DBP.0b013e3181dbaf32			9	Behavioral Sciences; Psychology, Developmental; Pediatrics	Behavioral Sciences; Psychology; Pediatrics	597PE	WOS:000277769600007	20431399	Green Accepted			2021-06-18	
J	Osuka, S; Matsushita, A; Yamamoto, T; Saotome, K; Isobe, T; Nagatomo, Y; Masumoto, T; Komatsu, Y; Ishikawa, E; Matsumura, A				Osuka, Satoru; Matsushita, Akira; Yamamoto, Tetsuya; Saotome, Kousaku; Isobe, Tomonori; Nagatomo, Yasushi; Masumoto, Tomohiko; Komatsu, Yoji; Ishikawa, Eiichi; Matsumura, Akira			Evaluation of ventriculomegaly using diffusion tensor imaging: correlations with chronic hydrocephalus and atrophy Clinical article	JOURNAL OF NEUROSURGERY			English	Article						diffusion tensor imaging; ventriculomegaly; hydrocephalus; diffusion anisotropy; caudate nucleus	NORMAL-PRESSURE HYDROCEPHALUS; WHITE-MATTER; CSF DYNAMICS; BRAIN; DIAGNOSIS; PATHOLOGY; TISSUES; MRI	Object. Ventriculomegaly is a common imaging finding in many types of conditions. It is difficult to determine whether it is related to true hydrocephalus or to an atrophic process by using only imaging procedures such as MR imaging after traumatic injury, stroke, or infectious disease. Diffusion tensor (DT) imaging can distinguish the compression characteristics of white matter, indicating that increased diffusion anisotropy may be related to white matter compression. In this preliminary study, the authors compared the DT imaging findings of ventriculomegaly with those of chronic hydrocephalus or atrophy to clarify the potential of diffusion anisotropy in the identification of hydrocephalus. Methods. Ten patients with chronic hydrocephalus, 8 patients with atrophy (defined by conventional devices and surgical outcome), and 14 healthy volunteers underwent DT imaging. Images were acquired before and after shunting or once in cases without shunting. The fractional anisotropy (FA) values at many points around the lateral ventricle were evaluated. Results. The FA patterns around the lateral ventricle in the chronic hydrocephalus and atrophy groups were different. Especially in the caudate nucleus. FA was increased in the chronic hydrocephalus group compared with the atrophy group. Furthermore, the FA values returned to normal levels after shunt placement. Conclusions. Assessment of the FA value of the caudate nucleus may be an important, less invasive method for distinguishing true hydrocephalus from ventriculomegaly. Further research in a large number of patients is needed to verify the diagnostic ability of this method. (DOI: 10.3171/2009.7.JNS09550)	[Ishikawa, Eiichi] Univ Tsukuba, Dept Neurosurg, Inst Clin Med, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Masumoto, Tomohiko] Univ Tsukuba, Dept Radiol, Inst Clin Med, Tsukuba, Ibaraki 3058575, Japan; [Saotome, Kousaku] Tsukuba Med Ctr Hosp, Dept Radiol Technol, Tsukuba, Ibaraki, Japan; [Komatsu, Yoji] Tsukuba Med Ctr Hosp, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Nagatomo, Yasushi] Katsuta Hosp Mito GammaHouse, Dept Neurosurg, Hitachi, Ibaraki, Japan	Ishikawa, E (corresponding author), Univ Tsukuba, Dept Neurosurg, Inst Clin Med, Grad Sch Comprehens Human Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	e-ishikawa@md.tsukuba.ac.jp	Matsushita, Akira/I-5810-2013; Osuka, Satoru/J-6037-2013	Matsushita, Akira/0000-0003-2335-674X; 	Ministry of Health, Labour and Welfare, JapanMinistry of Health, Labour and Welfare, Japan [20B-9]	This work was supported by the research Grant No. 20B-9 for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan.	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; DELBIGIO MR, 1988, ACTA NEUROPATHOL, V77, P186, DOI 10.1007/BF00687430; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DeVito EE, 2007, ACTA NEUROL SCAND, V116, P328, DOI 10.1111/j.1600-0404.2007.00906.x; Dixon GR, 2002, MAYO CLIN PROC, V77, P509, DOI 10.4065/77.6.509; FLETCHER JM, 1992, ARCH NEUROL-CHICAGO, V49, P818, DOI 10.1001/archneur.1992.00530320042010; GYLDENSTED C, 1977, NEURORADIOLOGY, V14, P183, DOI 10.1007/BF00496982; Hasan KM, 2009, MAGN RESON IMAGING, V27, P631, DOI 10.1016/j.mri.2008.10.007; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Kitagaki H, 1998, AM J NEURORADIOL, V19, P1277; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mataro M, 2007, J NEUROL NEUROSUR PS, V78, P395, DOI 10.1136/jnnp.2006.096164; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; PAGE RB, 1979, ANAT REC, V194, P83, DOI 10.1002/ar.1091940106; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Pickard JD, 2005, NEUROPSYCHOL REHABIL, V15, P224, DOI 10.1080/09602010443000614; Poca MA, 2002, ACT NEUR S, V81, P7; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Segev Y, 2001, AM J NEURORADIOL, V22, P1674; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; TORVIK A, 1977, ACTA NEUROPATHOL, V38, P21, DOI 10.1007/BF00691271; Wieshmann UC, 2000, J NEUROL NEUROSUR PS, V68, P501, DOI 10.1136/jnnp.68.4.501	26	29	29	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2010	112	4					832	839		10.3171/2009.7.JNS09550			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	574ZQ	WOS:000276033200027	19698041				2021-06-18	
J	Thaut, MH				Thaut, Michael H.			NEUROLOGIC MUSIC THERAPY IN COGNITIVE REHABILITATION	MUSIC PERCEPTION			English	Article						neurology; music; cognition; rehabilitation; brain	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEGLECT PATIENTS; IMPLICIT MEMORY; WORKING-MEMORY; TERM-MEMORY; DEMENTIA; RECALL; TEXT; SONG	NEUROLOGIC MUSIC THERAPY LAST CAME INTO research and clinical focus via cognitive rehabilitation. New imaging techniques studying higher cognitive functions in the human brain 'in vivo' and theoretical advancements in music and brain function have facilitated this development. There are shared cognitive and perceptual mechanisms and shared neural systems between musical cognition and parallel nonmusical cognitive functions that provide access for music to affect general nonmusical functions, such as memory, attention, and executive function. The emerging clinical literature shows substantial support for these effects in rehabilitative retraining of the injured brain. Key findings relevant for clinical applications of neurologic music therapy to cognitive rehabilitation are presented and discussed below.	Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA	Thaut, MH (corresponding author), Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA.	Michael.Thaut@ColoState.EDU					Baur B, 2000, NEUROCASE, V6, P415, DOI 10.1080/13554790008402712; Bhattacharya J, 2001, INT J PSYCHOPHYSIOL, V42, P287, DOI 10.1016/S0167-8760(01)00153-2; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; CLAUSSEN DW, 1997, CAN J MUSIC THER, V5, P55; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Cowles A, 2003, NEUROCASE, V9, P493, DOI 10.1076/neur.9.6.493.29378; CRYSTAL HA, 1989, J NEUROL NEUROSUR PS, V52, P1415, DOI 10.1136/jnnp.52.12.1415; Cuddy LL, 2005, MED HYPOTHESES, V64, P229, DOI 10.1016/j.mehy.2004.09.005; Deutsch D., 1982, MUSIC MIND BRAIN, P119; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Foster NA, 2001, EXP AGING RES, V27, P215, DOI 10.1080/036107301300208664; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Frassinetti F, 2002, J COGNITIVE NEUROSCI, V14, P62, DOI 10.1162/089892902317205320; GFELLER KE, 1983, J MUSIC THER, V20, P179, DOI 10.1093/jmt/20.4.179; Glassman RB, 1999, BRAIN RES BULL, V50, P77, DOI 10.1016/S0361-9230(99)00090-8; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Halpern AR, 2000, NEUROPSYCHOLOGY, V14, P391, DOI 10.1037//0894-4105.14.3.391; Haslam C, 2002, NEUROCASE, V8, P453, DOI 10.1093/neucas/8.6.453; Hitch GJ, 1996, Q J EXP PSYCHOL-A, V49, P116, DOI 10.1080/027249896392829; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; HOMMEL M, 1990, ARCH NEUROL-CHICAGO, V47, P573, DOI 10.1001/archneur.1990.00530050097018; Irish M, 2006, DEMENT GERIATR COGN, V22, P108, DOI 10.1159/000093487; Jakobson LS, 2003, MUSIC PERCEPT, V20, P307, DOI 10.1525/mp.2003.20.3.307; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; JENSEN US, 2004, P SOC NEUR, P14; JONES MR, 1982, PERCEPT PSYCHOPHYS, V32, P211, DOI 10.3758/BF03206225; JONES MR, 1992, COGNITIVE BASES OF MUSICAL COMMUNICATION, P91, DOI 10.1037/10104-006; JONES MR, 1991, MEM COGNITION, V19, P8, DOI 10.3758/BF03198492; Kilgour AR, 2000, MEM COGNITION, V28, P700, DOI 10.3758/BF03198404; Klein JM, 1996, PERCEPT PSYCHOPHYS, V58, P34, DOI 10.3758/BF03205473; Kleinstauber M., 2006, J COGN REHAB, V24, P4; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Maeller D. H., 1996, THESIS COLORADO STAT; MATZEL LD, 1988, LEARN MOTIV, V19, P317, DOI 10.1016/0023-9690(88)90044-6; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; Rainey DW, 2002, MUSIC PERCEPT, V20, P173, DOI 10.1525/mp.2002.20.2.173; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Robertson IH, 1995, NEUROREPORT, V7, P246, DOI 10.1097/00001756-199512000-00059; ROSENBAUM RS, 2004, P SOC NEUR, P14; Samson S, 2009, ANN NY ACAD SCI, V1169, P245, DOI 10.1111/j.1749-6632.2009.04555.x; Sarnthein J, 1997, NEUROL RES, V19, P107; Sohlberg M. M., 1989, ATTENTION PROCESS TR; Son GR, 2002, J NURS SCHOLARSHIP, V34, P263, DOI 10.1111/j.1547-5069.2002.00263.x; Thaut M., 2005, RHYTHM MUSIC BRAIN S; Thaut MH, 2005, ANN NY ACAD SCI, V1060, P243, DOI 10.1196/annals.1360.017; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Vanstone AD, 2010, AGING NEUROPSYCHOL C, V17, P108, DOI 10.1080/13825580903042676; Vanstone AD, 2009, ANN NY ACAD SCI, V1169, P291, DOI 10.1111/j.1749-6632.2009.04763.x; Verwey WB, 2001, ACTA PSYCHOL, V106, P69, DOI 10.1016/S0001-6918(00)00027-5; WALLACE WT, 1994, J EXP PSYCHOL LEARN, V20, P1471, DOI 10.1037/0278-7393.20.6.1471; WOLFE DE, 1993, J MUSIC THER, V30, P100, DOI 10.1093/jmt/30.2.100	53	29	29	0	75	UNIV CALIFORNIA PRESS	BERKELEY	C/O JOURNALS DIVISION, 2000 CENTER ST, STE 303, BERKELEY, CA 94704-1223 USA	0730-7829			MUSIC PERCEPT	Music Percept.	APR	2010	27	4					281	285		10.1525/MP.2010.27.4.281			5	Music; Psychology, Experimental	Music; Psychology	581CR	WOS:000276499200005					2021-06-18	
J	Adeleye, A; Shohami, E; Nachman, D; Alexandrovich, A; Trembovler, V; Yaka, R; Shoshan, Y; Dhawan, J; Biegon, A				Adeleye, Amos; Shohami, Esther; Nachman, Dean; Alexandrovich, Alexander; Trembovler, Victoria; Yaka, Rami; Shoshan, Yigal; Dhawan, Jasbeer; Biegon, Anat			D-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Glutamate; N-methyl-D-aspartate (NMDA) receptor; Neuroprotection; Head injury	CLOSED-HEAD INJURY; EXCITATORY AMINO-ACIDS; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; NMDA ANTAGONISTS; ISCHEMIC-STROKE; DYNAMIC CHANGES; MOUSE MODEL; RAT; RECOVERY	It has been long thought that hyperactivation of N-methyl-D-aspartate (NMDA) receptors underlies neurological decline after traumatic brain injury. However, all clinical trials with NMDA receptor antagonists failed. Since NMDA receptors are down-regulated from 4 h to 2 weeks after brain injury, activation at 24 h, rather than inhibition, of these receptors, was previously shown to be beneficial in mice. Here, we tested the therapeutic window, dose regimen and mechanism of action of the NMDA receptor partial agonist D-cycloserine (DCS) in traumatic brain injury. Male mice were subjected to trauma using a weight-drop model, and administered 10 mg/kg (i.p.) DCS or vehicle once (8, 16,24, or 72 h) twice (24 and 48 h) or three times (24, 48 and 72 h). Functional recovery was assessed for up to 60 days, using a Neurological Severity Score that measures neurobehavioral parameters. In all groups in which treatment was begun at 24 or 72 h neurobehavioral function was significantly better than in the vehicle-treated groups. Additional doses, on days 2 and 3 did not further improve recovery. Mice treated at 8 h or 16 h post injury did not differ from the vehicle-treated controls. Co-administration of the NMDA receptor antagonist MK-801 completely blocked the protective effect of DCS given at 24 h. Infarct volume measured by 2,3,5-triphenyltetrazolium chloride staining at 48 h or by cresyl violet at 28 days was not affected by DCS treatment. Since DCS is used clinically for other indications, the present study offers a novel approach for treating human traumatic brain injury with a therapeutic window of at least 24 h. (C) 2009 Elsevier B.V. All rights reserved.	[Adeleye, Amos; Shohami, Esther; Nachman, Dean; Alexandrovich, Alexander; Trembovler, Victoria; Yaka, Rami] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Adeleye, Amos; Nachman, Dean; Shoshan, Yigal] Hebrew Univ Jerusalem, Hadassah Hosp, Dept Neurosurg, IL-91120 Jerusalem, Israel; [Dhawan, Jasbeer; Biegon, Anat] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.	esty@cc.huji.ac.il	nachman, Dean/K-2920-2019		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS050285]; IDF; Israel Ministry of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050285] Funding Source: NIH RePORTER	This study was Supported by NIH grant 1R01NS050285 (A. Biegon) and, in part, by a grant from the IDF and the Israel Ministry of Defense (E. Shohami). E. Shohami is the incumbent of the Dr. Leon and Dr. Mina Deutsch Chair in Psychopharmacology at The Hebrew University, and a member of the Brettler Center for Research in Molecular Pharmacology and Therapeutics, The Hebrew University.	Alessandri B, 1996, ACT NEUR S, V67, P6; Andersen JM, 2002, BEHAV BRAIN RES, V129, P211, DOI 10.1016/S0166-4328(01)00318-7; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BARTH TM, 1990, STROKE, V21, P153; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; BIEGON, 2002, J NEUROCHEM, V82, P1; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; Danysz W, 1998, PHARMACOL REV, V50, P597; Di X, 1996, J NEUROSURG, V85, P655, DOI 10.3171/jns.1996.85.4.0655; Duncan EJ, 2004, SCHIZOPHR RES, V71, P239, DOI 10.1016/j.schres.2004.03.013; EMMETT MR, 1991, NEUROPHARMACOLOGY, V30, P1167, DOI 10.1016/0028-3908(91)90161-4; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fisher M, 1998, EUR NEUROL, V40, P65, DOI 10.1159/000007959; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Heifets L B, 1994, Semin Respir Infect, V9, P84; Heresco-Levy U, 2002, INT J NEUROPSYCHOPH, V5, P301, DOI 10.1017/S1461145702003061; Hoane MR, 2000, BRAIN RES BULL, V53, P175, DOI 10.1016/S0361-9230(00)00327-0; Ji S, 2009, EXP NEUROL, V216, P321, DOI 10.1016/j.expneurol.2008.12.007; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LAAKE K, 2002, COCHRANE DB SYST REV; Lees KR, 1997, NEUROLOGY, V49, pS66, DOI 10.1212/WNL.49.5_Suppl_4.S66; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mark VW, 2008, RESTOR NEUROL NEUROS, V26, P13; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; ROD MR, 1989, CAN J NEUROL SCI, V16, P340, DOI 10.1017/S031716710002919X; Schneider JS, 2000, BRAIN RES, V860, P190, DOI 10.1016/S0006-8993(00)02036-9; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com	52	29	32	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	MAR 10	2010	629	1-3					25	30		10.1016/j.ejphar.2009.11.066			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	561UN	WOS:000275004900005	19958766	Green Accepted			2021-06-18	
J	Cadosch, D; Toffoli, AM; Gautschi, OP; Frey, SP; Zellweger, R; Skirving, AP; Filgueira, L				Cadosch, Dieter; Toffoli, Andrew M.; Gautschi, Oliver P.; Frey, Soenke P.; Zellweger, Rene; Skirving, Allan P.; Filgueira, Luis			Serum After Traumatic Brain Injury Increases Proliferation and Supports Expression of Osteoblast Markers in Muscle Cells	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							BONE MORPHOGENETIC PROTEIN-2; TRANSCRIPTION FACTOR OSTERIX; SKELETAL-MUSCLE; STEM-CELLS; HETEROTOPIC OSSIFICATION; HEAD-INJURY; TISSUE; DIFFERENTIATION; OSTEOINDUCTION; PHOSPHATASE	Background: Traumatic brain injury is associated with an increased rate of heterotopic ossification within skeletal muscle, possibly as a result of humoral factors. In this study, we investigated whether cells from skeletal muscle adopt an osteoblastic phenotype in response to serum from patients with traumatic brain injury. Methods: Serum was collected from thirteen patients with severe traumatic brain injury, fourteen patients with a long-bone fracture, and ten control subjects. Primary cultures of skeletal muscle cells isolated from patients undergoing orthopaedic surgery were performed and characterized with use of immunofluorescence microscopy, reverse transcription-polymerase chain reaction, and Western blot analysis. Proliferation and osteoblastic differentiation were assessed with use of commercial cell assays, Western blot analysis (for Osterix protein), and the Villanueva bone stain. Results: All serum-treated cell populations expressed the osteoblast marker Osterix after one week in culture. Cells treated with serum from all study groups in mineralization medium had increased alkaline phosphatase activity and mineralized nodules within the mesenchymal cell subpopulation after three weeks in culture. Serum from patients with traumatic brain injury induced a significant increase (p = 0.02) in the rate of proliferation of primary skeletal muscle cells (1.87 [95% confidence interval, 1.66 to 2.09]) compared with the rate induced by serum from patients with a fracture (1.42 [95% confidence interval, 1.21 to 1.58]) or by serum from controls (1.35 [95% confidence interval, 1.15 to 1.54]). Conclusions: Human serum supports the osteoblastic differentiation of cells derived from human skeletal muscle, and serum from patients with severe traumatic brain injury accelerates proliferation of these cells. These findings suggest the early presence of humoral factors following traumatic brain injury that stimulate the expansion of mesenchymal cells and osteoprogenitors within skeletal muscle.	[Cadosch, Dieter] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia; Royal Perth Hosp, Perth, WA, Australia	Cadosch, D (corresponding author), Univ Western Australia, Sch Anat & Human Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	dcadosch@gmx.net	Filgueira, Luis/B-6492-2008	Filgueira, Luis/0000-0002-2266-6650			Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; [Anonymous], 1998, ABBR INJ SCAL AIS 19; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Bosse A, 1997, Veroff Pathol, V146, P1; Bujan J, 2005, HISTOL HISTOPATHOL, V20, P891, DOI 10.14670/HH-20.891; CADOSCH D, 2010, ANZ J SURG IN PRESS; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P938; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; Cohly HHP, 2003, BIOMED SCI INSTRUM, V39, P446; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; COPE R, 1990, SOUTH MED J, V83, P1058, DOI 10.1097/00007611-199009000-00020; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; EKELUND A, 1991, CLIN ORTHOP RELAT R, P102; Flin C., 2002, Annales de Readaptation et de Medecine Physique, V45, P517, DOI 10.1016/S0168-6054(02)00305-7; Fujimura K, 2001, BRIT J ORAL MAX SURG, V39, P294, DOI 10.1054/bjom.2001.0647; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; GRIM M, 1990, J HISTOCHEM CYTOCHEM, V38, P1907, DOI 10.1177/38.12.1701462; Huggins CB, 1931, BIOCHEM J, V25, P728, DOI 10.1042/bj0250728; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; Le Du MH, 2002, J BIOL CHEM, V277, P49808, DOI 10.1074/jbc.M207394200; Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2; Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3; Marusic A, 1999, BONE, V25, P25, DOI 10.1016/S8756-3282(99)00095-2; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; Musgrave DS, 2002, J BONE JOINT SURG BR, V84B, P120, DOI 10.1302/0301-620X.84B1.11708; Musgrave DS, 2000, CLIN ORTHOP RELAT R, P290; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Okubo Y, 2000, INT J ORAL MAX SURG, V29, P62, DOI 10.1034/j.1399-0020.2000.290114.x; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; Purpura KA, 2003, J CELL BIOCHEM, V90, P109, DOI 10.1002/jcb.10596; PUZAS JE, 1989, CLIN ORTHOP RELAT R, V245, P269; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; SOREN A, 1983, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V127, P91; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525; Sun JS, 2005, BIOMATERIALS, V26, P3953, DOI 10.1016/j.biomaterials.2004.10.016; Tai GP, 2005, BIOCHEM BIOPH RES CO, V333, P1116, DOI 10.1016/j.bbrc.2005.05.195; TEASDALE G, 1974, LANCET, V2, P81; URIST MR, 1973, P NATL ACAD SCI USA, V70, P3511, DOI 10.1073/pnas.70.12.3511; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; Williams JT, 1999, AM SURGEON, V65, P22; Yoshida K, 1998, J CRANIO MAXILL SURG, V26, P112, DOI 10.1016/S1010-5182(98)80050-4	51	29	31	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	MAR	2010	92A	3					645	653		10.2106/JBJS.I.00097			9	Orthopedics; Surgery	Orthopedics; Surgery	564KT	WOS:000275213800015	20194323	Green Accepted			2021-06-18	
J	Diestel, A; Troeller, S; Billecke, N; Sauer, IM; Berger, F; Schmitt, KRL				Diestel, Antje; Troeller, Silke; Billecke, Nils; Sauer, Igor M.; Berger, Felix; Schmitt, Katharina R. L.			Mechanisms of hypothermia-induced cell protection mediated by microglial cells in vitro	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cytokines; IkappaB-alpha; microglia; morphology; phagocytosis	PRO-INFLAMMATORY CYTOKINES; TRAUMATIC BRAIN-INJURY; FACTOR-KAPPA-B; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; AMEBOID MICROGLIA; TNF-ALPHA; DISEASE; IL-10; SLIDEREACTOR	Despite the widespread interest in the clinical applications of hypothermia, the cellular mechanisms of hypothermia-induced neuroprotection have not yet been clearly understood. Therefore, the aim of this study was to elucidate the cellular effects of clinically relevant hypothermia and rewarming on the morphological and functional characteristics of microglia. Microglial cells were exposed to a dynamic cooling and rewarming protocol. For stimulation, microglial cells were treated with 1 mu g/mL lipopolysaccharide (LPS). We found that hypothermia led to morphological changes from ramified to ameboid cell shapes. At 2 h after hypothermia and rewarming, microglial cells were again ramified with extended branches. Moreover, we found enhanced cell activation after rewarming, accompanied by increased phagocytosis and adenosine triphosphate consumption. Interestingly, hypothermia and rewarming led to a time-dependent significant up-regulation of the anti-inflammatory cytokines interleukin-10 and interleukin-1 receptor antagonist in stimulated microglial cells. This is in line with the reduced proliferation and time-dependent down-regulation of the pro-inflammatory cytokines tumor necrosis factor-alpha and monocyte chemotactic protein-1 in comparison to normothermic control cells after LPS stimulation. Furthermore, degradation of the inhibitor of the nuclear transcription factor-kappaB (IkappaB-alpha) was diminished and delayed under conditions of cooling and rewarming in LPS-stimulated microglial cells. Thus, our results show that hypothermia and rewarming activate microglial cells, increase phagocytosis and shift the balance of cytokine release in stimulated microglial cells towards the anti-inflammatory cytokines. This could be a new cellular mechanism of hypothermia-induced neuroprotection mediated by activated microglial cells.	[Troeller, Silke; Berger, Felix; Schmitt, Katharina R. L.] Deutsch Herzzentrum Berlin, Dept Congenital Heart Dis Pediat Cardiol, D-13353 Berlin, Germany; [Diestel, Antje; Berger, Felix] Charite, Dept Pediat Cardiol, D-13353 Berlin, Germany	Schmitt, KRL (corresponding author), Deutsch Herzzentrum Berlin, Dept Congenital Heart Dis Pediat Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany.	katharina.schmitt@charite.de	Sauer, Igor/AAM-4217-2021; Billecke, Nils/E-9276-2013	Billecke, Nils/0000-0002-2343-8684; Berger, Felix/0000-0001-7881-1557; Sauer, Igor/0000-0001-9355-937X	European Foundation (efre); Fordergemeinschaft Deutsche Kinderherzzentren e.V.; Deutsche Stiftung fur Herzforschung	The authors wish to thank Chantel Spencer Haensch and Franka Brey for excellent technical assistance and Anne Gale for editing the manuscript. The sources of financial support were the European Foundation (efre), Fordergemeinschaft Deutsche Kinderherzzentren e.V. and Deutsche Stiftung fur Herzforschung.	Acarin L, 2001, Prog Brain Res, V132, P375; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bachis A, 2001, J NEUROSCI, V21, P3104, DOI 10.1523/JNEUROSCI.21-09-03104.2001; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; Christov A, 2004, NEUROL RES, V26, P540, DOI 10.1179/016164104225016218; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; Deng YY, 2009, GLIA, V57, P604, DOI 10.1002/glia.20790; Diestel A, 2009, J HEART LUNG TRANSPL, V28, P718, DOI 10.1016/j.healun.2009.04.003; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; DINARELLO CA, 1997, SEMIN ONCOL, V24; Froen JF, 2002, BRAIN RES, V942, P87, DOI 10.1016/S0006-8993(02)02700-2; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Hu SX, 1999, J LEUKOCYTE BIOL, V65, P815; Koller H, 1997, J NEUROIMMUNOL, V76, P185, DOI 10.1016/S0165-5728(97)00056-8; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lucas R, 1997, INFECT IMMUN, V65, P2006, DOI 10.1128/IAI.65.6.2006-2010.1997; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Molina-Holgado E, 2001, EUR J NEUROSCI, V13, P493, DOI 10.1046/j.0953-816x.2000.01412.x; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nomura F, 1996, ANN THORAC SURG, V62, P115, DOI 10.1016/0003-4975(96)00331-1; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Pinteaux E, 2006, GLIA, V53, P551, DOI 10.1002/glia.20308; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; Sauer IM, 2005, ARTIF ORGANS, V29, P264, DOI 10.1111/j.1525-1594.2005.29049.x; Schilling M, 2009, BRAIN RES, V1289, P79, DOI 10.1016/j.brainres.2009.06.054; Schmitt KRL, 2007, J NEUROIMMUNOL, V189, P7, DOI 10.1016/j.jneuroim.2007.06.010; Schwartlander R, 2007, TISSUE ENG, V13, P187, DOI 10.1089/ten.2006.0071; SHENG WS, 1995, CLIN DIAGN LAB IMMUN, V2, P604, DOI 10.1128/CDLI.2.5.604-608.1995; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001	43	29	29	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAR	2010	31	5					779	787		10.1111/j.1460-9568.2010.07128.x			9	Neurosciences	Neurosciences & Neurology	563AC	WOS:000275096500001	20374279				2021-06-18	
J	Meyer, M; Deniselle, MCG; Garay, LI; Monachelli, GG; Lima, A; Roig, P; Guennoun, R; Schumacher, M; De Nicola, AF				Meyer, Maria; Gonzalez Deniselle, Maria Claudia; Garay, Laura I.; Monachelli, Gisella Gargiulo; Lima, Analia; Roig, Paulina; Guennoun, Rachida; Schumacher, Michael; De Nicola, Alejandro F.			Stage Dependent Effects of Progesterone on Motoneurons and Glial Cells of Wobbler Mouse Spinal Cord Degeneration	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Wobbler; Progesterone; Glial fibrillary acidic protein; Glutamine synthetase; Neurodegeneration; Neuroprotection	MOTOR-NEURON DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; ANTERIOR HORN CELLS; TRAUMATIC BRAIN-INJURY; BINDING-PROTEIN 25-DX; NITRIC-OXIDE; GLUTAMINE-SYNTHETASE; NEUROTROPHIC FACTOR; CHOLINE-ACETYLTRANSFERASE	In the Wobbler mouse, a mutation in the Vps54 gene is accompanied by motoneuron degeneration and astrogliosis in the cervical spinal cord. Previous work has shown that these abnormalities are greatly attenuated by progesterone treatment of clinically afflicted Wobblers. However, whether progesterone is effective at all disease stages has not yet been tested. The present work used genotyped (wr/wr) Wobbler mice at three periods of the disease: early progressive (1-2 months), established (5-8 months) or late stages (12 months) and age-matched wildtype controls (NFR/NFR), half of which were implanted with a progesterone pellet (20 mg) for 18 days. In untreated Wobblers, degenerating vacuolated motoneurons were initially abundant, experienced a slight reduction at the established stage and dramatically diminished during the late period. In motoneurons, the cholinergic marker choline acetyltransferase (ChAT) was reduced at all stages of the Wobbler disease, whereas hyperexpression of the growth-associated protein (GAP43) mRNA preferentially occurred at the early progressive and established stages. Progesterone therapy significantly reduced motoneuron vacuolation, enhanced ChAT immunoreactive perikarya and reduced the hyperexpression of GAP43 during the early progressive and established stages. At all stage periods, untreated Wobblers showed high density of glial fibrillary acidic protein (GFAP)+ astrocytes and decreased number of glutamine synthase (GS) immunostained cells. Progesterone treatment down-regulated GFAP+ astrocytes and up-regulated GS+ cell number. These data reinforced the usefulness of progesterone to improve motoneuron and glial cell abnormalities of Wobbler mice and further showed that therapeutic benefit seems more effective at the early progressive and established periods, rather than on advance stages of spinal cord neurodegeneration.	[Meyer, Maria; Gonzalez Deniselle, Maria Claudia; Garay, Laura I.; Monachelli, Gisella Gargiulo; Lima, Analia; Roig, Paulina; De Nicola, Alejandro F.] Consejo Nacl Invest Cient & Tecn, Lab Bioquim Neuroendocrina, Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina; [Gonzalez Deniselle, Maria Claudia; Garay, Laura I.; De Nicola, Alejandro F.] Univ Buenos Aires, Fac Med, Dept Human Biochem, Buenos Aires, DF, Argentina; [Guennoun, Rachida; Schumacher, Michael] INSERM, UMR788, Le Kremlin Bicetre, France; [Guennoun, Rachida; Schumacher, Michael] Univ Paris 11, Le Kremlin Bicetre, France	De Nicola, AF (corresponding author), Consejo Nacl Invest Cient & Tecn, Lab Bioquim Neuroendocrina, Inst Biol & Med Expt, Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	denicola@dna.uba.ar	Schumacher, Michael/G-3581-2013; Guennoun, Rachida/F-2420-2011	Schumacher, Michael/0000-0001-6117-5371; Guennoun, Rachida/0000-0002-9219-7300	FONCYTFONCyT [BID 1728 OC AR PICT 2004 5-25610, BID 1728 OC AR PICT 2007-01044]; CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 112-200801-00542]; University of Buenos AiresUniversity of Buenos Aires [M016, M611]; INSERM/CONICETInstitut National de la Sante et de la Recherche Medicale (Inserm)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	This work was supported by FONCYT (BID 1728 OC AR PICT 2004 5-25610 and PICT 2007-01044), CONICET (PIP 112-200801-00542), the University of Buenos Aires (M016 and M611) and a cooperative program INSERM/CONICET.	Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bigini P, 2001, NEUROREPORT, V12, P1815, DOI 10.1097/00001756-200107030-00011; Bigini P, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-71; Bigini P, 2007, NEUROSCI LETT, V426, P106, DOI 10.1016/j.neulet.2007.08.057; BLONDET B, 1995, NEUROSCI LETT, V183, P179, DOI 10.1016/0304-3940(94)11145-9; Boillee S, 2001, GLIA, V33, P277, DOI 10.1002/1098-1136(20010315)33:4<277::AID-GLIA1026>3.0.CO;2-Y; Boillee S, 2003, MOL NEUROBIOL, V28, P65, DOI 10.1385/MN:28:1:65; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; CAMMER W, 1990, J NEUROIMMUNOL, V26, P173, DOI 10.1016/0165-5728(90)90088-5; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Clowry GJ, 1996, NEUROSCI LETT, V215, P177, DOI 10.1016/0304-3940(96)12971-2; Corvino V, 2003, NEUROCHEM RES, V28, P341, DOI 10.1023/A:1022345720852; Cudkowicz ME, 1996, J NEUROL SCI, V139, P10, DOI 10.1016/0022-510X(96)00084-6; Dave KR, 2003, EXP NEUROL, V182, P412, DOI 10.1016/S0014-4886(03)00091-8; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Deniselle MCG, 2005, EXP NEUROL, V195, P518, DOI 10.1016/j.expneurol.2005.06.015; Deniselle MCG, 2004, BRAIN RES, V1014, P71, DOI 10.1016/j.braines.2004.04.004; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Deniselle MCG, 1999, BRAIN RES, V841, P78, DOI 10.1016/S0006-8993(99)01783-7; Deniselle MCG, 1999, NEUROCHEM RES, V24, P1535, DOI 10.1023/A:1021199931682; Dennis JS, 2009, NEUROSCIENCE, V158, P745, DOI 10.1016/j.neuroscience.2008.10.030; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Elliott EJ, 1997, BRAIN RES, V755, P221, DOI 10.1016/S0006-8993(97)00100-5; FERRINI M, 1995, LIFE SCI, V57, P2403, DOI 10.1016/0024-3205(95)02236-3; Fumagalli E, 2006, EXP NEUROL, V198, P114, DOI 10.1016/j.expneurol.2005.11.010; Gago N, 2004, J NEUROSCI RES, V78, P770, DOI 10.1002/jnr.20348; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Hantaz-Ambroise D, 2001, DIFFERENTIATION, V69, P100, DOI 10.1046/j.1432-0436.2001.690204.x; Henderson JT, 1996, J NEUROSCI, V16, P7574; Ikeda K, 2000, BRAIN RES, V858, P84, DOI 10.1016/S0006-8993(99)02427-0; Ikemoto A, 1999, ACTA NEUROPATHOL, V98, P367, DOI 10.1007/s004010051096; Ishiyama T, 2004, BRAIN RES, V1019, P226, DOI 10.1016/j.brainres.2004.06.002; Ishiyama T, 2002, BRAIN RES, V944, P195, DOI 10.1016/S0006-8993(02)02881-0; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Julien JP, 2007, NAT NEUROSCI, V10, P535, DOI 10.1038/nn0507-535; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; Kong JM, 1998, J NEUROSCI, V18, P3241; LAAGE S, 1988, DEV NEUROSCI-BASEL, V10, P190, DOI 10.1159/000111969; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2000, NEUROSCI LETT, V288, P29, DOI 10.1016/S0304-3940(00)01191-5; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Migheli A, 1999, NAT MED, V5, P966, DOI 10.1038/12381; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; MITSUMOTO H, 1987, J NEUROPATH EXP NEUR, V46, P214, DOI 10.1097/00005072-198703000-00008; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Oda Y, 1995, PATHOL INT, V45, P933, DOI 10.1111/j.1440-1827.1995.tb03418.x; Pajovic SB, 2008, PHYSIOL RES, V57, P801, DOI 10.33549/physiolres.931377; PARHAD IM, 1992, ANN NEUROL, V31, P593, DOI 10.1002/ana.410310605; Popper P, 1997, EXP NEUROL, V143, P246, DOI 10.1006/exnr.1996.6364; Rathke-Hartlieb S, 1999, NEUROREPORT, V10, P3411, DOI 10.1097/00001756-199911080-00028; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Santoro B, 2004, NEUROBIOL DIS, V17, P349, DOI 10.1016/j.nbd.2004.07.003; Saravia F, 2007, PSYCHONEUROENDOCRINO, V32, P480, DOI 10.1016/j.psyneuen.2007.02.012; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; TANSEY FA, 1991, J NEUROCHEM, V56, P266, DOI 10.1111/j.1471-4159.1991.tb02591.x; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Tsuzaka K, 2001, MUSCLE NERVE, V24, P474, DOI 10.1002/mus.1029; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; Xu GP, 2001, NEUROSCI LETT, V300, P141, DOI 10.1016/S0304-3940(01)01575-0; YUNG KKL, 1992, NEUROSCIENCE, V50, P209, DOI 10.1016/0306-4522(92)90393-G; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019; Zoccolella S, 2007, EUR J NEUROL, V14, P262, DOI 10.1111/j.1468-1331.2006.01575.x; Zoing MC, 2006, J CLIN NEUROSCI, V13, P78, DOI 10.1016/j.jocn.2004.04.011	81	29	30	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2010	30	1					123	135		10.1007/s10571-009-9437-8			13	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	549XI	WOS:000274087400013	19693665				2021-06-18	
J	Ord, JS; Greve, KW; Bianchini, KJ; Aguerrevere, LE				Ord, Jonathan S.; Greve, Kevin W.; Bianchini, Kevin J.; Aguerrevere, Luis E.			Executive dysfunction in traumatic brain injury: The effects of injury severity and effort on the Wisconsin Card Sorting Test	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Wisconsin Card Sorting Test; Executive function; Outcome; Performance validity; Effort; Malingering	DIGIT RECOGNITION TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; CLOSED-HEAD INJURY; CLASSIFICATION ACCURACY; NEUROPSYCHOLOGICAL ASSESSMENT; LATENT STRUCTURE; PERFORMANCE; COMPENSATION; INDICATORS; EXAGGERATION	This study examined the persistent effects of traumatic brain injury (TBI) on Wisconsin Card Sorting Test (WCST) performance. Since poor effort can contaminate results in populations with incentive to perform poorly, performance validity was explicitly assessed and controlled for using multiple well-validated cognitive malingering indicators. Participants were 109 patients with mild TBI and 67 patients with moderate-to-severe TBI seen for neuropsychological evaluation at least one year post injury. Patients with diffuse neurological impairment and healthy controls were included for comparison. Results suggested a dose-response effect of TBI severity on WCST performance in patients providing good effort; the mild TBI group did not differ from controls while increased levels of impairment were observed in the moderate-to-severe TBI group. Effort during testing had a larger impact on WCST performance than mild or moderate-to-severe TBI. Clinical implications of these findings are discussed.	[Ord, Jonathan S.; Greve, Kevin W.; Bianchini, Kevin J.; Aguerrevere, Luis E.] Univ New Orleans, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA	Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu	Aguerrevere, Luis/P-5684-2019	Aguerrevere, Luis/0000-0001-9160-1044			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1993, PORTLAND DIGIT RECOG; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Doane BM, 2005, CLIN NEUROPSYCHOL, V19, P99, DOI 10.1080/13854040490524100; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green P, 2001, NEUROREHABILITATION, V16, P237; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1996, MANUAL COMPUTERIZED; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Greve KW, 1997, BRIT J CLIN PSYCHOL, V36, P283, DOI 10.1111/j.2044-8260.1997.tb01414.x; Greve KW, 2002, ASSESSMENT, V9, P271, DOI 10.1177/1073191102009003006; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R. K, 1981, WISCONSIN CARD SORTI; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Iverson G L, 2000, Appl Neuropsychol, V7, P247, DOI 10.1207/S15324826AN0704_7; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Love JM, 2003, APPL NEUROPSYCHOL, V10, P246, DOI 10.1207/s15324826an1004_7; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205	64	29	29	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	2					132	140		10.1080/13803390902858874			9	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	550YX	WOS:000274172300003	19484646				2021-06-18	
J	Su, E; Bell, MJ; Wisniewski, SR; Adelson, PD; Janesko-Feldman, KL; Salonia, R; Clark, RSB; Kochanek, PM; Kagan, VE; Bayir, H				Su, Erik; Bell, Michael J.; Wisniewski, Stephen R.; Adelson, P. David; Janesko-Feldman, Keri L.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Kagan, Valerian E.; Bayir, Huelya			alpha-Synuclein Levels Are Elevated in Cerebrospinal Fluid following Traumatic Brain Injury in Infants and Children: The Effect of Therapeutic Hypothermia	DEVELOPMENTAL NEUROSCIENCE			English	Article						Nonaccidental head injury; Abusive head injury; Synaptic dysfunction; Apoptosis; Mitochondrial injury; Cell death; Oxidative stress; Secondary injury	FAMILIAL PARKINSONS-DISEASE; SEVERE HEAD-INJURY; CYTOCHROME-C; HUMAN PLASMA; POSTISCHEMIC HYPOTHERMIA; GENDER-DIFFERENCES; PREFRONTAL CORTEX; OXIDATIVE DAMAGE; GAMMA-SYNUCLEIN; TRANSGENIC MICE	alpha-Synuclein is one of the most abundant proteins in presynaptic terminals. Normal expression of alpha-synuclein is essential for neuronal survival and it prevents the initiation of apoptosis in neurons through covalent cross-linking of cytochrome c released from mitochondria. Exocytosis of alpha-synuclein occurs with neuronal mitochondrial dysfunction, making its detection in cerebrospinal fluid (CSF) of children after severe traumatic brain injury (TBI) a potentially important marker of injury. Experimental therapeutic hypothermia (TH) improves mitochondrial function and attenuates cell death, and therefore may also affect CSF alpha-synuclein concentrations. We assessed alpha-synuclein levels in CSF of 47 infants and children with severe TBI using a commercial ELISA for detection of monomeric protein. 23 patients were randomized to TH based on published protocols where cooling (32-33 degrees C) was initiated within 6-24 h, maintained for 48 h, and then followed by slow rewarming. CSF samples were obtained continuously via an intraventricular catheter for 6 days after TBI. Control CSF (n = 9) was sampled from children receiving lumbar puncture for CSF analysis of infection that was proven negative. Associations of initial Glasgow Coma Scale (GCS) score, age, gender, treatment, mechanism of injury and Glasgow Outcome Scale (GOS) score with CSF alpha-synuclein were compared by multivariate regression analysis. CSF alpha-synuclein levels were elevated in TBI patients compared to controls (p = 0.0093), with a temporal profile showing an early, approximately 5-fold increase on days 1-3 followed by a delayed, >10-fold increase on days 4-6 versus control. alpha-Synuclein levels were higher in patients treated with normothermia versus hypothermia (p = 0.0033), in patients aged <4 years versus >= 4 years (p < 0.0001), in females versus males (p = 0.0007), in nonaccidental TBI versus accidental TBI victims (p = 0.0003), and in patients with global versus focal injury on computed tomography of the brain (p = 0.046). Comparisons of CSF alpha-synuclein levels with initial GCS and GOS scores were not statistically significant. Further studies are needed to evaluate the conformational status of alpha-synuclein in CSF, and whether TH affects alpha-synuclein aggregation. Copyright (C) 2010 S. Karger AG, Basel	[Su, Erik; Bell, Michael J.; Janesko-Feldman, Keri L.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Su, Erik; Bell, Michael J.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15260 USA; [Su, Erik; Bell, Michael J.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth & Pharmacol, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol & Publ Hlth, Pittsburgh, PA 15260 USA; [Adelson, P. David] Phoenix Childrens Hosp, Childrens Neurosci Inst, Phoenix, AZ USA	Bayir, H (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	suer4@upmc.edu; bayihx@ccm.upmc.edu	Adelson, David/W-2083-2019; Su, Erik/AAG-9374-2019; Kochanek, Patrick M/D-2371-2015	Su, Erik/0000-0002-1054-308X; Kochanek, Patrick M/0000-0002-2627-913X; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, NS30318, T32 HD040686-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318, R01NS061817] Funding Source: NIH RePORTER	This study was supported by grants from the National Institutes of Health (NS061817, NS30318, T32 HD040686-10).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bayir H, 2009, J BIOL CHEM, V284, P15951, DOI 10.1074/jbc.M900418200; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Canevari L, 1999, BRAIN RES, V817, P241, DOI 10.1016/S0006-8993(98)01278-5; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Dong H, 2001, STROKE, V32, P788, DOI 10.1161/01.STR.32.3.788; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jellinger KA, 2004, J NEURAL TRANSM, V111, P1219, DOI 10.1007/s00702-004-0138-7; Jia F, 2009, J NEUROTRAUMA; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Li WX, 2004, J NEUROCHEM, V88, P401, DOI 10.1046/j.1471-4159.2003.02166.x; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2009, MOVEMENT DISORD, V24, P1411, DOI 10.1002/mds.22510; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Mukaetova-Ladinska EB, 2008, DEMENT GERIATR COGN, V26, P32, DOI 10.1159/000141039; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Quilty MC, 2003, EXP NEUROL, V182, P195, DOI 10.1016/S0014-4886(03)00108-0; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.3.CO;2-6; Stephan A, 2002, HIPPOCAMPUS, V12, P55, DOI 10.1002/hipo.10006; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Fjorback AW, 2007, SCAND J CLIN LAB INV, V67, P431, DOI 10.1080/00365510601161497	78	29	29	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					385	395		10.1159/000321342			11	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900006	21124000	Green Published, Bronze			2021-06-18	
J	Sullivan, JR; Riccio, CA				Sullivan, Jeremy R.; Riccio, Cynthia A.			Language Functioning and Deficits Following Pediatric Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						children; language; TBI; traumatic brain injury	CLOSED-HEAD INJURY; CHILDREN; COMPREHENSION; ADOLESCENTS; DISCOURSE; CHILDHOOD; FLUENCY; MEMORY; SKILLS; MILD	The purpose of this article is to provide a current review of language functioning and deficits following traumatic brain injury (TBI), specifically among the pediatric population. This paper will: (a) outline the manner in which these deficits may impede functioning across environments; (b) review methods of assessing language functioning within this population; and (c) discuss empirically supported interventions to address noted language deficits as they present in pediatric TBI.	[Sullivan, Jeremy R.] Univ Texas San Antonio, Dept Educ Psychol, San Antonio, TX 78207 USA; [Riccio, Cynthia A.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA	Sullivan, JR (corresponding author), Univ Texas San Antonio, Dept Educ Psychol, 501 W Durango Blvd, San Antonio, TX 78207 USA.	jeremy.sullivan@utsa.edu					Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Carrow-Woolfolk E., 1999, TEST AUDITORY COMPRE; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SS, 2005, BEHAV INTERVENT, V20, P37, DOI 10.1002/bin.168; Delis D, 1994, CALIFORNIA VERBAL LE; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Dunn L., 2007, PEABODY PICTURE VOCA, V4th ed.; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; Gardner MF., 2000, EXPRESSIVE ONE WORD; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; Hammill D. D., 2007, TEST ADOLESCENT ADUL; Hammill D. D., 2002, COMPREHENSIVE RECEPT; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Huisingh R, 2005, WORD TEST; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Morse S, 1999, Pediatr Rehabil, V3, P139; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; Phelps-Terasaki D., 2007, TEST PRAGMATIC LANGU, V2nd; RICCIO CA, 1999, MILD BRAIN INJURY CL, P77; Secord, 1989, TEST LANGUAGE COMPET; Semel E., 2003, CLIN EVALUATION LANG; Shinn M., 1989, CURRICULUM BASED MEA; Sohlberg M. M., 1992, IMPROVING PRAGMATIC; Thomas-Stonell N, 1994, J HEAD TRAUMA REHAB, V9, P25, DOI DOI 10.1097/00001199-199412000-00005; Wagner RK., 1999, COMPREHENSIVE TEST P; Weatherington C.E., 2006, EXCEPTIONALITY, V14, P155; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME, V3; Williams K. T., 2007, EXPRESSIVE VOCABULAR; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Woodcock R.W., 2001, WOODCOCKJOHNSON 3 TE	42	29	29	0	17	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					93	98	PII 922162312	10.1080/09084281003708852			6	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800003	20467948				2021-06-18	
J	Buritica, E; Villamil, L; Guzman, F; Escobar, MI; Garcia-Cairasco, N; Pimienta, HJ				Buritica, Efrain; Villamil, Liliana; Guzman, Francisco; Escobar, Martha I.; Garcia-Cairasco, Norberto; Pimienta, Heman J.			Changes in Calcium-Binding Protein Expression in Human Cortical Contusion Tissue	JOURNAL OF NEUROTRAUMA			English	Article						calcium-binding proteins; epileptogenesis; GABA interneurons; human traumatic brain injury	CHANDELIER CELL AXONS; HUMAN TEMPORAL CORTEX; PREFRONTAL CORTEX; PARVALBUMIN-IMMUNOREACTIVITY; SYNAPTIC CONNECTIONS; CALBINDIN D-28K; CEREBRAL-CORTEX; NEURONS; CALRETININ; RAT	Traumatic brain injury (TBI) produces several cellular changes, such as gliosis, axonal and dendritic plasticity, and inhibition-excitation imbalance, as well as cell death, which can initiate epileptogenesis. It has been demonstrated that dysfunction of the inhibitory components of the cerebral cortex after injury may cause status epilepticus in experimental models; we proposed to analyze the response of cortical interneurons and astrocytes after TBI in humans. Twelve contusion samples were evaluated, identifying the expression of glial fibrillary acidic protein (GFAP) and calcium-binding proteins (CaBPs). The study was made in sectors with and without preserved cytoarchitecture evaluated with NeuN immunoreactivity (IR). In sectors with total loss of NeuN-IR the results showed a remarkable loss of CaBP-IR both in neuropil and somata. In sectors with conserved cytoarchitecture less drastic changes in CaBP-IR were detected. These changes include a decrease in the amount of parvalbumin (PV-IR) neurons in layer II, an increase of calbindin (CB-IR) neurons in layers III and V, and an increase in calretinin (CR-IR) neurons in layer II. We also observed glial fibrillary acidic protein immunoreactivity (GFAP-IR) in the white matter, in the gray-white matter transition, and around the sectors with NeuN-IR total loss. These findings may reflect dynamic activity as a consequence of the lesion that is associated with changes in the excitatory circuits of neighboring hyperactivated glutamatergic neurons, possibly due to the primary impact, or secondary events such as hypoxia-ischemia. Temporal evolution of these changes may be the substrate linking severe cortical contusion and the resulting epileptogenic activity observed in some patients.	[Buritica, Efrain; Villamil, Liliana; Guzman, Francisco; Escobar, Martha I.; Pimienta, Heman J.] Univ Valle, Centro Estudios Cerebrales, Fac Salud, Cali, Valle, Colombia; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Sch Med, Sao Paulo, Brazil	Pimienta, HJ (corresponding author), Univ Valle, Centro Estudios Cerebrales, Fac Salud, Calle 4B 36-00, Cali, Valle, Colombia.	hempim@yahoo.com	Buritica, Efrain/C-3315-2011; Cairasco, Norberto Garcia/E-3250-2015; Escobar, Martha/E-4288-2015; Escobar, Martha Isabel/C-3310-2011	Cairasco, Norberto Garcia/0000-0001-8857-3775; Escobar, Martha/0000-0002-0036-7473; Buritica Ramirez, Efrain/0000-0001-6747-9587; Pimienta, Hernan/0000-0002-8254-2078	ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [1106-04-16329]; Fundacao de amparo a Pesquisa do estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50261-4]; FAPESP-CinapceFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/56447-7]; Conselho Nacional de Desenvolvimento cientifico e Technologico Programa Sud-Americano de Apoyoa a las actividades deCooperacion en Ciencia y technologia (CNPq-PROSUL) BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [490660/2007-0]	The authors wish to thanks Colciencias for financial support (code 1106-04-16329). N.G.C. is a principal investigator in Fundacao de amparo a Pesquisa do estado de Sao Paulo (FAPESP) (grant no. 2007/50261-4), FAPESP-Cinapce (grant no. 2005/56447-7,) and Conselho Nacional de Desenvolvimento cientifico e Technologico Programa Sud-Americano de Apoyoa a las actividades deCooperacion en Ciencia y technologia (CNPq-PROSUL) Brazil Project (grant no. 490660/2007-0). E.B., M.I.E., and H.J.P. are invited collaborators at the CNPq-PROSUL-Brazil Project. Special thanks to Olagide Wagner Castro and Artur Fernandes of the Neurophysiology and Experimental Neuroethology Laboratory for their excellent technical support and training on the use of the Olympus BX-60/Optronics/Image ProPlus image capturing system to E.B.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Ashman TA, 2006, MT SINAI J MED, V73, P999; Barbado MV, 2002, EXP NEUROL, V177, P133, DOI 10.1006/exnr.2002.7951; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Blumcke I, 1996, J NEUROPATH EXP NEUR, V55, P329; Buritica-Ramirez E, 2007, REV LAT AM PSICOL, V39, P127; Chu ZG, 2003, J NEUROSCI, V23, P96; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DEFELIPE J, 1989, P NATL ACAD SCI USA, V86, P2093, DOI 10.1073/pnas.86.6.2093; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; delRio MR, 1997, J CHEM NEUROANAT, V13, P243, DOI 10.1016/S0891-0618(97)00050-1; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Fajardo C, 2008, NEUROSCI LETT, V435, P215, DOI 10.1016/j.neulet.2008.02.048; FONSECA M, 1993, NEUROSCIENCE, V55, P1107, DOI 10.1016/0306-4522(93)90324-9; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; Gonzalez-Albo MC, 2001, CEREB CORTEX, V11, P1170, DOI 10.1093/cercor/11.12.1170; HOF PR, 1993, NEUROSCI LETT, V152, P145, DOI 10.1016/0304-3940(93)90504-E; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; Escobar MI, 2008, COLOMB MEDICA, V39, P51; Kang YS, 2002, NEUROSCI LETT, V330, P104, DOI 10.1016/S0304-3940(02)00723-1; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Medina AM, 2008, COLOMB MEDICA, V39, P14; MEDINA AM, 2002, REV COLOMB PSIQUIATR, V31, P187; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Pantazopoulos H, 2007, BIOL PSYCHIAT, V61, P640, DOI 10.1016/j.biopsych.2006.04.026; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ruttimann E, 2004, BIOCHEM PHARMACOL, V68, P1613, DOI 10.1016/j.bcp.2004.07.019; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573; Tooney PA, 2004, PROG NEURO-PSYCHOPH, V28, P273, DOI 10.1016/j.pnpbp.2003.10.004; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Yang L, 1997, J NEUROPHYSIOL, V78, P2804; Yang L, 1998, NEUROSCI LETT, V257, P33, DOI 10.1016/S0304-3940(98)00798-8; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yenari MA, 2001, STROKE, V32, P1028, DOI 10.1161/01.STR.32.4.1028	45	29	32	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2145	2155		10.1089/neu.2009.0894			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200002	19645526				2021-06-18	
J	Chen, WA; Smith, R; Ji, SY; Ward, KR; Najarian, K				Chen, Wenan; Smith, Rebecca; Ji, Soo-Yeon; Ward, Kevin R.; Najarian, Kayvan			Automated ventricular systems segmentation in brain CT images by combining low-level segmentation and high-level template matching	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article; Proceedings Paper	International Workshop on Biomedical and Health Informatics	NOV 03, 2008	Philadelphia, PA				MAGNETIC-RESONANCE IMAGES; CLASSIFICATION; EXTRACTION; PLANE; MR	Background: Accurate analysis of CT brain scans is vital for diagnosis and treatment of Traumatic Brain Injuries (TBI). Automatic processing of these CT brain scans could speed up the decision making process, lower the cost of healthcare, and reduce the chance of human error. In this paper, we focus on automatic processing of CT brain images to segment and identify the ventricular systems. The segmentation of ventricles provides quantitative measures on the changes of ventricles in the brain that form vital diagnosis information. Methods: First all CT slices are aligned by detecting the ideal midlines in all images. The initial estimation of the ideal midline of the brain is found based on skull symmetry and then the initial estimate is further refined using detected anatomical features. Then a two-step method is used for ventricle segmentation. First a low-level segmentation on each pixel is applied on the CT images. For this step, both Iterated Conditional Mode (ICM) and Maximum A Posteriori Spatial Probability (MASP) are evaluated and compared. The second step applies template matching algorithm to identify objects in the initial low-level segmentation as ventricles. Experiments for ventricle segmentation are conducted using a relatively large CT dataset containing mild and severe TBI cases. Results: Experiments show that the acceptable rate of the ideal midline detection is over 95%. Two measurements are defined to evaluate ventricle recognition results. The first measure is a sensitivity-like measure and the second is a false positive-like measure. For the first measurement, the rate is 100% indicating that all ventricles are identified in all slices. The false positives-like measurement is 8.59%. We also point out the similarities and differences between ICM and MASP algorithms through both mathematically relationships and segmentation results on CT images. Conclusion: The experiments show the reliability of the proposed algorithms. The novelty of the proposed method lies in its incorporation of anatomical features for ideal midline detection and the two-step ventricle segmentation method. Our method offers the following improvements over existing approaches: accurate detection of the ideal midline and accurate recognition of ventricles using both anatomical features and spatial templates derived from Magnetic Resonance Images.	[Chen, Wenan; Smith, Rebecca; Ji, Soo-Yeon; Najarian, Kayvan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Ward, Kevin R.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA USA	Chen, WA (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, 401 E Main St, Richmond, VA 23284 USA.	chenw6@vcu.edu; smithr@vcu.edu; jisy@vcu.edu; krward@vcu.edu; knajarian@vcu.edu	Najarian, Kayvan/B-2303-2010				BAK E, 2004, P INT C INF TECHN CO; BESAG J, 1986, J ROY STAT SOC B MET, V48, P259; CHEN W, 2008, BIOINF BIOM WORKSH 2, P48; DING F, 2005, 1 INT WORKSH COMP VI, P459; He RJ, 2008, ANN BIOMED ENG, V36, P1580, DOI 10.1007/s10439-008-9520-1; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Khoo VS, 1997, RADIOTHER ONCOL, V42, P1, DOI 10.1016/S0167-8140(96)01866-X; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee ME, 2007, INT C INTELL COMP CO, P105; Leung CK, 1997, IEE P-VIS IMAGE SIGN, V144, P161, DOI 10.1049/ip-vis:19971181; LI HY, 1995, IEEE T MED IMAGING, V14, P212, DOI 10.1109/42.387703; Liao CC, 2006, ICDM 2006: SIXTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, WORKSHOPS, P463; Liu YX, 2001, IEEE T MED IMAGING, V20, P175, DOI 10.1109/42.918469; LONCARIC S, 1997, P 9 INT C IM AN PROC, P388; Moore EE, 2003, TRAUMA; Novack T., 2000, TBI INFORM INTRO BRA; Ochs RA, 2007, MED IMAGE ANAL, V11, P315, DOI 10.1016/j.media.2007.03.004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pitiot A, 2004, NEUROIMAGE, V23, pS85, DOI 10.1016/j.neuroimage.2004.07.040; Prima S, 2002, IEEE T MED IMAGING, V21, P122, DOI 10.1109/42.993131; Reddick WE, 1997, IEEE T MED IMAGING, V16, P911, DOI 10.1109/42.650887; Schonmeyer R, 2006, MAGN RESON IMAGING, V24, P1377, DOI 10.1016/j.mri.2006.08.013; VANLEEMPUT K, 2006, P MICCAI, P704; Weng J, 1997, IEEE T MED IMAGING, V16, P378, DOI 10.1109/42.611346; WM W, 1996, IEEE T MED IMAGING, V15, P429; Xia Y, 2004, NEUROIMAGE, V21, P269, DOI 10.1016/j.neuroimage.2003.09.029	26	29	29	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	NOV 3	2009	9			1					S4	10.1186/1472-6947-9-S1-S4			14	Medical Informatics	Medical Informatics	587XW	WOS:000277030800004	19891798	DOAJ Gold, Green Published			2021-06-18	
J	Genet, F; Marmorat, JL; Lautridou, C; Schnitzler, A; Mailhan, L; Denormandie, P				Genet, F.; Marmorat, J. -L.; Lautridou, C.; Schnitzler, A.; Mailhan, L.; Denormandie, P.			Impact of late surgical intervention on heterotopic ossification of the hip after traumatic neurological injury	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							SPINAL-CORD-INJURY; BRAIN-INJURY; BONE-FORMATION; ARTICULAR-CARTILAGE; RADIATION-THERAPY; RESECTION; IMMOBILIZATION; EXCISION; KNEE	Heterotopic ossification (HO) of the hip after injury to the central nervous system can lead to joint ankylosis. Surgery is usually delayed to avoid recurrence, even if the functional status is affected. We report a consecutive series of patients with HO of the hip after injury to the central nervous system who required surgery in a single, specialised tertiary referral unit. As was usual practice, they all underwent CT to determine the location of the HO and to evaluate the density of the femoral head and articular surface. The outcome of surgery was correlated with the pre-, peri- and post-operative findings. In all, 183 hips (143 patients) were included of which 70 were ankylosed. A total of 25 peri-operative fractures of the femoral neck occurred, all of which arose in patients with ankylosed hips and were associated with intra-articular lesions in 18 and severe osteopenia of the femoral head in seven. All the intra-articular lesions were predicted by CT and strongly associated with post-operative complications. The loss of the range of movement before ankylosis is a more important factor than the maturity of the HO in deciding the timing of surgery. Early surgical intervention minimises the development of intra-articular pathology, osteoporosis and the resultant complications without increasing the risk of recurrence of HO.	[Genet, F.] Hosp R Poincare, Serv Med Physioque & Readaptat, F-92380 Garches, France	Genet, F (corresponding author), Hosp R Poincare, Serv Med Physioque & Readaptat, 104 Blvd R Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; BAIRD EO, 2009, J ORTHOP SURG RES, V20, P12; Baker W de C, 1969, J Bone Joint Surg Br, V51, P736; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Board TN, 2007, J BONE JOINT SURG BR, V89B, P434, DOI 10.1302/0301-620X.89B4.18845; Brissot R., 2005, Annales de Readaptation et de Medecine Physique, V48, P581, DOI 10.1016/j.annrmp.2005.04.014; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; Dai LY, 1998, CHINESE MED J-PEKING, V111, P1099; Denys P, 1996, BRAIN INJURY, V10, P149, DOI 10.1080/026990596124656; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; ENNEKING WF, 1972, J BONE JOINT SURG AM, VA 54, P973, DOI 10.2106/00004623-197254050-00003; Freebourn TM, 1999, SPINAL CORD, V37, P50, DOI 10.1038/sj.sc.3100719; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GUILLAUMAT M, 1988, CAHIERS ENSEIGNEMENT, P257; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jaovisidha S, 1998, SPINAL CORD, V36, P647, DOI 10.1038/sj.sc.3100701; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Maier D, 2005, ORTHOPADE, V34, P120, DOI 10.1007/s00132-004-0754-9; MAJOR P, 1980, RADIOLOGY, V136, P797, DOI 10.1148/radiology.136.3.6773108; Meiners T, 1997, SPINAL CORD, V35, P443, DOI 10.1038/sj.sc.3100415; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Narmoneva DA, 2002, J ORTHOP RES, V20, P83, DOI 10.1016/S0736-0266(01)00076-6; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; PAUKKONEN K, 1986, CLIN ORTHOP RELAT R, V206, P270; Pelissier J., 2002, Annales de Readaptation et de Medecine Physique, V45, P188, DOI 10.1016/S0168-6054(02)00202-7; SALTER RB, 1960, J BONE JOINT SURG AM, V42, P31, DOI 10.2106/00004623-196042010-00004; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; Shehab D, 2002, J NUCL MED, V43, P346; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	42	29	31	0	2	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X	2044-5377		J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	NOV	2009	91B	11					1493	1498		10.1302/0301-620X.91B11.22305			6	Orthopedics; Surgery	Orthopedics; Surgery	513ZK	WOS:000271362600017	19880896				2021-06-18	
J	Olivecrona, M; Rodling-Wahlstrom, M; Naredi, S; Koskinen, LOD				Olivecrona, M.; Rodling-Wahlstrom, M.; Naredi, S.; Koskinen, L-O D.			S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SEVERE HEAD-INJURY; SERUM S100B LEVELS; PROTEIN MEASUREMENTS; CEREBROSPINAL-FLUID; CARDIAC-SURGERY; DAMAGE; MARKERS; BLOOD; ELIMINATION; TOMOGRAPHY	Objective: To prospectively study S-100B and neuron specific enolase (NSE) levels in subjects treated for severe head injury (sTBI), and investigate the prognostic value of these biomarkers. Methods: Subjects included in a prospective double blind randomised study for sTBI. Inclusion criteria: Glasgow Coma Score (GCS) <= 8, age 15-70 years, first recorded cerebral perfusion pressure of >10 mm Hg and arrival, 24 h after trauma. Subjects were treated with an intracranial pressure (ICP) targeted therapy. Blood samples for S-100B and NSE were drawn immediately after arrival and every 12 h for 5 days. Outcome was evaluated as Glasgow Outcome Scale (GOS) by independent staff at 3 and 12 months. Results: 48 subjects, mean age 35.5 years, and median GCS 6 were included. The first blood sample was drawn at 15.6 (1.4) h after injury. Initial concentration of S-100B was 1.04 (0.21) mu g/l and for NSE 18.94 (2.32) mu g/l. The biomarkers were significantly higher in subjects with GCS 3 and in those who died compared with those with GCS 4-8 and GOS 2-5, respectively. Receiver operated characteristic curve analyses of the initial S-100B and NSE levels to GOS dichotomised as unfavourable (GOS 1-3) and favourable (GOS 4-5) showed a weak correlation: AUC 0.585 and 0.555, respectively. Using the dichotomisation dead (GOS 1)/alive (GOS 2-5), the AUC values were 0.687 and 0.734, respectively. Furthermore, a correlation was found between the biomarkers themselves and the biomarkers and ICP. Conclusion: At 3 and 12 months after trauma, no differences in prognostic values between the markers were apparent nor was there any clinical significant value of the markers as predictors of clinical outcome.	[Olivecrona, M.; Koskinen, L-O D.] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, Div Neurosurg, S-90185 Umea, Sweden; [Rodling-Wahlstrom, M.; Naredi, S.] Umea Univ Hosp, Dept Surg & Perioperat Sci, Div Anaesthesiol, S-90185 Umea, Sweden	Olivecrona, M (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@vll.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Naredi, Silvana/0000-0002-4409-6089	Department of Clinical Neurosciences; University Hospital Research Found; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation	This study was financially supported by the Department of Clinical Neurosciences, University Hospital Research Found, Tore Nilsson Foundation, Kempe Foundation and Capio Research Foundation.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; RABOW L, 1985, ACTA NEUROCHIR, V76, P137, DOI 10.1007/BF01418476; Rabow L, 1979, Acta Neurochir Suppl (Wien), V28, P108; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 2000, ACT NEUR S, V76, P97; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2007, NEUROCRIT CARE, V6, P94, DOI 10.1007/s12028-007-0005-0; USUI A, 1989, CLIN CHEM, V35, P1942; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; Ytrebo LM, 2000, SCAND J GASTROENTERO, V35, P546	39	29	30	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2009	80	11					1241	1247		10.1136/jnnp.2008.158196			7	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	512PE	WOS:000271261400206	19602473				2021-06-18	
J	Sugiyama, K; Kondo, T; Oouchida, Y; Suzukamo, Y; Higano, S; Endo, M; Watanabe, H; Shindo, K; Izumi, SI				Sugiyama, Ken; Kondo, Takeo; Oouchida, Yutaka; Suzukamo, Yoshimi; Higano, Shuichi; Endo, Minoru; Watanabe, Hiroshi; Shindo, Keiichiro; Izumi, Shin-Ichi			Clinical Utility of Diffusion Tensor Imaging for Evaluating Patients with Diffuse Axonal Injury and Cognitive Disorders in the Chronic Stage	JOURNAL OF NEUROTRAUMA			English	Article						cognitive disorder; diffuse axonal injury; diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; LESIONS; HIPPOCAMPUS; AMYGDALA; MONKEYS; MEMORY; DAMAGE; TRAIL; MRI	Although diffuse axonal injury (DAI) usually ellicits cognitive disorders, abnormal brain findings are generally undetected by conventional imaging techniques. The aim of this study was to evaluate the feasibility of using diffusion tensor imaging (DTI) to detect lesions in DAI patients and to investigate the correlation between DAI lesions and cognitive disorders. We examined 16 healthy controls and 11 patients with DAI. Using voxel-based analysis, we found that there were significantly more brain regions with decreased fractional anisotropy (FA) in the brain but DAI patients compared to healthy controls (p < 0.001), whereas few lesions were detected via conventional magnetic resonance imaging. There was a significant relationship between the results of the Wechsler Adult Intelligence Scale-Revised, Trail Making Test, and some indices of the Wechsler Memory Scale-Revised and the decreased FA observed in various areas of the brain (p < 0.001). The total cognitive scores on the functional independence and functional assessment measures, which represent behavioral problems, were correlated with the cluster (number of DAI lesions, p = 0.007) and voxel numbers (total size of all DAI lesions, p = 0.001). In the fiber tractography-based analysis, DAI patients with memory disorders showed an interruption of fibers within the fornix compared to healthy controls. These results indicate that DTI is a useful technique not only for detecting DAI lesions but also for examining cognitive disorders in DAI patients.	[Sugiyama, Ken] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Higano, Shuichi] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808575, Japan; [Endo, Minoru] Tohoku Employees Pens Welf Hosp, Div Neurol, Sendai, Miyagi, Japan; [Watanabe, Hiroshi] Tohoku Employees Pens Welf Hosp, Div Phys Med & Rehabil, Sendai, Miyagi, Japan	Sugiyama, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Aoba Ku, 2-1 Seiryocho, Sendai, Miyagi 9808575, Japan.	s-ken@mail.tains.tohoku.ac.jp	Suzukamo, Yoshimi/T-6500-2019; oocuhida, yutaka/H-8686-2019	Oouchida, Yutaka/0000-0002-6367-7081; Suzukamo, Yoshimi/0000-0001-7162-4871	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20240056] Funding Source: KAKEN		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Ezaki Y, 2006, ACTA NEUROCHIR, V148, P547, DOI 10.1007/s00701-005-0692-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; FUJIWARA T, 2001, JPN J REHABIL MED, V38, P253; Furutani K, 2005, J MED INVESTIG, V52, P186, DOI 10.2152/jmi.52.186; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, P854; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; KADO Y, 2004, TO HATTATSU, V36, P475; KASHIMA H, 1995, BRAIN SCI MENT DISOR, V6, P209; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Murray EA, 1998, J NEUROSCI, V18, P6568; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Takeda Takahiro, 2007, Rinsho Shinkeigaku, V47, P135; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Toyokura M., 1996, BRAIN SCI MENTAL DIS, V7, P401; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; WECHSLER D, 1984, MANUAL WECHSLER MEMO; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, BEHAV ASSESSMENT DYS; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	51	29	37	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1879	1890		10.1089/neu.2008.0839			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600003	19514848				2021-06-18	
J	Zemlyak, I; Sapolsky, R; Gozes, I				Zemlyak, Ilona; Sapolsky, Robert; Gozes, Illana			NAP protects against cytochrome c release: Inhibition of the initiation of apoptosis	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Neuroprotection; Microtubule; Oxygen-glucose deprivation; Cytochrome c; Cortical neuron; Neuroprotective peptide	DEPENDENT NEUROPROTECTIVE PROTEIN; FETAL ALCOHOL SYNDROME; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; MOUSE MODEL; ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; DRUG CANDIDATE	NAPVSIPQ (NAP), an 8 amino acid peptide derived from activity-dependent neuroprotective protein (ADNP), provides neuroprotection through interaction with microtubules. Previous results have demonstrated NAP protection against oxygen-glucose deprivation in hippocampal cells in culture. Furthermore, in vivo studies have shown that NAP reduces caspase 3 activation in rats subjected to permanent mid-cerebral artery occlusion (a rat model of stroke). Oxygen-glucose deprivation (ischemia) has been associated with microtubule breakdown and cytochrome c release from mitochondria leading to apoptosis. Here, NAP in concentrations ranging from 10(-14) M to 10(-8) M Completely blocked cytochrome c release in cortical neurons subjected to oxygen-glucose deprivation. Furthermore, quantitative microscopy coupled to microtubule immunocytochemistry suggested that NAP prevented microtubule degradation under oxidative stress. As cytochrome c release is a known initiator of the apoptotic pathway, it is suggested that NAP inhibits the early events of apoptosis. (C) 2009 Elsevier B.V. All rights reserved.	[Sapolsky, Robert; Gozes, Illana] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Zemlyak, Ilona; Sapolsky, Robert] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Gozes, I (corresponding author), Lily & Avraham Gildor Chair Invest Growth Factors, Tel Aviv, Israel.	igozes@post.tau.ac.il					Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brooke S, 1997, P NATL ACAD SCI USA, V94, P9457, DOI 10.1073/pnas.94.17.9457; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Cattano D, 2008, NEUROSCI LETT, V440, P217, DOI 10.1016/j.neulet.2008.05.086; CHEN S, 2008, P NATL ACAD SCI US; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cosgrave AS, 2008, NEUROBIOL DIS, V30, P281, DOI 10.1016/j.nbd.2008.02.005; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Furman S, 2004, NEURON GLIA BIOL, V1, P193, DOI 10.1017/S1740925X05000013; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Gozes I, 2007, CURR ALZHEIMER RES, V4, P507, DOI 10.2174/156720507783018208; Gozes I, 2005, CNS DRUG REV, V11, P353; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Gozes Illana, 2006, Current Alzheimer Research, V3, P197; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; Longuet M, 2004, INT J ONCOL, V25, P309; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Olney JW, 2002, NEUROBIOL DIS, V9, P205, DOI 10.1006/nbdi.2001.0475; Pascual M, 2007, J NEUROCHEM, V103, P557, DOI 10.1111/j.1471-4159.2007.04761.x; Poggi SH, 2003, AM J OBSTET GYNECOL, V189, P790, DOI 10.1067/S0002-9378(03)00834-2; Rotstein M, 2006, J PHARMACOL EXP THER, V319, P332, DOI 10.1124/jpet.106.106898; Santa-Maria I, 2005, BBA-MOL BASIS DIS, V1740, P472, DOI 10.1016/j.bbadis.2004.11.024; Sari Y, 2006, BRAIN RES REV, V52, P107, DOI 10.1016/j.brainresrev.2006.01.004; SCHMECHEL DE, 2008, J ALZHEIMERS ASS, V4, pT483; Seyb KI, 2006, J MOL NEUROSCI, V28, P111, DOI 10.1385/JMN:28:2:111; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Steingart RA, 2000, J MOL NEUROSCI, V15, P137, DOI 10.1385/JMN:15:3:137; Stewart AJ, 2007, EXPERT OPIN INV DRUG, V16, P1183, DOI 10.1517/13543784.16.8.1183; Valleggi S, 2008, J NEUROSURG ANESTH, V20, P226, DOI 10.1097/ANA.0b013e31817da878; Visochek L, 2005, J NEUROSCI, V25, P7420, DOI 10.1523/JNEUROSCI.0333-05.2005; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Zaltzman R, 2005, PEPTIDES, V26, P1520, DOI 10.1016/j.peptides.2005.03.014; Zaltzman R, 2004, J MOL NEUROSCI, V24, P181, DOI 10.1385/JMN:24:2:181; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1; Zemlyak I, 2007, PEPTIDES, V28, P2004, DOI 10.1016/j.peptides.2007.08.004; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	51	29	30	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	SEP 15	2009	618	1-3					9	14		10.1016/j.ejphar.2009.07.013			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	498BN	WOS:000270110500002	19619522				2021-06-18	
J	Ortolano, F; Colombo, A; Zanier, ER; Sclip, A; Longhi, L; Perego, C; Stocchetti, N; Borsello, T; De Simoni, MG				Ortolano, Fabrizio; Colombo, Alessio; Zanier, Elisa Roncati; Sclip, Allessandra; Longhi, Luca; Perego, Carlo; Stocchetti, Nino; Borsello, Tiziana; De Simoni, Maria Grazia			c-Jun N-Terminal Kinase Pathway Activation in Human and Experimental Cerebral Contusion	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Brain contusion; c-Jun N-terminal kinase pathway; D-JNKI1; Neuroprotection; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; CELL-DEATH; PEPTIDE INHIBITOR; HEAD-INJURY; SELECTIVE VULNERABILITY; SIGNAL-TRANSDUCTION; NEURONAL APOPTOSIS; COGNITIVE DEFICITS; ACOUSTIC TRAUMA	The c-Jun N-terminal kinase (JNK) pathway is involved in cell stress and apoptosis. We tested the hypothesis that this pathway plays a role in traumatic brain injury (TBI) by assessing JNK activation in human brain tissues and in brains of mice subjected to controlled cortical impact brain injury. We also assessed the effects of specific inhibition of the JNK pathway by the cell-permeable JNK inhibitor peptide, D-JNKI1, on neurobehavioral function and posttraumatic cell loss in mice. The inhibitor was administered intraperitoneally 10 minutes after injury. The JNK pathway showed robust activation both in human contusion specimens and in injured cortex and hippocampi of TBI-injured mice, 1, 4, and 48 hours after injury. D-JNKI1 treatment significantly improved motor performance at 48 hours and 7 days after injury and reduced the contusion volume compared with saline treatment; the numbers of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells were significantly decreased in the hippocampi of injured mice 48 hours after treatment. Thus, because the JNK pathway is activated after human and experimental TBI and the inhibitor peptide D-JNKI1 affords significant neuroprotection and amelioration of neurobehavioral deficits after experimental TBI, therapeutic targeting of the JNK activation pathway may hold promise for future clinical applications.	[De Simoni, Maria Grazia] Mario Negri Inst Pharmacol Res, Lab Inflammat & Nervous Syst Dis, Dept Neurosci, I-20156 Milan, Italy; [Ortolano, Fabrizio; Zanier, Elisa Roncati; Longhi, Luca; Stocchetti, Nino] Univ Milan, Neurosurg Intens Care Unit, Dept Anesthesia & Crit Care Med, Fdn IRCCS,Osped Maggiore Policlin, Milan, Italy	De Simoni, MG (corresponding author), Mario Negri Inst Pharmacol Res, Lab Inflammat & Nervous Syst Dis, Dept Neurosci, I-20156 Milan, Italy.	desimoni@marionegri.it	Stocchetti, Nino/O-7444-2017; Borsello, Tiziana/ABG-7759-2020; Longhi, Luca/AAF-9903-2021; Zanier, Elisa/AAA-8095-2020; Perego, Carlo/AAA-6513-2020; De Simoni, Maria Grazia/I-6021-2012; Borsello, Tiziana/J-8232-2016	Stocchetti, Nino/0000-0003-3250-6834; Longhi, Luca/0000-0001-9894-8788; Perego, Carlo/0000-0002-0259-0003; De Simoni, Maria Grazia/0000-0001-6695-5297; Zanier, Elisa/0000-0002-3011-8718; Ortolano, Fabrizio/0000-0003-1996-948X; Borsello, Tiziana/0000-0002-9729-7642	Botnar Foundation FNRS (Swiss National Science Foundation)Swiss National Science Foundation (SNSF) [310000-107888]	Tiziana Borsello was supported by Grant No. 310000-107888 from the Botnar Foundation FNRS (Swiss National Science Foundation).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Beckham JD, 2007, J VIROL, V81, P6984, DOI 10.1128/JVI.00467-07; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hirt L, 2004, STROKE, V35, P1738, DOI 10.1161/01.STR.0000131480.03994.b1; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/0897715042664876; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Suckfuell M, 2007, ACTA OTO-LARYNGOL, V127, P938, DOI 10.1080/00016480601110212; TEASDALE G, 1974, LANCET, V2, P81; Wang J, 2003, J NEUROSCI, V23, P8596; Yao MZ, 2005, J NEUROSCI, V25, P1149, DOI 10.1523/JNEUROSCI.4736-04.2005; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	43	29	29	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	SEP	2009	68	9					964	971		10.1097/NEN.0b013e3181b20670			8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	491LV	WOS:000269581300002	19680147	Bronze			2021-06-18	
J	Kelso, ML; Scheff, SW; Pauly, JR; Loftin, CD				Kelso, Matthew L.; Scheff, Stephen W.; Pauly, James R.; Loftin, Charles D.			Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice	BMC NEUROSCIENCE			English	Article							CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; INDUCIBLE CYCLOOXYGENASE; BENZODIAZEPINE-RECEPTORS; PERSISTENT ACCUMULATION; INFLAMMATORY RESPONSE; ACTIVATED MICROGLIA; UP-REGULATION; RAT	Background: Neuroinflammation contributes to the pathophysiology of acute CNS injury, including traumatic brain injury (TBI). Although prostaglandin lipid mediators of inflammation contribute to a variety of inflammatory responses, their importance in neuroinflammation is not clear. There are conflicting reports as to the efficacy of inhibiting the enzymes required for prostaglandin formation, cyclooxygenase (COX)-1 and COX-2, for improving outcomes following TBI. The purpose of the current study was to determine the role of the COX isoforms in contributing to pathological processes resulting from TBI by utilizing mice deficient in COX-1 or COX-2. Results: Following a mild controlled cortical impact injury, the amount of cortical tissue loss, the level of microglial activation, and the capacity for functional recovery was compared between COX-1-deficient mice or COX-2-deficient mice, and their matching wild-type controls. The deficiency of COX-2 resulted in a minor (6%), although statistically significant, increase in the sparing of cortical tissue following TBI. The deficiency of COX-1 resulted in no detectable effect on cortical tissue loss following TBI. As determined by (3)[H]-PK11195 autoradiography, TBI produced a similar increase in microglial activation in multiple brain regions of both COX-1 wildtype and COX-1-deficient mice. In COX-2 wild-type and COX-2-deficient mice, TBI increased (3)[H]-PK11195 binding in all brain regions that were analyzed. Following injury, (3)[H]-PK11195 binding in the dentate gyrus and CA1 region of the hippocampus was greater in COX-2-deficient mice, as compared to COX-2 wild-type mice. Cognitive assessment was performed in the wildtype, COX-1-deficient and COX-2-deficient mice following 4 days of recovery from TBI. There was no significant cognitive effect that resulted from the deficiency of either COX-1 or COX-2, as determined by acquisition and spatial memory retention testing in a Morris water maze. Conclusion: These findings suggest that the deficiency of neither COX-1 nor COX-2 is sufficient to alter cognitive outcomes following TBI in mice.	[Kelso, Matthew L.; Pauly, James R.; Loftin, Charles D.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Kelso, Matthew L.; Scheff, Stephen W.; Pauly, James R.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA	Loftin, CD (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA.	mlkels2@email.uky.edu; sscheff@email.uky.edu; jim.pauly@uky.edu; cdloft2@email.uky.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL083122]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL083122] Funding Source: NIH RePORTER	The authors acknowledge the technical assistance of Deann Hopkins, Nicole Scheff, Kelly Roberts, and Alex McFarland-Watts. C. D. L is supported by the National Institutes of Health [HL083122].	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Candelario-Jalil E, 2007, J NEUROCHEM, V100, P1108, DOI 10.1111/j.1471-4159.2006.04280.x; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Giusti L, 2004, CLIN BIOCHEM, V37, P61, DOI 10.1016/j.clinbiochem.2003.10.004; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Koyfman L, 2000, J NEUROSURG ANESTH, V12, P44, DOI 10.1097/00008506-200001000-00009; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MYERS R, 1991, J CEREBR BLOOD F MET, V11, P314, DOI 10.1038/jcbfm.1991.64; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Schwab JM, 2000, ACTA NEUROPATHOL, V99, P609, DOI 10.1007/s004010051170; Schwab JM, 2000, J NEUROIMMUNOL, V111, P122, DOI 10.1016/S0165-5728(00)00372-6; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Venneti S, 2007, NEUROSCI LETT, V426, P117, DOI 10.1016/j.neulet.2007.08.053; Venneti S, 2009, NEUROBIOL AGING, V30, P1217, DOI 10.1016/j.neurobiolaging.2007.11.005; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	41	29	29	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	AUG 31	2009	10								108	10.1186/1471-2202-10-108			9	Neurosciences	Neurosciences & Neurology	503SB	WOS:000270558800001	19719848	DOAJ Gold, Green Published			2021-06-18	
J	Liu, W; Zhou, XW; Liu, SJ; Hu, KH; Wang, C; He, QY; Li, MT				Liu, Wei; Zhou, Xing-wang; Liu, Shaojun; Hu, Kunhua; Wang, Chong; He, Qingyu; Li, Mingtao			Calpain-truncated CRMP-3 and-4 contribute to potassium deprivation-induced apoptosis of cerebellar granule neurons	PROTEOMICS			English	Article						Apoptosis; Calpain substrates; CRMPs; Neuron	RESPONSE MEDIATOR PROTEINS; TRAUMATIC BRAIN-INJURY; FAS-INDUCED APOPTOSIS; PROTEOME ANALYSIS; CELL-DEATH; ALZHEIMERS-DISEASE; PROTEASE FAMILIES; NERVOUS-SYSTEM; GROWTH CONES; CROSS-TALK	Increasing evidence shows that calpain-mediated proteolytic processing of a selective number of proteins plays an important role in neuronal apoptosis. Study of calpain-mediated cleavage events and related functions may contribute to a better understanding of neuronal apoptosis and neurodegenerative diseases. We, therefore, investigated the role of calpain substrates in potassium deprivation-induced apoptosis of cerebellar granule neurons (CGNs). Twelve previously known and seven novel candidates of calpain substrates were identified by 2-D DIGE and MALDI-TOF/TOF MS analysis. Further, the identified novel calpain substrates were validated by Western blot analysis. Moreover, we focused on the collapsin response mediator proteins (CRMP-1, -2, -3 and -4 isoforms) and found that CRMPs were proteolytically processed by calpain but not by caspase, both in vivo and in vitro. To clarify the properties of the calpain-mediated proteolysis of CRMPs, we constructed the deletion mutants of CRMPs for additional biochemical studies. In vitro cleavage assays revealed that CRMP-1, -2 and -4 were truncated by calpain at the C-terminus, whereas CRMP-3 was cleaved at the N-terminus. Finally, we assessed the role of CRMPs in the process of potassium deprivation-triggered neuronal apoptosis by overexpressing the truncated CRMPs in CGNs. Our data clearly showed that the truncated CRMP-3 and -4, but not CRMP-1 and -2, significantly induced neuronal apoptosis. These findings demonstrated that calpain-truncated CRMP-3 and -4 act as pro-apoptotic players when CGNs undergo apoptosis.	[Liu, Wei; Zhou, Xing-wang; Liu, Shaojun; Hu, Kunhua; Wang, Chong; Li, Mingtao] Sun Yat Sen Univ, Prote Ctr, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Shaojun; Hu, Kunhua; Wang, Chong; Li, Mingtao] Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [He, Qingyu] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China	Li, MT (corresponding author), Sun Yat Sen Univ, Prote Ctr, Zhongshan Sch Med, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	limt@mail.sysu.edu.cn	Liu, Wei/AAH-5037-2020; He, Qing-Yu/H-7078-2014	Liu, Wei/0000-0002-4935-7591; He, Qing-Yu/0000-0003-0503-9492	NSFCNational Natural Science Foundation of China (NSFC) [U0632006, 30629002, 30870786, 30870988]	This work was supported by grants from NSFC (No. U0632006, No. 30629002 and No. 30870786 to M-T Li, and No. 30870988 to X-W Zhou). The authors thank Dr. Joachim Kappler for generously providing anti-CRMPs sera and pQE-80-CRMps constructions, and Dr. Bjorn Kafsack for critically reading the manuscript.	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; Bachis A, 2003, J NEUROSCI, V23, P5715; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cadel S, 1997, P NATL ACAD SCI USA, V94, P2963, DOI 10.1073/pnas.94.7.2963; Canals F, 2006, PROTEOMICS, V6, pS28, DOI 10.1002/pmic.200500446; Canu N, 2000, J NEUROSCI, V20, P589, DOI 10.1523/JNEUROSCI.20-02-00589.2000; Canu N, 1998, J NEUROSCI, V18, P7061; Chan SO, 1998, NEUROCHEM RES, V23, P393, DOI 10.1023/A:1022417819356; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; COOK JC, 1992, J BIOL CHEM, V267, P24315; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Kaneda Y, 1998, CELL DEATH DIFFER, V5, P20, DOI 10.1038/sj.cdd.4400315; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kimura E, 2003, BIOSCI BIOTECH BIOCH, V67, P1786, DOI 10.1271/bbb.67.1786; Kito S, 2005, J ORAL PATHOL MED, V34, P478, DOI 10.1111/j.1600-0714.2005.00346.x; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee MH, 1996, J BIOL CHEM, V271, P3420; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li MT, 2001, J NEUROSCI, V21, P6544; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; McCollum AT, 2002, J NEUROCHEM, V82, P1208, DOI 10.1046/j.1471-4159.2002.01057.x; Mori K, 2004, NEUROSCI RES, V48, P439, DOI 10.1016/j.neures.2003.12.012; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; NELSON WJ, 1983, MOL CELL BIOL, V3, P1146, DOI 10.1128/MCB.3.6.1146; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Shaw G, 2004, BIOCHEM BIOPH RES CO, V325, P619, DOI 10.1016/j.bbrc.2004.09.223; SIMAN R, 1990, J NEUROSCI, V10, P2400; Singh R, 2002, J BIOL CHEM, V277, P37630, DOI 10.1074/jbc.M203648200; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Thiede B, 2004, MASS SPECTROM REV, V23, P333, DOI 10.1002/mas.10079; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang LH, 1996, J NEUROSCI, V16, P6197; Xie M, 2007, J BIOL CHEM, V282, P23275, DOI 10.1074/jbc.M610779200; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278	81	29	31	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	JUL	2009	9	14					3712	3728		10.1002/pmic.200800979			17	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	483MN	WOS:000268971000008	19639589				2021-06-18	
J	Nicholl, J; LaFrance, WC				Nicholl, Jeffrey; LaFrance, W. Curt, Jr.			Neuropsychiatric Sequelae of Traumatic Brain Injury	SEMINARS IN NEUROLOGY			English	Article						Traumatic brain injury; concussion; neuropsychiatric sequelae; cognitive disorders; mood disorders; treatment	POSTTRAUMATIC-STRESS-DISORDER; FRONTAL-SUBCORTICAL CIRCUITS; HEAD-INJURY; DEPRESSION; SYMPTOMS; BEHAVIOR; REHABILITATION; HALOPERIDOL; ADOLESCENTS; AFGHANISTAN	The prevalence of traumatic brain injury (TBI) is increasing, particularly in the population of veterans. Many times, the motor and sensory consequences of TBI are addressed, but the post-TBI neuropsychiatric sequelae, which may be as, or even more devastating than the motor and sensory deficits, are left unattended. Cognitive, mood, anxiety, thought, impulse, and substance disorders, and a variety of personality disorders can be seen following TBI. The neuropsychiatric sequelae of TBI not only interfere with day-to-day function, but can severely impede rehabilitation efforts. To date, there have been few large-scale studies looking at the effectiveness of the various treatment modalities, including psychotherapeutic and pharmacological interventions.	[LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Brown Med Sch, Div Neuropsychiat & Behav Neurol, Providence, RI 02903 USA; [Nicholl, Jeffrey] Tulane Univ, Sch Med, Dept Psychiat & Neurol, New Orleans, LA 70112 USA	LaFrance, WC (corresponding author), Rhode Isl Hosp, Brown Med Sch, Div Neuropsychiat & Behav Neurol, 593 Eddy St,Potter 3, Providence, RI 02903 USA.	William_LaFrance_Jr@brown.edu	LaFrance, W Curt/AAN-6707-2021	LaFrance, W Curt/0000-0002-4901-3852			Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Barsky AJ, 2004, JAMA-J AM MED ASSOC, V291, P1464, DOI 10.1001/jama.291.12.1464; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brown A.D., 1979, P139; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, TRAUM BRAIN INJ US; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAROL RL, 2003, NEUROPSYCHOSOCIAL IN, P133; KAROL RL, 2003, NEUROPSYCHOSOCIAL IN, P49; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; LaFrance WC, 2009, EPILEPSY BEHAV, V14, P591, DOI 10.1016/j.yebeh.2009.02.016; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levy M, 2005, NEUROREHABILITATION, V20, P279; LINNOILA VMI, 1992, J CLIN PSYCHIAT, V53, P46; MacKenzie E J, 1989, Md Med J, V38, P725; MARIN R, 2005, TXB TRAUMATIC BRAIN, P343; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; SILVER JM, 2005, TXB TRAUMATIC BRAIN, P261; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TRZEPACZ PT, 1990, AM J PSYCHIAT, V147, P675; TRZEPACZ PT, 2005, TXB TRAUMATIC BRAIN, P182; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	66	29	31	0	12	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	JUL	2009	29	3					247	255		10.1055/s-0029-1223878			9	Clinical Neurology	Neurosciences & Neurology	464XU	WOS:000267544900008	19551601				2021-06-18	
J	Danish, SF; Barone, D; Lega, BC; Stein, SC				Danish, Shabbar F.; Barone, Dean; Lega, Bradley C.; Stein, Sherman C.			Quality of life after hemicraniectomy for traumatic brain injury in adults	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; hemicraniectomy; outcome	SEVERE HEAD-INJURY; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; CEREBRAL EDEMA; MANAGEMENT; PRESSURE; EXPERIENCE; EXPANSION; THERAPY; ICP	Decompressive hemicraniectomy is well accepted for the surgical treatment of intractable intracranial hypertension in cases in which medical management fails. Although it is performed as a life-saving procedure when death is imminent from intracranial hypertension, little is known about the functional outcomes for these patients on long-term follow-up. In this study, the authors performed a systematic review of the literature to examine neurological outcome after hemicraniectomy. A literature search revealed 29 studies that reported outcomes using GOS scores. The GOS scores were transformed to utility values for quality of life using a conversion method based on decision analysis modeling. Based on the literature, 1422 cases were analyzed. The average 6-month-postoperative mortality rate was 28.2%. The mean QOL value among survivors was 0.592, which corresponds roughly to a GOS score of 4. Although more studies are needed for validation of long-term neurological outcome after hemicraniectomy, the assumption that most patients remain in a vegetative state after this intervention is clearly incorrect. (DOI: 10.3171/2009.3.FOCUS945)	[Danish, Shabbar F.; Barone, Dean] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Neurosurg, New Brunswick, NJ 08901 USA; [Lega, Bradley C.; Stein, Sherman C.] Univ Penn Hlth Syst, Dept Neurosurg, Philadelphia, PA USA	Danish, SF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Neurosurg, 125 Paterson St,CAB 2100, New Brunswick, NJ 08901 USA.	danishsh@umdnj.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Csokay A, 2001, ACTA NEUROCHIR, V143, P173, DOI 10.1007/s007010170125; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gold M., 1996, Cost-Effectiveness in Health and Medicine.; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kunze E, 1998, ACT NEUR S, V71, P16; Lee MC, 2003, PEDIATR NEUROSURG, V38, P181, DOI 10.1159/000069096; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P373; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Ogawa M, 1974, Med J Osaka Univ, V25, P73; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Razack N, 1997, J TRAUMA, V43, P840, DOI 10.1097/00005373-199711000-00017; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schneider GH, 2002, ACT NEUR S, V81, P77; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Xiong G, 2001, Chin J Traumatol, V4, P126; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	40	29	31	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUN	2009	26	6							E2	10.3171/2009.3.FOCUS945			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	451WK	WOS:000266501400002	19485715	Bronze			2021-06-18	
J	Gould, TE; Piland, SG; Shin, J; Hoyle, CE; Nazarenko, S				Gould, Trenton E.; Piland, Scott G.; Shin, Junghwan; Hoyle, Charles E.; Nazarenko, Sergei			Characterization of mouthguard materials: Physical and mechanical properties of commercialized products	DENTAL MATERIALS			English	Article						Mouthguard materials; Impact testing; Dental materials; Shock absorption; Ethylene vinyl acetate; Material characterization	PROTECTORS; PHOTOPOLYMERS; PREVENTION; CONCUSSION; HISTORY; INJURY	Objectives. Contemporary mouthguard materials need to perform consistently over a wide range of possible temperatures (-20 to 40 degrees C). Therefore the specific aim of this study was to characterize commercialized mouthguard materials' properties and investigate the effect of temperature on these properties. Methods. Five commercially representative thermoplastic mouthguard materials (Essix (TM) Resin, Erkoflex (TM), Proform (TM)-regular, Proform (TM)-laminate, and Polyshok (TM)) were tested. The durometer hardness, water absorption, tear strength, and impact attenuation of the mouthguard materials were measured according to ASTM D2240-05, D570-98 (2005), D624-00, and ASTM D6110-06f (modified) guidelines. Tests were conducted on five separate specimens at both room 23 +/- 2 degrees C and intra-oral 37 +/- 2 degrees C temperatures. Independent t-tests (alpha=0.05) were used to test for differences between room and intra-oral temperatures. Results. Material hardness decreased (p < 0.05) from room to intra-oral temperatures for all mouthguard materials. Water absorption increased (p <0.05) from room to intra-oral temperatures for all mouthguard materials. Tear strength decreased (p<0.05) from room to intra-oral temperatures for all mouthguard materials. Impact attenuation between room and intra-oral temperatures was different (p < 0.05) for the Erkoflex (TM), Proform (TM)-laminate, and Polyshok (TM) material respectfully. However, there was no difference between temperatures for the Essix (TM) Resin (p=.058) or Proform (TM)-regular (p=.275) materials. Significance. Temperature measureably affects the physical and mechanical properties of mouthguard materials. It is particularly noteworthy that none of the commercialized products met current ANSI and SAI standards for impact attenuation. Published by Elsevier Ltd on behalf of Academy of Dental Materials.	[Gould, Trenton E.] Univ So Mississippi, Sch Human Performance, Sport & High Performance Mat Program, Hattiesburg, MS 39406 USA; [Shin, Junghwan; Hoyle, Charles E.; Nazarenko, Sergei] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA	Gould, TE (corresponding author), Univ So Mississippi, Sch Human Performance, Sport & High Performance Mat Program, 118 Coll Dr,5142, Hattiesburg, MS 39406 USA.	Trent.Gould@usm.edu					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM NAT STAND I AM, 2001, 99 AM NAT STAND I AM; [Anonymous], 2005, D2240 ASTM; *ASTM, 2000, D624 ASTM; *ASTM, 2000, 697 ASTM; ASTM, 1998, D570 ASTM; ASTM (American Society for Testing and Materials), 2006, D6110 ASTM; Beachy G, 2004, J ATHL TRAINING, V39, P310; Craig R G, 1967, J Mich State Dent Assoc, V49, P34; Craig RG, 2002, J ORAL REHABIL, V29, P146, DOI 10.1046/j.1365-2842.2002.00831.x; Duhaime CF, 2006, DENT TRAUMATOL, V22, P186, DOI 10.1111/j.1600-9657.2006.00360.x; GODWIN WC, 1968, J AM DENT ASSOC, V77, P1316, DOI 10.14219/jada.archive.1968.0363; GOING RE, 1974, J AM DENT ASSOC, V89, P132, DOI 10.14219/jada.archive.1974.0354; Gould TE, 2007, MAT SPORTS EQUIPMENT, V2; Greasley A, 1998, BRIT J SPORT MED, V32, P17, DOI 10.1136/bjsm.32.1.17; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Low D, 2002, DENT MATER, V18, P211, DOI 10.1016/S0109-5641(01)00084-7; Meng FH, 2007, DENT MATER, V23, P1492, DOI 10.1016/j.dental.2007.01.006; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Senyurt AF, 2007, MACROMOLECULES, V40, P4901, DOI 10.1021/ma062534b; Senyurt AF, 2007, MACROMOLECULES, V40, P3174, DOI 10.1021/ma0626463; Seymour RB, 1981, POLYM CHEM INTRO; *STAND AUSTR INT, 2003, 2092003 HB STAND AUS; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Tran D, 2001, DENT TRAUMATOL, V17, P260, DOI 10.1034/j.1600-9657.2001.170604.x; Warnet L, 2001, BRIT J SPORT MED, V35, P257, DOI 10.1136/bjsm.35.4.257; Westman F, 2002, IEEE CIRCUITS DEVICE, V18, P7, DOI 10.1109/MCD.2002.1175754; Winters JE, 2001, J ATHL TRAINING, V36, P339; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	30	29	30	1	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	JUN	2009	25	6					771	780		10.1016/j.dental.2008.12.005			10	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	450VI	WOS:000266428800011	19195697				2021-06-18	
J	Radolovich, DK; Czosnyka, M; Timofeev, I; Lavinio, A; Hutchinson, P; Gupta, A; Pickard, JD; Smielewski, P				Radolovich, Danila K.; Czosnyka, Marek; Timofeev, Ivan; Lavinio, Andrea; Hutchinson, Peter; Gupta, Arun; Pickard, John D.; Smielewski, Peter			Reactivity of Brain Tissue Oxygen to Change in Cerebral Perfusion Pressure in Head Injured Patients	NEUROCRITICAL CARE			English	Article						Brain tissue oxygen; Autoregulation; Cerebral perfusion pressure; Head injury	CEREBROVASCULAR AUTOREGULATION; BLOOD-FLOW; LICOX	It has been reported recently that correlation between brain tissue oxygen (PbtO(2)) and cerebral perfusion pressure (CPP) may serve as an indicator of cerebral autoregulation after subarachnoid hemorrhage. We aimed to compare similar indices describing interaction between changes in intracranial pressure (ICP), arterial blood pressure (ABP), and brain tissue oxygen to verify their clinical utility in patients after traumatic brain injury. Retrospective analysis of multimodal monitoring of 32 patients suffering from head injury, admitted in the Neurosciences Critical Care Unit, Addenbrooke's Hospital, Cambridge, UK. Initial 24 h intervals of continuous ABP, ICP, and PbtO(2) recordings were analyzed. Index of tissue oxygen reactivity ORx was evaluated as the correlation coefficient between PbtO(2) and CPP over a period of 60 min and compared to the index of pressure reactivity PRx. "Optimal CPP" and a hypothetical "optimal PbtO(2)" were defined as the ranges of CPP and PbtO(2) at which PRx or ORx were indicating best cerebrovascular milieu. PRx and ORx mean values did not show any correlation with each other (R = 0.012; P = 0.95) between patients. There was also no correlation between ORx and PbtO(2) (R = 0.098; P = 0.61) and between PRx and PbtO(2) (R = 0.019; P = 0.923). No clear and consistent value of "optimal CPP" minimizing ORx or of hypothetical "optimal PbtO(2)" were found analyzing PbtO(2) or ORx trend over the 24 h of monitoring. However, in most of patients 'optimal CPP' has been found for PRx index. The same has been confirmed when the data from whole monitoring period were analyzed. There was no correlation between values of 'optimal CPP' assessed using ORx and 'optimal CPP' assessed with PRx. The relationships between PbtO(2), ORx, and CPP in head injury appear less useful than reported before for patients after subarachnoid hemorrhage.	[Radolovich, Danila K.; Czosnyka, Marek; Timofeev, Ivan; Lavinio, Andrea; Hutchinson, Peter; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Radolovich, Danila K.] Univ Pavia, Dept Anaesthesiol & Intens Care, I-27100 Pavia, Italy; [Lavinio, Andrea; Gupta, Arun] Addenbrookes Hosp, Dept Anaesthesiol, Cambridge, England	Radolovich, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Dept Clin Neurosci, POB 167, Cambridge CB2 2QQ, England.	dkr22@cam.ac.uk	Timofeev, Ivan/AAE-7019-2019; Lavinio, Andrea/M-1778-2016	Smielewski, Peter/0000-0001-5096-3938; Timofeev, Ivan/0000-0002-1168-0393	National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G9439390, G0600986, G0001237] Funding Source: Medline		Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Valadka AB, 2002, ACT NEUR S, V81, P299	16	29	29	1	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2009	10	3					274	279		10.1007/s12028-009-9190-3			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	449KG	WOS:000266328900004	19184551				2021-06-18	
J	Duchnick, JJ; Letsch, EA; Curtiss, G				Duchnick, Jennifer J.; Letsch, Elizabeth A.; Curtiss, Glenn			Coping Effectiveness Training During Acute Rehabilitation of Spinal Cord Injury/Dysfunction: A Randomized Clinical Trial	REHABILITATION PSYCHOLOGY			English	Article						SCI; group therapy; anxiety; depression; emotional adjustment; randomized clinical trial	TRAUMATIC BRAIN-INJURY; LONGITUDINAL ANALYSIS; DEPRESSION; INTERVENTION; ANXIETY; SCALE; DISABILITY; ADJUSTMENT; STRATEGIES; ACCEPTANCE	Purpose: To compare coping effectiveness training (CET) with supportive group therapy (SGT) for anxiety, depression, and adjustment to injury in an acute spinal cord injury/dysfunction (SCI/D) rehabilitation population. CET was shown to result in decreased anxiety and depression symptoms when compared to historical no-treatment control groups (Kennedy, Duff, Evans, & Beedie, 2003; King & Kennedy, 1999). The present study sought to extend those findings with a comparison of CET to an alternative active therapy condition, SGT. Research Method: Participants (N = 40) entering a hospital-based program were assigned to treatment condition using block randomization. Questionnaire mood measures were completed at program admission, program discharge, and 3-month postdischarge follow-up. Adjustment to disability was assessed at follow-up only. Analyses of variance tested for group differences in anxiety, depression, and adjustment to injury. Results: Both groups reported reductions in mood symptoms with no differences between treatment conditions. However, similar reductions were obtained after fewer sessions of CET. Symptoms of depression increased in both groups following hospital discharge. Conclusions: Clinical and research implications, including innovative interventions during the period after discharge, are discussed.	[Duchnick, Jennifer J.; Letsch, Elizabeth A.; Curtiss, Glenn] James A Haley Vet Affairs Med Ctr, Tampa, FL 33612 USA; [Curtiss, Glenn] Univ S Florida, Dept Psychiat & Behav Sci, Tampa, FL USA	Duchnick, JJ (corresponding author), James A Haley Vet Affairs Med Ctr, Psychol 116B,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Jennifer.Duchnick@va.gov	Curtiss, Glenn/ABB-5566-2020				*AM SPIN INJ ASS I, 2000, INT STAND NEUR CLASS; BECK AT, 1979, COGNITIVE THERAPY DE; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; BOEKAMP JR, 1998, DISS ABSTR INT B, V59, P2412; Botella C, 2004, J CLIN PSYCHOL, V60, P821, DOI 10.1002/jclp.20040; Bowers J E, 1987, Rehabil Nurs, V12, P313; BUCKELEW SP, 1991, PARAPLEGIA, V29, P125, DOI 10.1038/sc.1991.17; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chesney MA, 2003, PSYCHOSOM MED, V65, P1038, DOI 10.1097/01.PSY.0000097344.78697.ED; CIMPERMAN A, 1974, REHABIL PSYCHOL, V21, P44; CRAIG AR, 1994, PARAPLEGIA, V32, P675, DOI 10.1038/sc.1994.109; Craig AR, 1997, ARCH PHYS MED REHAB, V78, P33, DOI 10.1016/S0003-9993(97)90006-X; DEVIVO MJ, 1991, PARAPLEGIA, V29, P620, DOI 10.1038/sc.1991.91; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2004, REHABIL PSYCHOL, V49, P134, DOI 10.1037/0090-5550.49.2.134; Elliott TR, 1999, REHABIL PSYCHOL, V44, P315, DOI 10.1037/0090-5550.44.4.315; ELLIOTT TR, 1996, ARCH PHYS MED REHAB, V47, P131; Folkman S., 1991, SOCIAL CONTEXT COPIN, P239, DOI DOI 10.1007/978-1-4899-3740-7; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; FOW NR, 1995, J APPL REHABILITATIO, V26, P30; Groomes DAG, 2007, J REHABIL, V73, P3; HANCOCK K, 1993, AUST NZ J PSYCHIAT, V27, P450, DOI 10.3109/00048679309075802; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; HOLAHAN CJ, 1995, HEALTH PSYCHOL, V14, P152, DOI 10.1037/0278-6133.14.2.152; Hufford BJ, 1999, REHABIL PSYCHOL, V44, P176, DOI 10.1037/0090-5550.44.2.176; Kennedy P, 2005, J CLIN PSYCHOL MED S, V12, P93, DOI 10.1007/s10880-005-0917-9; Kennedy P, 2000, BRIT J HEALTH PSYCH, V5, P157, DOI 10.1348/135910700168838; Kennedy P, 2003, BRIT J CLIN PSYCHOL, V42, P41, DOI 10.1348/014466503762842002; KENNEDY P, 2001, COPING EFFECTIVELY S; King C, 1999, BRIT J CLIN PSYCHOL, V38, P5, DOI 10.1348/014466599162629; Kirk R. E., 1995, EXPT DESIGN PROCEDUR; KISHI Y, 1994, J NEUROPSYCH CLIN N, V6, P237; KISHI Y, 1995, J NERV MENT DIS, V183, P286, DOI 10.1097/00005053-199505000-00002; Lazarus R.S., 1984, STRESS APPRAISAL COP; LINKOWSKI DC, 1971, REHABIL COUNS BULL, V14, P236; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; LIVNEH H, 2000, J APPL REHABILITATIO, V32, P3; MACDONALD MR, 1987, ARCH PHYS MED REHAB, V68, P339; MACLEOD AD, 1988, PARAPLEGIA, V26, P340, DOI 10.1038/sc.1988.48; MCAWEENEY MJ, 1997, SCI PSYCHOSOCIAL PRO, V10, P58; Miller WC, 2008, SPINAL CORD, V46, P287, DOI 10.1038/sj.sc.3102127; PEARSON ES, 1951, BIOMETRIKA, V38, P112, DOI 10.1093/biomet/38.1-2.112; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RICHARDS JS, 1986, ARCH PHYS MED REHAB, V67, P362; RINTALA DH, 1994, REHABIL PSYCHOL, V39, P15, DOI 10.1037/h0080311; Saravay SM, 1996, AM J PSYCHIAT, V153, P397; Spielberger CD, 1983, STATE TRAIT ANXIETY; Stanley MA, 2005, COGN BEHAV PRACT, V12, P424, DOI 10.1016/S1077-7229(05)80070-7; Verdier-Taillefer MH, 2001, NEUROEPIDEMIOLOGY, V20, P262, DOI 10.1159/000054800; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337	51	29	30	1	12	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2009	54	2					123	132		10.1037/a0015571			10	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	448HP	WOS:000266254000001	19469601				2021-06-18	
J	Mihalik, JP; Ondrak, KS; Guskiewicz, KA; McMurray, RG				Mihalik, Jason P.; Ondrak, Kristin S.; Guskiewicz, Kevin A.; McMurray, Robert G.			The effects of menstrual cycle phase on clinical measures of concussion in healthy college-aged females	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Athletic injuries; Cerebral concussion; Menstrual cycle; Neuropsychological tests; Postural balance; Traumatic brain injuries	SPORTS-RELATED CONCUSSION; IMPACT; SYMPTOMS; INJURIES; WOMEN	The management of concussion and mild traumatic brain injury is an area of clinical uncertainty for many sports medicine professionals. While recent Studies suggest sex differences in neurocognitive function may exist, our understanding of the effects of menstrual cycle phase and oral contraceptive pill (OCP) use in healthy females is limited. The purpose of this study was to investigate whether there were changes in neurocognitive function, postural stability and self-reported symptoms between the early and late stages of the menstrual cycle, and also to identify whether performance across menstrual cycle would differ between females using OCP and eumenorrheic females not using OCP. Healthy college-aged females completed a standard concussion test battery including computerised assessment of neurocognitive function, Postural stability and symptom status. Participants completed the counterbalanced testing design during the early and late phases of their menstrual cycle. No significant main effects or interactions for any neurocognitive function or postural stability Outcome measure were observed. Eumenorrheic females endorsed a higher number of symptoms and reported an increased symptom severity score compared to females using OCP. Menstrual cycle phase had no effect oil the total severity or the number of symptoms endorsed. These results suggest preseason neurocognitive and postural stability baseline tests are stable across the menstrual cycle, regardless Of OCP use. Therefore, decreased performance on these measures following a Suspected concussion is likely not attributable to menstrual cycle phase or use of OCP. (c) 2008 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[McMurray, Robert G.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Human Movement Sci, Chapel Hill, NC 27599 USA	McMurray, RG (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Gymnasium,South Rd, Chapel Hill, NC 27599 USA.	exphys@email.unc.edu	Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130			Abraham S, 2003, J PSYCHOSOM OBST GYN, V24, P185, DOI 10.3109/01674820309039672; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Friden C, 2003, GYNECOL ENDOCRINOL, V17, P433, DOI 10.1080/09513590312331290358; GARRETT K F, 1984, International Journal of Psychophysiology, V1, P209, DOI 10.1016/0167-8760(84)90039-4; GORDON HW, 1993, PSYCHONEUROENDOCRINO, V18, P521, DOI 10.1016/0306-4530(93)90045-M; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HAMPSON E, 1990, PSYCHONEUROENDOCRINO, V15, P97, DOI 10.1016/0306-4530(90)90018-5; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; MIHALIK JP, 2004, BRIT J SPORT MED, V38, P661; MOLLERNIELSEN J, 1989, MED SCI SPORT EXER, V21, P126; Morgan M, 1996, OBSTET GYNECOL, V88, P961, DOI 10.1016/S0029-7844(96)00362-6; Myklebust G, 1998, SCAND J MED SCI SPOR, V8, P149, DOI 10.1111/j.1600-0838.1998.tb00185.x; Ross C, 2003, J PSYCHOSOM OBST GYN, V24, P15, DOI 10.3109/01674820309042797; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Symonds CS, 2004, PSYCHOL MED, V34, P93, DOI 10.1017/S0033291703008535	22	29	29	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2009	12	3					383	387		10.1016/j.jsams.2008.05.003			5	Sport Sciences	Sport Sciences	448IN	WOS:000266256400009	18771954				2021-06-18	
J	Adelson, PD				Adelson, P. David			Hypothermia following Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	2nd International Brain Hypothermia Symposium	OCT, 2007	Miami Beach, FL			children; clinical trial; hypothermia; pediatric; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; INTRACRANIAL-PRESSURE; CARDIAC-ARREST; PHASE-II; CHILDREN; METABOLISM; OUTCOMES	Preclinical as well as clinical studies in traumatic brain injury (TBI) have established the likely association of secondary injury and outcome in adults in children following severe injury. Similarly, there is growing evidence in experimental laboratory studies that moderate hypothermia has a beneficial effect on outcome, though the exact mechanisms remain to be absolutely defined. The Pediatric TBI Guidelines provided the knowledge and background for standard management of children following severe TBI and highlighted that there are very few clinical studies to date. In particular with respect to temperature regulation and the use of hypothermia, initial findings of case series of small numbers were promising. Further preliminary randomized clinical trials, both single institution and multicenter, have provided the initial data on safety and efficacy, though larger, Phase III studies are necessary to ensure both the safety and efficacy of hypothermia in pediatric TBI prior to implementation as part of the standard of care. It is expected that hypothermia initiated early after severe TBI will have a protective effect on the pediatric brain and can be done safely, but this still remains to be definitively tested.	Phoenix Childrens Hosp, Childrens Neurosci Inst, Phoenix, AZ 85016 USA	Adelson, PD (corresponding author), Phoenix Childrens Hosp, Childrens Neurosci Inst, 1919 E Thomas Rd Bldg B,4th Floor, Phoenix, AZ 85016 USA.	dadelson@phoenixchildrens.com	Adelson, David/W-2083-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042298, U01NS052478] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS052478, U01 NS052478-01A2, R01 NS42298, R01 NS052478] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ADELSON PD, 1996, J NEUROTRAUM, V13, P607; ADELSON PD, 1995, J NEUROTRAUM, V12, P984; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Bayir H, 2003, CRIT CARE MED, V31, pA92; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BIJUR PE, 1990, PEDIATRICS, V86, P337; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; *BRAIN TRUAM FDN, 2007, J NEUROTRAUMA S, V24; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Bruce DA, 1996, J NEUROSURG, V84, P726; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Choi SC, 1998, J NEUROTRAUM, V15, P771, DOI 10.1089/neu.1998.15.771; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COHADON F, 1991, J NEUROL SCI, V103, pS27; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DRAKE CG, 1962, CAN MED ASSOC J, V87, P887; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Gruszkiewicz J, 1973, Surg Neurol, V1, P197; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KLONOFF H, 1977, J TRAUMA, V63, P1271; Kochanek Patrick M, 2005, Curr Treat Options Neurol, V7, P441, DOI 10.1007/s11940-005-0044-9; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; KRAUS JF, 1987, HEAD INJURY, P1; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; Shafi NI, 2006, PEDIATR CRIT CARE ME, V7, P468, DOI 10.1097/01.PCC.0000235258.79253.8C; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHORE PM, 2003, PEDIATR CRIT CARE ME, V4, pA143; SIESJO BK, 1985, CENTRAL NERVOUS SYST, P513; Strachan R D, 1989, Brain Inj, V3, P51, DOI 10.3109/02699058909008073; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Teasdale G, 1991, J Neurotrauma, V8 Suppl 1, pS53; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	70	29	30	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2009	26	3					429	436		10.1089/neu.2008.0571			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	420ZO	WOS:000264327900018	19271965	Green Published, Green Accepted			2021-06-18	
J	Ruff, R				Ruff, Ronald			Best Practice Guidelines for Forensic Neuropsychological Examinations of Patients With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						forensic neuropsychology; guidelines; traumatic brain injury		Forensic examiners generally agree that their contributions to the forensic process have to be based on scientific principles, high ethical values, and sound clinical skills and judgment. In part I, the challenges of maintaining high ethical standards as a scientist-practitioner are addressed. In part II, the scientific strengths and weaknesses of our neuropsychological assessments are explored within the context of the 4 articles published in this issue. Specifically, Wood points out that while most traumatic brain injuries (TBIs) compromise the prefrontal cortex (PFC), traditional neuropsychological examinations do not fully capture to what extent PFC damage disrupts cognitive, emotional, and social regulation. New advances in clinical neuroscience are presented to facilitate a more detailed understanding of PFC functioning. Schwarz et al examine how clinical neuropsychology services can adequately handle forensic consultations. Frederick and Bowden, meanwhile, identify the persistent weaknesses of various Symptom Validity Tests in reliably classifying poor effort and malingering. Bailey et al conclude that the findings from sport concussion studies cannot be generalized to clinical populations, who, as a rule, have more premorbid and comorbid vulnerabilities. Finally, part III provides guidelines based on the introductory article by Bigler and Brooks, as well as a synopsis of the main conclusions offered by the contributors in this journal issue. Guidelines for both the diagnosis of mild TBI and the diagnosis of postconcussional disorder are included.	[Ruff, Ronald] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Ruff, R (corresponding author), 909 Hyde St, San Francisco, CA 94109 USA.	ronruff@mindspring.com					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aronson E., 1969, ADV EXPT SOCIAL PSYC, V4, P1, DOI [DOI 10.1016/S0065-2601(08)60075-1, 10.1016/S0065-2601(08)60075-1]; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Festinger L., 1957, THEORY COGNITIVE DIS; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Green P., 1996, WORD MEMORY TEST USE; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Hegel G. W. F., 1967, PHENOMENOLOGY MIND; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; HOWIESON DB, 1993, NEUROLOGY, V43, P1882, DOI 10.1212/WNL.43.10.1882; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; KOSS E, 1991, DEV NEUROPSYCHOL, V7, P99, DOI 10.1080/87565649109540479; MARKOWITSCH HJ, 2003, HDB CLIN NEUROPSYCHO; McCrea M, 2008, MILD TRAUMATIC BRAIN; MILNER B, 1970, BIOL MEMORY; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUFF RM, ARCH CLIN N IN PRESS; Seidenberg M, 1998, NEUROPSYCHOLOGY, V12, P303, DOI 10.1037/0894-4105.12.2.303; SQUIRE LR, 1987, MEMORY BRAIN; SWEET JJ, 1999, J FORENSIC NEUROPSYC, V1, P73; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; *WHO, 2003, MULT PRES ICD 10 US; Wood RL, 2009, J HEAD TRAUMA REHAB, V24, P88, DOI 10.1097/HTR.0b013e31819b118a	33	29	30	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2009	24	2					131	140		10.1097/01.HTR.0000348755.42649.e9			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	427WF	WOS:000264809100007	19333068				2021-06-18	
J	Mate, M; Janos, F; David, N; Gabriella, R; Zsolt, K; Laszlo, V; Jozsef, T; Ruban-Matuzani, A; Teichberg, VI; Farkas, T				Mate Marosi; Janos Fuzik; David Nagy; Gabriella Rakos; Zsolt Kis; Laszlo Vecsei; Jozsef Toldi; Ruban-Matuzani, Angela; Teichberg, Vivian I.; Farkas, Tamas			Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Glutamate neurotoxicity; Hypoperfusion; 2-vessel occlusion; Oxaloacetate; Glutamate-scavenging; LTP	D-ASPARTATE RECEPTOR; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; TYROSINE PHOSPHORYLATION; GLUTAMATE TRANSPORTERS; CEREBROSPINAL-FLUID; GERBIL HIPPOCAMPUS; CEREBRAL-ISCHEMIA; ARTERY OCCLUSION	Various acute brain pathological conditions are characterized by the presence of elevated glutamate concentrations in the brain interstitial fluids. It has been established that a decrease in the blood glutamate level enhances the brain-to-blood efflux of glutamate, removal of which from the brain may prevent glutamate excitotoxicity and its contribution to the long-lasting neurological deficits seen in stroke. A decrease in blood glutamate level can be achieved by exploiting the glutamate-scavenging properties of the blood-resident enzyme glutamate-oxaloacetate transaminase, which transforms glutamate into 2-ketoglutarate in the presence of the glutamate co-substrate oxaloacetate. The present study had the aim of an evaluation of the effects of the blood glutamate scavenger oxaloacetate on the impaired long-term potentiation (LTP) induced in the 2-vessel occlusion ischaemic model in rat. Transient (30-min) incomplete forebrain ischaemia was produced 72 h before LTP induction. Although the short transient brain hypoperfusion did not induce histologically identifiable injuries in the CA1 region (Fluoro-jade B, S-100 and cresyl violet), it resulted in an impaired LTP function in the hippocampal CA1 region without damaging the basal synaptic transmission between the Schaffer collaterals and the pyramidal neurons. This impairment could be fended off in a dose-dependent manner by the intravenous administration of oxaloacetate in saline (at doses between 1.5 mmol and 0.1 mu mol) immediately after the transient hypoperfusion. Our results suggest that oxaloacetate-mediated blood and brain glutamate scavenging contributes to the restoration of the LTP after its impairment by brain ischaemia. (C) 2008 Elsevier B.V. All rights reserved.	[Mate Marosi; Janos Fuzik; David Nagy; Gabriella Rakos; Zsolt Kis; Jozsef Toldi; Farkas, Tamas] Univ Szeged, Dept Physiol Anat & Neurosci, H-6726 Szeged, Hungary; [Laszlo Vecsei] Univ Szeged, Dept Neurol, H-6701 Szeged, Hungary; [Ruban-Matuzani, Angela; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Jozsef, T (corresponding author), Univ Szeged, Dept Physiol Anat & Neurosci, Kozep Fasor 52, H-6726 Szeged, Hungary.	toldi@bio.u-szeged.hu	Kis, Zsolt/A-4583-2009; Vecsei, Laszlo/B-2066-2010; Marosi, Mate/B-1807-2009; Farkas, Tamas/B-7193-2008; Toldi, Jozsef/M-4858-2018	Kis, Zsolt/0000-0002-6896-5883; Vecsei, Laszlo/0000-0001-8037-3672; Toldi, Jozsef/0000-0001-7355-0503; Ruban, Angela/0000-0003-1091-8854	Hungarian National Bureau of Research and DevelopmentNational Office for Research and Technology [NKTH RET 08/2004];  [OTKA K 75628];  [GVOP-3.2.1-2004-04-0357/3.0]	This work was supported by the Hungarian National Bureau of Research and Development (NKTH RET 08/2004). OTKA K 75628 and GVOP-3.2.1-2004-04-0357/3.0. T.F. was a Bolyai Fellow of the Hungarian Academy of Sciences.	Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; Bi RF, 2000, J BIOL CHEM, V275, P26477, DOI 10.1074/jbc.M003763200; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen XM, 1999, J CLIN INVEST, V103, P1159, DOI 10.1172/JCI5392; Cheung HH, 2003, J NEUROCHEM, V86, P1441, DOI 10.1046/j.1471-4159.2003.01951.x; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 2000, J Stroke Cerebrovasc Dis, V9, P2, DOI 10.1053/jscd.2000.18908; DREWES LR, 1977, AM J PHYSIOL, V233, pE320; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Martinez G, 1998, INT J DEV NEUROSCI, V16, P519, DOI 10.1016/S0736-5748(98)00035-5; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; MITANI A, 1992, NEUROSCIENCE, V48, P307, DOI 10.1016/0306-4522(92)90492-K; Mori K, 1998, BRAIN RES, V795, P221, DOI 10.1016/S0006-8993(98)00295-9; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; OLDENDORF WH, 1976, AM J PHYSIOL, V230, P94; Pei L, 2000, ACTA PHARMACOL SIN, V21, P695; Rao VLR, 2000, NEUROCHEM INT, V36, P531, DOI 10.1016/S0197-0186(99)00153-9; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sas K, 2008, NEUROBIOL DIS, V32, P302, DOI 10.1016/j.nbd.2008.07.013; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; TODD NV, 1984, STROKE, V15, P579, DOI 10.1161/str.15.3.579a; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wahl AS, 2009, NEUROSCIENCE, V158, P344, DOI 10.1016/j.neuroscience.2008.06.018; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zalewska T, 2005, BRAIN RES, V1042, P214, DOI 10.1016/j.brainres.2005.02.025; ZIOTNIK A, 2008, NEUROCHEM RES, V33, P1044; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	55	29	29	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 14	2009	604	1-3					51	57		10.1016/j.ejphar.2008.12.022			7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	412XE	WOS:000263756700007	19135048				2021-06-18	
